Citrus Sinensis ID: 002616
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 900 | 2.2.26 [Sep-21-2011] | |||||||
| Q559T8 | 2102 | Probable serine/threonine | yes | no | 0.364 | 0.156 | 0.525 | 1e-102 | |
| Q60592 | 1734 | Microtubule-associated se | yes | no | 0.358 | 0.186 | 0.473 | 1e-84 | |
| Q6P0Q8 | 1798 | Microtubule-associated se | yes | no | 0.345 | 0.172 | 0.480 | 2e-84 | |
| Q6AX33 | 1482 | Microtubule-associated se | N/A | no | 0.337 | 0.205 | 0.481 | 6e-83 | |
| Q3U214 | 1321 | Microtubule-associated se | no | no | 0.337 | 0.230 | 0.484 | 2e-82 | |
| O15021 | 2626 | Microtubule-associated se | no | no | 0.337 | 0.115 | 0.471 | 4e-82 | |
| Q9Y2H9 | 1570 | Microtubule-associated se | no | no | 0.398 | 0.228 | 0.433 | 4e-82 | |
| Q811L6 | 2618 | Microtubule-associated se | no | no | 0.358 | 0.123 | 0.462 | 7e-82 | |
| O60307 | 1309 | Microtubule-associated se | no | no | 0.337 | 0.232 | 0.481 | 8e-82 | |
| Q9R1L5 | 1570 | Microtubule-associated se | no | no | 0.387 | 0.222 | 0.436 | 2e-81 |
| >sp|Q559T8|Y0701_DICDI Probable serine/threonine-protein kinase DDB_G0272282 OS=Dictyostelium discoideum GN=DDB_G0272282 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 372 bits (954), Expect = e-102, Method: Compositional matrix adjust.
Identities = 197/375 (52%), Positives = 241/375 (64%), Gaps = 47/375 (12%)
Query: 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 553
I DFEIIKPISRGAFGRV+LA+K+ TGDL+AIKVLKKLD IRKN + ++ ERNIL V+
Sbjct: 1524 IADFEIIKPISRGAFGRVYLAQKKKTGDLYAIKVLKKLDTIRKNMVNHVIVERNILAMVQ 1583
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 613
N FVV+ FY+F D LYLVMEYL GGD SLLR +GC EE +A+ YIAE VL LEYLH
Sbjct: 1584 NEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHYIAETVLCLEYLHK 1643
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI-------------NNTIDLSGPETDG 660
IVHRDLKPDN+LI GHIKLTDFGLSKIG+I N + S T+
Sbjct: 1644 SAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIGIIDDKKMEDSGNTNTNTHFNFSTSPTNT 1703
Query: 661 IMPSDAH-----------------------YPEYQQT----DNRNRHSAVGTPDYLAPEI 693
M D+ YP+ + T + VGTPDYL+PEI
Sbjct: 1704 SMMDDSSTTGNPNGNGNTSLNSSQTNILSPYPQRKNTLKTPLKKPVKKVVGTPDYLSPEI 1763
Query: 694 LLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL--NRKIPWPCVPSDMSFE 751
LLGT HG DWW++GIIL+EF+TG PPF ++PE+IF +IL +R++ W P ++S E
Sbjct: 1764 LLGTGHGQTVDWWALGIILYEFLTGSPPFNDDTPELIFQHILHRDREMEW---PEEISSE 1820
Query: 752 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKA--VFVPQPESVDDTSY 809
A+DLI + L DP +RLGANGA EVK HPFF VNWD+L Q+ +F+P+PE+ DT Y
Sbjct: 1821 AKDLILKLLNPDPYKRLGANGAYEVKTHPFFANVNWDTLIDQEMDNIFLPKPENNYDTDY 1880
Query: 810 FLSRFSQISSGLPDD 824
F R S DD
Sbjct: 1881 FWDRQSMYDDEAEDD 1895
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q60592|MAST2_MOUSE Microtubule-associated serine/threonine-protein kinase 2 OS=Mus musculus GN=Mast2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 315 bits (807), Expect = 1e-84, Method: Compositional matrix adjust.
Identities = 163/344 (47%), Positives = 219/344 (63%), Gaps = 21/344 (6%)
Query: 472 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 531
DSV + GVS P + E +DFE IK IS GA+G VFL R ++T FA+K + K
Sbjct: 433 DSV-EGRGVSQPSQKTPSE----EDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQ 487
Query: 532 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 591
++I +N I++ ER+IL NPFVV F SF + +L +VMEY+ GGD +LL+ +G
Sbjct: 488 NLILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA 547
Query: 592 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651
L D+ R+Y AE VLALEYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T
Sbjct: 548 LPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 607
Query: 652 DLSGPETDGIMPSDAHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVG 709
+L Y + + D R GTP+Y+APE++L +G DWW++G
Sbjct: 608 NL--------------YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMG 653
Query: 710 IILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 769
IIL+EF+ G PF ++PE +F +++ +I WP + +AQDL ++ L +P +RLG
Sbjct: 654 IILYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDDALPPDAQDLTSKLLHQNPLERLG 713
Query: 770 ANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSR 813
+ A EVK HPFF G++W L QKA F+PQ ES DDTSYF +R
Sbjct: 714 TSSAYEVKQHPFFMGLDWTGLLRQKAEFIPQLESEDDTSYFDTR 757
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6P0Q8|MAST2_HUMAN Microtubule-associated serine/threonine-protein kinase 2 OS=Homo sapiens GN=MAST2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 314 bits (805), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 157/327 (48%), Positives = 211/327 (64%), Gaps = 16/327 (4%)
Query: 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 548
K+ S +DFE IK IS GA+G VFL R ++T FA+K + K ++I +N I++ ER+I
Sbjct: 504 KKTPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQNLILRNQIQQAFVERDI 563
Query: 549 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 608
L NPFVV F SF + +L +VMEY+ GGD +LL+ +G L D+ R+Y AE VLAL
Sbjct: 564 LTFAENPFVVSMFCSFDTKRHLCMVMEYVEGGDCATLLKNIGALPVDMVRLYFAETVLAL 623
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
EYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T +L Y
Sbjct: 624 EYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL--------------Y 669
Query: 669 PEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 726
+ + D R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++
Sbjct: 670 EGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT 729
Query: 727 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786
PE +F +++ +I WP + +AQDL ++ L +P +RLG A EVK HPFF G++
Sbjct: 730 PEELFGQVISDEIVWPEGDEALPPDAQDLTSKLLHQNPLERLGTGSAYEVKQHPFFTGLD 789
Query: 787 WDSLALQKAVFVPQPESVDDTSYFLSR 813
W L QKA F+PQ ES DDTSYF +R
Sbjct: 790 WTGLLRQKAEFIPQLESEDDTSYFDTR 816
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6AX33|MAST3_XENLA Microtubule-associated serine/threonine-protein kinase 3 OS=Xenopus laevis GN=mast3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 309 bits (792), Expect = 6e-83, Method: Compositional matrix adjust.
Identities = 154/320 (48%), Positives = 205/320 (64%), Gaps = 16/320 (5%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
DFE IK IS GA+G V+L R + T FA+K + K ++I +N I ++ ER+IL NP
Sbjct: 398 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIHQVFVERDILTFAENP 457
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 615
FVV F SF R +L +VMEY+ GGD +LL+ +G L D++R+Y AE VLALEYLH+ G
Sbjct: 458 FVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMSRMYFAETVLALEYLHNYG 517
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
IVHRDLKPDNLLI GHIKLTDFGLSK+GL+N T +L Y + + D
Sbjct: 518 IVHRDLKPDNLLITSLGHIKLTDFGLSKVGLMNMTTNL--------------YEGHIEKD 563
Query: 676 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733
R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F
Sbjct: 564 TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 623
Query: 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 793
+++ I WP + ++QDLI R L + +RLG GA EVK H FF ++W+ L Q
Sbjct: 624 VISDDIIWPGGEEALPADSQDLITRLLRQNSLERLGTGGAQEVKQHTFFLSLDWNGLLRQ 683
Query: 794 KAVFVPQPESVDDTSYFLSR 813
KA FVPQ E+ DDTSYF +R
Sbjct: 684 KAEFVPQLEADDDTSYFDTR 703
|
Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3U214|MAST3_MOUSE Microtubule-associated serine/threonine-protein kinase 3 OS=Mus musculus GN=Mast3 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 308 bits (788), Expect = 2e-82, Method: Compositional matrix adjust.
Identities = 155/320 (48%), Positives = 202/320 (63%), Gaps = 16/320 (5%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
DFE IK IS GA+G V+L R R T FAIK + K ++I +N I+++ ER+IL NP
Sbjct: 388 DFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVERDILTFAENP 447
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 615
FVV F SF R +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 448 FVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARMYFAETVLALEYLHNYG 507
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
IVHRDLKPDNLLI GHIKLTDFGLSKIGL++ +L Y + + D
Sbjct: 508 IVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNL--------------YEGHIEKD 553
Query: 676 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733
R GTP+Y+APE++ +G DWW++G+IL+EF+ G PF ++PE +F
Sbjct: 554 AREFVDKQVCGTPEYIAPEVIFRQGYGKPVDWWAMGVILYEFLVGCVPFFGDTPEELFGQ 613
Query: 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 793
+++ +I WP + +AQDLI R L P RLG G EVK HPFF ++W L
Sbjct: 614 VVSDEIMWPEGDEALPLDAQDLITRLLRQSPMDRLGTGGTHEVKQHPFFLALDWAGLLRH 673
Query: 794 KAVFVPQPESVDDTSYFLSR 813
KA FVPQ E+ DDTSYF +R
Sbjct: 674 KAEFVPQLEAEDDTSYFDTR 693
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O15021|MAST4_HUMAN Microtubule-associated serine/threonine-protein kinase 4 OS=Homo sapiens GN=MAST4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 306 bits (785), Expect = 4e-82, Method: Compositional matrix adjust.
Identities = 151/320 (47%), Positives = 206/320 (64%), Gaps = 16/320 (5%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
DFE IK IS GA+G V+ R + + FA+K + K ++I +N I++ ER+IL NP
Sbjct: 572 DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENP 631
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 615
FVV + SF R +L +VMEY+ GGD +L++ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 632 FVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGPLPVDMARMYFAETVLALEYLHNYG 691
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
IVHRDLKPDNLL+ GHIKLTDFGLSK+GL++ T +L Y + + D
Sbjct: 692 IVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTTNL--------------YEGHIEKD 737
Query: 676 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733
R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F
Sbjct: 738 AREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 797
Query: 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 793
+++ +I WP +AQDLI L +P +RLG GA EVK H FF+ ++W+SL Q
Sbjct: 798 VISDEINWPEKDEAPPPDAQDLITLLLRQNPLERLGTGGAYEVKQHRFFRSLDWNSLLRQ 857
Query: 794 KAVFVPQPESVDDTSYFLSR 813
KA F+PQ ES DDTSYF +R
Sbjct: 858 KAEFIPQLESEDDTSYFDTR 877
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9Y2H9|MAST1_HUMAN Microtubule-associated serine/threonine-protein kinase 1 OS=Homo sapiens GN=MAST1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 306 bits (785), Expect = 4e-82, Method: Compositional matrix adjust.
Identities = 169/390 (43%), Positives = 230/390 (58%), Gaps = 31/390 (7%)
Query: 486 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 545
S K+ +DF+ IK IS GA+G V+L R R T FA+K + K ++I +N I++ E
Sbjct: 363 SKAKKPPGENDFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRNQIQQAFVE 422
Query: 546 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 605
R+IL NPFVV F SF R +L +VMEY+ GGD +LL+ +G L ++AR+Y AE V
Sbjct: 423 RDILTFAENPFVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAETV 482
Query: 606 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 665
LALEYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSK+GL++ T +L
Sbjct: 483 LALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNL------------ 530
Query: 666 AHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 723
Y + + D R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF
Sbjct: 531 --YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFF 588
Query: 724 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
++PE +F +++ I WP + EAQ LI+ L +P RLGA GA EVK H FF+
Sbjct: 589 GDTPEELFGQVISDDILWPEGDEALPTEAQLLISSLLQTNPLVRLGAGGAFEVKQHSFFR 648
Query: 784 GVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRT 843
++W L QKA F+P ES DDTSYF +R + SY + DT +
Sbjct: 649 DLDWTGLLRQKAEFIPHLESEDDTSYFDTRSDRY------HHVNSYDEDDTTE------- 695
Query: 844 EMDECGDLAEFGSCPLDLSLINFSFKNLSQ 873
+E ++ +F SC S + S + LSQ
Sbjct: 696 --EEPVEIRQFSSCSPRFSKVYSSMEQLSQ 723
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q811L6|MAST4_MOUSE Microtubule-associated serine/threonine-protein kinase 4 OS=Mus musculus GN=Mast4 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 306 bits (783), Expect = 7e-82, Method: Compositional matrix adjust.
Identities = 159/344 (46%), Positives = 217/344 (63%), Gaps = 21/344 (6%)
Query: 472 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 531
+SVS S+ T L K R S DFE IK IS GA+G V+ R + + FA+K + K
Sbjct: 548 ESVSSSN---TSLRLRRKPRES--DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQ 602
Query: 532 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 591
++I +N I++ ER+IL NPFVV + SF R +L +VMEY+ GGD +L++ +G
Sbjct: 603 NLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGP 662
Query: 592 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651
L D+AR+Y AE VLALEYLH+ GIVHRDLKPDNLL+ GHIKLTDFGLSK+GL++ T
Sbjct: 663 LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTT 722
Query: 652 DLSGPETDGIMPSDAHYPEYQQTDNRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVG 709
+L Y + + D R GTP+Y+APE++L +G DWW++G
Sbjct: 723 NL--------------YEGHIEKDAREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMG 768
Query: 710 IILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 769
IIL+EF+ G PF ++PE +F +++ +I WP +AQ+LI L +P +RLG
Sbjct: 769 IILYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPPDAQELITLLLRQNPLERLG 828
Query: 770 ANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSR 813
GA EVK H FF+ ++W+SL QKA F+PQ ES DDTSYF +R
Sbjct: 829 TGGAYEVKQHRFFRSLDWNSLLRQKAEFIPQLESEDDTSYFDTR 872
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O60307|MAST3_HUMAN Microtubule-associated serine/threonine-protein kinase 3 OS=Homo sapiens GN=MAST3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 305 bits (782), Expect = 8e-82, Method: Compositional matrix adjust.
Identities = 154/320 (48%), Positives = 202/320 (63%), Gaps = 16/320 (5%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
DFE IK IS GA+G V+L R R T FAIK + K ++I +N I+++ ER+IL NP
Sbjct: 366 DFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVERDILTFAENP 425
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 615
FVV F SF R +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 426 FVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARLYFAETVLALEYLHNYG 485
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
IVHRDLKPDNLLI GHIKLTDFGLSKIGL++ +L Y + + D
Sbjct: 486 IVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNL--------------YEGHIEKD 531
Query: 676 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733
R GTP+Y+APE++ +G DWW++G++L+EF+ G PF ++PE +F
Sbjct: 532 AREFIDKQVCGTPEYIAPEVIFRQGYGKPVDWWAMGVVLYEFLVGCVPFFGDTPEELFGQ 591
Query: 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 793
+++ +I WP + +AQDLI R L P RLG G EVK HPFF ++W L
Sbjct: 592 VVSDEIMWPEGDEALPADAQDLITRLLRQSPLDRLGTGGTHEVKQHPFFLALDWAGLLRH 651
Query: 794 KAVFVPQPESVDDTSYFLSR 813
KA FVPQ E+ DDTSYF +R
Sbjct: 652 KAEFVPQLEAEDDTSYFDTR 671
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9R1L5|MAST1_MOUSE Microtubule-associated serine/threonine-protein kinase 1 OS=Mus musculus GN=Mast1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 304 bits (779), Expect = 2e-81, Method: Compositional matrix adjust.
Identities = 166/380 (43%), Positives = 226/380 (59%), Gaps = 31/380 (8%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
DF+ IK IS GA+G V+L R R T FA+K + K ++I +N I++ ER+IL NP
Sbjct: 375 DFDTIKLISNGAYGAVYLVRHRDTRQRFAMKKINKQNLILRNQIQQAFVERDILTFAENP 434
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 615
FVV F SF R +L +VMEY+ GGD +LL+ +G L ++AR+Y AE VLALEYLH+ G
Sbjct: 435 FVVGMFCSFETRRHLCMVMEYVEGGDCATLLKNIGALPVEMARMYFAETVLALEYLHNYG 494
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
IVHRDLKPDNLLI GHIKLTDFGLSK+GL++ T +L Y + + D
Sbjct: 495 IVHRDLKPDNLLITSMGHIKLTDFGLSKMGLMSLTTNL--------------YEGHIEKD 540
Query: 676 NRN--RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733
R GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F
Sbjct: 541 AREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 600
Query: 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 793
+++ I WP + +AQ LI+ L +P RLGA GA EVK H FF+ ++W L Q
Sbjct: 601 VISDDILWPEGDEALPTDAQLLISSLLQTNPLVRLGAGGAFEVKQHSFFRDLDWTGLLRQ 660
Query: 794 KAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAE 853
KA F+P ES DDTSYF +R + SY + DT + +E ++ +
Sbjct: 661 KAEFIPHLESEDDTSYFDTRSDRY------HHVNSYDEDDTTE---------EEPVEIRQ 705
Query: 854 FGSCPLDLSLINFSFKNLSQ 873
F SC S + S + LSQ
Sbjct: 706 FSSCSPRFSKVYSSMEQLSQ 725
|
Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 900 | ||||||
| 255538590 | 1106 | kinase, putative [Ricinus communis] gi|2 | 0.993 | 0.808 | 0.731 | 0.0 | |
| 359492673 | 1109 | PREDICTED: uncharacterized protein LOC10 | 0.995 | 0.807 | 0.727 | 0.0 | |
| 302142471 | 948 | unnamed protein product [Vitis vinifera] | 0.761 | 0.722 | 0.761 | 0.0 | |
| 145324180 | 1067 | protein kinase-like protein [Arabidopsis | 0.966 | 0.815 | 0.618 | 0.0 | |
| 7767670 | 1092 | F27F5.23 [Arabidopsis thaliana] | 0.966 | 0.796 | 0.601 | 0.0 | |
| 297852258 | 1101 | predicted protein [Arabidopsis lyrata su | 0.967 | 0.791 | 0.598 | 0.0 | |
| 145336472 | 1042 | protein kinase-like protein [Arabidopsis | 0.905 | 0.782 | 0.623 | 0.0 | |
| 110740013 | 1042 | similar to IRE homolog 1 [Arabidopsis th | 0.905 | 0.782 | 0.622 | 0.0 | |
| 168060390 | 1073 | predicted protein [Physcomitrella patens | 0.986 | 0.827 | 0.470 | 0.0 | |
| 356529485 | 1395 | PREDICTED: uncharacterized protein LOC10 | 0.976 | 0.630 | 0.487 | 0.0 |
| >gi|255538590|ref|XP_002510360.1| kinase, putative [Ricinus communis] gi|223551061|gb|EEF52547.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1328 bits (3437), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 667/912 (73%), Positives = 751/912 (82%), Gaps = 18/912 (1%)
Query: 1 MNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVK 60
M+VLE +DS E +M EDLLILAQ C+EM FR CE IVQDLTEKR QCQ GLVK
Sbjct: 193 MDVLEIIDSSLQEELKMAEDLLILAQLCMEMACSQFRLKCEIIVQDLTEKRLQCQTGLVK 252
Query: 61 WLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPGTAESDLD 120
WL TRMLFILTRCTRLL FQK++EPI EKSL K KKCLESVP+V+ SWV + ++DLD
Sbjct: 253 WLYTRMLFILTRCTRLLQFQKDTEPIDEKSLRKLKKCLESVPSVDMSWVANHVIDDTDLD 312
Query: 121 YASYQKANAKKKISGQQKVSTVPEISDCSCSESLDH---TSENKSVFIEQNFPPQKSQHY 177
A QK + K+K+ GQ +S++PE C ES D TS S+ EQ QKS++
Sbjct: 313 DALNQKGDIKRKLQGQNNLSSLPEAVCCGSQESDDQSGVTSGKDSLDFEQKLSCQKSRNE 372
Query: 178 SRMQEQQ------------SHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVV 225
S + +Q + + + K S EQ + LDGSD VICRICEE+V
Sbjct: 373 SLFEVRQFCETDKSAISNSVNNSSCSLHDQEKFLDDSLQEQERVLDGSDLVICRICEEIV 432
Query: 226 PISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPENSRTQ 285
PISHLESHSYICAYADKC+LNCLDVDERL L+E+LEQI ES N + H GSPENSR Q
Sbjct: 433 PISHLESHSYICAYADKCDLNCLDVDERLSNLAEMLEQIVESRNMNVHQSHGSPENSRPQ 492
Query: 286 SMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLKLSGYG 345
+ NSA T + SPKISEWRNKGVEGMFEDIHEMDTA IDDSHL +NL+GHLG+KL YG
Sbjct: 493 NANSATT-EACSPKISEWRNKGVEGMFEDIHEMDTAFIDDSHLPPVNLKGHLGMKLCNYG 551
Query: 346 ASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEG 405
A SSTGSMTS+SSTNTPKAGHFD FWLE N+P+ELEDV QMI LADIAR VA+TD SKEG
Sbjct: 552 APSSTGSMTSLSSTNTPKAGHFDSFWLEHNNPSELEDVPQMINLADIARSVANTDLSKEG 611
Query: 406 S-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYK 464
S EFLLACM DLQDVLQHSKLKALVIDTFG RIEKLLREKY+LAC++ D KSP S SK K
Sbjct: 612 SYEFLLACMQDLQDVLQHSKLKALVIDTFGGRIEKLLREKYLLACDITDAKSPKSDSKLK 671
Query: 465 ENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFA 524
ENSRL+LD+ SQSS +STP+HSSHKERTSIDDFEIIKPISRGAFG+VFLARKR TGDLFA
Sbjct: 672 ENSRLLLDNASQSSAMSTPVHSSHKERTSIDDFEIIKPISRGAFGKVFLARKRITGDLFA 731
Query: 525 IKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYS 584
IKVLKKLDM+RKND++RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYS
Sbjct: 732 IKVLKKLDMLRKNDVQRILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYS 791
Query: 585 LLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644
LLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN+LIAHDGHIKLTDFGLSKI
Sbjct: 792 LLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNILIAHDGHIKLTDFGLSKI 851
Query: 645 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 704
GLIN+T+DL+GPET+ SDAH P + QT+ NR SAVGTPDYLAPEILLGTEHGYAAD
Sbjct: 852 GLINSTMDLAGPETNEDEVSDAHNP-HIQTEETNRQSAVGTPDYLAPEILLGTEHGYAAD 910
Query: 705 WWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDP 764
WWSVGIILFE ITGIPPFTAE PEIIFDNILNRKIPWP VP MS+EAQDLINR + +DP
Sbjct: 911 WWSVGIILFELITGIPPFTAERPEIIFDNILNRKIPWPPVPESMSYEAQDLINRLITYDP 970
Query: 765 NQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDD 824
+QRLG+NG+AEVK++PFF+G++WD+LALQKAVFVP P+S DDTSYF+SRFSQ+SSG+P+D
Sbjct: 971 DQRLGSNGSAEVKSYPFFRGIDWDNLALQKAVFVPSPDSADDTSYFVSRFSQMSSGMPND 1030
Query: 825 QNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASINHEVLVQ 884
+ S+SD D DSS NS EMDECGDLAEF S PL+LSLINFSFKNLSQLASINH+V +Q
Sbjct: 1031 CSSSHSDTDAYDSSPNSGVEMDECGDLAEFDSSPLNLSLINFSFKNLSQLASINHDVYLQ 1090
Query: 885 NVKDSTRSSPAK 896
KDS ++SP++
Sbjct: 1091 TGKDSAKNSPSR 1102
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492673|ref|XP_002282958.2| PREDICTED: uncharacterized protein LOC100259179 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1278 bits (3306), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 660/907 (72%), Positives = 740/907 (81%), Gaps = 11/907 (1%)
Query: 1 MNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVK 60
M+ L++ DS S G++M E LLILAQQC+EMT FR CETIVQ LTEKRQ CQ +K
Sbjct: 207 MDALQRNDS--SPGQKMAEGLLILAQQCMEMTPSEFRIKCETIVQGLTEKRQHCQTAFLK 264
Query: 61 WLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPGTAESDLD 120
WL TRMLFILTRCTRLL FQK+SEPI EKSLH F KCLES+PAVE +W P +S D
Sbjct: 265 WLFTRMLFILTRCTRLLRFQKDSEPIDEKSLHNFTKCLESIPAVEMNWAPYSRIVDSGSD 324
Query: 121 YASYQKANAKKKISGQQKVSTVPEISDCSCSESLDH---TSENKSVFIEQNFPPQKSQHY 177
Y S K++AK ++ + +VS++ E + C E D TS S+ + Q Q SQ
Sbjct: 325 YDSNGKSDAKHELQWRNRVSSLLEQTWCRSEEPADKSGITSRKDSMVLVQKPLSQNSQID 384
Query: 178 SRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYIC 237
+Q G+ + + GS HE + LDGSDSVICRICEE VP SHLESHSYIC
Sbjct: 385 FLPHIEQDGDYPGKSMNSFED--GSLHEPERGLDGSDSVICRICEENVPTSHLESHSYIC 442
Query: 238 AYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPENSRTQSMNSAITYDGYS 297
AYADKC+L LD+DERL KL+EILEQI ES N + SPENSR Q NSA+ +G S
Sbjct: 443 AYADKCDLKYLDIDERLSKLAEILEQIIESRNLNFQASFCSPENSRMQITNSAVISEGCS 502
Query: 298 PKISEWRNKGVEGMFEDIHEMDTACIDDSHLGS-LNLRGHLGLKLSGYGASSSTGSMTSV 356
PKISEWRNKGVEGMFED+HEMDTACIDDS+L + LNL+GH G KLS YGA SSTGSMTS+
Sbjct: 503 PKISEWRNKGVEGMFEDLHEMDTACIDDSYLTNPLNLKGHWGTKLSQYGAPSSTGSMTSM 562
Query: 357 SSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGS-EFLLACMHD 415
SSTNTP+AGHFD FWLE N+P++LEDVQQM +LADIARCVA TD SKEGS +FLLACM D
Sbjct: 563 SSTNTPRAGHFDLFWLEHNNPSKLEDVQQMADLADIARCVAGTDLSKEGSCDFLLACMED 622
Query: 416 LQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVS 475
LQDVLQ++KLK+LVIDTFG RIE LLREKYILACEL D KSP S ++ KE+SRL+ D+ S
Sbjct: 623 LQDVLQNTKLKSLVIDTFGGRIENLLREKYILACELADTKSPKSDNRIKESSRLLFDNAS 682
Query: 476 QSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR 535
SS +STPLH HKERTSIDDFEIIKPISRGAFG+VFLARKRTTGDLFAIKVLKKLDMIR
Sbjct: 683 HSSTMSTPLHPLHKERTSIDDFEIIKPISRGAFGKVFLARKRTTGDLFAIKVLKKLDMIR 742
Query: 536 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 595
KNDIERILAERNILITVRNPFVVRFFYSFTCRDN+YLVMEYLNGGDLYSLLRK+GCLEED
Sbjct: 743 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNVYLVMEYLNGGDLYSLLRKLGCLEED 802
Query: 596 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655
VARIYIAELVLALEYLHSLGIVHRDLKPDN+LIAHDGHIKLTDFGLSKIGLIN+T+DLSG
Sbjct: 803 VARIYIAELVLALEYLHSLGIVHRDLKPDNILIAHDGHIKLTDFGLSKIGLINSTVDLSG 862
Query: 656 PETDGIMPS--DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 713
PETDG + D+ QQTD+R+R SAVGTPDYLAPEILLGTEHGYAADWWSVGIILF
Sbjct: 863 PETDGSTDAFLDSLNLHTQQTDDRHRQSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 922
Query: 714 EFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 773
E ITG+PPFTAE PEIIFDNILNRKIPWP VP DMS+EAQDLINRFLIHDP+ RLGANG
Sbjct: 923 ELITGVPPFTAEHPEIIFDNILNRKIPWPSVPGDMSYEAQDLINRFLIHDPDLRLGANGL 982
Query: 774 AEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDAD 833
+EVK HPFFKGVNWD+LALQKAVFVPQP+S DDTSYF+SR+SQI SGLPD+Q+ S S D
Sbjct: 983 SEVKTHPFFKGVNWDTLALQKAVFVPQPDSADDTSYFVSRYSQIPSGLPDEQDCSDSATD 1042
Query: 834 TCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASINHEVLVQNVKDSTRSS 893
+ D SNS EMDECGDLAEF S PL+LSLINFSFKNLSQLASIN++VL+Q KD T+ S
Sbjct: 1043 SSDLYSNSGLEMDECGDLAEFDSSPLNLSLINFSFKNLSQLASINYDVLLQTGKDPTKCS 1102
Query: 894 PAKDAGT 900
P+K T
Sbjct: 1103 PSKSRDT 1109
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|302142471|emb|CBI19674.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1072 bits (2773), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 555/729 (76%), Positives = 607/729 (83%), Gaps = 44/729 (6%)
Query: 184 QSHIVEGRIVEVTKSNCGSPHEQGQSL-------DGSDSVICRICEEVVPISHLESHSYI 236
Q IV GR++ N E G L DGSDSVICRICEE VP SHLESHSYI
Sbjct: 252 QIMIVMGRVM----PNMNYSGETGYLLSLSKLGADGSDSVICRICEENVPTSHLESHSYI 307
Query: 237 CAYADKCELNCLDVDERLLKLSEILEQISES-CNSSSHPILGSPENSRTQSMNSAITYDG 295
CAYADKC+L LD+DERL KL+EILEQI ES C
Sbjct: 308 CAYADKCDLKYLDIDERLSKLAEILEQIIESRC--------------------------- 340
Query: 296 YSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLGS-LNLRGHLGLKLSGYGASSSTGSMT 354
SPKISEWRNKGVEGMFED+HEMDTACIDDS+L + LNL+GH G KLS YGA SSTGSMT
Sbjct: 341 -SPKISEWRNKGVEGMFEDLHEMDTACIDDSYLTNPLNLKGHWGTKLSQYGAPSSTGSMT 399
Query: 355 SVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGS-EFLLACM 413
S+SSTNTP+AGHFD FWLE N+P++LEDVQQM +LADIARCVA TD SKEGS +FLLACM
Sbjct: 400 SMSSTNTPRAGHFDLFWLEHNNPSKLEDVQQMADLADIARCVAGTDLSKEGSCDFLLACM 459
Query: 414 HDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDS 473
DLQDVLQ++KLK+LVIDTFG RIE LLREKYILACEL D KSP S ++ KE+SRL+ D+
Sbjct: 460 EDLQDVLQNTKLKSLVIDTFGGRIENLLREKYILACELADTKSPKSDNRIKESSRLLFDN 519
Query: 474 VSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM 533
S SS +STPLH HKERTSIDDFEIIKPISRGAFG+VFLARKRTTGDLFAIKVLKKLDM
Sbjct: 520 ASHSSTMSTPLHPLHKERTSIDDFEIIKPISRGAFGKVFLARKRTTGDLFAIKVLKKLDM 579
Query: 534 IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 593
IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN+YLVMEYLNGGDLYSLLRK+GCLE
Sbjct: 580 IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNVYLVMEYLNGGDLYSLLRKLGCLE 639
Query: 594 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653
EDVARIYIAELVLALEYLHSLGIVHRDLKPDN+LIAHDGHIKLTDFGLSKIGLIN+T+DL
Sbjct: 640 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNILIAHDGHIKLTDFGLSKIGLINSTVDL 699
Query: 654 SGPETDGIMPS--DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 711
SGPETDG + D+ QQTD+R+R SAVGTPDYLAPEILLGTEHGYAADWWSVGII
Sbjct: 700 SGPETDGSTDAFLDSLNLHTQQTDDRHRQSAVGTPDYLAPEILLGTEHGYAADWWSVGII 759
Query: 712 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 771
LFE ITG+PPFTAE PEIIFDNILNRKIPWP VP DMS+EAQDLINRFLIHDP+ RLGAN
Sbjct: 760 LFELITGVPPFTAEHPEIIFDNILNRKIPWPSVPGDMSYEAQDLINRFLIHDPDLRLGAN 819
Query: 772 GAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSD 831
G +EVK HPFFKGVNWD+LALQKAVFVPQP+S DDTSYF+SR+SQI SGLPD+Q+ S S
Sbjct: 820 GLSEVKTHPFFKGVNWDTLALQKAVFVPQPDSADDTSYFVSRYSQIPSGLPDEQDCSDSA 879
Query: 832 ADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASINHEVLVQNVKDSTR 891
D+ D SNS EMDECGDLAEF S PL+LSLINFSFKNLSQLASIN++VL+Q KD T+
Sbjct: 880 TDSSDLYSNSGLEMDECGDLAEFDSSPLNLSLINFSFKNLSQLASINYDVLLQTGKDPTK 939
Query: 892 SSPAKDAGT 900
SP+K T
Sbjct: 940 CSPSKSRDT 948
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145324180|ref|NP_001077679.1| protein kinase-like protein [Arabidopsis thaliana] gi|332193965|gb|AEE32086.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1056 bits (2730), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 559/904 (61%), Positives = 679/904 (75%), Gaps = 34/904 (3%)
Query: 3 VLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWL 62
+EKMD E +EM E LL +A+ C+EMTS RA CE+IVQDLT KR+QCQ GLVKWL
Sbjct: 192 AMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCESIVQDLTRKRKQCQAGLVKWL 251
Query: 63 STRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPGTAESDLDYA 122
+++LFILT CTR+++FQKE+EPI E S KFK+CLE +PA+ET W +P +S Y
Sbjct: 252 FSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIPALETDWGSTPRVDDSGSGYP 311
Query: 123 SYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSENKSVFIEQNFPPQKSQHYSRM 180
YQ+ A +K + K S E + ++ ++ + +Q FP + Q S++
Sbjct: 312 EYQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAAREGYAAAKQEFPSHEPQFDSKV 371
Query: 181 QEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYA 240
EQ+ ++ + E SN E G+ L GSD VICRICEE VP+ HLE HSYICAYA
Sbjct: 372 VEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRICEEEVPLFHLEPHSYICAYA 424
Query: 241 DKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPENSRTQSMNSAITYDGYSPKI 300
DKCE+NC+DVDERLLKL EILEQI +S + +S G ENS + S + +G SPKI
Sbjct: 425 DKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLENSVLR--KSGVASEGCSPKI 482
Query: 301 SEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLKLSGYGASSSTGSMTSVSSTN 360
+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K + SSSTGS+TSVSSTN
Sbjct: 483 NEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAKFCHHATSSSTGSITSVSSTN 542
Query: 361 TPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGS-EFLLACMHDLQDV 419
TP+ HFD +WLER+ P E ED++ M++L+DIARC A TDFSKEGS ++++ACM D+Q V
Sbjct: 543 TPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTDFSKEGSCDYIMACMQDIQAV 601
Query: 420 LQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSG 479
L+ KLKALVIDTFG RIEKLL EKY+ A EL +KS K E+ +L+ S +
Sbjct: 602 LKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVGNIKESED---VLEHASATPQ 658
Query: 480 VSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI 539
+ K+R SIDDFEIIKPISRGAFG+VFLARKRTTGD FAIKVLKKLDMIRKNDI
Sbjct: 659 LLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTTGDFFAIKVLKKLDMIRKNDI 712
Query: 540 ERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI 599
ERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLNGGDLYSLL+KVGCL+E++ARI
Sbjct: 713 ERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLNGGDLYSLLQKVGCLDEEIARI 772
Query: 600 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659
YIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDFGLSKIGLINNTIDLSG E+D
Sbjct: 773 YIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDFGLSKIGLINNTIDLSGHESD 832
Query: 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 719
+++H+ + Q + R RHSAVGTPDYLAPEILLGTEHGYAADWWS GI+LFE +TGI
Sbjct: 833 VSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEHGYAADWWSAGIVLFELLTGI 892
Query: 720 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779
PPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR L+H+P +RLGANGAAEVK+H
Sbjct: 893 PPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEVKSH 952
Query: 780 PFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSS 839
PFF+GV+W++LALQKA FVPQPES++DTSYF+SRFS+ S + N S S+ D+ D
Sbjct: 953 PFFQGVDWENLALQKAAFVPQPESINDTSYFVSRFSESSCSDTETGNNSGSNPDSGD--- 1009
Query: 840 NSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASINHEVLVQNVKDSTRS---SPAK 896
E+DEC +L +F S P LSLINFSFKNLSQLASINH+VL+Q KD + SP K
Sbjct: 1010 ----ELDECTNLEKFDSPPYYLSLINFSFKNLSQLASINHDVLLQ--KDPAKGGGDSPFK 1063
Query: 897 DAGT 900
GT
Sbjct: 1064 SHGT 1067
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7767670|gb|AAF69167.1|AC007915_19 F27F5.23 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1038 bits (2683), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 559/929 (60%), Positives = 679/929 (73%), Gaps = 59/929 (6%)
Query: 3 VLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWL 62
+EKMD E +EM E LL +A+ C+EMTS RA CE+IVQDLT KR+QCQ GLVKWL
Sbjct: 192 AMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCESIVQDLTRKRKQCQAGLVKWL 251
Query: 63 STRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPGTAESDLDYA 122
+++LFILT CTR+++FQKE+EPI E S KFK+CLE +PA+ET W +P +S Y
Sbjct: 252 FSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIPALETDWGSTPRVDDSGSGYP 311
Query: 123 SYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSENKSVFIEQNFPPQKSQHYSRM 180
YQ+ A +K + K S E + ++ ++ + +Q FP + Q S++
Sbjct: 312 EYQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAAREGYAAAKQEFPSHEPQFDSKV 371
Query: 181 QEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYA 240
EQ+ ++ + E SN E G+ L GSD VICRICEE VP+ HLE HSYICAYA
Sbjct: 372 VEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRICEEEVPLFHLEPHSYICAYA 424
Query: 241 DKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPENSRTQSMNSAITYDGYSPKI 300
DKCE+NC+DVDERLLKL EILEQI +S + +S G ENS + S + +G SPKI
Sbjct: 425 DKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLENSVLR--KSGVASEGCSPKI 482
Query: 301 SEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLKLSGYGASSSTGSMTSVSSTN 360
+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K + SSSTGS+TSVSSTN
Sbjct: 483 NEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAKFCHHATSSSTGSITSVSSTN 542
Query: 361 TPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGS-EFLLACMHDLQDV 419
TP+ HFD +WLER+ P E ED++ M++L+DIARC A TDFSKEGS ++++ACM D+Q V
Sbjct: 543 TPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTDFSKEGSCDYIMACMQDIQAV 601
Query: 420 LQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSG 479
L+ KLKALVIDTFG RIEKLL EKY+ A EL +KS K E+ +L+ S +
Sbjct: 602 LKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVGNIKESED---VLEHASATPQ 658
Query: 480 VSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI 539
+ K+R SIDDFEIIKPISRGAFG+VFLARKRTTGD FAIKVLKKLDMIRKNDI
Sbjct: 659 LLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTTGDFFAIKVLKKLDMIRKNDI 712
Query: 540 ERILAERNILITVRNPFV---------VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 590
ERIL ERNILITVR PF+ VRFFYSFTCRDNLYLVMEYLNGGDLYSLL+KVG
Sbjct: 713 ERILQERNILITVRYPFLAEHLMLLMQVRFFYSFTCRDNLYLVMEYLNGGDLYSLLQKVG 772
Query: 591 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650
CL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDFGLSKIGLINNT
Sbjct: 773 CLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDFGLSKIGLINNT 832
Query: 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG---------- 700
IDLSG E+D +++H+ + Q + R RHSAVGTPDYLAPEILLGTEHG
Sbjct: 833 IDLSGHESDVSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEHGLDTTFKSGFH 892
Query: 701 ------YAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQD 754
YAADWWS GI+LFE +TGIPPFTA PE IFDNILN K+PWP VP +MS+EAQD
Sbjct: 893 EAPVNCYAADWWSAGIVLFELLTGIPPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQD 952
Query: 755 LINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRF 814
LINR L+H+P +RLGANGAAEVK+HPFF+GV+W++LALQKA FVPQPES++DTSYF+SRF
Sbjct: 953 LINRLLVHEPEKRLGANGAAEVKSHPFFQGVDWENLALQKAAFVPQPESINDTSYFVSRF 1012
Query: 815 SQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQL 874
S+ S + N S S+ D+ D E+DEC +L +F S P LSLINFSFKNLSQL
Sbjct: 1013 SESSCSDTETGNNSGSNPDSGD-------ELDECTNLEKFDSPPYYLSLINFSFKNLSQL 1065
Query: 875 ASINHEVLVQNVKDSTRS---SPAKDAGT 900
ASINH+VL+Q KD + SP K GT
Sbjct: 1066 ASINHDVLLQ--KDPAKGGGDSPFKSHGT 1092
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297852258|ref|XP_002894010.1| predicted protein [Arabidopsis lyrata subsp. lyrata] gi|297339852|gb|EFH70269.1| predicted protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1036 bits (2680), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 561/937 (59%), Positives = 677/937 (72%), Gaps = 66/937 (7%)
Query: 3 VLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWL 62
+EKMD P E +EM E+LL +A+ C+EMTS RA CE+IV DLT KR+QCQ GLVKWL
Sbjct: 192 AMEKMDPPCPEDREMAEELLDVARACMEMTSAQLRATCESIVHDLTRKRKQCQAGLVKWL 251
Query: 63 STRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPGTAESDLDYA 122
+++LFILT CTR+++FQKE+EPI E S KFK+CLE +PA+ET W +P +S Y
Sbjct: 252 FSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIPALETDWGSTPRVDDSGSGYP 311
Query: 123 SYQKANAKKKISGQQKVSTVPEIS---DCSCSESLDHTSENKSVFIEQNFPPQKSQHYSR 179
YQ+ A +K ++ S E + S + +E +V +Q FP Q+ Q S+
Sbjct: 312 KYQRDEAGQKFKRRETESLESETTFDYVIPNDHSNNAATEGYAV-AKQEFPSQEPQFDSK 370
Query: 180 MQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAY 239
+ +Q+ ++ + E P ++ L SD VICRICEE VP+SHLE HSYICAY
Sbjct: 371 VVQQRFYLSD----EYEHKMLNEPVKE---LGRSDYVICRICEEEVPLSHLEPHSYICAY 423
Query: 240 ADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPENSRTQSMNSAITYDGYSPK 299
ADKCE+NCLDVDERLLKL EILEQI +S + +S G ENS + S + +G SPK
Sbjct: 424 ADKCEINCLDVDERLLKLEEILEQIIDSRSLNSFTQAGGLENSVLR--KSGVASEGCSPK 481
Query: 300 ISEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLKLSGYGASSSTGSMTSVSST 359
I+EWRNKG+EGMFED+HEMDTA ID+S+ +NL+ H+G K+ + SSSTGS+TSVSST
Sbjct: 482 INEWRNKGLEGMFEDLHEMDTAFIDESYTYPINLKSHVGAKICHHATSSSTGSITSVSST 541
Query: 360 NTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGS-EFLLACMHDLQD 418
NTP+ HFD +WLER+ P E ED+Q M++L+DIARC A TD SKEGS ++++ACM D+Q
Sbjct: 542 NTPRTSHFDSYWLERHCP-EQEDLQLMMDLSDIARCGASTDLSKEGSCDYIMACMQDIQA 600
Query: 419 VLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSS 478
VL+ KLKALVIDTFG RIEKLL EKY+ A EL +KS K E+ +L+ S +
Sbjct: 601 VLKQGKLKALVIDTFGGRIEKLLCEKYLYARELTADKSSVGNVKESED---VLEHASATP 657
Query: 479 GVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND 538
+ K+R SIDDFEIIKPISRGAFG+VFLARKRTTGD FAIKVLKKLDMIRKND
Sbjct: 658 QLLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTTGDFFAIKVLKKLDMIRKND 711
Query: 539 IERILAERNILITVRNPFV---------VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV 589
IERIL ERNILITVR PF+ VRFFYSFTCRDNLYLVMEYLNGGDLYSLL+KV
Sbjct: 712 IERILQERNILITVRYPFLAEHLILLMQVRFFYSFTCRDNLYLVMEYLNGGDLYSLLQKV 771
Query: 590 GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649
GCL+E++ARIYIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDFGLSKIGLINN
Sbjct: 772 GCLDEEIARIYIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDFGLSKIGLINN 831
Query: 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---------- 699
TIDLSG E+D + +H+ + Q + R RHSAVGTPDYLAPEILLGTEH
Sbjct: 832 TIDLSGHESDVSPRTGSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEHGLDTTLYLGF 891
Query: 700 --------------GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVP 745
GYA+DWWSVGI+LFE ITGIPPFTA PEIIFDNILN K+PWP VP
Sbjct: 892 SEAIGNYIQLLGLAGYASDWWSVGIVLFELITGIPPFTAARPEIIFDNILNGKMPWPDVP 951
Query: 746 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVD 805
+MS+EAQDLINR L+H+P +RLGANGAAEVK+HPFF+GV+WD+LALQKA FVPQPES+
Sbjct: 952 GEMSYEAQDLINRLLVHEPEKRLGANGAAEVKSHPFFQGVDWDNLALQKAAFVPQPESIA 1011
Query: 806 DTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLIN 865
DTSYF+SRF + S+ + N S S D+ D E+DEC +L +F S P LSLIN
Sbjct: 1012 DTSYFVSRFCENSASDSETDNNSGSFPDSGD-------ELDECTNLEKFDSPPYYLSLIN 1064
Query: 866 FSFKNLSQLASINHEVLVQN--VKDSTRSSPAKDAGT 900
FSFKNLSQLASINH+VL+Q K SP K GT
Sbjct: 1065 FSFKNLSQLASINHDVLLQKDPAKGGGGDSPFKSHGT 1101
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|145336472|ref|NP_175130.2| protein kinase-like protein [Arabidopsis thaliana] gi|332193964|gb|AEE32085.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1001 bits (2588), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 522/837 (62%), Positives = 636/837 (75%), Gaps = 22/837 (2%)
Query: 3 VLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWL 62
+EKMD E +EM E LL +A+ C+EMTS RA CE+IVQDLT KR+QCQ GLVKWL
Sbjct: 192 AMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCESIVQDLTRKRKQCQAGLVKWL 251
Query: 63 STRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPGTAESDLDYA 122
+++LFILT CTR+++FQKE+EPI E S KFK+CLE +PA+ET W +P +S Y
Sbjct: 252 FSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIPALETDWGSTPRVDDSGSGYP 311
Query: 123 SYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSENKSVFIEQNFPPQKSQHYSRM 180
YQ+ A +K + K S E + ++ ++ + +Q FP + Q S++
Sbjct: 312 EYQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAAREGYAAAKQEFPSHEPQFDSKV 371
Query: 181 QEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYA 240
EQ+ ++ + E SN E G+ L GSD VICRICEE VP+ HLE HSYICAYA
Sbjct: 372 VEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRICEEEVPLFHLEPHSYICAYA 424
Query: 241 DKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPENSRTQSMNSAITYDGYSPKI 300
DKCE+NC+DVDERLLKL EILEQI +S + +S G ENS + S + +G SPKI
Sbjct: 425 DKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLENSVLR--KSGVASEGCSPKI 482
Query: 301 SEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLKLSGYGASSSTGSMTSVSSTN 360
+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K + SSSTGS+TSVSSTN
Sbjct: 483 NEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAKFCHHATSSSTGSITSVSSTN 542
Query: 361 TPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGS-EFLLACMHDLQDV 419
TP+ HFD +WLER+ P E ED++ M++L+DIARC A TDFSKEGS ++++ACM D+Q V
Sbjct: 543 TPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTDFSKEGSCDYIMACMQDIQAV 601
Query: 420 LQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSG 479
L+ KLKALVIDTFG RIEKLL EKY+ A EL +KS K E+ +L+ S +
Sbjct: 602 LKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVGNIKESED---VLEHASATPQ 658
Query: 480 VSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI 539
+ K+R SIDDFEIIKPISRGAFG+VFLARKRTTGD FAIKVLKKLDMIRKNDI
Sbjct: 659 LLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTTGDFFAIKVLKKLDMIRKNDI 712
Query: 540 ERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI 599
ERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLNGGDLYSLL+KVGCL+E++ARI
Sbjct: 713 ERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLNGGDLYSLLQKVGCLDEEIARI 772
Query: 600 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659
YIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDFGLSKIGLINNTIDLSG E+D
Sbjct: 773 YIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDFGLSKIGLINNTIDLSGHESD 832
Query: 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 719
+++H+ + Q + R RHSAVGTPDYLAPEILLGTEHGYAADWWS GI+LFE +TGI
Sbjct: 833 VSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEHGYAADWWSAGIVLFELLTGI 892
Query: 720 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779
PPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR L+H+P +RLGANGAAEVK+H
Sbjct: 893 PPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEVKSH 952
Query: 780 PFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCD 836
PFF+GV+W++LALQKA FVPQPES++DTSYF+SRFS+ S + N S S+ D+ D
Sbjct: 953 PFFQGVDWENLALQKAAFVPQPESINDTSYFVSRFSESSCSDTETGNNSGSNPDSGD 1009
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|110740013|dbj|BAF01910.1| similar to IRE homolog 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 997 bits (2578), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 521/837 (62%), Positives = 635/837 (75%), Gaps = 22/837 (2%)
Query: 3 VLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWL 62
+EKMD E +EM E LL +A+ C+EMTS RA CE+IVQDLT KR+QCQ GLVKWL
Sbjct: 192 AMEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCESIVQDLTRKRKQCQAGLVKWL 251
Query: 63 STRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPGTAESDLDYA 122
+++LFILT CTR+++FQKE+EPI E S KFK+CLE +PA+ET W +P +S Y
Sbjct: 252 FSQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIPALETDWGSTPRVDDSGSGYP 311
Query: 123 SYQKANAKKKISGQQKVSTVPE--ISDCSCSESLDHTSENKSVFIEQNFPPQKSQHYSRM 180
Q+ A +K + K S E + ++ ++ + +Q FP + Q S++
Sbjct: 312 ECQRNEAGQKFKRRDKESLESETALDYVVPNDHGNNAAREGYAAAKQEFPSHEPQFDSKV 371
Query: 181 QEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYA 240
EQ+ ++ + E SN E G+ L GSD VICRICEE VP+ HLE HSYICAYA
Sbjct: 372 VEQRFYLSDE--YEDKMSN-----EPGKELGGSDYVICRICEEEVPLFHLEPHSYICAYA 424
Query: 241 DKCELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPENSRTQSMNSAITYDGYSPKI 300
DKCE+NC+DVDERLLKL EILEQI +S + +S G ENS + S + +G SPKI
Sbjct: 425 DKCEINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLENSVLR--KSGVASEGCSPKI 482
Query: 301 SEWRNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLKLSGYGASSSTGSMTSVSSTN 360
+EWRNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K + SSSTGS+TSVSSTN
Sbjct: 483 NEWRNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAKFCHHATSSSTGSITSVSSTN 542
Query: 361 TPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGS-EFLLACMHDLQDV 419
TP+ HFD +WLER+ P E ED++ M++L+DIARC A TDFSKEGS ++++ACM D+Q V
Sbjct: 543 TPRTSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTDFSKEGSCDYIMACMQDIQAV 601
Query: 420 LQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSG 479
L+ KLKALVIDTFG RIEKLL EKY+ A EL +KS K E+ +L+ S +
Sbjct: 602 LKQGKLKALVIDTFGGRIEKLLCEKYLHARELTADKSSVGNIKESED---VLEHASATPQ 658
Query: 480 VSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI 539
+ K+R SIDDFEIIKPISRGAFG+VFLARKRTTGD FAIKVLKKLDMIRKNDI
Sbjct: 659 LLL------KDRISIDDFEIIKPISRGAFGKVFLARKRTTGDFFAIKVLKKLDMIRKNDI 712
Query: 540 ERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI 599
ERIL ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLNGGDLYSLL+KVGCL+E++ARI
Sbjct: 713 ERILQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLNGGDLYSLLQKVGCLDEEIARI 772
Query: 600 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659
YIAELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDFGLSKIGLINNTIDLSG E+D
Sbjct: 773 YIAELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDFGLSKIGLINNTIDLSGHESD 832
Query: 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 719
+++H+ + Q + R RHSAVGTPDYLAPEILLGTEHGYAADWWS GI+LFE +TGI
Sbjct: 833 VSPRTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEHGYAADWWSAGIVLFELLTGI 892
Query: 720 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779
PPFTA PE IFDNILN K+PWP VP +MS+EAQDLINR L+H+P +RLGANGAAEVK+H
Sbjct: 893 PPFTASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEVKSH 952
Query: 780 PFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCD 836
PFF+GV+W++LALQKA FVPQPES++DTSYF+SRFS+ S + N S S+ D+ D
Sbjct: 953 PFFQGVDWENLALQKAAFVPQPESINDTSYFVSRFSESSCSDTETGNNSGSNPDSGD 1009
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|168060390|ref|XP_001782179.1| predicted protein [Physcomitrella patens subsp. patens] gi|162666345|gb|EDQ53002.1| predicted protein [Physcomitrella patens subsp. patens] | Back alignment and taxonomy information |
|---|
Score = 810 bits (2091), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 470/998 (47%), Positives = 616/998 (61%), Gaps = 110/998 (11%)
Query: 1 MNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVK 60
+ VLE +E +EDLLILA+ C M +FR CE IVQDL +KRQ+ +G++K
Sbjct: 83 VGVLEDTTDMDPYHQERIEDLLILARDCAFMDPQVFRKECEAIVQDLDDKRQELPMGVLK 142
Query: 61 WLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKK------CLESVPAVETSWVPSPGT 114
L TRMLFILTRCTRLL F+KE+ + E LH+ ++ C+ES + SW G
Sbjct: 143 RLHTRMLFILTRCTRLLQFEKEN-GLDEVELHRLQQQAKTGSCIESWKKI-ISW-NEKGK 199
Query: 115 A------ESDLDYASYQKANAKKKISGQQKVSTVPEISDC------SCSESLDHTSENKS 162
A L +S + + K++S + +S P S S ES+ S
Sbjct: 200 ALLKVVRPQRLSLSSKPQEKSSKRVSDEVSISGTPTFSGITEQAVESDKESISKASGGSV 259
Query: 163 VFIEQNFPPQKS--QHYSRM--QEQQSHIVE-------GRIVEVTKSNC----------- 200
I +++ +H+S E +SH E G +V +T +
Sbjct: 260 SPIHSVVADRQTSWKHFSVAPPNELKSHGGESDVETEMGSVVYITPESSQLCADGGMVIS 319
Query: 201 --------------------GSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYA 240
G +Q + LD + ICRICE+ V S LE HS ICA A
Sbjct: 320 RTSEEVQRIPSSKRHQRVAWGHWTDQPEVLDDNLDFICRICEDEVATSCLEDHSRICALA 379
Query: 241 DKCELNCLDVDERLLKLSEILEQISESCNSSSHPIL--GSPENSRTQSMNSA-------- 290
D+C+ LDVD+RL +++E LE+++ES S + GSP+ ++T N+
Sbjct: 380 DRCDQQGLDVDDRLRRIAETLERMAESLTPKSFSLAAGGSPDTAKTSGSNNGGCSSDGAL 439
Query: 291 ----ITYDGYSPKI-SEWRNKGVEGMFEDIHEMDTACI--DDSHLGSLNLRGHLGLKL-- 341
ITY ++ K+ E KG E + ED +E+D A + D+ S+ + G K+
Sbjct: 440 SERCITYPTFTDKVWGELLRKGSEELLEDTYEIDAASMGDDNKKANSVTCKTRFGPKIEQ 499
Query: 342 ---------SGYGASSSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADI 392
S +SS GS+T S TP+ D +RN E++D Q+ E+ADI
Sbjct: 500 SSVPTSSPGSALAPASSAGSLTPRSPLATPRISQIDVLLSDRNGFNEIDDALQINEIADI 559
Query: 393 ARCVADTDFSKEGSEFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELL 452
ARC+A ++G+E+LL+C+ D+QD+L+++K++AL + TFG RIEKL EKY E+L
Sbjct: 560 ARCIAGASPDEDGTEYLLSCLEDVQDILRYNKVEALTVATFGKRIEKLCMEKYHKFLEIL 619
Query: 453 DEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVF 512
D S ++ +L+ + S STP+H S+K+RT+IDDFEIIKPISRGAFGRVF
Sbjct: 620 DPNGVEVASSVGDDE--LLEDDTFHSYKSTPVHPSYKDRTTIDDFEIIKPISRGAFGRVF 677
Query: 513 LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572
LARKRTTGDLFAIKVLKK DMIRKN +E + AERNILI+ RNPFVVRFFYSFTC +NLYL
Sbjct: 678 LARKRTTGDLFAIKVLKKADMIRKNAVESVKAERNILISARNPFVVRFFYSFTCAENLYL 737
Query: 573 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 632
VMEYLNGGD+YSLLR +GCL+E +AR+YIAELVLALE LHSLG+VHRDLKPDN+LIAHDG
Sbjct: 738 VMEYLNGGDMYSLLRTLGCLDEALARVYIAELVLALECLHSLGVVHRDLKPDNILIAHDG 797
Query: 633 HIKLTDFGLSKIGLINNTIDLSGPETDGIM------PSDAHYPEYQ-QTDNRNRHSAVGT 685
HIKLTDFGLS++GLIN+T DLSGP G M + P+++ Q R + SAVGT
Sbjct: 798 HIKLTDFGLSRVGLINSTDDLSGPAATGTMVMEESTKNQCASPKHEHQRKIRQQRSAVGT 857
Query: 686 PDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVP 745
PDYLAPEILLGT HG AADWWS G+ILFEF+TGIPPF AE P+++FDNILNR IPWP VP
Sbjct: 858 PDYLAPEILLGTSHGPAADWWSTGVILFEFLTGIPPFNAEHPQVVFDNILNRHIPWPAVP 917
Query: 746 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVD 805
MS+EAQDLI+R L DP +RLGANGAAEVKAHPFFK +NW++LA QKA F+P P+
Sbjct: 918 EYMSYEAQDLIDRLLTEDPTERLGANGAAEVKAHPFFKDINWETLARQKAAFIPSPDGAH 977
Query: 806 DTSYFLSRFSQISS-GLPDDQNGSYSDADTCDSSSNSRTEM----DECGDLAEF---GSC 857
DTSYF SR++ S+ G D ++ SD ++ S S S + + DE GD+AEF SC
Sbjct: 978 DTSYFSSRYAWNSNEGNFDTEHFDESDDESTCSGSTSDSALVLQTDEFGDMAEFENSSSC 1037
Query: 858 PLDLSLINFSFKNLSQLASINHEVLVQNVKDSTRSSPA 895
S NFSFKNLSQLASIN+++L Q+ + + P+
Sbjct: 1038 KYTFS--NFSFKNLSQLASINYDLLQQSERRDSPQGPS 1073
|
Source: Physcomitrella patens subsp. patens Species: Physcomitrella patens Genus: Physcomitrella Family: Funariaceae Order: Funariales Class: Bryopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356529485|ref|XP_003533321.1| PREDICTED: uncharacterized protein LOC100776995 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 805 bits (2079), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 464/952 (48%), Positives = 602/952 (63%), Gaps = 73/952 (7%)
Query: 1 MNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVK 60
+ +LEK + +E +EDLL+LA+ C +S F CE+IVQ+L ++RQ+ G++K
Sbjct: 351 VGILEKNADTHPDWQETIEDLLVLARSCAMTSSGEFWLQCESIVQELDDRRQEHPPGMLK 410
Query: 61 WLSTRMLFILTRCTRLLLFQKES-----EPI----AEKSLHKFKKCLESVPAVETSWVPS 111
L TRMLFILTRCTRLL F KES EP+ + LH K + +T
Sbjct: 411 QLHTRMLFILTRCTRLLQFHKESGLAEDEPVFNLRQSRVLHSAGKFIPPSVGRDTK---- 466
Query: 112 PGTAESDLDYASYQKANAKKKISGQQKVSTVPE----ISDCSCSESLDHTSENKSVFIEQ 167
+A L +S + + ++ + G +K PE +D ++ D +S + +
Sbjct: 467 SSSAAKALKPSSKKAFSQEQSMMGWKKDVMQPENLSIPADDDNAKLFDSSSGRNRMASWK 526
Query: 168 NFP------PQ-----KSQHYSRMQEQQSHIVEGRIVEVTKSNC--------------GS 202
FP P+ K Q+Y R++ ++ + +V S S
Sbjct: 527 KFPSPTGRSPKEAVQLKDQNYGRVESSKASNNKRFTSDVDLSTAKPSELLPVKDSLDHAS 586
Query: 203 PHE----------QGQSLDGSDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDE 252
H+ Q + +S+ICRICEE VP SH+E HS ICA AD+C+ L V+E
Sbjct: 587 KHQHKVSWGYWGDQQNNNSEENSIICRICEEDVPTSHVEDHSRICAVADRCDQKGLSVNE 646
Query: 253 RLLKLSEILEQISESCNSS-SHPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGM 311
RL+++S+ LE++ ESC + ++GSP+ ++ + + D SPK+S+W +G E M
Sbjct: 647 RLVRISDTLEKMMESCTQKDTQQMVGSPDVAKVSNSSMTEESDVPSPKLSDWSRRGSEDM 706
Query: 312 FEDIHEMDTACIDDSHLGS--LNLRGHLGLKLSGYGASSSTGSMTSVSSTNTPKAGHFDP 369
+ E D + D G ++ + G K +SS GSMT S TP+ D
Sbjct: 707 LDCFPEADNSVFMDDLKGLPLMSCKTRFGPKSDQGMTTSSAGSMTPRSPLMTPRTSQIDL 766
Query: 370 FWLERNHPAELEDVQQMIELADIARCVADTDFSKE-GSEFLLACMHDLQDVLQHSKLKAL 428
+ +E +D+ QM ELADIARCVA+ + + +LL+C+ DL+ V+ K AL
Sbjct: 767 LLAGKGAYSEHDDLPQMNELADIARCVANAPLDDDRTTSYLLSCLDDLRVVVDRRKFDAL 826
Query: 429 VIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSH 488
++TFG+RIEKL+REKY+ E++D + + S ++ ++ D V +S S P+HSS
Sbjct: 827 TVETFGTRIEKLIREKYLQLTEMVDVEKIDTESTVDDD--ILEDDVVRSLRTS-PIHSS- 882
Query: 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 548
++RTSIDDFEIIKPISRGAFGRVFLA+KRTTGDLFAIKVLKK DMIRKN +E ILAER+I
Sbjct: 883 RDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLFAIKVLKKADMIRKNAVESILAERDI 942
Query: 549 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 608
LITVRNPFVVRFFYSFTCR+NLYLVMEYLNGGDLYSLLR +GCL+E+VAR+YIAE+VLAL
Sbjct: 943 LITVRNPFVVRFFYSFTCRENLYLVMEYLNGGDLYSLLRNLGCLDEEVARVYIAEVVLAL 1002
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG--IMPSDA 666
EYLHSL +VHRDLKPDNLLIAHDGHIKLTDFGLSK+GLIN+T DLSGP +G ++ D
Sbjct: 1003 EYLHSLRVVHRDLKPDNLLIAHDGHIKLTDFGLSKVGLINSTDDLSGPAVNGTSLLEEDE 1062
Query: 667 H--YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 724
+ Q + R + SAVGTPDYLAPEILLGT HG+ ADWWSVG+ILFE + GIPPF A
Sbjct: 1063 TDVFTSADQRERREKRSAVGTPDYLAPEILLGTGHGFTADWWSVGVILFELLVGIPPFNA 1122
Query: 725 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
E P+IIFDNILNRKIPWP VP +MS EA DLI+R L DPNQRLG+ GA+EVK H FFK
Sbjct: 1123 EHPQIIFDNILNRKIPWPAVPEEMSPEALDLIDRLLTEDPNQRLGSKGASEVKQHVFFKD 1182
Query: 785 VNWDSLALQKAVFVPQPESVDDTSYFLSRFS-QISSGL--PDDQNGSYSDAD----TCDS 837
+NWD+LA QKA FVP ES DTSYF SR+S S G P SDAD +
Sbjct: 1183 INWDTLARQKAAFVPASESALDTSYFTSRYSWNTSDGFVYPASDVEDSSDADSLSGSSSC 1242
Query: 838 SSNSRTEMDECGDLAEFGS-CPLDLSLINFSFKNLSQLASINHEVLVQNVKD 888
SN + E DECG L EF S ++ S NFSFKNLSQLASIN++ L + KD
Sbjct: 1243 LSNRQDEGDECGGLTEFDSGTSVNYSFSNFSFKNLSQLASINYD-LTKGWKD 1293
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 900 | ||||||
| TAIR|locus:2028285 | 1067 | AT1G45160 [Arabidopsis thalian | 0.967 | 0.816 | 0.610 | 9.5e-279 | |
| TAIR|locus:2088515 | 1296 | AT3G17850 [Arabidopsis thalian | 0.79 | 0.548 | 0.528 | 1.2e-208 | |
| TAIR|locus:2198012 | 1235 | AT1G48490 [Arabidopsis thalian | 0.797 | 0.581 | 0.500 | 2.2e-197 | |
| TAIR|locus:2167953 | 1168 | IRE "INCOMPLETE ROOT HAIR ELON | 0.964 | 0.743 | 0.467 | 3.7e-190 | |
| DICTYBASE|DDB_G0272282 | 2102 | DDB_G0272282 "MAST family prot | 0.182 | 0.078 | 0.682 | 6.7e-93 | |
| DICTYBASE|DDB_G0276157 | 1367 | pkgA "MAST family protein kina | 0.3 | 0.197 | 0.436 | 1.3e-92 | |
| UNIPROTKB|E1C067 | 1111 | MAST3 "Uncharacterized protein | 0.356 | 0.288 | 0.486 | 2.6e-82 | |
| UNIPROTKB|F1S920 | 729 | MAST3 "Uncharacterized protein | 0.371 | 0.458 | 0.468 | 5.8e-82 | |
| RGD|1310139 | 968 | Mast4 "microtubule associated | 0.375 | 0.349 | 0.460 | 4e-81 | |
| RGD|1304573 | 1795 | Mast2 "microtubule associated | 0.361 | 0.181 | 0.482 | 6.6e-81 |
| TAIR|locus:2028285 AT1G45160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2679 (948.1 bits), Expect = 9.5e-279, P = 9.5e-279
Identities = 550/901 (61%), Positives = 661/901 (73%)
Query: 4 LEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVKWLS 63
+EKMD E +EM E LL +A+ C+EMTS RA CE+IVQDLT KR+QCQ GLVKWL
Sbjct: 193 MEKMDPSCPEDREMAEQLLDVARACMEMTSAQLRATCESIVQDLTRKRKQCQAGLVKWLF 252
Query: 64 TRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPGTAESDLDYAS 123
+++LFILT CTR+++FQKE+EPI E S KFK+CLE +PA+ET W +P +S Y
Sbjct: 253 SQLLFILTHCTRVVMFQKETEPIDESSFRKFKECLERIPALETDWGSTPRVDDSGSGYPE 312
Query: 124 YQKANAKKKISGQQKVSTVPEISDCSCSESLDHTSENKSVFIEQNFPPQKSQHYSRMQEQ 183
YQ+ A +K + K S E + DH N + + + K + S +
Sbjct: 313 YQRNEAGQKFKRRDKESLESETA-LDYVVPNDH-GNNAA---REGYAAAKQEFPSHEPQF 367
Query: 184 QSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYADKC 243
S +VE R + +E G+ L GSD VICRICEE VP+ HLE HSYICAYADKC
Sbjct: 368 DSKVVEQRFYLSDEYEDKMSNEPGKELGGSDYVICRICEEEVPLFHLEPHSYICAYADKC 427
Query: 244 ELNCLDVDERLLKLSEILEQISESCNSSSHPILGSPENSRTQSMNSAITYDGYSPKISEW 303
E+NC+DVDERLLKL EILEQI +S + +S G ENS + S + +G SPKI+EW
Sbjct: 428 EINCVDVDERLLKLEEILEQIIDSRSLNSFTQAGGLENSVLRK--SGVASEGCSPKINEW 485
Query: 304 RNKGVEGMFEDIHEMDTACIDDSHLGSLNLRGHLGLKLXXXXXXXXXXXXXXXXXXNTPK 363
RNKG+EGMFED+HEMDTA ID+S+ ++L+ H+G K NTP+
Sbjct: 486 RNKGLEGMFEDLHEMDTAFIDESYTYPIHLKSHVGAKFCHHATSSSTGSITSVSSTNTPR 545
Query: 364 AGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGS-EFLLACMHDLQDVLQH 422
HFD +WLER+ P E ED++ M++L+DIARC A TDFSKEGS ++++ACM D+Q VL+
Sbjct: 546 TSHFDSYWLERHCP-EQEDLRLMMDLSDIARCGASTDFSKEGSCDYIMACMQDIQAVLKQ 604
Query: 423 SKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVST 482
KLKALVIDTFG RIEKLL EKY+ A EL +KS S KE S +L+ S +T
Sbjct: 605 GKLKALVIDTFGGRIEKLLCEKYLHARELTADKS--SVGNIKE-SEDVLEHAS-----AT 656
Query: 483 PLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI 542
P K+R SIDDFEIIKPISRGAFG+VFLARKRTTGD FAIKVLKKLDMIRKNDIERI
Sbjct: 657 P-QLLLKDRISIDDFEIIKPISRGAFGKVFLARKRTTGDFFAIKVLKKLDMIRKNDIERI 715
Query: 543 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 602
L ERNILITVR PF+VRFFYSFTCRDNLYLVMEYLNGGDLYSLL+KVGCL+E++ARIYIA
Sbjct: 716 LQERNILITVRYPFLVRFFYSFTCRDNLYLVMEYLNGGDLYSLLQKVGCLDEEIARIYIA 775
Query: 603 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 662
ELVLALEYLHSL IVHRDLKPDNLLIA++GHIKLTDFGLSKIGLINNTIDLSG E+D
Sbjct: 776 ELVLALEYLHSLKIVHRDLKPDNLLIAYNGHIKLTDFGLSKIGLINNTIDLSGHESDVSP 835
Query: 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 722
+++H+ + Q + R RHSAVGTPDYLAPEILLGTEHGYAADWWS GI+LFE +TGIPPF
Sbjct: 836 RTNSHHFQKNQEEERIRHSAVGTPDYLAPEILLGTEHGYAADWWSAGIVLFELLTGIPPF 895
Query: 723 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
TA PE IFDNILN K+PWP VP +MS+EAQDLINR L+H+P +RLGANGAAEVK+HPFF
Sbjct: 896 TASRPEKIFDNILNGKMPWPDVPGEMSYEAQDLINRLLVHEPEKRLGANGAAEVKSHPFF 955
Query: 783 KGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSR 842
+GV+W++LALQKA FVPQPES++DTSYF+SRFS+ S + N S S+ D+ D
Sbjct: 956 QGVDWENLALQKAAFVPQPESINDTSYFVSRFSESSCSDTETGNNSGSNPDSGD------ 1009
Query: 843 TEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASINHEVLVQNVKDSTRS---SPAKDAG 899
E+DEC +L +F S P LSLINFSFKNLSQLASINH+VL+Q KD + SP K G
Sbjct: 1010 -ELDECTNLEKFDSPPYYLSLINFSFKNLSQLASINHDVLLQ--KDPAKGGGDSPFKSHG 1066
Query: 900 T 900
T
Sbjct: 1067 T 1067
|
|
| TAIR|locus:2088515 AT3G17850 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1829 (648.9 bits), Expect = 1.2e-208, Sum P(2) = 1.2e-208
Identities = 394/745 (52%), Positives = 484/745 (64%)
Query: 168 NFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRICEEVVPI 227
NFPP K H + H + + G EQ + S++CRICEE VP
Sbjct: 565 NFPPAKDSH--EHSSKHRHNI----------SWGYWGEQ-PLISEESSIMCRICEEEVPT 611
Query: 228 SHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESC-NSSSHPILGSPENSRTQS 286
+H+E HS +C ADK + L VDERL+ ++ L++I+E+ + S SP+ + +
Sbjct: 612 THVEDHSRVCTLADKYDQKGLSVDERLMAVAGTLDKIAETFRHKDSLAAAESPDGMKVSN 671
Query: 287 MNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTAC-IDDSH-LGSLNLRGHLGLKLXXX 344
+ D SP++S+W KG E M + E D + +DD L ++ R G K
Sbjct: 672 SHLTEESDVLSPRLSDWSRKGSEDMLDCFPEADNSIFMDDLRGLPLMSCRTRFGPKSDQG 731
Query: 345 XXXXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKE 404
TP+ + + + +D+ QM ELADIA+C AD +
Sbjct: 732 MTTSSASSMTPRSPIPTPRPDPIEQILGGKGTFHDQDDIPQMSELADIAKCAADAIPGDD 791
Query: 405 GS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKY 463
S FLL+C+ DL+ V+ K AL ++TFG+RIEKL+REKY+ CEL+D++ S
Sbjct: 792 QSIPFLLSCLEDLRVVIDRRKFDALTVETFGTRIEKLIREKYVHMCELMDDEKVDLLSTV 851
Query: 464 KENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF 523
+ + D V +S S P+H ++RTSIDDFEIIKPISRGAFGRVFLA+KRTTGDLF
Sbjct: 852 IDEDAPLEDDVVRSLRTS-PVHP--RDRTSIDDFEIIKPISRGAFGRVFLAKKRTTGDLF 908
Query: 524 AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 583
AIKVLKK DMIRKN +E ILAER+ILI VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY
Sbjct: 909 AIKVLKKADMIRKNAVESILAERDILINVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 968
Query: 584 SLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
SLLR +GCLEED+ R+YIAE+VLALEYLHS G+VHRDLKPDNLLIAHDGHIKLTDFGLSK
Sbjct: 969 SLLRNLGCLEEDIVRVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHIKLTDFGLSK 1028
Query: 644 IGLINNTIDLSGPETDGIMPSDAHYPEY----QQTDNRNRHSAVGTPDYLAPEILLGTEH 699
+GLIN+T DL+GP G D +Q + R + SAVGTPDYLAPEILLGT H
Sbjct: 1029 VGLINSTDDLAGPAVSGTSLLDEEESRLAASEEQLERRKKRSAVGTPDYLAPEILLGTGH 1088
Query: 700 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 759
G ADWWSVGIILFE I GIPPF AE P+ IFDNILNRKIPWP VP +MS EA D+I+RF
Sbjct: 1089 GATADWWSVGIILFELIVGIPPFNAEHPQQIFDNILNRKIPWPHVPEEMSAEAHDIIDRF 1148
Query: 760 LIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISS 819
L DP+QRLGA GAAEVK H FFK +NWD+LA QKA FVP ES DTSYF SR+S +S
Sbjct: 1149 LTEDPHQRLGARGAAEVKQHIFFKDINWDTLARQKAAFVPASESAIDTSYFRSRYSWNTS 1208
Query: 820 G---LPDDQNGSYSDADT------CDSSSNSRTEMDECGDLAEFGS-CPLDLSLINFSFK 869
P + YSDAD+ C S+ + E +EC AEF S P+D S NFSFK
Sbjct: 1209 DEQFFPSGEVPDYSDADSMTNSSGCSSNHHEEGEAEECEGHAEFESGIPVDYSFSNFSFK 1268
Query: 870 NLSQLASINHEVLVQNVKDSTRSSP 894
NLSQLASIN+++L + KD + P
Sbjct: 1269 NLSQLASINYDLLSKGWKDEPQQIP 1293
|
|
| TAIR|locus:2198012 AT1G48490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1703 (604.5 bits), Expect = 2.2e-197, Sum P(3) = 2.2e-197
Identities = 374/747 (50%), Positives = 476/747 (63%)
Query: 161 KSVFIEQNFPPQKSQHYSRMQEQQSHIVEGRIVEVTKSNCGSPHEQGQSLDGSDSVICRI 220
K V I + K S + Q H+ + R ++ G H+ + S+ICRI
Sbjct: 500 KLVAISDDMAVAKLPEVSSAKASQEHMSKNRH-NISWGYWG--HQS--CISEESSIICRI 554
Query: 221 CEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESC-NSSSHPILGSP 279
CEE +P +H+E HS ICA ADK + + VDERL+ ++ LE+I+++ S + SP
Sbjct: 555 CEEEIPTTHVEDHSRICALADKYDQKGVGVDERLMAVAVTLEKITDNVIQKDSLAAVESP 614
Query: 280 ENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTAC-IDDSH-LGSLNLRGHL 337
E + + + D SPK+S+W +G E M + E D + +DD L S++ R
Sbjct: 615 EGMKISNASLTEELDVLSPKLSDWSRRGSEDMLDCFPETDNSVFMDDMGCLPSMSCRTRF 674
Query: 338 GLKLXXXXXXXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVA 397
G K TP+ + + + +D QM ELADIARC A
Sbjct: 675 GPKSDQGMATSSAGSMTPRSPIPTPRPDPIELLLEGKGTFHDQDDFPQMSELADIARCAA 734
Query: 398 DT-DFSKEGSEFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKS 456
+ + + LL+C+ DL+ V+ K AL+++TFG+RIEKL++EKY+ CEL+D++
Sbjct: 735 NAIPVDDQSIQLLLSCLEDLRVVIDRRKFDALIVETFGTRIEKLIQEKYLQLCELMDDEK 794
Query: 457 PTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARK 516
T E++ L D V +S S P+H ++R SIDDFE++K ISRGAFG V LARK
Sbjct: 795 GTIID---EDAPLE-DDVVRSLRTS-PVHL--RDRISIDDFEVMKSISRGAFGHVILARK 847
Query: 517 RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 576
TTGDLFAIKVL+K DMIRKN +E ILAER+ILI RNPFVVRFFYSFTC +NLYLVMEY
Sbjct: 848 NTTGDLFAIKVLRKADMIRKNAVESILAERDILINARNPFVVRFFYSFTCSENLYLVMEY 907
Query: 577 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 636
LNGGD YS+LRK+GCL+E AR+YIAE+VLALEYLHS G+VHRDLKPDNLLIAHDGH+KL
Sbjct: 908 LNGGDFYSMLRKIGCLDEANARVYIAEVVLALEYLHSEGVVHRDLKPDNLLIAHDGHVKL 967
Query: 637 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG 696
TDFGLSK+GLINNT DLSGP + P+ D++ SAVGTPDYLAPEILLG
Sbjct: 968 TDFGLSKVGLINNTDDLSGPVSSATSLLVEEKPKLPTLDHKR--SAVGTPDYLAPEILLG 1025
Query: 697 TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLI 756
T HG ADWWSVGIIL+EF+ GIPPF A+ P+ IFDNILNR I WP VP DMS EA+DLI
Sbjct: 1026 TGHGATADWWSVGIILYEFLVGIPPFNADHPQQIFDNILNRNIQWPPVPEDMSHEARDLI 1085
Query: 757 NRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQ 816
+R L DP+QRLGA GAAEVK H FFK ++W++LA QKA FVP E+ DTSYF SR+S
Sbjct: 1086 DRLLTEDPHQRLGARGAAEVKQHSFFKDIDWNTLAQQKAAFVPDSENAFDTSYFQSRYSW 1145
Query: 817 ISSG---LPDDQNGSYSDADT-CDSSSNSRTEMDE-----CGDLAEFG-SCPLDLSLINF 866
SG P ++N S+ D+ C SS DE CG AEF S + NF
Sbjct: 1146 NYSGERCFPTNENEDSSEGDSLCGSSGRLSNHHDEGVDIPCGP-AEFETSVSENYPFDNF 1204
Query: 867 SFKNLSQLASINHEVLVQNVKDSTRSS 893
SFKNLSQLA IN+ ++ + KD T+ S
Sbjct: 1205 SFKNLSQLAYINYNLMSKGHKDETQPS 1231
|
|
| TAIR|locus:2167953 IRE "INCOMPLETE ROOT HAIR ELONGATION" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1843 (653.8 bits), Expect = 3.7e-190, P = 3.7e-190
Identities = 436/933 (46%), Positives = 579/933 (62%)
Query: 1 MNVLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEKRQQCQVGLVK 60
+ LE + E + LEDLL+ A+QC M + F CE IVQ L +KRQ+ +G +K
Sbjct: 252 VTTLESTPESNKELRVGLEDLLVEARQCATMPASEFWLKCEGIVQKLDDKRQELPMGGLK 311
Query: 61 WLSTRMLFILTRCTRLLLFQKESEPIAEKSLHKFKKCLESVPAVETSWVPSPGTAESDL- 119
R+LFILTRC RL+ F+KES + E L + L + V + + DL
Sbjct: 312 QAHNRLLFILTRCNRLVQFRKESGYVEEHILGMHQ--LSDLGVYPEQMVEI--SRQQDLL 367
Query: 120 DYASYQKANAKKKISGQQKVSTVPEISD---CSCSESLDHTSENKSVFIEQNFPP--QKS 174
QK N K+ ++G+Q +D + + S D TS N + + P +K+
Sbjct: 368 REKEIQKINEKQNLAGKQDDQNSNSGADGVEVNTARSTDSTSSNFRMSSWKKLPSAAEKN 427
Query: 175 QHYSRMQEQQSHI-VEGRIV-EVTKSNCGSPHEQGQSLDGS---------------DSVI 217
+ + + + ++ ++ + N SP Q S D S +S+I
Sbjct: 428 RSLNNTPKAKGESKIQPKVYGDENAENLHSPSGQPASADRSALWGFWADHQCVTYDNSMI 487
Query: 218 CRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCNSSSHPILG 277
CRICE +P+ H+E HS IC AD+C+L ++V+ RL +++E LE+I ES S
Sbjct: 488 CRICEVEIPVVHVEEHSRICTIADRCDLKGINVNLRLERVAESLEKILESWTPKSSVTPR 547
Query: 278 SPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDI-HEMDTACIDDSHLGSLNLRGH 336
+ +S S NS+ D + E + + M + + +T +D+ LN+
Sbjct: 548 AVADSARLS-NSSRQED-----LDEISQRCSDDMLDCVPRSQNTFSLDE-----LNILNE 596
Query: 337 LGLKLXXXXXXXXXXXXXXXXXXNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCV 396
+ + TP+ D R +ELE+ QQ+ +L DIAR V
Sbjct: 597 MSM---TNGTKDSSAGSLTPPSPATPRNSQVDLLLSGRKTISELENYQQINKLLDIARSV 653
Query: 397 ADTDFSKEGS-EFLLACMHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLD-E 454
A+ + S +F++ + +L+ V+Q K ALV++TFG RIEKLL+EKYI C L+D E
Sbjct: 654 ANVNVCGYSSLDFMIEQLDELKYVIQDRKADALVVETFGRRIEKLLQEKYIELCGLIDDE 713
Query: 455 KSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLA 514
K +S + E S D+V ++PL+ K+RTSI+DFEIIKPISRGAFGRVFLA
Sbjct: 714 KVDSSNAMPDEESSADEDTVRSLR--ASPLNPRAKDRTSIEDFEIIKPISRGAFGRVFLA 771
Query: 515 RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574
+KR TGDLFAIKVLKK DMIRKN +E ILAERNILI+VRNPFVVRFFYSFTCR+NLYLVM
Sbjct: 772 KKRATGDLFAIKVLKKADMIRKNAVESILAERNILISVRNPFVVRFFYSFTCRENLYLVM 831
Query: 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHI 634
EYLNGGDL+SLLR +GCL+ED+ARIYIAE+VLALEYLHS+ I+HRDLKPDNLLI DGHI
Sbjct: 832 EYLNGGDLFSLLRNLGCLDEDMARIYIAEVVLALEYLHSVNIIHRDLKPDNLLINQDGHI 891
Query: 635 KLTDFGLSKIGLINNTIDLSGPET---DGIMPSDAHYPEYQQ-TDNRNRHSAVGTPDYLA 690
KLTDFGLSK+GLIN+T DLSG + G D ++ Q D+R +H+ VGTPDYLA
Sbjct: 892 KLTDFGLSKVGLINSTDDLSGESSLGNSGFFAEDGSKAQHSQGKDSRKKHAVVGTPDYLA 951
Query: 691 PEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSF 750
PEILLG HG ADWWSVG+ILFE + GIPPF AE+P+ IF+NI+NR IPWP VP ++S+
Sbjct: 952 PEILLGMGHGKTADWWSVGVILFEVLVGIPPFNAETPQQIFENIINRDIPWPNVPEEISY 1011
Query: 751 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYF 810
EA DLIN+ L +P QRLGA GA EVK H FFK +NWD+LA QKA+FVP E DTSYF
Sbjct: 1012 EAHDLINKLLTENPVQRLGATGAGEVKQHHFFKDINWDTLARQKAMFVPSAEP-QDTSYF 1070
Query: 811 LSRFSQISSGLPDDQN---GS-YSD-ADTCDSSS-NSRTEM-DECGDLAEFGSCP---LD 860
+SR+ I + P+D+N GS + D DTC SSS N++ E DECG LAEFG+ P +
Sbjct: 1071 MSRY--IWN--PEDENVHGGSDFDDLTDTCSSSSFNTQEEDGDECGSLAEFGNGPNLAVK 1126
Query: 861 LSLINFSFKNLSQLASINHEVLVQNVKDSTRSS 893
S NFSFKNLSQLASIN++++++N K+S +S
Sbjct: 1127 YSFSNFSFKNLSQLASINYDLVLKNAKESVEAS 1159
|
|
| DICTYBASE|DDB_G0272282 DDB_G0272282 "MAST family protein kinase DDB_G0272282" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 558 (201.5 bits), Expect = 6.7e-93, Sum P(6) = 6.7e-93
Identities = 112/164 (68%), Positives = 130/164 (79%)
Query: 486 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 545
SS+ SI DFEIIKPISRGAFGRV+LA+K+ TGDL+AIKVLKKLD IRKN + ++ E
Sbjct: 1516 SSNTTSISIADFEIIKPISRGAFGRVYLAQKKKTGDLYAIKVLKKLDTIRKNMVNHVIVE 1575
Query: 546 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 605
RNIL V+N FVV+ FY+F D LYLVMEYL GGD SLLR +GC EE +A+ YIAE V
Sbjct: 1576 RNILAMVQNEFVVKLFYAFQSTDKLYLVMEYLIGGDCASLLRALGCFEEHMAKHYIAETV 1635
Query: 606 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649
L LEYLH IVHRDLKPDN+LI GHIKLTDFGLSKIG+I++
Sbjct: 1636 LCLEYLHKSAIVHRDLKPDNMLIDGLGHIKLTDFGLSKIGIIDD 1679
|
|
| DICTYBASE|DDB_G0276157 pkgA "MAST family protein kinase PkgA" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 536 (193.7 bits), Expect = 1.3e-92, Sum P(4) = 1.3e-92
Identities = 128/293 (43%), Positives = 186/293 (63%)
Query: 372 LERNHPAELEDVQQMIELADIARCVADTDFSKEGSEFLLACMHDLQDVLQHSKLKALVID 431
L R++ E + +IEL +IA + KE L +H + D++++ K +
Sbjct: 676 LTRSNDIPHEKRKMIIELREIALFAVENGI-KEN----LKMIHIMNDIIKNFDPKDDNRE 730
Query: 432 TFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDS-----VSQSS------GV 480
+I+ L+ +K + A + D+ +S ++ NS IL S +SQ+
Sbjct: 731 -LAIKIQSLISDK-VNALKRADDVINSSPRIFRTNSPRILKSPREEELSQTPLGGRLRSD 788
Query: 481 STPLHSS---HKER--TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR 535
S P+H + +K + +I DFE IKPI++G +G+VFLA+K TGD++AIK LKK DMI+
Sbjct: 789 SDPVHQTQIEYKPKGVPTISDFEFIKPITKGGYGKVFLAKKIRTGDIYAIKRLKKSDMIK 848
Query: 536 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 595
KN ++ + ERNIL NPFVV+ +YSF ++ YLVMEYL GGD +SLL+ +G ++E+
Sbjct: 849 KNQLDHVKVERNILAYTSNPFVVKMYYSFQTKEYYYLVMEYLQGGDCFSLLQMLGSMDEN 908
Query: 596 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648
+A++ IAE VLALEYLHS GIVHRD+KPDNLLI GHIKLTDFGLSK+GL++
Sbjct: 909 MAKMIIAETVLALEYLHSHGIVHRDVKPDNLLIDKKGHIKLTDFGLSKVGLLD 961
|
|
| UNIPROTKB|E1C067 MAST3 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 769 (275.8 bits), Expect = 2.6e-82, Sum P(3) = 2.6e-82
Identities = 162/333 (48%), Positives = 216/333 (64%)
Query: 481 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE 540
S P S+ + + DFE IK IS GA+G V+L R R T FA+K + K ++I +N I+
Sbjct: 178 SQPTVSAPRRKPCEGDFETIKLISNGAYGAVYLVRHRETRQRFALKKINKQNLILRNQIQ 237
Query: 541 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 600
++ ER+IL NPFVV F SF + +L +VMEY+ GGD +LL+ +G L D+A++Y
Sbjct: 238 QVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNMGPLPVDMAKMY 297
Query: 601 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 660
AE VLALEYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSKIGL+N T +L +G
Sbjct: 298 FAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMNMTTNLY----EG 353
Query: 661 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 720
M D E+ D + GTP+Y+APE++L +G DWW++GIIL+EF+ G
Sbjct: 354 HMEKDTR--EFM--DKQ----VCGTPEYIAPEVILIQGYGKPVDWWAMGIILYEFLVGCV 405
Query: 721 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 780
PF ++PE +F +++ +I WP + +AQDLI R L P +RLG GA EVK H
Sbjct: 406 PFFGDTPEELFGQVISDEIMWPEGDEALPADAQDLITRLLRQCPLERLGTGGAHEVKHHA 465
Query: 781 FFKGVNWDSLALQKAVFVPQPESVDDTSYFLSR 813
FF ++W+ L QKA F+PQ ES DDTSYF +R
Sbjct: 466 FFLHLDWNGLLRQKAEFIPQLESEDDTSYFDTR 498
|
|
| UNIPROTKB|F1S920 MAST3 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 752 (269.8 bits), Expect = 5.8e-82, Sum P(3) = 5.8e-82
Identities = 163/348 (46%), Positives = 216/348 (62%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
DFE IK IS GA+G V+L R R T FAIK + K ++I +N I+++ ER+IL NP
Sbjct: 376 DFETIKLISNGAYGAVYLVRHRDTRQRFAIKKINKQNLILRNQIQQVFVERDILTFAENP 435
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 615
FVV F SF R +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+ G
Sbjct: 436 FVVSMFCSFETRRHLCMVMEYVEGGDCATLLKNMGPLPVDMARMYFAETVLALEYLHNYG 495
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
IVHRDLKPDNLLI GHIKLTDFGLSKIGL++ +L +G + D E+ D
Sbjct: 496 IVHRDLKPDNLLITSLGHIKLTDFGLSKIGLMSMATNLY----EGHIEKDTR--EF--VD 547
Query: 676 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 735
+ GTP+Y+APE++ +G DWW++G++L+EF+ G PF ++PE +F ++
Sbjct: 548 KQ----VCGTPEYIAPEVIFRQGYGKPVDWWAMGVVLYEFLVGCVPFFGDTPEELFGQVV 603
Query: 736 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKA 795
+ +I WP + +AQDLI R L P RLG G EVK HPFF ++W L KA
Sbjct: 604 SDEIMWPEGDEALPADAQDLITRLLRQSPLDRLGTGGTHEVKQHPFFWTLDWAGLLRHKA 663
Query: 796 VFVPQPESVDDTSYFLSRFSQISS-GLPDDQ-NGSYSDADTCDSSSNS 841
FVPQ E+ DDTSYF +R + G DD+ N S + SS S
Sbjct: 664 EFVPQLEAEDDTSYFDTRSERYRHLGSEDDETNDEESSTEIPQFSSCS 711
|
|
| RGD|1310139 Mast4 "microtubule associated serine/threonine kinase family member 4" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 757 (271.5 bits), Expect = 4.0e-81, Sum P(3) = 4.0e-81
Identities = 165/358 (46%), Positives = 227/358 (63%)
Query: 472 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 531
+SVS S+ T L K R S DFE IK IS GA+G V+ R + + FA+K + K
Sbjct: 301 ESVSSSN---TSLRLRRKPRES--DFETIKLISNGAYGAVYFVRHKESRQRFAMKKINKQ 355
Query: 532 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 591
++I +N I++ ER+IL NPFVV + SF R +L +VMEY+ GGD +L++ +G
Sbjct: 356 NLILRNQIQQAFVERDILTFAENPFVVSMYCSFETRRHLCMVMEYVEGGDCATLMKNMGP 415
Query: 592 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651
L D+AR+Y AE VLALEYLH+ GIVHRDLKPDNLL+ GHIKLTDFGLSK+GL++ T
Sbjct: 416 LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLVTSMGHIKLTDFGLSKVGLMSMTT 475
Query: 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 711
+L +G + DA E+ D + GTP+Y+APE++L +G DWW++GII
Sbjct: 476 NLY----EGHIEKDAR--EF--LDKQ----VCGTPEYIAPEVILRQGYGKPVDWWAMGII 523
Query: 712 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 771
L+EF+ G PF ++PE +F +++ +I WP +AQDLI L +P +RLG
Sbjct: 524 LYEFLVGCVPFFGDTPEELFGQVISDEINWPEKDEAPPPDAQDLITLLLRQNPLERLGTG 583
Query: 772 GAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSR---FSQISSGLPDDQN 826
GA EVK H FF+ ++W+SL QKA F+PQ ES DDTSYF +R + + + DD N
Sbjct: 584 GAYEVKQHRFFRSLDWNSLLRQKAEFIPQLESEDDTSYFDTRSEKYHHMETEEEDDTN 641
|
|
| RGD|1304573 Mast2 "microtubule associated serine/threonine kinase 2" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 778 (278.9 bits), Expect = 6.6e-81, Sum P(3) = 6.6e-81
Identities = 165/342 (48%), Positives = 223/342 (65%)
Query: 472 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 531
DSV + G S P K+ S +DFE IK IS GA+G VFL R ++T FA+K + K
Sbjct: 500 DSV-EGRGASQP----SKKTPSEEDFETIKLISNGAYGAVFLVRHKSTRQRFAMKKINKQ 554
Query: 532 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 591
++I +N I++ ER+IL NPFVV F SF + +L +VMEY+ GGD +LL+ +G
Sbjct: 555 NLILRNQIQQAFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA 614
Query: 592 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651
L D+ R+Y AE VLALEYLH+ GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T
Sbjct: 615 LPVDMVRLYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 674
Query: 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 711
+L +G + DA E+ D + GTP+Y+APE++L +G DWW++GII
Sbjct: 675 NLY----EGHIEKDAR--EF--LDKQ----VCGTPEYIAPEVILRQGYGKPVDWWAMGII 722
Query: 712 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 771
L+EF+ G PF ++PE +F +++ +I WP + +AQDL ++ L +P +RLG +
Sbjct: 723 LYEFLVGCVPFFGDTPEELFGQVISDEIVWPEGDDALPPDAQDLTSKLLHQNPLERLGTS 782
Query: 772 GAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSR 813
A EVK HPFF G++W L QKA F+PQ ES DDTSYF +R
Sbjct: 783 SAYEVKQHPFFMGLDWTGLLRQKAEFIPQLESEDDTSYFDTR 824
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| AT1G45160 | kinase; kinase; FUNCTIONS IN- kinase activity; INVOLVED IN- protein amino acid phosphorylation; LOCATED IN- cellular_component unknown; EXPRESSED IN- 25 plant structures; EXPRESSED DURING- 15 growth stages; CONTAINS InterPro DOMAIN/s- Serine/threonine protein kinase (InterPro-IPR002290), Tyrosine protein kinase (InterPro-IPR001245), Serine/threonine protein kinase-related (InterPro-IPR017442), Protein kinase-like (InterPro-IPR011009), AGC-kinase, C-terminal (InterPro-IPR000961), Serine/threonine protein kinase, active site (InterPro-IPR008271), Protein kinase, core (InterPro-IPR000719) [...] (1067 aa) | ||||||||||
(Arabidopsis thaliana) | |||||||||||
Predicted Functional Partners: | |||||||||||
| AT1G69210 | unknown protein; unknown protein; FUNCTIONS IN- molecular_function unknown; INVOLVED IN- biolog [...] (305 aa) | • | 0.819 | ||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 900 | |||
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-150 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-122 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-121 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-119 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-118 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-117 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-110 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-102 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-101 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-99 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-95 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-95 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 7e-92 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-88 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 7e-88 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-87 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-86 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-85 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-84 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-83 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-82 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 6e-80 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-78 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 3e-78 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-77 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-77 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-77 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-77 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-77 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-76 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-75 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-74 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-73 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-73 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-72 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-71 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-71 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-71 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-70 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-69 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-68 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-68 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 8e-68 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 4e-67 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-66 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-66 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-66 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-65 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-64 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-64 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-64 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-63 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-63 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-63 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-63 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-62 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-62 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 6e-61 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-59 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-59 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-58 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-58 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-57 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-56 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-53 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-52 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-52 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-50 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-49 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-49 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-49 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-49 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-48 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-47 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-46 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-46 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-45 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-45 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-45 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-45 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-44 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-43 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-43 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-42 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-42 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-42 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-41 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-40 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-40 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-40 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-39 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-39 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-39 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 7e-38 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-38 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-37 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-37 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-36 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-36 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-35 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-35 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-35 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-34 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-34 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-34 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-34 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-34 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-33 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-33 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-33 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-33 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-33 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-33 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-33 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-32 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-32 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-32 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-32 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-31 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-31 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-31 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-31 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-30 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-30 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-30 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-30 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-30 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-30 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-30 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-29 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-29 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-29 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-28 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-28 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-28 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-28 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-28 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-28 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-28 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-27 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 4e-27 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-26 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-26 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-26 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 6e-26 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-26 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-25 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-25 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 6e-25 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-24 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-24 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-24 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-24 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-24 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 3e-24 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-24 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 4e-24 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 6e-24 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-24 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-23 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-23 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-23 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-22 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-22 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-22 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-22 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-22 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-21 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-21 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 7e-21 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-21 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 9e-21 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-20 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-20 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-20 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-20 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-19 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-19 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-19 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-18 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 5e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-17 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-17 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-16 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-15 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-15 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-15 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-15 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 4e-15 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-15 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-14 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-14 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 7e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 8e-14 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-13 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 4e-13 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-13 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-13 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-12 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-12 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-12 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-11 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 4e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-11 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 9e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-10 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-10 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 9e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-09 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-09 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-09 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 4e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-09 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 5e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 7e-09 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-08 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 1e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-08 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-08 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 3e-08 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 3e-08 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-08 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 4e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-08 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-07 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-06 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-06 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-06 | |
| cd05119 | 187 | cd05119, RIO, RIO kinase family, catalytic domain | 1e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-05 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-05 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 9e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-04 | |
| PRK09188 | 365 | PRK09188, PRK09188, serine/threonine protein kinas | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| cd05145 | 190 | cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 | 3e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 6e-04 | |
| cd05144 | 198 | cd05144, RIO2_C, RIO kinase family; RIO2, C-termin | 6e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 0.001 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 0.001 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 442 bits (1139), Expect = e-150
Identities = 166/285 (58%), Positives = 210/285 (73%), Gaps = 20/285 (7%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
IS+GA+GRVFLA+K++TGD++AIKV+KK DMIRKN ++++L ER+IL ++P+VV+ +Y
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 622
SF + NLYLVMEYL GGDL SLL VG L+EDVARIYIAE+VLALEYLHS GI+HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 623 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 682
PDN+LI +GH+KLTDFGLSK+GL+ I+L+ E + D R
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE---------------DKR----I 161
Query: 683 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 742
VGTPDY+APE++LG H DWWS+G IL+EF+ GIPPF E+PE IF NILN KI WP
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221
Query: 743 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 787
S EA DLI++ L+ DP +RLGA E+K HPFFKG++W
Sbjct: 222 EDVEV-SDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 369 bits (949), Expect = e-122
Identities = 131/280 (46%), Positives = 183/280 (65%), Gaps = 30/280 (10%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
+ +G+FG+V L RK+ TG L+A+KVLKK +I++ ++E L ERNIL + +PF+V+ Y
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 622
+F + LYLV+EY GG+L+S L K G E+ AR Y AE+VLALEYLHSLGI++RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 623 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 682
P+N+L+ DGHIKLTDFGL+K ++ ++
Sbjct: 121 PENILLDADGHIKLTDFGLAKELS---------------------------SEGSRTNTF 153
Query: 683 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 742
GTP+YLAPE+LLG +G A DWWS+G++L+E +TG PPF AE + I++ IL + +
Sbjct: 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRF- 212
Query: 743 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
P +S EA+DLI+ L DP +RLG+ GA E+KAHPFF
Sbjct: 213 --PEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 366 bits (942), Expect = e-121
Identities = 155/291 (53%), Positives = 195/291 (67%), Gaps = 33/291 (11%)
Query: 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVV 558
+KPIS+GAFG V+LA+KR+TGD FAIKVLKK DMI KN + + AER I++ +P+V
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 559 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 618
+ +YSF +D LYLVMEYLNGGD SL++ +G L ED A+ YIAE+VL +E LH GI+H
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 619 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 678
RD+KP+NLLI GH+KLTDFGLS+ GL N
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRNGLENKKF--------------------------- 153
Query: 679 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 738
VGTPDYLAPE +LG +DWWS+G ++FEF+ G PPF AE+P+ +FDNIL+R+
Sbjct: 154 ----VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR 209
Query: 739 IPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 788
I WP V S EA DLINR L DP +RLGANG E+K+HPFFK +NWD
Sbjct: 210 INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 366 bits (942), Expect = e-119
Identities = 149/321 (46%), Positives = 204/321 (63%), Gaps = 10/321 (3%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
DDFE+IK I RGAFG V+L R + TG ++A+KVL+K DMI++N I + AER+IL +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
P++V+ +YSF ++LYLVMEY+ GGDL +LL + E+ AR YIAELVLAL+ +H L
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN---TIDLSGPETDGIMPSDAHYPEY 671
G +HRD+KPDN+LI DGHIKL DFGL K + L+ +
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCK-KMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731
+ +S VGTPDY+APE+L GT +G DWWS+G+IL+E + G PPF +++ + +
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239
Query: 732 DNILNRKIPWPCVPSD--MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 789
+ I+N K P D +S EA DLI R L DP RLG+ E+K+HPFFKG++W++
Sbjct: 240 NKIINWKESL-RFPPDPPVSPEAIDLICRLLC-DPEDRLGS--FEEIKSHPFFKGIDWEN 295
Query: 790 LALQKAVFVPQPESVDDTSYF 810
L K FVP+ S DTS F
Sbjct: 296 LRETKPPFVPELSSPLDTSNF 316
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 362 bits (931), Expect = e-118
Identities = 156/316 (49%), Positives = 209/316 (66%), Gaps = 12/316 (3%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+DFE IK IS GA+G V+L R + T FA+K + K ++I +N I+++ ER+IL N
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
PFVV F SF + +L +VMEY+ GGD +LL+ +G L D+AR+Y AE VLALEYLH+
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
GIVHRDLKPDNLLI GHIKLTDFGLSKIGL++ T +L +G + D +Q
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY----EGHIEKDTREFLDKQV 176
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734
GTP+Y+APE++L +G DWW++GIIL+EF+ G PF ++PE +F +
Sbjct: 177 --------CGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228
Query: 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK 794
++ I WP + +AQDLI+R L +P +RLG GA EVK H FF G++W+ L QK
Sbjct: 229 ISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQK 288
Query: 795 AVFVPQPESVDDTSYF 810
A F+PQ ES DDTSYF
Sbjct: 289 AEFIPQLESEDDTSYF 304
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 357 bits (918), Expect = e-117
Identities = 137/321 (42%), Positives = 197/321 (61%), Gaps = 39/321 (12%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
DDFE IK + G+FGRV L R + +G +A+K+L K +++ +E +L E+ IL ++R+
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
PF+V + SF NLYLVMEY+ GG+L+S LRK G E VAR Y A++VLALEYLHSL
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
IV+RDLKP+NLL+ DG+IK+TDFG +K + T
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKR-VKGRT------------------------ 155
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734
++ GTP+YLAPEI+L +G A DWW++GI+++E + G PPF ++P I++ I
Sbjct: 156 -----YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI 210
Query: 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLAL 792
L K+ PS S +A+DLI L D +RLG NG ++K HP+F G++W +L L
Sbjct: 211 LEGKVR---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIAL-L 266
Query: 793 QKAV---FVPQPESVDDTSYF 810
Q+ + F+P+ + DTS F
Sbjct: 267 QRKIEAPFIPKVKGPGDTSNF 287
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 342 bits (878), Expect = e-110
Identities = 143/331 (43%), Positives = 202/331 (61%), Gaps = 19/331 (5%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
DDFE IK I RGAFG V L +K+ TG ++A+K L+K +M+ K + + AER+IL N
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
P+VV+ +YSF + LYL+MEYL GGD+ +LL K E+ R YIAE +LA++ +H L
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI-----DLSGPETDGIMPSDAHYP 669
G +HRD+KPDNLL+ GHIKL+DFGL GL + LS P
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCT-GLKKSHRTEFYRILSHALPS-NFLDFISKP 178
Query: 670 EYQ----QTDNRNR----HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 721
+T RNR +S VGTPDY+APE+ L T + DWWS+G+I++E + G PP
Sbjct: 179 MSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP 238
Query: 722 FTAESPEIIFDNILNRKIPWPCVPSDM--SFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779
F +++P+ + I+N K P ++ S EA+DLI R + +RLG NG E+K+H
Sbjct: 239 FCSDNPQETYRKIINWKETLQ-FPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296
Query: 780 PFFKGVNWDSLALQKAVFVPQPESVDDTSYF 810
PFFKGV+W+ + + A +P+ +S+ DTS F
Sbjct: 297 PFFKGVDWEHIRERPAPIIPELKSITDTSNF 327
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 317 bits (815), Expect = e-102
Identities = 129/287 (44%), Positives = 173/287 (60%), Gaps = 34/287 (11%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
+EI++ + G+FG+V+LAR + TG L AIKV+KK + K D ERIL E IL +++P
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 616
+VR + F D LYLVMEY GGDL+ LL+K G L ED AR Y+ +++ ALEYLHS GI
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 617 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 676
VHRDLKP+N+L+ DGH+KL DFGL++ Q
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR----------------------------QLDPG 150
Query: 677 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFDNIL 735
+ VGTP+Y+APE+LLG +G A D WS+G+IL+E +TG PPF + +F I
Sbjct: 151 EKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIG 210
Query: 736 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
K P+P D+S EA+DLI + L+ DP +RL A E HPFF
Sbjct: 211 KPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL---TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 316 bits (813), Expect = e-101
Identities = 136/326 (41%), Positives = 195/326 (59%), Gaps = 24/326 (7%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
F+ IK + +G GRVFL R + TG LFA+KVL K +MI++N ++R+L E+ IL T+ +
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLH 612
PF+ + SF L LVM+Y GG+L+ LL++ CL E+VAR Y AE++LALEYLH
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET-----DGIMPSDAH 667
LGIV+RDLKP+N+L+ GHI L+DF LSK S E S
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSK---------QSDVEPPPVSKALRKGSRRS 171
Query: 668 YPEYQQTD------NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 721
++ + +S VGT +Y+APE++ G HG A DWW++GI+L+E + G P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
Query: 722 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVKAHP 780
F + + F NIL +++ +P P S A+DLI + L+ DP++RLG GAAE+K HP
Sbjct: 232 FKGSNRDETFSNILKKEVTFPGSPPV-SSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP 290
Query: 781 FFKGVNWDSLALQKAVFVPQPESVDD 806
FF+GVNW + +P+P+ D
Sbjct: 291 FFRGVNWALIRHTTPPIIPRPDDGID 316
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 314 bits (805), Expect = 4e-99
Identities = 157/370 (42%), Positives = 211/370 (57%), Gaps = 30/370 (8%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
F IK I GAFG V L RK T L+A+K L+K D++ +N + AER+IL N +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 616
VV+ +YSF +DNLY VM+Y+ GGD+ SLL ++G EED+AR YIAEL A+E +H +G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 617 VHRDLKPDNLLIAHDGHIKLTDFGL---------SKIGLINN-----TIDLSGPETDGIM 662
+HRD+KPDN+LI DGHIKLTDFGL SK + +++ S E I
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS-EEWSEID 181
Query: 663 PSDAHYPEYQQTDNRNR---HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 719
E ++ R HS VGTP+Y+APE+LL T + DWWSVG+IL+E + G
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 720 PPFTAESPEIIFDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 775
PPF A++P ++N + IP + +S EA DLI R L RLG NGA E
Sbjct: 242 PPFLADTPAETQLKVINWETTLHIP-SQ--AKLSREASDLILR-LCCGAEDRLGKNGADE 297
Query: 776 VKAHPFFKGVNWDSLAL-QKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADT 834
+KAHPFFKG+++ SL QKA ++P+ DTS F L D +G S
Sbjct: 298 IKAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSNF-DPVDP--EKLRSDDSGESSPDRN 354
Query: 835 CDSSSNSRTE 844
++ RTE
Sbjct: 355 VKPNNRKRTE 364
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 301 bits (773), Expect = 1e-95
Identities = 109/290 (37%), Positives = 170/290 (58%), Gaps = 12/290 (4%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVR 553
DDF+ K I G+F V LA+++ T +AIK+L K +I++ ++ + E+ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 613
+P +++ +Y+F +NLY V+EY G+L +RK G L+E R Y AE++LALEYLHS
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
GI+HRDLKP+N+L+ D HIK+TDFG +K+ + D+ + +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVL---DPNSSPESNKGDATNIDSQIEKNR- 176
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733
R S VGT +Y++PE+L G ++D W++G I+++ +TG PPF + + F
Sbjct: 177 ---RRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233
Query: 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVKAHPFF 782
IL + + P + +A+DLI + L+ DP RLG N G E+KAHPFF
Sbjct: 234 ILKLEYSF---PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 302 bits (774), Expect = 5e-95
Identities = 129/320 (40%), Positives = 193/320 (60%), Gaps = 38/320 (11%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
DF+I+ + +G +G+VFLA+K+ TG++ A+K +KK + + N++ +L ER+IL T ++
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 615
++V+ Y+F + LYL MEY+ GGD +LL +G L ED AR Y+AE+ A++ LH LG
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
+HRDLKP+N LI GHIKLTDFGLSK + +
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK-----GIVTYA--------------------- 155
Query: 676 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 735
+S VG+PDY+APE+L G + + D+WS+G +L+EF+ G PPF+ +P ++N+
Sbjct: 156 ----NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLK 211
Query: 736 NRK--IPWPC---VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 790
K + P ++S EA DLI + LI+DP++R G ++K HPFFK V+W+ L
Sbjct: 212 YWKETLQRPVYDDPRFNLSDEAWDLITK-LINDPSRRFG--SLEDIKNHPFFKEVDWNEL 268
Query: 791 ALQKAVFVPQPESVDDTSYF 810
K FVP+ ES DT YF
Sbjct: 269 RELKPPFVPELESEIDTGYF 288
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 295 bits (756), Expect = 7e-92
Identities = 146/352 (41%), Positives = 205/352 (58%), Gaps = 52/352 (14%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+DF +K I +GAFG V L +K+ TG ++A+K L K +M +K+ + + AER++L +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
P+VV +YSF LYL+ME+L GGDL ++L K EDV R Y+AE VLA+E +H L
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLS---------------------------KIGLI 647
G +HRD+KPDN+LI GHIKL+DFGLS + +
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR----HSAVGTPDYLAPEILLGTEHGYAA 703
++I+L+ D I T +NR +S VGTPDY+APEI L +G
Sbjct: 181 VDSINLTMSSKDQI-----------ATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQEC 229
Query: 704 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP---CVPSD--MSFEAQDLINR 758
DWWS+G I+FE + G PPF +E+ + I+N W P D +S EA+DLI R
Sbjct: 230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIIN----WRETLYFPDDIHLSVEAEDLIRR 285
Query: 759 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYF 810
LI + RLG GA E+K+HPFF+GV+WD++ +A F+PQ +S+ DTSYF
Sbjct: 286 -LITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDTSYF 336
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 283 bits (725), Expect = 3e-88
Identities = 115/331 (34%), Positives = 186/331 (56%), Gaps = 36/331 (10%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVR 559
K + +G+FG+V LA + T +L+A+KVLKK +++ +D+E + E+ +L PF+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 560 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 619
F +D L+ VMEY+NGGDL +++ G +E AR Y AE+VL L++LH GI++R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 620 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 679
DLK DN+L+ +GHIK+ DFG+ K G++
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCKEGILG--------------------------GVTTS 154
Query: 680 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739
+ GTPDY+APEIL +G A DWW++G++L+E + G PF + + +F +IL ++
Sbjct: 155 -TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV 213
Query: 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV- 796
+ P +S EA+ ++ FL +P +RLG G ++K HPFF+ ++WD L ++
Sbjct: 214 RY---PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKP 270
Query: 797 -FVPQPESVDDTSYFLSRFSQISSGL-PDDQ 825
F P+ + D S F F++ L P D+
Sbjct: 271 PFKPKIKGRFDVSNFDDEFTKEKPVLTPPDE 301
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 281 bits (720), Expect = 7e-88
Identities = 129/318 (40%), Positives = 185/318 (58%), Gaps = 44/318 (13%)
Query: 496 DFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILIT 551
+FE+++ + GA+G+VFL RK G L+A+KVLKK +++K E ER +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 552 VR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 610
VR PF+V Y+F L+L+++Y+NGG+L++ L + E R+YIAE+VLAL++
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDH 120
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
LH LGI++RD+K +N+L+ +GH+ LTDFGLSK L
Sbjct: 121 LHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL------------------------ 156
Query: 671 YQQTDNRNR-HSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAE-- 725
+ R +S GT +Y+APE++ G G+ A DWWS+G++ FE +TG PFT +
Sbjct: 157 ---AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213
Query: 726 --SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
S I IL K P P MS EA+D I + L DP +RLGANGA E+K HPFF+
Sbjct: 214 QNSQSEISRRILKSKPP---FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
Query: 784 GVNWDSLALQ--KAVFVP 799
G++WD LA + A F P
Sbjct: 271 GIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 278 bits (714), Expect = 6e-87
Identities = 122/320 (38%), Positives = 179/320 (55%), Gaps = 37/320 (11%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
DD E IK + G FGRV L R R + +A+KV+ ++IR + + E+ +L V +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
PF++R F++ + LY++MEY+ GG+L+S LR G Y +E+V ALEYLHS
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
IV+RDLKP+N+L+ +GHIKLTDFG +K L + T L
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAK-KLRDRTWTL--------------------- 158
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734
GTP+YLAPE++ H A DWW++GI+++E + G PPF ++P I++ I
Sbjct: 159 --------CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210
Query: 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLAL 792
L K+ + P + A+DLI + L+ D +RLG NGA +VK H +FK V+WD +
Sbjct: 211 LAGKLEF---PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQ 267
Query: 793 QKAV--FVPQPESVDDTSYF 810
+K VP+ DTS F
Sbjct: 268 RKLKPPIVPKVSHDGDTSNF 287
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 277 bits (709), Expect = 7e-86
Identities = 141/340 (41%), Positives = 203/340 (59%), Gaps = 39/340 (11%)
Query: 500 IKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRNP 555
+K + +G +G+VF RK T TG +FA+KVLKK ++R + D AERNIL V++P
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 615
F+V Y+F LYL++EYL+GG+L+ L + G ED A Y++E+ LALE+LH G
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
I++RDLKP+N+L+ GH+KLTDFGL K + T+
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVT----------------------- 157
Query: 676 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 735
H+ GT +Y+APEIL+ + HG A DWWS+G ++++ +TG PPFTAE+ + D IL
Sbjct: 158 ----HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213
Query: 736 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ 793
K+ +P ++ EA+DL+ + L +P+ RLGA AAEV++HPFF+ VNWD L +
Sbjct: 214 KGKL---NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLAR 270
Query: 794 K--AVFVPQPESVDDTSYFLSRFS-QISSGLPDDQNGSYS 830
K F P +S +D S F S+F+ Q PDD S S
Sbjct: 271 KVEPPFKPLLQSEEDVSQFDSKFTRQTPVDSPDDSTLSES 310
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 274 bits (703), Expect = 7e-85
Identities = 126/330 (38%), Positives = 191/330 (57%), Gaps = 42/330 (12%)
Query: 489 KERTS---IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 545
K TS + DFE+ + + G+FGRV +A+ + TG+ +AIK LKK ++++ ++ + E
Sbjct: 9 KPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQE 68
Query: 546 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 605
++IL+ + +PF+V SF + +Y ++E++ GG+L++ LRK G DVA+ Y AELV
Sbjct: 69 KSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELV 128
Query: 606 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 665
LA EYLHS I++RDLKP+NLL+ + GH+K+TDFG +K
Sbjct: 129 LAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK---------------------- 166
Query: 666 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 725
P+ T GTP+YLAPE++ HG A DWW++G++L+EFI G PPF +
Sbjct: 167 -KVPDRTFT-------LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218
Query: 726 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFK 783
+P I++ IL ++ + P+ A+DL+ L D +RLG G A+VK HP+F
Sbjct: 219 TPFRIYEKILAGRLKF---PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFH 275
Query: 784 GVNWDSLALQKAVFVPQP---ESVDDTSYF 810
G NWD L + P P +S DTS F
Sbjct: 276 GANWDKL-YARYYPAPIPVRVKSPGDTSNF 304
|
Length = 329 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 270 bits (692), Expect = 4e-84
Identities = 105/291 (36%), Positives = 161/291 (55%), Gaps = 36/291 (12%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
+E+++ + G+FG V+ A+ + TG + A+K+LKK + + E IL + +P
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRS-EKSKKDQTARREIRILRRLSHPN 59
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 616
+VR +F +D+LYLVMEY GGDL+ L + G L ED A+ +++ LEYLHS GI
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 617 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 676
+HRDLKP+N+L+ +G +K+ DFGL+K L +++
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSSS-------------------------- 153
Query: 677 RNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAE---SPEIIFD 732
+ + VGTP Y+APE+LL G +G D WS+G+IL+E +TG PPF+ E +
Sbjct: 154 -SLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR 212
Query: 733 NILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
IL + + S S EA+DLI + L DP++R A E+ HP+F
Sbjct: 213 RILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP---TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 268 bits (687), Expect = 2e-83
Identities = 104/293 (35%), Positives = 169/293 (57%), Gaps = 39/293 (13%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
+ G FGRV L + ++ FA+K +KK ++ E I +E+ IL +PF+V+ +
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 622
+F + +Y++MEY GG+L+++LR G +E AR YIA +VLA EYLH+ GI++RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 623 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR-HS 681
P+NLL+ +G++KL DFG +K + + + +
Sbjct: 121 PENLLLDSNGYVKLVDFGFAK-----------------------------KLKSGQKTWT 151
Query: 682 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA--ESPEIIFDNIL--NR 737
GTP+Y+APEI+L + ++ D+WS+GI+L+E +TG PPF E P I+++IL N
Sbjct: 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG 211
Query: 738 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWD 788
K+ + P+ + A+DLI + L +P +RLG G ++K H +F G +W+
Sbjct: 212 KLEF---PNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 268 bits (686), Expect = 5e-82
Identities = 143/329 (43%), Positives = 205/329 (62%), Gaps = 18/329 (5%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
DDFE +K I RGAFG V L +K+ TG ++A+K+L+K DM+ K + I AER+IL+
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
+VV+ FYSF + NLYL+ME+L GGD+ +LL K L E+ + YIAE VLA++ +H L
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ-- 672
G +HRD+KPDNLL+ GH+KL+DFGL GL PSD +
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCT-GLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179
Query: 673 ---QTDNRNR----HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 725
+T +NR +S VGTPDY+APE+ + T + DWWS+G+I++E + G PPF +E
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 726 SPEIIFDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
+P+ + ++N K P P VP +S +A+DLI RF D R+G+NG E+K+HPF
Sbjct: 240 TPQETYRKVMNWKETLVFP-PEVP--ISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295
Query: 782 FKGVNWDSLALQKAVFVPQPESVDDTSYF 810
F+GV+W + + A + +S+DDTS F
Sbjct: 296 FEGVDWGHIRERPAAIPIEIKSIDDTSNF 324
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 263 bits (674), Expect = 6e-80
Identities = 148/336 (44%), Positives = 200/336 (59%), Gaps = 23/336 (6%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
F IK + GAFG V LARK T L+A+K L+K D++ +N + + AER+IL N +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 616
VVR +YSF +DNLY VM+Y+ GGD+ SLL ++G ED+AR YIAEL A+E +H +G
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 617 VHRDLKPDNLLIAHDGHIKLTDFGL--------------SKIGLINNTIDLSGPETD--G 660
+HRD+KPDN+LI DGHIKLTDFGL S + +++D S D
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 661 IMPSDAHYP-EYQQTDNRNR---HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 716
D P E + R HS VGTP+Y+APE+LL T + DWWSVG+IL+E +
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 717 TGIPPFTAESPEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAE 775
G PPF A++P ++N + P + +S EA DLI + L P RLG NGA E
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADE 301
Query: 776 VKAHPFFKGVNWDS-LALQKAVFVPQPESVDDTSYF 810
+KAHPFFK +++ S L Q A ++P+ DTS F
Sbjct: 302 IKAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNF 337
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 259 bits (663), Expect = 1e-78
Identities = 141/328 (42%), Positives = 206/328 (62%), Gaps = 16/328 (4%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+DFE +K I RGAFG V L +K+ TG ++A+K+L+K DM+ K + I AER+IL+ +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
+VV+ FYSF + NLYL+ME+L GGD+ +LL K L E+ + YIAE VLA++ +H L
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ-- 672
G +HRD+KPDNLL+ GH+KL+DFGL GL + +PSD +
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCT-GLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179
Query: 673 ---QTDNRNRH----SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 725
+T RNR S VGTPDY+APE+ + T + DWWS+G+I++E + G PPF +E
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 726 SPEIIFDNILNRK---IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
+P+ + ++N K I P VP +S +A+DLI RF + R+GA G E+K +PFF
Sbjct: 240 TPQETYKKVMNWKETLIFPPEVP--ISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFF 296
Query: 783 KGVNWDSLALQKAVFVPQPESVDDTSYF 810
+GV+W+ + + A + +S+DDTS F
Sbjct: 297 EGVDWEHIRERPAAIPIEIKSIDDTSNF 324
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 257 bits (657), Expect = 3e-78
Identities = 135/324 (41%), Positives = 194/324 (59%), Gaps = 35/324 (10%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
DDFEI+K I RGAFG V + + + TG ++A+K+L K +M+++ + ER++L+
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHS 613
++ Y+F +NLYLVM+Y GGDL +LL K L ED+AR Y+AE+VLA++ +H
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
LG VHRD+KPDN+L+ +GHI+L DFG S + L+ DG + S+
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFG-SCLRLL----------ADGTVQSNV------- 162
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPFTAESPE 728
AVGTPDY++PEIL E +G DWWS+G+ ++E + G PF AES
Sbjct: 163 --------AVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 729 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786
+ I+N K +P +D+S EA+DLI R LI P RLG NG + K HPFF+G++
Sbjct: 215 ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRR-LICSPETRLGRNGLQDFKDHPFFEGID 273
Query: 787 WDSLALQKAVFVPQPESVDDTSYF 810
WD++ A +VP+ S DTS F
Sbjct: 274 WDNIRNSTAPYVPEVSSPTDTSNF 297
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 255 bits (653), Expect = 1e-77
Identities = 127/333 (38%), Positives = 180/333 (54%), Gaps = 35/333 (10%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 560
K + +G FG+V L R++ TG +A+K+LKK +I K+++ L E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 561 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 620
YSF D L VMEY NGG+L+ L + ED AR Y AE+V AL YLHS +V+RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 621 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 680
LK +NL++ DGHIK+TDFGL K G+ +D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGI---------------------------SDGATMK 153
Query: 681 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 740
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 213
Query: 741 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV-- 796
+ P +S EA+ L+ L DP QRLG A E+ H FF +NW + +K
Sbjct: 214 F---PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPP 270
Query: 797 FVPQPESVDDTSYFLSRF-SQISSGLPDDQNGS 828
F PQ S DT YF F +Q + P D+ S
Sbjct: 271 FKPQVTSETDTRYFDEEFTAQSITITPPDRYDS 303
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 255 bits (652), Expect = 1e-77
Identities = 125/344 (36%), Positives = 187/344 (54%), Gaps = 41/344 (11%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 559
K I +G+FG+V LA+ + G +A+KVL+K +++K + + I+AERN+L+ V++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 560 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 619
YSF D LY V++Y+NGG+L+ L++ E AR Y AE+ AL YLHSL I++R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 620 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 679
DLKP+N+L+ GH+ LTDFGL K +GI S
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK---------------EGIEHSK------------TT 153
Query: 680 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739
+ GTP+YLAPE+L + DWW +G +L+E + G+PPF + ++DNILN+ +
Sbjct: 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL 213
Query: 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQK--AV 796
+ ++S A+ L+ L D +RLGA + E+K H FF +NWD L +K
Sbjct: 214 R---LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPP 270
Query: 797 FVPQPESVDDTSYFLSRFSQI----SSGLPDDQN---GSYSDAD 833
F P D +F F++ S G D S +AD
Sbjct: 271 FNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEAD 314
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 255 bits (653), Expect = 4e-77
Identities = 125/328 (38%), Positives = 187/328 (57%), Gaps = 37/328 (11%)
Query: 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 550
R +DF++IK I RGAFG V L R +++ ++A+K+L K +MI+++D ER+I+
Sbjct: 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 610
+ ++V+ Y+F LY+VMEY+ GGDL +L+ + E AR Y AE+VLAL+
Sbjct: 99 HANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLALDA 157
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
+HS+G +HRD+KPDN+L+ GH+KL DFG + + + +G++ D
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFG--------TCMKM---DANGMVRCD----- 201
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAES 726
+AVGTPDY++PE+L +G DWWSVG+ L+E + G PF A+S
Sbjct: 202 ----------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251
Query: 727 PEIIFDNILNRKIPWPCVPSD--MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
+ I++ K P D +S +A+DLI FL D RLG NG E+K+HPFFK
Sbjct: 252 LVGTYSKIMDHKNSL-TFPDDIEISKQAKDLICAFLT-DREVRLGRNGVDEIKSHPFFKN 309
Query: 785 --VNWDSLALQKAVFVPQPESVDDTSYF 810
+D++ A VP+ S DTS F
Sbjct: 310 DQWTFDNIRETVAPVVPELSSDIDTSNF 337
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 253 bits (647), Expect = 8e-77
Identities = 132/333 (39%), Positives = 197/333 (59%), Gaps = 37/333 (11%)
Query: 496 DFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILIT 551
+FE++K + GA+G+VFL RK T TG L+A+KVL+K +++K +E ERN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 552 VR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 610
VR +PF+V Y+F L+L+++Y++GG++++ L + ED R Y E++LALE+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
LH LGIV+RD+K +N+L+ +GH+ LTDFGLSK E
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK--------------------------E 154
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEI 729
+ + +S GT +Y+APEI+ G HG A DWWS+GI++FE +TG PFT E
Sbjct: 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214
Query: 730 IFDNILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVN 786
+ R + P PS + EAQDL+++ L DP +RLGA GA+E+K HPFFKG++
Sbjct: 215 TQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274
Query: 787 WDSLALQK--AVFVPQPESVDDTSYFLSRFSQI 817
W++LAL+K F P + D F F+ +
Sbjct: 275 WEALALRKVNPPFRPSIRNELDVGNFAEEFTNL 307
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 254 bits (651), Expect = 9e-77
Identities = 154/382 (40%), Positives = 206/382 (53%), Gaps = 49/382 (12%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
F IK + GAFG V LA K T L+A+K L+K D++ +N + + AER+IL N +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 616
VV+ +YSF +DNLY VM+Y+ GGD+ SLL ++ E +AR YIAEL LA+E +H +G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 617 VHRDLKPDNLLIAHDGHIKLTDFGL---------SKIGLINNTIDLSGPETDGIMPSD-- 665
+HRD+KPDN+LI DGHIKLTDFGL SK + I D + PSD
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI-----RQDSMEPSDLW 177
Query: 666 -----------AHYPEYQQTDNRNR---HSAVGTPDYLAPEILLGTEHGYAADWWSVGII 711
E + T R HS VGTP+Y+APE+LL + DWWSVG+I
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 712 LFEFITGIPPFTAESPE------IIFDNILNRKIPWPCVPSD--MSFEAQDLINRFLIHD 763
LFE + G PPF A +P I ++N L+ +P +S EA DLI + L
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTLH-------IPPQVKLSPEAVDLITK-LCCS 289
Query: 764 PNQRLGANGAAEVKAHPFFKGVNWDS-LALQKAVFVPQPESVDDTSYFLSRFSQISSGLP 822
+RLG NGA ++KAHPFF V++ S + Q A +VP+ DTS F + S
Sbjct: 290 AEERLGRNGADDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDP--VEEESPWN 347
Query: 823 DDQNGSYSDADTCDSSSNSRTE 844
D S DT S + E
Sbjct: 348 DASGDSTRTWDTLCSPNGKHPE 369
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 251 bits (641), Expect = 3e-76
Identities = 120/318 (37%), Positives = 183/318 (57%), Gaps = 36/318 (11%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
I +G+FG+V RKR T ++A+K ++K ++ ++++ LAER +L V PF+V +
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 622
SF + LYLV+ ++NGG+L+ L++ G + AR Y AEL+ ALE LH +++RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 623 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 682
P+N+L+ + GHI L DFGL K+ + + D N +
Sbjct: 121 PENILLDYQGHIALCDFGLCKLNMKD-------------------------DDKTN--TF 153
Query: 683 VGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 740
GTP+YLAPE+LLG HGY A DWW++G++L+E +TG+PPF E+ ++ IL +
Sbjct: 154 CGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR 211
Query: 741 WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAV--FV 798
+ P +A+DL+ L DP +RLG NGA E+K HPFF ++W L ++ F
Sbjct: 212 F---PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFK 268
Query: 799 PQPESVDDTSYFLSRFSQ 816
P S DTS F F++
Sbjct: 269 PAVSSAIDTSNFDEEFTR 286
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 247 bits (633), Expect = 7e-75
Identities = 120/328 (36%), Positives = 178/328 (54%), Gaps = 40/328 (12%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---R 553
F + + RG FG+V LA + TG+L+AIK LKK D+I ++++E ++ E+ I T R
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 613
+PF+V F F D++ VMEY GGDL + E A Y A +VL L+YLH
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE 119
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
IV+RDLK DNLL+ +G +K+ DFGL K +G+ D
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK---------------EGMGFGD-------- 156
Query: 674 TDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732
R S GTP++LAPE+L T + A DWW +G++++E + G PF + E +FD
Sbjct: 157 -----RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211
Query: 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSL 790
+I+N ++ +P +S EA ++ R L +P +RLG+ A +VK PFF+ +NWD L
Sbjct: 212 SIVNDEVRYPRF---LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDL 268
Query: 791 ALQK--AVFVPQPESVDDTSYFLSRFSQ 816
+K FVP + +D S F F+
Sbjct: 269 LARKIKPPFVPTIKGPEDVSNFDEEFTS 296
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 246 bits (629), Expect = 2e-74
Identities = 133/342 (38%), Positives = 194/342 (56%), Gaps = 48/342 (14%)
Query: 500 IKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
+K + +G+FG+VFL RK T G L+A+KVLKK + + D R ER+IL V +PF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPF 59
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLG 615
+V+ Y+F LYL++++L GGDL++ L K V EEDV + Y+AEL LAL++LHSLG
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-KFYLAELALALDHLHSLG 118
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
I++RDLKP+N+L+ +GHIKLTDFGLSK + D
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSK----------------------------ESID 150
Query: 676 NRNR-HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734
+ + +S GT +Y+APE++ H +ADWWS G+++FE +TG PF + + I
Sbjct: 151 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
Query: 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLAL 792
L K+ +P +S EAQ L+ +P RLGA +G E+K HPFF ++W+ L
Sbjct: 211 LKAKLG---MPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKL-Y 266
Query: 793 QKAV---FVPQPESVDDTSYFLSRFS----QISSGLPDDQNG 827
++ + F P DDT YF F+ + S G+P N
Sbjct: 267 RREIKPPFKPAVGRPDDTFYFDPEFTSRTPKDSPGIPPSANA 308
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 241 bits (617), Expect = 2e-73
Identities = 106/287 (36%), Positives = 157/287 (54%), Gaps = 31/287 (10%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
FE+++ I +GAFG+V + +KR T +FA+K + K + K + +L ER IL + +PF
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDL-YSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 615
+V +YSF +N+YLV++ L GGDL Y L +KV E+ + +I E+VLALEYLHS G
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK-FSEEQVKFWICEIVLALEYLHSKG 120
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
I+HRD+KPDN+L+ GH+ +TDF ++ T
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATK----------------------------VTP 152
Query: 676 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 735
+ S GTP Y+APE+L + A DWWS+G+ +E + G P+ S I
Sbjct: 153 DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA 212
Query: 736 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
++ P+ S EA D IN+ L DP +RLG N ++K HP+F
Sbjct: 213 KQETADVLYPATWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 242 bits (619), Expect = 9e-73
Identities = 121/325 (37%), Positives = 179/325 (55%), Gaps = 40/325 (12%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
DF++ + RG FG V + R++ TGD++A+KV+KK ++ + + ER+IL +
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEYLHS 613
P++ + Y+F +DNLYLVMEY GGDL SLL R +ED+A+ Y+AELVLA+ +H
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
+G VHRD+KP+N+LI GHIKL DFG + + ++
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSA-----------------ARLTANKMV----- 158
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEFITGIPPFTAESP 727
N VGTPDY+APE+L +G DWWS+G+I +E I G PF +
Sbjct: 159 ----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214
Query: 728 EIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785
++NI+N R + +P P +S + DLI L+ +RLG G + HPFF +
Sbjct: 215 AKTYNNIMNFQRFLKFPEDPK-VSSDFLDLIQS-LLCGQKERLGYEG---LCCHPFFSKI 269
Query: 786 NWDSLALQKAVFVPQPESVDDTSYF 810
+W+++ FVP +S DDTS F
Sbjct: 270 DWNNIRNSLPPFVPTLKSDDDTSNF 294
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 241 bits (617), Expect = 2e-72
Identities = 109/337 (32%), Positives = 180/337 (53%), Gaps = 36/337 (10%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRN 554
DF + + +G+FG+V LA ++ T +L+AIK+LKK +I+ +D+E + E+ +L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
PF+ + F D LY VMEY+NGGDL +++VG +E A Y AE+ + L +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
GI++RDLK DN+++ +GHIK+ DFG+ K + I
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCK---------------ENIFGGK--------- 156
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734
+ GTPDY+APEI+ +G + DWW+ G++L+E + G PPF E + +F +I
Sbjct: 157 ---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213
Query: 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLAL 792
+ + + P +S EA + L P +RLG G +++ H FF+ ++W+ L
Sbjct: 214 MEHNVSY---PKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLER 270
Query: 793 Q--KAVFVPQPESVDDTSYFLSRFSQISSGL-PDDQN 826
+ + F P+ + F F++ L P D+
Sbjct: 271 REIQPPFKPKVKGRRSAENFDKFFTREPPVLTPPDKL 307
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 239 bits (610), Expect = 1e-71
Identities = 126/324 (38%), Positives = 185/324 (57%), Gaps = 38/324 (11%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVR 559
I +G FG+V+ RK+ T ++A+KVL K +++ K ++ + ERNIL+ +PF+V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 560 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 619
+SF +LYLV +Y++GG+L+ L+K G ED A+ YIAELVLALE+LH IV+R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 620 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 679
DLKP+N+L+ GHI L DFGLSK L TDN+
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANL---------------------------TDNKTT 153
Query: 680 HSAVGTPDYLAPEILLGTEHGYA--ADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 737
++ GT +YLAPE+LL E GY D+WS+G+++FE G PF AE + ++ NI
Sbjct: 154 NTFCGTTEYLAPEVLL-DEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG 212
Query: 738 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQKAV 796
K+ +P + +S E + + L +P RLGA A E+K HPFF ++WD L+ ++
Sbjct: 213 KVRFP--KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQIT 270
Query: 797 --FVPQPESVDDTSYFLSRFSQIS 818
F P +S +D S F F+ S
Sbjct: 271 PPFKPIVDSDEDVSNFDPEFTNSS 294
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 236 bits (603), Expect = 9e-71
Identities = 118/321 (36%), Positives = 187/321 (58%), Gaps = 38/321 (11%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFF 561
+ +G+FG+V LAR + +G L+A+KVLKK +++ +D+E + E+ IL RN PF+ + +
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 562 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 621
F D L+ VME++NGGDL ++K +E AR Y AE+ AL +LH GI++RDL
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDL 122
Query: 622 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 681
K DN+L+ H+GH KL DFG+ K G+ N G S +
Sbjct: 123 KLDNVLLDHEGHCKLADFGMCKEGIFN-----------GKTTS----------------T 155
Query: 682 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW 741
GTPDY+APEIL +G + DWW++G++L+E + G PF AE+ + +F+ ILN ++ +
Sbjct: 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVY 215
Query: 742 PCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQKAV-- 796
P+ +S +A D++ F+ +P RLG+ G + HPFFK ++W+ L ++ +
Sbjct: 216 ---PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLN-RRQIEP 271
Query: 797 -FVPQPESVDDTSYFLSRFSQ 816
F P+ +S +D S F F +
Sbjct: 272 PFRPRIKSREDVSNFDPDFIK 292
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 235 bits (600), Expect = 9e-71
Identities = 123/319 (38%), Positives = 191/319 (59%), Gaps = 45/319 (14%)
Query: 496 DFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILIT 551
+FE++K + GA+G+VFL RK + +G L+A+KVLKK +++K E ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 552 VR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 610
+R +PF+V Y+F L+L+++Y+NGG+L++ L + +E +IY E+VLALE+
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
LH LGI++RD+K +N+L+ +GH+ LTDFGLSK E
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK--------------------------E 154
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAE--- 725
+ + + +S GT +Y+AP+I+ G + G+ A DWWS+G++++E +TG PFT +
Sbjct: 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214
Query: 726 -SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFF 782
S I IL + P+ P +MS A+D+I R L+ DP +RLG + A E+K HPFF
Sbjct: 215 NSQAEISRRILKSEPPY---PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF 271
Query: 783 KGVNWDSLALQKAVFVPQP 801
+ +NWD LA +K VP P
Sbjct: 272 QKINWDDLAAKK---VPAP 287
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 235 bits (600), Expect = 3e-70
Identities = 116/317 (36%), Positives = 179/317 (56%), Gaps = 35/317 (11%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 559
K + +G+FG+V LA + T + FAIK LKK ++ +D+E + ER +L +PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 560 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 619
F +F +++L+ VMEYLNGGDL ++ G +E AR Y AE++ L++LH GI++R
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120
Query: 620 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 679
DLK DN+L+ DGHIK+ DFG+ K +
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCKENMNGEG---------------------------KA 153
Query: 680 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739
+ GTPDY+APEIL G ++ + DWWS G++L+E + G PF E + +FD+ILN
Sbjct: 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN-DR 212
Query: 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK--AVF 797
P P +S EA+D +++ DP +RLG +G +++ HPFF+G++W+ L ++ F
Sbjct: 213 PH--FPRWISKEAKDCLSKLFERDPTKRLGVDG--DIRQHPFFRGIDWERLEKREIPPPF 268
Query: 798 VPQPESVDDTSYFLSRF 814
P+ +S D S F F
Sbjct: 269 KPKVKSPSDASNFDREF 285
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 2e-69
Identities = 124/342 (36%), Positives = 184/342 (53%), Gaps = 38/342 (11%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 560
K + +G FG+V L R++ TG +A+K+L+K +I K+++ + E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 561 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 620
Y+F D L VMEY NGG+L+ L + E+ AR Y AE+V ALEYLHS +V+RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 621 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 680
+K +NL++ DGHIK+TDFGL K G+ +D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCKEGI---------------------------SDGATMK 153
Query: 681 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 740
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 213
Query: 741 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV-- 796
+ P +S EA+ L+ L DP QRLG + A EV H FF +NW + +K +
Sbjct: 214 F---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPP 270
Query: 797 FVPQPESVDDTSYFLSRFSQISSGL-PDDQNGSYSDADTCDS 837
F PQ S DT YF F+ S + P D+ Y +
Sbjct: 271 FKPQVTSEVDTRYFDDEFTAQSITITPPDR---YDSLGLLEL 309
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 231 bits (589), Expect = 1e-68
Identities = 133/347 (38%), Positives = 191/347 (55%), Gaps = 39/347 (11%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 560
K + +G FG+V L R++ +G +A+K+LKK +I K+++ L E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 561 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 620
YSF +D L VMEY+NGG+L+ L + ED R Y AE+V AL+YLHS IV+RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 621 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 680
LK +NL++ DGHIK+TDFGL K G+ TD
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCKEGI---------------------------TDAATMK 153
Query: 681 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 740
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL I
Sbjct: 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213
Query: 741 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV-- 796
+ P +S +A+ L++ LI DPN+RLG + A E+ H FF GVNW + +K V
Sbjct: 214 F---PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPP 270
Query: 797 FVPQPESVDDTSYFLSRFS-QISSGLPDDQNGSYSDADTCDSSSNSR 842
F PQ S DT YF F+ Q + P ++ D D D N R
Sbjct: 271 FKPQVTSETDTRYFDEEFTAQTITITPPEK----YDEDGMDCMDNER 313
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 229 bits (585), Expect = 4e-68
Identities = 111/323 (34%), Positives = 186/323 (57%), Gaps = 37/323 (11%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVR 559
K + +G+FG+V LA + T +++AIKVLKK +++ +D++ + E+ IL + ++PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 560 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 619
F +D L+ VMEY+NGGDL +++ +E +R Y AE+ LAL +LH G+++R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120
Query: 620 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 679
DLK DN+L+ +GH KL DFG+ K G++N
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTT--------------------------- 153
Query: 680 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739
+ GTPDY+APEIL E+G + DWW++G++++E + G PPF A++ + +F++IL+ +
Sbjct: 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV 213
Query: 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLG----ANGAAEVKAHPFFKGVNWDSLALQ-- 793
+P +S EA ++ F+ +PN+RLG G +K HPFFK ++W L +
Sbjct: 214 LYPVW---LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKI 270
Query: 794 KAVFVPQPESVDDTSYFLSRFSQ 816
K F P+ ++ D + F F++
Sbjct: 271 KPPFKPKIKTKRDVNNFDQDFTK 293
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 229 bits (584), Expect = 8e-68
Identities = 129/324 (39%), Positives = 186/324 (57%), Gaps = 35/324 (10%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
DDFEIIK I RGAFG V + + + T ++A+K+L K +M+++ + ERN+L+
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 613
++ Y+F + LYLVM+Y GGDL +LL K L ED+AR YIAE+VLA+ +H
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
L VHRD+KPDN+L+ +GHI+L DFG S + + DG + S
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFG-SCLKMNQ----------DGTVQSSV------- 162
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTEHGYA-----ADWWSVGIILFEFITGIPPFTAESPE 728
AVGTPDY++PEIL E G DWWS+G+ ++E + G PF AES
Sbjct: 163 --------AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 729 IIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786
+ I+N + +P +D+S EA+DLI R LI +RLG NG + K H FF+G++
Sbjct: 215 ETYGKIMNHEERFQFPSHITDVSEEAKDLIQR-LICSRERRLGQNGIEDFKKHAFFEGID 273
Query: 787 WDSLALQKAVFVPQPESVDDTSYF 810
W+++ +A ++P S DTS F
Sbjct: 274 WENIRNLEAPYIPDVSSPSDTSNF 297
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 227 bits (579), Expect = 4e-67
Identities = 129/324 (39%), Positives = 190/324 (58%), Gaps = 35/324 (10%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+DFEI+K I RGAFG V + + + +FA+K+L K +M+++ + ER++L+ N
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 613
++ Y+F +NLYLVM+Y GGDL +LL K L ED+AR Y+AE+V+A++ +H
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
L VHRD+KPDN+L+ +GHI+L DFG S + L+ DG + S
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFG-SCLKLME----------DGTVQSSV------- 162
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPFTAESPE 728
AVGTPDY++PEIL E +G DWWS+G+ ++E + G PF AES
Sbjct: 163 --------AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214
Query: 729 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786
+ I+N K +P +D+S +A+DLI R LI RLG NG + K HPFF G++
Sbjct: 215 ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRR-LICSREHRLGQNGIEDFKQHPFFTGID 273
Query: 787 WDSLALQKAVFVPQPESVDDTSYF 810
WD++ +A ++P+ S DTS F
Sbjct: 274 WDNIRNCEAPYIPEVSSPTDTSNF 297
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 225 bits (574), Expect = 1e-66
Identities = 121/342 (35%), Positives = 190/342 (55%), Gaps = 39/342 (11%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 559
K I +G+FG+V LA++++ G +A+KVL+K +++K + I+AERN+L+ +++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 560 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 619
YSF + LY V++Y+NGG+L+ L++ C E AR Y AE+ A+ YLHSL I++R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 620 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 679
DLKP+N+L+ GH+ LTDFGL K +G+ P +
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK---------------EGVEPEE------------TT 153
Query: 680 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739
+ GTP+YLAPE+L + DWW +G +L+E + G+PPF + ++DNIL++ +
Sbjct: 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL 213
Query: 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA-AEVKAHPFFKGVNWDSLALQKAV-- 796
+P + A DL+ L D +RLGA E+K H FF +NWD L ++
Sbjct: 214 Q---LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPP 270
Query: 797 FVPQPESVDDTSYFLSRFSQ--ISSGL---PDDQNGSYSDAD 833
+ P D +F F+Q +SS + PD S S +
Sbjct: 271 YNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTASSSSASS 312
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 1e-66
Identities = 97/290 (33%), Positives = 152/290 (52%), Gaps = 33/290 (11%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
++ + + RG+FG V+LA + TG+L A+K ++ + +E + E IL ++++P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEE-LEALEREIRILSSLQHP 59
Query: 556 FVVRFFYSFT--CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 613
+VR++ S ++ L + +EY++GG L SLL+K G L E V R Y +++ L YLHS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
GIVHRD+K N+L+ DG +KL DFG +K T +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE--------------------- 158
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733
S GTP ++APE++ G E+G AAD WS+G + E TG PP++ +
Sbjct: 159 ----GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY 214
Query: 734 -ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
I + P P +P +S EA+D + + L DP +R A E+ HPF
Sbjct: 215 KIGSSGEP-PEIPEHLSEEAKDFLRKCLRRDPKKRP---TADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 224 bits (573), Expect = 2e-66
Identities = 115/319 (36%), Positives = 184/319 (57%), Gaps = 39/319 (12%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVR 559
K + +G+FG+VFLA + T FAIK LKK ++ +D+E + E+ +L + +PF+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 560 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR--IYIAELVLALEYLHSLGIV 617
+ +F ++NL+ VMEYLNGGDL ++ C + D+ R Y AE++ L++LHS GIV
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 618 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 677
+RDLK DN+L+ DGHIK+ DFG+ K ++ DA +
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGMCKENML----------------GDAKTCTF------ 156
Query: 678 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 737
GTPDY+APEILLG ++ + DWWS G++L+E + G PF E +F +I
Sbjct: 157 -----CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI--- 208
Query: 738 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK--A 795
++ PC P ++ EA+D++ + + +P +RLG G +++ HPFF+ ++W +L ++
Sbjct: 209 RMDNPCYPRWLTREAKDILVKLFVREPERRLGVKG--DIRQHPFFREIDWSALEEREIEP 266
Query: 796 VFVPQPESVDDTSYFLSRF 814
F P+ +S +D S F F
Sbjct: 267 PFKPKVKSANDCSNFDKEF 285
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 221 bits (563), Expect = 6e-65
Identities = 128/340 (37%), Positives = 186/340 (54%), Gaps = 36/340 (10%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 560
K + +G FG+V L +++ TG +A+K+LKK ++ K+++ L E +L R+PF+
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 561 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHR 619
YSF D L VMEY NGG+L+ L + ED AR Y AE+V AL+YLHS +V+R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 620 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 679
DLK +NL++ DGHIK+TDFGL K G+ D
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCKEGI---------------------------KDGATM 153
Query: 680 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 213
Query: 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRL--GANGAAEVKAHPFFKGVNWDSLALQKAV- 796
+ P +S EA+ L++ L DP QRL G + A E+ H FF G+ W + +K V
Sbjct: 214 RF---PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVP 270
Query: 797 -FVPQPESVDDTSYFLSRFS-QISSGLPDDQNGSYSDADT 834
F PQ S DT YF F+ Q+ + P DQ+ S D
Sbjct: 271 PFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMETVDN 310
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 221 bits (565), Expect = 1e-64
Identities = 129/328 (39%), Positives = 186/328 (56%), Gaps = 37/328 (11%)
Query: 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 550
R +D+E++K I RGAFG V L R ++T ++A+K+L K +MI+++D ER+I+
Sbjct: 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 98
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 610
+P+VV+ FY+F LY+VMEY+ GGDL +L+ + E AR Y AE+VLAL+
Sbjct: 99 FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDA 157
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
+HS+G +HRD+KPDN+L+ GH+KL DFG +G++ D
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM-----------KMNKEGMVRCD----- 201
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAES 726
+AVGTPDY++PE+L +G DWWSVG+ L+E + G PF A+S
Sbjct: 202 ----------TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251
Query: 727 PEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
+ I+N K + +P +D+S EA++LI FL D RLG NG E+K H FFK
Sbjct: 252 LVGTYSKIMNHKNSLTFP-DDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKN 309
Query: 785 VN--WDSLALQKAVFVPQPESVDDTSYF 810
W++L A VP S DTS F
Sbjct: 310 DQWAWETLRDTVAPVVPDLSSDIDTSNF 337
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 220 bits (561), Expect = 1e-64
Identities = 120/320 (37%), Positives = 181/320 (56%), Gaps = 34/320 (10%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 559
K I +G+FG+V LAR + +A+KVL+K +++K + + I++ERN+L+ V++PF+V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 560 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 619
+SF D LY V++Y+NGG+L+ L++ C E AR Y AE+ AL YLHSL IV+R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 620 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 679
DLKP+N+L+ GHI LTDFGL K + I N
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK---------------ENIEH------------NGTT 153
Query: 680 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739
+ GTP+YLAPE+L + DWW +G +L+E + G+PPF + + ++DNILN+
Sbjct: 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK-- 211
Query: 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQKAV-- 796
P P +++ A+ L+ L D +RLGA + E+K H FF +NWD L +K
Sbjct: 212 PLQLKP-NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPP 270
Query: 797 FVPQPESVDDTSYFLSRFSQ 816
F P +D +F F++
Sbjct: 271 FNPNVSGPNDLRHFDPEFTE 290
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 2e-64
Identities = 124/333 (37%), Positives = 180/333 (54%), Gaps = 42/333 (12%)
Query: 485 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDL--FAIKVLKKLDMIRKNDIERI 542
K + +DF I+ + G+FGRV LA + D AIK +K +I++ ++ +
Sbjct: 20 EPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKN-EDFPPVAIKRFEKSKIIKQKQVDHV 78
Query: 543 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 602
+ER IL + +PF V + SF LYLV+E++ GG+ ++ LR+ DV Y A
Sbjct: 79 FSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAA 138
Query: 603 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 662
++VL EYL SL IV+RDLKP+NLL+ DG IK+TDFG +K+
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV------------------ 180
Query: 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 722
D R ++ GTP+Y+APEILL HG AADWW++GI ++E + G PPF
Sbjct: 181 -----------VDTRT-YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPF 228
Query: 723 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHP 780
A P +I+ IL I + P + + L+ + L HD +R G GA VK HP
Sbjct: 229 YANEPLLIYQKILEGIIYF---PKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285
Query: 781 FFKGVNWDSLALQKAVFVP-QP--ESVDDTSYF 810
+F ++W SL L K V VP +P ++V D+S F
Sbjct: 286 WFGNIDWVSL-LHKNVEVPYKPKYKNVFDSSNF 317
|
Length = 340 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 216 bits (552), Expect = 2e-63
Identities = 121/345 (35%), Positives = 187/345 (54%), Gaps = 43/345 (12%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVR 559
K I +G+FG+V LA+++ G +A+KVL+K ++ + + + I+AERN+L+ V++PF+V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 560 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 619
YSF + LY V++++NGG+L+ L++ E AR Y AE+ AL YLHS+ IV+R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 620 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 679
DLKP+N+L+ GH+ LTDFGL K +GI SD
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK---------------EGIAQSD------------TT 153
Query: 680 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739
+ GTP+YLAPE++ + DWW +G +L+E + G+PPF ++DNIL++ +
Sbjct: 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL 213
Query: 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQK--AV 796
+ S A ++ L D +RLGA E++ HPFF+ ++W L +K
Sbjct: 214 ---VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPP 270
Query: 797 FVPQPESVDDTSYFLSRFSQ--------ISSGLPDDQNGSYSDAD 833
F P E DD S F + F++ SS N S +AD
Sbjct: 271 FNPNVEGPDDISNFDAVFTEETVPYSVCFSSD-YSIVNASVLEAD 314
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 217 bits (555), Expect = 3e-63
Identities = 125/324 (38%), Positives = 183/324 (56%), Gaps = 37/324 (11%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+D++++K I RGAFG V L R +++ ++A+K+L K +MI+++D ER+I+ +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
P+VV+ F +F LY+VMEY+ GGDL +L+ + E A+ Y AE+VLAL+ +HS+
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSM 161
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
G++HRD+KPDN+L+ GH+KL DFG M D +T
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTC-------------------MKMD-------ET 195
Query: 675 DNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAESPEII 730
+AVGTPDY++PE+L +G DWWSVG+ LFE + G PF A+S
Sbjct: 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT 255
Query: 731 FDNILNRKIPWPCVPSD--MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG--VN 786
+ I++ K P D +S A++LI FL D RLG NG E+K HPFFK N
Sbjct: 256 YSKIMDHKNSL-NFPEDVEISKHAKNLICAFLT-DREVRLGRNGVEEIKQHPFFKNDQWN 313
Query: 787 WDSLALQKAVFVPQPESVDDTSYF 810
WD++ A VP+ S D+S F
Sbjct: 314 WDNIRETAAPVVPELSSDIDSSNF 337
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 3e-63
Identities = 119/351 (33%), Positives = 192/351 (54%), Gaps = 48/351 (13%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVR 559
K + +G+FG+V LA + G+ FA+K LKK ++ +D+E + E+ +L + NPF+
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 560 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 619
+ +F +++L+ VME+LNGGDL ++ G + A Y AE+V L++LHS GI++R
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120
Query: 620 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 679
DLK DN+++ DGHIK+ DFG+ K + DNR
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFG--------------------------DNRAS 154
Query: 680 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739
+ GTPDY+APEIL G ++ ++ DWWS G++L+E + G PF + + +F++I ++
Sbjct: 155 -TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI---RV 210
Query: 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQK--AVF 797
P P ++ E++D++ + DP +RLG G ++ HPFFK +NW +L ++ F
Sbjct: 211 DTPHYPRWITKESKDILEKLFERDPTRRLGVVG--NIRGHPFFKTINWTALEKRELDPPF 268
Query: 798 VPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDEC 848
P+ +S D S F F L + SYSD + DS MD+
Sbjct: 269 KPKVKSPSDYSNFDREF------LSEKPRLSYSDKNLIDS-------MDQS 306
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 8e-63
Identities = 93/276 (33%), Positives = 151/276 (54%), Gaps = 34/276 (12%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
+EIIK I +G+FG+V+L R+++ G L+ +K + +M K + E L E IL + +P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK-EREDALNEVKILKKLNHP 59
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC----LEEDVARIYIAELVLALEYL 611
+++++ SF + L +VMEY +GGDL ++K E+ + +L LAL+YL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
HS I+HRD+KP N+ + +G +KL DFG+SK+ +++T+DL+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLA----------------- 160
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731
+ VGTP YL+PE+ + Y +D WS+G +L+E T PF E+ +
Sbjct: 161 --------KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212
Query: 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
IL + P P PS S E ++L++ L DP +R
Sbjct: 213 LKILKGQYP-PI-PSQYSSELRNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 2e-62
Identities = 118/339 (34%), Positives = 188/339 (55%), Gaps = 48/339 (14%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFF 561
I RG++ +V L + T ++A+KV+KK + DI+ + E+++ T N PF+V
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 562 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 621
F L+ V+E+++GGDL +++ L E+ AR Y AE+ LAL +LH GI++RDL
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDL 122
Query: 622 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 681
K DN+L+ +GHIKLTD+G+ K +GI P D +
Sbjct: 123 KLDNVLLDAEGHIKLTDYGMCK---------------EGIRPGDT------------TST 155
Query: 682 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF----TAESPE-----IIFD 732
GTP+Y+APEIL G ++G++ DWW++G+++FE + G PF +++P+ +F
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQ 215
Query: 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN---GAAEVKAHPFFKGVNWDS 789
IL ++I +P +S +A ++ FL DP +RLG + G ++K+HPFF+ ++WD
Sbjct: 216 VILEKQIR---IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDL 272
Query: 790 LALQKAV---FVPQPESVDDTSYFLSRFSQISSGL-PDD 824
L QK V + P ES D F +F+ L PDD
Sbjct: 273 LE-QKQVLPPYKPNIESDRDLDNFDPQFTDEPVQLTPDD 310
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 5e-62
Identities = 98/290 (33%), Positives = 149/290 (51%), Gaps = 41/290 (14%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
FEI++ I +G FG V+ AR + TG AIKV+K + K E+I+ E IL ++P
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIK---LESKEKKEKIINEIQILKKCKHP 57
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSL 614
+V+++ S+ +D L++VME+ +GG L LL+ L E EL+ LEYLHS
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
GI+HRD+K N+L+ DG +KL DFGLS Q +
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSA----------------------------QLS 149
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDN 733
D + R++ VGTP ++APE++ G + Y AD WS+GI E G PP++ P + +F
Sbjct: 150 DTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF-- 207
Query: 734 ILNRKIPWPCVPSDM--SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
P + + S E +D + + L +P +R A ++ HPF
Sbjct: 208 -KIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP---TAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 6e-61
Identities = 88/154 (57%), Positives = 120/154 (77%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 552
SI++F I+KPISRGAFG+V+L RK+ L+A+KV+KK DMI KN + ++ AER+ L
Sbjct: 2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS 61
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 612
++PF+V +YS +N+YLVMEYL GGD+ SLL G +E++A YI+E+ LAL+YLH
Sbjct: 62 KSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646
GI+HRDLKPDN+LI+++GHIKLTDFGLSK+ L
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL 155
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 203 bits (519), Expect = 2e-59
Identities = 96/304 (31%), Positives = 149/304 (49%), Gaps = 35/304 (11%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
+ +G FG V + + TG ++A K L K + ++ + L E+ IL V + F+V Y
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRD 620
+F +D+L LVM +NGGDL + VG E A Y A+++ LE+LH IV+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 621 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 680
LKP+N+L+ G+++++D GL+ ++
Sbjct: 121 LKPENVLLDDHGNVRISDLGLA-----------------------VELKGGKKI-----K 152
Query: 681 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 740
GTP Y+APE+L G + ++ DW+++G L+E I G PF ++ + + R +
Sbjct: 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212
Query: 741 WPC-VPSDMSFEAQDLINRFLIHDPNQRLGANG--AAEVKAHPFFKGVNWDSLALQKAV- 796
P S EA+DL L DP +RLG G A EV+ HP FK +NW L
Sbjct: 213 MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEP 272
Query: 797 -FVP 799
F+P
Sbjct: 273 PFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 204 bits (519), Expect = 6e-59
Identities = 111/335 (33%), Positives = 183/335 (54%), Gaps = 35/335 (10%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRN 554
DF + + +G+FG+V LA ++ T +L+AIK+LKK +I+ +D+E + E+ +L ++ +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
PF+ + F D LY VMEY+NGGDL +++VG +E A Y AE+ + L +LHS
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
GI++RDLK DN+++ +GHIK+ DFG+ K + DG+
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW-----------DGV------------- 156
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734
+ GTPDY+APEI+ +G + DWW+ G++L+E + G PF E + +F +I
Sbjct: 157 ---TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213
Query: 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLAL 792
+ + + P MS EA + + P +RLG G ++K H FF+ ++W+ L
Sbjct: 214 MEHNVAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLER 270
Query: 793 QKAVFVPQPESVD-DTSYFLSRFSQISSGL-PDDQ 825
++ +P++ D F F++ L P DQ
Sbjct: 271 KEVQPPYKPKACGRDAENFDKFFTRHPPVLTPPDQ 305
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 202 bits (514), Expect = 3e-58
Identities = 120/341 (35%), Positives = 191/341 (56%), Gaps = 50/341 (14%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFF 561
I RG++ +V L R + ++A+KV+KK + DI+ + E+++ NPF+V
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 562 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 621
F L+LV+EY+NGGDL +++ L E+ AR Y AE+ +AL +LH GI++RDL
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDL 122
Query: 622 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 681
K DN+L+ DGHIKLTD+G+ K +G+ P D +
Sbjct: 123 KLDNVLLDADGHIKLTDYGMCK---------------EGLGPGD------------TTST 155
Query: 682 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF--TAESPEI-----IFDNI 734
GTP+Y+APEIL G E+G++ DWW++G+++FE + G PF ++P++ +F I
Sbjct: 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI 215
Query: 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLA 791
L + I +P +S +A ++ FL DP +RLG G +++K+H FF+ ++WD L
Sbjct: 216 LEKPIR---IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLE 272
Query: 792 LQKAVFVP-QPESVDDTSYFLSRF-SQISSG----LPDDQN 826
+K V P +P+ DD Y L F +Q +S PDD++
Sbjct: 273 -KKQVTPPFKPQITDD--YGLENFDTQFTSEPVQLTPDDED 310
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 201 bits (511), Expect = 9e-58
Identities = 116/340 (34%), Positives = 187/340 (55%), Gaps = 46/340 (13%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFF 561
I RG++ +V L R + T ++A+KV+KK + DI+ + E+++ N PF+V
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 562 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL 621
F L+ V+EY+NGGDL +++ L E+ AR Y AE+ LAL YLH GI++RDL
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDL 122
Query: 622 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 681
K DN+L+ +GHIKLTD+G+ K +G+ P D +
Sbjct: 123 KLDNVLLDSEGHIKLTDYGMCK---------------EGLRPGDT------------TST 155
Query: 682 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF----TAESP-----EIIFD 732
GTP+Y+APEIL G ++G++ DWW++G+++FE + G PF ++++P + +F
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 215
Query: 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDS 789
IL ++I +P +S +A ++ FL DP +RLG G A+++ HPFF+ V+WD
Sbjct: 216 VILEKQIR---IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDL 272
Query: 790 LALQKAV--FVPQPESVDDTSYFLSRFSQISSGL-PDDQN 826
+ ++ V F P F ++F+ L PDD +
Sbjct: 273 MEQKQVVPPFKPNISGEFGLDNFDAQFTNEPVQLTPDDDD 312
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 199 bits (506), Expect = 4e-57
Identities = 102/299 (34%), Positives = 169/299 (56%), Gaps = 33/299 (11%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRN 554
DF + + +G+FG+V LA ++ T +L+AIK+LKK +I+ +D+E + E+ +L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
PF+ + F D LY VMEY+NGGDL +++VG +E A Y AE+ + L +LH
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
GI++RDLK DN+++ +GHIK+ DFG+ K ++ DG+
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV-----------DGV------------- 156
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734
+ GTPDY+APEI+ +G + DWW+ G++L+E + G PPF E + +F +I
Sbjct: 157 ---TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213
Query: 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLA 791
+ + + P +S EA + + P++RLG G +++ H FF+ ++WD L
Sbjct: 214 MEHNVSY---PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLE 269
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 3e-56
Identities = 95/281 (33%), Positives = 136/281 (48%), Gaps = 69/281 (24%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
+ G FG V+LAR + TG AIK++KK D + +E +L E IL + +P +V+ +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDL 621
F ++LYLVMEY GG L LL++ G L ED + +++ LEYLHS GI+HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 622 KPDNLLIAHD-GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 680
KP+N+L+ D G +KL DFGLSK+ +D
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLL---------------------------TSDKSLLK 151
Query: 681 SAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739
+ VGTP Y+APE+LLG + +D WS+G+IL+E
Sbjct: 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE------------------------- 186
Query: 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 780
+ E +DLI + L DP +R A E+ H
Sbjct: 187 --------LP-ELKDLIRKMLQKDPEKRPSAK---EILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 4e-53
Identities = 93/295 (31%), Positives = 147/295 (49%), Gaps = 39/295 (13%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
D E +K + +G+ G V+ R + TG ++A+K + + +++L E L + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG--DEEFRKQLLRELKTLRSCES 58
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS- 613
P+VV+ + +F + +V+EY++GG L LL+KVG + E V +++ L+YLH+
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
I+HRD+KP NLLI G +K+ DFG+SK+ + NT+D
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLD--------------------- 155
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEII-- 730
++ VGT Y++PE + G + YAAD WS+G+ L E G PF P
Sbjct: 156 ----QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211
Query: 731 FDNILNRKIP-WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
I + P P + S E +D I+ L DP +R AAE+ HPF K
Sbjct: 212 MQAICDGPPPSLP--AEEFSPEFRDFISACLQKDPKKRP---SAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 3e-52
Identities = 99/284 (34%), Positives = 146/284 (51%), Gaps = 33/284 (11%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
I G FG+V+ A TG+L A+K ++ D K I+ I E +L +++P +V+++
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKT-IKEIADEMKVLELLKHPNLVKYYG 66
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 622
R+ +Y+ MEY +GG L LL L+E V R+Y +L+ L YLHS GIVHRD+K
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126
Query: 623 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 682
P N+ + H+G IKL DFG + + + E Q S
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVK----------------LKNNTTTMGEEVQ-------SL 163
Query: 683 VGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGIPPFTAESPE--IIFDNILNR 737
GTP Y+APE++ G + HG AAD WS+G ++ E TG P++ E I+F
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH 223
Query: 738 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
K P P +S E +D ++R L DP +R A+E+ HPF
Sbjct: 224 KPPIP-DSLQLSPEGKDFLDRCLESDPKKRP---TASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 6e-52
Identities = 94/289 (32%), Positives = 148/289 (51%), Gaps = 37/289 (12%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
++ ++ I GA G V+ A R TG AIK ++ +RK + E I+ E I+ ++P
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPN 76
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSL 614
+V ++ S+ D L++VMEY++GG L ++ V E +A + E++ LEYLHS
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYV-CREVLQGLEYLHSQ 135
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
++HRD+K DN+L++ DG +KL DFG + L+
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQ--------LT-------------------K 168
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734
+ R+S VGTP ++APE++ ++G D WS+GI+ E G PP+ E P I
Sbjct: 169 EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLI 228
Query: 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+ IP P S E +D +N+ L+ DP +R A E+ HPF K
Sbjct: 229 TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP---SAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (452), Expect = 4e-50
Identities = 99/312 (31%), Positives = 152/312 (48%), Gaps = 35/312 (11%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 614
VV Y++ +D L LV+ +NGGDL + +G +E+ A Y AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
IV+RDLKP+N+L+ GHI+++D GL+ PE +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLA-----------------------VEIPEGETI 158
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734
R VGT Y+APE++ + ++ DWW +G +++E I G PF ++ + +
Sbjct: 159 RGR-----VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV 213
Query: 735 LNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSL- 790
R S+ S A+ + + L DP RLG GA EVKAHPFF+ N+ L
Sbjct: 214 ERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLE 273
Query: 791 -ALQKAVFVPQP 801
+ + F P P
Sbjct: 274 AGMLEPPFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 2e-49
Identities = 81/287 (28%), Positives = 143/287 (49%), Gaps = 33/287 (11%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
++++ I RGAFG V+ TGD AIK + I++ ++ I+ E ++L +++P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHP 59
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 615
+V++ S D+LY+++EY G L +++K G E + +Y+ +++ L YLH G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
++HRD+K N+L DG +KL DFG++
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKL---------------------------NDV 152
Query: 676 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 735
+++ S VGTP ++APE++ + A+D WS+G + E +TG PP+ +P I+
Sbjct: 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212
Query: 736 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
P +P +S E +D + + DPN R A ++ HP+
Sbjct: 213 QD--DHPPLPEGISPELKDFLMQCFQKDPNLRP---TAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 4e-49
Identities = 105/313 (33%), Positives = 157/313 (50%), Gaps = 37/313 (11%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 614
VV Y++ +D L LV+ +NGGDL + +G EE+ A Y AE++ LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLS-KIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
V+RDLKP+N+L+ GHI+++D GL+ KI PE + I
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGLAVKI-----------PEGESI------------ 158
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733
R R VGT Y+APE+L + + D+W +G +++E I G PF ++ +
Sbjct: 159 ---RGR---VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212
Query: 734 ILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSL 790
+ R + V + S EA+ + L DP QRLG GA EVK HPFF+ +N+ L
Sbjct: 213 VDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRL 272
Query: 791 --ALQKAVFVPQP 801
+ FVP P
Sbjct: 273 EAGMLDPPFVPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 4e-49
Identities = 88/282 (31%), Positives = 138/282 (48%), Gaps = 35/282 (12%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLD--MIRKNDIERILAERNILITVRNPFVVRF 560
+ G+FG V+ GD FA+K + D + ++++ E +L +++P +V++
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 561 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 620
+ DNLY+ +E + GG L LL+K G E V R+Y +++L LEYLH VHRD
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRD 127
Query: 621 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 680
+K N+L+ +G +KL DFG++K Q +
Sbjct: 128 IKGANILVDTNGVVKLADFGMAK----------------------------QVVEFSFAK 159
Query: 681 SAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739
S G+P ++APE++ +G AAD WS+G + E TG PP++ I K
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE 219
Query: 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
P +P +S EA+D I + L DP+ R AAE+ HPF
Sbjct: 220 -LPPIPDHLSDEAKDFILKCLQRDPSLRP---TAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 177 bits (449), Expect = 7e-49
Identities = 117/403 (29%), Positives = 180/403 (44%), Gaps = 45/403 (11%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-N 554
+ I++ + G+FG V+LAR R A+KVL K + ++ER L E IL ++
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVLALEYL 611
P +V+ + F +LYLVMEY++GG L LL+K G L E A +A+++ ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 612 HSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
HS GI+HRD+KP+N+L+ DG +KL DFGL+K+ P
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL---------------------LPDPG 156
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPFTAES- 726
+ ++VGTP Y+APE+LLG Y ++D WS+GI L+E +TG+PPF E
Sbjct: 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216
Query: 727 ---PEIIFDNILNRKIPWPCVPSDMSF------EAQDLINRFLIHDPNQRLGANGA--AE 775
IL P P S A DL+ + L DP RL ++ +
Sbjct: 217 SSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276
Query: 776 VKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTC 835
+ AH K + L + +S + ++ D + + +
Sbjct: 277 LLAHLKLKESDLSDLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKEL 336
Query: 836 DSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASIN 878
+ S + L + SL S ++ S +
Sbjct: 337 APNGVSSSP-HNSSSLLLSTASSKRSSLPKISARSSPSSLSSS 378
|
Length = 384 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 1e-48
Identities = 89/289 (30%), Positives = 144/289 (49%), Gaps = 34/289 (11%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ F +++ I +G+FG V+ A + T + AIKV+ L+ +++IE I E L R+
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVID-LEE-AEDEIEDIQQEIQFLSQCRS 58
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
P++ +++ SF L+++MEY GG LL K G L+E + E++L LEYLH
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
G +HRD+K N+L++ +G +KL DFG+S G + +T+
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVS--GQLTSTMS---------------------- 153
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734
R++ VGTP ++APE++ + + AD WS+GI E G PP + P + I
Sbjct: 154 ---KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210
Query: 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
P + S +D ++ L DP +R A E+ H F K
Sbjct: 211 PKNNPP-SLEGNKFSKPFKDFVSLCLNKDPKERPSAK---ELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 1e-47
Identities = 103/301 (34%), Positives = 152/301 (50%), Gaps = 41/301 (13%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVR 559
I RG FG V+ RK TG ++A+K L K + K L ER +L V PF+V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 560 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 619
Y+F D L +++ +NGGDL+ L + G E R Y AE++L LE++H+ +V+R
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121
Query: 620 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 679
DLKP N+L+ GH++++D GL+ D S +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLA--------CDFS---------------------KKKP 152
Query: 680 HSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPF---TAESPEIIFDNIL 735
H++VGT Y+APE+L G + +ADW+S+G +LF+ + G PF + I L
Sbjct: 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212
Query: 736 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ 793
+ P S E + L+ L D N+RLG GA EVK HPFF+ ++W + LQ
Sbjct: 213 TMAVELP---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269
Query: 794 K 794
K
Sbjct: 270 K 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 168 bits (426), Expect = 1e-46
Identities = 103/313 (32%), Positives = 154/313 (49%), Gaps = 37/313 (11%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 614
VV Y++ +D L LV+ +NGGDL + +G EE A Y AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
IV+RDLKP+N+L+ GHI+++D GL+ H PE Q
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLA-----------------------VHVPEGQTI 158
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734
R VGT Y+APE++ + ++ DWW++G +L+E I G PF +I + +
Sbjct: 159 KGR-----VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 213
Query: 735 --LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG--AAEVKAHPFFKGVNWDSL 790
L +++ S +A+ L L DP +RLG G A EVK HP FK +N+ L
Sbjct: 214 ERLVKEVQEE-YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRL 272
Query: 791 A--LQKAVFVPQP 801
+ + F P P
Sbjct: 273 EAGMLEPPFKPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 90/306 (29%), Positives = 153/306 (50%), Gaps = 36/306 (11%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
+ +G FG V + R TG L+A K L K + ++ E + E+ IL V + F+V Y
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 563 SFTCRDNLYLVMEYLNGGDL----YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 618
+F + +L LVM +NGGDL Y++ + E A Y A+++ LE+LH I++
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 619 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 678
RDLKP+N+L+ +DG+++++D GL+ E + ++
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAV--------------------------ELKDGQSKT 154
Query: 679 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 738
+ A GTP ++APE+L G E+ ++ D++++G+ L+E I PF A ++ + R
Sbjct: 155 KGYA-GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI 213
Query: 739 IPWPCVPSD-MSFEAQDLINRFLIHDPNQRLG-ANGA-AEVKAHPFFKGVNWDSL--ALQ 793
+ D S ++ L DP +RLG +G ++ HP F+ +NW L +
Sbjct: 214 LNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGML 273
Query: 794 KAVFVP 799
FVP
Sbjct: 274 PPPFVP 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 2e-45
Identities = 106/303 (34%), Positives = 157/303 (51%), Gaps = 45/303 (14%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVR 559
I RG FG V+ RK TG ++A+K L K + K L ER +L V PF+V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 560 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 619
Y+F D L +++ +NGGDL+ L + G E R Y E++L LE++H+ +V+R
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121
Query: 620 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 679
DLKP N+L+ GH++++D GL+ D S +
Sbjct: 122 DLKPANILLDEHGHVRISDLGLA--------CDFS---------------------KKKP 152
Query: 680 HSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPF----TAESPEIIFDNI 734
H++VGT Y+APE+L GT + +ADW+S+G +LF+ + G PF T + EI D +
Sbjct: 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRM 210
Query: 735 -LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLA 791
L + +P S E + L+ L D ++RLG GA EVK H FFKG++W +
Sbjct: 211 TLTVNVE---LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVY 267
Query: 792 LQK 794
LQK
Sbjct: 268 LQK 270
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 4e-45
Identities = 88/299 (29%), Positives = 142/299 (47%), Gaps = 43/299 (14%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-DIERILAERNILITVR 553
DD+E+I+ I GA V+ A + AIK ++D+ + ++ + E +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIK---RIDLEKCQTSVDELRKEVQAMSQCN 57
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---KVGCLEEDVARIYIAELVLALEY 610
+P VV+++ SF D L+LVM YL+GG L +++ G L+E + + E++ LEY
Sbjct: 58 HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEY 117
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
LHS G +HRD+K N+L+ DG +K+ DFG+S A +
Sbjct: 118 LHSNGQIHRDIKAGNILLGEDGSVKIADFGVS-----------------------ASLAD 154
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESPE 728
+ R + VGTP ++APE+ + HGY AD WS GI E TG P++ P
Sbjct: 155 GGDRTRKVRKTFVGTPCWMAPEV-MEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM 213
Query: 729 IIFDNILNRKIPWPCVPSDMSFEA-----QDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
+ L P + + ++ + +I+ L DP++R A E+ H FF
Sbjct: 214 KVLMLTLQN--DPPSLETGADYKKYSKSFRKMISLCLQKDPSKR---PTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 6e-45
Identities = 99/319 (31%), Positives = 147/319 (46%), Gaps = 70/319 (21%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITV 552
+E ++ + G +G V+ AR + TG++ A+K ++ LD N+ E I L E ++L +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR-LD----NEEEGIPSTALREISLLKEL 55
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYL 611
++P +V+ LYLV EY + DL L K G L ++ + + +L+ L Y
Sbjct: 56 KHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYC 114
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
HS I+HRDLKP N+LI DG +KL DFGL++ I P + E
Sbjct: 115 HSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI---------------PLRTYTHE- 158
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI- 729
V T Y APEILLG++H A D WSVG I E ITG P F +S EI
Sbjct: 159 -----------VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS-EID 206
Query: 730 ----IFD-----------------NILNRKIPWPCVP-----SDMSFEAQDLINRFLIHD 763
IF + +P + E DL+++ L ++
Sbjct: 207 QLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYN 266
Query: 764 PNQRLGANGAAEVKAHPFF 782
P +R+ A A + HP+F
Sbjct: 267 PAKRISAKEALK---HPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 7e-45
Identities = 97/320 (30%), Positives = 139/320 (43%), Gaps = 68/320 (21%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND--IERILAERNILITVR 553
++I+ I GA G VF A+ R TG+ A+K K+ + R + L E L +
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALK---KVALRRLEGGIPNQALREIKALQACQ 57
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLH 612
+P+VV+ F LVMEY+ DL +LR L E + Y+ L+ + Y+H
Sbjct: 58 HPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
+ GI+HRDLKP NLLI+ DG +K+ DFGL++ + +
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLAR-----------------LFSEEEPRLYSH 159
Query: 673 QTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES----- 726
Q V T Y APE+L G D W+VG I E + G P F E+
Sbjct: 160 Q---------VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL 210
Query: 727 ---------------PE---------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIH 762
P I F ++ IP + D S EA DL+ L++
Sbjct: 211 AIVFRTLGTPNEETWPGLTSLPDYNKITFPE--SKPIPLEEIFPDASPEALDLLKGLLVY 268
Query: 763 DPNQRLGANGAAEVKAHPFF 782
DP++RL AAE HP+F
Sbjct: 269 DPSKRL---SAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 8e-44
Identities = 98/312 (31%), Positives = 150/312 (48%), Gaps = 35/312 (11%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
F + + +G FG V + R TG ++A K L+K + ++ L E+ IL V + F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 614
VV Y++ +D L LV+ +NGGDL + +G +E A Y AEL LE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
IV+RDLKP+N+L+ GHI+++D GL+ PE +
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLA-----------------------VQIPEGETV 158
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734
R VGT Y+APE++ ++ ++ DWW +G +++E I G PF + + +
Sbjct: 159 RGR-----VGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEV 213
Query: 735 LNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLA 791
R K S +A+ + L +P +RLG NGAA VK HP FK +N+ L
Sbjct: 214 DRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLE 273
Query: 792 --LQKAVFVPQP 801
+ + F P P
Sbjct: 274 ANMLEPPFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 85/286 (29%), Positives = 143/286 (50%), Gaps = 47/286 (16%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
D+E+++ I +G+FG V R+++ G + K + +M K + +++++E NIL +++P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-EKQQLVSEVNILRELKHP 59
Query: 556 FVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALE 609
+VR++ R N LY+VMEY GGDL L++K +EE+ + +L+LAL
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 610 YLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 664
H+ ++HRDLKP N+ + + ++KL DFGL+KI
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-------------------- 159
Query: 665 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 724
D+ + VGTP Y++PE L + +D WS+G +++E PPFTA
Sbjct: 160 -------LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212
Query: 725 ESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQR 767
+ L KI + +P S E ++I L DP++R
Sbjct: 213 RNQL-----QLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 2e-43
Identities = 84/292 (28%), Positives = 140/292 (47%), Gaps = 42/292 (14%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ F+I++ + G++G V+ A + TG + AIKV+ + D++ I+ E +IL +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV-----EEDLQEIIKEISILKQCDS 57
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGG---DLYSLLRKVGCLEEDVARIYIAELVLALEYL 611
P++V+++ S+ +L++VMEY G D+ + K L E+ + + + LEYL
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT--LTEEEIAAILYQTLKGLEYL 115
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
HS +HRD+K N+L+ +G KL DFG+S
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ--------------------------- 148
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EII 730
R++ +GTP ++APE++ + AD WS+GI E G PP++ P I
Sbjct: 149 LTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI 208
Query: 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
F I N+ P P S E D + + L+ DP +R A ++ HPF
Sbjct: 209 F-MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEER---PSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-42
Identities = 70/131 (53%), Positives = 89/131 (67%), Gaps = 3/131 (2%)
Query: 683 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 742
+GTPDYLAPE+LLG HG A DWW++G+ LFEF+TGIPPF E+P+ +F NILNR IPWP
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 743 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPE 802
+S AQ+ I L DP +R G E+K HP F GV+W++L Q F+PQP+
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLK---ELKQHPLFHGVDWENLQNQTMPFIPQPD 657
Query: 803 SVDDTSYFLSR 813
DTSYF +R
Sbjct: 658 DETDTSYFEAR 668
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 98/299 (32%), Positives = 138/299 (46%), Gaps = 51/299 (17%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+D+E+I+ I G +G V+ AR TG+L AIKV+K + +D E I E ++L R+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIK---LEPGDDFEIIQQEISMLKECRH 59
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGG---DLYSLLRKVGCLEEDVARIYIA----ELVLA 607
P +V +F S+ RD L++VMEY GG D+Y + R G L E IA E +
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQ----IAYVCRETLKG 113
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
L YLH G +HRD+K N+L+ DG +KL DFG+S + TI
Sbjct: 114 LAYLHETGKIHRDIKGANILLTEDGDVKLADFGVS--AQLTATI---------------- 155
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGY--AADWWSVGIILFEFITGIPPFTA 724
R S +GTP ++APE + + GY D W++GI E PP
Sbjct: 156 ---------AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206
Query: 725 ESPEIIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
P I P P + S D I + L DP +R A ++ HPF
Sbjct: 207 LHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKR---PTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 6e-42
Identities = 89/294 (30%), Positives = 144/294 (48%), Gaps = 39/294 (13%)
Query: 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 550
R+ +D+F I G+ G V +A ++TG A+K K+D+ ++ E + E I+
Sbjct: 18 RSYLDNF---VKIGEGSTGIVCIATDKSTGRQVAVK---KMDLRKQQRRELLFNEVVIMR 71
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALE 609
++P +V + S+ D L++VME+L GG L ++ EE +A + VL AL
Sbjct: 72 DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLAVLKALS 129
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 669
+LH+ G++HRD+K D++L+ DG +KL+DFG + +P
Sbjct: 130 FLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA-------------QVSKEVP------ 170
Query: 670 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 729
R S VGTP ++APE++ +G D WS+GI++ E + G PP+ E P
Sbjct: 171 --------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ 222
Query: 730 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
I + P +S + ++R L+ DP QR AAE+ HPF
Sbjct: 223 AMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA---TAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 80/292 (27%), Positives = 140/292 (47%), Gaps = 45/292 (15%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI--LAERNILITVR 553
DF+++K + +G++G V+ ++ + +A LK++D+ + ER + E IL +V
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYA---LKEVDLGSMSQKEREDAVNEIRILASVN 57
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL-----EEDVARIYIAELVLAL 608
+P ++ + +F + L +VMEY GDL + K E+++ RI+I +L+ L
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI-QLLRGL 116
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
+ LH I+HRDLK N+L+ + +K+ D G+SK+
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIGDLGISKV------------------------ 152
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 728
+ +GTP Y+APE+ G + Y +D WS+G +L+E T PPF A S +
Sbjct: 153 -----LKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ 207
Query: 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 780
+ + K +P +P S + Q+ I L P R + ++ A P
Sbjct: 208 DLRYKVQRGK--YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCD---KILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 102/325 (31%), Positives = 148/325 (45%), Gaps = 77/325 (23%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--TVRN 554
+E I I G +G+V+ AR + TG+L A LKK+ M + + I A R I + +R+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVA---LKKIRMENEKEGFPITAIREIKLLQKLRH 57
Query: 555 PFVVRFFYSFTCRD--NLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYL 611
P +VR T + ++Y+V EY++ DL LL E + Y+ +L+ L+YL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYL 116
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
HS GI+HRD+K N+LI +DG +KL DFGL++ Y +
Sbjct: 117 HSNGILHRDIKGSNILINNDGVLKLADFGLAR-----------------------PYTKR 153
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP--- 727
D NR V T Y PE+LLG T +G D WSVG IL E G P F +
Sbjct: 154 NSADYTNR---VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ 210
Query: 728 -EIIFD-----NILNRKIPWPCVPSDMSF------------------------EAQDLIN 757
E IF+ N WP V S + + A DL++
Sbjct: 211 LEKIFELCGSPTDEN----WPGV-SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLD 265
Query: 758 RFLIHDPNQRLGANGAAEVKAHPFF 782
+ L DP +R+ A+ A + H +F
Sbjct: 266 KLLTLDPKKRISADQALQ---HEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 149 bits (377), Expect = 3e-40
Identities = 97/301 (32%), Positives = 151/301 (50%), Gaps = 46/301 (15%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
DD E + + G G V R TG + A+K ++ L+ I + ++IL E +IL +
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIR-LE-INEAIQKQILRELDILHKCNS 58
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDV-ARIYIAELVLALEYLH 612
P++V F+ +F ++ + MEY++GG L +L++V G + E + +I +A ++ L YLH
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA-VLKGLTYLH 117
Query: 613 S-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
I+HRD+KP N+L+ G IKL DFG+S L+N+
Sbjct: 118 EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ-LVNSLAK------------------- 157
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--SPEI 729
+ VGT Y+APE + G ++ +D WS+G+ L E TG P+ E P+
Sbjct: 158 ---------TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG 208
Query: 730 IFD---NILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785
IF+ I+N P P +PS S + QD +N LI DP +R E+ HPF K
Sbjct: 209 IFELLQYIVNE--PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYK---ELLEHPFIKKY 263
Query: 786 N 786
Sbjct: 264 E 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 9e-40
Identities = 91/317 (28%), Positives = 148/317 (46%), Gaps = 65/317 (20%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI--LITVRN 554
++ + I G +G V+ AR + TG++ AIK K+ + +++ A R I L + +
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIK---KIKLRFESEGIPKTALREIKLLKELNH 57
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHS 613
P +++ F + +LYLV E+++ DLY L++ L E + + Y+ +L+ L + HS
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
GI+HRDLKP+NLLI +G +KL DFGL++ Y Y
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARS----------------FGSPVRPYTHY-- 158
Query: 674 TDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES------ 726
V T Y APE+LLG + D WSVG I E ++ P F +S
Sbjct: 159 ---------VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF 209
Query: 727 --------------PEII---FDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPN 765
P+ + + +P P + + S +A DL+++ L +DP+
Sbjct: 210 KIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPH 269
Query: 766 QRLGANGAAEVKAHPFF 782
+R+ A A AHP+F
Sbjct: 270 KRITAEQAL---AHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-39
Identities = 88/325 (27%), Positives = 145/325 (44%), Gaps = 67/325 (20%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITVRN 554
+E++KPI GA+G V A + TG AIK K+ + + I+ RIL E +L +R+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIK---KISNVFDDLIDAKRILREIKLLRHLRH 58
Query: 555 PFVVR---FFY--SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 609
++ S +++Y+V E + DL+ +++ L +D + ++ +++ L+
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 669
YLHS ++HRDLKP N+L+ + +K+ DFGL++ + + G +
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD-------EDEKGFLT------ 164
Query: 670 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP- 727
EY V T Y APE+LL + A D WSVG I E +T P F
Sbjct: 165 EY-----------VVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI 213
Query: 728 ---EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLINRFL 760
+I + I + K P + S EA DL+ + L
Sbjct: 214 DQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKML 273
Query: 761 IHDPNQRLGANGAAEVKAHPFFKGV 785
+ DP +R+ A E AHP+ +
Sbjct: 274 VFDPKKRI---TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 87/285 (30%), Positives = 139/285 (48%), Gaps = 32/285 (11%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKVLK--KLDMIRKNDIERILAERNILITVRNPFVV 558
K + +GAFGRV+L TG A+K + K ++ + E +L +++ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67
Query: 559 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 618
+++ + L + MEY+ GG + L+ G L E V R Y +++ +EYLHS IVH
Sbjct: 68 QYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVH 127
Query: 619 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 678
RD+K N+L G++KL DFG SK TI SG T +
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASK---RLQTICSSG------------------TGMK- 165
Query: 679 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNILNR 737
S GTP +++PE++ G +G AD WSVG + E +T PP+ E+ IF +
Sbjct: 166 --SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK--IAT 221
Query: 738 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
+ P +PS +S +A++ + R + + +R A E+ H F
Sbjct: 222 QPTNPQLPSHVSPDARNFLRRTFVENAKKR---PSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 87/304 (28%), Positives = 148/304 (48%), Gaps = 36/304 (11%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
+ +G FG V + + TG ++A K L K + +K+ + L E+ IL V +PF+V Y
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLGIVHRD 620
+F + +L LVM +NGGDL + VG ++ R+ Y A++ + +LHS+ IV+RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 621 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 680
+KP+N+L+ G+ +L+D GL+ + + R
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLA-----------------------VELKDGKTITQR--- 154
Query: 681 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 740
GT Y+APEIL + Y DW+++G ++E + G PF ++ + + R +
Sbjct: 155 --AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212
Query: 741 WPCVPSDMSF--EAQDLINRFLIHDPNQRLGANGAA-EVKAHPFFKGVNWDSLALQKAVF 797
+F E++D+ FL P RLG+ + + H FFK +N+ L +A
Sbjct: 213 DEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRL---EAGL 269
Query: 798 VPQP 801
+P P
Sbjct: 270 IPPP 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 7e-38
Identities = 96/320 (30%), Positives = 143/320 (44%), Gaps = 71/320 (22%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI--LITV-R 553
+++IK + G FG V+LAR + TG+L AIK +KK + E + R + L +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKK----KFYSWEECMNLREVKSLRKLNE 56
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYL 611
+P +V+ F D LY V EY+ G +LY L+ RK E V R I +++ L ++
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHI 115
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
H G HRDLKP+NLL++ +K+ DFGL++ E P Y +Y
Sbjct: 116 HKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-------------EIRSRPP----YTDY 158
Query: 672 QQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPF--TAESPE 728
V T Y APEILL T + D W++G I+ E T P F ++E +
Sbjct: 159 -----------VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQ 207
Query: 729 I--IFD-----------------NILNRKIPWPCVPSDMSF-------EAQDLINRFLIH 762
+ I + L + P P+ + EA DLI L
Sbjct: 208 LYKICSVLGTPTKQDWPEGYKLASKLGFRFP-QFAPTSLHQLIPNASPEAIDLIKDMLRW 266
Query: 763 DPNQRLGANGAAEVKAHPFF 782
DP +R A++ HP+F
Sbjct: 267 DPKKRP---TASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 8e-38
Identities = 73/234 (31%), Positives = 114/234 (48%), Gaps = 34/234 (14%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD---MIRKNDIERILAERNILITVR 553
+E++ + GA+G V R + TG++ AIK K+ + ++K L E +L +R
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKT----ALREVKVLRQLR 58
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 613
+ +V +F + LYLV EY+ L L G L D R YI +L+ A+ Y HS
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
I+HRD+KP+N+L++ G +KL DFG ++ L + +Y
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARA--------LRA-------RPASPLTDY-- 161
Query: 674 TDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 726
V T Y APE+L+G T +G D W++G I+ E + G P F +S
Sbjct: 162 ---------VATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 86/295 (29%), Positives = 143/295 (48%), Gaps = 39/295 (13%)
Query: 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 553
D +EII + GAFG+V+ A+ + TG A K++ + + ++E + E +IL +
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKII---QIESEEELEDFMVEIDILSECK 60
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLH 612
+P +V + ++ + L++++E+ +GG L S++ ++ L E R +++ AL +LH
Sbjct: 61 HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLH 120
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
S ++HRDLK N+L+ DG +KL DFG+S
Sbjct: 121 SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK-------------------------- 154
Query: 673 QTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP 727
T + R + +GTP ++APE++ + Y AD WS+GI L E PP +P
Sbjct: 155 STLQK-RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213
Query: 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
+ IL + P PS S D + L+ DP+ R AAE+ HPF
Sbjct: 214 MRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP---TAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 8e-37
Identities = 83/275 (30%), Positives = 139/275 (50%), Gaps = 34/275 (12%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
DFEI+ I +G+FG VF ++ ++A+K + M R+ + E + E +L + +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR-EREEAIDEARVLAKLDSS 59
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLALEYLH 612
+++R++ SF + L +VMEY GDL+ LL R E+ V R +I +++L L +LH
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
S I+HRD+K NL + ++K+ D G++K+ L +NT +
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKL-LSDNTN-------------------FA 158
Query: 673 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732
T VGTP YL+PE+ + +D W++G++L+E TG PF A + +
Sbjct: 159 NT-------IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALIL 211
Query: 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
I+ +P V S + LI++ L D QR
Sbjct: 212 KIIRGV--FPPVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 1e-36
Identities = 92/303 (30%), Positives = 136/303 (44%), Gaps = 50/303 (16%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
FE+++ I G +G+V+ AR + TG L AIK++ I +++ E I E NIL N
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSN 61
Query: 555 -PFVVRFFYSF------TCRDNLYLVMEYLNGG---DLYSLLRKVG-CLEEDVARIYIAE 603
P + F+ +F D L+LVME GG DL LRK G L+E+ + E
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 604 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
+ L YLH ++HRD+K N+L+ + +KL DFG+S
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-------------------- 161
Query: 664 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITG 718
+ T R R++ +GTP ++APE++ E + +D WS+GI E G
Sbjct: 162 ------QLDSTLGR-RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214
Query: 719 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778
PP P I P P + S + D I+ LI + QR E+
Sbjct: 215 KPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQR---PFMEELLE 271
Query: 779 HPF 781
HPF
Sbjct: 272 HPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 5e-36
Identities = 98/319 (30%), Positives = 139/319 (43%), Gaps = 66/319 (20%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITV 552
+E K + G + V+ AR + TG + AIK +K + RK + I L E +L +
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGE--RKEAKDGINFTALREIKLLQEL 59
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYL 611
++P ++ F + N+ LV E++ DL +++ K L + Y+ + LEYL
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYL 118
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
HS I+HRDLKP+NLLIA DG +KL DFGL++ S
Sbjct: 119 HSNWILHRDLKPNNLLIASDGVLKLADFGLAR-----------------SFGS------- 154
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP--- 727
NR V T Y APE+L G H G D WSVG I E + +P +S
Sbjct: 155 ---PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ 211
Query: 728 -EIIFDNILNRKIP--WPCVPSDMSF--------------------EAQDLINRFLIHDP 764
IF L WP V S + +A DL+ R L +P
Sbjct: 212 LGKIF-EALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNP 270
Query: 765 NQRLGANGAAEVKAHPFFK 783
N+R+ A A E HP+F
Sbjct: 271 NKRITARQALE---HPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 90/281 (32%), Positives = 134/281 (47%), Gaps = 34/281 (12%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
I +GA G V+ A TG AIK + +K E I+ E ++ ++P +V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 622
S+ D L++VMEYL GG L ++ + C++E E + ALE+LHS ++HRD+K
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 142
Query: 623 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 682
DN+L+ DG +KLTDFG I P + R +
Sbjct: 143 SDNILLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 175
Query: 683 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 742
VGTP ++APE++ +G D WS+GI+ E + G PP+ E+P I P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
Query: 743 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
P +S +D +NR L D +R A E+ HPF K
Sbjct: 236 QNPEKLSAIFRDFLNRCLEMDVEKR---GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 79/280 (28%), Positives = 140/280 (50%), Gaps = 37/280 (13%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVR 559
I RGA+G V+ + TG + A+K++ LD +D+ I E +L +R P + +
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIIN-LDT-PDDDVSDIQREVALLSQLRQSQPPNITK 66
Query: 560 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 619
++ S+ L+++MEY GG + +L+ K G + E + I E+++AL+Y+H +G++HR
Sbjct: 67 YYGSYLKGPRLWIIMEYAEGGSVRTLM-KAGPIAEKYISVIIREVLVALKYIHKVGVIHR 125
Query: 620 DLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 679
D+K N+L+ + G++KL DFG++ Q ++ R
Sbjct: 126 DIKAANILVTNTGNVKLCDFGVAA--------------------------LLNQNSSK-R 158
Query: 680 HSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 738
+ VGTP ++APE++ G + AD WS+GI ++E TG PP++ I K
Sbjct: 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK 218
Query: 739 IPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVK 777
P + + S ++ + L +P +RL A + K
Sbjct: 219 PPR--LEDNGYSKLLREFVAACLDEEPKERLSAEELLKSK 256
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 95/297 (31%), Positives = 151/297 (50%), Gaps = 47/297 (15%)
Query: 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 550
RT +D+F IK I G+ G V +A +++G L A+K K+D+ ++ E + E I+
Sbjct: 19 RTYLDNF--IK-IGEGSTGIVCIATVKSSGKLVAVK---KMDLRKQQRRELLFNEVVIMR 72
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 610
++ VV + S+ D L++VME+L GG L ++ EE +A + +A L AL
Sbjct: 73 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLK-ALSV 131
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
LH+ G++HRD+K D++L+ HDG +KL+DFG ++ +
Sbjct: 132 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFC--AQVSKEV------------------- 170
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP--- 727
R S VGTP ++APE++ +G D WS+GI++ E + G PP+ E P
Sbjct: 171 ------PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 224
Query: 728 -EIIFDNILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
++I DN+ + K PS F ++R L+ DP QR A E+ HPF
Sbjct: 225 MKMIRDNLPPKLKNLHKVSPSLKGF-----LDRLLVRDPAQRATAA---ELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 91/296 (30%), Positives = 146/296 (49%), Gaps = 39/296 (13%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
+EII + GAFG+V+ A+ + TG L A KV+ + + ++E + E IL T +P+
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYMVEIEILATCNHPY 70
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLG 615
+V+ +F L++++E+ GG + +++ ++ L E ++ +++ AL+YLHS+
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
I+HRDLK N+L+ DG IKL DFG+S N L
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSA----KNVKTL---------------------- 164
Query: 676 NRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730
+ R S +GTP ++APE+++ T + Y AD WS+GI L E PP +P +
Sbjct: 165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 223
Query: 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786
I + P PS S E +D + L P R AA++ HPF V
Sbjct: 224 LLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETR---PSAAQLLEHPFVSSVT 276
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 2e-34
Identities = 92/281 (32%), Positives = 138/281 (49%), Gaps = 34/281 (12%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
I +GA G VF A TG AIK ++++ ++ E I+ E ++ ++NP +V F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIK---QINLQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 622
SF D L++VMEYL GG L ++ + C++E E + ALE+LH+ ++HRD+K
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIK 142
Query: 623 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 682
DN+L+ DG +KLTDFG I P + R +
Sbjct: 143 SDNVLLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 175
Query: 683 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 742
VGTP ++APE++ +G D WS+GI+ E + G PP+ E+P I P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
Query: 743 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
P +S +D +NR L D +R A E+ HPF K
Sbjct: 236 QNPEKLSPIFRDFLNRCLEMDVEKR---GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 89/281 (31%), Positives = 138/281 (49%), Gaps = 34/281 (12%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
I +GA G V+ A TG AIK ++++ ++ E I+ E ++ +NP +V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIK---QMNLQQQPKKELIINEILVMRENKNPNIVNYLD 83
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 622
S+ D L++VMEYL GG L ++ + C++E E + AL++LHS ++HRD+K
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQVIHRDIK 142
Query: 623 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 682
DN+L+ DG +KLTDFG I P + R +
Sbjct: 143 SDNILLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 175
Query: 683 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 742
VGTP ++APE++ +G D WS+GI+ E + G PP+ E+P I P
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPEL 235
Query: 743 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
P +S +D +NR L D ++R A E+ HPF K
Sbjct: 236 QNPERLSAVFRDFLNRCLEMDVDRR---GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 5e-34
Identities = 100/323 (30%), Positives = 156/323 (48%), Gaps = 68/323 (21%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERILAERNILITVRN- 554
+EI++ + +GA+G V+ A R T ++ A+K K D R D +R E L + +
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALK--KIFDAFRNATDAQRTFREIMFLQELGDH 66
Query: 555 PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYL 611
P +V+ ++ +YLV EY+ DL++++R LE DV + YI +L+ AL+Y+
Sbjct: 67 PNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRA-NILE-DVHKRYIMYQLLKALKYI 123
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID-LSGPETDGIMPSDAHYPE 670
HS ++HRDLKP N+L+ D +KL DFGL++ ++ L + ++ +
Sbjct: 124 HSGNVIHRDLKPSNILLNSDCRVKLADFGLAR------SLSELEENPENPVLT------D 171
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITG---------- 718
Y V T Y APEILLG+ Y D WSVG IL E + G
Sbjct: 172 Y-----------VATRWYRAPEILLGSTR-YTKGVDMWSVGCILGEMLLGKPLFPGTSTL 219
Query: 719 ---------IPPFTAE------SP--EIIFDNILNRKI-PWPCVPSDMSFEAQDLINRFL 760
I P +AE SP + D++ +R P + S +A DL+ + L
Sbjct: 220 NQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLL 279
Query: 761 IHDPNQRLGANGAAEVKAHPFFK 783
+ +PN+RL A A E HP+
Sbjct: 280 VFNPNKRLTAEEALE---HPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 8e-34
Identities = 96/332 (28%), Positives = 139/332 (41%), Gaps = 91/332 (27%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVR-- 553
+E + I GA+G V+ AR TG A LKK+ + L+E I L T+R
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVA---LKKVRVP--------LSEEGIPLSTLREI 49
Query: 554 ----------NPFVVRFF-YSFTCRDN----LYLVMEYLNGGDLYSLLRKV---GCLEED 595
+P +VR R + L LV E+++ DL + L K G L +
Sbjct: 50 ALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG-LPPE 107
Query: 596 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655
+ + +L+ +++LHS IVHRDLKP N+L+ DG +K+ DFGL++I
Sbjct: 108 TIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI----------- 156
Query: 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 715
Y + S V T Y APE+LL + + D WSVG I E
Sbjct: 157 ------------Y-----SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
Query: 716 ITGIPPFTAESPEI-----IFDNI---------LNRKIPWPCVPS-----------DMSF 750
P F S E IFD I N +P PS ++
Sbjct: 200 FRRRPLFRGTS-EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICE 258
Query: 751 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
E DL+ + L +P++R+ A E HP+F
Sbjct: 259 EGLDLLKKMLTFNPHKRI---SAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-33
Identities = 88/294 (29%), Positives = 150/294 (51%), Gaps = 41/294 (13%)
Query: 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 550
R+ ++++ IK I G+ G V +AR++ +G A+K++ D+ ++ E + E I+
Sbjct: 20 RSLLENY--IK-IGEGSTGIVCIAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMR 73
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALE 609
++ VV + S+ + L+++ME+L GG L ++ + EE +A + E VL AL
Sbjct: 74 DYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATV--CESVLQALC 131
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL-SKIGLINNTIDLSGPETDGIMPSDAHY 668
YLHS G++HRD+K D++L+ DG +KL+DFG ++I
Sbjct: 132 YLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI------------------------ 167
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 728
D R S VGTP ++APE++ T +G D WS+GI++ E + G PP+ ++SP
Sbjct: 168 ----SKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV 223
Query: 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
+ + P +S +D + R L +P +R A E+ HPF
Sbjct: 224 QAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQER---ATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 79/282 (28%), Positives = 134/282 (47%), Gaps = 36/282 (12%)
Query: 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 553
+ +F+I K I +G F V+ A G + A+K ++ +M+ + L E ++L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALE 609
+P V+++ SF + L +V+E + GDL +++ + E Y +L ALE
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 669
++HS I+HRD+KP N+ I G +KL D GL + S T
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRF--------FSSKTTAA--------- 163
Query: 670 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 729
HS VGTP Y++PE + + + +D WS+G +L+E PF + +
Sbjct: 164 ----------HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213
Query: 730 --IFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRL 768
+ I K +P +P+D S E +DL++R + DP +R
Sbjct: 214 YSLCKKI--EKCDYPPLPADHYSEELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 89/281 (31%), Positives = 136/281 (48%), Gaps = 34/281 (12%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
I +GA G V+ A TG AI+ ++++ ++ E I+ E ++ +NP +V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIR---QMNLQQQPKKELIINEILVMRENKNPNIVNYLD 84
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 622
S+ D L++VMEYL GG L ++ + C++E E + ALE+LHS ++HRD+K
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 623 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 682
DN+L+ DG +KLTDFG I P + R +
Sbjct: 144 SDNILLGMDGSVKLTDFGFCA----------------QITP-----------EQSKRSTM 176
Query: 683 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 742
VGTP ++APE++ +G D WS+GI+ E I G PP+ E+P I P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL 236
Query: 743 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
P +S +D +NR L D +R A E+ H F K
Sbjct: 237 QNPEKLSAIFRDFLNRCLDMDVEKR---GSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-33
Identities = 86/289 (29%), Positives = 142/289 (49%), Gaps = 39/289 (13%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA--ERNILITVRN 554
+ I+ + +GAFG L R+ L V K++++ R ++ ER A E IL +++
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLV---VWKEVNLTRLSEKERRDALNEIVILSLLQH 58
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYLH 612
P ++ ++ F + L + MEY NGG LY + +K EE++ Y+ ++V A+ Y+H
Sbjct: 59 PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
GI+HRD+K N+ + G IKL DFG+SKI + S+ E
Sbjct: 119 KAGILHRDIKTLNIFLTKAGLIKLGDFGISKI-----------------LGSEYSMAE-- 159
Query: 673 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732
+ VGTP Y++PE+ G ++ + +D W++G +L+E +T F A +P +
Sbjct: 160 --------TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV 211
Query: 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
I+ + V S S E L++ L DP +R A EV P
Sbjct: 212 KIVQGN--YTPVVSVYSSELISLVHSLLQQDPEKR---PTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 77/280 (27%), Positives = 125/280 (44%), Gaps = 41/280 (14%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILITV 552
E+ K + GAFG V+ + G+ A+K LK+ + E L E +I+ +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEE--EREEFLEEASIMKKL 58
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIA-ELVLAL 608
+P +VR T + LY+V EY+ GGDL LRK G L++ + +A ++ +
Sbjct: 59 SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKD---LLQMALQIAKGM 115
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
EYL S VHRDL N L+ + +K++DFGLS+ I D
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRD----------------IYEDD--- 156
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 727
Y++ ++APE L + +D WS G++L+E T G P+ S
Sbjct: 157 -YYRKRGG-----GKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN 210
Query: 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
E + + + + P P + E +L+ + +DP R
Sbjct: 211 EEVLELLEDGYRL-PR-PENCPDELYELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 6e-33
Identities = 85/289 (29%), Positives = 145/289 (50%), Gaps = 40/289 (13%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIK------VLKKLDMIRKNDIERILAERNILITVRNPF 556
I G+FG V+L ++G+L A+K V +++ ++ + E +L +++
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 616
+V++ S D+L + +EY+ GG + +LL G EE + R ++ +++ L YLH+ GI
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 617 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 676
+HRD+K N+L+ + G IK++DFG+SK N+ N
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISKKLEANSLS---------------------TKTN 166
Query: 677 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF-TAESPEIIF---D 732
R S G+ ++APE++ T + AD WS+G ++ E +TG PF + IF +
Sbjct: 167 GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE 226
Query: 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
N P +PS++S EA D + + D N+R AAE+ HPF
Sbjct: 227 NAS------PEIPSNISSEAIDFLEKTFEIDHNKR---PTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-33
Identities = 74/279 (26%), Positives = 144/279 (51%), Gaps = 36/279 (12%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--TVRN 554
+ +K I G+FG+ L + + G + V+K++++ + + ER + + + + +++
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQY---VIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYLH 612
P +V++ SF NLY+VM+Y GGDLY + ++ ED + ++ LAL+++H
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH 118
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
I+HRD+K N+ + DG IKL DFG++++ +N+T++L+
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELA------------------ 158
Query: 673 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732
+ +GTP YL+PEI + +D W++G +L+E T F A + + +
Sbjct: 159 -------RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211
Query: 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 771
I+ +P V S S++ ++L+++ +P R N
Sbjct: 212 KIIRGS--YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVN 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 94/301 (31%), Positives = 143/301 (47%), Gaps = 46/301 (15%)
Query: 497 FEIIKP--ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL-------AERN 547
F+ +K I +G +GRV+LA TTG++ A+K ++ I R +E
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 548 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 607
L + + +V++ T + L + +EY+ GG + S LR G EE + R + +++
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG 120
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
L YLHS GI+HRDLK DNLL+ DG K++DFG+SK SD
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGICKISDFGISK-------------------KSDDI 161
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPF-TA 724
Y DN S G+ ++APE++ GY+A D WS+G ++ E G P+
Sbjct: 162 Y------DNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215
Query: 725 ESPEIIFDNILNRKIPWPCVPSD----MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 780
E+ +F L K P +P D +S A D +N +P+ R A E+ HP
Sbjct: 216 EAIAAMFK--LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTAR---ELLQHP 270
Query: 781 F 781
F
Sbjct: 271 F 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 6e-32
Identities = 74/282 (26%), Positives = 118/282 (41%), Gaps = 48/282 (17%)
Query: 498 EIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 553
+ K + GAFG V+ + A+K LK+ + IE L E I+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKLD 59
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL------- 606
+P VV+ T + LY+VMEY+ GGDL S LRK ++ +++L+
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP------KLSLSDLLSFALQIAR 113
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
+EYL S +HRDL N L+ + +K++DFGLS+
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL--------------------- 152
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 725
+ R + ++APE L + +D WS G++L+E T G P+
Sbjct: 153 --YDDDYYRKRGGKLPI---RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGM 207
Query: 726 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
S E + + + N P + E DL+ + DP R
Sbjct: 208 SNEEVLEYLKNGYRLPQ--PPNCPPELYDLMLQCWAEDPEDR 247
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 6e-32
Identities = 69/280 (24%), Positives = 110/280 (39%), Gaps = 43/280 (15%)
Query: 498 EIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 553
+ K + GAFG V+ A+K LK+ IE L E I+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASE--QQIEEFLREARIMRKLD 59
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY-----IAELVLAL 608
+P +V+ T + L +VMEY+ GGDL LRK E ++ + IA +
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR---GM 116
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
EYL S +HRDL N L+ + +K++DFGLS+
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL----------------------- 153
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 727
+ + + ++APE L + +D WS G++L+E T G P+ S
Sbjct: 154 YDDDYYKVKGGKLPI---RWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN 210
Query: 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
+ + + P + E L+ + DP R
Sbjct: 211 AEVLEYLKKGYRLPK--PPNCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 8e-32
Identities = 76/280 (27%), Positives = 116/280 (41%), Gaps = 42/280 (15%)
Query: 501 KPISRGAFGRVFLAR---KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 557
K + GAFG V+ + K A+K LK+ + + + L E ++ + +P V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNV 58
Query: 558 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---------AL 608
VR T + LYLV+EY+ GGDL LRK + + ++ L +
Sbjct: 59 VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
EYL S VHRDL N L+ D +K++DFGLS+ ++ T G +P
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK---TGGKLP----- 170
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 727
R ++APE L +D WS G++L+E T G P+ S
Sbjct: 171 -------IR----------WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213
Query: 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
E + + + P P E +L+ DP R
Sbjct: 214 EEVLEYLRKGYRL-PK-PEYCPDELYELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 84/279 (30%), Positives = 126/279 (45%), Gaps = 47/279 (16%)
Query: 506 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 565
G +V L T F +K L+K + ER +I P +V
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSR--------ERLTIIPHCVPNMVCLHKYIV 55
Query: 566 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 625
D+++LV+++ GG L+S + K + E+ + + AE+V+AL+ LH GIV RDL P+N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 626 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGT 685
+L+ GHI+LT F E + +A +N
Sbjct: 116 ILLDDRGHIQLTYFS-------------RWSEVEDSCDGEA-------VENM-------- 147
Query: 686 PDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVP 745
Y APE+ +E A DWWS+G ILFE +TG I LN +P
Sbjct: 148 --YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLN-------IP 198
Query: 746 SDMSFEAQDLINRFLIHDPNQRLGANGAA--EVKAHPFF 782
+S EA+ L+ + L +P +RLGA A ++K+HPFF
Sbjct: 199 EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 89/321 (27%), Positives = 138/321 (42%), Gaps = 74/321 (23%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--- 553
++I+ I G F V A+ R TG +AIK +KK +E++ R I R
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56
Query: 554 NPFVVRF----FYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLAL 608
+P ++R F T R L LV E ++ +LY L++ + L E + Y+ +L+ +L
Sbjct: 57 HPNILRLIEVLFDRKTGR--LALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSL 113
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
+++H GI HRD+KP+N+LI D +KL DFG + I P Y
Sbjct: 114 DHMHRNGIFHRDIKPENILI-KDDILKLADFGSCR------GIYSKPP-----------Y 155
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE-- 725
EY + T Y APE LL +G D W+VG + FE ++ P F
Sbjct: 156 TEY-----------ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204
Query: 726 --------------SPEIIFD----NILNRKIP------WPCVPSDMSFEAQDLINRFLI 761
E++ +N P + + S E DL+ + L
Sbjct: 205 LDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLA 264
Query: 762 HDPNQRLGANGAAEVKAHPFF 782
+DP++R+ A A HP+F
Sbjct: 265 YDPDERITAKQALR---HPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 101/347 (29%), Positives = 148/347 (42%), Gaps = 113/347 (32%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI------LAER 546
S+D++E + I G +G V+ AR + TG++ A LKKL K + E+ L E
Sbjct: 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVA---LKKL----KMEKEKEGFPITSLREI 55
Query: 547 NILITVRNPFVVRFFYSFTCR--------DNLYLVMEYLNGGDLYSLLR---------KV 589
NIL+ +++P +V T + D +Y+VMEY+ DL SL+ +V
Sbjct: 56 NILLKLQHPNIV------TVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEV 108
Query: 590 GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649
CL + +L+ + +LH I+HRDLK NLL+ + G +K+ DFGL++
Sbjct: 109 KCL--------MLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAR------ 154
Query: 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSV 708
EY + V T Y APE+LLG E+ A D WSV
Sbjct: 155 --------------------EYGSP-LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSV 193
Query: 709 GIILFEFITGIPPFTAESP----EIIFD-----------------------------NIL 735
G I E +T P F +S IF N L
Sbjct: 194 GCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQL 253
Query: 736 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
+K P +S DL+NR L +DP +R+ A A + HP+F
Sbjct: 254 RKKFP----ALSLSDNGFDLLNRLLTYDPAKRISAEDALK---HPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 90/293 (30%), Positives = 144/293 (49%), Gaps = 37/293 (12%)
Query: 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 550
R +D F IK I G+ G V +A ++ TG A+K K+D+ ++ E + E I+
Sbjct: 21 REYLDSF--IK-IGEGSTGIVCIATEKHTGKQVAVK---KMDLRKQQRRELLFNEVVIMR 74
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 610
+ VV + S+ D L++VME+L GG L ++ EE +A + ++ ++ AL Y
Sbjct: 75 DYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLS-VLRALSY 133
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
LH+ G++HRD+K D++L+ DG IKL+DFG + +P
Sbjct: 134 LHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCA-------------QVSKEVP------- 173
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730
R S VGTP ++APE++ +G D WS+GI++ E I G PP+ E P
Sbjct: 174 -------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA 226
Query: 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
I + P +S + ++ L+ +P+QR A E+ HPF K
Sbjct: 227 MRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRA---TAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 8e-31
Identities = 83/290 (28%), Positives = 133/290 (45%), Gaps = 38/290 (13%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND---IERILAERNILITVRNPFVVR 559
+ GAF + AR TG L A+K + + +E + E ++ + +P ++R
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 560 FFYSFTCRDNLY-LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 618
TC D+ + L +E++ GG + LL K G +E V Y +L+ L YLH I+H
Sbjct: 68 M-LGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 619 RDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 677
RD+K NLLI G +++ DFG + + +G E G +
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAA--ARLAAKGTGAG-EFQGQL--------------- 168
Query: 678 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDN 733
+GT ++APE+L G ++G + D WSVG ++ E T PP+ AE +IF
Sbjct: 169 -----LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF-K 222
Query: 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
I + P +P +S +D+ R L P R + E+ HP F+
Sbjct: 223 IASATTA-PSIPEHLSPGLRDVTLRCLELQPEDR---PPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 8e-31
Identities = 98/343 (28%), Positives = 152/343 (44%), Gaps = 78/343 (22%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
DDFE + + G G V R +G + A K L L+ I+ +I+ E +L +
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARK-LIHLE-IKPAIRNQIIRELKVLHECNS 58
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-ARIYIAELVLALEYLHS 613
P++V F+ +F + + ME+++GG L +L+K G + E++ +I IA ++ L YL
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA-VLRGLTYLRE 117
Query: 614 -LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
I+HRD+KP N+L+ G IKL DFG+S LI++ +
Sbjct: 118 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-LIDSMAN-------------------- 156
Query: 673 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESPEI 729
S VGT Y++PE L GT + +D WS+G+ L E G IPP A+ E
Sbjct: 157 --------SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA 208
Query: 730 IF---------------------------------DNILNRKIPWPCVPSD-MSFEAQDL 755
+F D I+N P P +PS S E QD
Sbjct: 209 MFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNE--PPPKLPSGAFSDEFQDF 266
Query: 756 INRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFV 798
+++ L +P +R E+ HPF K + + A +V
Sbjct: 267 VDKCLKKNPKERA---DLKELTKHPFIK--RAELEEVDFAGWV 304
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 95/323 (29%), Positives = 147/323 (45%), Gaps = 77/323 (23%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERI----LAERNILIT 551
++ ++ I G +G V+ AR + TG++ A LKK IR + + E + + E ++L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVA---LKK---IRLETEDEGVPSTAIREISLLKE 54
Query: 552 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALE 609
+ +P +VR + LYLV E+L+ DL + L+ + + Y+ +L+ +
Sbjct: 55 LNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 669
Y HS ++HRDLKP NLLI +G +KL DFGL++ G+ P
Sbjct: 114 YCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF--------------GV-------P 152
Query: 670 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESP 727
T H V T Y APEILLG+ Y D WS+G I E + P F +S
Sbjct: 153 VRTYT-----HEVV-TLWYRAPEILLGSRQ-YSTPVDIWSIGCIFAEMVNRRPLFPGDS- 204
Query: 728 EI-----IFDNILN--RKIPWPCVPSDMSF---------------------EAQDLINRF 759
EI IF L + WP V S + + DL+++
Sbjct: 205 EIDQLFRIF-RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKM 263
Query: 760 LIHDPNQRLGANGAAEVKAHPFF 782
L++DP +R+ A A + HP+F
Sbjct: 264 LVYDPAKRISAKAALQ---HPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 2e-30
Identities = 86/333 (25%), Positives = 140/333 (42%), Gaps = 81/333 (24%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIK--------------VLKKLDMIRKNDIE 540
++ I+ I GA+G V A +G AIK L++L ++R +
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 541 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 600
I+A R+IL F ++Y+VM+ L DL+ ++ L E+ R +
Sbjct: 65 NIIAIRDILRPPGADF-----------KDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYF 112
Query: 601 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 660
+ +L+ L+Y+HS ++HRDLKP NLL+ D +++ DFG+++ GL ++ +
Sbjct: 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMAR-GLSSSPTEHKY----- 166
Query: 661 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFI--- 716
EY V T Y APE+LL E+ A D WSVG I E +
Sbjct: 167 ------FMTEY-----------VATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209
Query: 717 ------------------TGIPP------FTAESPEIIFDNILNRK-IPWPCVPSDMSFE 751
G P ++ N+ ++ +PW + S E
Sbjct: 210 QLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPE 269
Query: 752 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
A DL+++ L DP +R+ A + HPF
Sbjct: 270 ALDLLSQMLQFDPEERITVEQALQ---HPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 84/287 (29%), Positives = 136/287 (47%), Gaps = 47/287 (16%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTG-DLFAIK-------VLKKLDMIRKNDIERILAERNI 548
+ +++ + GAFG V+ RK+ G +L A+K K R I I++E I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 549 LI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNG---GDLYSLLRKVG--CLEEDVARIYIA 602
+ +R+P +VR++ +F D LY+VM+ + G G+ ++ L++ EE + I++
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV- 120
Query: 603 ELVLALEYLH-SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 661
++VLAL YLH IVHRDL P+N+++ D + +TDFGL+K
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------------------ 162
Query: 662 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 721
Q+ S VGT Y PEI+ +G AD W+ G IL++ T PP
Sbjct: 163 ----------QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212
Query: 722 FTAESPEIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQR 767
F + + + I+ + +P M S + D+I L D R
Sbjct: 213 FYSTNMLSLATKIVEAV--YEPLPEGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 4e-30
Identities = 90/300 (30%), Positives = 136/300 (45%), Gaps = 60/300 (20%)
Query: 496 DFEIIKPI--SRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 553
+ EI+K + G FG+V + + + T LF K++K + N IE V
Sbjct: 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF---NAIE---------PMVH 62
Query: 554 -----NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 608
NP ++ +YS T L+M+Y+ GDL+ LL+K G L E + I +LV AL
Sbjct: 63 QLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEAL 122
Query: 609 EYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
LH I+H D+K +N+L I L D+GL KI I T D
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKI--IG---------TPSCY--D-- 167
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 727
GT DY +PE + G + + DWW+VG++ +E +TG PF +
Sbjct: 168 ----------------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED 211
Query: 728 EII-FDNILNR---KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
E + +++L R K+P ++S A D + L ++ N RL E+ HPF K
Sbjct: 212 EELDLESLLKRQQKKLP---FIKNVSKNANDFVQSMLKYNINYRL--TNYNEIIKHPFLK 266
|
Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 84/287 (29%), Positives = 141/287 (49%), Gaps = 39/287 (13%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
F ++ I +G+FG V+ T ++ AIK++ + +++IE I E +L +P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 616
+ R++ S+ L+++MEYL GG LL K G LEE + E++ L+YLHS
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 617 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 676
+HRD+K N+L++ G +KL DFG++ Q TD
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG----------------------------QLTDT 154
Query: 677 R-NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDNI 734
+ R++ VGTP ++APE++ + + + AD WS+GI E G PP + P ++F +
Sbjct: 155 QIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF--L 212
Query: 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
+ + P P + S ++ + L DP R A E+ H F
Sbjct: 213 IPKNSP-PTLEGQYSKPFKEFVEACLNKDPRFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 6e-30
Identities = 95/330 (28%), Positives = 139/330 (42%), Gaps = 79/330 (23%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI--LAERNILI 550
S+ +FE + I G +G V+ AR T+G++ A LKK+ M + D I L E +L+
Sbjct: 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVA---LKKVRMDNERDGIPISSLREITLLL 61
Query: 551 TVRNPFVVRFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLA 607
+R+P +V + D+++LVMEY DL SLL + E + + +L+
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRG 120
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
L+YLH I+HRDLK NLL+ G +K+ DFGL++
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART---------------------YG 159
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 726
P T V T Y APE+LLG T + A D W+VG IL E + P +S
Sbjct: 160 LPAKPMTPK------VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKS 213
Query: 727 P----EIIFD-----------------------------NILNRKIPWPCVPSDMSFEAQ 753
++I N L K PW +S
Sbjct: 214 EIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPW------LSEAGL 267
Query: 754 DLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
L+N L++DP +R A E +FK
Sbjct: 268 RLLNFLLMYDPKKRA---TAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 6e-30
Identities = 83/233 (35%), Positives = 119/233 (51%), Gaps = 29/233 (12%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI-ERILAERNILITVR 553
+ FE++ + GA+G V R + T ++ AIK K D ++ E L E +L T++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFK--DSEENEEVKETTLRELKMLRTLK 58
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 613
+V +F R LYLV EY+ L L + + R YI +L+ A+ + H
Sbjct: 59 QENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHK 118
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
IVHRD+KP+NLLI+H+ +KL DFG ++ +LS +G S+A+Y EY
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFAR--------NLS----EG---SNANYTEY-- 161
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 726
V T Y +PE+LLG +G A D WSVG IL E G P F ES
Sbjct: 162 ---------VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 96/330 (29%), Positives = 148/330 (44%), Gaps = 72/330 (21%)
Query: 473 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVL--KK 530
S S SS S+ S+ S+ + E + I GA G V+ R TG L+A+KV+
Sbjct: 52 SSSSSSSSSSASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH 111
Query: 531 LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 590
D +R+ +I E IL V +P VV+ F + +++E+++GG L +
Sbjct: 112 EDTVRR----QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG--THIA 165
Query: 591 CLEE--DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648
+ DVAR +++ + YLH IVHRD+KP NLLI ++K+ DFG+S+I +
Sbjct: 166 DEQFLADVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LA 219
Query: 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-----LGTEHGYAA 703
T+D P + S+VGT Y++PE + G GYA
Sbjct: 220 QTMD----------PCN---------------SSVGTIAYMSPERINTDLNHGAYDGYAG 254
Query: 704 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPW------------PCVPSDMSFE 751
D WS+G+ + EF G PF + R+ W P P+ S E
Sbjct: 255 DIWSLGVSILEFYLGRFPFG-----------VGRQGDWASLMCAICMSQPPEAPATASRE 303
Query: 752 AQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
+ I+ L +P +R A ++ HPF
Sbjct: 304 FRHFISCCLQREPAKRWSAM---QLLQHPF 330
|
Length = 353 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 3e-29
Identities = 87/293 (29%), Positives = 143/293 (48%), Gaps = 39/293 (13%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ +EII + GAFG+V+ A+ + TG L A KV+ D + ++E + E +IL + +
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVI---DTKSEEELEDYMVEIDILASCDH 61
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHS 613
P +V+ +F +NL++++E+ GG + +++ ++ L E R+ + + AL YLH
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
I+HRDLK N+L DG IKL DFG+S NT +
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSA----KNTRTI-------------------- 157
Query: 674 TDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 728
+ R S +GTP ++APE+++ + Y AD WS+GI L E PP +P
Sbjct: 158 ---QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM 214
Query: 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
+ I + P PS S E +D + + L + + R ++ HPF
Sbjct: 215 RVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARW---TTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-29
Identities = 85/302 (28%), Positives = 136/302 (45%), Gaps = 52/302 (17%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKV--LKKLDMIRKNDIERILAERNILITV 552
+D E I + G G V + TG + A KV + +RK +IL E I+
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRK----QILRELQIMHEC 60
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 612
R+P++V F+ +F +N+ + ME+++ G L + +K G + ++ +V L YL+
Sbjct: 61 RSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLY 120
Query: 613 S-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
+ I+HRD+KP N+L+ G IKL DFG+S LIN+ D
Sbjct: 121 NVHRIMHRDIKPSNILVNSRGQIKLCDFGVSG-ELINSIAD------------------- 160
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA------- 724
+ VGT Y++PE + G ++ +D WS+GI + E G PF
Sbjct: 161 ---------TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211
Query: 725 -ESPEIIFD---NILNRKIPWPCVPS-DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779
+ P I D I+ P P +PS D + +D ++ L+ DP +R
Sbjct: 212 QDDPMGILDLLQQIVQE--PPPRLPSSDFPEDLRDFVDACLLKDPTER--PTPQQLCAMP 267
Query: 780 PF 781
PF
Sbjct: 268 PF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 92/328 (28%), Positives = 142/328 (43%), Gaps = 74/328 (22%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 553
D +E ++ I G +G+V+ AR + TG L A+K +L+M + L E ++L +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSE 59
Query: 554 NPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLL----RKVGC-LEEDVARIYIAE 603
+ ++VR + +LYLV EYL+ DL + R G L + ++ +
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 604 LVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLINNTIDLSGPETDGIM 662
L+ + + H G++HRDLKP NLL+ G +K+ D GL + +I +
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR----AFSIPVK-------- 166
Query: 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPP 721
H V T Y APE+LLG+ H D WSVG I E P
Sbjct: 167 --------------SYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211
Query: 722 FTAESPEI-----IFDNI--LNRKIPWPCV-------------PSDMSF-------EAQD 754
F +S E+ IF + ++ WP V P D+S E D
Sbjct: 212 FPGDS-ELQQLLHIFKLLGTPTEQV-WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLD 269
Query: 755 LINRFLIHDPNQRLGANGAAEVKAHPFF 782
L+ + L +DP +R+ A A HP+F
Sbjct: 270 LLQKMLRYDPAKRISAKAALT---HPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 84/286 (29%), Positives = 137/286 (47%), Gaps = 37/286 (12%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
F ++ I +G+FG VF T + AIK++ + +++IE I E +L +P+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 616
V +++ S+ L+++MEYL GG LLR G +E + E++ L+YLHS
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 617 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 676
+HRD+K N+L++ G +KL DFG++ Q TD
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAG----------------------------QLTDT 154
Query: 677 R-NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 735
+ R++ VGTP ++APE++ + + AD WS+GI E G PP + P + I
Sbjct: 155 QIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI- 213
Query: 736 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
K P + + S ++ I+ L DP+ R A E+ H F
Sbjct: 214 -PKNNPPTLTGEFSKPFKEFIDACLNKDPSFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 80/288 (27%), Positives = 136/288 (47%), Gaps = 39/288 (13%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
+E I+ + RGAFG V L R++ L IK + M + E +L + +P
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER-LAAQNECQVLKLLSHPN 60
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSL 614
++ ++ +F L +VMEY GG L ++K L+ED + +++LAL ++H+
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 615 GIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
I+HRDLK N+L+ H +K+ DFG+SKI LS S A
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKI--------LSS-------KSKA------- 158
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFD 732
++ VGTP Y++PE+ G + +D W++G +L+E + F A + P ++
Sbjct: 159 ------YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK 212
Query: 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 780
+ P + S + + LI L DP++R + ++ A P
Sbjct: 213 IMSGTFAP---ISDRYSPDLRQLILSMLNLDPSKRPQLS---QIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 77/234 (32%), Positives = 112/234 (47%), Gaps = 33/234 (14%)
Query: 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 550
R +DFE+I+ I G +G V+ AR TG+L AIKV+K + D + E ++
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMK 61
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 610
++ +V +F S+ RD L++ ME+ GG L + G L E E + L Y
Sbjct: 62 DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYY 121
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
LHS G +HRD+K N+L+ +GH+KL DFG+S I TI
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGHVKLADFGVS--AQITATI------------------- 160
Query: 671 YQQTDNRNRHSAVGTPDYLAPEI-LLGTEHGY--AADWWSVGIILFEFITGIPP 721
R S +GTP ++APE+ + + GY D W+VGI E PP
Sbjct: 161 ------AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 78/273 (28%), Positives = 135/273 (49%), Gaps = 37/273 (13%)
Query: 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NILITVRNPFV 557
++ + +G++G V L R RT G + V+KKL++ + ER AE+ +L +++P +
Sbjct: 5 VRVVGKGSYGEVSLVRHRTDGKQY---VIKKLNLRNASRRERKAAEQEAQLLSQLKHPNI 61
Query: 558 VRFFYSFTCRDN-LYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSL 614
V + S+ D LY+VM + GGDLY L+ K L E+ + ++ +AL+YLH
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK 121
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
I+HRDLK N+ + IK+ D G++++ + N D++
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMAS------------------- 160
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734
+ +GTP Y++PE+ + Y +D W++G ++E T F A+ + I
Sbjct: 161 ------TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI 214
Query: 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
+ K+ P +P D S E +LI L P +R
Sbjct: 215 IEGKL--PPMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 80/274 (29%), Positives = 136/274 (49%), Gaps = 33/274 (12%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
+EIIK I G+FG+++LA+ ++ + IK + M K E E +L +++P
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEK-EASKKEVILLAKMKHPN 60
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCL-EEDVARIYIAELVLALEYLHSL 614
+V FF SF L++VMEY +GGDL + R+ G L ED + ++ L L+++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 615 GIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
I+HRD+K N+ ++ +G + KL DFG+++ +N++++L+
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELA------------------- 159
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733
++ VGTP YL+PEI + D WS+G +L+E T PF + +
Sbjct: 160 ------YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLK 213
Query: 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
I P P + S + + LI++ P R
Sbjct: 214 ICQGYFA-PISP-NFSRDLRSLISQLFKVSPRDR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 77/286 (26%), Positives = 138/286 (48%), Gaps = 36/286 (12%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER----ILAERNILITVRNPFVV 558
+ +GA+G V+ G L A+K ++ LD E+ + E ++L ++++ +V
Sbjct: 8 LGKGAYGTVYCGLT-NQGQLIAVKQVE-LDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 559 RFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 616
+ Y TC D+ + + ME++ GG + S+L + G L E V Y +++ + YLH+ +
Sbjct: 66 Q--YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 617 VHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
VHRD+K +N+++ +G IKL DFG ++ + + L G ++ +
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG----LHGTHSNML-------------- 165
Query: 676 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 735
S GTP ++APE++ + +G +D WS+G +FE TG PP + I
Sbjct: 166 ----KSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIG 221
Query: 736 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
+ P +P S A D + L D ++R A ++ H F
Sbjct: 222 AHRGLMPRLPDSFSAAAIDFVTSCLTRDQHER---PSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 4e-28
Identities = 95/305 (31%), Positives = 138/305 (45%), Gaps = 51/305 (16%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
D +EII+ I +G +G+V+ + G L A+K+L D I D E I AE NIL ++ N
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL---DPISDVD-EEIEAEYNILQSLPN 77
Query: 555 -PFVVRFFYSFTCRDN-----LYLVMEYLNGGDLYSL----LRKVGCLEEDVARIYIAEL 604
P VV+F+ F D L+LV+E NGG + L L L+E + +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 605 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 664
+L L++LH+ I+HRD+K +N+L+ +G +KL DFG+S
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA--------------------- 176
Query: 665 DAHYPEYQQTDNR-NRHSAVGTPDYLAPEILLGTE---HGYAA--DWWSVGIILFEFITG 718
Q T R R+++VGTP ++APE++ + + Y A D WS+GI E G
Sbjct: 177 -------QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
Query: 719 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778
PP P I P P I++ LI D R E
Sbjct: 230 DPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE--- 286
Query: 779 HPFFK 783
HPF K
Sbjct: 287 HPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 95/317 (29%), Positives = 148/317 (46%), Gaps = 65/317 (20%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
F+ ++ I G +G V+ AR + TG++ A+K ++ LD + + E ++L + +P
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPN 60
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDL--YSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
+V+ + LYLV E+L+ DL + + + + + Y+ +L+ L + HS
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH 119
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
++HRDLKP NLLI +G IKL DFGL++ G+ P
Sbjct: 120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV----------------------PVRTY 157
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEI--- 729
T H V T Y APEILLG + + A D WS+G I E +T F +S EI
Sbjct: 158 T-----HEVV-TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS-EIDQL 210
Query: 730 --IFDNI-LNRKIPWPCV--------------PSDMSF-------EAQDLINRFLIHDPN 765
IF + ++ WP V D S + +DL+++ L +DPN
Sbjct: 211 FRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPN 270
Query: 766 QRLGANGAAEVKAHPFF 782
+R+ A A AHPFF
Sbjct: 271 KRISAKAAL---AHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 88/289 (30%), Positives = 134/289 (46%), Gaps = 48/289 (16%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
D +EII+ I +G +G+VF + G A+K+L D I D E I AE NIL + +
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL---DPIHDID-EEIEAEYNILKALSD 73
Query: 555 -PFVVRFFYSFTCRD-----NLYLVMEYLNGGDLYSL----LRKVGCLEEDVARIYIAEL 604
P VV+F+ + +D L+LV+E NGG + L L++ +EE + + E
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 605 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 664
++ L++LH +HRD+K +N+L+ +G +KL DFG+S
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA--------------------- 172
Query: 665 DAHYPEYQQTDNR-NRHSAVGTPDYLAPEIL-----LGTEHGYAADWWSVGIILFEFITG 718
Q T R R+++VGTP ++APE++ L + + D WS+GI E G
Sbjct: 173 -------QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDG 225
Query: 719 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
PP P I P P S E D I + L D +R
Sbjct: 226 DPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKR 274
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-27
Identities = 73/279 (26%), Positives = 132/279 (47%), Gaps = 37/279 (13%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
+ +++ + G+FGR L + + +A+K ++ + +E E +L +++P
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRL--PKSSSAVEDSRKEAVLLAKMKHP 58
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHS 613
+V F SF +LY+VMEY +GGDL ++ + ED + ++ L ++++H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
++HRD+K N+ + +G +KL DFG +++ L+ P Y
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARL--------LTSP-----GAYACTY----- 160
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733
VGTP Y+ PEI + +D WS+G IL+E T PF A S + N
Sbjct: 161 ---------VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS----WKN 207
Query: 734 ILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 770
++ + + + +PS S+E + LI + +P R A
Sbjct: 208 LILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSA 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 82/287 (28%), Positives = 141/287 (49%), Gaps = 39/287 (13%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
F ++ I +G+FG VF T + AIK++ + +++IE I E +L +P+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 616
V +++ S+ L+++MEYL GG LL G L+E + E++ L+YLHS
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK 122
Query: 617 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 676
+HRD+K N+L++ G +KL DFG++ Q TD
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAG----------------------------QLTDT 154
Query: 677 R-NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDNI 734
+ R++ VGTP ++APE++ + + AD WS+GI E G PP + P +++F +
Sbjct: 155 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF--L 212
Query: 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
+ + P P + + S ++ + L +P+ R A E+ H F
Sbjct: 213 IPKNNP-PTLEGNYSKPLKEFVEACLNKEPSFR---PTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 84/303 (27%), Positives = 141/303 (46%), Gaps = 51/303 (16%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK-KLDMIRKNDIERILAERNILITVR 553
D+ E++ + +G +G V+ R TG A+K ++ +LD + N +I+ E +IL
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFN---QIIMELDILHKAV 57
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGD---LYSLLRKVGCLEEDVARIYIAELVLALEY 610
+P++V F+ +F +Y+ MEY++ G LY+ + EDV R +V L++
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 611 L-HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 669
L I+HRD+KP N+L+ +G +KL DFG+S + S +T+
Sbjct: 118 LKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS------GNLVASLAKTN---------- 161
Query: 670 EYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGYA-----ADWWSVGIILFEFITGIPPFT 723
+G Y+APE I G + +D WS+G+ + E G P+
Sbjct: 162 -------------IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP 208
Query: 724 AESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 780
E+ IF + I P +PS S +AQD + + L PN+R A++ HP
Sbjct: 209 PETYANIFAQL--SAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRR---PTYAQLLEHP 263
Query: 781 FFK 783
+
Sbjct: 264 WLV 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 93/336 (27%), Positives = 144/336 (42%), Gaps = 92/336 (27%)
Query: 497 FEI------IKPISRGAFGRVFLARKRTTGDLFAIK--------------VLKKLDMIRK 536
FE+ IKPI RGA+G V A+ T + AIK L+++ ++R
Sbjct: 1 FEVDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRH 60
Query: 537 NDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 595
D E ++A ++I+ R F +++Y+V E L DL+ ++R L +D
Sbjct: 61 LDHENVIAIKDIMPPPHREAF-----------NDVYIVYE-LMDTDLHQIIRSSQTLSDD 108
Query: 596 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655
+ ++ +L+ L+Y+HS ++HRDLKP NLL+ + +K+ DFGL++
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTS--------- 159
Query: 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFE 714
E M EY V T Y APE+LL +E+ A D WSVG I E
Sbjct: 160 -EKGDFM------TEY-----------VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAE 201
Query: 715 FITGIPPFTAE--------------SP-EIIFDNILN-------RKIP-WPCVP-----S 746
+ P F + SP E I N R +P P
Sbjct: 202 LLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFP 261
Query: 747 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
+ A DL+ + L+ DP++R+ A HP+
Sbjct: 262 HANPLAIDLLEKMLVFDPSKRITVEEALA---HPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 89/310 (28%), Positives = 135/310 (43%), Gaps = 59/310 (19%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITV 552
+ + + GA G V R + TG +FA+K + N ++IL E I +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTI----TTDPNPDLQKQILRELEINKSC 56
Query: 553 RNPFVVRFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI------YIAEL 604
++P++V+++ +F ++ + MEY GG L S+ +KV ++ RI IAE
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKV---KKRGGRIGEKVLGKIAES 113
Query: 605 VL-ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
VL L YLHS I+HRD+KP N+L+ G +KL DFG+S L+N S T
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG-ELVN-----SLAGT----- 162
Query: 664 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 723
GT Y+APE + G + +D WS+G+ L E PF
Sbjct: 163 ------------------FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP 204
Query: 724 AESPEI-----IFDNILNRKIPW----PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 774
E + I+N P P S E +D I + L DP +R
Sbjct: 205 PEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRR---PTPW 261
Query: 775 EVKAHPFFKG 784
++ HP+ K
Sbjct: 262 DMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 2e-26
Identities = 87/286 (30%), Positives = 136/286 (47%), Gaps = 35/286 (12%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKVLK--KLDMIRKNDIERILAERNILITVRNPFVV 558
K + +GAFGRV+L TG A K ++ ++ + E +L +++ +V
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 559 RFFYSFTCR--DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 616
+++ R L + MEY+ GG + L+ G L E V R Y +++ + YLHS I
Sbjct: 68 QYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 617 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 676
VHRD+K N+L G++KL DFG SK TI +SG GI
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASK---RLQTICMSG---TGI--------------- 166
Query: 677 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNIL 735
S GTP +++PE++ G +G AD WS+G + E +T PP+ E+ IF +
Sbjct: 167 ---RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK--I 221
Query: 736 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
+ P +PS +S A+D + + + R A E+ HPF
Sbjct: 222 ATQPTNPQLPSHISEHARDFLGCIFV-EARHR---PSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 77/280 (27%), Positives = 130/280 (46%), Gaps = 38/280 (13%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
+F I K I RG F V+ A G A+K ++ D++ + E ++L + +P
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYL 611
V++++ SF + L +V+E + GDL +++ + E Y +L ALE++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
HS ++HRD+KP N+ I G +KL D GL + +
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGR---------------------------F 155
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731
+ HS VGTP Y++PE + + + +D WS+G +L+E PF + +
Sbjct: 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY- 214
Query: 732 DNILNRKIP---WPCVPSD-MSFEAQDLINRFLIHDPNQR 767
L +KI +P +PSD S E + L+N + DP +R
Sbjct: 215 --SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 6e-26
Identities = 70/229 (30%), Positives = 109/229 (47%), Gaps = 33/229 (14%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
D+E+I+ + G +G V+ AR TG+L A+K++K + +D I E ++ ++
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK---LEPGDDFSLIQQEIFMVKECKHC 66
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 615
+V +F S+ R+ L++ MEY GG L + G L E E + L YLHS G
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
+HRD+K N+L+ +G +KL DFG++ I TI
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVA--AKITATI------------------------ 160
Query: 676 NRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPP 721
R S +GTP ++APE+ ++G D W+VGI E PP
Sbjct: 161 -AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 9e-26
Identities = 72/228 (31%), Positives = 114/228 (50%), Gaps = 31/228 (13%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI-LAERNILITVR 553
+ +E + I G++G VF R R TG + AIK K ++ I++I L E +L ++
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIK--KFVESEDDPVIKKIALREIRMLKQLK 58
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 613
+P +V F + L+LV EY + L L + + E + + I + + A+ + H
Sbjct: 59 HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHK 118
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
+HRD+KP+N+LI G IKL DFG ++I L+GP D Y +Y
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARI--------LTGPGDD--------YTDY-- 160
Query: 674 TDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIP 720
V T Y APE+L+G T++G D W++G + E +TG P
Sbjct: 161 ---------VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 89/331 (26%), Positives = 135/331 (40%), Gaps = 64/331 (19%)
Query: 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI- 550
+ + D+EI+ + G FG V+ AR+ TG + A LKK+ M + D I A R I I
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVA---LKKILMHNEKDGFPITALREIKIL 61
Query: 551 -TVRNPFVVRF---FYSFT-----CRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 600
+++P VV R ++Y+V Y++ DL LL L E + Y
Sbjct: 62 KKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCY 120
Query: 601 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE-TD 659
+ +L+ + YLH I+HRD+K N+LI + G +K+ DFGL++ D P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP------YDGPPPNPKG 174
Query: 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG 718
G Y + V T Y PE+LLG + A D W +G + E T
Sbjct: 175 GGGGGTRKYT-----------NLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
Query: 719 IPPFTAESP----EIIFD-----------------NILNRKIPWPCVPS-DMSFEAQ--- 753
P +S +IF + + F
Sbjct: 224 RPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE 283
Query: 754 --DLINRFLIHDPNQRLGANGAAEVKAHPFF 782
DL+++ L DP +RL A+ A HP+F
Sbjct: 284 GLDLLSKLLSLDPYKRLTASDA---LEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 82/276 (29%), Positives = 130/276 (47%), Gaps = 38/276 (13%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
+ +G +G V+ AR +T AIK + + D ++ + E + +++ +V++
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLG 72
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLE--EDVARIYIAELVLALEYLHSLGIVHR 619
S + + ME + GG L +LLR K G L+ E Y +++ L+YLH IVHR
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 620 DLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 678
D+K DN+L+ + G +K++DFG SK GI P +
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSK-------------RLAGINPCTETF---------- 169
Query: 679 RHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTA-ESPEIIFDNIL 735
GT Y+APE++ GY AD WS+G + E TG PPF P+ +
Sbjct: 170 ----TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVG 225
Query: 736 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 771
KI P +P +S EA++ I R DP++R A+
Sbjct: 226 MFKIH-PEIPESLSAEAKNFILRCFEPDPDKRASAH 260
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 90/336 (26%), Positives = 138/336 (41%), Gaps = 83/336 (24%)
Query: 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI--T 551
+ +E + I +G FG VF AR + T + A LKK+ M + + I A R I I
Sbjct: 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVA---LKKVLMENEKEGFPITALREIKILQL 67
Query: 552 VRNPFVVRFF---------YSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIY 600
+++ VV Y+ + + YLV E+ DL LL + V ++ ++
Sbjct: 68 LKHENVVNLIEICRTKATPYN-RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKV- 124
Query: 601 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 660
+ L+ L Y+H I+HRD+K N+LI DG +KL DFGL++ ++
Sbjct: 125 MKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLS------------ 172
Query: 661 IMPSDAHYPEYQQTDNRNRHSA-VGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITG 718
+ NR++ V T Y PE+LLG G D W G I+ E T
Sbjct: 173 ------------KNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR 220
Query: 719 IPPFTAES----------------PEI--------IFDNI-----LNRKIP---WPCVPS 746
P + PE+ +F + RK+ P V
Sbjct: 221 SPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKD 280
Query: 747 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
A DLI++ L+ DP +R+ A+ A H FF
Sbjct: 281 P---HALDLIDKLLVLDPAKRIDADTALN---HDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 83/267 (31%), Positives = 127/267 (47%), Gaps = 33/267 (12%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 560
K + +GAFGRV+L TG A+K ++ D + + A + ++N R
Sbjct: 8 KLLGQGAFGRVYLCYDADTGRELAVKQVQ-FDPESPETSKEVNALECEIQLLKNLLHERI 66
Query: 561 FYSFTC-RD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 615
+ C RD L + ME++ GG + L+ G L E+V R Y +++ + YLHS
Sbjct: 67 VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
IVHRD+K N+L G++KL DFG SK TI LSG G+
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASK---RLQTICLSG---TGMK------------- 167
Query: 676 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNI 734
S GTP +++PE++ G +G AD WSVG + E +T PP+ E+ IF
Sbjct: 168 -----SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-- 220
Query: 735 LNRKIPWPCVPSDMSFEAQDLINRFLI 761
+ + P +P +S +D + R +
Sbjct: 221 IATQPTNPVLPPHVSDHCRDFLKRIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 94/325 (28%), Positives = 146/325 (44%), Gaps = 78/325 (24%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-KNDIERI----LAERNILI 550
D+ I+ I G +G V+ R + TG + A +KK IR +++ E + + E ++L
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVA---MKK---IRLESEEEGVPSTAIREISLLK 54
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLA 607
+++P +V LYL+ E+L+ DL L K ++ ++ + Y+ +++
Sbjct: 55 ELQHPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQG 113
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
+ + HS ++HRDLKP NLLI + G IKL DFGL++ GI P +
Sbjct: 114 ILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR--------------AFGI-PVRVY 158
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 726
E V T Y APE+LLG + D WS+G I E T P F +S
Sbjct: 159 THE------------VVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206
Query: 727 PEI-----IFDNIL---NRKIPWPCVPS---------------------DMSFEAQDLIN 757
EI IF IL + WP V S ++ + DL+
Sbjct: 207 -EIDQLFRIF-RILGTPTEDV-WPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLE 263
Query: 758 RFLIHDPNQRLGANGAAEVKAHPFF 782
+ LI+DP +R+ A A HP+F
Sbjct: 264 KMLIYDPAKRISAKKALN---HPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 86/301 (28%), Positives = 144/301 (47%), Gaps = 48/301 (15%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVR 553
DD E+I+ + RGA+G V R TG + A+K ++ + + +R+L + +I + +V
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRA--TVNSQEQKRLLMDLDISMRSVD 58
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALE 609
P+ V F+ + ++++ ME ++ L +KV + ED+ +V ALE
Sbjct: 59 CPYTVTFYGALFREGDVWICMEVMDTS-LDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 610 YLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
YLHS L ++HRD+KP N+LI +G +KL DFG+S
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG------------------------- 152
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEIL--LGTEHGY--AADWWSVGIILFEFITGIPPFTA 724
D+ + G Y+APE + + GY +D WS+GI + E TG P+
Sbjct: 153 ---YLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY-- 207
Query: 725 ESPEIIFDNILN-RKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
+S + F + + P P +P++ S E QD +N+ L + +R E+ HPFF
Sbjct: 208 DSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYP---ELLQHPFF 264
Query: 783 K 783
+
Sbjct: 265 E 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 94/328 (28%), Positives = 142/328 (43%), Gaps = 79/328 (24%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITV 552
D ++ + P+ GA+G+V A TG AIK KL ++ I +R E +L +
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK---KLSRPFQSAIHAKRTYRELRLLKHM 71
Query: 553 RNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELV 605
+ V+ FT +L YLV L G DL ++++ + L +D + + +++
Sbjct: 72 DHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNIVKCQK--LSDDHIQFLVYQIL 128
Query: 606 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 665
L+Y+HS GI+HRDLKP N+ + D +K+ DFGL++ TD M
Sbjct: 129 RGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-------------HTDDEM--- 172
Query: 666 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFT 723
T V T Y APEI+L H Y D WSVG I+ E +TG F
Sbjct: 173 --------TGY------VATRWYRAPEIMLNWMH-YNQTVDIWSVGCIMAELLTGKTLFP 217
Query: 724 AESPEIIFDNILN----------RKIP----------WPCVP--------SDMSFEAQDL 755
I+N +KI P +P S + A DL
Sbjct: 218 GSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDL 277
Query: 756 INRFLIHDPNQRLGANGAAEVKAHPFFK 783
+ + L+ DP++R+ AAE AHP+
Sbjct: 278 LEKMLVLDPDKRI---TAAEALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 69/227 (30%), Positives = 111/227 (48%), Gaps = 35/227 (15%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
D + + + G G V+ A T + A+KV+ LD I ++I++E IL +P
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIP-LD-ITVELQKQIMSELEILYKCDSP 59
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 615
+++ F+ +F + + + E+++GG L + RK+ E + RI +A +V L YL SL
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGSL-DVYRKIP--EHVLGRIAVA-VVKGLTYLWSLK 115
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
I+HRD+KP N+L+ G +KL DFG+S Q
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVST-----------------------------QLV 146
Query: 676 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 722
N + VGT Y+APE + G ++G +D WS+GI E G P+
Sbjct: 147 NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-24
Identities = 90/321 (28%), Positives = 137/321 (42%), Gaps = 80/321 (24%)
Query: 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKK--------LDMIRKNDIERILAERNILIT 551
++P+ GAFG V AR + TG AIK + K R+ + + L NI I+
Sbjct: 15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENI-IS 73
Query: 552 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 611
+ + F+ + +++Y V E L G DL+ LL LE+ + ++ +++ L+Y+
Sbjct: 74 LSDIFI-------SPLEDIYFVTELL-GTDLHRLL-TSRPLEKQFIQYFLYQILRGLKYV 124
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
HS G+VHRDLKP N+LI + +K+ DFGL++I D Y
Sbjct: 125 HSAGVVHRDLKPSNILINENCDLKICDFGLARI-------------------QDPQMTGY 165
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP--- 727
V T Y APEI+L ++ D WS G I E + G P F +
Sbjct: 166 -----------VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ 214
Query: 728 -EIIFD----------------NILN--------RKIPWPCVPSDMSFEAQDLINRFLIH 762
II D N L +P+ + A DL+ + L+
Sbjct: 215 FSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVF 274
Query: 763 DPNQRLGANGAAEVKAHPFFK 783
DP +R+ AAE AHP+
Sbjct: 275 DPQKRI---SAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 71/236 (30%), Positives = 118/236 (50%), Gaps = 39/236 (16%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVL---KKLDMIRKNDIERILAERNI--LIT 551
+E + + G++G V + + TG + AIK + M++K +A R I L
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKK------IAMREIRMLKQ 56
Query: 552 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 611
+R+ +V F + LYLV E+++ L L + L+E R Y+ +++ +E+
Sbjct: 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFC 116
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
HS I+HRD+KP+N+L++ G +KL DFG ++ L+ P Y +Y
Sbjct: 117 HSHNIIHRDIKPENILVSQSGVVKLCDFGFART--------LAAPGEV--------YTDY 160
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 726
V T Y APE+L+G T++G A D W+VG ++ E +TG P F +S
Sbjct: 161 -----------VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-24
Identities = 90/332 (27%), Positives = 146/332 (43%), Gaps = 82/332 (24%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--DIERILAE-------- 545
D E +PI GAFG V+ G A LKK+ + +N +R+ E
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVA---LKKMPNVFQNLVSCKRVFRELKMLCFFK 57
Query: 546 -RNIL--ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 602
N+L + + P + F + +Y+V E + DL+ ++ L D ++++
Sbjct: 58 HDNVLSALDILQPPHIDPF------EEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLY 110
Query: 603 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 662
+++ L+YLHS GI+HRD+KP NLL+ + +K+ DFGL+++
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARV------------------ 152
Query: 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPP 721
+ ++++ V T Y APEIL+G+ H A D WSVG I E +
Sbjct: 153 --------EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRIL 204
Query: 722 FTAESP----EIIFD-------------------NILNRKIPWPCVP------SDMSFEA 752
F A+SP ++I D +IL P +P S + EA
Sbjct: 205 FQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEA 264
Query: 753 QDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
L+ R L+ DP++R+ AA+ AHP+
Sbjct: 265 VHLLCRMLVFDPDKRI---SAADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 72/282 (25%), Positives = 134/282 (47%), Gaps = 38/282 (13%)
Query: 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 553
+ +F+I K I RG F V+ A A+K ++ +M+ + + E ++L +
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL----RKVGCLEEDVARIYIAELVLALE 609
+P V+++ SF + L +V+E + GDL ++ ++ + E Y +L A+E
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 669
++HS ++HRD+KP N+ I G +KL D GL +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR-------------------------- 154
Query: 670 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 729
+ + HS VGTP Y++PE + + + +D WS+G +L+E PF + +
Sbjct: 155 -FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213
Query: 730 IFDNILNRKIP---WPCVPSD-MSFEAQDLINRFLIHDPNQR 767
L +KI +P +P++ S + ++L++ + DP+QR
Sbjct: 214 F---SLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-24
Identities = 94/332 (28%), Positives = 143/332 (43%), Gaps = 74/332 (22%)
Query: 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK--------KLDMIRKNDIERI 542
+ +D F+II I G +G+V+ AR + TG+L A+K ++ + IR+ I R
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQ 62
Query: 543 LAERNIL----ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVA 597
L RNI+ I + F + YLV EY++ DL LL + ED
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKD---KGAFYLVFEYMDH-DLMGLLESGLVHFSEDHI 118
Query: 598 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 657
+ ++ +L+ L Y H +HRD+K N+L+ + G IKL DFGL+++
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL------------- 165
Query: 658 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFI 716
Y ++R + V T Y PE+LLG E +G A D WS G IL E
Sbjct: 166 -------------YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELF 212
Query: 717 TGIPPFTAES--------------------PEII----FDNILNRKIPWPCVPSDMSF-- 750
T P F A P++I F+ + +K + + SF
Sbjct: 213 TKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIP 272
Query: 751 -EAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
A DL++ L DP++R A E P+
Sbjct: 273 TPALDLLDHMLTLDPSKRCTAE---EALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 6e-24
Identities = 85/289 (29%), Positives = 135/289 (46%), Gaps = 41/289 (14%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLD---MIRKNDIERILAERNILITVRNPFV 557
K + RGAFG V+L TG A+K + D ++ + E +L +R+ +
Sbjct: 8 KLLGRGAFGEVYLCYDADTGRELAVKQVP-FDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 558 VRFFYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 613
V+++ RD L + +EY+ GG + L+ G L E+V R Y +++ + YLHS
Sbjct: 67 VQYYGCL--RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
IVHRD+K N+L G++KL DFG SK TI +SG GI
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASK---RIQTICMSG---TGI------------ 166
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFD 732
S GTP +++PE++ G +G AD WSV + E +T PP+ E+ IF
Sbjct: 167 ------KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFK 220
Query: 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
+ + P +P +S +D + + + + + A + HPF
Sbjct: 221 --IATQPTKPMLPDGVSDACRDFLKQIFVEEKRRPT----AEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 7e-24
Identities = 69/247 (27%), Positives = 117/247 (47%), Gaps = 49/247 (19%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---R 553
FE+++ + G +G+V+ R TG L AIKV+ + +++ E I E N+L R
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSHHR 73
Query: 554 NPFVVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELV 605
N + ++ +F + D L+LVME+ G + L++ L+ED E++
Sbjct: 74 N--IATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 606 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 665
L +LH+ ++HRD+K N+L+ + +KL DFG+S
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---------------------- 169
Query: 666 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIP 720
+ +T R R++ +GTP ++APE++ E + Y +D WS+GI E G P
Sbjct: 170 ----QLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224
Query: 721 PFTAESP 727
P P
Sbjct: 225 PLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 92/336 (27%), Positives = 145/336 (43%), Gaps = 84/336 (25%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
DDFE I + G G VF + +G + A K++ I+ +I+ E +L +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-ARIYIAELVLALEYLHS 613
P++V F+ +F + + ME+++GG L +L+K G + E + ++ IA ++ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA-VIKGLTYLRE 121
Query: 614 L-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
I+HRD+KP N+L+ G IKL DFG+S
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----------------------------- 152
Query: 673 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESPEI 729
Q + +S VGT Y++PE L GT + +D WS+G+ L E G IPP A+ E+
Sbjct: 153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL 212
Query: 730 IF-----------------------------------------DNILNRKIPWPCVPSDM 748
+F D I+N P P +PS +
Sbjct: 213 MFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNE--PPPKLPSGV 270
Query: 749 -SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
E QD +N+ LI +P +R ++ H F K
Sbjct: 271 FGAEFQDFVNKCLIKNPAERADLK---QLMVHAFIK 303
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 87/330 (26%), Positives = 147/330 (44%), Gaps = 83/330 (25%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIK-------------VLKKLDMIRKNDIER 541
++ + I GA+G V A + TG AIK L+++ ++R+ E
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 542 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 601
I+ +I+ F SF +++Y+V E + DLY L++ L D + ++
Sbjct: 65 IIGILDIIR-------PPSFESF---NDVYIVQELMET-DLYKLIKTQH-LSNDHIQYFL 112
Query: 602 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 661
+++ L+Y+HS ++HRDLKP NLL+ + +K+ DFGL++I + D +G T
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLT--- 167
Query: 662 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGI 719
EY V T Y APEI+L GY A D WSVG IL E ++
Sbjct: 168 --------EY-----------VATRWYRAPEIML-NSKGYTKAIDIWSVGCILAEMLSNR 207
Query: 720 PPFTAE--------------SPEII-FDNILNRK-------------IPWPCVPSDMSFE 751
P F + +P + I++ + +PW + + +
Sbjct: 208 PLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPK 267
Query: 752 AQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
A DL+++ L +P++R+ E AHP+
Sbjct: 268 ALDLLDKMLTFNPHKRITVE---EALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 89/324 (27%), Positives = 141/324 (43%), Gaps = 70/324 (21%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITVRN 554
+E+IK + +GA+G V AR T + + + KK+ + I +R L E +L R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAI-KKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 555 --------PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 606
+ F +F + LYL E L DL+ ++R L + + +I +++
Sbjct: 61 HKNITCLYDMDIVFPGNF---NELYLYEE-LMEADLHQIIRSGQPLTDAHFQSFIYQILC 116
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
L+Y+HS ++HRDLKP NLL+ D +K+ DFGL++ G N + +G
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR-GFSENPGENAG----------- 164
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 725
EY V T Y APEI+L + A D WSVG IL E + P F +
Sbjct: 165 FMTEY-----------VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213
Query: 726 S-----PEIIF------DNILNR-----------------KIPWPCVPSDMSFEAQDLIN 757
+I+ + L+R K P+ + + + A DL+
Sbjct: 214 DYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLE 273
Query: 758 RFLIHDPNQRLGANGAAEVKAHPF 781
+ L DP +R+ A E HP+
Sbjct: 274 KLLAFDPTKRISVEEALE---HPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 80/307 (26%), Positives = 141/307 (45%), Gaps = 50/307 (16%)
Query: 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 548
K ++D E + I G G+V+ R + TG + A+K +++ K + +RIL + ++
Sbjct: 9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG--NKEENKRILMDLDV 66
Query: 549 LITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVL 606
++ + P++V+ + F ++++ ME L L LL+++ G + ED+ +V
Sbjct: 67 VLKSHDCPYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVK 125
Query: 607 ALEYL---HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
AL YL H G++HRD+KP N+L+ G++KL DFG+S G +
Sbjct: 126 ALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGIS-----------------GRL- 165
Query: 664 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL----LGTEHGYAADWWSVGIILFEFITGI 719
D++ + + G Y+APE + ++ AD WS+GI L E TG
Sbjct: 166 ----------VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
Query: 720 PPFTAESPEI-IFDNILNRKIPWPCVPSDMSF--EAQDLINRFLIHDPNQRLGANGAAEV 776
P+ E + IL P +P + F + ++ L D +R E+
Sbjct: 216 FPYKNCKTEFEVLTKILQE--EPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYR---EL 270
Query: 777 KAHPFFK 783
HPF +
Sbjct: 271 LQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 2e-22
Identities = 94/330 (28%), Positives = 152/330 (46%), Gaps = 76/330 (23%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--DIERILAERNILITVRN 554
++I + I +G++G V A TG+ AIK K++ + ++ D RIL E +L +R+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIK---KINDVFEHVSDATRILREIKLLRLLRH 58
Query: 555 PFVV---RFFYSFTCRD--NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 609
P +V + R+ ++Y+V E L DL+ +++ L + + ++ +L+ AL+
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 669
Y+H+ + HRDLKP N+L D +K+ DFGL+++ N+T P+ +
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAF-NDT------------PTAIFWT 164
Query: 670 EYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAE- 725
+Y V T Y APE L G +++ A D WS+G I E +TG P F +
Sbjct: 165 DY-----------VATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212
Query: 726 ---------------SPEII----------FDNILNRKIPWPCVPSDMSFEAQD-----L 755
SPE I + + + +K P VP F D L
Sbjct: 213 VVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQP---VPFSQKFPNADPLALRL 269
Query: 756 INRFLIHDPNQRLGANGAAEVKAHPFFKGV 785
+ R L DP R A E A P+FKG+
Sbjct: 270 LERLLAFDPKDR---PTAEEALADPYFKGL 296
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-22
Identities = 89/326 (27%), Positives = 135/326 (41%), Gaps = 83/326 (25%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD--------MIRKNDIERILAERNI 548
F+ ++ + G + V+ R RTTG++ A+K + LD IR+ + + L NI
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIH-LDAEEGTPSTAIREISLMKELKHENI 60
Query: 549 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL--YSLLRKV-GCLEEDVARIYIAELV 605
VR + L LV EY++ DL Y V G L+ + + + +L+
Sbjct: 61 ---------VRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL 110
Query: 606 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPS 664
+ + H ++HRDLKP NLLI G +KL DFGL++ G+ NT
Sbjct: 111 KGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS------------ 158
Query: 665 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFT 723
+ V T Y AP++LLG+ + + D WSVG I+ E ITG P F
Sbjct: 159 ----------------NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP 202
Query: 724 AESPE----IIFDNI----------------LNRKIPWPCVPSDMSF-------EAQDLI 756
+ E IF + P P D+ DL+
Sbjct: 203 GTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP-RYPPQDLQQLFPHADPLGIDLL 261
Query: 757 NRFLIHDPNQRLGANGAAEVKAHPFF 782
+R L +P R+ A+ A HP+F
Sbjct: 262 HRLLQLNPELRISAHDAL---QHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 7e-22
Identities = 80/301 (26%), Positives = 136/301 (45%), Gaps = 53/301 (17%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
FE+++ + G +G+V+ R TG L AIKV+ + ++ E I E N+L +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 557 VVRFFYSFTCR-------DNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLA 607
+ +Y + D L+LVME+ G + L++ K L+E+ E++
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
L +LH ++HRD+K N+L+ + +KL DFG+S
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA------------------------ 159
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPF 722
+ +T R R++ +GTP ++APE++ E + + +D WS+GI E G PP
Sbjct: 160 --QLDRTVGR-RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
Query: 723 TAESP-EIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 780
P +F L + P P + S S + Q I L+ + +QR ++ HP
Sbjct: 217 CDMHPMRALF---LIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQR---PTTEQLMKHP 270
Query: 781 F 781
F
Sbjct: 271 F 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 9e-22
Identities = 97/325 (29%), Positives = 146/325 (44%), Gaps = 72/325 (22%)
Query: 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI--LIT 551
+D +E ++ I G +G V+ AR R T + A LKK+ + ++++ A R I L
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIA---LKKIRLEQEDEGVPSTAIREISLLKE 57
Query: 552 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED--VARIYIAELVLALE 609
+++ +VR LYLV EYL+ DL + ++ + + Y+ +++ +
Sbjct: 58 MQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
Y HS ++HRDLKP NLLI + +KL DFGL++ GI P
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLAR--------------AFGI-PVRTFT 161
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPFTAES 726
E V T Y APEILLG+ H Y+ D WSVG I E + P F +S
Sbjct: 162 HE------------VVTLWYRAPEILLGSRH-YSTPVDIWSVGCIFAEMVNQKPLFPGDS 208
Query: 727 PEI-----IFDNILN--RKIPWPCVPSDMSFEAQ---------------------DLINR 758
EI IF IL + WP V S +++ DL+++
Sbjct: 209 -EIDELFKIF-RILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSK 266
Query: 759 FLIHDPNQRLGANGAAEVKAHPFFK 783
L DP++R+ A A E H +FK
Sbjct: 267 MLRLDPSKRITARAALE---HEYFK 288
|
Length = 294 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 1e-21
Identities = 68/234 (29%), Positives = 104/234 (44%), Gaps = 44/234 (18%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER---ILAERNILITVR 553
F ++ I G+FG V+ AR T ++ AIK K+ K E+ I+ E L +R
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIK---KMSYSGKQSNEKWQDIIKEVRFLQQLR 73
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNG--GDLYSLLRKVGCLEEDVARIYIAELVLALEYL 611
+P + + + +LVMEY G D+ + +K E ++A I L L YL
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK-PLQEVEIAAICHGALQ-GLAYL 131
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
HS +HRD+K N+L+ G +KL DFG + + + P++
Sbjct: 132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASL----------------VSPAN------ 169
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 722
S VGTP ++APE++L + G D WS+GI E PP
Sbjct: 170 ---------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 87/326 (26%), Positives = 137/326 (42%), Gaps = 75/326 (23%)
Query: 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE----RILAERNIL 549
++ ++ + + G++ V+ R + TG L A+K IR E + E ++L
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKE------IRLEHEEGAPFTAIREASLL 57
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLAL 608
+++ +V + L LV EYL+ DL + G L R+++ +L+ L
Sbjct: 58 KDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
Y H ++HRDLKP NLLI+ G +KL DFGL++ + PS +
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV---------------PSKTYS 161
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF----- 722
E V T Y P++LLG TE+ + D W VG I +E TG P F
Sbjct: 162 NE------------VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD 209
Query: 723 TAESPEIIFDNILNRKIP--WPCVPSDMSF------------------------EAQDLI 756
+ IF +L WP V S+ F ++L
Sbjct: 210 VEDQLHKIF-RVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELA 268
Query: 757 NRFLIHDPNQRLGANGAAEVKAHPFF 782
+FL ++P +R+ AAE HP+F
Sbjct: 269 LKFLQYEPKKRI---SAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 81/319 (25%), Positives = 135/319 (42%), Gaps = 69/319 (21%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITV 552
+E ++ I G +G VF A+ R T ++ A+K ++ LD +D E + L E +L +
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LD----DDDEGVPSSALREICLLKEL 56
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYL 611
++ +VR + L LV EY + DL G ++ ++ + ++ +L+ L +
Sbjct: 57 KHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
HS ++HRDLKP NLLI +G +KL DFGL++ GI P + E
Sbjct: 116 HSHNVLHRDLKPQNLLINKNGELKLADFGLAR--------------AFGI-PVRCYSAE- 159
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEF--------------- 715
V T Y P++L G + + D WS G I E
Sbjct: 160 -----------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 208
Query: 716 -------ITGIP-----PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHD 763
+ G P P ++ P+ + V ++ +DL+ L+ +
Sbjct: 209 QLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCN 268
Query: 764 PNQRLGANGAAEVKAHPFF 782
P QR+ A A + HP+F
Sbjct: 269 PVQRISAEEALQ---HPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 67/294 (22%), Positives = 115/294 (39%), Gaps = 53/294 (18%)
Query: 495 DDFEIIKPISRGAFGRVF--LARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNIL 549
+ +I+ + +G+FG V+ LA+ G+ AIK + + +R + L E +++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR--ERIEFLNEASVM 63
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA----------RI 599
VVR + +VME + GDL S LR E +
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRS--RRPEAENNPGLGPPTLQKF 121
Query: 600 Y--IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 657
AE+ + YL + VHRDL N ++A D +K+ DFG+++ I T D
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR--DIYET-DYYRKG 178
Query: 658 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 717
G++P ++APE L +D WS G++L+E T
Sbjct: 179 GKGLLPV----------------------RWMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
Query: 718 -GIPPFTAESPEIIFDNILNRKI-PWP-CVPSDMSFEAQDLINRFLIHDPNQRL 768
P+ S E + +++ P P + +L+ ++P R
Sbjct: 217 LAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKL----LELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 4e-21
Identities = 78/275 (28%), Positives = 134/275 (48%), Gaps = 42/275 (15%)
Query: 506 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 565
GA G V A++ + G+ FA+KV+ ++ + + D R AE L+ +V+ F
Sbjct: 43 GATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFA 101
Query: 566 CRDN--------LYLVMEYLNGGDLYSLLR---KVG-CLEEDVARIYIAELVLALEYLHS 613
+D + LV++Y N GDL ++ K E A + +++LA+ ++HS
Sbjct: 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS 161
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
++HRD+K N+L+ +G +KL DFG SK + T+
Sbjct: 162 KHMIHRDIKSANILLCSNGLVKLGDFGFSK--MYAATV---------------------- 197
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFD 732
+D+ R + GTP Y+APEI + AD +S+G++L+E +T PF E+ E++
Sbjct: 198 SDDVGR-TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHK 256
Query: 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
+ R P +P +S E Q+++ L DP +R
Sbjct: 257 TLAGRYDP---LPPSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 7e-21
Identities = 72/242 (29%), Positives = 117/242 (48%), Gaps = 37/242 (15%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
DDFE I + G G V + + +G + A K++ I+ +I+ E +L +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHL--EIKPAIRNQIIRELQVLHECNS 62
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-ARIYIAELVLALEYLHS 613
P++V F+ +F + + ME+++GG L +L++ + E++ ++ IA ++ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA-VLRGLAYLRE 121
Query: 614 L-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
I+HRD+KP N+L+ G IKL DFG+S
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSG----------------------------- 152
Query: 673 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESPEI 729
Q + +S VGT Y++PE L GT + +D WS+G+ L E G IPP A+ E
Sbjct: 153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA 212
Query: 730 IF 731
IF
Sbjct: 213 IF 214
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.9 bits (243), Expect = 9e-21
Identities = 76/264 (28%), Positives = 124/264 (46%), Gaps = 63/264 (23%)
Query: 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 551
+ ++++E+IK I G FG VFL + + T + F K + + ++ + +++ E N++
Sbjct: 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRE 68
Query: 552 VRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELV 605
+++ +VR+ F + N LY++ME+ + GDL ++K G +EE +L+
Sbjct: 69 LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLL 128
Query: 606 LALEYLHSLG-------IVHRDLKPDNLL----IAHDGHI-------------KLTDFGL 641
AL Y H+L ++HRDLKP N+ I H G I K+ DFGL
Sbjct: 129 HALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL 188
Query: 642 SK-IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 700
SK IG+ HS VGTP Y +PE+LL
Sbjct: 189 SKNIGI-----------------------------ESMAHSCVGTPYYWSPELLLHETKS 219
Query: 701 Y--AADWWSVGIILFEFITGIPPF 722
Y +D W++G I++E +G PF
Sbjct: 220 YDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 9e-21
Identities = 85/274 (31%), Positives = 124/274 (45%), Gaps = 43/274 (15%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA----ERNILITVRNPFVV 558
+ R F+A T G KV+ K M+ ND ER A E + L + +V
Sbjct: 75 VGRNPTTAAFVA---TRGSDPKEKVVAKFVML--ND-ERQAAYARSELHCLAACDHFGIV 128
Query: 559 RFFYSFTCRDNLYLVMEYLNGGDL----YSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
+ F F D L L+MEY +GGDL L++ +E + ++VLAL+ +HS
Sbjct: 129 KHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR 188
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
++HRDLK N+ + G IKL DFG SK + ++D++
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS------------------- 229
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734
S GTP YLAPE+ + AD WS+G+IL+E +T PF S I +
Sbjct: 230 ------SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283
Query: 735 LNRKI-PWPCVPSDMSFEAQDLINRFLIHDPNQR 767
L K P+PC S + L++ L +P R
Sbjct: 284 LYGKYDPFPCPVSS---GMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-20
Identities = 91/326 (27%), Positives = 141/326 (43%), Gaps = 75/326 (23%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITV 552
D + +K + GA+G V A R TG AIK KL ++++ +R E +L +
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHM 71
Query: 553 RNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 606
++ V+ FT +L YLVM ++ G DL L+ K L ED + + +++
Sbjct: 72 KHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLM-KHEKLSEDRIQFLVYQMLK 129
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
L+Y+H+ GI+HRDLKP NL + D +K+ DFGL++
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR----------------------- 166
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 725
QTD+ V T Y APE++L H D WSVG I+ E +TG P F
Sbjct: 167 ------QTDSEMTGYVV-TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219
Query: 726 --------------SPEIIFDNILN--------------RKIPWPCVPSDMSFEAQDLIN 757
+P F L RK + + + + A +++
Sbjct: 220 DHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLE 279
Query: 758 RFLIHDPNQRLGANGAAEVKAHPFFK 783
+ L+ D R+ AAE AHP+F+
Sbjct: 280 KMLVLDAESRI---TAAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-20
Identities = 84/295 (28%), Positives = 140/295 (47%), Gaps = 46/295 (15%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE------RILAERNILI 550
++II+ I +G G V+LA A LKK IR++ E R L E I
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVA---LKK---IREDLSENPLLKKRFLREAKIAA 57
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV---GCLEEDVA---------R 598
+ +P +V + + D +Y M Y+ G L SLL+ V L +++A
Sbjct: 58 DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 599 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG--LSKIGLINNTIDLSGP 656
I+ ++ +EY+HS G++HRDLKPDN+L+ G + + D+G + K + +D+
Sbjct: 118 IFH-KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 657 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 716
E I S P VGTPDY+APE LLG + D +++G+IL++ +
Sbjct: 177 ER-NICYSSMTIP----------GKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
Query: 717 TGIPPFTAES-PEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQR 767
T P+ + +I + +++ I P+ +P +S + + L DP +R
Sbjct: 226 TLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLS----QIAMKALAVDPAER 276
|
Length = 932 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 3e-20
Identities = 86/321 (26%), Positives = 133/321 (41%), Gaps = 60/321 (18%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLK--KLDMIRKNDIERI---------LAERNILIT 551
+ G +G+V A TG + AIK +K ++ D + + L E I+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 552 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEY 610
+++ ++ + D + LVM+ + DL ++ RK+ E V I + +++ L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCI-LLQILNGLNV 134
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
LH +HRDL P N+ I G K+ DFGL++ SD +
Sbjct: 135 LHKWYFMHRDLSPANIFINSKGICKIADFGLAR-------------RYGYPPYSDTLSKD 181
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEI 729
S V T Y APE+L+G E + +A D WSVG I E +TG P F E+ EI
Sbjct: 182 ETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN-EI 240
Query: 730 -----IFDNILNRKIP--WP---CVPSDMSF-----------------EAQDLINRFLIH 762
IF +L WP +P F +A DL+ L
Sbjct: 241 DQLGRIF-ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299
Query: 763 DPNQRLGANGAAEVKAHPFFK 783
+P +R+ A A + H +FK
Sbjct: 300 NPLERISAKEALK---HEYFK 317
|
Length = 335 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 66/245 (26%), Positives = 104/245 (42%), Gaps = 49/245 (20%)
Query: 500 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVR 553
IK + G FG+V L R TG+ A+K L ++D ER E IL T+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNH-SGEEQHRSDFER---EIEILRTLD 64
Query: 554 NPFVVRFFYSFT--CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 606
+ +V++ +L L+MEYL G L L++ +I + L+L
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR------DQINLKRLLLFSSQI 118
Query: 607 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 664
++YL S +HRDL N+L+ + +K++DFGL+K ++P
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAK-----------------VLPE 161
Query: 665 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 724
D Y S + + APE L ++ A+D WS G+ L+E T P +
Sbjct: 162 DKDY----YYVKEPGESPI---FWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQS 214
Query: 725 ESPEI 729
E
Sbjct: 215 PPAEF 219
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 9e-20
Identities = 78/287 (27%), Positives = 136/287 (47%), Gaps = 43/287 (14%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA--ERNILITVRNPFVVRF 560
+ +G+FG V+L + + +KVLK++ + N E + A E +L + +P +V+F
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 561 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE----LVLALEYLHSLGI 616
SF RD ++ EY G DL L ++ + ++ + E L+L + Y+H I
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 617 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 676
+HRDLK N+ + ++ +K+ DFG+S+ L+ + DL+ T
Sbjct: 128 LHRDLKAKNIFLKNN-LLKIGDFGVSR--LLMGSCDLATTFT------------------ 166
Query: 677 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 736
GTP Y++PE L + +D WS+G IL+E F ++ F +++
Sbjct: 167 -------GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVVL 215
Query: 737 RKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
R + P P +P S + ++ L DP+ R AAE+ +PF
Sbjct: 216 RIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRP---SAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 2e-19
Identities = 83/322 (25%), Positives = 136/322 (42%), Gaps = 69/322 (21%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
D +E ++ + G++ V+ + + G L A+KV++ + + + E ++L +++
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLKH 62
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
+V ++ L LV EY++ + + G L + ++++ +L+ L Y+H
Sbjct: 63 ANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR 122
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
I+HRDLKP NLLI+ G +KL DFGL++ + PS + E
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSV---------------PSHTYSNE---- 163
Query: 675 DNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA-----ESPE 728
V T Y P++LLG TE+ D W VG I E I G+ F + E
Sbjct: 164 --------VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLE 215
Query: 729 IIFDNILNRKIP----WPCVPSDMSFE------------------------AQDLINRFL 760
IF L P WP V S F+ A+DL ++ L
Sbjct: 216 RIF---LVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLL 272
Query: 761 IHDPNQRLGANGAAEVKAHPFF 782
P RL A A +H +F
Sbjct: 273 QCFPKNRLSAQAAL---SHEYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 81/318 (25%), Positives = 133/318 (41%), Gaps = 71/318 (22%)
Query: 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNILITVRNP 555
++ + G++ V+ R G L A+KV I E + + E ++L +++
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKV------ISMKTEEGVPFTAIREASLLKGLKHA 63
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 615
+V ++ L V EY++ +++ G L R+++ +L+ L Y+H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
I+HRDLKP NLLI++ G +KL DFGL++ I PS + E
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSI---------------PSQTYSSE----- 163
Query: 676 NRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF--TAESPEII-- 730
V T Y P++LLG T++ A D W G I E + G P F ++ E +
Sbjct: 164 -------VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK 216
Query: 731 ---------------FDNILNRKIPW--PCVPSDM---------SFEAQDLINRFLIHDP 764
+ N K W PC P + +A+DL ++ L+ P
Sbjct: 217 IWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFP 276
Query: 765 NQRLGANGAAEVKAHPFF 782
R+ A A HP+F
Sbjct: 277 KDRISAQDAL---LHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 90/326 (27%), Positives = 135/326 (41%), Gaps = 79/326 (24%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK--------KLDMIRKNDIERILAERNI 548
+E + I GA+G V+ AR +G A+K ++ L +R E L +R
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVR----EVALLKR-- 55
Query: 549 LITVRNPFVVRFF----YSFTCRD-NLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYI 601
L +P +VR S T R+ + LV E+++ DL + L KV L + + +
Sbjct: 56 LEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLM 114
Query: 602 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 661
+ + L++LH+ IVHRDLKP+N+L+ G +KL DFGL++I +
Sbjct: 115 RQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALT--------- 165
Query: 662 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 721
V T Y APE+LL + + D WSVG I E P
Sbjct: 166 -------------------PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPL 206
Query: 722 FTAESPE----IIFDNI-LNRKIPWP--------------------CVPSDMSFEAQDLI 756
F S IFD I L + WP VP ++ L+
Sbjct: 207 FCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVP-EIEESGAQLL 265
Query: 757 NRFLIHDPNQRLGANGAAEVKAHPFF 782
L +P++R+ A A + HPFF
Sbjct: 266 LEMLTFNPHKRISAFRALQ---HPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 84/332 (25%), Positives = 137/332 (41%), Gaps = 85/332 (25%)
Query: 500 IKPISRGAFGRVFLARKRTTGDLFAIK------------VLKKLDMIRKNDIERILAERN 547
++P+ G+ G VF A A+K L+++ +IR+ D + I+
Sbjct: 10 LRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYE 69
Query: 548 ILIT--VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 605
+L V +++Y+V EY+ DL ++L + G L E+ AR+++ +L+
Sbjct: 70 VLGPSGSDLTEDVGSLTEL---NSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLL 124
Query: 606 LALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 664
L+Y+HS ++HRDLKP N+ I D +K+ DFGL++I
Sbjct: 125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARI-------------------V 165
Query: 665 DAHYPEYQQTDNRNRHSA-----VGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG 718
D HY H + T Y +P +LL + A D W+ G I E +TG
Sbjct: 166 DPHY----------SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
Query: 719 IPPFTA----ESPEIIFDNI----------LNRKIPW--------PCVP-----SDMSFE 751
P F E ++I +++ L IP P P ++ E
Sbjct: 216 KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPE 275
Query: 752 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
A D + + L +P RL A A HP+
Sbjct: 276 ALDFLEQILTFNPMDRLTAEEAL---MHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 4e-19
Identities = 84/308 (27%), Positives = 139/308 (45%), Gaps = 59/308 (19%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE----RILAERNILI 550
+D + + I RGAFG V + +G + A+K IR E R+L + ++++
Sbjct: 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVK------RIRSTVDEKEQKRLLMDLDVVM 57
Query: 551 TVRN-PFVVRFFYSFTCRDNLYLVMEYLNGG--DLYSL--LRKVGCLEEDV-ARIYIAEL 604
+ P++V+F+ + + ++ ME ++ Y + E++ +I +A
Sbjct: 58 RSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVA-T 116
Query: 605 VLALEYL-HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
V AL YL L I+HRD+KP N+L+ +G+IKL DFG+S G + ++I
Sbjct: 117 VKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS--GQLVDSI------------ 162
Query: 664 SDAHYPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGY--AADWWSVGIILFEFITGIP 720
+T + G Y+APE I GY +D WS+GI L+E TG
Sbjct: 163 --------AKTRD------AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKF 208
Query: 721 PFTAESPEIIFDNILN-RKIPWPCVPSD----MSFEAQDLINRFLIHDPNQRLGANGAAE 775
P+ + +FD + K P + + S + IN LI D ++R E
Sbjct: 209 PYPKWNS--VFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYK---E 263
Query: 776 VKAHPFFK 783
+ HPF K
Sbjct: 264 LLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-18
Identities = 77/274 (28%), Positives = 115/274 (41%), Gaps = 45/274 (16%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
I RG FG VF R R A+K + + + + + L E IL +P +VR
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LALEYLHSLG 615
T + +Y+VME + GGD + LR G R+ + EL+ +EYL S
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEG------PRLKVKELIQMVENAAAGMEYLESKH 114
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
+HRDL N L+ +K++DFG+S+ E DG+ S +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSR------------EEEDGVYASTGGMKQ----- 157
Query: 676 NRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAESPEIIFDN 733
P + APE L + +D WS GI+L+E F G P+ S + +
Sbjct: 158 ---------IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA 208
Query: 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
I + + PC P L+ R +DP QR
Sbjct: 209 I-EQGVRLPC-PELCPDAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 78/242 (32%), Positives = 111/242 (45%), Gaps = 43/242 (17%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFA----IKVLKKLDMIRKNDIERILAERNILITV 552
+E + I GA+G+VF AR G F ++V + + + I + R+ L T
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH-LETF 61
Query: 553 RNPFVVRFF----YSFTCRDN-LYLVMEYLNGGDLYSLLRKV---GCLEEDVARIYIAEL 604
+P VVR F S T R+ L LV E+++ DL + L KV G E + + + +L
Sbjct: 62 EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM-MFQL 119
Query: 605 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 664
+ L++LHS +VHRDLKP N+L+ G IKL DFGL++I
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI-------------------- 159
Query: 665 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 724
+Q S V T Y APE+LL + + D WSVG I E P F
Sbjct: 160 ----YSFQMALT----SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRG 211
Query: 725 ES 726
S
Sbjct: 212 SS 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 88/316 (27%), Positives = 130/316 (41%), Gaps = 76/316 (24%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAERNILITVRNP 555
+ G + VF R + T +L A+K ++ IR+ + + L NI +T+ +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANI-VTLHD- 70
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE-DVARIYIAELVLALEYLHSL 614
++ T LV EYL+ DL L G L +I++ +L+ L Y H
Sbjct: 71 -IIHTERCLT------LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
I+HRDLKP NLLI G +KL DFGL++ + P+ + E
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSV---------------PTKTYSNE---- 163
Query: 675 DNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF----TAESPEI 729
V T Y P++LLG TE+ D W VG IL+E TG P F E +
Sbjct: 164 --------VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL 215
Query: 730 IFDNI-LNRKIPWPCVPSDMSFE--------AQDLINR--------------FLIHDPNQ 766
IF + + WP + S+ F AQ LIN L+++
Sbjct: 216 IFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKS 275
Query: 767 RLGANGAAEVKAHPFF 782
R+ A A H +F
Sbjct: 276 RISAEAALR---HSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 5e-18
Identities = 65/255 (25%), Positives = 104/255 (40%), Gaps = 29/255 (11%)
Query: 519 TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN-LYLVMEYL 577
TG AIK+L+ ++ R E + + +P +V S L+ V EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 578 NGGDLYSLLRKVGCLE-EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---H 633
G L +L G L + R+ + +++ AL H+ GIVHRDLKP N++++ G H
Sbjct: 62 PGRTLREVLAADGALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 634 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEI 693
K+ DFG+ + + +GTP Y APE
Sbjct: 121 AKVLDFGIGTLL------------------PGVRDADVATLTRT--TEVLGTPTYCAPEQ 160
Query: 694 LLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFDNILNRKIPWPCVPSDMSFEA 752
L G +D ++ G+I E +TG S EI++ + + P P
Sbjct: 161 LRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLP--PWIAGHPL 218
Query: 753 QDLINRFLIHDPNQR 767
++ + L DP QR
Sbjct: 219 GQVLRKALNKDPRQR 233
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 5e-18
Identities = 91/347 (26%), Positives = 144/347 (41%), Gaps = 87/347 (25%)
Query: 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITVRNPFV 557
+K + GA+G V A + TG+ AIK KL +++I +R E +L +++ V
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIK---KLSRPFQSEIFAKRAYRELTLLKHMQHENV 76
Query: 558 VRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKVGCLE--EDVARIYIAELVLALE 609
+ FT + YLVM Y+ + L+K+ ED + + +++ L+
Sbjct: 77 IGLLDVFTSAVSGDEFQDFYLVMPYM-----QTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 669
Y+HS GI+HRDLKP NL + D +K+ DFGL++ +DA
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------------HADAEMT 172
Query: 670 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES-- 726
Y V T Y APE++L H D WSVG I+ E +TG F +
Sbjct: 173 GY-----------VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 221
Query: 727 --------------PEII--FDNILNRKI--PWPCVPS--------DMSFEAQDLINRFL 760
PE + ++ + P P S +A DL+ + L
Sbjct: 222 DQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKML 281
Query: 761 IHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDT 807
D ++RL A A E HP+F + + A + + DD+
Sbjct: 282 ELDVDKRLTATEALE---HPYFD-------SFRDADEETEQQPYDDS 318
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-17
Identities = 67/248 (27%), Positives = 109/248 (43%), Gaps = 55/248 (22%)
Query: 497 FEIIKPISRGAFGRVFLAR--KRTTGDLFAIKVLK--KLDM-------IRKNDIERILAE 545
+EI I RG +GRV+ A+ G +AIK K K R+ + R L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 546 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-----KVGCLEEDVARIY 600
N+ +++ F+ S +YL+ +Y DL+ +++ K + + +
Sbjct: 62 ENV-VSLVEVFLEHADKS------VYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSL 113
Query: 601 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH----IKLTDFGLSKIGLINNTIDLSGP 656
+ +++ + YLHS ++HRDLKP N+L+ +G +K+ D GL++ L N +
Sbjct: 114 LWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKPLAD 171
Query: 657 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFE 714
D + V T Y APE+LLG H Y A D W++G I E
Sbjct: 172 L-DPV---------------------VVTIWYRAPELLLGARH-YTKAIDIWAIGCIFAE 208
Query: 715 FITGIPPF 722
+T P F
Sbjct: 209 LLTLEPIF 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-17
Identities = 88/326 (26%), Positives = 137/326 (42%), Gaps = 77/326 (23%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK--LDMIRKNDIERILAERNILITV 552
+ ++ + P+ GA+G V A TG A+K L + +I +R E +L +
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA---KRTYRELRLLKHM 73
Query: 553 RNPFVVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 606
++ V+ FT +++YLV +L G DL +++ K L +D + I +++
Sbjct: 74 KHENVIGLLDVFTPARSLEEFNDVYLVT-HLMGADLNNIV-KCQKLTDDHVQFLIYQILR 131
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
L+Y+HS I+HRDLKP NL + D +K+ DFGL++ TD M
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------------HTDDEMT--- 175
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 725
V T Y APEI+L H D WSVG I+ E +TG F
Sbjct: 176 --------------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221
Query: 726 SPEIIFDNILN----------RKIP----------WPCVPSDMSFE---------AQDLI 756
IL +KI +P M+F A DL+
Sbjct: 222 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPK-MNFANVFIGANPLAVDLL 280
Query: 757 NRFLIHDPNQRLGANGAAEVKAHPFF 782
+ L+ D ++R+ AA+ AH +F
Sbjct: 281 EKMLVLDSDKRI---TAAQALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 5e-17
Identities = 69/228 (30%), Positives = 109/228 (47%), Gaps = 40/228 (17%)
Query: 500 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
I+ + +G FG V L R + TG++ A+K L+ D ER E IL ++++
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFER---EIEILKSLQHD 65
Query: 556 FVVRFFYSFTC----RDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEY 610
+V+ Y C R NL LVMEYL G L L+K L+ +Y +++ +EY
Sbjct: 66 NIVK--YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
L S VHRDL N+L+ + +K+ DFGL+K+ +P D Y +
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKV-----------------LPQDKEYYK 166
Query: 671 YQQTDNRNRHSAVGTPDY-LAPEILLGTEHGYAADWWSVGIILFEFIT 717
++ +P + APE L ++ A+D WS G++L+E T
Sbjct: 167 VREPGE--------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 64/231 (27%), Positives = 102/231 (44%), Gaps = 38/231 (16%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
F ++ I G+FG V+ AR ++ AIK + + I+ E L +R+P
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
+++ + +LVMEY G DL + +K E ++A + L L YLHS
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAVTHGAL-QGLAYLHSH 134
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
++HRD+K N+L++ G +KL DFG + I + P++
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASI----------------MAPAN--------- 169
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 722
VGTP ++APE++L + G D WS+GI E PP
Sbjct: 170 ------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 1e-16
Identities = 66/231 (28%), Positives = 101/231 (43%), Gaps = 38/231 (16%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
F ++ I G+FG V+ AR T ++ AIK + + I+ E L +++P
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
+ + + +LVMEY G DL + +K E ++A I L L YLHS
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGAL-QGLAYLHSH 144
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
++HRD+K N+L+ G +KL DFG + I P++
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASI----------------ASPAN--------- 179
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 722
S VGTP ++APE++L + G D WS+GI E PP
Sbjct: 180 ------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 60/228 (26%), Positives = 97/228 (42%), Gaps = 42/228 (18%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
I +G FG V+ + ++ A+K + + + L E IL +P +V+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEV-AVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LALEYLHSLG 615
+ +Y+VME + GG L + LRK R+ + +L+ +EYL S
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKK------NRLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
+HRDL N L+ + +K++DFG+S+ E GI Y +D
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR------------EEEGGI---------YTVSD 152
Query: 676 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 722
+ T APE L + +D WS GI+L+E F G P+
Sbjct: 153 GLKQIPIKWT----APEALNYGRYTSESDVWSYGILLWETFSLGDTPY 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 8/153 (5%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 552
+ + ++ I +G FG V L R G A+K LK + LAE +++ T+
Sbjct: 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKD----DSTAAQAFLAEASVMTTL 57
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEY 610
R+P +V+ + LY+V EY+ G L LR G + + ++ +EY
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
L VHRDL N+L++ D K++DFGL+K
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 7e-16
Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 38/225 (16%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
I G+FG V+ A T ++ A+K + + I+ E L +++P + +
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 563 SFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRD 620
+ +LVMEY G DL + +K E ++A I L L YLHS ++HRD
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKK-PLQEVEIAAITHGAL-QGLAYLHSHNMIHRD 146
Query: 621 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 680
+K N+L+ G +KL DFG + S P +
Sbjct: 147 IKAGNILLTEPGQVKLADFGSASK---------SSPA----------------------N 175
Query: 681 SAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFEFITGIPPF 722
S VGTP ++APE++L + G D WS+GI E PP
Sbjct: 176 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 83/314 (26%), Positives = 129/314 (41%), Gaps = 72/314 (22%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE----RILAERNILITVRNPFVV 558
+ G + V+ R + T +L A+K IR E + E ++L +++ +V
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALK------EIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 559 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIV 617
+L LV EYL+ DL L G + ++++ +L+ L Y H ++
Sbjct: 68 TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL 126
Query: 618 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 677
HRDLKP NLLI G +KL DFGL++ I P+ + E
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSI---------------PTKTYSNE------- 164
Query: 678 NRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE----IIFD 732
V T Y P+ILLG T++ D W VG I +E TG P F + E IF
Sbjct: 165 -----VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF- 218
Query: 733 NILNRKI--PWPCVPSDMSF----------------------EAQDLINRFLIHDPNQRL 768
IL WP + S+ F + +L+++ L + +R+
Sbjct: 219 RILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI 278
Query: 769 GANGAAEVKAHPFF 782
A A + HP+F
Sbjct: 279 SAEEAMK---HPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 2e-15
Identities = 68/229 (29%), Positives = 104/229 (45%), Gaps = 46/229 (20%)
Query: 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILITVRNPFV 557
+KPI GA G V A TG AIK KL +N +R E ++ V + +
Sbjct: 21 LKPIGSGAQGIVCAAYDTVTGQNVAIK---KLSRPFQNVTHAKRAYRELVLMKLVNHKNI 77
Query: 558 VRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALE 609
+ FT + +L YLVME ++ L +V ++ D R+ + +++ ++
Sbjct: 78 IGLLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMDLDHERMSYLLYQMLCGIK 132
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 669
+LHS GI+HRDLKP N+++ D +K+ DFGL++ M + Y
Sbjct: 133 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA------------GTSFMMTP--Y- 177
Query: 670 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 718
V T Y APE++LG + D WSVG I+ E I G
Sbjct: 178 -------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 70/278 (25%), Positives = 124/278 (44%), Gaps = 41/278 (14%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ +++K + G FG V++ + AIK LK+ M E LAE N++ +++
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQH 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLH 612
P +VR Y+ ++ +Y++ EY+ G L L+ ++ + ++ A++ + ++
Sbjct: 61 PRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
+HRDL+ N+L++ K+ DFGL+++ I + EY
Sbjct: 120 RKNYIHRDLRAANILVSETLCCKIADFGLARL--IEDN-------------------EYT 158
Query: 673 QTDNRNRHSAVGTPDYLAPE-ILLGTEHGYAADWWSVGIILFEFIT--GIPPFTAESPEI 729
R A + APE I GT +D WS GI+L E +T IP +PE+
Sbjct: 159 A-----REGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV 212
Query: 730 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
I + L R P P + E +L+ P +R
Sbjct: 213 IQN--LERGYRMPR-PDNCPEELYELMRLCWKEKPEER 247
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 68/235 (28%), Positives = 100/235 (42%), Gaps = 48/235 (20%)
Query: 503 ISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 557
+ GAFG+VFLA L A+K LK+ + D +R E +L +++ +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTVLQHQHI 69
Query: 558 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLE--EDVA--------RIYIAE 603
VRF+ T L +V EY+ GDL LR G L EDVA + IA
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 604 LVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 662
+ + + YL SL VHRDL N L+ +K+ DFG+S+
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR------------------- 170
Query: 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 717
D + +Y + R P PE +L + +D WS G++L+E T
Sbjct: 171 --DIYSTDYYRVGGRTMLPIRWMP----PESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 3e-15
Identities = 82/337 (24%), Positives = 139/337 (41%), Gaps = 84/337 (24%)
Query: 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 551
T + ++ +KPI GA G V A G A+K L + + +R E +L
Sbjct: 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRAYRELVLLKC 76
Query: 552 VRNPFVVRFFYSFTCR------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAE 603
V + ++ FT + ++YLVME ++ L +V +E D R+ + +
Sbjct: 77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDHERMSYLLYQ 131
Query: 604 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
++ +++LHS GI+HRDLKP N+++ D +K+ DFGL++ N
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--------------- 176
Query: 664 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT------ 717
+ T V T Y APE++LG + D WSVG I+ E +
Sbjct: 177 -------FMMT------PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQ 223
Query: 718 ---------------GIPP--FTAESPEIIFDNILNRK----------IPWPCVPSD--- 747
G P F + + + NR P PS+
Sbjct: 224 GTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESER 283
Query: 748 ---MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
+ +A+DL+++ L+ DP++R+ + E HP+
Sbjct: 284 DKLKTSQARDLLSKMLVIDPDKRISVD---EALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-15
Identities = 82/322 (25%), Positives = 136/322 (42%), Gaps = 76/322 (23%)
Query: 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAERNILITV 552
++ + G + VF R + T +L A+K ++ IR+ + + L NI +T+
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI-VTL 69
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYL 611
+ +V S T LV EYL+ DL + G + +I++ +++ L Y
Sbjct: 70 HD--IVHTDKSLT------LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYC 120
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
H ++HRDLKP NLLI G +KL DFGL++ + P+ + E
Sbjct: 121 HRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV---------------PTKTYSNE- 164
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE-- 728
V T Y P++LLG +E+ D W VG I FE +G P F + E
Sbjct: 165 -----------VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDE 213
Query: 729 --IIFDNI-LNRKIPWPCVPSDMSF----------------------EAQDLINRFLIHD 763
+IF + + WP + S+ F E +L+ +FL ++
Sbjct: 214 LHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYE 273
Query: 764 PNQRLGANGAAEVKAHPFFKGV 785
+R+ A E H +F+ +
Sbjct: 274 SKKRISAE---EAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 59/229 (25%), Positives = 108/229 (47%), Gaps = 33/229 (14%)
Query: 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR 559
+K + G FG V L + R + AIK + + M ++ IE E +++ + +P +V+
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQ 63
Query: 560 FFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVH 618
+ T + LY+V E++ G L + LR + G L +D+ ++ +EYL +H
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123
Query: 619 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 678
RDL N L++ G +K++DFG+++ L + SG A +P
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG----------AKFP--------- 164
Query: 679 RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAES 726
+ PE+ +++ +D WS G++++E F G PF +S
Sbjct: 165 -------VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-15
Identities = 85/327 (25%), Positives = 134/327 (40%), Gaps = 83/327 (25%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK--LDMIRKNDIERILAERNILITVRN 554
++ + P+ GA+G V A A+K L + +I R E +L +++
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHA---RRTYRELRLLKHMKH 73
Query: 555 PFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 608
V+ FT ++ YLV L G DL +++ K L ++ + I +L+ L
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTN-LMGADLNNIV-KCQKLSDEHVQFLIYQLLRGL 131
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
+Y+HS GI+HRDLKP N+ + D +++ DFGL++
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR------------------------- 166
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 727
Q D+ V T Y APEI+L H D WSVG I+ E + G F P
Sbjct: 167 ----QADDE-MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF----P 217
Query: 728 EIIFDNILNRKI-----PWPCVPSDMSFE---------------------------AQDL 755
+ + L R + P P V +S E A DL
Sbjct: 218 GNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDL 277
Query: 756 INRFLIHDPNQRLGANGAAEVKAHPFF 782
+ + L+ D ++R+ A+E AHP+F
Sbjct: 278 LEKMLVLDSDKRI---SASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 2e-14
Identities = 56/231 (24%), Positives = 94/231 (40%), Gaps = 35/231 (15%)
Query: 503 ISRGAFGR--VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRF 560
I + V LA+ + T L A+K + LD K D++ + E +++P ++ +
Sbjct: 6 IGKCFEDLMIVHLAKHKPTNTLVAVKKIN-LDSCSKEDLKLLQQEIITSRQLQHPNILPY 64
Query: 561 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVH 618
SF LY+V + G LL+ L E + +++ AL+Y+HS G +H
Sbjct: 65 VTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIH 124
Query: 619 RDLKPDNLLIAHDGHIKLTDF----GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
R +K ++L++ DG + L+ + K G +
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP------------------- 165
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPFT 723
+ S P +L+PE+L GY D +SVGI E G PF
Sbjct: 166 ----KSSVKNLP-WLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 83/337 (24%), Positives = 139/337 (41%), Gaps = 84/337 (24%)
Query: 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 551
T + ++ +KPI GA G V A AIK L + + +R E ++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 72
Query: 552 VRNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAE 603
V + ++ FT + +L YLVME ++ L +V +E D R+ + +
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-----LCQVIQMELDHERMSYLLYQ 127
Query: 604 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
++ +++LHS GI+HRDLKP N+++ D +K+ DFGL++ T G
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------------TAGTSF 173
Query: 664 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI------- 716
Y V T Y APE++LG + D WSVG I+ E +
Sbjct: 174 MMTPY--------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFP 219
Query: 717 ----------------TGIPPFTAESPEIIFDNILNRK----------IPWPCVPSD--- 747
T P F + + + + NR P P+D
Sbjct: 220 GRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEH 279
Query: 748 ---MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
+ +A+DL+++ L+ DP +R+ + A + HP+
Sbjct: 280 NKLKASQARDLLSKMLVIDPAKRISVDEALQ---HPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 27/171 (15%)
Query: 495 DDFEIIKPISRGAFGRVFLARKR---TTGD--LFAIKVLKK--LDMIRKNDIERILAERN 547
D + + + GAFG+VFL D L A+K LK+ + RK D ER E
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARK-DFER---EAE 60
Query: 548 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG---------------CL 592
+L ++ +V+F+ T D +V EY+ GDL LR G
Sbjct: 61 LLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELT 120
Query: 593 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
+ +I + ++ + YL S VHRDL N L+ +D +K+ DFG+S+
Sbjct: 121 LSQLLQIAV-QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 3e-14
Identities = 77/299 (25%), Positives = 121/299 (40%), Gaps = 70/299 (23%)
Query: 500 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
I+ + G FG+V L TG++ A+K LK+ + ++N E NIL T+ +
Sbjct: 9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKR-ECGQQNT-SGWKKEINILKTLYHE 66
Query: 556 FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 606
+V+ Y C + L L+MEY+ G L L K ++ +A+L+L
Sbjct: 67 NIVK--YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--------HKLNLAQLLLFAQQI 116
Query: 607 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 664
+ YLHS +HRDL N+L+ +D +K+ DFGL+K
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAK--------------------- 155
Query: 665 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 724
PE + R R + A E L + YA+D WS G+ L+E +T
Sbjct: 156 --AVPEGHEY-YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSK-- 210
Query: 725 ESPEIIFD----------------NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
+SP F+ +L R + PC P + E L+ + R
Sbjct: 211 QSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPC-PKNCPQEVYILMKNCWETEAKFR 268
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 79/298 (26%), Positives = 126/298 (42%), Gaps = 58/298 (19%)
Query: 496 DFEIIKPISRGAFGRVFLAR---KRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILI 550
D + + + GAFG+VFLA T D L A+K LK + + D +R E +L
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLT 62
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVL 606
+++ +V+F+ D L +V EY+ GDL LR G L + R EL L
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 607 A------------LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654
+ + YL S VHRDL N L+ + +K+ DFG+S+
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----------- 171
Query: 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 714
D + +Y + H+ + ++ PE ++ + +D WS G+IL+E
Sbjct: 172 ----------DVYSTDYYRVGG---HTMLPI-RWMPPESIMYRKFTTESDVWSFGVILWE 217
Query: 715 FIT-GIPPFTAESPEIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQRL 768
T G P+ S + + I ++ P C P E D++ +P QRL
Sbjct: 218 IFTYGKQPWFQLSNTEVIECITQGRVLERPRVC-PK----EVYDIMLGCWQREPQQRL 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 7e-14
Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 44/236 (18%)
Query: 506 GAFG----RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 561
G FG V+ RK+ AIKVLK + K+ + ++ E I+ + NP++VR
Sbjct: 6 GNFGCVKKGVYKMRKKQID--VAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 562 YSFTCR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV----LALEYLHSLGI 616
C + L LVME +GG L L ++++ + EL+ + ++YL
Sbjct: 62 G--VCEAEALMLVMEMASGGPLNKFL---SGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 617 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 676
VHRDL N+L+ + + K++DFGLSK + D++Y
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSK----------------ALGADDSYY-------- 152
Query: 677 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTA-ESPEII 730
+ R + + APE + + +D WS GI ++E F G P+ + PE++
Sbjct: 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM 208
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 7e-14
Identities = 73/303 (24%), Positives = 131/303 (43%), Gaps = 71/303 (23%)
Query: 501 KPISRGAFGRV-----FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
K + G FG+V F + R A+K+LK+ +++ +L+E N+L V +P
Sbjct: 6 KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKE--NASSSELRDLLSEFNLLKQVNHP 63
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---KVGC-------------LEEDVARI 599
V++ + + + L L++EY G L S LR KVG L+ R
Sbjct: 64 HVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERA 123
Query: 600 YIAELVLA--------LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651
+++ ++YL + +VHRDL N+L+A +K++DFGLS+
Sbjct: 124 LTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR-------- 175
Query: 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGI 710
+ + D+ + S P ++A E L + +D WS G+
Sbjct: 176 ------------------DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGV 217
Query: 711 ILFEFIT-GIPPFTAESPEIIFDNI-----LNRKIPWPCVPSDMSFEAQDLINRFLIHDP 764
+L+E +T G P+ +PE +F+ + + R P + S E +L+ +P
Sbjct: 218 LLWEIVTLGGNPYPGIAPERLFNLLKTGYRMER-------PENCSEEMYNLMLTCWKQEP 270
Query: 765 NQR 767
++R
Sbjct: 271 DKR 273
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 8e-14
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 49/226 (21%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
+ +IK ++ G+ GRVF+A K D +K+ +K L E +L V +P
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---------GTTLIEAMLLQNVNHPS 118
Query: 557 VVR-----FFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEY 610
V+R + TC +V+ + + DLY+ L ++ L D A I +++ L Y
Sbjct: 119 VIRMKDTLVSGAITC-----MVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRY 172
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
LH+ I+HRD+K +N+ I + + D G ++ + P G+
Sbjct: 173 LHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-------FPVVAPAFLGL--------- 216
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 716
GT + APE+L ++ AD WS GI+LFE +
Sbjct: 217 ------------AGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 1e-13
Identities = 61/229 (26%), Positives = 101/229 (44%), Gaps = 35/229 (15%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
+F + + + G FG V+ + + AIK+LK D++++ D ++ E L +R+
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQK---EVQALKRLRHK 62
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIAELVL-ALEYLHS 613
++ F + + +Y++ E + G L + LR VA I +A V + YL
Sbjct: 63 HLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
+HRDL N+L+ D K+ DFGL+++ I + LS SD P Y+
Sbjct: 123 QNSIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLS---------SDKKIP-YKW 170
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT--GIP 720
T APE +D WS GI+L+E T +P
Sbjct: 171 T---------------APEAASHGTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 2e-13
Identities = 64/227 (28%), Positives = 102/227 (44%), Gaps = 37/227 (16%)
Query: 500 IKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
I+ + G FG+V L R TG+ A+K LK N I + E IL + +
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHE 66
Query: 556 FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEY 610
+V+ Y C ++ + L+ME+L G L L R + Y ++ ++Y
Sbjct: 67 NIVK--YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY 124
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
L S VHRDL N+L+ + +K+ DFGL+K + +D Y
Sbjct: 125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKA-----------------IETDKEY-- 165
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 717
Y D+ + S V + APE L+ ++ A+D WS G+ L+E +T
Sbjct: 166 YTVKDDLD--SPVF---WYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 2e-13
Identities = 55/223 (24%), Positives = 98/223 (43%), Gaps = 35/223 (15%)
Query: 506 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 565
G +G V+ + A+K LK+ M ++E L E ++ +++P +V+ T
Sbjct: 17 GQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 566 CRDNLYLVMEYLNGGDLYSLLRKVGCLEED-VARIYIA-ELVLALEYLHSLGIVHRDLKP 623
Y++ E++ G+L LR+ E + V +Y+A ++ A+EYL +HRDL
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 132
Query: 624 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAV 683
N L+ + +K+ DFGLS++ D H+
Sbjct: 133 RNCLVGENHLVKVADFGLSRL---------------------------MTGDTYTAHAGA 165
Query: 684 GTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 724
P + APE L + +D W+ G++L+E T G+ P+
Sbjct: 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 43/228 (18%)
Query: 503 ISRGAFGRVF---LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR 559
+ +G FG VF L K A+K K+ D+ ++ I + L+E IL +P +V+
Sbjct: 3 LGKGNFGEVFKGTLKDKTPV----AVKTCKE-DLPQELKI-KFLSEARILKQYDHPNIVK 56
Query: 560 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----ALEYLHSLG 615
T R +Y+VME + GGD S LRK ++++ + + L + YL S
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN 113
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
+HRDL N L+ + +K++DFG+S+ E DGI S +Q
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR------------QEDDGIYSSSG----LKQIP 157
Query: 676 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 722
+ + APE L + +D WS GI+L+E F G+ P+
Sbjct: 158 IK----------WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-13
Identities = 89/331 (26%), Positives = 138/331 (41%), Gaps = 77/331 (23%)
Query: 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIK-VLKKLDMIRKNDIERILAERNIL 549
R+ +++ I G+FG V+ A T + AIK VL+ D KN I+ N +
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ--DPQYKNRELLIMKNLNHI 119
Query: 550 ITVRNPFVVRFFYSFTCRDN-----LYLVMEYLNGG-----DLYSLLRKVGCLEEDVARI 599
+ F+ ++Y+ + N L +VME++ Y+ R L + ++
Sbjct: 120 NII---FLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYA--RNNHALPLFLVKL 174
Query: 600 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTIDLSGPET 658
Y +L AL Y+HS I HRDLKP NLLI + H +KL DFG +K +L
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK--------NLLA--- 223
Query: 659 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 717
+ S + + Y APE++LG T + D WS+G I+ E I
Sbjct: 224 -----------------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266
Query: 718 GIPPFTAESP-------------------EIIFDNILNRKIP-------WPCVPSDMSFE 751
G P F+ +S + + N + K P P +
Sbjct: 267 GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDD 326
Query: 752 AQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
A + I++FL ++P +RL E A PFF
Sbjct: 327 AINFISQFLKYEPLKRL---NPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 58/226 (25%), Positives = 104/226 (46%), Gaps = 38/226 (16%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
D +K + G FG V + R D+ AIK++K+ M IE E +++ + +
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIE----EAKVMMKLSHE 59
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYLHSL 614
+V+ + T + +Y+V EY++ G L + LR+ G + + + + V + YL S
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK 119
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
+HRDL N L+ G +K++DFGLS+ L D Y
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVL------------------DDEYT----- 156
Query: 675 DNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFEFIT 717
S+VG+ + PE+LL ++ +D W+ G++++E +
Sbjct: 157 ------SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-13
Identities = 65/235 (27%), Positives = 105/235 (44%), Gaps = 42/235 (17%)
Query: 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 551
T + ++ +KPI GA G V A AIK L + + +R E ++
Sbjct: 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 79
Query: 552 VRNPFVVRFFYSFTCRDNL------YLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAE 603
V + ++ FT + +L Y+VME ++ L +V +E D R+ + +
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDHERMSYLLYQ 134
Query: 604 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
++ +++LHS GI+HRDLKP N+++ D +K+ DFGL++ T + P
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPY------ 185
Query: 664 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 718
V T Y APE++LG + D WSVG I+ E I G
Sbjct: 186 -------------------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 61/234 (26%), Positives = 102/234 (43%), Gaps = 44/234 (18%)
Query: 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
+RTSI ++++ + G FG V+ T + A+K LK M D + LAE I+
Sbjct: 4 DRTSI---QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIM 55
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC----LEE--DVARIYIAE 603
+R+P +++ + T + +Y+V E + G L L+ L + D+A A+
Sbjct: 56 KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA----AQ 111
Query: 604 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
+ + YL + +HRDL N+L+ + K+ DFGL+++ I
Sbjct: 112 VASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARV----------------IKE 155
Query: 664 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 717
Y+ R A + APE L +D WS GI+L E +T
Sbjct: 156 D-----IYEA-----REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 6e-13
Identities = 65/264 (24%), Positives = 116/264 (43%), Gaps = 52/264 (19%)
Query: 493 SIDDFEIIKPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAE 545
S D + KP+ G FG+V +A K A+K+LK D + D+ +++E
Sbjct: 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSE 70
Query: 546 RNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE----DVARIY 600
++ + ++ ++ + T LY+++EY + G+L LR D+AR+
Sbjct: 71 MEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVP 130
Query: 601 IAELVL------------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648
++ +EYL S +HRDL N+L+ + +K+ DFGL++ +N
Sbjct: 131 DEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD--VN 188
Query: 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 708
N ID T+G +P ++APE L + + +D WS
Sbjct: 189 N-IDYYKKTTNGRLPV----------------------KWMAPEALFDRVYTHQSDVWSF 225
Query: 709 GIILFEFIT-GIPPFTAESPEIIF 731
G++++E T G P+ E +F
Sbjct: 226 GVLMWEIFTLGGSPYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 7e-13
Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 54/238 (22%)
Query: 494 IDDFEI--IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 551
ID E+ +K + G FG V L + R D+ AIK++++ M + IE E +++
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIE----EAKVMMK 55
Query: 552 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 606
+ +P +V+ + T + +++V EY+ G L + LR+ E +L
Sbjct: 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLG-------TEWLLDMCSD 108
Query: 607 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
A+EYL S G +HRDL N L+ D +K++DFGL++ L
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVL----------------- 151
Query: 664 SDAHYPEYQQTDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFEFITG 718
D Y S+ GT + PE+ + +D WS G++++E +
Sbjct: 152 -DDQYT-----------SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 7e-13
Identities = 63/235 (26%), Positives = 102/235 (43%), Gaps = 48/235 (20%)
Query: 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 550
R S+ ++ + + G FG V++ T + A+K LK M E L E I+
Sbjct: 5 RESL---KLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIMK 56
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-------KVGCLEEDVARIYIAE 603
+R+ +V+ + + + +Y+V EY++ G L L+ ++ L + A+I AE
Sbjct: 57 KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQI--AE 114
Query: 604 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIM 662
+ YL S +HRDL N+L+ + + K+ DFGL++ LI E D
Sbjct: 115 ---GMAYLESRNYIHRDLAARNILVG-ENLVCKIADFGLAR--LI---------EDD--- 156
Query: 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 717
EY R A + APE +D WS GI+L E +T
Sbjct: 157 -------EYTA-----REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 8e-13
Identities = 60/223 (26%), Positives = 99/223 (44%), Gaps = 41/223 (18%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
I G FG V + TG A+K +K D+ + L E ++ + + +VR
Sbjct: 14 IGEGEFGAVL--QGEYTGQKVAVKNIK-CDVT----AQAFLEETAVMTKLHHKNLVRLL- 65
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA--LEYLHSLGIVHRD 620
+ LY+VME ++ G+L + LR G V ++ L +A +EYL S +VHRD
Sbjct: 66 GVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRD 125
Query: 621 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 680
L N+L++ DG K++DFGL+++G +
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARVG------------------------------SMGVD 155
Query: 681 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 722
++ + APE L + +D WS G++L+E F G P+
Sbjct: 156 NSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 71/281 (25%), Positives = 119/281 (42%), Gaps = 47/281 (16%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ ++IK + G FG V++ + A+K LK M E L E I+ +R+
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTM----SPESFLEEAQIMKKLRH 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-------KVGCLEEDVARIYIAELVLA 607
+V+ Y+ + +Y+V EY++ G L L+ K+ L D+A A++
Sbjct: 61 DKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV-DMA----AQVAAG 114
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
+ Y+ + +HRDL+ N+L+ K+ DFGL++ LI +
Sbjct: 115 MAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR--LIEDN----------------- 155
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 726
EY R A + APE L +D WS GI+L E +T G P+ +
Sbjct: 156 --EYTA-----RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMN 208
Query: 727 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
+ + + R PC P D +L+ + DP +R
Sbjct: 209 NREVLEQV-ERGYRMPC-PQDCPISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 61/240 (25%), Positives = 98/240 (40%), Gaps = 33/240 (13%)
Query: 501 KPISRGAFGRVFLAR-KRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITVRNPFV 557
K + G+FG V + G + A+K LK + + ++ L E I+ ++ + +
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLDHENL 58
Query: 558 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLG 615
+R Y L +V E G L LRK ++ + Y ++ + YL S
Sbjct: 59 IRL-YGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
+HRDL N+L+A D +K+ DFGL + L N + H Y +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMR-ALPQN---------------EDH---YVMEE 158
Query: 676 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAESPEIIFDNI 734
+ A + APE L +A+D W G+ L+E F G P+ S I I
Sbjct: 159 HLKVPFA-----WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 65/264 (24%), Positives = 109/264 (41%), Gaps = 52/264 (19%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDL-----FAIKVLKKLDMIRKNDIERILAERNIL 549
D + KP+ GAFG+V A + A+K+LK D + D+ +++E ++
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLK--DDATEKDLSDLVSEMEMM 69
Query: 550 ITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE----DVARIYIAEL 604
+ ++ ++ T LY+V+EY G+L LR E D R L
Sbjct: 70 KMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETL 129
Query: 605 VL------------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652
+E+L S +HRDL N+L+ D +K+ DFGL++
Sbjct: 130 TQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--------- 180
Query: 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGII 711
D H+ +Y + R P ++APE L + + +D WS G++
Sbjct: 181 ------------DIHHIDYYRKTTNGR-----LPVKWMAPEALFDRVYTHQSDVWSFGVL 223
Query: 712 LFEFIT-GIPPFTAESPEIIFDNI 734
L+E T G P+ E +F +
Sbjct: 224 LWEIFTLGGSPYPGIPVEELFKLL 247
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-12
Identities = 60/230 (26%), Positives = 91/230 (39%), Gaps = 52/230 (22%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
F I++ + GA G F T + IK ++ E +IL + +P
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPS 144
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALE 609
+++ +FT L++ DLY C I I +++ A++
Sbjct: 145 IIQLKGTFTYNKFTCLILPRYKT-DLY-------CYLAAKRNIAICDILAIERSVLRAIQ 196
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 669
YLH I+HRD+K +N+ I H G + L DFG + P D
Sbjct: 197 YLHENRIIHRDIKAENIFINHPGDVCLGDFGAA------------------CFPVDI--- 235
Query: 670 EYQQTDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 718
N N++ GT APE+L +G A D WS GI+LFE T
Sbjct: 236 ------NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 4e-12
Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 44/227 (19%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI--ERILAERNILI 550
++ + ++++ I +G FG V L R G+ A+K +K ND + LAE +++
Sbjct: 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIK-------NDATAQAFLAEASVMT 54
Query: 551 TVRNPFVVRFFYSFT-CRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLA 607
+R+ +V+ + LY+V EY+ G L LR G L D + ++ A
Sbjct: 55 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
+EYL + VHRDL N+L++ D K++DFGL+K + S + G +P
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPV--- 163
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 714
+ APE L + +D WS GI+L+E
Sbjct: 164 -------------------KWTAPEALREKKFSTKSDVWSFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 61/235 (25%), Positives = 102/235 (43%), Gaps = 46/235 (19%)
Query: 501 KPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
+ + GAFG+VFLA L A+K LK + D R E +L +++
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR---EAELLTNLQHE 67
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR------------IYIAE 603
+V+F+ D L +V EY+ GDL LR G +A ++IA+
Sbjct: 68 HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127
Query: 604 LVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 662
+ A + YL S VHRDL N L+ + +K+ DFG+S+
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR------------------- 168
Query: 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 717
D + +Y + H+ + ++ PE ++ + +D WS+G++L+E T
Sbjct: 169 --DVYSTDYYRVGG---HTMLPI-RWMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 66/250 (26%), Positives = 107/250 (42%), Gaps = 50/250 (20%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDL----FAIKVLKKLDMIRKNDIERILAERNILITV 552
E IK + GAFG V+ G+ AIKVL++ + K + IL E ++ +V
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKA-NKEILDEAYVMASV 66
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLAL 608
+P VVR + L+ + + G L +R +G + IA+ +
Sbjct: 67 DHPHVVRL-LGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAK---GM 122
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
YL +VHRDL N+L+ H+K+TDFGL+K+ L E
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL--------LDVDEK---------- 164
Query: 669 PEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-------GIP 720
EY + P ++A E +L + + +D WS G+ ++E +T GIP
Sbjct: 165 -EYHAEGGK-------VPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP 216
Query: 721 PFTAESPEII 730
E P+++
Sbjct: 217 --AVEIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 35/124 (28%), Positives = 58/124 (46%), Gaps = 11/124 (8%)
Query: 524 AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 583
A+K LK+ + + L E +++ + +P +VR + L LVME G L
Sbjct: 27 AVKTLKQEHI--AAGKKEFLREASVMAQLDHPCIVRLI-GVCKGEPLMLVMELAPLGPLL 83
Query: 584 SLLRKVGCLEEDVARIYIAELVL----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 639
L+K ++ + EL + YL S VHRDL N+L+ + K++DF
Sbjct: 84 KYLKKRR----EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDF 139
Query: 640 GLSK 643
G+S+
Sbjct: 140 GMSR 143
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 69/282 (24%), Positives = 117/282 (41%), Gaps = 51/282 (18%)
Query: 501 KPISRGAFGRV---FLARKRTTGDLFAIKVLKKLDMIRKNDI---ERILAERNILITVRN 554
+ G FG V K++ + A+K+LK + ND + +L E N++ + N
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTV-AVKILKNDN----NDPALKDELLREANVMQQLDN 55
Query: 555 PFVVRFFYSFTCR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV----LALE 609
P++VR C ++ LVME G L L+K + V I ELV + ++
Sbjct: 56 PYIVRMIG--ICEAESWMLVMELAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMK 109
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 669
YL VHRDL N+L+ + K++DFGLSK + +D +Y
Sbjct: 110 YLEETNFVHRDLAARNVLLVTQHYAKISDFGLSK-----------------ALGADENYY 152
Query: 670 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTA-ESP 727
+ + + APE + + +D WS G++++E F G P+ +
Sbjct: 153 KAKTHGK-------WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN 205
Query: 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 769
E+ ++ C P E DL+ + ++R G
Sbjct: 206 EVT--QMIESGERMEC-PQRCPPEMYDLMKLCWTYGVDERPG 244
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 54/235 (22%), Positives = 104/235 (44%), Gaps = 34/235 (14%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ +++K + G FG V++ + + A+K LK M ++ L E N++ T+++
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMKTLQH 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLH 612
+VR + T + +Y++ EY+ G L L+ + + ++ + A++ + Y+
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
+HRDL+ N+L++ K+ DFGL+++ D Y
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLARV------------------IEDNEYTA-- 160
Query: 673 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 726
R A + APE + +D WS GI+L+E +T G P+ S
Sbjct: 161 ------REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 48/285 (16%)
Query: 500 IKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
I + RG FG VFLA+ + + L +K L+K +N E ++ + +
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSH 67
Query: 555 PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDV--------ARIYIA-E 603
VVR CR+ Y+++EY + GDL LR +E + ++ + +
Sbjct: 68 KNVVRLLG--LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 604 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
+ L +++L + VHRDL N L++ +K++ LSK
Sbjct: 126 IALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK-------------------- 165
Query: 664 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 722
D + EY + N A+ +LAPE + + +D WS G++++E F G PF
Sbjct: 166 -DVYNSEYYKLRN-----ALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219
Query: 723 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
S E + + + K+ P VP L+ R +P R
Sbjct: 220 YGLSDEEVLNRLQAGKLELP-VPEGCPSRLYKLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 3e-11
Identities = 71/316 (22%), Positives = 120/316 (37%), Gaps = 81/316 (25%)
Query: 495 DDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKK---LDMIRKNDIERILAER 546
++ E ++ I +GAFGRVF AR + A+K+LK+ DM + D +R E
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM--QADFQR---EA 59
Query: 547 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-------------KVGCLE 593
++ +P +V+ + L+ EY+ GDL LR +
Sbjct: 60 ALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARK 119
Query: 594 EDVARIYIAELVL---------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644
+ + ++ + YL VHRDL N L+ + +K+ DFGLS+
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 645 GLINNTIDLSGPETDGI----MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 700
I + E D I MP PE + +
Sbjct: 180 --IYSADYYKASENDAIPIRWMP---------------------------PESIFYNRYT 210
Query: 701 YAADWWSVGIILFE-FITGIPPFTAES-PEIIF----DNILNRKIPWPCVPSDMSFEAQD 754
+D W+ G++L+E F G+ P+ + E+I+ N+L+ C P + E +
Sbjct: 211 TESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLS------C-PDNCPLELYN 263
Query: 755 LINRFLIHDPNQRLGA 770
L+ P+ R
Sbjct: 264 LMRLCWSKLPSDRPSF 279
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 4e-11
Identities = 49/162 (30%), Positives = 71/162 (43%), Gaps = 36/162 (22%)
Query: 500 IKPISRGAFGRVFLARKRTTGDLFAIKVL-----------KKLD-MIRKNDIERILAERN 547
+K I RGA ++L GD IK + +LD IR+ ER E
Sbjct: 1 MKLIKRGAEAEIYL------GDFLGIKAVIKWRIPKRYRHPELDERIRR---ERTRREAR 51
Query: 548 ILIT-----VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 602
I+ V P V +N +VMEY+ G L L+ G E +++R
Sbjct: 52 IMSRARKAGVNVPAVYFVDP-----ENFIIVMEYIEGEPLKDLINSNGMEELELSR---- 102
Query: 603 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644
E+ + LHS GI+H DL N+++ G I L DFGL++
Sbjct: 103 EIGRLVGKLHSAGIIHGDLTTSNMIL-SGGKIYLIDFGLAEF 143
|
Length = 211 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 63/256 (24%), Positives = 109/256 (42%), Gaps = 52/256 (20%)
Query: 501 KPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV- 552
KP+ G FG+V +A K A+K+LK D K D+ +++E ++ +
Sbjct: 24 KPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKS-DATEK-DLSDLISEMEMMKMIG 81
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------CLEED---VARIYIAE 603
++ ++ + T LY+++EY + G+L LR C ++ +
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 604 LV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 656
LV +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR------------- 188
Query: 657 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 716
D H+ +Y + R ++APE L + + +D WS G++L+E
Sbjct: 189 --------DIHHIDYYKKTTNGRLPV----KWMAPEALFDRIYTHQSDVWSFGVLLWEIF 236
Query: 717 T-GIPPFTAESPEIIF 731
T G P+ E +F
Sbjct: 237 TLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 6e-11
Identities = 67/274 (24%), Positives = 115/274 (41%), Gaps = 50/274 (18%)
Query: 450 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSID-------DFEIIKP 502
EL D T + Y + +S+S + V + +S D + I+
Sbjct: 47 ELGDSDDVTHATDYDADE----ESLSPQTDVCQ---EPCETTSSSDPASVVRMQYNILSS 99
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
++ G+ G VF+ K GD KV+ K + R E +IL T+ + ++ +
Sbjct: 100 LTPGSEGEVFVCTKH--GDEQRKKVIVKA-VTGGKTPGR---EIDILKTISHRAIINLIH 153
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYLHSLGIVHRDL 621
++ + + +VM DL++ + + G L + A I I +L AL YLH GI+HRD+
Sbjct: 154 AYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA-ITIQRRLLEALAYLHGRGIIHRDV 211
Query: 622 KPDNLLIAHDGHIKLTDFGLS-KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 680
K +N+ + + L DFG + K+ +T P +
Sbjct: 212 KTENIFLDEPENAVLGDFGAACKLDAHPDT------------PQC--------------Y 245
Query: 681 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 714
GT + +PE+L + D WS G++LFE
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE 279
|
Length = 392 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 59/243 (24%), Positives = 108/243 (44%), Gaps = 46/243 (18%)
Query: 503 ISRGAFGRVFLARKRT-----TGDL-FAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
+ GAFG V+ +G + A+K L+K ++ + L E +++ +P
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK--KEFLKEAHLMSNFNHPN 60
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LALE------ 609
+V+ + Y++ME + GGDL S LR + + EL+ + L+
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIGLINNTIDLSGPETDGIMPS 664
YL + +HRDL N L++ G+ +K+ DFGL++ + + D E +G++P
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-DIYKS--DYYRKEGEGLLPV 177
Query: 665 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFT 723
++APE LL + +D WS G++++E +T G P+
Sbjct: 178 ----------------------RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP 215
Query: 724 AES 726
A +
Sbjct: 216 ALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 9e-11
Identities = 68/273 (24%), Positives = 112/273 (41%), Gaps = 47/273 (17%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
+ +G FG V++ T + AIK LK M+ E L E I+ +R+ +V Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMP----EAFLQEAQIMKKLRHDKLVPL-Y 67
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALEYLHSLG 615
+ + +Y+V E++ G L L+ E D + + +LV + Y+ +
Sbjct: 68 AVVSEEPIYIVTEFMGKGSLLDFLK-----EGDGKYLKLPQLVDMAAQIADGMAYIERMN 122
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
+HRDL+ N+L+ + K+ DFGL++ LI + EY
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLAR--LIEDN-------------------EYTA-- 159
Query: 676 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 734
R A + APE L +D WS GI+L E +T G P+ + + +
Sbjct: 160 ---RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216
Query: 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
R PC P +L+ DP++R
Sbjct: 217 -ERGYRMPC-PQGCPESLHELMKLCWKKDPDER 247
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 64/270 (23%), Positives = 116/270 (42%), Gaps = 51/270 (18%)
Query: 500 IKPISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
++ + AFG+++ G L AIK LK D+ E +++ + +P
Sbjct: 10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHP 67
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL------RKVGCLEEDVARI---------- 599
+V T + ++ EYLN GDL+ L VGC ++ +
Sbjct: 68 NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127
Query: 600 YIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 658
+IA ++ +EYL S VH+DL N+LI H+K++D GLS+
Sbjct: 128 HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR--------------- 172
Query: 659 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FIT 717
I +D + R + ++ ++ PE ++ + +D WS G++L+E F
Sbjct: 173 -EIYSADYY---------RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSF 222
Query: 718 GIPPFTAESPEIIFDNILNRKIPWPCVPSD 747
G+ P+ S + + + + R++ PC D
Sbjct: 223 GLQPYYGFSNQEVIEMVRKRQL-LPC-SED 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 67/268 (25%), Positives = 112/268 (41%), Gaps = 37/268 (13%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
+ +G FG V++ T + AIK LK M E L E ++ +R+ +V+ Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQL-Y 67
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLGIVHRD 620
+ + +Y+V EY++ G L L+ + ++ A++ + Y+ + VHRD
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 621 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 680
L+ N+L+ + K+ DFGL++ LI + EY R
Sbjct: 128 LRAANILVGENLVCKVADFGLAR--LIEDN-------------------EYTA-----RQ 161
Query: 681 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKI 739
A + APE L +D WS GI+L E T G P+ + D + R
Sbjct: 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGY 220
Query: 740 PWPCVPSDMSFEAQDLINRFLIHDPNQR 767
PC P + DL+ + +P +R
Sbjct: 221 RMPC-PPECPESLHDLMCQCWRKEPEER 247
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 5e-10
Identities = 64/262 (24%), Positives = 112/262 (42%), Gaps = 55/262 (20%)
Query: 500 IKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
+K + GAFG V+ G+ AIKVL++ + N + IL E ++ V +P
Sbjct: 12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMAGVGSP 69
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI-------YIAELVLAL 608
+V R + LV + + G L +R E+ RI + ++ +
Sbjct: 70 YVCRLL-GICLTSTVQLVTQLMPYGCLLDYVR------ENKDRIGSQDLLNWCVQIAKGM 122
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
YL + +VHRDL N+L+ H+K+TDFGL+++ I+ T
Sbjct: 123 SYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET------------------ 164
Query: 669 PEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA-- 724
EY + P ++A E +L + +D WS G+ ++E +T G P+
Sbjct: 165 -EYHADGGK-------VPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216
Query: 725 --ESPEIIFDNILNRKIPWPCV 744
E P+++ ++P P +
Sbjct: 217 AREIPDLLEK---GERLPQPPI 235
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 6e-10
Identities = 63/265 (23%), Positives = 109/265 (41%), Gaps = 70/265 (26%)
Query: 501 KPISRGAFGRVFLA------RKRTTGDL-FAIKVLKKLDMIRKNDIERILAERNILITV- 552
KP+ G FG+V +A + + + A+K+LK D D+ +++E ++ +
Sbjct: 18 KPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLK--DDATDKDLSDLVSEMEMMKMIG 75
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK------------------------ 588
++ ++ + T LY+++EY + G+L LR
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 589 -VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647
V C + VAR +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 136 LVSCAYQ-VAR--------GMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLAR---- 182
Query: 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 707
D H +Y + R ++APE L + + +D WS
Sbjct: 183 -----------------DVHNIDYYKKTTNGRLPV----KWMAPEALFDRVYTHQSDVWS 221
Query: 708 VGIILFEFIT-GIPPFTAESPEIIF 731
G++L+E T G P+ E +F
Sbjct: 222 FGVLLWEIFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 9e-10
Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 46/231 (19%)
Query: 499 IIKPISRGAFGRVFLARKRTTGD---LFAIKVLKK--LDMIRKNDIERILAERNILITVR 553
I K I G FG V R + G AIK LK + R++ L+E +I+
Sbjct: 8 IEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD----FLSEASIMGQFD 63
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------L 606
+P ++ T + +V EY+ G L + LRK + + +LV
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK------HDGQFTVIQLVGMLRGIAS 117
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
++YL +G VHRDL N+L+ + K++DFGLS++ + + + + G +P
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV--LEDDPEAAYTTRGGKIPI-- 173
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 717
+ APE + + A+D WS GI+++E ++
Sbjct: 174 --------------------RWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 9e-10
Identities = 49/166 (29%), Positives = 66/166 (39%), Gaps = 53/166 (31%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKK-----------LD-MIRKNDIERILAERNILI 550
I++GA ++L GD +K + K LD IR+ ER E +L
Sbjct: 2 IAKGAEAIIYL------GDFLGLKAVIKERVPKSYRHPELDERIRR---ERTRNEARLLS 52
Query: 551 TVR----NPFVVRFFYSFTCRDNLYLVMEYLNGGDL--------YSLLRKVGCLEEDVAR 598
R N VV DN +VMEY+ G L LLR++G V +
Sbjct: 53 RARKAGVNTPVVYDVD----PDNKTIVMEYIEGKPLKDVIEEGNDELLREIG---RLVGK 105
Query: 599 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644
LH GIVH DL N+++ D + L DFGL K
Sbjct: 106 ------------LHKAGIVHGDLTTSNIIV-RDDKLYLIDFGLGKY 138
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 56/236 (23%), Positives = 108/236 (45%), Gaps = 40/236 (16%)
Query: 501 KPISRGAFGRVFLA--RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV 558
K + G FG V++A K T A+K +K M +E LAE N++ T+++ +V
Sbjct: 12 KKLGAGQFGEVWMATYNKHTK---VAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLV 64
Query: 559 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLHSLGI 616
+ ++ ++ +Y++ E++ G L L+ ++ + ++ + A++ + ++
Sbjct: 65 KL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY 123
Query: 617 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 676
+HRDL+ N+L++ K+ DFGL+++ N G A +P
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG----------AKFP------- 166
Query: 677 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA-ESPEII 730
+ APE + +D WS GI+L E +T G P+ +PE+I
Sbjct: 167 ---------IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 213
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 60/237 (25%), Positives = 105/237 (44%), Gaps = 42/237 (17%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILIT 551
+F+ IK + GAFG V+ G+ AIK L++ + N + IL E ++ +
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMAS 65
Query: 552 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI----AELVLA 607
V NP V R + L+ + + G L +R+ ++++ Y+ ++
Sbjct: 66 VDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKG 121
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
+ YL +VHRDL N+L+ H+K+TDFGL+K+ L E
Sbjct: 122 MNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL--------LGADEK--------- 164
Query: 668 YPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 722
EY + P ++A E +L + + +D WS G+ ++E +T G P+
Sbjct: 165 --EYHAEGGK-------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 1e-09
Identities = 58/235 (24%), Positives = 96/235 (40%), Gaps = 41/235 (17%)
Query: 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERI--LAER 546
I K I G FG V R + G AIK LK +D +R+ L E
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA----GSSDKQRLDFLTEA 56
Query: 547 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV- 605
+I+ +P ++R T + ++ EY+ G L LR+ + + ++
Sbjct: 57 SIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLR 113
Query: 606 ---LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 662
++YL + VHRDL N+L+ + K++DFGLS+ +
Sbjct: 114 GIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR----------------LE 157
Query: 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 717
S+A Y T + T APE + + A+D WS GI+++E ++
Sbjct: 158 DSEATY-----TTKGGKIPIRWT----APEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 67/280 (23%), Positives = 117/280 (41%), Gaps = 53/280 (18%)
Query: 491 RTSIDDFEIIKPISRGAFGRV-----FLARKRTTGDLFAIKVLKKLDMIR-KNDIERILA 544
+ ++ + GAFG+V +R + AIK LK+ + + + +
Sbjct: 1 EIPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQ--- 57
Query: 545 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL------RKVGCLEEDVAR 598
E ++ +++P +V T ++ EYL GDL+ L VG D
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 599 ---------IYIAELVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648
++IA + A +EYL S VHRDL N L+ +K++DFGLS+
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIY-- 175
Query: 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 708
S +Y R + ++ ++ PE +L + +D WS
Sbjct: 176 ---------------SADYY--------RVQSKSLLPVRWMPPEAILYGKFTTESDIWSF 212
Query: 709 GIILFE-FITGIPPFTAESPEIIFDNILNRKIPWPCVPSD 747
G++L+E F G+ P+ S + + + I +R++ PC P D
Sbjct: 213 GVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQL-LPC-PED 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 9/154 (5%)
Query: 495 DDFEIIKPISRGAFGRVFLA-RKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILIT 551
+D + + I G FG V+ + A+K K + E+ L E I+
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQ 63
Query: 552 VRNPFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALE 609
+P +V+ +N +++VME G+L S L+ L+ +Y +L AL
Sbjct: 64 FDHPHIVKLIG--VITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALA 121
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
YL S VHRD+ N+L++ +KL DFGLS+
Sbjct: 122 YLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 43/151 (28%), Positives = 70/151 (46%), Gaps = 35/151 (23%)
Query: 576 YLNGGDLYSLLRKVGCLEEDVAR-IYIAELVL-------ALEYLHSLGIVHRDLKPDNLL 627
Y+N G+L L++ E + + + +LV + YLH G++H+D+ N +
Sbjct: 90 YMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCV 149
Query: 628 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP- 686
I + +K+TD LS+ DL P D H DN NR P
Sbjct: 150 IDEELQVKITDNALSR--------DL--------FPMDYHC----LGDNENR------PV 183
Query: 687 DYLAPEILLGTEHGYAADWWSVGIILFEFIT 717
++A E L+ E+ A+D WS G++L+E +T
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 62/258 (24%), Positives = 112/258 (43%), Gaps = 56/258 (21%)
Query: 501 KPISRGAFGRVFLAR----KRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITV- 552
KP+ G FG+V A ++ D A+K+LK D D+ +++E ++ +
Sbjct: 18 KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLK--DNATDKDLADLISEMELMKLIG 75
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR------------------KVGCLEE 594
++ ++ T LY+++EY G+L LR + ++
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135
Query: 595 DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654
V+ Y ++ +EYL S +HRDL N+L+ D +K+ DFGL++ G+ + ID
Sbjct: 136 LVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR-GV--HDIDYY 190
Query: 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 714
++G +P ++APE L + + +D WS GI+++E
Sbjct: 191 KKTSNGRLPV----------------------KWMAPEALFDRVYTHQSDVWSFGILMWE 228
Query: 715 FIT-GIPPFTAESPEIIF 731
T G P+ E +F
Sbjct: 229 IFTLGGSPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 4e-09
Identities = 63/255 (24%), Positives = 112/255 (43%), Gaps = 42/255 (16%)
Query: 495 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
++ K + GAFG+V A K A+K+LK ++ E +++E I+
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKP--TAHSSEREALMSELKIM 92
Query: 550 ITVRNPF-VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVL 606
+ N +V + T + ++ EY GDL + LR+ L + + ++
Sbjct: 93 SHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIMPSD 665
+ +L S +HRDL N+L+ H G I K+ DFGL++ IM +D
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTH-GKIVKICDFGLAR----------------DIM-ND 194
Query: 666 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTA 724
++Y + +A ++APE + + + +D WS GI+L+E F G P+
Sbjct: 195 SNYV--------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY-- 244
Query: 725 ESPEIIFDNILNRKI 739
P + D+ + I
Sbjct: 245 --PGMPVDSKFYKLI 257
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 61/251 (24%), Positives = 111/251 (44%), Gaps = 52/251 (20%)
Query: 503 ISRGAFGRVFLARKRTTGDL--FAIKVLK----KLDMIRKNDIERILAERNILITVRNPF 556
+ RG +G V+ A+++ D +A+K ++ + R+ + R L N++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIA------ 62
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---------KVGCLEEDVARIYIAELVLA 607
+ + F S + R ++L+ +Y DL+ +++ K L + + + +++
Sbjct: 63 LQKVFLSHSDR-KVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
+ YLH+ ++HRDLKP N+L+ + G +K+ D G ++ L N+ + P D
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLK---PLAD---- 171
Query: 664 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF 722
V T Y APE+LLG H A D W++G I E +T P F
Sbjct: 172 ---------------LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
Query: 723 TAESPEIIFDN 733
+I N
Sbjct: 217 HCRQEDIKTSN 227
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 17/166 (10%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 553
+D + I G FG+V AR + G + + + K+D E +L +
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI-------------- 599
+P ++ + R LYL +EY G+L LRK LE D A
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 600 --YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
+ A++ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 5e-09
Identities = 58/225 (25%), Positives = 89/225 (39%), Gaps = 64/225 (28%)
Query: 480 VSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIK------------- 526
V PL R S DDF++ + G FG F + D +
Sbjct: 130 VGAPLADGANSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRV 189
Query: 527 VLKKLDMIR--------------KNDIERILAERNILITV-RNPFVVR-------FFYSF 564
VLK+++M R K E + E + + RNP +F S
Sbjct: 190 VLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSN 249
Query: 565 TC-----RDNLYLVMEYLNGGDLYSLLR-KVG----CLEE-------------------D 595
T + + +LV ++ + L L K+G CLEE +
Sbjct: 250 TADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN 309
Query: 596 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 640
V + + +++ L LH +GIVHRD+KP+NLL+ DG +K+ DFG
Sbjct: 310 VIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 5e-09
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 44/218 (20%)
Query: 522 LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 581
L A+K+L+ + KN L E I+ +++P ++R D L ++ EY+ GD
Sbjct: 48 LVAVKMLR--EDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105
Query: 582 LYSLLR----KVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAH 630
L L + + DV I + L+ ++YL SL VHRDL N L+
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK 165
Query: 631 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLA 690
+ IK+ DFG+S+ + + +Y + R AV +++
Sbjct: 166 NYTIKIADFGMSR---------------------NLYSGDYYRIQGR----AVLPIRWMS 200
Query: 691 PE-ILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 727
E ILLG + A+D W+ G+ L+E +T E P
Sbjct: 201 WESILLG-KFTTASDVWAFGVTLWEILT----LCKEQP 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 55/237 (23%), Positives = 105/237 (44%), Gaps = 39/237 (16%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ +++ I G FG V+L AIK +++ M ++ IE E +++ + +
Sbjct: 4 SELTLVQEIGSGQFGLVWLGYWLEK-RKVAIKTIREGAMSEEDFIE----EAQVMMKLSH 58
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHS 613
P +V+ + T R + LV E++ G L LR + G ++ ++ + YL S
Sbjct: 59 PKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES 118
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
++HRDL N L+ + +K++DFG+++ L D Y
Sbjct: 119 SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVL------------------DDQYT---- 156
Query: 674 TDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAES 726
S+ GT + +PE+ +++ +D WS G++++E F G P+ S
Sbjct: 157 -------SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS 206
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 54/233 (23%), Positives = 98/233 (42%), Gaps = 48/233 (20%)
Query: 522 LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 581
L A+K+L+ KN L E IL +++P ++R D L ++ EY+ GD
Sbjct: 48 LVAVKILRP--DANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105
Query: 582 LYSLLRKVGCLEEDV------------------ARIYIA-ELVLALEYLHSLGIVHRDLK 622
L L +++ + +++A ++ ++YL SL VHRDL
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLA 165
Query: 623 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA 682
N L+ + IK+ DFG+S+ + + +Y + R A
Sbjct: 166 TRNCLVGENLTIKIADFGMSR---------------------NLYAGDYYRIQGR----A 200
Query: 683 VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT--GIPPFTAESPEIIFDN 733
V ++A E +L + A+D W+ G+ L+E + P+ + E + +N
Sbjct: 201 VLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIEN 253
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 70/293 (23%), Positives = 121/293 (41%), Gaps = 56/293 (19%)
Query: 497 FEIIKPISRGAFGRV---FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 553
F + + + +G FG V L + + A+K+LK D+ +DIE L E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKA-DIFSSSDIEEFLREAACMKEFD 59
Query: 554 NPFVVRFF-YSFTCRDNLYL-----VMEYLNGGDLYS--LLRKVG----CLEEDVARIYI 601
+P V++ S R L ++ ++ GDL++ L+ ++G L ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 602 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 661
++ +EYL S +HRDL N ++ + + + DFGLSK I
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK----------------KI 163
Query: 662 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 719
D Y+Q A P +LA E L + +D W+ G+ ++E +T G
Sbjct: 164 YSGDY----YRQG------CASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQ 213
Query: 720 PPFTA-ESPEI----IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
P+ E+ EI I N L + P D + +L+ + +P R
Sbjct: 214 TPYAGVENSEIYNYLIKGNRLKQ-------PPDCLEDVYELMCQCWSPEPKCR 259
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 58/255 (22%), Positives = 93/255 (36%), Gaps = 70/255 (27%)
Query: 498 EIIKPISRGAFGRVFLA-----------------RKRTTGDLFAIKVLKK-LDMIRKNDI 539
++ + G FG V L L A+KVL+ + D
Sbjct: 8 NFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAP-VLVAVKVLRPDASDNAREDF 66
Query: 540 ERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK----------- 588
+ E IL + +P + R T L ++MEY+ GDL L+K
Sbjct: 67 LK---EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 589 -----VGCLEEDVARIYIAELVLA-LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 642
L +Y+A + + + YL SL VHRDL N L+ + IK+ DFG
Sbjct: 124 SKSLSFSTL------LYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFG-- 175
Query: 643 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA 702
M + + +Y + R A ++A E +L +
Sbjct: 176 -------------------MSRNLYSSDYYRVQGR----APLPIRWMAWESVLLGKFTTK 212
Query: 703 ADWWSVGIILFEFIT 717
+D W+ G+ L+E +T
Sbjct: 213 SDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 45/169 (26%), Positives = 63/169 (37%), Gaps = 53/169 (31%)
Query: 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKK-----------LDM-IRKNDIERILAERN 547
+ I +GA ++L D + + K LD +R+ ER E
Sbjct: 1 MDLIKQGAEAIIYL------TDFLGLPAVVKERIPKRYRHPELDEKLRR---ERTRREAR 51
Query: 548 ILITVR----NPFVVRFFYSFTCRDNLYLVMEYLNGGDL--------YSLLRKVGCLEED 595
IL R +V DN +VMEY+ G L LLR+VG
Sbjct: 52 ILAKAREAGVPVPIVYDVDP----DNGLIVMEYIEGELLKDALEEARPDLLREVG---RL 104
Query: 596 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644
V + LH GIVH DL N++++ G I DFGL +
Sbjct: 105 VGK------------LHKAGIVHGDLTTSNIILS-GGRIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 66/234 (28%), Positives = 107/234 (45%), Gaps = 33/234 (14%)
Query: 498 EIIKPISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
E++ I RG V LAR + TG+ ++ + L+ + + E ++ +P
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHP 59
Query: 556 FVVRFFYSFTCRDNLYLV---MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYL 611
+V + +F + L++V M Y + DL G E +A YI + VL AL+Y+
Sbjct: 60 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIA--YILQGVLKALDYI 117
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGL-SKIGLINNTIDLSGPETDGIMPSDAHYPE 670
H +G VHR +K ++LI+ DG + L+ GL S + +IN H
Sbjct: 118 HHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMIN------------------HGQR 157
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA--DWWSVGIILFEFITGIPPF 722
+ + ++S P +L+PE+L GY A D +SVGI E G PF
Sbjct: 158 LRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-08
Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 34/139 (24%)
Query: 581 DLYSLL----RKVGCLE-EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 635
DLY+ L R +G + VAR +L+ A++Y+H GI+HRD+K +N+L+ I
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVAR----QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDIC 300
Query: 636 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL 695
L DFG + G + HY GT D APE+L
Sbjct: 301 LGDFGAACF-------------ARGSWSTPFHY------------GIAGTVDTNAPEVLA 335
Query: 696 GTEHGYAADWWSVGIILFE 714
G + + D WS G+++FE
Sbjct: 336 GDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 59/220 (26%), Positives = 104/220 (47%), Gaps = 33/220 (15%)
Query: 511 VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT---VRNPFVVRFFYSFTCR 567
V+LAR TG L +++ D+ + E + A +N ++ R+P ++ + FT
Sbjct: 16 VYLARHTPTGTLVTVRIT---DLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTG 71
Query: 568 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 625
L+++ ++ G SLL+ + E + + + L YLH G +HR++K +
Sbjct: 72 SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASH 131
Query: 626 LLIAHDGHIKLTDFGLSKI-GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 684
+LI+ DG + L+ GLS + L+ N G + + +P++ S
Sbjct: 132 ILISGDGLVSLS--GLSHLYSLVRN-----GQKAKVVY----DFPQF---------STSV 171
Query: 685 TPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPF 722
P +L+PE+L +GY +D +SVGI E TG PF
Sbjct: 172 LP-WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 57/226 (25%), Positives = 96/226 (42%), Gaps = 41/226 (18%)
Query: 522 LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 581
L A+K+L+ + K L E I+ ++NP ++R D L ++ EY+ GD
Sbjct: 46 LVAVKMLRA--DVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 582 LYSLL-----RKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIA 629
L L ++ + IA L+ ++YL SL VHRDL N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 630 HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYL 689
+ IK+ DFG+S+ + + +Y + R AV ++
Sbjct: 164 NHYTIKIADFGMSR---------------------NLYSGDYYRIQGR----AVLPIRWM 198
Query: 690 APEILLGTEHGYAADWWSVGIILFEFITGIP--PFTAESPEIIFDN 733
A E +L + A+D W+ G+ L+E T P++ S E + +N
Sbjct: 199 AWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIEN 244
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 46/168 (27%), Positives = 74/168 (44%), Gaps = 21/168 (12%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITV 552
+D + I G FG+V A + G AIK+LK + +ND E +L +
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK--EFASENDHRDFAGELEVLCKL 59
Query: 553 -RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI------------ 599
+P ++ + R LY+ +EY G+L LRK LE D A
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ 119
Query: 600 ----YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
+ +++ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 120 QLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 60/244 (24%), Positives = 101/244 (41%), Gaps = 41/244 (16%)
Query: 495 DDFEIIKPISRGAFGRVFLARKR-TTGDLFAIKV-LKKL-DMIRKNDIERILAERNILIT 551
D +++ + GAFG V+ R GD ++V +K L + + D L E I+
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65
Query: 552 VRNPFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LALE 609
+ +VR SF R ++++E + GGDL S LR+ E + + + +L+ A +
Sbjct: 66 FNHQNIVRLIGVSFE-RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 610 ------YLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDG 660
YL +HRD+ N L+ G K+ DFG+++
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----------------- 167
Query: 661 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGI 719
D + Y + R A+ ++ PE L D WS G++L+E F G
Sbjct: 168 ----DIYRASYYRKGGR----AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGY 219
Query: 720 PPFT 723
P+
Sbjct: 220 MPYP 223
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 56.4 bits (137), Expect = 4e-08
Identities = 47/160 (29%), Positives = 63/160 (39%), Gaps = 42/160 (26%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLK-----KLD-MIRKNDIERILAERNILITVRN-- 554
I +GA + + +V K +LD +R ER AE +L R
Sbjct: 341 IGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRT---ERTRAEARLLSEARRAG 397
Query: 555 ---PFVVRFFYSFTCRDNLYLVMEYLNGGDLY-------SLLRKVGCLEEDVARIYIAEL 604
P + Y + +VMEY+ G DL L+RKVG E VA+
Sbjct: 398 VPTPVI----YDVD-PEEKTIVMEYIGGKDLKDVLEGNPELVRKVG---EIVAK------ 443
Query: 605 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644
LH GIVH DL N ++ D + L DFGL K
Sbjct: 444 ------LHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 61/251 (24%), Positives = 110/251 (43%), Gaps = 52/251 (20%)
Query: 503 ISRGAFGRVFLARKRTTGDL--FAIKVLK----KLDMIRKNDIERILAERNILITVRNPF 556
+ RG +G V+ A+++ D +A+K ++ + R+ + R L N++
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVIS------ 62
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR---------KVGCLEEDVARIYIAELVLA 607
+ + F S R ++L+ +Y DL+ +++ K L + + + +++
Sbjct: 63 LQKVFLSHADR-KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
+ YLH+ ++HRDLKP N+L+ + G +K+ D G ++ L N+ + P D
Sbjct: 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR--LFNSPLK---PLAD---- 171
Query: 664 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF 722
V T Y APE+LLG H A D W++G I E +T P F
Sbjct: 172 ---------------LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216
Query: 723 TAESPEIIFDN 733
+I N
Sbjct: 217 HCRQEDIKTSN 227
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 6e-08
Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 43/242 (17%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL-DMIRKNDIERILAERNILIT 551
S F+I+ + G FG+V A R + A+K+++ + R IE E+
Sbjct: 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQAD 186
Query: 552 VRNPF----VVRFFYSFTCRDNLYLVM-EYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 606
+ F + R+F + T ++ +VM +Y G L + K G ++A+++
Sbjct: 187 PADRFPLMKIQRYFQNET--GHMCIVMPKY--GPCLLDWIMKHGPFSHR----HLAQIIF 238
Query: 607 ----ALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 661
AL+Y H+ L ++H DLKP+N+L+ + +D P T+
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILMETS----------------DTVVD---PVTNRA 279
Query: 662 MPSDAHYPEYQQ----TDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 716
+P D D R+ +A V T Y +PE++LG Y+ D WS+G I++E
Sbjct: 280 LPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELY 339
Query: 717 TG 718
TG
Sbjct: 340 TG 341
|
Length = 467 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 64/260 (24%), Positives = 106/260 (40%), Gaps = 71/260 (27%)
Query: 495 DDFEIIKPISRGAFGRVF--LARKRTTGDL---FAIKVLKKLDMIRKNDIERI--LAERN 547
+ +++ + +G+FG V+ AR G+ A+K + + +R ERI L E +
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR----ERIEFLNEAS 61
Query: 548 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR--------- 598
++ VVR + +VME + GDL S LR L +
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLR---SLRPEAENNPGRPPPTL 118
Query: 599 ----IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654
AE+ + YL++ VHRDL N ++AHD +K+ DFG+++ D+
Sbjct: 119 QEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--------DIY 170
Query: 655 GPETD-------GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 707
ETD G++P ++APE L ++D WS
Sbjct: 171 --ETDYYRKGGKGLLPV----------------------RWMAPESLKDGVFTTSSDMWS 206
Query: 708 VGIILFEFITGIPPFTAESP 727
G++L+E + AE P
Sbjct: 207 FGVVLWEITS-----LAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 47/160 (29%), Positives = 71/160 (44%), Gaps = 21/160 (13%)
Query: 503 ISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR 559
I G FG+V AR + G AIK +K + K+D E +L + +P ++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 560 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI----------------YIAE 603
+ R LYL +EY G+L LRK LE D A + A+
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 604 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
+ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 58/230 (25%), Positives = 100/230 (43%), Gaps = 50/230 (21%)
Query: 503 ISRGAFGRVFLARKRTTG---DLFAIKVLKK--LDMIRKNDIERILAERNILITVRNPFV 557
I G FG V R + G AIK LK + R++ L+E +I+ +P +
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD----FLSEASIMGQFDHPNI 67
Query: 558 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-------LALEY 610
+ T + ++ E++ G L S LR ++ + + +LV ++Y
Sbjct: 68 IHLEGVVTKSRPVMIITEFMENGALDSFLR------QNDGQFTVIQLVGMLRGIAAGMKY 121
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
L + VHRDL N+L+ + K++DFGLS+ L ++T D P
Sbjct: 122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRF-LEDDTSD----------------PT 164
Query: 671 YQQTDNRNRHSAVGTP---DYLAPEILLGTEHGYAADWWSVGIILFEFIT 717
Y S++G + APE + + A+D WS GI+++E ++
Sbjct: 165 YT--------SSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 3e-07
Identities = 64/276 (23%), Positives = 113/276 (40%), Gaps = 51/276 (18%)
Query: 465 ENSRLILDSVSQSSGVSTPLHSSHKERTS--IDDFEIIKPISRGAFGRVFL-ARKRTTGD 521
+ S L D + PL + + + F +I + GAFG++F+ A + +T +
Sbjct: 116 DASHLDFDEAPPDAAGPVPLAQAKLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEE 175
Query: 522 LFAIKVLKKLDMIRKNDIERILA-------------ERNILITVR--NPFVVRFFYSFTC 566
A + + + K ER++A E IL R + +++
Sbjct: 176 AEARRGVNSTNQ-GKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRS 234
Query: 567 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-----ARIYIAELVLALEYLHSLGIVHRDL 621
N Y++ + + DLYS + +D R + +L+ A+EY+H ++HRD+
Sbjct: 235 EANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDI 293
Query: 622 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 681
K +N+ + DG I L DFG MP +++ +
Sbjct: 294 KLENIFLNCDGKIVLGDFGT-------------------AMP-------FEKEREAFDYG 327
Query: 682 AVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 717
VGT +PEIL G + D WS G+IL + ++
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 42/158 (26%), Positives = 76/158 (48%), Gaps = 16/158 (10%)
Query: 501 KPISRGAFGRVF---LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 557
K + G FG V L++ + A+K +K LD+ ++IE L+E + +P V
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 558 VRFF-YSFTCRDNLYL-----VMEYLNGGDLYSLL--RKVGCLEEDVAR----IYIAELV 605
++ F + ++ ++ GDL+S L ++G L E + ++ ++
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 606 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
L +EYL + +HRDL N ++ D + + DFGLSK
Sbjct: 124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 55/231 (23%), Positives = 94/231 (40%), Gaps = 50/231 (21%)
Query: 501 KPISRGAFGRVFLARKRTTGD---LFAIKVLKK-LDMIRKNDIERILAERNILITVRNPF 556
K I G FG VF + G AIK LK ++ D L+E +I+ +
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDF---LSEASIMGQFSHHN 67
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDL----------YSLLRKVGCLEEDVARIYIAELVL 606
++R T ++ EY+ G L +S + VG L A
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAA--------- 118
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
++YL + VHRDL N+L+ + K++DFGLS++ + + + + + G +P
Sbjct: 119 GMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRV--LEDDPEGTYTTSGGKIPI-- 174
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 717
+ APE + + A+D WS GI+++E ++
Sbjct: 175 --------------------RWTAPEAIAYRKFTSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 3e-06
Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 17/151 (11%)
Query: 499 IIKPISRGAFGRVFLARKRTTGDLFAIKV----LKKLDMIRKNDIERILAERNILITVRN 554
IK + G RV+L T + + +K+ K D R+ I ++LA + + +
Sbjct: 2 SIKLLKGGLTNRVYLLG--TKDEDYVLKINPSREKGADREREVAILQLLARKGLPV---- 55
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
P V+ S YL+ME++ G L +V E++ +AEL+ L L L
Sbjct: 56 PKVL---ASGESDGWSYLLMEWIEG----ETLDEVSEEEKEDIAEQLAELLAKLHQLPLL 108
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645
+ H DL P N+L+ + + D+ + G
Sbjct: 109 VLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 4e-06
Identities = 59/246 (23%), Positives = 104/246 (42%), Gaps = 48/246 (19%)
Query: 500 IKPISRGAFGRVF----LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
+K + GAFG V+ + T AIK+L + + N + E I+ ++ +P
Sbjct: 12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN--VEFMDEALIMASMDHP 69
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI----YIAELVLALEYL 611
+VR + LV + + G LL V ++++ + ++ + YL
Sbjct: 70 HLVRLL-GVCLSPTIQLVTQLMPHG---CLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
+VHRDL N+L+ H+K+TDFGL+++ L G E EY
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARL--------LEGDEK-----------EY 166
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-------GIPPFTA 724
N ++A E + + + +D WS G+ ++E +T GIP T
Sbjct: 167 ------NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP--TR 218
Query: 725 ESPEII 730
E P+++
Sbjct: 219 EIPDLL 224
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 7e-06
Identities = 49/188 (26%), Positives = 74/188 (39%), Gaps = 36/188 (19%)
Query: 483 PLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND---I 539
PL + DDF + K + GAFG V+ + + K K + + + +
Sbjct: 120 PLEGLFRPSFKKDDFVLGKKLGEGAFGVVY----KASLVNKQSKKEGKYVLKKATEYGAV 175
Query: 540 ERILAERNILITVRNPFVVRFFYSFTC------RDNLYLVMEYLNGGDLYSL-------- 585
E + ER + N F Y F D +LV Y L L
Sbjct: 176 EIWMNER-VRRACPN-SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPY 233
Query: 586 ------LRKVGCL------EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DG 632
L KV L E + + + +++ AL+ LHS GIVHRD+KP N++ + G
Sbjct: 234 NVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSG 293
Query: 633 HIKLTDFG 640
K+ D G
Sbjct: 294 SFKIIDLG 301
|
Length = 566 |
| >gnl|CDD|240158 cd05119, RIO, RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Score = 46.3 bits (111), Expect = 1e-05
Identities = 25/72 (34%), Positives = 37/72 (51%), Gaps = 7/72 (9%)
Query: 572 LVMEYLNGGDLYS-LLRKVGCLEEDVARIY--IAELVLALEYLHSLGIVHRDLKPDNLLI 628
LVME++ G + + L+ V L ED +Y I EL+ L G+VH DL N+L+
Sbjct: 92 LVMEFIGGDGIPAPRLKDVR-LLEDPEELYDQILELMRKL--YREAGLVHGDLSEYNILV 148
Query: 629 AHDGHIKLTDFG 640
DG + + D
Sbjct: 149 -DDGKVYIIDVP 159
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They function as non-ribosomal factors necessary for late 18S rRNA processing. RIO1 is also required for proper cell cycle progression and chromosome maintenance. The biological substrates for RIO kinases are still unknown. Length = 187 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 64/263 (24%), Positives = 104/263 (39%), Gaps = 64/263 (24%)
Query: 503 ISRGAFGRVFLARKRTTGDLF---------AIKVLKKLDMIRKNDIERILAERNILITVR 553
I +G FG V+ G L A+K L ++ + ++E+ L E I+
Sbjct: 3 IGKGHFGCVY------HGTLIDSDGQKIHCAVKSLNRITDLE--EVEQFLKEGIIMKDFS 54
Query: 554 NPFVVRFFYSFTCRDNLYLV-MEYLNGGDLYSLLRK----------VGCLEEDVARIYIA 602
+P V+ + LV + Y+ GDL + +R +G VA+
Sbjct: 55 HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG-FGLQVAK---- 109
Query: 603 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 662
+EYL S VHRDL N ++ +K+ DFGL++
Sbjct: 110 ----GMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLAR------------------- 146
Query: 663 PSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 720
D + EY N H+ P ++A E L + +D WS G++L+E +T G P
Sbjct: 147 --DIYDKEYYSVHN---HTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201
Query: 721 PFTAESPEIIFDNILN-RKIPWP 742
P+ I +L R++ P
Sbjct: 202 PYPDVDSFDITVYLLQGRRLLQP 224
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 60/245 (24%), Positives = 101/245 (41%), Gaps = 53/245 (21%)
Query: 501 KPISRGAFGRVF--LAR---KRTTGDLFAIKVLKKLDMIRKNDIERI--LAERNILITVR 553
+ + +G+FG V+ +A+ K AIK + + +R ERI L E +++
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR----ERIEFLNEASVMKEFN 67
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA---------RIYIA-E 603
VVR + ++ME + GDL S LR + E+ I +A E
Sbjct: 68 CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127
Query: 604 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
+ + YL++ VHRDL N ++A D +K+ DFG+++
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------------------- 167
Query: 664 SDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 722
+ +TD + P +++PE L +D WS G++L+E T
Sbjct: 168 ------DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----- 216
Query: 723 TAESP 727
AE P
Sbjct: 217 LAEQP 221
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 2e-05
Identities = 52/238 (21%), Positives = 96/238 (40%), Gaps = 32/238 (13%)
Query: 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKL--DMIRKNDIERILAERNILITVRNPFV 557
+K + G FG V GD I V K D + + I + ++ + ++
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 558 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGI 616
VR +L LV + G L +R+ L+ + ++ + YL +
Sbjct: 72 VRLL-GICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130
Query: 617 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 676
VHR+L N+L+ D +++ DFG+ +D YP+ D
Sbjct: 131 VHRNLAARNILLKSDSIVQIADFGV----------------------ADLLYPD----DK 164
Query: 677 RNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD 732
+ +S TP ++A E +L + + +D WS G+ ++E ++ G P+ P + D
Sbjct: 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPD 222
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 3e-05
Identities = 54/241 (22%), Positives = 100/241 (41%), Gaps = 46/241 (19%)
Query: 524 AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY 583
AIK LK D E E + +++P +V T L ++ Y + DL+
Sbjct: 39 AIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLH 96
Query: 584 SLL------RKVGCLEEDVARI----------YIAELVLALEYLHSLGIVHRDLKPDNLL 627
L VG ++D + ++ +E+L S +VH+DL N+L
Sbjct: 97 EFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156
Query: 628 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 687
+ ++K++D GL + + L G + ++P
Sbjct: 157 VFDKLNVKISDLGLFREVYAADYYKLMG---NSLLPI----------------------R 191
Query: 688 YLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAESPEIIFDNILNRKIPWPCVPS 746
+++PE ++ + +D WS G++L+E F G+ P+ S + + + I NR++ PC P
Sbjct: 192 WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV-LPC-PD 249
Query: 747 D 747
D
Sbjct: 250 D 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 5e-05
Identities = 67/298 (22%), Positives = 115/298 (38%), Gaps = 72/298 (24%)
Query: 501 KPISRGAFGRVFL--ARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAERNILIT 551
I G FG+V L A + + +K L+ +L +++ R L N+L
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 552 VRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRK-----VGCLEEDVARIYIAEL 604
+ C ++ LV+E+ GDL + LR ++DV + E+
Sbjct: 61 LGQ-----------CIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV 109
Query: 605 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 664
L +LH +H DL N + D +K+ D+GL+
Sbjct: 110 ASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLAL--------------------- 148
Query: 665 DAHYPE-YQQTDNRNRHSAVGTPDYLAPEI-------LLGTEHGYAADWWSVGIILFE-F 715
YPE Y T + + +LAPE+ LL + ++ WS+G+ ++E F
Sbjct: 149 -EQYPEDYYITKDCH----AVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELF 203
Query: 716 ITGIPPFTAESPEIIFDNIL---NRKIPWPCVP---SDMSFEAQDLINRFLIHDPNQR 767
P+ S E + ++ + K+P P + SD +E + +F DP R
Sbjct: 204 TAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE----VMQFCWLDPETR 257
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 6e-05
Identities = 38/153 (24%), Positives = 70/153 (45%), Gaps = 13/153 (8%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIK----VLKKLDMIRKNDIERILAERNILITVRNPFVV 558
+ +G F ++F +R GD + +LK LD +N E +++ + + +V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 559 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHSLGIV 617
+ C D +V EY+ G L + L+K L ++ +A +L AL +L G+
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT 122
Query: 618 HRDLKPDNLLIAHDGH--------IKLTDFGLS 642
H ++ N+L+ + IKL+D G+S
Sbjct: 123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 30/134 (22%)
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
+E+L S VHRDL N+L+A +K+ DFGL++ IM D+
Sbjct: 249 GMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLAR----------------DIM-HDS 291
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPFTAE 725
+Y ++ S ++APE + + +D WS GI+L+E F G P+
Sbjct: 292 NYV--------SKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPY--- 340
Query: 726 SPEIIFDNILNRKI 739
P +I D+ KI
Sbjct: 341 -PGMIVDSTFYNKI 353
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 19/90 (21%), Positives = 46/90 (51%), Gaps = 8/90 (8%)
Query: 559 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 618
R +Y F + L + + +++ C + + + + +++ LEY+H GI H
Sbjct: 98 RMYYRFILLEKLVE--------NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISH 149
Query: 619 RDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648
D+KP+N+++ + + D+G++ +I+
Sbjct: 150 GDIKPENIMVDGNNRGYIIDYGIASHFIIH 179
|
Length = 294 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 32/124 (25%), Positives = 57/124 (45%), Gaps = 26/124 (20%)
Query: 600 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659
Y ++ +E+L S +HRDL N+L++ + +K+ DFGL++ D+
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR--------DI------ 224
Query: 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITG 718
Y+ D + SA ++APE + + +D WS G++L+E F G
Sbjct: 225 -----------YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLG 273
Query: 719 IPPF 722
P+
Sbjct: 274 ASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|236400 PRK09188, PRK09188, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 37/105 (35%), Positives = 44/105 (41%), Gaps = 13/105 (12%)
Query: 541 RILA--ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR 598
R LA E L TVR VV + LV + G L+ L R G D A
Sbjct: 65 RHLAAREIRALKTVRGIGVVPQLLAT---GKDGLVRGWTEGVPLH-LARPHG----DPA- 115
Query: 599 IYIAELVLALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLS 642
+ AL LH GI H DL KP N L+ DG + DF L+
Sbjct: 116 -WFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159
|
Length = 365 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 39/143 (27%), Positives = 67/143 (46%), Gaps = 31/143 (21%)
Query: 581 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 640
DLY +KV LE+ + Y ++ +E+L S +HRDL N+L++ + +K+ DFG
Sbjct: 170 DLY---KKVLTLEDLIC--YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG 224
Query: 641 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 700
L++ D+ + D + DA P ++APE + +
Sbjct: 225 LAR--------DIY-KDPDYVRKGDARLPL----------------KWMAPETIFDRVYT 259
Query: 701 YAADWWSVGIILFE-FITGIPPF 722
+D WS G++L+E F G P+
Sbjct: 260 IQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|240168 cd05145, RIO1_like, RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Score = 42.5 bits (101), Expect = 3e-04
Identities = 41/169 (24%), Positives = 66/169 (39%), Gaps = 40/169 (23%)
Query: 502 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE---RNI--------LI 550
IS G V+ AR G+ A+K+ K + K+ + I + R+ L+
Sbjct: 4 CISTGKEANVYHAR-TGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLV 62
Query: 551 TV------RN-----------PFVVRFFYSFTCRDNLYLVMEYL-NGGDLYSLLRKVGCL 592
RN P + + N+ LVME++ + G L+ V
Sbjct: 63 FAWAEKEFRNLKRLYEAGVPVPEPI------LLKKNV-LVMEFIGDDGSPAPRLKDVPLE 115
Query: 593 EEDVARIYIAELVLALEYL-HSLGIVHRDLKPDNLLIAHDGHIKLTDFG 640
EE+ +Y ++V + L G+VH DL N+L HDG + D
Sbjct: 116 EEEAEELY-EQVVEQMRRLYQEAGLVHGDLSEYNILY-HDGKPYIIDVS 162
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and chromosome maintenance. The biological substrates for RIO1 are unknown. The function of RIO3 is also unknown. Length = 190 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 4e-04
Identities = 41/147 (27%), Positives = 64/147 (43%), Gaps = 28/147 (19%)
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
+E+L S VHRDL N+LI +K+ DFGL++ IM D++
Sbjct: 252 MEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR----------------DIM-RDSN 294
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 726
Y ++ S ++APE + + +D WS GI+L+E T G P+
Sbjct: 295 YI--------SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346
Query: 727 PEIIFDNILNR--KIPWPCVPSDMSFE 751
F N + R ++ P SD +E
Sbjct: 347 MNEQFYNAIKRGYRMAKPAHASDEIYE 373
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 44/176 (25%), Positives = 70/176 (39%), Gaps = 27/176 (15%)
Query: 543 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYI 601
LAE L + +VR T + + +V EY++ G L S LRK G L +
Sbjct: 54 LAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGML 113
Query: 602 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 661
L ++YL +G VH+ L +L+ D K++ F E
Sbjct: 114 PGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR-------------RLQEDK-- 158
Query: 662 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 717
S+A Y T + + APE + A+D WS GI+++E ++
Sbjct: 159 --SEAIY-----TTMSGKSPVLWA----APEAIQYHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 40/187 (21%), Positives = 61/187 (32%), Gaps = 47/187 (25%)
Query: 602 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 661
A + L L L HR K N+L+ DG +KL G PE
Sbjct: 21 AVCLQCLGALREL---HRQAKSGNILLTWDGLLKL--DGSVAF---------KTPEQSR- 65
Query: 662 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 721
P ++APE++ G + AD +S+GI L+E + P
Sbjct: 66 ----------------------PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
Query: 722 FTAESP-----EIIFDNILNRKIPWPCVPSDMS--FEAQDLINRFLIHDPNQRLGANGAA 774
+ E EI+ + + +S +D + P +R AN
Sbjct: 104 YNEERELSAILEILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAAN--- 160
Query: 775 EVKAHPF 781
AH
Sbjct: 161 HYLAHCR 167
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|240167 cd05144, RIO2_C, RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Score = 41.7 bits (99), Expect = 6e-04
Identities = 21/67 (31%), Positives = 36/67 (53%), Gaps = 6/67 (8%)
Query: 573 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 632
VMEY++G +LY + R + ED + E++ + + GI+H DL N+L+ D
Sbjct: 109 VMEYIDGVELYRV-RVL----EDPEEVL-DEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162
Query: 633 HIKLTDF 639
I + D+
Sbjct: 163 KIYIIDW 169
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH domains may be involved in RNA recognition. RIO2 is essential for survival and is necessary for rRNA cleavage during 40S ribosomal subunit maturation. The biological substrates of RIO2 are still unknown. Length = 198 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.001
Identities = 36/158 (22%), Positives = 72/158 (45%), Gaps = 17/158 (10%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKV-LKKLDMIRKNDIERILAERNILITVRNPFVVR 559
K + G FG V + + + V K+ + ++++E L+E + +P V+R
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 560 FFYSFTCRDNL--------YLVMEYLNGGDLYSLL--RKVG----CLEEDVARIYIAELV 605
C + +++ ++ GDL+S L ++G L + ++ ++
Sbjct: 65 LIG--VCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 606 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
+EYL S +HRDL N ++ + ++ + DFGLSK
Sbjct: 123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.001
Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 26/116 (22%)
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
+ +L S +HRDL N+L+ H K+ DFGL++ I N +++ ++ +A
Sbjct: 227 MSFLASKNCIHRDLAARNILLTHGRITKICDFGLARD--IRN-------DSNYVVKGNAR 277
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 722
P ++APE + + + +D WS GI+L+E F G P+
Sbjct: 278 LP----------------VKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY 317
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 0.001
Identities = 56/229 (24%), Positives = 92/229 (40%), Gaps = 49/229 (21%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
ISRG G + + G F +K + ++ I ++I + +++P +V+
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD-------MGKLQHPNIVKLIG 750
Query: 563 SFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH---SLGIV 617
CR YL+ EY+ G +L +LR + I IA+ AL +LH S +V
Sbjct: 751 --LCRSEKGAYLIHEYIEGKNLSEVLRNLSWERRRKIAIGIAK---ALRFLHCRCSPAVV 805
Query: 618 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 677
+L P+ ++I DG D ++ L P TD +
Sbjct: 806 VGNLSPEKIII--DG----KDEPHLRLSL----------------------PGLLCTDTK 837
Query: 678 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 726
S+ Y+APE + +D + G+IL E +TG P AE
Sbjct: 838 CFISSA----YVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882
|
Length = 968 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.001
Identities = 24/69 (34%), Positives = 36/69 (52%), Gaps = 7/69 (10%)
Query: 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-ALEYLHSLGIVHRDLKPDNLLIAH 630
+VMEY+ G +LY L V +E I + +L + + GIVH DL N+L+
Sbjct: 184 VVMEYIEGVELYRLRLDVENPDE------ILDKILEEVRKAYRRGIVHGDLSEFNILVTE 237
Query: 631 DGHIKLTDF 639
DG I + D+
Sbjct: 238 DGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 22/80 (27%), Positives = 34/80 (42%), Gaps = 6/80 (7%)
Query: 567 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 626
L + L LL ++ L E + + L+ AL L +VH DL P NL
Sbjct: 123 LKLLRQLAAALRRLVAAELLDRLAELWERLLA-ALLALLPALP----LVLVHGDLHPGNL 177
Query: 627 LIAHDGHIK-LTDFGLSKIG 645
L+ G + + DF + +G
Sbjct: 178 LVDPGGRVTGVIDFEDAGLG 197
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.004
Identities = 31/116 (26%), Positives = 54/116 (46%), Gaps = 26/116 (22%)
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
+E+L S +HRDL N+L++ + +K+ DFGL++ D+ + D + DA
Sbjct: 186 MEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR--------DIY-KDPDYVRKGDAR 236
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE-FITGIPPF 722
P ++APE + + +D WS G++L+E F G P+
Sbjct: 237 LP----------------LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 900 | |||
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.98 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.93 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.92 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.85 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.77 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.76 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.68 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.63 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.63 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.63 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.39 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.34 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.33 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.24 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.23 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.13 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.02 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.9 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.87 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.74 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.67 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.64 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.58 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.54 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.45 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.24 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.22 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.19 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.17 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.09 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.02 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 97.96 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.92 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.9 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.84 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.79 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.74 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.63 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.62 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.58 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.37 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.25 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.23 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.18 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.13 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.03 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.94 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.89 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 96.87 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.85 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.22 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.1 | |
| PLN02236 | 344 | choline kinase | 95.99 | |
| smart00133 | 64 | S_TK_X Extension to Ser/Thr-type protein kinases. | 95.97 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.82 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.73 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 95.67 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.09 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.06 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.69 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 94.68 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 94.63 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 94.34 | |
| PTZ00384 | 383 | choline kinase; Provisional | 93.78 | |
| PF00433 | 48 | Pkinase_C: Protein kinase C terminal domain; Inter | 93.32 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 92.06 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 91.83 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 91.39 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 89.81 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 88.79 | |
| PTZ00296 | 442 | choline kinase; Provisional | 88.49 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 88.29 |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-78 Score=675.74 Aligned_cols=373 Identities=46% Similarity=0.795 Sum_probs=319.6
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 570 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~L 570 (900)
++..++|+++++||+|+||+||+|+.+.||+.||||+|+|..+...+++++++.|+++|...++||||+||++||+.+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 46889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
||||||+||||++++|.+.+.|+++.+++|+++++.||+.||++|||||||||+|+|||..||+||+|||||+.....+.
T Consensus 217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~ 296 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR 296 (550)
T ss_pred EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999975444333
Q ss_pred ccCCC-----------CCCCCCC---------CCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhH
Q 002616 651 IDLSG-----------PETDGIM---------PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 710 (900)
Q Consensus 651 ~~l~~-----------~~~~~~~---------~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGV 710 (900)
.+..+ ....... .....+..|+.+++..+++.+|||.|||||||.+.+|+..||||||||
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ 376 (550)
T KOG0605|consen 297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC 376 (550)
T ss_pred hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence 33211 0000000 012233567788888999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHhhhcCC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 002616 711 ILFEFITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 788 (900)
Q Consensus 711 ILyEMLtGk~PF~~~s~~ei~~kIl~~~--l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~ 788 (900)
||||||.|+|||++.++.+++++|++.. +.||. ...++++++|||.+||+ ||++|++..++.||++||||++|+|+
T Consensus 377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~-~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~ 454 (550)
T KOG0605|consen 377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE-EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD 454 (550)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC-cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence 9999999999999999999999999865 67774 46789999999999999 99999999999999999999999999
Q ss_pred hhhhccCCccCCCCCCCCccccccccccCCCCCCCCCCCCCcCCCCCCCCCCCchhhhhcCCccccCCCCCCccccccee
Q 002616 789 SLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSF 868 (900)
Q Consensus 789 ~L~~~~ppf~P~~~s~~D~s~fd~~fs~~~~~l~~~d~~~~s~~~t~~~s~~~~~~~~e~~~f~~~~~~~~~~~f~g~t~ 868 (900)
.+....|||+|.+.++.|++||+.+ ++.....+.. .....|+. |.. +.......++-+|+||||
T Consensus 455 ~l~~~~apfvP~v~~~~DT~yFddF-~e~~~~~~~~-----------~~~~~~~k-~~~---~~~~~~~~~~~~FvgfTy 518 (550)
T KOG0605|consen 455 HLREMPAPFVPQVNSELDTQYFDDF-PEEDSMTPTA-----------DKSGPSRK-MLS---MVDTNNSSKDINFVGFTY 518 (550)
T ss_pred hhhcCCCCCCCCCCCcccccccccC-cccccCcccc-----------cccccchh-hhh---cccccCCcccccccceee
Confidence 9999999999999999999999964 4432221111 11112222 111 111224567889999999
Q ss_pred eccchhhccchhh
Q 002616 869 KNLSQLASINHEV 881 (900)
Q Consensus 869 ~~~~~~~~~~~~~ 881 (900)
|+|+++.+-+...
T Consensus 519 k~~~~~~~~~~~~ 531 (550)
T KOG0605|consen 519 KNFDGLNKANSLL 531 (550)
T ss_pred ecccccccccccc
Confidence 9999999888764
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-70 Score=593.40 Aligned_cols=302 Identities=49% Similarity=0.913 Sum_probs=283.8
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 570 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~L 570 (900)
....++|+++++||+|+||+|++|+.++|++.||||+++|..+......+++++|+.||..++||+||+|++.||+.+.+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 56789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
|||+||++||+|+.+|++.+.|+|+.+++|+++|+.||.|||++|||||||||+|||||.+||++|+|||||+...
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~---- 176 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL---- 176 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999532
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei 730 (900)
.....+.++|||+.|||||++.+.+|+..+||||||+++||||+|.+||.+.+...+
T Consensus 177 -----------------------~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~ 233 (357)
T KOG0598|consen 177 -----------------------KDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM 233 (357)
T ss_pred -----------------------cCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH
Confidence 223355679999999999999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC-hhcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCc
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDT 807 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpS-a~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~ 807 (900)
+++|+.+++..+ |..++.++++||+++|++||++|++ ..++.+|++||||+++||+.+.++ .|||+|......|+
T Consensus 234 ~~~I~~~k~~~~--p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~~~~~ 311 (357)
T KOG0598|consen 234 YDKILKGKLPLP--PGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTGLEDT 311 (357)
T ss_pred HHHHhcCcCCCC--CccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCCcccc
Confidence 999999986555 3669999999999999999999997 457999999999999999999877 79999999999999
Q ss_pred cccccccccCCCCC
Q 002616 808 SYFLSRFSQISSGL 821 (900)
Q Consensus 808 s~fd~~fs~~~~~l 821 (900)
++|+..|+...+..
T Consensus 312 ~~Fd~eft~~~~~~ 325 (357)
T KOG0598|consen 312 SNFDNEFTSYTVDY 325 (357)
T ss_pred ccccHHHHhccccC
Confidence 99999998885443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-69 Score=640.67 Aligned_cols=847 Identities=39% Similarity=0.515 Sum_probs=662.8
Q ss_pred cccccCCCChhhHHHHHHHHHHHHHhhhhhcchhhhhhhHHHHhhHHh---HhcCcchHHHHhhhhhHHHhHhhhHHhhc
Q 002616 3 VLEKMDSPSSEGKEMLEDLLILAQQCIEMTSCLFRANCETIVQDLTEK---RQQCQVGLVKWLSTRMLFILTRCTRLLLF 79 (900)
Q Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 79 (900)
..|+++..-.|.++|+++||.-+-+|-.||.=-||+-||-|+|.||.+ ||+|+-+.++|...+|+||+|||+|+-+|
T Consensus 277 wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsyfdTRs~Ryh~~ 356 (1205)
T KOG0606|consen 277 WPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSYFDTRSDRYHHF 356 (1205)
T ss_pred ccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccccccccccchhhcccchheeec
Confidence 468888888999999999999999999999999999999999999999 99999999999999999999999999999
Q ss_pred cccccchhcc--chhhHhhhcccCCcccccccC-------CCCccccchhhHHHHhhhccccccccc--ccccccccccc
Q 002616 80 QKESEPIAEK--SLHKFKKCLESVPAVETSWVP-------SPGTAESDLDYASYQKANAKKKISGQQ--KVSTVPEISDC 148 (900)
Q Consensus 80 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 148 (900)
.+|...+++- ..++|.-|.+-..++..+|-- .+-.-++...+-.++ -+-.++. +...-|++..-
T Consensus 357 ~se~~~~ees~~~~~qFsscs~r~~kv~ss~~~l~~~~t~~~~~~~~~~~~~~~~-----~~~~g~k~~~~~~sp~~~kl 431 (1205)
T KOG0606|consen 357 ESEDTGDEESSLEFRQFSSCSPRFSKVYSSWESLAQLETATPREKSSQSSQGEVS-----PSSAGQKDSWKSNSPESSKL 431 (1205)
T ss_pred cccCCccccccccccccccccccccccccchhhhhcccccccccccccccccccc-----CCccccccccccCChhhhhc
Confidence 9999999888 678999999999999999965 111111111111111 0111111 12222322222
Q ss_pred CccCccccccccccceeccCCCCccccchhhh----h------hhhcccccce------EEEEeecC-------C-----
Q 002616 149 SCSESLDHTSENKSVFIEQNFPPQKSQHYSRM----Q------EQQSHIVEGR------IVEVTKSN-------C----- 200 (900)
Q Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~------~~~~~~~~~~------~~~~~~~~-------~----- 200 (900)
.-+..+++..+| -.--|.|.+-++-- + --.+++..+| ++.-++.. |
T Consensus 432 ~~st~~ss~s~~------~~~s~~~~~~~~~s~~~~~~~~s~~~~ds~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~s~ 505 (1205)
T KOG0606|consen 432 ELSTALSSVSPN------HPGSPSKSLTSAASTLRTALRTSSPSEDSKIFPLRAPPPPSSYASEEPESPKPKFSVSPESG 505 (1205)
T ss_pred cccchhhhcccc------cCCCccccccchhhhhccccccCCCCCCccccccCCCCCccccccCCCCCCCcccccCCCCC
Confidence 222122222222 01222233322211 1 1123333443 22111110 1
Q ss_pred ---------CCCCcCCCCCCCCCceeeeeccccccccccccccccccccccccccccchhhhHHhHHHHHHHHHhhcc--
Q 002616 201 ---------GSPHEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKLSEILEQISESCN-- 269 (900)
Q Consensus 201 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 269 (900)
...|..-+.+..+|+.||||||.++|..|.|.|++||+++++|+.+|++++.|+.|+.+.++++..|..
T Consensus 506 ~~~d~s~~~~~~r~~~~~v~~~d~~i~~~~e~~~p~~~~e~~~~~~~~~~ks~~~s~e~~~~~~kv~ks~s~~alS~~i~ 585 (1205)
T KOG0606|consen 506 QPGDDSEALDRSRLWSKCVGTSDSGICRICEAEGPRLHSENHSRICKHQAKSELNSIEVKSRLRKVNKSLSASALSLMIN 585 (1205)
T ss_pred CcccchhhhccccccccccccCCcccccccccccccccccCcchHHHhhhhcccCccccccchhhHHHHHHhhhcccccc
Confidence 134556688999999999999999999999999999999999999999999999999999999877654
Q ss_pred CCCCCCCCCCcccccccCccceeccCCCccchhhhccCcchhhhccccccccccccCCCc--ceeecccccccccCCCCC
Q 002616 270 SSSHPILGSPENSRTQSMNSAITYDGYSPKISEWRNKGVEGMFEDIHEMDTACIDDSHLG--SLNLRGHLGLKLSGYGAS 347 (900)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 347 (900)
++.+| .|+|..+..+ +...-++..| +.+.|+|+++++|+++.+.++.. +.+..+| .+.++-..|-+. .|.--
T Consensus 586 s~~~~-~~~~l~s~lS--~~~~sS~p~S-rdsspsrd~s~~~~~~~ppI~i~-~~~~~yGft~~airVy~Gd~d-~ytvh 659 (1205)
T KOG0606|consen 586 SSDTP-TGGPLCSPLS--PRSLSSNPSS-RDSSPSRDSSAAMLSLRPPITIH-FSGKKYGFTLRAIRVYMGDKD-VYTVH 659 (1205)
T ss_pred cccCC-cccccccccC--CCCCCCCccc-CccccccccchhhcCcCCceeee-ccccccCceeeeEEEecCCcc-cceee
Confidence 33444 4667776663 5556677777 99999999999999999977654 4555677 677788889988 88888
Q ss_pred CCCCCccccCCCCCCCCCCCcccccccCCchhhHHHhhChHHHH--HHHhhccccccccChHHHH-HhhcchHHHhhhcc
Q 002616 348 SSTGSMTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELAD--IARCVADTDFSKEGSEFLL-ACMHDLQDVLQHSK 424 (900)
Q Consensus 348 s~~~s~~~~~~~~~~~~~h~~~~~~~~~~~~~~~d~~~~~~~~~--~~~~~~~~~l~k~~~~~l~-~~~~~l~~~~~~~~ 424 (900)
++.++-+..||..+|...|.|.+|..+|+.-+-++.+++.+|+. +++....|-..+....+.+ ++...++-+|.+.+
T Consensus 660 h~v~sv~egsPA~~agls~~DlIthvnge~v~gl~H~ev~~Lll~~gn~v~~~ttplenTSik~g~arr~~~k~~m~~R~ 739 (1205)
T KOG0606|consen 660 HSVGSVEEGSPAFEAGLSAGDLITHVNGEPVHGLVHTEVMELLLKSGNKVTLRTTPLENTSIKSGPARRDSYKAVMARRK 739 (1205)
T ss_pred eeeeeecCCCCccccCCCccceeEeccCcccchhhHHHHHHHHHhcCCeeEEEeeccccchhhhhHHHHHHHHHHHhhcc
Confidence 99999999999999999999999999999999999999999999 8888888777777665544 88889999999999
Q ss_pred cceeeccchh-HHHHHHHhhhHHHHhhhhccCCCCccccccccchhhhcccccCCC---CCCCCCCCccccccCCCeEEE
Q 002616 425 LKALVIDTFG-SRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSG---VSTPLHSSHKERTSIDDFEII 500 (900)
Q Consensus 425 ~~~~~~d~fg-~ri~k~~r~~~~l~~~lL~~ksp~s~s~~~~~sr~llds~~~~~~---~~~p~~ss~~~~~~~~dYeil 500 (900)
.+.++++.|+ .|+.+++++.+.-.|+++..+.....+ . +++..... ...|.... ..+.+.++|.+.
T Consensus 740 kk~~~~E~~~~rr~~kLlr~~~~q~~~l~~~~~s~~ss------~---eS~pgdp~~sls~sP~sp~-~yrsS~d~~~i~ 809 (1205)
T KOG0606|consen 740 KKALVPETFGIRRIEKLLRKISKQDCELLHTSRSFLSS------S---ESLPGDPTRSLSASPRSPT-KYRSSPDGFEIT 809 (1205)
T ss_pred cccccccccccccHHHHHHHHHhhhhhhhccccccccc------c---ccCCCCcccccccCCCCcc-cccCCCccceec
Confidence 9999999999 889999999998878776553321000 0 01111111 11122222 256788999999
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 580 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GG 580 (900)
+-+-+|+|+.++.+....+|...++|+..+..+...++.+.++.+..++-...+|.++..+..|.....++|||+|+.||
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 99999999999999999999999999998888888888888888988888788999999999998999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecC-CcccccccccccCCCCCCC
Q 002616 581 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG-LSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 581 sL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFG-LAk~~~~~~s~~l~~~~~~ 659 (900)
+|...|++.++.+++.++.++..++.+++|||...++|||++|.|+|+..+|+.+++||| +.+.+......+++++...
T Consensus 890 ~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~ 969 (1205)
T KOG0606|consen 890 DLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSS 969 (1205)
T ss_pred CchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCccccccc
Confidence 999999999999999999999999999999999999999999999999999999999999 5555555555555544332
Q ss_pred CCC---CCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhc
Q 002616 660 GIM---PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 736 (900)
Q Consensus 660 ~~~---~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~ 736 (900)
+.. ......+.............+||+.|.|||.+.+...+..+|||++|++++|.++|.+||....+..+++.|.+
T Consensus 970 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~ 1049 (1205)
T KOG0606|consen 970 GTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILN 1049 (1205)
T ss_pred CccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhcccc
Confidence 221 11222233333333556778999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhccCCccCCCCCCCCcccccccccc
Q 002616 737 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQ 816 (900)
Q Consensus 737 ~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~~ppf~P~~~s~~D~s~fd~~fs~ 816 (900)
+..+||.-+...++++++++.++|..+|.+|.++.++.+...||||++++|+.+..+...|+|.+.+..|++||.+.|..
T Consensus 1050 ~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~~s~~dtS~~~~r~~~ 1129 (1205)
T KOG0606|consen 1050 RDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQKAEFVPQPESTQDTSYFESRFSE 1129 (1205)
T ss_pred CCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccccccCccCCCCCCCCccchhhccccc
Confidence 99999999999999999999999999999999988888999999999999999999999999999999999999999885
Q ss_pred CCCCCCCCCCCCCcCCCC-CCCCCCCchhhhhcCCccccCCCCCCcccccceeeccchhhccchhhhhh
Q 002616 817 ISSGLPDDQNGSYSDADT-CDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASINHEVLVQ 884 (900)
Q Consensus 817 ~~~~l~~~d~~~~s~~~t-~~~s~~~~~~~~e~~~f~~~~~~~~~~~f~g~t~~~~~~~~~~~~~~~~~ 884 (900)
....+.....+..+...+ +......+.++ +....-++.|+||+||+..+|.+|||+++++
T Consensus 1130 ~~~~e~~sg~s~~~~~~s~~~~~~~~~pe~--------~~~~~~~~sl~~~~~k~~s~l~s~~p~~~l~ 1190 (1205)
T KOG0606|consen 1130 ESQDETVSGSSSGSKLDSPDESPECTTPEL--------KPAMCGNLSLINFSFKNLSQLASINPDKLLQ 1190 (1205)
T ss_pred ccccccccCCCcccCccCccccccccCccc--------cCCcCccccccccCccChhhccccChHhhcC
Confidence 533333222222222211 22222222222 2222337789999999999999999999998
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-66 Score=548.46 Aligned_cols=289 Identities=43% Similarity=0.837 Sum_probs=276.6
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
..+++|+++++||.|+||.|.+++.+.+|..||+|++++..+.+-.++++..+|..+|+.+.||++++|++.|.+..++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 67899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
|||||++||.|+.+|++.++|++..++||++||+.||+|||+++||||||||+|||||++|++||+|||+|+..
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v------ 194 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV------ 194 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe------
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999853
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~ 731 (900)
...+.+.||||.|+|||++..++|+.++|||||||++|||+.|++||.+.++..+|
T Consensus 195 ------------------------~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY 250 (355)
T KOG0616|consen 195 ------------------------SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIY 250 (355)
T ss_pred ------------------------cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHH
Confidence 22478899999999999999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC--hhcHHHHHcCCCCCCCCcchhhhc--cCCccC-CCCCCCC
Q 002616 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVP-QPESVDD 806 (900)
Q Consensus 732 ~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpS--a~~a~EIL~HPFFk~idw~~L~~~--~ppf~P-~~~s~~D 806 (900)
.+|+.+++.|| ..++++++|||+++|++|-.+|.+ .+|..+|+.||||++++|+.+..+ +||++| ....+.|
T Consensus 251 ~KI~~~~v~fP---~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~~~gd 327 (355)
T KOG0616|consen 251 EKILEGKVKFP---SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIHGPGD 327 (355)
T ss_pred HHHHhCcccCC---cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCCccccCCcc
Confidence 99999999998 799999999999999999999988 458999999999999999999877 789988 7778999
Q ss_pred ccccccc
Q 002616 807 TSYFLSR 813 (900)
Q Consensus 807 ~s~fd~~ 813 (900)
+++|+..
T Consensus 328 tsnfd~y 334 (355)
T KOG0616|consen 328 TSNFDDY 334 (355)
T ss_pred ccccccc
Confidence 9999875
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-65 Score=588.49 Aligned_cols=303 Identities=38% Similarity=0.766 Sum_probs=285.4
Q ss_pred ccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD 568 (900)
Q Consensus 490 ~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~ 568 (900)
.++++++|.++++||+|+||+|+++..+.+++.||||+++|..+...++++..+.|..|+...+ ||++++||.+||+.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4788999999999999999999999999999999999999999999999999999999999886 999999999999999
Q ss_pred eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
++|+||||+.||| +.+++..+.|++..+++|+++|+.||.|||++||||||||.+|||||.+||+||+|||+|+.++
T Consensus 443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-- 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-- 519 (694)
T ss_pred eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC--
Confidence 9999999999999 4455566889999999999999999999999999999999999999999999999999999643
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 728 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ 728 (900)
.....+.++||||.|||||++.++.|+.++|||||||+|||||+|..||.+++.+
T Consensus 520 -------------------------~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe 574 (694)
T KOG0694|consen 520 -------------------------GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE 574 (694)
T ss_pred -------------------------CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence 1234678899999999999999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCC
Q 002616 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESV 804 (900)
Q Consensus 729 ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~ 804 (900)
+++..|++..+.+| ..+|.++.++++++|++||++|++. .++.+|+.||||+.|+|+.|..+ +|||+|...++
T Consensus 575 e~FdsI~~d~~~yP---~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~ 651 (694)
T KOG0694|consen 575 EVFDSIVNDEVRYP---RFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGP 651 (694)
T ss_pred HHHHHHhcCCCCCC---CcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCCh
Confidence 99999999998877 7999999999999999999999995 57999999999999999999887 89999999999
Q ss_pred CCccccccccccCCCCCCC
Q 002616 805 DDTSYFLSRFSQISSGLPD 823 (900)
Q Consensus 805 ~D~s~fd~~fs~~~~~l~~ 823 (900)
.|.+|||.+|+.....+.+
T Consensus 652 ~D~snFd~eFt~e~p~Lt~ 670 (694)
T KOG0694|consen 652 EDVSNFDEEFTSEKPALTP 670 (694)
T ss_pred hhhcccchhhhcCCCccCC
Confidence 9999999999998777765
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-65 Score=606.29 Aligned_cols=296 Identities=44% Similarity=0.773 Sum_probs=276.0
Q ss_pred cccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 002616 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 489 ~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~ 568 (900)
..++..+||+++++||+|+||+|.+++++.|++.||||+++|-.+.++.....|..|++||...+.+|||+|++.|++++
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 44677899999999999999999999999999999999999999998889999999999999999999999999999999
Q ss_pred eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
++|+|||||+||||..++.+.+.+++..|+||+++|+.||..||++|+|||||||+|||||.+||+||+|||.|-.+..
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~- 227 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA- 227 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999998864321
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-----CCCCccceeechhHHHHHHHhCCCCCC
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFT 723 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~ksDIWSLGVILyEMLtGk~PF~ 723 (900)
.........||||.|++||+|.. +.|+..|||||+||++||||+|..||+
T Consensus 228 -------------------------dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY 282 (1317)
T KOG0612|consen 228 -------------------------DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY 282 (1317)
T ss_pred -------------------------CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence 12234567899999999999973 458999999999999999999999999
Q ss_pred CCChHHHHHhhhcC--CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhccCCccCCC
Q 002616 724 AESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQP 801 (900)
Q Consensus 724 ~~s~~ei~~kIl~~--~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~~ppf~P~~ 801 (900)
.++-.++|.+|++. .+.||. ...+|.++++||+++++ +|+.|+|.+|+.+|+.||||.|++|+.++...|||+|.+
T Consensus 283 adslveTY~KIm~hk~~l~FP~-~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPev 360 (1317)
T KOG0612|consen 283 ADSLVETYGKIMNHKESLSFPD-ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEV 360 (1317)
T ss_pred HHHHHHHHHHHhchhhhcCCCc-ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcC
Confidence 99999999999986 677773 46699999999999999 999999999999999999999999999999999999999
Q ss_pred CCCCCcccccc
Q 002616 802 ESVDDTSYFLS 812 (900)
Q Consensus 802 ~s~~D~s~fd~ 812 (900)
.++.||+||+.
T Consensus 361 ssd~DTsnFd~ 371 (1317)
T KOG0612|consen 361 SSDDDTSNFDV 371 (1317)
T ss_pred CCCCccccccc
Confidence 99999999954
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-64 Score=551.95 Aligned_cols=433 Identities=32% Similarity=0.529 Sum_probs=355.9
Q ss_pred CCCCCCCcccccccCCchhhHHHhhChHHHHHHHhhccccccccChHHHHHhhcchH--HHhhhc---ccceeeccchhH
Q 002616 361 TPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGSEFLLACMHDLQ--DVLQHS---KLKALVIDTFGS 435 (900)
Q Consensus 361 ~~~~~h~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~k~~~~~l~~~~~~l~--~~~~~~---~~~~~~~d~fg~ 435 (900)
.|..--+..|| ...++-|-.. ..+..+.++.|++..||++ +.+++++.. .++.+. +...+..+.|..
T Consensus 74 ~~~~~~~i~Fl---~~v~eYE~~~-~~~r~~~~~~i~~~~l~~~----~~~~~~~~s~~~~v~~~~~~l~~~~~~~lf~~ 145 (591)
T KOG0986|consen 74 RPELRPAIEFL---EEVKEYEKAD-DDERKDKARQILDAYLMKE----LLACLPQFSSKDLVTHVQEHLLEKPPKDLFQP 145 (591)
T ss_pred CchhhhHHHHH---HHHHHHhcCC-cccchhhHHHHHHHHhhcc----ccccCCCcchhhhhHHHhhhccccCchhhhHH
Confidence 45555566788 3333333333 6778899999999999999 677887773 333333 334456777776
Q ss_pred HHHHHHhhhHHHHhhhhccCCCCccccccccchhhhcccccCCCCCCCCCCCccccccCCCeEEEEEeccCCceEEEEEE
Q 002616 436 RIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLAR 515 (900)
Q Consensus 436 ri~k~~r~~~~l~~~lL~~ksp~s~s~~~~~sr~llds~~~~~~~~~p~~ss~~~~~~~~dYeil~~LGkG~FG~Vyla~ 515 (900)
.+... |..|.. ..|..|.+.. ..+++.++... +...+..+.|...++||+||||+||-++
T Consensus 146 ~~~~~--------~~~L~~---~pF~~f~~S~--yf~rFlQWK~l-------E~qpvt~n~F~~~RvlGkGGFGEV~acq 205 (591)
T KOG0986|consen 146 LARAI--------CAYLRG---DPFQEFLESD--YFTRFLQWKWL-------ELQPVTKNTFRVYRVLGKGGFGEVCACQ 205 (591)
T ss_pred HHHHH--------HHHhcc---chHhHhHHHH--HHHHHHHHHHH-------HhhhccccceeeeEEEecccccceeEEE
Confidence 65544 333322 1122222111 11222232211 2234677899999999999999999999
Q ss_pred ECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCChHHHHHhcC--CCC
Q 002616 516 KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLE 593 (900)
Q Consensus 516 ~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g--~Ls 593 (900)
.+.||+.||+|.+.|.++.++......++|..||.+++.|+||.|-+.|++.+.+++||..|+||||..+|.+.+ .|+
T Consensus 206 vraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~ 285 (591)
T KOG0986|consen 206 VRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFD 285 (591)
T ss_pred EecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCc
Confidence 999999999999999999888899999999999999999999999999999999999999999999999998877 799
Q ss_pred HHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccc
Q 002616 594 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673 (900)
Q Consensus 594 e~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~ 673 (900)
+..++||+++|+.||++||+.+||+|||||+|||||+.|||+|+|+|||..+..
T Consensus 286 e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~-------------------------- 339 (591)
T KOG0986|consen 286 EQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE-------------------------- 339 (591)
T ss_pred hHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC--------------------------
Confidence 999999999999999999999999999999999999999999999999985422
Q ss_pred cccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC----hHHHHHhhhcCCCCCCCCCCCCC
Q 002616 674 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES----PEIIFDNILNRKIPWPCVPSDMS 749 (900)
Q Consensus 674 ~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s----~~ei~~kIl~~~l~~P~ip~~lS 749 (900)
+......+||.+|||||++.+..|++++|||||||+||||+.|+.||.... .+++-+++++....+| ..+|
T Consensus 340 --g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~---~kFS 414 (591)
T KOG0986|consen 340 --GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS---DKFS 414 (591)
T ss_pred --CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc---cccC
Confidence 333455699999999999999999999999999999999999999997643 4577788888887777 7999
Q ss_pred HHHHHHHHHhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCC-----CCCccccccccccCCCC
Q 002616 750 FEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPES-----VDDTSYFLSRFSQISSG 820 (900)
Q Consensus 750 ~eakDLIk~cL~~DP~kRpSa--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s-----~~D~s~fd~~fs~~~~~ 820 (900)
+++++|++.+|++||.+|++. +++.++++||||+++||..+.++ .|||+|.+.. ..|+..|+ +-.++.
T Consensus 415 ~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs---~VKGV~ 491 (591)
T KOG0986|consen 415 EEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFS---TVKGVK 491 (591)
T ss_pred HHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhhhcc---ccccee
Confidence 999999999999999999993 57999999999999999999888 8999999864 45655554 234889
Q ss_pred CCCCCCCCCcCCCCCCCCCCCchhhhhcCCccccC
Q 002616 821 LPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFG 855 (900)
Q Consensus 821 l~~~d~~~~s~~~t~~~s~~~~~~~~e~~~f~~~~ 855 (900)
++++|..+|..|.|+..+++|++||.|+++|.+.+
T Consensus 492 ld~~D~~fy~~F~tg~vsipWQnE~~ET~~f~eln 526 (591)
T KOG0986|consen 492 LDDTDTDFYKNFATGSVSIPWQNEMIETECFEELN 526 (591)
T ss_pred cccccHHHHHhccCCcccchHHHHHHHhhhHHHhh
Confidence 99999999999999999999999999999999874
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-62 Score=516.96 Aligned_cols=310 Identities=41% Similarity=0.745 Sum_probs=292.8
Q ss_pred CCccccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 002616 486 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 565 (900)
Q Consensus 486 ss~~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~ 565 (900)
.....++..++|+.+++||+|.||+|.+|+.+.+|+.||||+++|..+..+.++.+.+.|-++|...+||++..|-++|+
T Consensus 159 ~~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ 238 (516)
T KOG0690|consen 159 AKRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ 238 (516)
T ss_pred ccccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc
Confidence 34556788999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccc
Q 002616 566 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645 (900)
Q Consensus 566 d~~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~ 645 (900)
..+.+|+||||+.||.|+.+|.+...|+++.+++|.++|+.||.|||+++||+||||.+|+|||.+||+||+|||||+..
T Consensus 239 t~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 239 TQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred cCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002616 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 725 (900)
Q Consensus 646 ~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~ 725 (900)
. .......++||||.|+|||++....|+.++|||.+||+||||++|+.||+..
T Consensus 319 I---------------------------~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~ 371 (516)
T KOG0690|consen 319 I---------------------------KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNK 371 (516)
T ss_pred c---------------------------cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCccccc
Confidence 2 2244667899999999999999999999999999999999999999999999
Q ss_pred ChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC--hhcHHHHHcCCCCCCCCcchhhhc--cCCccCCC
Q 002616 726 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 801 (900)
Q Consensus 726 s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpS--a~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~ 801 (900)
+...++..|+.+.++|| ..++++++.|+..+|.+||.+|++ .++|.||.+|+||++++|+.+... .|||+|++
T Consensus 372 dh~kLFeLIl~ed~kFP---r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqV 448 (516)
T KOG0690|consen 372 DHEKLFELILMEDLKFP---RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQV 448 (516)
T ss_pred chhHHHHHHHhhhccCC---ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCCc
Confidence 99999999999999998 799999999999999999999998 568999999999999999998766 89999999
Q ss_pred CCCCCccccccccccCCCCCCCCC
Q 002616 802 ESVDDTSYFLSRFSQISSGLPDDQ 825 (900)
Q Consensus 802 ~s~~D~s~fd~~fs~~~~~l~~~d 825 (900)
.+..|++|||.+|+..+..+++-+
T Consensus 449 tSetDTryFD~EFT~q~v~lTPP~ 472 (516)
T KOG0690|consen 449 TSETDTRYFDEEFTSQPVTLTPPD 472 (516)
T ss_pred ccccchhhhhhhhhcceeEecCCC
Confidence 999999999999999988876544
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-60 Score=532.11 Aligned_cols=322 Identities=44% Similarity=0.745 Sum_probs=278.5
Q ss_pred ccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 569 (900)
Q Consensus 490 ~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ 569 (900)
.++..+-|..++.||-|+||+|.+++..+|...||||.|+|.+...++++.++..|++||...+++|||+||++|++.++
T Consensus 624 aKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 624 AKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred hhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc
Confidence 35667789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 570 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
+|+||+|++|||++.+|.+.+.|+|+.|+||++++.+|++++|++|+|||||||+|||||.+|||||+|||||+-+.=.+
T Consensus 704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998543111
Q ss_pred cccCCCCCC----CCCCCCC------CCCC-----cccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHH
Q 002616 650 TIDLSGPET----DGIMPSD------AHYP-----EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 714 (900)
Q Consensus 650 s~~l~~~~~----~~~~~s~------~~~~-----~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyE 714 (900)
.....+... +.+.+.. .... ......+-.+.+.+||+.|+|||+|...+|+..|||||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 111111110 1111110 0000 001122345677899999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHhhhcCC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhh
Q 002616 715 FITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 792 (900)
Q Consensus 715 MLtGk~PF~~~s~~ei~~kIl~~~--l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~ 792 (900)
|+.|++||-..++.++..+|.+.. +.+|. ...+|.++.+||.++++ ++++|++..++.+++.||||++|||..++.
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~-~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfsslRk 941 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHIPY-QGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSSLRK 941 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhcccccc-ccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHhhhh
Confidence 999999999999999888887743 34442 36899999999999887 999999999999999999999999999999
Q ss_pred ccCCccCCCCCCCCccccccc
Q 002616 793 QKAVFVPQPESVDDTSYFLSR 813 (900)
Q Consensus 793 ~~ppf~P~~~s~~D~s~fd~~ 813 (900)
+.++|+|.+..+.|++|||..
T Consensus 942 q~ApYIP~ItHptDTSNFdpv 962 (1034)
T KOG0608|consen 942 QRAPYIPRITHPTDTSNFDPV 962 (1034)
T ss_pred ccCCcCccccCCCccccCCcC
Confidence 999999999999999999874
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-60 Score=514.43 Aligned_cols=335 Identities=35% Similarity=0.700 Sum_probs=305.6
Q ss_pred CccccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeec
Q 002616 487 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFT 565 (900)
Q Consensus 487 s~~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~ 565 (900)
+....+...+|.++.+||+|+||+|.++..+.|.+.||||+++|..+....+++-.+.|.++|.... -|++|+|+.+|+
T Consensus 341 ~~~d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ 420 (683)
T KOG0696|consen 341 SKRDRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ 420 (683)
T ss_pred CcccceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh
Confidence 3445678899999999999999999999999999999999999988888888999999999998764 789999999999
Q ss_pred cCCeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccc
Q 002616 566 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645 (900)
Q Consensus 566 d~~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~ 645 (900)
+-+.+|+||||+.||+|+.+++..+.|.|..|.+|+++|+-||-|||++|||+||||.+|||||.+|||||+|||+|+..
T Consensus 421 TmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 421 TMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred hhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002616 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 725 (900)
Q Consensus 646 ~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~ 725 (900)
. .....+.++||||.|||||++..++|+.++||||+||+|||||.|++||.++
T Consensus 501 i---------------------------~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe 553 (683)
T KOG0696|consen 501 I---------------------------FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE 553 (683)
T ss_pred c---------------------------cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC
Confidence 2 2244677899999999999999999999999999999999999999999999
Q ss_pred ChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC--hhcHHHHHcCCCCCCCCcchhhhc--cCCccCCC
Q 002616 726 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 801 (900)
Q Consensus 726 s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpS--a~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~ 801 (900)
+..++++.|...++.+| ..+|.++.++++.+|.+.|.+|++ .++-.+|..||||+.|+|+.++.. +|||+|.+
T Consensus 554 DE~elF~aI~ehnvsyP---KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~ 630 (683)
T KOG0696|consen 554 DEDELFQAIMEHNVSYP---KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKI 630 (683)
T ss_pred CHHHHHHHHHHccCcCc---ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCcc
Confidence 99999999999999888 799999999999999999999999 356789999999999999999877 89999999
Q ss_pred CCCCCccccccccccCCCCCCCCCCCCCcCCCCCCCCCCCchhhhhcCCccccCCCCCCcccccceeeccchhhcc
Q 002616 802 ESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASI 877 (900)
Q Consensus 802 ~s~~D~s~fd~~fs~~~~~l~~~d~~~~s~~~t~~~s~~~~~~~~e~~~f~~~~~~~~~~~f~g~t~~~~~~~~~~ 877 (900)
+...+.+|||..|+.....+++.|.-++.. .+ .-.|+||||.|.+.+..+
T Consensus 631 k~~r~~eNFD~~Ft~~~~~lTPpD~~v~~n----------------------ld----q~eF~gFsfvNpefv~~~ 680 (683)
T KOG0696|consen 631 KCGRDAENFDKFFTREPTDLTPPDKLVMMN----------------------LD----QSEFEGFSFVNPEFVKPI 680 (683)
T ss_pred ccCCchhhhhHHHhcCCCCCCCchHHHHhc----------------------Cc----hhhcCceeeeChhhcCCC
Confidence 999999999999999988887766443321 11 224899999999988765
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-59 Score=509.69 Aligned_cols=316 Identities=40% Similarity=0.712 Sum_probs=273.1
Q ss_pred ccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 569 (900)
Q Consensus 490 ~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ 569 (900)
..+.+++|++++.||+|.-|+||+|+.+.++..+|||++.|..+..++...++..|.+||+.++||+++.||..|+.++.
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY 151 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence 34677899999999999999999999999999999999999988888899999999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccc
Q 002616 570 LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~ 647 (900)
.|+|||||+||+|..+++++ ..|++..++||+++++.||+|||-+|||+|||||+||||-++|||.|+||.|+.....
T Consensus 152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 99999999999999999875 4699999999999999999999999999999999999999999999999999875432
Q ss_pred cccccCCC-CCC------------CCCCCC-----C----------CCCCcc-cccccCCcccccCCCCCCChhhhcCCC
Q 002616 648 NNTIDLSG-PET------------DGIMPS-----D----------AHYPEY-QQTDNRNRHSAVGTPDYLAPEILLGTE 698 (900)
Q Consensus 648 ~~s~~l~~-~~~------------~~~~~s-----~----------~~~~~~-~~~~~~~~~s~vGTp~YmAPEvL~g~~ 698 (900)
..+...+. +.. ..+.+. . ...+.. .........++|||-.|+|||++.|.+
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 21111110 000 000000 0 000111 122345678899999999999999999
Q ss_pred CCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC-hhcHHHHH
Q 002616 699 HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVK 777 (900)
Q Consensus 699 ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpS-a~~a~EIL 777 (900)
++.++|||+|||++||||+|..||.+.+..+++.+|+...+.||..+ .++..++|||+++|.+||.+|++ ..||.||+
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK 390 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence 99999999999999999999999999999999999999999999755 78999999999999999999999 56899999
Q ss_pred cCCCCCCCCcchhhhccCCccCCCCCCCC
Q 002616 778 AHPFFKGVNWDSLALQKAVFVPQPESVDD 806 (900)
Q Consensus 778 ~HPFFk~idw~~L~~~~ppf~P~~~s~~D 806 (900)
+||||++++|.-++...||++|.+.....
T Consensus 391 ~HpFF~gVnWaLir~~~PP~iP~~~d~~~ 419 (459)
T KOG0610|consen 391 RHPFFEGVNWALIRCARPPEIPKPVDGGL 419 (459)
T ss_pred cCccccCCChhheeccCCCcCCCccccCc
Confidence 99999999999777779999998865433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-58 Score=518.59 Aligned_cols=287 Identities=39% Similarity=0.748 Sum_probs=261.1
Q ss_pred ccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD 568 (900)
Q Consensus 490 ~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~ 568 (900)
......||.+.+.||.|+|++|++|+.+.+++.||||++.|..+.+++.+..+..|.++|.++ .||.||+||..|++..
T Consensus 68 ~kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~ 147 (604)
T KOG0592|consen 68 EKKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEE 147 (604)
T ss_pred ccCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeeccc
Confidence 367889999999999999999999999999999999999999999999999999999999999 6999999999999999
Q ss_pred eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
.+|+|+||+++|+|.++|++.|.|++..+|+|++||+.||+|||++|||||||||+|||||.+||+||+|||.|+.+...
T Consensus 148 sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 148 SLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred ceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999965321
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 728 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ 728 (900)
.... . .+...........++|||..|.+||+|.....++.+|+|+||||||.|+.|.+||.+.+.-
T Consensus 228 ~~~~-------------~-~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney 293 (604)
T KOG0592|consen 228 QKSQ-------------E-NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY 293 (604)
T ss_pred hccc-------------c-CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH
Confidence 1100 0 0000101112246799999999999999999999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhccCC
Q 002616 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAV 796 (900)
Q Consensus 729 ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~~pp 796 (900)
.++++|+.-.+.|| .++++.+.|||+++|..||.+|+| +.+|++||||.+|+|+.|..+.||
T Consensus 294 liFqkI~~l~y~fp---~~fp~~a~dLv~KLLv~dp~~Rlt---~~qIk~HpFF~~Vdw~nlw~~~PP 355 (604)
T KOG0592|consen 294 LIFQKIQALDYEFP---EGFPEDARDLIKKLLVRDPSDRLT---SQQIKAHPFFEGVDWENLWQQTPP 355 (604)
T ss_pred HHHHHHHHhcccCC---CCCCHHHHHHHHHHHccCcccccc---HHHHhhCcccccCChhhhhhcCCC
Confidence 99999999999988 799999999999999999999999 789999999999999999888543
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-55 Score=479.64 Aligned_cols=351 Identities=40% Similarity=0.736 Sum_probs=280.0
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++++.||+|+||+||+|+++.+|+.||||++++...........+.+|+.+|..++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 57999999999999999999999999999999998765555566778899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999998753211110000
Q ss_pred CCCCCCC---------C--CCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCC
Q 002616 655 GPETDGI---------M--PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 723 (900)
Q Consensus 655 ~~~~~~~---------~--~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~ 723 (900)
....... . ........|.........+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 0000000 0 0001111122222223456789999999999999999999999999999999999999999
Q ss_pred CCChHHHHHhhhcCCC--CCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhccCCccCCC
Q 002616 724 AESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQP 801 (900)
Q Consensus 724 ~~s~~ei~~kIl~~~l--~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~~ppf~P~~ 801 (900)
+.++.+.+..+..... .+|. ...+++++++||.+||. +|.+|++...+.+++.||||++++|+.+....+++.|..
T Consensus 241 ~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 318 (364)
T cd05599 241 SDNPQETYRKIINWKETLQFPD-EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWEHIRERPAPIIPEL 318 (364)
T ss_pred CCCHHHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCCC
Confidence 9999888888876443 3332 23579999999999997 999999877799999999999999999888888999999
Q ss_pred CCCCCccccccccccCCCCCCCCCCCCCcCCCCCCCCCCCchhhhhcCCccccCCCCCCcccccceeeccc
Q 002616 802 ESVDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLS 872 (900)
Q Consensus 802 ~s~~D~s~fd~~fs~~~~~l~~~d~~~~s~~~t~~~s~~~~~~~~e~~~f~~~~~~~~~~~f~g~t~~~~~ 872 (900)
.+..|.++|+.+ +......+... . .. ......+||.|+||||++|+
T Consensus 319 ~~~~~~~~~~~~-~~~~~~~~~~~-----------~--~~-----------~~~~~~~~~~~~~~~~~~~~ 364 (364)
T cd05599 319 KSITDTSNFDDF-EEIDLDVPTSP-----------G--PP-----------RGKIKSKDLAFIGYTYKRFE 364 (364)
T ss_pred CCchhhhhcccc-ccccccccCCC-----------c--cc-----------cccccccCCCCCCCeeeCCC
Confidence 888888888753 22221111100 0 00 01124569999999999986
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-54 Score=478.90 Aligned_cols=352 Identities=39% Similarity=0.700 Sum_probs=274.2
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++++.||+|+||+||+|+++.+|+.||+|++++...........+.+|+.++..++||||+++++.|++...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999998765555566778999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||+++...........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999999753211110000
Q ss_pred CCCCCCCCCCCC---------CCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002616 655 GPETDGIMPSDA---------HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 725 (900)
Q Consensus 655 ~~~~~~~~~s~~---------~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~ 725 (900)
..... ..+... ....+...........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.
T Consensus 161 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNH-SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccc-cccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 00000 000000 00111112222335678999999999999999999999999999999999999999999
Q ss_pred ChHHHHHhhhcC--CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhccCCccCCCCC
Q 002616 726 SPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPES 803 (900)
Q Consensus 726 s~~ei~~kIl~~--~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~~ppf~P~~~s 803 (900)
++.+.+.++... .+.+|. ...+++++++||.+|++ +|.+|++...+.+|++||||++++|+.+....++..+...+
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~ 317 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEHIRERPAAIPIEIKS 317 (363)
T ss_pred CHHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHHHHhCCCCCCccCCC
Confidence 999999988864 344443 23578999999999887 77777654458999999999999999997775555556667
Q ss_pred CCCccccccccccCCCCCCCCCCCCCcCCCCCCCCCCCchhhhhcCCccccCCCCCCcccccceeeccc
Q 002616 804 VDDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLS 872 (900)
Q Consensus 804 ~~D~s~fd~~fs~~~~~l~~~d~~~~s~~~t~~~s~~~~~~~~e~~~f~~~~~~~~~~~f~g~t~~~~~ 872 (900)
..|+++|+...... ...+ .. ..+ .-.+....+.+|.|+||||+.|+
T Consensus 318 ~~~~~~~~~~~~~~-~~~~-~~----------~~~-----------~~~~~~~~~~~~~~~~~~~~~~~ 363 (363)
T cd05628 318 IDDTSNFDEFPDSD-ILKP-TV----------ATS-----------NHPETDYKNKDWVFINYTYKRFE 363 (363)
T ss_pred cchhhccCCCCccc-cccc-cc----------ccc-----------CCcccccCcCCcccCCceeecCC
Confidence 77887776532111 0000 00 000 00123456779999999999774
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-55 Score=497.29 Aligned_cols=256 Identities=35% Similarity=0.650 Sum_probs=245.7
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
..|...+.||+|||+.||.+++..+|+.||+|++.|..+.+..+.+.+.+|++|.+.++|||||++|++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 67999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
|+|..|+|+.++++...++|.++++|+.||+.||.|||+++|||||||..|++|+++.+|||+|||||....
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le-------- 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE-------- 169 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec--------
Confidence 999999999999999999999999999999999999999999999999999999999999999999998532
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhh
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kI 734 (900)
.+..+..+.||||.|+||||+...++++.+||||+||+||-||+|+|||...+-.+++.+|
T Consensus 170 -------------------~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I 230 (592)
T KOG0575|consen 170 -------------------YDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI 230 (592)
T ss_pred -------------------CcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH
Confidence 2345678899999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCC
Q 002616 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 735 l~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk 783 (900)
....+.+| ..+|.+|+|||.+||..||.+||+ +.+||.|+||+
T Consensus 231 k~~~Y~~P---~~ls~~A~dLI~~lL~~~P~~Rps---l~~vL~h~Ff~ 273 (592)
T KOG0575|consen 231 KLNEYSMP---SHLSAEAKDLIRKLLRPNPSERPS---LDEVLDHPFFK 273 (592)
T ss_pred HhcCcccc---cccCHHHHHHHHHHhcCCcccCCC---HHHHhcCHhhh
Confidence 99999988 699999999999999999999999 88999999993
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-54 Score=476.42 Aligned_cols=317 Identities=44% Similarity=0.809 Sum_probs=258.7
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|++++..++|||||+++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998765555566788999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC-
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL- 653 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l- 653 (900)
||++||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.+|++||+|||+++..........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 9999999999999888899999999999999999999999999999999999999999999999999964221100000
Q ss_pred ----CC-CCCC------CC--------CCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHH
Q 002616 654 ----SG-PETD------GI--------MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 714 (900)
Q Consensus 654 ----~~-~~~~------~~--------~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyE 714 (900)
.. .... .. .........+.........+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 00 0000 00 00000001111111122235689999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHhhhcC--CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhh
Q 002616 715 FITGIPPFTAESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 792 (900)
Q Consensus 715 MLtGk~PF~~~s~~ei~~kIl~~--~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~ 792 (900)
|++|.+||.+.+..+.+..+... .+.+|. ...++.++++||.+||+ +|.+|++...+.+++.||||++++|+.+..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~ 318 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRETLYFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDWDTIRQ 318 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCCccCCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCHHHHcc
Confidence 99999999999888888888763 334442 23589999999999998 888887544599999999999999999988
Q ss_pred ccCCccCCCCCCCCccccccc
Q 002616 793 QKAVFVPQPESVDDTSYFLSR 813 (900)
Q Consensus 793 ~~ppf~P~~~s~~D~s~fd~~ 813 (900)
..+|+.|......+..+|...
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~ 339 (377)
T cd05629 319 IRAPFIPQLKSITDTSYFPTD 339 (377)
T ss_pred CCCCcccCCCCccccccCCcc
Confidence 889999998888888777554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=473.69 Aligned_cols=317 Identities=44% Similarity=0.730 Sum_probs=258.1
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
+.|++++.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.++|||||++++.|.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36899999999999999999999999999999998766555667788999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+...........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998632110000000
Q ss_pred CC------CCCCCC-----CCCC-------CC--CcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHH
Q 002616 655 GP------ETDGIM-----PSDA-------HY--PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 714 (900)
Q Consensus 655 ~~------~~~~~~-----~s~~-------~~--~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyE 714 (900)
.. ...... +... .. ............+.+||+.|||||++.+..|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 00 000000 0000 00 0000011112345789999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHhhhcCC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhh
Q 002616 715 FITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 792 (900)
Q Consensus 715 MLtGk~PF~~~s~~ei~~kIl~~~--l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~ 792 (900)
|++|++||.+.++.+...++.... ..+|. ...+++++.+||.+|+. ||.+|++..++.+++.||||++++|.....
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~ 318 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPP-QAKLSPEASDLIIKLCR-GPEDRLGKNGADEIKAHPFFKTIDFSSDLR 318 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcCCCC-cccCCHHHHHHHHHHcc-CHhHcCCCCCHHHHhcCCCcCCcChHHHHh
Confidence 999999999998888888777643 23332 24689999999999865 999999877799999999999999987544
Q ss_pred -ccCCccCCCCCCCCccccccc
Q 002616 793 -QKAVFVPQPESVDDTSYFLSR 813 (900)
Q Consensus 793 -~~ppf~P~~~s~~D~s~fd~~ 813 (900)
..+|+.|....+.|+++|+..
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~ 340 (382)
T cd05625 319 QQSAPYIPKITHPTDTSNFDPV 340 (382)
T ss_pred cCCCCccCcCCCcchhhhcCCC
Confidence 478899999999999998764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-55 Score=477.86 Aligned_cols=265 Identities=36% Similarity=0.605 Sum_probs=236.0
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccc----hhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR----KNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~----~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
...+.|.+.+.||+|+||.|.+|..+.||+.||||++++..... ......+.+|++||++++|||||+++++|..+
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 34566788899999999999999999999999999998765433 22344578999999999999999999999999
Q ss_pred CeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCC---CcEEEEecCCccc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKI 644 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~---G~VKLsDFGLAk~ 644 (900)
+..||||||+.||+|++.+..++.+.+..-+.|++|++.||.|||++||+||||||+||||..+ -.+||+|||+|++
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 9999999999999999999999999999999999999999999999999999999999999876 7899999999996
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCC---CccceeechhHHHHHHHhCCCC
Q 002616 645 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPP 721 (900)
Q Consensus 645 ~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y---s~ksDIWSLGVILyEMLtGk~P 721 (900)
.. ......+.||||.|.|||++.+.++ ..++|+|||||+||-+|+|.+|
T Consensus 329 ~g----------------------------~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pP 380 (475)
T KOG0615|consen 329 SG----------------------------EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPP 380 (475)
T ss_pred cc----------------------------cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCC
Confidence 31 1234678999999999999998664 4588999999999999999999
Q ss_pred CCCCChHH-HHHhhhcCCCCCC-CCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCc
Q 002616 722 FTAESPEI-IFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 787 (900)
Q Consensus 722 F~~~s~~e-i~~kIl~~~l~~P-~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw 787 (900)
|.+..... +.+.|..+.+.|- .....+|+++.+||++||..||++||+ +.|+|+||||+.+.-
T Consensus 381 FS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s---~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 381 FSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPS---ADEALNHPWFKDAPC 445 (475)
T ss_pred cccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcC---HHHHhcChhhhcccc
Confidence 99877665 8899999988763 455789999999999999999999999 889999999997653
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-55 Score=466.61 Aligned_cols=308 Identities=37% Similarity=0.733 Sum_probs=282.0
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCe
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 569 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~ 569 (900)
.+.+++|.++++||+|+|++|.+++.++|.+.||||+++|.-....+.+.-+..|..+..+. +||++|.|+.+|+++..
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesr 325 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESR 325 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccce
Confidence 35788999999999999999999999999999999999887777777888999999998876 59999999999999999
Q ss_pred eEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 570 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
+++|.||++||+|+.++++...++++.|++|.++|+.||.|||++|||+||||.+|+|||..||+||+|+|+|+.+.
T Consensus 326 lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l--- 402 (593)
T KOG0695|consen 326 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL--- 402 (593)
T ss_pred EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998642
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCC-----
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA----- 724 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~----- 724 (900)
.+...+.++||||.|+|||++.|..|++++|||+|||+||||+.|+.||.-
T Consensus 403 ------------------------~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n 458 (593)
T KOG0695|consen 403 ------------------------GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN 458 (593)
T ss_pred ------------------------CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC
Confidence 234567789999999999999999999999999999999999999999952
Q ss_pred ---CChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCh---hcHHHHHcCCCCCCCCcchhhhc--cCC
Q 002616 725 ---ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KAV 796 (900)
Q Consensus 725 ---~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa---~~a~EIL~HPFFk~idw~~L~~~--~pp 796 (900)
.+...+++-|+...+++| ..+|-.+..+++..|++||.+|++. -+..+++.||||+.++|+.++.+ .||
T Consensus 459 ~d~ntedylfqvilekqirip---rslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~pp 535 (593)
T KOG0695|consen 459 PDMNTEDYLFQVILEKQIRIP---RSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPP 535 (593)
T ss_pred cccchhHHHHHHHhhhccccc---ceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCC
Confidence 234567888888888877 7899999999999999999999982 37899999999999999999876 799
Q ss_pred ccCCCCCCCCccccccccccCCCCCCCCCCCC
Q 002616 797 FVPQPESVDDTSYFLSRFSQISSGLPDDQNGS 828 (900)
Q Consensus 797 f~P~~~s~~D~s~fd~~fs~~~~~l~~~d~~~ 828 (900)
|.|...+..+..+|+..|++..+++.+++.+.
T Consensus 536 f~p~i~~d~~l~~fd~qft~e~~qltpdd~d~ 567 (593)
T KOG0695|consen 536 FQPQITDDYGLDNFDTQFTSEPVQLTPDDEDA 567 (593)
T ss_pred CCCccccccCccccccccccCCcccCCCCHHH
Confidence 99999999999999999999999988876543
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-53 Score=467.40 Aligned_cols=350 Identities=40% Similarity=0.717 Sum_probs=274.7
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++++.||+|+||+||+|+++.+|+.||+|++++...........+.+|+.++..++||||+++++.|++.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998765555666788999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||++||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+||||+.+|++||+|||+++...........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999998889999999999999999999999999999999999999999999999999998743211111000
Q ss_pred CCCCC----C----CCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 655 GPETD----G----IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 655 ~~~~~----~----~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
..... . ..........+.........+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 00000 0 000000001111222233456789999999999999999999999999999999999999999999
Q ss_pred hHHHHHhhhcCC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhccCCccCCCCCC
Q 002616 727 PEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESV 804 (900)
Q Consensus 727 ~~ei~~kIl~~~--l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~~ppf~P~~~s~ 804 (900)
+...+.++.... +.+|. ...+++++++||.+|+. ||.+|++..++.+++.||||++++|..+....++..+...+.
T Consensus 241 ~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~~~~~ 318 (360)
T cd05627 241 PQETYRKVMNWKETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWGHIRERPAAIPIEIKSI 318 (360)
T ss_pred HHHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCCCCCCccCCCc
Confidence 999888887643 33442 13479999999999875 999999877799999999999999999877655444556677
Q ss_pred CCccccccccccCCCCCCCCCCCCCcCCCCCCCCCCCchhhhhcCCccccCCCCCCcccccceeeccc
Q 002616 805 DDTSYFLSRFSQISSGLPDDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLS 872 (900)
Q Consensus 805 ~D~s~fd~~fs~~~~~l~~~d~~~~s~~~t~~~s~~~~~~~~e~~~f~~~~~~~~~~~f~g~t~~~~~ 872 (900)
.|.++|+.. +.. +..... . .-.+-....++|.|-||+|++++
T Consensus 319 ~~~~~~~~~-~~~-------~~~~~~-----------~-------~~~~~~~~~~~~~~~~~~~~~~~ 360 (360)
T cd05627 319 DDTSNFDEF-PES-------DILQPA-----------E-------NTIEPDYKSKDWVFLNYTYKRFE 360 (360)
T ss_pred chhhhcCCC-Ccc-------cccCCC-----------c-------cccccccCcCCcccCCceeecCC
Confidence 788777542 111 000000 0 00012345679999999999875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=465.18 Aligned_cols=315 Identities=43% Similarity=0.685 Sum_probs=253.0
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
+.|++++.||+|+||+||+|+++.+++.||+|++++..........++.+|+.+|..++|||||+++++|.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 36899999999999999999999999999999998766666667788999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||++||+|.+++.+.+.+++..++.+++||+.||+|||++||+||||||+||||+.+|++||+|||+++...........
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999998642111000000
Q ss_pred CCC----CCCCCCC----C-------CCC-----CcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHH
Q 002616 655 GPE----TDGIMPS----D-------AHY-----PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 714 (900)
Q Consensus 655 ~~~----~~~~~~s----~-------~~~-----~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyE 714 (900)
... .....+. . ... ............+.+||+.|||||++.+..|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 000 0000000 0 000 0000011112345789999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHhhhcC--CCCCCCCCCCCCHHHHHHHHHhccCCcC--CCCChhcHHHHHcCCCCCCCCcchh
Q 002616 715 FITGIPPFTAESPEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPN--QRLGANGAAEVKAHPFFKGVNWDSL 790 (900)
Q Consensus 715 MLtGk~PF~~~s~~ei~~kIl~~--~l~~P~ip~~lS~eakDLIk~cL~~DP~--kRpSa~~a~EIL~HPFFk~idw~~L 790 (900)
|++|.+||...++.+...++... ...+|. ...+++++.+||.+||+.+++ .|++ +.+++.||||++++|...
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~dli~~ll~~~~~~~~R~~---~~~~l~hp~f~~~~~~~~ 316 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPP-QVKLSPEAVDLITKLCCSAEERLGRNG---ADDIKAHPFFSEVDFSSD 316 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCC-CCCCCHHHHHHHHHHccCcccccCCCC---HHHHhcCcccCCCChhHH
Confidence 99999999998887777777643 333332 236899999999997765444 4888 889999999999999875
Q ss_pred hhc-cCCccCCCCCCCCccccccc
Q 002616 791 ALQ-KAVFVPQPESVDDTSYFLSR 813 (900)
Q Consensus 791 ~~~-~ppf~P~~~s~~D~s~fd~~ 813 (900)
... .+|+.|....+.++++|+..
T Consensus 317 ~~~~~~~~~p~~~~~~~~~~~~~~ 340 (381)
T cd05626 317 IRTQPAPYVPKISHPMDTSNFDPV 340 (381)
T ss_pred hhcCCCCccCcCCCcchhhhcCCC
Confidence 434 67899999989999888653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=455.22 Aligned_cols=289 Identities=43% Similarity=0.768 Sum_probs=256.8
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 580 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GG 580 (900)
+.||+|+||.||+|+++.+|+.||+|++++...........+.+|+.+|..++||||++++++|...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555566778899999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCC
Q 002616 581 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 660 (900)
Q Consensus 581 sL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~ 660 (900)
+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~------------- 147 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS------------- 147 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-------------
Confidence 9999999888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCCC
Q 002616 661 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 740 (900)
Q Consensus 661 ~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l~ 740 (900)
........+||+.|||||++.+..|+.++|||||||++|||++|..||.+.+...++..+......
T Consensus 148 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~ 213 (323)
T cd05571 148 --------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 213 (323)
T ss_pred --------------CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 011223568999999999999999999999999999999999999999999888888888887766
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccccc
Q 002616 741 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 816 (900)
Q Consensus 741 ~P~ip~~lS~eakDLIk~cL~~DP~kRpSa--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~fs~ 816 (900)
+| ..+++++.+||++||+.||++||+. ..+.++++||||++++|..+... .||+.|...+..++.+|+..++.
T Consensus 214 ~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (323)
T cd05571 214 FP---RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTA 290 (323)
T ss_pred CC---CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccccc
Confidence 65 6899999999999999999999952 24899999999999999988754 67889998888999998876655
Q ss_pred CCC
Q 002616 817 ISS 819 (900)
Q Consensus 817 ~~~ 819 (900)
...
T Consensus 291 ~~~ 293 (323)
T cd05571 291 QSI 293 (323)
T ss_pred CCc
Confidence 533
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-54 Score=479.19 Aligned_cols=292 Identities=36% Similarity=0.715 Sum_probs=276.1
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 570 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~L 570 (900)
...+.+++++..||-||||.|=+++.......+|+|+++|..+....+.+|+..|.+||..++.|+||+||-.|.+..++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 45678899999999999999999998876667999999999999999999999999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
||+||-|-||+|++.|+..+.|++..++||++.++.|++|||++|||+|||||+|+|||.+|.+||.|||+|+..
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki----- 570 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI----- 570 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHh-----
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999964
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei 730 (900)
.....++++||||.|.|||++++++++.++|+||||+++||||+|.|||.+.+++.+
T Consensus 571 -----------------------~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt 627 (732)
T KOG0614|consen 571 -----------------------GSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT 627 (732)
T ss_pred -----------------------ccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH
Confidence 234578899999999999999999999999999999999999999999999999999
Q ss_pred HHhhhcCC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCC--hhcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCC
Q 002616 731 FDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESV 804 (900)
Q Consensus 731 ~~kIl~~~--l~~P~ip~~lS~eakDLIk~cL~~DP~kRpS--a~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~ 804 (900)
|..|+++- +.|| ..++..+.+||++++..+|.+|++ .+++.+|+.|.||.++||+.|..+ +||++|.+.++
T Consensus 628 Yn~ILkGid~i~~P---r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~p 704 (732)
T KOG0614|consen 628 YNLILKGIDKIEFP---RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANP 704 (732)
T ss_pred HHHHHhhhhhhhcc---cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCc
Confidence 99999863 4445 899999999999999999999999 789999999999999999999887 89999999999
Q ss_pred CCccccccc
Q 002616 805 DDTSYFLSR 813 (900)
Q Consensus 805 ~D~s~fd~~ 813 (900)
.|++||+.+
T Consensus 705 tD~s~Fd~~ 713 (732)
T KOG0614|consen 705 TDVSNFDNF 713 (732)
T ss_pred ccchhccCC
Confidence 999999985
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=449.45 Aligned_cols=289 Identities=42% Similarity=0.809 Sum_probs=257.6
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 570 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~L 570 (900)
....++|++.+.||+|+||.||+|+++.+|+.||+|++++.........+.+.+|+.+|..++||||+++++++...+.+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 45678999999999999999999999999999999999876555555677899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
|+||||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~---- 169 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP---- 169 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC----
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999987421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei 730 (900)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.++.++
T Consensus 170 --------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~ 223 (329)
T PTZ00263 170 --------------------------DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI 223 (329)
T ss_pred --------------------------CCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH
Confidence 112345799999999999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCC
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDD 806 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D 806 (900)
+..+..+...+| ..++..+++||++||+.||.+||+. ..+.+++.||||++++|..+..+ .+|+.+......+
T Consensus 224 ~~~i~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (329)
T PTZ00263 224 YEKILAGRLKFP---NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGD 300 (329)
T ss_pred HHHHhcCCcCCC---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCCCccc
Confidence 999988876665 6789999999999999999999983 45899999999999999988654 4556666666666
Q ss_pred cccccc
Q 002616 807 TSYFLS 812 (900)
Q Consensus 807 ~s~fd~ 812 (900)
..+|..
T Consensus 301 ~~~~~~ 306 (329)
T PTZ00263 301 TSNFEK 306 (329)
T ss_pred chhccC
Confidence 666654
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-51 Score=447.27 Aligned_cols=315 Identities=46% Similarity=0.809 Sum_probs=259.8
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++.+.||+|+||+||+|++..+|+.||+|++++...........+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765555566788999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++...........
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999753221100000
Q ss_pred --CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002616 655 --GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 655 --~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~ 732 (900)
........+...................+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 240 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence 000000000000000001111223345689999999999999999999999999999999999999999999888888
Q ss_pred hhhc--CCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhccCCccCCCCCCCCcccc
Q 002616 733 NILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYF 810 (900)
Q Consensus 733 kIl~--~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~~ppf~P~~~s~~D~s~f 810 (900)
++.. ....+|.. ..+++++.+||.+||. ||.+|++ .+.++++||||++++|+......+|++|...+..+..+|
T Consensus 241 ~i~~~~~~~~~p~~-~~~~~~~~~li~~ll~-dp~~R~~--s~~~ll~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (350)
T cd05573 241 KIINWKESLRFPPD-PPVSPEAIDLICRLLC-DPEDRLG--SFEEIKSHPFFKGIDWENLRETKPPFVPELSSPLDTSNF 316 (350)
T ss_pred HHhccCCcccCCCC-CCCCHHHHHHHHHHcc-ChhhcCC--CHHHHhcCCCcCCCCHHHHhhCCCCcCCCCCCchhhhhc
Confidence 8877 44555532 3479999999999998 9999998 366999999999999999887788999999888888877
Q ss_pred ccc
Q 002616 811 LSR 813 (900)
Q Consensus 811 d~~ 813 (900)
+..
T Consensus 317 ~~~ 319 (350)
T cd05573 317 DDF 319 (350)
T ss_pred CCC
Confidence 663
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-51 Score=442.77 Aligned_cols=291 Identities=36% Similarity=0.756 Sum_probs=256.1
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CceEEEeeeeccCCeeEEEE
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~H-PnIVkL~~~f~d~~~LyLVm 574 (900)
+|++++.||+|+||.||+|+++.+++.||+|++++.........+.+..|..++..+.| ++|++++++|...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999987555455667788999999999976 46889999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~------- 153 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF------- 153 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC-------
Confidence 9999999999999888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhh
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kI 734 (900)
........+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+.+..+
T Consensus 154 --------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i 213 (324)
T cd05587 154 --------------------GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI 213 (324)
T ss_pred --------------------CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 011223467999999999999999999999999999999999999999999999999998
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccc
Q 002616 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYF 810 (900)
Q Consensus 735 l~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~f 810 (900)
......+| ..++.++.+||.+||.+||.+|++. ....++++||||+.++|..+..+ .+++.|......+.++|
T Consensus 214 ~~~~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (324)
T cd05587 214 MEHNVSYP---KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENF 290 (324)
T ss_pred HcCCCCCC---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCCCcchhhhc
Confidence 88776655 6899999999999999999999984 34679999999999999988655 57788888777888888
Q ss_pred cccccc
Q 002616 811 LSRFSQ 816 (900)
Q Consensus 811 d~~fs~ 816 (900)
+..+..
T Consensus 291 ~~~~~~ 296 (324)
T cd05587 291 DKFFTR 296 (324)
T ss_pred Cccccc
Confidence 775433
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-51 Score=442.26 Aligned_cols=291 Identities=36% Similarity=0.742 Sum_probs=255.7
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEE
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~LyLVm 574 (900)
+|++++.||+|+||.||+|+++.+++.||+|++++...........+..|..++..+ .||+|+++++++...+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 689999999999999999999999999999999875544455566778888888877 4899999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||++||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~------- 153 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW------- 153 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC-------
Confidence 9999999999998888899999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhh
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kI 734 (900)
........+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+...++..+
T Consensus 154 --------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i 213 (323)
T cd05616 154 --------------------DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 213 (323)
T ss_pred --------------------CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 011223467999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccc
Q 002616 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYF 810 (900)
Q Consensus 735 l~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~f 810 (900)
......+| ..++.++.+||.+||++||.+|++. ....++++||||+.++|+.+... .+|+.|... ..|..+|
T Consensus 214 ~~~~~~~p---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 289 (323)
T cd05616 214 MEHNVAYP---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPYKPKAC-GRDAENF 289 (323)
T ss_pred HhCCCCCC---CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCC-Cchhhhc
Confidence 88877665 6799999999999999999999984 35789999999999999998765 678888764 4677777
Q ss_pred ccccccC
Q 002616 811 LSRFSQI 817 (900)
Q Consensus 811 d~~fs~~ 817 (900)
+..|...
T Consensus 290 ~~~~~~~ 296 (323)
T cd05616 290 DKFFTRH 296 (323)
T ss_pred CchhccC
Confidence 7766543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-51 Score=439.26 Aligned_cols=285 Identities=42% Similarity=0.791 Sum_probs=255.9
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++.+.||+|+||.||+|.++.+|+.||+|++...........+.+.+|+.+|..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997654444456678899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||+++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~-------- 152 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR-------- 152 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhcc--------
Confidence 999999999999988899999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhh
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kI 734 (900)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..+
T Consensus 153 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i 210 (291)
T cd05612 153 ----------------------DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210 (291)
T ss_pred ----------------------CCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 1123457999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC--hhcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccc
Q 002616 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYF 810 (900)
Q Consensus 735 l~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpS--a~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~f 810 (900)
..+...+| ..+++.+++||++||+.||.+|++ ...+.+++.||||+.++|..+... .|++.|......++.+|
T Consensus 211 ~~~~~~~~---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 287 (291)
T cd05612 211 LAGKLEFP---RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNF 287 (291)
T ss_pred HhCCcCCC---ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCCCccccccc
Confidence 88877766 678999999999999999999996 235889999999999999987655 67778888888888887
Q ss_pred cc
Q 002616 811 LS 812 (900)
Q Consensus 811 d~ 812 (900)
++
T Consensus 288 ~~ 289 (291)
T cd05612 288 DD 289 (291)
T ss_pred cC
Confidence 64
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-51 Score=441.29 Aligned_cols=287 Identities=40% Similarity=0.783 Sum_probs=249.4
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~I-L~~L~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|..+ ++.++||||+++++.|...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999987554444455666677664 5779999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 580 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 580 GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~------------ 148 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE------------ 148 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc------------
Confidence 99999999888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCC
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l 739 (900)
........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 213 (323)
T cd05575 149 ---------------HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL 213 (323)
T ss_pred ---------------CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 01122346799999999999999999999999999999999999999999999999999888766
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCh-hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccccc
Q 002616 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 816 (900)
Q Consensus 740 ~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa-~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~fs~ 816 (900)
.++ ..++.++.+||++||+.||.+||++ ....+++.||||+.++|..+... .+|+.|......+...|+..+..
T Consensus 214 ~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (323)
T cd05575 214 RLK---PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTE 290 (323)
T ss_pred CCC---CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCCCcchhhhcCccccc
Confidence 544 6789999999999999999999995 35789999999999999988655 67888888877777777765544
Q ss_pred C
Q 002616 817 I 817 (900)
Q Consensus 817 ~ 817 (900)
.
T Consensus 291 ~ 291 (323)
T cd05575 291 E 291 (323)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=438.04 Aligned_cols=284 Identities=41% Similarity=0.819 Sum_probs=254.5
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCCh
Q 002616 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 582 (900)
Q Consensus 503 LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GGsL 582 (900)
||+|+||.||+|+++.+++.||+|++++...........+.+|+.+|..++||||++++++|...+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999876555566678889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCCCC
Q 002616 583 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 662 (900)
Q Consensus 583 ~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~ 662 (900)
.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--------------- 145 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--------------- 145 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc---------------
Confidence 99999888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCCCCC
Q 002616 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 742 (900)
Q Consensus 663 ~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l~~P 742 (900)
........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+..+......+|
T Consensus 146 ------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 213 (312)
T cd05585 146 ------------DDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP 213 (312)
T ss_pred ------------CCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC
Confidence 01122346799999999999999999999999999999999999999999999999999888776665
Q ss_pred CCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccccc
Q 002616 743 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 816 (900)
Q Consensus 743 ~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~fs~ 816 (900)
..+++++++||.+||..||.+||+...+.+++.||||+.++|..+... .+++.|...+..++++|+..++.
T Consensus 214 ---~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (312)
T cd05585 214 ---DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTR 286 (312)
T ss_pred ---CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCccchhhcCccccc
Confidence 689999999999999999999999877999999999999999877544 67888888888888888776543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=445.67 Aligned_cols=290 Identities=40% Similarity=0.772 Sum_probs=257.7
Q ss_pred cccccCCCeEEEEEeccCCceEEEEEEECCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 489 ~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tG-k~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
...+..++|++.+.||+|+||.||+|+++.++ ..||+|++.+.........+.+.+|+.++..++|||||+++++|.+.
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 34567889999999999999999999977665 68999999876555556677899999999999999999999999999
Q ss_pred CeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~ 647 (900)
+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~- 182 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD- 182 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC-
Confidence 9999999999999999999988899999999999999999999999999999999999999999999999999987421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 727 (900)
Q Consensus 648 ~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~ 727 (900)
....+.+||+.|||||++.+..++.++|||||||++|||++|.+||.+.++
T Consensus 183 -----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 183 -----------------------------TRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred -----------------------------CCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 012346799999999999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCC
Q 002616 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPES 803 (900)
Q Consensus 728 ~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s 803 (900)
..++..+..+...+| ..+++++.+||++||+.||.+|++. ..+.++++||||++++|..+... .+|+.|....
T Consensus 234 ~~~~~~i~~~~~~~p---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~~ 310 (340)
T PTZ00426 234 LLIYQKILEGIIYFP---KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKN 310 (340)
T ss_pred HHHHHHHhcCCCCCC---CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCC
Confidence 999999988876665 6789999999999999999999752 24899999999999999987655 6788888877
Q ss_pred CCCccccc
Q 002616 804 VDDTSYFL 811 (900)
Q Consensus 804 ~~D~s~fd 811 (900)
..+.++|.
T Consensus 311 ~~~~~~~~ 318 (340)
T PTZ00426 311 VFDSSNFE 318 (340)
T ss_pred CcchhhcC
Confidence 77766654
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-51 Score=441.15 Aligned_cols=287 Identities=39% Similarity=0.780 Sum_probs=253.7
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
+.||+|+||+||+|+++.+++.||+|++++.........+.+..|..++..+ +||||++++++|...+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999875544555677888899998876 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 580 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 580 GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~------------ 148 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF------------ 148 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc------------
Confidence 99999999888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCC
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l 739 (900)
........+||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~ 213 (320)
T cd05590 149 ---------------NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV 213 (320)
T ss_pred ---------------CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC
Confidence 01122346799999999999999999999999999999999999999999999999999988776
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCh---hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccc
Q 002616 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRF 814 (900)
Q Consensus 740 ~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa---~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~f 814 (900)
.+| ..++.++.+||++||++||.+||++ .+..+++.||||++++|+.+..+ .||+.|...+..|.++|+..+
T Consensus 214 ~~~---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (320)
T cd05590 214 VYP---TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIKSREDVSNFDPDF 290 (320)
T ss_pred CCC---CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCccc
Confidence 655 6789999999999999999999995 23589999999999999987655 688999999999999988754
Q ss_pred ccC
Q 002616 815 SQI 817 (900)
Q Consensus 815 s~~ 817 (900)
...
T Consensus 291 ~~~ 293 (320)
T cd05590 291 IKE 293 (320)
T ss_pred ccC
Confidence 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=440.52 Aligned_cols=287 Identities=43% Similarity=0.789 Sum_probs=253.9
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 580 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GG 580 (900)
+.||+|+||.||+++++.+|+.||+|++++...........+.+|+.+|+.++||||+++++++...+.+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555566788899999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCC
Q 002616 581 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 660 (900)
Q Consensus 581 sL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~ 660 (900)
+|..++...+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~------------- 147 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT------------- 147 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC-------------
Confidence 9999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCCC
Q 002616 661 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 740 (900)
Q Consensus 661 ~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l~ 740 (900)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+......
T Consensus 148 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~ 213 (328)
T cd05593 148 --------------DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213 (328)
T ss_pred --------------cccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCcc
Confidence 011223467999999999999999999999999999999999999999998888888888777666
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccccc
Q 002616 741 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 816 (900)
Q Consensus 741 ~P~ip~~lS~eakDLIk~cL~~DP~kRpSa--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~fs~ 816 (900)
+| ..+++++.+||++||.+||.+|++. ..+.++++||||.+++|..+... .+|+.|...+..+..+|+..|+.
T Consensus 214 ~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (328)
T cd05593 214 FP---RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTSETDTRYFDEEFTA 290 (328)
T ss_pred CC---CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCccccc
Confidence 55 6899999999999999999999852 34899999999999999987655 67888888888888888776655
Q ss_pred C
Q 002616 817 I 817 (900)
Q Consensus 817 ~ 817 (900)
.
T Consensus 291 ~ 291 (328)
T cd05593 291 Q 291 (328)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=438.39 Aligned_cols=285 Identities=39% Similarity=0.776 Sum_probs=250.6
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
+.||+|+||+||+|+++.+|+.||+|++++.........+.+..|..++..+ +||||++++++|...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999999999999999999876555556677788899999866 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 580 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 580 GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~------------ 148 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL------------ 148 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc------------
Confidence 99999999888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCC
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l 739 (900)
........+||+.|+|||++.+..++.++|||||||++|||++|++||...+..+.+..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~ 213 (321)
T cd05591 149 ---------------NGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV 213 (321)
T ss_pred ---------------CCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC
Confidence 01122346799999999999999999999999999999999999999999999999999988776
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCChh----cHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccccccc
Q 002616 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN----GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSR 813 (900)
Q Consensus 740 ~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~----~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~ 813 (900)
.+| ..++.++.+||.+||+.||.+||+.. .+.++++||||.+++|..+... .+++.|......+..+|+..
T Consensus 214 ~~p---~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (321)
T cd05591 214 LYP---VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQD 290 (321)
T ss_pred CCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCCCcchhhhcCCc
Confidence 655 67899999999999999999999532 4889999999999999988655 56788887777777777665
Q ss_pred cc
Q 002616 814 FS 815 (900)
Q Consensus 814 fs 815 (900)
+.
T Consensus 291 ~~ 292 (321)
T cd05591 291 FT 292 (321)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-51 Score=445.95 Aligned_cols=260 Identities=32% Similarity=0.572 Sum_probs=236.4
Q ss_pred ccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 569 (900)
Q Consensus 490 ~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ 569 (900)
..+..++++.++.||+|..|+||+|+++.|++.||+|++.- ..+....+++.+|++++..++||+||++|++|..+..
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~ 151 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE 151 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc
Confidence 34667799999999999999999999999999999999932 3355667889999999999999999999999999995
Q ss_pred -eEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhh-cCeEeccCCCCcEEecCCCcEEEEecCCcccccc
Q 002616 570 -LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 570 -LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~ 647 (900)
++|+||||.||+|.+++.+.++++|.....++.+|++||.|||. ++||||||||+||||+..|.|||||||.++...
T Consensus 152 ~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv- 230 (364)
T KOG0581|consen 152 EISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV- 230 (364)
T ss_pred eEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh-
Confidence 99999999999999999999999999999999999999999995 999999999999999999999999999998531
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC--
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-- 725 (900)
Q Consensus 648 ~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~-- 725 (900)
+..+.+++||..|||||-+.+..|+.++||||||+.++||++|+.||...
T Consensus 231 ----------------------------nS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~ 282 (364)
T KOG0581|consen 231 ----------------------------NSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP 282 (364)
T ss_pred ----------------------------hhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC
Confidence 12567899999999999999999999999999999999999999999875
Q ss_pred ---ChHHHHHhhhcCCCCCCCCCCC-CCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 726 ---SPEIIFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 726 ---s~~ei~~kIl~~~l~~P~ip~~-lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
+..+++..|+.+.. |.+|.. +|+++++||..||++||.+|++ +.++++|||++..
T Consensus 283 ~~~~~~~Ll~~Iv~~pp--P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s---~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 283 PYLDIFELLCAIVDEPP--PRLPEGEFSPEFRSFVSCCLRKDPSERPS---AKQLLQHPFIKKF 341 (364)
T ss_pred CCCCHHHHHHHHhcCCC--CCCCcccCCHHHHHHHHHHhcCCcccCCC---HHHHhcCHHHhhc
Confidence 66788888888653 445666 9999999999999999999999 8899999999864
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=439.74 Aligned_cols=286 Identities=39% Similarity=0.766 Sum_probs=249.1
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~I-L~~L~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
+.||+|+||+||+|+++.+|+.||+|++.+...........+..|..+ ++.++||||+++++.|...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999987544444455666777654 6778999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 580 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 580 GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~------------ 148 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA------------ 148 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC------------
Confidence 99999998888999999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCC
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l 739 (900)
........+||+.|||||++.+..++.++|||||||++|||++|.+||...+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~ 213 (325)
T cd05604 149 ---------------QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL 213 (325)
T ss_pred ---------------CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc
Confidence 01122346799999999999999999999999999999999999999999999999998887765
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCh-hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccccc
Q 002616 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 816 (900)
Q Consensus 740 ~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa-~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~fs~ 816 (900)
.++ +..+..+.++|++||..||.+||+. ..+.+++.||||++++|..+... .+|+.|......+.++|+..+..
T Consensus 214 ~~~---~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (325)
T cd05604 214 VLR---PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTE 290 (325)
T ss_pred cCC---CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCCcccc
Confidence 544 5789999999999999999999995 35789999999999999987655 56888888888888888765443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=438.54 Aligned_cols=287 Identities=41% Similarity=0.745 Sum_probs=250.7
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++.+.||+|+||+||+|+++.+|+.||+|++++...........+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544556678899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 575 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~----- 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN----- 155 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC-----
Confidence 999999999999876 67999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc------CCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL------GTEHGYAADWWSVGIILFEFITGIPPFTAESP 727 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~------g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~ 727 (900)
........+||+.|+|||++. +..++.++|||||||++|||++|..||...+.
T Consensus 156 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 214 (330)
T cd05601 156 ---------------------KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214 (330)
T ss_pred ---------------------CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH
Confidence 011123357999999999997 45678999999999999999999999999888
Q ss_pred HHHHHhhhcCC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhccCCccCCCCCCC
Q 002616 728 EIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVD 805 (900)
Q Consensus 728 ~ei~~kIl~~~--l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~~ppf~P~~~s~~ 805 (900)
...+.++.... ..+|. ...++.++.+||.+||+ ||.+||+ +.+++.||||+.++|..+....|++.|......
T Consensus 215 ~~~~~~i~~~~~~~~~~~-~~~~~~~~~~li~~ll~-~p~~R~t---~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (330)
T cd05601 215 AKTYNNIMNFQRFLKFPE-DPKVSSDFLDLIQSLLC-GQKERLG---YEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDD 289 (330)
T ss_pred HHHHHHHHcCCCccCCCC-CCCCCHHHHHHHHHHcc-ChhhCCC---HHHHhCCCCcCCCCHHHHhhCCCCccCcCCCcc
Confidence 88888877643 33443 24689999999999998 9999999 789999999999999999887888899888888
Q ss_pred Ccccccc
Q 002616 806 DTSYFLS 812 (900)
Q Consensus 806 D~s~fd~ 812 (900)
|.++|..
T Consensus 290 ~~~~~~~ 296 (330)
T cd05601 290 DTSNFDE 296 (330)
T ss_pred hhhhcCC
Confidence 8777654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=440.02 Aligned_cols=291 Identities=41% Similarity=0.751 Sum_probs=256.7
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 580 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GG 580 (900)
+.||+|+||.||+|+++.+|+.||+|++++...........+.+|+.++..++||||++++++|...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998755445556778889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCC
Q 002616 581 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 660 (900)
Q Consensus 581 sL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~ 660 (900)
+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~------------- 147 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS------------- 147 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC-------------
Confidence 9999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCCC
Q 002616 661 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 740 (900)
Q Consensus 661 ~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l~ 740 (900)
........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+....+..+......
T Consensus 148 --------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 213 (323)
T cd05595 148 --------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 213 (323)
T ss_pred --------------CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC
Confidence 011123467999999999999999999999999999999999999999999888888888877766
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccccc
Q 002616 741 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 816 (900)
Q Consensus 741 ~P~ip~~lS~eakDLIk~cL~~DP~kRpSa--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~fs~ 816 (900)
+| ..+++++.+||.+||+.||.+|++. ..+.++++||||.+++|..+... .||+.|...+..+..+|+..++.
T Consensus 214 ~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (323)
T cd05595 214 FP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTA 290 (323)
T ss_pred CC---CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCChhhhhhcCccccc
Confidence 55 6899999999999999999999952 25899999999999999987655 57889998888999988877666
Q ss_pred CCCCC
Q 002616 817 ISSGL 821 (900)
Q Consensus 817 ~~~~l 821 (900)
.....
T Consensus 291 ~~~~~ 295 (323)
T cd05595 291 QSITI 295 (323)
T ss_pred CCccC
Confidence 64443
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-50 Score=444.27 Aligned_cols=316 Identities=46% Similarity=0.761 Sum_probs=253.8
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.+|..++||||+++++.|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765545556778899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||++||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|............
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999998632110000000
Q ss_pred CC----CCCCCCCCCC-------CCC-----cccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhC
Q 002616 655 GP----ETDGIMPSDA-------HYP-----EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 718 (900)
Q Consensus 655 ~~----~~~~~~~s~~-------~~~-----~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtG 718 (900)
.. ..+...+... ... .............+||+.|||||++.+..++.++|||||||++|||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 00 0000000000 000 0000011122356899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHhhhcCCC--CCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhh-ccC
Q 002616 719 IPPFTAESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL-QKA 795 (900)
Q Consensus 719 k~PF~~~s~~ei~~kIl~~~l--~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~-~~p 795 (900)
++||.+.++.+....+..... .+|. ...+++++.+||.+|+. +|.+|++...+.++++||||++++|..+.. ..+
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~l~~-~p~~R~~~~t~~ell~h~~~~~~~~~~~~~~~~~ 318 (376)
T cd05598 241 QPPFLADTPAETQLKVINWETTLHIPS-QAKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKA 318 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCccccCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhCCCCcCCCCHHHHhhcCCC
Confidence 999999988887777665432 2221 24689999999999875 999999654589999999999999998853 367
Q ss_pred CccCCCCCCCCcccccc
Q 002616 796 VFVPQPESVDDTSYFLS 812 (900)
Q Consensus 796 pf~P~~~s~~D~s~fd~ 812 (900)
++.|....+.++++|+.
T Consensus 319 ~~~~~~~~~~~~~~~~~ 335 (376)
T cd05598 319 PYIPKITHPTDTSNFDP 335 (376)
T ss_pred CCCCcCCCcchhhhcCC
Confidence 88898888888888765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-50 Score=439.03 Aligned_cols=292 Identities=37% Similarity=0.739 Sum_probs=248.1
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
+.||+|+||.||+|+++.+++.||+|++++...........+.+|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999999999999999999875544455667788999999988 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 580 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 580 GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~------------- 147 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI------------- 147 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccc-------------
Confidence 9999999888899999999999999999999999999999999999999999999999999987321
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC---------ChHHH
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---------SPEII 730 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~---------s~~ei 730 (900)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||... .....
T Consensus 148 --------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05588 148 --------------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL 213 (329)
T ss_pred --------------cCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH
Confidence 0011233568999999999999999999999999999999999999999632 12234
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChh---cHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCC
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN---GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVD 805 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~---~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~ 805 (900)
+..+......+| ..++.++.+||++||++||.+|+++. .+.++++||||+.++|+.+... .|++.|......
T Consensus 214 ~~~~~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
T cd05588 214 FQVILEKQIRIP---RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDR 290 (329)
T ss_pred HHHHHcCCCCCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCCCcc
Confidence 555666655544 78999999999999999999999853 4789999999999999988654 567788877777
Q ss_pred CccccccccccCCCCCC
Q 002616 806 DTSYFLSRFSQISSGLP 822 (900)
Q Consensus 806 D~s~fd~~fs~~~~~l~ 822 (900)
+..+|+..+.......+
T Consensus 291 ~~~~~~~~~~~~~~~~~ 307 (329)
T cd05588 291 DLDNFDPQFTDEPVQLT 307 (329)
T ss_pred hhhhcCCccccCccccC
Confidence 77777776655544433
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=438.00 Aligned_cols=285 Identities=43% Similarity=0.802 Sum_probs=252.9
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++++.||+|+||.||+|++..+|+.||+|++++...........+.+|+.++..++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998755444556778899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~-------- 152 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV-------- 152 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccc--------
Confidence 999999999999988889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhh
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kI 734 (900)
......+||+.|+|||++.+..++.++|||||||++|||++|.+||...+..+.+..+
T Consensus 153 ----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i 210 (333)
T cd05600 153 ----------------------TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL 210 (333)
T ss_pred ----------------------cccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH
Confidence 0234567999999999999999999999999999999999999999999888888777
Q ss_pred hcCC--CCCCCCC---CCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhccCCccCCCCCCCCccc
Q 002616 735 LNRK--IPWPCVP---SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSY 809 (900)
Q Consensus 735 l~~~--l~~P~ip---~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~~ppf~P~~~s~~D~s~ 809 (900)
.... ...|... ..+++++.+||.+||..+|.+||+ +.+++.||||++++|..+....||+.|......+..+
T Consensus 211 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s---~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (333)
T cd05600 211 KYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGS---LEDIKNHPFFKEVDWNELRELKPPFVPELESEIDTGY 287 (333)
T ss_pred HhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCC---HHHHHhCcccCCCCHHHHhhCCCCCCCCCCCcchhhh
Confidence 6532 2222211 256899999999999999999999 8899999999999999988778899998888777777
Q ss_pred ccc
Q 002616 810 FLS 812 (900)
Q Consensus 810 fd~ 812 (900)
|+.
T Consensus 288 ~~~ 290 (333)
T cd05600 288 FDD 290 (333)
T ss_pred ccC
Confidence 654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-50 Score=436.50 Aligned_cols=288 Identities=38% Similarity=0.735 Sum_probs=247.3
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
+.||+|+||+||+|+.+.+++.||+|++++...........+.+|+.++.++ +||||++++++|...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876555556677889999999888 599999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 580 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 580 GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~------------ 148 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG------------ 148 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC-------ChHHHHH
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-------SPEIIFD 732 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~-------s~~ei~~ 732 (900)
........+||+.|+|||++.+..++.++|||||||++|||++|..||... .....+.
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~ 213 (327)
T cd05617 149 ---------------PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ 213 (327)
T ss_pred ---------------CCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH
Confidence 011223568999999999999999999999999999999999999999642 2234555
Q ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCh---hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCc
Q 002616 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDT 807 (900)
Q Consensus 733 kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa---~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~ 807 (900)
.+......+| ..++..+.+||.+||..||.+|+++ .+..+++.||||++++|+.+... .++|.|......+.
T Consensus 214 ~~~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (327)
T cd05617 214 VILEKPIRIP---RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQITDDYGL 290 (327)
T ss_pred HHHhCCCCCC---CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCCCCcch
Confidence 5655555544 6789999999999999999999984 35789999999999999988755 67888988887788
Q ss_pred cccccccccCC
Q 002616 808 SYFLSRFSQIS 818 (900)
Q Consensus 808 s~fd~~fs~~~ 818 (900)
++|+..+...+
T Consensus 291 ~~~~~~~~~~~ 301 (327)
T cd05617 291 ENFDTQFTSEP 301 (327)
T ss_pred hhcCCccccCc
Confidence 88876554443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-51 Score=445.77 Aligned_cols=260 Identities=34% Similarity=0.647 Sum_probs=239.1
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
...+|.+.+.||+|+||+||+|+++.++..||||.+.+... .+...+.+..|+.+|+.++|||||.|++++.+++.+||
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~l 86 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYL 86 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEE
Confidence 46799999999999999999999999999999999987654 45667889999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCC------CcEEEEecCCccccc
Q 002616 573 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD------GHIKLTDFGLSKIGL 646 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~------G~VKLsDFGLAk~~~ 646 (900)
|||||.||||.+++++.+.+++..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+|+..
T Consensus 87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L- 165 (429)
T KOG0595|consen 87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL- 165 (429)
T ss_pred EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC-
Confidence 99999999999999999999999999999999999999999999999999999999875 46899999999963
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
..+....+.||+|.|||||++..+.|+.|+|+||+|+|+|+|++|++||...+
T Consensus 166 ---------------------------~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t 218 (429)
T KOG0595|consen 166 ---------------------------QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET 218 (429)
T ss_pred ---------------------------CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence 13445678999999999999999999999999999999999999999999999
Q ss_pred hHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 727 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 727 ~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
+.+++..+..+....|.++..++....+|+..+|+++|..|.+ ..+.+.|+|...
T Consensus 219 ~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~---~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 219 PKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRIS---FEDFFDHPFLAA 273 (429)
T ss_pred HHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCc---hHHhhhhhhccc
Confidence 9999999988877777778889999999999999999999998 557777888753
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-50 Score=436.73 Aligned_cols=290 Identities=37% Similarity=0.737 Sum_probs=245.7
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
+.||+|+||+||+|+++.+++.||+|++++...........+.+|..++.++ +||||++++++|...+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999875544555667788999998876 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 580 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 580 GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~------------ 148 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR------------ 148 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC---------ChHHH
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---------SPEII 730 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~---------s~~ei 730 (900)
........+||+.|+|||++.+..++.++|||||||++|||++|..||... ....+
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (329)
T cd05618 149 ---------------PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL 213 (329)
T ss_pred ---------------CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHH
Confidence 011223468999999999999999999999999999999999999999531 12335
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCh---hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCC
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVD 805 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa---~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~ 805 (900)
...+......+| ..++.++.+||++||+.||.+||++ .++.++++||||++++|+.+... .|++.|......
T Consensus 214 ~~~i~~~~~~~p---~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (329)
T cd05618 214 FQVILEKQIRIP---RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEF 290 (329)
T ss_pred HHHHhcCCCCCC---CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCCCcc
Confidence 556666665555 7889999999999999999999984 24689999999999999987654 678888887777
Q ss_pred CccccccccccCCCC
Q 002616 806 DTSYFLSRFSQISSG 820 (900)
Q Consensus 806 D~s~fd~~fs~~~~~ 820 (900)
+..+|+..+......
T Consensus 291 ~~~~~~~~~~~~~~~ 305 (329)
T cd05618 291 GLDNFDAQFTNEPVQ 305 (329)
T ss_pred cchhcCcccccCCcc
Confidence 777776654444333
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-50 Score=432.77 Aligned_cols=288 Identities=40% Similarity=0.780 Sum_probs=249.5
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
+.||+|+||+||+|+++.+++.||+|++++.........+.+..|..++... +||||+++++++...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999875444445566677788877654 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 580 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 580 GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~------------ 148 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN------------ 148 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC------------
Confidence 99999998888999999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCC
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l 739 (900)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~ 213 (316)
T cd05592 149 ---------------GEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRP 213 (316)
T ss_pred ---------------CCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCC
Confidence 01123356799999999999999999999999999999999999999999998888888876554
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccccccccccC
Q 002616 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQI 817 (900)
Q Consensus 740 ~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~fs~~ 817 (900)
.+ +..++.++.+||.+||..||.+||+. +.+++.||||+.++|..+... .|++.|......+.++|+..|+..
T Consensus 214 ~~---~~~~~~~~~~ll~~~l~~~P~~R~~~--~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (316)
T cd05592 214 HF---PRWISKEAKDCLSKLFERDPTKRLGV--DGDIRQHPFFRGIDWERLEKREIPPPFKPKVKSPSDASNFDREFTNE 288 (316)
T ss_pred CC---CCCCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccc
Confidence 43 47899999999999999999999983 358899999999999987654 678888888888888988776655
Q ss_pred CCC
Q 002616 818 SSG 820 (900)
Q Consensus 818 ~~~ 820 (900)
...
T Consensus 289 ~~~ 291 (316)
T cd05592 289 KVR 291 (316)
T ss_pred ccc
Confidence 433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=433.00 Aligned_cols=291 Identities=36% Similarity=0.743 Sum_probs=253.2
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEE
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~LyLVm 574 (900)
+|++.+.||+|+||+||+|+++.+|+.||+|++++...........+..|..++..+. ||+|++++++|.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5889999999999999999999999999999998755444556677888999998886 578889999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~------- 153 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV------- 153 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC-------
Confidence 9999999999999888999999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhh
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kI 734 (900)
........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+...+...+
T Consensus 154 --------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i 213 (323)
T cd05615 154 --------------------DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI 213 (323)
T ss_pred --------------------CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 011223467999999999999999999999999999999999999999999999999999
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccc
Q 002616 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYF 810 (900)
Q Consensus 735 l~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~f 810 (900)
......+| ..++.++.+|+.+||++||.+|++. ....++++||||++++|..+... .+|+.|.... ....+|
T Consensus 214 ~~~~~~~p---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 289 (323)
T cd05615 214 MEHNVSYP---KSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPFKPKVCG-KGAENF 289 (323)
T ss_pred HhCCCCCC---ccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCcCccCccCC-Cchhhc
Confidence 88776655 6789999999999999999999984 34789999999999999988766 5788876544 346667
Q ss_pred ccccccC
Q 002616 811 LSRFSQI 817 (900)
Q Consensus 811 d~~fs~~ 817 (900)
+..+...
T Consensus 290 ~~~~~~~ 296 (323)
T cd05615 290 DKFFTRG 296 (323)
T ss_pred Ccccccc
Confidence 6655443
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=441.63 Aligned_cols=292 Identities=41% Similarity=0.738 Sum_probs=245.6
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
...++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.+++.++||||++++++|.+++.+|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 45678999999999999999999999999999999998755555556677889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
+||||++||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+....
T Consensus 120 lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~---- 194 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE---- 194 (370)
T ss_pred EEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc----
Confidence 999999999999998654 589999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCC----CCccceeechhHHHHHHHhCCCCCCCCCh
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPFTAESP 727 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~----ys~ksDIWSLGVILyEMLtGk~PF~~~s~ 727 (900)
.......+.+||+.|||||++.+.. ++.++|||||||++|||++|.+||.+.+.
T Consensus 195 ----------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 195 ----------------------TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred ----------------------CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 0011223568999999999997643 78899999999999999999999999998
Q ss_pred HHHHHhhhcCC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcc--hhhhccCCccCCCCC
Q 002616 728 EIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD--SLALQKAVFVPQPES 803 (900)
Q Consensus 728 ~ei~~kIl~~~--l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~--~L~~~~ppf~P~~~s 803 (900)
...+.+|.... +.+|. ...++..+++||.+||+. +.+|++...+.++++||||++..|+ .+....+|+.|....
T Consensus 253 ~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~~L~~-~~~r~~R~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~~ 330 (370)
T cd05621 253 VGTYSKIMDHKNSLNFPE-DVEISKHAKNLICAFLTD-REVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSS 330 (370)
T ss_pred HHHHHHHHhCCcccCCCC-cccCCHHHHHHHHHHccC-chhccCCCCHHHHhcCcccCCCCcChHhcCCCCCCcCCCCCC
Confidence 88888887644 34442 235799999999999984 4444332238899999999986665 444447788898888
Q ss_pred CCCcccccc
Q 002616 804 VDDTSYFLS 812 (900)
Q Consensus 804 ~~D~s~fd~ 812 (900)
..|.++|+.
T Consensus 331 ~~~~~~~~~ 339 (370)
T cd05621 331 DIDSSNFDD 339 (370)
T ss_pred cchhhhcCC
Confidence 888877764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-50 Score=432.45 Aligned_cols=288 Identities=39% Similarity=0.793 Sum_probs=252.4
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
+.||+|+||+||+|+++.+++.||+|++++...........+..|..++..+ +||||++++++|...+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999876555555677788899999887 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 580 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 580 GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
|+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~------------ 148 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL------------ 148 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc------------
Confidence 99999998888999999999999999999999999999999999999999999999999999863210
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCC
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l 739 (900)
........+||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+....+..+.....
T Consensus 149 ---------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~ 213 (318)
T cd05570 149 ---------------GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV 213 (318)
T ss_pred ---------------CCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC
Confidence 01122345799999999999999999999999999999999999999999998888888887776
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccccccccc
Q 002616 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 815 (900)
Q Consensus 740 ~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~fs 815 (900)
.+| ..++.++.+||++||..||.+||++ ....+++.||||+.++|..+... .+|+.|......+.++|+..|.
T Consensus 214 ~~~---~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (318)
T cd05570 214 RYP---RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFT 290 (318)
T ss_pred CCC---CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCchhc
Confidence 555 6789999999999999999999993 22389999999999999877654 6788888888888888877654
Q ss_pred cCC
Q 002616 816 QIS 818 (900)
Q Consensus 816 ~~~ 818 (900)
...
T Consensus 291 ~~~ 293 (318)
T cd05570 291 KEK 293 (318)
T ss_pred cCc
Confidence 443
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-50 Score=434.57 Aligned_cols=286 Identities=42% Similarity=0.773 Sum_probs=248.8
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 503 LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L---~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
||+|+||+||+|+++.+|+.||+|++.+...........+..|..++... .||||+++++.|...+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999875554555566677788888765 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 580 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 580 GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~------------ 148 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT------------ 148 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC------------
Confidence 99999999888999999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCC
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 738 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~ 738 (900)
........+||+.|||||++.+. .++.++|||||||++|||++|+.||.+.+..+++..+..+.
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~ 213 (330)
T cd05586 149 ---------------DNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK 213 (330)
T ss_pred ---------------CCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC
Confidence 01123456899999999999764 58999999999999999999999999999889998888877
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCcCCCCCh-hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccccccccc
Q 002616 739 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 815 (900)
Q Consensus 739 l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa-~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~fs 815 (900)
..+|. ..+++++.+||++||+.||.+||++ ..+.++++||||+.++|+.+... .+++.|......+.++|+..|.
T Consensus 214 ~~~~~--~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (330)
T cd05586 214 VRFPK--NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPIVDSDEDVSNFDPEFT 291 (330)
T ss_pred CCCCC--ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCccCCCCCCcchhhcCcccc
Confidence 77663 4689999999999999999999974 35899999999999999987655 6788888888888888876544
Q ss_pred cC
Q 002616 816 QI 817 (900)
Q Consensus 816 ~~ 817 (900)
..
T Consensus 292 ~~ 293 (330)
T cd05586 292 NS 293 (330)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=431.26 Aligned_cols=290 Identities=40% Similarity=0.757 Sum_probs=252.0
Q ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHH---hcCCCceEEEeeeeccCCeeEEE
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI---TVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~---~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
|++++.||+|+||.||+|+++.+|+.||+|++++.........+.+.+|+.++. .++||||++++++|...+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999999999999999998765444556677888877764 56799999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 574 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|||++||+|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~------- 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM------- 152 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCC-------
Confidence 999999999988764 579999999999999999999999999999999999999999999999999986321
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
.........+||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+....
T Consensus 153 --------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~ 212 (324)
T cd05589 153 --------------------GFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS 212 (324)
T ss_pred --------------------CCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 001122356899999999999999999999999999999999999999999998888888
Q ss_pred hhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChh--cHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccc
Q 002616 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSY 809 (900)
Q Consensus 734 Il~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~--~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~ 809 (900)
+......+| ..++.++.+||.+||+.||.+||+.. .+.+++.||||++++|..+... .+|+.|......|.++
T Consensus 213 i~~~~~~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 289 (324)
T cd05589 213 IVNDEVRYP---RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSN 289 (324)
T ss_pred HHhCCCCCC---CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCCCcchhhh
Confidence 888776655 67899999999999999999999732 4899999999999999987654 5788888888888888
Q ss_pred cccccccC
Q 002616 810 FLSRFSQI 817 (900)
Q Consensus 810 fd~~fs~~ 817 (900)
|...+...
T Consensus 290 ~~~~~~~~ 297 (324)
T cd05589 290 FDEEFTSE 297 (324)
T ss_pred cCcccccc
Confidence 76654443
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=430.09 Aligned_cols=291 Identities=44% Similarity=0.806 Sum_probs=249.8
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++++.||+|+||+||+++.+.+++.||+|++.+...........+.+|+.++..++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999998755555566777899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 575 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 575 Ey~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~----- 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD----- 155 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC-----
Confidence 99999999999976 457999999999999999999999999999999999999999999999999998642110
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-----CCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTAESPE 728 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ 728 (900)
........+||+.|||||++.+ ..++.++|||||||++|||++|+.||.+.+..
T Consensus 156 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~ 214 (331)
T cd05597 156 ---------------------GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred ---------------------CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH
Confidence 0011123579999999999973 45788999999999999999999999999888
Q ss_pred HHHHhhhcCC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhccCCccCCCCCCCC
Q 002616 729 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDD 806 (900)
Q Consensus 729 ei~~kIl~~~--l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~~ppf~P~~~s~~D 806 (900)
+.+..+.... ..+|.....+++++++||++||+. |.+|++...+.+++.||||++++|..+....+++.|...+..+
T Consensus 215 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~-~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (331)
T cd05597 215 ETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLGRNGLQDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTD 293 (331)
T ss_pred HHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccC-cccccCCCCHHHHhcCCCCCCCCHHHHhhCCCCccCcCCCcch
Confidence 8888887643 344443456899999999999985 5565544449999999999999999998888889998888888
Q ss_pred cccccc
Q 002616 807 TSYFLS 812 (900)
Q Consensus 807 ~s~fd~ 812 (900)
+++|+.
T Consensus 294 ~~~~~~ 299 (331)
T cd05597 294 TSNFDV 299 (331)
T ss_pred hhhcCC
Confidence 777754
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-49 Score=439.39 Aligned_cols=291 Identities=41% Similarity=0.709 Sum_probs=249.8
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 570 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~L 570 (900)
.+..++|++.+.||+|+||.||+|+++.+|+.||+|++++...........+.+|+.++..++||||+++++++.+.+.+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~ 118 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL 118 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 35678999999999999999999999999999999999875555555567788999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
|+||||++||+|.+++.+ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~--- 194 (370)
T cd05596 119 YMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA--- 194 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC---
Confidence 999999999999998865 4589999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC----CCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~----~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
.........+||+.|||||++.+. .++.++|||||||++|||++|.+||.+.+
T Consensus 195 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 195 -----------------------NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred -----------------------CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 001122346799999999999754 37889999999999999999999999999
Q ss_pred hHHHHHhhhcCC--CCCCCCCCCCCHHHHHHHHHhccCCcCC--CCChhcHHHHHcCCCCCCCCcchh--hhccCCccCC
Q 002616 727 PEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQ--RLGANGAAEVKAHPFFKGVNWDSL--ALQKAVFVPQ 800 (900)
Q Consensus 727 ~~ei~~kIl~~~--l~~P~ip~~lS~eakDLIk~cL~~DP~k--RpSa~~a~EIL~HPFFk~idw~~L--~~~~ppf~P~ 800 (900)
....+.+|.... +.+|. ...+|.++++||++||+.+|.+ |++ +.++++||||++.+|... ....+|+.|.
T Consensus 252 ~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~~~p~r~~R~s---~~ell~h~~~~~~~~~~~~~~~~~~~~~p~ 327 (370)
T cd05596 252 LVGTYSKIMDHKNSLTFPD-DIEISKQAKDLICAFLTDREVRLGRNG---VDEIKSHPFFKNDQWTFDNIRETVAPVVPE 327 (370)
T ss_pred HHHHHHHHHcCCCcCCCCC-cCCCCHHHHHHHHHHccChhhccCCCC---HHHHhcCcccCCCChhhHHhcCCCcCccCc
Confidence 888888887654 34442 2358999999999999988987 888 889999999999888754 3346788898
Q ss_pred CCCCCCcccccc
Q 002616 801 PESVDDTSYFLS 812 (900)
Q Consensus 801 ~~s~~D~s~fd~ 812 (900)
.....+..+|+.
T Consensus 328 ~~~~~~~~~~~~ 339 (370)
T cd05596 328 LSSDIDTSNFDD 339 (370)
T ss_pred CCCcchhhhcCC
Confidence 888888877764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=422.32 Aligned_cols=275 Identities=33% Similarity=0.615 Sum_probs=236.4
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
.|++.+.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.++..++||||++++++|.+.+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 48899999999999999999999999999999987554444455678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 576 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 576 y~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~------ 154 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE------ 154 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC------
Confidence 99999999887643 3589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH----H
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE----I 729 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~----e 729 (900)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||...+.. .
T Consensus 155 ----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05631 155 ----------------------GETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE 212 (285)
T ss_pred ----------------------CCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH
Confidence 11123457999999999999999999999999999999999999999876542 2
Q ss_pred HHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhhc--cCCccCCC
Q 002616 730 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 801 (900)
Q Consensus 730 i~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~ 801 (900)
+...+......+ +..++.++.+||++||+.||.+||+. ..+.++++||||++++|+.+... +|||+|.+
T Consensus 213 ~~~~~~~~~~~~---~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05631 213 VDRRVKEDQEEY---SEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPDP 285 (285)
T ss_pred HHHHhhcccccC---CccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCcCCcCCCCCC
Confidence 333333333333 36789999999999999999999984 35899999999999999999887 78999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=428.83 Aligned_cols=286 Identities=40% Similarity=0.781 Sum_probs=247.3
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~-IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
+.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+. +++.++||||+++++.|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999998755444445556666665 57889999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 580 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 580 GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
|+|..++.+...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~------------ 148 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE------------ 148 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCC
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l 739 (900)
........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+...++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 213 (321)
T cd05603 149 ---------------PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPL 213 (321)
T ss_pred ---------------CCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCC
Confidence 01122346799999999999999999999999999999999999999999998888888887766
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCh-hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccccc
Q 002616 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 816 (900)
Q Consensus 740 ~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa-~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~fs~ 816 (900)
.+| ...+.++.+||.+||+.||.+||++ ..+.++++||||..++|..+... .+++.|......+...|+..++.
T Consensus 214 ~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (321)
T cd05603 214 QLP---GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQ 290 (321)
T ss_pred CCC---CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCCcccc
Confidence 555 6789999999999999999999984 45789999999999999987654 56777777777777777665443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-49 Score=428.19 Aligned_cols=290 Identities=42% Similarity=0.779 Sum_probs=248.8
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++.+.||+|+||+||+++++.+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998755555555667889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 575 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 575 Ey~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~----- 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED----- 155 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-----
Confidence 99999999999987 467999999999999999999999999999999999999999999999999998642100
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 728 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ 728 (900)
........+||+.|||||++. ...++.++|||||||++|||++|+.||...+..
T Consensus 156 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~ 214 (332)
T cd05623 156 ---------------------GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (332)
T ss_pred ---------------------CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH
Confidence 011123357999999999986 346889999999999999999999999999999
Q ss_pred HHHHhhhcCC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhccCCccCCCCCCCC
Q 002616 729 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDD 806 (900)
Q Consensus 729 ei~~kIl~~~--l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~~ppf~P~~~s~~D 806 (900)
+.+.++.... ..+|.....+++++++||++||+.++ +|++...+.++++||||.+++|+.+....+|+.|...++.+
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~-~r~~r~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~ 293 (332)
T cd05623 215 ETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSRE-HRLGQNGIEDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTD 293 (332)
T ss_pred HHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChh-hhcCCCCHHHHhCCCCcCCCCHHHHhhCCCCccCCCCCCcc
Confidence 9998887754 34454445789999999999998644 45443348999999999999999998888889988877777
Q ss_pred ccccc
Q 002616 807 TSYFL 811 (900)
Q Consensus 807 ~s~fd 811 (900)
.+++.
T Consensus 294 ~~~~~ 298 (332)
T cd05623 294 TSNFD 298 (332)
T ss_pred cccCC
Confidence 76653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=430.02 Aligned_cols=285 Identities=46% Similarity=0.849 Sum_probs=244.9
Q ss_pred EEeccCCceEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 002616 501 KPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMI-RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 576 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k---~tGk~VAIKiLkK~~~~-~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy 576 (900)
+.||+|+||.||+|++. .+++.||+|++++.... .......+.+|+.+|+.++||||++++++|..++.+|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 67999999999999874 57899999999865432 223456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCC
Q 002616 577 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 656 (900)
Q Consensus 577 ~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~ 656 (900)
++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--------- 152 (323)
T cd05584 82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--------- 152 (323)
T ss_pred CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc---------
Confidence 99999999999888899999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhc
Q 002616 657 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 736 (900)
Q Consensus 657 ~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~ 736 (900)
........+||+.|+|||++.+..++.++|||||||++|||++|++||...+.......+..
T Consensus 153 ------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~ 214 (323)
T cd05584 153 ------------------EGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK 214 (323)
T ss_pred ------------------CCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 01122346799999999999999999999999999999999999999999998888888888
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC--hhcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccc
Q 002616 737 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLS 812 (900)
Q Consensus 737 ~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpS--a~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~ 812 (900)
+...+| ..+++++.+||.+||++||.+||+ ...+.+++.||||+..+|..+... .+++.+...+..+.+.|+.
T Consensus 215 ~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (323)
T cd05584 215 GKLNLP---PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDS 291 (323)
T ss_pred CCCCCC---CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCCcCCCCCCcchhhhcCc
Confidence 776555 688999999999999999999994 234889999999999999887654 5667776666666666665
Q ss_pred ccc
Q 002616 813 RFS 815 (900)
Q Consensus 813 ~fs 815 (900)
.++
T Consensus 292 ~~~ 294 (323)
T cd05584 292 KFT 294 (323)
T ss_pred hhc
Confidence 443
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=429.87 Aligned_cols=283 Identities=37% Similarity=0.756 Sum_probs=245.3
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
+.||+|+||.||+|+++.+|+.||+|++++...........+..|..++... +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999999875443344566778888888754 899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 580 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 580 GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
|+|..++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~------------ 148 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF------------ 148 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc------------
Confidence 99999998888899999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCC
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l 739 (900)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~ 213 (316)
T cd05620 149 ---------------GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTP 213 (316)
T ss_pred ---------------CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 01122346799999999999999999999999999999999999999999988888888776654
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccccccccc
Q 002616 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 815 (900)
Q Consensus 740 ~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~fs 815 (900)
.+ +..++.++++||++||..||.+||+. +.+++.||||++++|..+... .+|+.|....+.+.++|+..+.
T Consensus 214 ~~---~~~~~~~~~~li~~~l~~dP~~R~~~--~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (316)
T cd05620 214 HY---PRWITKESKDILEKLFERDPTRRLGV--VGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFL 286 (316)
T ss_pred CC---CCCCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccc
Confidence 44 46789999999999999999999993 247999999999999987654 5788888888888888776543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=445.81 Aligned_cols=262 Identities=39% Similarity=0.683 Sum_probs=238.4
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccch--hHHHHHHHHHHHHHhcC-CCceEEEeeeeccC
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK--NDIERILAERNILITVR-NPFVVRFFYSFTCR 567 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~--~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~ 567 (900)
....+.|.+.+.||.|+||+|++|++..+|..||+|++.+...... ...+.+.+|+.+++.++ ||||++++.++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 3567899999999999999999999999999999998876533211 34566778999999999 99999999999999
Q ss_pred CeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCC-CcEEEEecCCccccc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGL 646 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~-G~VKLsDFGLAk~~~ 646 (900)
..+|+||||+.||+|++++.+.+++.|..++.|++|++.|++|||++||+||||||+|||++.+ +++||+|||++....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999 999999999998521
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCC-C-CccceeechhHHHHHHHhCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-H-GYAADWWSVGIILFEFITGIPPFTA 724 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-y-s~ksDIWSLGVILyEMLtGk~PF~~ 724 (900)
.......+.||||.|+|||++.+.. | +.++||||+||+||.|++|+.||..
T Consensus 173 ---------------------------~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d 225 (370)
T KOG0583|consen 173 ---------------------------GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD 225 (370)
T ss_pred ---------------------------CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 1233567889999999999999988 8 5899999999999999999999999
Q ss_pred CChHHHHHhhhcCCCCCCCCCCCC-CHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 725 ESPEIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 725 ~s~~ei~~kIl~~~l~~P~ip~~l-S~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
.+...++.+|..+.+.+| ..+ |+++++||++||..||.+|++ +.+|+.||||+.-
T Consensus 226 ~~~~~l~~ki~~~~~~~p---~~~~S~~~~~Li~~mL~~~P~~R~t---~~~i~~h~w~~~~ 281 (370)
T KOG0583|consen 226 SNVPNLYRKIRKGEFKIP---SYLLSPEARSLIEKMLVPDPSTRIT---LLEILEHPWFQKE 281 (370)
T ss_pred ccHHHHHHHHhcCCccCC---CCcCCHHHHHHHHHHcCCCcccCCC---HHHHhhChhhccC
Confidence 999999999999998887 667 999999999999999999999 8899999999863
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-49 Score=438.35 Aligned_cols=294 Identities=43% Similarity=0.747 Sum_probs=249.4
Q ss_pred ccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 569 (900)
Q Consensus 490 ~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ 569 (900)
..+..++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+.+|+.++..++||||+++++++.+.+.
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34567899999999999999999999999999999999987555555566778899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 570 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
+|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~-- 194 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK-- 194 (371)
T ss_pred EEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc--
Confidence 99999999999999998654 589999999999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCC----CCccceeechhHHHHHHHhCCCCCCCC
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPFTAE 725 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~----ys~ksDIWSLGVILyEMLtGk~PF~~~ 725 (900)
.........+||+.|||||++.+.. ++.++|||||||++|||++|.+||.+.
T Consensus 195 ------------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~ 250 (371)
T cd05622 195 ------------------------EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD 250 (371)
T ss_pred ------------------------CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence 0011223568999999999997643 788999999999999999999999999
Q ss_pred ChHHHHHhhhcCC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCc--chhhhccCCccCCC
Q 002616 726 SPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW--DSLALQKAVFVPQP 801 (900)
Q Consensus 726 s~~ei~~kIl~~~--l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw--~~L~~~~ppf~P~~ 801 (900)
+....+.+|.... ..+|. +..++.++++||.+||. +|.+|++...+.+|++||||++..| ..+....+|++|..
T Consensus 251 ~~~~~~~~i~~~~~~~~~~~-~~~~s~~~~~li~~~L~-~~~~r~~r~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~ 328 (371)
T cd05622 251 SLVGTYSKIMNHKNSLTFPD-DNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDL 328 (371)
T ss_pred CHHHHHHHHHcCCCcccCCC-cCCCCHHHHHHHHHHcC-ChhhhcCCCCHHHHhcCcccCCCChhHHhcCCCCCCCCCCC
Confidence 9988898888654 34443 34789999999999998 7777766556999999999998655 45555577888887
Q ss_pred CCCCCcccccc
Q 002616 802 ESVDDTSYFLS 812 (900)
Q Consensus 802 ~s~~D~s~fd~ 812 (900)
.+..+.++|+.
T Consensus 329 ~~~~~~~~~~~ 339 (371)
T cd05622 329 SSDIDTSNFDD 339 (371)
T ss_pred CCcchhhhcCC
Confidence 77777766643
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=429.92 Aligned_cols=286 Identities=41% Similarity=0.782 Sum_probs=246.5
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHH-HHHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN-ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~-IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
+.||+|+||+||+|+++.+++.||+|++.+...........+..|.. +++.++||||++++++|...+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999998754443444455565654 46778999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 580 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 580 GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~------------ 148 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE------------ 148 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc------------
Confidence 99999999888899999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCC
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l 739 (900)
........+||+.|||||++.+..++.++|||||||++|||++|.+||.+.+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 213 (325)
T cd05602 149 ---------------HNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL 213 (325)
T ss_pred ---------------CCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc
Confidence 01123356799999999999999999999999999999999999999999999898888887765
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCh-hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccccccccc
Q 002616 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQ 816 (900)
Q Consensus 740 ~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa-~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~fs~ 816 (900)
.++ ..++.++.+||.+||++||.+|+++ +...++++|+||..++|+.+... .+++.|....+.+...|+..++.
T Consensus 214 ~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (325)
T cd05602 214 QLK---PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTE 290 (325)
T ss_pred CCC---CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCCCcchhhhcCCcccc
Confidence 544 6789999999999999999999995 35779999999999999998654 56778887777777777665443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-49 Score=428.58 Aligned_cols=291 Identities=42% Similarity=0.755 Sum_probs=250.1
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++.+.||+|+||+||+++++.+++.||+|++.+...........+.+|+.++..++||||++++++|.+.+.+|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999998755545556677889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 575 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 575 Ey~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
||++||+|.+++.+ ...+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~----- 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD----- 155 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC-----
Confidence 99999999999987 467999999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-----CCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTAESPE 728 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ 728 (900)
........+||+.|||||++.+ ..++.++|||||||++|||++|+.||...+..
T Consensus 156 ---------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~ 214 (331)
T cd05624 156 ---------------------GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV 214 (331)
T ss_pred ---------------------CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH
Confidence 0011123579999999999976 46788999999999999999999999999888
Q ss_pred HHHHhhhcCC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhccCCccCCCCCCCC
Q 002616 729 IIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDD 806 (900)
Q Consensus 729 ei~~kIl~~~--l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~~ppf~P~~~s~~D 806 (900)
+.+.++.... .++|.....++.++++||.+||+.+ .+|++...+.++++||||++++|+.+....+|+.|....+.+
T Consensus 215 ~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~-~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~p~~~~~~~ 293 (331)
T cd05624 215 ETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSR-ERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSD 293 (331)
T ss_pred HHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCc-hhhcCCCCHHHHhcCCCcCCCCHHHHhhCCCCccCCCCCcch
Confidence 8888887654 3444434567999999999999954 466655568999999999999999998878899998877777
Q ss_pred cccccc
Q 002616 807 TSYFLS 812 (900)
Q Consensus 807 ~s~fd~ 812 (900)
.++|+.
T Consensus 294 ~~~~~~ 299 (331)
T cd05624 294 TSNFDV 299 (331)
T ss_pred hhhcCC
Confidence 776654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=431.09 Aligned_cols=287 Identities=42% Similarity=0.767 Sum_probs=253.1
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 580 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GG 580 (900)
+.||+|+||.||+|+++.+|+.||+|++++...........+.+|+.++..++||||++++++|...+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765555556778889999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhh-cCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 581 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 581 sL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
+|..++.+...+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~------------ 148 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK------------ 148 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC------------
Confidence 999999888889999999999999999999997 7999999999999999999999999999874210
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCC
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l 739 (900)
........+||+.|||||++.+..++.++|||||||++|||++|..||.+.+.......+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~ 213 (325)
T cd05594 149 ---------------DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 213 (325)
T ss_pred ---------------CCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCC
Confidence 01112345799999999999999999999999999999999999999999888888888887776
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccccccccc
Q 002616 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFS 815 (900)
Q Consensus 740 ~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~fs 815 (900)
.+| ..+++++.+||++||++||.+|++. ..+.++++||||+++.|...... .+|+.|...+..++.+|+..+.
T Consensus 214 ~~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (325)
T cd05594 214 RFP---RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFT 290 (325)
T ss_pred CCC---CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCCCcchhhhcCchhh
Confidence 665 6789999999999999999999842 24889999999999999987654 5788888888888888887765
Q ss_pred cC
Q 002616 816 QI 817 (900)
Q Consensus 816 ~~ 817 (900)
..
T Consensus 291 ~~ 292 (325)
T cd05594 291 AQ 292 (325)
T ss_pred cC
Confidence 54
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=424.24 Aligned_cols=289 Identities=45% Similarity=0.822 Sum_probs=243.7
Q ss_pred CeEEEEEeccCCceEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCee
Q 002616 496 DFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMI-RKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 570 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k---~tGk~VAIKiLkK~~~~-~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~L 570 (900)
+|++++.||+|+||.||+|+.. .+|+.||+|++++.... .....+.+.+|+.+|..++ ||||++++++|...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 57899999999764432 2334567889999999995 99999999999999999
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
|+||||++||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~--- 157 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS--- 157 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccc---
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCC----
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE---- 725 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~PF~~~---- 725 (900)
.........+||+.|||||++.+. .++.++|||||||++|||++|..||...
T Consensus 158 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 214 (332)
T cd05614 158 -----------------------EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN 214 (332)
T ss_pred -----------------------cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC
Confidence 011123356899999999999875 4789999999999999999999999643
Q ss_pred ChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChh--cHHHHHcCCCCCCCCcchhhhc--cCCccCCC
Q 002616 726 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 801 (900)
Q Consensus 726 s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~--~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~ 801 (900)
....+...+......+ +..+++.+.+||.+||..||++||++. .+.++++||||++++|..+... .+++.|..
T Consensus 215 ~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~ 291 (332)
T cd05614 215 TQSEVSRRILKCDPPF---PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSI 291 (332)
T ss_pred CHHHHHHHHhcCCCCC---CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 2344555555554443 467899999999999999999999754 6999999999999999987654 67788887
Q ss_pred CCCCCccccccc
Q 002616 802 ESVDDTSYFLSR 813 (900)
Q Consensus 802 ~s~~D~s~fd~~ 813 (900)
....+...|...
T Consensus 292 ~~~~~~~~~~~~ 303 (332)
T cd05614 292 RNELDVGNFAEE 303 (332)
T ss_pred CCcchhhhcCcc
Confidence 777777766554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=424.27 Aligned_cols=285 Identities=38% Similarity=0.754 Sum_probs=247.8
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~-L~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
+.||+|+||+||+|+++.+++.||+|++++...........+..|..++.. ++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999987543334455667778888876 4899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 580 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 580 GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
|+|..++.....+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~------------ 148 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML------------ 148 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC------------
Confidence 99999998888899999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCC
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l 739 (900)
........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+++..+.....
T Consensus 149 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~ 213 (316)
T cd05619 149 ---------------GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNP 213 (316)
T ss_pred ---------------CCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 01122346799999999999999999999999999999999999999999988888888766554
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccccccccccC
Q 002616 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQI 817 (900)
Q Consensus 740 ~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~fs~~ 817 (900)
.+| ..++.++++||.+||++||.+||++. .+++.||||+.++|..+... .+++.|...+..+.++|+..+.+.
T Consensus 214 ~~~---~~~~~~~~~li~~~l~~~P~~R~~~~--~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (316)
T cd05619 214 CYP---RWLTREAKDILVKLFVREPERRLGVK--GDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNE 288 (316)
T ss_pred CCC---ccCCHHHHHHHHHHhccCHhhcCCCh--HHHHcCcccCCCCHHHHHhCCCCCCcCCCCCCccchhhcChhhhcC
Confidence 433 67899999999999999999999932 38999999999999987654 688999999999999998875544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-49 Score=423.80 Aligned_cols=282 Identities=43% Similarity=0.785 Sum_probs=244.6
Q ss_pred EEeccCCceEEEEEEE---CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeec
Q 002616 501 KPISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 577 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~---k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~ 577 (900)
+.||+|+||.||++++ +.+|+.||+|++++... .......+.+|+.+|.+++||||++++++|.+.+.+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATL-KVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHh-hhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999986 35789999999976432 2334556788999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCC
Q 002616 578 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 657 (900)
Q Consensus 578 ~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~ 657 (900)
++|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~----------- 149 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI----------- 149 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccC-----------
Confidence 999999999888889999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcC
Q 002616 658 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 737 (900)
Q Consensus 658 ~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~ 737 (900)
.........+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+...
T Consensus 150 ----------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~ 213 (318)
T cd05582 150 ----------------DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA 213 (318)
T ss_pred ----------------CCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC
Confidence 0111234568999999999999999999999999999999999999999999988888888877
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhc--HHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccccccc
Q 002616 738 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG--AAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSR 813 (900)
Q Consensus 738 ~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~--a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~ 813 (900)
...+| ..+++++.+||++||+.||.+||++.+ +.+++.||||+.++|..+... .+++.|......+..++++.
T Consensus 214 ~~~~p---~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (318)
T cd05582 214 KLGMP---QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDPE 290 (318)
T ss_pred CCCCC---CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCcCCCCCCcchhhhcCcc
Confidence 76655 678999999999999999999999766 899999999999999987654 56677766665665555544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-49 Score=446.65 Aligned_cols=260 Identities=34% Similarity=0.631 Sum_probs=243.7
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
...-|++.+.||+|+-|.|.+|++..||+..|||++.+...........+.+|+-||+.+.||||+.||+.+.+..++|+
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lyl 89 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYL 89 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEE
Confidence 45668999999999999999999999999999999998765666677889999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 573 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
|.||++||.|++++.+.|++++.++..|++||+.|+.|+|..+|+||||||+|+|||..++|||+|||+|.+-
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe------- 162 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE------- 162 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc-------
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999741
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~ 731 (900)
.++....+.||+|.|.|||++.|.+| +.++||||.|||||.||+|+.||.+.+...++
T Consensus 163 ---------------------~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LL 221 (786)
T KOG0588|consen 163 ---------------------VPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLL 221 (786)
T ss_pred ---------------------cCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHH
Confidence 23445678899999999999999998 68999999999999999999999999999999
Q ss_pred HhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 002616 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786 (900)
Q Consensus 732 ~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~id 786 (900)
.++..+.+.+| ..+|.++++||.+||.+||.+|+| .++|++|||+.+..
T Consensus 222 lKV~~G~f~MP---s~Is~eaQdLLr~ml~VDp~~RiT---~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 222 LKVQRGVFEMP---SNISSEAQDLLRRMLDVDPSTRIT---TEEILKHPFLSGYT 270 (786)
T ss_pred HHHHcCcccCC---CcCCHHHHHHHHHHhccCcccccc---HHHHhhCchhhcCC
Confidence 99999999888 899999999999999999999999 88999999998754
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-49 Score=439.15 Aligned_cols=256 Identities=36% Similarity=0.631 Sum_probs=237.7
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
+++|.+.+.||+|+||.||+|+.+.|.+.||||.+.|... .+.+...+.+|++|++.++|||||.++++|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 3688999999999999999999999999999999987553 345688899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 574 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
+||+.| +|+.+|...+.++|+.++.++.+++.||.|||+++|+|||+||.||||+.+|++|+||||+|+....+
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~----- 153 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN----- 153 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-----
Confidence 999987 99999999999999999999999999999999999999999999999999999999999999964321
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
.....+..|||.|||||++.+++|+..+|+||||||+|||++|+|||...+..++.+.
T Consensus 154 ----------------------t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~ 211 (808)
T KOG0597|consen 154 ----------------------TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKS 211 (808)
T ss_pred ----------------------ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHH
Confidence 1234557899999999999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 734 Il~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
|+.....+| ..+|.++..|++.+|.+||.+|++ -.+++.|||.++
T Consensus 212 I~~d~v~~p---~~~S~~f~nfl~gLL~kdP~~Rlt---W~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 212 ILKDPVKPP---STASSSFVNFLQGLLIKDPAQRLT---WTDLLGHPFWKG 256 (808)
T ss_pred HhcCCCCCc---ccccHHHHHHHHHHhhcChhhccc---HHHHhcChHHhh
Confidence 999998887 689999999999999999999999 668999999986
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=403.73 Aligned_cols=262 Identities=35% Similarity=0.664 Sum_probs=245.5
Q ss_pred ccccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 488 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 488 ~~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
.....++++|++.+.||+|-||.||+|+.+.++..||+|++.|..+........+.+|++|.+.++||||+++|++|.+.
T Consensus 15 ~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 15 ATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 34567899999999999999999999999999999999999998887777778899999999999999999999999999
Q ss_pred CeeEEEEeecCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccc
Q 002616 568 DNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~--k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~ 645 (900)
..+|+++||.++|+|+..|. ....|++..+..|++|++.||.|+|..+||||||||+|+|++..|.+||+|||-+...
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 99999999999999999999 6678999999999999999999999999999999999999999999999999988641
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002616 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 725 (900)
Q Consensus 646 ~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~ 725 (900)
+.....+.|||..|.+||+..+..++..+|+|++|++.||+++|.+||...
T Consensus 175 -----------------------------p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~ 225 (281)
T KOG0580|consen 175 -----------------------------PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQ 225 (281)
T ss_pred -----------------------------CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhh
Confidence 123456789999999999999999999999999999999999999999999
Q ss_pred ChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 726 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 726 s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
+..++|++|....+.+| ..++.+++|||.+||.++|.+|+. ..+++.|||...
T Consensus 226 ~~~etYkrI~k~~~~~p---~~is~~a~dlI~~ll~~~p~~r~~---l~~v~~hpwI~a 278 (281)
T KOG0580|consen 226 SHSETYKRIRKVDLKFP---STISGGAADLISRLLVKNPIERLA---LTEVMDHPWIVA 278 (281)
T ss_pred hhHHHHHHHHHccccCC---cccChhHHHHHHHHhccCcccccc---HHHHhhhHHHHh
Confidence 99999999999998888 799999999999999999999999 889999999753
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=400.07 Aligned_cols=275 Identities=34% Similarity=0.613 Sum_probs=233.5
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
.|++.+.||+|+||+||++.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+...+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999976544444445667889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 576 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 576 y~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++++++.++|+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~------ 154 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE------ 154 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC------
Confidence 99999999888654 3589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH--
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF-- 731 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~-- 731 (900)
.......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+.....
T Consensus 155 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~ 212 (285)
T cd05605 155 ----------------------GETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE 212 (285)
T ss_pred ----------------------CCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH
Confidence 01112457999999999999989999999999999999999999999887654332
Q ss_pred --HhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChh--cHHHHHcCCCCCCCCcchhhhc--cCCccCCC
Q 002616 732 --DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 801 (900)
Q Consensus 732 --~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~--~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~ 801 (900)
..+...... .+..++..+.+||.+||..||.+||+.. .+.+++.||||...+|..+... .|||.|.|
T Consensus 213 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05605 213 VERRVKEDQEE---YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPFCPDP 285 (285)
T ss_pred HHHHhhhcccc---cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCCCCCCCCCCC
Confidence 223222222 3367899999999999999999999533 4889999999999999988765 56787753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=400.35 Aligned_cols=267 Identities=33% Similarity=0.631 Sum_probs=226.5
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCCh
Q 002616 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 582 (900)
Q Consensus 503 LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GGsL 582 (900)
||+|+||+||+|.++.+|+.||+|++.+.........+.+..|+.+++.++||||++++++|.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999875554445567788999999999999999999999999999999999999999
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCC
Q 002616 583 YSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 658 (900)
Q Consensus 583 ~dlL~k----~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~ 658 (900)
..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~----------- 149 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKD----------- 149 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCC-----------
Confidence 888743 34689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh----HHHHHhh
Q 002616 659 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDNI 734 (900)
Q Consensus 659 ~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~----~ei~~kI 734 (900)
.........||+.|+|||++.+..++.++|+|||||++|||++|+.||..... ......+
T Consensus 150 ----------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 213 (280)
T cd05608 150 ----------------GQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI 213 (280)
T ss_pred ----------------CCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh
Confidence 01112345799999999999999999999999999999999999999986543 3334444
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChh--cHHHHHcCCCCCCCCcchhhhc--cCCccC
Q 002616 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVP 799 (900)
Q Consensus 735 l~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~--~a~EIL~HPFFk~idw~~L~~~--~ppf~P 799 (900)
......+ +..+++++.+|+.+||+.||.+||++. .+.++++||||++++|..+... .+||.|
T Consensus 214 ~~~~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~ 279 (280)
T cd05608 214 LNDSVTY---PDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVP 279 (280)
T ss_pred cccCCCC---cccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCCCCCC
Confidence 4444333 367899999999999999999999742 4889999999999999988654 455554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=398.16 Aligned_cols=305 Identities=51% Similarity=0.891 Sum_probs=260.2
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++++.||+|+||.||++.++.+++.||+|.+.+...........+.+|++++..++||||+++++.+...+.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654444455678889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.........+.
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998743211110000
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhh
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kI 734 (900)
. .... ............|++.|+|||.+.+..++.++|+|||||++|||++|..||.+.++.+....+
T Consensus 161 ~----~~~~--------~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~ 228 (305)
T cd05609 161 E----GHIE--------KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV 228 (305)
T ss_pred c----cccc--------cchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0 0000 000011122356899999999999889999999999999999999999999998888888888
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhccCCccCCCCCCCCccccc
Q 002616 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFL 811 (900)
Q Consensus 735 l~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~~ppf~P~~~s~~D~s~fd 811 (900)
......+|..+..++.++.+||.+||..||++||+...+.++++||||.+.+|..+......++|.+....+.+||+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (305)
T cd05609 229 ISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFIPQLESEDDTSYFD 305 (305)
T ss_pred HhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhcCCCCCCCCCCccccccCC
Confidence 87776666555578999999999999999999999888999999999999999998877888899998888888764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=423.05 Aligned_cols=270 Identities=36% Similarity=0.657 Sum_probs=231.4
Q ss_pred ccccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccc-----------hhHHHHHHHHHHHHHhcCCCc
Q 002616 488 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-----------KNDIERILAERNILITVRNPF 556 (900)
Q Consensus 488 ~~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~-----------~~~~e~~l~Ei~IL~~L~HPn 556 (900)
...+..+++|++++.||+|.||.|.+|++..+++.||||++.|..... ...++.+++|+.||+++.|||
T Consensus 90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~n 169 (576)
T KOG0585|consen 90 DQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPN 169 (576)
T ss_pred cccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcC
Confidence 455678999999999999999999999999999999999998754322 123578999999999999999
Q ss_pred eEEEeeeeccCC--eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcE
Q 002616 557 VVRFFYSFTCRD--NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHI 634 (900)
Q Consensus 557 IVkL~~~f~d~~--~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~V 634 (900)
||+|+.+..+.. .+|||+|||..|.+...=-...-+++.+|+.|+++++.||+|||.+|||||||||+|+||+.+|+|
T Consensus 170 VV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 170 VVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred eeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 999999998764 699999999999886543322238999999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC---C-CCccceeechhH
Q 002616 635 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---E-HGYAADWWSVGI 710 (900)
Q Consensus 635 KLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~---~-ys~ksDIWSLGV 710 (900)
||+|||.+....... ...........+|||.|||||...+. . .+++.||||+||
T Consensus 250 KIsDFGVs~~~~~~~----------------------~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGV 307 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGS----------------------DEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGV 307 (576)
T ss_pred EeeccceeeecccCC----------------------ccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhh
Confidence 999999887432110 00111122337999999999999873 2 367999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCC
Q 002616 711 ILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 711 ILyEMLtGk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk 783 (900)
+||.|+.|+.||-+....+++.+|++..+.||.. +.+.++++|||.+||++||++|++ +.+|+.|||..
T Consensus 308 TLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~-pe~~e~~kDli~~lL~KdP~~Ri~---l~~ik~Hpwvt 376 (576)
T KOG0585|consen 308 TLYCLLFGQLPFFDDFELELFDKIVNDPLEFPEN-PEINEDLKDLIKRLLEKDPEQRIT---LPDIKLHPWVT 376 (576)
T ss_pred hHHHhhhccCCcccchHHHHHHHHhcCcccCCCc-ccccHHHHHHHHHHhhcChhheee---hhhheecceec
Confidence 9999999999999999999999999999999964 368999999999999999999999 88999999975
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=415.39 Aligned_cols=261 Identities=35% Similarity=0.600 Sum_probs=223.2
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC--eeE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--NLY 571 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~--~Ly 571 (900)
..++...+.||+|+||.||++.++++|..+|+|.+.... ....+.+.+|+.+|.+++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 456888999999999999999999999999999886542 122677899999999999999999999865555 699
Q ss_pred EEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecC-CCcEEEEecCCcccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~-~G~VKLsDFGLAk~~~~~~ 649 (900)
++|||++||+|.+++.+.+ .|++..++.|++||+.||+|||++|||||||||+||||+. +|.+||+|||+++....
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~-- 170 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES-- 170 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc--
Confidence 9999999999999999887 7999999999999999999999999999999999999999 79999999999885310
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCC-CCh
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTA-ESP 727 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~PF~~-~s~ 727 (900)
............|||.|||||++.+. ..++++|||||||++.||+||.+||.. ...
T Consensus 171 ----------------------~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~ 228 (313)
T KOG0198|consen 171 ----------------------KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE 228 (313)
T ss_pred ----------------------ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch
Confidence 00112234567899999999999962 234599999999999999999999988 455
Q ss_pred HHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 728 ~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
.+..-+|.... ..|.+|..+|+++++||.+||.+||.+||| |.++|.|||.+..
T Consensus 229 ~~~~~~ig~~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpt---a~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 229 AEALLLIGRED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPT---AEELLEHPFLKQN 282 (313)
T ss_pred HHHHHHHhccC-CCCCCCcccCHHHHHHHHHHhhcCcccCcC---HHHHhhChhhhcc
Confidence 55555555554 446788999999999999999999999999 8899999999753
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=394.56 Aligned_cols=284 Identities=48% Similarity=0.874 Sum_probs=252.7
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++.+.||+|+||.||++.+..+++.||+|++++...........+.+|+++++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765555566788999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||+|.|||++.+|.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~-------- 152 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK-------- 152 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccC--------
Confidence 999999999999988899999999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhh
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kI 734 (900)
......+|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+
T Consensus 153 ----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 210 (290)
T cd05580 153 ----------------------GRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKI 210 (290)
T ss_pred ----------------------CCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0123457899999999999888999999999999999999999999988888888888
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCcccc
Q 002616 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYF 810 (900)
Q Consensus 735 l~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~f 810 (900)
..+...+| ..++..++++|.+||+.||.+|++. ..+.++++||||+.++|..+... .+|+.|......+.+.|
T Consensus 211 ~~~~~~~~---~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (290)
T cd05580 211 LEGKVRFP---SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNF 287 (290)
T ss_pred hcCCccCC---ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCCCccCCCCCccccccc
Confidence 77665554 6789999999999999999999952 25899999999999999988655 67788877776676666
Q ss_pred c
Q 002616 811 L 811 (900)
Q Consensus 811 d 811 (900)
+
T Consensus 288 ~ 288 (290)
T cd05580 288 D 288 (290)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-48 Score=408.81 Aligned_cols=250 Identities=30% Similarity=0.549 Sum_probs=225.5
Q ss_pred ccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEee-eeccCC
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY-SFTCRD 568 (900)
Q Consensus 490 ~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~-~f~d~~ 568 (900)
...+..+|+++++||+|+||+||++++..+|..+|.|.+. -.+......+.+..|+.+|++++|||||++|+ .|...+
T Consensus 14 ~~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~ 92 (375)
T KOG0591|consen 14 PQKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN 92 (375)
T ss_pred CcccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence 3456789999999999999999999999999999999997 55667778889999999999999999999998 676666
Q ss_pred e-eEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHhhhh--cC--eEeccCCCCcEEecCCCcEEEEec
Q 002616 569 N-LYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHS--LG--IVHRDLKPDNLLIAHDGHIKLTDF 639 (900)
Q Consensus 569 ~-LyLVmEy~~GGsL~dlL~k----~g~Lse~~ar~ya~QIl~AL~yLHs--~g--IIHRDLKPeNILLd~~G~VKLsDF 639 (900)
. ++||||||.+|||..+++. ...++|..++.|+.|++.||.++|+ .. |+||||||.||+|+.+|.|||+||
T Consensus 93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf 172 (375)
T KOG0591|consen 93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF 172 (375)
T ss_pred hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence 5 9999999999999998863 3469999999999999999999998 44 999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCC
Q 002616 640 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 719 (900)
Q Consensus 640 GLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk 719 (900)
||++++. .....+.+.||||.||+||.+.+.+|++++||||+||++|||+.-.
T Consensus 173 GL~r~l~---------------------------s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~ 225 (375)
T KOG0591|consen 173 GLGRFLS---------------------------SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQ 225 (375)
T ss_pred hhHhHhc---------------------------chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcC
Confidence 9999643 1223467789999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCCC-CCCCHHHHHHHHHhccCCcCCCCC
Q 002616 720 PPFTAESPEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLG 769 (900)
Q Consensus 720 ~PF~~~s~~ei~~kIl~~~l~~P~ip-~~lS~eakDLIk~cL~~DP~kRpS 769 (900)
+||.+.+-.++.++|.++.+ |.+| ...|.++..||..|+..||+.||+
T Consensus 226 ~PF~g~n~~~L~~KI~qgd~--~~~p~~~YS~~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 226 SPFYGDNLLSLCKKIEQGDY--PPLPDEHYSTDLRELINMCIAVDPEQRPD 274 (375)
T ss_pred CCcccccHHHHHHHHHcCCC--CCCcHHHhhhHHHHHHHHHccCCcccCCC
Confidence 99999999999999999865 4445 678999999999999999999998
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-46 Score=393.26 Aligned_cols=267 Identities=33% Similarity=0.597 Sum_probs=224.9
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCCh
Q 002616 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 582 (900)
Q Consensus 503 LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GGsL 582 (900)
||+|+||.||+++.+.+|+.||+|.+.+...........+..|++++..++||||+++++.|.....+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765444334455667799999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCC
Q 002616 583 YSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 660 (900)
Q Consensus 583 ~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~ 660 (900)
.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~------------- 147 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD------------- 147 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC-------------
Confidence 98886543 488899999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh----HHHHHhhhc
Q 002616 661 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDNILN 736 (900)
Q Consensus 661 ~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~----~ei~~kIl~ 736 (900)
........||+.|+|||++.+..++.++|+|||||++|||++|+.||..... .++...+..
T Consensus 148 ---------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 212 (277)
T cd05607 148 ---------------GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLE 212 (277)
T ss_pred ---------------CceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhc
Confidence 0111234689999999999998899999999999999999999999976432 344445544
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChh-cHHHHHcCCCCCCCCcchhhhc--cCCccC
Q 002616 737 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVKAHPFFKGVNWDSLALQ--KAVFVP 799 (900)
Q Consensus 737 ~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~-~a~EIL~HPFFk~idw~~L~~~--~ppf~P 799 (900)
....++ ...+++++.+||.+||++||.+||++. ...+++.||||++++|..+... .+||+|
T Consensus 213 ~~~~~~--~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05607 213 DEVKFE--HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFVP 276 (277)
T ss_pred cccccc--cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCCCCCCC
Confidence 444433 256899999999999999999999953 3478999999999999998865 566665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=401.50 Aligned_cols=261 Identities=33% Similarity=0.553 Sum_probs=237.5
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
..++|++...||+|.|+.|+++.++.||+.+|+|++.-... +....+.+.+|+.|-..++|||||+|...++.....||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~-~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhh-ccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence 45789999999999999999999999999999999975443 44478889999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecC---CCcEEEEecCCcccccccc
Q 002616 573 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~---~G~VKLsDFGLAk~~~~~~ 649 (900)
|+|+|.||+|..-+-..-.++|..+-.|++||+.||.|+|.+||||||+||+|+||-. ..-+||+|||+|...
T Consensus 88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l---- 163 (355)
T KOG0033|consen 88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV---- 163 (355)
T ss_pred EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe----
Confidence 9999999999887766677899999999999999999999999999999999999954 346999999999743
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 729 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~e 729 (900)
........++|||+|||||++...+|+..+|||+-|||||-||.|++||.+.+...
T Consensus 164 ------------------------~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r 219 (355)
T KOG0033|consen 164 ------------------------NDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 219 (355)
T ss_pred ------------------------CCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH
Confidence 12345677899999999999999999999999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 730 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 730 i~~kIl~~~l~~P~-ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
+|+.|..+.+.+|. ..+.+++++++||++||..||.+|+| |.|.|+|||.++-
T Consensus 220 lye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIt---a~EAL~HpWi~~r 273 (355)
T KOG0033|consen 220 LYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRIT---ADEALKHPWICNR 273 (355)
T ss_pred HHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhcc---HHHHhCCchhcch
Confidence 99999999998876 45789999999999999999999999 8899999999863
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=403.29 Aligned_cols=259 Identities=28% Similarity=0.491 Sum_probs=219.5
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
+.|+.+.++|+|+||+||+|++++||+.||||.+...+ ..+...+-.++|+++|++++|||+|.|+.+|.....+++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 56889999999999999999999999999999986533 23444566789999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 575 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|||+. ++.+.|.+. ..++++.++.|+.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+...
T Consensus 81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~------- 152 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLS------- 152 (396)
T ss_pred eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhc-------
Confidence 99988 555555544 469999999999999999999999999999999999999999999999999999532
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~ 732 (900)
.+.......|.|.+|.|||.+.| ..|+..+||||+||++.||++|.+-|.+.+..+..-
T Consensus 153 --------------------~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy 212 (396)
T KOG0593|consen 153 --------------------APGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY 212 (396)
T ss_pred --------------------CCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH
Confidence 12233445789999999999998 789999999999999999999999999988765544
Q ss_pred hhhc-------------------CCCCCCCCC---------CCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 733 NILN-------------------RKIPWPCVP---------SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 733 kIl~-------------------~~l~~P~ip---------~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
.|.. .++.+|..+ +.++.-+.||+++||..||.+|++ .++++.||||.+
T Consensus 213 ~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s---c~qll~H~yFd~ 289 (396)
T KOG0593|consen 213 LIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS---CEQLLHHPYFDG 289 (396)
T ss_pred HHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc---HHHHhcChHHHH
Confidence 4322 122333311 356788999999999999999999 889999999955
Q ss_pred C
Q 002616 785 V 785 (900)
Q Consensus 785 i 785 (900)
+
T Consensus 290 ~ 290 (396)
T KOG0593|consen 290 F 290 (396)
T ss_pred H
Confidence 3
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=392.08 Aligned_cols=276 Identities=35% Similarity=0.631 Sum_probs=232.4
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
.|++.+.||+|+||.||++.++.+++.||+|.+.+...........+.+|+.++..++|+||+++++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999976555444455678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 576 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 576 y~~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|++||+|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~------ 154 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE------ 154 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC------
Confidence 999999999886543 589999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH---HH
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE---II 730 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~---ei 730 (900)
........||+.|+|||++.+..++.++|+|||||++|+|++|++||...... +.
T Consensus 155 ----------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~ 212 (285)
T cd05630 155 ----------------------GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 212 (285)
T ss_pred ----------------------CccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH
Confidence 01112357999999999999999999999999999999999999999865432 22
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChh--cHHHHHcCCCCCCCCcchhhhc--cCCccCCC
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 801 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~--~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~ 801 (900)
...+.... . ...+..+++++.+||.+||+.||.+|||.+ .+.++++||||+.++|..+... .|+|+|.+
T Consensus 213 ~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05630 213 VERLVKEV-Q-EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPFKPDP 285 (285)
T ss_pred HHhhhhhh-h-hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcCCCCCCCCCCC
Confidence 22222211 1 123367899999999999999999999843 5889999999999999977653 67888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-46 Score=416.11 Aligned_cols=261 Identities=40% Similarity=0.669 Sum_probs=238.6
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~Ly 571 (900)
....|++.+.||+|.||.||+|+.+.||+.||+|++.|.........+.+.+|+.||+++. |||||.+++.|++...+|
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 4467999999999999999999999999999999999877766667789999999999999 999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCC----CcEEEEecCCcccccc
Q 002616 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLI 647 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~----G~VKLsDFGLAk~~~~ 647 (900)
+|||++.||+|++.+.+. .+++..+..+++|++.|+.|||+.||+||||||+|+|+... +.+|++|||+++...
T Consensus 113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~- 190 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK- 190 (382)
T ss_pred EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc-
Confidence 999999999999999876 49999999999999999999999999999999999999643 579999999998531
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 727 (900)
Q Consensus 648 ~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~ 727 (900)
........||||.|+|||++.+.+|+..+|+||+||++|.|++|.+||.+.+.
T Consensus 191 ---------------------------~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~ 243 (382)
T KOG0032|consen 191 ---------------------------PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE 243 (382)
T ss_pred ---------------------------CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh
Confidence 13355678999999999999999999999999999999999999999999999
Q ss_pred HHHHHhhhcCCCCCCCC-CCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 728 EIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 728 ~ei~~kIl~~~l~~P~i-p~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
..++.+|..+.+.|+.- ...+|..+++||++||..||.+|++ |.++|+|||+++.
T Consensus 244 ~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~t---a~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 244 FEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLT---AAQALQHPWIKSI 299 (382)
T ss_pred hHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCC---HHHHhcCccccCC
Confidence 99999999998876542 3578999999999999999999999 8899999998765
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=424.95 Aligned_cols=257 Identities=35% Similarity=0.571 Sum_probs=229.5
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
...|....+||+|+.|.||.++...+++.||+|.+..... ...+-+++|+.+|+..+|+|||+++..|...+.+|+|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q---~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ---PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC---CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 3467788899999999999999999999999999876433 3356789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 574 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
||||+||+|.+.+... .++|.++..++++++.||+|||.+||||||||.+|||++.+|.+||+|||||..+..
T Consensus 349 MEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~------ 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE------ 421 (550)
T ss_pred EeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc------
Confidence 9999999999988654 599999999999999999999999999999999999999999999999999985421
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
......+.+|||.|||||++....|++++||||||++++||+-|.|||-.+++-.....
T Consensus 422 ---------------------~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyL 480 (550)
T KOG0578|consen 422 ---------------------EQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 480 (550)
T ss_pred ---------------------ccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHH
Confidence 12245678999999999999999999999999999999999999999999888877777
Q ss_pred hhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 734 Il~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
|...+.+--..+..+|++++||+.+||+.|+.+|++ |.++|.||||+-
T Consensus 481 Ia~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~Ras---A~eLL~HpFl~~ 528 (550)
T KOG0578|consen 481 IATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRAS---AKELLEHPFLKM 528 (550)
T ss_pred HhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCC---HHHHhcChhhhh
Confidence 776554333356899999999999999999999999 889999999953
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=389.31 Aligned_cols=258 Identities=34% Similarity=0.490 Sum_probs=215.7
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++.+.||+|+||.||+|+++.+++.||+|+++.... .....+.+.+|+.++..++||||++++++|...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976432 2344567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||++++.+..+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~------- 152 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE------- 152 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc-------
Confidence 9999987766655556799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhh
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kI 734 (900)
.........+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+
T Consensus 153 -------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (287)
T cd07848 153 -------------------GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213 (287)
T ss_pred -------------------cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0011122457999999999999999999999999999999999999999887654443332
Q ss_pred hcC-------------------CCCCCC----------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 735 LNR-------------------KIPWPC----------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 735 l~~-------------------~l~~P~----------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
... ...+|. ....+|.++.+||++||++||++||+ +.++++||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s---~~~~l~hp~f 287 (287)
T cd07848 214 QKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL---TEQCLNHPAF 287 (287)
T ss_pred HHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC---HHHHhcCCCC
Confidence 211 011111 01237889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=404.42 Aligned_cols=269 Identities=31% Similarity=0.529 Sum_probs=233.6
Q ss_pred cccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 002616 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 489 ~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~ 568 (900)
......++|++..+||.|..++||+|+...++..||||++.-.+ .. ...+.+++|+..|+.++||||++++.+|..+.
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEk-c~-~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEK-CN-NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhh-hh-hhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 34567889999999999999999999999999999999996433 22 33788999999999999999999999999999
Q ss_pred eeEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
.+|+||.||.+|++.++++.. ..|+|..+..+++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..+.
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999999999864 359999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCc-ccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR-HSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFT 723 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~-~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGVILyEMLtGk~PF~ 723 (900)
.+. .+.... .+++|||.|||||++.. .+|++|+||||||++..||.+|..||.
T Consensus 178 ~~G------------------------~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~ 233 (516)
T KOG0582|consen 178 DSG------------------------DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFS 233 (516)
T ss_pred ccC------------------------ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcc
Confidence 110 011112 67899999999999764 689999999999999999999999999
Q ss_pred CCChHHHHHhhhcCCCCCCCC-------CCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 002616 724 AESPEIIFDNILNRKIPWPCV-------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786 (900)
Q Consensus 724 ~~s~~ei~~kIl~~~l~~P~i-------p~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~id 786 (900)
...|+++....+++..+.+.. ...++..++.+|..||.+||.+||| |.++|+|+||+...
T Consensus 234 k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRpt---AskLlkh~FFk~~k 300 (516)
T KOG0582|consen 234 KYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPT---ASKLLKHAFFKKAK 300 (516)
T ss_pred cCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCC---HHHHhccHHHhhcc
Confidence 999999888888877654331 1345678999999999999999999 88999999998753
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=388.31 Aligned_cols=307 Identities=43% Similarity=0.806 Sum_probs=250.1
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++.+.||+|+||.||+|....+++.||+|.+.+...........+.+|++++..++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998765544456778999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 575 EYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
||+.|++|.+++.+. ..+++..++.++.|++.||+|||++|++||||||+||+++.+|.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 569999999999999999999999999999999999999999999999999987432111000
Q ss_pred CCCCCCCCCCC--CCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002616 653 LSGPETDGIMP--SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 653 l~~~~~~~~~~--s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei 730 (900)
........... ...................+||..|+|||++.+..++.++||||||+++|+|++|..||.+.+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 00000000000 0000001111122234457899999999999998999999999999999999999999999988888
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC-hhcHHHHHcCCCCCCCCcchhhhccCCccCCCC
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG-ANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPE 802 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpS-a~~a~EIL~HPFFk~idw~~L~~~~ppf~P~~~ 802 (900)
+..+......++. ...++.++.+||.+||..||++||+ ...+.+++.||||++++|..+....+|..|.+.
T Consensus 241 ~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (316)
T cd05574 241 FSNILKKEVTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPD 312 (316)
T ss_pred HHHHhcCCccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCCCcc
Confidence 8888776666653 2337999999999999999999999 456889999999999999999887777776654
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=408.07 Aligned_cols=259 Identities=31% Similarity=0.504 Sum_probs=224.5
Q ss_pred cccccCCCeEEEEEeccCCceEEEEEEECCCCcE-EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDL-FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 489 ~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~-VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
...+...++.+.+.||+|+||+||+|.|+ |.. ||+|++......... .+.|.+|+.+|.+++|||||++++++...
T Consensus 35 ~~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~ 111 (362)
T KOG0192|consen 35 EEEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSP 111 (362)
T ss_pred ceecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 33455677778888999999999999998 666 999999765543333 78999999999999999999999999999
Q ss_pred C-eeEEEEeecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHhhhhcC-eEeccCCCCcEEecCCC-cEEEEecCCc
Q 002616 568 D-NLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLG-IVHRDLKPDNLLIAHDG-HIKLTDFGLS 642 (900)
Q Consensus 568 ~-~LyLVmEy~~GGsL~dlL~k--~g~Lse~~ar~ya~QIl~AL~yLHs~g-IIHRDLKPeNILLd~~G-~VKLsDFGLA 642 (900)
. .+++|||||++|+|..++.+ ...++...+..++.||+.||+|||+++ ||||||||+||||+.++ ++||+|||++
T Consensus 112 ~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls 191 (362)
T KOG0192|consen 112 PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLS 191 (362)
T ss_pred CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence 8 79999999999999999988 578999999999999999999999999 99999999999999998 9999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc--CCCCCccceeechhHHHHHHHhCCC
Q 002616 643 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL--GTEHGYAADWWSVGIILFEFITGIP 720 (900)
Q Consensus 643 k~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~--g~~ys~ksDIWSLGVILyEMLtGk~ 720 (900)
+..... ........||+.|||||++. ...|+.++||||||++||||+||..
T Consensus 192 r~~~~~---------------------------~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~ 244 (362)
T KOG0192|consen 192 REKVIS---------------------------KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEI 244 (362)
T ss_pred eeeccc---------------------------cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCC
Confidence 852100 01223368999999999999 6699999999999999999999999
Q ss_pred CCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 721 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 721 PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
||.+..+......+.....+ |.+|...++.+..||.+||..||.+||++.++...|+
T Consensus 245 Pf~~~~~~~~~~~v~~~~~R-p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~ 301 (362)
T KOG0192|consen 245 PFEDLAPVQVASAVVVGGLR-PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLE 301 (362)
T ss_pred CCCCCCHHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHH
Confidence 99999987777777766554 5567789999999999999999999999766655554
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=407.12 Aligned_cols=254 Identities=31% Similarity=0.583 Sum_probs=238.5
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
..+|++.+.||+|.||+|-+|.....|+.||||.|+|..+..+++.-++++|++||+.++||||+.+|.+|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 46799999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 574 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|||..+|+|++++.+.+.+++.+++.+++||+.|+.|+|+++++|||||.+|||||.|+++||+||||+....
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~------- 204 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA------- 204 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc-------
Confidence 9999999999999999999999999999999999999999999999999999999999999999999987531
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~ 732 (900)
......++||+|.|.+||++.|.+| +..+|-|||||+||-|+.|..||.+.+...+.+
T Consensus 205 ---------------------~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvr 263 (668)
T KOG0611|consen 205 ---------------------DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVR 263 (668)
T ss_pred ---------------------cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHH
Confidence 2334568999999999999999999 789999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 733 kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
.|..+.+.-|. -+.++.-||+.||.+||++|.| +.+|-.|-|.
T Consensus 264 QIs~GaYrEP~----~PSdA~gLIRwmLmVNP~RRAT---ieDiAsHWWv 306 (668)
T KOG0611|consen 264 QISRGAYREPE----TPSDASGLIRWMLMVNPERRAT---IEDIASHWWV 306 (668)
T ss_pred HhhcccccCCC----CCchHHHHHHHHHhcCcccchh---HHHHhhhhee
Confidence 99999887663 4567899999999999999999 8899999886
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=412.97 Aligned_cols=262 Identities=33% Similarity=0.531 Sum_probs=227.2
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--C
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--D 568 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~ 568 (900)
....+.|+.+++||+|+||.||+|++..||+.||+|.++... .+.....-..+|+.||++++||||++|.+...+. .
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~ 191 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSG 191 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCc
Confidence 345678999999999999999999999999999999997543 3445566778999999999999999999998887 6
Q ss_pred eeEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~ 647 (900)
.+|||+|||+. ||.-++...+ .|++.+++.|+.||+.||+|||++||+|||||..|||||.+|.+||+|||||++...
T Consensus 192 siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 192 SIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred eEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence 89999999998 9999988744 699999999999999999999999999999999999999999999999999996421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 648 ~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
.......+.|-|.+|.|||.|+| ..|+.++|+||.||||.||++|++.|.+.+
T Consensus 271 --------------------------~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 271 --------------------------SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred --------------------------CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 11223566789999999999998 579999999999999999999999999999
Q ss_pred hHHHHHhhhcC-----CCCCC-----C----------------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCC
Q 002616 727 PEIIFDNILNR-----KIPWP-----C----------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 780 (900)
Q Consensus 727 ~~ei~~kIl~~-----~l~~P-----~----------------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HP 780 (900)
..+...+|.+- .-.|+ . ....++..+.+|+..||+.||.+|.| |.+.|.|+
T Consensus 325 EveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t---A~~aL~se 401 (560)
T KOG0600|consen 325 EVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT---ASSALQSE 401 (560)
T ss_pred HHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc---HHHHhcCc
Confidence 98888888651 00122 1 11357899999999999999999999 88999999
Q ss_pred CCC
Q 002616 781 FFK 783 (900)
Q Consensus 781 FFk 783 (900)
||.
T Consensus 402 yF~ 404 (560)
T KOG0600|consen 402 YFT 404 (560)
T ss_pred ccc
Confidence 994
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=387.77 Aligned_cols=256 Identities=29% Similarity=0.502 Sum_probs=215.0
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
+++|++.+.||.|+||.||+|+++.++..||+|+++.... ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 5789999999999999999999999999999999865321 22345678999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 574 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
|||+++ +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~----- 155 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV----- 155 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC-----
Confidence 999985 9999887654 578999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~ 731 (900)
.........||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+..
T Consensus 156 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~ 213 (288)
T cd07871 156 ----------------------PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL 213 (288)
T ss_pred ----------------------CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0111234578999999999876 56899999999999999999999999988776655
Q ss_pred HhhhcCC-------------------CCCCC--------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 732 DNILNRK-------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 732 ~kIl~~~-------------------l~~P~--------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
..+.... ..+|. ....++.++.+||++||+.||.+||| +.++++||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t---~~~~l~hp~f 288 (288)
T cd07871 214 HLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS---AEAALRHSYF 288 (288)
T ss_pred HHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC---HHHHhcCCCC
Confidence 5443210 01111 12357889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=383.78 Aligned_cols=275 Identities=35% Similarity=0.622 Sum_probs=233.8
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
.|+..+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|..++|+||+.+++.|...+.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37889999999999999999999999999999976554444455667889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 576 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 576 y~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~------ 154 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE------ 154 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC------
Confidence 99999999888654 3699999999999999999999999999999999999999999999999999863210
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
........||+.|+|||++.+..++.++|+|||||++|||++|..||...........
T Consensus 155 ----------------------~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~ 212 (285)
T cd05632 155 ----------------------GESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE 212 (285)
T ss_pred ----------------------CCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 0111245799999999999999999999999999999999999999988765443333
Q ss_pred h----hcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChh--cHHHHHcCCCCCCCCcchhhhc--cCCccCCC
Q 002616 734 I----LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ--KAVFVPQP 801 (900)
Q Consensus 734 I----l~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~--~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~ 801 (900)
+ ...... ++..++.++.+|+.+||..||.+||+.. .+.+++.||||+.++|+.+... .|+|+|.+
T Consensus 213 ~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (285)
T cd05632 213 VDRRVLETEEV---YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPDP 285 (285)
T ss_pred HHHhhhccccc---cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCCC
Confidence 3 222222 3367889999999999999999999942 4789999999999999987655 67888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=389.93 Aligned_cols=261 Identities=29% Similarity=0.518 Sum_probs=212.5
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
.++|++.+.||.|+||.||+|+++.+|+.||+|+++.... ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999975432 22334678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 574 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
|||++ |+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~----- 155 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV----- 155 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC-----
Confidence 99996 5888877654 5689999999999999999999999999999999999999999999999999863210
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCCh-HHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP-EII 730 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~-~ei 730 (900)
........+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+... .+.
T Consensus 156 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 213 (303)
T cd07869 156 ----------------------PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ 213 (303)
T ss_pred ----------------------CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH
Confidence 0111234578999999999876 4588999999999999999999999987543 222
Q ss_pred HHhhhcC-----CCCCCC------------------------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCC
Q 002616 731 FDNILNR-----KIPWPC------------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781 (900)
Q Consensus 731 ~~kIl~~-----~l~~P~------------------------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPF 781 (900)
...+... ...++. .....++++.+||.+||+.||.+||| +.++++|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s---~~~~l~h~~ 290 (303)
T cd07869 214 LERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS---AQAALSHEY 290 (303)
T ss_pred HHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC---HHHHhcCcc
Confidence 2222110 000000 00124578999999999999999999 889999999
Q ss_pred CCCCCc
Q 002616 782 FKGVNW 787 (900)
Q Consensus 782 Fk~idw 787 (900)
|+++.+
T Consensus 291 f~~~~~ 296 (303)
T cd07869 291 FSDLPP 296 (303)
T ss_pred cccCCh
Confidence 998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=389.95 Aligned_cols=263 Identities=30% Similarity=0.487 Sum_probs=213.4
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----Cee
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-----DNL 570 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~-----~~L 570 (900)
+|++.+.||+|+||.||+|+++.+|..||+|+++... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999986432 2233456788999999999999999999887543 358
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
|+||||+. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~- 157 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDT- 157 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccccc-
Confidence 99999995 6999999888889999999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPE 728 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ 728 (900)
.........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..
T Consensus 158 -----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~ 214 (338)
T cd07859 158 -----------------------PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVV 214 (338)
T ss_pred -----------------------CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChH
Confidence 00011234679999999999876 67899999999999999999999999876643
Q ss_pred HHHHhhhc--------------------------CC--CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCC
Q 002616 729 IIFDNILN--------------------------RK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 780 (900)
Q Consensus 729 ei~~kIl~--------------------------~~--l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HP 780 (900)
.....+.. .. .++....+.+++++.+||.+||+.||++||+ +.++++||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~e~l~hp 291 (338)
T cd07859 215 HQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT---AEEALADP 291 (338)
T ss_pred HHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC---HHHHhcCc
Confidence 32221110 00 0111111356788999999999999999999 88999999
Q ss_pred CCCCCCc
Q 002616 781 FFKGVNW 787 (900)
Q Consensus 781 FFk~idw 787 (900)
||+++..
T Consensus 292 ~f~~~~~ 298 (338)
T cd07859 292 YFKGLAK 298 (338)
T ss_pred hhhhcCc
Confidence 9987654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=413.94 Aligned_cols=259 Identities=32% Similarity=0.493 Sum_probs=222.1
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC-e
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD-N 569 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~-~ 569 (900)
...++|.++++||.|+||.||+|+.+.+|+.||||.+++.- .. -+...-++|+..|++++ |||||+|+..+.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf-~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF-YS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh-cc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 45678999999999999999999999999999999997633 22 22334478999999999 999999999999998 9
Q ss_pred eEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 570 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
+|+|||||+. +|+.+++.. ..|++..++.|+.||+.||+|+|++|+.||||||+|||+..+..|||+|||||+...
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~-- 161 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVR-- 161 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccc--
Confidence 9999999976 999999765 469999999999999999999999999999999999999989999999999999532
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 727 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~ 727 (900)
........|-|.+|+|||+|+. ..|+.++|+||+|||++|+.+-++.|.|.+.
T Consensus 162 --------------------------SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE 215 (538)
T KOG0661|consen 162 --------------------------SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE 215 (538)
T ss_pred --------------------------cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH
Confidence 1122345789999999999986 5689999999999999999999999999988
Q ss_pred HHHHHhhhc-------------------CCCCCCC--------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCC
Q 002616 728 EIIFDNILN-------------------RKIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 780 (900)
Q Consensus 728 ~ei~~kIl~-------------------~~l~~P~--------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HP 780 (900)
.+..-+|.. .++.||. +-+..+.++.+||.+||.+||.+||| |.++|+||
T Consensus 216 ~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT---A~~al~~p 292 (538)
T KOG0661|consen 216 IDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT---ASQALQHP 292 (538)
T ss_pred HHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc---HHHHhcCc
Confidence 776666643 1233443 12348999999999999999999999 88999999
Q ss_pred CCCC
Q 002616 781 FFKG 784 (900)
Q Consensus 781 FFk~ 784 (900)
||..
T Consensus 293 ffq~ 296 (538)
T KOG0661|consen 293 FFQV 296 (538)
T ss_pred cccc
Confidence 9974
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=390.45 Aligned_cols=263 Identities=30% Similarity=0.501 Sum_probs=234.6
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccc-----cchhHHHHHHHHHHHHHhcC-CCceEEEeeeec
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-----IRKNDIERILAERNILITVR-NPFVVRFFYSFT 565 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~-----~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~ 565 (900)
-..+.|+-.+.||+|..++|.++.++.||+.+|+|++.-... ....-.+..+.|+.||+++. ||+|+++.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 345677888899999999999999999999999999864221 12233456788999999986 999999999999
Q ss_pred cCCeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccc
Q 002616 566 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645 (900)
Q Consensus 566 d~~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~ 645 (900)
++..+++|+|.|+.|.|+++|...-.+++..++.+++|++.|++|||.++||||||||+|||+|++.++||+|||+|+..
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 99999999999999999999999889999999999999999999999999999999999999999999999999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc------CCCCCccceeechhHHHHHHHhCC
Q 002616 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL------GTEHGYAADWWSVGIILFEFITGI 719 (900)
Q Consensus 646 ~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~------g~~ys~ksDIWSLGVILyEMLtGk 719 (900)
.++......||||+|+|||.+. ..+|+..+|+|+.|||||.||.|.
T Consensus 174 ----------------------------~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGc 225 (411)
T KOG0599|consen 174 ----------------------------EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGC 225 (411)
T ss_pred ----------------------------CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCC
Confidence 2345566789999999999985 357899999999999999999999
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 720 PPFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 720 ~PF~~~s~~ei~~kIl~~~l~~P~-ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
+||......-+.+.|+.+++.|.. -..++|.+++|||.+||++||.+|+| +.+.|+||||..+
T Consensus 226 pPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Rit---ake~LaHpff~q~ 289 (411)
T KOG0599|consen 226 PPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRIT---AKEALAHPFFIQI 289 (411)
T ss_pred CchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhccc---HHHHhcChHHHHH
Confidence 999999999999999999988754 13578999999999999999999999 8899999999654
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=389.47 Aligned_cols=261 Identities=28% Similarity=0.464 Sum_probs=221.5
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
+..++|++++.||+|+||.||+++++.+|..||+|+++.. ........+.+|+++|..++||||+++++++...+.+|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 3468999999999999999999999999999999998653 23345677999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhc-CeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~-gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
+||||++||+|.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~---- 155 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---- 155 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc----
Confidence 9999999999999999888899999999999999999999986 69999999999999999999999999986421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei 730 (900)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++
T Consensus 156 -------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~ 210 (331)
T cd06649 156 -------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210 (331)
T ss_pred -------------------------ccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0112345799999999999999999999999999999999999999987665443
Q ss_pred HHhhh----------------------------------------------cCCCCCCCC-CCCCCHHHHHHHHHhccCC
Q 002616 731 FDNIL----------------------------------------------NRKIPWPCV-PSDMSFEAQDLINRFLIHD 763 (900)
Q Consensus 731 ~~kIl----------------------------------------------~~~l~~P~i-p~~lS~eakDLIk~cL~~D 763 (900)
...+. ... .|.. ...+++++++||.+||.+|
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~~ 288 (331)
T cd06649 211 EAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEP--PPKLPNGVFTPDFQEFVNKCLIKN 288 (331)
T ss_pred HHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCC--CcCCCCccccHHHHHHHHHHccCC
Confidence 22211 110 0111 1247889999999999999
Q ss_pred cCCCCChhcHHHHHcCCCCCCCCcc
Q 002616 764 PNQRLGANGAAEVKAHPFFKGVNWD 788 (900)
Q Consensus 764 P~kRpSa~~a~EIL~HPFFk~idw~ 788 (900)
|++||+ +.++++||||+.....
T Consensus 289 P~~Rpt---~~ell~h~~~~~~~~~ 310 (331)
T cd06649 289 PAERAD---LKMLMNHTFIKRSEVE 310 (331)
T ss_pred cccCCC---HHHHhcChHHhhcccc
Confidence 999999 8899999999865433
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=378.05 Aligned_cols=258 Identities=33% Similarity=0.549 Sum_probs=222.0
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
.+|..+++||+|.||.||+|++..||+.||||.++..+ .+.......++|+..|+.++||||+.|+++|....++-||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~-~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGN-AKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccc-cccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 46888999999999999999999999999999997653 23333456889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 575 EYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|||+. ||...++... .++...++.|+.++++||+|||.+.|+||||||.|+||+.+|.+||+|||+|+.+..
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~------ 153 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS------ 153 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCC------
Confidence 99987 9999997554 689999999999999999999999999999999999999999999999999996431
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~ 732 (900)
+.......|-|.+|.|||.+.| +.|+..+|+||.|||+.||+-|.|-|.+.+..+...
T Consensus 154 ---------------------p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~ 212 (318)
T KOG0659|consen 154 ---------------------PNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLS 212 (318)
T ss_pred ---------------------CCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHH
Confidence 1111222388999999999987 579999999999999999999999999999888777
Q ss_pred hhhcC-----CCCCCC--------------------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 733 NILNR-----KIPWPC--------------------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 733 kIl~~-----~l~~P~--------------------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
.|..- .-.||. +-+..+.++.||+.+||.+||.+|++ |.+.|+|+||+.
T Consensus 213 ~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit---a~qaL~~~yf~~ 286 (318)
T KOG0659|consen 213 KIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRIT---ASQALKHPYFKS 286 (318)
T ss_pred HHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhccc---HHHHhcchhhhc
Confidence 77641 111221 12346788999999999999999999 889999999985
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=422.18 Aligned_cols=316 Identities=51% Similarity=0.928 Sum_probs=264.2
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
+++|++++.||+|+||+||+|++..+++.||||++++...........+.+|+.++..++||||+++++++...+.+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999876666666678899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc--
Q 002616 574 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI-- 651 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~-- 651 (900)
|||+.||+|.+++...+.+++..++.|+.||+.||.|||.+|||||||||+||||+.+|++||+|||+++........
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~~~ 162 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMM 162 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCccccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999999743210000
Q ss_pred cC------------------------------------------------------------------------------
Q 002616 652 DL------------------------------------------------------------------------------ 653 (900)
Q Consensus 652 ~l------------------------------------------------------------------------------ 653 (900)
++
T Consensus 163 ~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (669)
T cd05610 163 DILTTPSMAKPKNDYSRTPGQVLSLISSLGFNTPVGEKDQGSVNSGQNNGTSSVRTGTSHPLLMINKESLPMSLKLSKSC 242 (669)
T ss_pred ccccCccccCccccccCCCCceeeeeeecCcCCccccccccccccccccccccccccCCCCcccccccccccccHhhhhc
Confidence 00
Q ss_pred ----C----CCC---CC-----------------------------------------CCC-------------------
Q 002616 654 ----S----GPE---TD-----------------------------------------GIM------------------- 662 (900)
Q Consensus 654 ----~----~~~---~~-----------------------------------------~~~------------------- 662 (900)
. .+. .. +..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (669)
T cd05610 243 LETSESSPSLPVRSLTPNLLKSRKRPEASTSSTHSCMTNSLSSCESECCSSNLKLLEQASSPSQSPRWSVDEGNIISEGE 322 (669)
T ss_pred cccccCCCCCCccccCcccccccccCCcccccchhhhhhhhhhccccccCcchhhhhhccCCCCCccccccCCCCccccc
Confidence 0 000 00 000
Q ss_pred --------------------------------------------------------------------------------
Q 002616 663 -------------------------------------------------------------------------------- 662 (900)
Q Consensus 663 -------------------------------------------------------------------------------- 662 (900)
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (669)
T cd05610 323 KSEKGSVKRSFELVEKSPCQELLQSKKTNAEYKRGCSITETNGNQSTGLTMEIQSLNLSKHKSRPKFLAGNEKRTGPKKK 402 (669)
T ss_pred ccccCCccccccccccChHHHHhcccccccccccceeeccccccccccceeecchhhhhhhhcCchhhhccccccCcccC
Confidence
Q ss_pred -----------CC-------------------------------CCCC-------Cccc-------c-------------
Q 002616 663 -----------PS-------------------------------DAHY-------PEYQ-------Q------------- 673 (900)
Q Consensus 663 -----------~s-------------------------------~~~~-------~~~~-------~------------- 673 (900)
.. .... ..+. .
T Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 482 (669)
T cd05610 403 SNPVVAKNLMCELDDDGEKDGKYSNSSTSCGDDREIVLKLSLNSDSSFPEMSKNAVAFRSYNSPINVSNVSEPSTMSSLD 482 (669)
T ss_pred CCcchhhhhhccccccccccCCccccccccCccHHHhhhhhhccccccccccccceeeeccCchhhccccCCCCcccccc
Confidence 00 0000 0000 0
Q ss_pred ------------------c-------------------------------ccCCcccccCCCCCCChhhhcCCCCCccce
Q 002616 674 ------------------T-------------------------------DNRNRHSAVGTPDYLAPEILLGTEHGYAAD 704 (900)
Q Consensus 674 ------------------~-------------------------------~~~~~~s~vGTp~YmAPEvL~g~~ys~ksD 704 (900)
. ........+||+.|||||++.+..|+.++|
T Consensus 483 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~D 562 (669)
T cd05610 483 AMKMSGSQSGSYPAITPTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVD 562 (669)
T ss_pred hhhccccccCCCcccCCCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHH
Confidence 0 000012247899999999999999999999
Q ss_pred eechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 705 WWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 705 IWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
||||||+||||++|++||.+....+.+..++...+++|.....++..+.+++.+||..||.+||+ +.+++.||||+.
T Consensus 563 iwSlG~il~ElltG~~pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~~dP~~R~t---a~e~l~h~~~~~ 639 (669)
T cd05610 563 WWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAG---LKELKQHPLFHG 639 (669)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhHCcC---HHHHHhCHhhcC
Confidence 99999999999999999999999999999988888888766788999999999999999999999 889999999999
Q ss_pred CCcchhhhccCCccCCCCCCCCcccccc
Q 002616 785 VNWDSLALQKAVFVPQPESVDDTSYFLS 812 (900)
Q Consensus 785 idw~~L~~~~ppf~P~~~s~~D~s~fd~ 812 (900)
++|..+.....+|.|.+....|+.+|+.
T Consensus 640 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 667 (669)
T cd05610 640 VDWENLQNQTMPFIPQPDDETDTSYFEA 667 (669)
T ss_pred CCHHHhcccCCCCCCCCCCccccccccc
Confidence 9999999889999999988888888865
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=388.45 Aligned_cols=263 Identities=33% Similarity=0.507 Sum_probs=223.6
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--C
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--D 568 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~ 568 (900)
--++++|+.+..|+.|+||.||+|+++.|++.||+|.++... .+..---.-++|+.+|.+++|||||.+-.+..-. +
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 456889999999999999999999999999999999987533 2222233468899999999999999998766543 5
Q ss_pred eeEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~ 647 (900)
.+|||||||+. ||..++.+.+ +|...+++.++.|++.||+|||.+.|+||||||+|+|+...|.+||+|||||+...
T Consensus 151 ~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg- 228 (419)
T KOG0663|consen 151 KIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG- 228 (419)
T ss_pred eeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc-
Confidence 79999999988 9999998876 89999999999999999999999999999999999999999999999999999531
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 648 ~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
.+.......|-|.+|.|||.|++ ..|+.++|+||+|||+.||++++|-|.+.+
T Consensus 229 --------------------------sp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~s 282 (419)
T KOG0663|consen 229 --------------------------SPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKS 282 (419)
T ss_pred --------------------------CCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCc
Confidence 12234456789999999999998 469999999999999999999999999999
Q ss_pred hHHHHHhhhcC-------------------CCCCCCCC---------C-CCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 727 PEIIFDNILNR-------------------KIPWPCVP---------S-DMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 727 ~~ei~~kIl~~-------------------~l~~P~ip---------~-~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
..+...+|... ...++..| . .+++...+|+..+|.+||.+|+| |.+.|
T Consensus 283 E~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t---A~~~L 359 (419)
T KOG0663|consen 283 EIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT---AEDGL 359 (419)
T ss_pred hHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc---HHHhh
Confidence 88887777641 11122111 1 26799999999999999999999 88999
Q ss_pred cCCCCCCC
Q 002616 778 AHPFFKGV 785 (900)
Q Consensus 778 ~HPFFk~i 785 (900)
+|.||++.
T Consensus 360 ~h~~F~e~ 367 (419)
T KOG0663|consen 360 KHEYFRET 367 (419)
T ss_pred cccccccC
Confidence 99999863
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=375.32 Aligned_cols=255 Identities=33% Similarity=0.517 Sum_probs=209.4
Q ss_pred CCeEEEEEeccCCceEEEEEEECC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeec-----
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFT----- 565 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~-tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L---~HPnIVkL~~~f~----- 565 (900)
++|++.+.||+|+||+||+|++.. +|+.||+|+++.... .......+.+|+.++..+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999854 468899999865332 222334566777777665 6999999999875
Q ss_pred cCCeeEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcc
Q 002616 566 CRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643 (900)
Q Consensus 566 d~~~LyLVmEy~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk 643 (900)
....+|+||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3456999999997 5999998754 358999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCC
Q 002616 644 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 723 (900)
Q Consensus 644 ~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~ 723 (900)
.... ........||+.|+|||++.+..++.++|||||||++|||++|.+||.
T Consensus 159 ~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 210 (290)
T cd07862 159 IYSF----------------------------QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 210 (290)
T ss_pred eccC----------------------------CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcC
Confidence 4210 112234679999999999999999999999999999999999999999
Q ss_pred CCChHHHHHhhhcCCC-----CCC-------------------CCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcC
Q 002616 724 AESPEIIFDNILNRKI-----PWP-------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 724 ~~s~~ei~~kIl~~~l-----~~P-------------------~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~H 779 (900)
+.+..+.+..|..... .+| .+.+.+++.+++||.+||+.||++||+ +.++++|
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~~~l~h 287 (290)
T cd07862 211 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYSALSH 287 (290)
T ss_pred CCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC---HHHHhcC
Confidence 9888777776654210 111 112357889999999999999999999 8899999
Q ss_pred CCC
Q 002616 780 PFF 782 (900)
Q Consensus 780 PFF 782 (900)
|||
T Consensus 288 p~f 290 (290)
T cd07862 288 PYF 290 (290)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=368.10 Aligned_cols=257 Identities=60% Similarity=1.054 Sum_probs=224.0
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHH-HhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL-~~L~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
+.||.|+||.||+|.+..+|+.||+|++++...........+..|..++ ...+||||+++++++...+.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999765443334444556666554 445899999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 580 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 580 GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
|+|.+++...+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.+||+|||+++...
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~------------- 148 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGL------------- 148 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecc-------------
Confidence 9999999888889999999999999999999999999999999999999999999999999886321
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCC
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l 739 (900)
......|++.|+|||.+.+..++.++||||||+++|+|++|.+||...+....+..+.....
T Consensus 149 ------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 210 (260)
T cd05611 149 ------------------ENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRI 210 (260)
T ss_pred ------------------ccccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhccc
Confidence 01234688999999999988899999999999999999999999999888888887776655
Q ss_pred CCCC-CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 002616 740 PWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 788 (900)
Q Consensus 740 ~~P~-ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~ 788 (900)
.++. ....+++++.++|.+||+.||.+||++.++.+++.||||++++|+
T Consensus 211 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 211 NWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred CCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 5442 234689999999999999999999998889999999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=400.52 Aligned_cols=261 Identities=34% Similarity=0.585 Sum_probs=239.4
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
...-|.+-+.||+|.|++|-+|++--||..||||++.|..+. .-...+++.|++.|+.++|||||+||.+..+...+||
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 445688899999999999999999999999999999987653 3456789999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEec-CCCcEEEEecCCccccccccc
Q 002616 573 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd-~~G~VKLsDFGLAk~~~~~~s 650 (900)
|+|+-.+|+|+++|.++. .+.|+.++.|++||+.||.|+|++.+|||||||+||.+. .-|-|||+||||+-.+
T Consensus 95 iLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf----- 169 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF----- 169 (864)
T ss_pred EEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC-----
Confidence 999999999999998875 699999999999999999999999999999999999775 4689999999998642
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCC-ccceeechhHHHHHHHhCCCCCCCCChHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG-YAADWWSVGIILFEFITGIPPFTAESPEI 729 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys-~ksDIWSLGVILyEMLtGk~PF~~~s~~e 729 (900)
.+++...+.||+..|-|||+|+|..|+ +++||||||||||-|++|++||...+..+
T Consensus 170 -----------------------~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE 226 (864)
T KOG4717|consen 170 -----------------------QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE 226 (864)
T ss_pred -----------------------CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence 345667889999999999999999996 58999999999999999999999999999
Q ss_pred HHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 002616 730 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 788 (900)
Q Consensus 730 i~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~ 788 (900)
+..+|+..++..| ..+|.+++|||..||.+||.+|.+ +++|-.|+|++.+|-.
T Consensus 227 TLTmImDCKYtvP---shvS~eCrdLI~sMLvRdPkkRAs---lEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 227 TLTMIMDCKYTVP---SHVSKECRDLIQSMLVRDPKKRAS---LEEIVSTSWLQAGDRG 279 (864)
T ss_pred hhhhhhcccccCc---hhhhHHHHHHHHHHHhcCchhhcc---HHHHhccccccCCCCC
Confidence 9999999998877 799999999999999999999999 8899999999987754
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=371.79 Aligned_cols=266 Identities=36% Similarity=0.664 Sum_probs=224.7
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCCh
Q 002616 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 582 (900)
Q Consensus 503 LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GGsL 582 (900)
||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.+|+.++||||+++++.|...+..|+||||+++|+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999765544444566778899999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCC
Q 002616 583 YSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 660 (900)
Q Consensus 583 ~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~ 660 (900)
.+++.+.. .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.....
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~------------- 147 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG------------- 147 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc-------------
Confidence 99998765 799999999999999999999999999999999999999999999999998864210
Q ss_pred CCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh----HHHHHhhhc
Q 002616 661 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP----EIIFDNILN 736 (900)
Q Consensus 661 ~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~----~ei~~kIl~ 736 (900)
........|+..|+|||++.+..++.++|+|||||++|+|++|+.||..... ..+...+..
T Consensus 148 ---------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 212 (277)
T cd05577 148 ---------------GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE 212 (277)
T ss_pred ---------------CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc
Confidence 0112234688999999999988899999999999999999999999977654 333333333
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCh-h-cHHHHHcCCCCCCCCcchhhhc--cCCccC
Q 002616 737 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA-N-GAAEVKAHPFFKGVNWDSLALQ--KAVFVP 799 (900)
Q Consensus 737 ~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa-~-~a~EIL~HPFFk~idw~~L~~~--~ppf~P 799 (900)
.... .+..+++++.+||.+||+.||.+||+. + .+.+++.||||+.++|..+... .|||.|
T Consensus 213 ~~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05577 213 MAVE---YPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276 (277)
T ss_pred cccc---CCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcCCCCCCCCC
Confidence 3322 346789999999999999999999963 2 3889999999999999887544 456654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=389.32 Aligned_cols=261 Identities=31% Similarity=0.510 Sum_probs=218.3
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----ee
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----NL 570 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~-----~L 570 (900)
+|++.+.||+|+||.||+|.+..+|+.||+|++.+. .........+.+|+.+|..++||||+++++++...+ .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc-ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 588999999999999999999999999999998643 222334567889999999999999999999998887 79
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
|+||||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-- 156 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-- 156 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC--
Confidence 99999997 589998888788999999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEI 729 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~e 729 (900)
........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.++.+
T Consensus 157 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 212 (372)
T cd07853 157 ------------------------ESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212 (372)
T ss_pred ------------------------ccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH
Confidence 01112234689999999999874 47899999999999999999999999887766
Q ss_pred HHHhhhc-----------------------CCCCCC------CCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCC
Q 002616 730 IFDNILN-----------------------RKIPWP------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 780 (900)
Q Consensus 730 i~~kIl~-----------------------~~l~~P------~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HP 780 (900)
....|.. .....| .+....++++.+||.+||+.||.+||+ +.++++||
T Consensus 213 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t---~~e~l~hp 289 (372)
T cd07853 213 QLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS---AADALAHP 289 (372)
T ss_pred HHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC---HHHHhcCH
Confidence 5554432 111111 122456889999999999999999999 88999999
Q ss_pred CCCCCCc
Q 002616 781 FFKGVNW 787 (900)
Q Consensus 781 FFk~idw 787 (900)
||++..+
T Consensus 290 ~~~~~~~ 296 (372)
T cd07853 290 YLDEGRL 296 (372)
T ss_pred hhCCCcc
Confidence 9998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=372.95 Aligned_cols=260 Identities=38% Similarity=0.665 Sum_probs=213.4
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh---cCCCceEEEeeeeccCCeeEEEEeecC
Q 002616 502 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT---VRNPFVVRFFYSFTCRDNLYLVMEYLN 578 (900)
Q Consensus 502 ~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~---L~HPnIVkL~~~f~d~~~LyLVmEy~~ 578 (900)
.||+|+||.||++.+..+|+.||+|++.+...........+.+|..++.. .+||||+.+++.+...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999999999999999999976544333333444555544443 479999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCC
Q 002616 579 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 658 (900)
Q Consensus 579 GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~ 658 (900)
||+|..++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~------------ 148 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS------------ 148 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecc------------
Confidence 99999999888889999999999999999999999999999999999999999999999999986321
Q ss_pred CCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc-CCCCCccceeechhHHHHHHHhCCCCCCCCCh---HHHHHhh
Q 002616 659 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESP---EIIFDNI 734 (900)
Q Consensus 659 ~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~---~ei~~kI 734 (900)
........||+.|+|||++. +..++.++|+|||||++|||++|..||..... .......
T Consensus 149 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 211 (279)
T cd05633 149 -----------------KKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211 (279)
T ss_pred -----------------ccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh
Confidence 00112346999999999987 46689999999999999999999999975432 2222222
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC--hhcHHHHHcCCCCCCCCcchhhhc
Q 002616 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWDSLALQ 793 (900)
Q Consensus 735 l~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpS--a~~a~EIL~HPFFk~idw~~L~~~ 793 (900)
..... .++..+++++.+||++||..||.+|++ ...+.++++||||++++|......
T Consensus 212 ~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~ 269 (279)
T cd05633 212 LTVNV---ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQ 269 (279)
T ss_pred hcCCc---CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcC
Confidence 22222 234678999999999999999999995 234889999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=403.32 Aligned_cols=257 Identities=30% Similarity=0.415 Sum_probs=210.4
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC----
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR---- 567 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~---- 567 (900)
....+|++.+.||+|+||.||+|.+..+++.||||++.+.. ....+|+.+|+.++|||||+++++|...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 34568999999999999999999999999999999885422 2245799999999999999998876432
Q ss_pred ----CeeEEEEeecCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCC-cEEEEe
Q 002616 568 ----DNLYLVMEYLNGGDLYSLLR----KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTD 638 (900)
Q Consensus 568 ----~~LyLVmEy~~GGsL~dlL~----k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G-~VKLsD 638 (900)
..+|+||||+++ +|.+++. ....+++..++.|+.||+.||.|||++|||||||||+||||+.++ .+||+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 247899999986 6766664 345799999999999999999999999999999999999999765 699999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHh
Q 002616 639 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFIT 717 (900)
Q Consensus 639 FGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLt 717 (900)
||+|+.... .......+||+.|||||++.+. .|+.++|||||||++|||++
T Consensus 215 FGla~~~~~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt 266 (440)
T PTZ00036 215 FGSAKNLLA----------------------------GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMIL 266 (440)
T ss_pred cccchhccC----------------------------CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 999974210 1122346789999999998764 68999999999999999999
Q ss_pred CCCCCCCCChHHHHHhhhcC-----------------CCCCCC---------CCCCCCHHHHHHHHHhccCCcCCCCChh
Q 002616 718 GIPPFTAESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGAN 771 (900)
Q Consensus 718 Gk~PF~~~s~~ei~~kIl~~-----------------~l~~P~---------ip~~lS~eakDLIk~cL~~DP~kRpSa~ 771 (900)
|.+||.+.+..+.+.++... .+.+|. +|...++++.+||.+||++||.+||+
T Consensus 267 G~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t-- 344 (440)
T PTZ00036 267 GYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN-- 344 (440)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC--
Confidence 99999998776665555431 111221 23457899999999999999999999
Q ss_pred cHHHHHcCCCCCCCCc
Q 002616 772 GAAEVKAHPFFKGVNW 787 (900)
Q Consensus 772 ~a~EIL~HPFFk~idw 787 (900)
+.+++.||||..+..
T Consensus 345 -a~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 345 -PIEALADPFFDDLRD 359 (440)
T ss_pred -HHHHhCChhHHhhhc
Confidence 889999999987654
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=370.52 Aligned_cols=254 Identities=30% Similarity=0.503 Sum_probs=207.9
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeeccC-----
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTCR----- 567 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L---~HPnIVkL~~~f~d~----- 567 (900)
+|++.+.||+|+||+||+|+++.+|+.||+|+++.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 58999999999999999999999999999999875322 222233456677776655 799999999988653
Q ss_pred CeeEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~ 645 (900)
..+++||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 458999999985 898888764 34899999999999999999999999999999999999999999999999998742
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002616 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 725 (900)
Q Consensus 646 ~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~ 725 (900)
.. ........||+.|+|||++.+..++.++|||||||++|+|++|++||.+.
T Consensus 159 ~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 159 SC----------------------------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred cC----------------------------cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 10 11122357899999999999999999999999999999999999999888
Q ss_pred ChHHHHHhhhcC-----CCCCC-------------------CCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCC
Q 002616 726 SPEIIFDNILNR-----KIPWP-------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781 (900)
Q Consensus 726 s~~ei~~kIl~~-----~l~~P-------------------~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPF 781 (900)
+..+...++... ...+| ...+.++.++.+||.+||++||.+||+ +.+++.|||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~~~l~hp~ 287 (288)
T cd07863 211 SEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS---AFRALQHPF 287 (288)
T ss_pred CHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC---HHHHhcCCC
Confidence 776666555431 00011 112357888999999999999999999 889999999
Q ss_pred C
Q 002616 782 F 782 (900)
Q Consensus 782 F 782 (900)
|
T Consensus 288 f 288 (288)
T cd07863 288 F 288 (288)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=385.54 Aligned_cols=258 Identities=31% Similarity=0.490 Sum_probs=212.4
Q ss_pred ccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 569 (900)
Q Consensus 490 ~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ 569 (900)
.....++|++++.||+|+||.||+|+++.+|+.||+|++.... .......+.+|+.+|+.++||||++++++|...+.
T Consensus 69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 146 (353)
T PLN00034 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE 146 (353)
T ss_pred CCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence 3456788999999999999999999999999999999986532 23445678999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 570 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
+|+||||+++|+|... ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 147 ~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~-- 220 (353)
T PLN00034 147 IQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ-- 220 (353)
T ss_pred EEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccc--
Confidence 9999999999998653 3456778889999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-----CCCCccceeechhHHHHHHHhCCCCCCC
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTA 724 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~ksDIWSLGVILyEMLtGk~PF~~ 724 (900)
........+||+.|+|||++.. ..++.++|||||||++|||++|+.||..
T Consensus 221 -------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 221 -------------------------TMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred -------------------------ccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 0011234579999999999843 2345789999999999999999999974
Q ss_pred CChHH---HHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 725 ESPEI---IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 725 ~s~~e---i~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
....+ ....+.... .+..+..++.++.+||.+||..||++||+ +.++++||||.+.
T Consensus 276 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rpt---~~ell~hp~~~~~ 334 (353)
T PLN00034 276 GRQGDWASLMCAICMSQ--PPEAPATASREFRHFISCCLQREPAKRWS---AMQLLQHPFILRA 334 (353)
T ss_pred CCCccHHHHHHHHhccC--CCCCCCccCHHHHHHHHHHccCChhhCcC---HHHHhcCcccccC
Confidence 43222 222222211 13344678999999999999999999999 8899999999874
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=360.99 Aligned_cols=260 Identities=31% Similarity=0.503 Sum_probs=224.2
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~--~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
++|++.+.||.|+||.||+|....+++.||+|.+...... .......+.+|+.++++++||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999999999999998754322 22345678999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 573 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
||||++|++|.+++.+.+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||+++......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~--- 158 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC--- 158 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc---
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~ 732 (900)
..........|++.|+|||++.+..++.++|+||||+++|||++|++||...+......
T Consensus 159 ---------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 217 (263)
T cd06625 159 ---------------------SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF 217 (263)
T ss_pred ---------------------cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH
Confidence 00001123568899999999999889999999999999999999999998877766665
Q ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 733 kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
.+...... +.++..++.++.+||.+||..+|.+||+ +.++++||||
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~ 263 (263)
T cd06625 218 KIATQPTN-PQLPSHVSPDARNFLRRTFVENAKKRPS---AEELLRHFFV 263 (263)
T ss_pred HHhccCCC-CCCCccCCHHHHHHHHHHhhcCcccCCC---HHHHhhCCCC
Confidence 55544333 3355788999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=403.18 Aligned_cols=258 Identities=30% Similarity=0.503 Sum_probs=230.5
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
...|+.+..||+|+||.||+|.+..|++.||+|++.-.. .+.+++.+.+|+.+|.++++|||.++|++|..+..++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 345777899999999999999999999999999997533 356788999999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 574 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
||||.||++.++|+....+.+..+..++++++.||.|||..+.||||||+.|||+..+|.|||+|||.+....
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~------- 162 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT------- 162 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee-------
Confidence 9999999999999988888999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
.......+++|||.||||||+.+.+|+.++||||||++.|||++|.|||....|+.....
T Consensus 163 --------------------~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl 222 (467)
T KOG0201|consen 163 --------------------NTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL 222 (467)
T ss_pred --------------------chhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe
Confidence 112234789999999999999999999999999999999999999999999988655444
Q ss_pred hhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 734 Il~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
|-+.. .|.+...+|+.+++||..||.+||+.||+ |.++|+|+|.+..
T Consensus 223 Ipk~~--PP~L~~~~S~~~kEFV~~CL~k~P~~Rps---A~~LLKh~FIk~a 269 (467)
T KOG0201|consen 223 IPKSA--PPRLDGDFSPPFKEFVEACLDKNPEFRPS---AKELLKHKFIKRA 269 (467)
T ss_pred ccCCC--CCccccccCHHHHHHHHHHhhcCcccCcC---HHHHhhhHHHHhc
Confidence 43333 35566789999999999999999999999 8899999999863
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=360.39 Aligned_cols=265 Identities=62% Similarity=1.126 Sum_probs=230.1
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCCh
Q 002616 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 582 (900)
Q Consensus 503 LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GGsL 582 (900)
||.|+||.||+|++..+|+.||+|++.+...........+.+|++++..++||||+++++.+.....+|+||||+++|+|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999775554456678899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCCCC
Q 002616 583 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 662 (900)
Q Consensus 583 ~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~ 662 (900)
.+++.+.+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++...........
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--------- 151 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL--------- 151 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc---------
Confidence 99999888899999999999999999999999999999999999999999999999999874321100000
Q ss_pred CCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCCCCC
Q 002616 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 742 (900)
Q Consensus 663 ~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l~~P 742 (900)
...........+++.|+|||.+.+..++.++|+||||+++|+|++|..||....+.+.+..+..+...+|
T Consensus 152 ----------~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 221 (265)
T cd05579 152 ----------NDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWP 221 (265)
T ss_pred ----------ccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCC
Confidence 0001122345688999999999988899999999999999999999999999998888888887666655
Q ss_pred CCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCc
Q 002616 743 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 787 (900)
Q Consensus 743 ~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw 787 (900)
.. ..++..+.+||.+||+.+|.+||++..+.++++||||++++|
T Consensus 222 ~~-~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 222 ED-VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred cc-ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 32 235899999999999999999999877799999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=380.58 Aligned_cols=258 Identities=31% Similarity=0.517 Sum_probs=218.3
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
+..++|++.+.||.|+||.||+++++.+|..+|+|++... ........+.+|+++|..++||||++++++|.+.+.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 3457899999999999999999999999999999988653 23345567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhc-CeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~-gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
+||||++||+|.+++.+.+.+++..+..++.+++.||.|||+. +|+||||||+|||++.+|.+||+|||++....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~---- 155 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---- 155 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh----
Confidence 9999999999999999888899999999999999999999975 79999999999999999999999999986421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei 730 (900)
.......+||+.|+|||++.+..++.++|+|||||++|||++|+.||......+.
T Consensus 156 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 210 (333)
T cd06650 156 -------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210 (333)
T ss_pred -------------------------hhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHH
Confidence 0112235799999999999998999999999999999999999999976554333
Q ss_pred HHhh--------------------------------------------hcCCCCCCCCC-CCCCHHHHHHHHHhccCCcC
Q 002616 731 FDNI--------------------------------------------LNRKIPWPCVP-SDMSFEAQDLINRFLIHDPN 765 (900)
Q Consensus 731 ~~kI--------------------------------------------l~~~l~~P~ip-~~lS~eakDLIk~cL~~DP~ 765 (900)
...+ .+... |..+ ..++.++++||.+||++||.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~P~ 288 (333)
T cd06650 211 ELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPA 288 (333)
T ss_pred HHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCCcc
Confidence 2111 11110 1111 24678999999999999999
Q ss_pred CCCChhcHHHHHcCCCCCCC
Q 002616 766 QRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 766 kRpSa~~a~EIL~HPFFk~i 785 (900)
+||+ +.+++.||||+..
T Consensus 289 ~Rpt---~~ell~h~~~~~~ 305 (333)
T cd06650 289 ERAD---LKQLMVHAFIKRS 305 (333)
T ss_pred cCcC---HHHHhhCHHHhcC
Confidence 9999 8899999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=374.23 Aligned_cols=259 Identities=27% Similarity=0.510 Sum_probs=214.9
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
.++|.+.+.||+|+||.||+|+++.+++.||+|.++.... ......+.+|+.+++.++||||+++++++..++.+|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 5789999999999999999999999999999999875332 22344577899999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 574 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
|||+++ +|..++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~----- 156 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV----- 156 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC-----
Confidence 999975 8888876544 589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~ 731 (900)
........+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+..+..
T Consensus 157 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 214 (309)
T cd07872 157 ----------------------PTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDEL 214 (309)
T ss_pred ----------------------CccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 0111223468999999999875 46899999999999999999999999887765554
Q ss_pred HhhhcC-------------------CCCCCC--------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 732 DNILNR-------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 732 ~kIl~~-------------------~l~~P~--------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
..+... ...+|. ....+++++++||.+||+.||.+||| +.+++.||||++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~~ 291 (309)
T cd07872 215 HLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS---AEEAMKHAYFRS 291 (309)
T ss_pred HHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC---HHHHhcChhhhh
Confidence 443321 011111 11357899999999999999999999 889999999986
Q ss_pred C
Q 002616 785 V 785 (900)
Q Consensus 785 i 785 (900)
+
T Consensus 292 ~ 292 (309)
T cd07872 292 L 292 (309)
T ss_pred c
Confidence 4
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=378.54 Aligned_cols=259 Identities=24% Similarity=0.365 Sum_probs=207.8
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeee
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSF 564 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k-----~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f 564 (900)
.+..++|++.+.||+|+||.||+|.+. .+++.||+|+++... .......+.+|+.+|..+ +|||||++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 355678999999999999999999852 346789999986432 234456789999999999 899999999988
Q ss_pred ccCC-eeEEEEeecCCCChHHHHHhc------------------------------------------------------
Q 002616 565 TCRD-NLYLVMEYLNGGDLYSLLRKV------------------------------------------------------ 589 (900)
Q Consensus 565 ~d~~-~LyLVmEy~~GGsL~dlL~k~------------------------------------------------------ 589 (900)
...+ .+|+||||+++|+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 7654 589999999999999998753
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCCC
Q 002616 590 --------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 661 (900)
Q Consensus 590 --------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~ 661 (900)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~------------ 228 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------------ 228 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCc------------
Confidence 236778888999999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHhhhcCCCC
Q 002616 662 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIP 740 (900)
Q Consensus 662 ~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ei~~kIl~~~l~ 740 (900)
.........+|+.|||||++.+..|+.++|||||||++|||++ |.+||.+....+.+...+.....
T Consensus 229 -------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~ 295 (338)
T cd05102 229 -------------DYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR 295 (338)
T ss_pred -------------chhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC
Confidence 0011123456789999999999999999999999999999997 99999886654433333332222
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 741 WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 741 ~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
+..+..+++++.+||.+||..||.+||++.++.+.|
T Consensus 296 -~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l 331 (338)
T cd05102 296 -MRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331 (338)
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 223567899999999999999999999966555444
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=360.81 Aligned_cols=257 Identities=39% Similarity=0.787 Sum_probs=225.4
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCCh
Q 002616 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 582 (900)
Q Consensus 503 LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GGsL 582 (900)
||.|+||.||+|++..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.+.++..+|+||||+++|+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999876555555668899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCCCC
Q 002616 583 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 662 (900)
Q Consensus 583 ~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~ 662 (900)
.+++.+...+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~--------------- 145 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS--------------- 145 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCc---------------
Confidence 99998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC--hHHHHHhhhcCCCC
Q 002616 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--PEIIFDNILNRKIP 740 (900)
Q Consensus 663 ~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s--~~ei~~kIl~~~l~ 740 (900)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... +.+.+.++..+...
T Consensus 146 -------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 212 (262)
T cd05572 146 -------------GQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGK 212 (262)
T ss_pred -------------ccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCC
Confidence 002234578999999999998889999999999999999999999998776 67777777742222
Q ss_pred CCCCCCCCCHHHHHHHHHhccCCcCCCCC--hhcHHHHHcCCCCCCCCcc
Q 002616 741 WPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVNWD 788 (900)
Q Consensus 741 ~P~ip~~lS~eakDLIk~cL~~DP~kRpS--a~~a~EIL~HPFFk~idw~ 788 (900)
+..|...++++.+||.+||..||.+||+ ...+.++++||||++.+|+
T Consensus 213 -~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 213 -LEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred -CCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 2234667899999999999999999998 2347899999999999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=392.40 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=210.0
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
+...+|++++.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+|+.++|||||+++++|......|
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 456789999999999999999999999999999996532 34678999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
+|||++. ++|..++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+++....
T Consensus 160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~---- 234 (391)
T PHA03212 160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD---- 234 (391)
T ss_pred EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccc----
Confidence 9999995 69999998888899999999999999999999999999999999999999999999999999864210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC-----
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES----- 726 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s----- 726 (900)
.........+||+.|+|||++.+..|+.++|||||||++|||++|..||....
T Consensus 235 ----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~ 292 (391)
T PHA03212 235 ----------------------INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGD 292 (391)
T ss_pred ----------------------ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCccccccc
Confidence 00112234689999999999999999999999999999999999998875422
Q ss_pred --hHHHHHhhhc--------------------------CCCCCCC------CCCCCCHHHHHHHHHhccCCcCCCCChhc
Q 002616 727 --PEIIFDNILN--------------------------RKIPWPC------VPSDMSFEAQDLINRFLIHDPNQRLGANG 772 (900)
Q Consensus 727 --~~ei~~kIl~--------------------------~~l~~P~------ip~~lS~eakDLIk~cL~~DP~kRpSa~~ 772 (900)
.......+.. .....|. ....++.++.+||.+||+.||.+||+
T Consensus 293 ~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt--- 369 (391)
T PHA03212 293 CDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS--- 369 (391)
T ss_pred CchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC---
Confidence 1111111111 0000010 00135678999999999999999999
Q ss_pred HHHHHcCCCCCCC
Q 002616 773 AAEVKAHPFFKGV 785 (900)
Q Consensus 773 a~EIL~HPFFk~i 785 (900)
|.++|+||||+.+
T Consensus 370 a~elL~hp~f~~~ 382 (391)
T PHA03212 370 AEALLDFAAFQDI 382 (391)
T ss_pred HHHHhcChhhccC
Confidence 8899999999764
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=398.49 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=205.9
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC------CceEEEeeeec
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN------PFVVRFFYSFT 565 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~H------PnIVkL~~~f~ 565 (900)
...++|++++.||+|+||+||+|.+..+++.||||++++.. .....+..|+.++..+.| ++|++++++|.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34578999999999999999999999999999999996532 223445667777776654 56899998887
Q ss_pred cC-CeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhh-cCeEeccCCCCcEEecCCC-----------
Q 002616 566 CR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDG----------- 632 (900)
Q Consensus 566 d~-~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~G----------- 632 (900)
.. ..+|+|||++ |++|.+++.+.+.+++..++.++.||+.||+|||+ .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 65 4789999988 77999999888899999999999999999999997 6999999999999998766
Q ss_pred -----cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeec
Q 002616 633 -----HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 707 (900)
Q Consensus 633 -----~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWS 707 (900)
.+||+|||++... .......+||+.|||||++.+..|+.++||||
T Consensus 281 ~~~~~~vkl~DfG~~~~~------------------------------~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwS 330 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDE------------------------------RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWS 330 (467)
T ss_pred CCCCceEEECCCCccccC------------------------------ccccccccCCccccCcHHhhcCCCCcHHHHHH
Confidence 4999999987531 11223568999999999999999999999999
Q ss_pred hhHHHHHHHhCCCCCCCCChHHHHHhhhcCCCCCC------------------------CC---------------CCCC
Q 002616 708 VGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP------------------------CV---------------PSDM 748 (900)
Q Consensus 708 LGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l~~P------------------------~i---------------p~~l 748 (900)
|||++|||++|++||.+.+..+....+......+| .. ....
T Consensus 331 lGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (467)
T PTZ00284 331 MGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIR 410 (467)
T ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhc
Confidence 99999999999999988776554433322100000 00 0011
Q ss_pred CHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 749 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 749 S~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
++.+.|||.+||++||.+||+ +.++|+||||..
T Consensus 411 ~~~~~dli~~mL~~dP~~R~t---a~e~L~Hp~~~~ 443 (467)
T PTZ00284 411 DDLLCDLIYGLLHYDRQKRLN---ARQMTTHPYVLK 443 (467)
T ss_pred hHHHHHHHHHhCCcChhhCCC---HHHHhcCccccc
Confidence 456789999999999999999 889999999975
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=365.67 Aligned_cols=260 Identities=38% Similarity=0.650 Sum_probs=215.0
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH---HHhcCCCceEEEeeeeccCCeeEEEEeecC
Q 002616 502 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI---LITVRNPFVVRFFYSFTCRDNLYLVMEYLN 578 (900)
Q Consensus 502 ~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~I---L~~L~HPnIVkL~~~f~d~~~LyLVmEy~~ 578 (900)
.||+|+||.||+|++..+|+.||+|++.+...........+..|..+ +....||+|+++++.|...+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999976544333333334445444 444579999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCC
Q 002616 579 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 658 (900)
Q Consensus 579 GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~ 658 (900)
||+|..++.+.+.+++..++.++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~------------ 148 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS------------ 148 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccC------------
Confidence 99999999888889999999999999999999999999999999999999999999999999986321
Q ss_pred CCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCC---ChHHHHHhh
Q 002616 659 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE---SPEIIFDNI 734 (900)
Q Consensus 659 ~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~---s~~ei~~kI 734 (900)
.......+||+.|+|||++.+ ..++.++|+||+||++|||++|+.||... ........+
T Consensus 149 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 211 (278)
T cd05606 149 -----------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT 211 (278)
T ss_pred -----------------ccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh
Confidence 001123579999999999975 46899999999999999999999999876 333333333
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChh--cHHHHHcCCCCCCCCcchhhhc
Q 002616 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN--GAAEVKAHPFFKGVNWDSLALQ 793 (900)
Q Consensus 735 l~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~--~a~EIL~HPFFk~idw~~L~~~ 793 (900)
......+ +..++.++.+||.+||..||.+||... .+.++++||||++++|..+...
T Consensus 212 ~~~~~~~---~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~ 269 (278)
T cd05606 212 LTMAVEL---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQ 269 (278)
T ss_pred hccCCCC---CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhhc
Confidence 3333333 466799999999999999999999322 3889999999999999988655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=383.10 Aligned_cols=262 Identities=33% Similarity=0.534 Sum_probs=220.0
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-----CC
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-----RD 568 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d-----~~ 568 (900)
...|..++.||+|+||.|+.+.++.||+.||||.+.. .....-..++..+|+.+|+.++|+||+.+++.+.. -+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3455668999999999999999999999999998853 24455667889999999999999999999999877 24
Q ss_pred eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
.+|+|+|+|. -||...++....++++.+++++.||+.||+|+|+.||+||||||.|+|++.+..+||+|||||+.....
T Consensus 100 DvYiV~elMe-tDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~ 178 (359)
T KOG0660|consen 100 DVYLVFELME-TDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF 178 (359)
T ss_pred eeEEehhHHh-hHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc
Confidence 6999999995 599999988888999999999999999999999999999999999999999999999999999853110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 727 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~ 727 (900)
.........+-|.+|.|||++.. ..|+.++||||+|||+.|||+|++-|.+.+.
T Consensus 179 -------------------------~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~ 233 (359)
T KOG0660|consen 179 -------------------------FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY 233 (359)
T ss_pred -------------------------CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence 01122345788999999999874 6899999999999999999999999998875
Q ss_pred HHHHHhhhc----------------------------CCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcC
Q 002616 728 EIIFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 728 ~ei~~kIl~----------------------------~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~H 779 (900)
......|+. .+.+|..+-+..++.+.||+.+||..||.+|+| |+|.|+|
T Consensus 234 v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit---a~eAL~h 310 (359)
T KOG0660|consen 234 VHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT---AEEALAH 310 (359)
T ss_pred HHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC---HHHHhcC
Confidence 444443322 011222233578999999999999999999999 8899999
Q ss_pred CCCCCC
Q 002616 780 PFFKGV 785 (900)
Q Consensus 780 PFFk~i 785 (900)
|||...
T Consensus 311 PYl~~~ 316 (359)
T KOG0660|consen 311 PYLAPY 316 (359)
T ss_pred hhhhhh
Confidence 999764
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=380.01 Aligned_cols=257 Identities=27% Similarity=0.433 Sum_probs=212.5
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 568 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~---- 568 (900)
..++|++.+.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+++.++||||++++++|....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 4689999999999999999999999999999999986532 23344567889999999999999999998876543
Q ss_pred --eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 569 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 569 --~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
.+|+||||+++ +|...+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 57999999976 77777653 48889999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 178 ~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 178 T----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred C----------------------------CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 0 111234579999999999999999999999999999999999999999887
Q ss_pred hHHHHHhhhcCCC----------------------C--------------CC---CCCCCCCHHHHHHHHHhccCCcCCC
Q 002616 727 PEIIFDNILNRKI----------------------P--------------WP---CVPSDMSFEAQDLINRFLIHDPNQR 767 (900)
Q Consensus 727 ~~ei~~kIl~~~l----------------------~--------------~P---~ip~~lS~eakDLIk~cL~~DP~kR 767 (900)
..+.+.+++..-. . ++ ......+.++++||.+||+.||.+|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 309 (364)
T cd07875 230 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309 (364)
T ss_pred HHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccC
Confidence 7666555543100 0 00 0011235678999999999999999
Q ss_pred CChhcHHHHHcCCCCCC
Q 002616 768 LGANGAAEVKAHPFFKG 784 (900)
Q Consensus 768 pSa~~a~EIL~HPFFk~ 784 (900)
|| +.++|+||||..
T Consensus 310 ~t---~~e~L~hp~~~~ 323 (364)
T cd07875 310 IS---VDEALQHPYINV 323 (364)
T ss_pred CC---HHHHhcCccccc
Confidence 99 889999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=379.35 Aligned_cols=257 Identities=28% Similarity=0.467 Sum_probs=210.4
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 568 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~---- 568 (900)
..++|++.+.||+|+||.||+|+++.+|+.||+|++.+.. ........+.+|+.++..++||||++++++|....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 4689999999999999999999999999999999996532 23345667889999999999999999999987554
Q ss_pred --eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 569 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 569 --~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
.+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 47999999976 5666654 348899999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
. ........||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+
T Consensus 175 ~----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 175 T----------------------------NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred c----------------------------CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 0 111234578999999999999999999999999999999999999998776
Q ss_pred hHHHHHhhhc----------------------CCCCCCC-----------------CCCCCCHHHHHHHHHhccCCcCCC
Q 002616 727 PEIIFDNILN----------------------RKIPWPC-----------------VPSDMSFEAQDLINRFLIHDPNQR 767 (900)
Q Consensus 727 ~~ei~~kIl~----------------------~~l~~P~-----------------ip~~lS~eakDLIk~cL~~DP~kR 767 (900)
....+..+.. ....++. .....++++++||.+||+.||++|
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 306 (359)
T cd07876 227 HIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306 (359)
T ss_pred HHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccC
Confidence 5433322211 1111110 112346789999999999999999
Q ss_pred CChhcHHHHHcCCCCCC
Q 002616 768 LGANGAAEVKAHPFFKG 784 (900)
Q Consensus 768 pSa~~a~EIL~HPFFk~ 784 (900)
|| +.+++.||||..
T Consensus 307 ~t---~~e~l~hp~~~~ 320 (359)
T cd07876 307 IS---VDEALRHPYITV 320 (359)
T ss_pred CC---HHHHhcCchhhh
Confidence 99 889999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=365.53 Aligned_cols=268 Identities=33% Similarity=0.574 Sum_probs=228.2
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
..+.|++++.||.|+||.||+|++..++..||+|++... .......+.+|+.+++.++||||+++++.+.....+|+
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 346799999999999999999999999999999998653 34456778899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 573 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
||||++||+|..++.+ ...+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~---- 162 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK---- 162 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc----
Confidence 9999999999888764 45689999999999999999999999999999999999999999999999998863210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
.........|++.|+|||++. ...++.++|||||||++|||++|.+||...+
T Consensus 163 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 163 -----------------------TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred -----------------------cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 011123456889999999985 3457889999999999999999999999888
Q ss_pred hHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhc
Q 002616 727 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ 793 (900)
Q Consensus 727 ~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~ 793 (900)
+...+.++.....+....+..++.++.+||.+||..||++||+ +.++++||||..++|......
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~~~~~~ 283 (292)
T cd06644 220 PMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPS---AAQLLEHPFVSSVTSNRPLRE 283 (292)
T ss_pred HHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcC---HHHHhcCccccccccchhHHH
Confidence 7777666655433322234678899999999999999999999 789999999999998875443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=352.14 Aligned_cols=254 Identities=28% Similarity=0.534 Sum_probs=219.8
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-CeeEEEE
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-DNLYLVM 574 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~-~~LyLVm 574 (900)
+|++++.||+|+||.||+++++.+++.||+|.+.... ......+.+.+|+.++++++||||+++++.+... ..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh-cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999986533 2344566788999999999999999999988754 4689999
Q ss_pred eecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 575 EYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
||+++++|.+++... ..+++..+..++.+++.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~----- 154 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN----- 154 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc-----
Confidence 999999999998763 4589999999999999999999999999999999999999999999999999874310
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~ 732 (900)
.........|++.|+|||++.+..++.++|+||||+++|+|++|+.||...+......
T Consensus 155 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~ 212 (257)
T cd08223 155 ----------------------QCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY 212 (257)
T ss_pred ----------------------cCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 0111234568999999999999999999999999999999999999999888777766
Q ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 733 kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
.+..+.. +..+..+++++.+||.+||+.||.+||+ +.+++.||||
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~~~~ 257 (257)
T cd08223 213 RIIEGKL--PPMPKDYSPELGELIATMLSKRPEKRPS---VKSILRQPYI 257 (257)
T ss_pred HHHhcCC--CCCccccCHHHHHHHHHHhccCcccCCC---HHHHhcCCCC
Confidence 6666544 3345778999999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=395.22 Aligned_cols=259 Identities=29% Similarity=0.406 Sum_probs=224.3
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCC-CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTT-GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~t-Gk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
...|.+.+.||+|+||.||+|....+ +..||+|.+... .......+.+|+.+|..++|||||+++++|...+.+|+
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence 34599999999999999999998877 788999976432 33455678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 573 VMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k----~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.....
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 9999999999988753 346899999999999999999999999999999999999999999999999999743110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 728 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ 728 (900)
.........+||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..
T Consensus 223 -------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~ 277 (478)
T PTZ00267 223 -------------------------VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR 277 (478)
T ss_pred -------------------------cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0011234568999999999999999999999999999999999999999999888
Q ss_pred HHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 729 ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
+++..+..+... ..+..++.++.+||.+||..||++||+ +.+++.|||++.+
T Consensus 278 ~~~~~~~~~~~~--~~~~~~s~~~~~li~~~L~~dP~~Rps---~~~~l~~~~~~~~ 329 (478)
T PTZ00267 278 EIMQQVLYGKYD--PFPCPVSSGMKALLDPLLSKNPALRPT---TQQLLHTEFLKYV 329 (478)
T ss_pred HHHHHHHhCCCC--CCCccCCHHHHHHHHHHhccChhhCcC---HHHHHhCHHHHHH
Confidence 888888776543 234678999999999999999999999 7899999998643
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=397.21 Aligned_cols=264 Identities=29% Similarity=0.478 Sum_probs=227.6
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC--
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-- 568 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~-- 568 (900)
....++|++.+.||+|+||+||+|++..+|+.||||++..... .......+.+|+.+|..++|+||++++..|...+
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 4456799999999999999999999999999999999976433 4456677889999999999999999988775433
Q ss_pred ------eeEEEEeecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEe
Q 002616 569 ------NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 638 (900)
Q Consensus 569 ------~LyLVmEy~~GGsL~dlL~k~----g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsD 638 (900)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||||+.++++||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 378999999999999998643 4689999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhC
Q 002616 639 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 718 (900)
Q Consensus 639 FGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtG 718 (900)
||+++..... .........+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 187 FGls~~~~~~-------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG 241 (496)
T PTZ00283 187 FGFSKMYAAT-------------------------VSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTL 241 (496)
T ss_pred cccCeecccc-------------------------ccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 9998742100 001122356899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 719 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 719 k~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
+.||.+.+..+.+.++..+... .++..+++++.+||.+||+.||.+||+ +.++++|||++..
T Consensus 242 ~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~RPs---~~ell~~p~~~~~ 303 (496)
T PTZ00283 242 KRPFDGENMEEVMHKTLAGRYD--PLPPSISPEMQEIVTALLSSDPKRRPS---SSKLLNMPICKLF 303 (496)
T ss_pred CCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccChhhCcC---HHHHHhCHHHHHh
Confidence 9999999988888888776543 245789999999999999999999999 7899999998753
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=350.64 Aligned_cols=254 Identities=30% Similarity=0.529 Sum_probs=223.2
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+|++.+.||+|+||.||+|.++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++...+.+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 58899999999999999999999999999999865433 34556788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 576 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 576 y~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|++|++|.+++... ..+++..+..++.+++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~------ 153 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD------ 153 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccC------
Confidence 99999999999764 5689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
.........|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+......+
T Consensus 154 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 212 (256)
T cd08529 154 ---------------------NTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK 212 (256)
T ss_pred ---------------------ccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 01112345689999999999999999999999999999999999999998888777777
Q ss_pred hhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 734 Il~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
+..+.. +.++..++.++.++|.+||+.+|++||+ +.+++.|||+
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 256 (256)
T cd08529 213 IIRGVF--PPVSQMYSQQLAQLIDQCLTKDYRQRPD---TFQLLRNPSL 256 (256)
T ss_pred HHcCCC--CCCccccCHHHHHHHHHHccCCcccCcC---HHHHhhCCCC
Confidence 766543 3344678899999999999999999999 8899999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=377.20 Aligned_cols=256 Identities=29% Similarity=0.471 Sum_probs=211.1
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC------
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------ 567 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~------ 567 (900)
.++|++++.||+|+||+||+|.+..+++.||+|++.+.. ........+.+|+.+|+.++||||++++++|...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 478999999999999999999999999999999986532 2223456678999999999999999999888644
Q ss_pred CeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~ 647 (900)
...|++|+++ +++|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~- 169 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD- 169 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC-
Confidence 3479999988 779988775 4569999999999999999999999999999999999999999999999999987421
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 648 ~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+
T Consensus 170 -----------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 220 (343)
T cd07878 170 -----------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGND 220 (343)
T ss_pred -----------------------------CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCC
Confidence 01234579999999999987 568999999999999999999999998876
Q ss_pred hHHHHHhhhcCCC--------------------CCCC--------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 727 PEIIFDNILNRKI--------------------PWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 727 ~~ei~~kIl~~~l--------------------~~P~--------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
..+....+..... .++. .....++.+.+||.+||..||.+||+ +.+++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s---~~ell~ 297 (343)
T cd07878 221 YIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS---ASEALA 297 (343)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC---HHHHhc
Confidence 5554444322100 0011 11245778999999999999999999 889999
Q ss_pred CCCCCCC
Q 002616 779 HPFFKGV 785 (900)
Q Consensus 779 HPFFk~i 785 (900)
||||...
T Consensus 298 hp~~~~~ 304 (343)
T cd07878 298 HPYFSQY 304 (343)
T ss_pred Ccchhcc
Confidence 9999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=376.60 Aligned_cols=261 Identities=31% Similarity=0.523 Sum_probs=221.0
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeccCC----
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRD---- 568 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPn-IVkL~~~f~d~~---- 568 (900)
...|+.+++||.|+||+||+|+.+.+|+.||+|.++-... .+..-....+|+.+|+.++|+| ||.|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~-~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE-EEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc-ccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 5568888899999999999999999999999999875322 1233456789999999999999 999999999988
Q ss_pred --eeEEEEeecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCc
Q 002616 569 --NLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 642 (900)
Q Consensus 569 --~LyLVmEy~~GGsL~dlL~k~g----~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLA 642 (900)
.+|+|+||+.. +|..++.... .++...++.+++||+.||+|||+++|+||||||+||||+++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999976 9999998765 5788899999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCC
Q 002616 643 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 721 (900)
Q Consensus 643 k~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~P 721 (900)
+... .+.......++|.+|.|||++.|. .|+..+||||+|||++||+++++-
T Consensus 168 ra~~---------------------------ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~L 220 (323)
T KOG0594|consen 168 RAFS---------------------------IPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPL 220 (323)
T ss_pred HHhc---------------------------CCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCC
Confidence 8421 112224456899999999999986 799999999999999999999999
Q ss_pred CCCCChHHHHHhhhc-----CCCCCCC-------------C---------CCCCCHHHHHHHHHhccCCcCCCCChhcHH
Q 002616 722 FTAESPEIIFDNILN-----RKIPWPC-------------V---------PSDMSFEAQDLINRFLIHDPNQRLGANGAA 774 (900)
Q Consensus 722 F~~~s~~ei~~kIl~-----~~l~~P~-------------i---------p~~lS~eakDLIk~cL~~DP~kRpSa~~a~ 774 (900)
|.+.+..+...+|.. ....||. . .+..++++.+|+.+||+++|.+|.+ |.
T Consensus 221 FpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S---a~ 297 (323)
T KOG0594|consen 221 FPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS---AK 297 (323)
T ss_pred CCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC---HH
Confidence 999998777777654 1112221 1 1234468999999999999999999 77
Q ss_pred HHHcCCCCCCCC
Q 002616 775 EVKAHPFFKGVN 786 (900)
Q Consensus 775 EIL~HPFFk~id 786 (900)
.++.||||....
T Consensus 298 ~al~h~yf~~~~ 309 (323)
T KOG0594|consen 298 GALTHPYFSELP 309 (323)
T ss_pred HHhcChhhcccc
Confidence 899999998763
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=356.33 Aligned_cols=262 Identities=27% Similarity=0.465 Sum_probs=221.7
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeeccc---ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD---MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~---~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
+|++.+.||+|+||+||+|.. .+|+.+|+|.++... .........+.+|+++|+.++||||+++++++.+.+.+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 578899999999999999986 478999999886432 1223445678999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 573 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
||||++||+|.+++.+.+.+++..+..++.|++.||+|||+.||+|+||||+||+++.++.+||+|||++.........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~- 158 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH- 158 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc-
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998743110000
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~ 732 (900)
...........||+.|+|||++.+..++.++|+|||||++|+|++|..||...+......
T Consensus 159 --------------------~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~ 218 (265)
T cd06631 159 --------------------GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF 218 (265)
T ss_pred --------------------ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH
Confidence 000111234569999999999999899999999999999999999999998876655555
Q ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 733 kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
.+.......|.++..++.++.+||++||..+|.+||+ +.+++.||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~l~~~~~ 265 (265)
T cd06631 219 YIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPS---ALQLLRHDFL 265 (265)
T ss_pred HhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCC---HHHHhcCCCC
Confidence 5544433445566789999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=362.45 Aligned_cols=274 Identities=46% Similarity=0.845 Sum_probs=229.0
Q ss_pred CeEEEEEeccCCceEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCee
Q 002616 496 DFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMI-RKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 570 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k---~tGk~VAIKiLkK~~~~-~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~L 570 (900)
+|++.+.||+|+||.||++++. .+++.||+|++++.... ......++.+|+.++..+ +||||+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 46789999999764432 233456788999999999 599999999999999999
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
|+||||+++|+|.+++.....+++..++.++.|++.||.|||+.|++||||||.||+++.++.++|+|||+++.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-- 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc--
Confidence 999999999999999988788999999999999999999999999999999999999999999999999998742110
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCC--CCccceeechhHHHHHHHhCCCCCCCCC--
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAES-- 726 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~--ys~ksDIWSLGVILyEMLtGk~PF~~~s-- 726 (900)
.........|++.|+|||.+.+.. ++.++|+||||+++|||++|..||....
T Consensus 159 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~ 214 (288)
T cd05583 159 ------------------------EEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ 214 (288)
T ss_pred ------------------------cccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc
Confidence 011122356899999999987654 7889999999999999999999996543
Q ss_pred --hHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhc--cCCcc
Q 002616 727 --PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFV 798 (900)
Q Consensus 727 --~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~--~ppf~ 798 (900)
..++.+.+.....+ .+..++.++.+||.+||+.||++||++.++.++|+||||+.++|+.+... .++|.
T Consensus 215 ~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 287 (288)
T cd05583 215 NSQSEISRRILKSKPP---FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAPFK 287 (288)
T ss_pred chHHHHHHHHHccCCC---CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHHHhhhccCCCCC
Confidence 23344444444333 34678899999999999999999999989999999999999999988665 34443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=365.02 Aligned_cols=261 Identities=27% Similarity=0.503 Sum_probs=215.9
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
..++|++++.||.|+||.||+|+++.+++.||+|.++.... ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 46789999999999999999999999999999999865322 2234567789999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 573 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
||||++ ++|..++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~---- 156 (301)
T cd07873 82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI---- 156 (301)
T ss_pred EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC----
Confidence 999997 5898888754 4689999999999999999999999999999999999999999999999999863210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei 730 (900)
.........+++.|+|||++.+ ..++.++|||||||++|||++|++||...+..+.
T Consensus 157 -----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~ 213 (301)
T cd07873 157 -----------------------PTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213 (301)
T ss_pred -----------------------CCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 0111223467899999999876 4578899999999999999999999998776555
Q ss_pred HHhhhcC-------------------CCCCCC--------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCC
Q 002616 731 FDNILNR-------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 731 ~~kIl~~-------------------~l~~P~--------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk 783 (900)
...+... ...+|. ....+++++++||.+||+.||.+||+ +.++++||||+
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t---~~eil~h~~f~ 290 (301)
T cd07873 214 LHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS---AEEAMKHPYFH 290 (301)
T ss_pred HHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC---HHHHhcCcccc
Confidence 4433210 001111 11357889999999999999999999 88999999998
Q ss_pred CCC
Q 002616 784 GVN 786 (900)
Q Consensus 784 ~id 786 (900)
.+.
T Consensus 291 ~~~ 293 (301)
T cd07873 291 CLG 293 (301)
T ss_pred ccc
Confidence 654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=361.82 Aligned_cols=260 Identities=33% Similarity=0.576 Sum_probs=224.7
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
.++|++++.||.|+||.||+|++..++..||+|+++.. .......+.+|+.+++.++||||+++++.+.....+|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 46799999999999999999999989999999998642 344567889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 574 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
|||+++|+|.+++.+. ..+++..++.++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~----- 155 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS----- 155 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcc-----
Confidence 9999999999998764 4699999999999999999999999999999999999999999999999998764210
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP 727 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~ 727 (900)
.........||+.|+|||++. +..++.++|+|||||++|||++|++||...+.
T Consensus 156 ----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~ 213 (280)
T cd06611 156 ----------------------TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213 (280)
T ss_pred ----------------------cccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence 011223457899999999985 34567899999999999999999999998888
Q ss_pred HHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 002616 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786 (900)
Q Consensus 728 ~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~id 786 (900)
.....++.....+....+..++.++.+||.+||+.||.+||+ +.++++||||+...
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~~ 269 (280)
T cd06611 214 MRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPT---AAELLKHPFVSDQS 269 (280)
T ss_pred HHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcC---HHHHhcChhhcccc
Confidence 777777766543322334678999999999999999999999 88999999998764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=354.45 Aligned_cols=261 Identities=31% Similarity=0.528 Sum_probs=221.2
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeeccccc------chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI------RKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 569 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~------~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ 569 (900)
.|.+...||.|+||.||+|.+..+++.||+|.+...... .....+.+.+|+.++..++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999999989999999988654322 12345678899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 570 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
+++||||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....+.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999987532100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 729 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~e 729 (900)
. ............|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...+...
T Consensus 161 ~---------------------~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 219 (267)
T cd06628 161 L---------------------STKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219 (267)
T ss_pred c---------------------cCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH
Confidence 0 0000112234568999999999999889999999999999999999999998876655
Q ss_pred HHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 730 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 730 i~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
....+... ..+.++..++.++.+||++||+.||.+||+ +.++++||||
T Consensus 220 ~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~ 267 (267)
T cd06628 220 AIFKIGEN--ASPEIPSNISSEAIDFLEKTFEIDHNKRPT---AAELLKHPFL 267 (267)
T ss_pred HHHHHhcc--CCCcCCcccCHHHHHHHHHHccCCchhCcC---HHHHhhCCCC
Confidence 55554442 224455788999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=366.19 Aligned_cols=244 Identities=20% Similarity=0.219 Sum_probs=211.1
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----CCeeEEEEee
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNLYLVMEY 576 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d----~~~LyLVmEy 576 (900)
..||+|++|.||+|.+ +|+.||+|++++.........+.+.+|+.+|.+++|||||++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5799999999999988 489999999976544444446788999999999999999999999877 3578999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhh-cCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCC
Q 002616 577 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 577 ~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
++||+|.+++.+...+++.....++.+++.||.|||+ .+++||||||+|||++.+|.+||+|||+++...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~--------- 174 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS--------- 174 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc---------
Confidence 9999999999988889999999999999999999998 499999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+..+++..
T Consensus 175 ---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~ 233 (283)
T PHA02988 175 ---------------------SPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL 233 (283)
T ss_pred ---------------------cccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 01123578999999999976 6899999999999999999999999999998888888
Q ss_pred hhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 734 Il~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
+.....+++ ++...++++++||.+||+.||.+||++.++.+.|
T Consensus 234 i~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l 276 (283)
T PHA02988 234 IINKNNSLK-LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNL 276 (283)
T ss_pred HHhcCCCCC-CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHH
Confidence 876655433 4467899999999999999999999965554443
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=356.16 Aligned_cols=255 Identities=40% Similarity=0.739 Sum_probs=222.6
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+|++.+.||.|+||.||+|++..+++.||+|++.+.........+.+.+|++++++++||||+++++++.....+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999987655555667889999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCC
Q 002616 576 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 576 y~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
|+.|++|..++.+...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~-------- 152 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP-------- 152 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC--------
Confidence 999999999998877899999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh---HHHHH
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP---EIIFD 732 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~---~ei~~ 732 (900)
........|+..|+|||++.+..++.++|+||||+++|+|++|..||...+. ..+..
T Consensus 153 --------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (258)
T cd05578 153 --------------------DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA 212 (258)
T ss_pred --------------------CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence 0012335688999999999988899999999999999999999999988774 33333
Q ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 733 kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
...... +..+..++.++.++|.+||..||.+||++. +.++++||||
T Consensus 213 ~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~-~~~l~~~~~~ 258 (258)
T cd05578 213 KQETAD---VLYPATWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258 (258)
T ss_pred Hhcccc---ccCcccCcHHHHHHHHHHccCChhHcCCcc-HHHHhcCCCC
Confidence 332222 334577899999999999999999999943 4899999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=357.99 Aligned_cols=255 Identities=38% Similarity=0.663 Sum_probs=215.6
Q ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 576 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy 576 (900)
|++.+.||+|+||+||++++..+++.||+|++....... .......+|+.++..++||||+++++++.....+|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhccccccccccccccccccccccccccccc
Confidence 789999999999999999999999999999998754322 2233445699999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCC
Q 002616 577 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 656 (900)
Q Consensus 577 ~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~ 656 (900)
+++++|.+++.+.+.+++..+..++.||+.||++||++||+||||||+|||++.++.++|+|||++....
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~---------- 149 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS---------- 149 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST----------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------
Confidence 9999999999988889999999999999999999999999999999999999999999999999986320
Q ss_pred CCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc-CCCCCccceeechhHHHHHHHhCCCCCCCCC---hHHHHH
Q 002616 657 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAES---PEIIFD 732 (900)
Q Consensus 657 ~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s---~~ei~~ 732 (900)
..........||+.|+|||++. +..++.++||||||+++|+|++|..||.... ......
T Consensus 150 -----------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~ 212 (260)
T PF00069_consen 150 -----------------ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE 212 (260)
T ss_dssp -----------------STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH
T ss_pred -----------------ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh
Confidence 1122334567899999999998 7889999999999999999999999999873 334444
Q ss_pred hhhcCCCCCCC-CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 733 NILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 733 kIl~~~l~~P~-ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
+........+. .....+.++.+||.+||..||++||+ +.++++||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~---~~~l~~~~~~ 260 (260)
T PF00069_consen 213 KILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPS---AEELLKHPWF 260 (260)
T ss_dssp HHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTT---HHHHHTSGGG
T ss_pred hcccccccccccccchhHHHHHHHHHHHccCChhHCcC---HHHHhcCCCC
Confidence 43332221110 01123489999999999999999999 8899999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=359.86 Aligned_cols=256 Identities=33% Similarity=0.556 Sum_probs=219.3
Q ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 576 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy 576 (900)
|++.+.||.|+||.||+|++..++..+|+|.+... .......+.+|+.+++.++||||+++++.|...+..|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 68889999999999999999999999999998643 234567788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCC
Q 002616 577 LNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 577 ~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
+++|+|..++.+ ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~-------- 155 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-------- 155 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc--------
Confidence 999999988765 45689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei 730 (900)
.........||+.|+|||++. +..++.++|+|||||++|||++|.+||...++.+.
T Consensus 156 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 216 (282)
T cd06643 156 -------------------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV 216 (282)
T ss_pred -------------------cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH
Confidence 001123457899999999984 35578899999999999999999999998887777
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
...+..........+..++.++.+||.+||..||.+||+ +.++++||||+..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~ 268 (282)
T cd06643 217 LLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWT---TTQLLQHPFVTVN 268 (282)
T ss_pred HHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCCCEecc
Confidence 666655433222334678999999999999999999999 7899999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=358.70 Aligned_cols=257 Identities=32% Similarity=0.500 Sum_probs=217.1
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
...++|++.+.||+|+||.||+|++..+++.||+|+++... ......+.+|+.+++.++||||+++++++...+.+|
T Consensus 6 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred CcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence 34568999999999999999999999999999999986532 234456788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
+||||+++|+|.+++...+.+++..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~---- 158 (267)
T cd06645 83 ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA---- 158 (267)
T ss_pred EEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC----
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999864210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc---CCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 728 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ 728 (900)
.........||+.|+|||++. ...++.++|+|||||++|+|++|.+||....+.
T Consensus 159 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~ 215 (267)
T cd06645 159 -----------------------TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred -----------------------cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch
Confidence 001123457999999999985 456888999999999999999999999776655
Q ss_pred HHHHhhhcCCCCCCCC--CCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCC
Q 002616 729 IIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781 (900)
Q Consensus 729 ei~~kIl~~~l~~P~i--p~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPF 781 (900)
.....+.......+.. ...++..+.+||.+||..||++||+ +.+++.|||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~---~~~ll~~~~ 267 (267)
T cd06645 216 RALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPT---AEKLLQHPF 267 (267)
T ss_pred hhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcC---HHHHhcCCC
Confidence 4443333333322221 1357889999999999999999999 889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=391.32 Aligned_cols=257 Identities=31% Similarity=0.539 Sum_probs=234.2
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe-eEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN-LYL 572 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~-LyL 572 (900)
.++|..++++|+|+||.+++++++..++.|++|.+.-.... ....+...+|+.+++++.|||||.+.+.|..++. ++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t-~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT-EPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC-chhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 57899999999999999999999999999999999765443 3445588999999999999999999999999998 999
Q ss_pred EEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 573 VMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
||+||+||+|.+.+.+.. .|+++.+..|+.|++.|+.|||+++|+|||||+.||+++.++.|||+|||+|+...
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~---- 157 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN---- 157 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC----
Confidence 999999999999997544 59999999999999999999999999999999999999999999999999999632
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei 730 (900)
.....+.+.+|||.||.||++.+.+|+.++|||||||++|||++-+++|.+.+...+
T Consensus 158 -----------------------~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L 214 (426)
T KOG0589|consen 158 -----------------------PEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL 214 (426)
T ss_pred -----------------------CchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH
Confidence 112256778999999999999999999999999999999999999999999999999
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCC
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk 783 (900)
..+|....+ ..+|...+.+++.||+.||..+|..||+ |.++|.+|...
T Consensus 215 i~ki~~~~~--~Plp~~ys~el~~lv~~~l~~~P~~RPs---a~~LL~~P~l~ 262 (426)
T KOG0589|consen 215 ILKINRGLY--SPLPSMYSSELRSLVKSMLRKNPEHRPS---ALELLRRPHLL 262 (426)
T ss_pred HHHHhhccC--CCCCccccHHHHHHHHHHhhcCCccCCC---HHHHhhChhhh
Confidence 999998873 3356899999999999999999999999 88999998876
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=351.27 Aligned_cols=260 Identities=32% Similarity=0.547 Sum_probs=221.4
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++.+.||.|+||+||+|.+..++..+|+|++...... .....+.+|+.+|+.++||||+++++.+...+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 5799999999999999999999999999999998654332 26678999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 575 EYLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~---g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
||++|++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++++++.+||+|||++........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~- 157 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD- 157 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc-
Confidence 999999999999764 4589999999999999999999999999999999999999999999999999875321000
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei 730 (900)
.........+|++.|+|||++... .++.++|+|||||++|+|++|+.||...+....
T Consensus 158 ----------------------~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~ 215 (267)
T cd06610 158 ----------------------RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV 215 (267)
T ss_pred ----------------------ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh
Confidence 000122445799999999999876 789999999999999999999999998887776
Q ss_pred HHhhhcCCCC-CCCCC--CCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 731 FDNILNRKIP-WPCVP--SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 731 ~~kIl~~~l~-~P~ip--~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
+.++...... ++... ..+++++.+||.+||..||.+||+ +.+++.||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~ll~~p~~ 267 (267)
T cd06610 216 LMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT---AEELLKHKFF 267 (267)
T ss_pred HHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcC---HHHHhhCCCC
Confidence 6666554321 12111 367899999999999999999999 8899999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=365.78 Aligned_cols=256 Identities=31% Similarity=0.514 Sum_probs=216.5
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++.+.||+|+||.||++++..+|..||+|.+... ........+.+|++++..++||||++++++|...+.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 4799999999999999999999999999999998642 23344567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhh-cCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
||++||+|.+++.+.+.+++..++.++.|++.||.|||+ .+++||||||+|||++.+|.+||+|||++....
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~------- 151 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI------- 151 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc-------
Confidence 999999999999988889999999999999999999997 599999999999999999999999999886321
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
.......+|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......
T Consensus 152 ----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~ 209 (308)
T cd06615 152 ----------------------DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209 (308)
T ss_pred ----------------------ccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHh
Confidence 0112345799999999999888899999999999999999999999976654433322
Q ss_pred hhcCCC----------------------------------CCCCCC-CCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 734 ILNRKI----------------------------------PWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 734 Il~~~l----------------------------------~~P~ip-~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
+..... ..|..+ ..++.++++||.+||..||++||+ +.+++.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~ 286 (308)
T cd06615 210 FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERAD---LKELTK 286 (308)
T ss_pred hcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcC---HHHHhc
Confidence 211000 001111 236789999999999999999999 889999
Q ss_pred CCCCCC
Q 002616 779 HPFFKG 784 (900)
Q Consensus 779 HPFFk~ 784 (900)
||||.+
T Consensus 287 ~~~~~~ 292 (308)
T cd06615 287 HPFIKR 292 (308)
T ss_pred Chhhhh
Confidence 999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=375.52 Aligned_cols=257 Identities=27% Similarity=0.451 Sum_probs=210.4
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 568 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~---- 568 (900)
..++|++++.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||++++++|....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 4689999999999999999999999999999999986532 23344567889999999999999999999886543
Q ss_pred --eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 569 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 569 --~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
.+|+||||+++ +|...+.. .+++..+..++.|++.||.|||++||+||||||+||||+.+|.+||+|||+++...
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 57999999976 67666653 48899999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+
T Consensus 171 ----------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 171 ----------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred ----------------------------CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 0111234579999999999999999999999999999999999999998876
Q ss_pred hHHHHHhhhcC----------------------C-----CCCC------------CCCCCCCHHHHHHHHHhccCCcCCC
Q 002616 727 PEIIFDNILNR----------------------K-----IPWP------------CVPSDMSFEAQDLINRFLIHDPNQR 767 (900)
Q Consensus 727 ~~ei~~kIl~~----------------------~-----l~~P------------~ip~~lS~eakDLIk~cL~~DP~kR 767 (900)
..+.+..+... . ..+| ..+...+.++++||.+||..||.+|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R 302 (355)
T cd07874 223 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302 (355)
T ss_pred HHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhc
Confidence 54443322210 0 0000 0112346788999999999999999
Q ss_pred CChhcHHHHHcCCCCCC
Q 002616 768 LGANGAAEVKAHPFFKG 784 (900)
Q Consensus 768 pSa~~a~EIL~HPFFk~ 784 (900)
|+ +.++++||||..
T Consensus 303 ps---~~ell~hp~~~~ 316 (355)
T cd07874 303 IS---VDEALQHPYINV 316 (355)
T ss_pred CC---HHHHhcCcchhc
Confidence 99 889999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=394.08 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=219.8
Q ss_pred cccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 002616 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 489 ~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~ 568 (900)
...+..+.+.+++.||+|-||+||+|.+.. ...||+|.++...+ ..+.|.+|+++|++++|+|||+|++++..+.
T Consensus 200 ~wei~r~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 200 PWEIPREELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred CeeecHHHHHHHHHhcCCccceEEEEEEcC-CCcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 334555667788999999999999999984 23799999976433 3467889999999999999999999999999
Q ss_pred eeEEEEeecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k--~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
.+|||||||+.|+|.++|+. ...+...+...++.|||.||+||+++++|||||-..||||++++.+||+|||||+...
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999999987 4569999999999999999999999999999999999999999999999999999532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 725 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~ 725 (900)
.+... .....--...|.|||++....++.++|||||||+||||+| |+.||.+.
T Consensus 355 d~~Y~--------------------------~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m 408 (468)
T KOG0197|consen 355 DDEYT--------------------------ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM 408 (468)
T ss_pred CCcee--------------------------ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC
Confidence 21111 0111123467999999999999999999999999999998 99999999
Q ss_pred ChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcC
Q 002616 726 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 726 s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~H 779 (900)
+..++.+.+..+ .++|. |..+|+++.+++..||..+|++|||++.....+..
T Consensus 409 sn~ev~~~le~G-yRlp~-P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~ 460 (468)
T KOG0197|consen 409 SNEEVLELLERG-YRLPR-PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLED 460 (468)
T ss_pred CHHHHHHHHhcc-CcCCC-CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence 999999887654 45553 68999999999999999999999998765555543
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=356.22 Aligned_cols=257 Identities=29% Similarity=0.474 Sum_probs=217.2
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
...++|++.+.||+|+||.||+|+++.+|+.||+|++.... ......+.+|+.++..++||||+++++++...+.+|
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW 82 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence 34568999999999999999999999999999999986432 234456889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
+||||+++|+|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~---- 158 (267)
T cd06646 83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA---- 158 (267)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc----
Confidence 9999999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc---CCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 728 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ 728 (900)
.........|++.|+|||.+. ...++.++|+|||||++|||++|.+||...++.
T Consensus 159 -----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~ 215 (267)
T cd06646 159 -----------------------TIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM 215 (267)
T ss_pred -----------------------cccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 001123457899999999985 345788999999999999999999999876665
Q ss_pred HHHHhhhcCCCCCCCC--CCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCC
Q 002616 729 IIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781 (900)
Q Consensus 729 ei~~kIl~~~l~~P~i--p~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPF 781 (900)
.....+.......+.. ...++..+.+||++||+.||++||+ +.+|++|+|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~~l~ 267 (267)
T cd06646 216 RALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPT---AERLLTHLF 267 (267)
T ss_pred hhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcC---HHHHhcCCC
Confidence 5444443333332221 2457899999999999999999999 779999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=376.87 Aligned_cols=251 Identities=33% Similarity=0.563 Sum_probs=213.0
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----ee
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----NL 570 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~-----~L 570 (900)
.|.-.+++|.|+||.||+|....+++.||||.+-..... -.+|.++|..++|||||+|.++|.... .+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 578889999999999999999999999999987543322 246999999999999999998886543 46
Q ss_pred EEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCC-CcEEEEecCCcccc
Q 002616 571 YLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIG 645 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k----~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~-G~VKLsDFGLAk~~ 645 (900)
.+||||||. +|...++. ...++.-.++.|+.||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+..
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 789999997 99998874 4678999999999999999999999999999999999999976 99999999999964
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCC
Q 002616 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 724 (900)
Q Consensus 646 ~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~ 724 (900)
. .+....+...|..|+|||.+.| ..|+.+.||||.||+|.||+-|++-|.+
T Consensus 177 ~----------------------------~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG 228 (364)
T KOG0658|consen 177 V----------------------------KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPG 228 (364)
T ss_pred c----------------------------cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCC
Confidence 2 1233456778999999999987 6799999999999999999999999999
Q ss_pred CChHHHHHhhhcC-----------------CCCCCC---------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 725 ESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 725 ~s~~ei~~kIl~~-----------------~l~~P~---------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
.+..+....|.+. ...+|. +...+++++.+|+.++|.++|.+|.+ +.+++.
T Consensus 229 ~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~---~~~~l~ 305 (364)
T KOG0658|consen 229 DSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS---ALEALA 305 (364)
T ss_pred CCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC---HHHHhc
Confidence 9877766665431 111222 23567999999999999999999999 889999
Q ss_pred CCCCCCC
Q 002616 779 HPFFKGV 785 (900)
Q Consensus 779 HPFFk~i 785 (900)
||||..+
T Consensus 306 h~fFdel 312 (364)
T KOG0658|consen 306 HPFFDEL 312 (364)
T ss_pred chhhHHh
Confidence 9999764
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=358.43 Aligned_cols=252 Identities=28% Similarity=0.478 Sum_probs=212.7
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++++.||+|+||.||+|.+..+++.||+|++.+.. .......+.+|+.++.+++||||+++++.|...+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 47899999999999999999999999999999986532 2344567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||+++|+|..+ ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.+||+|||++....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~-------- 146 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLV-------- 146 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecc--------
Confidence 99999998654 357889999999999999999999999999999999999999999999999987421
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh-------
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP------- 727 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~------- 727 (900)
.......+||+.|+|||++.+..++.++|+|||||++|+|++|..||.....
T Consensus 147 ---------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 205 (279)
T cd06619 147 ---------------------NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP 205 (279)
T ss_pred ---------------------cccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch
Confidence 0112345799999999999999999999999999999999999999965321
Q ss_pred HHHHHhhhcCCC-CCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 002616 728 EIIFDNILNRKI-PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786 (900)
Q Consensus 728 ~ei~~kIl~~~l-~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~id 786 (900)
......+..... ..+ ....++++.+||.+||+.||.+||+ +.+++.||||...+
T Consensus 206 ~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~---~~eil~~~~~~~~~ 260 (279)
T cd06619 206 LQLLQCIVDEDPPVLP--VGQFSEKFVHFITQCMRKQPKERPA---PENLMDHPFIVQYN 260 (279)
T ss_pred HHHHHHHhccCCCCCC--CCcCCHHHHHHHHHHhhCChhhCCC---HHHHhcCccccccc
Confidence 233333332221 111 2457889999999999999999999 88999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=356.55 Aligned_cols=255 Identities=30% Similarity=0.507 Sum_probs=209.3
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+|++.+.||.|+||.||+|+++.+|..||+|+++... ........+.+|+.++..++||||+++++++.+++.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 5899999999999999999999999999999986532 223345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 576 YLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 576 y~~GGsL~dlL~k~---g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
|++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 153 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI----- 153 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC-----
Confidence 997 5888887643 4689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~ 731 (900)
.........|++.|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+.....
T Consensus 154 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~ 211 (285)
T cd07861 154 ----------------------PVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL 211 (285)
T ss_pred ----------------------CcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 0011123467899999999876 45788999999999999999999999876654332
Q ss_pred HhhhcCC------------------CCC--------CCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 732 DNILNRK------------------IPW--------PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 732 ~kIl~~~------------------l~~--------P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
..+.... ..+ ......+++++.+||++||+.||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt---~~~ll~~~~~ 285 (285)
T cd07861 212 FRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS---AKKALNHPYF 285 (285)
T ss_pred HHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC---HHHHhcCCCC
Confidence 2221100 000 0012457899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=352.68 Aligned_cols=260 Identities=30% Similarity=0.488 Sum_probs=218.3
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cee
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 570 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~--~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~L 570 (900)
.+|++.+.||+|+||.||+|.+..+|..||+|+++.... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 478999999999999999999999999999999865332 2234567789999999999999999999988763 578
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
|++|||+++++|.+++.+.+.+++.....++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~- 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC- 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei 730 (900)
..........|+..|+|||.+.+..++.++|+|||||++|||++|++||........
T Consensus 161 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~ 217 (266)
T cd06651 161 -----------------------MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA 217 (266)
T ss_pred -----------------------ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH
Confidence 000111234689999999999998899999999999999999999999988766555
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCC
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk 783 (900)
...+..... .|.++..+++.+++|| +||..+|++||+ +.++++||||+
T Consensus 218 ~~~~~~~~~-~~~~~~~~~~~~~~li-~~~~~~p~~Rp~---~~eil~hp~~~ 265 (266)
T cd06651 218 IFKIATQPT-NPQLPSHISEHARDFL-GCIFVEARHRPS---AEELLRHPFAQ 265 (266)
T ss_pred HHHHhcCCC-CCCCchhcCHHHHHHH-HHhcCChhhCcC---HHHHhcCcccc
Confidence 554443322 2455677889999999 577789999999 88999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=350.67 Aligned_cols=260 Identities=29% Similarity=0.483 Sum_probs=219.6
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeeccc--ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cee
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD--MIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 570 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~--~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~L 570 (900)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .........+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 58999999999999999999999999999999886432 12234567889999999999999999999998774 468
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
|+||||++||+|.+++.+.+.+++..+..++.|++.||+|||+.||+|+||||+|||++.++.+||+|||+++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~- 160 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC- 160 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc-
Confidence 8999999999999999888889999999999999999999999999999999999999999999999999987421000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei 730 (900)
..........||..|+|||++.+..++.++|+|||||++|||++|++||........
T Consensus 161 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 217 (265)
T cd06652 161 -----------------------LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA 217 (265)
T ss_pred -----------------------ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH
Confidence 000112335689999999999988899999999999999999999999988766665
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCC
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk 783 (900)
...+.... ..+..|..++..+.++|.+||. +|.+||+ +.+++.|||++
T Consensus 218 ~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~---~~~il~~~~~~ 265 (265)
T cd06652 218 IFKIATQP-TNPVLPPHVSDHCRDFLKRIFV-EAKLRPS---ADELLRHTFVH 265 (265)
T ss_pred HHHHhcCC-CCCCCchhhCHHHHHHHHHHhc-ChhhCCC---HHHHhcCcccC
Confidence 55544332 2244567788999999999996 9999999 88999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=357.92 Aligned_cols=269 Identities=43% Similarity=0.820 Sum_probs=224.7
Q ss_pred CeEEEEEeccCCceEEEEEEEC---CCCcEEEEEEeeccccc-chhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCee
Q 002616 496 DFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMI-RKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 570 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k---~tGk~VAIKiLkK~~~~-~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~L 570 (900)
+|++.+.||.|+||.||+|+.. .+|+.||+|++++.... .....+++.+|+.+|..+ +||||++++++|.....+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5889999999999999999875 47899999999764332 223456788999999999 599999999999999999
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
|+||||+++|+|.+++.....+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-- 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc--
Confidence 999999999999999988888999999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCCCCCC--
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAES-- 726 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGVILyEMLtGk~PF~~~s-- 726 (900)
.........|++.|+|||.+.+ ..++.++|+||||+++|+|++|..||....
T Consensus 159 ------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~ 214 (290)
T cd05613 159 ------------------------EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK 214 (290)
T ss_pred ------------------------cccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc
Confidence 0111234578999999999875 357889999999999999999999997543
Q ss_pred --hHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhhc
Q 002616 727 --PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ 793 (900)
Q Consensus 727 --~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa--~~a~EIL~HPFFk~idw~~L~~~ 793 (900)
..++...+.....++ +..+++.+.+|+.+||..||.+||+. ..+.+++.||||..++|+.+...
T Consensus 215 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 282 (290)
T cd05613 215 NSQAEISRRILKSEPPY---PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAK 282 (290)
T ss_pred ccHHHHHHHhhccCCCC---CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHhhc
Confidence 234444444444333 46789999999999999999999863 35899999999999999887533
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=349.72 Aligned_cols=254 Identities=31% Similarity=0.568 Sum_probs=218.6
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
.++|++.+.||.|+||.||+|.++.+++.||+|.++... ..+.+.+|+.+++.++||||+++++.+.....+|++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 368999999999999999999999989999999986532 267899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 574 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 574 mEy~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
|||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.....
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~----- 151 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD----- 151 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhccc-----
Confidence 999999999999975 45689999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~ 732 (900)
.........|++.|+|||++.+..++.++|||||||++|+|++|++||...++.....
T Consensus 152 ----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~ 209 (256)
T cd06612 152 ----------------------TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF 209 (256)
T ss_pred ----------------------CccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh
Confidence 0111233558999999999999999999999999999999999999998877655544
Q ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 733 kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
.+..........+..++.++.+||.+||+.||.+||+ +.+++.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps---~~~il~~~~~ 256 (256)
T cd06612 210 MIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPS---AIQLLQHPFI 256 (256)
T ss_pred hhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcC---HHHHhcCCCC
Confidence 4433322222223567889999999999999999999 8899999998
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=358.05 Aligned_cols=267 Identities=23% Similarity=0.356 Sum_probs=220.3
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 566 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~-----tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d 566 (900)
+..++|++.+.||+|+||.||+|..+. .+..||+|.++... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSK 80 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 556889999999999999999997653 34589999886432 22334568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEE
Q 002616 567 RDNLYLVMEYLNGGDLYSLLRKVG----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 636 (900)
Q Consensus 567 ~~~LyLVmEy~~GGsL~dlL~k~g----------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKL 636 (900)
.+..|+||||+++|+|.+++.+.. .++...+..++.|++.||.|||++||+||||||+|||++.++.+||
T Consensus 81 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 81 GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999999997532 2456778889999999999999999999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHH
Q 002616 637 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 716 (900)
Q Consensus 637 sDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEML 716 (900)
+|||+++...... .........++..|+|||.+.+..++.++|+|||||++|||+
T Consensus 161 ~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~ 215 (288)
T cd05061 161 GDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEIT 215 (288)
T ss_pred CcCCccccccccc-------------------------cccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHH
Confidence 9999987421000 000112234678899999999889999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc---CCCCCCCCc
Q 002616 717 T-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA---HPFFKGVNW 787 (900)
Q Consensus 717 t-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~---HPFFk~idw 787 (900)
+ |.+||.+.+..+....+..... +..+...++.+.+||.+||+.||.+||++.++.+.+. ||||++++|
T Consensus 216 ~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 216 SLAEQPYQGLSNEQVLKFVMDGGY--LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 8 8999999888887777765533 2234677899999999999999999999665555433 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=353.21 Aligned_cols=257 Identities=30% Similarity=0.480 Sum_probs=213.6
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++.+.||+|+||.||+|+++.+|+.||+|++.+... .....+.+.+|+.+++.++||||+++++++.....+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 479999999999999999999999999999999865332 2223456789999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||++++.|..++.....+++..++.++.||+.||+|||++|++||||||+||+++.+|.+||+|||++.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------- 152 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTG------- 152 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCC-------
Confidence 9999998888887777899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
.........|+..|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+....
T Consensus 153 --------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~ 212 (286)
T cd07847 153 --------------------PGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL 212 (286)
T ss_pred --------------------CcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 0001223468899999999876 5578999999999999999999999988765444333
Q ss_pred hhcC-------------------CCCCCC---------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 734 ILNR-------------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 734 Il~~-------------------~l~~P~---------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
+... ....|. ....++..+.+||.+||+.||++||+ +.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~eil~~~~f 286 (286)
T cd07847 213 IRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS---CEELLEHPYF 286 (286)
T ss_pred HHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCC---HHHHhcCCCC
Confidence 2210 000111 01356889999999999999999999 7899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=379.83 Aligned_cols=263 Identities=23% Similarity=0.361 Sum_probs=214.9
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 570 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~--tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~L 570 (900)
...+|++++.||.|+||.||+|.... ++..||+|.+.+. ....+|+.+|+.++|||||++++.|.....+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 34579999999999999999998653 4678999987642 1245799999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
|+|||++. ++|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.....
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~-- 238 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH-- 238 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc--
Confidence 99999996 589999977788999999999999999999999999999999999999999999999999998742110
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh---
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP--- 727 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~--- 727 (900)
.........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+...
T Consensus 239 -----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~ 295 (392)
T PHA03207 239 -----------------------PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSS 295 (392)
T ss_pred -----------------------cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCc
Confidence 001122356899999999999999999999999999999999999999976542
Q ss_pred HHHHHhhhc----CCCCC-------------------------CCC--CCCCCHHHHHHHHHhccCCcCCCCChhcHHHH
Q 002616 728 EIIFDNILN----RKIPW-------------------------PCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 776 (900)
Q Consensus 728 ~ei~~kIl~----~~l~~-------------------------P~i--p~~lS~eakDLIk~cL~~DP~kRpSa~~a~EI 776 (900)
...+..+.. ....+ |.. ...++.++++||++||+.||++||+ +.++
T Consensus 296 ~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps---a~e~ 372 (392)
T PHA03207 296 SSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS---AQDI 372 (392)
T ss_pred HHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC---HHHH
Confidence 112222211 00001 100 1245778999999999999999999 8899
Q ss_pred HcCCCCCCCCcchhhh
Q 002616 777 KAHPFFKGVNWDSLAL 792 (900)
Q Consensus 777 L~HPFFk~idw~~L~~ 792 (900)
|.||||+...|+.+..
T Consensus 373 l~~p~f~~~~~~~~~~ 388 (392)
T PHA03207 373 LSLPLFTKEPINLLNI 388 (392)
T ss_pred hhCchhhccchhhhcC
Confidence 9999999988887653
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=351.62 Aligned_cols=261 Identities=29% Similarity=0.498 Sum_probs=218.0
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccc---hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR---KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~---~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
+|+..+.||+|+||.||+|..+.+++.||+|+++...... ......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999999999999999987543211 2245788999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCC-cEEEEecCCcccccccccc
Q 002616 573 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G-~VKLsDFGLAk~~~~~~s~ 651 (900)
||||++|++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~-- 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG-- 158 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc--
Confidence 999999999999998888899999999999999999999999999999999999998876 59999999987431000
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~ 731 (900)
...........||..|+|||++.+..++.++|+||||+++|+|++|..||.........
T Consensus 159 ---------------------~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~ 217 (268)
T cd06630 159 ---------------------TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL 217 (268)
T ss_pred ---------------------ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH
Confidence 00011123357899999999999888999999999999999999999999765433322
Q ss_pred Hhh---hcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCC
Q 002616 732 DNI---LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 732 ~kI---l~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk 783 (900)
..+ .... ..+..+..+++++.++|.+||..||.+||+ +.++++||||+
T Consensus 218 ~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~ll~~~~~~ 268 (268)
T cd06630 218 ALIFKIASAT-TAPSIPEHLSPGLRDVTLRCLELQPEDRPP---SRELLKHPVFR 268 (268)
T ss_pred HHHHHHhccC-CCCCCchhhCHHHHHHHHHHcCCCcccCcC---HHHHhcCcccC
Confidence 222 2222 224455778999999999999999999999 88999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=353.52 Aligned_cols=255 Identities=29% Similarity=0.505 Sum_probs=212.9
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC----
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR---- 567 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~---- 567 (900)
..+.|++.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.++..+ +||||++++++|...
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 3467889999999999999999999999999999986532 2345788899999998 699999999998753
Q ss_pred --CeeEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcc
Q 002616 568 --DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643 (900)
Q Consensus 568 --~~LyLVmEy~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk 643 (900)
..+|+||||+++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 4689999999999999999863 368999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhC
Q 002616 644 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITG 718 (900)
Q Consensus 644 ~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGVILyEMLtG 718 (900)
.... .........|++.|+|||++. +..|+.++|||||||++|||++|
T Consensus 160 ~~~~---------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g 212 (272)
T cd06637 160 QLDR---------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG 212 (272)
T ss_pred eccc---------------------------ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhC
Confidence 4210 001123467999999999986 34688899999999999999999
Q ss_pred CCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 719 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 719 k~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
..||....+......+.....+. ..+..++.++.+||.+||..||.+||+ +.+++.||||
T Consensus 213 ~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~~~~~ 272 (272)
T cd06637 213 APPLCDMHPMRALFLIPRNPAPR-LKSKKWSKKFQSFIESCLVKNHSQRPT---TEQLMKHPFI 272 (272)
T ss_pred CCCccccCHHHHHHHHhcCCCCC-CCCCCcCHHHHHHHHHHcCCChhhCCC---HHHHhhCCCC
Confidence 99998776655554443332221 123567899999999999999999999 7899999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=348.10 Aligned_cols=255 Identities=35% Similarity=0.548 Sum_probs=219.5
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
.++|++.+.||.|+||.||+|.+..+++.+|+|++.... ......+.+|+.+++.++||||+++++++...+.+|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 468999999999999999999999999999999997532 23567889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 574 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+|+||||+||+++.+|.+||+|||++.....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~----- 153 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA----- 153 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh-----
Confidence 9999999999998876 7899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC---CCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EHGYAADWWSVGIILFEFITGIPPFTAESPEI 729 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~---~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~e 729 (900)
.........|+..|+|||.+.+. .++.++|+|||||++|||++|.+||...++..
T Consensus 154 ----------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~ 211 (262)
T cd06613 154 ----------------------TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR 211 (262)
T ss_pred ----------------------hhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 00112335789999999999876 78999999999999999999999999887666
Q ss_pred HHHhhhcCCCCCCC--CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCC
Q 002616 730 IFDNILNRKIPWPC--VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781 (900)
Q Consensus 730 i~~kIl~~~l~~P~--ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPF 781 (900)
....+....+..+. .+...+.++.+||++||..||.+||+ +.+++.|||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~~~~ 262 (262)
T cd06613 212 ALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT---ATKLLQHPF 262 (262)
T ss_pred HHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCC---HHHHhcCCC
Confidence 55555444332221 23456788999999999999999999 889999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=357.58 Aligned_cols=255 Identities=30% Similarity=0.550 Sum_probs=216.2
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++++.||+|+||.||+|++..+|..||+|.++.. ........+.+|+.++.+++||||+++++++...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 4789999999999999999999999999999988642 23344578899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHhhhh-cCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 575 EYLNGGDLYSLLRKV---GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~---g~Lse~~ar~ya~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
||++|++|..++... ..+++..++.++.+++.||.|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~---- 154 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---- 154 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc----
Confidence 999999999988763 378999999999999999999996 599999999999999999999999999986321
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC------CCCccceeechhHHHHHHHhCCCCCCC
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFITGIPPFTA 724 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~------~ys~ksDIWSLGVILyEMLtGk~PF~~ 724 (900)
........|++.|+|||.+.+. .++.++|+|||||++|+|++|..||..
T Consensus 155 -------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 209 (286)
T cd06622 155 -------------------------ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209 (286)
T ss_pred -------------------------CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence 0112234688999999998653 357899999999999999999999987
Q ss_pred CChHHHHHh---hhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 725 ESPEIIFDN---ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 725 ~s~~ei~~k---Il~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
......+.. +... ..+.++..++.++.+||.+||..+|.+||+ +.+++.||||...
T Consensus 210 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~l~~~~~~~~~ 268 (286)
T cd06622 210 ETYANIFAQLSAIVDG--DPPTLPSGYSDDAQDFVAKCLNKIPNRRPT---YAQLLEHPWLVKY 268 (286)
T ss_pred cchhhHHHHHHHHhhc--CCCCCCcccCHHHHHHHHHHcccCcccCCC---HHHHhcChhhhhc
Confidence 665554433 2222 223445679999999999999999999999 7899999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=367.09 Aligned_cols=264 Identities=22% Similarity=0.357 Sum_probs=210.3
Q ss_pred EEEEeccC--CceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 002616 499 IIKPISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 576 (900)
Q Consensus 499 il~~LGkG--~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy 576 (900)
++++||+| +||+||+++.+.+|+.||+|.++... ......+.+.+|+.+++.++||||++++++|..++.+|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA-CTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhh-ccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 78999999999999999999986532 2334556788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 577 LNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 577 ~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
+++|+|.+++... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.++++|||.+...... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~-~~--- 156 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH-GQ--- 156 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccc-cc---
Confidence 9999999999653 45899999999999999999999999999999999999999999999999875421100 00
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~ 732 (900)
.. ..........+++..|+|||++.+ ..|+.++|||||||++|||++|+.||..........
T Consensus 157 ----------~~------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 220 (327)
T cd08227 157 ----------RL------RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 220 (327)
T ss_pred ----------cc------cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH
Confidence 00 000001123467888999999976 468999999999999999999999998765544333
Q ss_pred hhhcCCCCC-------------------------------------------CCCCCCCCHHHHHHHHHhccCCcCCCCC
Q 002616 733 NILNRKIPW-------------------------------------------PCVPSDMSFEAQDLINRFLIHDPNQRLG 769 (900)
Q Consensus 733 kIl~~~l~~-------------------------------------------P~ip~~lS~eakDLIk~cL~~DP~kRpS 769 (900)
.......+. ......+++++.+||.+||+.||.+|||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt 300 (327)
T cd08227 221 EKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS 300 (327)
T ss_pred HHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCC
Confidence 332221110 0011235788999999999999999999
Q ss_pred hhcHHHHHcCCCCCCCC
Q 002616 770 ANGAAEVKAHPFFKGVN 786 (900)
Q Consensus 770 a~~a~EIL~HPFFk~id 786 (900)
+.++++||||+.+.
T Consensus 301 ---~~ell~~p~f~~~~ 314 (327)
T cd08227 301 ---ASTLLNHSFFKQIK 314 (327)
T ss_pred ---HHHHhcChhhhhcc
Confidence 88999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=359.18 Aligned_cols=257 Identities=34% Similarity=0.542 Sum_probs=219.1
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
..+|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.+.||||+++++.|.....+|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 4689999999999999999999999999999999875332 2356788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 574 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|||++||+|.+++.+ ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~------ 168 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------ 168 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccc------
Confidence 999999999999864 4689999999999999999999999999999999999999999999999999873210
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
.........|++.|+|||.+.+..++.++|+|||||++|+|++|++||...++......
T Consensus 169 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~ 227 (296)
T cd06654 169 ---------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227 (296)
T ss_pred ---------------------cccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH
Confidence 00112235789999999999988899999999999999999999999988776544433
Q ss_pred hhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 734 Il~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
+.....+....+..++..+.+||.+||..||.+||+ +.+++.||||..
T Consensus 228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~eil~~~~~~~ 275 (296)
T cd06654 228 IATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS---AKELLQHQFLKI 275 (296)
T ss_pred HhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcC---HHHHhhChhhhc
Confidence 333322222234678899999999999999999999 889999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=369.22 Aligned_cols=284 Identities=29% Similarity=0.502 Sum_probs=234.9
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEeecCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
..||.|+||.|--+....||..||||++.|. ......++.+|++++.+++ |+||++|+.+|+++...|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 4799999999999999999999999999875 3455678999999999986 99999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCC---cEEEEecCCcccccccccccCCCC
Q 002616 580 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKIGLINNTIDLSGP 656 (900)
Q Consensus 580 GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G---~VKLsDFGLAk~~~~~~s~~l~~~ 656 (900)
|.|..+|.+...|++.+|..++++|+.||.|||.+||.||||||+|||-.... -||||||.|..-...++...
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s---- 236 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS---- 236 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCC----
Confidence 99999999999999999999999999999999999999999999999987655 48999999876432222111
Q ss_pred CCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhCCCCCCCCC-----
Q 002616 657 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAES----- 726 (900)
Q Consensus 657 ~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s----- 726 (900)
| .......+.||+..|||||++. ...|+..||.||||||+|-||.|++||.+.-
T Consensus 237 ------p----------astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG 300 (463)
T KOG0607|consen 237 ------P----------ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG 300 (463)
T ss_pred ------C----------CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC
Confidence 0 1122345789999999999874 2568999999999999999999999996531
Q ss_pred ----------hHHHHHhhhcCCCCCCCC-CCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhccC
Q 002616 727 ----------PEIIFDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKA 795 (900)
Q Consensus 727 ----------~~ei~~kIl~~~l~~P~i-p~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~~p 795 (900)
...++..|..+.+.||.- ...+|.+++|||+.+|.+|+..|++ |..+++|||++.+.-+.-. ..|
T Consensus 301 WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rls---a~~vlnhPw~~~~~~ekal-ptp 376 (463)
T KOG0607|consen 301 WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS---AAQVLNHPWVQRCAPEKAL-PTP 376 (463)
T ss_pred ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh---hhhccCCccccccchhccC-CCC
Confidence 467899999999999963 2568999999999999999999999 8899999999987654221 223
Q ss_pred CccCCCCCCCCccccc
Q 002616 796 VFVPQPESVDDTSYFL 811 (900)
Q Consensus 796 pf~P~~~s~~D~s~fd 811 (900)
+.+-..++-.+.+.|.
T Consensus 377 ~v~~r~~s~~~lslfa 392 (463)
T KOG0607|consen 377 QVLQRNSSTMDLSLFA 392 (463)
T ss_pred cccccCccchhhHHHH
Confidence 3333333333555554
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=356.63 Aligned_cols=255 Identities=30% Similarity=0.521 Sum_probs=208.3
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+|++.+.||+|+||.||+|+++.+|+.||+|.++... ........+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccc-ccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 4889999999999999999999999999999986532 222334567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 576 YLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 576 y~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
|+.+ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~------- 151 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI------- 151 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC-------
Confidence 9975 78887765 46799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCC-CCCChHHHHH
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPF-TAESPEIIFD 732 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~PF-~~~s~~ei~~ 732 (900)
.........+++.|+|||++.+. .++.++|||||||++|||++|..|| .+.+..+.+.
T Consensus 152 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~ 211 (284)
T cd07839 152 --------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 211 (284)
T ss_pred --------------------CCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHH
Confidence 00111234678999999998774 4789999999999999999988875 4445444444
Q ss_pred hhhcC-----------------CCCCC---------CCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 733 NILNR-----------------KIPWP---------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 733 kIl~~-----------------~l~~P---------~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
.+... ...++ ...+.+++++.+||.+||..||.+||| +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~~il~h~~f 284 (284)
T cd07839 212 RIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS---AEEALQHPYF 284 (284)
T ss_pred HHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCC---HHHHhcCCCC
Confidence 33210 00011 112357899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=345.44 Aligned_cols=254 Identities=29% Similarity=0.536 Sum_probs=222.8
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+|++.+.||+|+||.||+++...+|+.||+|.+..... .......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 58999999999999999999999999999999875433 23455688999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 576 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 576 y~~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~------ 153 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS------ 153 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCc------
Confidence 999999999987643 578999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
.........|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....
T Consensus 154 ---------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08218 154 ---------------------TVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLK 212 (256)
T ss_pred ---------------------chhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHH
Confidence 00112234689999999999998899999999999999999999999998888888887
Q ss_pred hhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 734 Il~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
+..+.. +..+..++.++.++|.+||+.+|.+||+ +.+++.||||
T Consensus 213 ~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~vl~~~~~ 256 (256)
T cd08218 213 IIRGSY--PPVSSHYSYDLRNLVSQLFKRNPRDRPS---VNSILEKNFI 256 (256)
T ss_pred HhcCCC--CCCcccCCHHHHHHHHHHhhCChhhCcC---HHHHhhCcCC
Confidence 776653 3345788999999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=344.65 Aligned_cols=254 Identities=31% Similarity=0.536 Sum_probs=224.0
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+|++++.||.|+||.||.++...+++.+++|.+..... .......+.+|+.++++++||||+++++++.+.+.+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 58999999999999999999999999999999865432 34456778899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 576 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 576 y~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|+++|+|.+++.+. ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||+++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~----- 154 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE----- 154 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc-----
Confidence 99999999999764 46899999999999999999999999999999999999999999999999998743110
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
........|++.|+|||++.+..++.++|+||||+++|||++|..||...+..+....
T Consensus 155 ----------------------~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~ 212 (256)
T cd08221 155 ----------------------YSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVK 212 (256)
T ss_pred ----------------------cccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 0012345789999999999988899999999999999999999999999888888888
Q ss_pred hhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 734 Il~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
+..+... ..+..++.++.++|.+||..+|.+||+ +.++++|||+
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~R~s---~~~ll~~~~l 256 (256)
T cd08221 213 IVQGNYT--PVVSVYSSELISLVHSLLQQDPEKRPT---ADEVLDQPLL 256 (256)
T ss_pred HHcCCCC--CCccccCHHHHHHHHHHcccCcccCCC---HHHHhhCcCC
Confidence 8766543 234678999999999999999999999 8899999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=352.91 Aligned_cols=257 Identities=33% Similarity=0.579 Sum_probs=223.1
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++.+.||.|+||.||+|++..+|+.||+|++.... .......+.+|+.+++.++||||+++++++.+...+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 47889999999999999999999999999999986532 2344567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||+++|+|.+++... .+++..+..++.|++.||.|||+.+++||||+|+||+++.+|.++|+|||+++....
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~------- 150 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS------- 150 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecc-------
Confidence 999999999998765 789999999999999999999999999999999999999999999999999875310
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhh
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kI 734 (900)
.........|++.|+|||++.+..++.++|||||||++|+|++|.+||...++......+
T Consensus 151 --------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~ 210 (274)
T cd06609 151 --------------------TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210 (274)
T ss_pred --------------------cccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh
Confidence 001223457899999999999988999999999999999999999999888777666665
Q ss_pred hcCCCCCCCCCCC-CCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 002616 735 LNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786 (900)
Q Consensus 735 l~~~l~~P~ip~~-lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~id 786 (900)
..... |.++.. ++.++.++|.+||..||.+||+ +.+++.||||.+..
T Consensus 211 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt---~~~il~~~~~~~~~ 258 (274)
T cd06609 211 PKNNP--PSLEGNKFSKPFKDFVSLCLNKDPKERPS---AKELLKHKFIKKAK 258 (274)
T ss_pred hhcCC--CCCcccccCHHHHHHHHHHhhCChhhCcC---HHHHhhChhhcCCC
Confidence 55432 222334 8899999999999999999999 88999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=351.59 Aligned_cols=278 Identities=39% Similarity=0.744 Sum_probs=231.2
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~LyLV 573 (900)
++|++.+.||+|+||.||+|..+.+|..||+|++.+...........+.+|..++.++. ||||+++++++...+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998755555556678899999999999 99999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 574 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|||+++++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||||+||+++.+|.++|+|||++...........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999875321110000
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
.. ...... ...............|++.|+|||++.+..++.++|+||||+++|+|++|..||...+....+..
T Consensus 161 -~~--~~~~~~----~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 233 (280)
T cd05581 161 -NK--GDATNI----DSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK 233 (280)
T ss_pred -CC--CCCccc----cccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH
Confidence 00 000000 00000111233456789999999999988899999999999999999999999998887777777
Q ss_pred hhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChh-cHHHHHcCCCC
Q 002616 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN-GAAEVKAHPFF 782 (900)
Q Consensus 734 Il~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~-~a~EIL~HPFF 782 (900)
+......+| ..+++.+.+||.+||+.||.+||++. ...++++||||
T Consensus 234 ~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 234 ILKLEYSFP---PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHhcCCCCC---CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 776655555 67899999999999999999999930 12899999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.60 Aligned_cols=258 Identities=32% Similarity=0.504 Sum_probs=212.2
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeec----
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFT---- 565 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~---- 565 (900)
....++|++.+.||+|+||.||+|.++.+++.||+|+++... .....+.+|+.++..+ +||||+++++++.
T Consensus 14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 89 (286)
T cd06638 14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV 89 (286)
T ss_pred CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence 346789999999999999999999999999999999886422 2235678899999998 6999999999873
Q ss_pred -cCCeeEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecC
Q 002616 566 -CRDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 640 (900)
Q Consensus 566 -d~~~LyLVmEy~~GGsL~dlL~k----~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFG 640 (900)
..+.+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||
T Consensus 90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg 169 (286)
T cd06638 90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG 169 (286)
T ss_pred CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence 45679999999999999988753 3468899999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-----CCCCccceeechhHHHHHH
Q 002616 641 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEF 715 (900)
Q Consensus 641 LAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~ksDIWSLGVILyEM 715 (900)
+++.... .........||+.|+|||++.. ..++.++|||||||++|||
T Consensus 170 ~~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el 222 (286)
T cd06638 170 VSAQLTS---------------------------TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222 (286)
T ss_pred ceeeccc---------------------------CCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHH
Confidence 9874210 0111234569999999999853 4578899999999999999
Q ss_pred HhCCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 716 ITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 716 LtGk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
++|+.||...++......+..........+...+.++.+||.+||+.||++||+ +.++++||||
T Consensus 223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~ell~~~~~ 286 (286)
T cd06638 223 GDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPT---VSDLLQHVFI 286 (286)
T ss_pred hcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCC---HHHHhhcccC
Confidence 999999988776554444333221111123456889999999999999999999 8899999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=393.96 Aligned_cols=261 Identities=33% Similarity=0.590 Sum_probs=233.7
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
+-|+|+..||-|+||+||+|..+.++-..|.|+|. .......+.++-|++||..++||+||+|++.|..++.++|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe---tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE---TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc---ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 44688899999999999999999999999999885 345678899999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 575 EYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|||.||-+..++-.-+ .+++.+++.++++++.||.|||+++|||||||..|||++.+|.|+|+|||.+....
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~------- 181 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNK------- 181 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccch-------
Confidence 9999999988876654 69999999999999999999999999999999999999999999999999875311
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 728 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ 728 (900)
.......++.|||.|||||++. ..+|++++||||||++|.||.-+.||-...+++
T Consensus 182 --------------------~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM 241 (1187)
T KOG0579|consen 182 --------------------STRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM 241 (1187)
T ss_pred --------------------hHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH
Confidence 1234567899999999999975 578999999999999999999999999999999
Q ss_pred HHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 002616 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 788 (900)
Q Consensus 729 ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~ 788 (900)
.+..+|.+...+--..|..++..+.||+++||.+||..||+ +.+|+.||||.++.-.
T Consensus 242 RVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~---aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 242 RVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPP---AAQLLKHPFVQNAPSN 298 (1187)
T ss_pred HHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCC---HHHHhhCcccccCCcc
Confidence 99999988765544457899999999999999999999999 8899999999976543
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=362.83 Aligned_cols=250 Identities=25% Similarity=0.433 Sum_probs=193.6
Q ss_pred EEEeccCCceEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--CCeeEEEEe
Q 002616 500 IKPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLYLVME 575 (900)
Q Consensus 500 l~~LGkG~FG~Vyla~~k~--tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d--~~~LyLVmE 575 (900)
.++||+|+||+||+|+++. +++.||+|.+.... ....+.+|+.+|+.++||||+++++.|.. ...+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 3589999999999999763 67899999986532 23456789999999999999999998854 456899999
Q ss_pred ecCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEe----cCCCcEEEEecCCc
Q 002616 576 YLNGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGLS 642 (900)
Q Consensus 576 y~~GGsL~dlL~k~---------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILL----d~~G~VKLsDFGLA 642 (900)
|+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9865 888887532 248999999999999999999999999999999999999 45689999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCC
Q 002616 643 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPP 721 (900)
Q Consensus 643 k~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~P 721 (900)
+...... .........+||+.|+|||++.+ ..|+.++|||||||++|||++|++|
T Consensus 160 ~~~~~~~------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~ 215 (317)
T cd07868 160 RLFNSPL------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215 (317)
T ss_pred eccCCCC------------------------ccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 7421000 00112234689999999999987 4589999999999999999999999
Q ss_pred CCCCCh---------HHHHHhhhcC-CC----------CCC------------------------CCCCCCCHHHHHHHH
Q 002616 722 FTAESP---------EIIFDNILNR-KI----------PWP------------------------CVPSDMSFEAQDLIN 757 (900)
Q Consensus 722 F~~~s~---------~ei~~kIl~~-~l----------~~P------------------------~ip~~lS~eakDLIk 757 (900)
|..... .....++... .. .++ ......+.++.+||.
T Consensus 216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~ 295 (317)
T cd07868 216 FHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQ 295 (317)
T ss_pred ccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHH
Confidence 975432 1111111110 00 000 001123567899999
Q ss_pred HhccCCcCCCCChhcHHHHHcCCCC
Q 002616 758 RFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 758 ~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
+||+.||.+||| +.++|+||||
T Consensus 296 ~mL~~dP~~R~t---~~e~l~hp~f 317 (317)
T cd07868 296 KLLTMDPIKRIT---SEQAMQDPYF 317 (317)
T ss_pred HHhccCcccCCC---HHHHhcCCCC
Confidence 999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=367.56 Aligned_cols=255 Identities=32% Similarity=0.535 Sum_probs=221.5
Q ss_pred ccCCCeEEE-EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeecc---
Q 002616 492 TSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC--- 566 (900)
Q Consensus 492 ~~~~dYeil-~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d--- 566 (900)
-.+++|.+. ++||-|-.|+|..+.++.||+.+|+|++.. ....++|+++.-..+ |||||.++++|..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~ 129 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYENSYQ 129 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc
Confidence 346777775 579999999999999999999999998853 345678888877665 9999999987754
Q ss_pred -CCeeEEEEeecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecC---CCcEEEEecC
Q 002616 567 -RDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFG 640 (900)
Q Consensus 567 -~~~LyLVmEy~~GGsL~dlL~k~g~--Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~---~G~VKLsDFG 640 (900)
...+.+|||.|+||+|+..++..+. |+|.++..+++||..|+.|||+++|.||||||+|+|... |..+||+|||
T Consensus 130 ~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 130 GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccc
Confidence 4569999999999999999988764 999999999999999999999999999999999999975 4579999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCC
Q 002616 641 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 720 (900)
Q Consensus 641 LAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~ 720 (900)
||+... ......+.|.||.|.|||++...+|+..+|+||+||+||-||+|++
T Consensus 210 FAK~t~----------------------------~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyP 261 (400)
T KOG0604|consen 210 FAKETQ----------------------------EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261 (400)
T ss_pred cccccC----------------------------CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCC
Confidence 998521 1223456799999999999999999999999999999999999999
Q ss_pred CCCCCC----hHHHHHhhhcCCCCCCCCC-CCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 721 PFTAES----PEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 721 PF~~~s----~~ei~~kIl~~~l~~P~ip-~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
||+... ...+..+|..+.+.||.-+ ..+|++++|+|+.+|..+|.+|+| +.++++|||..+.
T Consensus 262 PFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlT---I~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 262 PFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLT---IEEVMDHPWINQY 328 (400)
T ss_pred cccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhee---HHHhhcCchhccc
Confidence 998765 3567889999999998622 458999999999999999999999 8899999998753
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=347.38 Aligned_cols=256 Identities=32% Similarity=0.530 Sum_probs=214.7
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCC---
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRD--- 568 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~--- 568 (900)
..++|++.+.||.|+||.||+|.++.+++.||+|++.... ...+.+.+|+.++.++ .||||++++++|....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 4589999999999999999999999999999999986532 2346788999999998 6999999999997644
Q ss_pred ---eeEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCC
Q 002616 569 ---NLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 641 (900)
Q Consensus 569 ---~LyLVmEy~~GGsL~dlL~k----~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGL 641 (900)
.+|+||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 48999999999999998865 34799999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-----CCCCccceeechhHHHHHHH
Q 002616 642 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFI 716 (900)
Q Consensus 642 Ak~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~ksDIWSLGVILyEML 716 (900)
+..... .........|++.|+|||++.. ..++.++|+|||||+||+|+
T Consensus 160 ~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~ 212 (275)
T cd06608 160 SAQLDS---------------------------TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA 212 (275)
T ss_pred ceeccc---------------------------chhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHH
Confidence 864210 0111234568999999999864 34678999999999999999
Q ss_pred hCCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 717 TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 717 tGk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
+|++||....+......+..........+..++.++.+||.+||..||.+||+ +.+++.|||+
T Consensus 213 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~ll~~~~~ 275 (275)
T cd06608 213 DGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPF---MEELLEHPFI 275 (275)
T ss_pred hCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcC---HHHHhcCCCC
Confidence 99999987776666666555432211122347889999999999999999999 8899999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=358.47 Aligned_cols=258 Identities=34% Similarity=0.553 Sum_probs=219.1
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
..+|++++.||.|+||.||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.++||||++++++|...+.+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 478999999999999999999999999999999986533 23356788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 574 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|||++||+|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~------ 167 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------ 167 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccC------
Confidence 999999999999865 4589999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
.........|++.|+|||.+.+..++.++|+|||||++|+|++|.+||...++......
T Consensus 168 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~ 226 (297)
T cd06656 168 ---------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (297)
T ss_pred ---------------------CccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee
Confidence 00112234689999999999998899999999999999999999999987766443333
Q ss_pred hhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 734 Il~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
+.....+....+..++..+.+||.+||..||.+||+ +.+++.||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~ 275 (297)
T cd06656 227 IATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGS---AKELLQHPFLKLA 275 (297)
T ss_pred eccCCCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCchhccc
Confidence 333222222234678899999999999999999999 8899999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=350.89 Aligned_cols=256 Identities=21% Similarity=0.270 Sum_probs=214.4
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEEC---CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKR---TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k---~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~ 568 (900)
+..++|++.+.||+|+||.||+|.++ ..+..||+|+++... .......+.+|+.++..++||||+++++++...+
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 34578999999999999999999875 345689999987532 2344577899999999999999999999999999
Q ss_pred eeEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~ 647 (900)
.+|+||||+++|+|.+++... +.+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999999764 5789999999999999999999999999999999999999999999999998753110
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCC
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 726 (900)
Q Consensus 648 ~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s 726 (900)
. .........+++.|+|||++.+..++.++|||||||++|||++ |..||...+
T Consensus 160 ~--------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~ 213 (266)
T cd05064 160 E--------------------------AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred c--------------------------chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCC
Confidence 0 0001122345788999999999999999999999999999775 999999988
Q ss_pred hHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 727 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 727 ~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
..+....+..+. ..| .+..++..+.+++.+||+.+|.+||++.++.+++
T Consensus 214 ~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l 262 (266)
T cd05064 214 GQDVIKAVEDGF-RLP-APRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262 (266)
T ss_pred HHHHHHHHHCCC-CCC-CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHH
Confidence 887777765442 223 4577899999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=356.60 Aligned_cols=258 Identities=24% Similarity=0.341 Sum_probs=207.5
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECC----------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRT----------------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~----------------tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPn 556 (900)
..++|++.+.||+|+||.||+|++.. ++..||+|+++... .......+.+|+.+|.+++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 45689999999999999999998643 34479999986532 3445677999999999999999
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHhhhhcCeE
Q 002616 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-------------------CLEEDVARIYIAELVLALEYLHSLGIV 617 (900)
Q Consensus 557 IVkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g-------------------~Lse~~ar~ya~QIl~AL~yLHs~gII 617 (900)
|+++++++.+.+..|+||||+++|+|.+++.... .++...+..++.||+.||.|||+.||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999986532 356778889999999999999999999
Q ss_pred eccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC
Q 002616 618 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT 697 (900)
Q Consensus 618 HRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~ 697 (900)
||||||+|||++.++.+||+|||+++...... .........+++.|||||++.+.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~ 215 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGD-------------------------YYRIQGRAVLPIRWMAWECILMG 215 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCc-------------------------eeEecCcCCCCccccCHHHHhcC
Confidence 99999999999999999999999987421100 00112234568899999999988
Q ss_pred CCCccceeechhHHHHHHHh--CCCCCCCCChHHHHHhhhc-----CCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCh
Q 002616 698 EHGYAADWWSVGIILFEFIT--GIPPFTAESPEIIFDNILN-----RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 770 (900)
Q Consensus 698 ~ys~ksDIWSLGVILyEMLt--Gk~PF~~~s~~ei~~kIl~-----~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa 770 (900)
.++.++|||||||++|||++ |..||...+..+....+.. ....++..++.++..+.+||.+||..||.+||++
T Consensus 216 ~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 295 (304)
T cd05096 216 KFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF 295 (304)
T ss_pred CCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence 99999999999999999986 6789988776665544321 1111222346788999999999999999999996
Q ss_pred hcHHHHH
Q 002616 771 NGAAEVK 777 (900)
Q Consensus 771 ~~a~EIL 777 (900)
.++..+|
T Consensus 296 ~~i~~~l 302 (304)
T cd05096 296 SDIHAFL 302 (304)
T ss_pred HHHHHHH
Confidence 5554443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=350.69 Aligned_cols=258 Identities=32% Similarity=0.520 Sum_probs=214.4
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC---
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR--- 567 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~--- 567 (900)
...++|++.+.||+|+||.||+|..+.+++.||+|++.... .....+.+|+.++.++ +||||++++++|...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 35688999999999999999999999999999999986532 2345677899999988 799999999988754
Q ss_pred --CeeEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCC
Q 002616 568 --DNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 641 (900)
Q Consensus 568 --~~LyLVmEy~~GGsL~dlL~k----~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGL 641 (900)
..+|+||||++||+|.+++.. ...+++..++.++.|++.||+|||+.||+||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 358999999999999998863 35689999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-----CCCccceeechhHHHHHHH
Q 002616 642 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----EHGYAADWWSVGIILFEFI 716 (900)
Q Consensus 642 Ak~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-----~ys~ksDIWSLGVILyEML 716 (900)
+..... ........+|++.|+|||++... .++.++|||||||++|||+
T Consensus 175 ~~~~~~---------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~ 227 (291)
T cd06639 175 SAQLTS---------------------------TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG 227 (291)
T ss_pred chhccc---------------------------ccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHh
Confidence 874210 00112235689999999998643 3678999999999999999
Q ss_pred hCCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCC
Q 002616 717 TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 717 tGk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk 783 (900)
+|++||...++......+..........+...+..+.+||.+||..||++||+ +.+++.||||+
T Consensus 228 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~il~~~~~~ 291 (291)
T cd06639 228 DGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPS---VTHLLEHPFIK 291 (291)
T ss_pred hCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcC---HHHHhcCcccC
Confidence 99999998877666555544432211123567789999999999999999999 88999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=353.08 Aligned_cols=254 Identities=23% Similarity=0.367 Sum_probs=215.4
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 566 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tG-----k~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d 566 (900)
+..++|++++.||+|+||.||+|.....+ ..||+|.++... .......+.+|+.++..++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 45678999999999999999999987655 679999886432 33445678999999999999999999999999
Q ss_pred CCeeEEEEeecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecC
Q 002616 567 RDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 630 (900)
Q Consensus 567 ~~~LyLVmEy~~GGsL~dlL~k~----------------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~ 630 (900)
....|++|||+++|+|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 99999999999999999999764 45788899999999999999999999999999999999999
Q ss_pred CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhH
Q 002616 631 DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 710 (900)
Q Consensus 631 ~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGV 710 (900)
++.+||+|||+++.....+ .........+|+.|+|||.+.+..++.++|||||||
T Consensus 160 ~~~~~L~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~ 214 (283)
T cd05048 160 GLTVKISDFGLSRDIYSAD-------------------------YYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGV 214 (283)
T ss_pred CCcEEECCCcceeeccccc-------------------------cccccCCCcccccccCHHHhccCcCchhhhHHHHHH
Confidence 9999999999987421100 001122346789999999999889999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHH
Q 002616 711 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 774 (900)
Q Consensus 711 ILyEMLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~ 774 (900)
++|||++ |..||.+.+..++...+..... +..+..+++++.+|+.+||+.||.+||++.++.
T Consensus 215 il~el~~~g~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~ 277 (283)
T cd05048 215 VLWEIFSYGLQPYYGFSNQEVIEMIRSRQL--LPCPEDCPARVYALMIECWNEIPARRPRFKDIH 277 (283)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 9999998 9999999998888888776543 234578999999999999999999999944333
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=356.96 Aligned_cols=258 Identities=35% Similarity=0.560 Sum_probs=221.4
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
..+|++.+.||.|+||.||+|.+..+|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++...+.+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 356999999999999999999999999999999986532 23456788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 574 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|||+++|+|..++.. ..+++..+..++.+++.||+|||++|++||||||+||+++.+|.+||+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~------ 167 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP------ 167 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccc------
Confidence 999999999998865 4689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
.........|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...++......
T Consensus 168 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~ 226 (296)
T cd06655 168 ---------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (296)
T ss_pred ---------------------ccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 00112235689999999999988899999999999999999999999998877655555
Q ss_pred hhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 734 Il~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
+.....+....+..+++.+.+||++||..||.+||+ +.+++.||||+..
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~il~~~~~~~~ 275 (296)
T cd06655 227 IATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGS---AKELLQHPFLKLA 275 (296)
T ss_pred HHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCC---HHHHhhChHhhhc
Confidence 544333222234678999999999999999999999 8899999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=341.85 Aligned_cols=254 Identities=33% Similarity=0.574 Sum_probs=220.2
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--CCeeEEE
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLYLV 573 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d--~~~LyLV 573 (900)
+|++++.||.|+||.||+|.+..+|..||+|++..... .....+.+.+|+.+++.++||||+++++.+.. ...+|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999999875433 34556788999999999999999999987754 4568999
Q ss_pred EeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHhhh-----hcCeEeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 574 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLH-----SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 574 mEy~~GGsL~dlL~k----~g~Lse~~ar~ya~QIl~AL~yLH-----s~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
|||+++|+|.+++.. ...+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999875 357899999999999999999999 89999999999999999999999999999874
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCC
Q 002616 645 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 724 (900)
Q Consensus 645 ~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~ 724 (900)
... .........|++.|+|||++.+..++.++|+||||+++|+|++|..||..
T Consensus 160 ~~~---------------------------~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 212 (265)
T cd08217 160 LGH---------------------------DSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA 212 (265)
T ss_pred ccC---------------------------CcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccC
Confidence 210 01112335789999999999988899999999999999999999999998
Q ss_pred CChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 725 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 725 ~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
.+...+...+..... +.++..++.++.+|+.+||..+|.+||+ +.+|++|||+
T Consensus 213 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rp~---~~~il~~~~~ 265 (265)
T cd08217 213 RNQLQLASKIKEGKF--RRIPYRYSSELNEVIKSMLNVDPDKRPS---TEELLQLPLI 265 (265)
T ss_pred cCHHHHHHHHhcCCC--CCCccccCHHHHHHHHHHccCCcccCCC---HHHHhhCCCC
Confidence 887777777665543 4456788999999999999999999999 8899999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=344.17 Aligned_cols=249 Identities=28% Similarity=0.520 Sum_probs=216.6
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+|++.+.||.|+||.||+++++.+++.||+|.++... .....+.+.+|+.+++.++||||+++++.+.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 5899999999999999999999999999999986532 23456778899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 576 YLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 576 y~~GGsL~dlL~k--~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|+++|+|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~------ 152 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS------ 152 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecc------
Confidence 9999999998864 34589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
.........|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......
T Consensus 153 ---------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~ 211 (255)
T cd08219 153 ---------------------PGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILK 211 (255)
T ss_pred ---------------------cccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHH
Confidence 01112345789999999999998899999999999999999999999998888777777
Q ss_pred hhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 734 Il~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
+..+... .++..++..+.+||.+||+.||.+||+ +.+++.
T Consensus 212 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~ 251 (255)
T cd08219 212 VCQGSYK--PLPSHYSYELRSLIKQMFKRNPRSRPS---ATTILS 251 (255)
T ss_pred HhcCCCC--CCCcccCHHHHHHHHHHHhCCcccCCC---HHHHhh
Confidence 7655433 245778999999999999999999999 667664
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=342.78 Aligned_cols=255 Identities=34% Similarity=0.566 Sum_probs=219.9
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~--~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
+|+..+.||+|+||+||+|....+++.||+|.+..... ......+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 36778899999999999999998999999999865332 2234567889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 574 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|||+++++|.+++.+.+.+++..+..++.||+.||+|||++||+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~------ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVE------ 154 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccc------
Confidence 99999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCC-CCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~ 732 (900)
........|++.|+|||.+.... ++.++|+|||||++|+|++|.+||..........
T Consensus 155 ----------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~ 212 (258)
T cd06632 155 ----------------------FSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVF 212 (258)
T ss_pred ----------------------cccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHH
Confidence 00123456899999999998766 8999999999999999999999998776555554
Q ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 733 kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
.+... ...+.++..+++++.+||.+||..+|.+||+ +.+++.|||+
T Consensus 213 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~~~~ 258 (258)
T cd06632 213 KIGRS-KELPPIPDHLSDEAKDFILKCLQRDPSLRPT---AAELLEHPFV 258 (258)
T ss_pred HHHhc-ccCCCcCCCcCHHHHHHHHHHhhcCcccCcC---HHHHhcCCCC
Confidence 44331 2334456788999999999999999999999 8899999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=353.69 Aligned_cols=257 Identities=30% Similarity=0.482 Sum_probs=214.4
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++.+.||+|+||.||+|.++.+++.||+|++.+.... ....+.+.+|++++..++||||++++++|...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4799999999999999999999999999999998654332 234567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||+++++|..+......+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~------- 152 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA------- 152 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC-------
Confidence 9999999988877766799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
.........|+..|+|||++.+ ..++.++|||||||++|||++|.+||...+..+....
T Consensus 153 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~ 212 (286)
T cd07846 153 --------------------PGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYH 212 (286)
T ss_pred --------------------CccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHH
Confidence 0111223568999999999876 4578899999999999999999999987665443333
Q ss_pred hhcC-------------------CCCCCC---------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 734 ILNR-------------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 734 Il~~-------------------~l~~P~---------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
+... ....|. ..+.++..+.+||.+||..||.+||+ +.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~~~~~ 286 (286)
T cd07846 213 IIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS---SSQLLHHEFF 286 (286)
T ss_pred HHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchh---HHHHhcCCCC
Confidence 2210 011111 12467889999999999999999999 7799999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=341.48 Aligned_cols=253 Identities=30% Similarity=0.502 Sum_probs=220.8
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+|++.+.||+|+||.||+|....+++.+|+|.+..... .......+.+|+.+|+.++||||+++++.+...+.+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999976433 34456789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCC-cEEEEecCCccccccccccc
Q 002616 576 YLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 576 y~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G-~VKLsDFGLAk~~~~~~s~~ 652 (900)
|+++++|.+++... ..+++..+..++.+++.||+|||++||+|+||||+||+++.++ .+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~----- 154 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS----- 154 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC-----
Confidence 99999999999764 3489999999999999999999999999999999999998654 689999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~ 732 (900)
........|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+......
T Consensus 155 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~ 211 (256)
T cd08220 155 -----------------------KSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL 211 (256)
T ss_pred -----------------------CccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence 111223568999999999998889999999999999999999999999888877777
Q ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 733 kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
.+..... +.++..++.++.+||.+||..||.+||+ +.++++||||
T Consensus 212 ~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~ll~~p~~ 256 (256)
T cd08220 212 KIMSGTF--APISDRYSPDLRQLILSMLNLDPSKRPQ---LSQIMAQPIC 256 (256)
T ss_pred HHHhcCC--CCCCCCcCHHHHHHHHHHccCChhhCCC---HHHHhhCCCC
Confidence 7765433 2344678999999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=350.10 Aligned_cols=256 Identities=29% Similarity=0.493 Sum_probs=212.5
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeecc----
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC---- 566 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d---- 566 (900)
...+.|++.+.||.|+||.||+|+++.+++.||+|++... ......+..|+.++.++ +||||++++++|..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 3557899999999999999999999999999999998653 23446688899999988 69999999999853
Q ss_pred --CCeeEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCc
Q 002616 567 --RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 642 (900)
Q Consensus 567 --~~~LyLVmEy~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLA 642 (900)
.+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 45789999999999999998753 35888899999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHh
Q 002616 643 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFIT 717 (900)
Q Consensus 643 k~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGVILyEMLt 717 (900)
..... ........+|++.|+|||++. +..++.++|+|||||++|||++
T Consensus 169 ~~~~~---------------------------~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~ 221 (282)
T cd06636 169 AQLDR---------------------------TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAE 221 (282)
T ss_pred hhhhc---------------------------cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHh
Confidence 74210 001123467999999999986 3568889999999999999999
Q ss_pred CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 718 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 718 Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
|.+||....+......+...... ......++.++.+||.+||..||.+||+ +.+|+.||||
T Consensus 222 g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~---~~ell~~~~~ 282 (282)
T cd06636 222 GAPPLCDMHPMRALFLIPRNPPP-KLKSKKWSKKFIDFIEGCLVKNYLSRPS---TEQLLKHPFI 282 (282)
T ss_pred CCCCccccCHHhhhhhHhhCCCC-CCcccccCHHHHHHHHHHhCCChhhCcC---HHHHhcCCCC
Confidence 99999877665444433332211 1123468899999999999999999999 8899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=342.68 Aligned_cols=258 Identities=35% Similarity=0.598 Sum_probs=223.8
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++.+.||.|+||.||+|+++.+|+.||+|++..... ......+.+|+.++..++||||+++++++...+.+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 479999999999999999999999999999999876432 145678999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhh-cCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~------ 152 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN------ 152 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceeccc------
Confidence 999999999999888889999999999999999999999 9999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC---ChHHH
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE---SPEII 730 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~---s~~ei 730 (900)
.........|+..|+|||.+.+..++.++|+||||+++|+|++|..||... ...+.
T Consensus 153 ---------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~ 211 (264)
T cd06623 153 ---------------------TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL 211 (264)
T ss_pred ---------------------CCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH
Confidence 011112456899999999999988999999999999999999999999877 44555
Q ss_pred HHhhhcCCCCCCCCCCC-CCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 002616 731 FDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~-lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~id 786 (900)
...+..... +..+.. ++..+.++|.+||..+|.+||+ +.++++||||+.++
T Consensus 212 ~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~~---~~~ll~~~~~~~~~ 263 (264)
T cd06623 212 MQAICDGPP--PSLPAEEFSPEFRDFISACLQKDPKKRPS---AAELLQHPFIKKAD 263 (264)
T ss_pred HHHHhcCCC--CCCCcccCCHHHHHHHHHHccCChhhCCC---HHHHHhCHHHHhcc
Confidence 555554332 223455 8899999999999999999999 88999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=348.05 Aligned_cols=258 Identities=30% Similarity=0.510 Sum_probs=208.8
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHH-HHhcCCCceEEEeeeeccCCeeEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-LITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~I-L~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
++|++.+.||+|+||.||+|+++.+|+.||+|.+++... .. ....+..|..+ ++..+||||+++++++...+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 579999999999999999999999999999999875322 22 23345556654 6667899999999999999999999
Q ss_pred EeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHhhhhc-CeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 574 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 574 mEy~~GGsL~dlL~k----~g~Lse~~ar~ya~QIl~AL~yLHs~-gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
|||++ |+|.+++.. ...+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 156 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD- 156 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence 99997 588877754 24689999999999999999999997 999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC----CCCCccceeechhHHHHHHHhCCCCCCC
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEFITGIPPFTA 724 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g----~~ys~ksDIWSLGVILyEMLtGk~PF~~ 724 (900)
........|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||..
T Consensus 157 ---------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 157 ---------------------------SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ---------------------------ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 001123468999999999865 4578899999999999999999999975
Q ss_pred C-ChHHHHHhhhcC-CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 002616 725 E-SPEIIFDNILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 788 (900)
Q Consensus 725 ~-s~~ei~~kIl~~-~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~ 788 (900)
. ...+....+... ...+| ...+|.++.+||.+||..+|.+||+ +.+++.||||....+.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~ 270 (283)
T cd06617 210 WKTPFQQLKQVVEEPSPQLP--AEKFSPEFQDFVNKCLKKNYKERPN---YPELLQHPFFELHLSK 270 (283)
T ss_pred cccCHHHHHHHHhcCCCCCC--ccccCHHHHHHHHHHccCChhhCcC---HHHHhcCchhhhcccc
Confidence 3 233333333332 22222 2467899999999999999999999 7899999999886654
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=345.53 Aligned_cols=254 Identities=28% Similarity=0.477 Sum_probs=212.9
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
.++|++.+.||+|+||.||+|+++.+++.||+|.++............+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 36899999999999999999999999999999998765555566677889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 574 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 574 mEy~~GGsL~dlL~k----~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
|||+++|+|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~-- 158 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS-- 158 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccc--
Confidence 999999999988853 34588999999999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC--h
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--P 727 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s--~ 727 (900)
.........|++.|+|||.+.+..++.++|+||||+++|||++|..||.... .
T Consensus 159 -------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~ 213 (267)
T cd08228 159 -------------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213 (267)
T ss_pred -------------------------hhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH
Confidence 0011223568999999999999889999999999999999999999997654 2
Q ss_pred HHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHH
Q 002616 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 775 (900)
Q Consensus 728 ~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~E 775 (900)
......+.....+ +..+...+..+.+||.+||+.+|.+||++.++.+
T Consensus 214 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 214 FSLCQKIEQCDYP-PLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred HHHHHHHhcCCCC-CCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 3444444333221 2222467889999999999999999999554443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=372.20 Aligned_cols=261 Identities=23% Similarity=0.345 Sum_probs=212.5
Q ss_pred cccccCCCeEEEEEeccCCceEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 002616 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 562 (900)
Q Consensus 489 ~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tG-----k~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~ 562 (900)
.+....++|++.+.||+|+||.||+|++..+| ..||+|+++... .......+.+|+.+++.+ +|||||++++
T Consensus 32 ~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~ 109 (374)
T cd05106 32 KWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLG 109 (374)
T ss_pred cccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEee
Confidence 34466779999999999999999999875443 579999997533 233456789999999999 8999999999
Q ss_pred eeccCCeeEEEEeecCCCChHHHHHhc-----------------------------------------------------
Q 002616 563 SFTCRDNLYLVMEYLNGGDLYSLLRKV----------------------------------------------------- 589 (900)
Q Consensus 563 ~f~d~~~LyLVmEy~~GGsL~dlL~k~----------------------------------------------------- 589 (900)
+|...+.+|+||||+++|+|.+++.+.
T Consensus 110 ~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (374)
T cd05106 110 ACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSS 189 (374)
T ss_pred EecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccc
Confidence 999999999999999999999998642
Q ss_pred -----------------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 590 -----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 590 -----------------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
..+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++......
T Consensus 190 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~--- 266 (374)
T cd05106 190 SSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDS--- 266 (374)
T ss_pred cccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCc---
Confidence 136788899999999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 731 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ei~ 731 (900)
.........+++.|||||++.+..|+.++|||||||++|||++ |+.||........+
T Consensus 267 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~ 324 (374)
T cd05106 267 ----------------------NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF 324 (374)
T ss_pred ----------------------ceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH
Confidence 0001122345678999999999999999999999999999997 99999887665555
Q ss_pred HhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 732 ~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
..+.......+ .+..+++++.+||.+||+.||.+||++.++.+.+
T Consensus 325 ~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l 369 (374)
T cd05106 325 YKMVKRGYQMS-RPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLI 369 (374)
T ss_pred HHHHHcccCcc-CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 45444443322 3466789999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=370.77 Aligned_cols=253 Identities=27% Similarity=0.415 Sum_probs=203.6
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
....+|++++.||+|+||.||+|++..+++.||+|+..+. ....|+.++..++||||+++++++......|
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence 3456799999999999999999999999999999975432 2346899999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 572 LVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
+||||+. |+|.+++.+ ...+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+++....
T Consensus 134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~--- 209 (357)
T PHA03209 134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV--- 209 (357)
T ss_pred EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---
Confidence 9999996 588888765 45699999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCC-CCCCCCChH-
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI-PPFTAESPE- 728 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk-~PF~~~s~~- 728 (900)
........||+.|+|||++.+..|+.++|||||||++|||+++. ++|......
T Consensus 210 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~ 264 (357)
T PHA03209 210 -------------------------APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTP 264 (357)
T ss_pred -------------------------CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcH
Confidence 11123457999999999999999999999999999999999854 444432110
Q ss_pred --------HHHHhhhc----CCCCCCC---------------------------CCCCCCHHHHHHHHHhccCCcCCCCC
Q 002616 729 --------IIFDNILN----RKIPWPC---------------------------VPSDMSFEAQDLINRFLIHDPNQRLG 769 (900)
Q Consensus 729 --------ei~~kIl~----~~l~~P~---------------------------ip~~lS~eakDLIk~cL~~DP~kRpS 769 (900)
.....+.. ....+|. ....++.++.+||.+||+.||.+||+
T Consensus 265 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpt 344 (357)
T PHA03209 265 EEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPS 344 (357)
T ss_pred HHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcC
Confidence 11111111 0001110 01245778889999999999999999
Q ss_pred hhcHHHHHcCCCCCCC
Q 002616 770 ANGAAEVKAHPFFKGV 785 (900)
Q Consensus 770 a~~a~EIL~HPFFk~i 785 (900)
|.++++||||+.+
T Consensus 345 ---a~e~l~hp~f~~~ 357 (357)
T PHA03209 345 ---AEEILNYPMFAQL 357 (357)
T ss_pred ---HHHHhcCchhccC
Confidence 8899999999864
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=345.90 Aligned_cols=259 Identities=32% Similarity=0.530 Sum_probs=215.6
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeeccccc-------chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-------RKNDIERILAERNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~-------~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~ 568 (900)
.|.+.+.||.|+||.||+|....+|+.||+|.++..... .....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 478889999999999999999999999999988642111 1223467889999999999999999999999999
Q ss_pred eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
.+|+||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCC--CCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~--ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
..........|+..|+|||++.+.. ++.++|+||||+++|+|++|..||....
T Consensus 162 -------------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 216 (272)
T cd06629 162 -------------------------YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE 216 (272)
T ss_pred -------------------------ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc
Confidence 0011123456899999999998754 7899999999999999999999998766
Q ss_pred hHHHHHhhhcCCC--CCC-CCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 727 PEIIFDNILNRKI--PWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 727 ~~ei~~kIl~~~l--~~P-~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
..+....+..... .++ .....++.++.+||.+||..||.+||+ +.++++||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~ 272 (272)
T cd06629 217 AIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT---ARELLQHPFI 272 (272)
T ss_pred hHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCC---HHHHhhCCCC
Confidence 5554444433222 222 122356899999999999999999999 8899999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=344.87 Aligned_cols=256 Identities=30% Similarity=0.451 Sum_probs=210.3
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
..+.+.....||+|+||.||+|++..++..||+|.+.... ....+.+.+|+.++..++||||+++++++...+..|+
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 4455556678999999999999999999999999886532 3456788999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecC-CCcEEEEecCCccccccc
Q 002616 573 VMEYLNGGDLYSLLRKV-GCL--EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~-g~L--se~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~-~G~VKLsDFGLAk~~~~~ 648 (900)
||||+++++|.+++... ..+ ++..+..++.||+.||+|||++||+||||||+||+++. ++.+||+|||++.....
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 161 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG- 161 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc-
Confidence 99999999999999764 455 88889999999999999999999999999999999986 67999999999864210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC--CCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~--~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
.........|++.|+|||++.+. .++.++|+||||+++|+|++|.+||....
T Consensus 162 --------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 162 --------------------------INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred --------------------------CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 00112234589999999998764 47889999999999999999999997654
Q ss_pred hHH-HHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 727 PEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 727 ~~e-i~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
... ....+... ...+.++..+++++.+||.+||..+|.+||+ +.+++.||||
T Consensus 216 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~ 268 (268)
T cd06624 216 EPQAAMFKVGMF-KIHPEIPESLSAEAKNFILRCFEPDPDKRAS---AHDLLQDPFL 268 (268)
T ss_pred ChhhhHhhhhhh-ccCCCCCcccCHHHHHHHHHHcCCCchhCCC---HHHHHhCCCC
Confidence 322 11111111 1224455788999999999999999999999 8899999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=384.11 Aligned_cols=253 Identities=32% Similarity=0.533 Sum_probs=214.3
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-C-----CceEEEeeeeccCCe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-N-----PFVVRFFYSFTCRDN 569 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-H-----PnIVkL~~~f~d~~~ 569 (900)
+|+++++||+|+||.|.+|.+..|++.||||++++. +.-..+...|+.+|..++ | -|||+++++|...++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 899999999999999999999999999999999863 345666788999999997 4 389999999999999
Q ss_pred eEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCC--cEEEEecCCcccc
Q 002616 570 LYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--HIKLTDFGLSKIG 645 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G--~VKLsDFGLAk~~ 645 (900)
+|||+|.+.. +|+++|+... .|+...++.++.||+.||.+||++||||+||||+||||..-+ .|||+|||.|+..
T Consensus 263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~ 341 (586)
T KOG0667|consen 263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE 341 (586)
T ss_pred eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence 9999999965 9999998654 689999999999999999999999999999999999997644 7999999999852
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002616 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 725 (900)
Q Consensus 646 ~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~ 725 (900)
....++.+-+..|+|||+++|.+|+.+.||||||||++||++|.|.|.+.
T Consensus 342 ------------------------------~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 342 ------------------------------SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred ------------------------------CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 12334677889999999999999999999999999999999999999999
Q ss_pred ChHHHHHhhhcC--------------------C--------------------------------CCCC-CC-------C
Q 002616 726 SPEIIFDNILNR--------------------K--------------------------------IPWP-CV-------P 745 (900)
Q Consensus 726 s~~ei~~kIl~~--------------------~--------------------------------l~~P-~i-------p 745 (900)
+..+.+..|+.- . ...| .. +
T Consensus 392 ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~ 471 (586)
T KOG0667|consen 392 NEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLP 471 (586)
T ss_pred CHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcc
Confidence 877766655320 0 0011 00 0
Q ss_pred CCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 002616 746 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786 (900)
Q Consensus 746 ~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~id 786 (900)
..-...+.|||++||.+||.+|+| +.+.|+||||.+..
T Consensus 472 ~~~~~~F~dflk~~L~~dP~~R~t---p~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 472 KADDKLFIDFLKRCLEWDPAERIT---PAQALNHPFLTGTS 509 (586)
T ss_pred cccHHHHHHHHHHHhccCchhcCC---HHHHhcCccccccc
Confidence 011245689999999999999999 77889999998653
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=385.05 Aligned_cols=261 Identities=33% Similarity=0.574 Sum_probs=239.3
Q ss_pred cccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 002616 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 489 ~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~ 568 (900)
........|.+.++||+|.|++|.++++..||..||||++.|..... ...+.+.+|+++|..++|||||+||.+.....
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 34456788999999999999999999999999999999998866543 34456899999999999999999999999999
Q ss_pred eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
.+|+||||+.+|++++++.++++..+..++.++.|++.|++|||+++|||||||.+||||+.+.++||+|||++.++.
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999998642
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCCCCCCh
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 727 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGVILyEMLtGk~PF~~~s~ 727 (900)
......++||+|.|.|||++.+..| ++.+|+||+|+++|-|+.|..||.+.+-
T Consensus 207 --------------------------~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l 260 (596)
T KOG0586|consen 207 --------------------------YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL 260 (596)
T ss_pred --------------------------ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc
Confidence 2334567899999999999999888 6899999999999999999999999998
Q ss_pred HHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 728 ~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
.+.-.+.+.+++++| ..++.++++||+++|..+|.+|++ ..+|..|.|...
T Consensus 261 k~Lr~rvl~gk~rIp---~~ms~dce~lLrk~lvl~Pskr~~---~dqim~~~W~n~ 311 (596)
T KOG0586|consen 261 KELRPRVLRGKYRIP---FYMSCDCEDLLRKFLVLNPSKRGP---CDQIMKDRWRND 311 (596)
T ss_pred ccccchheeeeeccc---ceeechhHHHHHHhhccCccccCC---HHHhhhhcccch
Confidence 888888888888876 789999999999999999999999 779999999853
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=347.56 Aligned_cols=254 Identities=34% Similarity=0.579 Sum_probs=218.4
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++.+.||.|+||.||+|.++.+++.+|+|.+.... .......+.+|+++++.++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 47888999999999999999999999999999987643 2345677899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhh-cCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 575 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
||+++++|.+++... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.+|.+||+|||++.....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~----- 153 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN----- 153 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH-----
Confidence 999999999999876 789999999999999999999999 9999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC-----Ch
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-----SP 727 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~-----s~ 727 (900)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|..||... ..
T Consensus 154 ------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 209 (265)
T cd06605 154 ------------------------SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI 209 (265)
T ss_pred ------------------------HHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH
Confidence 0111267899999999999999999999999999999999999999764 23
Q ss_pred HHHHHhhhcCCCCCCCCCCC-CCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 728 EIIFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 728 ~ei~~kIl~~~l~~P~ip~~-lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
.+..+.+..... |..+.. ++.++.+||.+||..||.+||+ +.+++.||||+.
T Consensus 210 ~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~~~ 262 (265)
T cd06605 210 FELLQYIVNEPP--PRLPSGKFSPDFQDFVNLCLIKDPRERPS---YKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHhcCCC--CCCChhhcCHHHHHHHHHHcCCCchhCcC---HHHHhhCchhhc
Confidence 344444444322 223333 8899999999999999999999 889999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=353.15 Aligned_cols=259 Identities=34% Similarity=0.519 Sum_probs=215.6
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeeccccc--chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~--~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
+|++.+.||.|+||.||+|.++.+|+.||+|.++..... .......+..|+.++..++||||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 488999999999999999999999999999999765432 123345677899999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 574 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
|||+ +|+|.+++.... .+++..+..++.||+.||.|||++||+|+||||+|||++.+|.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~----- 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGS----- 154 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccC-----
Confidence 9999 899999998766 799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~ 731 (900)
.........+++.|+|||.+.+ ..++.++|+|||||++|||++|.+||.+.+..+.+
T Consensus 155 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~ 212 (298)
T cd07841 155 ----------------------PNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL 212 (298)
T ss_pred ----------------------CCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH
Confidence 0111223457889999999865 46789999999999999999999999887766655
Q ss_pred HhhhcCCC--------------------CCC-----CCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 732 DNILNRKI--------------------PWP-----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 732 ~kIl~~~l--------------------~~P-----~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
.++..... ..+ ......+.++.+||.+||..||++||+ +.+++.||||++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~e~l~~~~~~~~ 288 (298)
T cd07841 213 GKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT---ARQALEHPYFSND 288 (298)
T ss_pred HHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC---HHHHhhCccccCC
Confidence 55432100 000 011345789999999999999999999 8899999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=362.00 Aligned_cols=338 Identities=20% Similarity=0.278 Sum_probs=294.7
Q ss_pred CCCCCCCCCCCcccccccCCchhhHHHhhChHHHHHHHhhccccccccChHHHHHhhcchHHHhhhcccceeeccchhHH
Q 002616 357 SSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGSEFLLACMHDLQDVLQHSKLKALVIDTFGSR 436 (900)
Q Consensus 357 ~~~~~~~~~h~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~l~k~~~~~l~~~~~~l~~~~~~~~~~~~~~d~fg~r 436 (900)
-+-||| -|||||| ||..++|||+..|+.+.+|||+|.||++|+ |+.|...|.++++.++|+..++.++|
T Consensus 98 ehgntp--lhyacfw---gydqiaedli~~ga~v~icnk~g~tpldka-kp~l~~~l~e~aek~gq~~nripfkd----- 166 (448)
T KOG0195|consen 98 EHGNTP--LHYACFW---GYDQIAEDLISCGAAVNICNKKGMTPLDKA-KPMLKNTLLEIAEKHGQSPNRIPFKD----- 166 (448)
T ss_pred ccCCCc--hhhhhhh---cHHHHHHHHHhccceeeecccCCCCchhhh-chHHHHHHHHHHHHhCCCCCcccccc-----
Confidence 344565 6999999 999999999999999999999999999999 99999999999999999999999998
Q ss_pred HHHHHhhhHHHHhhhhccCCCCccccccccchhhhcccccCCCCCCCCCCCccccccCCCeEEEEEeccCCceEEEEEEE
Q 002616 437 IEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARK 516 (900)
Q Consensus 437 i~k~~r~~~~l~~~lL~~ksp~s~s~~~~~sr~llds~~~~~~~~~p~~ss~~~~~~~~dYeil~~LGkG~FG~Vyla~~ 516 (900)
+.|....++.+....+....+...+..++.+|.....|+.|+|+|
T Consensus 167 -----------------------------------t~wkgtktr~rdatlsr~~gid~~~lnl~tkl~e~hsgelwrgrw 211 (448)
T KOG0195|consen 167 -----------------------------------TTWKGTKTRTRDATLSRYTGIDVSSLNLITKLAESHSGELWRGRW 211 (448)
T ss_pred -----------------------------------cccccccccccccccccccCcchhhhhhhhhhccCCCcccccccc
Confidence 456666666666666777788889999999999999999999999
Q ss_pred CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCChHHHHHhcCC--CCH
Q 002616 517 RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEE 594 (900)
Q Consensus 517 k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g~--Lse 594 (900)
+ |..++.|+++. +.......+.|..|...|+.+.||||+.+++.|+.+.++.+|..||+.|+|+.+|+.... .+.
T Consensus 212 q--gndivakil~v-r~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~ 288 (448)
T KOG0195|consen 212 Q--GNDIVAKILNV-REVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDH 288 (448)
T ss_pred c--Ccchhhhhhhh-hhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEec
Confidence 8 67778898854 445566678899999999999999999999999999999999999999999999987653 688
Q ss_pred HHHHHHHHHHHHHHHhhhhcC--eEeccCCCCcEEecCCCcEEEE--ecCCcccccccccccCCCCCCCCCCCCCCCCCc
Q 002616 595 DVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLT--DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670 (900)
Q Consensus 595 ~~ar~ya~QIl~AL~yLHs~g--IIHRDLKPeNILLd~~G~VKLs--DFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~ 670 (900)
.++..++.+++.|++|||+.. |.---|....++||++.+.+|+ |-.++.
T Consensus 289 sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--------------------------- 341 (448)
T KOG0195|consen 289 SQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--------------------------- 341 (448)
T ss_pred chHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee---------------------------
Confidence 899999999999999999985 4455789999999999888775 433332
Q ss_pred ccccccCCcccccCCCCCCChhhhcCCCCC---ccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCCCCCCCCCC
Q 002616 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSD 747 (900)
Q Consensus 671 ~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys---~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l~~P~ip~~ 747 (900)
+.......|.||+||.++.++-+ .++|+|||++++||+.|...||...++++.-.+|.-+.++ +.+|++
T Consensus 342 -------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr-v~ippg 413 (448)
T KOG0195|consen 342 -------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR-VHIPPG 413 (448)
T ss_pred -------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc-ccCCCC
Confidence 11234567999999999887654 4899999999999999999999999999999999988877 567899
Q ss_pred CCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 748 MSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 748 lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
++..+..|++.|++.||.+||.++++..||+
T Consensus 414 is~hm~klm~icmnedpgkrpkfdmivpile 444 (448)
T KOG0195|consen 414 ISRHMNKLMNICMNEDPGKRPKFDMIVPILE 444 (448)
T ss_pred ccHHHHHHHHHHhcCCCCcCCCcceehhhHH
Confidence 9999999999999999999999888877764
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=348.44 Aligned_cols=257 Identities=36% Similarity=0.587 Sum_probs=215.1
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+|++.+.||.|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.....+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 58999999999999999999999999999999876432 23445778999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 576 YLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 576 y~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
|+ +++|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~------ 152 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE------ 152 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC------
Confidence 99 99999998653 56899999999999999999999999999999999999999999999999998742100
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
.........|++.|+|||++.+. .++.++|||||||++|||++|.+||.+.+....+..
T Consensus 153 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 212 (286)
T cd07832 153 --------------------EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI 212 (286)
T ss_pred --------------------CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHH
Confidence 00112235789999999998764 468999999999999999999999988776665554
Q ss_pred hhcC-------------------CCCCC--------CCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCC
Q 002616 734 ILNR-------------------KIPWP--------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 734 Il~~-------------------~l~~P--------~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk 783 (900)
+... ...++ ...+..+.++.+||.+||..||.+||+ +.+++.||||.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~---~~~~l~h~~~~ 286 (286)
T cd07832 213 VFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS---AAEALRHPYFT 286 (286)
T ss_pred HHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC---HHHHhhCcCcC
Confidence 4321 01111 111356789999999999999999999 88999999993
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=348.67 Aligned_cols=256 Identities=27% Similarity=0.401 Sum_probs=215.2
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~-----tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
..++|.+.+.||+|+||.||+|++.. ++..||+|+++... .......+.+|+++|..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35679999999999999999998753 36789999986532 233567899999999999999999999999999
Q ss_pred CeeEEEEeecCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKVG--------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH 633 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~g--------------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~ 633 (900)
..+|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||++|++||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999997643 3788899999999999999999999999999999999999999
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHH
Q 002616 634 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 713 (900)
Q Consensus 634 VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILy 713 (900)
+||+|||+++...... .........+++.|+|||++.+..++.++|||||||++|
T Consensus 161 ~kl~d~g~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 215 (280)
T cd05049 161 VKIGDFGMSRDVYTTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLW 215 (280)
T ss_pred EEECCcccceecccCc-------------------------ceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHH
Confidence 9999999987421000 000112345688999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 714 EFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 714 EMLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
||++ |..||...+..+....+..+.... .+..++..+.+||.+||+.||.+||+++++.+.+
T Consensus 216 e~~~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l 278 (280)
T cd05049 216 EIFTYGKQPWYGLSNEEVIECITQGRLLQ--RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278 (280)
T ss_pred HHHhcCCCCCCCCCHHHHHHHHHcCCcCC--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHh
Confidence 9998 999999888888887777655433 2467899999999999999999999955544443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=347.81 Aligned_cols=258 Identities=33% Similarity=0.543 Sum_probs=215.2
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++.+.||+|+||.||+|.++.+++.||+|+++... ........+.+|+++++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE-DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc-ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 47999999999999999999999999999999986532 23344577899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||++++.+..++.+...+++..+..++.+|+.||.|||++|++||||+|+||+++.++.+||+|||++......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~------ 153 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRAR------ 153 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCC------
Confidence 99999888777776677999999999999999999999999999999999999999999999999998743110
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
........+|++.|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+..+....
T Consensus 154 --------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~ 213 (288)
T cd07833 154 --------------------PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213 (288)
T ss_pred --------------------ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 00122345789999999999887 889999999999999999999999987665443332
Q ss_pred hhcC-------------------CCCCCC----------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 734 ILNR-------------------KIPWPC----------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 734 Il~~-------------------~l~~P~----------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
+... ...++. .+..++.++.+||++||..||++||+ +.+++.||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~f 288 (288)
T cd07833 214 IQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT---CDELLQHPYF 288 (288)
T ss_pred HHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc---HHHHhcCCCC
Confidence 2110 000110 12345899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=349.94 Aligned_cols=257 Identities=31% Similarity=0.505 Sum_probs=209.8
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCe----
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN---- 569 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~---- 569 (900)
++|++.+.||.|+||.||+|.+..+|+.||+|+++... ........+.+|+.++..+. ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 47999999999999999999999999999999886532 22334467888999999995 6999999999987766
Q ss_pred -eEEEEeecCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecC-CCcEEEEecCCc
Q 002616 570 -LYLVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLS 642 (900)
Q Consensus 570 -LyLVmEy~~GGsL~dlL~k~-----g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~-~G~VKLsDFGLA 642 (900)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 888887643 35799999999999999999999999999999999999998 899999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCC
Q 002616 643 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPP 721 (900)
Q Consensus 643 k~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~P 721 (900)
+.... .........+++.|+|||++.+ ..++.++||||||+++|+|++|.+|
T Consensus 159 ~~~~~---------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~ 211 (295)
T cd07837 159 RAFSI---------------------------PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPL 211 (295)
T ss_pred eecCC---------------------------CccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCC
Confidence 74210 0011122357899999999875 4578999999999999999999999
Q ss_pred CCCCChHHHHHhhhcCC-----CC------------CCC--------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHH
Q 002616 722 FTAESPEIIFDNILNRK-----IP------------WPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 776 (900)
Q Consensus 722 F~~~s~~ei~~kIl~~~-----l~------------~P~--------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EI 776 (900)
|.+.+......++...- .. ++. ..+.++.++.+||.+||.+||.+||+ +.++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~---~~ei 288 (295)
T cd07837 212 FPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS---AKAA 288 (295)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC---HHHH
Confidence 99887666554443210 00 010 01357899999999999999999999 8899
Q ss_pred HcCCCCC
Q 002616 777 KAHPFFK 783 (900)
Q Consensus 777 L~HPFFk 783 (900)
+.||||+
T Consensus 289 l~~~~~~ 295 (295)
T cd07837 289 LTHPYFD 295 (295)
T ss_pred hcCCCcC
Confidence 9999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=368.97 Aligned_cols=261 Identities=23% Similarity=0.346 Sum_probs=210.5
Q ss_pred cccccCCCeEEEEEeccCCceEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 002616 489 KERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 562 (900)
Q Consensus 489 ~~~~~~~dYeil~~LGkG~FG~Vyla~~-----k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~ 562 (900)
...+..++|++.+.||+|+||+||+|++ ..++..||+|+++... .....+.+.+|+.+|..+ +|||||++++
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 3445567899999999999999999975 3457789999986432 233456788999999999 8999999999
Q ss_pred eeccCCeeEEEEeecCCCChHHHHHhcC----------------------------------------------------
Q 002616 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVG---------------------------------------------------- 590 (900)
Q Consensus 563 ~f~d~~~LyLVmEy~~GGsL~dlL~k~g---------------------------------------------------- 590 (900)
+|...+..|+||||++||+|.+++....
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 9999999999999999999999986421
Q ss_pred -----------------------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccc
Q 002616 591 -----------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 591 -----------------------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~ 647 (900)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 367788889999999999999999999999999999999999999999999874311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCC
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 726 (900)
Q Consensus 648 ~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s 726 (900)
.. .........+++.|+|||++.+..++.++|||||||++|||++ |.+||....
T Consensus 267 ~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 267 DS-------------------------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred cc-------------------------cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 00 0001112345678999999999999999999999999999998 999998776
Q ss_pred hHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 727 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 727 ~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
....+.+++...... ..+...+.++.+||.+||+.||++||++.++.+.+
T Consensus 322 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l 371 (375)
T cd05104 322 VDSKFYKMIKEGYRM-LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371 (375)
T ss_pred chHHHHHHHHhCccC-CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHH
Confidence 544444444443332 23456789999999999999999999965555444
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=351.55 Aligned_cols=256 Identities=30% Similarity=0.514 Sum_probs=218.2
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
..++|++++.||+|+||+||++.+..+|+.||+|++.... .......+.+|++++..++||||+++++++...+.+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4578999999999999999999999999999999986532 23446788999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhh-cCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 573 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
||||+++|+|.+++.+.+.+++..++.++.+++.||.|||+ .|++||||||+||+++.++.++|+|||++....
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~----- 155 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI----- 155 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh-----
Confidence 99999999999999888889999999999999999999997 589999999999999999999999999886321
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH---
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE--- 728 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~--- 728 (900)
.......+||..|+|||++.+..++.++|+|||||++|+|++|..||......
T Consensus 156 ------------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~ 211 (284)
T cd06620 156 ------------------------NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDG 211 (284)
T ss_pred ------------------------hhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhh
Confidence 00112357999999999998888999999999999999999999999865542
Q ss_pred --------HHHHhhhcCCCCCCCCC-CCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 729 --------IIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 729 --------ei~~kIl~~~l~~P~ip-~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
+....+..... +.++ ..++.++.+||.+||..||.+||+ +.++++||||..
T Consensus 212 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~e~~~~~~~~~ 271 (284)
T cd06620 212 QDDPMGILDLLQQIVQEPP--PRLPSSDFPEDLRDFVDACLLKDPTERPT---PQQLCAMPPFIQ 271 (284)
T ss_pred hhhhhHHHHHHHHHhhccC--CCCCchhcCHHHHHHHHHHhcCCcccCcC---HHHHhcCccccc
Confidence 23333333221 1122 237889999999999999999999 789999999953
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=339.37 Aligned_cols=259 Identities=37% Similarity=0.620 Sum_probs=216.6
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+|++.+.||+|+||.||+|....+++.||+|+++.... .....+.+.+|+.+++.++||||+++++.+...+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 58899999999999999999998999999999976543 24577889999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCC
Q 002616 576 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 576 y~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
|+++++|.+++.+.+.+++..++.++.+++.||.|||++||+|+||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~----- 154 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT----- 154 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC-----
Confidence 999999999998887899999999999999999999999999999999999999999999999999875321000
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCC---CCccceeechhHHHHHHHhCCCCCCCCCh-HHHH
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGIPPFTAESP-EIIF 731 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~---ys~ksDIWSLGVILyEMLtGk~PF~~~s~-~ei~ 731 (900)
..........|++.|+|||++.+.. ++.++|+||||+++|+|++|..||..... ....
T Consensus 155 ------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~ 216 (264)
T cd06626 155 ------------------TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM 216 (264)
T ss_pred ------------------cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH
Confidence 0000022356899999999998766 88999999999999999999999976533 2232
Q ss_pred HhhhcC-CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 732 DNILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 732 ~kIl~~-~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
..+... ...+|. ...+++.+.+||.+||+.||.+||+ +.+++.|||+
T Consensus 217 ~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~---~~~i~~~~~~ 264 (264)
T cd06626 217 FHVGAGHKPPIPD-SLQLSPEGKDFLDRCLESDPKKRPT---ASELLQHPFV 264 (264)
T ss_pred HHHhcCCCCCCCc-ccccCHHHHHHHHHHccCCcccCCC---HHHHhcCCCC
Confidence 233322 222221 1234899999999999999999999 8899999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=343.54 Aligned_cols=255 Identities=21% Similarity=0.361 Sum_probs=216.6
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
+...+|++.+.||.|+||.||+|.++.+++.||+|++++. ......+.+|++++..++||||+++++++...+.+|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 4567899999999999999999999999999999998643 234567889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
+||||+++|+|.+++... ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999999998754 358899999999999999999999999999999999999999999999999987421000
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChH
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 728 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ 728 (900)
........+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..
T Consensus 159 --------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 212 (263)
T cd05052 159 --------------------------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 212 (263)
T ss_pred --------------------------eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 001112334678999999999999999999999999999998 99999998888
Q ss_pred HHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 729 ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
+.+..+.... . +..+..++.++.+||.+||..||++||++.++.+.++
T Consensus 213 ~~~~~~~~~~-~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~ 260 (263)
T cd05052 213 QVYELLEKGY-R-MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFE 260 (263)
T ss_pred HHHHHHHCCC-C-CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 8777765532 2 2345788999999999999999999999766666554
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=354.17 Aligned_cols=261 Identities=33% Similarity=0.486 Sum_probs=214.3
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cee
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 570 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~L 570 (900)
..++|++.+.||.|+||.||+|.++.+|+.||+|+++.... .......+.+|+.++.+++||||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 56899999999999999999999999999999999865332 222234567899999999999999999998765 568
Q ss_pred EEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
|+||||+.+ +|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~-- 160 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL-- 160 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCC--
Confidence 999999975 888888753 5689999999999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE 728 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ 728 (900)
.........+++.|+|||++.+ ..++.++|+|||||++|||++|.+||.+.+..
T Consensus 161 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~ 215 (309)
T cd07845 161 -------------------------PAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI 215 (309)
T ss_pred -------------------------ccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 0011122356889999999876 56789999999999999999999999998887
Q ss_pred HHHHhhhcCC-------------------CCCCCC--------CCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCC
Q 002616 729 IIFDNILNRK-------------------IPWPCV--------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781 (900)
Q Consensus 729 ei~~kIl~~~-------------------l~~P~i--------p~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPF 781 (900)
+.+..+.... ...+.. ...+++++.+||.+||+.||++||+ +.+++.|||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t---~~~il~h~~ 292 (309)
T cd07845 216 EQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT---AEEALESSY 292 (309)
T ss_pred HHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC---HHHHhcChh
Confidence 7776655410 011100 0235889999999999999999999 889999999
Q ss_pred CCCC
Q 002616 782 FKGV 785 (900)
Q Consensus 782 Fk~i 785 (900)
|++.
T Consensus 293 f~~~ 296 (309)
T cd07845 293 FKEK 296 (309)
T ss_pred hccC
Confidence 9753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=349.45 Aligned_cols=255 Identities=33% Similarity=0.538 Sum_probs=210.2
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+|++++.||.|+||.||+|+++.+|+.||+|.++... ........+.+|++++++++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc-cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 5899999999999999999999999999999886432 223344678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 576 YLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 576 y~~GGsL~dlL~k--~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|+. ++|..++.. ...+++..++.++.|++.||+|||++|++||||+|+||+++.++.+||+|||++.....
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~------ 152 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV------ 152 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhccc------
Confidence 996 589888865 35689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCC-CCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~ 732 (900)
.........+++.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+......
T Consensus 153 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~ 211 (284)
T cd07860 153 ---------------------PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 211 (284)
T ss_pred ---------------------CccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 001112335789999999987644 6889999999999999999999998876554443
Q ss_pred hhhcCC------------------CCCC--------CCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 733 NILNRK------------------IPWP--------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 733 kIl~~~------------------l~~P--------~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
++.... ..++ .+...+++++.+||.+||+.||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~~l~~~~f 284 (284)
T cd07860 212 RIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS---AKAALAHPFF 284 (284)
T ss_pred HHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCC---HHHHhcCCCC
Confidence 332210 0011 012357889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=339.14 Aligned_cols=250 Identities=52% Similarity=0.962 Sum_probs=223.1
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCCh
Q 002616 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 582 (900)
Q Consensus 503 LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GGsL 582 (900)
||.|+||.||++.+..+++.||+|++++...........+.+|+.+++.++||||+++++.+...+.+|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999999886665566778899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCCCC
Q 002616 583 YSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 662 (900)
Q Consensus 583 ~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~ 662 (900)
.+++.....+++..+..++.|++.||.|||+.+++|+||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~--------------- 145 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSS--------------- 145 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceeccc---------------
Confidence 99998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCCCCC
Q 002616 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP 742 (900)
Q Consensus 663 ~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l~~P 742 (900)
.........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+......+|
T Consensus 146 ------------~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 213 (250)
T cd05123 146 ------------EGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP 213 (250)
T ss_pred ------------CCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC
Confidence 00123345789999999999988889999999999999999999999988888788888777655544
Q ss_pred CCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 743 CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 743 ~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
..++..+.+||++||..||.+||++..+.++++||||
T Consensus 214 ---~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 214 ---EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred ---CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 6779999999999999999999995335899999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=341.71 Aligned_cols=249 Identities=24% Similarity=0.400 Sum_probs=210.4
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
..++|++.+.||+|+||.||+++++. +..+|+|.+++... ....+.+|+.+|+.++||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 35689999999999999999998864 56799998864332 24568889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 573 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
||||+++|+|.+++... +.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~--- 153 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD--- 153 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC---
Confidence 99999999999998753 56899999999999999999999999999999999999999999999999998742100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHH
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 730 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ei 730 (900)
.........++..|+|||++.+..++.++|+||||+++|||++ |++||...+..+.
T Consensus 154 -----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~ 210 (256)
T cd05114 154 -----------------------EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV 210 (256)
T ss_pred -----------------------ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 0001122346678999999998899999999999999999999 9999999988888
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHH
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 774 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~ 774 (900)
...+..+... ..+...+.++.+|+.+||+.||.+||++.++.
T Consensus 211 ~~~i~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~ 252 (256)
T cd05114 211 VEMISRGFRL--YRPKLASMTVYEVMYSCWHEKPEGRPTFAELL 252 (256)
T ss_pred HHHHHCCCCC--CCCCCCCHHHHHHHHHHccCCcccCcCHHHHH
Confidence 8888765432 22456788999999999999999999954443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=334.59 Aligned_cols=254 Identities=36% Similarity=0.658 Sum_probs=224.1
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+|++.+.||.|+||.||++.+..++..||+|++..... .......+.+|+++++.++|||++++++.+......++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58999999999999999999999999999999865432 34556778999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 576 YLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 576 y~~GGsL~dlL~k~----g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
|+++++|.+++.+. ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~---- 155 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS---- 155 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeeccc----
Confidence 99999999999764 6799999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~ 731 (900)
.........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.....
T Consensus 156 -----------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~ 212 (258)
T cd08215 156 -----------------------TVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212 (258)
T ss_pred -----------------------CcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH
Confidence 001223457899999999999988999999999999999999999999988887777
Q ss_pred HhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 732 ~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
..+.... ++.++..++.++.++|.+||..+|.+||+ +.+++.||||
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 258 (258)
T cd08215 213 LKILKGQ--YPPIPSQYSSELRNLVSSLLQKDPEERPS---IAQILQSPFI 258 (258)
T ss_pred HHHhcCC--CCCCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCCCC
Confidence 7776554 33445788999999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=347.69 Aligned_cols=247 Identities=33% Similarity=0.554 Sum_probs=203.3
Q ss_pred CCCeEEEEEe--ccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCceEEEeeeeccCCee
Q 002616 494 IDDFEIIKPI--SRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCRDNL 570 (900)
Q Consensus 494 ~~dYeil~~L--GkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~-L~HPnIVkL~~~f~d~~~L 570 (900)
.++|++.+.+ |.|+||.||+++.+.++..||+|++.+..... .|..+... .+||||++++++|...+.+
T Consensus 13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3456666665 99999999999999999999999987532211 12222222 2699999999999999999
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCC-cEEEEecCCcccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINN 649 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G-~VKLsDFGLAk~~~~~~ 649 (900)
|+||||+++|+|.+++.+...+++..++.++.||+.||.|||+.|++||||||+||+++.++ .++|+|||+++...
T Consensus 85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~--- 161 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG--- 161 (267)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC---
Confidence 99999999999999998887899999999999999999999999999999999999999998 99999999986421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 729 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~e 729 (900)
......||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus 162 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~ 213 (267)
T PHA03390 162 ----------------------------TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213 (267)
T ss_pred ----------------------------CCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch
Confidence 1112468999999999999999999999999999999999999998654432
Q ss_pred H----HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 730 I----FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 730 i----~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
+ ......... ..+..+++.+.+||.+||+.||.+||+. +.++|+||||++
T Consensus 214 ~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~R~~~--~~~~l~h~~~~~ 267 (267)
T PHA03390 214 LDLESLLKRQQKKL---PFIKNVSKNANDFVQSMLKYNINYRLTN--YNEIIKHPFLKI 267 (267)
T ss_pred hhHHHHHHhhcccC---CcccccCHHHHHHHHHHhccChhhCCch--HHHHhcCCcccC
Confidence 2 111112222 2335789999999999999999999962 579999999974
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=338.90 Aligned_cols=255 Identities=30% Similarity=0.503 Sum_probs=215.5
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
++|++.+.||.|+||.||+|....+|+.||+|.++............+.+|+.++++++|+||+++++++...+..|+||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999997655555556788999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 575 EYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 575 Ey~~GGsL~dlL~k----~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
||+++|+|..++.. ...+++..+..++.+++.||.|||+.||+||||||+||+++.+|.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~--- 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS--- 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccC---
Confidence 99999999999864 24589999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC--hH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES--PE 728 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s--~~ 728 (900)
.........|++.|+|||.+.+..++.++|+|||||++|+|++|..||.... ..
T Consensus 159 ------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T cd08224 159 ------------------------KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY 214 (267)
T ss_pred ------------------------CCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH
Confidence 0111233568999999999999999999999999999999999999996543 23
Q ss_pred HHHHhhhcCCCCCCCCCC-CCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 729 IIFDNILNRKIPWPCVPS-DMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 729 ei~~kIl~~~l~~P~ip~-~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
+....+..+.. +..+. .++.++.++|.+||..+|.+||++.++.+.++
T Consensus 215 ~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~ 263 (267)
T cd08224 215 SLCKKIEKCDY--PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAK 263 (267)
T ss_pred HHHhhhhcCCC--CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHH
Confidence 44444444322 22233 78889999999999999999999665555543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=340.46 Aligned_cols=259 Identities=29% Similarity=0.492 Sum_probs=219.3
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeeccc--ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cee
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD--MIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 570 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~--~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~L 570 (900)
.+|++.+.||+|+||.||+|+++.+|+.||+|++.... .........+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999875421 12234567889999999999999999999998764 468
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
++||||+++++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~-- 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI-- 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc--
Confidence 999999999999999988788999999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei 730 (900)
...........|++.|+|||++.+..++.++|+|||||++|+|++|++||........
T Consensus 160 ----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~ 217 (264)
T cd06653 160 ----------------------CMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA 217 (264)
T ss_pred ----------------------cccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH
Confidence 0001112235689999999999998899999999999999999999999988776666
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
..++...... +.+|..+++++.++|.+||. +|.+||+ +.+++.|||.
T Consensus 218 ~~~~~~~~~~-~~~p~~~~~~~~~~i~~~l~-~~~~r~~---~~~~~~~~~~ 264 (264)
T cd06653 218 IFKIATQPTK-PMLPDGVSDACRDFLKQIFV-EEKRRPT---AEFLLRHPFV 264 (264)
T ss_pred HHHHHcCCCC-CCCCcccCHHHHHHHHHHhc-CcccCcc---HHHHhcCCCC
Confidence 6555543322 44568899999999999999 6899999 7799999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=347.65 Aligned_cols=256 Identities=30% Similarity=0.553 Sum_probs=207.1
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
.++|++.+.||.|+||.||+|..+.+++.||+|.+..... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999865321 12234567899999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 574 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
|||+++ +|.+++.+. ..+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 155 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV----- 155 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCC-----
Confidence 999985 999988764 4689999999999999999999999999999999999999999999999999863110
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCC-hHHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES-PEII 730 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s-~~ei 730 (900)
.........+++.|+|||++.+ ..++.++|||||||++|+|++|++||.... ..+.
T Consensus 156 ----------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~ 213 (291)
T cd07844 156 ----------------------PSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213 (291)
T ss_pred ----------------------CCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH
Confidence 0001122357889999999876 458899999999999999999999997655 2222
Q ss_pred HHhhhcC-------------------CCCCCC--------CCCCCC--HHHHHHHHHhccCCcCCCCChhcHHHHHcCCC
Q 002616 731 FDNILNR-------------------KIPWPC--------VPSDMS--FEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781 (900)
Q Consensus 731 ~~kIl~~-------------------~l~~P~--------ip~~lS--~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPF 781 (900)
...+... ...++. ....++ .++.+||.+||+.||.+||+ +.+++.|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps---~~e~l~~~~ 290 (291)
T cd07844 214 LHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS---AAEAMKHPY 290 (291)
T ss_pred HHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC---HHHHhcCCC
Confidence 2222110 000000 001344 88999999999999999999 789999999
Q ss_pred C
Q 002616 782 F 782 (900)
Q Consensus 782 F 782 (900)
|
T Consensus 291 f 291 (291)
T cd07844 291 F 291 (291)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=352.49 Aligned_cols=254 Identities=25% Similarity=0.391 Sum_probs=210.4
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCcE--EEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDL--FAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR 567 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~--VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~ 567 (900)
.+..++|++.+.||+|+||.||+|.++.+|.. +|+|.++. .........+.+|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc--cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 35678999999999999999999999888765 46666543 22345567888999999999 899999999999999
Q ss_pred CeeEEEEeecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCC
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 631 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~g----------------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~ 631 (900)
+.+|+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~ 160 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 160 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCC
Confidence 99999999999999999997543 47889999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHH
Q 002616 632 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 711 (900)
Q Consensus 632 G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVI 711 (900)
+.+||+|||++..... ........+++.|+|||++.+..++.++|||||||+
T Consensus 161 ~~~kl~dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 212 (303)
T cd05088 161 YVAKIADFGLSRGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVL 212 (303)
T ss_pred CcEEeCccccCcccch----------------------------hhhcccCCCcccccCHHHHhccCCcccccchhhhhH
Confidence 9999999999862100 001112234678999999988889999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcC
Q 002616 712 LFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 712 LyEMLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~H 779 (900)
+|||++ |.+||...+..+.+..+... .. +..+..+++++.+||.+||+.+|.+||+ +.+++.+
T Consensus 213 l~ellt~g~~p~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~ 276 (303)
T cd05088 213 LWEIVSLGGTPYCGMTCAELYEKLPQG-YR-LEKPLNCDDEVYDLMRQCWREKPYERPS---FAQILVS 276 (303)
T ss_pred HHHHHhcCCCCcccCChHHHHHHHhcC-Cc-CCCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 999998 99999988887777766443 22 1233567899999999999999999999 4455543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=360.40 Aligned_cols=257 Identities=28% Similarity=0.467 Sum_probs=211.4
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 568 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~---- 568 (900)
..++|++.+.||+|+||.||+|++..+|+.||+|++.+.. ........+.+|+.++..++||||++++++|....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3578999999999999999999999999999999986532 23344567788999999999999999999886543
Q ss_pred --eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 569 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 569 --~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
.+|+||||+.+ +|.+.+... +++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 93 FQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred cCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 57999999965 888887654 8999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
. ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 170 ~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 170 T----------------------------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred C----------------------------CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 0 011233568999999999999999999999999999999999999998876
Q ss_pred hHHHHHhhhcCC---------------------------CC---------CCC----CCCCCCHHHHHHHHHhccCCcCC
Q 002616 727 PEIIFDNILNRK---------------------------IP---------WPC----VPSDMSFEAQDLINRFLIHDPNQ 766 (900)
Q Consensus 727 ~~ei~~kIl~~~---------------------------l~---------~P~----ip~~lS~eakDLIk~cL~~DP~k 766 (900)
....+.++...- .. ++. .+...+.++.+||.+||+.||.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 301 (353)
T cd07850 222 HIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301 (353)
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhh
Confidence 555444432210 00 000 01234667899999999999999
Q ss_pred CCChhcHHHHHcCCCCCC
Q 002616 767 RLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 767 RpSa~~a~EIL~HPFFk~ 784 (900)
||+ +.++|.||||+.
T Consensus 302 R~t---~~eiL~~~~~~~ 316 (353)
T cd07850 302 RIS---VDDALQHPYINV 316 (353)
T ss_pred CcC---HHHHhcChhHhh
Confidence 999 889999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=347.84 Aligned_cols=256 Identities=31% Similarity=0.551 Sum_probs=219.8
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
.|...+.||.|+||.||++.++.+++.+|+|.+... .....+.+.+|+.+++.++||||+++++++...+..|+|+|
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 455567999999999999999999999999988532 23345668899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCC
Q 002616 576 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 576 y~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
|++|++|.+++.. +.+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++.....
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~-------- 167 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK-------- 167 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhcc--------
Confidence 9999999999877 6789999999999999999999999999999999999999999999999998763210
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhh
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 735 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl 735 (900)
.........|++.|+|||++.+..++.++|+|||||++|||++|..||...++......+.
T Consensus 168 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~ 228 (285)
T cd06648 168 -------------------EVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR 228 (285)
T ss_pred -------------------CCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 0011223568999999999998889999999999999999999999999888877777766
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 736 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 736 ~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
....+....+..++..+.+||.+||+.||.+||+ +.++++||||+..
T Consensus 229 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~ 275 (285)
T cd06648 229 DNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT---AAELLNHPFLAKA 275 (285)
T ss_pred hcCCCCCcccccCCHHHHHHHHHHcccChhhCcC---HHHHccCcccccC
Confidence 5533322223447899999999999999999999 7899999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=338.63 Aligned_cols=254 Identities=29% Similarity=0.520 Sum_probs=219.3
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+|++.+.||+|+||.||+|..+.+|..||+|.+..... .....+.+.+|+.+++.++||||+++++.+.....+|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58999999999999999999999999999999876432 22345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCc-EEEEecCCccccccccccc
Q 002616 576 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-IKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 576 y~~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~-VKLsDFGLAk~~~~~~s~~ 652 (900)
|+++++|.+++.+.. .+++..+..++.|++.||.|||+++++|+||||+||+++.++. +||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~----- 154 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND----- 154 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC-----
Confidence 999999999987643 4789999999999999999999999999999999999998864 69999998864210
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~ 732 (900)
.........|++.|+|||++.+..++.++|+||||+++|||++|..||...+..+...
T Consensus 155 ----------------------~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 212 (257)
T cd08225 155 ----------------------SMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL 212 (257)
T ss_pred ----------------------CcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 0111223468999999999998889999999999999999999999999888777777
Q ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 733 kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
.+..... +.+++.++.++.++|.+||..+|++||+ +.+++.||||
T Consensus 213 ~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~ll~~~~~ 257 (257)
T cd08225 213 KICQGYF--APISPNFSRDLRSLISQLFKVSPRDRPS---ITSILKRPFL 257 (257)
T ss_pred HHhcccC--CCCCCCCCHHHHHHHHHHhccChhhCcC---HHHHhhCCCC
Confidence 6665543 3334678899999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=348.78 Aligned_cols=261 Identities=31% Similarity=0.488 Sum_probs=212.5
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
.++|++.+.||+|+||+||+|.++.+|+.||+|.++.... .......+.+|+++++.++||||+++++++...+.+|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 3689999999999999999999999999999999865332 223446788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecC-CCcEEEEecCCccccccccc
Q 002616 574 MEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~g~--Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~-~G~VKLsDFGLAk~~~~~~s 650 (900)
|||++ ++|..++..... +++..++.++.||+.||+|||++|++||||||+||+++. ++.+||+|||++.....
T Consensus 80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~--- 155 (294)
T PLN00009 80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI--- 155 (294)
T ss_pred Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCC---
Confidence 99996 488888765443 578888999999999999999999999999999999985 56799999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEI 729 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~e 729 (900)
.........|++.|+|||++.+. .++.++|||||||++|+|++|.+||...+..+
T Consensus 156 ------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~ 211 (294)
T PLN00009 156 ------------------------PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID 211 (294)
T ss_pred ------------------------CccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 00111234678999999998764 57899999999999999999999998877665
Q ss_pred HHHhhhcC---C------------------CCCCC-----CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCC
Q 002616 730 IFDNILNR---K------------------IPWPC-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 730 i~~kIl~~---~------------------l~~P~-----ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk 783 (900)
...++... . ..++. ....+++++.+||.+||+.||++||+ +.+++.||||+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps---~~~~l~~~~~~ 288 (294)
T PLN00009 212 ELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT---ARAALEHEYFK 288 (294)
T ss_pred HHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC---HHHHhcCchHh
Confidence 55544321 0 00000 12457889999999999999999999 88999999998
Q ss_pred CCC
Q 002616 784 GVN 786 (900)
Q Consensus 784 ~id 786 (900)
+++
T Consensus 289 ~~~ 291 (294)
T PLN00009 289 DLG 291 (294)
T ss_pred HHh
Confidence 653
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=343.61 Aligned_cols=256 Identities=29% Similarity=0.492 Sum_probs=214.3
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
+++|++.+.||+|+||.||+|+++.+|+.||+|.+.+...........+.+|+.+++.++||||++++++|...+.+|+|
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 36789999999999999999999999999999998765555555667899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 574 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 574 mEy~~GGsL~dlL~k----~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
|||+++++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~- 159 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC-
Confidence 999999999998863 346899999999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh--
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-- 727 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~-- 727 (900)
........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+...
T Consensus 160 --------------------------~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 213 (267)
T cd08229 160 --------------------------TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL 213 (267)
T ss_pred --------------------------CcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH
Confidence 0112235689999999999998999999999999999999999999976543
Q ss_pred HHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 728 ~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
......+.....+ +..+..++.++.+||.+||..||.+||++..+.+.+
T Consensus 214 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~ 262 (267)
T cd08229 214 YSLCKKIEQCDYP-PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVA 262 (267)
T ss_pred HHHhhhhhcCCCC-CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHH
Confidence 3444444433221 112346889999999999999999999965444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=400.41 Aligned_cols=264 Identities=31% Similarity=0.518 Sum_probs=219.2
Q ss_pred ccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-- 567 (900)
Q Consensus 490 ~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~-- 567 (900)
.....++|++++.||+|+||+||+|+++.++..||+|++..... .......+..|+.+|..++|||||+++++|...
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34567899999999999999999999999999999999875432 344567889999999999999999999988554
Q ss_pred CeeEEEEeecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHhhhhc-------CeEeccCCCCcEEecC------
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSL-------GIVHRDLKPDNLLIAH------ 630 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~----g~Lse~~ar~ya~QIl~AL~yLHs~-------gIIHRDLKPeNILLd~------ 630 (900)
..+||||||+++|+|.++|... +.+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 5699999999999999998752 5799999999999999999999985 4999999999999964
Q ss_pred -----------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC--C
Q 002616 631 -----------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--T 697 (900)
Q Consensus 631 -----------~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~ 697 (900)
.+.+||+|||+++.... .......+||+.|+|||++.+ .
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~----------------------------~s~~~s~vGTp~YmAPEvL~ge~~ 218 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGI----------------------------ESMAHSCVGTPYYWSPELLLHETK 218 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccc----------------------------cccccccCCCccccCHHHHhccCC
Confidence 34599999999874210 111234679999999999965 4
Q ss_pred CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 698 EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 698 ~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
.++.++||||||||||||++|.+||...+....+..++.....+| ....+.++.+||..||..+|.+||+ +.++|
T Consensus 219 ~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp--i~~~S~eL~dLI~~~L~~dPeeRPS---a~QlL 293 (1021)
T PTZ00266 219 SYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP--IKGKSKELNILIKNLLNLSAKERPS---ALQCL 293 (1021)
T ss_pred CCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC--cCCCCHHHHHHHHHHhcCChhHCcC---HHHHh
Confidence 588999999999999999999999987665444444444433333 2467899999999999999999999 88999
Q ss_pred cCCCCCCCCc
Q 002616 778 AHPFFKGVNW 787 (900)
Q Consensus 778 ~HPFFk~idw 787 (900)
.||||+.+..
T Consensus 294 ~h~~ik~i~~ 303 (1021)
T PTZ00266 294 GYQIIKNVGP 303 (1021)
T ss_pred ccHHHhhcCC
Confidence 9999987643
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=351.72 Aligned_cols=249 Identities=24% Similarity=0.420 Sum_probs=192.1
Q ss_pred EEeccCCceEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--CCeeEEEEee
Q 002616 501 KPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLYLVMEY 576 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~--tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d--~~~LyLVmEy 576 (900)
.+||+|+||+||+|+.+. ++..||+|.+.... ....+.+|+.+|+.++||||++++++|.. ...+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999999764 56889999886532 23457789999999999999999998854 5678999999
Q ss_pred cCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEe----cCCCcEEEEecCCcc
Q 002616 577 LNGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI----AHDGHIKLTDFGLSK 643 (900)
Q Consensus 577 ~~GGsL~dlL~k~---------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILL----d~~G~VKLsDFGLAk 643 (900)
+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.+|.+||+|||+++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 875 788777522 248889999999999999999999999999999999999 567899999999997
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCC
Q 002616 644 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF 722 (900)
Q Consensus 644 ~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF 722 (900)
...... .........+||+.|+|||++.+ ..++.++|||||||++|||++|.+||
T Consensus 161 ~~~~~~------------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f 216 (317)
T cd07867 161 LFNSPL------------------------KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIF 216 (317)
T ss_pred ccCCCc------------------------ccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCc
Confidence 421000 00112234679999999999987 45899999999999999999999999
Q ss_pred CCCChH---------HHHHhhhcC--------------CCC---------------------CCCCCCCCCHHHHHHHHH
Q 002616 723 TAESPE---------IIFDNILNR--------------KIP---------------------WPCVPSDMSFEAQDLINR 758 (900)
Q Consensus 723 ~~~s~~---------ei~~kIl~~--------------~l~---------------------~P~ip~~lS~eakDLIk~ 758 (900)
...... ....++... ... .+......+..+.+||.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ 296 (317)
T cd07867 217 HCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQK 296 (317)
T ss_pred ccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHH
Confidence 754321 011111100 000 000112345678899999
Q ss_pred hccCCcCCCCChhcHHHHHcCCCC
Q 002616 759 FLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 759 cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
||+.||.+||| +.++|+||||
T Consensus 297 ~l~~dP~~R~t---~~e~l~hp~f 317 (317)
T cd07867 297 LLTMDPTKRIT---SEQALQDPYF 317 (317)
T ss_pred HhccCcccccC---HHHHhcCCCC
Confidence 99999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=339.54 Aligned_cols=254 Identities=23% Similarity=0.377 Sum_probs=214.4
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
+..++|+++++||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.+++.++||||+++++.+...+.+|
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 45689999999999999999999865 46779999876432 23567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
+||||+++|+|.+++.+. ..++...+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~- 156 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN- 156 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC-
Confidence 999999999999999753 45888899999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChH
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 728 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ 728 (900)
.........++..|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 157 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 211 (261)
T cd05072 157 -------------------------EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS 211 (261)
T ss_pred -------------------------ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH
Confidence 0001122346788999999998889999999999999999998 99999988887
Q ss_pred HHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 729 ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
.....+... ..+| .+..++.++.+||.+||..+|++||+++.+.++|+
T Consensus 212 ~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 259 (261)
T cd05072 212 DVMSALQRG-YRMP-RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLD 259 (261)
T ss_pred HHHHHHHcC-CCCC-CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHh
Confidence 777776544 2333 23568899999999999999999999776666654
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=344.56 Aligned_cols=256 Identities=29% Similarity=0.559 Sum_probs=216.5
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCeeEE
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~---HPnIVkL~~~f~d~~~LyL 572 (900)
.|++.+.||.|+||.||+|.+..+|+.||+|+++... .......+.+|+.+++.+. ||||+++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5788999999999999999999999999999986532 2345667889999999986 9999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 573 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
||||++|++|.+++.. +.+++..+..++.+++.||.|||+.||+|+||+|+||+++.++.++|+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~----- 153 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ----- 153 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC-----
Confidence 9999999999999865 4789999999999999999999999999999999999999999999999999874211
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~ 731 (900)
.........|++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.........
T Consensus 154 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~ 211 (277)
T cd06917 154 ----------------------NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM 211 (277)
T ss_pred ----------------------CccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh
Confidence 0111234579999999999875 45788999999999999999999999887765555
Q ss_pred HhhhcCCCCCCCCCC-CCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 002616 732 DNILNRKIPWPCVPS-DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786 (900)
Q Consensus 732 ~kIl~~~l~~P~ip~-~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~id 786 (900)
..+... ..|.++. .++.++.+||.+||..||.+||+ +.+++.||||+...
T Consensus 212 ~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~il~~~~~~~~~ 262 (277)
T cd06917 212 MLIPKS--KPPRLEDNGYSKLLREFVAACLDEEPKERLS---AEELLKSKWIKAHS 262 (277)
T ss_pred hccccC--CCCCCCcccCCHHHHHHHHHHcCCCcccCcC---HHHHhhChHhhccc
Confidence 443332 2233333 37899999999999999999999 88999999997654
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=347.11 Aligned_cols=258 Identities=31% Similarity=0.527 Sum_probs=221.7
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
..|+.++.||.|+||.||+|.++.++..||+|++.... .......+.+|+.+++.+.||||+++++++.+.+.+|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45788899999999999999999999999999987532 2345678999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||++||+|.+++.. +.+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~------- 153 (277)
T cd06640 82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD------- 153 (277)
T ss_pred ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccC-------
Confidence 99999999999865 5689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhh
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kI 734 (900)
.........|+..|+|||++.+..++.++|+|||||++|||++|.+||...++......+
T Consensus 154 --------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~ 213 (277)
T cd06640 154 --------------------TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213 (277)
T ss_pred --------------------CccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh
Confidence 001122346889999999999888999999999999999999999999988776665554
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCc
Q 002616 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 787 (900)
Q Consensus 735 l~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw 787 (900)
.... .|.++..++..+.+||.+||..+|.+||+ +.+++.||||.....
T Consensus 214 ~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~ 261 (277)
T cd06640 214 PKNN--PPTLTGEFSKPFKEFIDACLNKDPSFRPT---AKELLKHKFIVKNAK 261 (277)
T ss_pred hcCC--CCCCchhhhHHHHHHHHHHcccCcccCcC---HHHHHhChHhhhcch
Confidence 3332 23345678899999999999999999999 789999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=344.16 Aligned_cols=254 Identities=30% Similarity=0.510 Sum_probs=212.0
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+|++.+.||.|++|.||+|+++.+|..||+|+++.... ......+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999875432 2334567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 576 YLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 576 y~~GGsL~dlL~k~g---~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
|+++ +|.+++...+ .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~----- 152 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI----- 152 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC-----
Confidence 9985 8888886543 589999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~ 731 (900)
........++|+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+.+
T Consensus 153 ----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 210 (284)
T cd07836 153 ----------------------PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQL 210 (284)
T ss_pred ----------------------CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 00111234678999999998764 5788999999999999999999999988776665
Q ss_pred HhhhcCC------------------CCCCC--------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 732 DNILNRK------------------IPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 732 ~kIl~~~------------------l~~P~--------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
.++.... ..+|. +.+.++.++.++|.+||+.||.+||+ +.++++||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~~l~~~~f 284 (284)
T cd07836 211 LKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS---AHDALQHPWF 284 (284)
T ss_pred HHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC---HHHHhcCCCC
Confidence 5543210 00110 11346788999999999999999999 7899999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=345.83 Aligned_cols=263 Identities=34% Similarity=0.572 Sum_probs=225.7
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
..+.|++.+.||.|+||.||+|.+..++..||+|+++.... ....+.+|+.++..++||||+++++++...+..|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 34568889999999999999999998999999999975332 46678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 573 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
|+||++|++|.+++.... .++...+..++.+++.||.|||++||+|+||||+||+++.+|.+||+|||++.....
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~---- 168 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK---- 168 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhcc----
Confidence 999999999999998876 899999999999999999999999999999999999999999999999998763210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~ 731 (900)
.........|++.|+|||++.+..++.++|+|||||++|+|++|..||...++....
T Consensus 169 -----------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~ 225 (286)
T cd06614 169 -----------------------EKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL 225 (286)
T ss_pred -----------------------chhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 001123345889999999999888999999999999999999999999988776666
Q ss_pred HhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcch
Q 002616 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 789 (900)
Q Consensus 732 ~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~ 789 (900)
..+..........+..++.++.+||.+||+.+|.+||+ +.+++.||||+...|..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~~~~~ 280 (286)
T cd06614 226 FLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS---AEELLQHPFLKKACPKE 280 (286)
T ss_pred HHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcC---HHHHhhChHhhccCchH
Confidence 66554433221122348899999999999999999999 78999999999876653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=344.49 Aligned_cols=256 Identities=22% Similarity=0.372 Sum_probs=212.6
Q ss_pred cCCCeEEEEEeccCCceEEEEEEEC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKR----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k----~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~ 568 (900)
..++|++.+.||+|+||.||+|++. .++..||+|.++.. ........+.+|+.+++.++||||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4578999999999999999999863 35678999998643 23345577889999999999999999999999999
Q ss_pred eeEEEEeecCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCC
Q 002616 569 NLYLVMEYLNGGDLYSLLRKV-----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 631 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~-----------------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~ 631 (900)
..|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999998532 237788889999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHH
Q 002616 632 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 711 (900)
Q Consensus 632 G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVI 711 (900)
+.+||+|||+++...... .........++..|+|||++.+..++.++|+|||||+
T Consensus 161 ~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i 215 (283)
T cd05090 161 LHVKISDLGLSREIYSAD-------------------------YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVV 215 (283)
T ss_pred CcEEeccccccccccCCc-------------------------ceecccCCCccceecChHHhccCCCCchhhhHHHHHH
Confidence 999999999987431100 0011233456788999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 712 LFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 712 LyEMLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
+|||++ |.+||.+.++..+...+..... +..+..+++.+.+||.+||+.||.+||+++++.+.+
T Consensus 216 l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 280 (283)
T cd05090 216 LWEIFSFGLQPYYGFSNQEVIEMVRKRQL--LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280 (283)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHh
Confidence 999998 9999998887777666655432 224577899999999999999999999955544433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=330.76 Aligned_cols=257 Identities=38% Similarity=0.614 Sum_probs=220.9
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--CeeEEE
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLYLV 573 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~LyLV 573 (900)
+|++.+.||+|+||.||+|....+++.|++|++..... .....+.+.+|+.++++++||||+++++.+... ..+|+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 58889999999999999999999999999999876433 245678899999999999999999999999988 899999
Q ss_pred EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 574 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|||+++++|.+++.+...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.+||+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 156 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET--- 156 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc---
Confidence 99999999999998888899999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC-hHHHHH
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PEIIFD 732 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s-~~ei~~ 732 (900)
........++..|+|||.+.+..++.++|+||||+++|+|++|..||.... ......
T Consensus 157 ----------------------~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 214 (260)
T cd06606 157 ----------------------GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALY 214 (260)
T ss_pred ----------------------cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence 001234578999999999998889999999999999999999999998766 333333
Q ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 733 kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
.+.. ....+.++..++.++.+||.+||..||.+||+ +.+++.||||
T Consensus 215 ~~~~-~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 260 (260)
T cd06606 215 KIGS-SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPT---ADELLQHPFL 260 (260)
T ss_pred hccc-cCCCcCCCcccCHHHHHHHHHhCcCChhhCCC---HHHHhhCCCC
Confidence 3332 12334456788999999999999999999999 8899999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=353.63 Aligned_cols=256 Identities=31% Similarity=0.541 Sum_probs=218.3
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
.|+....||+|+||.||+|....+++.||+|++..... ...+.+.+|+.++..++||||++++++|...+.+|+|||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 34455579999999999999998999999999865322 234668899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCC
Q 002616 576 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 576 y~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
|+++++|..++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 99 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~-------- 169 (297)
T cd06659 99 FLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK-------- 169 (297)
T ss_pred cCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccc--------
Confidence 9999999987754 5689999999999999999999999999999999999999999999999999863210
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhh
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 735 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl 735 (900)
........+|++.|+|||++.+..++.++|+|||||++|||++|+.||...++.+....+.
T Consensus 170 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~ 230 (297)
T cd06659 170 -------------------DVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR 230 (297)
T ss_pred -------------------ccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 0111234579999999999999899999999999999999999999999888777666665
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 736 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 736 ~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
.........+..++..+.++|.+||+.+|.+||+ +.++++||||...
T Consensus 231 ~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps---~~~ll~~~~~~~~ 277 (297)
T cd06659 231 DSPPPKLKNAHKISPVLRDFLERMLTREPQERAT---AQELLDHPFLLQT 277 (297)
T ss_pred ccCCCCccccCCCCHHHHHHHHHHhcCCcccCcC---HHHHhhChhhccC
Confidence 4433333334568899999999999999999999 8899999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=354.07 Aligned_cols=257 Identities=31% Similarity=0.534 Sum_probs=217.2
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
+.|.....||.|+||.||++....++..||+|.+.... ....+.+.+|+.++..++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 44555678999999999999999999999999886422 344567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
||+++++|.+++.. +.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~------- 170 (292)
T cd06658 99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK------- 170 (292)
T ss_pred eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc-------
Confidence 99999999998754 5689999999999999999999999999999999999999999999999999863210
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhh
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kI 734 (900)
.........||+.|+|||++.+..++.++|+||||+++|||++|+.||...++...+..+
T Consensus 171 --------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~ 230 (292)
T cd06658 171 --------------------EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230 (292)
T ss_pred --------------------ccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 001123457899999999999888999999999999999999999999988776666555
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 735 l~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
..............+..+.+||.+||..||.+||+ +.++++||||+..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~il~~~~~~~~ 278 (292)
T cd06658 231 RDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT---AQELLQHPFLKLA 278 (292)
T ss_pred HhcCCCccccccccCHHHHHHHHHHccCChhHCcC---HHHHhhChhhhcc
Confidence 43221111122457889999999999999999999 8899999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=346.31 Aligned_cols=256 Identities=26% Similarity=0.404 Sum_probs=215.9
Q ss_pred cCCCeEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k-----~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
..++|.+.+.||+|+||.||++... .++..||+|.+++. .......+.+|+.++.+++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4568999999999999999999853 34567999988653 234567789999999999999999999999999
Q ss_pred CeeEEEEeecCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcE
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKVG-------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHI 634 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~g-------------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~V 634 (900)
+.+|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++|++||||||+|||++.++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999997543 38999999999999999999999999999999999999999999
Q ss_pred EEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHH
Q 002616 635 KLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 714 (900)
Q Consensus 635 KLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyE 714 (900)
||+|||+++...... .........+++.|+|||++.+..++.++|+|||||++|+
T Consensus 160 kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~ 214 (288)
T cd05093 160 KIGDFGMSRDVYSTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWE 214 (288)
T ss_pred EeccCCccccccCCc-------------------------eeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHH
Confidence 999999987421000 0011123456789999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 715 FIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 715 MLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
|++ |.+||...+..+....+..+... ..+..++.++.+|+.+||+.||.+||++.++...++
T Consensus 215 l~t~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~ 277 (288)
T cd05093 215 IFTYGKQPWYQLSNNEVIECITQGRVL--QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQ 277 (288)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHH
Confidence 998 99999998888888888776532 234678899999999999999999999766655554
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=375.86 Aligned_cols=255 Identities=25% Similarity=0.337 Sum_probs=206.6
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
.....|.+.+.||+|+||.||+|.+..+++.||+|... ...+.+|+++|++++|||||++++++......|
T Consensus 166 ~~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~ 236 (461)
T PHA03211 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTC 236 (461)
T ss_pred cccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEE
Confidence 34568999999999999999999999999999999532 123568999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
+|||++. |+|..++... ..+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+++......
T Consensus 237 lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~- 314 (461)
T PHA03211 237 LVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW- 314 (461)
T ss_pred EEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc-
Confidence 9999995 6888888654 469999999999999999999999999999999999999999999999999987431100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC----
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES---- 726 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s---- 726 (900)
........+||+.|||||++.+..++.++|||||||+||||++|..|+....
T Consensus 315 ------------------------~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~ 370 (461)
T PHA03211 315 ------------------------STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE 370 (461)
T ss_pred ------------------------ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccc
Confidence 0011234679999999999999999999999999999999999876653321
Q ss_pred ----hHHHHHhhhcCCCC---CCCC----------------------------CCCCCHHHHHHHHHhccCCcCCCCChh
Q 002616 727 ----PEIIFDNILNRKIP---WPCV----------------------------PSDMSFEAQDLINRFLIHDPNQRLGAN 771 (900)
Q Consensus 727 ----~~ei~~kIl~~~l~---~P~i----------------------------p~~lS~eakDLIk~cL~~DP~kRpSa~ 771 (900)
...+.+.|...... ++.. ...++.++.+||.+||+.||.+||+
T Consensus 371 ~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs-- 448 (461)
T PHA03211 371 RRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS-- 448 (461)
T ss_pred cCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC--
Confidence 12333332221111 1100 0135678999999999999999999
Q ss_pred cHHHHHcCCCCCC
Q 002616 772 GAAEVKAHPFFKG 784 (900)
Q Consensus 772 ~a~EIL~HPFFk~ 784 (900)
+.|+|+||||+.
T Consensus 449 -a~elL~hp~f~~ 460 (461)
T PHA03211 449 -AAELLRLPLFQS 460 (461)
T ss_pred -HHHHhhCcccCC
Confidence 889999999974
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=340.25 Aligned_cols=256 Identities=23% Similarity=0.318 Sum_probs=213.8
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 566 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~t-----Gk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d 566 (900)
+..++|++.+.||+|+||.||+|.++.. +..||+|.+.... .......+.+|+.+|..++||||+++++++..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 4567899999999999999999998744 3789999986432 23445678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEE
Q 002616 567 RDNLYLVMEYLNGGDLYSLLRKV----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 636 (900)
Q Consensus 567 ~~~LyLVmEy~~GGsL~dlL~k~----------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKL 636 (900)
....|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 99999999999999999998643 23677889999999999999999999999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHH
Q 002616 637 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 716 (900)
Q Consensus 637 sDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEML 716 (900)
+|||+++...... .........+|..|+|||.+.+..++.++|+|||||++|||+
T Consensus 161 ~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~ 215 (277)
T cd05032 161 GDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215 (277)
T ss_pred CCcccchhhccCc-------------------------ccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhh
Confidence 9999987431100 001122345788999999999888999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHH
Q 002616 717 T-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 776 (900)
Q Consensus 717 t-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EI 776 (900)
+ |.+||.+.+..+..+.+..... +..|..++.++.+||.+||+.+|.+||++.++.+.
T Consensus 216 t~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 216 TLAEQPYQGLSNEEVLKFVIDGGH--LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred ccCCCCCccCCHHHHHHHHhcCCC--CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 8 9999999888887777764432 33457789999999999999999999995544443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=347.61 Aligned_cols=257 Identities=33% Similarity=0.501 Sum_probs=212.6
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--CeeE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLY 571 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~Ly 571 (900)
.++|++.+.||.|+||.||+|.++.+++.+|+|.++..... ......+.+|+.++.+++||||+++++++... ..+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 46899999999999999999999999999999999754322 23344677899999999999999999998877 8899
Q ss_pred EEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
+||||+++ +|.+++.... .+++..++.++.||+.||+|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~--- 158 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS--- 158 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccC---
Confidence 99999975 9999887644 589999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEI 729 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~e 729 (900)
.........+++.|+|||++.+. .++.++|+||||+++|+|++|.+||...+..+
T Consensus 159 ------------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~ 214 (293)
T cd07843 159 ------------------------PLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID 214 (293)
T ss_pred ------------------------CccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 00112234678999999998764 46889999999999999999999999887766
Q ss_pred HHHhhhcCCC-------------------CC---------CCCCCC-CCHHHHHHHHHhccCCcCCCCChhcHHHHHcCC
Q 002616 730 IFDNILNRKI-------------------PW---------PCVPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 780 (900)
Q Consensus 730 i~~kIl~~~l-------------------~~---------P~ip~~-lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HP 780 (900)
.+.++..... .+ ..++.. +++.+.+||++||+.||++||+ +.+++.||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t---~~ell~~~ 291 (293)
T cd07843 215 QLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS---AEDALKHP 291 (293)
T ss_pred HHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCC---HHHHhcCC
Confidence 6555432100 00 011222 6889999999999999999999 88999999
Q ss_pred CC
Q 002616 781 FF 782 (900)
Q Consensus 781 FF 782 (900)
||
T Consensus 292 ~f 293 (293)
T cd07843 292 YF 293 (293)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=331.89 Aligned_cols=254 Identities=31% Similarity=0.610 Sum_probs=222.4
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+|++.+.||+|+||.||++++..+++.||+|.+..... .......+.+|++++.+++||||+++++++.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 58899999999999999999999999999999976543 23566789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCC
Q 002616 576 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 576 y~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
|+++++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~-------- 151 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLND-------- 151 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCC--------
Confidence 999999999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhh
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 735 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl 735 (900)
.........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.
T Consensus 152 -------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (254)
T cd06627 152 -------------------VSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212 (254)
T ss_pred -------------------CcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 0011234568999999999988888999999999999999999999998877655555544
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 736 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 736 ~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
.. ..+.++..++..+.++|.+||..+|++||+ +.+++.||||
T Consensus 213 ~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~---~~~~l~~~~~ 254 (254)
T cd06627 213 QD--DHPPLPEGISPELKDFLMQCFQKDPNLRPT---AKQLLKHPWI 254 (254)
T ss_pred cc--CCCCCCCCCCHHHHHHHHHHHhCChhhCcC---HHHHhcCCCC
Confidence 32 223455788999999999999999999999 8899999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=351.47 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=206.7
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDL----FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~----VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
+...+|++.+.||+|+||.||+|++..+|.. ||+|+++.. ......+.+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 4567899999999999999999998776664 899988642 2234556788999999999999999999998765
Q ss_pred CeeEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
..++|+||+++|+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 578999999999999999874 468889999999999999999999999999999999999999999999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 725 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~ 725 (900)
... .........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 161 ~~~-------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 161 ADE-------------------------KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred CCC-------------------------cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 100 0001112335778999999999999999999999999999997 99999987
Q ss_pred ChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhc
Q 002616 726 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 772 (900)
Q Consensus 726 s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~ 772 (900)
...++... ......+| .+...+.++.++|.+||..||.+||++.+
T Consensus 216 ~~~~~~~~-~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~ 260 (316)
T cd05108 216 PASEISSI-LEKGERLP-QPPICTIDVYMIMVKCWMIDADSRPKFRE 260 (316)
T ss_pred CHHHHHHH-HhCCCCCC-CCCCCCHHHHHHHHHHccCChhhCcCHHH
Confidence 76665543 33333333 24678899999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=346.29 Aligned_cols=256 Identities=29% Similarity=0.474 Sum_probs=205.0
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
.++|.+.+.||+|+||.||+|..+.+|+.||+|++..... ......+.+|+.+++.++|+||+++++++...+..|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999865332 22334667899999999999999999999999999999
Q ss_pred EeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 574 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 574 mEy~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
|||+. ++|.+.+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~----- 155 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI----- 155 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC-----
Confidence 99996 577766654 35688889999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChH-HH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE-II 730 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~-ei 730 (900)
.........+++.|+|||++.+ ..++.++|+|||||++|||++|.+||...+.. +.
T Consensus 156 ----------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~ 213 (291)
T cd07870 156 ----------------------PSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ 213 (291)
T ss_pred ----------------------CCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH
Confidence 0011223467999999999876 45788999999999999999999999865432 22
Q ss_pred HHhhhcC-C------------------CCCCC--------C--CCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCC
Q 002616 731 FDNILNR-K------------------IPWPC--------V--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781 (900)
Q Consensus 731 ~~kIl~~-~------------------l~~P~--------i--p~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPF 781 (900)
...+... . ..++. + ....+.++.+||.+||..||.+||+ +.+++.|||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t---~~~~l~h~~ 290 (291)
T cd07870 214 LEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS---AQDALLHPY 290 (291)
T ss_pred HHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcC---HHHHhcCCC
Confidence 2221100 0 00000 0 0123678999999999999999999 889999999
Q ss_pred C
Q 002616 782 F 782 (900)
Q Consensus 782 F 782 (900)
|
T Consensus 291 ~ 291 (291)
T cd07870 291 F 291 (291)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=342.54 Aligned_cols=253 Identities=21% Similarity=0.307 Sum_probs=209.5
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 566 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~-----tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d 566 (900)
+..++|++.+.||+|+||.||+|.++. ++..||+|++.... .......+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 456789999999999999999998752 35679999886432 22345678899999999999999999999999
Q ss_pred CCeeEEEEeecCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEE
Q 002616 567 RDNLYLVMEYLNGGDLYSLLRKVG----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 636 (900)
Q Consensus 567 ~~~LyLVmEy~~GGsL~dlL~k~g----------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKL 636 (900)
....|+||||+++|+|.+++.+.. .++...+..++.|++.||.|||++|++||||||+|||++.++.+||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999999987532 2567788889999999999999999999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHH
Q 002616 637 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 716 (900)
Q Consensus 637 sDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEML 716 (900)
+|||+++....... ........+++.|||||++.+..++.++|+|||||++|||+
T Consensus 161 ~dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 215 (277)
T cd05062 161 GDFGMTRDIYETDY-------------------------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 215 (277)
T ss_pred CCCCCccccCCcce-------------------------eecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHH
Confidence 99999874210000 00111235678999999999989999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcH
Q 002616 717 T-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 773 (900)
Q Consensus 717 t-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a 773 (900)
+ |..||.+.+..+....+..... +..+..++..+.+||.+||+.||.+||++.++
T Consensus 216 ~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~ 271 (277)
T cd05062 216 TLAEQPYQGMSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEI 271 (277)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 9 7999998888877777666543 23357789999999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=341.98 Aligned_cols=251 Identities=31% Similarity=0.499 Sum_probs=205.5
Q ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccC--CeeEEE
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCR--DNLYLV 573 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~--~~LyLV 573 (900)
|++.+.||+|+||.||+|..+.+++.||+|++++... . .......+|+.++.++. ||||+++++++.+. +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-S-LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-C-chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6789999999999999999999999999999875322 1 22234457888888885 99999999999988 889999
Q ss_pred EeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 574 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 574 mEy~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
|||+++ +|.+.+.. ...+++..++.++.|++.||.|||+.|++||||||+||+++. |.+||+|||+++....
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~----- 151 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS----- 151 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc-----
Confidence 999975 88888765 357899999999999999999999999999999999999999 9999999999874210
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~ 731 (900)
........+|+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+..
T Consensus 152 -----------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~ 208 (282)
T cd07831 152 -----------------------KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI 208 (282)
T ss_pred -----------------------CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH
Confidence 001122468899999998754 45688999999999999999999999988766555
Q ss_pred HhhhcC------------------CCCCCC--------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 732 DNILNR------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 732 ~kIl~~------------------~l~~P~--------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
..+... ...+|. ....++.++.+||.+||.+||.+||+ +.+++.||||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~---~~~~l~~~~~ 282 (282)
T cd07831 209 AKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT---AKQALRHPYF 282 (282)
T ss_pred HHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC---HHHHhhCCCC
Confidence 444321 111111 11357899999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=349.18 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=215.8
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
..|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||++++++|...+..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 55899999999999999999999999999999987654444556678899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 575 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 575 Ey~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
||++| +|.+++.. ...+++..+..++.|++.||.|||++||+||||+|+||+++.+|.+||+|||++....
T Consensus 95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~------- 166 (307)
T cd06607 95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVS------- 166 (307)
T ss_pred HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecC-------
Confidence 99974 77777653 4568999999999999999999999999999999999999999999999999886421
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc---CCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei 730 (900)
......|++.|+|||++. ...++.++||||||+++|||++|.+||...+....
T Consensus 167 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~ 222 (307)
T cd06607 167 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (307)
T ss_pred ------------------------CCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH
Confidence 112346889999999985 35688899999999999999999999988877665
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
...+.....+ ...+..++.++.+||.+||..||.+||+ +.+++.||||..
T Consensus 223 ~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~ 272 (307)
T cd06607 223 LYHIAQNDSP-TLSSNDWSDYFRNFVDSCLQKIPQDRPS---SEELLKHRFVLR 272 (307)
T ss_pred HHHHhcCCCC-CCCchhhCHHHHHHHHHHhcCChhhCcC---HHHHhcChhhcc
Confidence 5554433221 1112457889999999999999999999 889999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=327.07 Aligned_cols=250 Identities=38% Similarity=0.649 Sum_probs=215.6
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+|++.+.||+|+||.||++.+..++..|++|++..... .....+.+|+.+++.++||||+++++.+......|+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58899999999999999999998999999999976432 356788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 576 YLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 576 y~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
|++|++|.+++... ..+++..+..++.+++.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~------- 150 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD------- 150 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccc-------
Confidence 99999999999776 5799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhh
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kI 734 (900)
........|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+
T Consensus 151 ---------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 209 (253)
T cd05122 151 ---------------------TKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI 209 (253)
T ss_pred ---------------------cccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH
Confidence 00023457899999999999888999999999999999999999999887655544444
Q ss_pred hcCCCCCCCCC--CCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCC
Q 002616 735 LNRKIPWPCVP--SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781 (900)
Q Consensus 735 l~~~l~~P~ip--~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPF 781 (900)
..... +..+ ..++.++.++|.+||+.||.+||+ +.+++.|||
T Consensus 210 ~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t---~~~~l~~~~ 253 (253)
T cd05122 210 ATNGP--PGLRNPEKWSDEFKDFLKKCLQKNPEKRPT---AEQLLKHPF 253 (253)
T ss_pred HhcCC--CCcCcccccCHHHHHHHHHHccCChhhCCC---HHHHhcCCC
Confidence 33221 2222 234899999999999999999999 889999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=338.38 Aligned_cols=250 Identities=23% Similarity=0.323 Sum_probs=208.6
Q ss_pred EeccCCceEEEEEEE--CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 502 PISRGAFGRVFLARK--RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 502 ~LGkG~FG~Vyla~~--k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
.||+|+||.||+|.+ +.++..+|+|+++.. .......+.+.+|+.++..++||||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKND-NNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCC-CCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999975 456789999998643 233445678999999999999999999999875 4567999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 580 GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 580 GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
|+|.+++.+...+++..+..++.|++.||+|||++||+||||||.|||++.++.+||+|||+++......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~---------- 149 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE---------- 149 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCC----------
Confidence 9999999888889999999999999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHhhhcCC
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 738 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ei~~kIl~~~ 738 (900)
..........+++.|+|||.+.+..++.++|+|||||++|||++ |.+||...+..++...+..+.
T Consensus 150 --------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~ 215 (257)
T cd05116 150 --------------NYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE 215 (257)
T ss_pred --------------CeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC
Confidence 00001122345689999999988889999999999999999998 999999888888877776543
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcC
Q 002616 739 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 739 l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~H 779 (900)
. +..|..+++++++||.+||+.||.+||++..+.+.|+.
T Consensus 216 ~--~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 216 R--MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred C--CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 2 33457899999999999999999999997766665543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=344.90 Aligned_cols=263 Identities=30% Similarity=0.452 Sum_probs=208.1
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC---
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 568 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~--- 568 (900)
...++|++.+.||+|+||.||+|+++.+++.||+|++..... .......+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 9 DEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred chhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccc
Confidence 346789999999999999999999999999999999865322 2223345678999999999999999999887654
Q ss_pred -----eeEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCc
Q 002616 569 -----NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 642 (900)
Q Consensus 569 -----~LyLVmEy~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLA 642 (900)
..|+||||+.+ +|.+++.+.. .+++..++.++.||+.||+|||++|++|+||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 166 (310)
T cd07865 88 NRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166 (310)
T ss_pred cCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence 45999999965 8888876543 6899999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCC
Q 002616 643 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 721 (900)
Q Consensus 643 k~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~P 721 (900)
........ ..........+++.|+|||.+.+. .++.++|+||||+++|||++|.+|
T Consensus 167 ~~~~~~~~-----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~ 223 (310)
T cd07865 167 RAFSLSKN-----------------------SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPI 223 (310)
T ss_pred ccccCCcc-----------------------cCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCC
Confidence 74321000 001112335688999999998764 478899999999999999999999
Q ss_pred CCCCChHHHHHhhhc--CCC-----------------CCCCC----------CCCCCHHHHHHHHHhccCCcCCCCChhc
Q 002616 722 FTAESPEIIFDNILN--RKI-----------------PWPCV----------PSDMSFEAQDLINRFLIHDPNQRLGANG 772 (900)
Q Consensus 722 F~~~s~~ei~~kIl~--~~l-----------------~~P~i----------p~~lS~eakDLIk~cL~~DP~kRpSa~~ 772 (900)
|.+.++......+.. +.. .+|.. +...+..+.+||.+||..||.+||+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t--- 300 (310)
T cd07865 224 MQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID--- 300 (310)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC---
Confidence 988776544333222 000 01100 0123567889999999999999999
Q ss_pred HHHHHcCCCC
Q 002616 773 AAEVKAHPFF 782 (900)
Q Consensus 773 a~EIL~HPFF 782 (900)
+.++++||||
T Consensus 301 ~~e~l~h~~f 310 (310)
T cd07865 301 ADTALNHDFF 310 (310)
T ss_pred HHHHhcCCCC
Confidence 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=349.41 Aligned_cols=257 Identities=31% Similarity=0.536 Sum_probs=218.8
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
.|+..+.||+|+||.||+|.+..++..||+|+++... .......+.+|+.+++.++||||++++++|...+.+|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 4667788999999999999999999999999986432 23345678999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCC
Q 002616 576 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 576 y~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
|+++|+|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.....
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~-------- 153 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD-------- 153 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccC--------
Confidence 9999999998864 5689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhh
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 735 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl 735 (900)
.........|+..|+|||.+.+..++.++|+|||||++|||++|.+||....+......+.
T Consensus 154 -------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~ 214 (277)
T cd06642 154 -------------------TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP 214 (277)
T ss_pred -------------------cchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhh
Confidence 0011223468999999999999899999999999999999999999998777666555443
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCc
Q 002616 736 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 787 (900)
Q Consensus 736 ~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw 787 (900)
... .+..+..++.++.+||.+||..+|.+||+ +.+++.||||....+
T Consensus 215 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~ 261 (277)
T cd06642 215 KNS--PPTLEGQYSKPFKEFVEACLNKDPRFRPT---AKELLKHKFITRYTK 261 (277)
T ss_pred cCC--CCCCCcccCHHHHHHHHHHccCCcccCcC---HHHHHHhHHHHHHhh
Confidence 332 23344678899999999999999999999 889999999976543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=345.45 Aligned_cols=264 Identities=26% Similarity=0.437 Sum_probs=212.6
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~LyL 572 (900)
.++|+..+.||+|+||.||++.+..+|+.||+|.+.+... ......+.+|+.++.++. ||||+++++++..+...|+
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 4577888899999999999999999999999999875432 245667889999999996 9999999999999999999
Q ss_pred EEeecCCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHhhhhc-CeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 573 VMEYLNGGDLYSLLR-----KVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 573 VmEy~~GGsL~dlL~-----k~g~Lse~~ar~ya~QIl~AL~yLHs~-gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
+|||+.+ +|.++.. ....+++..+..++.+++.||+|||+. ||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9999864 5554332 235799999999999999999999974 99999999999999999999999999986421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC---CCCccceeechhHHHHHHHhCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EHGYAADWWSVGIILFEFITGIPPFT 723 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~---~ys~ksDIWSLGVILyEMLtGk~PF~ 723 (900)
. ........||+.|+|||++.+. .++.++|||||||++|||++|++||.
T Consensus 160 ~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 211 (288)
T cd06616 160 D----------------------------SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP 211 (288)
T ss_pred c----------------------------CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCch
Confidence 0 0111234689999999999876 68999999999999999999999997
Q ss_pred CCCh-HHHHHhhhcCCC-CCC-CCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhh
Q 002616 724 AESP-EIIFDNILNRKI-PWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 791 (900)
Q Consensus 724 ~~s~-~ei~~kIl~~~l-~~P-~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~ 791 (900)
.... .+....+..... ..+ ..+..++.++.+||.+||..||.+||+ +.+|+.||||+...|....
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~i~~~~~~~~~~~~~~~ 279 (288)
T cd06616 212 KWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPK---YKELLEHPFIKDYEERNVD 279 (288)
T ss_pred hcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcC---HHHHhcChhhhchhhcchh
Confidence 6542 222233322221 111 112357899999999999999999999 7899999999987666543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.66 Aligned_cols=258 Identities=33% Similarity=0.550 Sum_probs=218.0
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
.++|++.+.||.|+||.||++....+++.||+|.+.... ....+.+.+|+.+++.++||||+++++.|...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 478999999999999999999999899999999985432 23456789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 574 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
+||+++|+|.+++.+. .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~------ 167 (293)
T cd06647 95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP------ 167 (293)
T ss_pred EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccc------
Confidence 9999999999998753 588999999999999999999999999999999999999999999999998863210
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
.........|++.|+|||.+.+..++.++|+|||||++|+|++|+.||...++......
T Consensus 168 ---------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~ 226 (293)
T cd06647 168 ---------------------EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (293)
T ss_pred ---------------------cccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee
Confidence 01112235689999999999988899999999999999999999999987766544333
Q ss_pred hhcCC-CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 002616 734 ILNRK-IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786 (900)
Q Consensus 734 Il~~~-l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~id 786 (900)
+.... ..++ .+..++..+.+||.+||..+|.+||+ +.+++.||||+...
T Consensus 227 ~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~h~~~~~~~ 276 (293)
T cd06647 227 IATNGTPELQ-NPEKLSAIFRDFLNRCLEMDVEKRGS---AKELLQHPFLKIAK 276 (293)
T ss_pred hhcCCCCCCC-CccccCHHHHHHHHHHccCChhhCcC---HHHHhcCHHHhcCc
Confidence 32222 2222 23567889999999999999999999 78999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=356.30 Aligned_cols=263 Identities=29% Similarity=0.441 Sum_probs=214.1
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc----CCee
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNL 570 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d----~~~L 570 (900)
++|++.+.||.|+||.||+|..+.+|+.||+|++.+.. ........+.+|+.+|..++||||++++++|.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEecccc-ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 68999999999999999999999999999999987532 223345678889999999999999999988764 3468
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
|+||||+. |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999996 59999998777899999999999999999999999999999999999999999999999999874211000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEI 729 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~e 729 (900)
.........+|+..|+|||++.+ ..++.++|||||||++|||++|++||.+.+...
T Consensus 163 -----------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~ 219 (334)
T cd07855 163 -----------------------EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH 219 (334)
T ss_pred -----------------------CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH
Confidence 00111234579999999999876 568999999999999999999999998776543
Q ss_pred HHHhhhcC----------------------------CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCC
Q 002616 730 IFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781 (900)
Q Consensus 730 i~~kIl~~----------------------------~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPF 781 (900)
....+... ..++.......+.++.+||++||+.||.+||+ +.+++.|||
T Consensus 220 ~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~~l~~~~ 296 (334)
T cd07855 220 QLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT---VEQALQHPF 296 (334)
T ss_pred HHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC---HHHHHhChh
Confidence 33222210 00111112457899999999999999999999 789999999
Q ss_pred CCCC
Q 002616 782 FKGV 785 (900)
Q Consensus 782 Fk~i 785 (900)
|++.
T Consensus 297 ~~~~ 300 (334)
T cd07855 297 LAQY 300 (334)
T ss_pred hhhc
Confidence 9854
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=341.73 Aligned_cols=258 Identities=31% Similarity=0.489 Sum_probs=213.1
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--CeeEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLYL 572 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~LyL 572 (900)
++|+..+.||.|++|.||+|.+..+++.||+|.+.... .......+.+|+++++.++||||++++++|... ..+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 47999999999999999999999999999999987532 224457789999999999999999999988654 46899
Q ss_pred EEeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 573 VMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k----~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
||||++||+|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~- 157 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN- 157 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc-
Confidence 9999999999888753 34589999999999999999999999999999999999999999999999999864210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC---
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--- 725 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~--- 725 (900)
.......++..|+|||.+.+..++.++|+|||||++|+|++|..||...
T Consensus 158 ----------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 209 (287)
T cd06621 158 ----------------------------SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEP 209 (287)
T ss_pred ----------------------------cccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCC
Confidence 0111345788999999999999999999999999999999999999865
Q ss_pred --ChHHHHHhhhcCCC-CCCCCC---CCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 002616 726 --SPEIIFDNILNRKI-PWPCVP---SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786 (900)
Q Consensus 726 --s~~ei~~kIl~~~l-~~P~ip---~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~id 786 (900)
.+.+....+..... .++..+ ..+++++.+||.+||..||.+||+ +.+++.||||+...
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~eil~~~~~~~~~ 273 (287)
T cd06621 210 PLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT---PWDMLEHPWIKAQM 273 (287)
T ss_pred CCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCC---HHHHHhCccccccc
Confidence 23444444443221 111111 235678999999999999999999 78999999997653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=341.69 Aligned_cols=255 Identities=31% Similarity=0.534 Sum_probs=219.8
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
-|++++.||.|+||.||+|.+..++..||+|++..... ......+.+|+.++..++||||+++++++...+.+|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 47788999999999999999998999999998864332 2345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCC
Q 002616 576 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 576 y~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
|+++|+|..++.. +.+++..+..++.+++.||.|||+.|++|+||||+||+++.+|.++|+|||++.....
T Consensus 83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~-------- 153 (277)
T cd06641 83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD-------- 153 (277)
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceeccc--------
Confidence 9999999998865 4689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhh
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 735 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl 735 (900)
.........|+..|+|||.+.+..++.++|+|||||++|+|++|.+||...++......+.
T Consensus 154 -------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 214 (277)
T cd06641 154 -------------------TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP 214 (277)
T ss_pred -------------------chhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHh
Confidence 0011223568999999999988888999999999999999999999998877766666654
Q ss_pred cCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 736 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 736 ~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
... .+.++..++.++.++|.+||..+|.+||+ +.++++||||...
T Consensus 215 ~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~l~~~~~~~~ 259 (277)
T cd06641 215 KNN--PPTLEGNYSKPLKEFVEACLNKEPSFRPT---AKELLKHKFIVRF 259 (277)
T ss_pred cCC--CCCCCcccCHHHHHHHHHHccCChhhCcC---HHHHHhCHHHhhh
Confidence 433 23345678899999999999999999999 8899999999753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=336.74 Aligned_cols=252 Identities=24% Similarity=0.334 Sum_probs=208.2
Q ss_pred eEEEEEeccCCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe----
Q 002616 497 FEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN---- 569 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~t---Gk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~---- 569 (900)
|++.+.||+|+||.||+|....+ +..||+|+++.. .........+.+|+.+++.++||||+++++.+.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD-IHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC-cCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 57889999999999999987653 478999998653 3334556789999999999999999999998766554
Q ss_pred --eEEEEeecCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCC
Q 002616 570 --LYLVMEYLNGGDLYSLLRKV------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 641 (900)
Q Consensus 570 --LyLVmEy~~GGsL~dlL~k~------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGL 641 (900)
.++||||+++|+|..++... ..+++..+..++.|++.||.|||++||+||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999988542 2589999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCC
Q 002616 642 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 720 (900)
Q Consensus 642 Ak~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~ 720 (900)
++....... ........++..|+|||++.+..++.++|||||||++|||++ |.+
T Consensus 160 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~ 214 (273)
T cd05035 160 SKKIYSGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQT 214 (273)
T ss_pred eeecccccc-------------------------ccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCC
Confidence 875321000 001112335678999999988899999999999999999999 999
Q ss_pred CCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHH
Q 002616 721 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 776 (900)
Q Consensus 721 PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EI 776 (900)
||.+.+..+++..+..+.. +..+..++.++.++|.+||+.||.+||++.++...
T Consensus 215 p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 215 PYPGVENHEIYDYLRHGNR--LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCCCCHHHHHHHHHcCCC--CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999888888877765532 33457889999999999999999999995544443
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=377.54 Aligned_cols=250 Identities=33% Similarity=0.516 Sum_probs=216.2
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCC
Q 002616 502 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGD 581 (900)
Q Consensus 502 ~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GGs 581 (900)
+||+|.||+||-|+++.|...+|||.+... .....+-+..|+.+.+.++|.|||++++++..++.+-|.||-+|||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 799999999999999999999999988643 34567788999999999999999999999999999999999999999
Q ss_pred hHHHHHh-cCCC--CHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecC-CCcEEEEecCCcccccccccccCCCCC
Q 002616 582 LYSLLRK-VGCL--EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTIDLSGPE 657 (900)
Q Consensus 582 L~dlL~k-~g~L--se~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~-~G~VKLsDFGLAk~~~~~~s~~l~~~~ 657 (900)
|.++|+. .|++ +|...-+|.+||+.||.|||.+.|||||||-+|+||+. .|.+||+|||-++..-
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA----------- 727 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA----------- 727 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhc-----------
Confidence 9999984 5777 88999999999999999999999999999999999974 7999999999988531
Q ss_pred CCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCCCCCCh-HHHHHhh
Q 002616 658 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDNI 734 (900)
Q Consensus 658 ~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~-~ei~~kI 734 (900)
+ -+..+.++.||..|||||++.. .+|+.++|||||||++.||.||+|||..... +..+-++
T Consensus 728 --g--------------inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkV 791 (1226)
T KOG4279|consen 728 --G--------------INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKV 791 (1226)
T ss_pred --c--------------CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhh
Confidence 1 1234567899999999999975 5799999999999999999999999976543 3322222
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 735 l~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
..--..|.+|..+|.+++.||.+|+..||.+||+ |.++|..||++.-
T Consensus 792 -GmyKvHP~iPeelsaeak~FilrcFepd~~~R~s---A~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 792 -GMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPS---AKDLLQDPFLQHN 838 (1226)
T ss_pred -cceecCCCCcHHHHHHHHHHHHHHcCCCcccCcc---HHHhccCcccccC
Confidence 2222346678999999999999999999999999 8899999999753
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=371.88 Aligned_cols=257 Identities=35% Similarity=0.595 Sum_probs=225.0
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 580 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GG 580 (900)
++||.|.||+||-|+++.+|+.||||+|.|.+...+ +...+++|+.||..+.||.||.|-..|++.+.+++|||-+.|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~k-qesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTK-QESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCc-hHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 589999999999999999999999999999876654 458899999999999999999999999999999999999965
Q ss_pred ChHHHHH--hcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCC---CcEEEEecCCcccccccccccCCC
Q 002616 581 DLYSLLR--KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 581 sL~dlL~--k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~---G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
|+...+- +.+++++...+|++.||+.||.|||-+||+|+||||+||||... -.+||||||+|++..+
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE-------- 719 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE-------- 719 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecch--------
Confidence 7766653 56889999999999999999999999999999999999999764 3799999999997432
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhh
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 735 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl 735 (900)
.....+.+|||.|+|||+|..++|+.+-|+||+|||+|--|.|..||... +++-..|.
T Consensus 720 --------------------ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQ 777 (888)
T KOG4236|consen 720 --------------------KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQ 777 (888)
T ss_pred --------------------hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhh
Confidence 22356789999999999999999999999999999999999999999754 45666777
Q ss_pred cCCCCCCCCC-CCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC-Ccchhhh
Q 002616 736 NRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV-NWDSLAL 792 (900)
Q Consensus 736 ~~~l~~P~ip-~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i-dw~~L~~ 792 (900)
+..+.+|..| ..+++++.|||..+|++.-.+|.+ +...|.|||+++. -|-.|+.
T Consensus 778 NAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRys---vdk~lsh~Wlq~yq~w~DLRe 833 (888)
T KOG4236|consen 778 NAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYS---VDKSLSHPWLQDYQTWLDLRE 833 (888)
T ss_pred ccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcc---hHhhccchhhhcchHHHHHHH
Confidence 7766666433 678999999999999999999999 7788999999874 4555543
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=342.61 Aligned_cols=256 Identities=25% Similarity=0.352 Sum_probs=211.4
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCC----------------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTG----------------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tG----------------k~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPn 556 (900)
..++|++.+.||+|+||.||+|.+..++ ..||+|++.... .....+.+.+|++++.+++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCC
Confidence 4578999999999999999999877544 458999987532 2345678999999999999999
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCc
Q 002616 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 625 (900)
Q Consensus 557 IVkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g-----------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeN 625 (900)
|+++++++...+.+++||||+++++|.+++.+.. .+++..+..++.|++.||.|||++||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999998765 68999999999999999999999999999999999
Q ss_pred EEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCcccee
Q 002616 626 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 705 (900)
Q Consensus 626 ILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDI 705 (900)
|+++.++.++|+|||+++...... .........+|+.|||||++.+..++.++||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSD-------------------------YYRVQGRAPLPIRWMAWESVLLGKFTTKSDV 215 (296)
T ss_pred eeecCCCceEEccccceeecccCc-------------------------ceeecCcCCCCceecCHHHhhcCCCCccchh
Confidence 999999999999999987421100 0011224457889999999998889999999
Q ss_pred echhHHHHHHHh--CCCCCCCCChHHHHHhhhcC-----CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHH
Q 002616 706 WSVGIILFEFIT--GIPPFTAESPEIIFDNILNR-----KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 775 (900)
Q Consensus 706 WSLGVILyEMLt--Gk~PF~~~s~~ei~~kIl~~-----~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~E 775 (900)
|||||++|||++ |..||...+..++...+... .......+..++.++.+||.+||+.||.+||++.++.+
T Consensus 216 ~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 216 WAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred hhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 999999999998 78999887777766655432 11111224567899999999999999999999554433
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=346.09 Aligned_cols=259 Identities=28% Similarity=0.482 Sum_probs=206.8
Q ss_pred CeEEEEEeccCCceEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--CeeE
Q 002616 496 DFEIIKPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLY 571 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~--tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~Ly 571 (900)
.|++.+.||+|+||.||+|.++. +++.||+|.+.+...........+.+|+.++..++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 8999999999764333334456778899999999999999999999998 7899
Q ss_pred EEEeecCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecC----CCcEEEEecCCc
Q 002616 572 LVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLS 642 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~-----g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~----~G~VKLsDFGLA 642 (900)
+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. +|.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 777766432 36899999999999999999999999999999999999999 999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCC
Q 002616 643 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 721 (900)
Q Consensus 643 k~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~P 721 (900)
+...... .........+||+.|+|||++.+. .++.++|+|||||++|+|++|++|
T Consensus 160 ~~~~~~~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~ 215 (316)
T cd07842 160 RLFNAPL------------------------KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI 215 (316)
T ss_pred cccCCCc------------------------ccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence 7532100 001122345789999999998764 578999999999999999999999
Q ss_pred CCCCChHH---------HHHhhhc--------------------------CCCCCCC------CC--CCCCHHHHHHHHH
Q 002616 722 FTAESPEI---------IFDNILN--------------------------RKIPWPC------VP--SDMSFEAQDLINR 758 (900)
Q Consensus 722 F~~~s~~e---------i~~kIl~--------------------------~~l~~P~------ip--~~lS~eakDLIk~ 758 (900)
|.+..... ....++. ....++. .+ ...+.++.++|.+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 295 (316)
T cd07842 216 FKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK 295 (316)
T ss_pred CcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHH
Confidence 98654321 1111100 0011110 00 1567889999999
Q ss_pred hccCCcCCCCChhcHHHHHcCCCC
Q 002616 759 FLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 759 cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
||..||++||+ +.+++.||||
T Consensus 296 ~l~~~P~~Rps---~~eil~~~~f 316 (316)
T cd07842 296 LLEYDPTKRIT---AEEALEHPYF 316 (316)
T ss_pred HhcCCcccCcC---HHHHhcCCCC
Confidence 99999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=331.32 Aligned_cols=247 Identities=29% Similarity=0.429 Sum_probs=212.4
Q ss_pred EEeccCCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeec
Q 002616 501 KPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 577 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~t---Gk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~ 577 (900)
+.||+|+||.||+|.+... +..||+|+++..... ...+.+.+|+.++..++||||+++++++.....+|+||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASE--EERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccch--hHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999866 889999999764332 25778999999999999999999999999999999999999
Q ss_pred CCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 578 NGGDLYSLLRKV---------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 578 ~GGsL~dlL~k~---------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
++|+|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 77999999999999999999999999999999999999999999999999998753210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCCh
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 727 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~ 727 (900)
.. ........+++.|+|||.+.+..++.++|+|||||++|||++ |..||...+.
T Consensus 159 ~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 213 (262)
T cd00192 159 DY-------------------------YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN 213 (262)
T ss_pred cc-------------------------cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH
Confidence 00 012234567899999999998889999999999999999999 6999999988
Q ss_pred HHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcC
Q 002616 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 728 ~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~H 779 (900)
.+....+..... +..+..++.++.+++.+||+.||.+||+ +.+++.|
T Consensus 214 ~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~l~~~ 260 (262)
T cd00192 214 EEVLEYLRKGYR--LPKPEYCPDELYELMLSCWQLDPEDRPT---FSELVER 260 (262)
T ss_pred HHHHHHHHcCCC--CCCCccCChHHHHHHHHHccCCcccCcC---HHHHHHh
Confidence 888888776322 2345778999999999999999999999 5566543
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=340.82 Aligned_cols=256 Identities=22% Similarity=0.357 Sum_probs=212.1
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 566 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~-----tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d 566 (900)
+..++|++.+.||+|+||.||+|.++. ++..||+|.+... ........+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345789999999999999999999987 7789999987542 223345678999999999999999999999999
Q ss_pred CCeeEEEEeecCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCC---cEEE
Q 002616 567 RDNLYLVMEYLNGGDLYSLLRKVG-------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKL 636 (900)
Q Consensus 567 ~~~LyLVmEy~~GGsL~dlL~k~g-------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G---~VKL 636 (900)
....|+||||++||+|.+++...+ .+++..+..++.||+.||+|||+++++||||||+|||++.++ .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999999997653 488899999999999999999999999999999999998765 5999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHH
Q 002616 637 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 716 (900)
Q Consensus 637 sDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEML 716 (900)
+|||+++...... + ........+++.|+|||++.+..++.++|||||||++|||+
T Consensus 161 ~dfg~~~~~~~~~---------------------~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 215 (277)
T cd05036 161 ADFGMARDIYRAS---------------------Y----YRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIF 215 (277)
T ss_pred ccCccccccCCcc---------------------c----eecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHH
Confidence 9999987421000 0 00111223457899999999889999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcC
Q 002616 717 T-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 717 t-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~H 779 (900)
+ |..||.+.+..+....+..... +..+..++..+.+|+.+||+.||++||+ +.++++|
T Consensus 216 ~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~cl~~~p~~Rps---~~~vl~~ 274 (277)
T cd05036 216 SLGYMPYPGRTNQEVMEFVTGGGR--LDPPKGCPGPVYRIMTDCWQHTPEDRPN---FATILER 274 (277)
T ss_pred cCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCCcccCcC---HHHHHHH
Confidence 7 9999998887777766654321 2234778999999999999999999999 5566654
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=354.54 Aligned_cols=257 Identities=31% Similarity=0.478 Sum_probs=213.3
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 568 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~---- 568 (900)
..++|++++.||+|+||.||+|.+..+|..||+|++.+.. ........+.+|+.+|+.++||||++++++|....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 3567999999999999999999999999999999986532 23334567889999999999999999999998765
Q ss_pred --eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 569 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 569 --~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
..|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 358999999 7799888764 579999999999999999999999999999999999999999999999999986321
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 725 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~ 725 (900)
.......|++.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.
T Consensus 170 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 170 ------------------------------SEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ------------------------------cCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 01123467899999999876 45889999999999999999999999887
Q ss_pred ChHHHHHhhhcCCCC----------------------------CCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 726 SPEIIFDNILNRKIP----------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 726 s~~ei~~kIl~~~l~----------------------------~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
+....+..+...... +......+++++.+||.+||+.||.+||+ +.+++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t---~~~~l 296 (343)
T cd07880 220 DHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT---AAEAL 296 (343)
T ss_pred CHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC---HHHHh
Confidence 765554444321110 01122467889999999999999999999 78999
Q ss_pred cCCCCCCC
Q 002616 778 AHPFFKGV 785 (900)
Q Consensus 778 ~HPFFk~i 785 (900)
.||||+..
T Consensus 297 ~~~~~~~~ 304 (343)
T cd07880 297 AHPYFEEF 304 (343)
T ss_pred cCccHhhh
Confidence 99999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=338.66 Aligned_cols=253 Identities=33% Similarity=0.529 Sum_probs=210.0
Q ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc---CCCceEEEeeeeccCCe----
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTCRDN---- 569 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L---~HPnIVkL~~~f~d~~~---- 569 (900)
|++.+.||+|+||.||+|+++.+++.||+|+++.... .......+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7889999999999999999998999999999975332 223345567788877666 59999999999998887
Q ss_pred -eEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 570 -LYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 570 -LyLVmEy~~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
+|++|||+++ +|.+++.... .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 8998887643 58999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
. ........+++.|+|||++.+..++.++|+|||||++|||++|.+||.+.+
T Consensus 159 ~----------------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 159 F----------------------------EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred C----------------------------CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 0 011123457899999999999999999999999999999999999999988
Q ss_pred hHHHHHhhhcC-----CCCCC-------------------CCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 727 PEIIFDNILNR-----KIPWP-------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 727 ~~ei~~kIl~~-----~l~~P-------------------~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
..+.+.++... ...++ .....+++.+.+||.+||+.||.+||+ +.+++.||||
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~---~~~il~~~~~ 287 (287)
T cd07838 211 EADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS---AFEALQHPYF 287 (287)
T ss_pred hHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC---HHHHhcCcCC
Confidence 87776666431 01111 011245688899999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=379.29 Aligned_cols=268 Identities=24% Similarity=0.335 Sum_probs=202.1
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCC-cEEEEE--------------EeecccccchhHHHHHHHHHHHHHhcCCCce
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIK--------------VLKKLDMIRKNDIERILAERNILITVRNPFV 557 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tG-k~VAIK--------------iLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnI 557 (900)
..++|++++.||+|+||+||+|..+... ..++.| ++.+...........+.+|+.+|..++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999999875432 222222 1111111222345678899999999999999
Q ss_pred EEEeeeeccCCeeEEEEeecCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCC
Q 002616 558 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 632 (900)
Q Consensus 558 VkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~-----g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G 632 (900)
|++++++...+..|+||+++. ++|..++... .......++.++.||+.||.|||++|||||||||+||||+.+|
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~ 304 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDG 304 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC
Confidence 999999999999999999995 4787776542 2234667888999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHH
Q 002616 633 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 712 (900)
Q Consensus 633 ~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVIL 712 (900)
.+||+|||+++.... .........+||+.|+|||++.+..|+.++|||||||+|
T Consensus 305 ~vkL~DFGla~~~~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 358 (501)
T PHA03210 305 KIVLGDFGTAMPFEK--------------------------EREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLIL 358 (501)
T ss_pred CEEEEeCCCceecCc--------------------------ccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHH
Confidence 999999999974310 001122346899999999999999999999999999999
Q ss_pred HHHHhCCCC-CCCC--ChHHHHHhhhcC----CCCCCC-------------------------CCCCCCHHHHHHHHHhc
Q 002616 713 FEFITGIPP-FTAE--SPEIIFDNILNR----KIPWPC-------------------------VPSDMSFEAQDLINRFL 760 (900)
Q Consensus 713 yEMLtGk~P-F~~~--s~~ei~~kIl~~----~l~~P~-------------------------ip~~lS~eakDLIk~cL 760 (900)
|||++|..| |... ++...+.+++.. ...+|. ....++.++.++|.+||
T Consensus 359 ~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL 438 (501)
T PHA03210 359 LDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKML 438 (501)
T ss_pred HHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHh
Confidence 999998754 4332 222222222110 001110 01235677889999999
Q ss_pred cCCcCCCCChhcHHHHHcCCCCCCCCcchh
Q 002616 761 IHDPNQRLGANGAAEVKAHPFFKGVNWDSL 790 (900)
Q Consensus 761 ~~DP~kRpSa~~a~EIL~HPFFk~idw~~L 790 (900)
++||.+||+ |.|+|.||||.+...+.+
T Consensus 439 ~~DP~~Rps---a~elL~hp~f~~~~~~~~ 465 (501)
T PHA03210 439 TFDWHLRPG---AAELLALPLFSAEEEEEI 465 (501)
T ss_pred ccCcccCcC---HHHHhhChhhhcCCchHH
Confidence 999999999 889999999998776654
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=331.47 Aligned_cols=252 Identities=30% Similarity=0.515 Sum_probs=221.4
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+|++.+.||.|+||.||+++++.+++.||+|.+.+... .......+.+|+.+++.++||||+++++++......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 58999999999999999999999999999999976443 23456778899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 576 YLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 576 y~~GGsL~dlL~k----~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
|+++++|..++.+ ...+++..+..++.+++.||.|||++|++|+||+|+||+++.++.+||+|||+++....
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~---- 155 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKK---- 155 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhcc----
Confidence 9999999999866 35689999999999999999999999999999999999999999999999999874210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~ 731 (900)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+..
T Consensus 156 -------------------------~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~ 210 (256)
T cd08530 156 -------------------------NMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR 210 (256)
T ss_pred -------------------------CCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 0122346889999999999999999999999999999999999999998887777
Q ss_pred HhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 732 ~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
..+..... +.++..++.++.++|.+||..+|.+||+ +.++++||+.
T Consensus 211 ~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~p~~ 256 (256)
T cd08530 211 YKVQRGKY--PPIPPIYSQDLQNFIRSMLQVKPKLRPN---CDKILASPAV 256 (256)
T ss_pred HHHhcCCC--CCCchhhCHHHHHHHHHHcCCCcccCCC---HHHHhcCCCC
Confidence 76655443 4445688999999999999999999999 8899999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=341.85 Aligned_cols=254 Identities=31% Similarity=0.529 Sum_probs=210.9
Q ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 576 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy 576 (900)
|++.+.||.|++|.||+|.++.+|..||+|++.... ........+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccc-ccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 678899999999999999999999999999987533 2233446788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 577 LNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 577 ~~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
++ ++|.+++.... .+++..+..++.|++.||+|||+++++||||+|+||+++.++.++|+|||++.....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~------- 151 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV------- 151 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCC-------
Confidence 95 69999987765 689999999999999999999999999999999999999999999999999864210
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
.........+++.|+|||++.+. .++.++|+||||+++|+|++|++||...+......+
T Consensus 152 --------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 211 (283)
T cd07835 152 --------------------PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR 211 (283)
T ss_pred --------------------CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 00111233578999999988764 578899999999999999999999988776544433
Q ss_pred hhcCC--------------------------CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 734 ILNRK--------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 734 Il~~~--------------------------l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
+.... .........++.++.+||.+||+.||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~il~~~~~ 283 (283)
T cd07835 212 IFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS---AKAALQHPYF 283 (283)
T ss_pred HHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcC---HHHHhcCCCC
Confidence 32210 0001123567889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=334.55 Aligned_cols=248 Identities=27% Similarity=0.394 Sum_probs=205.5
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 580 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GG 580 (900)
+.||+|+||.||+|+++.+|+.||+|.+.+. ........+.+|+++++.++||||+++++++.....+|+||||+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 3699999999999999999999999987642 23445678999999999999999999999999999999999999999
Q ss_pred ChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 581 DLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 581 sL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
+|.+++.+.+ .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-~---------- 147 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEED-G---------- 147 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCccccc-c----------
Confidence 9999997644 589999999999999999999999999999999999999999999999999863210 0
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHhhhcCC
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 738 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ei~~kIl~~~ 738 (900)
. . ........++..|+|||.+.+..++.++|+|||||++|||++ |.+||...+.......+....
T Consensus 148 -~------~-------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~ 213 (252)
T cd05084 148 -V------Y-------ASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV 213 (252)
T ss_pred -c------c-------cccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC
Confidence 0 0 000011123567999999998889999999999999999998 999998877766666554432
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 739 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 739 l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
. +..+...+..+.+|+.+||+.||.+||++.++.+.|
T Consensus 214 -~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 250 (252)
T cd05084 214 -R-LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250 (252)
T ss_pred -C-CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 2 123467889999999999999999999966555443
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=353.81 Aligned_cols=261 Identities=30% Similarity=0.499 Sum_probs=208.8
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----C
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR-----D 568 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~-----~ 568 (900)
.++|++.+.||+|+||.||+|++..+|+.||+|++... ........+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 36899999999999999999999999999999998642 2234456788899999999999999999876544 3
Q ss_pred eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
.+|+||||+.+ +|..++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 58999999975 88887754 56999999999999999999999999999999999999999999999999998742100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 727 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~ 727 (900)
. .........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.
T Consensus 160 ~------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~ 215 (336)
T cd07849 160 H------------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY 215 (336)
T ss_pred c------------------------cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 0 00111234578999999998765 5689999999999999999999999987654
Q ss_pred HHHHHhhhc---------------CC-------------CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcC
Q 002616 728 EIIFDNILN---------------RK-------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 728 ~ei~~kIl~---------------~~-------------l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~H 779 (900)
......+.. .. .+++...+..++++.+||.+||+.||.+||+ +.+++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt---~~e~l~h 292 (336)
T cd07849 216 LHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT---VEEALAH 292 (336)
T ss_pred HHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC---HHHHhcC
Confidence 332222211 00 0000111356888999999999999999999 8899999
Q ss_pred CCCCCC
Q 002616 780 PFFKGV 785 (900)
Q Consensus 780 PFFk~i 785 (900)
|||+..
T Consensus 293 p~~~~~ 298 (336)
T cd07849 293 PYLEQY 298 (336)
T ss_pred cccccc
Confidence 999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=339.93 Aligned_cols=258 Identities=24% Similarity=0.374 Sum_probs=214.1
Q ss_pred cccccCCCeEEEEEeccCCceEEEEEEECCCC-----cEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 002616 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTG-----DLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 562 (900)
Q Consensus 489 ~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tG-----k~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~ 562 (900)
...+..++|++.+.||+|+||.||++.++..+ ..+|+|++.... .......+.+|+.++..+ +||||+++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34566789999999999999999999987543 689999986532 234556789999999999 7999999999
Q ss_pred eeccCCeeEEEEeecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcE
Q 002616 563 SFTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 626 (900)
Q Consensus 563 ~f~d~~~LyLVmEy~~GGsL~dlL~k~----------------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNI 626 (900)
++.....+|+||||+++|+|..++... +.+++..+..++.|++.||.|||++||+||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999998642 3588899999999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceee
Q 002616 627 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 706 (900)
Q Consensus 627 LLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIW 706 (900)
|++.++.+||+|||+++....... ........+++.|+|||++.+..++.++|||
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 218 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDY-------------------------YRKTTNGRLPVKWMAPEALFDRVYTHQSDVW 218 (293)
T ss_pred EEcCCCeEEeCccccccccccccc-------------------------eeccCCCCCCccccCHHHhccCCcCccccee
Confidence 999999999999999874211000 0011122356789999999999999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 707 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 707 SLGVILyEMLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
||||++|||++ |..||...+..+.+..+..... +..+...+.++.+|+.+||..||.+||+ +.++++
T Consensus 219 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~eil~ 286 (293)
T cd05053 219 SFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR--MEKPQNCTQELYHLMRDCWHEVPSQRPT---FKQLVE 286 (293)
T ss_pred ehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccCcccCcC---HHHHHH
Confidence 99999999997 9999998888887777655432 2234678899999999999999999999 555554
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=354.08 Aligned_cols=260 Identities=30% Similarity=0.462 Sum_probs=213.5
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 568 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~----- 568 (900)
.+.|.+.+.||+|+||.||+|++..+|+.||+|.+++.. ........+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 357999999999999999999999999999999986532 23334567788999999999999999999886553
Q ss_pred eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
.+|+||||+. ++|.+++...+.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~- 160 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE- 160 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC-
Confidence 4899999996 68999998888899999999999999999999999999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 727 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~ 727 (900)
.........||..|+|||++.+ ..++.++|+|||||++|+|++|++||.+.+.
T Consensus 161 --------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 214 (337)
T cd07858 161 --------------------------KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY 214 (337)
T ss_pred --------------------------CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh
Confidence 0011234568999999999875 4688999999999999999999999987654
Q ss_pred HHHHHhhhcC----------------------------CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcC
Q 002616 728 EIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 728 ~ei~~kIl~~----------------------------~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~H 779 (900)
......+... ...+....+.+++++.+||++||+.||.+||+ +.++++|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps---~~ell~h 291 (337)
T cd07858 215 VHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT---VEEALAH 291 (337)
T ss_pred HHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC---HHHHHcC
Confidence 3333222110 00011122468899999999999999999999 8899999
Q ss_pred CCCCCC
Q 002616 780 PFFKGV 785 (900)
Q Consensus 780 PFFk~i 785 (900)
|||+.+
T Consensus 292 ~~~~~~ 297 (337)
T cd07858 292 PYLASL 297 (337)
T ss_pred cchhhh
Confidence 999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=335.41 Aligned_cols=256 Identities=24% Similarity=0.306 Sum_probs=213.7
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 569 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~t---Gk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ 569 (900)
..++|++.+.||+|+||.||+|+++.+ ...||+|+++... .......+.+|+.++..++||||+++++.+...+.
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 356899999999999999999998754 4579999886532 34456678899999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 570 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
+|+||||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999998764 46899999999999999999999999999999999999999999999999999853100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCCh
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 727 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~ 727 (900)
..........+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus 160 -------------------------~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~ 214 (266)
T cd05033 160 -------------------------EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214 (266)
T ss_pred -------------------------ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH
Confidence 00001112345788999999998899999999999999999998 9999988887
Q ss_pred HHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 728 ~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
.+....+..... .| .+...+..+.+|+.+||+.+|++||++.++.+.+
T Consensus 215 ~~~~~~~~~~~~-~~-~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l 262 (266)
T cd05033 215 QDVIKAVEDGYR-LP-PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262 (266)
T ss_pred HHHHHHHHcCCC-CC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 777777765422 12 2467899999999999999999999955544443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=338.79 Aligned_cols=251 Identities=24% Similarity=0.380 Sum_probs=208.2
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk----~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
+..++|++++.||+|+||+||+|++..+|+ .||+|+++... .......+.+|+.++..++||||+++++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~- 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT- 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-
Confidence 456899999999999999999999887776 48999886432 33446678899999999999999999999875
Q ss_pred CeeEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
...+++|||+++|+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 81 STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 4578999999999999999764 569999999999999999999999999999999999999999999999999987531
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 725 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~ 725 (900)
.... ........+++.|+|||.+.+..++.++|||||||++|||++ |.+||...
T Consensus 161 ~~~~-------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 161 IDET-------------------------EYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred cccc-------------------------eeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 1000 001112345678999999999999999999999999999998 99999887
Q ss_pred ChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhc
Q 002616 726 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 772 (900)
Q Consensus 726 s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~ 772 (900)
....+...+.... ..+ .+...+.++.++|.+||..||++||++.+
T Consensus 216 ~~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~dp~~Rp~~~~ 260 (279)
T cd05109 216 PAREIPDLLEKGE-RLP-QPPICTIDVYMIMVKCWMIDSECRPRFRE 260 (279)
T ss_pred CHHHHHHHHHCCC-cCC-CCccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 7776666554432 222 34678999999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=363.84 Aligned_cols=260 Identities=23% Similarity=0.347 Sum_probs=212.5
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeee
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSF 564 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~t-----Gk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f 564 (900)
....++|++.+.||+|+||.||+|.+... +..||+|+++... .....+.+.+|+.+|..+. |||||++++++
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 45577899999999999999999987533 3469999986532 3345578999999999996 99999999999
Q ss_pred ccCCeeEEEEeecCCCChHHHHHhc-------------------------------------------------------
Q 002616 565 TCRDNLYLVMEYLNGGDLYSLLRKV------------------------------------------------------- 589 (900)
Q Consensus 565 ~d~~~LyLVmEy~~GGsL~dlL~k~------------------------------------------------------- 589 (900)
...+.+|+||||+++|+|.+++.+.
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 9999999999999999999988642
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEe
Q 002616 590 -----------------------------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 628 (900)
Q Consensus 590 -----------------------------------------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILL 628 (900)
..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 136777888999999999999999999999999999999
Q ss_pred cCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeech
Q 002616 629 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 708 (900)
Q Consensus 629 d~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSL 708 (900)
+.++.+||+|||+++...... .........|++.|||||++.+..++.++|||||
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSl 325 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDS-------------------------NYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY 325 (400)
T ss_pred eCCCEEEEEeCCcceeccccc-------------------------cccccCCcCCCcceEChhhhcCCCCCchhhHHHH
Confidence 999999999999987421100 0011233467889999999999999999999999
Q ss_pred hHHHHHHHh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 709 GIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 709 GVILyEMLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
||++|||++ |..||............+.....++ .+..++.++.+||.+||+.||++||++.++.+++.
T Consensus 326 Gvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~ 395 (400)
T cd05105 326 GILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA-KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVE 395 (400)
T ss_pred HHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC-CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHH
Confidence 999999997 9999987655444433344333332 34678999999999999999999999777776664
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=335.99 Aligned_cols=246 Identities=23% Similarity=0.401 Sum_probs=206.5
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
..+|++.+.||+|+||.||+|+++ ++..+|+|++.+... ....+.+|+.+++.++||||+++++++...+..|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 457899999999999999999886 467899999865332 234678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccccc
Q 002616 574 MEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~ 652 (900)
|||++|++|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~--- 154 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ--- 154 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc---
Confidence 9999999999999764 468999999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHH
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 731 (900)
Q Consensus 653 l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ei~ 731 (900)
........++..|+|||.+.+..++.++|+||||+++|||++ |.+||...+..+..
T Consensus 155 -----------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~ 211 (256)
T cd05059 155 -----------------------YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV 211 (256)
T ss_pred -----------------------ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH
Confidence 000111234568999999999999999999999999999999 89999988887777
Q ss_pred HhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhc
Q 002616 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 772 (900)
Q Consensus 732 ~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~ 772 (900)
..+.... . +..+...+.++.+|+.+||+.+|++||++.+
T Consensus 212 ~~~~~~~-~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~ 250 (256)
T cd05059 212 ESVSAGY-R-LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKK 250 (256)
T ss_pred HHHHcCC-c-CCCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence 7765442 2 1234668999999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=342.42 Aligned_cols=252 Identities=21% Similarity=0.323 Sum_probs=211.8
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~t-----Gk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
...+|++.+.||+|+||.||+|++..+ +..||+|+++... .....+.+.+|+.++..++||||+++++.+...
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 456788999999999999999987643 5789999986432 233456788999999999999999999999999
Q ss_pred CeeEEEEeecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCC
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 631 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~----------------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~ 631 (900)
..+++++||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998532 247888899999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHH
Q 002616 632 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 711 (900)
Q Consensus 632 G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVI 711 (900)
+.+||+|||+++...... .........+++.|+|||++.+..++.++|||||||+
T Consensus 161 ~~~kl~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 215 (283)
T cd05091 161 LNVKISDLGLFREVYAAD-------------------------YYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVV 215 (283)
T ss_pred CceEecccccccccccch-------------------------heeeccCccCCccccCHHHHhcCCCCcchhHHHHHHH
Confidence 999999999987421100 0011223456789999999998889999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcH
Q 002616 712 LFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 773 (900)
Q Consensus 712 LyEMLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a 773 (900)
+|||++ |.+||.+....+....+...... ..+..++.++.+|+.+||+.+|.+||++.++
T Consensus 216 l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i 276 (283)
T cd05091 216 LWEVFSYGLQPYCGYSNQDVIEMIRNRQVL--PCPDDCPAWVYTLMLECWNEFPSRRPRFKDI 276 (283)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCcC--CCCCCCCHHHHHHHHHHhCCCcccCCCHHHH
Confidence 999998 99999998888888888776543 2357899999999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=353.93 Aligned_cols=257 Identities=32% Similarity=0.478 Sum_probs=210.4
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 568 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~----- 568 (900)
.++|.+.+.||+|+||.||+|+++.+|+.||+|++.+.. ........+.+|+.+++.++||||++++++|....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 368999999999999999999999999999999987532 22333456889999999999999999999987653
Q ss_pred -eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccc
Q 002616 569 -NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 569 -~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~ 647 (900)
.+|+||||+.+ +|..++ ...+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 93 ~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~- 168 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD- 168 (342)
T ss_pred ceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC-
Confidence 46999999964 776654 2468999999999999999999999999999999999999999999999999986311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 648 ~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+
T Consensus 169 -----------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 169 -----------------------------AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred -----------------------------CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 01123468899999999876 468899999999999999999999999877
Q ss_pred hHHHHHhhhcCC-----------------------CCCC-----CCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 727 PEIIFDNILNRK-----------------------IPWP-----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 727 ~~ei~~kIl~~~-----------------------l~~P-----~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
....+..+.... ..++ ...+..+.++.+||.+||+.||.+||+ +.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~---~~e~l~ 296 (342)
T cd07879 220 YLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT---ATEALE 296 (342)
T ss_pred HHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC---HHHHhc
Confidence 655554433210 0000 011356788999999999999999999 889999
Q ss_pred CCCCCCCCc
Q 002616 779 HPFFKGVNW 787 (900)
Q Consensus 779 HPFFk~idw 787 (900)
||||+.+..
T Consensus 297 h~~f~~~~~ 305 (342)
T cd07879 297 HPYFDSFRD 305 (342)
T ss_pred Ccchhhccc
Confidence 999988654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=336.95 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=215.4
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
...+|++.+.||.|+||.||+|.++. ++.+|+|++.+.. ......+.+|+.+++.++||||+++++++...+.+|+
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 45679999999999999999999987 8999999987543 2235578899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 573 VMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~--- 156 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE--- 156 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCC---
Confidence 99999999999999753 4589999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 729 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~e 729 (900)
.........+++.|+|||++.+..++.++||||||+++|+|++ |+.||...+..+
T Consensus 157 ------------------------~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~ 212 (261)
T cd05148 157 ------------------------DVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE 212 (261)
T ss_pred ------------------------ccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 0001113346788999999998899999999999999999998 899999988888
Q ss_pred HHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 730 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 730 i~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
++..+... ...+ .+...++.+.++|.+||+.||.+||++.++.+.|
T Consensus 213 ~~~~~~~~-~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L 258 (261)
T cd05148 213 VYDQITAG-YRMP-CPAKCPQEIYKIMLECWAAEPEDRPSFKALREEL 258 (261)
T ss_pred HHHHHHhC-CcCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 88877654 2222 3478899999999999999999999966665554
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=332.68 Aligned_cols=248 Identities=26% Similarity=0.423 Sum_probs=208.8
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeee-ccCCee
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF-TCRDNL 570 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f-~d~~~L 570 (900)
+...+|++.+.||+|+||.||++... |..||+|.++.. ...+.+.+|+.+++.++||||+++++++ ...+.+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 45678999999999999999999875 888999988542 2346788999999999999999999865 455679
Q ss_pred EEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
|+||||+++|+|.+++.+.+ .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~- 154 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 154 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc-
Confidence 99999999999999997654 488999999999999999999999999999999999999999999999999874210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCCh
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 727 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~ 727 (900)
......++..|+|||++.+..++.++|||||||++|||++ |++||...+.
T Consensus 155 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~ 205 (256)
T cd05082 155 -----------------------------TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred -----------------------------cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 0112345678999999999899999999999999999997 9999998887
Q ss_pred HHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 728 ~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
.+....+..+. . +..+..+++.+.+||.+||..||.+||++.++.+.|+
T Consensus 206 ~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 254 (256)
T cd05082 206 KDVVPRVEKGY-K-MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254 (256)
T ss_pred HHHHHHHhcCC-C-CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHh
Confidence 77776665442 2 2344678999999999999999999999665555543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=335.43 Aligned_cols=253 Identities=22% Similarity=0.329 Sum_probs=206.2
Q ss_pred eEEEEEeccCCceEEEEEEECCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC------C
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------D 568 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk--~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~------~ 568 (900)
|.+.+.||+|+||.||+|++..++. .||+|.++.. .......+.+.+|..++..++||||+++++.+... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIA-ICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccC-cCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999999987775 6999988653 33455678899999999999999999999876322 2
Q ss_pred eeEEEEeecCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCc
Q 002616 569 NLYLVMEYLNGGDLYSLLRK------VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 642 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k------~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLA 642 (900)
..++||||+++|+|..++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57999999999999988742 134789999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCC
Q 002616 643 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 721 (900)
Q Consensus 643 k~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~P 721 (900)
+....... ........+++.|+|||++.+..++.++|||||||++|||++ |.+|
T Consensus 160 ~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p 214 (272)
T cd05075 160 KKIYNGDY-------------------------YRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214 (272)
T ss_pred cccCcccc-------------------------eecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCC
Confidence 74311000 001122346788999999999999999999999999999999 8999
Q ss_pred CCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 722 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 722 F~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
|.+....++...+..+... ..+..++..+.++|.+||+.||.+||+++++.+.+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l 268 (272)
T cd05075 215 YPGVENSEIYDYLRQGNRL--KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCEL 268 (272)
T ss_pred CCCCCHHHHHHHHHcCCCC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9988888887777665431 23467889999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.30 Aligned_cols=262 Identities=31% Similarity=0.471 Sum_probs=220.2
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----ee
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----NL 570 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~-----~L 570 (900)
+|++.+.||.|+||.||+|++..+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++...+ .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5899999999999999999999999999999987532 22445677899999999999999999999998876 79
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
|+||||+++ +|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.......
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~- 157 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE- 157 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccc-
Confidence 999999984 899999887789999999999999999999999999999999999999999999999999987431100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEI 729 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~e 729 (900)
..........||+.|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+..+
T Consensus 158 -----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~ 214 (330)
T cd07834 158 -----------------------DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214 (330)
T ss_pred -----------------------cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 000122345689999999999887 88999999999999999999999999888777
Q ss_pred HHHhhhcCCCC----------------------------CCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCC
Q 002616 730 IFDNILNRKIP----------------------------WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781 (900)
Q Consensus 730 i~~kIl~~~l~----------------------------~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPF 781 (900)
.+..+....-. +......++.++.+||.+||++||.+||+ +.+++.|||
T Consensus 215 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~~~~ 291 (330)
T cd07834 215 QLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT---ADEALAHPY 291 (330)
T ss_pred HHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC---HHHHHhCcc
Confidence 66655442110 01112347889999999999999999999 889999999
Q ss_pred CCCCC
Q 002616 782 FKGVN 786 (900)
Q Consensus 782 Fk~id 786 (900)
|+++.
T Consensus 292 ~~~~~ 296 (330)
T cd07834 292 LAQLH 296 (330)
T ss_pred HHhhc
Confidence 98653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=342.31 Aligned_cols=247 Identities=24% Similarity=0.382 Sum_probs=207.2
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk--~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~Ly 571 (900)
++|++.+.||+|+||.||+|..+.++. .+|+|.++. .......+.+.+|+.++.++ +||||+++++++.....+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~--~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccc--cCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999999987765 468887753 22334566789999999999 6999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEE
Q 002616 572 LVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 635 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g----------------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VK 635 (900)
+||||+++|+|.+++.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999997542 478889999999999999999999999999999999999999999
Q ss_pred EEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHH
Q 002616 636 LTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 715 (900)
Q Consensus 636 LsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEM 715 (900)
|+|||++..... ........++..|+|||++.+..++.++|||||||++|||
T Consensus 160 l~dfg~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 211 (297)
T cd05089 160 IADFGLSRGEEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211 (297)
T ss_pred ECCcCCCccccc----------------------------eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHH
Confidence 999999862100 0001112235679999999988999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcH
Q 002616 716 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 773 (900)
Q Consensus 716 Lt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a 773 (900)
++ |.+||...+..+.+.++..+. . +..+..++.++.+||.+||..||.+||++.++
T Consensus 212 ~t~g~~pf~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 268 (297)
T cd05089 212 VSLGGTPYCGMTCAELYEKLPQGY-R-MEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268 (297)
T ss_pred HcCCCCCCCCCCHHHHHHHHhcCC-C-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 97 999999988888887776542 2 22346789999999999999999999995443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=333.79 Aligned_cols=252 Identities=25% Similarity=0.423 Sum_probs=209.7
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
+..++|++.+.||+|+||.||+|.+. .+..+|+|.++.... ..+.+.+|+.++++++||||+++++++. ....|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 45678999999999999999999876 466799999875332 2356889999999999999999999885 45689
Q ss_pred EEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
+||||+++|+|.+++... ..+++..+..++.+++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~- 155 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN- 155 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc-
Confidence 999999999999999763 35899999999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChH
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 728 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ 728 (900)
.........++..|+|||++.+..++.++|+||||+++|||++ |.+||.+.+..
T Consensus 156 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~ 210 (260)
T cd05070 156 -------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR 210 (260)
T ss_pred -------------------------ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 0001122345678999999998889999999999999999999 99999988888
Q ss_pred HHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 729 ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
+....+... ...+ .+...+..+.+||.+||..||.+||+++.+.++|
T Consensus 211 ~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l 257 (260)
T cd05070 211 EVLEQVERG-YRMP-CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFL 257 (260)
T ss_pred HHHHHHHcC-CCCC-CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 877777653 2222 3467889999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=339.57 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=212.7
Q ss_pred cCCCeEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k-----~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
...+|.+.++||+|+||.||+|... .++..+|+|.+++. .......+.+|++++..++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 4568899999999999999999753 34678999987643 244567899999999999999999999999999
Q ss_pred CeeEEEEeecCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCC
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKVG---------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 632 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~g---------------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G 632 (900)
+..|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||+++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999997653 478899999999999999999999999999999999999999
Q ss_pred cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHH
Q 002616 633 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 712 (900)
Q Consensus 633 ~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVIL 712 (900)
.+||+|||+++...... .........+++.|+|||++.+..++.++|||||||++
T Consensus 160 ~~kL~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 214 (280)
T cd05092 160 VVKIGDFGMSRDIYSTD-------------------------YYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVL 214 (280)
T ss_pred CEEECCCCceeEcCCCc-------------------------eeecCCCccccccccCHHHhccCCcCchhhHHHHHHHH
Confidence 99999999987421000 00111234467899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 713 FEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 713 yEMLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
|||++ |.+||......+....+..+.. +..+..+++.+.+||.+||+.||.+||+++++.+.+
T Consensus 215 ~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l 278 (280)
T cd05092 215 WEIFTYGKQPWYQLSNTEAIECITQGRE--LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRL 278 (280)
T ss_pred HHHHcCCCCCCccCCHHHHHHHHHcCcc--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHH
Confidence 99998 9999988887777777665432 223467899999999999999999999965554443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=354.93 Aligned_cols=259 Identities=25% Similarity=0.367 Sum_probs=207.8
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeee
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSF 564 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~-----tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f 564 (900)
.+..++|++.+.||.|+||.||+|++.. +++.||+|+++... .......+..|+.++.++ +||||+++++++
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 3455689999999999999999997543 45789999986432 234456788999999999 799999999987
Q ss_pred ccC-CeeEEEEeecCCCChHHHHHhc------------------------------------------------------
Q 002616 565 TCR-DNLYLVMEYLNGGDLYSLLRKV------------------------------------------------------ 589 (900)
Q Consensus 565 ~d~-~~LyLVmEy~~GGsL~dlL~k~------------------------------------------------------ 589 (900)
... ..+|+||||+++|+|.+++...
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 654 5689999999999999988542
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCCCC
Q 002616 590 -------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 662 (900)
Q Consensus 590 -------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~ 662 (900)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~------------- 227 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP------------- 227 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCc-------------
Confidence 257888999999999999999999999999999999999999999999999997531100
Q ss_pred CCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHhhhcCCCCC
Q 002616 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPW 741 (900)
Q Consensus 663 ~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ei~~kIl~~~l~~ 741 (900)
.........+++.|||||++.+..++.++|||||||++|||++ |..||.+....+.+...+.....
T Consensus 228 ------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~- 294 (337)
T cd05054 228 ------------DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR- 294 (337)
T ss_pred ------------chhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC-
Confidence 0011223456788999999999999999999999999999998 99999876655544444443332
Q ss_pred CCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 742 PCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 742 P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
+..+...++++.+++.+||+.+|++||++.++.+.|
T Consensus 295 ~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l 330 (337)
T cd05054 295 MRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEIL 330 (337)
T ss_pred CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 223467889999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=333.88 Aligned_cols=250 Identities=21% Similarity=0.356 Sum_probs=210.6
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
..++|++++.||+|+||.||+|++.. +..||+|.++.... ..+.+.+|+.++..++||||+++++++...+.+|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 35689999999999999999998764 45699998865332 24568899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 573 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+|||++.++.+||+|||+++......
T Consensus 77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-- 154 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-- 154 (256)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc--
Confidence 99999999999999764 468999999999999999999999999999999999999999999999999987421000
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHH
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 730 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ei 730 (900)
........++..|+|||++.+..++.++|+|||||++|+|++ |..||...+..+.
T Consensus 155 ------------------------~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~ 210 (256)
T cd05113 155 ------------------------YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET 210 (256)
T ss_pred ------------------------eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence 001112346678999999998889999999999999999998 9999998888888
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
...+....... .+...+..+.+++.+||..||.+||+ +.+|+.
T Consensus 211 ~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~---~~~ll~ 253 (256)
T cd05113 211 VEKVSQGLRLY--RPHLASEKVYAIMYSCWHEKAEERPT---FQQLLS 253 (256)
T ss_pred HHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCcccCCC---HHHHHH
Confidence 77776654332 24567899999999999999999999 556554
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=340.94 Aligned_cols=269 Identities=30% Similarity=0.479 Sum_probs=210.3
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 568 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~---- 568 (900)
.+++|++.+.||.|+||.||+|+++.+++.||+|++..... .......+.+|+++++.++||||+++++.+....
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcCCCCccchhhheeccccccc
Confidence 36899999999999999999999999999999999865332 2222345678999999999999999998875443
Q ss_pred ----eeEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcc
Q 002616 569 ----NLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643 (900)
Q Consensus 569 ----~LyLVmEy~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk 643 (900)
.+|+||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++
T Consensus 85 ~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 47999999975 67777654 4579999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCC
Q 002616 644 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF 722 (900)
Q Consensus 644 ~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF 722 (900)
........ .... ............|++.|+|||++.+ ..++.++|||||||++|||++|++||
T Consensus 164 ~~~~~~~~-----------~~~~-----~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~ 227 (311)
T cd07866 164 PYDGPPPN-----------PKGG-----GGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227 (311)
T ss_pred hccCCCcc-----------cccC-----CcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC
Confidence 43211000 0000 0001112234678999999999875 45889999999999999999999999
Q ss_pred CCCChHHHHHhhhcCCC-----CC------C---------CC-------CCCCCHHHHHHHHHhccCCcCCCCChhcHHH
Q 002616 723 TAESPEIIFDNILNRKI-----PW------P---------CV-------PSDMSFEAQDLINRFLIHDPNQRLGANGAAE 775 (900)
Q Consensus 723 ~~~s~~ei~~kIl~~~l-----~~------P---------~i-------p~~lS~eakDLIk~cL~~DP~kRpSa~~a~E 775 (900)
.+.+.......+..... .+ + .. ...+++.+.+||.+||+.||.+||+ +.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t---~~e 304 (311)
T cd07866 228 QGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT---ASD 304 (311)
T ss_pred CCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC---HHH
Confidence 98877665555432100 00 0 00 0234578899999999999999999 889
Q ss_pred HHcCCCC
Q 002616 776 VKAHPFF 782 (900)
Q Consensus 776 IL~HPFF 782 (900)
++.||||
T Consensus 305 ll~~~~f 311 (311)
T cd07866 305 ALEHPYF 311 (311)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=332.90 Aligned_cols=252 Identities=25% Similarity=0.339 Sum_probs=207.6
Q ss_pred EeccCCceEEEEEEEC--CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 502 PISRGAFGRVFLARKR--TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 502 ~LGkG~FG~Vyla~~k--~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
.||+|+||.||+|.++ .++..||+|++... ......+.+.+|+.++++++||||++++++++. +.+|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE--NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc--cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 3899999999999875 44567999998653 234455779999999999999999999998864 578999999999
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCC
Q 002616 580 GDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 658 (900)
Q Consensus 580 GsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~ 658 (900)
|+|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~-------- 150 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDS-------- 150 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcc--------
Confidence 999999874 45789999999999999999999999999999999999999999999999999874211000
Q ss_pred CCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHhhhcC
Q 002616 659 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNR 737 (900)
Q Consensus 659 ~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ei~~kIl~~ 737 (900)
.........+++.|+|||++.+..++.++|+|||||++|||++ |.+||......+....+..+
T Consensus 151 ----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 214 (257)
T cd05115 151 ----------------YYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG 214 (257)
T ss_pred ----------------ceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC
Confidence 0001111234678999999998889999999999999999996 99999988887777666554
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 738 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 738 ~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
.. +..+...++++.+||.+||..||++||++.++.+.++.-||
T Consensus 215 ~~--~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~~ 257 (257)
T cd05115 215 KR--LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYYY 257 (257)
T ss_pred CC--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhcC
Confidence 32 23457789999999999999999999998878777776665
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=332.37 Aligned_cols=254 Identities=24% Similarity=0.368 Sum_probs=212.7
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
+..++|++.+.||+|+||.||+|.+.. ++.||+|.++.... ..+.+.+|+.++++++||||+++++++...+.+|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 455789999999999999999999754 57899999865332 2456889999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~- 156 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED- 156 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC-
Confidence 9999999999999997654 6899999999999999999999999999999999999999999999999998753100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChH
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 728 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ 728 (900)
.........++..|+|||++.+..++.++|+||||+++|||++ |++||.+.+..
T Consensus 157 -------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 211 (261)
T cd05068 157 -------------------------IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA 211 (261)
T ss_pred -------------------------cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 0000111223568999999999899999999999999999999 99999998887
Q ss_pred HHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 729 ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
.+...+.... ..+ .+...+..+.+|+.+||+.||.+||+++++...|+
T Consensus 212 ~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~ 259 (261)
T cd05068 212 EVLQQVDQGY-RMP-CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLE 259 (261)
T ss_pred HHHHHHHcCC-CCC-CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHh
Confidence 7777765442 222 34678899999999999999999999766655543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=331.15 Aligned_cols=249 Identities=22% Similarity=0.299 Sum_probs=206.9
Q ss_pred EEeccCCceEEEEEEECCCC---cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeec
Q 002616 501 KPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 577 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tG---k~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~ 577 (900)
+.||+|+||.||+|.+..++ ..||+|.+...... ...+.+.+|+.+++.++|||||++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999876655 78999998764432 45567899999999999999999999876 45689999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCC
Q 002616 578 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 657 (900)
Q Consensus 578 ~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~ 657 (900)
++|+|.+++.+...+++..+..++.|++.||+|||..|++||||||+|||++.++.+||+|||+++.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~------- 150 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD------- 150 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCc-------
Confidence 9999999998888899999999999999999999999999999999999999999999999999874321100
Q ss_pred CCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHhhhc
Q 002616 658 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 736 (900)
Q Consensus 658 ~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ei~~kIl~ 736 (900)
.........++..|+|||.+.+..++.++|+|||||++|||++ |.+||...+..+....+..
T Consensus 151 -----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05060 151 -----------------YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLES 213 (257)
T ss_pred -----------------ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHc
Confidence 0000111234578999999999899999999999999999998 9999998888777776655
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 737 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 737 ~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
... ...+..++..+++||.+||..||.+||++.++.+++.
T Consensus 214 ~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~ 253 (257)
T cd05060 214 GER--LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFR 253 (257)
T ss_pred CCc--CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence 432 2245678999999999999999999999766665553
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=338.22 Aligned_cols=257 Identities=22% Similarity=0.377 Sum_probs=214.2
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~-----tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
..++|++.+.||+|+||.||+|++.. ++..||+|++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 45789999999999999999998753 67899999986532 234456788999999999999999999999999
Q ss_pred CeeEEEEeecCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKVG----------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 625 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~g----------------------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeN 625 (900)
+.+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999997432 36788889999999999999999999999999999
Q ss_pred EEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCcccee
Q 002616 626 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 705 (900)
Q Consensus 626 ILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDI 705 (900)
||++.++.+||+|||++....... .........+++.|+|||++.+..++.++||
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 215 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSAD-------------------------YYKASENDAIPIRWMPPESIFYNRYTTESDV 215 (288)
T ss_pred eEecCCCceEECccccceecccCc-------------------------cccccCCCccChhhcCHHHHhcCCCCchhHH
Confidence 999999999999999986421000 0001112235678999999999999999999
Q ss_pred echhHHHHHHHh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 706 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 706 WSLGVILyEMLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
|||||++|||++ |..||.+.+..+....+..+... ..+..++.++.+||.+||+.||.+||++.++...|+
T Consensus 216 ~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 216 WAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVL--SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 999999999997 88999988888888777665432 234678899999999999999999999766666554
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.39 Aligned_cols=256 Identities=26% Similarity=0.385 Sum_probs=213.2
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~-----tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
...+|.+.+.||+|+||.||+|++.. ++..+|+|.++... ......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 45679999999999999999998643 45678999875422 23446788999999999999999999999999
Q ss_pred CeeEEEEeecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCC
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 631 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~g----------------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~ 631 (900)
+.+++||||+++|+|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999997543 37889999999999999999999999999999999999999
Q ss_pred CcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHH
Q 002616 632 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 711 (900)
Q Consensus 632 G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVI 711 (900)
+.+||+|||+++...... .........|++.|+|||++.+..++.++|||||||+
T Consensus 160 ~~~~l~dfg~a~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 214 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTD-------------------------YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVI 214 (291)
T ss_pred CcEEECCCCcccccCCCc-------------------------eeecCCCCCcceeecChHHhccCCCCchhhHHHHHHH
Confidence 999999999987421100 0011223467889999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 712 LFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 712 LyEMLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
+|||++ |.+||...+..+....+..+... ..+...+..+.+||.+||+.||.+||++.++.+.+.
T Consensus 215 l~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~ 280 (291)
T cd05094 215 LWEIFTYGKQPWFQLSNTEVIECITQGRVL--ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILH 280 (291)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHhCCCCC--CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHH
Confidence 999998 99999988888777776655432 234667899999999999999999999665555443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=360.30 Aligned_cols=256 Identities=30% Similarity=0.535 Sum_probs=223.9
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
+-|.++.+||.|+||.||++.++.+|..+|||.+.. ..+.+.+..|+.|+.+++.|+||++|++|.....+|+||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc-----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 458899999999999999999999999999997753 346788999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 575 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 575 Ey~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|||..|++.+.++- ...+++.++..+++..+.||+|||.+.-||||||..||||+.+|+.||+|||.|-...
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT------- 180 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT------- 180 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh-------
Confidence 99999999999874 4679999999999999999999999999999999999999999999999999886321
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHh
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~k 733 (900)
..-...++..|||.|||||++..-+|+.++||||||++..||.-|++||.+..|+...-.
T Consensus 181 --------------------DTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM 240 (502)
T KOG0574|consen 181 --------------------DTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM 240 (502)
T ss_pred --------------------hhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe
Confidence 012245678999999999999999999999999999999999999999999887655444
Q ss_pred hhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 734 Il~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
|-....+--.-|..+|.++.|||+.||.++|++|-| |.++++|||.++.
T Consensus 241 IPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~T---A~~L~~H~FiknA 289 (502)
T KOG0574|consen 241 IPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKT---ALRLCEHTFIKNA 289 (502)
T ss_pred ccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHH---HHHHhhhhhhcCC
Confidence 433322111124668999999999999999999998 8999999999864
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=343.42 Aligned_cols=260 Identities=22% Similarity=0.360 Sum_probs=213.7
Q ss_pred ccccCCCeEEEEEeccCCceEEEEEEE-----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARK-----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYS 563 (900)
Q Consensus 490 ~~~~~~dYeil~~LGkG~FG~Vyla~~-----k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~ 563 (900)
.....++|++.+.||+|+||.||++.+ ..++..||+|++++.. .....+.+.+|+.+++++ +||||++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 346667899999999999999999985 3345689999986532 234467889999999999 79999999999
Q ss_pred eccCCeeEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCC
Q 002616 564 FTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 641 (900)
Q Consensus 564 f~d~~~LyLVmEy~~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGL 641 (900)
+...+.+|+||||+++|+|.+++.... .+++..+..++.+++.||.|||++||+|+||||+|||++.++.+||+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997543 389999999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCC
Q 002616 642 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 720 (900)
Q Consensus 642 Ak~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~ 720 (900)
++...... .........+++.|+|||++.+..++.++|||||||++|||++ |.+
T Consensus 188 ~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~ 242 (302)
T cd05055 188 ARDIMNDS-------------------------NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSN 242 (302)
T ss_pred cccccCCC-------------------------ceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCC
Confidence 87421100 0001122356789999999999999999999999999999998 999
Q ss_pred CCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 721 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 721 PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
||......+.+.+........+ .+...++++.+|+.+||..+|++||++.++.+.+
T Consensus 243 p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l 298 (302)
T cd05055 243 PYPGMPVDSKFYKLIKEGYRMA-QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298 (302)
T ss_pred CcCCCCchHHHHHHHHcCCcCC-CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 9988776665555554443322 3467889999999999999999999955544433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=343.84 Aligned_cols=254 Identities=28% Similarity=0.428 Sum_probs=217.4
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
..|+..+.||+|+||.||+|++..+|..||+|++.+...........+.+|+.+++.++|||++++++++...+..|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34888999999999999999999999999999987654444455678999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 575 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 575 Ey~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
||++| +|.+++.. ...+++..+..++.+++.||.|||++||+||||+|+||+++.++.+||+|||++....
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~------- 176 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS------- 176 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-------
Confidence 99975 78777754 4568999999999999999999999999999999999999999999999999876311
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc---CCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei 730 (900)
......|++.|+|||++. +..++.++|||||||++|||++|.+||...+....
T Consensus 177 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~ 232 (317)
T cd06635 177 ------------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 232 (317)
T ss_pred ------------------------CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence 112346899999999984 35688899999999999999999999988877766
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
...+........ ....+++.+.+||.+||+.+|.+||+ +.+++.|||+..
T Consensus 233 ~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~ 282 (317)
T cd06635 233 LYHIAQNESPTL-QSNEWSDYFRNFVDSCLQKIPQDRPT---SEELLKHMFVLR 282 (317)
T ss_pred HHHHHhccCCCC-CCccccHHHHHHHHHHccCCcccCcC---HHHHHhChhhhc
Confidence 666665543322 23567889999999999999999999 889999999954
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=342.61 Aligned_cols=254 Identities=26% Similarity=0.423 Sum_probs=215.2
Q ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 576 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy 576 (900)
|...+.||+|+||+||+|++..+|..||+|++.............+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 56677899999999999999999999999999765444455667889999999999999999999999999999999999
Q ss_pred cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCC
Q 002616 577 LNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 577 ~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
+. |+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~---------- 171 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS---------- 171 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCccc----------
Confidence 96 478777765 456899999999999999999999999999999999999999999999999987531
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc---CCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~ 732 (900)
.......|++.|+|||++. +..++.++|+|||||++|+|++|.+||...+......
T Consensus 172 ---------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~ 230 (313)
T cd06633 172 ---------------------SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 230 (313)
T ss_pred ---------------------CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 0112357899999999985 3567889999999999999999999998887766655
Q ss_pred hhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 002616 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786 (900)
Q Consensus 733 kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~id 786 (900)
.+.....+.. ....++..+++||.+||+++|.+||+ +.+++.||||+..+
T Consensus 231 ~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~P~~Rp~---~~~~l~~~~~~~~~ 280 (313)
T cd06633 231 HIAQNDSPTL-QSNEWTDSFRGFVDYCLQKIPQERPA---SAELLRHDFVRRDR 280 (313)
T ss_pred HHHhcCCCCC-CccccCHHHHHHHHHHccCChhhCcC---HHHHhcCcccCCCc
Confidence 5544332211 12457788999999999999999999 88999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=333.37 Aligned_cols=257 Identities=25% Similarity=0.352 Sum_probs=213.1
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 570 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk---~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~L 570 (900)
..+|++.+.||+|+||.||+|+++.++. .+|+|.++... .......+.+|+.++..++||||+++++++...+.+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 4689999999999999999999875543 79999886532 234467889999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
|+||||+++|+|.+++.+. +.++...+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 9999999999999999765 468999999999999999999999999999999999999999999999999987421000
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChH
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 728 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ 728 (900)
..........+++.|+|||.+.+..++.++|+|||||++|||++ |..||...+..
T Consensus 161 ------------------------~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~ 216 (267)
T cd05066 161 ------------------------EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216 (267)
T ss_pred ------------------------ceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH
Confidence 00001112234678999999998899999999999999999886 99999988877
Q ss_pred HHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 729 ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
+....+... ...| .+..+++.+.+|+.+||+++|.+||+++++.+++.
T Consensus 217 ~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 264 (267)
T cd05066 217 DVIKAIEEG-YRLP-APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILD 264 (267)
T ss_pred HHHHHHhCC-CcCC-CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHH
Confidence 777776654 2323 34678899999999999999999999666655543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=331.34 Aligned_cols=258 Identities=23% Similarity=0.317 Sum_probs=213.2
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk---~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~ 568 (900)
+..++|+..+.||+|+||.||+|+.+.++. .+|+|.++... .....+.+.+|+.++..++||||+++++++...+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 345789999999999999999999876665 79999886432 2344567899999999999999999999999999
Q ss_pred eeEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~ 647 (900)
..|+||||+++|+|.+++.+. +.+++..+..++.+++.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999999764 5789999999999999999999999999999999999999999999999999874311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCC
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 726 (900)
Q Consensus 648 ~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s 726 (900)
.. ...........++.|+|||++.+..++.++|||||||++|||++ |..||...+
T Consensus 160 ~~------------------------~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 160 DP------------------------EGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred cc------------------------ccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 00 00000111223567999999998889999999999999999997 999999888
Q ss_pred hHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 727 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 727 ~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
..+....+.... ..| .+...+.++.+|+.+||..||.+||++.++.+.+
T Consensus 216 ~~~~~~~i~~~~-~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l 264 (268)
T cd05063 216 NHEVMKAINDGF-RLP-APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264 (268)
T ss_pred HHHHHHHHhcCC-CCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 878777776542 323 2356789999999999999999999965554443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=333.84 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=210.1
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
+..++|++.+.||+|+||.||+|++..+ ..||+|++++... ..+.+.+|++++..++||||+++++.+.. ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 3456799999999999999999998765 4599999875332 23568899999999999999999988754 5689
Q ss_pred EEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
+||||+++|+|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~- 155 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN- 155 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc-
Confidence 999999999999999763 35789999999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChH
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 728 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ 728 (900)
.........++..|+|||++.+..++.++|+|||||++|||++ |.+||.+....
T Consensus 156 -------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~ 210 (262)
T cd05071 156 -------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 210 (262)
T ss_pred -------------------------ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence 0001123456788999999998899999999999999999999 89999988887
Q ss_pred HHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 729 ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
++...+.... ..+ .+..++..+.+||.+||+.||.+||++.++.+.++
T Consensus 211 ~~~~~~~~~~-~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~ 258 (262)
T cd05071 211 EVLDQVERGY-RMP-CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 258 (262)
T ss_pred HHHHHHhcCC-CCC-CccccCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence 7777765442 222 24678899999999999999999999776666653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=330.47 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=209.9
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
+..++|++.++||+|+||.||+|..+ +++.||+|.+.+... ....+.+|+.+++.++||||+++++++. .+.+|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45678999999999999999999865 578899999875332 3457889999999999999999998874 45789
Q ss_pred EEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
+||||+++|+|.+++... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~- 155 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN- 155 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC-
Confidence 999999999999998753 35888999999999999999999999999999999999999999999999998642100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChH
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 728 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ 728 (900)
.........++..|+|||++.+..++.++|+||||+++|||++ |++||.+.+..
T Consensus 156 -------------------------~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 210 (260)
T cd05067 156 -------------------------EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP 210 (260)
T ss_pred -------------------------CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH
Confidence 0001123356789999999998889999999999999999999 99999988877
Q ss_pred HHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 729 ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
+....+... ... ..+...+.++.+||.+||+.+|++||+++.+..+|
T Consensus 211 ~~~~~~~~~-~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 257 (260)
T cd05067 211 EVIQNLERG-YRM-PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVL 257 (260)
T ss_pred HHHHHHHcC-CCC-CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHh
Confidence 777665443 222 23467889999999999999999999966665554
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=340.31 Aligned_cols=258 Identities=24% Similarity=0.350 Sum_probs=209.1
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCC--------------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTG--------------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV 558 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tG--------------k~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIV 558 (900)
..++|++.+.||+|+||.||+|++..++ ..||+|+++.. ........+.+|++++.+++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhCCCCCcC
Confidence 3468999999999999999999875432 35899998653 2344566799999999999999999
Q ss_pred EEeeeeccCCeeEEEEeecCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcE
Q 002616 559 RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 626 (900)
Q Consensus 559 kL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g------------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNI 626 (900)
++++++...+.+|+||||+++++|.+++.... .+++..+..++.|++.||.|||++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999986532 367888899999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceee
Q 002616 627 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 706 (900)
Q Consensus 627 LLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIW 706 (900)
|++.++.+||+|||++....... .........+++.|+|||++.+..++.++|+|
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 215 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGD-------------------------YYRIQGRAVLPIRWMAWESILLGKFTTASDVW 215 (295)
T ss_pred EEcCCCcEEecccccccccccCc-------------------------ceeccCcCcCceeecChhhhccCCcCchhhHH
Confidence 99999999999999987421100 00111234567899999999988999999999
Q ss_pred chhHHHHHHHh--CCCCCCCCChHHHHHhhhc-----CCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 707 SVGIILFEFIT--GIPPFTAESPEIIFDNILN-----RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 707 SLGVILyEMLt--Gk~PF~~~s~~ei~~kIl~-----~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
||||++|+|++ |..||...+..+....+.. ....+...+..+++.+.+||.+||..||.+||+++++.+.|
T Consensus 216 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l 293 (295)
T cd05097 216 AFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFL 293 (295)
T ss_pred HHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 99999999988 7789988777666554432 12222333466789999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=340.63 Aligned_cols=258 Identities=24% Similarity=0.356 Sum_probs=212.5
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 562 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~-------tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~ 562 (900)
....++|.+.+.||+|+||.||+|++.. .+..+|+|+++... .......+.+|+.++..+ .||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3456789999999999999999998642 34579999886432 344567789999999999 5999999999
Q ss_pred eeccCCeeEEEEeecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcE
Q 002616 563 SFTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 626 (900)
Q Consensus 563 ~f~d~~~LyLVmEy~~GGsL~dlL~k~----------------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNI 626 (900)
++.....+|+||||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 999999999999999999999999753 2478888999999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceee
Q 002616 627 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 706 (900)
Q Consensus 627 LLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIW 706 (900)
|++.++.+||+|||+++...... .........+++.|||||++.+..++.++|||
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 220 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDID-------------------------YYKKTSNGRLPVKWMAPEALFDRVYTHQSDVW 220 (314)
T ss_pred EEcCCCcEEEccccccccccccc-------------------------cccccccCCCCccccCHHHHccCCcCccchhh
Confidence 99999999999999997421000 00011122345689999999998999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 707 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 707 SLGVILyEMLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
||||++|||++ |..||.+.+..+++..+..... +..+..++.++.+||.+||..||.+||++.++.+.+
T Consensus 221 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l 290 (314)
T cd05099 221 SFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR--MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290 (314)
T ss_pred HHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 99999999999 9999999888888887765432 223467889999999999999999999965555444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=328.37 Aligned_cols=248 Identities=27% Similarity=0.405 Sum_probs=212.1
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
+..++|++.+.||.|+||.||+|... |+.||+|.++.... ...++.+|+.++..++||||+++++++.+.+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 45678999999999999999999875 89999999865322 5678999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++....
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~-- 154 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ-- 154 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccc--
Confidence 9999999999999998765 689999999999999999999999999999999999999999999999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChH
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 728 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ 728 (900)
......++..|+|||.+.+..++.++|+||||+++|||++ |..||...+..
T Consensus 155 ----------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 206 (256)
T cd05039 155 ----------------------------GQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 206 (256)
T ss_pred ----------------------------ccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 0012234668999999988889999999999999999997 99999988877
Q ss_pred HHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 729 ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
++...+.... . +..+..+++++.+||.+||..+|.+||++.++.+.|
T Consensus 207 ~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l 253 (256)
T cd05039 207 DVVPHVEKGY-R-MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253 (256)
T ss_pred HHHHHHhcCC-C-CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHH
Confidence 7766655432 2 223467899999999999999999999965554444
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=333.44 Aligned_cols=255 Identities=35% Similarity=0.577 Sum_probs=211.8
Q ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--CeeEEEE
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNLYLVM 574 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~LyLVm 574 (900)
|++.+.||.|+||.||+|.+..+|+.||+|+++... ........+.+|+.+++.++||||+++++.+... ..+|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 688999999999999999999999999999997643 2334456788999999999999999999999988 8899999
Q ss_pred eecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 575 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
||+++ +|.+++... ..+++..+..++.||+.||+|||+.|++|+||||+|||++++|.+||+|||++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~---- 154 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN---- 154 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC----
Confidence 99975 899888765 579999999999999999999999999999999999999999999999999987431100
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~ 732 (900)
........+++.|+|||.+.+ ..++.++||||||+++|||++|++||...+......
T Consensus 155 ----------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~ 212 (287)
T cd07840 155 ----------------------SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE 212 (287)
T ss_pred ----------------------cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 011123457889999998775 467899999999999999999999999888766655
Q ss_pred hhhcCC-----CCCCC----------------------CCCC-CCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 733 NILNRK-----IPWPC----------------------VPSD-MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 733 kIl~~~-----l~~P~----------------------ip~~-lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
.+.... ..++. .... ++.++.++|++||..||.+||+ +.+++.||||
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~~l~~~~~ 287 (287)
T cd07840 213 KIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS---ADQALQHEYF 287 (287)
T ss_pred HHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC---HHHHhhCcCC
Confidence 544310 00110 0012 3889999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=332.48 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=214.0
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCC-----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~t-----Gk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~ 568 (900)
.++|++++.||.|+||+||+|+.+.+ .+.||+|.+.... .......+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 46899999999999999999997643 4679999875422 2235677999999999999999999999999999
Q ss_pred eeEEEEeecCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEec
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVG---------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 639 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~g---------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDF 639 (900)
..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999998655 6899999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-C
Q 002616 640 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-G 718 (900)
Q Consensus 640 GLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-G 718 (900)
|+++..... .........+++.|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 162 ~~~~~~~~~--------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~ 215 (275)
T cd05046 162 SLSKDVYNS--------------------------EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215 (275)
T ss_pred ccccccCcc--------------------------cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 998632100 0011223456788999999998889999999999999999998 8
Q ss_pred CCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 719 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 719 k~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
..||...........+......++. +..++..+.++|.+||..||.+||+ +.+++.
T Consensus 216 ~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~~i~~~l~~~p~~Rp~---~~~~l~ 271 (275)
T cd05046 216 ELPFYGLSDEEVLNRLQAGKLELPV-PEGCPSRLYKLMTRCWAVNPKDRPS---FSELVS 271 (275)
T ss_pred CCCccccchHHHHHHHHcCCcCCCC-CCCCCHHHHHHHHHHcCCCcccCCC---HHHHHH
Confidence 9999888877777777766665542 4678899999999999999999999 445543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=349.47 Aligned_cols=261 Identities=25% Similarity=0.351 Sum_probs=206.1
Q ss_pred EEeccC--CceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecC
Q 002616 501 KPISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 578 (900)
Q Consensus 501 ~~LGkG--~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~ 578 (900)
..||+| +||+||++++..+|+.||+|++..... .....+.+.+|+.+++.++||||++++++|...+.+|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 356666 999999999999999999999865432 23456788999999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCC
Q 002616 579 GGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 656 (900)
Q Consensus 579 GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~ 656 (900)
+|+|.+++.+.. .+++..++.++.|++.||+|||++||+||||||+|||++.++.+|++|||.+........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~------ 156 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQ------ 156 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCc------
Confidence 999999987643 489999999999999999999999999999999999999999999999986542110000
Q ss_pred CCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC--CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhh
Q 002616 657 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734 (900)
Q Consensus 657 ~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~--~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kI 734 (900)
.... .........++..|||||++.+. .++.++|||||||++|||++|.+||...........+
T Consensus 157 ------~~~~--------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~ 222 (328)
T cd08226 157 ------KAKV--------VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQK 222 (328)
T ss_pred ------cccc--------cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHH
Confidence 0000 00001123456789999999763 5789999999999999999999999877655444333
Q ss_pred hcCCCCCC--------------------------------------------CCCCCCCHHHHHHHHHhccCCcCCCCCh
Q 002616 735 LNRKIPWP--------------------------------------------CVPSDMSFEAQDLINRFLIHDPNQRLGA 770 (900)
Q Consensus 735 l~~~l~~P--------------------------------------------~ip~~lS~eakDLIk~cL~~DP~kRpSa 770 (900)
+......| ..+..+++.+.+||++||+.||++|||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt- 301 (328)
T cd08226 223 LKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS- 301 (328)
T ss_pred hcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC-
Confidence 32211000 011345778999999999999999999
Q ss_pred hcHHHHHcCCCCCCC
Q 002616 771 NGAAEVKAHPFFKGV 785 (900)
Q Consensus 771 ~~a~EIL~HPFFk~i 785 (900)
+.++++||||+++
T Consensus 302 --a~e~l~~~~~~~~ 314 (328)
T cd08226 302 --ASSLLSHAFFKQV 314 (328)
T ss_pred --HHHHhhCHHHHHH
Confidence 8899999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=331.58 Aligned_cols=254 Identities=28% Similarity=0.493 Sum_probs=215.6
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~--~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
.|.+.+.||+|+||.||++.+..++..+++|+++.... ........+..|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 48899999999999999999988888888888765332 2233445677899999999999999999999999999999
Q ss_pred EeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 574 MEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 574 mEy~~GGsL~dlL~k----~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
|||+++++|.+++.+ ...+++..++.++.|++.||.|||++|++|+||||+||+++. +.+||+|||+++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~-- 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG-- 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence 999999999998864 346899999999999999999999999999999999999975 6799999999874210
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 729 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~e 729 (900)
.........|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+...
T Consensus 158 -------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~ 212 (260)
T cd08222 158 -------------------------SCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS 212 (260)
T ss_pred -------------------------CcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence 0111223568899999999988889999999999999999999999998877777
Q ss_pred HHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 730 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 730 i~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
....+.... .|..+..++.++.++|.+||..||.+||+ +.+++.||||
T Consensus 213 ~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~ 260 (260)
T cd08222 213 VVLRIVEGP--TPSLPETYSRQLNSIMQSMLNKDPSLRPS---AAEILRNPFI 260 (260)
T ss_pred HHHHHHcCC--CCCCcchhcHHHHHHHHHHhcCChhhCcC---HHHHhhCCCC
Confidence 666665543 23445778999999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=328.46 Aligned_cols=253 Identities=24% Similarity=0.367 Sum_probs=213.0
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
+..++|++.+.||+|+||.||+|... .+..||+|.+..... ....+.+|+.+++.++||||+++++++.....+|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 56789999999999999999999976 457899999875332 3456889999999999999999999999989999
Q ss_pred EEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
+||||+++++|.+++.... .++...+..++.+++.||.|||++|++|+||||+||+++.++.+||+|||+++.....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~- 156 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD- 156 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch-
Confidence 9999999999999997653 6899999999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChH
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 728 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ 728 (900)
.........++..|+|||.+.+..++.++|+||||+++|+|++ |+.||.+.+..
T Consensus 157 -------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~ 211 (261)
T cd05034 157 -------------------------EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR 211 (261)
T ss_pred -------------------------hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 0001112235678999999999899999999999999999998 99999988887
Q ss_pred HHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 729 ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
.....+.... ..+ .+...+.++.+++.+||+.+|.+||+++++.+.+
T Consensus 212 ~~~~~~~~~~-~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l 258 (261)
T cd05034 212 EVLEQVERGY-RMP-RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFL 258 (261)
T ss_pred HHHHHHHcCC-CCC-CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHH
Confidence 7777776542 222 2456789999999999999999999966555554
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=349.82 Aligned_cols=257 Identities=32% Similarity=0.482 Sum_probs=214.7
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe---
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN--- 569 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~--- 569 (900)
..++|++.+.||.|+||.||+|++..++..||+|++.... ........+.+|+.+++.+.||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 4678999999999999999999999999999999986532 223445678889999999999999999988877665
Q ss_pred ---eEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 570 ---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 570 ---LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
+|+|+||+ +++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence 89999998 6699998865 569999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 725 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~ 725 (900)
.......+|+.|+|||++.+ ..++.++|||||||++|||++|++||.+.
T Consensus 170 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 170 ------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred ------------------------------ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 01233468899999999875 46789999999999999999999999888
Q ss_pred ChHHHHHhhhcCCC----------------------------CCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 726 SPEIIFDNILNRKI----------------------------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 726 s~~ei~~kIl~~~l----------------------------~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
+....+..+..... .+.......++++.+||.+||+.||.+||+ +.+++
T Consensus 220 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt---~~ell 296 (343)
T cd07851 220 DHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT---AAEAL 296 (343)
T ss_pred ChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC---HHHHh
Confidence 77666555543210 001111346899999999999999999999 88999
Q ss_pred cCCCCCCC
Q 002616 778 AHPFFKGV 785 (900)
Q Consensus 778 ~HPFFk~i 785 (900)
.||||+..
T Consensus 297 ~h~~~~~~ 304 (343)
T cd07851 297 AHPYLAEY 304 (343)
T ss_pred cCCCcccc
Confidence 99999853
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=339.82 Aligned_cols=254 Identities=24% Similarity=0.363 Sum_probs=209.1
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeee
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYS 563 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~-------tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~ 563 (900)
+..++|.+.+.||+|+||.||+|++.. ++..||+|+++... .......+.+|+.++..+ +||||++++++
T Consensus 15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (307)
T cd05098 15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA 92 (307)
T ss_pred eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 445789999999999999999998753 23579999987532 234556788999999999 79999999999
Q ss_pred eccCCeeEEEEeecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEE
Q 002616 564 FTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 627 (900)
Q Consensus 564 f~d~~~LyLVmEy~~GGsL~dlL~k~g----------------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNIL 627 (900)
+...+.+|+||||+++|+|.+++.... .++...+..++.|++.||+|||++|++||||||+|||
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil 172 (307)
T cd05098 93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 172 (307)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence 999999999999999999999997642 4788889999999999999999999999999999999
Q ss_pred ecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeec
Q 002616 628 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 707 (900)
Q Consensus 628 Ld~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWS 707 (900)
++.++.+||+|||+++....... ........+++.|+|||++.+..++.++|+||
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvws 227 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDY-------------------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 227 (307)
T ss_pred EcCCCcEEECCCcccccccccch-------------------------hhccccCCCccceeChHHhccCCCCcHHHHHH
Confidence 99999999999999874210000 00011123457899999999988999999999
Q ss_pred hhHHHHHHHh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHH
Q 002616 708 VGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 774 (900)
Q Consensus 708 LGVILyEMLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~ 774 (900)
|||++|||++ |.+||.+.+..+++..+..... +..+..++.++.+||.+||..+|.+||++.++.
T Consensus 228 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl 293 (307)
T cd05098 228 FGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV 293 (307)
T ss_pred HHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCC--CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHH
Confidence 9999999998 9999988887777776654432 223467899999999999999999999955443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=330.41 Aligned_cols=257 Identities=24% Similarity=0.350 Sum_probs=211.5
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 569 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk---~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ 569 (900)
..++|++.+.||+|+||.||+|.++.+++ .||+|++++. ........+..|+.+++.++||||+++++++.....
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 79 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP 79 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence 35679999999999999999999987765 6999998653 234456789999999999999999999999999999
Q ss_pred eEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 570 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
+|+||||+++|+|.+++... +.+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999999998754 56899999999999999999999999999999999999999999999999998742110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCCh
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 727 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~ 727 (900)
.. .+. ........++..|+|||.+.+..++.++|||||||++|||++ |..||...+.
T Consensus 160 ~~-----------------~~~-----~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~ 217 (269)
T cd05065 160 TS-----------------DPT-----YTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217 (269)
T ss_pred cc-----------------ccc-----cccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH
Confidence 00 000 000111123567999999999999999999999999999886 9999998888
Q ss_pred HHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHH
Q 002616 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 775 (900)
Q Consensus 728 ~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~E 775 (900)
.+....+... .+.| .+..++..+.+++.+||..+|.+||+++++..
T Consensus 218 ~~~~~~i~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 218 QDVINAIEQD-YRLP-PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHHHHcC-CcCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7777776443 3333 23678899999999999999999999554433
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=334.16 Aligned_cols=252 Identities=19% Similarity=0.299 Sum_probs=204.7
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcE----EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDL----FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~----VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
+..++|++++.||+|+||+||+|.+..+|.. +|+|.+... ........+..|+.++..++||||+++++++. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~ 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-G 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-C
Confidence 3457899999999999999999999888874 566665321 12234467788888999999999999999875 4
Q ss_pred CeeEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
...++|+||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 5678999999999999999764 568999999999999999999999999999999999999999999999999987431
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 725 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~ 725 (900)
... .........|+..|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 161 ~~~-------------------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 215 (279)
T cd05111 161 PDD-------------------------KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM 215 (279)
T ss_pred CCC-------------------------cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 100 0011123457789999999998889999999999999999998 99999988
Q ss_pred ChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcH
Q 002616 726 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 773 (900)
Q Consensus 726 s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a 773 (900)
.+..+...+..+... ..+...+.++.+++.+||..||.+||++.++
T Consensus 216 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rps~~el 261 (279)
T cd05111 216 RPHEVPDLLEKGERL--AQPQICTIDVYMVMVKCWMIDENVRPTFKEL 261 (279)
T ss_pred CHHHHHHHHHCCCcC--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 777665555443322 2245678899999999999999999995443
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=346.86 Aligned_cols=256 Identities=30% Similarity=0.451 Sum_probs=209.7
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-----
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 567 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~----- 567 (900)
..++|++.+.||+|+||.||+|.+..+|+.||+|++++.. ......+.+.+|+.++.+++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 4588999999999999999999999999999999986532 2233456788999999999999999999988643
Q ss_pred -CeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 568 -DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 568 -~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
...|++++++ |++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||+++.+|.+||+|||+++...
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3478888887 7799887754 469999999999999999999999999999999999999999999999999986311
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 725 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~ 725 (900)
.......||+.|+|||++.+ ..++.++|||||||++|||++|++||...
T Consensus 172 ------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 172 ------------------------------DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred ------------------------------ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 01123568999999999876 56889999999999999999999999876
Q ss_pred ChHHHHHhhhcCCC----------------------------CCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 726 SPEIIFDNILNRKI----------------------------PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 726 s~~ei~~kIl~~~l----------------------------~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
+.......+..... .+.......++++.+||.+||+.||.+||+ +.+++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~e~l 298 (345)
T cd07877 222 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQAL 298 (345)
T ss_pred CHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC---HHHHh
Confidence 65544433322100 001111246888999999999999999999 88999
Q ss_pred cCCCCCC
Q 002616 778 AHPFFKG 784 (900)
Q Consensus 778 ~HPFFk~ 784 (900)
.||||+.
T Consensus 299 ~h~~f~~ 305 (345)
T cd07877 299 AHAYFAQ 305 (345)
T ss_pred cChhhhh
Confidence 9999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=337.07 Aligned_cols=260 Identities=33% Similarity=0.502 Sum_probs=211.4
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC---
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD--- 568 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~--- 568 (900)
...++|++.+.||.|+||.||+|.++.+|+.||+|+++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 456889999999999999999999999999999999875332 2233456778999999999999999999987765
Q ss_pred -------eeEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecC
Q 002616 569 -------NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 640 (900)
Q Consensus 569 -------~LyLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFG 640 (900)
.+|+||||+++ +|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 79999999986 777777653 468999999999999999999999999999999999999999999999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCC
Q 002616 641 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGI 719 (900)
Q Consensus 641 LAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk 719 (900)
++...... .........+++.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 162 ~~~~~~~~--------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~ 215 (302)
T cd07864 162 LARLYNSE--------------------------ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215 (302)
T ss_pred ccccccCC--------------------------cccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 98743110 0011122356889999999875 45788999999999999999999
Q ss_pred CCCCCCChHHHHHhhhcC---CC--CCCC----------------------CCCCCCHHHHHHHHHhccCCcCCCCChhc
Q 002616 720 PPFTAESPEIIFDNILNR---KI--PWPC----------------------VPSDMSFEAQDLINRFLIHDPNQRLGANG 772 (900)
Q Consensus 720 ~PF~~~s~~ei~~kIl~~---~l--~~P~----------------------ip~~lS~eakDLIk~cL~~DP~kRpSa~~ 772 (900)
+||...+..+....+... .. .+|. ....++..+.+||.+||..||.+||+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~--- 292 (302)
T cd07864 216 PIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT--- 292 (302)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC---
Confidence 999887766555444331 00 0110 01246899999999999999999999
Q ss_pred HHHHHcCCCC
Q 002616 773 AAEVKAHPFF 782 (900)
Q Consensus 773 a~EIL~HPFF 782 (900)
+.+++.||||
T Consensus 293 ~~~il~~~~~ 302 (302)
T cd07864 293 AEEALNSPWL 302 (302)
T ss_pred HHHHhcCCCC
Confidence 8899999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=328.54 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=207.5
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
..++|++.+.||.|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++||||+++++++. .+..|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 4 PRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred ChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEE
Confidence 446799999999999999999998754 4699998765332 2456888999999999999999998875 456899
Q ss_pred EEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 573 VMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
||||+++|+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~-- 155 (260)
T cd05069 78 VTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN-- 155 (260)
T ss_pred EEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC--
Confidence 999999999999997643 4788999999999999999999999999999999999999999999999998742100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 729 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~e 729 (900)
.........++..|+|||.+.+..++.++|+|||||++|||++ |.+||.+....+
T Consensus 156 ------------------------~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 211 (260)
T cd05069 156 ------------------------EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE 211 (260)
T ss_pred ------------------------cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 0001122346788999999998889999999999999999999 999999988877
Q ss_pred HHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 730 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 730 i~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
....+... ... ..+..++..+.+||++||.+||.+||+++.+.+.+
T Consensus 212 ~~~~~~~~-~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l 257 (260)
T cd05069 212 VLEQVERG-YRM-PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFL 257 (260)
T ss_pred HHHHHHcC-CCC-CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHH
Confidence 77776544 222 23467899999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=343.37 Aligned_cols=261 Identities=31% Similarity=0.456 Sum_probs=209.2
Q ss_pred CeEEEEEeccCCceEEEEEEECCC--CcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeecc----CC
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTT--GDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTC----RD 568 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~t--Gk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d----~~ 568 (900)
+|++.+.||+|+||.||+|++..+ +..||+|++... .........+.+|+.++.++ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNV-FSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccc-cccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999988 899999998642 22233456788899999999 59999999986432 24
Q ss_pred eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
.+|++|+|+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.....
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 5889999986 599999988888999999999999999999999999999999999999999999999999998743110
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 727 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~ 727 (900)
.. .........+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.
T Consensus 159 ~~-----------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~ 215 (332)
T cd07857 159 PG-----------------------ENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDY 215 (332)
T ss_pred cc-----------------------cccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCH
Confidence 00 00111234679999999998876 5789999999999999999999999987664
Q ss_pred HHHHHhhhcC----------------------------CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcC
Q 002616 728 EIIFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 728 ~ei~~kIl~~----------------------------~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~H 779 (900)
...+..++.. ...++......+..+.+||.+||+.||.+||+ +.+++.|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~~ll~~ 292 (332)
T cd07857 216 VDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS---VEEALEH 292 (332)
T ss_pred HHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC---HHHHhcC
Confidence 4333322210 11122222456889999999999999999999 7899999
Q ss_pred CCCCC
Q 002616 780 PFFKG 784 (900)
Q Consensus 780 PFFk~ 784 (900)
|||+.
T Consensus 293 ~~~~~ 297 (332)
T cd07857 293 PYLAI 297 (332)
T ss_pred hhhhh
Confidence 99964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=330.71 Aligned_cols=251 Identities=22% Similarity=0.319 Sum_probs=199.3
Q ss_pred EEeccCCceEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecC
Q 002616 501 KPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 578 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~--tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~ 578 (900)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.....+|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999997543 34468888765322 23445678899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 579 GGDLYSLLRKVG-----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 579 GGsL~dlL~k~g-----~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~---- 154 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED---- 154 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch----
Confidence 999999997643 24677888999999999999999999999999999999999999999999986321000
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-------CCCCccceeechhHHHHHHHh-CCCCCCCC
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADWWSVGIILFEFIT-GIPPFTAE 725 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-------~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~ 725 (900)
.........+++.|+|||++.. ..++.++|||||||++|||++ |.+||...
T Consensus 155 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 155 ---------------------YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred ---------------------heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 0001123456788999999753 356789999999999999999 88999888
Q ss_pred ChHHHHHhhhcC-CCC--CCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcC
Q 002616 726 SPEIIFDNILNR-KIP--WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 726 s~~ei~~kIl~~-~l~--~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~H 779 (900)
.+.+....+... ..+ -|.++..++....+++..|+. ||.+||+++++.+++.|
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-dp~~Rpt~~~v~~~l~~ 269 (269)
T cd05042 214 SDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCWL-DPETRPTAEEVHELLTY 269 (269)
T ss_pred CHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHhc-CcccccCHHHHHHHhcC
Confidence 776666555433 222 233456788999999999985 99999998777777765
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=326.82 Aligned_cols=249 Identities=25% Similarity=0.337 Sum_probs=207.5
Q ss_pred EEeccCCceEEEEEEECC-CCc--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeec
Q 002616 501 KPISRGAFGRVFLARKRT-TGD--LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 577 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~-tGk--~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~ 577 (900)
+.||+|+||.||+|.+.. .++ .||+|.++..... ...+.+.+|+.++++++||||+++++.+.. ..+|+||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999999865 333 6999998764432 567789999999999999999999999988 8899999999
Q ss_pred CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCC
Q 002616 578 NGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 578 ~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
++|+|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~------ 151 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE------ 151 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccc------
Confidence 9999999997754 68999999999999999999999999999999999999999999999999987531100
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHhh
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 734 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ei~~kI 734 (900)
. . ........++..|+|||.+.+..++.++|+|||||++|||++ |..||...+..+....+
T Consensus 152 ----------~---~-----~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 213 (257)
T cd05040 152 ----------D---H-----YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213 (257)
T ss_pred ----------c---c-----eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 0 0 001113457889999999999999999999999999999998 99999988888877776
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 735 l~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
......++ .+...+..+.+|+.+||+.+|++||++.++.+.+
T Consensus 214 ~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 255 (257)
T cd05040 214 DKEGERLE-RPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255 (257)
T ss_pred HhcCCcCC-CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHh
Confidence 65333322 3467889999999999999999999955554443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=336.42 Aligned_cols=260 Identities=28% Similarity=0.508 Sum_probs=211.2
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCe
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 569 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~ 569 (900)
....++|++.+.||+|+||+||+|.+..+++.||+|.+++... ......+..|+.++.... ||||+++++++.+...
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 4667899999999999999999999999999999999976432 233455667777666665 9999999999999999
Q ss_pred eEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhh-cCeEeccCCCCcEEecCCCcEEEEecCCcccccc
Q 002616 570 LYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~ 647 (900)
+|+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.+||+|||++.....
T Consensus 89 ~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 89 VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9999999854 77777765 3568999999999999999999997 5999999999999999999999999999864210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCC----CCccceeechhHHHHHHHhCCCCCC
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----HGYAADWWSVGIILFEFITGIPPFT 723 (900)
Q Consensus 648 ~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~----ys~ksDIWSLGVILyEMLtGk~PF~ 723 (900)
........|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||.
T Consensus 168 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 219 (296)
T cd06618 168 ----------------------------SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYK 219 (296)
T ss_pred ----------------------------CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCC
Confidence 00112235789999999997653 7889999999999999999999997
Q ss_pred CCCh-HHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 724 AESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 724 ~~s~-~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
.... .+....+.............++.++.+||.+||..||.+||+ +.+++.||||..
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~~~~~~~ 278 (296)
T cd06618 220 NCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPK---YRELLQHPFIRR 278 (296)
T ss_pred cchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCC---HHHHhcChhhhc
Confidence 6433 345555554432211112347899999999999999999999 789999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=337.56 Aligned_cols=256 Identities=23% Similarity=0.359 Sum_probs=211.8
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEEC-------CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEee
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKR-------TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFY 562 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k-------~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~ 562 (900)
.+..++|++.+.||+|+||.||+|++. .++..||+|.++.. ........+.+|+.++..+ +||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 466788999999999999999999853 23457999988642 2334567889999999999 7999999999
Q ss_pred eeccCCeeEEEEeecCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcE
Q 002616 563 SFTCRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 626 (900)
Q Consensus 563 ~f~d~~~LyLVmEy~~GGsL~dlL~k~----------------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNI 626 (900)
++.....+|+||||+++|+|.+++.+. ..++...+..++.||+.||.|||++||+||||||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Ni 168 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceE
Confidence 999999999999999999999999763 2367778889999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceee
Q 002616 627 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 706 (900)
Q Consensus 627 LLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIW 706 (900)
|++.++.+||+|||+++...... .........+++.|+|||++.+..++.++|||
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 223 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNID-------------------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 223 (304)
T ss_pred EEcCCCcEEECCCccceeccccc-------------------------ccccccCCCCCceeeCchhhccCCCCchhhHH
Confidence 99999999999999987431100 00111223467889999999998999999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHH
Q 002616 707 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 775 (900)
Q Consensus 707 SLGVILyEMLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~E 775 (900)
|||+++|+|++ |..||.+.+..++...+..... +..+..++.++.+||.+||..+|.+||++.++.+
T Consensus 224 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~ 291 (304)
T cd05101 224 SFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVE 291 (304)
T ss_pred HHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 99999999998 8999999888888877755432 1234678999999999999999999999554433
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=344.59 Aligned_cols=274 Identities=27% Similarity=0.399 Sum_probs=215.4
Q ss_pred CCeE-EEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchh-----------HHHHHHHHHHHHHhcCCCceEEEee
Q 002616 495 DDFE-IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-----------DIERILAERNILITVRNPFVVRFFY 562 (900)
Q Consensus 495 ~dYe-il~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~-----------~~e~~l~Ei~IL~~L~HPnIVkL~~ 562 (900)
++|. +.+.||.|+||+||+|.++.+|+.||+|+++........ ....+.+|+.++..++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4555 457799999999999999999999999998754322110 0124778999999999999999999
Q ss_pred eeccCCeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCc
Q 002616 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 642 (900)
Q Consensus 563 ~f~d~~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLA 642 (900)
+|...+.+|+||||+. |+|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999997 599999988788999999999999999999999999999999999999999999999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCC
Q 002616 643 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPP 721 (900)
Q Consensus 643 k~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~P 721 (900)
............. ..... ..........+++.|+|||++.+. .++.++|+|||||++|||++|.+|
T Consensus 167 ~~~~~~~~~~~~~---------~~~~~----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p 233 (335)
T PTZ00024 167 RRYGYPPYSDTLS---------KDETM----QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPL 233 (335)
T ss_pred eeccccccccccc---------ccccc----cccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 7532111000000 00000 001122334678999999999764 468999999999999999999999
Q ss_pred CCCCChHHHHHhhhcCC-----CCCC--------------------CCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHH
Q 002616 722 FTAESPEIIFDNILNRK-----IPWP--------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 776 (900)
Q Consensus 722 F~~~s~~ei~~kIl~~~-----l~~P--------------------~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EI 776 (900)
|.+.+..+....+.... ..|| ......+.++.+||.+||..||.+||+ +.++
T Consensus 234 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s---~~~~ 310 (335)
T PTZ00024 234 FPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS---AKEA 310 (335)
T ss_pred CCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC---HHHH
Confidence 99888776665554310 0011 011345788999999999999999999 8899
Q ss_pred HcCCCCCCC
Q 002616 777 KAHPFFKGV 785 (900)
Q Consensus 777 L~HPFFk~i 785 (900)
+.||||++.
T Consensus 311 l~~~~~~~~ 319 (335)
T PTZ00024 311 LKHEYFKSD 319 (335)
T ss_pred hcCcccCCC
Confidence 999999854
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=340.87 Aligned_cols=253 Identities=32% Similarity=0.543 Sum_probs=212.8
Q ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecC
Q 002616 499 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 578 (900)
Q Consensus 499 il~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~ 578 (900)
...+||+|+||.||++..+.+|..||+|.+... .......+.+|+.+++.++||||+++++.|...+..|+||||++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 346799999999999999999999999987532 23345678899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCC
Q 002616 579 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 658 (900)
Q Consensus 579 GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~ 658 (900)
+++|.+++.. +.+++..++.++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus 101 ~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~----------- 168 (292)
T cd06657 101 GGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK----------- 168 (292)
T ss_pred CCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccc-----------
Confidence 9999988754 5689999999999999999999999999999999999999999999999998763210
Q ss_pred CCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCC
Q 002616 659 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRK 738 (900)
Q Consensus 659 ~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~ 738 (900)
.........||+.|+|||.+.+..++.++|+||||+++|+|++|.+||.+....+....+....
T Consensus 169 ----------------~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~ 232 (292)
T cd06657 169 ----------------EVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL 232 (292)
T ss_pred ----------------ccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC
Confidence 0011233568999999999988888999999999999999999999999877766555443322
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 739 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 739 l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
.........+++.+.++|.+||..||.+||+ +.+++.||||...
T Consensus 233 ~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~---~~~ll~~~~~~~~ 276 (292)
T cd06657 233 PPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAKA 276 (292)
T ss_pred CcccCCcccCCHHHHHHHHHHHhCCcccCcC---HHHHhcChHHhcc
Confidence 1111112467899999999999999999999 8899999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=381.56 Aligned_cols=266 Identities=26% Similarity=0.386 Sum_probs=208.0
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
+++|++.+.||+|+||.||+|++..+|+.||+|++++..........++.+|+.++..++||||+++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 36899999999999999999999999999999999764433344567899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCc
Q 002616 574 MEYLNGGDLYSLLRKV-----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 642 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~-----------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLA 642 (900)
|||++||+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999998642 22455667888999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCC
Q 002616 643 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 722 (900)
Q Consensus 643 k~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF 722 (900)
+......... .....................+||+.|||||++.+..++.++|||||||++|||++|..||
T Consensus 161 k~i~~~~~~~---------~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF 231 (932)
T PRK13184 161 IFKKLEEEDL---------LDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231 (932)
T ss_pred eecccccccc---------cccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence 8531110000 0000000000000111223468999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHh-hhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC
Q 002616 723 TAESPEIIFDN-ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 769 (900)
Q Consensus 723 ~~~s~~ei~~k-Il~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpS 769 (900)
...+....... .......+. ....+++.+.+++.+||..||++|++
T Consensus 232 ~~~~~~ki~~~~~i~~P~~~~-p~~~iP~~L~~LI~rcL~~DP~kR~s 278 (932)
T PRK13184 232 RRKKGRKISYRDVILSPIEVA-PYREIPPFLSQIAMKALAVDPAERYS 278 (932)
T ss_pred CCcchhhhhhhhhccChhhcc-ccccCCHHHHHHHHHHccCChhhCcC
Confidence 87655443322 111111111 11467899999999999999999998
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=367.07 Aligned_cols=246 Identities=26% Similarity=0.431 Sum_probs=212.6
Q ss_pred ccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 569 (900)
Q Consensus 490 ~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~ 569 (900)
+.+.++...-++-||.|+-|.||+|+.+ ++.||||.++.. ++ .+++-|++++||||+.+.++|.....
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el---kE-------TdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL---KE-------TDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh---hh-------hhHHHHHhccCcceeeEeeeecCCce
Confidence 3455566667788999999999999987 899999976532 22 36677899999999999999999999
Q ss_pred eEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 570 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
+|||||||+.|-|+.+|+....++......|..+|+.||.|||.+.|||||||.-||||..+..|||+|||-++...
T Consensus 187 yCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~--- 263 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS--- 263 (904)
T ss_pred eEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999887421
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHH
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 729 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~e 729 (900)
.....-+++||..|||||++...+.+.++|||||||+|||||||..||.+.+...
T Consensus 264 -------------------------~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA 318 (904)
T KOG4721|consen 264 -------------------------DKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA 318 (904)
T ss_pred -------------------------hhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe
Confidence 1223457899999999999999999999999999999999999999998877665
Q ss_pred HHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcC
Q 002616 730 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 730 i~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~H 779 (900)
+.--+-.+.+.+| +|...++-++=||+.||+-.|..||+ ..+||.|
T Consensus 319 IIwGVGsNsL~Lp-vPstcP~GfklL~Kqcw~sKpRNRPS---Frqil~H 364 (904)
T KOG4721|consen 319 IIWGVGSNSLHLP-VPSTCPDGFKLLLKQCWNSKPRNRPS---FRQILLH 364 (904)
T ss_pred eEEeccCCccccc-CcccCchHHHHHHHHHHhcCCCCCcc---HHHHHHH
Confidence 5444334444444 46889999999999999999999999 5566666
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=335.08 Aligned_cols=256 Identities=24% Similarity=0.377 Sum_probs=206.6
Q ss_pred CCCeEEEEEeccCCceEEEEEEECC----------------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRT----------------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 557 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~----------------tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnI 557 (900)
.++|++.+.||+|+||.||+|++.. ++..||+|+++... .......+.+|+.+|+.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4579999999999999999996543 34579999986432 33456788999999999999999
Q ss_pred EEEeeeeccCCeeEEEEeecCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcE
Q 002616 558 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 626 (900)
Q Consensus 558 VkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g-----------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNI 626 (900)
+++++++...+..|+||||+++|+|.+++.+.. .+++..+..++.|++.||+|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999987643 366778999999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceee
Q 002616 627 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 706 (900)
Q Consensus 627 LLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIW 706 (900)
|++.++.+||+|||+++...... .........+++.|+|||+..+..++.++|+|
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Diw 216 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGD-------------------------YYRIQGRAVLPIRWMSWESILLGKFTTASDVW 216 (296)
T ss_pred EEcCCCCEEeccCcccccccCCc-------------------------ceeccCcCcCccccCCHHHHhcCCccchhhhh
Confidence 99999999999999987421000 00011223457889999999888899999999
Q ss_pred chhHHHHHHHh--CCCCCCCCChHHHHHhhhc------CCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 707 SVGIILFEFIT--GIPPFTAESPEIIFDNILN------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 707 SLGVILyEMLt--Gk~PF~~~s~~ei~~kIl~------~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
||||++|||++ |..||...+..+....... ....+| .+..+++.+.+||.+||..||.+||++.++.++|
T Consensus 217 SlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l 294 (296)
T cd05095 217 AFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLP-KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATL 294 (296)
T ss_pred HHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCC-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHH
Confidence 99999999998 7899988776665543321 111122 2456789999999999999999999966665554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=331.98 Aligned_cols=254 Identities=34% Similarity=0.562 Sum_probs=211.9
Q ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 576 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy 576 (900)
|++.+.||.|++|.||+|....+|+.+|+|.++... ........+.+|+.+|+.++||||+++++.+.+.+.+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF-ESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 677899999999999999999999999999986543 2234456788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCC
Q 002616 577 LNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 577 ~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
+++ +|..++... ..+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||.+......
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~------- 151 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSP------- 151 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCC-------
Confidence 976 888888664 57899999999999999999999999999999999999999999999999988742100
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhh
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kI 734 (900)
........++..|+|||.+.+. .++.++|+||||+++|+|++|++||...+..+...++
T Consensus 152 --------------------~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~ 211 (283)
T cd05118 152 --------------------VRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKI 211 (283)
T ss_pred --------------------cccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 0011224588999999999876 7899999999999999999999999887766555444
Q ss_pred hcCC-------------------CCCC--------CCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 735 LNRK-------------------IPWP--------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 735 l~~~-------------------l~~P--------~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
.... ..++ .....++.++.+||.+||..||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~ll~~~~~ 283 (283)
T cd05118 212 FRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT---AEQALAHPYF 283 (283)
T ss_pred HHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcC---HHHHhhCCCC
Confidence 3210 0000 112347889999999999999999999 8899999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=331.22 Aligned_cols=254 Identities=36% Similarity=0.561 Sum_probs=212.4
Q ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 576 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy 576 (900)
|++.+.||.|+||.||+|+...+++.||+|++.... ........+..|+.+++.++||||+++++++...+.+|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677889999999999999999999999999997643 2333456788899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCC
Q 002616 577 LNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 577 ~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
++ ++|.+++.+. ..+++..+..++.+++.||.|||++||+||||+|+||+++.++.+||+|||+++....
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~-------- 150 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI-------- 150 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCC--------
Confidence 98 4999999876 5799999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhh
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kI 734 (900)
.........++..|+|||.+.+. .++.++|+|||||++|||++|.+||...+..+...++
T Consensus 151 -------------------~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~ 211 (282)
T cd07829 151 -------------------PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKI 211 (282)
T ss_pred -------------------CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 00111234567889999999876 7899999999999999999999999888766555444
Q ss_pred hcC------------------CCCCCC--------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 735 LNR------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 735 l~~------------------~l~~P~--------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
... ...++. ..+.++..+.++|++||..||.+||+ +.+++.||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~~~l~~p~~ 282 (282)
T cd07829 212 FQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS---AKEALKHPYF 282 (282)
T ss_pred HHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCC---HHHHhhCcCC
Confidence 320 001111 11245789999999999999999999 8899999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=330.00 Aligned_cols=241 Identities=25% Similarity=0.391 Sum_probs=200.4
Q ss_pred EeccCCceEEEEEEECCCCc--EEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeEEEEeecC
Q 002616 502 PISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLN 578 (900)
Q Consensus 502 ~LGkG~FG~Vyla~~k~tGk--~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~LyLVmEy~~ 578 (900)
.||+|+||.||+|+.+.+|. .+|+|.++.. ........+.+|+.++.++ +||||+++++++.....+|+||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 68999999999999988876 4688877532 2344567889999999999 79999999999999999999999999
Q ss_pred CCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCc
Q 002616 579 GGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 642 (900)
Q Consensus 579 GGsL~dlL~k~g----------------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLA 642 (900)
+|+|.+++.+.. .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999997543 4788899999999999999999999999999999999999999999999997
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCC
Q 002616 643 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 721 (900)
Q Consensus 643 k~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~P 721 (900)
..... ........+++.|+|||++.+..++.++|+|||||++|||++ |..|
T Consensus 160 ~~~~~----------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~p 211 (270)
T cd05047 160 RGQEV----------------------------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211 (270)
T ss_pred cccch----------------------------hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 52100 000111234678999999998899999999999999999997 9999
Q ss_pred CCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHH
Q 002616 722 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 774 (900)
Q Consensus 722 F~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~ 774 (900)
|.+.+..+.+..+.... . +..+..++.++.+|+.+||..||.+||++.++.
T Consensus 212 f~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 262 (270)
T cd05047 212 YCGMTCAELYEKLPQGY-R-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQIL 262 (270)
T ss_pred ccccCHHHHHHHHhCCC-C-CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence 99888877777765432 2 123456889999999999999999999955443
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=333.66 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=208.2
Q ss_pred CeEEEEEeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 002616 496 DFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 570 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~-----tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~L 570 (900)
+|++.+.||+|+||.||+|+... ....+|+|.+.+.. .......+.+|+.++..++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 57889999999999999998753 23578999886432 234457789999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcE
Q 002616 571 YLVMEYLNGGDLYSLLRKV------------------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 626 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~------------------------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNI 626 (900)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998642 2477888999999999999999999999999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceee
Q 002616 627 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 706 (900)
Q Consensus 627 LLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIW 706 (900)
|++.++.+||+|||+++...... .........++..|+|||++.+..++.++|||
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~ 213 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEED-------------------------SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVW 213 (290)
T ss_pred EEcCCCcEEeccccccccccCcc-------------------------chhcccCCCCCccccCHHHHccCCcchHhHHH
Confidence 99999999999999987421100 00011223467789999999988899999999
Q ss_pred chhHHHHHHHh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 707 SVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 707 SLGVILyEMLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
|||+++|||++ |.+||.+..+..+...+... ..++ .+..++.++.+||.+||+.||.+||++.++.+.+
T Consensus 214 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l 283 (290)
T cd05045 214 SFGVLLWEIVTLGGNPYPGIAPERLFNLLKTG-YRME-RPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283 (290)
T ss_pred HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCC-CCCC-CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHH
Confidence 99999999998 99999988887777655433 2322 3577899999999999999999999965554443
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=322.70 Aligned_cols=248 Identities=28% Similarity=0.438 Sum_probs=211.4
Q ss_pred eEEEEEeccCCceEEEEEEECCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tG----k~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
|++.+.||.|+||.||++++..++ ..||+|+++... .......+..|+.++..++||||+++++.+.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 467789999999999999998766 899999986532 22256789999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 573 VMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~g~--Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
||||+++++|.+++..... +++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||+++.......
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976554 99999999999999999999999999999999999999999999999999875321000
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 729 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~e 729 (900)
+ ......+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||...+...
T Consensus 159 --------------------~------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~ 212 (258)
T smart00219 159 --------------------Y------KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE 212 (258)
T ss_pred --------------------c------ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 0 0001237889999999988889999999999999999998 899999988888
Q ss_pred HHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 730 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 730 i~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
+...+...... ..+...+.++.+++.+||..||.+||+ +.+++
T Consensus 213 ~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~ll 255 (258)
T smart00219 213 VLEYLKKGYRL--PKPENCPPEIYKLMLQCWAEDPEDRPT---FSELV 255 (258)
T ss_pred HHHHHhcCCCC--CCCCcCCHHHHHHHHHHCcCChhhCcC---HHHHH
Confidence 88877665432 234668999999999999999999999 55555
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=338.54 Aligned_cols=261 Identities=25% Similarity=0.380 Sum_probs=204.9
Q ss_pred EeccC--CceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 502 PISRG--AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 502 ~LGkG--~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
+||+| ++|.||+++.+.+|+.||+|+++... ........+.+|+.+++.++||||++++++|...+..|++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 34444 55667777777789999999997642 3445678899999999999999999999999999999999999999
Q ss_pred CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCC
Q 002616 580 GDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 657 (900)
Q Consensus 580 GsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~ 657 (900)
|+|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~------- 156 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGK------- 156 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccc-------
Confidence 9999999764 4589999999999999999999999999999999999999999999999998864311000
Q ss_pred CCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhh
Q 002616 658 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 735 (900)
Q Consensus 658 ~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl 735 (900)
.............++..|+|||++.+ ..|+.++|+|||||++|||++|..||.............
T Consensus 157 -------------~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~ 223 (314)
T cd08216 157 -------------RQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKV 223 (314)
T ss_pred -------------cccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 00001112234568889999999976 468899999999999999999999998765443322111
Q ss_pred cCCCC-------CC------------------------CCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 736 NRKIP-------WP------------------------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 736 ~~~l~-------~P------------------------~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
.+... +| ..+..++.++.+||.+||+.||.+||+ +.++++||||+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~ll~~p~~~~ 300 (314)
T cd08216 224 RGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS---ASQLLNHSFFKQ 300 (314)
T ss_pred hccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC---HHHHhcCchHhh
Confidence 11100 00 011234578899999999999999999 889999999986
Q ss_pred CC
Q 002616 785 VN 786 (900)
Q Consensus 785 id 786 (900)
+.
T Consensus 301 ~~ 302 (314)
T cd08216 301 CK 302 (314)
T ss_pred hc
Confidence 53
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=324.45 Aligned_cols=247 Identities=22% Similarity=0.386 Sum_probs=207.6
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
...+|++.+.||.|+||.||+|.+. .+..+|+|++++... ....+.+|+++++.++||||+++++++......|+
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence 3568999999999999999999886 477899998865332 23468889999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 573 VMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
||||+++|+|.+++... +.+++..++.++.+++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--- 153 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD--- 153 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccC---
Confidence 99999999999998764 46899999999999999999999999999999999999999999999999998742100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHH
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 730 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ei 730 (900)
.........++..|+|||.+.+..++.++|+||||+++|||++ |.+||.......+
T Consensus 154 -----------------------~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 210 (256)
T cd05112 154 -----------------------QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210 (256)
T ss_pred -----------------------cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence 0001122345678999999998889999999999999999998 9999998887777
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhc
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 772 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~ 772 (900)
...+..+...+ .+...+..+.+|+.+||+.+|++||++++
T Consensus 211 ~~~~~~~~~~~--~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~ 250 (256)
T cd05112 211 VETINAGFRLY--KPRLASQSVYELMQHCWKERPEDRPSFSL 250 (256)
T ss_pred HHHHhCCCCCC--CCCCCCHHHHHHHHHHcccChhhCCCHHH
Confidence 77765543222 23567899999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=343.52 Aligned_cols=256 Identities=33% Similarity=0.527 Sum_probs=210.2
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-CCeeE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RDNLY 571 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d-~~~Ly 571 (900)
..++|++.+.||.|+||.||+|.++.+|+.||+|++.+.. ........+.+|+.++..++||||++++++|.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 5678999999999999999999999999999999886532 233445678899999999999999999999876 56789
Q ss_pred EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
+||||+ +++|..++.. ..+++..+..++.|++.||.|||++||+||||||.|||++.++.+||+|||++....
T Consensus 87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~----- 159 (328)
T cd07856 87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD----- 159 (328)
T ss_pred EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC-----
Confidence 999998 5689888764 468889999999999999999999999999999999999999999999999986310
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei 730 (900)
.......+++.|+|||++.+ ..++.++|+|||||++|+|++|++||........
T Consensus 160 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~ 214 (328)
T cd07856 160 -------------------------PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQ 214 (328)
T ss_pred -------------------------CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 01123467899999999866 5789999999999999999999999987665333
Q ss_pred HHhhhc----------------------------CCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 731 FDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 731 ~~kIl~----------------------------~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
+..+.+ ...++....+.+++++.++|.+||+.+|++||+ +.+++.||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t---~~ell~~~~~ 291 (328)
T cd07856 215 FSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS---AAEALAHPYL 291 (328)
T ss_pred HHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC---HHHHhcCCcc
Confidence 222111 001111112357889999999999999999999 8899999999
Q ss_pred CC
Q 002616 783 KG 784 (900)
Q Consensus 783 k~ 784 (900)
..
T Consensus 292 ~~ 293 (328)
T cd07856 292 AP 293 (328)
T ss_pred cc
Confidence 63
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=328.22 Aligned_cols=250 Identities=22% Similarity=0.324 Sum_probs=196.6
Q ss_pred EEeccCCceEEEEEEECC--CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecC
Q 002616 501 KPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 578 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~--tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~ 578 (900)
+.||+|+||.||+|.+.. ++..+|+|.++... .......+.+|+.++..++||||+++++++.+...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 368999999999998653 45679999886533 22344578899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 579 GGDLYSLLRKVG-----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 579 GGsL~dlL~k~g-----~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
+|+|.+++.... .+++..++.++.|++.||+|||++|++||||||+||+++.++++||+|||+++......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~---- 154 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED---- 154 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc----
Confidence 999999997532 35667788899999999999999999999999999999999999999999986321000
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-------CCCccceeechhHHHHHHHh-CCCCCCCC
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-------EHGYAADWWSVGIILFEFIT-GIPPFTAE 725 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-------~ys~ksDIWSLGVILyEMLt-Gk~PF~~~ 725 (900)
.........|++.|+|||++.+. .++.++|+|||||++|||++ |.+||...
T Consensus 155 ---------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 155 ---------------------YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred ---------------------eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 00011235678999999998642 35789999999999999996 99999887
Q ss_pred ChHHHHHhhhcC-CC--CCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 726 SPEIIFDNILNR-KI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 726 s~~ei~~kIl~~-~l--~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
.+.+........ .. +.|.+....++.+.+++.+|+ .+|++||+++++...|.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 214 SDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred ChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 766654443322 22 223333467889999999999 58999999665555443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=344.31 Aligned_cols=259 Identities=28% Similarity=0.458 Sum_probs=208.9
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-------
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR------- 567 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~------- 567 (900)
.+|++.+.||.|+||.||+|.++.+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 68999999999999999999999999999999986543 24567788999999999999999999776654
Q ss_pred -------CeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecC-CCcEEEEec
Q 002616 568 -------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDF 639 (900)
Q Consensus 568 -------~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~-~G~VKLsDF 639 (900)
..+|+||||++ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df 159 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF 159 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence 35899999997 589888754 56999999999999999999999999999999999999984 567899999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhC
Q 002616 640 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG 718 (900)
Q Consensus 640 GLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtG 718 (900)
|+++.... .. .........+||+.|+|||++.+ ..++.++|+|||||++|+|++|
T Consensus 160 g~~~~~~~--~~----------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g 215 (342)
T cd07854 160 GLARIVDP--HY----------------------SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215 (342)
T ss_pred ccceecCC--cc----------------------ccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhC
Confidence 99874210 00 00001122368999999998765 5688899999999999999999
Q ss_pred CCCCCCCChHHHHHhhhcCC-------------------------CC--CCCCCCCCCHHHHHHHHHhccCCcCCCCChh
Q 002616 719 IPPFTAESPEIIFDNILNRK-------------------------IP--WPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 771 (900)
Q Consensus 719 k~PF~~~s~~ei~~kIl~~~-------------------------l~--~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~ 771 (900)
+.||...++.+....+.... .. .......++.++.+||.+||+.||.+||+
T Consensus 216 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-- 293 (342)
T cd07854 216 KPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT-- 293 (342)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC--
Confidence 99998877655544433210 00 00112357889999999999999999999
Q ss_pred cHHHHHcCCCCCCC
Q 002616 772 GAAEVKAHPFFKGV 785 (900)
Q Consensus 772 ~a~EIL~HPFFk~i 785 (900)
+.+++.||||+.+
T Consensus 294 -~~ell~h~~~~~~ 306 (342)
T cd07854 294 -AEEALMHPYMSCY 306 (342)
T ss_pred -HHHHhCCCccccc
Confidence 8899999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=338.66 Aligned_cols=255 Identities=27% Similarity=0.403 Sum_probs=215.1
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
..|+..+.||.|+||.||+|+++.++..+|+|.+.............+.+|+.+++.++|||++++++++......|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 44778899999999999999999999999999987543334455677889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 575 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 575 Ey~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
||+. |+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~------- 166 (308)
T cd06634 95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------- 166 (308)
T ss_pred EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeec-------
Confidence 9997 588777754 4468999999999999999999999999999999999999999999999999886421
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc---CCCCCccceeechhHHHHHHHhCCCCCCCCChHHH
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei 730 (900)
......|++.|+|||++. ...++.++|||||||++|+|++|..||...+..+.
T Consensus 167 ------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 222 (308)
T cd06634 167 ------------------------PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA 222 (308)
T ss_pred ------------------------CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH
Confidence 112346899999999985 34578899999999999999999999988776655
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
...+.....+.. .+..++..+.+||++||..+|.+||+ +.+++.||||...
T Consensus 223 ~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~---~~~ll~~~~~~~~ 273 (308)
T cd06634 223 LYHIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLRE 273 (308)
T ss_pred HHHHhhcCCCCc-CcccccHHHHHHHHHHhhCCcccCCC---HHHHhhCcccccc
Confidence 555544433221 23568899999999999999999999 8899999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=360.80 Aligned_cols=260 Identities=27% Similarity=0.471 Sum_probs=212.6
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCe
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 569 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~ 569 (900)
.+.-..|++++.||+||.++||+|...+ ...||+|.+.- .......+..+.+|+..|.+++ |.+||+||++-..++.
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~-~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~ 434 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVL-LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY 434 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHH-hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence 4556789999999999999999998764 45667665532 2345566889999999999997 9999999999999999
Q ss_pred eEEEEeecCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 570 LYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k~g~-Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
+||||||-+- ||..+|++... ++....++|..|++.|+.++|..||||.||||.|+|+- .|.+||+|||+|..+..+
T Consensus 435 lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 435 LYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred EEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 9999998754 99999987765 44468999999999999999999999999999999994 699999999999853211
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCC-----------CCccceeechhHHHHHHHh
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----------HGYAADWWSVGIILFEFIT 717 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-----------ys~ksDIWSLGVILyEMLt 717 (900)
. -.....+.+||+.||+||.+.... .+.++||||||||||+|+.
T Consensus 513 T-------------------------TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvY 567 (677)
T KOG0596|consen 513 T-------------------------TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVY 567 (677)
T ss_pred c-------------------------cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHh
Confidence 1 122345789999999999997543 3568999999999999999
Q ss_pred CCCCCCCCC-hHHHHHhhhcC--CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 718 GIPPFTAES-PEIIFDNILNR--KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 718 Gk~PF~~~s-~~ei~~kIl~~--~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
|++||.... ...-+..|..- .++||.++.. .++.++++.||.+||.+||+ +.++|+|||+..
T Consensus 568 gktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~s---i~eLLqhpFl~~ 632 (677)
T KOG0596|consen 568 GKTPFGQIINQIAKLHAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWS---IPELLQHPFLQI 632 (677)
T ss_pred cCCchHHHHHHHHHHHhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCC---cHHHhcCccccc
Confidence 999997653 33444455543 4577765543 34999999999999999999 889999999975
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=344.68 Aligned_cols=266 Identities=33% Similarity=0.525 Sum_probs=213.7
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccC--C
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCR--D 568 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~--~ 568 (900)
...++|++.+.||+|+||.||+|.+..+|+.+|+|.+.+.. ........+.+|+.++.++ +||||++++++|... .
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~ 82 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK 82 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence 34678999999999999999999999899999999886432 2233456678899999999 999999999988654 3
Q ss_pred eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~ 648 (900)
.+|+||||++ ++|..++.+. .+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 6899999997 4999988765 7889999999999999999999999999999999999999999999999998743210
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCCh
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 727 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~ 727 (900)
.. ..........+||+.|+|||++.+ ..++.++|+||||+++|+|++|++||.+...
T Consensus 161 ~~----------------------~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~ 218 (337)
T cd07852 161 EE----------------------NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTST 218 (337)
T ss_pred cc----------------------cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCCh
Confidence 00 000112233578999999998865 4578899999999999999999999987765
Q ss_pred HHHHHhhhcCC----------------------------CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcC
Q 002616 728 EIIFDNILNRK----------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 728 ~ei~~kIl~~~----------------------------l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~H 779 (900)
.+...++.... ..+....+.++.++.+||.+||+.||.+||+ +.++++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps---~~~il~~ 295 (337)
T cd07852 219 LNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT---AEEALEH 295 (337)
T ss_pred HHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccC---HHHHhhC
Confidence 54443332210 0111112347899999999999999999999 8899999
Q ss_pred CCCCCC
Q 002616 780 PFFKGV 785 (900)
Q Consensus 780 PFFk~i 785 (900)
|||+..
T Consensus 296 ~~~~~~ 301 (337)
T cd07852 296 PYVAQF 301 (337)
T ss_pred hhhhhh
Confidence 999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=328.78 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=211.0
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk----~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
+...+|++.+.||+|+||+||+|.++.+|. .+|+|.+++.. .......+.+|+.++..++||||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 345789999999999999999999887765 58999876543 24456778999999999999999999999887
Q ss_pred CeeEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
...++||||+++|+|.+++.+. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 7899999999999999999764 468999999999999999999999999999999999999999999999999987431
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 725 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~ 725 (900)
.... ........+++.|+|||.+....++.++|+|||||++|||++ |..||.+.
T Consensus 161 ~~~~-------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 215 (279)
T cd05057 161 VDEK-------------------------EYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI 215 (279)
T ss_pred Cccc-------------------------ceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 1000 000111234678999999988889999999999999999998 99999998
Q ss_pred ChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHH
Q 002616 726 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 774 (900)
Q Consensus 726 s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~ 774 (900)
...++...+..... ++ .+...+.++.+++.+||..||.+||++..+.
T Consensus 216 ~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~ 262 (279)
T cd05057 216 PAVEIPDLLEKGER-LP-QPPICTIDVYMVLVKCWMIDAESRPTFKELI 262 (279)
T ss_pred CHHHHHHHHhCCCC-CC-CCCCCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 88888777765432 22 2456789999999999999999999955433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=340.63 Aligned_cols=259 Identities=24% Similarity=0.354 Sum_probs=211.2
Q ss_pred cccccCCCeEEEEEeccCCceEEEEEEECCC-------CcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEE
Q 002616 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTT-------GDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRF 560 (900)
Q Consensus 489 ~~~~~~~dYeil~~LGkG~FG~Vyla~~k~t-------Gk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL 560 (900)
...+...+|++.+.||+|+||.||+|++... +..||+|+++.. ........+.+|+.++.++ +||||+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3345556899999999999999999987532 236899988642 2334567889999999999 79999999
Q ss_pred eeeeccCCeeEEEEeecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCC
Q 002616 561 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 624 (900)
Q Consensus 561 ~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g----------------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPe 624 (900)
+++|...+.+|+||||+++|+|.+++.+.. .++...+..++.|++.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999997532 3677788889999999999999999999999999
Q ss_pred cEEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccce
Q 002616 625 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 704 (900)
Q Consensus 625 NILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksD 704 (900)
|||++.++.+||+|||+++...... .........++..|+|||++.+..++.++|
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 218 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNID-------------------------YYKKTTNGRLPVKWMAPEALFDRVYTHQSD 218 (334)
T ss_pred eEEEcCCCcEEECCcccceeccccc-------------------------ccccccCCCcCceEcCHHHhccCCcCchhh
Confidence 9999999999999999987421100 000112233467899999999999999999
Q ss_pred eechhHHHHHHHh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcC
Q 002616 705 WWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 705 IWSLGVILyEMLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~H 779 (900)
||||||++|||++ |.+||.+.+..+.+..+..... +..+...+.++.+||.+||..+|.+||++ .+++.+
T Consensus 219 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~Rps~---~ell~~ 289 (334)
T cd05100 219 VWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR--MDKPANCTHELYMIMRECWHAVPSQRPTF---KQLVED 289 (334)
T ss_pred hHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--CCCCCCCCHHHHHHHHHHcccChhhCcCH---HHHHHH
Confidence 9999999999998 8999999888888777755432 22346788999999999999999999994 455543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.20 Aligned_cols=252 Identities=23% Similarity=0.365 Sum_probs=209.7
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
+..++|++.+.||+|+||.||+|... .+..+|+|.++.. ......+.+|+.+++.++|+||+++++.+.. ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 45678999999999999999999865 4567999988642 2245678899999999999999999999988 7789
Q ss_pred EEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
+||||+++|+|.+++.+. ..++...+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~- 155 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN- 155 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC-
Confidence 999999999999999763 35788889999999999999999999999999999999999999999999998742100
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChH
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 728 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ 728 (900)
.........++..|+|||++.+..++.++|+|||||++|+|++ |++||.+.+..
T Consensus 156 -------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~ 210 (260)
T cd05073 156 -------------------------EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 210 (260)
T ss_pred -------------------------CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH
Confidence 0001112346678999999998889999999999999999998 99999988877
Q ss_pred HHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 729 ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
.....+.... ..+ .+...+.++.+++.+||+.||++||+...+..+|
T Consensus 211 ~~~~~~~~~~-~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L 257 (260)
T cd05073 211 EVIRALERGY-RMP-RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257 (260)
T ss_pred HHHHHHhCCC-CCC-CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHH
Confidence 7776665432 222 3467889999999999999999999976665555
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=327.87 Aligned_cols=232 Identities=34% Similarity=0.542 Sum_probs=194.8
Q ss_pred CCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCChHHH
Q 002616 506 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL 585 (900)
Q Consensus 506 G~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GGsL~dl 585 (900)
|.||.||+|+++.+|+.||+|.+++.. .+.+|...+....||||+++++++...+..|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 899999999999999999999997632 123345555566799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCC
Q 002616 586 LRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 665 (900)
Q Consensus 586 L~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~ 665 (900)
+.+...+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++....
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~------------------- 136 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE------------------- 136 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccc-------------------
Confidence 9888889999999999999999999999999999999999999999999999999875321
Q ss_pred CCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCCCCCCCC
Q 002616 666 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVP 745 (900)
Q Consensus 666 ~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l~~P~ip 745 (900)
.......++..|+|||.+.+..++.++|+||+|+++|||++|+.||...... ... ..... +|
T Consensus 137 -----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~~~---~~~~~---~~ 198 (237)
T cd05576 137 -----------DSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-INT---HTTLN---IP 198 (237)
T ss_pred -----------cccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-ccc---ccccC---Cc
Confidence 0112345678899999998888999999999999999999999998643211 100 01112 34
Q ss_pred CCCCHHHHHHHHHhccCCcCCCCCh--hcHHHHHcCCCC
Q 002616 746 SDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFF 782 (900)
Q Consensus 746 ~~lS~eakDLIk~cL~~DP~kRpSa--~~a~EIL~HPFF 782 (900)
..+++.+++||.+||+.||.+||++ ..+.++++||||
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 6789999999999999999999995 346899999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=329.68 Aligned_cols=252 Identities=35% Similarity=0.530 Sum_probs=207.6
Q ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEe
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~LyLVmE 575 (900)
|++.+.||.|+||+||+|+...+++.||+|.+.+... ........+|+..+.+++ ||||+++++++...+..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999999999999999865322 122334557889999999 9999999999999999999999
Q ss_pred ecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 576 YLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 576 y~~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|+ +|+|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++....
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~------ 151 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS------ 151 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC------
Confidence 99 789999987764 789999999999999999999999999999999999999999999999999874210
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~ 732 (900)
........|+..|+|||++.+ ..++.++|+||||+++|||++|++||...+..+.+.
T Consensus 152 ----------------------~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~ 209 (283)
T cd07830 152 ----------------------RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY 209 (283)
T ss_pred ----------------------CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH
Confidence 011123468899999998854 557899999999999999999999998877665554
Q ss_pred hhhcC-------------------CCCCCC--------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 733 NILNR-------------------KIPWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 733 kIl~~-------------------~l~~P~--------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
++... ...++. .....+.++.+||++||+.||.+||+ +.+++.||||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt---~~ei~~~~~~ 283 (283)
T cd07830 210 KICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT---ASQALQHPYF 283 (283)
T ss_pred HHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC---HHHHhhCCCC
Confidence 43321 000010 11233688999999999999999999 7899999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=345.90 Aligned_cols=257 Identities=26% Similarity=0.377 Sum_probs=203.9
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeec
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFT 565 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k-----~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~ 565 (900)
...++|++.+.||+|+||+||+|++. .+++.||||+++... .......+.+|+.+|..+ +||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 45678999999999999999999853 467899999996532 234466788999999999 6899999998876
Q ss_pred cC-CeeEEEEeecCCCChHHHHHhc-------------------------------------------------------
Q 002616 566 CR-DNLYLVMEYLNGGDLYSLLRKV------------------------------------------------------- 589 (900)
Q Consensus 566 d~-~~LyLVmEy~~GGsL~dlL~k~------------------------------------------------------- 589 (900)
.. ..+|+||||+++|+|.+++...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 54 4689999999999999998642
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCC
Q 002616 590 ------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 657 (900)
Q Consensus 590 ------------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~ 657 (900)
..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~-------- 233 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDP-------- 233 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCc--------
Confidence 136777888899999999999999999999999999999999999999999987421100
Q ss_pred CCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHhhhc
Q 002616 658 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 736 (900)
Q Consensus 658 ~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ei~~kIl~ 736 (900)
.........+++.|+|||++.+..++.++||||||+++|+|++ |..||............+.
T Consensus 234 -----------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 296 (343)
T cd05103 234 -----------------DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 296 (343)
T ss_pred -----------------chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh
Confidence 0001122346778999999999999999999999999999997 9999987654433333333
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcC
Q 002616 737 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 737 ~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~H 779 (900)
.... +..+...++++.+++.+||+.||.+||+ +.+|++|
T Consensus 297 ~~~~-~~~~~~~~~~~~~~~~~cl~~~p~~Rps---~~eil~~ 335 (343)
T cd05103 297 EGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 335 (343)
T ss_pred ccCC-CCCCCCCCHHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 2222 2234567889999999999999999999 5555544
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=332.35 Aligned_cols=247 Identities=32% Similarity=0.503 Sum_probs=203.3
Q ss_pred EEEEEeccCCceEEEEEEEC----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 498 EIIKPISRGAFGRVFLARKR----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 498 eil~~LGkG~FG~Vyla~~k----~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
++.+.||.|+||.||+|.+. ..+..|+||+++. .......+.+.+|++++.+++||||+++++++...+.+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP--SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST--TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc--ccccccceeeeeccccccccccccccccccccccccccccc
Confidence 57789999999999999998 4456899999954 23344578899999999999999999999999988889999
Q ss_pred EeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 574 MEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 574 mEy~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
|||+++|+|.++|... ..+++.....++.||+.||.|||+++|+|++|+++|||++.++.+||+|||++......
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~--- 156 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK--- 156 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS---
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---
Confidence 9999999999999886 67999999999999999999999999999999999999999999999999998753100
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHH
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 730 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ei 730 (900)
..........+...|+|||.+.+..++.++||||||+++|||++ |+.||...+..++
T Consensus 157 ----------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~ 214 (259)
T PF07714_consen 157 ----------------------SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI 214 (259)
T ss_dssp ----------------------SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH
T ss_pred ----------------------cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 00012233456788999999998889999999999999999999 7899999988888
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcH
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 773 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a 773 (900)
..++..... +..+..++..+.++|..||..||.+||++.++
T Consensus 215 ~~~~~~~~~--~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i 255 (259)
T PF07714_consen 215 IEKLKQGQR--LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEI 255 (259)
T ss_dssp HHHHHTTEE--TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHH
T ss_pred ccccccccc--ceeccchhHHHHHHHHHHcCCChhhCcCHHHH
Confidence 888855433 22357889999999999999999999995443
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=362.60 Aligned_cols=261 Identities=29% Similarity=0.454 Sum_probs=225.5
Q ss_pred cccccCCCeEEEEEeccCCceEEEEEEECCCCc---E-EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 002616 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGD---L-FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 564 (900)
Q Consensus 489 ~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk---~-VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f 564 (900)
.+.+.-++..+.++||+|+||+||+|+.+..+. . ||+|..+......+.++..+++|.++|++++|||||++||+.
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345666777888999999999999999876433 3 899988754556778899999999999999999999999999
Q ss_pred ccCCeeEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcc
Q 002616 565 TCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643 (900)
Q Consensus 565 ~d~~~LyLVmEy~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk 643 (900)
.....+|+|||+|+||+|.++|++.+ .++..+...|+.+.+.||+|||++++|||||-.+|+|++.++.+||+||||++
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 99999999999999999999999887 49999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCC
Q 002616 644 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 722 (900)
Q Consensus 644 ~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF 722 (900)
... .+.. ......-...|+|||.+...-|++++|||||||++||+++ |..||
T Consensus 311 ~~~-----------------------~~~~----~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py 363 (474)
T KOG0194|consen 311 AGS-----------------------QYVM----KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPY 363 (474)
T ss_pred CCc-----------------------ceee----ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCC
Confidence 531 0000 0001124578999999999999999999999999999998 89999
Q ss_pred CCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 723 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 723 ~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
.+....++..+|....++.+ .|...+.++..++.+|+..||++||++..+...+
T Consensus 364 ~g~~~~~v~~kI~~~~~r~~-~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l 417 (474)
T KOG0194|consen 364 PGMKNYEVKAKIVKNGYRMP-IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKL 417 (474)
T ss_pred CCCCHHHHHHHHHhcCccCC-CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHH
Confidence 99999999999977766655 3578889999999999999999999966554443
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=325.39 Aligned_cols=246 Identities=25% Similarity=0.408 Sum_probs=206.2
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyL 572 (900)
..++|++.+.||+|+||.||++.. +++.||+|+++.. .....+.+|+.++..++||||+++++++... .+|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~-----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD-----VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCc-----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 457899999999999999999864 5889999988542 1345788999999999999999999998764 5799
Q ss_pred EEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 573 VMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 573 VmEy~~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
||||+++|+|.+++.... .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~--- 152 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM--- 152 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc---
Confidence 999999999999997654 478999999999999999999999999999999999999999999999999874210
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 729 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~e 729 (900)
......++..|+|||.+.+..++.++|+|||||++|||++ |++||...+..+
T Consensus 153 ---------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 205 (254)
T cd05083 153 ---------------------------GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE 205 (254)
T ss_pred ---------------------------cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence 0011234568999999998889999999999999999997 999999888877
Q ss_pred HHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 730 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 730 i~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
....+..+. ..+ .+..++.++.+||.+||+.+|.+||+++++.+.++
T Consensus 206 ~~~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 252 (254)
T cd05083 206 VKECVEKGY-RME-PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252 (254)
T ss_pred HHHHHhCCC-CCC-CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence 776665442 222 24678899999999999999999999665555443
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=328.98 Aligned_cols=253 Identities=26% Similarity=0.355 Sum_probs=198.7
Q ss_pred eEEEEEeccCCceEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--Cee
Q 002616 497 FEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--DNL 570 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~----k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~~L 570 (900)
|++++.||+|+||+||++.. ..++..||+|+++... .......+.+|+++|+.++||||+++++++... ..+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 38999999999999988753 3568899999986532 223456788999999999999999999987654 468
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
|+||||+++|+|.+++... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~- 161 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH- 161 (283)
T ss_pred EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc-
Confidence 9999999999999998764 59999999999999999999999999999999999999999999999999987431100
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH--
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE-- 728 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~-- 728 (900)
..........++..|+|||.+.+..++.++||||||+++|||++|..||......
T Consensus 162 -----------------------~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~ 218 (283)
T cd05080 162 -----------------------EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE 218 (283)
T ss_pred -----------------------hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh
Confidence 0000111234567799999999888999999999999999999999998654321
Q ss_pred HH------------HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 729 II------------FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 729 ei------------~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
+. .......... +..+..++.++.+|+.+||+.||.+||+++++.+.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l 278 (283)
T cd05080 219 EMIGPKQGQMTVVRLIELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278 (283)
T ss_pred hhhcccccccchhhhhhhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 10 0111111111 123467889999999999999999999966555444
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=354.23 Aligned_cols=260 Identities=24% Similarity=0.344 Sum_probs=211.3
Q ss_pred ccccCCCeEEEEEeccCCceEEEEEEEC-----CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeee
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYS 563 (900)
Q Consensus 490 ~~~~~~dYeil~~LGkG~FG~Vyla~~k-----~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~ 563 (900)
..+..++|.+.+.||+|+||.||+|++. .+++.||+|+++... .....+.+.+|+.+|..+. |||||+++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 4567788999999999999999999964 345689999997532 2334567899999999998 9999999999
Q ss_pred eccCCeeEEEEeecCCCChHHHHHhcC-----------------------------------------------------
Q 002616 564 FTCRDNLYLVMEYLNGGDLYSLLRKVG----------------------------------------------------- 590 (900)
Q Consensus 564 f~d~~~LyLVmEy~~GGsL~dlL~k~g----------------------------------------------------- 590 (900)
+.....+|+||||+++|+|.+++++.+
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999996532
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCc
Q 002616 591 ---------------------------------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDN 625 (900)
Q Consensus 591 ---------------------------------------------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeN 625 (900)
.++...+..++.||+.||+|||++||+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 25666778899999999999999999999999999
Q ss_pred EEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCcccee
Q 002616 626 LLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 705 (900)
Q Consensus 626 ILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDI 705 (900)
||++.++.+||+|||+++...... .........|++.|||||++.+..++.++||
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~-------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 324 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDS-------------------------NYISKGSTFLPLKWMAPESIFNNLYTTLSDV 324 (401)
T ss_pred EEEeCCCEEEEEecCcceeccccc-------------------------ccccCCCcCCCCceeChHHhcCCCCCcHhHH
Confidence 999999999999999987421100 0011223467899999999998889999999
Q ss_pred echhHHHHHHHh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 706 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 706 WSLGVILyEMLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
|||||++|||++ |..||......+.....+....+. ..|..++.++.+||.+||..+|.+||++.++...|
T Consensus 325 wslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L 396 (401)
T cd05107 325 WSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM-AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396 (401)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC-CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHH
Confidence 999999999998 899998766555544444443332 24567899999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=397.25 Aligned_cols=259 Identities=36% Similarity=0.589 Sum_probs=222.0
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+++-...||.|.||.||-|.+.+||...|+|-++-.... ......+.+|..+|..++|||+|++|++-...+.+||.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 345566899999999999999999999999988654433 5567788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCC
Q 002616 576 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 576 y~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
||.||+|.+++...+..++...+.|..|++.|++|||+.|||||||||+||+|+.+|.+|++|||.|+... ++.-++
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~-~~~~~~-- 1391 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK-NNAQTM-- 1391 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEec-CchhcC--
Confidence 99999999999988889999999999999999999999999999999999999999999999999998532 111011
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC---CCCCccceeechhHHHHHHHhCCCCCCCCChH-HHH
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESPE-IIF 731 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~-ei~ 731 (900)
.......+|||.|||||++.+ ++.+.++|||||||++.||+||+.||...+.. .++
T Consensus 1392 --------------------~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIM 1451 (1509)
T KOG4645|consen 1392 --------------------PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIM 1451 (1509)
T ss_pred --------------------CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHH
Confidence 122346789999999999986 46788999999999999999999999876544 344
Q ss_pred HhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCC
Q 002616 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 732 ~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk 783 (900)
-++..+.. |.+|..+|++.+|||.+||..||++|++ +.+|++|.|=+
T Consensus 1452 y~V~~gh~--Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~---~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1452 YHVAAGHK--PQIPERLSSEGRDFLEHCLEQDPKMRWT---ASQLLEHAFGK 1498 (1509)
T ss_pred hHHhccCC--CCCchhhhHhHHHHHHHHHhcCchhhhH---HHHHHHhhccc
Confidence 44444432 5667889999999999999999999998 77999998865
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=327.91 Aligned_cols=257 Identities=20% Similarity=0.314 Sum_probs=212.1
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRT----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC- 566 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~----tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d- 566 (900)
+..++|++.+.||+|+||.||+|.+.. ++..||+|.++.. ........+.+|..+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 456789999999999999999999876 3578999988642 344567889999999999999999999997655
Q ss_pred CCeeEEEEeecCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEe
Q 002616 567 RDNLYLVMEYLNGGDLYSLLRKV--------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTD 638 (900)
Q Consensus 567 ~~~LyLVmEy~~GGsL~dlL~k~--------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsD 638 (900)
....+++++|+++|+|.+++... ..+++..+..++.|++.||+|||+++++||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 56789999999999999998753 3588999999999999999999999999999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-
Q 002616 639 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT- 717 (900)
Q Consensus 639 FGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt- 717 (900)
||+++....... ........++..|+|||++.+..++.++|||||||++|||++
T Consensus 161 ~g~~~~~~~~~~-------------------------~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~ 215 (280)
T cd05043 161 NALSRDLFPMDY-------------------------HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTL 215 (280)
T ss_pred CCCcccccCCce-------------------------EEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcC
Confidence 999874311000 000112345778999999999899999999999999999999
Q ss_pred CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 718 GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 718 Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
|++||...++.++...+..+ ..++ .+..+++++.+++.+||..||++||++.++.+.|
T Consensus 216 g~~p~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l 273 (280)
T cd05043 216 GQTPYVEIDPFEMAAYLKDG-YRLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273 (280)
T ss_pred CCCCcCcCCHHHHHHHHHcC-CCCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 99999988887777665543 2222 2456789999999999999999999966555544
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=321.04 Aligned_cols=243 Identities=26% Similarity=0.354 Sum_probs=203.3
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 580 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GG 580 (900)
++||.|+||.||+|.+.. ++.||+|+++.... ......+.+|+++++.++||||+++++++......|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 469999999999999987 99999998865432 245678999999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 581 DLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 581 sL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
+|.+++.+. ..+++..+..++.+++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~---------- 147 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI---------- 147 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCc----------
Confidence 999999763 468889999999999999999999999999999999999999999999999987421000
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHhhhcCC
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 738 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ei~~kIl~~~ 738 (900)
+ ........++..|+|||.+.+..++.++|+|||||++|||++ |..||...........+....
T Consensus 148 -----------~----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~ 212 (251)
T cd05041 148 -----------Y----TVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY 212 (251)
T ss_pred -----------c----eeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC
Confidence 0 000112234677999999998899999999999999999999 899998888777666665432
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcH
Q 002616 739 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 773 (900)
Q Consensus 739 l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a 773 (900)
..+ .+..++.++.+||.+||+.+|.+||++.++
T Consensus 213 -~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~el 245 (251)
T cd05041 213 -RMP-APQLCPEEIYRLMLQCWAYDPENRPSFSEI 245 (251)
T ss_pred -CCC-CCccCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 212 346788999999999999999999994433
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=325.21 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=207.6
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~t---Gk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~ 568 (900)
+..++|.+.+.||+|+||.||+|.+... ...||+|...... .....+.+.+|+.+++.++||||+++++++.+ .
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 3456799999999999999999997654 3468999875432 23456789999999999999999999998876 4
Q ss_pred eeEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~ 647 (900)
..|+||||+++|+|.+++.+.. .+++..+..++.+++.||+|||+.|++||||||+|||++.++.+||+|||+++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 5789999999999999997644 589999999999999999999999999999999999999999999999999874311
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCC
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 726 (900)
Q Consensus 648 ~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s 726 (900)
.. ........+++.|+|||.+.+..++.++|+|||||++|||++ |..||...+
T Consensus 160 ~~--------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 160 ES--------------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred cc--------------------------ceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 00 001112235678999999988889999999999999999996 999999888
Q ss_pred hHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHH
Q 002616 727 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 774 (900)
Q Consensus 727 ~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~ 774 (900)
..+....+..+.. +..+..++.++.+||.+||..+|.+||++.++.
T Consensus 214 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~ 259 (270)
T cd05056 214 NNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELK 259 (270)
T ss_pred HHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 7777766655432 123478899999999999999999999954433
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=320.17 Aligned_cols=243 Identities=25% Similarity=0.363 Sum_probs=201.9
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 580 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GG 580 (900)
++||+|+||.||+|... ++..||+|+++... .......+.+|+.++..++||||+++++.+...+..|+||||+++|
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999865 68899999886532 2334557889999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCC
Q 002616 581 DLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659 (900)
Q Consensus 581 sL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~ 659 (900)
+|.+++... ..+++..+..++.+++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~----------- 146 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDG----------- 146 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccc-----------
Confidence 999998753 45889999999999999999999999999999999999999999999999998632100
Q ss_pred CCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHhhhcCC
Q 002616 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRK 738 (900)
Q Consensus 660 ~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ei~~kIl~~~ 738 (900)
. ........+++.|+|||++.+..++.++|+||||+++|+|++ |..||...........+....
T Consensus 147 -~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~ 211 (250)
T cd05085 147 -I--------------YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY 211 (250)
T ss_pred -c--------------cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC
Confidence 0 000112234678999999998889999999999999999998 999999888777766665432
Q ss_pred CCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHH
Q 002616 739 IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 774 (900)
Q Consensus 739 l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~ 774 (900)
. +..+..++.++.+|+.+||..+|++||++.++.
T Consensus 212 -~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~ 245 (250)
T cd05085 212 -R-MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQ 245 (250)
T ss_pred -C-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHH
Confidence 1 223467899999999999999999999955443
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=326.71 Aligned_cols=249 Identities=24% Similarity=0.397 Sum_probs=204.7
Q ss_pred EEeccCCceEEEEEEECCCC------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 501 KPISRGAFGRVFLARKRTTG------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tG------k~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
+.||+|+||.||+|+++..+ ..||+|.+.+.. .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36999999999999987544 689999886532 2234567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCC-----cEEEEecCCc
Q 002616 575 EYLNGGDLYSLLRKV-------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-----HIKLTDFGLS 642 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~-------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G-----~VKLsDFGLA 642 (900)
||+++|+|.+++.+. ..+++..+..++.|++.||.|||+++++|+||||+|||++.++ .+||+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999743 2478888999999999999999999999999999999999888 8999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCC
Q 002616 643 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 721 (900)
Q Consensus 643 k~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~P 721 (900)
+....... ........++..|+|||++.+..++.++|||||||++|||++ |..|
T Consensus 159 ~~~~~~~~-------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p 213 (269)
T cd05044 159 RDIYKSDY-------------------------YRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213 (269)
T ss_pred cccccccc-------------------------cccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCC
Confidence 74211000 001122356789999999999899999999999999999998 9999
Q ss_pred CCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 722 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 722 F~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
|...+..+....+..... +..+..++..+.+||.+||..+|.+||+++++.+.|+
T Consensus 214 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 214 YPALNNQEVLQHVTAGGR--LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred CcccCHHHHHHHHhcCCc--cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 998887777776654332 1234678899999999999999999999666655543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-39 Score=365.41 Aligned_cols=244 Identities=36% Similarity=0.569 Sum_probs=212.9
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCeeE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~Ly 571 (900)
..++|++...+|.|+|+.|..+.+..+++.+++|++.+.. ....+|+.++... +||||+++++.+.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence 5678999999999999999999999999999999997742 2234466665554 6999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEe-cCCCcEEEEecCCccccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILL-d~~G~VKLsDFGLAk~~~~~~s 650 (900)
+|||++.||.|.+.+.....+. ..+..|+++|+.|+.|||.+|||||||||+|||+ ++.|+++|+|||+++...
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~---- 467 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE---- 467 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCc----
Confidence 9999999999999888776666 7888999999999999999999999999999999 699999999999988421
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChH-H
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE-I 729 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~-e 729 (900)
....+.|-|..|.|||++...+|+.+|||||||++||+||+|+.||...... +
T Consensus 468 --------------------------~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e 521 (612)
T KOG0603|consen 468 --------------------------RSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE 521 (612)
T ss_pred --------------------------hhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH
Confidence 1134567899999999999999999999999999999999999999876555 6
Q ss_pred HHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 730 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 730 i~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
+..+|..+.. ...+|++++|||++||+.||.+||+ +.+++.||||
T Consensus 522 i~~~i~~~~~-----s~~vS~~AKdLl~~LL~~dP~~Rl~---~~~i~~h~w~ 566 (612)
T KOG0603|consen 522 IHTRIQMPKF-----SECVSDEAKDLLQQLLQVDPALRLG---ADEIGAHPWF 566 (612)
T ss_pred HHHhhcCCcc-----ccccCHHHHHHHHHhccCChhhCcC---hhhhccCcch
Confidence 6666644433 2789999999999999999999999 7799999999
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=361.99 Aligned_cols=251 Identities=28% Similarity=0.437 Sum_probs=222.1
Q ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 576 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy 576 (900)
|.-++.||.|+||.||.+++..+.+.||||.+.-...........++.|+..|.+++|||+|.+-+||.-+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 66678999999999999999999999999998765555566778999999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCC
Q 002616 577 LNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 577 ~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
|-| +-.+++.-+ .++-+..+..+..+.+.||+|||+.+.||||||..||||.+.|.|||+|||.|...
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~---------- 176 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM---------- 176 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc----------
Confidence 965 777777543 46888999999999999999999999999999999999999999999999988642
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC---CCCCccceeechhHHHHHHHhCCCCCCCCChHHHHH
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~ 732 (900)
..+++++|||.||||||++. +.|+-++||||||++..||.-.+||+...+.+...-
T Consensus 177 ---------------------~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY 235 (948)
T KOG0577|consen 177 ---------------------APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 235 (948)
T ss_pred ---------------------CchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH
Confidence 24678999999999999974 578999999999999999999999999888887777
Q ss_pred hhhcCCCC-CCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 733 NILNRKIP-WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 733 kIl~~~l~-~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
-|..+..+ .+ .+.+|..+..||..||++-|.+||| .+++|.|+|...
T Consensus 236 HIAQNesPtLq--s~eWS~~F~~Fvd~CLqKipqeRpt---se~ll~H~fv~R 283 (948)
T KOG0577|consen 236 HIAQNESPTLQ--SNEWSDYFRNFVDSCLQKIPQERPT---SEELLKHRFVLR 283 (948)
T ss_pred HHHhcCCCCCC--CchhHHHHHHHHHHHHhhCcccCCc---HHHHhhcchhcc
Confidence 77665432 23 3678999999999999999999999 889999999853
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=329.78 Aligned_cols=236 Identities=24% Similarity=0.392 Sum_probs=193.6
Q ss_pred EeccCCceEEEEEEECCCCcE-------EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 502 PISRGAFGRVFLARKRTTGDL-------FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 502 ~LGkG~FG~Vyla~~k~tGk~-------VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
.||+|+||.||+|.++.++.. ||+|.+.+. .....+.+.+|..++..++||||+++++++...+..++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 699999999999998765543 888877542 2344567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCc--------EEEEecCCcccc
Q 002616 575 EYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--------IKLTDFGLSKIG 645 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~--------VKLsDFGLAk~~ 645 (900)
||+++|+|..++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. +|++|||++...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 9999999999997654 5899999999999999999999999999999999999988765 689999987531
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhC-CCCCC
Q 002616 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITG-IPPFT 723 (900)
Q Consensus 646 ~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtG-k~PF~ 723 (900)
. ......|++.|+|||++.+ ..++.++|||||||++|||++| .+||.
T Consensus 159 ~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~ 207 (258)
T cd05078 159 L-------------------------------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS 207 (258)
T ss_pred C-------------------------------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChh
Confidence 1 1123568899999999986 4579999999999999999998 57777
Q ss_pred CCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 724 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 724 ~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
..++..... +......+| ...+.++.+||.+||+.||.+||+ +.+|++
T Consensus 208 ~~~~~~~~~-~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps---~~~il~ 255 (258)
T cd05078 208 ALDSQKKLQ-FYEDRHQLP---APKWTELANLINQCMDYEPDFRPS---FRAIIR 255 (258)
T ss_pred hccHHHHHH-HHHccccCC---CCCcHHHHHHHHHHhccChhhCCC---HHHHHH
Confidence 666554433 233333333 567789999999999999999999 555553
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=325.27 Aligned_cols=255 Identities=28% Similarity=0.419 Sum_probs=200.1
Q ss_pred CCCeEEEEEeccCCceEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--C
Q 002616 494 IDDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--R 567 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~----k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d--~ 567 (900)
..+|++++.||+|+||.||+|.. ..++..||+|.+... .....+.+.+|+.++..++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 35799999999999999999984 457889999998643 24456788999999999999999999987644 3
Q ss_pred CeeEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
..+|+||||+++|+|.+++.+. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 4689999999999999999764 468999999999999999999999999999999999999999999999999987431
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
.... .........++..|+|||++.+..++.++|||||||++|||++|..|+....
T Consensus 160 ~~~~------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~ 215 (284)
T cd05081 160 QDKE------------------------YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPP 215 (284)
T ss_pred CCCc------------------------ceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcc
Confidence 1000 0000111234556999999998899999999999999999999887764332
Q ss_pred hHH---------------HHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHH
Q 002616 727 PEI---------------IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 776 (900)
Q Consensus 727 ~~e---------------i~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EI 776 (900)
... ....++.....++ .+..++.++.+||.+||..+|++||++.++...
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 216 AEFMRMMGNDKQGQMIVYHLIELLKNNGRLP-APPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred hhhhhhcccccccccchHHHHHHHhcCCcCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 110 0111222222222 346788999999999999999999995544433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=322.80 Aligned_cols=250 Identities=22% Similarity=0.293 Sum_probs=199.1
Q ss_pred EEeccCCceEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeec-cCCeeEEEEee
Q 002616 501 KPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT-CRDNLYLVMEY 576 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~---tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~-d~~~LyLVmEy 576 (900)
+.||+|+||.||+|.+.. .+..||+|.+... ........+.+|+.+++.++||||+++++.+. .++..|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998754 3457999987542 23445678889999999999999999999765 45568999999
Q ss_pred cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCC
Q 002616 577 LNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 577 ~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
+++|+|.+++.+. ..++...+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~----- 153 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY----- 153 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc-----
Confidence 9999999999764 3467777888999999999999999999999999999999999999999999874211000
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHHHHHhh
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 734 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ei~~kI 734 (900)
..........+++.|+|||.+.+..++.++|||||||++|||++ |.+||...+..++...+
T Consensus 154 ------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~ 215 (262)
T cd05058 154 ------------------YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL 215 (262)
T ss_pred ------------------eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 00001123356788999999998899999999999999999999 57888888777777666
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 735 l~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
..+.. +..+..++..+.+++.+||..+|++||++.++...+
T Consensus 216 ~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l 256 (262)
T cd05058 216 LQGRR--LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRI 256 (262)
T ss_pred hcCCC--CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHH
Confidence 55432 223456789999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=327.00 Aligned_cols=250 Identities=25% Similarity=0.366 Sum_probs=199.1
Q ss_pred CCeEEEEEeccCCceEEEEEEE----CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC--C
Q 002616 495 DDFEIIKPISRGAFGRVFLARK----RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR--D 568 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~----k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~--~ 568 (900)
.-|++++.||+|+||.||+|+. +.++..||+|.++... .......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 3478999999999999999985 4568899999986432 234457799999999999999999999988875 5
Q ss_pred eeEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~ 647 (900)
.+|+||||++||+|.+++.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 6899999999999999997653 589999999999999999999999999999999999999999999999999874210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC-
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES- 726 (900)
Q Consensus 648 ~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s- 726 (900)
.. ..........|+..|+|||++.+..++.++|+|||||++|||+++..|+....
T Consensus 162 ~~------------------------~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~ 217 (284)
T cd05079 162 DK------------------------EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217 (284)
T ss_pred Cc------------------------cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc
Confidence 00 00011123557888999999998889999999999999999999877653211
Q ss_pred -------------hHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChh
Q 002616 727 -------------PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 771 (900)
Q Consensus 727 -------------~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~ 771 (900)
...............+ .+..++..+.+||.+||+.||.+||+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 274 (284)
T cd05079 218 LFLKMIGPTHGQMTVTRLVRVLEEGKRLP-RPPNCPEEVYQLMRKCWEFQPSKRTTFQ 274 (284)
T ss_pred hhhhhcccccccccHHHHHHHHHcCccCC-CCCCCCHHHHHHHHHHccCCcccCcCHH
Confidence 0111111222222222 3467899999999999999999999944
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=362.71 Aligned_cols=253 Identities=26% Similarity=0.480 Sum_probs=219.0
Q ss_pred EEEEEeccCCceEEEEEEECCCCcEEEEEEeeccc-ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe--eEEEE
Q 002616 498 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD-MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN--LYLVM 574 (900)
Q Consensus 498 eil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~-~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~--LyLVm 574 (900)
+.-.+||+|+|-+||+|.+..+|..||--.++-.+ .......++|..|+.+|+.|+|||||++|+++.+..+ +.+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 44568999999999999999999988855443222 2345567999999999999999999999999998876 88999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcC--eEeccCCCCcEEecC-CCcEEEEecCCcccccccccc
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~g--IIHRDLKPeNILLd~-~G~VKLsDFGLAk~~~~~~s~ 651 (900)
|++..|+|..|+++++.++...++.|++||+.||.|||++. |||||||.+||+|+. -|.|||+|+|||+...
T Consensus 123 EL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r----- 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR----- 197 (632)
T ss_pred ecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh-----
Confidence 99999999999999999999999999999999999999985 999999999999975 5899999999998632
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCC-CChHHH
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEII 730 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~-~s~~ei 730 (900)
...+.+.+|||.|||||++. ..|+..+||||||++|.||+|+..||.. .++.++
T Consensus 198 ------------------------~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI 252 (632)
T KOG0584|consen 198 ------------------------KSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI 252 (632)
T ss_pred ------------------------ccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH
Confidence 22345589999999999987 7899999999999999999999999964 678999
Q ss_pred HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
|+++..+..+-. +..--.+++++||.+||.. ...||+ |.|+|.||||..-
T Consensus 253 YKKV~SGiKP~s-l~kV~dPevr~fIekCl~~-~~~R~s---a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 253 YKKVTSGIKPAA-LSKVKDPEVREFIEKCLAT-KSERLS---AKELLKDPFFDED 302 (632)
T ss_pred HHHHHcCCCHHH-hhccCCHHHHHHHHHHhcC-chhccC---HHHHhhChhhccc
Confidence 999988765321 1223368999999999997 999999 8899999999753
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=321.09 Aligned_cols=251 Identities=31% Similarity=0.509 Sum_probs=209.0
Q ss_pred CeEEEEEeccCCceEEEEEEECC-CCcEEEEEEeecccc-------cchhHHHHHHHHHHHHHh-cCCCceEEEeeeecc
Q 002616 496 DFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDM-------IRKNDIERILAERNILIT-VRNPFVVRFFYSFTC 566 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~-tGk~VAIKiLkK~~~-------~~~~~~e~~l~Ei~IL~~-L~HPnIVkL~~~f~d 566 (900)
+|++.+.||+|+||.||+|.++. +++.+|+|.+..... ........+.+|+.++.+ ++||||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999987 688999998864221 223445667888888865 789999999999999
Q ss_pred CCeeEEEEeecCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHhhhh-cCeEeccCCCCcEEecCCCcEEEEecCC
Q 002616 567 RDNLYLVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGL 641 (900)
Q Consensus 567 ~~~LyLVmEy~~GGsL~dlL~k----~g~Lse~~ar~ya~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~G~VKLsDFGL 641 (900)
.+..|+||||++|++|.+++.. ...+++..+..++.|++.||.|||+ .|++|+||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3468999999999999999999996 7899999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCC
Q 002616 642 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 721 (900)
Q Consensus 642 Ak~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~P 721 (900)
+..... ........|+..|+|||++.+..++.++|+||||+++|||++|.+|
T Consensus 161 ~~~~~~----------------------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p 212 (269)
T cd08528 161 AKQKQP----------------------------ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP 212 (269)
T ss_pred eeeccc----------------------------ccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCc
Confidence 874210 0022345689999999999988899999999999999999999999
Q ss_pred CCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHH
Q 002616 722 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 775 (900)
Q Consensus 722 F~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~E 775 (900)
|...+.......+...... |.....+++++.+||.+||..||.+||++.++.+
T Consensus 213 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 213 FYSTNMLSLATKIVEAVYE-PLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred ccccCHHHHHHHHhhccCC-cCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 9888777777666654433 2222467899999999999999999999554433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=370.69 Aligned_cols=263 Identities=25% Similarity=0.400 Sum_probs=225.6
Q ss_pred ccccccCCCeEEEEEeccCCceEEEEEEECC-----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEee
Q 002616 488 HKERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562 (900)
Q Consensus 488 ~~~~~~~~dYeil~~LGkG~FG~Vyla~~k~-----tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~ 562 (900)
....+...+.+..+.||+|+||+||+|+... ....||||.++... ..+...+|++|+++|..++|||||+|+|
T Consensus 479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlG 556 (774)
T KOG1026|consen 479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLG 556 (774)
T ss_pred ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEE
Confidence 3445677888899999999999999998642 33579999997643 3446789999999999999999999999
Q ss_pred eeccCCeeEEEEeecCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEe
Q 002616 563 SFTCRDNLYLVMEYLNGGDLYSLLRKVG--------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 628 (900)
Q Consensus 563 ~f~d~~~LyLVmEy~~GGsL~dlL~k~g--------------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILL 628 (900)
.|..++.+|||+|||..|||..+|+... .++..+...++.||+.||+||-++.+|||||-..|+||
T Consensus 557 VC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV 636 (774)
T KOG1026|consen 557 VCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV 636 (774)
T ss_pred EEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee
Confidence 9999999999999999999999997432 27888999999999999999999999999999999999
Q ss_pred cCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeech
Q 002616 629 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 708 (900)
Q Consensus 629 d~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSL 708 (900)
.++..|||+||||++..... +|-+ ......-..+||+||.++..+|+.++|||||
T Consensus 637 ge~l~VKIsDfGLsRdiYss---------------------DYYk----~~~~t~lPIRWMppEsIly~kFTteSDVWs~ 691 (774)
T KOG1026|consen 637 GENLVVKISDFGLSRDIYSS---------------------DYYK----VRGNTLLPIRWMPPESILYGKFTTESDVWSF 691 (774)
T ss_pred ccceEEEecccccchhhhhh---------------------hhhc----ccCCceeeeecCCHHHhhcCcccchhhhhhh
Confidence 99999999999999853211 1111 0111234678999999999999999999999
Q ss_pred hHHHHHHHh-CCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcC
Q 002616 709 GIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 709 GVILyEMLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~H 779 (900)
||+|||+++ |+.||.+.+.+++.+.|..+++ ++ .|...|.++.+|+..||+.+|.+||++.++.-+|++
T Consensus 692 GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~-~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~ 761 (774)
T KOG1026|consen 692 GVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LS-CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQA 761 (774)
T ss_pred hhhhhhhhccccCcccccchHHHHHHHHcCCc-cc-CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHH
Confidence 999999998 9999999999999999999887 55 478999999999999999999999997766666643
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=323.74 Aligned_cols=238 Identities=22% Similarity=0.281 Sum_probs=192.2
Q ss_pred EEeccCCceEEEEEEECCC------------CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 002616 501 KPISRGAFGRVFLARKRTT------------GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~t------------Gk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~ 568 (900)
+.||+|+||.||+|.+... ...+|+|++... .......+.+|+.++..++||||+++++++....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3689999999999986432 235888887542 2334567888999999999999999999999999
Q ss_pred eeEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCc-------EEEEecC
Q 002616 569 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH-------IKLTDFG 640 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~-------VKLsDFG 640 (900)
..++||||+++|+|..++.+. +.+++..+..++.||+.||.|||++||+||||||+|||++.++. +|++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 999999999999999888754 56899999999999999999999999999999999999987664 8999999
Q ss_pred CcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc-CCCCCccceeechhHHHHHHH-hC
Q 002616 641 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFI-TG 718 (900)
Q Consensus 641 LAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-g~~ys~ksDIWSLGVILyEML-tG 718 (900)
++.... ......||+.|+|||++. +..++.++|||||||++|||+ .|
T Consensus 158 ~~~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~ 206 (262)
T cd05077 158 IPITVL-------------------------------SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNG 206 (262)
T ss_pred CCcccc-------------------------------CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 886321 112346889999999987 467899999999999999998 58
Q ss_pred CCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcC
Q 002616 719 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 719 k~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~H 779 (900)
.+||......+... +........ ...++++.+||.+||+.||.+||+ ..+|+.+
T Consensus 207 ~~p~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~li~~cl~~dp~~Rp~---~~~il~~ 260 (262)
T cd05077 207 EIPLKDKTLAEKER-FYEGQCMLV---TPSCKELADLMTHCMNYDPNQRPF---FRAIMRD 260 (262)
T ss_pred CCCCCCcchhHHHH-HHhcCccCC---CCChHHHHHHHHHHcCCChhhCcC---HHHHHHh
Confidence 99998766544432 223322222 345688999999999999999999 5566543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=329.81 Aligned_cols=252 Identities=21% Similarity=0.336 Sum_probs=205.3
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk----~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
+..++|+..+.||+|+||.||+|++..+|. .+|+|.+.... .......+.+|+.++..++||||+++++.+...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 456789999999999999999999988776 46888775432 233345688999999999999999999998764
Q ss_pred CeeEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
..++|+||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 5789999999999999987654 58999999999999999999999999999999999999999999999999987421
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 725 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~ 725 (900)
... .........+++.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 161 ~~~-------------------------~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 161 GDE-------------------------KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred Ccc-------------------------cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 000 0011122446789999999999999999999999999999997 99999887
Q ss_pred ChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcH
Q 002616 726 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 773 (900)
Q Consensus 726 s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a 773 (900)
........+.. ...++ .+...+..+.+++.+||..||++||++.++
T Consensus 216 ~~~~~~~~~~~-~~~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l 261 (303)
T cd05110 216 PTREIPDLLEK-GERLP-QPPICTIDVYMVMVKCWMIDADSRPKFKEL 261 (303)
T ss_pred CHHHHHHHHHC-CCCCC-CCCCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence 76655544433 32323 245678899999999999999999995443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=356.64 Aligned_cols=258 Identities=19% Similarity=0.339 Sum_probs=214.6
Q ss_pred ccccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 488 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 488 ~~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
..+.+..+++.+...||+|.||+||+|+|-. .||||+++... ....+.+.|++|+.++++-+|-||+-+.|++..+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~-pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDD-PTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCC-CCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 4556788899999999999999999999973 49999997654 4556899999999999999999999999999888
Q ss_pred CeeEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
.. .||+.+|.|-+|+.+|+-. ..|.....+.|++||++||.|||.++|||||||..||+|.+++.|||+||||+..-.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 76 9999999999999999743 469999999999999999999999999999999999999999999999999987411
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC---CCCCccceeechhHHHHHHHhCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFT 723 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~ksDIWSLGVILyEMLtGk~PF~ 723 (900)
.| .........-|...|||||++.. .+|++.+||||||+++|||++|..||.
T Consensus 540 -----------------------~w--~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys 594 (678)
T KOG0193|consen 540 -----------------------RW--SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS 594 (678)
T ss_pred -----------------------ee--ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence 01 12223344568899999999974 478999999999999999999999999
Q ss_pred CCChHHHHHhhhcCCC--CCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHH
Q 002616 724 AESPEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 775 (900)
Q Consensus 724 ~~s~~ei~~kIl~~~l--~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~E 775 (900)
..+.+.+.-.+-.+.+ +...+-...+.++++|+..||.+++++||.+.++..
T Consensus 595 i~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 595 IQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred CCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 6666665544433322 112233567789999999999999999999654444
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=318.09 Aligned_cols=232 Identities=24% Similarity=0.317 Sum_probs=191.2
Q ss_pred EEeccCCceEEEEEEECCCC----------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCee
Q 002616 501 KPISRGAFGRVFLARKRTTG----------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 570 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tG----------k~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~L 570 (900)
+.||+|+||.||+|.+..++ ..+++|++.... .....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36999999999999998777 347778765422 126788899999999999999999999888 778
Q ss_pred EEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCC-------cEEEEecCCc
Q 002616 571 YLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-------HIKLTDFGLS 642 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G-------~VKLsDFGLA 642 (900)
|+||||+++|+|.+++.... .++...+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998766 789999999999999999999999999999999999999888 8999999998
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC--CCCccceeechhHHHHHHHh-CC
Q 002616 643 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFIT-GI 719 (900)
Q Consensus 643 k~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~--~ys~ksDIWSLGVILyEMLt-Gk 719 (900)
.... ......++..|+|||++.+. .++.++|+|||||++|||++ |.
T Consensus 156 ~~~~-------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~ 204 (259)
T cd05037 156 ITVL-------------------------------SREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204 (259)
T ss_pred cccc-------------------------------cccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCC
Confidence 7421 01234577889999999876 78999999999999999999 68
Q ss_pred CCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhc
Q 002616 720 PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 772 (900)
Q Consensus 720 ~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~ 772 (900)
.||...+..+...... .....+ ......+.+||.+||..+|.+||++.+
T Consensus 205 ~p~~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~ 253 (259)
T cd05037 205 EPLSTLSSSEKERFYQ-DQHRLP---MPDCAELANLINQCWTYDPTKRPSFRA 253 (259)
T ss_pred CCcccCCchhHHHHHh-cCCCCC---CCCchHHHHHHHHHhccChhhCCCHHH
Confidence 8998776544433332 222222 223488999999999999999999443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=319.34 Aligned_cols=253 Identities=22% Similarity=0.346 Sum_probs=205.3
Q ss_pred eEEEEEeccCCceEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 002616 497 FEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 568 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~---tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~----- 568 (900)
|++.++||+|+||.||+|.++. ++..||||+++. ........+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~-~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKA-DIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecc-ccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 6778899999999999998653 578999999864 3334455778899999999999999999999886543
Q ss_pred -eeEEEEeecCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCC
Q 002616 569 -NLYLVMEYLNGGDLYSLLRKV------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 641 (900)
Q Consensus 569 -~LyLVmEy~~GGsL~dlL~k~------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGL 641 (900)
..+++++|+++|+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 247899999999998887432 2478889999999999999999999999999999999999999999999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCC
Q 002616 642 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 720 (900)
Q Consensus 642 Ak~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~ 720 (900)
++....... ........+++.|++||.+.+..++.++|||||||++|||++ |.+
T Consensus 160 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~ 214 (273)
T cd05074 160 SKKIYSGDY-------------------------YRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQT 214 (273)
T ss_pred cccccCCcc-------------------------eecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCC
Confidence 874211000 001122346778999999999899999999999999999999 999
Q ss_pred CCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 721 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 721 PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
||.+.+..+.+..+..... +..+...+..+.+|+.+||..+|.+||++.++.+.+
T Consensus 215 p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l 269 (273)
T cd05074 215 PYAGVENSEIYNYLIKGNR--LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269 (273)
T ss_pred CCCCCCHHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 9998888887777665432 122357789999999999999999999955444433
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=326.24 Aligned_cols=236 Identities=25% Similarity=0.331 Sum_probs=191.3
Q ss_pred EeccCCceEEEEEEECCCC------------------------cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce
Q 002616 502 PISRGAFGRVFLARKRTTG------------------------DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV 557 (900)
Q Consensus 502 ~LGkG~FG~Vyla~~k~tG------------------------k~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnI 557 (900)
.||+|+||.||+|....++ ..||+|++... .......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence 5999999999999864221 35888887542 22345678889999999999999
Q ss_pred EEEeeeeccCCeeEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCC----
Q 002616 558 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---- 632 (900)
Q Consensus 558 VkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G---- 632 (900)
+++++++......|+||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999999875 46789999999999999999999999999999999999998654
Q ss_pred ---cEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeech
Q 002616 633 ---HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSV 708 (900)
Q Consensus 633 ---~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSL 708 (900)
.+||+|||++.... ......+++.|+|||.+.+ ..++.++|+|||
T Consensus 159 ~~~~~kl~d~g~~~~~~-------------------------------~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~sl 207 (274)
T cd05076 159 TSPFIKLSDPGVSFTAL-------------------------------SREERVERIPWIAPECVPGGNSLSTAADKWSF 207 (274)
T ss_pred ccceeeecCCccccccc-------------------------------cccccccCCcccCchhhcCCCCCCcHHHHHHH
Confidence 48999999875311 0112357888999999875 568999999999
Q ss_pred hHHHHHHH-hCCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 709 GIILFEFI-TGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 709 GVILyEML-tGk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
||++|||+ +|.+||....+.+.... ......+| ...++++.+||.+||+.+|.+||+ +.++++
T Consensus 208 G~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rps---~~~il~ 271 (274)
T cd05076 208 GTTLLEICFDGEVPLKERTPSEKERF-YEKKHRLP---EPSCKELATLISQCLTYEPTQRPS---FRTILR 271 (274)
T ss_pred HHHHHHHHhCCCCCccccChHHHHHH-HHhccCCC---CCCChHHHHHHHHHcccChhhCcC---HHHHHH
Confidence 99999995 69999988776554332 23333333 456678999999999999999999 556654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=320.35 Aligned_cols=248 Identities=19% Similarity=0.285 Sum_probs=195.6
Q ss_pred EeccCCceEEEEEEECCCC--cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCC
Q 002616 502 PISRGAFGRVFLARKRTTG--DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 502 ~LGkG~FG~Vyla~~k~tG--k~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
.||+|+||.||+++....+ ..+++|.++... .....+.+.+|+.+++.++||||+++++.|.....+|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 6999999999999764332 345566554322 234567899999999999999999999999999999999999999
Q ss_pred CChHHHHHhc----CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCC
Q 002616 580 GDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 580 GsL~dlL~k~----g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
|+|.+++.+. ..+++..++.++.||+.||+|||+.+++||||||+|||++.++.+||+|||++......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~------- 152 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE------- 152 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcc-------
Confidence 9999999764 23566778889999999999999999999999999999999999999999987631100
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-------CCCCccceeechhHHHHHHHh-CCCCCCCCCh
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-------TEHGYAADWWSVGIILFEFIT-GIPPFTAESP 727 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-------~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~ 727 (900)
.........+|++.|+|||++.. ..++.++|||||||++|||++ |.+||...+.
T Consensus 153 ------------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~ 214 (268)
T cd05086 153 ------------------DYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD 214 (268)
T ss_pred ------------------hhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 00011224578999999999853 245779999999999999997 6789988887
Q ss_pred HHHHHhhhcCCC---CCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 728 EIIFDNILNRKI---PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 728 ~ei~~kIl~~~l---~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
.+.+..+..+.. .-|.++..+++.+.+++..|| .+|.+||+++++.+.|
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 215 REVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred HHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 777776654421 224445678899999999999 5899999966555444
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=364.40 Aligned_cols=254 Identities=26% Similarity=0.445 Sum_probs=209.4
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccC--
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCR-- 567 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~-- 567 (900)
.+.-..+++.+.|.+|||+.||+|+....|..||+|.+-.. .+...+.+.+|+++|+.|+ |||||.++++....
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 45566788999999999999999999988899999987542 5678899999999999998 99999999942211
Q ss_pred -----CeeEEEEeecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHhhhhcC--eEeccCCCCcEEecCCCcEEEEe
Q 002616 568 -----DNLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTD 638 (900)
Q Consensus 568 -----~~LyLVmEy~~GGsL~dlL~k--~g~Lse~~ar~ya~QIl~AL~yLHs~g--IIHRDLKPeNILLd~~G~VKLsD 638 (900)
-.++|+||||.||.|-+++.+ ...|++.++..|+.++++|+.+||... |||||||-|||||+.+|+.||||
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence 247899999999999999974 356999999999999999999999998 99999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc---CCCCCccceeechhHHHHHH
Q 002616 639 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEF 715 (900)
Q Consensus 639 FGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGVILyEM 715 (900)
||.++.... .+...+ ...-....-...-|+.|+|||++. +.+.+.|+|||+|||+||.|
T Consensus 190 FGSatt~~~--------------~~~~~~----e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkL 251 (738)
T KOG1989|consen 190 FGSATTKIL--------------SPTSAQ----EVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKL 251 (738)
T ss_pred ccccccccC--------------CCccHH----HHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHH
Confidence 999873210 000000 000001112234699999999974 67789999999999999999
Q ss_pred HhCCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCh
Q 002616 716 ITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 770 (900)
Q Consensus 716 LtGk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa 770 (900)
+....||..... -.|+++.+.||.. +..+..+++||+.||+.||.+||..
T Consensus 252 Cy~t~PFe~sg~----laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI 301 (738)
T KOG1989|consen 252 CYFTTPFEESGK----LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNI 301 (738)
T ss_pred HHhCCCcCcCcc----eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCH
Confidence 999999987543 3688999999964 5789999999999999999999993
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=319.89 Aligned_cols=257 Identities=25% Similarity=0.362 Sum_probs=205.4
Q ss_pred CCCeEEEEEeccCCceEEEEEEECC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc--C
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRT----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--R 567 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~----tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d--~ 567 (900)
..+|++.+.||+|+||.||+|++.. +++.||+|+++..... .....+.+|+.+++.+.||||+++++++.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 3578899999999999999999753 4789999999754321 456789999999999999999999998877 5
Q ss_pred CeeEEEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
...|+||||+++|+|.+++.+.. .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 67999999999999999997654 58999999999999999999999999999999999999999999999999987431
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
.... .........++..|+|||.+.+..++.++|+||||+++|||++|..||....
T Consensus 161 ~~~~------------------------~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~ 216 (284)
T cd05038 161 EDKD------------------------YYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPP 216 (284)
T ss_pred cCCc------------------------ceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCccccc
Confidence 0000 0000112345667999999998899999999999999999999999986543
Q ss_pred hHH--------------HHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 727 PEI--------------IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 727 ~~e--------------i~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
... ....++.....++ .+..++.++.+|+.+||..+|.+||++.++.+.+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l 280 (284)
T cd05038 217 AEFLRMIGIAQGQMIVTRLLELLKEGERLP-RPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIV 280 (284)
T ss_pred chhccccccccccccHHHHHHHHHcCCcCC-CCccCCHHHHHHHHHHhccChhhCCCHHHHHHHH
Confidence 211 1122223333333 2456788999999999999999999966555444
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=323.40 Aligned_cols=260 Identities=15% Similarity=0.229 Sum_probs=193.7
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCC---CcEEEEEEeecccccchhH--------HHHHHHHHHHHHhcCCCceEEE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKND--------IERILAERNILITVRNPFVVRF 560 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~t---Gk~VAIKiLkK~~~~~~~~--------~e~~l~Ei~IL~~L~HPnIVkL 560 (900)
+..++|++.+.||+|+||.||+|++..+ +..+|+|+..........+ ......+...+..+.|++|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3457899999999999999999999887 6677887643211110000 0112233344556789999999
Q ss_pred eeeeccCC----eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEE
Q 002616 561 FYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 636 (900)
Q Consensus 561 ~~~f~d~~----~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKL 636 (900)
++++.... ..|++|+++.. ++.+.+.....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98766554 34788888754 77777766666788999999999999999999999999999999999999999999
Q ss_pred EecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHH
Q 002616 637 TDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI 716 (900)
Q Consensus 637 sDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEML 716 (900)
+|||+|+....+... . . ..........||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 168 ~DFGla~~~~~~~~~----------------~-~---~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~ 227 (294)
T PHA02882 168 IDYGIASHFIIHGKH----------------I-E---YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA 227 (294)
T ss_pred EEcCCceeeccCCcc----------------c-c---cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999853211000 0 0 0011223457999999999999999999999999999999999
Q ss_pred hCCCCCCCCCh-H--------HHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHH
Q 002616 717 TGIPPFTAESP-E--------IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 776 (900)
Q Consensus 717 tGk~PF~~~s~-~--------ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EI 776 (900)
+|.+||.+.+. . +...++......+ ...+.++.++++.|+..+|++||+++.+.++
T Consensus 228 ~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~ 292 (294)
T PHA02882 228 GIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI----KNANKFIYDFIECVTKLSYEEKPDYDALIKI 292 (294)
T ss_pred hCCCCCCccccchHHHHHhHHHHHHHhhhhhhcc----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHh
Confidence 99999987732 2 2233343343332 3567899999999999999999996544443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=342.77 Aligned_cols=262 Identities=27% Similarity=0.361 Sum_probs=204.9
Q ss_pred CCCccccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeee
Q 002616 485 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSF 564 (900)
Q Consensus 485 ~ss~~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f 564 (900)
++..+....+++|.--+.||+|+||.||+|...+ |..||||.+....... ...|.+|+.+|.+++|||+|+|+|+|
T Consensus 65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred eeHHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 3445566778999999999999999999999875 4899999776532211 44599999999999999999999999
Q ss_pred ccCC-eeEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcC---eEeccCCCCcEEecCCCcEEEEe
Q 002616 565 TCRD-NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLG---IVHRDLKPDNLLIAHDGHIKLTD 638 (900)
Q Consensus 565 ~d~~-~LyLVmEy~~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~g---IIHRDLKPeNILLd~~G~VKLsD 638 (900)
.+.+ ..+||+|||++|+|.++|.... .+++.....|+.+++.||+|||... ||||||||+|||||+++.+||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9999 5999999999999999998655 8999999999999999999999854 99999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccc-cCCCCCCChhhhcCCCCCccceeechhHHHHHHHh
Q 002616 639 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSA-VGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 717 (900)
Q Consensus 639 FGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~-vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt 717 (900)
||+|+..... .....+. .||.+|+|||.+..+..+.++|||||||+|.||++
T Consensus 221 FGLa~~~~~~---------------------------~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElit 273 (361)
T KOG1187|consen 221 FGLAKLGPEG---------------------------DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELIT 273 (361)
T ss_pred ccCcccCCcc---------------------------ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHh
Confidence 9999753210 0011112 79999999999998889999999999999999999
Q ss_pred CCCCCCCCC---h---HHHHHhhh-cCCCC---CCCCC-CCCC--HH---HHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 718 GIPPFTAES---P---EIIFDNIL-NRKIP---WPCVP-SDMS--FE---AQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 718 Gk~PF~~~s---~---~ei~~kIl-~~~l~---~P~ip-~~lS--~e---akDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
|+.|..... . .+.....+ .+.+. -|.+. ...+ .+ +..+..+|++.+|.+||+..++...|
T Consensus 274 gr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L 349 (361)
T KOG1187|consen 274 GRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKEL 349 (361)
T ss_pred CCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHH
Confidence 998886432 1 11111111 11110 11111 1222 22 55677889999999999976655555
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=326.17 Aligned_cols=258 Identities=29% Similarity=0.536 Sum_probs=217.3
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCe
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 569 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~ 569 (900)
...+++.+.+..||.|+.|.||+++.+.+|...|||.+++.. .+++..+++..++++.... +|+||+.|++|..+..
T Consensus 88 ~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d 165 (391)
T KOG0983|consen 88 QADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD 165 (391)
T ss_pred ccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch
Confidence 345778889999999999999999999999999999998743 4566788888888877665 9999999999999999
Q ss_pred eEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhh-cCeEeccCCCCcEEecCCCcEEEEecCCcccccc
Q 002616 570 LYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~ 647 (900)
+++.||.|.. -+..++++ .++++|..+=.+...++.||.||.. .||||||+||+|||+|..|++||||||++-....
T Consensus 166 V~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 166 VFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred HHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeec
Confidence 9999999854 45555554 4679999988999999999999985 5899999999999999999999999999865321
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC---CCCCccceeechhHHHHHHHhCCCCCCC
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTA 724 (900)
Q Consensus 648 ~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~ksDIWSLGVILyEMLtGk~PF~~ 724 (900)
........|-+.|||||-+.- ..|+..+||||||+.++||.||..||.+
T Consensus 245 ----------------------------SkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~ 296 (391)
T KOG0983|consen 245 ----------------------------SKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKG 296 (391)
T ss_pred ----------------------------ccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCC
Confidence 112233579999999999864 4789999999999999999999999998
Q ss_pred CC-hHHHHHhhhcCCCCCCCCC--CCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 725 ES-PEIIFDNILNRKIPWPCVP--SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 725 ~s-~~ei~~kIl~~~l~~P~ip--~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
.+ .-++..+|++... |.++ .++|+.+++|+..||++|+.+||. -.++|+|||.+.
T Consensus 297 c~tdFe~ltkvln~eP--P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~---Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 297 CKTDFEVLTKVLNEEP--PLLPGHMGFSPDFQSFVKDCLTKDHRKRPK---YNKLLEHPFIKR 354 (391)
T ss_pred CCccHHHHHHHHhcCC--CCCCcccCcCHHHHHHHHHHhhcCcccCcc---hHHHhcCcceee
Confidence 54 5677778887543 3333 458999999999999999999998 668999999964
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=365.85 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=215.2
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 566 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk-----~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d 566 (900)
+.....++.+.||+|+||+||.|....... .||+|.+++ ..+...+..|++|..+|+.++|||||++++.+.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~--~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKR--LSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccc--cCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 456678899999999999999999875433 389998876 4466788999999999999999999999999999
Q ss_pred CCeeEEEEeecCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEec
Q 002616 567 RDNLYLVMEYLNGGDLYSLLRKV-------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 639 (900)
Q Consensus 567 ~~~LyLVmEy~~GGsL~dlL~k~-------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDF 639 (900)
....+|++|||.||||..+|++. ..++......++.+|++|++||+++++|||||..+|+||+....|||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999876 24888999999999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-C
Q 002616 640 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-G 718 (900)
Q Consensus 640 GLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-G 718 (900)
|+|+........ .+. .. ..-...|||||.|....++.++|||||||+|||+++ |
T Consensus 847 GlArDiy~~~yy--------------------r~~-~~----a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG 901 (1025)
T KOG1095|consen 847 GLARDIYDKDYY--------------------RKH-GE----AMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLG 901 (1025)
T ss_pred chhHhhhhchhe--------------------ecc-Cc----cccceecCCHHHHhhcccccccchhhhHHHHHHHHhCC
Confidence 999843211110 000 00 123468999999999999999999999999999999 9
Q ss_pred CCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChh
Q 002616 719 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 771 (900)
Q Consensus 719 k~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~ 771 (900)
..||.+.++.+++...+.+. +++ .|..++..+.++|..||+.+|++||++.
T Consensus 902 ~~PY~~~~n~~v~~~~~~gg-RL~-~P~~CP~~ly~lM~~CW~~~pe~RP~F~ 952 (1025)
T KOG1095|consen 902 ATPYPSRSNFEVLLDVLEGG-RLD-PPSYCPEKLYQLMLQCWKHDPEDRPSFR 952 (1025)
T ss_pred CCCCCCcchHHHHHHHHhCC-ccC-CCCCCChHHHHHHHHHccCChhhCccHH
Confidence 99999999999988666654 333 2589999999999999999999999954
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=359.71 Aligned_cols=276 Identities=41% Similarity=0.733 Sum_probs=248.8
Q ss_pred EeccCCceEEEEEEE---CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEeec
Q 002616 502 PISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYL 577 (900)
Q Consensus 502 ~LGkG~FG~Vyla~~---k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~LyLVmEy~ 577 (900)
++|.|+||.|++++. .+.|..||||++++......... +...|+.++..++ ||++|++++.|+.+..+|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999998764 34578899999988765544444 7888999999998 999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCC
Q 002616 578 NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 657 (900)
Q Consensus 578 ~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~ 657 (900)
.||+|+..+.+...+++...++|.++++.|++++|+++|||||+|++||+++.+||+|+.|||+++....
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~---------- 149 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK---------- 149 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh----------
Confidence 9999999999999999999999999999999999999999999999999999999999999999986421
Q ss_pred CCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcC
Q 002616 658 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNR 737 (900)
Q Consensus 658 ~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~ 737 (900)
....|||..|||||++. ++..++||||||+++|||++|..||.. ++...|+..
T Consensus 150 ---------------------~~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~ 202 (612)
T KOG0603|consen 150 ---------------------EKIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKA 202 (612)
T ss_pred ---------------------hhhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhh
Confidence 01129999999999998 788899999999999999999999988 888889888
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCCh--hcHHHHHcCCCCCCCCcchhhhc--cCCccCCCCCCCCccccccc
Q 002616 738 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYFLSR 813 (900)
Q Consensus 738 ~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~ 813 (900)
.+.+| ..++..+++++..++.++|.+|++. +++.+|++|+||..++|+.+..+ +|||+|....+.|+.+|+.+
T Consensus 203 ~~~~p---~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~~e~~~~~fd~e 279 (612)
T KOG0603|consen 203 ELEMP---RELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSITERDVAQFDPE 279 (612)
T ss_pred ccCCc---hhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCcccchhhhhhcCch
Confidence 87776 7899999999999999999999995 68999999999999999988766 78999999999999999998
Q ss_pred cccCC
Q 002616 814 FSQIS 818 (900)
Q Consensus 814 fs~~~ 818 (900)
|+...
T Consensus 280 ft~~~ 284 (612)
T KOG0603|consen 280 FTSQV 284 (612)
T ss_pred hccCC
Confidence 87763
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=328.29 Aligned_cols=264 Identities=29% Similarity=0.490 Sum_probs=209.8
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-C
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-R 567 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk----~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d-~ 567 (900)
....|+++..||+|+||.||+|..++++. .||||.++.... .........+|+.+++.++||||+.|..+|.. +
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d 100 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHD 100 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence 45679999999999999999997665543 799998865322 22334567889999999999999999999988 7
Q ss_pred CeeEEEEeecCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCC----CcEEEEe
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKV-----GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTD 638 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~-----g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~----G~VKLsD 638 (900)
..+++++||++. ||+.+++-+ ..++...++.++.||+.|+.|||++.|+||||||.|||+..+ |.|||+|
T Consensus 101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence 789999999988 999988633 358999999999999999999999999999999999999877 8999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHh
Q 002616 639 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 717 (900)
Q Consensus 639 FGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLt 717 (900)
|||++... +. + .+-......|-|.+|.|||.|+| ..|+.++|+||+|||+.|||+
T Consensus 180 lGlaR~~~--~p----------l------------kpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLt 235 (438)
T KOG0666|consen 180 LGLARLFN--NP----------L------------KPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLT 235 (438)
T ss_pred ccHHHHhh--cc----------c------------cccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHc
Confidence 99999642 00 0 01112345688999999999998 568999999999999999999
Q ss_pred CCCCCCCCCh---------HHHHHhhhcC-----CCCCCCC---C--------------------------CCCCHHHHH
Q 002616 718 GIPPFTAESP---------EIIFDNILNR-----KIPWPCV---P--------------------------SDMSFEAQD 754 (900)
Q Consensus 718 Gk~PF~~~s~---------~ei~~kIl~~-----~l~~P~i---p--------------------------~~lS~eakD 754 (900)
-.|.|.+... .+...+|++- .-.||.+ | ..-++.+.+
T Consensus 236 l~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~ 315 (438)
T KOG0666|consen 236 LEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALD 315 (438)
T ss_pred cCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHH
Confidence 9999976421 2334444431 1122221 0 113566889
Q ss_pred HHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 755 LINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 755 LIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
|+.+||++||.+|++ +.+.++|+||...
T Consensus 316 LL~klL~yDP~kRIt---a~qAleh~yF~~d 343 (438)
T KOG0666|consen 316 LLQKLLTYDPIKRIT---AEQALEHPYFTED 343 (438)
T ss_pred HHHHHhccCchhhcc---HHHHhcccccccC
Confidence 999999999999999 7788999999764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=305.53 Aligned_cols=259 Identities=30% Similarity=0.525 Sum_probs=218.1
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
..|.-.++||+|.||+||++++++|++.||+|.++-.+ ..+......++|+-+|+.++|.|||++++....+..+-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 35677789999999999999999999999999986533 33444567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccC
Q 002616 575 EYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 575 Ey~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l 653 (900)
|||.. +|..+... .+.++.+.++.++.|++.||.|+|+.++.||||||.|+||+.+|.+||+|||+++.+..
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi------ 153 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI------ 153 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC------
Confidence 99976 88877764 46799999999999999999999999999999999999999999999999999985320
Q ss_pred CCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHh-CCCCCCCCChHHHH
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 731 (900)
Q Consensus 654 ~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~ei~ 731 (900)
+.+-....+-|.+|.+|.++.|. -|+.+.|+||.|||+.|+.. |+|.|.+.+..+..
T Consensus 154 ---------------------pvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddql 212 (292)
T KOG0662|consen 154 ---------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212 (292)
T ss_pred ---------------------ceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHH
Confidence 11122335779999999999984 58999999999999999986 89999999988888
Q ss_pred HhhhcC-----CCCCC------------C---------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 732 DNILNR-----KIPWP------------C---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 732 ~kIl~~-----~l~~P------------~---------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
++|... .-.|| . +-+.++...+||++++|..+|.+|++ |++.++||||.+.
T Consensus 213 krif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qris---aeaalqhpyf~d~ 289 (292)
T KOG0662|consen 213 KRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS---AEAALQHPYFSDF 289 (292)
T ss_pred HHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccC---HHHHhcCcccccc
Confidence 887641 11122 1 12345667889999999999999999 7788999999764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=364.92 Aligned_cols=273 Identities=31% Similarity=0.476 Sum_probs=210.6
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc------
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------ 566 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d------ 566 (900)
-.++|+.+..||+||||.||+|+++-+|+.||||.|.-.. .......+.+|+.+|++++|||||++|..+..
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 4678999999999999999999999999999999986533 45567789999999999999999998864300
Q ss_pred ------------------------------------------------------------------------C-------
Q 002616 567 ------------------------------------------------------------------------R------- 567 (900)
Q Consensus 567 ------------------------------------------------------------------------~------- 567 (900)
.
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred ----------------------------------CeeEEEEeecCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHhhh
Q 002616 568 ----------------------------------DNLYLVMEYLNGGDLYSLLRKVGCL-EEDVARIYIAELVLALEYLH 612 (900)
Q Consensus 568 ----------------------------------~~LyLVmEy~~GGsL~dlL~k~g~L-se~~ar~ya~QIl~AL~yLH 612 (900)
..+||=||||+.-.|.++++.+... ....++.+++||+.||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 1278999999997777777665544 47788999999999999999
Q ss_pred hcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc-cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCCh
Q 002616 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN-TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAP 691 (900)
Q Consensus 613 s~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~-s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAP 691 (900)
++|||||||||.||+||+++.|||+|||+|+....+. .++.. ... .............+.+||.-|+||
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~----~~~------~~~~~g~~~~~~Ts~VGTalYvAP 784 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQD----LSF------STNRAGSNDGDLTSQVGTALYVAP 784 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhc----cCc------cccccCCCCcccccccceeeeecH
Confidence 9999999999999999999999999999998532110 00000 000 000011112245678999999999
Q ss_pred hhhcCCC---CCccceeechhHHHHHHHhCCCCCCC-CChHHHHHhhhcCCCCCC-CCCCCCCHHHHHHHHHhccCCcCC
Q 002616 692 EILLGTE---HGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQ 766 (900)
Q Consensus 692 EvL~g~~---ys~ksDIWSLGVILyEMLtGk~PF~~-~s~~ei~~kIl~~~l~~P-~ip~~lS~eakDLIk~cL~~DP~k 766 (900)
|++.+.. |+.|+|+|||||++|||+. ||.. .....+...+.++.+++| .+...--+....+|+.||+.||.+
T Consensus 785 Ell~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 785 ELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSK 861 (1351)
T ss_pred HHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCcc
Confidence 9998754 9999999999999999984 5753 334445555555665555 112333456778999999999999
Q ss_pred CCChhcHHHHHcCCCCC
Q 002616 767 RLGANGAAEVKAHPFFK 783 (900)
Q Consensus 767 RpSa~~a~EIL~HPFFk 783 (900)
||| |.++|++.||-
T Consensus 862 RPt---A~eLL~s~llp 875 (1351)
T KOG1035|consen 862 RPT---ATELLNSELLP 875 (1351)
T ss_pred CCC---HHHHhhccCCC
Confidence 999 89999999997
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=314.86 Aligned_cols=265 Identities=26% Similarity=0.352 Sum_probs=213.5
Q ss_pred cccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 002616 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 489 ~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~ 568 (900)
...++-++|++.+.||.|||+-||+|+...+++.||+|.+... ..++.+..++|++..++++||||++++++...+.
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~ 91 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREE 91 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence 3456778999999999999999999999999999999988643 2467889999999999999999999998776554
Q ss_pred e-----eEEEEeecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHhhhhcC--eEeccCCCCcEEecCCCcEEEE
Q 002616 569 N-----LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLT 637 (900)
Q Consensus 569 ~-----LyLVmEy~~GGsL~dlL~k~----g~Lse~~ar~ya~QIl~AL~yLHs~g--IIHRDLKPeNILLd~~G~VKLs 637 (900)
. .|++++|...|+|.+.+... ..+++.++..|+.+|++||++||... ++||||||.|||+...+.++|.
T Consensus 92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence 4 99999999999999998642 36999999999999999999999999 9999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC---CCCCccceeechhHHHHH
Q 002616 638 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFE 714 (900)
Q Consensus 638 DFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~ksDIWSLGVILyE 714 (900)
|||.++..... +.+ ..... .-+.......|..|.|||.+.- ...+.++|||||||+||+
T Consensus 172 D~GS~~~a~i~----i~~---------~~~a~-----~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa 233 (302)
T KOG2345|consen 172 DLGSATQAPIQ----IEG---------SRQAL-----RLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYA 233 (302)
T ss_pred eccCccccceE----eec---------hHHHH-----HHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHH
Confidence 99998753210 000 00000 0011122346899999999974 345789999999999999
Q ss_pred HHhCCCCCCCCC--hHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHc
Q 002616 715 FITGIPPFTAES--PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 715 MLtGk~PF~~~s--~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~ 778 (900)
|+.|..||...- ...+.-.+.+.++.||.- ...|..+.+||+.||++||.+||+ +.+++.
T Consensus 234 ~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~---i~~ll~ 295 (302)
T KOG2345|consen 234 MMFGESPFERIYQQGGSLALAVQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPT---IPELLS 295 (302)
T ss_pred HHHcCCcchHHhhcCCeEEEeeeccccccCCC-CCccHHHHHHHHHHhcCCcccCCC---HHHHHH
Confidence 999999995321 122233456677888864 459999999999999999999999 556654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=331.85 Aligned_cols=256 Identities=30% Similarity=0.534 Sum_probs=211.7
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC--CC----ceEEEeeeec
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--NP----FVVRFFYSFT 565 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~--HP----nIVkL~~~f~ 565 (900)
.-.+.|.++..+|+|+||.|..+.+..++..||+|+++... ...+..+-|+++|.++. .| .+|.+.++|.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 34678999999999999999999999999999999997643 33456678999999984 23 3889999999
Q ss_pred cCCeeEEEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecC-------------
Q 002616 566 CRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH------------- 630 (900)
Q Consensus 566 d~~~LyLVmEy~~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~------------- 630 (900)
..++.++|+|.+ |-+++++|.++. +|+-..++.+++|++.+++|||+++++|-||||+|||+.+
T Consensus 162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcc
Confidence 999999999998 559999998754 6899999999999999999999999999999999999842
Q ss_pred -------CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccc
Q 002616 631 -------DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 703 (900)
Q Consensus 631 -------~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ks 703 (900)
+-+|||+|||.|++. .....+.+-|..|.|||++++-+++..|
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~------------------------------~e~hs~iVsTRHYRAPEViLgLGwS~pC 290 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFD------------------------------HEHHSTIVSTRHYRAPEVILGLGWSQPC 290 (415)
T ss_pred ceeccCCCcceEEEecCCccee------------------------------ccCcceeeeccccCCchheeccCcCCcc
Confidence 336899999998852 1223567899999999999999999999
Q ss_pred eeechhHHHHHHHhCCCCCCCCChHH---HHHhhhc------------------CCCCCCCCC-----------------
Q 002616 704 DWWSVGIILFEFITGIPPFTAESPEI---IFDNILN------------------RKIPWPCVP----------------- 745 (900)
Q Consensus 704 DIWSLGVILyEMLtGk~PF~~~s~~e---i~~kIl~------------------~~l~~P~ip----------------- 745 (900)
||||+||||+|+.+|...|...+..+ ++++|+. +.+.||...
T Consensus 291 DvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~ 370 (415)
T KOG0671|consen 291 DVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKK 370 (415)
T ss_pred CceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHH
Confidence 99999999999999999998877544 5555442 223333210
Q ss_pred -----CCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 746 -----SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 746 -----~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
..--.++.|||++||.+||.+|+| +.|+|.||||+..
T Consensus 371 ~~~~~d~e~~~LfDLl~~mL~fDP~~RiT---l~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 371 YMLQDDLEHVQLFDLLRRMLEFDPARRIT---LREALSHPFFARL 412 (415)
T ss_pred HhccCcHHHhHHHHHHHHHHccCcccccc---HHHHhcCHHhhcC
Confidence 001224679999999999999999 8899999999854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=295.33 Aligned_cols=243 Identities=50% Similarity=0.851 Sum_probs=209.0
Q ss_pred CceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCChHHHH
Q 002616 507 AFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL 586 (900)
Q Consensus 507 ~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GGsL~dlL 586 (900)
+||.||+|.+..+|+.+|+|++........ ...+.+|+..++.++|+||+++++.+......+++|||+++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999999999999999876433221 678999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCC
Q 002616 587 RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666 (900)
Q Consensus 587 ~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~ 666 (900)
.....++...+..++.+++.||.|||+.|++|+||+|.||+++.++.++|+|||++.....
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~------------------- 139 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDP------------------- 139 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecc-------------------
Confidence 8776689999999999999999999999999999999999999999999999999874311
Q ss_pred CCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCC-CChHHHHHhhhcCCCCCCCCC
Q 002616 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA-ESPEIIFDNILNRKIPWPCVP 745 (900)
Q Consensus 667 ~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~-~s~~ei~~kIl~~~l~~P~ip 745 (900)
........|++.|++||.+.+..++.++|+||||+++|+|++|..||.. .+.......+.......+...
T Consensus 140 ---------~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 210 (244)
T smart00220 140 ---------GGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPE 210 (244)
T ss_pred ---------ccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcccc
Confidence 0022345688999999999988899999999999999999999999987 566666666555544433211
Q ss_pred CCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 746 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 746 ~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
..++.++.+++.+||..+|.+||+ +.++++||||
T Consensus 211 ~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~~~~~~~ 244 (244)
T smart00220 211 WKISPEAKDLIRKLLVKDPEKRLT---AEEALQHPFF 244 (244)
T ss_pred ccCCHHHHHHHHHHccCCchhccC---HHHHhhCCCC
Confidence 228899999999999999999999 8899999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-35 Score=343.44 Aligned_cols=264 Identities=25% Similarity=0.344 Sum_probs=184.4
Q ss_pred ccccCCCeEEEEEeccCCceEEEEEEECCC----CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeee--
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTT----GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYS-- 563 (900)
Q Consensus 490 ~~~~~~dYeil~~LGkG~FG~Vyla~~k~t----Gk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~-- 563 (900)
.....++|++.+.||+|+||.||+|++..+ +..||+|.+.... ..+...+|. +....+.+++.++..
T Consensus 127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e~--l~~~~~~~~~~~~~~~~ 199 (566)
T PLN03225 127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNER--VRRACPNSCADFVYGFL 199 (566)
T ss_pred CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHHH--HHhhchhhHHHHHHhhh
Confidence 345778999999999999999999999998 8999999875422 111112221 122222223222222
Q ss_pred ----eccCCeeEEEEeecCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHhhhhcCeEec
Q 002616 564 ----FTCRDNLYLVMEYLNGGDLYSLLRKVGC--------------------LEEDVARIYIAELVLALEYLHSLGIVHR 619 (900)
Q Consensus 564 ----f~d~~~LyLVmEy~~GGsL~dlL~k~g~--------------------Lse~~ar~ya~QIl~AL~yLHs~gIIHR 619 (900)
......+|+||||+++|+|.+++..... ..+..++.++.||+.||+|||++|||||
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHR 279 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHR 279 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence 2455679999999999999999875321 1234466789999999999999999999
Q ss_pred cCCCCcEEecC-CCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-
Q 002616 620 DLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT- 697 (900)
Q Consensus 620 DLKPeNILLd~-~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~- 697 (900)
||||+|||++. ++.+||+|||+|+.... .........+||+.|||||.+...
T Consensus 280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~--------------------------~~~~~~~~~~~t~~Y~APE~~~~~~ 333 (566)
T PLN03225 280 DVKPQNIIFSEGSGSFKIIDLGAAADLRV--------------------------GINYIPKEFLLDPRYAAPEQYIMST 333 (566)
T ss_pred cCCHHHEEEeCCCCcEEEEeCCCcccccc--------------------------ccccCCcccccCCCccChHHhhccC
Confidence 99999999986 68999999999974210 001123456899999999976432
Q ss_pred ---------------------CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhc-CCCCC------------CC
Q 002616 698 ---------------------EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN-RKIPW------------PC 743 (900)
Q Consensus 698 ---------------------~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~-~~l~~------------P~ 743 (900)
.++.++|||||||+||||+++..|+.. ....+.+++. ....+ +.
T Consensus 334 ~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 411 (566)
T PLN03225 334 QTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPD 411 (566)
T ss_pred CCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchh
Confidence 234567999999999999997666432 2222222211 11100 00
Q ss_pred ------CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhh
Q 002616 744 ------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 791 (900)
Q Consensus 744 ------ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~ 791 (900)
+.......+.+||.+||++||.+||| +.++|+||||++..+..+.
T Consensus 412 ~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t---a~e~L~Hpff~~~~~~~~~ 462 (566)
T PLN03225 412 LRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS---AKAALAHPYFDREGLLGLS 462 (566)
T ss_pred hhhhhhhccccchHHHHHHHHHccCCcccCCC---HHHHhCCcCcCCCCccccc
Confidence 01112345669999999999999999 8899999999998776443
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=344.24 Aligned_cols=253 Identities=33% Similarity=0.465 Sum_probs=201.1
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC------
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD------ 568 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~------ 568 (900)
..+..-+.||+||||.||+++++.||+.||+|.+++.. .....+...+|+++|++++|||||+++++-.+..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 34566788999999999999999999999999998743 3455778899999999999999999998866654
Q ss_pred eeEEEEeecCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecC--CC--cEEEEecCC
Q 002616 569 NLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DG--HIKLTDFGL 641 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k---~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~--~G--~VKLsDFGL 641 (900)
...+|||||+||||+..|++ ...+++.+.+.++.+++.||.|||.+|||||||||.||++-. +| .-||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 46899999999999999974 346999999999999999999999999999999999999853 34 469999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc-CCCCCccceeechhHHHHHHHhCCC
Q 002616 642 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIP 720 (900)
Q Consensus 642 Ak~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-g~~ys~ksDIWSLGVILyEMLtGk~ 720 (900)
|+... .+....+.+||+.|.+||++. .+.|+..+|.|||||++|+++||..
T Consensus 171 Arel~----------------------------d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~l 222 (732)
T KOG4250|consen 171 ARELD----------------------------DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGEL 222 (732)
T ss_pred cccCC----------------------------CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCC
Confidence 98532 223556789999999999998 4889999999999999999999999
Q ss_pred CCCCCChH----HHHHhhhc---------------CCCC----CCCCCCCCCHHH----HHHHHHhccCCcCCCC--C--
Q 002616 721 PFTAESPE----IIFDNILN---------------RKIP----WPCVPSDMSFEA----QDLINRFLIHDPNQRL--G-- 769 (900)
Q Consensus 721 PF~~~s~~----ei~~kIl~---------------~~l~----~P~ip~~lS~ea----kDLIk~cL~~DP~kRp--S-- 769 (900)
||...... ++.-.+.. +.+. +| .|..+++.. ...+..+|..+|++|. +
T Consensus 223 PF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP-~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~ 301 (732)
T KOG4250|consen 223 PFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLP-QPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFD 301 (732)
T ss_pred CCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCC-CcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcc
Confidence 99654322 23322222 1222 22 134555443 3567778999999999 4
Q ss_pred --hhcHHHHHc
Q 002616 770 --ANGAAEVKA 778 (900)
Q Consensus 770 --a~~a~EIL~ 778 (900)
+....+||+
T Consensus 302 ~~Fa~~~dIL~ 312 (732)
T KOG4250|consen 302 RFFAEVDDILN 312 (732)
T ss_pred hHHHHHHHHHh
Confidence 233555654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=326.84 Aligned_cols=267 Identities=29% Similarity=0.460 Sum_probs=218.2
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccc----cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC-
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM----IRKNDIERILAERNILITVRNPFVVRFFYSFTCR- 567 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~----~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~- 567 (900)
-.++|-++..||+|||++||+|.+...++.||+|+-.-... .+.+...+..+|.+|.+.++||.||++|++|.-+
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 34678889999999999999999999999999998543222 2344567899999999999999999999999755
Q ss_pred CeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhc--CeEeccCCCCcEEecC---CCcEEEEecCCc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--GIVHRDLKPDNLLIAH---DGHIKLTDFGLS 642 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~--gIIHRDLKPeNILLd~---~G~VKLsDFGLA 642 (900)
+.+|-|+|||+|.||..+|+.+..+++.+|+.++.||+.||.||... .|||.||||.||||.. .|.+||+||||+
T Consensus 541 dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 56899999999999999999999999999999999999999999976 5999999999999954 578999999999
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC----CCCccceeechhHHHHHHHhC
Q 002616 643 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT----EHGYAADWWSVGIILFEFITG 718 (900)
Q Consensus 643 k~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~----~ys~ksDIWSLGVILyEMLtG 718 (900)
+++.....- .. ..-..+....||.+|++||.|.-. +.+.++||||+|||+|.++.|
T Consensus 621 KIMdddSy~-----~v---------------dGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYG 680 (775)
T KOG1151|consen 621 KIMDDDSYN-----SV---------------DGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYG 680 (775)
T ss_pred hhccCCccC-----cc---------------cceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhcc
Confidence 964321110 00 112234557899999999988632 457899999999999999999
Q ss_pred CCCCCCCC-hHHHHH--hhhc-CCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCC
Q 002616 719 IPPFTAES-PEIIFD--NILN-RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 719 k~PF~~~s-~~ei~~--kIl~-~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk 783 (900)
+.||.... ..++.+ .|++ ..+.||. .+.++.++++||++||++--+.|.. +.++-.||||.
T Consensus 681 rKPFGhnqsQQdILqeNTIlkAtEVqFP~-KPvVsseAkaFIRRCLaYRKeDR~D---V~qLA~dpyll 745 (775)
T KOG1151|consen 681 RKPFGHNQSQQDILQENTILKATEVQFPP-KPVVSSEAKAFIRRCLAYRKEDRID---VQQLACDPYLL 745 (775)
T ss_pred CCCCCCchhHHHHHhhhchhcceeccCCC-CCccCHHHHHHHHHHHHhhhhhhhh---HHHHccCcccc
Confidence 99997643 333332 2333 3456774 3578999999999999999999987 88999999995
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=340.76 Aligned_cols=259 Identities=32% Similarity=0.538 Sum_probs=223.2
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeecc----
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC---- 566 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d---- 566 (900)
...+-|++..+||.|.+|.||+++.+.+|+..|+|++... ....+.+..|.+||+... |||++.+||+|.-
T Consensus 16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~----~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~ 91 (953)
T KOG0587|consen 16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT----EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG 91 (953)
T ss_pred CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC----ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence 3457799999999999999999999999999999998643 234566778999998875 9999999998854
Q ss_pred -CCeeEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcc
Q 002616 567 -RDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643 (900)
Q Consensus 567 -~~~LyLVmEy~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk 643 (900)
++.+|||||||.||+.-+++++. .++.|+.+..++++++.|+.+||.+.+||||||-.||||+.+|.|||+|||.+.
T Consensus 92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSa 171 (953)
T KOG0587|consen 92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSA 171 (953)
T ss_pred CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeee
Confidence 35799999999999999999753 579999999999999999999999999999999999999999999999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-----CCCCccceeechhHHHHHHHhC
Q 002616 644 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITG 718 (900)
Q Consensus 644 ~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-----~~ys~ksDIWSLGVILyEMLtG 718 (900)
... .......+.+|||.|||||++.- ..|+..+|+||||++..||.-|
T Consensus 172 Qld---------------------------sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG 224 (953)
T KOG0587|consen 172 QLD---------------------------STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEG 224 (953)
T ss_pred eee---------------------------cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCC
Confidence 421 12346678999999999999963 3577899999999999999999
Q ss_pred CCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 719 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 719 k~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
.||+.+..|+..+-.|-....+-..-|..++.++.+||..||.+|-.+||+ ..+++.|||.+.
T Consensus 225 ~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~---~~~ll~hpFi~e 287 (953)
T KOG0587|consen 225 APPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPS---TEELLKHPFITE 287 (953)
T ss_pred CCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcc---hhhhccCCcccc
Confidence 999999999887777755443222235778999999999999999999999 889999999974
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=313.09 Aligned_cols=263 Identities=30% Similarity=0.445 Sum_probs=210.8
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 568 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~----- 568 (900)
.+.|+-+.+||+|.||+||+|+.+++|+.||+|++-.. ..+...-...++|+++|..++|+|++.++..|....
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme-neKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME-NEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh-ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 45677788999999999999999999999999865321 112333456788999999999999999987775432
Q ss_pred ---eeEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 569 ---NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 569 ---~LyLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
.+|+||.+|+. ||..+|.+. .+|+...++.++.+++.||.|+|.+.|+|||+||+|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 48999999987 999999765 5799999999999999999999999999999999999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCC
Q 002616 645 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT 723 (900)
Q Consensus 645 ~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~ 723 (900)
+.... ..........+-|.+|.+||.+.| ..|+.+.|+|+.||||.||.+|.+-|.
T Consensus 174 fs~~~-----------------------n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimq 230 (376)
T KOG0669|consen 174 FSTSK-----------------------NVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQ 230 (376)
T ss_pred eeccc-----------------------ccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCcccc
Confidence 42110 001112345678999999999987 579999999999999999999999999
Q ss_pred CCChHHHHHhhhc--C---CCCCCC--------------C-------------CCCCCHHHHHHHHHhccCCcCCCCChh
Q 002616 724 AESPEIIFDNILN--R---KIPWPC--------------V-------------PSDMSFEAQDLINRFLIHDPNQRLGAN 771 (900)
Q Consensus 724 ~~s~~ei~~kIl~--~---~l~~P~--------------i-------------p~~lS~eakDLIk~cL~~DP~kRpSa~ 771 (900)
+.+.......|.. + .-.||. + |-.-.+++.||+.+||..||.+|+.
T Consensus 231 gnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~-- 308 (376)
T KOG0669|consen 231 GNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID-- 308 (376)
T ss_pred CChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc--
Confidence 8887665544422 1 111221 0 1123568999999999999999999
Q ss_pred cHHHHHcCCCCCC
Q 002616 772 GAAEVKAHPFFKG 784 (900)
Q Consensus 772 ~a~EIL~HPFFk~ 784 (900)
+.++++|.||..
T Consensus 309 -ad~alnh~~F~k 320 (376)
T KOG0669|consen 309 -ADQALNHDFFWK 320 (376)
T ss_pred -hHhhhchhhhhc
Confidence 778899999953
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=324.81 Aligned_cols=265 Identities=23% Similarity=0.304 Sum_probs=192.7
Q ss_pred ccccCCCeEEEEEeccCCceEEEEEEEC----------------CCCcEEEEEEeecccccc-----------hhHHHHH
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARKR----------------TTGDLFAIKVLKKLDMIR-----------KNDIERI 542 (900)
Q Consensus 490 ~~~~~~dYeil~~LGkG~FG~Vyla~~k----------------~tGk~VAIKiLkK~~~~~-----------~~~~e~~ 542 (900)
.+...++|++.++||+|+||+||+|... ..++.||||.++...... ....+..
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 3567899999999999999999999752 235679999885422110 0111233
Q ss_pred HHHHHHHHhcCCCce-----EEEeeeecc--------CCeeEEEEeecCCCChHHHHHhcC-------------------
Q 002616 543 LAERNILITVRNPFV-----VRFFYSFTC--------RDNLYLVMEYLNGGDLYSLLRKVG------------------- 590 (900)
Q Consensus 543 l~Ei~IL~~L~HPnI-----VkL~~~f~d--------~~~LyLVmEy~~GGsL~dlL~k~g------------------- 590 (900)
..|+.++.+++|.++ ++++++|.. ....|+||||+++|+|.++++...
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 456777777776554 566666543 356899999999999999886421
Q ss_pred -----CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCC
Q 002616 591 -----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 665 (900)
Q Consensus 591 -----~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~ 665 (900)
.+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++.....
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~----------------- 362 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTG----------------- 362 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccC-----------------
Confidence 2356678889999999999999999999999999999999999999999998642100
Q ss_pred CCCCcccccccCCcccccCCCCCCChhhhcCCC--------------------CC--ccceeechhHHHHHHHhCCC-CC
Q 002616 666 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE--------------------HG--YAADWWSVGIILFEFITGIP-PF 722 (900)
Q Consensus 666 ~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~--------------------ys--~ksDIWSLGVILyEMLtGk~-PF 722 (900)
.........+|+.|+|||++.... |+ ...|+||+||++|+|++|.. ||
T Consensus 363 ---------~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~ 433 (507)
T PLN03224 363 ---------INFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPV 433 (507)
T ss_pred ---------CccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCc
Confidence 000111234589999999986432 22 24799999999999999875 77
Q ss_pred CCCCh-----------HHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCc---CCCCChhcHHHHHcCCCCCC
Q 002616 723 TAESP-----------EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDP---NQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 723 ~~~s~-----------~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP---~kRpSa~~a~EIL~HPFFk~ 784 (900)
..... ...++.+....+.++. ....++.++||+.+||.++| .+|+| +.++|+||||..
T Consensus 434 ~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~-~d~~s~~~~dLi~~LL~~~~~~~~~RlS---a~eaL~Hp~f~~ 505 (507)
T PLN03224 434 ANIRLFNTELRQYDNDLNRWRMYKGQKYDFSL-LDRNKEAGWDLACKLITKRDQANRGRLS---VGQALSHRFFLP 505 (507)
T ss_pred cchhhhhhHHhhccchHHHHHhhcccCCCccc-ccccChHHHHHHHHHhccCCCCcccCCC---HHHHhCCCCcCC
Confidence 54221 1122233334455552 35689999999999999876 68999 889999999953
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=323.89 Aligned_cols=262 Identities=21% Similarity=0.350 Sum_probs=221.6
Q ss_pred ccccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 488 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 488 ~~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
.++.+.-.+..+..+||-|.||+||.|.|+...-.||||.++... ..++.|+.|..+|+.++|||+|+|+++|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 456667778888999999999999999999988999999997543 3688999999999999999999999999999
Q ss_pred CeeEEEEeecCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~g~--Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~ 645 (900)
..+|||+|||..|+|.++|++..+ ++.-....++.||..||+||..+++|||||-..|+|+.++..||++||||++++
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 999999999999999999997653 666666777789999999999999999999999999999999999999999975
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCC
Q 002616 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 724 (900)
Q Consensus 646 ~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~ 724 (900)
..+..+. ....--...|.|||-|....++.++|||+|||+|||+.| |..||.+
T Consensus 416 tgDTYTA--------------------------HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG 469 (1157)
T KOG4278|consen 416 TGDTYTA--------------------------HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG 469 (1157)
T ss_pred cCCceec--------------------------ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC
Confidence 3211110 011123567999999998889999999999999999997 9999999
Q ss_pred CChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCC
Q 002616 725 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781 (900)
Q Consensus 725 ~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPF 781 (900)
.+..++|..+.+ .+++. -|.++++.+..|++.||++.|..||++.++-+.++.-|
T Consensus 470 idlSqVY~LLEk-gyRM~-~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 470 IDLSQVYGLLEK-GYRMD-GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred ccHHHHHHHHhc-ccccc-CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 999988876544 44443 25899999999999999999999999655544444333
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=321.92 Aligned_cols=254 Identities=25% Similarity=0.335 Sum_probs=210.9
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
..-+...+.++||+|-||+|.+|.-.. +..||+|+++... ..+....|.+|+++|.+++|||||.|+++|..++.++
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 444566788999999999999998753 6899999997533 3455688999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
+|||||++|+|.+++.++. .+.......++.||+.||+||.+.+||||||.+.|+|+|.++++||+|||+++-.....
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999999999998873 33455666799999999999999999999999999999999999999999998432111
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHH--hCCCCCCCCCh
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI--TGIPPFTAESP 727 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEML--tGk~PF~~~s~ 727 (900)
.. +.....+-...|||||.+.-.+++.++|+|+||++|||++ +...||...+.
T Consensus 692 yy-------------------------~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~ 746 (807)
T KOG1094|consen 692 YY-------------------------RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD 746 (807)
T ss_pred ce-------------------------eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH
Confidence 11 1112345678999999999999999999999999999976 58899998887
Q ss_pred HHHHHhhhc-----CCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcH
Q 002616 728 EIIFDNILN-----RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 773 (900)
Q Consensus 728 ~ei~~kIl~-----~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a 773 (900)
+++.+..-. +....+..|.-++..+.+||.+||.+|..+||+++++
T Consensus 747 e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l 797 (807)
T KOG1094|consen 747 EQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL 797 (807)
T ss_pred HHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence 777665432 1222344567899999999999999999999996643
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=332.94 Aligned_cols=256 Identities=25% Similarity=0.341 Sum_probs=222.6
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCc---EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk---~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
.+..+...|-++||.|.||+|++|+.+..|+ .||||.++.. ..+.+...|+.|..||-+++||||++|-++....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 4667788999999999999999999987774 6999999764 3566788999999999999999999999999999
Q ss_pred CeeEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
..+.||+|||++|+|..+|+++ +.|+..+..-+++.|+.||+||-++|+|||||-..|||++.+..+|++||||+++..
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 9999999999999999999865 569999999999999999999999999999999999999999999999999999642
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCccccc---CCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAV---GTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 722 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~v---GTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF 722 (900)
.+. ...++.. -...|.|||.+...+++.++|+||+||+|||.++ |..||
T Consensus 783 dd~---------------------------~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 783 DDP---------------------------EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred cCC---------------------------CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 110 1112222 2478999999999999999999999999999765 99999
Q ss_pred CCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 723 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 723 ~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
.+.+.++..+.|..+ +++|. |.++|..+..|+..||++|-.+||.+.++..+|
T Consensus 836 WdmSNQdVIkaIe~g-yRLPp-PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~l 888 (996)
T KOG0196|consen 836 WDMSNQDVIKAIEQG-YRLPP-PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTL 888 (996)
T ss_pred cccchHHHHHHHHhc-cCCCC-CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHH
Confidence 999999999888654 44453 589999999999999999999999976655544
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=306.08 Aligned_cols=260 Identities=27% Similarity=0.455 Sum_probs=211.0
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh-cCCCceEEEeeeeccCCe
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTCRDN 569 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~-L~HPnIVkL~~~f~d~~~ 569 (900)
....++.+-+..||.|+||+|++-.++.+|+..|+|.|+.... +.+..+++.|.+...+ -+.||||++|+..-.+..
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd 137 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD 137 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc
Confidence 3455677778899999999999999999999999999986543 4556778888876554 469999999999999999
Q ss_pred eEEEEeecCCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHhhhh-cCeEeccCCCCcEEecCCCcEEEEecCCcc
Q 002616 570 LYLVMEYLNGGDLYSLLR-----KVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~-----k~g~Lse~~ar~ya~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~G~VKLsDFGLAk 643 (900)
.|+.||+|.- +|..+-+ +...++|...-.+....+.||+||-. ..||||||||+||||+..|.|||||||.|-
T Consensus 138 cWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcG 216 (361)
T KOG1006|consen 138 CWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICG 216 (361)
T ss_pred eeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchH
Confidence 9999999964 6544332 34579999988898899999999985 589999999999999999999999999986
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCC
Q 002616 644 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPP 721 (900)
Q Consensus 644 ~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGVILyEMLtGk~P 721 (900)
.... ......-+|-..|||||-+.. .+|+.++|+||||++|||+.||..|
T Consensus 217 qLv~----------------------------SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fP 268 (361)
T KOG1006|consen 217 QLVD----------------------------SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFP 268 (361)
T ss_pred hHHH----------------------------HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCC
Confidence 4210 111223478899999999964 5799999999999999999999999
Q ss_pred CCCCCh-HHHHHhhhcCCCCCCCCCC---CCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 722 FTAESP-EIIFDNILNRKIPWPCVPS---DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 722 F~~~s~-~ei~~kIl~~~l~~P~ip~---~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
+...+. .+....++.+..+.-..+. ..+..+..||..||.+|-..||. ..+++.+||++.
T Consensus 269 yr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpk---y~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 269 YRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPK---YDDLKKFPFYRM 332 (361)
T ss_pred cchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcc---hhhhhcCchhhh
Confidence 987653 4455555566544322223 47899999999999999999999 668999999974
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=340.24 Aligned_cols=270 Identities=51% Similarity=0.865 Sum_probs=229.4
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
-.-++|+.++.|..|+||.||+++++.+.+.+|+|+ +|..+.-++ ||.....|++|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~lilRn----------ilt~a~npfvv------------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNLILRN----------ILTFAGNPFVV------------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcc-cccchhhhc----------cccccCCccee-------------
Confidence 346799999999999999999999999999999954 443322111 55556677776
Q ss_pred EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
||=.++++..+.++.+. +.+++|||+.||+|||+||+|.||..-||+|++|||+++.+.+..+.
T Consensus 136 --------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at 199 (1205)
T KOG0606|consen 136 --------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT 199 (1205)
T ss_pred --------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence 67777787777777554 88999999999999999999999999999999999999987654433
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~ 731 (900)
.+.. + ++.. ..+.......||||.|+||||+..++|+..+|||++|+|+||.+.|..||.++++++++
T Consensus 200 nl~e----g------~I~k--~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf 267 (1205)
T KOG0606|consen 200 NLKE----G------HIEK--DTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF 267 (1205)
T ss_pred hhhh----c------chHH--HHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH
Confidence 2111 0 1110 11223345579999999999999999999999999999999999999999999999999
Q ss_pred HhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhhccCCccCCCCCCCCccccc
Q 002616 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFL 811 (900)
Q Consensus 732 ~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~~~ppf~P~~~s~~D~s~fd 811 (900)
..++...+.||.-...++++++++|.++|..+|..|.+..++.++++|+||+.+||..|..+++.|+|.....+|++||+
T Consensus 268 g~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRqkaefvpql~~eddtsyfd 347 (1205)
T KOG0606|consen 268 GQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQKAEFVPQLESEDDTSYFD 347 (1205)
T ss_pred hhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhhhccccccccccccchhhc
Confidence 99999999999877788999999999999999999999889999999999999999999999999999999999999999
Q ss_pred cc
Q 002616 812 SR 813 (900)
Q Consensus 812 ~~ 813 (900)
.+
T Consensus 348 TR 349 (1205)
T KOG0606|consen 348 TR 349 (1205)
T ss_pred cc
Confidence 75
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=323.29 Aligned_cols=254 Identities=24% Similarity=0.333 Sum_probs=214.8
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCC-c--EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTG-D--LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tG-k--~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~ 567 (900)
-+..++..+.+.||.|.||.|++|.|...+ + .||||+++..... .....|++|+.+|.+++|||+++||+...+
T Consensus 106 lIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 106 LIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD- 182 (1039)
T ss_pred eccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-
Confidence 355667788899999999999999998643 3 5899999764432 267899999999999999999999999988
Q ss_pred CeeEEEEeecCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k--~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~ 645 (900)
..+.||||+++.|+|.+.|++ .+.|.....-.|+.||+.||.||..+++|||||-..||||.....|||+||||.+.+
T Consensus 183 qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaL 262 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRAL 262 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceecc
Confidence 678899999999999999987 346888999999999999999999999999999999999999999999999999854
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCC
Q 002616 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 724 (900)
Q Consensus 646 ~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~ 724 (900)
..+.. . |. .....--...|+|||.|....++.++|+|+|||+||||++ |..||.+
T Consensus 263 g~ned----------------~---Yv-----m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G 318 (1039)
T KOG0199|consen 263 GENED----------------M---YV-----MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG 318 (1039)
T ss_pred CCCCc----------------c---eE-----ecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC
Confidence 32111 0 00 1111223567999999999999999999999999999998 8999999
Q ss_pred CChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcH
Q 002616 725 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 773 (900)
Q Consensus 725 ~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a 773 (900)
....++.++|-.+ -.+| -|..+|+++.++++.||..+|.+||++..+
T Consensus 319 ~~g~qIL~~iD~~-erLp-RPk~csedIY~imk~cWah~paDRptFsai 365 (1039)
T KOG0199|consen 319 CRGIQILKNIDAG-ERLP-RPKYCSEDIYQIMKNCWAHNPADRPTFSAI 365 (1039)
T ss_pred CCHHHHHHhcccc-ccCC-CCCCChHHHHHHHHHhccCCccccccHHHH
Confidence 9999999998743 3333 258899999999999999999999996544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=344.65 Aligned_cols=241 Identities=23% Similarity=0.322 Sum_probs=187.1
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
..|...+.||+|+||.||+|+++.+|..||+|.++..... ...|+.++.+++|||||++++++.+.+..|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3466778899999999999999999999999988653221 124578899999999999999999999999999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhh---hcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH---SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLH---s~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
||+++|+|.++++. +++..+..++.||+.||+||| +.+|+||||||+|||++.++..++. ||......
T Consensus 763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~----- 833 (968)
T PLN00113 763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC----- 833 (968)
T ss_pred eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc-----
Confidence 99999999999964 788999999999999999999 6799999999999999999888876 66543210
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh----
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP---- 727 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~---- 727 (900)
......||+.|||||++.+..|+.++|||||||++|||++|+.||.....
T Consensus 834 --------------------------~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~ 887 (968)
T PLN00113 834 --------------------------TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS 887 (968)
T ss_pred --------------------------cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCc
Confidence 01123689999999999999999999999999999999999999954321
Q ss_pred -HHHHHhhhcC-CC---CCCCC------CCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 728 -EIIFDNILNR-KI---PWPCV------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 728 -~ei~~kIl~~-~l---~~P~i------p~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
.+..+..... .. .-|.+ +.....++.+++.+||+.||++||++.++.+.+
T Consensus 888 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L 948 (968)
T PLN00113 888 IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948 (968)
T ss_pred HHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHH
Confidence 1111111100 00 00111 111223577899999999999999965554443
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=316.27 Aligned_cols=251 Identities=24% Similarity=0.392 Sum_probs=208.9
Q ss_pred CeEEEEEeccCCceEEEEEEECCC--C--cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTT--G--DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~t--G--k~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
...+.+.||.|.||.||.|....- | -.||||.-++.. .....+.|+.|.-+|+.++|||||+|+|.+.+. ..|
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~W 466 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMW 466 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-cee
Confidence 344567899999999999987533 2 358999886633 345578999999999999999999999999765 579
Q ss_pred EEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
||||+++-|.|..+|+.. ..++......|+.||+.||+|||+..+|||||-..|||+...-.|||+||||++.......
T Consensus 467 ivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~y 546 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAY 546 (974)
T ss_pred EEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccch
Confidence 999999999999999865 4688899999999999999999999999999999999999999999999999986421110
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 729 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~e 729 (900)
| .+....-..-|||||.+.-..++.++|||-|||+|||+|. |..||.+....+
T Consensus 547 -----------------Y---------kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD 600 (974)
T KOG4257|consen 547 -----------------Y---------KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD 600 (974)
T ss_pred -----------------h---------hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence 0 1111223567999999999999999999999999999987 999999998888
Q ss_pred HHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 730 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 730 i~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
+...|.++. +.| .|+.+++.+..|+.+||.+||.+||.+.++..+|
T Consensus 601 VI~~iEnGe-RlP-~P~nCPp~LYslmskcWayeP~kRPrftei~~~l 646 (974)
T KOG4257|consen 601 VIGHIENGE-RLP-CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAIL 646 (974)
T ss_pred eEEEecCCC-CCC-CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHH
Confidence 888877654 223 4689999999999999999999999965544333
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=315.28 Aligned_cols=256 Identities=31% Similarity=0.510 Sum_probs=210.5
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC------CceEEEeeeec
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN------PFVVRFFYSFT 565 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~H------PnIVkL~~~f~ 565 (900)
+--+.|.+....|+|-|++|..|.+..-|..||||+|+....+.+ .=+.|++||++|+. -++++|+-.|.
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~K----tGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHK----TGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhh----hhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 445789999999999999999999999999999999988665433 34679999999962 48999999999
Q ss_pred cCCeeEEEEeecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCC-cEEEEecCC
Q 002616 566 CRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGL 641 (900)
Q Consensus 566 d~~~LyLVmEy~~GGsL~dlL~k~g---~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G-~VKLsDFGL 641 (900)
..+++|||+|.+.- +|..+|++.| .|....++.|+.|+..||..|-..||+|.||||+|||+++.. .+||||||.
T Consensus 505 hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 99999999999854 9999999876 478889999999999999999999999999999999999764 689999999
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCC
Q 002616 642 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 721 (900)
Q Consensus 642 Ak~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~P 721 (900)
|.....+. .....-+..|.|||+++|.+|++..|+||+||+||||.||+..
T Consensus 584 A~~~~ene-----------------------------itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIl 634 (752)
T KOG0670|consen 584 ASFASENE-----------------------------ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKIL 634 (752)
T ss_pred cccccccc-----------------------------ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeecccee
Confidence 87542211 1123445679999999999999999999999999999999999
Q ss_pred CCCCChHHHHHhhhcCCCCCCC---------------------------------------------------------C
Q 002616 722 FTAESPEIIFDNILNRKIPWPC---------------------------------------------------------V 744 (900)
Q Consensus 722 F~~~s~~ei~~kIl~~~l~~P~---------------------------------------------------------i 744 (900)
|.+.+...+.+..+.-+-+||. -
T Consensus 635 FpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~de 714 (752)
T KOG0670|consen 635 FPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDE 714 (752)
T ss_pred cCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCch
Confidence 9998876665543322211211 0
Q ss_pred CCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 745 PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 745 p~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
...+-.++++|+.+||..||++|++ +.+.|.||||.+
T Consensus 715 q~~~~~~~rdLLdkml~LdP~KRit---~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 715 QPKIVQQLRDLLDKMLILDPEKRIT---VNQALKHPFITE 751 (752)
T ss_pred hHHHHHHHHHHHHHHhccChhhcCC---HHHHhcCCcccC
Confidence 1112345789999999999999999 778899999964
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=290.03 Aligned_cols=253 Identities=33% Similarity=0.559 Sum_probs=207.5
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCC--e
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRD--N 569 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~--~ 569 (900)
..++|++.+++|+|-|++||.|.+..+++.++||+++.. ....+.+|+.||..+. ||||++|++...++. .
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 678999999999999999999999999999999999642 3456889999999998 999999999998875 4
Q ss_pred eEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCC-CcEEEEecCCccccccc
Q 002616 570 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~-G~VKLsDFGLAk~~~~~ 648 (900)
.-||+||+.+.+...+- ..++.-.+++|+.|++.||.|+|++||+|||+||.|++||.. -.++|+|+|||.+-.
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH-- 184 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-- 184 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC--
Confidence 78999999998776654 358888999999999999999999999999999999999964 579999999997531
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCC-CCCC
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPF-TAES 726 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF-~~~s 726 (900)
++..-+..+.+..|--||.+.. +.|+.+-|+|||||++..|+..+-|| .+.+
T Consensus 185 --------------------------p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d 238 (338)
T KOG0668|consen 185 --------------------------PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 238 (338)
T ss_pred --------------------------CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence 1223345677888999999875 67899999999999999999998887 4555
Q ss_pred hHHHHHhhhc---------------------------C--CCCCC-----CCCCCCCHHHHHHHHHhccCCcCCCCChhc
Q 002616 727 PEIIFDNILN---------------------------R--KIPWP-----CVPSDMSFEAQDLINRFLIHDPNQRLGANG 772 (900)
Q Consensus 727 ~~ei~~kIl~---------------------------~--~l~~P-----~ip~~lS~eakDLIk~cL~~DP~kRpSa~~ 772 (900)
..+..-+|.+ . +.+|. ....-.++++.||+.++|.+|-.+|||
T Consensus 239 N~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT--- 315 (338)
T KOG0668|consen 239 NYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT--- 315 (338)
T ss_pred CHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc---
Confidence 4443333321 0 01111 111235799999999999999999999
Q ss_pred HHHHHcCCCCCCC
Q 002616 773 AAEVKAHPFFKGV 785 (900)
Q Consensus 773 a~EIL~HPFFk~i 785 (900)
|.|.+.||||..+
T Consensus 316 akEam~HpyF~~~ 328 (338)
T KOG0668|consen 316 AKEAMAHPYFAPV 328 (338)
T ss_pred hHHHhcCchHHHH
Confidence 8899999999754
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=302.77 Aligned_cols=254 Identities=26% Similarity=0.393 Sum_probs=199.1
Q ss_pred ccccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--cCCCceEEEeeeec
Q 002616 488 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFT 565 (900)
Q Consensus 488 ~~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~--L~HPnIVkL~~~f~ 565 (900)
...+....+..+.+.||+|.||+||+|+|+ |+.||||++... +.+...+|.+|-+. ++|+||+.++++-.
T Consensus 204 LVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~ 275 (513)
T KOG2052|consen 204 LVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADN 275 (513)
T ss_pred HhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccc
Confidence 455667788999999999999999999999 999999999653 34567788888754 68999999998765
Q ss_pred cCC----eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhc--------CeEeccCCCCcEEecCCCc
Q 002616 566 CRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDLKPDNLLIAHDGH 633 (900)
Q Consensus 566 d~~----~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~--------gIIHRDLKPeNILLd~~G~ 633 (900)
..+ .+|||++|.+.|+|+|+|.+ ..++.+....++..++.||+|||.. .|.|||||..|||+.++|.
T Consensus 276 ~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 276 KDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred cCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 554 59999999999999999987 6789999999999999999999943 4999999999999999999
Q ss_pred EEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCC----C--Cccceeec
Q 002616 634 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE----H--GYAADWWS 707 (900)
Q Consensus 634 VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~----y--s~ksDIWS 707 (900)
+-|+|+|||....... ..-....+..|||..|||||+|...- + -..+||||
T Consensus 355 C~IADLGLAv~h~~~t-----------------------~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYa 411 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDT-----------------------DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYA 411 (513)
T ss_pred EEEeeceeeEEecccC-----------------------CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHH
Confidence 9999999997432110 00112345689999999999997532 1 23689999
Q ss_pred hhHHHHHHHhC----------CCCCCCCC-----hHHHHHhhhcCCCCCCCCCCCCC-----HHHHHHHHHhccCCcCCC
Q 002616 708 VGIILFEFITG----------IPPFTAES-----PEIIFDNILNRKIPWPCVPSDMS-----FEAQDLINRFLIHDPNQR 767 (900)
Q Consensus 708 LGVILyEMLtG----------k~PF~~~s-----~~ei~~kIl~~~l~~P~ip~~lS-----~eakDLIk~cL~~DP~kR 767 (900)
||.+|||++.. .+||++.. .+++.+-+...+++ |.+|..+. ..+..|++.||..||.-|
T Consensus 412 fgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~R-P~ipnrW~s~~~l~~m~klMkeCW~~Np~aR 490 (513)
T KOG2052|consen 412 FGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLR-PNIPNRWKSDPALRVMAKLMKECWYANPAAR 490 (513)
T ss_pred HHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccC-CCCCcccccCHHHHHHHHHHHHhhcCCchhh
Confidence 99999999763 47887542 24444444445554 55555543 235688999999999999
Q ss_pred CChhcHHHHH
Q 002616 768 LGANGAAEVK 777 (900)
Q Consensus 768 pSa~~a~EIL 777 (900)
+| |..|+
T Consensus 491 lt---ALriK 497 (513)
T KOG2052|consen 491 LT---ALRIK 497 (513)
T ss_pred hH---HHHHH
Confidence 99 55554
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8e-33 Score=296.32 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=209.7
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC----
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 568 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~---- 568 (900)
...+|.-++.+|.|+- .|..+-+.-+++.||+|.+... ........+..+|..++..++|+||++++.+|.-..
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence 3457888889999988 7888888888999999988654 333455677889999999999999999999997655
Q ss_pred --eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccc
Q 002616 569 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 569 --~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~ 646 (900)
..|+|||||.+ +|...+. -.++...++++..|++.|+.|||+.||+||||||+||++..++.+||.|||+|+...
T Consensus 93 ~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 93 FQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 48999999975 8888876 347888999999999999999999999999999999999999999999999998411
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
........+.|..|.|||++.+.+|...+||||+|||+.||++|..-|.+.+
T Consensus 170 ----------------------------~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d 221 (369)
T KOG0665|consen 170 ----------------------------TDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD 221 (369)
T ss_pred ----------------------------cccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch
Confidence 1123445789999999999999999999999999999999999999999877
Q ss_pred hHHHHHhhhcC---------------------------CCC----CCC--------CCCCCCHHHHHHHHHhccCCcCCC
Q 002616 727 PEIIFDNILNR---------------------------KIP----WPC--------VPSDMSFEAQDLINRFLIHDPNQR 767 (900)
Q Consensus 727 ~~ei~~kIl~~---------------------------~l~----~P~--------ip~~lS~eakDLIk~cL~~DP~kR 767 (900)
..+.+.+|... ... ||. .++.-+..+.||+.+||..||++|
T Consensus 222 ~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~R 301 (369)
T KOG0665|consen 222 HIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKR 301 (369)
T ss_pred HHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhc
Confidence 55554444220 001 111 011224568999999999999999
Q ss_pred CChhcHHHHHcCCCCC
Q 002616 768 LGANGAAEVKAHPFFK 783 (900)
Q Consensus 768 pSa~~a~EIL~HPFFk 783 (900)
.+ +.++|+||||+
T Consensus 302 is---v~daL~HPY~~ 314 (369)
T KOG0665|consen 302 IS---VDDALRHPYIK 314 (369)
T ss_pred cc---HHHHhcCCeee
Confidence 99 88999999998
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-33 Score=322.65 Aligned_cols=244 Identities=32% Similarity=0.441 Sum_probs=196.9
Q ss_pred EEeccCCceE-EEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEeecC
Q 002616 501 KPISRGAFGR-VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLN 578 (900)
Q Consensus 501 ~~LGkG~FG~-Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~LyLVmEy~~ 578 (900)
+++|.|+-|+ ||+|... |+.||||.+-. .-...+.+|+..|+..+ |||||++|+.-++...+||..|.|.
T Consensus 515 eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 515 EILGYGSNGTVVFRGVYE--GREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred HHcccCCCCcEEEEEeeC--CceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 4689999986 7999986 89999997632 34556789999999886 9999999999999999999999997
Q ss_pred CCChHHHHHhcCC----CCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecC---CC--cEEEEecCCcccccccc
Q 002616 579 GGDLYSLLRKVGC----LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DG--HIKLTDFGLSKIGLINN 649 (900)
Q Consensus 579 GGsL~dlL~k~g~----Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~---~G--~VKLsDFGLAk~~~~~~ 649 (900)
. +|.+++...+. ......+..+.|++.||++||+.+||||||||.||||+. +| .++|+|||+|+....+.
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 6 99999987411 111345778899999999999999999999999999986 34 68999999998642111
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhC-CCCCCCCChH
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG-IPPFTAESPE 728 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtG-k~PF~~~s~~ 728 (900)
+ .-....+..||-+|+|||++....-..++||+||||++|+.++| ..||.+.-..
T Consensus 666 s------------------------S~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 666 S------------------------SFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred c------------------------hhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 1 11124567899999999999998888899999999999999985 8999765433
Q ss_pred HHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 729 ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
-.+|+++....-.+.+....++.|||.+||..||..||+ |.++|.||||
T Consensus 722 --~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPs---a~~VL~HPlF 770 (903)
T KOG1027|consen 722 --QANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPS---ATDVLNHPLF 770 (903)
T ss_pred --hhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCC---HHHHhCCCcc
Confidence 335666665443332333339999999999999999999 8899999999
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-33 Score=294.05 Aligned_cols=261 Identities=30% Similarity=0.501 Sum_probs=213.9
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-----e
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD-----N 569 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~-----~ 569 (900)
.|.+--+.||.|+||.||-+.+-.+|+.||+|.+... ..+-....++.+|..+|.-++|.||+..++..+-.. .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 3455567899999999999999999999999987542 223345678999999999999999999998877664 4
Q ss_pred eEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccc
Q 002616 570 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~ 649 (900)
+|+|+|+|.. ||..++-.-..++.+.++-++.||++||+|||+.||.||||||.|+|++.|..+||||||+++.-.
T Consensus 132 iYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee--- 207 (449)
T KOG0664|consen 132 LYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWD--- 207 (449)
T ss_pred HHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccc---
Confidence 8999999976 898888887889999999999999999999999999999999999999999999999999998521
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC-CCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPE 728 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ 728 (900)
..........+-|..|.|||+++| ..|+.++||||+|||+.|+|-.+..|...++.
T Consensus 208 -----------------------~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi 264 (449)
T KOG0664|consen 208 -----------------------QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPI 264 (449)
T ss_pred -----------------------hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChH
Confidence 122233444578999999999998 56899999999999999999999999988876
Q ss_pred HHHHhhhc-----------------------CCCCCCCC--------CCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 729 IIFDNILN-----------------------RKIPWPCV--------PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 729 ei~~kIl~-----------------------~~l~~P~i--------p~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
+..+.|.. +..+-|.+ +..-..++.+++..+|..||.+|.+ ..+.+
T Consensus 265 qQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris---~~~A~ 341 (449)
T KOG0664|consen 265 EQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS---VEEAL 341 (449)
T ss_pred HHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc---Hhhhc
Confidence 65554432 22222322 1234457889999999999999998 77889
Q ss_pred cCCCCCCCC
Q 002616 778 AHPFFKGVN 786 (900)
Q Consensus 778 ~HPFFk~id 786 (900)
.|++.....
T Consensus 342 ~~~~~~e~R 350 (449)
T KOG0664|consen 342 QHRYLEEGR 350 (449)
T ss_pred ccccccccc
Confidence 999986543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-33 Score=315.50 Aligned_cols=261 Identities=31% Similarity=0.508 Sum_probs=227.4
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
-..++|+++.++|.|+||.||+++++.+++..|+|+++-. -.....-+..|+-+++.++|||||.+++.+...+.++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence 3467999999999999999999999999999999999642 3345667788999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
+.||||.||+|.+.-+-.+.+++.++.+..++.+.||+|||+.|=+|||||-.|||+++.|.+||+|||.+....
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit----- 163 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT----- 163 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh-----
Confidence 999999999999998888999999999999999999999999999999999999999999999999999875321
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc---CCCCCccceeechhHHHHHHHhCCCCCCCCChH
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 728 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~---g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ 728 (900)
.--.+..++.|||.|||||+.. ..+|+..||+|++|+...|+---++|-....++
T Consensus 164 ----------------------ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 164 ----------------------ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred ----------------------hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 0012456789999999999863 578999999999999999999888998777777
Q ss_pred HHHHhhhcCCCCCCCC--CCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCC
Q 002616 729 IIFDNILNRKIPWPCV--PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 729 ei~~kIl~~~l~~P~i--p~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~i 785 (900)
.....+.+..+.-|.+ +..+++.+.+|++.+|.++|++||+ ++.+|.|||...-
T Consensus 222 r~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRpt---aeklL~h~fvs~~ 277 (829)
T KOG0576|consen 222 RALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPT---AEKLLQHPFVSQT 277 (829)
T ss_pred HHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCC---hhhheeceeeccc
Confidence 7666666655544432 3568899999999999999999999 7788999998754
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=307.81 Aligned_cols=205 Identities=29% Similarity=0.513 Sum_probs=183.2
Q ss_pred cccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhH-----HHHHHHHHHHHHhcC---CCceEEEee
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-----IERILAERNILITVR---NPFVVRFFY 562 (900)
Q Consensus 491 ~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~-----~e~~l~Ei~IL~~L~---HPnIVkL~~ 562 (900)
.....+|..++.+|.|+||.|++|.++.+...|++|.|.|.++..... .-.+-.|+.||..++ |+||+++++
T Consensus 557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 456778999999999999999999999999999999999877653322 334677999999997 999999999
Q ss_pred eeccCCeeEEEEeec-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCC
Q 002616 563 SFTCRDNLYLVMEYL-NGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 641 (900)
Q Consensus 563 ~f~d~~~LyLVmEy~-~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGL 641 (900)
+|++++++||+||-. +|-||++++..+..++|.+++.+++||+.|+++||+.||||||||-+|+.++.+|.+||+|||.
T Consensus 637 fFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 637 FFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred eeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccc
Confidence 999999999999975 5679999999999999999999999999999999999999999999999999999999999998
Q ss_pred cccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCC
Q 002616 642 SKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIP 720 (900)
Q Consensus 642 Ak~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGVILyEMLtGk~ 720 (900)
|... ....-..++||.+|.|||++.|.+| +..-|||+||++||.++....
T Consensus 717 aa~~-----------------------------ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyken 767 (772)
T KOG1152|consen 717 AAYT-----------------------------KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKEN 767 (772)
T ss_pred hhhh-----------------------------cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccC
Confidence 8642 1223456899999999999999888 788999999999999999999
Q ss_pred CCCC
Q 002616 721 PFTA 724 (900)
Q Consensus 721 PF~~ 724 (900)
||+.
T Consensus 768 pyyn 771 (772)
T KOG1152|consen 768 PYYN 771 (772)
T ss_pred CCcC
Confidence 9874
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=309.65 Aligned_cols=259 Identities=28% Similarity=0.416 Sum_probs=211.4
Q ss_pred cccccCCCeEEEEEeccCCceEEEEEEECC-------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEE
Q 002616 489 KERTSIDDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRF 560 (900)
Q Consensus 489 ~~~~~~~dYeil~~LGkG~FG~Vyla~~k~-------tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL 560 (900)
...+..++..+.+.||.|+||.|++|.-.. ....||+|.++.... ..+.+.+..|+++|..+. |||||.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 444556666777899999999999997431 134799999876443 367888999999999985 9999999
Q ss_pred eeeeccCCeeEEEEeecCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCC
Q 002616 561 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 624 (900)
Q Consensus 561 ~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g----------------~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPe 624 (900)
++++.....+++|+||+..|+|..+|+... .++......++.||+.|++||++..+|||||-..
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999998765 3888889999999999999999999999999999
Q ss_pred cEEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccC--CCCCCChhhhcCCCCCcc
Q 002616 625 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG--TPDYLAPEILLGTEHGYA 702 (900)
Q Consensus 625 NILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vG--Tp~YmAPEvL~g~~ys~k 702 (900)
||||..+..+||+|||+|+....... .......| ...|||||.+....|+.+
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~--------------------------y~~~~~~~~LP~kWmApEsl~~~~ft~k 501 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDY--------------------------YRTKSSAGTLPVKWMAPESLFDRVFTSK 501 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCc--------------------------eEecCCCCccceeecCHHHhccCccccc
Confidence 99999999999999999984211000 00011122 345999999999999999
Q ss_pred ceeechhHHHHHHHh-CCCCCCCCC-hHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 703 ADWWSVGIILFEFIT-GIPPFTAES-PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 703 sDIWSLGVILyEMLt-Gk~PF~~~s-~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
+|||||||+||||++ |..||.+.. ..++++.+..+. +.. .|...++++.++++.||+.+|++||++.+..+.+
T Consensus 502 SDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~-r~~-~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~ 576 (609)
T KOG0200|consen 502 SDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGN-RME-QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFF 576 (609)
T ss_pred chhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCC-CCC-CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHH
Confidence 999999999999998 999999866 666766555443 322 3578899999999999999999999976655544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=295.28 Aligned_cols=133 Identities=29% Similarity=0.489 Sum_probs=115.5
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-----C---CceEEEeee
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----N---PFVVRFFYS 563 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-----H---PnIVkL~~~ 563 (900)
....+|.+.++||.|.|++||+|.+..+.+.||||+.+... ...+..+.|+.+|++++ | .+||+|++.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 34478999999999999999999999999999999997644 34566788999999874 3 369999999
Q ss_pred eccC----CeeEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhh-cCeEeccCCCCcEEec
Q 002616 564 FTCR----DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIA 629 (900)
Q Consensus 564 f~d~----~~LyLVmEy~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs-~gIIHRDLKPeNILLd 629 (900)
|... .+++||+|++ |-+|..+|.+. ..++...++.|++||+.||.|||. .||||-||||+||||-
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 9754 4799999999 66899998764 469999999999999999999996 5999999999999994
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-29 Score=244.74 Aligned_cols=212 Identities=44% Similarity=0.742 Sum_probs=185.6
Q ss_pred eccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCCh
Q 002616 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL 582 (900)
Q Consensus 503 LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GGsL 582 (900)
||.|++|.||+++...+|+.+++|++....... ....+.+|+.++..+.|++|+++++++......+++|||++|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999987543211 357799999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecC-CCcEEEEecCCcccccccccccCCCCCCCC
Q 002616 583 YSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGLINNTIDLSGPETDG 660 (900)
Q Consensus 583 ~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~-~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~ 660 (900)
.+++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+......
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~------------ 146 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD------------ 146 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC------------
Confidence 9999876 57899999999999999999999999999999999999999 899999999998742100
Q ss_pred CCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC-CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCC
Q 002616 661 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739 (900)
Q Consensus 661 ~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l 739 (900)
........+...|++||.+... .++.+.|+|+||+++|+|
T Consensus 147 ---------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------ 187 (215)
T cd00180 147 ---------------KSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------ 187 (215)
T ss_pred ---------------cchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------
Confidence 0012335688999999999887 888999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCC
Q 002616 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 780 (900)
Q Consensus 740 ~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HP 780 (900)
..+.+++.+||..||.+||+ +.++++|+
T Consensus 188 ----------~~~~~~l~~~l~~~p~~R~~---~~~l~~~~ 215 (215)
T cd00180 188 ----------PELKDLIRKMLQKDPEKRPS---AKEILEHL 215 (215)
T ss_pred ----------HHHHHHHHHHhhCCcccCcC---HHHHhhCC
Confidence 57899999999999999999 77888774
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-29 Score=252.98 Aligned_cols=214 Identities=45% Similarity=0.750 Sum_probs=184.3
Q ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 576 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy 576 (900)
|.+.+.||.|++|.||+|....+++.+|+|.+...... .....+.+|+..+..++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 57789999999999999999988999999998764322 2567889999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCC
Q 002616 577 LNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 577 ~~GGsL~dlL~k~g~-Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~ 655 (900)
+++++|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~------ 152 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL------ 152 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc------
Confidence 999999999987766 8999999999999999999999999999999999999999999999999987531100
Q ss_pred CCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhh-cCCCCCccceeechhHHHHHHHhCCCCCCC-CC-hHHHHH
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-LGTEHGYAADWWSVGIILFEFITGIPPFTA-ES-PEIIFD 732 (900)
Q Consensus 656 ~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL-~g~~ys~ksDIWSLGVILyEMLtGk~PF~~-~s-~~ei~~ 732 (900)
........++..|++||.+ ....++.++|+|+||+++|+|++|++||.. .+ ...+.+
T Consensus 153 --------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~ 212 (225)
T smart00221 153 --------------------AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSD 212 (225)
T ss_pred --------------------cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHH
Confidence 0022345688999999999 667788899999999999999999999987 34 446777
Q ss_pred hhhcCC
Q 002616 733 NILNRK 738 (900)
Q Consensus 733 kIl~~~ 738 (900)
.|..+.
T Consensus 213 ~~~~~~ 218 (225)
T smart00221 213 VWSFGV 218 (225)
T ss_pred HHhcCC
Confidence 776654
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-30 Score=286.70 Aligned_cols=244 Identities=26% Similarity=0.407 Sum_probs=191.2
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHh--cCCCceEEEeeeeccCC--
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTCRD-- 568 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~--L~HPnIVkL~~~f~d~~-- 568 (900)
.....++++.||+|.||.||+|+.. ++.||||++.. .+.+.+.+|.+|.+. ++|+||+++++.-.-..
T Consensus 208 ~l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~------~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~ 279 (534)
T KOG3653|consen 208 ELDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPE------QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD 279 (534)
T ss_pred cCCchhhHHHhhcCccceeehhhcc--CceeEEEecCH------HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc
Confidence 3566788899999999999999887 79999999853 567789999999775 57999999998766555
Q ss_pred --eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhc---------CeEeccCCCCcEEecCCCcEEEE
Q 002616 569 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL---------GIVHRDLKPDNLLIAHDGHIKLT 637 (900)
Q Consensus 569 --~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~---------gIIHRDLKPeNILLd~~G~VKLs 637 (900)
.++||++|.+.|+|.++|..+ .+++.....++..+++||+|||.- .|+|||||..||||.+++++-|+
T Consensus 280 ~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa 358 (534)
T KOG3653|consen 280 RMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA 358 (534)
T ss_pred ccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence 799999999999999999764 589999999999999999999953 59999999999999999999999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCC-CC-----ccceeechhHH
Q 002616 638 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HG-----YAADWWSVGII 711 (900)
Q Consensus 638 DFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-ys-----~ksDIWSLGVI 711 (900)
|||||..+... .....+...|||.+|||||+|.+.- .. ...||||+|.+
T Consensus 359 DFGLAl~~~p~-------------------------~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLV 413 (534)
T KOG3653|consen 359 DFGLALRLEPG-------------------------KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLV 413 (534)
T ss_pred ccceeEEecCC-------------------------CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHH
Confidence 99999864210 1112234479999999999998732 11 36899999999
Q ss_pred HHHHHhCCC------------CCCC-----CChHHHHHhhhcCCCCCCCCCCC-----CCHHHHHHHHHhccCCcCCCCC
Q 002616 712 LFEFITGIP------------PFTA-----ESPEIIFDNILNRKIPWPCVPSD-----MSFEAQDLINRFLIHDPNQRLG 769 (900)
Q Consensus 712 LyEMLtGk~------------PF~~-----~s~~ei~~kIl~~~l~~P~ip~~-----lS~eakDLIk~cL~~DP~kRpS 769 (900)
||||++... ||.. .+-+++...++..+.+ |.+|.. -..-+++.|..||..||+-|+|
T Consensus 414 LWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~R-P~~p~~W~~h~~~~~l~et~EeCWDhDaeARLT 492 (534)
T KOG3653|consen 414 LWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQR-PKIPDAWRKHAGMAVLCETIEECWDHDAEARLT 492 (534)
T ss_pred HHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccC-CCChhhhhcCccHHHHHHHHHHHcCCchhhhhh
Confidence 999998643 3431 1223444444443332 433332 2345789999999999999999
Q ss_pred hh
Q 002616 770 AN 771 (900)
Q Consensus 770 a~ 771 (900)
+.
T Consensus 493 A~ 494 (534)
T KOG3653|consen 493 AG 494 (534)
T ss_pred hH
Confidence 54
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=261.85 Aligned_cols=217 Identities=29% Similarity=0.523 Sum_probs=179.6
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEEEeeeeccCCee
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDNL 570 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVkL~~~f~d~~~L 570 (900)
+..++..-+..||+|+||.|-+.++..+|...|+|.++.. ...+...+.++|+++..+. .+|++|.+|+.+.....+
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t--vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT--VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh--cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 4456667778899999999999999999999999998652 3345667788888886554 699999999999999999
Q ss_pred EEEEeecCCCChHHH----HHhcCCCCHHHHHHHHHHHHHHHHhhhhc-CeEeccCCCCcEEecCCCcEEEEecCCcccc
Q 002616 571 YLVMEYLNGGDLYSL----LRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645 (900)
Q Consensus 571 yLVmEy~~GGsL~dl----L~k~g~Lse~~ar~ya~QIl~AL~yLHs~-gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~ 645 (900)
++.||.|.. +|..+ +.+.+.++|..+=.++..++.||.|||++ .+||||+||+||||+.+|+||+||||.+-..
T Consensus 121 wIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 121 WICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 999999965 76544 44567899999999999999999999965 8999999999999999999999999998642
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC----CCCCccceeechhHHHHHHHhCCCC
Q 002616 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEFITGIPP 721 (900)
Q Consensus 646 ~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g----~~ys~ksDIWSLGVILyEMLtGk~P 721 (900)
.. ........|-..|||||.+.. .+|+.++||||||++|+||.+++.|
T Consensus 200 ~d----------------------------SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~P 251 (282)
T KOG0984|consen 200 VD----------------------------SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFP 251 (282)
T ss_pred hh----------------------------hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccc
Confidence 10 011122468889999999863 4899999999999999999999999
Q ss_pred CCC-CChHHHHHhhhcCCC
Q 002616 722 FTA-ESPEIIFDNILNRKI 739 (900)
Q Consensus 722 F~~-~s~~ei~~kIl~~~l 739 (900)
|.. .++-+..+.++....
T Consensus 252 Y~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 252 YESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred ccccCCHHHHHHHHhcCCC
Confidence 975 467778888876643
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-30 Score=295.67 Aligned_cols=246 Identities=22% Similarity=0.335 Sum_probs=206.9
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCc----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeE
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk----~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~Ly 571 (900)
..+..++||.|+||+||+|.|-..|+ +||+|++.... .......++.|+-+|.+++|||+++|++++.... +-
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 34556799999999999999976665 68999886543 3445678999999999999999999999998877 88
Q ss_pred EEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccccccccc
Q 002616 572 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s 650 (900)
||++||++|.|.++++.+ +.+-......|..||++||.|||.+.++||||-..|||+..-.++||.|||+++....
T Consensus 774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~--- 850 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP--- 850 (1177)
T ss_pred HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCc---
Confidence 999999999999999865 4688888999999999999999999999999999999999999999999999985321
Q ss_pred ccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCCCChHH
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 729 (900)
Q Consensus 651 ~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~~s~~e 729 (900)
... ........-.+.|||=|.+....|+.++|||||||++||++| |..|+.+....+
T Consensus 851 -------------d~~---------ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e 908 (1177)
T KOG1025|consen 851 -------------DEK---------EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE 908 (1177)
T ss_pred -------------ccc---------cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH
Confidence 000 111122234578999999999999999999999999999998 999999998888
Q ss_pred HHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChh
Q 002616 730 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 771 (900)
Q Consensus 730 i~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~ 771 (900)
+-..+..+. +.+ .|+..+-++.-++.+||..|+..||++.
T Consensus 909 I~dlle~ge-RLs-qPpiCtiDVy~~mvkCwmid~~~rp~fk 948 (1177)
T KOG1025|consen 909 IPDLLEKGE-RLS-QPPICTIDVYMVMVKCWMIDADSRPTFK 948 (1177)
T ss_pred hhHHHhccc-cCC-CCCCccHHHHHHHHHHhccCcccCccHH
Confidence 776655443 333 3578999999999999999999999954
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=279.97 Aligned_cols=284 Identities=27% Similarity=0.437 Sum_probs=208.0
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECC---CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccC
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCR 567 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~---tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~ 567 (900)
...+.|.++.+||.|.|+.||++.... .++.||+|.+.... ...++.+|+++|..+. +.||+++.+++..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 345678999999999999999999877 78899999886533 3456999999999986 99999999999999
Q ss_pred CeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecC-CCcEEEEecCCccccc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKIGL 646 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~-~G~VKLsDFGLAk~~~ 646 (900)
+...+||||++..+..++... ++-..++.|++.++.||.++|.+|||||||||.|+|.+. -+.-.|+|||||..-.
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 999999999999888888765 678899999999999999999999999999999999985 4678999999997211
Q ss_pred ccc----cccCCCC-CC--CCC-CCC----C-CCCCccc----ccccCCcccccCCCCCCChhhhcCC-CCCccceeech
Q 002616 647 INN----TIDLSGP-ET--DGI-MPS----D-AHYPEYQ----QTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSV 708 (900)
Q Consensus 647 ~~~----s~~l~~~-~~--~~~-~~s----~-~~~~~~~----~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSL 708 (900)
... .-...++ .+ .+. ... . ..-..+. ...+.......|||+|.|||++... ..+.++||||.
T Consensus 185 ~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 000 0000000 00 000 000 0 0000111 1233445667899999999999874 45789999999
Q ss_pred hHHHHHHHhCCCCCCCCCh-----HHH--------HHhh--hcCC------CCCCC------------------------
Q 002616 709 GIILFEFITGIPPFTAESP-----EII--------FDNI--LNRK------IPWPC------------------------ 743 (900)
Q Consensus 709 GVILyEMLtGk~PF~~~s~-----~ei--------~~kI--l~~~------l~~P~------------------------ 743 (900)
|||+.-+++++.||-.... .++ +++. +.+. ..+|.
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 9999999999999853221 000 0000 0011 00000
Q ss_pred ---C-CCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 002616 744 ---V-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786 (900)
Q Consensus 744 ---i-p~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~id 786 (900)
. ....+..+.||+.+||..||.+|+| |++.|.||||...+
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRit---AEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRIT---AEDALKHPFFDEAD 388 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhccc---HHHHhcCcCCcchh
Confidence 0 1234568999999999999999999 88999999998543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=297.63 Aligned_cols=224 Identities=16% Similarity=0.175 Sum_probs=154.9
Q ss_pred cCC-CceEEEeeee-------ccCCeeEEEEeecCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCC
Q 002616 552 VRN-PFVVRFFYSF-------TCRDNLYLVMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK 622 (900)
Q Consensus 552 L~H-PnIVkL~~~f-------~d~~~LyLVmEy~~GGsL~dlL~k-~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLK 622 (900)
++| +||++++++| .....++++|||+ +++|.++|.. ...+++..++.|+.||+.||+|||++||||||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 445 5788888877 3334688889988 5599999975 3469999999999999999999999999999999
Q ss_pred CCcEEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCC-----CC---CCCcccc-cccCCcccccCCCCCCChhh
Q 002616 623 PDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS-----DA---HYPEYQQ-TDNRNRHSAVGTPDYLAPEI 693 (900)
Q Consensus 623 PeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s-----~~---~~~~~~~-~~~~~~~s~vGTp~YmAPEv 693 (900)
|+||||+..|.+|++|||++..........+... .-|.... .. ....... .........+||+.|||||+
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~-DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSR-EIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCccccc-ccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999998888888888887754211100000000 0000000 00 0000000 00011223579999999999
Q ss_pred hcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcH
Q 002616 694 LLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 773 (900)
Q Consensus 694 L~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a 773 (900)
+.+..|+.++|||||||+||||++|.+||.... ..+..+..... |.....-.+.+.+++.+||++||.+||+ +
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~L~~~P~~Rps---~ 259 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PPQILLNWPKEASFCLWLLHPEPSCRPS---M 259 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--ChhhhhcCHHHHHHHHHhCCCChhhCcC---h
Confidence 999999999999999999999999999986432 12222221111 1111122456789999999999999999 8
Q ss_pred HHHHcCCCCCC
Q 002616 774 AEVKAHPFFKG 784 (900)
Q Consensus 774 ~EIL~HPFFk~ 784 (900)
.++++||||..
T Consensus 260 ~eil~h~~~~~ 270 (793)
T PLN00181 260 SELLQSEFINE 270 (793)
T ss_pred HHHhhchhhhh
Confidence 89999999975
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-26 Score=232.06 Aligned_cols=260 Identities=40% Similarity=0.712 Sum_probs=208.2
Q ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC-ceEEEeeeeccCCeeEEEEe
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP-FVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HP-nIVkL~~~f~d~~~LyLVmE 575 (900)
|.+.+.||.|+||.||++.+. ..+|+|.+.+...........+.+|..++..+.|+ +|++++..+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999987 78999999775544444678899999999999988 79999999988888899999
Q ss_pred ecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCC-cEEEEecCCcccccccccc
Q 002616 576 YLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 576 y~~GGsL~dlL~k~g---~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G-~VKLsDFGLAk~~~~~~s~ 651 (900)
|+.++++.+++.... .+++..+..++.|++.++.|+|..|++||||||+|||++..+ .++++|||+++........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998777665 799999999999999999999999999999999999999998 7999999998732110000
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC---CCCCccceeechhHHHHHHHhCCCCCCCCCh-
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESP- 727 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~- 727 (900)
..........+||+.|+|||.+.+ ..+....|+||+|++++++++|..||.....
T Consensus 159 ---------------------~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~ 217 (384)
T COG0515 159 ---------------------SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS 217 (384)
T ss_pred ---------------------ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc
Confidence 000013456789999999999988 5788899999999999999999999887763
Q ss_pred ---HHHHHhhhcCCCC-CCC-CCCCC----CHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCC
Q 002616 728 ---EIIFDNILNRKIP-WPC-VPSDM----SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 728 ---~ei~~kIl~~~l~-~P~-ip~~l----S~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk 783 (900)
......+.....+ ... ..... ...+.+++.+++..+|..|.+ ..+...++|..
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~---~~~~~~~~~~~ 279 (384)
T COG0515 218 SATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS---SSSDLSHDLLA 279 (384)
T ss_pred ccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCC---HHHHhhchHhh
Confidence 4555555444432 111 11111 257899999999999999998 44555554443
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-28 Score=252.77 Aligned_cols=242 Identities=26% Similarity=0.388 Sum_probs=191.2
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEe-eeeccCCee
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFF-YSFTCRDNL 570 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~-~~f~d~~~L 570 (900)
-.+.|.+.+.||.|-||.+.+|+++.++..+++|.+.+.. ...+.|.+|..---.+. |.||+.-| ..|++.+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 3577999999999999999999999999999999987643 24567888876654454 89999877 568999999
Q ss_pred EEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecC--CCcEEEEecCCccccccc
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~--~G~VKLsDFGLAk~~~~~ 648 (900)
+++|||+|.|||..-+.. ..+-|...+.+++|++.||.|||+.++||||||.+||||-. .-.|||||||+.+...
T Consensus 98 vF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-- 174 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-- 174 (378)
T ss_pred EEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC--
Confidence 999999999999988765 34888999999999999999999999999999999999954 3479999999987421
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC---C--CCccceeechhHHHHHHHhCCCCCC
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---E--HGYAADWWSVGIILFEFITGIPPFT 723 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~---~--ys~ksDIWSLGVILyEMLtGk~PF~ 723 (900)
......-.+..|.|||+.... . .++..|+|.||+++|.+|+|.+||.
T Consensus 175 ----------------------------~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQ 226 (378)
T KOG1345|consen 175 ----------------------------TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQ 226 (378)
T ss_pred ----------------------------ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcch
Confidence 001112245679999987542 2 3678999999999999999999997
Q ss_pred CCC----hHHHHHhhhcC-CCCCCCCCCCCCHHHHHHHHHhccCCcCCCCC
Q 002616 724 AES----PEIIFDNILNR-KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 769 (900)
Q Consensus 724 ~~s----~~ei~~kIl~~-~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpS 769 (900)
... +---+.+...+ ....|.....+|+.+..+.++-|..+|++|--
T Consensus 227 ka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drck 277 (378)
T KOG1345|consen 227 KASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCK 277 (378)
T ss_pred hhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccch
Confidence 432 22223333322 22445555778999999999999999999843
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=232.94 Aligned_cols=161 Identities=25% Similarity=0.284 Sum_probs=129.7
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCC
Q 002616 580 GDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 658 (900)
Q Consensus 580 GsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~ 658 (900)
|+|.+++... ..+++..++.++.||+.||.|||+++ ||+|||++.++.+|+ ||+++...
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~------------ 60 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKT------------ 60 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeec------------
Confidence 7899999874 45999999999999999999999998 999999999999999 99987421
Q ss_pred CCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCCh-HHHHHhhhcC
Q 002616 659 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDNILNR 737 (900)
Q Consensus 659 ~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~-~ei~~kIl~~ 737 (900)
.....||+.|||||++.+..|+.++|||||||++|||++|++||..... ......+...
T Consensus 61 --------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~ 120 (176)
T smart00750 61 --------------------PEQSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNG 120 (176)
T ss_pred --------------------cccCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHH
Confidence 0112689999999999999999999999999999999999999976543 2333333332
Q ss_pred CCCC-C---CCCCCCCH--HHHHHHHHhccCCcCCCCChhcHHHHHcCCCCC
Q 002616 738 KIPW-P---CVPSDMSF--EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 738 ~l~~-P---~ip~~lS~--eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk 783 (900)
.... + ..+..++. ++.+||.+||..||.+||+ +.+++.|+|+.
T Consensus 121 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~---~~~ll~~~~~~ 169 (176)
T smart00750 121 MPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREA---ANHYLAHCRAL 169 (176)
T ss_pred hccCCccccccHHHHHhhhhHHHHHHHHHhcccccccC---HHHHHHHHHHH
Confidence 2111 0 01123344 6999999999999999999 78999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=245.70 Aligned_cols=255 Identities=20% Similarity=0.270 Sum_probs=204.7
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCc-----EEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeecc-C
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-R 567 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk-----~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d-~ 567 (900)
..++++...+-+|.||.||.|.|++... .+-+|.++. --+.-++..++.|.-.|..+.|||+..+.+.... .
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~--~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ--HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh--cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 3456777789999999999998875433 344555533 2244567889999999999999999999877654 4
Q ss_pred CeeEEEEeecCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEec
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKV--------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDF 639 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~--------g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDF 639 (900)
...++++.++.-|+|..+|... ..++..+...++.|++.|++|||+.||||.||-..|.+||+...|||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 5688899999999999999722 24777888889999999999999999999999999999999999999999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-C
Q 002616 640 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-G 718 (900)
Q Consensus 640 GLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-G 718 (900)
.+++-... .+-+. .. ...-....||+||.+.+..|+.++|+|||||+||||+| |
T Consensus 441 aLSRDLFP----------------~DYhc--LG-------DnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg 495 (563)
T KOG1024|consen 441 ALSRDLFP----------------GDYHC--LG-------DNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLG 495 (563)
T ss_pred hhccccCc----------------ccccc--cC-------CCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcC
Confidence 99884321 11110 00 01123567999999999999999999999999999998 9
Q ss_pred CCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH
Q 002616 719 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 719 k~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL 777 (900)
+.|+...+|.++...+..+. +.- .|.++|+++..++--||..+|++||++.+....|
T Consensus 496 ~~PyaeIDPfEm~~ylkdGy-Rla-QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cL 552 (563)
T KOG1024|consen 496 KLPYAEIDPFEMEHYLKDGY-RLA-QPFNCPDELFTVMACCWALLPEERPSFSQLVICL 552 (563)
T ss_pred CCCccccCHHHHHHHHhccc-eec-CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHH
Confidence 99999999999998877653 222 2478999999999999999999999977665554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.4e-26 Score=270.50 Aligned_cols=264 Identities=27% Similarity=0.388 Sum_probs=207.0
Q ss_pred EEEEEeccCCceEEEEEEECCCCcEEEEEEeecc---cccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 498 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL---DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 498 eil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~---~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
....++|.|++|.|+.+......+.++.|..+.. ..........+..|.-+-..+.|||++.....+++....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4567899999999998888877777777765421 1111222222667777778889999999888888887777779
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
|||++ ||+.++...+.+....+..++.|++.|++|||+.||.||||||+|+|+..+|.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~------ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP------ 473 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC------
Confidence 99999 99999998888999999999999999999999999999999999999999999999999998754210
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCc-cceeechhHHHHHHHhCCCCCCCCChHHHH--
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY-AADWWSVGIILFEFITGIPPFTAESPEIIF-- 731 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~-ksDIWSLGVILyEMLtGk~PF~~~s~~ei~-- 731 (900)
|. ........++|+..|+|||++.+..|+. .+||||.|++++.|++|+.||......+..
T Consensus 474 ----------------~e-~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~ 536 (601)
T KOG0590|consen 474 ----------------WE-KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK 536 (601)
T ss_pred ----------------cc-hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh
Confidence 00 0113456789999999999999999965 789999999999999999999765433221
Q ss_pred HhhhcCCC----CCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCcc
Q 002616 732 DNILNRKI----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 788 (900)
Q Consensus 732 ~kIl~~~l----~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~ 788 (900)
........ ..-.+...++.+.+.+|.+||+.||.+|.+ +.+|++.+||+.++-.
T Consensus 537 ~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~t---i~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 537 TNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRIT---IEQILNDEWIRSIECC 594 (601)
T ss_pred hhccccccccccChHHHHHhchhhHHHHHHHHccCChhheec---HHHHhhChHhhhcceE
Confidence 11111110 001123567889999999999999999999 8899999999987644
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.1e-24 Score=237.95 Aligned_cols=180 Identities=22% Similarity=0.173 Sum_probs=134.8
Q ss_pred cccccCCCeEEEEEeccCCceEEEEEEECC-CCcEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEEEeeeec
Q 002616 489 KERTSIDDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFT 565 (900)
Q Consensus 489 ~~~~~~~dYeil~~LGkG~FG~Vyla~~k~-tGk~VAIKiLkK~~~--~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~ 565 (900)
..+...++|.+.+.||+|+||+||+|+++. ++..||||++..... ........+.+|+.+|..++|+||+..+..+
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 345567889999999999999999999876 678889998753211 1233456789999999999999998533322
Q ss_pred cCCeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccC-CCCcEEecCCCcEEEEecCCccc
Q 002616 566 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 566 d~~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDL-KPeNILLd~~G~VKLsDFGLAk~ 644 (900)
...|+||||++|++|... .. .. ...++.+++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus 91 --~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 --GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred --CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 457999999999999632 11 11 1467889999999999999999999 99999999999999999999985
Q ss_pred ccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC
Q 002616 645 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT 697 (900)
Q Consensus 645 ~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~ 697 (900)
...... ...........+.+|++.|+|||.+...
T Consensus 162 ~~~~~~-------------------~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 162 FRRRGA-------------------LYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred cccCcc-------------------hhhhhhhhhhhhhhccCccCCcccCChh
Confidence 321000 0000001112367899999999998653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.4e-23 Score=225.16 Aligned_cols=257 Identities=22% Similarity=0.285 Sum_probs=194.4
Q ss_pred CeEEEEEeccCCceEEEEEEECCCC-cEEEEEEeecccccchhHHHHHHHHHHHHHhcC----CCceEEEeeee-ccCCe
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTG-DLFAIKVLKKLDMIRKNDIERILAERNILITVR----NPFVVRFFYSF-TCRDN 569 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tG-k~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~----HPnIVkL~~~f-~d~~~ 569 (900)
.|.+.+.||+|+||.||+|.+..++ ..+|+|+........ ...+..|..++..+. .+++..+++.+ .....
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999998775 679999876532211 115677888888876 26899999999 57778
Q ss_pred eEEEEeecCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCC-----CcEEEEecCCc
Q 002616 570 LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-----GHIKLTDFGLS 642 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~-----G~VKLsDFGLA 642 (900)
-|+||+.+ |-+|.++.... +.|+...+..++.|++.+|++||+.|+|||||||+|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999988 77999988654 479999999999999999999999999999999999999865 36999999999
Q ss_pred cccc--ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCC
Q 002616 643 KIGL--INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 720 (900)
Q Consensus 643 k~~~--~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~ 720 (900)
+... .... .. ....+.....+.||..|+++.+..+...+..-|+||++.++.||+.|..
T Consensus 175 r~~~~~~~~~---------------~~----~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~L 235 (322)
T KOG1164|consen 175 RRFKYVGDSG---------------GN----LRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSL 235 (322)
T ss_pred ccccccCCCC---------------cc----cccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCC
Confidence 8321 0000 00 0011122345779999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHhhhc---CCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHH
Q 002616 721 PFTAESPEIIFDNILN---RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 776 (900)
Q Consensus 721 PF~~~s~~ei~~kIl~---~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EI 776 (900)
||..........++.. .... .......+.+..++...+-..+...+|.......+
T Consensus 236 PW~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 236 PWEALEMTDLKSKFEKDPRKLLT-DRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred CCccccccchHHHHHHHhhhhcc-ccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 9977654322222221 1111 10123455778888887777888889985545444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.6e-22 Score=202.16 Aligned_cols=141 Identities=24% Similarity=0.192 Sum_probs=110.7
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhH-----------------------HHHHHHHHHHHHhcCCCc
Q 002616 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-----------------------IERILAERNILITVRNPF 556 (900)
Q Consensus 500 l~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~-----------------------~e~~l~Ei~IL~~L~HPn 556 (900)
...||+|+||.||+|... +|+.||+|+++......... .....+|..+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 357999999999999987 89999999997643211110 123345999999998776
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhh-hhcCeEeccCCCCcEEecCCCcEE
Q 002616 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL-HSLGIVHRDLKPDNLLIAHDGHIK 635 (900)
Q Consensus 557 IVkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yL-Hs~gIIHRDLKPeNILLd~~G~VK 635 (900)
|...+.. ... ..||||||++|+++...+.+.+.++...+..++.|++.+|.|| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~-~~~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPI-LLK-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEE-Eec-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 5332221 112 2389999999988876655567899999999999999999999 799999999999999998 58899
Q ss_pred EEecCCccc
Q 002616 636 LTDFGLSKI 644 (900)
Q Consensus 636 LsDFGLAk~ 644 (900)
|+|||+|..
T Consensus 158 LiDFG~a~~ 166 (190)
T cd05147 158 IIDVSQSVE 166 (190)
T ss_pred EEEcccccc
Confidence 999999873
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=201.99 Aligned_cols=279 Identities=23% Similarity=0.318 Sum_probs=211.0
Q ss_pred cccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-CceEEEeeeeccC
Q 002616 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCR 567 (900)
Q Consensus 489 ~~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~H-PnIVkL~~~f~d~ 567 (900)
...+..+.|.++++||.|+||.+|+|....+|..||||+-++.. ...++.-|..+-..+++ ..|..+..++.+.
T Consensus 9 ~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~ 83 (341)
T KOG1163|consen 9 EELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEK 83 (341)
T ss_pred hhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhcccc
Confidence 44567889999999999999999999999999999999865422 22346678888888874 6788888888899
Q ss_pred CeeEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCC---CcEEEEecCCcc
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD---GHIKLTDFGLSK 643 (900)
Q Consensus 568 ~~LyLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~---G~VKLsDFGLAk 643 (900)
++-.+||+++ |-+|.+++.-. ..|+...+...+-|++.-++|+|.+++|||||||+|+|..-+ ..+.|+|||||+
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchh
Confidence 9999999998 67998888643 468999999999999999999999999999999999999754 358899999998
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCC
Q 002616 644 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 723 (900)
Q Consensus 644 ~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~ 723 (900)
...... +..+++ -.......||..|.+--...+...+..-|+=|+|.+|.++..|..||.
T Consensus 163 ky~d~~--------------t~~HIp------yre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 163 KYRDIR--------------TRQHIP------YREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred hhcccc--------------ccccCc------cccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccc
Confidence 643211 111111 122345689999999888888888889999999999999999999998
Q ss_pred CCC---hHHHHHhhhcCCCCCCC--CCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHH-------cCCCCCCCCcchhh
Q 002616 724 AES---PEIIFDNILNRKIPWPC--VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK-------AHPFFKGVNWDSLA 791 (900)
Q Consensus 724 ~~s---~~ei~~kIl~~~l~~P~--ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL-------~HPFFk~idw~~L~ 791 (900)
+.. ..+-+++|...+...|. +-.++|.++.-.+.-|=..--++-|...-+.++. +|.+=--.||+.+.
T Consensus 223 glka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lk 302 (341)
T KOG1163|consen 223 GLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLK 302 (341)
T ss_pred ccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHH
Confidence 865 45667778776554331 2257788888888887665555556532233322 23222235888876
Q ss_pred hc
Q 002616 792 LQ 793 (900)
Q Consensus 792 ~~ 793 (900)
.+
T Consensus 303 qk 304 (341)
T KOG1163|consen 303 QK 304 (341)
T ss_pred HH
Confidence 54
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.8e-21 Score=204.45 Aligned_cols=251 Identities=23% Similarity=0.349 Sum_probs=191.5
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeE
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~Ly 571 (900)
.--.|++.++||.|+||++++|.+.-++++||||.-... ...-.+..|...-+.+. .+.|...|++.+..-+-.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 345799999999999999999999999999999975432 23345666777766665 799999999999999999
Q ss_pred EEEeecCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCC-----cEEEEecCCcccc
Q 002616 572 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-----HIKLTDFGLSKIG 645 (900)
Q Consensus 572 LVmEy~~GGsL~dlL~k~g-~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G-----~VKLsDFGLAk~~ 645 (900)
||||++ |-+|.++..-.+ .|+...+..++.|++.-++|+|.+.+|+|||||+|+||..-| .|.|+|||+|+..
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999998 679999887654 599999999999999999999999999999999999998644 5899999999853
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCC
Q 002616 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 725 (900)
Q Consensus 646 ~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~ 725 (900)
. .+.+....|. ....+..||..||+--..+|...+..-|+=|||-++++.|.|..||.+.
T Consensus 180 r--------Dp~TkqHIPY------------rE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL 239 (449)
T KOG1165|consen 180 R--------DPKTKQHIPY------------REHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 239 (449)
T ss_pred c--------CccccccCcc------------ccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence 2 2222222222 2234567999999999999999999999999999999999999999875
Q ss_pred ---ChHHHHHhhhcCCCCCC--CCCCCCCHHHHHHHHHhccCCcCCCCC
Q 002616 726 ---SPEIIFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQRLG 769 (900)
Q Consensus 726 ---s~~ei~~kIl~~~l~~P--~ip~~lS~eakDLIk~cL~~DP~kRpS 769 (900)
+..+-|++|-..+..-| .+-.++|.++..-++-.=..+-.+-|.
T Consensus 240 KA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PD 288 (449)
T KOG1165|consen 240 KADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPD 288 (449)
T ss_pred cCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCC
Confidence 45666777754332211 111344555554444333333344444
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-21 Score=206.97 Aligned_cols=234 Identities=27% Similarity=0.372 Sum_probs=152.8
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC-----------CceEE-----
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-----------PFVVR----- 559 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~H-----------PnIVk----- 559 (900)
.+...+.||.|+|+.||.+++..||+.+|+|++...........+.+.+|.-....+.+ ..++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45677899999999999999999999999999876554445566777776644433222 12222
Q ss_pred Ee---eeeccCC--------eeEEEEeecCCCChHHHHH---hcCCC---CHHHHHHH-HHHHHHHHHhhhhcCeEeccC
Q 002616 560 FF---YSFTCRD--------NLYLVMEYLNGGDLYSLLR---KVGCL---EEDVARIY-IAELVLALEYLHSLGIVHRDL 621 (900)
Q Consensus 560 L~---~~f~d~~--------~LyLVmEy~~GGsL~dlL~---k~g~L---se~~ar~y-a~QIl~AL~yLHs~gIIHRDL 621 (900)
+- .++.... +.+++|+-+. +||.+++. ..... ....++.+ ..|++..+++||..|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 11 0111111 3577888775 48888764 22222 12334333 479999999999999999999
Q ss_pred CCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCC----
Q 002616 622 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---- 697 (900)
Q Consensus 622 KPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~---- 697 (900)
||+|++++.+|.++|+||+...... ........+..|.+||.....
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g------------------------------~~~~~~~~~~~~~PPe~~~~~~~~~ 221 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAG------------------------------TRYRCSEFPVAFTPPELESCAGQFG 221 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETT------------------------------EEEEGGGS-TTTS-HHHHHHHTSCH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecC------------------------------ceeeccCCCcccCChhhhhhhcccC
Confidence 9999999999999999999765310 011113456889999987542
Q ss_pred ----CCCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCC
Q 002616 698 ----EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767 (900)
Q Consensus 698 ----~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kR 767 (900)
.++.+.|.|+||+++|.|.+|..||....+...... .|.... ++|+.+++||.++|++||.+|
T Consensus 222 ~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 222 QNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred cccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 468899999999999999999999987654322221 233333 788999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.9e-21 Score=193.54 Aligned_cols=141 Identities=25% Similarity=0.169 Sum_probs=111.7
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEeecccccch-----------------------hHHHHHHHHHHHHHhcCCCc
Q 002616 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK-----------------------NDIERILAERNILITVRNPF 556 (900)
Q Consensus 500 l~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~-----------------------~~~e~~l~Ei~IL~~L~HPn 556 (900)
...||+|+||.||+|++. +|+.||||+++....... .....+..|...+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 899999999986421100 01223467899999999988
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhh-cCeEeccCCCCcEEecCCCcEE
Q 002616 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIK 635 (900)
Q Consensus 557 IVkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~G~VK 635 (900)
|......... ..||||||++|+++.........++...+..++.+++.+|.+||. .||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 7443332222 248999999998665443344668888999999999999999999 9999999999999998 89999
Q ss_pred EEecCCccc
Q 002616 636 LTDFGLSKI 644 (900)
Q Consensus 636 LsDFGLAk~ 644 (900)
|+|||+++.
T Consensus 158 liDFG~a~~ 166 (190)
T cd05145 158 IIDVSQAVE 166 (190)
T ss_pred EEEccccee
Confidence 999999975
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.5e-21 Score=201.40 Aligned_cols=174 Identities=17% Similarity=0.187 Sum_probs=135.9
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHH------HHHHHHHHHhcCCCceEEEeeeec
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER------ILAERNILITVRNPFVVRFFYSFT 565 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~------~l~Ei~IL~~L~HPnIVkL~~~f~ 565 (900)
+-.++|+++++||.|+||.||++.. ++..+|+|+++......+..... +.+|+..+.++.||+|..+..++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4467899999999999999999755 47789999997544333333334 578999999999999999988866
Q ss_pred cC--------CeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEE
Q 002616 566 CR--------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLT 637 (900)
Q Consensus 566 d~--------~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLs 637 (900)
.. ...++||||++|.+|.++. .+++. ...+++.+|..||..|++|||+||+||+++.+| ++|+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence 44 3589999999999998763 23332 356999999999999999999999999999999 9999
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHH
Q 002616 638 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 715 (900)
Q Consensus 638 DFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEM 715 (900)
|||..+..... . ....+++...|+.++|+||||+++.-.
T Consensus 177 Dfg~~~~~~e~-----------------------------~----------a~d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 177 DLSGKRCTAQR-----------------------------K----------AKDRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred ECCCcccccch-----------------------------h----------hHHHHHHHhHhcccccccceeEeehHH
Confidence 99987632100 0 001155666788899999999987654
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.8e-20 Score=191.21 Aligned_cols=202 Identities=21% Similarity=0.263 Sum_probs=143.5
Q ss_pred EEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchh-HHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEe
Q 002616 498 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-DIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 498 eil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~-~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~LyLVmE 575 (900)
.+...|++|+||+|+++.. .+..++.+.+......... ....+.+|+++|+++. |++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999998765 4777887776543332221 2235789999999996 5789998875 45799999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccC-CCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 576 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDL-KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 576 y~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDL-KPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
|+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~--- 148 (218)
T PRK12274 79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW--- 148 (218)
T ss_pred eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH---
Confidence 9999998754422 1 1346789999999999999999999 799999999999999999999742110000
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcC--CCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g--~~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
..+-...........-..+++.|++|+--.- ..--...+|++.|.-+|.|+||..|+.+++
T Consensus 149 -----------~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 149 -----------MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred -----------HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0000000000111122347899999986432 222357899999999999999999986654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=3.6e-20 Score=203.49 Aligned_cols=272 Identities=28% Similarity=0.403 Sum_probs=187.7
Q ss_pred ccccCCCeEEEEEeccCCceEEEEEEECCCCc-----------------------------------EEEEEEeeccccc
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGD-----------------------------------LFAIKVLKKLDMI 534 (900)
Q Consensus 490 ~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk-----------------------------------~VAIKiLkK~~~~ 534 (900)
.+..+++|++...||+|.-+.||-++....|. +.|||++-.-+..
T Consensus 152 skFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~ 231 (598)
T KOG4158|consen 152 SKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHD 231 (598)
T ss_pred cccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccC
Confidence 35788999999999999999999887643211 2455655332221
Q ss_pred chhHHHHHHH----HH------HHH-----------H-----hcCCCceEEEeeeeccC---------------------
Q 002616 535 RKNDIERILA----ER------NIL-----------I-----TVRNPFVVRFFYSFTCR--------------------- 567 (900)
Q Consensus 535 ~~~~~e~~l~----Ei------~IL-----------~-----~L~HPnIVkL~~~f~d~--------------------- 567 (900)
+ ...++++ |. ..+ . ..+|||||+++..|.+.
T Consensus 232 s--~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p 309 (598)
T KOG4158|consen 232 S--GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP 309 (598)
T ss_pred C--chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence 1 1122221 11 011 0 13599999999888542
Q ss_pred ------CeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEe--cCCC--cEEEE
Q 002616 568 ------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDG--HIKLT 637 (900)
Q Consensus 568 ------~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILL--d~~G--~VKLs 637 (900)
..+|+||...+. +|..++-... .+....+.+++|+++|+.|||++||.|||+|.+|||| |.++ .+.|+
T Consensus 310 ~g~g~~~tlylvMkrY~~-tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 310 SGAGEPKTLYLVMKRYRQ-TLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred cccCCCceEEEehhcchh-hHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEc
Confidence 238999998876 8988886543 5667778889999999999999999999999999998 3444 57889
Q ss_pred ecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCC-----C-CccceeechhHH
Q 002616 638 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----H-GYAADWWSVGII 711 (900)
Q Consensus 638 DFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-----y-s~ksDIWSLGVI 711 (900)
|||.|-. ..++...++ + .......-|.-.-||||+....+ . -.++|.|+.|.+
T Consensus 388 DFGCcLA-d~~hGlqlp-------------y-------~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~Gal 446 (598)
T KOG4158|consen 388 DFGCCLA-DDNHGLQLP-------------Y-------ESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGAL 446 (598)
T ss_pred ccceeee-ccccccccc-------------c-------ccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhh
Confidence 9998752 111111110 1 11112234777889999987532 1 238999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCCc
Q 002616 712 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 787 (900)
Q Consensus 712 LyEMLtGk~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~idw 787 (900)
.||++....||++...+.+-.+.. ..-..|.+|..+++.+++|+..+|++||.||++.+-|..+++--.|..-+|
T Consensus 447 aYEIfg~~NPFY~rGem~L~~r~Y-qe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~ 521 (598)
T KOG4158|consen 447 AYEIFGRSNPFYKRGEMLLDTRTY-QESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGED 521 (598)
T ss_pred HHHHhccCCcccccchheechhhh-hhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchH
Confidence 999999999999854432222211 122456678999999999999999999999999776667765544444333
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.8e-20 Score=220.77 Aligned_cols=244 Identities=27% Similarity=0.415 Sum_probs=182.3
Q ss_pred CeEEEEEeccCCceEEEEEEECCCCcEEEEEEeeccc-ccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEE
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD-MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~-~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVm 574 (900)
+|...+.||.+.|=+|.+|++.+ |. |++|++-+.. ...-....+-+.|++ ....++||++++.-.-......|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 78899999999999999998863 44 8999987644 222233333444444 56678999999988888888899999
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCC
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~ 654 (900)
+|+.. +|+|.|.....+..-+-+.|+.|++.||.-+|..||+|+|||.+||||+.=+-+.|+||..-+... +
T Consensus 101 qyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY------L- 172 (1431)
T KOG1240|consen 101 QYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTY------L- 172 (1431)
T ss_pred HHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCcc------C-
Confidence 99977 999999988888889999999999999999999999999999999999998899999998654211 0
Q ss_pred CCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCC-----------CCccceeechhHHHHHHHh-CCCCC
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----------HGYAADWWSVGIILFEFIT-GIPPF 722 (900)
Q Consensus 655 ~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-----------ys~ksDIWSLGVILyEMLt-Gk~PF 722 (900)
+++ .|.+ +.-|-. +..--..|+|||-+.... .+++-||||+||+++||++ |+|||
T Consensus 173 -PeD---NPad--f~fFFD-------TSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF 239 (1431)
T KOG1240|consen 173 -PED---NPAD--FTFFFD-------TSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF 239 (1431)
T ss_pred -CCC---Cccc--ceEEEe-------cCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc
Confidence 000 0000 000100 111224699999886522 4568899999999999998 89999
Q ss_pred CC-----------CChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcC
Q 002616 723 TA-----------ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 723 ~~-----------~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~H 779 (900)
.- .+++...++|- +..++.||..|++.||.+|++ |++.|+.
T Consensus 240 ~LSQL~aYr~~~~~~~e~~Le~Ie-------------d~~~Rnlil~Mi~rdPs~RlS---AedyL~~ 291 (1431)
T KOG1240|consen 240 TLSQLLAYRSGNADDPEQLLEKIE-------------DVSLRNLILSMIQRDPSKRLS---AEDYLQK 291 (1431)
T ss_pred cHHHHHhHhccCccCHHHHHHhCc-------------CccHHHHHHHHHccCchhccC---HHHHHHh
Confidence 42 23333443331 125789999999999999999 6666654
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.2e-19 Score=182.79 Aligned_cols=134 Identities=18% Similarity=0.218 Sum_probs=107.7
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-----CCCceEEEeeeeccCC---eeE
Q 002616 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-----RNPFVVRFFYSFTCRD---NLY 571 (900)
Q Consensus 500 l~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-----~HPnIVkL~~~f~d~~---~Ly 571 (900)
.+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.++..+ +||||+++|++++++. .+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46899999999995 6666665 688876532 22456789999999999 5799999999999984 334
Q ss_pred -EEEee--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HhhhhcCeEeccCCCCcEEecCC----CcEEEEecCCc
Q 002616 572 -LVMEY--LNGGDLYSLLRKVGCLEEDVARIYIAELVLAL-EYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLS 642 (900)
Q Consensus 572 -LVmEy--~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL-~yLHs~gIIHRDLKPeNILLd~~----G~VKLsDFGLA 642 (900)
+|||| +++|+|.+++.+. .+++. ..++.+++.++ +|||+++||||||||+|||++.. +.++|+||+-+
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 78999 5689999999764 57666 35688888888 89999999999999999999743 37999994443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=177.06 Aligned_cols=137 Identities=31% Similarity=0.373 Sum_probs=113.9
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccc-----hhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-----KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~-----~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
+.||+|++|.||+|.+ .|..+++|+........ ......+.+|+.++..+.|++|+....++.+.+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 57889999765322111 1123567889999999999988776666667778999999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 576 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 576 y~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
|++|++|.+++..... ....++.+++.+|.+||+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999865432 7778899999999999999999999999999999 88999999999874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.5e-20 Score=217.96 Aligned_cols=264 Identities=27% Similarity=0.414 Sum_probs=211.3
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCee
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNL 570 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~-tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~L 570 (900)
....|.+.+.||+|+|+.|-+..... +...+|+|.+.... .......++..|..+-..+. |+|++.+++.....+..
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~ 96 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY 96 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccc
Confidence 35678899999999999999887743 34567777765432 33445667777888888887 99999999999999999
Q ss_pred EEEEeecCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHhhh-hcCeEeccCCCCcEEecCCC-cEEEEecCCccccc
Q 002616 571 YLVMEYLNGGDLYSLL-RKVG-CLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGL 646 (900)
Q Consensus 571 yLVmEy~~GGsL~dlL-~k~g-~Lse~~ar~ya~QIl~AL~yLH-s~gIIHRDLKPeNILLd~~G-~VKLsDFGLAk~~~ 646 (900)
+++++|..||+++..+ .... ..+...+.+|+.|+..++.|+| ..++.||||||+|.+++.++ .+|++|||+|....
T Consensus 97 ~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 97 LLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred ccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 9999999999999998 5554 6788899999999999999999 99999999999999999999 99999999998532
Q ss_pred ccccccCCCCCCCCCCCCCCCCCcccccccCCcccccC-CCCCCChhhhcCCCC-CccceeechhHHHHHHHhCCCCCCC
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG-TPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTA 724 (900)
Q Consensus 647 ~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vG-Tp~YmAPEvL~g~~y-s~ksDIWSLGVILyEMLtGk~PF~~ 724 (900)
.. ..........+| ++.|+|||.+.+..| +...|+||.|+++.-|++|..||..
T Consensus 177 ~~------------------------~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~ 232 (601)
T KOG0590|consen 177 NK------------------------NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDF 232 (601)
T ss_pred cc------------------------CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccc
Confidence 10 112233455678 999999999998544 7789999999999999999999976
Q ss_pred CChHHH-HHhhhcCCCC-CCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 725 ESPEII-FDNILNRKIP-WPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 725 ~s~~ei-~~kIl~~~l~-~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
...... +......... -......++..+.+++.+++..+|..|.+ ..++..+||+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s---~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 233 PSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLS---IEELKLDNWLSS 291 (601)
T ss_pred cccccccceeecccccccccCccccCChhhhhcccccccCCchhccc---cccccccccccc
Confidence 543321 1111111111 11123678999999999999999999999 778999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.76 E-value=3.2e-18 Score=181.42 Aligned_cols=144 Identities=24% Similarity=0.144 Sum_probs=114.4
Q ss_pred CeEEEEEeccCCceEEEEEE-ECCCCcEEEEEEeecccccc---------------------hhHHHHHHHHHHHHHhcC
Q 002616 496 DFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIR---------------------KNDIERILAERNILITVR 553 (900)
Q Consensus 496 dYeil~~LGkG~FG~Vyla~-~k~tGk~VAIKiLkK~~~~~---------------------~~~~e~~l~Ei~IL~~L~ 553 (900)
.|.+.+.||+|+||.||+|. +..+|+.||+|+++...... ......+..|..++.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 46788899999999999998 66789999999997532110 001234578999999997
Q ss_pred CC--ceEEEeeeeccCCeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcC-eEeccCCCCcEEecC
Q 002616 554 NP--FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG-IVHRDLKPDNLLIAH 630 (900)
Q Consensus 554 HP--nIVkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~g-IIHRDLKPeNILLd~ 630 (900)
+. .+.++++. ...|+||||++|++|.........+....+..++.||+.+|.+||+.| |+||||||+|||++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 53 34444442 235899999999888776544456677778899999999999999999 99999999999999
Q ss_pred CCcEEEEecCCccc
Q 002616 631 DGHIKLTDFGLSKI 644 (900)
Q Consensus 631 ~G~VKLsDFGLAk~ 644 (900)
++.++|+|||++..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999999873
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=5.4e-18 Score=206.40 Aligned_cols=198 Identities=24% Similarity=0.375 Sum_probs=160.2
Q ss_pred ccccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCceEEEeeeecc
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTC 566 (900)
Q Consensus 490 ~~~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~---HPnIVkL~~~f~d 566 (900)
..+....|.|-+.||+|+||.||+|...+ |+.||+|+=+....+. |.--.+++.+++ -+-|..+..++..
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34567789999999999999999999987 9999999875543332 111223344444 2456666777777
Q ss_pred CCeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecC-------CCcEEEEec
Q 002616 567 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-------DGHIKLTDF 639 (900)
Q Consensus 567 ~~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~-------~G~VKLsDF 639 (900)
.+.-++|+||.+.|+|.+++...+.+++..+.+++.|++.-+++||..+|||+||||+|.||.. +--++|+||
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 7888999999999999999998888999999999999999999999999999999999999953 346899999
Q ss_pred CCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCC
Q 002616 640 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 719 (900)
Q Consensus 640 GLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk 719 (900)
|-+--+.. . .++..-...++|-.+--+|+..|.++++.+|.|.|+.+++-||.|+
T Consensus 846 G~siDm~l--------------f-----------p~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 846 GRSIDMKL--------------F-----------PDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred ccceeeeE--------------c-----------CCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 98752210 0 1122334578899999999999999999999999999999999985
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=169.39 Aligned_cols=133 Identities=29% Similarity=0.322 Sum_probs=106.6
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEeeccccc-----chhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 002616 502 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI-----RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 576 (900)
Q Consensus 502 ~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~-----~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy 576 (900)
.||+|+||.||+|.+ +|..+++|+....... ......++.+|++++..+.|+++.....++...+..++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 389999999999985 4788999986542211 112246778999999999887654444444456677999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 577 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 577 ~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
++|++|.+++..... .++.+++.+|.+||+.|++|+|++|.|||++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988765321 7788999999999999999999999999999 89999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=2.9e-17 Score=167.73 Aligned_cols=137 Identities=21% Similarity=0.205 Sum_probs=107.8
Q ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccch-------------------hHHHHHHHHHHHHHhcCCC--
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK-------------------NDIERILAERNILITVRNP-- 555 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~-------------------~~~e~~l~Ei~IL~~L~HP-- 555 (900)
|.+.+.||.|+||.||++.+. +|+.||+|+++....... .....+..|..++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 677789999999999999875 799999999765321000 0112367788899888877
Q ss_pred ceEEEeeeeccCCeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEE
Q 002616 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 635 (900)
Q Consensus 556 nIVkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VK 635 (900)
.++..++ ....++||||++|++|..+... .....++.+++.++.++|..||+||||||+||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 4444443 2346899999999998765431 34567888999999999999999999999999999999999
Q ss_pred EEecCCccc
Q 002616 636 LTDFGLSKI 644 (900)
Q Consensus 636 LsDFGLAk~ 644 (900)
|+|||++..
T Consensus 166 liDfg~~~~ 174 (198)
T cd05144 166 IIDWPQMVS 174 (198)
T ss_pred EEECCcccc
Confidence 999999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=9.5e-17 Score=188.33 Aligned_cols=140 Identities=26% Similarity=0.235 Sum_probs=112.9
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccc-----cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-----IRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~-----~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~ 568 (900)
...|...+.||+|+||+||++.+.. ..+++|+...... ......+++.+|+.++..++|++|+..+.++.+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 3445667899999999999998764 3445554322111 11123467889999999999999988777777777
Q ss_pred eeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
..++||||++|++|.+++. ....++.+++.+|.|||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 8899999999999999885 346788999999999999999999999999999 678999999999974
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-16 Score=159.95 Aligned_cols=137 Identities=23% Similarity=0.275 Sum_probs=99.1
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHH---------------------HHHHHHHHHHhcCCC--c
Q 002616 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE---------------------RILAERNILITVRNP--F 556 (900)
Q Consensus 500 l~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e---------------------~~l~Ei~IL~~L~HP--n 556 (900)
.+.||+|+||+||+|.+. +|+.||||+++........... ....|...+..+.+. .
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 7999999998753221111111 113566666666543 2
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCChHHH-HHhcCCCCHHHHHHHHHHHHHHHHhhhh-cCeEeccCCCCcEEecCCCcE
Q 002616 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSL-LRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHI 634 (900)
Q Consensus 557 IVkL~~~f~d~~~LyLVmEy~~GGsL~dl-L~k~g~Lse~~ar~ya~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~G~V 634 (900)
+.+.+++ ...++||||++||.+... +.... .. ..++.++.+++.++.++|. .||+||||||+||+++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4444443 236899999999654321 22111 11 6678899999999999999 9999999999999999 9999
Q ss_pred EEEecCCccc
Q 002616 635 KLTDFGLSKI 644 (900)
Q Consensus 635 KLsDFGLAk~ 644 (900)
+|+|||.+..
T Consensus 154 ~liDfg~a~~ 163 (187)
T cd05119 154 YIIDVPQAVE 163 (187)
T ss_pred EEEECccccc
Confidence 9999999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.63 E-value=1.1e-15 Score=176.02 Aligned_cols=206 Identities=23% Similarity=0.303 Sum_probs=158.0
Q ss_pred HHhcCCCceEEEeeeeccCCeeEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHhhhhcCe-EeccCCCCcE
Q 002616 549 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGI-VHRDLKPDNL 626 (900)
Q Consensus 549 L~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~AL~yLHs~gI-IHRDLKPeNI 626 (900)
|+.+.|.|+.++++.+.+....+.|.+||..|+|.+.+... -.++.-....++++|+.||.|||.-.| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 35678999999999999999999999999999999999874 357777777788999999999998866 9999999999
Q ss_pred EecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCC-------C
Q 002616 627 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-------H 699 (900)
Q Consensus 627 LLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-------y 699 (900)
++|....+||+|||+...... .. .........-...|.|||.+.+.. -
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~--------------~~-----------~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~ 135 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEE--------------TA-----------EPEAHHPIRKALLWTAPELLRGALSQSLESAL 135 (484)
T ss_pred eeeeeEEEEechhhhcccccc--------------cc-----------cccccchhHHHHhccCHHHhcccccccccccc
Confidence 999999999999999764310 00 000011111345799999998742 3
Q ss_pred CccceeechhHHHHHHHhCCCCCCCC----ChHHHHHhhhcCCC--CCCCCC--CCCCHHHHHHHHHhccCCcCCCCChh
Q 002616 700 GYAADWWSVGIILFEFITGIPPFTAE----SPEIIFDNILNRKI--PWPCVP--SDMSFEAQDLINRFLIHDPNQRLGAN 771 (900)
Q Consensus 700 s~ksDIWSLGVILyEMLtGk~PF~~~----s~~ei~~kIl~~~l--~~P~ip--~~lS~eakDLIk~cL~~DP~kRpSa~ 771 (900)
+.+.|+||||++++|+++..-||... ++.++..++.++.. ..|.+. ..+.+++..++..||..+|.+||+.+
T Consensus 136 ~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~ 215 (484)
T KOG1023|consen 136 TQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIE 215 (484)
T ss_pred cccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHH
Confidence 56799999999999999999999763 34456666555221 223332 14566799999999999999999977
Q ss_pred cHHHHHcC
Q 002616 772 GAAEVKAH 779 (900)
Q Consensus 772 ~a~EIL~H 779 (900)
.+...+.-
T Consensus 216 ~i~~~~~~ 223 (484)
T KOG1023|consen 216 QIRSKLLT 223 (484)
T ss_pred HHHhhhhh
Confidence 66555543
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.3e-17 Score=183.55 Aligned_cols=182 Identities=28% Similarity=0.438 Sum_probs=134.6
Q ss_pred eeEEEEeecCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccc
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~dlL~k~g---~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~ 645 (900)
++||.|++|.-++|.++|.... ..+......++.|++.|++| +|.+|||+||.||....+..+||.||||....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 5899999999999999997443 35667788899999999999 99999999999999999999999999997632
Q ss_pred cccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHh-CCCCCCC
Q 002616 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 724 (900)
Q Consensus 646 ~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLt-Gk~PF~~ 724 (900)
.... ... .........+||+.||+||.+.+..|+.++||||||+||||+++ =..+|.
T Consensus 407 ~~~~----------~~~-----------~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e- 464 (516)
T KOG1033|consen 407 DKDE----------TVA-----------PAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE- 464 (516)
T ss_pred ccCC----------ccc-----------chhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-
Confidence 1100 000 11223455789999999999999999999999999999999997 222222
Q ss_pred CChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 725 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 725 ~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
...++..+-.+.++ |.+-.+ -++-.+|+.+||...|.+||+ +.+.--|+|.
T Consensus 465 --r~~t~~d~r~g~ip-~~~~~d-~p~e~~ll~~lls~~p~~RP~---~~~~~~~~~~ 515 (516)
T KOG1033|consen 465 --RIATLTDIRDGIIP-PEFLQD-YPEEYTLLQQLLSPSPEERPS---AIEVALHEFL 515 (516)
T ss_pred --HHHhhhhhhcCCCC-hHHhhc-CcHHHHHHHHhcCCCcccCch---HHHHhhhhhc
Confidence 22233333334332 111112 245668999999999999996 5555556553
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.2e-15 Score=141.60 Aligned_cols=132 Identities=23% Similarity=0.304 Sum_probs=112.4
Q ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeeeeccCCeeEEEEee
Q 002616 499 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRDNLYLVMEY 576 (900)
Q Consensus 499 il~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~H--PnIVkL~~~f~d~~~LyLVmEy 576 (900)
+++.||.|.++.||++... +..+++|....... ...+.+|..++..+.| +++++++.++...+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4578999999999999985 47899998865321 4568889999999976 5899999988888899999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhc---CeEeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 577 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL---GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 577 ~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~---gIIHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
++|+.+..+ +......++.+++.+|++||.. +++|+||+|+|||++..+.+++.|||+++.
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999887654 4455667788999999999985 799999999999999999999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.4e-15 Score=156.45 Aligned_cols=137 Identities=20% Similarity=0.346 Sum_probs=105.6
Q ss_pred EEec-cCCceEEEEEEECCCCcEEEEEEeecccc----------cchhHHHHHHHHHHHHHhcCCCce--EEEeeeeccC
Q 002616 501 KPIS-RGAFGRVFLARKRTTGDLFAIKVLKKLDM----------IRKNDIERILAERNILITVRNPFV--VRFFYSFTCR 567 (900)
Q Consensus 501 ~~LG-kG~FG~Vyla~~k~tGk~VAIKiLkK~~~----------~~~~~~e~~l~Ei~IL~~L~HPnI--VkL~~~f~d~ 567 (900)
..|| .||.|+||.+... +..+++|.+.+... ........+.+|+.++..+.|++| +..++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4577 7888888888764 78899998864321 111234578889999999998774 5666554333
Q ss_pred Ce----eEEEEeecCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCc
Q 002616 568 DN----LYLVMEYLNG-GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 642 (900)
Q Consensus 568 ~~----LyLVmEy~~G-GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLA 642 (900)
.. .++||||++| .+|.+++.. ..+++.. +.+|+.+|.+||+.||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 3599999998 689888765 3455543 568999999999999999999999999999999999999988
Q ss_pred cc
Q 002616 643 KI 644 (900)
Q Consensus 643 k~ 644 (900)
+.
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 74
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=7e-13 Score=153.42 Aligned_cols=251 Identities=26% Similarity=0.250 Sum_probs=186.4
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEEC-CCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCe
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKR-TTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 569 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k-~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~ 569 (900)
....+|..+..||.|.|+.|+.+..+ .++..|++|.+.+.... ......-+.|+.+...+. |.+++.++..+...++
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~-~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT-FASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccc-hHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 44678999999999999999998876 67889999988654332 222333455666666664 9999999999999999
Q ss_pred eEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCC-CcEEEEecCCccccccc
Q 002616 570 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~-G~VKLsDFGLAk~~~~~ 648 (900)
.|+=.||+.++++...+.-...+.+...+....|++.|+.++|++.++|+|+||+||++..+ +..++.|||..+.+...
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 99999999999987776555568888999999999999999999999999999999999886 77899999987631100
Q ss_pred ccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCC--ChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCC
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYL--APEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 649 ~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~Ym--APEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s 726 (900)
.....++-+++ +|+.+....+..++|++|||.-+++.++|.+--....
T Consensus 421 ------------------------------~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~ 470 (524)
T KOG0601|consen 421 ------------------------------SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV 470 (524)
T ss_pred ------------------------------cccccccccccccchhhccccccccccccccccccccccccCcccCcccc
Confidence 01122333444 4444555678899999999999999999865322111
Q ss_pred hHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCC
Q 002616 727 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 727 ~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFF 782 (900)
....|..+..+ .. +....+++.+.+.++..++..|+. +.++..|+=|
T Consensus 471 ---~~~~i~~~~~p--~~-~~~~~~~q~~~kv~~~~~~~~~~l---~~~l~~~~~~ 517 (524)
T KOG0601|consen 471 ---QSLTIRSGDTP--NL-PGLKLQLQVLLKVMINPDRKRRPS---AVELSLHSEF 517 (524)
T ss_pred ---cceeeeccccc--CC-CchHHhhhhhhhhhcCCccccchh---hhhhcccchh
Confidence 11223333332 22 344488999999999999999998 6666666554
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.38 E-value=3.2e-13 Score=158.49 Aligned_cols=143 Identities=23% Similarity=0.389 Sum_probs=96.0
Q ss_pred CCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeeccccc--------------------------c-----hhHHHHH
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI--------------------------R-----KNDIERI 542 (900)
Q Consensus 494 ~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~--------------------------~-----~~~~e~~ 542 (900)
..+|+. +.||.|++|.||+|+.+++|+.||||+++..... + .+..+.+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 456776 7899999999999999988999999999743100 0 0112233
Q ss_pred HHHHHHHHh------cC----CCceEEEeeeecc-CCeeEEEEeecCCCChHHH--HHhcC----CCCHHHHHHHHHHHH
Q 002616 543 LAERNILIT------VR----NPFVVRFFYSFTC-RDNLYLVMEYLNGGDLYSL--LRKVG----CLEEDVARIYIAELV 605 (900)
Q Consensus 543 l~Ei~IL~~------L~----HPnIVkL~~~f~d-~~~LyLVmEy~~GGsL~dl--L~k~g----~Lse~~ar~ya~QIl 605 (900)
.+|++.+.. +. +...+.+-..+.+ ....+|||||+.|+.+.++ +...+ .+.+..+..|+.|++
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif 277 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF 277 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH
Confidence 444444333 21 2222222222211 2345799999999999774 33333 244555555566654
Q ss_pred HHHHhhhhcCeEeccCCCCcEEecCCC----cEEEEecCCccc
Q 002616 606 LALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKI 644 (900)
Q Consensus 606 ~AL~yLHs~gIIHRDLKPeNILLd~~G----~VKLsDFGLAk~ 644 (900)
..|++|+|+||.||+++.+| .+++.|||++..
T Consensus 278 -------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~ 313 (537)
T PRK04750 278 -------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGS 313 (537)
T ss_pred -------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEE
Confidence 58999999999999999988 999999999864
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=5.8e-13 Score=154.10 Aligned_cols=260 Identities=26% Similarity=0.245 Sum_probs=191.5
Q ss_pred CCeEEEEEecc--CCceEEEEEEE--CCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCe
Q 002616 495 DDFEIIKPISR--GAFGRVFLARK--RTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDN 569 (900)
Q Consensus 495 ~dYeil~~LGk--G~FG~Vyla~~--k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~ 569 (900)
..|.+...+|. |.+|.||.++. ..++..+|+|.=+. .........+=++|..-..+++ |++.|+.+..+...+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~-p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKI-PFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccC-CCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 44567778898 99999999998 88899999996321 1111222233345666666665 9999999999999999
Q ss_pred eEEEEeecCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHhhhhcCeEeccCCCCcEEecCC-CcEEEEecCCcc
Q 002616 570 LYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVL----ALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSK 643 (900)
Q Consensus 570 LyLVmEy~~GGsL~dlL~k~g~-Lse~~ar~ya~QIl~----AL~yLHs~gIIHRDLKPeNILLd~~-G~VKLsDFGLAk 643 (900)
+|+-+|++. .+|..+...... +++..++.+..+... ||.++|+.+++|-|+||.||++..+ ...+++|||+..
T Consensus 193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 999999985 688888876655 888999999999999 9999999999999999999999999 889999999987
Q ss_pred cccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCC
Q 002616 644 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 723 (900)
Q Consensus 644 ~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~ 723 (900)
.+...+.. . . ........|..-|++||++.+ -++...|+++||.++.+-.+|..++.
T Consensus 272 ~i~~~~~~------------------~---~-~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~ 328 (524)
T KOG0601|consen 272 KISDGNFS------------------S---V-FKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPS 328 (524)
T ss_pred EccCCccc------------------c---c-eeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhccccc
Confidence 53211100 0 0 001122357788999999865 58889999999999999988876654
Q ss_pred CC--ChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCCCC
Q 002616 724 AE--SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786 (900)
Q Consensus 724 ~~--s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~id 786 (900)
.. +.-...+. ..++ ..+-...+.++...+..++..+|..|++ +..+++|++.....
T Consensus 329 ~g~~~~W~~~r~---~~ip-~e~~~~~s~~l~~~~~~~~d~~~~~~~~---~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 329 VGKNSSWSQLRQ---GYIP-LEFCEGGSSSLRSVTSQMLDEDPRLRLT---AQILTALNVIHSKL 386 (524)
T ss_pred CCCCCCcccccc---ccCc-hhhhcCcchhhhhHHHHhcCcchhhhhH---HHHHhccccccchh
Confidence 33 11001111 1111 1122455667777999999999999999 77899999987543
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.7e-12 Score=125.21 Aligned_cols=128 Identities=18% Similarity=0.286 Sum_probs=96.2
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceE-EEeeeeccCCeeEEEEeecC
Q 002616 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV-RFFYSFTCRDNLYLVMEYLN 578 (900)
Q Consensus 500 l~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIV-kL~~~f~d~~~LyLVmEy~~ 578 (900)
++.|+.|.++.||+++.. |+.|++|+...... ....+.+|..++..+.+.+++ ++++... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999865 78899998754321 122356788888887654444 4444433 34589999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCe-----EeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 579 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI-----VHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 579 GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gI-----IHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
|.++... . .....++.+++.+|..||..++ +|+|++|.||+++ ++.++++|||.+..
T Consensus 75 G~~l~~~----~----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE----D----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc----c----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9887643 0 1123456799999999999985 9999999999999 67899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.8e-12 Score=144.50 Aligned_cols=138 Identities=24% Similarity=0.317 Sum_probs=94.5
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccc---------------------------hhH----H------HHHH
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR---------------------------KND----I------ERIL 543 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~---------------------------~~~----~------e~~l 543 (900)
+.||.|++|.||+|+.+ +|+.||||+.+...... ... . -.+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 47999999999999976 69999999985421000 000 0 1244
Q ss_pred HHHHHHHhcC-----CCceE--EEeeeeccCCeeEEEEeecCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHhhhhc
Q 002616 544 AERNILITVR-----NPFVV--RFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVL-ALEYLHSL 614 (900)
Q Consensus 544 ~Ei~IL~~L~-----HPnIV--kL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~-g~Lse~~ar~ya~QIl~-AL~yLHs~ 614 (900)
+|...+.++. +++|. ++|.. .....++||||++|++|.++.... ..++ ...++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~--~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWD--RTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehh--hcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 4555555442 34332 23322 233468999999999998876532 1222 2334555555 46789999
Q ss_pred CeEeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 615 gIIHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
|++|+|+||.||+++.+|.++|+|||++..
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 999999999999999999999999999874
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.24 E-value=9.8e-11 Score=137.29 Aligned_cols=169 Identities=21% Similarity=0.340 Sum_probs=128.5
Q ss_pred EEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCChHHHHHhcCCC
Q 002616 513 LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 592 (900)
Q Consensus 513 la~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g~L 592 (900)
.|..+.++.+|.+.+.+...- ...+.+.+-+..|+.++||||++++..+...+.+|+|+|-+. .|..++.+.+
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-- 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-- 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH--
Confidence 456677889999888865332 345667788889999999999999999999999999999884 6777777644
Q ss_pred CHHHHHHHHHHHHHHHHhhh-hcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcc
Q 002616 593 EEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671 (900)
Q Consensus 593 se~~ar~ya~QIl~AL~yLH-s~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~ 671 (900)
......-+.||+.||.||| +.+++|++|.-.-|+++..|+.||++|-++..... ..+
T Consensus 103 -~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~-------------~~~-------- 160 (690)
T KOG1243|consen 103 -KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASG-------------FNA-------- 160 (690)
T ss_pred -HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEecccc-------------CCc--------
Confidence 5566667889999999997 66899999999999999999999999998753210 000
Q ss_pred cccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhC
Q 002616 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 718 (900)
Q Consensus 672 ~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtG 718 (900)
......---.|..|+.+.... ...|.|-|||+++|++.|
T Consensus 161 ------~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 ------PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ------ccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 001111122356666554322 467999999999999998
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.23 E-value=8e-11 Score=122.33 Aligned_cols=139 Identities=22% Similarity=0.166 Sum_probs=100.3
Q ss_pred EEeccCCceEEEEEEECC------CCcEEEEEEeecccc-------------------cchhHHHHH----HHHHHHHHh
Q 002616 501 KPISRGAFGRVFLARKRT------TGDLFAIKVLKKLDM-------------------IRKNDIERI----LAERNILIT 551 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~------tGk~VAIKiLkK~~~-------------------~~~~~~e~~----l~Ei~IL~~ 551 (900)
..||.|--+.||.|.... .+..+|||+.+-... .+......+ .+|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999997543 357999998753110 011122233 389999988
Q ss_pred cCC--CceEEEeeeeccCCeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhh-hhcCeEeccCCCCcEEe
Q 002616 552 VRN--PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL-HSLGIVHRDLKPDNLLI 628 (900)
Q Consensus 552 L~H--PnIVkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yL-Hs~gIIHRDLKPeNILL 628 (900)
+.. -++.+.+++ ..-+|||||+.++.+..-.-+...+++..+..+..+++.+|..| |+.||||+||+|.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 752 455555543 45689999997755533222333466666777789999999998 89999999999999999
Q ss_pred cCCCcEEEEecCCccc
Q 002616 629 AHDGHIKLTDFGLSKI 644 (900)
Q Consensus 629 d~~G~VKLsDFGLAk~ 644 (900)
+ +|.+.|+|||.+..
T Consensus 159 ~-~~~v~iIDF~qav~ 173 (197)
T cd05146 159 H-DGKVWFIDVSQSVE 173 (197)
T ss_pred E-CCcEEEEECCCcee
Confidence 6 57899999998863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=5.6e-11 Score=129.57 Aligned_cols=212 Identities=25% Similarity=0.337 Sum_probs=149.4
Q ss_pred HHHHhcCCCceEEEeeeeccCC-----eeEEEEeecCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHhhhhcC--
Q 002616 547 NILITVRNPFVVRFFYSFTCRD-----NLYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLALEYLHSLG-- 615 (900)
Q Consensus 547 ~IL~~L~HPnIVkL~~~f~d~~-----~LyLVmEy~~GGsL~dlL~k~----g~Lse~~ar~ya~QIl~AL~yLHs~g-- 615 (900)
.-|-++.|.|||+++.++.+.. ...++.|||..|+|..+|++. ..+.....+.|+.||+.||.|||+..
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 4455677999999998886654 488999999999999999764 35778888899999999999999875
Q ss_pred eEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc
Q 002616 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL 695 (900)
Q Consensus 616 IIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~ 695 (900)
|||+.+..+-|++..+|-+|+.---.... +. ..............|-++|.|||.=.
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~----------------------h~-s~~~~~~~Ek~~~~~~~g~~a~~sg~ 255 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDST----------------------HP-SVNSTREAEKSVNTSLPGFSAPESGT 255 (458)
T ss_pred cccCCcchhheeecCCceEEecccCcccc----------------------ch-hhhhhhHhhhhccccCCccccCCcCc
Confidence 99999999999999999998752211110 00 00001111222335778999999755
Q ss_pred CCCCCccceeechhHHHHHHHhCCCC-CCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHH
Q 002616 696 GTEHGYAADWWSVGIILFEFITGIPP-FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 774 (900)
Q Consensus 696 g~~ys~ksDIWSLGVILyEMLtGk~P-F~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~ 774 (900)
....+-++|||+||+...||..|..- -.+.+..+.-..|.+-.+-.. . .--+++|.+||+-.|..||+ ++
T Consensus 256 ~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le---n---~lqr~~i~kcl~~eP~~rp~---ar 326 (458)
T KOG1266|consen 256 TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE---N---GLQRGSITKCLEGEPNGRPD---AR 326 (458)
T ss_pred ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc---C---ccccCcCcccccCCCCCCcc---hh
Confidence 55567799999999999999988753 333332222222222111100 1 12357899999999999999 88
Q ss_pred HHHcCCCCCCCCcchh
Q 002616 775 EVKAHPFFKGVNWDSL 790 (900)
Q Consensus 775 EIL~HPFFk~idw~~L 790 (900)
+++.||..-++.-..+
T Consensus 327 ~llfHpllfeVhslkl 342 (458)
T KOG1266|consen 327 LLLFHPLLFEVHSLKL 342 (458)
T ss_pred hhhcCceeeecchHHH
Confidence 9999998866544333
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.8e-10 Score=114.93 Aligned_cols=140 Identities=20% Similarity=0.256 Sum_probs=105.0
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeeeeccC---CeeEEEEe
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCR---DNLYLVME 575 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~H--PnIVkL~~~f~d~---~~LyLVmE 575 (900)
+.||.|.++.||++...+ |+.|++|+....... .....+.+|..++..+.+ ..+.+++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 578999999999998753 688999987653321 134567889999999875 3456666666554 26789999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhh------------------------------------------
Q 002616 576 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS------------------------------------------ 613 (900)
Q Consensus 576 y~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs------------------------------------------ 613 (900)
|++|+++...+.. ..+++.....++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999888765432 345666666667777777777763
Q ss_pred --------------cCeEeccCCCCcEEecC--CCcEEEEecCCccc
Q 002616 614 --------------LGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKI 644 (900)
Q Consensus 614 --------------~gIIHRDLKPeNILLd~--~G~VKLsDFGLAk~ 644 (900)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 24799999999999998 67789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.4e-09 Score=111.64 Aligned_cols=134 Identities=29% Similarity=0.309 Sum_probs=98.6
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEee-cc----cccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEe
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLK-KL----DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLk-K~----~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmE 575 (900)
..+++|+-+.++.+.+. |..+++|.=. |. .+..+-...+..+|..+|.++.--.|..-+-++.+.+.-.|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999999875 5566677432 21 11122234567889999988764333333334556677789999
Q ss_pred ecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 576 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 576 y~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
|++|-.|.+.+... .-.++..+-.-+.-||..||||+||.++||++...+ +.++||||+.+
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888888765 134567777788889999999999999999997544 99999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=8.7e-09 Score=105.78 Aligned_cols=144 Identities=24% Similarity=0.239 Sum_probs=104.8
Q ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEEee-----cccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEE
Q 002616 499 IIKPISRGAFGRVFLARKRTTGDLFAIKVLK-----KLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 499 il~~LGkG~FG~Vyla~~k~tGk~VAIKiLk-----K~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLV 573 (900)
.+..|-+|+-+.|+++.+. |+.+.||.=. ...+..+-...+..+|..+|.++.--.|.--.-+|.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 5678889999999999886 8888888421 11222233356778899999887633333223345566666789
Q ss_pred EeecCC-CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCC---cEEEEecCCccc
Q 002616 574 MEYLNG-GDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKI 644 (900)
Q Consensus 574 mEy~~G-GsL~dlL~k~g--~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G---~VKLsDFGLAk~ 644 (900)
|||++| -++.+++.... .........++..|-..|.-||.++|||+||..+||+|..+| .+.|+|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 47777776543 223333367888999999999999999999999999997766 358999999863
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.4e-09 Score=128.25 Aligned_cols=171 Identities=21% Similarity=0.354 Sum_probs=122.6
Q ss_pred HHHHHHHHHhhhhc-CeEeccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCc
Q 002616 601 IAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNR 679 (900)
Q Consensus 601 a~QIl~AL~yLHs~-gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~ 679 (900)
+.+++.|+.|+|.. ++||+.|.|++|.++.+|.+||+.|+++..... + ....+..|. ....
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~--------~-------~~~p~~~yd---~~lp 166 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANG--------P-------TEYPFSEYD---PPLP 166 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCC--------C-------CccccccCC---CCCC
Confidence 34566999999965 899999999999999999999999998863210 0 000111111 1111
Q ss_pred ccccCCCCCCChhhhcCCCCCccceeechhHHHHHHH-hCCCCCCCCChHHHHHhhhc-CCCCCCCCCCCCCHHHHHHHH
Q 002616 680 HSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI-TGIPPFTAESPEIIFDNILN-RKIPWPCVPSDMSFEAQDLIN 757 (900)
Q Consensus 680 ~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEML-tGk~PF~~~s~~ei~~kIl~-~~l~~P~ip~~lS~eakDLIk 757 (900)
....-...|.|||++.+...+.++|++||||++|-+. .|+.-|...+....+..-.. .....-.....++.++++=|.
T Consensus 167 ~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~ 246 (700)
T KOG2137|consen 167 LLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLK 246 (700)
T ss_pred hhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHH
Confidence 2233457899999999988899999999999999998 56666666544333322211 122222234789999999999
Q ss_pred HhccCCcCCCCChhcHHHHHcCCCCCCCCcchhhh
Q 002616 758 RFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 792 (900)
Q Consensus 758 ~cL~~DP~kRpSa~~a~EIL~HPFFk~idw~~L~~ 792 (900)
++|..++..||+ +..++..|||.+..-..|+.
T Consensus 247 k~l~~~~~~rp~---~~~l~~~~ff~D~~~~aLrf 278 (700)
T KOG2137|consen 247 KLLNGDSAVRPT---LDLLLSIPFFSDPGLKALRF 278 (700)
T ss_pred HHhcCCcccCcc---hhhhhcccccCCchhhhhhh
Confidence 999999999997 77899999999876555543
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=1.4e-07 Score=102.52 Aligned_cols=131 Identities=15% Similarity=0.137 Sum_probs=90.0
Q ss_pred EEEEEECCCCcEEEEEEeecccc---cch-----hHHHHHHHHHHHHHhcC-----CCceEEEeeeecc--CCeeEEEEe
Q 002616 511 VFLARKRTTGDLFAIKVLKKLDM---IRK-----NDIERILAERNILITVR-----NPFVVRFFYSFTC--RDNLYLVME 575 (900)
Q Consensus 511 Vyla~~k~tGk~VAIKiLkK~~~---~~~-----~~~e~~l~Ei~IL~~L~-----HPnIVkL~~~f~d--~~~LyLVmE 575 (900)
|+++... |+.|.+|....... .+. .-...+.+|...+..+. -|.+|-+...-.. ...-|||||
T Consensus 38 vvr~~~~--g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte 115 (268)
T PRK15123 38 TLRFELA--GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE 115 (268)
T ss_pred EEEEEEC--CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence 4455443 67788886532110 000 11124778888887763 3433333211111 234789999
Q ss_pred ecCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecC-------CCcEEEEecCCcc
Q 002616 576 YLNGG-DLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-------DGHIKLTDFGLSK 643 (900)
Q Consensus 576 y~~GG-sL~dlL~k--~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~-------~G~VKLsDFGLAk 643 (900)
++++- +|.+++.. ....+......++.+++..+.-||..||+|+|+++.|||++. ++.+.|+||+.+.
T Consensus 116 ~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 116 DLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred eCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99986 79888864 234566778889999999999999999999999999999985 4689999999875
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.5e-07 Score=105.40 Aligned_cols=202 Identities=20% Similarity=0.231 Sum_probs=146.0
Q ss_pred ceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccC----CeeEEEEeecCC-CCh
Q 002616 508 FGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----DNLYLVMEYLNG-GDL 582 (900)
Q Consensus 508 FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~----~~LyLVmEy~~G-GsL 582 (900)
-.+.|++...-+|..|++|.+.-.+....+ ....-+++++++.|+|||++..+|.+. ..++||++|.|+ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~n---k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTN---KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcc---cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 457899999999999999998443333222 223346788999999999999999844 358999999987 677
Q ss_pred HHHHHh---------------cCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccc
Q 002616 583 YSLLRK---------------VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 583 ~dlL~k---------------~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~ 647 (900)
+++--. ....+|...+.|+.|+..||.++|+.|+.-+-|.|.+||++.+..++|+.-|+..+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 766421 22478899999999999999999999999999999999999888888887776543210
Q ss_pred cccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCC-CCCCC
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP-FTAES 726 (900)
Q Consensus 648 ~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~P-F~~~s 726 (900)
.+ + |-+.+. .+-|.=.||.+++.|.||..- +....
T Consensus 446 --------------------------d~--------~-------~~le~~---Qq~D~~~lG~ll~aLAt~~~ns~~~d~ 481 (655)
T KOG3741|consen 446 --------------------------DP--------T-------EPLESQ---QQNDLRDLGLLLLALATGTENSNRTDS 481 (655)
T ss_pred --------------------------CC--------C-------cchhHH---hhhhHHHHHHHHHHHhhcccccccccc
Confidence 00 0 111111 245777899999999999532 22222
Q ss_pred hHHH-HHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCC
Q 002616 727 PEII-FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 766 (900)
Q Consensus 727 ~~ei-~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~k 766 (900)
.+.. .+.| ....|.++.++|.-+...++++
T Consensus 482 ~~~s~~~~I----------~~~yS~D~rn~v~yl~s~~~~~ 512 (655)
T KOG3741|consen 482 TQSSHLTRI----------TTTYSTDLRNVVEYLESLNFRE 512 (655)
T ss_pred hHHHHHHHh----------hhhhhHHHHHHHHHHHhcCccc
Confidence 2222 2222 2467788999999999888884
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.1e-07 Score=96.32 Aligned_cols=127 Identities=25% Similarity=0.277 Sum_probs=82.0
Q ss_pred EEEEEEECCCCcEEEEEEeeccc-----------------------ccchhHHHHHHHHHHHHHhcCCC--ceEEEeeee
Q 002616 510 RVFLARKRTTGDLFAIKVLKKLD-----------------------MIRKNDIERILAERNILITVRNP--FVVRFFYSF 564 (900)
Q Consensus 510 ~Vyla~~k~tGk~VAIKiLkK~~-----------------------~~~~~~~e~~l~Ei~IL~~L~HP--nIVkL~~~f 564 (900)
.||.|... .|..+|+|+.+... ...........+|.+.|.++..- ++.+++++-
T Consensus 1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 38888864 47899999875311 01111235678899999999754 455665442
Q ss_pred ccCCeeEEEEeecC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHh-hhhcCeEeccCCCCcEEecCCCcEEEEecCC
Q 002616 565 TCRDNLYLVMEYLN--GGDLYSLLRKVGCLEEDVARIYIAELVLALEY-LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 641 (900)
Q Consensus 565 ~d~~~LyLVmEy~~--GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~y-LHs~gIIHRDLKPeNILLd~~G~VKLsDFGL 641 (900)
.-+|||||++ |..+..+... . ++......++.+++..+.. +|..||||+||.+.|||++.+ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~-~-~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV-D-LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC-G-GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhc-c-ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3479999998 6555443322 1 2244556677788886655 579999999999999999876 999999998
Q ss_pred ccc
Q 002616 642 SKI 644 (900)
Q Consensus 642 Ak~ 644 (900)
+..
T Consensus 153 av~ 155 (188)
T PF01163_consen 153 AVD 155 (188)
T ss_dssp EEE
T ss_pred cee
Confidence 863
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.58 E-value=9.9e-09 Score=120.05 Aligned_cols=243 Identities=23% Similarity=0.212 Sum_probs=164.3
Q ss_pred CCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeccCCeeEEE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPn-IVkL~~~f~d~~~LyLV 573 (900)
.-+.....+++|+++++++.+...+...+ .+.+... ....-++++|.+++||| .+..++.++.++.++++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 34455667899999999998876554444 5544321 34556888999999999 88888888888999999
Q ss_pred EeecCCC-ChHHHH-HhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCcccccccccc
Q 002616 574 MEYLNGG-DLYSLL-RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 574 mEy~~GG-sL~dlL-~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
|+++.+| +-.... ...-.|.+-+.....+.-++++++||+..=+||| |||..+ +..|+.||+.....
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L------ 381 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQL------ 381 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCccc------
Confidence 9999887 221111 1112344445555677788899999998778998 887754 78899999976521
Q ss_pred cCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhCCCCCCCCChHHHH
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 652 ~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~ 731 (900)
.+.....+..+|+.++|||+.....+....|.|++|+--.+|.-|-+|-.. |....
T Consensus 382 ----------------------~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~ 437 (829)
T KOG0576|consen 382 ----------------------TRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVL 437 (829)
T ss_pred ----------------------CcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--Ccccc
Confidence 112245677899999999999999999999999999877788888777544 11111
Q ss_pred HhhhcCCCCCCCCC-CCCCHH-HHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 732 DNILNRKIPWPCVP-SDMSFE-AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 732 ~kIl~~~l~~P~ip-~~lS~e-akDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
..+-++.-.+.... ...++. -.++...|+...|..|+. +...+.|.+|.+
T Consensus 438 ~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv---~mgacfsKvfng 489 (829)
T KOG0576|consen 438 PMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKV---HMGACFSKVFNG 489 (829)
T ss_pred CCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcc---hhhHHHHHHhcc
Confidence 11111110000000 001111 114667788888888887 556677888876
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.4e-07 Score=93.78 Aligned_cols=106 Identities=28% Similarity=0.322 Sum_probs=82.2
Q ss_pred HHHHHHHHHHHHhcCC--CceEEEeeeeccC----CeeEEEEeecCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHhh
Q 002616 539 IERILAERNILITVRN--PFVVRFFYSFTCR----DNLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLALEYL 611 (900)
Q Consensus 539 ~e~~l~Ei~IL~~L~H--PnIVkL~~~f~d~----~~LyLVmEy~~GG-sL~dlL~k~g~Lse~~ar~ya~QIl~AL~yL 611 (900)
.....+|...+..+.. =.+.+.+++.... ..-|||+|+++|. +|.+++......+......++.+++..+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 3457778777766642 1233333333332 2458999999984 7999998755577888889999999999999
Q ss_pred hhcCeEeccCCCCcEEecCCC---cEEEEecCCccc
Q 002616 612 HSLGIVHRDLKPDNLLIAHDG---HIKLTDFGLSKI 644 (900)
Q Consensus 612 Hs~gIIHRDLKPeNILLd~~G---~VKLsDFGLAk~ 644 (900)
|.+||+|+|++|.|||++.++ .+.|+||+-++.
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.2e-06 Score=95.67 Aligned_cols=232 Identities=17% Similarity=0.237 Sum_probs=147.5
Q ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhc-CCCceEE--------EeeeeccCCe
Q 002616 499 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVR--------FFYSFTCRDN 569 (900)
Q Consensus 499 il~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L-~HPnIVk--------L~~~f~d~~~ 569 (900)
..+.||+|+-+.+|-.-.- + ..+.|++.+...-. -...+..|... .||-+-. |++. .....
T Consensus 15 ~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~------~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAA------QAQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKV 84 (637)
T ss_pred CCccccCCccceeeecchh--h-chhheeecCCCchH------HHHHHHHhccCCCCcchhhhhcccHHHhhCC-Cccce
Confidence 3467999999999965332 2 23558776543211 11122333333 3553322 1211 12223
Q ss_pred eEEEEeecCCCCh-HHHH------HhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEEecCCc
Q 002616 570 LYLVMEYLNGGDL-YSLL------RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 642 (900)
Q Consensus 570 LyLVmEy~~GGsL-~dlL------~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLsDFGLA 642 (900)
+-++|..++|-.- ..+. +....+.+..+...+++++.+.+.||..|.+-+|++++|+|+.+++.|.|.|-..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 6788888877421 1111 11234678888999999999999999999999999999999999999999864321
Q ss_pred ccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhc-----CCCCCccceeechhHHHHHHHh
Q 002616 643 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFIT 717 (900)
Q Consensus 643 k~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGVILyEMLt 717 (900)
... .........+|.+.|.+||.-. +.+-+...|-|.|||++|++|.
T Consensus 165 qi~----------------------------~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ 216 (637)
T COG4248 165 QIN----------------------------ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLF 216 (637)
T ss_pred eec----------------------------cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHh
Confidence 110 0112234568999999999765 3344668999999999999998
Q ss_pred C-CCCCCCCC-------hHHHHHhhhcCCC-----------CCCC-C-CCCCCHHHHHHHHHhccCC--cCCCCCh
Q 002616 718 G-IPPFTAES-------PEIIFDNILNRKI-----------PWPC-V-PSDMSFEAQDLINRFLIHD--PNQRLGA 770 (900)
Q Consensus 718 G-k~PF~~~s-------~~ei~~kIl~~~l-----------~~P~-i-p~~lS~eakDLIk~cL~~D--P~kRpSa 770 (900)
| +.||.+.. +-++ .|..+.+ +-|. + -.-++++++.|..+|+..- +.-||++
T Consensus 217 ggrHPysGI~~~~~ap~p~E~--~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a 290 (637)
T COG4248 217 GGRHPYSGIPLISDAPNPLET--DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTA 290 (637)
T ss_pred cCCCCCCcccccCCCCCcchh--hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCH
Confidence 6 99997642 2221 2222111 1110 0 1346889999999999842 4579994
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.2e-05 Score=84.87 Aligned_cols=139 Identities=15% Similarity=0.225 Sum_probs=99.9
Q ss_pred ccCCceEEEEEEECCCCcEEEEEEeecc--cccc-hhHHHHHHHHHHHHHhcCC--CceEEEeeeeccC----CeeEEEE
Q 002616 504 SRGAFGRVFLARKRTTGDLFAIKVLKKL--DMIR-KNDIERILAERNILITVRN--PFVVRFFYSFTCR----DNLYLVM 574 (900)
Q Consensus 504 GkG~FG~Vyla~~k~tGk~VAIKiLkK~--~~~~-~~~~e~~l~Ei~IL~~L~H--PnIVkL~~~f~d~----~~LyLVm 574 (900)
|+||-+-|+..... |+.|-+|.-... .... +.....|.+|...|..+.. -.+.+....-... -.-+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 56788888887765 456777754310 0111 3456789999999988752 2244444222111 1368999
Q ss_pred eecCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCc--EEEEecCCccc
Q 002616 575 EYLNG-GDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKI 644 (900)
Q Consensus 575 Ey~~G-GsL~dlL~k~--g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~--VKLsDFGLAk~ 644 (900)
|-+.| -+|.+++.+. ...++...+.++.+++..|.-||+.|+.|+|+.+.|||++.+|. |+++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97764 5888888664 34577777889999999999999999999999999999987777 99999987663
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.22 E-value=1e-05 Score=100.52 Aligned_cols=239 Identities=23% Similarity=0.261 Sum_probs=159.0
Q ss_pred eccCCceEEEEEEECCCC----cEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCe----eEEEE
Q 002616 503 ISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN----LYLVM 574 (900)
Q Consensus 503 LGkG~FG~Vyla~~k~tG----k~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~----LyLVm 574 (900)
|..-.+|+|++..|...- .++-++-=.-.....+..+....-|...+.++.|+|++.++.+-..... +.+..
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~ 265 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPCGKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQ 265 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccchHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHH
Confidence 666677788877763210 1111110000001112334445567777888899999999877655432 34566
Q ss_pred eecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCC---cEEecCCCcEEEE--ecCCcccccccc
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD---NLLIAHDGHIKLT--DFGLSKIGLINN 649 (900)
Q Consensus 575 Ey~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPe---NILLd~~G~VKLs--DFGLAk~~~~~~ 649 (900)
++++.-++...+...+.++.+.++.+..++++||.|+|+....|.-|... +-..+..+.+.++ ||+.++....
T Consensus 266 ~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d-- 343 (1351)
T KOG1035|consen 266 EICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD-- 343 (1351)
T ss_pred hhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCC--
Confidence 88999999999999999999999999999999999999996655555444 4444556677776 8887764321
Q ss_pred cccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCcc--ceeechhHHHHHHHhCCCCCCCCCh
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYA--ADWWSVGIILFEFITGIPPFTAESP 727 (900)
Q Consensus 650 s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~k--sDIWSLGVILyEMLtGk~PF~~~s~ 727 (900)
.....+..-+..|.|||......+..+ .|+|.+|.....+..|..+-.-..
T Consensus 344 --------------------------~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~- 396 (1351)
T KOG1035|consen 344 --------------------------NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSA- 396 (1351)
T ss_pred --------------------------cccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCccccccc-
Confidence 112223345667889998887766554 699999999999988754321100
Q ss_pred HHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCCC
Q 002616 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 728 ~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk~ 784 (900)
. +.+..+.....+..+++.+|+..++++|++ +.+++.|||.+-
T Consensus 397 --~---------~~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~---~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 397 --V---------PVSLLDVLSTSELLDALPKCLDEDSEERLS---ALELLTHPFLRF 439 (1351)
T ss_pred --c---------hhhhhccccchhhhhhhhhhcchhhhhccc---hhhhhhchhccc
Confidence 0 001111222226788999999999999999 889999999864
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.19 E-value=2e-05 Score=83.80 Aligned_cols=141 Identities=23% Similarity=0.353 Sum_probs=90.9
Q ss_pred ccCCCeEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHH------HHHHHHHHHhcC-----C---Cce
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER------ILAERNILITVR-----N---PFV 557 (900)
Q Consensus 492 ~~~~dYeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~------~l~Ei~IL~~L~-----H---PnI 557 (900)
+...+|.+++++-......|.+..-. |+.|++|..+............ ..+++..+..+. . |.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~--~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID--GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC--CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 45678899999988887777777654 8899999876432211111111 122233222221 1 122
Q ss_pred EEEeeeeccCCeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEEE
Q 002616 558 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLT 637 (900)
Q Consensus 558 VkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKLs 637 (900)
+.---.+......+|||||++|..|.++.. +++. +...++.+|.-||+.|+.|+|..|.|+++..++ +++.
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEE
Confidence 222222222344578999999988866532 3332 345677889999999999999999999998555 9999
Q ss_pred ecCCcc
Q 002616 638 DFGLSK 643 (900)
Q Consensus 638 DFGLAk 643 (900)
||+..+
T Consensus 177 D~~~k~ 182 (229)
T PF06176_consen 177 DTQGKR 182 (229)
T ss_pred ECcccc
Confidence 998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.17 E-value=7.3e-06 Score=89.03 Aligned_cols=136 Identities=24% Similarity=0.259 Sum_probs=97.3
Q ss_pred EEEEEeccCCceEEEEEEECCCCcEEEEEEeecccc-------cc------------hhHHHHHHHHHHHHHhcCCC--c
Q 002616 498 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-------IR------------KNDIERILAERNILITVRNP--F 556 (900)
Q Consensus 498 eil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~-------~~------------~~~~e~~l~Ei~IL~~L~HP--n 556 (900)
.+...||-|--+.||.|... .|..+|||.=+-... .. .-......+|.++|.++... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999876 589999996432110 00 11123467888999888643 4
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEEE
Q 002616 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKL 636 (900)
Q Consensus 557 IVkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VKL 636 (900)
|.+.++ .+.-.+||||+.|-.|...- ++.+.+..++..|+.-+.-+-..||||+|+.+=|||++++|.+.+
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 444433 24567999999997765432 234444555666666666666899999999999999999999999
Q ss_pred EecCCcc
Q 002616 637 TDFGLSK 643 (900)
Q Consensus 637 sDFGLAk 643 (900)
+||--+.
T Consensus 244 IDwPQ~v 250 (304)
T COG0478 244 IDWPQAV 250 (304)
T ss_pred EeCcccc
Confidence 9998664
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.09 E-value=7e-05 Score=76.36 Aligned_cols=138 Identities=28% Similarity=0.384 Sum_probs=82.1
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC--ceEEEeeee---ccCCeeEEEE
Q 002616 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP--FVVRFFYSF---TCRDNLYLVM 574 (900)
Q Consensus 500 l~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HP--nIVkL~~~f---~d~~~LyLVm 574 (900)
++.|+.|..+.||++.... ..|++|+.... .....+.+|..++..+... .+.+++... ......|++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999998764 58999986542 3456677888888777522 245555533 2223479999
Q ss_pred eecCCCChHH----------------HHH---hc----CCCCHHH---H---HHH---------------HHHHHH-HHH
Q 002616 575 EYLNGGDLYS----------------LLR---KV----GCLEEDV---A---RIY---------------IAELVL-ALE 609 (900)
Q Consensus 575 Ey~~GGsL~d----------------lL~---k~----g~Lse~~---a---r~y---------------a~QIl~-AL~ 609 (900)
++++|..+.. .+. .. ..+.... . ... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987776 111 11 0001000 0 000 111222 233
Q ss_pred hhh-------hcCeEeccCCCCcEEec-CCCcEEEEecCCccc
Q 002616 610 YLH-------SLGIVHRDLKPDNLLIA-HDGHIKLTDFGLSKI 644 (900)
Q Consensus 610 yLH-------s~gIIHRDLKPeNILLd-~~G~VKLsDFGLAk~ 644 (900)
.++ ...++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 333 34699999999999999 667778999998864
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.02 E-value=5.4e-05 Score=80.31 Aligned_cols=134 Identities=16% Similarity=0.120 Sum_probs=82.8
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc--eEEEeeeeccCCeeEEEEeecC
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF--VVRFFYSFTCRDNLYLVMEYLN 578 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPn--IVkL~~~f~d~~~LyLVmEy~~ 578 (900)
..||.|..+.||+. .|..+++|...... ....+.+|.+++..+..-. +.+.+++....+..++|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999973 25567888875421 2345688999998876322 4566677777777899999999
Q ss_pred CCC-hH--------------HHH-------Hhc--CCCCHH-HHHHHHH----------HHHH-HHHhhh----hcCeEe
Q 002616 579 GGD-LY--------------SLL-------RKV--GCLEED-VARIYIA----------ELVL-ALEYLH----SLGIVH 618 (900)
Q Consensus 579 GGs-L~--------------dlL-------~k~--g~Lse~-~ar~ya~----------QIl~-AL~yLH----s~gIIH 618 (900)
|.+ +. ..+ +.. ...... ....+.. .+.. ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 964 11 101 110 001100 0000100 0111 112222 124789
Q ss_pred ccCCCCcEEecCCCcEEEEecCCccc
Q 002616 619 RDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 619 RDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
+|+.|.||+++.++ +.|+||+.+..
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcCc
Confidence 99999999999888 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.96 E-value=3.6e-05 Score=90.91 Aligned_cols=140 Identities=23% Similarity=0.303 Sum_probs=87.4
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccc--------------------------cc-hhH----HHH------HH
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--------------------------IR-KND----IER------IL 543 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~--------------------------~~-~~~----~e~------~l 543 (900)
..|+.++-|.||.|+.++ |+.||||+.+..-. .. ... .+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 579999999999999875 99999999752100 00 000 111 33
Q ss_pred HHHHHHHhcC-----CCceEEEeeeeccCCeeEEEEeecCCCChHHHH--HhcCCCCHHHHHHHHHHHHHHHHhhhhcCe
Q 002616 544 AERNILITVR-----NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLEEDVARIYIAELVLALEYLHSLGI 616 (900)
Q Consensus 544 ~Ei~IL~~L~-----HPnIVkL~~~f~d~~~LyLVmEy~~GGsL~dlL--~k~g~Lse~~ar~ya~QIl~AL~yLHs~gI 616 (900)
+|..-+.++. .|+|.--.-+.+-...-.|+|||++|-.+.+.. +. ..++...+.....++. +..+=..|+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgf 286 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGF 286 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCc
Confidence 4444444432 343322222222234457999999998888874 44 3455322222111111 222334799
Q ss_pred EeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 617 VHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 617 IHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
+|.|..|.||+++.+|.+-+.|||+...
T Consensus 287 fHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 287 FHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred cccCCCccceEEecCCcEEEEcCcceec
Confidence 9999999999999999999999998753
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.92 E-value=8.1e-05 Score=78.54 Aligned_cols=135 Identities=16% Similarity=0.116 Sum_probs=83.1
Q ss_pred EeccCCc-eEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEeecCC
Q 002616 502 PISRGAF-GRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNG 579 (900)
Q Consensus 502 ~LGkG~F-G~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~LyLVmEy~~G 579 (900)
.|-.|.+ ..||++... +..+.+|+..... ...+.+|+.++..+. +--+.+++++....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3445555 789998653 4678888775432 234667888887774 33455677777766678999999999
Q ss_pred CChHHHH-------------------HhcC----CCCHH------HHHHH-------------------HHHHHHHHHhh
Q 002616 580 GDLYSLL-------------------RKVG----CLEED------VARIY-------------------IAELVLALEYL 611 (900)
Q Consensus 580 GsL~dlL-------------------~k~g----~Lse~------~ar~y-------------------a~QIl~AL~yL 611 (900)
.+|.... +... .+... ..... ..++...|...
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 7765331 1000 11100 00000 11111111111
Q ss_pred ----hhcCeEeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 612 ----HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 612 ----Hs~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
....++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123589999999999999988889999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00024 Score=74.72 Aligned_cols=128 Identities=27% Similarity=0.390 Sum_probs=91.6
Q ss_pred CCeEEEEEeccCCc-eEEEEEEECCCCcEEEEEEeeccccc---------ch---------hHHHHHHHHHHHHHhcC--
Q 002616 495 DDFEIIKPISRGAF-GRVFLARKRTTGDLFAIKVLKKLDMI---------RK---------NDIERILAERNILITVR-- 553 (900)
Q Consensus 495 ~dYeil~~LGkG~F-G~Vyla~~k~tGk~VAIKiLkK~~~~---------~~---------~~~e~~l~Ei~IL~~L~-- 553 (900)
.+++.++.||.|.- |.||+++.. |+.||+|+++.-... .. ....-|..|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 78999999999999 999999876 889999994321110 00 12345677877665554
Q ss_pred -CCce--EEEeeeeccC------------------CeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhh
Q 002616 554 -NPFV--VRFFYSFTCR------------------DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 612 (900)
Q Consensus 554 -HPnI--VkL~~~f~d~------------------~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLH 612 (900)
+..+ |+.+++..-. ...-||.||++... .+.. .-+.+|..-|..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHHH
Confidence 4455 8988887322 12467888887643 1222 23567888899999
Q ss_pred hcCeEeccCCCCcEEecCCCcEEEEecCCc
Q 002616 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 642 (900)
Q Consensus 613 s~gIIHRDLKPeNILLd~~G~VKLsDFGLA 642 (900)
+.||+-+|+|+.|.. +| ||+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~---~G--~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR---GG--KLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc---CC--EEEecccC
Confidence 999999999999987 22 89999954
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.84 E-value=2.2e-06 Score=107.83 Aligned_cols=256 Identities=19% Similarity=0.112 Sum_probs=164.9
Q ss_pred cCCCeEEEEEeccCCceEEEEEEECCCC-cEEEEEEeecccc--cchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCC-
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTG-DLFAIKVLKKLDM--IRKNDIERILAERNILITVRNPFVVRFFYSFTCRD- 568 (900)
Q Consensus 493 ~~~dYeil~~LGkG~FG~Vyla~~k~tG-k~VAIKiLkK~~~--~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~- 568 (900)
...++++.--+|.|.++ +++|.... ..+.+|+.+.... ..+...+....|++-++...|++++..+.-.....
T Consensus 1227 ~~e~~EV~l~i~~~~~~---R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s 1303 (2724)
T KOG1826|consen 1227 AMEHSEVNLGISNHFHF---RNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSES 1303 (2724)
T ss_pred Hhhhhheeeecccceee---ccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCC
Confidence 34556665556555444 34433211 1234555543221 22334566677778778889999988765554433
Q ss_pred -eeEEEEeecCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHhhhhcC-----eEeccCCCCcEEecCCCcEEEEe
Q 002616 569 -NLYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVLALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTD 638 (900)
Q Consensus 569 -~LyLVmEy~~GGsL~dlL~k~g----~Lse~~ar~ya~QIl~AL~yLHs~g-----IIHRDLKPeNILLd~~G~VKLsD 638 (900)
..|.+++|+.+|.+++.+.++- .+.+..+.....+.+.+..-+|++. .+|++||+-|.+|..+..+|+.+
T Consensus 1304 ~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk 1383 (2724)
T KOG1826|consen 1304 TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGK 1383 (2724)
T ss_pred hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccc
Confidence 4789999999999999997642 3444444444445577777777542 78999999999999999999999
Q ss_pred cCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCCCCccceeechhHHHHHHHhC
Q 002616 639 FGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 718 (900)
Q Consensus 639 FGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyEMLtG 718 (900)
+|+.+.- + .........+++|.|++|++.+.-.++.++|+|..|+-+|+.-.|
T Consensus 1384 ~gLdKIk--n-------------------------p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~ 1436 (2724)
T KOG1826|consen 1384 GGLDKIK--N-------------------------PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDG 1436 (2724)
T ss_pred ccccccc--C-------------------------chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcc
Confidence 9998831 0 111233456889999999999998999889999999999999999
Q ss_pred CCCCCCCChHHHHHhhhcCCCCCCCCCCCCCHHHHHHHHHhccCCcCCCCChhcHHHHHcCCCCC
Q 002616 719 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 719 k~PF~~~s~~ei~~kIl~~~l~~P~ip~~lS~eakDLIk~cL~~DP~kRpSa~~a~EIL~HPFFk 783 (900)
.+||.......+...|.++. +-.++.-.|.++-.....+|-..-..||+ -..++.-+.|.
T Consensus 1437 n~~fi~flq~~Lkgiidn~t--f~sIe~l~pgdaNve~~~~Ll~K~~~rp~---q~isls~d~~a 1496 (2724)
T KOG1826|consen 1437 NAYFIFFLQPALKGIIDNHT--FFSIEKLKPGDANVEALHRLLWKYMERPG---QYISLSRDHFA 1496 (2724)
T ss_pred cHHHHHHHHHHHcCcccccc--cccccccCCCcccHHHHHHHHHHhhhcch---hhhhccccccc
Confidence 88885433333222222221 11222333344444444444445667888 44556666664
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00024 Score=88.53 Aligned_cols=80 Identities=16% Similarity=0.282 Sum_probs=56.6
Q ss_pred EEEeccCCceEEEEEEECCCC--cEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCce--EEEeeeeccC---CeeE
Q 002616 500 IKPISRGAFGRVFLARKRTTG--DLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFV--VRFFYSFTCR---DNLY 571 (900)
Q Consensus 500 l~~LGkG~FG~Vyla~~k~tG--k~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnI--VkL~~~f~d~---~~Ly 571 (900)
++.|+.|.+..+|+......+ ..|++|+....... .....+.+|..+|+.+. |++| .+++.++.+. +..|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~f 120 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAF 120 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCce
Confidence 577899999999998875432 46777765432211 12346788999999885 6554 7777777664 4679
Q ss_pred EEEeecCCCC
Q 002616 572 LVMEYLNGGD 581 (900)
Q Consensus 572 LVmEy~~GGs 581 (900)
+||||++|..
T Consensus 121 lVME~v~G~~ 130 (822)
T PLN02876 121 YIMEYLEGRI 130 (822)
T ss_pred EEEEecCCcc
Confidence 9999999864
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00024 Score=76.67 Aligned_cols=138 Identities=25% Similarity=0.207 Sum_probs=92.8
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEeecccccchh---------------------HHHHHHHHHHHHHhcC--CCc
Q 002616 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---------------------DIERILAERNILITVR--NPF 556 (900)
Q Consensus 500 l~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~---------------------~~e~~l~Ei~IL~~L~--HPn 556 (900)
...|+.|--+.||+|.. .++..+|+|+++.....-+. ...-..+|..-|.++. +-.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 34788888899999975 45889999998642211111 1122456666676653 222
Q ss_pred eEEEeeeeccCCeeEEEEeecCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhh-cCeEeccCCCCcEEecCCCcE
Q 002616 557 VVRFFYSFTCRDNLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHI 634 (900)
Q Consensus 557 IVkL~~~f~d~~~LyLVmEy~~GG-sL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs-~gIIHRDLKPeNILLd~~G~V 634 (900)
+.+-+.++ +-.|||||+... .-.-.|.. -.+....+..+..+++..+.-|-. .++||+||..=|||+. +|.+
T Consensus 132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 33333322 236999999653 11112222 123444788888899999998877 8999999999999999 8999
Q ss_pred EEEecCCccc
Q 002616 635 KLTDFGLSKI 644 (900)
Q Consensus 635 KLsDFGLAk~ 644 (900)
.|+|||-|..
T Consensus 206 ~iID~~QaV~ 215 (268)
T COG1718 206 YIIDVSQAVT 215 (268)
T ss_pred EEEECccccc
Confidence 9999998863
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.63 E-value=0.00026 Score=83.89 Aligned_cols=136 Identities=25% Similarity=0.377 Sum_probs=85.2
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccccc-----------------------------hhHHHH------HHHH
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR-----------------------------KNDIER------ILAE 545 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~-----------------------------~~~~e~------~l~E 545 (900)
+.||.-+.|.||+|+.+. |+.||+|+-+.. +.. .+-.+. |.+|
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~-l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPG-LEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcC-hHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 469999999999999987 999999986421 000 000111 2333
Q ss_pred HHHHH----hcCCCc------eEEEeeeeccCCeeEEEEeecCCCChHHH--HHhcCCCCHHHHHHHHHHHHHHHH-hhh
Q 002616 546 RNILI----TVRNPF------VVRFFYSFTCRDNLYLVMEYLNGGDLYSL--LRKVGCLEEDVARIYIAELVLALE-YLH 612 (900)
Q Consensus 546 i~IL~----~L~HPn------IVkL~~~f~d~~~LyLVmEy~~GGsL~dl--L~k~g~Lse~~ar~ya~QIl~AL~-yLH 612 (900)
.+-.. .+.|-+ |.++|..+.. .-.|+||||+|.-+.++ +.+.+ ++...+.. .+..+.. -|=
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st--~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~---~l~~~~~~qIf 318 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDLST--KRVLTMEYVDGIKINDLDAIDKRG-ISPHDILN---KLVEAYLEQIF 318 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhcCc--ceEEEEEecCCccCCCHHHHHHcC-CCHHHHHH---HHHHHHHHHHH
Confidence 33222 233433 4455544433 35799999999877665 34444 44443322 2223222 123
Q ss_pred hcCeEeccCCCCcEEecC----CCcEEEEecCCccc
Q 002616 613 SLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKI 644 (900)
Q Consensus 613 s~gIIHRDLKPeNILLd~----~G~VKLsDFGLAk~ 644 (900)
..|++|.|=.|.||++.. ++.+.+-|||+...
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 468999999999999984 56899999999874
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00021 Score=73.72 Aligned_cols=131 Identities=24% Similarity=0.326 Sum_probs=93.8
Q ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEee
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEY 576 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy 576 (900)
.+..+.||+|.+|.||+|.|. |..+|+|+-+... -...+..|.++|..+.--++.+=++.+-. -++.|||
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg~---~~i~me~ 93 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYGE---DFIRMEY 93 (201)
T ss_pred hhhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEech---hhhhhhh
Confidence 355678999999999999998 7799999765422 34567889999999886665553333322 2455999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCC-CCcEEecCCCcEEEEecCCccc
Q 002616 577 LNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLK-PDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 577 ~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLK-PeNILLd~~G~VKLsDFGLAk~ 644 (900)
+.|-.|...-... + +.-+..++.+---|-.+||-|..|. |..++|..++.+.|+||.-|++
T Consensus 94 i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 94 IDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred hcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 9998887765421 2 2223345555445677899999995 7777777777999999998873
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00043 Score=73.01 Aligned_cols=73 Identities=15% Similarity=0.138 Sum_probs=45.0
Q ss_pred EEeccCCce-EEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC---ceEEEeeeeccC---CeeEEE
Q 002616 501 KPISRGAFG-RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP---FVVRFFYSFTCR---DNLYLV 573 (900)
Q Consensus 501 ~~LGkG~FG-~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HP---nIVkL~~~f~d~---~~LyLV 573 (900)
+.|+.|+.. .||+. +..+++|+.+.. .....+.+|..+|..+... -+.++++..... ...|+|
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~-----~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA-----GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCcc-----chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 467777776 58876 234777865431 1234688899998877521 233444433332 235899
Q ss_pred EeecCCCChH
Q 002616 574 MEYLNGGDLY 583 (900)
Q Consensus 574 mEy~~GGsL~ 583 (900)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999997663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.37 E-value=0.0015 Score=68.26 Aligned_cols=137 Identities=17% Similarity=0.231 Sum_probs=80.2
Q ss_pred EEEeccCCceEEEEEEECC-CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC-CCceEEEeeeeccCCeeEEEEeec
Q 002616 500 IKPISRGAFGRVFLARKRT-TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYL 577 (900)
Q Consensus 500 l~~LGkG~FG~Vyla~~k~-tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~-HPnIVkL~~~f~d~~~LyLVmEy~ 577 (900)
++.|..|-...||++.... .++.|++|+...... ..-...+|..++..+. +...+++++.+.. .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 4678888888999997543 357899997754211 1112246888888775 3334445544432 3799999
Q ss_pred CCCChHHH--------------HH---hcC-CC----------C-HHHHHHHHH-------------------------H
Q 002616 578 NGGDLYSL--------------LR---KVG-CL----------E-EDVARIYIA-------------------------E 603 (900)
Q Consensus 578 ~GGsL~dl--------------L~---k~g-~L----------s-e~~ar~ya~-------------------------Q 603 (900)
+|-++... +. ... .. . ...+..|.. +
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 98665211 11 100 01 0 112112211 1
Q ss_pred HHHHHH-hh----hhcCeEeccCCCCcEEecC-CCcEEEEecCCccc
Q 002616 604 LVLALE-YL----HSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKI 644 (900)
Q Consensus 604 Il~AL~-yL----Hs~gIIHRDLKPeNILLd~-~G~VKLsDFGLAk~ 644 (900)
.+..|. .+ ...+++|+|+.|.|||++. ++.+.|+||..|..
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 111111 11 1246999999999999998 57899999998863
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.25 E-value=0.0035 Score=65.81 Aligned_cols=134 Identities=24% Similarity=0.274 Sum_probs=91.5
Q ss_pred EEeccCCceEEEEEEECCCCcEEEEEEeecccc-------------cchhHHHHHHHHHHHHHhcC------CCceEEEe
Q 002616 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-------------IRKNDIERILAERNILITVR------NPFVVRFF 561 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~-------------~~~~~~e~~l~Ei~IL~~L~------HPnIVkL~ 561 (900)
..||+|+.=.||.-- .+....||+++.... ..........+|+.-...+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 469999999998643 244567898876440 01122445566665554444 78899999
Q ss_pred eeeccCCeeEEEEeecCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCC---
Q 002616 562 YSFTCRDNLYLVMEYLNG------GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG--- 632 (900)
Q Consensus 562 ~~f~d~~~LyLVmEy~~G------GsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G--- 632 (900)
|..+++..+-+|+|.+.. -+|.+++.+ +.+++ ..+ ..+-.-..||-..+|+.+||+|.||++..++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 999999999999998754 257777754 44665 322 2333445678889999999999999996532
Q ss_pred -cEEEEe-cCCc
Q 002616 633 -HIKLTD-FGLS 642 (900)
Q Consensus 633 -~VKLsD-FGLA 642 (900)
.+.|+| ||-.
T Consensus 159 ~~lvlIDG~G~~ 170 (199)
T PF10707_consen 159 FRLVLIDGLGEK 170 (199)
T ss_pred eEEEEEeCCCCc
Confidence 467776 5543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0039 Score=68.83 Aligned_cols=78 Identities=12% Similarity=0.008 Sum_probs=54.9
Q ss_pred EEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC---CceEEEeeeecc---CCeeE
Q 002616 498 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVRFFYSFTC---RDNLY 571 (900)
Q Consensus 498 eil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~H---PnIVkL~~~f~d---~~~Ly 571 (900)
.-.+.||.|..+.||..... +..+.+|..+. . .....+.+|...|+.+.- ..|.++++.+.+ .+..|
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~-~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS--QGNPMPLMARS-F----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcC--CCCEEEEEecc-c----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 34567999999999998643 33467777432 1 123568889999988752 357777776654 35689
Q ss_pred EEEeecCCCCh
Q 002616 572 LVMEYLNGGDL 582 (900)
Q Consensus 572 LVmEy~~GGsL 582 (900)
||||+++|+++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998765
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0013 Score=68.24 Aligned_cols=98 Identities=23% Similarity=0.263 Sum_probs=79.1
Q ss_pred HHHHHHHHhcCC-CceEEEeeeeccCCeeEEEEeecCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHhhhh---cC
Q 002616 543 LAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL---LRKVGCLEEDVARIYIAELVLALEYLHS---LG 615 (900)
Q Consensus 543 l~Ei~IL~~L~H-PnIVkL~~~f~d~~~LyLVmEy~~GGsL~dl---L~k~g~Lse~~ar~ya~QIl~AL~yLHs---~g 615 (900)
.+|.-+|..+.+ +++.+++|+|- -++|.||...+++... +......++.....++.+++..+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357778888875 69999999983 3679999998776532 2222346888889999999999999997 35
Q ss_pred eEeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 616 IIHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
+.-.|++|+|+-++++|++|++|......
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88899999999999999999999987653
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.0088 Score=69.08 Aligned_cols=80 Identities=18% Similarity=0.169 Sum_probs=54.3
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEeecccc-c-c--hhHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCeeEE
Q 002616 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-I-R--KNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 500 l~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~-~-~--~~~~e~~l~Ei~IL~~L~---HPnIVkL~~~f~d~~~LyL 572 (900)
.+.||.|.+..||++.....++.++||.-..... . . ....++...|.+.|..+. ..++.+++.+ +.+.-++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999999864335899997431100 0 0 124567778888888763 3456666665 4455789
Q ss_pred EEeecCCCC
Q 002616 573 VMEYLNGGD 581 (900)
Q Consensus 573 VmEy~~GGs 581 (900)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.03 E-value=0.005 Score=67.72 Aligned_cols=141 Identities=21% Similarity=0.211 Sum_probs=81.9
Q ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeee------eccCC
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYS------FTCRD 568 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~H--PnIVkL~~~------f~d~~ 568 (900)
...++.++.|....+|++... +..|++|+..... ..+.+..|.+++..+.. -.+.+++.. ....+
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g 96 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTTD--VGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAG 96 (307)
T ss_pred ceeccccCCccccceEEEEeC--CCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCC
Confidence 345667888877899988643 4468889775421 12344556666666532 113343322 12245
Q ss_pred eeEEEEeecCCCChH----H-------H---HHhc-CCCC---------HHHHH--------------HHHHHHHHHHHh
Q 002616 569 NLYLVMEYLNGGDLY----S-------L---LRKV-GCLE---------EDVAR--------------IYIAELVLALEY 610 (900)
Q Consensus 569 ~LyLVmEy~~GGsL~----d-------l---L~k~-g~Ls---------e~~ar--------------~ya~QIl~AL~y 610 (900)
..++||+|++|..+. . . ++.. ..++ ..... .....+...+++
T Consensus 97 ~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~ 176 (307)
T TIGR00938 97 KPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDY 176 (307)
T ss_pred eEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHH
Confidence 678999999985432 0 0 1110 0110 00000 001123334555
Q ss_pred hh-------hcCeEeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 611 LH-------SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 611 LH-------s~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
+. ..+++|+|+.+.||+++.++.+.|.||+.+..
T Consensus 177 l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 177 LDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 53 36899999999999999988778999998863
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.0025 Score=68.09 Aligned_cols=133 Identities=20% Similarity=0.210 Sum_probs=75.4
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce-EEEeeeeccCCeeEEEEeecCCC
Q 002616 502 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV-VRFFYSFTCRDNLYLVMEYLNGG 580 (900)
Q Consensus 502 ~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnI-VkL~~~f~d~~~LyLVmEy~~GG 580 (900)
.+..|-.+.+|+.. .+|+.|++|+....... -. -...+|..+++.+..-.+ .++++.+. -++||||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~--~~-~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKA--LG-VDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccccc--cc-CcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCc
Confidence 35567778899887 34678888875432110 00 124668888887753222 23333332 36899999986
Q ss_pred ChHH--------------HHH---hcC----CCCH-HHHHHHHHHH---------HHHHHhhhh--------cCeEeccC
Q 002616 581 DLYS--------------LLR---KVG----CLEE-DVARIYIAEL---------VLALEYLHS--------LGIVHRDL 621 (900)
Q Consensus 581 sL~d--------------lL~---k~g----~Lse-~~ar~ya~QI---------l~AL~yLHs--------~gIIHRDL 621 (900)
.+.. .+. ... .++. ..+..|..++ ...+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 6531 111 111 1111 1222222111 111221211 24899999
Q ss_pred CCCcEEecCCCcEEEEecCCccc
Q 002616 622 KPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 622 KPeNILLd~~G~VKLsDFGLAk~ 644 (900)
.|.|||++.++ +.|+||..|..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999877 78999998874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0053 Score=66.98 Aligned_cols=76 Identities=12% Similarity=0.100 Sum_probs=47.5
Q ss_pred EEEeccCCceEEEEEEECC------CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC-ceEEEeeeeccCCeeEE
Q 002616 500 IKPISRGAFGRVFLARKRT------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP-FVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 500 l~~LGkG~FG~Vyla~~k~------tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HP-nIVkL~~~f~d~~~LyL 572 (900)
++.|..|-...||++.... +++.|++|+..... .......+|..++..+... -..++++.+.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3556667777889887543 35789999875421 1123456788787777532 23345555542 36
Q ss_pred EEeecCCCChH
Q 002616 573 VMEYLNGGDLY 583 (900)
Q Consensus 573 VmEy~~GGsL~ 583 (900)
|+||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999987653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.011 Score=64.20 Aligned_cols=137 Identities=19% Similarity=0.169 Sum_probs=81.9
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCC--ceEEEeee------eccCCeeE
Q 002616 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP--FVVRFFYS------FTCRDNLY 571 (900)
Q Consensus 500 l~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HP--nIVkL~~~------f~d~~~Ly 571 (900)
++.|..|....+|++... +..+++|+... .....+..|..++..+.+- .+.+++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~------~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEK------VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCC------CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 567878888899998643 45789998753 1224456677777666421 24444332 22345678
Q ss_pred EEEeecCCCChHH----HH----------Hhc-CCCCH--------HHHH------------HHHHHHHHHHHhhhh---
Q 002616 572 LVMEYLNGGDLYS----LL----------RKV-GCLEE--------DVAR------------IYIAELVLALEYLHS--- 613 (900)
Q Consensus 572 LVmEy~~GGsL~d----lL----------~k~-g~Lse--------~~ar------------~ya~QIl~AL~yLHs--- 613 (900)
+|++|++|..+.. .. +.. ..+.. .... .....+..++.++..
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999876421 11 110 00100 0000 011112334444443
Q ss_pred ----cCeEeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 614 ----LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 614 ----~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
.+++|+|+.|.|||++.++.+.|.||+.+..
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4699999999999999887789999998863
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.016 Score=63.70 Aligned_cols=31 Identities=32% Similarity=0.430 Sum_probs=26.8
Q ss_pred cCeEeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 614 ~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
.++||+|+.|.|||++.+...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 3799999999999998665568999999864
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.03 Score=64.01 Aligned_cols=78 Identities=19% Similarity=0.191 Sum_probs=49.0
Q ss_pred EeccCCceEEEEEEECCCCcEEEEEEeec-cc---ccchhHHHHHHHHHHHHHhcC--CCceEEEeeeeccCCeeEEEEe
Q 002616 502 PISRGAFGRVFLARKRTTGDLFAIKVLKK-LD---MIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 502 ~LGkG~FG~Vyla~~k~tGk~VAIKiLkK-~~---~~~~~~~e~~l~Ei~IL~~L~--HPnIVkL~~~f~d~~~LyLVmE 575 (900)
.||-|....||++.....++.++||.-.. .+ ..-+-..++..-|...|.... -|..|+-++.| +++...+|||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-D~e~~~~vME 80 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-DTEMAVTVME 80 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-ccccceehHh
Confidence 47999999999999754346899985321 11 111334566777888887764 35444433333 4445569999
Q ss_pred ecCCC
Q 002616 576 YLNGG 580 (900)
Q Consensus 576 y~~GG 580 (900)
+++..
T Consensus 81 dL~~~ 85 (370)
T TIGR01767 81 DLSHH 85 (370)
T ss_pred hCccc
Confidence 98653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.0056 Score=68.65 Aligned_cols=136 Identities=16% Similarity=0.193 Sum_probs=91.8
Q ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEEeecccc-------------------cchhHHHHHHHHHHHHHhcC-CCc
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-------------------IRKNDIERILAERNILITVR-NPF 556 (900)
Q Consensus 497 Yeil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~-------------------~~~~~~e~~l~Ei~IL~~L~-HPn 556 (900)
+.+.+.||-|--+.||.+-+. .|+++++|+-+-.+. +..-..-...+|...|+.+. |-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 467789999999999999875 489999996321110 00001123456777787775 332
Q ss_pred -eEEEeeeeccCCeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEeccCCCCcEEecCCCcEE
Q 002616 557 -VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIK 635 (900)
Q Consensus 557 -IVkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIHRDLKPeNILLd~~G~VK 635 (900)
|.+.+ +.+.-++|||++.|-.|...-+- .+ +..+...+..-|.-|...|+||+|..--||+++++++++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v---~d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHV---ED---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeeec---CC---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 22222 23456899999999877654321 11 122333455556678899999999999999999999999
Q ss_pred EEecCCcc
Q 002616 636 LTDFGLSK 643 (900)
Q Consensus 636 LsDFGLAk 643 (900)
++||--+.
T Consensus 243 vIDFPQmv 250 (465)
T KOG2268|consen 243 VIDFPQMV 250 (465)
T ss_pred EeechHhh
Confidence 99998653
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.054 Score=61.22 Aligned_cols=136 Identities=18% Similarity=0.211 Sum_probs=77.5
Q ss_pred EEeccCCceEEEEEEECC----CCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCc-eEEEeeeeccCCeeEEEEe
Q 002616 501 KPISRGAFGRVFLARKRT----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 501 ~~LGkG~FG~Vyla~~k~----tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPn-IVkL~~~f~d~~~LyLVmE 575 (900)
+.|-.|-.-.+|++.... +++.|++|+..... ...+.+ .+|..++..+..-. -.++++.+... .|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~e 113 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEE 113 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEE
Confidence 345557777889887532 34688999875421 122222 56888887775322 23445655432 5899
Q ss_pred ecCCCChHHH--------------H---HhcC----C-C-CHHHHHHHHHHH-----------------HHHHHh-----
Q 002616 576 YLNGGDLYSL--------------L---RKVG----C-L-EEDVARIYIAEL-----------------VLALEY----- 610 (900)
Q Consensus 576 y~~GGsL~dl--------------L---~k~g----~-L-se~~ar~ya~QI-----------------l~AL~y----- 610 (900)
|++|-+|... + +... . + ....+..+..++ ...+..
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 9987665311 1 1111 0 1 112222332111 111111
Q ss_pred ---hhhcCeEeccCCCCcEEecC-CCcEEEEecCCccc
Q 002616 611 ---LHSLGIVHRDLKPDNLLIAH-DGHIKLTDFGLSKI 644 (900)
Q Consensus 611 ---LHs~gIIHRDLKPeNILLd~-~G~VKLsDFGLAk~ 644 (900)
.+...++|+|+++.|||+++ ++.+.|+||..|..
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 12335899999999999986 47899999998863
|
|
| >smart00133 S_TK_X Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.0065 Score=51.26 Aligned_cols=35 Identities=37% Similarity=0.702 Sum_probs=28.9
Q ss_pred CCCCcchhhhc--cCCccCCCCCCCCccccccccccC
Q 002616 783 KGVNWDSLALQ--KAVFVPQPESVDDTSYFLSRFSQI 817 (900)
Q Consensus 783 k~idw~~L~~~--~ppf~P~~~s~~D~s~fd~~fs~~ 817 (900)
++++|+.|..+ .|||+|...+..|+++|+..|...
T Consensus 1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~~~~~ 37 (64)
T smart00133 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDEFTEE 37 (64)
T ss_pred CCCCHHHHHhCCCCCCcccccCCccHHhHcCCcCCCC
Confidence 47999999755 799999999999999998754443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.085 Score=59.40 Aligned_cols=143 Identities=20% Similarity=0.282 Sum_probs=80.1
Q ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcCC--CceEEEeeeeccCC--eeEEEE
Q 002616 499 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRD--NLYLVM 574 (900)
Q Consensus 499 il~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~H--PnIVkL~~~f~d~~--~LyLVm 574 (900)
+++.+..|..-.+|..... ++.+++. ... ............+|..++..+.- .-+...++.+.++. ..|.||
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 3344433333344444333 6777777 321 12223345556778888877653 23444566666665 679999
Q ss_pred eecCCCChHH------------------HHHh---c--------C---CCCHHHHHHHHHHH--------------HHHH
Q 002616 575 EYLNGGDLYS------------------LLRK---V--------G---CLEEDVARIYIAEL--------------VLAL 608 (900)
Q Consensus 575 Ey~~GGsL~d------------------lL~k---~--------g---~Lse~~ar~ya~QI--------------l~AL 608 (900)
+|+.|..+.+ .|.. - + .+...+...+..+. ..-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 9999843211 1110 0 0 00111111111111 2223
Q ss_pred Hhhhhc--------CeEeccCCCCcEEecCCCcEEEEecCCcccc
Q 002616 609 EYLHSL--------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645 (900)
Q Consensus 609 ~yLHs~--------gIIHRDLKPeNILLd~~G~VKLsDFGLAk~~ 645 (900)
.+|+.+ .++|+|+.+.||+++..+-+-|.||+++..+
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 444432 4899999999999999999999999999864
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.12 Score=56.33 Aligned_cols=30 Identities=27% Similarity=0.522 Sum_probs=26.5
Q ss_pred cCeEeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 614 ~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
.+++|+|+.+.|||++. +.+.|.||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 57999999999999987 6789999998764
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.094 Score=57.53 Aligned_cols=30 Identities=37% Similarity=0.626 Sum_probs=25.7
Q ss_pred CeEeccCCCCcEEecCCCc-EEEEecCCccc
Q 002616 615 GIVHRDLKPDNLLIAHDGH-IKLTDFGLSKI 644 (900)
Q Consensus 615 gIIHRDLKPeNILLd~~G~-VKLsDFGLAk~ 644 (900)
.++|+|+.|.|||++.++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999998875
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.09 E-value=0.11 Score=60.04 Aligned_cols=78 Identities=23% Similarity=0.173 Sum_probs=51.4
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEeec-cc--ccchhHHHHHHHHHHHHHhcC--CCc-eEEEeeeeccCCeeEEE
Q 002616 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKK-LD--MIRKNDIERILAERNILITVR--NPF-VVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 500 l~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK-~~--~~~~~~~e~~l~Ei~IL~~L~--HPn-IVkL~~~f~d~~~LyLV 573 (900)
++.||-|.-.-||++.....++.++||.-.. .+ ..-+-..++..-|.++|+... .|. +.++|. | +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~-D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-F-DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-E-CcHHhhHH
Confidence 6789999999999999854456788885321 11 111334677788888888764 454 444543 3 44556789
Q ss_pred EeecCC
Q 002616 574 MEYLNG 579 (900)
Q Consensus 574 mEy~~G 579 (900)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999865
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.06 E-value=0.14 Score=57.43 Aligned_cols=141 Identities=15% Similarity=0.182 Sum_probs=77.0
Q ss_pred CCeEEEEEeccCCceEEEEEEECCC---CcEEEEEEeecccccchhHHHHHHHHHHHHHhcCCCce-EEEeeeeccCCee
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTT---GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFV-VRFFYSFTCRDNL 570 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~t---Gk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnI-VkL~~~f~d~~~L 570 (900)
+++++.. |..|=...+|++..... +..|++|+..... .. .-.-.+|..+++.+..-.+ .++++++...
T Consensus 15 ~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G--- 86 (330)
T PLN02421 15 SDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---DY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG--- 86 (330)
T ss_pred CceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCc---Ce-EechHHHHHHHHHHHhcCCCCceeEEeCCc---
Confidence 4455544 44466778888875432 2378899875421 11 1112457778777754333 3455555322
Q ss_pred EEEEeecCCCChHH--------------HH---HhcC-C----C-CHHHHHHHHHHH----------------------H
Q 002616 571 YLVMEYLNGGDLYS--------------LL---RKVG-C----L-EEDVARIYIAEL----------------------V 605 (900)
Q Consensus 571 yLVmEy~~GGsL~d--------------lL---~k~g-~----L-se~~ar~ya~QI----------------------l 605 (900)
+|.+|++|-.|.. .+ +... . + ....+..|..++ .
T Consensus 87 -~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~ 165 (330)
T PLN02421 87 -MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELR 165 (330)
T ss_pred -EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHH
Confidence 5899998765421 11 1111 0 1 112222222221 1
Q ss_pred HHHH----hhhhc----CeEeccCCCCcEEecC-CCcEEEEecCCccc
Q 002616 606 LALE----YLHSL----GIVHRDLKPDNLLIAH-DGHIKLTDFGLSKI 644 (900)
Q Consensus 606 ~AL~----yLHs~----gIIHRDLKPeNILLd~-~G~VKLsDFGLAk~ 644 (900)
.-+. .+... -++|.|+.+.|||+++ ++.++++||..|..
T Consensus 166 ~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 166 DEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1111 12122 2799999999999975 57899999998863
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.3 Score=54.23 Aligned_cols=75 Identities=21% Similarity=0.301 Sum_probs=47.9
Q ss_pred EEEEEeccCCceEEEEEEECCCCcEEEEEEeecccccchhHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCeeEEEE
Q 002616 498 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 498 eil~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~---HPnIVkL~~~f~d~~~LyLVm 574 (900)
+-.+.|+.|....+|+.. .+++.|.+|+-.. .....+..|..-|+.+. .-.+.+.+.+....+.-||||
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLll 91 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLL 91 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEE
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecCh------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEE
Confidence 445679999999999987 5688899997652 23356778888888773 345777888887777789999
Q ss_pred eecCCC
Q 002616 575 EYLNGG 580 (900)
Q Consensus 575 Ey~~GG 580 (900)
||++.+
T Consensus 92 e~l~~~ 97 (288)
T PF03881_consen 92 EFLEMG 97 (288)
T ss_dssp E-----
T ss_pred EeecCC
Confidence 999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.38 Score=56.08 Aligned_cols=77 Identities=21% Similarity=0.168 Sum_probs=51.0
Q ss_pred EEEEeccCCceEEEEEEECCCCcEEEEEEeecccc-cch---hHHHHHHHHHHHHHhcC---CCceEEEeeeeccCCeeE
Q 002616 499 IIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IRK---NDIERILAERNILITVR---NPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 499 il~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~-~~~---~~~e~~l~Ei~IL~~L~---HPnIVkL~~~f~d~~~Ly 571 (900)
..+.||.|....||++... ++.|+||.-..... ... ....+...|...|..+. ..++.+++.+.. +.-+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3678999999999999863 55688886431111 111 13455556677776654 246777877776 4457
Q ss_pred EEEeecCC
Q 002616 572 LVMEYLNG 579 (900)
Q Consensus 572 LVmEy~~G 579 (900)
++|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=94.63 E-value=0.39 Score=53.04 Aligned_cols=30 Identities=17% Similarity=0.204 Sum_probs=28.0
Q ss_pred CeEeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 615 gIIHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
+++|+|+.+.|||++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998874
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.34 E-value=0.3 Score=56.13 Aligned_cols=140 Identities=28% Similarity=0.247 Sum_probs=89.0
Q ss_pred EEEeccCCceEEEEEEECCCCcEEEEEEeecccccch---------------------hH--HHHHHHHHHHHHhcCCCc
Q 002616 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---------------------ND--IERILAERNILITVRNPF 556 (900)
Q Consensus 500 l~~LGkG~FG~Vyla~~k~tGk~VAIKiLkK~~~~~~---------------------~~--~e~~l~Ei~IL~~L~HPn 556 (900)
-..|..|--+-||.|... +|..+|||+++..-+.-+ .. .-....|++-|.+++.-.
T Consensus 149 nGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred ccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 346788888999999864 588899999863211100 00 112344666666665322
Q ss_pred eEEEeeeeccCCeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhh-hcCeEeccCCCCcEEecCCCcEE
Q 002616 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNLLIAHDGHIK 635 (900)
Q Consensus 557 IVkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLH-s~gIIHRDLKPeNILLd~~G~VK 635 (900)
|..- ....- ..-.|||+|+.....-.=.-+...++...++.+-.+++.-|.-|- ..++||.||.-=|+|+ .+|.+.
T Consensus 228 IP~P-ePIlL-k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ly 304 (520)
T KOG2270|consen 228 IPCP-EPILL-KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKLY 304 (520)
T ss_pred CCCC-Cceee-ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEEE
Confidence 1100 00000 124699999954221111123345777888888888888888764 5689999999999998 479999
Q ss_pred EEecCCcc
Q 002616 636 LTDFGLSK 643 (900)
Q Consensus 636 LsDFGLAk 643 (900)
|+|-+-+.
T Consensus 305 iIDVSQSV 312 (520)
T KOG2270|consen 305 IIDVSQSV 312 (520)
T ss_pred EEEccccc
Confidence 99998775
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.78 E-value=0.46 Score=54.83 Aligned_cols=83 Identities=19% Similarity=0.223 Sum_probs=45.2
Q ss_pred CCeEEEEEeccCCceEEEEEEECCC-CcEEEEE-EeecccccchhHHHHHHHHHHHHHhcCCC-ceEEEeeeeccCCeeE
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTT-GDLFAIK-VLKKLDMIRKNDIERILAERNILITVRNP-FVVRFFYSFTCRDNLY 571 (900)
Q Consensus 495 ~dYeil~~LGkG~FG~Vyla~~k~t-Gk~VAIK-iLkK~~~~~~~~~e~~l~Ei~IL~~L~HP-nIVkL~~~f~d~~~Ly 571 (900)
+++++. .|..|-...+|++..... +..+.+| ++....-......-.-.+|..+++.+... .-.++++.|.. +
T Consensus 51 ~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g 125 (383)
T PTZ00384 51 EFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----F 125 (383)
T ss_pred ccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----E
Confidence 344444 555588889999975432 2233333 12111000111111224588888888643 44456666643 6
Q ss_pred EEEeecCCCCh
Q 002616 572 LVMEYLNGGDL 582 (900)
Q Consensus 572 LVmEy~~GGsL 582 (900)
+|.||++|-.|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 99999998765
|
|
| >PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=93.32 E-value=0.032 Score=45.39 Aligned_cols=22 Identities=27% Similarity=0.193 Sum_probs=15.6
Q ss_pred CCCCCCccccccccccCCCCCC
Q 002616 801 PESVDDTSYFLSRFSQISSGLP 822 (900)
Q Consensus 801 ~~s~~D~s~fd~~fs~~~~~l~ 822 (900)
+.+..|++|||..|+.+....+
T Consensus 2 v~~~~DtsnFD~eFt~~~~~~t 23 (48)
T PF00433_consen 2 VKSETDTSNFDPEFTEEPPVDT 23 (48)
T ss_dssp -SSTT-GTTSCHHHHTSSSSS-
T ss_pred CCchhhhhhcCcccccCCCCCC
Confidence 4678999999999998865443
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A .... |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=92.06 E-value=2.4 Score=54.80 Aligned_cols=31 Identities=32% Similarity=0.518 Sum_probs=26.3
Q ss_pred cCeEeccCCCCcEEecCCC--cEE-EEecCCccc
Q 002616 614 LGIVHRDLKPDNLLIAHDG--HIK-LTDFGLSKI 644 (900)
Q Consensus 614 ~gIIHRDLKPeNILLd~~G--~VK-LsDFGLAk~ 644 (900)
.++||.|+.+.|||++.++ .+. |+|||.+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 555 999998763
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=91.83 E-value=0.29 Score=56.13 Aligned_cols=73 Identities=26% Similarity=0.381 Sum_probs=52.4
Q ss_pred cCCeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhc-CeEeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 566 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL-GIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 566 d~~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~-gIIHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
...++|++|++. |+++.- + ..-..+++..++.+.+.-++-+... .+=||++.-.||||+ +|+|-|+||-+|+.
T Consensus 297 e~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 334678888875 445432 1 1124455666677766666666544 588999999999999 99999999999984
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=91.39 E-value=0.22 Score=59.06 Aligned_cols=164 Identities=21% Similarity=0.271 Sum_probs=100.7
Q ss_pred HHHHHHHHHHHhcCCCceEEEeeeeccC-CeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHhhhhcCeEe
Q 002616 540 ERILAERNILITVRNPFVVRFFYSFTCR-DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVH 618 (900)
Q Consensus 540 e~~l~Ei~IL~~L~HPnIVkL~~~f~d~-~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~QIl~AL~yLHs~gIIH 618 (900)
..++--.++++.+.|+|...+++.-... ....+|||++. -+|.+.+..+. +-.. ++. .+|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~-------s~~-------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDE-------SLL-------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchh-------hhc-------ccccce
Confidence 3455667788999999999888766544 35789999995 49999887643 2111 111 122222
Q ss_pred ccCCCCcEEecCCCcEEEEecCCcccccccccccCCCCCCCCCCCCCCCCCcccccccCCcccccCCCCCCChhhhcCCC
Q 002616 619 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 698 (900)
Q Consensus 619 RDLKPeNILLd~~G~VKLsDFGLAk~~~~~~s~~l~~~~~~~~~~s~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ 698 (900)
-| .++.+| -++.. ..+..|
T Consensus 91 -----~~-------~~~~td-~~~t~----------------------------------~~~~~~-------------- 109 (725)
T KOG1093|consen 91 -----LN-------IIYITD-HFLTK----------------------------------YPSPIG-------------- 109 (725)
T ss_pred -----eh-------hhhccc-ccccc----------------------------------CCCCCC--------------
Confidence 11 223333 11100 001111
Q ss_pred CCccceeechhHHHHHHHhCCCCCCCCChHHHHHhhhcCCCC-CC--------CCCCCCCHHHHHHHHHhccCCcCCCCC
Q 002616 699 HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP-WP--------CVPSDMSFEAQDLINRFLIHDPNQRLG 769 (900)
Q Consensus 699 ys~ksDIWSLGVILyEMLtGk~PF~~~s~~ei~~kIl~~~l~-~P--------~ip~~lS~eakDLIk~cL~~DP~kRpS 769 (900)
+++||||+|.++.|+..|..-|......+....|.+-... -. .+.-.++....++...|+...|..||.
T Consensus 110 --pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l 187 (725)
T KOG1093|consen 110 --PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPL 187 (725)
T ss_pred --cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccc
Confidence 3999999999999999998877766655555554432110 00 011234556678899999999999997
Q ss_pred hhcHHHHHcCCCCCCC
Q 002616 770 ANGAAEVKAHPFFKGV 785 (900)
Q Consensus 770 a~~a~EIL~HPFFk~i 785 (900)
..++.+|+-|..+
T Consensus 188 ---~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 188 ---PMELSKRCSFTEV 200 (725)
T ss_pred ---hhHHhcCccHHHH
Confidence 5577778777654
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=89.81 E-value=1.2 Score=48.26 Aligned_cols=100 Identities=17% Similarity=0.186 Sum_probs=64.7
Q ss_pred EEEEEeecccccchhHHHHHHHHHHHHHhcCCCceEEEeeeeccCCeeEEEEeecCCCChHHHHHhcCCCCHHHHHHHHH
Q 002616 523 FAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 602 (900)
Q Consensus 523 VAIKiLkK~~~~~~~~~e~~l~Ei~IL~~L~HPnIVkL~~~f~d~~~LyLVmEy~~GGsL~dlL~k~g~Lse~~ar~ya~ 602 (900)
..+|.++.....- ...-+.++.+++.++. .|++|..- ..-.+-+|+|+|---... . ..++.
T Consensus 88 L~lKKi~slp~~~--~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~------------~-~N~i~ 148 (308)
T PF07387_consen 88 LFLKKIRSLPCCI--NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN------------F-SNFIT 148 (308)
T ss_pred hhhhhccCCCccc--chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc------------h-hHHHH
Confidence 4566665433321 2345678888888775 57777622 333467899988431110 0 11121
Q ss_pred HHHHHHHhhhh--cCeEeccCCCCcEEecCCCcEEEEecCC
Q 002616 603 ELVLALEYLHS--LGIVHRDLKPDNLLIAHDGHIKLTDFGL 641 (900)
Q Consensus 603 QIl~AL~yLHs--~gIIHRDLKPeNILLd~~G~VKLsDFGL 641 (900)
-=+.+|.-.|+ .+.+|+|-.|+||+-|..|.+||.|=+.
T Consensus 149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence 12456777783 4699999999999999999999999874
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.79 E-value=8.5 Score=43.17 Aligned_cols=29 Identities=28% Similarity=0.416 Sum_probs=24.8
Q ss_pred cCeEeccCCCCcEEecCCCcEEEEecCCccc
Q 002616 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 614 ~gIIHRDLKPeNILLd~~G~VKLsDFGLAk~ 644 (900)
.++||+|+.+.|||++ + .+.|+||+.+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 4689999999999995 4 578999998874
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.49 E-value=4.3 Score=47.88 Aligned_cols=28 Identities=29% Similarity=0.521 Sum_probs=24.2
Q ss_pred CeEeccCCCCcEEecCCCcEEEEecCCcc
Q 002616 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643 (900)
Q Consensus 615 gIIHRDLKPeNILLd~~G~VKLsDFGLAk 643 (900)
.++|.|+-+.|||.+.++ ++|+||-.|.
T Consensus 285 VfCHNDl~~~NiL~~~~~-l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKC-LRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCCC-EEEEeecccc
Confidence 489999999999886544 9999999886
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.29 E-value=0.49 Score=53.69 Aligned_cols=51 Identities=27% Similarity=0.444 Sum_probs=35.9
Q ss_pred HHHHHHHHHHHHHHHHhhh----hcCeEeccCCCCcEEecCCC------------------cEEEEecCCccc
Q 002616 594 EDVARIYIAELVLALEYLH----SLGIVHRDLKPDNLLIAHDG------------------HIKLTDFGLSKI 644 (900)
Q Consensus 594 e~~ar~ya~QIl~AL~yLH----s~gIIHRDLKPeNILLd~~G------------------~VKLsDFGLAk~ 644 (900)
.+-++++..||+.-.-.+- ..+++|-||||+||||-.+. .++|.||.++..
T Consensus 278 ~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 278 VEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred HHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence 3457778888877654442 34699999999999995432 246677777764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 900 | ||||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-65 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-65 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-59 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-59 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-59 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-59 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-59 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-59 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 8e-59 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 9e-59 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-59 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-58 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-58 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-58 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-58 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-58 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-58 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-58 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-58 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-58 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-58 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-58 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-58 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-58 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-58 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-58 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-58 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-58 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-58 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-58 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-58 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-58 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-58 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-58 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-58 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-58 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-58 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-58 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-58 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 6e-58 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-58 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-58 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-58 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-58 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-58 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-58 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-58 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-58 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-58 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-58 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-58 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 9e-58 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-57 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-57 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-57 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-57 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-57 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-57 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-57 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 2e-57 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-57 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-57 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-57 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-57 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-57 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-57 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-57 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-57 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-57 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-57 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-57 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-57 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-57 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-56 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-56 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-56 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-56 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-56 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 9e-56 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-55 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-55 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-54 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-54 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-53 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-53 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-53 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-52 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-52 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-51 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-51 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-51 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 9e-51 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-50 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-50 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-50 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-50 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-50 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-50 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-50 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-50 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-50 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-50 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-50 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-50 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-50 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-50 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-50 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-50 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-50 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-50 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-50 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-50 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-42 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-42 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-42 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-41 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-41 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-41 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-41 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 7e-41 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-40 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-40 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-40 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-40 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-40 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-40 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-40 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-40 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-40 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-40 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-40 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-40 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-40 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 9e-40 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-39 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-39 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-39 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-39 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-39 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-39 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-39 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-39 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-39 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-39 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-39 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 7e-39 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 8e-39 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-38 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-38 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-38 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 4e-38 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-38 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-38 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-37 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-36 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-35 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-35 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-35 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-35 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-35 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-34 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-34 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-34 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-34 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-34 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-33 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-33 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-33 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-32 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-32 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-31 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-31 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-31 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-31 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-31 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-31 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-31 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-31 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 4e-31 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-31 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-31 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 4e-31 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-31 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-31 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-31 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-30 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-30 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-30 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-30 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-30 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-30 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-30 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-30 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-30 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-30 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-30 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-30 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-30 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-30 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-30 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-30 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-30 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-30 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-30 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-29 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-29 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-29 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-29 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-29 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-29 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-29 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-29 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-29 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 8e-29 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-28 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-28 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-28 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 5e-28 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-28 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-27 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-27 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-27 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-27 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-27 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-27 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-27 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-27 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-26 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-26 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-26 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-26 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-26 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-26 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-26 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-26 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-26 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-26 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-26 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-26 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-26 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-26 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 5e-26 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-26 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-26 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-26 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-26 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-26 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-25 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-25 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-25 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-25 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-25 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-25 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-25 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 6e-25 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-25 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-24 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-24 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-24 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-24 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-24 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-24 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-24 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-24 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-24 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-24 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-24 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-24 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-24 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-24 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-24 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-24 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-24 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-24 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-24 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-24 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-24 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-24 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-24 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-24 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-24 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-24 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-24 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-24 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 6e-24 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-24 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-24 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-23 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-23 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-23 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-23 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-23 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-23 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-23 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-23 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-23 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-23 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-23 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-23 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-23 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 5e-23 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-23 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-23 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-23 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-23 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-23 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-23 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-23 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-22 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-22 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-22 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-22 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-22 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-22 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-22 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-22 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-22 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-22 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-22 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-22 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-22 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-22 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-22 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-22 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-22 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-22 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 4e-22 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 4e-22 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-22 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-22 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-22 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-22 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-22 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-22 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 6e-22 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-22 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-22 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-22 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-22 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-22 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 7e-22 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-22 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-22 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-22 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-22 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-22 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-21 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-21 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-21 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-21 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-21 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-21 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-21 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-21 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-21 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-21 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-21 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-21 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 4e-21 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-21 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-21 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-20 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-20 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-20 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-20 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-20 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-20 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 4e-20 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 4e-20 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-20 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-20 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-20 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-20 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-20 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-20 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-20 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-20 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-20 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-20 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-20 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-20 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-20 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-19 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-19 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-19 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-19 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-19 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-19 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-19 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 6e-19 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-19 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-19 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-19 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-18 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-18 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-18 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-18 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-18 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-18 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 3e-18 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-18 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 5e-18 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-18 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 6e-18 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 6e-18 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 9e-18 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-17 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-17 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-17 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-17 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 6e-17 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-17 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-16 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-16 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-16 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-16 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-16 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 7e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-15 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-15 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-15 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 4e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-15 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 4e-15 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 5e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 5e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-15 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-15 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-15 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 6e-15 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 6e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-15 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 7e-15 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-15 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-15 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 9e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 9e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 9e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 9e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 9e-15 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-14 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-14 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-14 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-14 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-14 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-14 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-14 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-14 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-14 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-14 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-14 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-14 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-14 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-14 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-14 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-14 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-14 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-14 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-14 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-14 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-14 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-14 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-14 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-14 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-14 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-14 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-14 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-14 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-14 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-14 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-14 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-14 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-14 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-14 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-14 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-14 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-14 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-14 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-14 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-14 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-14 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-14 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-14 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-14 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-14 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-14 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-14 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-14 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-14 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-14 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-14 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 5e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 5e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-14 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 5e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-14 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 5e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-14 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-14 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 6e-14 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 6e-14 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 7e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-14 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-14 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-14 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-14 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-14 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-14 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-14 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-14 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-13 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-13 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-13 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-13 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-13 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-13 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-13 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-13 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-13 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-13 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-13 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 7e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-13 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-13 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-12 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-12 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-12 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-12 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-12 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-12 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-12 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 2e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-11 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-11 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-11 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 4e-11 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-11 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-11 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-11 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-11 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 9e-11 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-11 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-10 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-10 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-10 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-10 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-10 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-10 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-10 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-10 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-10 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-10 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-10 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-10 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-10 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-10 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 4e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-10 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 4e-10 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-10 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-10 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 5e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-10 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-10 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-10 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-10 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 8e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-10 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 9e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-10 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 9e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 9e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-09 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-09 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-09 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-09 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-09 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-09 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-09 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-09 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-09 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-09 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-09 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-09 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 4e-09 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-09 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 5e-09 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 6e-09 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-09 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 6e-09 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-09 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 6e-09 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 6e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-09 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 7e-09 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-09 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 7e-09 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 7e-09 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 7e-09 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 7e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 7e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-09 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 8e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-09 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 8e-09 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 8e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-09 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 9e-09 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 9e-09 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-08 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-08 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-08 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-08 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-08 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 2e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-08 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-08 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-08 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 3e-08 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 3e-08 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-08 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-08 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-08 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-08 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-08 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-08 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 3e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 3e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-08 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-08 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-08 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 4e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-08 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 4e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-08 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 7e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-07 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-07 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-07 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-07 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-07 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-07 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 4e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-07 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-07 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-06 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 1e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-06 |
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 900 | |||
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 1e-145 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-142 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 1e-137 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 1e-137 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 1e-134 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-133 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 1e-133 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-132 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-132 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-131 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-130 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 1e-129 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 1e-128 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 1e-128 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 1e-125 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 1e-125 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-123 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-123 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-118 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-117 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 1e-115 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 1e-114 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-107 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 1e-107 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-92 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-91 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 8e-87 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-86 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 4e-84 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 4e-84 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-79 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 2e-77 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 1e-74 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 5e-74 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 5e-74 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 6e-74 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 3e-73 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-73 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 2e-72 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-72 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 4e-72 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-71 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 3e-71 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-71 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 4e-71 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 1e-70 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 5e-70 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 1e-69 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-69 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-69 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 2e-69 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-69 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-69 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 2e-69 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-69 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 5e-69 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 6e-69 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 7e-69 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 8e-69 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-68 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 1e-68 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 2e-68 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-68 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 3e-68 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 9e-68 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 2e-67 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 4e-67 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 5e-67 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-66 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 5e-66 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 5e-66 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-65 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-65 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 4e-65 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 4e-65 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 6e-65 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 8e-65 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-64 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 2e-64 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 3e-64 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 5e-64 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 8e-64 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 8e-64 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-63 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 2e-63 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 6e-63 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 8e-63 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 1e-62 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 2e-62 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 1e-61 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 2e-61 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-60 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 7e-60 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 2e-59 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 8e-58 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 2e-57 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 7e-57 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-56 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 4e-56 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 8e-56 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 1e-55 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-55 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 9e-55 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-54 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 7e-53 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-52 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 7e-52 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 2e-51 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 6e-51 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 8e-51 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 1e-50 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 1e-50 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 3e-50 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 3e-49 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 3e-45 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 6e-45 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 1e-44 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 1e-44 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 1e-44 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 6e-44 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 1e-43 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-43 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 2e-43 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 2e-43 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 2e-43 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-43 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-43 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 5e-43 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 6e-43 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 8e-43 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 1e-42 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-42 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-42 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-42 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 7e-42 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 8e-42 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-41 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 5e-41 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 9e-41 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 1e-40 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 3e-40 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 7e-40 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 2e-39 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-39 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-39 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 9e-38 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-37 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 4e-37 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 8e-37 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 9e-37 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 4e-36 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 4e-36 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 5e-36 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 5e-36 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 1e-35 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-35 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-35 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 3e-35 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 8e-35 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 1e-34 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 3e-34 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 3e-34 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 3e-34 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 7e-34 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 8e-34 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 9e-34 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 3e-33 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 4e-33 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 5e-33 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-32 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 8e-31 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-26 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 4e-25 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 7e-25 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-24 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 3e-24 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 6e-24 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 2e-23 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 5e-23 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 5e-23 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 6e-23 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-22 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 7e-22 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 9e-22 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-21 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 2e-21 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-21 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 5e-21 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 1e-20 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 1e-20 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 2e-20 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 2e-20 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 3e-20 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 7e-20 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-19 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-19 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 2e-19 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 2e-19 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 4e-19 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 5e-19 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 6e-19 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 6e-19 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 8e-19 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 1e-18 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-18 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-18 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 2e-18 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-18 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-18 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 4e-18 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 5e-18 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 5e-18 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 6e-18 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 1e-17 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-17 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 4e-17 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 5e-17 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 5e-17 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 7e-17 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 8e-17 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 9e-17 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-16 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-16 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 2e-16 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 2e-16 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-16 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 2e-16 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 3e-16 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 4e-16 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 4e-16 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 5e-16 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-15 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 3e-15 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 7e-15 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-12 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 3e-13 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 5e-13 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 6e-08 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-05 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 2e-07 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 7e-05 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 9e-04 |
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 434 bits (1118), Expect = e-145
Identities = 133/462 (28%), Positives = 212/462 (45%), Gaps = 68/462 (14%)
Query: 425 LKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPL 484
++ LV+D +E LL L + E + ++ K + + +
Sbjct: 2 MQQLVLDPGFLGLEPLLD----LLLGVHQELGASELAQDKYVADFL-------QWAEPIV 50
Query: 485 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA 544
+ R DDFEI+K I RGAF V + + + TG ++A+K++ K DM+++ ++
Sbjct: 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 545 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAE 603
ER++L+ ++ + ++F + LYLVMEY GGDL +LL K G + ++AR Y+AE
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 604 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
+V+A++ +H LG VHRD+KPDN+L+ GHI+L DFG + T+
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV------------ 218
Query: 664 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-------HGYAADWWSVGIILFEFI 716
AVGTPDYL+PEIL +G DWW++G+ +E
Sbjct: 219 --------------RSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
Query: 717 TGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 774
G PF A+S + I++ K + P V + EA+D I R L P RLG GA
Sbjct: 265 YGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGRGGAG 323
Query: 775 EVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDADT 834
+ + HPFF G++WD L F P E DT F ++ G + +D
Sbjct: 324 DFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLT---AMVSGGGETLSDI 380
Query: 835 CDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLAS 876
+ + L + +S+ ++ S
Sbjct: 381 REGAPLGV-----------------HLPFVGYSYSCMALRDS 405
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 427 bits (1099), Expect = e-142
Identities = 134/423 (31%), Positives = 213/423 (50%), Gaps = 46/423 (10%)
Query: 423 SKLKALVIDTFGSRIEKLLREKYIL--ACELLDEKSPTSFSKYKENSRLILDSVSQSSGV 480
+L+ ++D + + +L L DE + + + K +
Sbjct: 7 RQLEQFILDGPAQTNGQCFSVETLLDILICLYDECNNSPLRREKNILEYL-------EWA 59
Query: 481 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE 540
+ R +DFEI+K I RGAFG V + + + +FA+K+L K +M+++ +
Sbjct: 60 KPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETA 119
Query: 541 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARI 599
ER++L+ + ++ Y+F +NLYLVM+Y GGDL +LL K L E++AR
Sbjct: 120 CFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF 179
Query: 600 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659
Y+AE+V+A++ +H L VHRD+KPDN+L+ +GHI+L DFG + + T+
Sbjct: 180 YLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ------- 232
Query: 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFE 714
AVGTPDY++PEIL E +G DWWS+G+ ++E
Sbjct: 233 -------------------SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
Query: 715 FITGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 772
+ G PF AES + I+N K +P +D+S A+DLI R LI RLG NG
Sbjct: 274 MLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRR-LICSREHRLGQNG 332
Query: 773 AAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRF--SQISSGLPDDQNGSYS 830
+ K HPFF G++WD++ +A ++P+ S DTS F + S +P + ++S
Sbjct: 333 IEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFS 392
Query: 831 DAD 833
Sbjct: 393 GHH 395
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 409 bits (1055), Expect = e-137
Identities = 117/326 (35%), Positives = 186/326 (57%), Gaps = 40/326 (12%)
Query: 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 550
+ S+ DF+I++ + G+FGRV L R R G +A+KVLKK ++R +E ER +L
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 610
V +PF++R + +F ++++M+Y+ GG+L+SLLRK VA+ Y AE+ LALEY
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
LHS I++RDLKP+N+L+ +GHIK+TDFG +K + + T
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY-VPDVT-------------------- 160
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730
++ GTPDY+APE++ + + DWWS GI+++E + G PF +
Sbjct: 161 ---------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 211
Query: 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWD 788
++ ILN ++ + P + + +DL++R + D +QRLG NG +VK HP+FK V W+
Sbjct: 212 YEKILNAELRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268
Query: 789 SLALQKAV---FVPQPESVD-DTSYF 810
L L + + + P + DTS F
Sbjct: 269 KL-LSRNIETPYEPPIQQGQGDTSQF 293
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 409 bits (1053), Expect = e-137
Identities = 101/327 (30%), Positives = 172/327 (52%), Gaps = 31/327 (9%)
Query: 472 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 531
+ + + + +DF+ K + G+F V LAR+ T +AIK+L+K
Sbjct: 7 EPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKR 66
Query: 532 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 591
+I++N + + ER+++ + +PF V+ +++F + LY + Y G+L +RK+G
Sbjct: 67 HIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS 126
Query: 592 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651
+E R Y AE+V ALEYLH GI+HRDLKP+N+L+ D HI++TDFG +K+
Sbjct: 127 FDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS----- 181
Query: 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 711
++ +S VGT Y++PE+L ++D W++G I
Sbjct: 182 --------------------PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCI 221
Query: 712 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 771
+++ + G+PPF A + +IF I+ + + P +A+DL+ + L+ D +RLG
Sbjct: 222 IYQLVAGLPPFRAGNEYLIFQKIIKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGCE 278
Query: 772 ---GAAEVKAHPFFKGVNWDSLALQKA 795
G +KAHPFF+ V W++L Q
Sbjct: 279 EMEGYGPLKAHPFFESVTWENLHQQTP 305
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 403 bits (1037), Expect = e-134
Identities = 134/345 (38%), Positives = 198/345 (57%), Gaps = 40/345 (11%)
Query: 479 GVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIR 535
G S + E+ + FE+++ + +G +G+VF RK T TG +FA+KVLKK ++R
Sbjct: 1 GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR 60
Query: 536 K-NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE 594
D AERNIL V++PF+V Y+F LYL++EYL+GG+L+ L + G E
Sbjct: 61 NAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME 120
Query: 595 DVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654
D A Y+AE+ +AL +LH GI++RDLKP+N+++ H GH+KLTDFGL K +
Sbjct: 121 DTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI-------- 172
Query: 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 714
D H+ GT +Y+APEIL+ + H A DWWS+G ++++
Sbjct: 173 -------------------HDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYD 213
Query: 715 FITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NG 772
+TG PPFT E+ + D IL K+ P ++ EA+DL+ + L + RLGA
Sbjct: 214 MLTGAPPFTGENRKKTIDKILKCKLNL---PPYLTQEARDLLKKLLKRNAASRLGAGPGD 270
Query: 773 AAEVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 814
A EV+AHPFF+ +NW+ L L + V F P +S +D S F S+F
Sbjct: 271 AGEVQAHPFFRHINWEEL-LARKVEPPFKPLLQSEEDVSQFDSKF 314
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 404 bits (1040), Expect = e-133
Identities = 127/338 (37%), Positives = 183/338 (54%), Gaps = 37/338 (10%)
Query: 481 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE 540
++ R +D+E++K I RGAFG V L R ++T ++A+K+L K +MI+++D
Sbjct: 55 KDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSA 114
Query: 541 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 600
ER+I+ +P+VV+ FY+F LY+VMEY+ GGDL +L+ + E AR Y
Sbjct: 115 FFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFY 173
Query: 601 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 660
AE+VLAL+ +HS+G +HRD+KPDN+L+ GH+KL DFG
Sbjct: 174 TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM----------------- 216
Query: 661 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG----TEHGYAADWWSVGIILFEFI 716
+ + +AVGTPDY++PE+L +G DWWSVG+ L+E +
Sbjct: 217 ---------KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267
Query: 717 TGIPPFTAESPEIIFDNILNRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 774
G PF A+S + I+N K + +P D+S EA++LI FL D RLG NG
Sbjct: 268 VGDTPFYADSLVGTYSKIMNHKNSLTFPDDN-DISKEAKNLICAFL-TDREVRLGRNGVE 325
Query: 775 EVKAHPFFKGVNWDSLALQKAV--FVPQPESVDDTSYF 810
E+K H FFK W L+ V VP S DTS F
Sbjct: 326 EIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNF 363
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 401 bits (1033), Expect = e-133
Identities = 117/327 (35%), Positives = 185/327 (56%), Gaps = 39/327 (11%)
Query: 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 548
+ +D F+ IK + G+FGRV L + + +G+ +A+K+L K +++ IE L E+ I
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 549 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 608
L V PF+V+ +SF NLY+VMEY+ GG+++S LR++G E AR Y A++VL
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
EYLHSL +++RDLKP+NLLI G+I++TDFG +K + T
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-VKGRT------------------ 195
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 728
+ GTP+ LAPEI+L + A DWW++G++++E G PPF A+ P
Sbjct: 196 -----------WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVN 786
I++ I++ K+ + PS S + +DL+ L D +R G NG ++K H +F +
Sbjct: 245 QIYEKIVSGKVRF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301
Query: 787 WDSLALQKAV---FVPQPESVDDTSYF 810
W ++ Q+ V F+P+ + DTS F
Sbjct: 302 WIAI-YQRKVEAPFIPKFKGPGDTSNF 327
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 400 bits (1030), Expect = e-132
Identities = 121/348 (34%), Positives = 186/348 (53%), Gaps = 36/348 (10%)
Query: 472 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 531
+ + L S DF +K I +G+FG+V LAR + +A+KVL+K
Sbjct: 15 PAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKK 74
Query: 532 DMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 590
+++K + + I++ERN+L+ V++PF+V +SF D LY V++Y+NGG+L+ L++
Sbjct: 75 AILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER 134
Query: 591 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650
C E AR Y AE+ AL YLHSL IV+RDLKP+N+L+ GHI LTDFGL K +
Sbjct: 135 CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI---- 190
Query: 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 710
N + GTP+YLAPE+L + DWW +G
Sbjct: 191 -----------------------EHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGA 227
Query: 711 ILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 770
+L+E + G+PPF + + ++DNILN+ + +++ A+ L+ L D +RLGA
Sbjct: 228 VLYEMLYGLPPFYSRNTAEMYDNILNKPLQL---KPNITNSARHLLEGLLQKDRTKRLGA 284
Query: 771 -NGAAEVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 814
+ E+K+H FF +NWD L + K + F P +D +F F
Sbjct: 285 KDDFMEIKSHVFFSLINWDDL-INKKITPPFNPNVSGPNDLRHFDPEF 331
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 398 bits (1025), Expect = e-132
Identities = 122/337 (36%), Positives = 185/337 (54%), Gaps = 40/337 (11%)
Query: 486 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRT---TGDLFAIKVLKKLDMIRKNDIERI 542
E+ FE++K + +G+FG+VFL +K + L+A+KVLKK ++ D R
Sbjct: 15 KEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKK-ATLKVRDRVRT 73
Query: 543 LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 602
ER+IL+ V +PF+V+ Y+F LYL++++L GGDL++ L K E+ + Y+A
Sbjct: 74 KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 133
Query: 603 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 662
EL LAL++LHSLGI++RDLKP+N+L+ +GHIKLTDFGLSK +
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI---------------- 177
Query: 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 722
+ +S GT +Y+APE++ H +ADWWS G+++FE +TG PF
Sbjct: 178 -----------DHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226
Query: 723 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHP 780
+ + IL K+ P +S EAQ L+ +P RLGA +G E+K H
Sbjct: 227 QGKDRKETMTMILKAKLGM---PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHS 283
Query: 781 FFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 814
FF ++W+ L ++ + F P +DT YF F
Sbjct: 284 FFSTIDWNKL-YRREIHPPFKPATGRPEDTFYFDPEF 319
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 395 bits (1018), Expect = e-131
Identities = 127/357 (35%), Positives = 193/357 (54%), Gaps = 37/357 (10%)
Query: 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 550
+ +++DF+ +K + +G FG+V L R++ TG +A+K+L+K +I K+++ + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 610
R+PF+ Y+F D L VMEY NGG+L+ L + E+ AR Y AE+V ALEY
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
LHS +V+RD+K +NL++ DGHIK+TDFGL K G+
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI------------------------ 156
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730
+D + GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +
Sbjct: 157 ---SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWD 788
F+ IL +I + P +S EA+ L+ L DP QRLG + A EV H FF +NW
Sbjct: 214 FELILMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270
Query: 789 SLALQKAV---FVPQPESVDDTSYFLSRFSQISSGL-PDDQNGSYSDADTCDSSSNS 841
+ +QK + F PQ S DT YF F+ S + P D+ S +
Sbjct: 271 DV-VQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQE 326
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 394 bits (1014), Expect = e-130
Identities = 129/374 (34%), Positives = 200/374 (53%), Gaps = 46/374 (12%)
Query: 453 DEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVF 512
S + + ++ + T + H E+ I++FE++K + GA+G+VF
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVF 71
Query: 513 LARKRT---TGDLFAIKVLKKLDMIRK-NDIERILAERNILITVRN-PFVVRFFYSFTCR 567
L RK + TG L+A+KVLKK +++K E ER +L +R PF+V Y+F
Sbjct: 72 LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131
Query: 568 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 627
L+L+++Y+NGG+L++ L + E +IY+ E+VLALE+LH LGI++RD+K +N+L
Sbjct: 132 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL 191
Query: 628 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 687
+ +GH+ LTDFGLSK + + + + GT +
Sbjct: 192 LDSNGHVVLTDFGLSKEFVAD--------------------------ETERAYDFCGTIE 225
Query: 688 YLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAE----SPEIIFDNILNRKIPW 741
Y+AP+I+ G + G+ A DWWS+G++++E +TG PFT + S I IL + P+
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 285
Query: 742 PCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV--- 796
P +MS A+DLI R L+ DP +RLG A E+K H FF+ +NWD L K V
Sbjct: 286 ---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDL-AAKKVPAP 341
Query: 797 FVPQPESVDDTSYF 810
F P D S F
Sbjct: 342 FKPVIRDELDVSNF 355
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 391 bits (1007), Expect = e-129
Identities = 125/347 (36%), Positives = 195/347 (56%), Gaps = 38/347 (10%)
Query: 475 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 534
+SS + + R ID+FE I+ + +G+FG+V LAR + TGDL+A+KVLKK ++
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62
Query: 535 RKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 593
+ +D+E + E+ IL RN PF+ + F F D L+ VME++NGGDL ++K +
Sbjct: 63 QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD 122
Query: 594 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653
E AR Y AE++ AL +LH GI++RDLK DN+L+ H+GH KL DFG+ K G+
Sbjct: 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI------- 175
Query: 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 713
+ + GTPDY+APEIL +G A DWW++G++L+
Sbjct: 176 --------------------CNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLY 215
Query: 714 EFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--- 770
E + G PF AE+ + +F+ ILN ++ + P+ + +A ++ F+ +P RLG+
Sbjct: 216 EMLCGHAPFEAENEDDLFEAILNDEVVY---PTWLHEDATGILKSFMTKNPTMRLGSLTQ 272
Query: 771 NGAAEVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 814
G + HPFFK ++W L + + F P+ +S +D S F F
Sbjct: 273 GGEHAILRHPFFKEIDWAQL-NHRQIEPPFRPRIKSREDVSNFDPDF 318
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 388 bits (998), Expect = e-128
Identities = 117/333 (35%), Positives = 185/333 (55%), Gaps = 37/333 (11%)
Query: 486 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 545
S + + I+DF + K + +G+FG+VFLA + T FAIK LKK ++ +D+E + E
Sbjct: 8 PSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVE 67
Query: 546 RNILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 604
+ +L +PF+ F +F ++NL+ VMEYLNGGDL ++ + A Y AE+
Sbjct: 68 KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127
Query: 605 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 664
+L L++LHS GIV+RDLK DN+L+ DGHIK+ DFG+ K +
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM------------------ 169
Query: 665 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 724
+ ++ GTPDY+APEILLG ++ ++ DWWS G++L+E + G PF
Sbjct: 170 ---------LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG 220
Query: 725 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
+ E +F +I + P + EA+DL+ + + +P +RLG G +++ HP F+
Sbjct: 221 QDEEELFHSIRMDNPFY---PRWLEKEAKDLLVKLFVREPEKRLGVRG--DIRQHPLFRE 275
Query: 785 VNWDSLALQKAV---FVPQPESVDDTSYFLSRF 814
+NW+ L +K + F P+ +S D S F F
Sbjct: 276 INWEEL-ERKEIDPPFRPKVKSPFDCSNFDKEF 307
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 388 bits (998), Expect = e-128
Identities = 106/344 (30%), Positives = 182/344 (52%), Gaps = 38/344 (11%)
Query: 477 SSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK 536
++ VS ++ +++R + DF + + +G+FG+V L+ ++ T +L+A+K+LKK +I+
Sbjct: 2 TNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQD 61
Query: 537 NDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 595
+D+E + E+ +L PF+ + F D LY VMEY+NGGDL +++VG +E
Sbjct: 62 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP 121
Query: 596 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655
A Y AE+ + L +L S GI++RDLK DN+++ +GHIK+ DFG+ K +
Sbjct: 122 HAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--------- 172
Query: 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 715
D + GTPDY+APEI+ +G + DWW+ G++L+E
Sbjct: 173 ------------------WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 214
Query: 716 ITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGA 773
+ G PF E + +F +I+ + + P MS EA + + P +RLG G
Sbjct: 215 LAGQAPFEGEDEDELFQSIMEHNVAY---PKSMSKEAVAICKGLMTKHPGKRLGCGPEGE 271
Query: 774 AEVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 814
++K H FF+ ++W+ L +K + + P+ + F F
Sbjct: 272 RDIKEHAFFRYIDWEKL-ERKEIQPPYKPKACG-RNAENFDRFF 313
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 381 bits (982), Expect = e-125
Identities = 115/343 (33%), Positives = 181/343 (52%), Gaps = 47/343 (13%)
Query: 488 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN 547
+ + DF++++ I RG++ +V L R + T ++A+KV+KK + DI+ + E++
Sbjct: 2 AMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKH 61
Query: 548 ILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 606
+ N PF+V F L+ V+EY+NGGDL +++ L E+ AR Y AE+ L
Sbjct: 62 VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL 121
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
AL YLH GI++RDLK DN+L+ +GHIKLTD+G+ K GL
Sbjct: 122 ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-------------------- 161
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT--- 723
+ GTP+Y+APEIL G ++G++ DWW++G+++FE + G PF
Sbjct: 162 -------RPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214
Query: 724 ------AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAA 774
+ + +F IL ++I P +S +A ++ FL DP +RLG G A
Sbjct: 215 SSDNPDQNTEDYLFQVILEKQIRIPR---SLSVKAASVLKSFLNKDPKERLGCHPQTGFA 271
Query: 775 EVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF 814
+++ HPFF+ V+WD + QK V F P F S+F
Sbjct: 272 DIQGHPFFRNVDWDMM-EQKQVVPPFKPNISGEFGLDNFDSQF 313
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 384 bits (989), Expect = e-125
Identities = 129/379 (34%), Positives = 198/379 (52%), Gaps = 38/379 (10%)
Query: 442 REKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIK 501
RE++ A + + + + + S + + L + K R ++++FE +K
Sbjct: 96 REEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSL-AKPKHRVTMNEFEYLK 154
Query: 502 PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF 561
+ +G FG+V L +++ TG +A+K+LKK ++ K+++ L E +L R+PF+
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 214
Query: 562 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRD 620
YSF D L VMEY NGG+L+ L + ED AR Y AE+V AL+YLHS +V+RD
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274
Query: 621 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH 680
LK +NL++ DGHIK+TDFGL K G+ D
Sbjct: 275 LKLENLMLDKDGHIKITDFGLCKEGI---------------------------KDGATMK 307
Query: 681 SAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIP 740
+ GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +F+ IL +I
Sbjct: 308 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 367
Query: 741 WPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV-- 796
+ P + EA+ L++ L DP QRLG A E+ H FF G+ W + +K +
Sbjct: 368 F---PRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV-YEKKLSP 423
Query: 797 -FVPQPESVDDTSYFLSRF 814
F PQ S DT YF F
Sbjct: 424 PFKPQVTSETDTRYFDEEF 442
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 378 bits (972), Expect = e-123
Identities = 119/381 (31%), Positives = 193/381 (50%), Gaps = 48/381 (12%)
Query: 450 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 509
D PT+ + Y + + + + ++T + DF++++ I RG++
Sbjct: 8 HHHDYDIPTTENLYFQGA-MGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYA 66
Query: 510 RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRD 568
+V L R + T ++A++V+KK + DI+ + E+++ N PF+V F
Sbjct: 67 KVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126
Query: 569 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 628
L+ V+EY+NGGDL +++ L E+ AR Y AE+ LAL YLH GI++RDLK DN+L+
Sbjct: 127 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186
Query: 629 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 688
+GHIKLTD+G+ K GL + GTP+Y
Sbjct: 187 DSEGHIKLTDYGMCKEGL---------------------------RPGDTTSTFCGTPNY 219
Query: 689 LAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT---------AESPEIIFDNILNRKI 739
+APEIL G ++G++ DWW++G+++FE + G PF + + +F IL ++I
Sbjct: 220 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI 279
Query: 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNWDSLALQKAV 796
P +S +A ++ FL DP +RLG G A+++ HPFF+ V+WD + QK V
Sbjct: 280 RIPR---SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM-EQKQV 335
Query: 797 ---FVPQPESVDDTSYFLSRF 814
F P F S+F
Sbjct: 336 VPPFKPNISGEFGLDNFDSQF 356
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 377 bits (971), Expect = e-123
Identities = 101/413 (24%), Positives = 187/413 (45%), Gaps = 53/413 (12%)
Query: 481 STPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE 540
S P E + D FEI++ I +G+FG+V + +K T ++A+K + K + +N++
Sbjct: 1 SMPPVFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVR 60
Query: 541 RILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 600
+ E I+ + +PF+V +YSF +++++V++ L GGDL L++ +E+ +++
Sbjct: 61 NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF 120
Query: 601 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 660
I ELV+AL+YL + I+HRD+KPDN+L+ GH+ +TDF ++ +
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML--------------- 165
Query: 661 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL---GTEHGYAADWWSVGIILFEFIT 717
+ GT Y+APE+ G + +A DWWS+G+ +E +
Sbjct: 166 -------------PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212
Query: 718 GIPPF---TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 774
G P+ ++ S + I + + PS S E L+ + L +P+QR +
Sbjct: 213 GRRPYHIRSSTSSKEIVHTFETTVVTY---PSAWSQEMVSLLKKLLEPNPDQRFS--QLS 267
Query: 775 EVKAHPFFKGVNWDSLALQKAV---FVPQPESVDDTSYFLSRF---SQISSGLPDDQNG- 827
+V+ P+ +NWD++ QK + F+P F I P +
Sbjct: 268 DVQNFPYMNDINWDAV-FQKRLIPGFIPNK----GRLNCDPTFELEEMILESKPLHKKKK 322
Query: 828 --SYSDADTCDSSSNSRTEMDECGDLAEFGSCPLDLSLINFSFKNLSQLASIN 878
+ + D S+ + E D + + +N F ++
Sbjct: 323 RLAKKEKDMRKCDSSQTCLLQEHLDSVQKEFIIFNREKVNRDFNKRQPNLALE 375
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 375 bits (964), Expect = e-118
Identities = 109/371 (29%), Positives = 189/371 (50%), Gaps = 38/371 (10%)
Query: 450 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 509
+E+ F + K ++ +S ++ +++R + DF + + +G+FG
Sbjct: 296 SEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFG 355
Query: 510 RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRD 568
+V L+ ++ T +L+A+K+LKK +I+ +D+E + E+ +L PF+ + F D
Sbjct: 356 KVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415
Query: 569 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 628
LY VMEY+NGGDL +++VG +E A Y AE+ + L +L S GI++RDLK DN+++
Sbjct: 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475
Query: 629 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 688
+GHIK+ DFG+ K + D + GTPDY
Sbjct: 476 DSEGHIKIADFGMCKENI---------------------------WDGVTTKTFCGTPDY 508
Query: 689 LAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDM 748
+APEI+ +G + DWW+ G++L+E + G PF E + +F +I+ + + P M
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---PKSM 565
Query: 749 SFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQKAV---FVPQPES 803
S EA + + P +RLG G ++K H FF+ ++W+ L +K + + P+ S
Sbjct: 566 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL-ERKEIQPPYKPKA-S 623
Query: 804 VDDTSYFLSRF 814
+ F F
Sbjct: 624 GRNAENFDRFF 634
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 367 bits (945), Expect = e-117
Identities = 98/381 (25%), Positives = 170/381 (44%), Gaps = 46/381 (12%)
Query: 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 548
+ D F + + RG FG VF + + TG L+A K L K + ++ + + E+ I
Sbjct: 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKI 238
Query: 549 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDL----YSLLRKVGCLEEDVARIYIAEL 604
L V + F+V Y+F + +L LVM +NGGD+ Y++ +E A Y A++
Sbjct: 239 LAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI 298
Query: 605 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 664
V LE+LH I++RDLKP+N+L+ DG+++++D GL+
Sbjct: 299 VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK------------------ 340
Query: 665 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 724
GTP ++APE+LLG E+ ++ D++++G+ L+E I PF A
Sbjct: 341 ---------AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRA 391
Query: 725 E----SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKA 778
+ + +L + + + P S ++D L DP +RLG ++
Sbjct: 392 RGEKVENKELKQRVLEQAVTY---PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448
Query: 779 HPFFKGVNWDSLALQK--AVFVPQPESVDDTSYF-LSRFSQI--SSGLPDDQNGSYSDAD 833
HP F+ ++W L FVP +V + + FS + + D + +
Sbjct: 449 HPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFSTVKGVAFEKADTE-FFQEFA 507
Query: 834 TCDSSSNSRTEMDECGDLAEF 854
+ + EM E G +
Sbjct: 508 SGTCPIPWQEEMIETGVFGDL 528
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 366 bits (941), Expect = e-115
Identities = 113/393 (28%), Positives = 175/393 (44%), Gaps = 56/393 (14%)
Query: 450 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFG 509
E+ F K+ E+ + + + +++DF + + I RG FG
Sbjct: 152 EICQNLRGDVFQKFIESDK--------FTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFG 203
Query: 510 RVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN---PFVVRFFYSFTC 566
V+ RK TG ++A+K L K + K L ER +L V PF+V Y+F
Sbjct: 204 EVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263
Query: 567 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 626
D L +++ +NGGDL+ L + G E R Y AE++L LE++H+ +V+RDLKP N+
Sbjct: 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 323
Query: 627 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP 686
L+ GH++++D GL+ H++VGT
Sbjct: 324 LLDEHGHVRISDLGLACDFSKKKP-----------------------------HASVGTH 354
Query: 687 DYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESP---EIIFDNILNRKIPWP 742
Y+APE+L G + +ADW+S+G +LF+ + G PF I L +
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL- 413
Query: 743 CVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQK--AVFV 798
P S E + L+ L D N+RLG GA EVK PFF+ ++W + LQK +
Sbjct: 414 --PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI 471
Query: 799 PQPESVD-----DTSYFLSRFSQISSGLPDDQN 826
P V+ D F ++ L DQ
Sbjct: 472 PPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQE 504
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 360 bits (925), Expect = e-114
Identities = 126/489 (25%), Positives = 197/489 (40%), Gaps = 64/489 (13%)
Query: 441 LREKYILACELLDEKSPTSFSKYKENSRLILDSVSQ--------SSGVSTPLHSSHKERT 492
+ + + C E+ P ++E +RL + +S S + L ER
Sbjct: 121 VPRQLVTNCTQRLEQGPCK-DLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQ 179
Query: 493 --SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 550
+ + F + + +G FG V + R TG ++A K L+K + ++ L E+ IL
Sbjct: 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLAL 608
V + FVV Y++ +D L LV+ +NGGDL + +G E A Y AE+ L
Sbjct: 240 KVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL 299
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
E LH IV+RDLKP+N+L+ GHI+++D GL+ TI
Sbjct: 300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI----------------- 342
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE--- 725
VGT Y+APE++ + ++ DWW++G +L+E I G PF
Sbjct: 343 -----------KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK 391
Query: 726 -SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFF 782
E + + + S +A+ L ++ L DP +RLG A EVK HP F
Sbjct: 392 IKREEVERLVKEVPEEY---SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
Query: 783 KGVNWDSLALQKAV--FVPQPESVD--DTSYFLSRFSQISSGL-PDDQNGSYSDADTCDS 837
K +N+ L F P P+++ D + L P DQ+ Y T
Sbjct: 449 KKLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFSTVKGVELEPTDQD-FYQKFATGSV 507
Query: 838 SSNSRTEMDECGDLAEF------GSCPLDLSLINFSFKNLSQLASINHEVLVQNVKDSTR 891
+ EM E E GS P DL + + +
Sbjct: 508 PIPWQNEMVETECFQELNVFGLDGSVPPDLDWKGQP--PAPPKKGLLQRLFSRQDSSGNS 565
Query: 892 SSPAKDAGT 900
S ++ T
Sbjct: 566 SDSEEELPT 574
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 330 bits (848), Expect = e-107
Identities = 95/308 (30%), Positives = 152/308 (49%), Gaps = 35/308 (11%)
Query: 487 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER 546
S K + +++DFEI +P+ +G FG V+LAR++ + + A+KVL K + + ++ E
Sbjct: 1 SKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 60
Query: 547 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 606
I +R+P ++R + F +YL++EY G +Y L+K+ +E YI EL
Sbjct: 61 EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
AL Y HS ++HRD+KP+NLL+ G +K+ DFG S
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV----------------------- 157
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 726
+ R GT DYL PE++ G H D WS+G++ +EF+ G PPF A +
Sbjct: 158 ------HAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 211
Query: 727 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786
+ + I + + P ++ A+DLI+R L H+P+QR EV HP+ +
Sbjct: 212 YQETYKRISRVEFTF---PDFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITANS 265
Query: 787 WDSLALQK 794
Q
Sbjct: 266 SKPSNCQN 273
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 330 bits (848), Expect = e-107
Identities = 98/324 (30%), Positives = 159/324 (49%), Gaps = 42/324 (12%)
Query: 482 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER 541
T L K + +IDDF+I +P+ +G FG V+LAR++ + A+KVL K + ++ +
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 542 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 601
+ E I +R+P ++R + F R +YL++E+ G+LY L+K G +E + ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 602 AELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 661
EL AL Y H ++HRD+KP+NLL+ + G +K+ DFG S
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV------------------ 162
Query: 662 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 721
+ R + GT DYL PE++ G H D W G++ +EF+ G+PP
Sbjct: 163 -----------HAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
Query: 722 FTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
F + S I+N + + P +S ++DLI++ L + P QRL V HP+
Sbjct: 212 FDSPSHTETHRRIVNVDLKF---PPFLSDGSKDLISKLLRYHPPQRL---PLKGVMEHPW 265
Query: 782 FKGVNWDSLALQKAVFVPQPESVD 805
K A + V P +S
Sbjct: 266 VK-------ANSRRVLPPVYQSTQ 282
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 295 bits (757), Expect = 1e-92
Identities = 72/361 (19%), Positives = 141/361 (39%), Gaps = 76/361 (21%)
Query: 472 DSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 531
D +S S + ++ I+D+ II+ +++G F ++ L K +A+K +K
Sbjct: 8 DILSNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKS 65
Query: 532 DMIRK--------------NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYL 577
+ +K + + E I+ ++N + + T D +Y++ EY+
Sbjct: 66 LLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYM 125
Query: 578 NGGDLYSLLRKVGCLE--------EDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLI 628
+ L+ V + I ++ + Y+H+ I HRD+KP N+L+
Sbjct: 126 ENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM 185
Query: 629 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 688
+G +KL+DFG S+ ++ + GT ++
Sbjct: 186 DKNGRVKLSDFGESEY-----------------------------MVDKKIKGSRGTYEF 216
Query: 689 LAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAE-SPEIIFDNILNRKIPWPCVP 745
+ PE +G D WS+GI L+ + PF+ + S +F+NI + I +P
Sbjct: 217 MPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDR 276
Query: 746 SD----------------MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDS 789
+ +S E D + FL +P +R+ + + H + N +
Sbjct: 277 NHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI---TSEDALKHEWLADTNIED 333
Query: 790 L 790
L
Sbjct: 334 L 334
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 3e-91
Identities = 89/312 (28%), Positives = 146/312 (46%), Gaps = 38/312 (12%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
DFE I + +GAFG+V AR +AIK ++ + + IL+E +L ++ +
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNH 61
Query: 555 PFVVRFFYSFTCRDN-------------LYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 600
+VVR++ ++ R N L++ MEY G LY L+ + D
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRL 121
Query: 601 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 660
+++ AL Y+HS GI+HRDLKP N+ I ++K+ DFGL+K ++ ++D+ ++
Sbjct: 122 FRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN--VHRSLDILKLDSQN 179
Query: 661 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGI 719
+ S N SA+GT Y+A E+L GT H D +S+GII FE I
Sbjct: 180 LPGSS-----------DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-- 226
Query: 720 PPFTAESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778
P T I + + I +P + + +I + HDPN+R GA +
Sbjct: 227 PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP---GARTLLN 283
Query: 779 HPFFKGVNWDSL 790
+ + D +
Sbjct: 284 SGWLPVKHQDEV 295
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 278 bits (714), Expect = 8e-87
Identities = 86/336 (25%), Positives = 131/336 (38%), Gaps = 43/336 (12%)
Query: 452 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHS-SHKERTSIDDFEIIKPISRGAFGR 510
L ++ S ++ R + S + +P + S E F+ + + G++G
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGE 72
Query: 511 VFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFTCRDN 569
VF R + G L+A+K K D R LAE V ++P VR ++
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131
Query: 570 LYLVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI 628
LYL E G L G L E Y+ + +LAL +LHS G+VH D+KP N+ +
Sbjct: 132 LYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL 190
Query: 629 AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 688
G KL DFGL L G P Y
Sbjct: 191 GPRGRCKLGDFGLLVE--------LGTAGA--------------------GEVQEGDPRY 222
Query: 689 LAPEILLGTEHGYAADWWSVGIILFEFITGIP-PFTAESPEIIFDNILNRKIPWPCVPSD 747
+APE+L G +G AAD +S+G+ + E + P E + + L P +
Sbjct: 223 MAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLP-----PEFTAG 276
Query: 748 MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+S E + ++ L DP R A + A P +
Sbjct: 277 LSSELRSVLVMMLEPDPKLRATAE---ALLALPVLR 309
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 2e-86
Identities = 81/298 (27%), Positives = 148/298 (49%), Gaps = 34/298 (11%)
Query: 487 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER 546
+ I+DF++ + +G+F V+ A TG AIK++ K M + ++R+ E
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 547 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELV 605
I +++P ++ + F + +YLV+E + G++ L+ +V E+ AR ++ +++
Sbjct: 63 KIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII 122
Query: 606 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 665
+ YLHS GI+HRDL NLL+ + +IK+ DFGL+
Sbjct: 123 TGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA----------------------- 159
Query: 666 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 725
+ + ++ GTP+Y++PEI + HG +D WS+G + + + G PPF +
Sbjct: 160 TQL----KMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTD 215
Query: 726 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+ + + ++ +PS +S EA+DLI++ L +P RL + V HPF
Sbjct: 216 TVKNTLNKVVLADYE---MPSFLSIEAKDLIHQLLRRNPADRL---SLSSVLDHPFMS 267
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 272 bits (698), Expect = 4e-84
Identities = 75/311 (24%), Positives = 133/311 (42%), Gaps = 33/311 (10%)
Query: 473 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD 532
++ + + + S + + + +G F + F T ++FA K++ K
Sbjct: 19 GAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSL 78
Query: 533 MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 592
+++ + E++ E +I ++ + VV F F D +++V+E L L ++ L
Sbjct: 79 LLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKAL 138
Query: 593 EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652
E AR Y+ ++VL +YLH ++HRDLK NL + D +K+ DFGL+ +
Sbjct: 139 TEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA------TKV- 191
Query: 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 712
+ D + GTP+Y+APE+L H + D WS+G I+
Sbjct: 192 --------------------EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 231
Query: 713 FEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 772
+ + G PPF + + I + P ++ A LI + L DP R
Sbjct: 232 YTLLVGKPPFETSCLKETYLRIKKNEYSI---PKHINPVAASLIQKMLQTDPTARP---T 285
Query: 773 AAEVKAHPFFK 783
E+ FF
Sbjct: 286 INELLNDEFFT 296
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 270 bits (694), Expect = 4e-84
Identities = 75/295 (25%), Positives = 129/295 (43%), Gaps = 33/295 (11%)
Query: 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 548
+ S + + + +G F + F T ++FA K++ K +++ + E++ E +I
Sbjct: 9 VDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISI 68
Query: 549 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 608
++ + VV F F D +++V+E L L ++ L E AR Y+ ++VL
Sbjct: 69 HRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
+YLH ++HRDLK NL + D +K+ DFGL+ +
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA------TKV----------------- 165
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 728
+ D + GTP+Y+APE+L H + D WS+G I++ + G PPF +
Sbjct: 166 ----EYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK 221
Query: 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+ I + P ++ A LI + L DP R E+ FF
Sbjct: 222 ETYLRIKKNEYSI---PKHINPVAASLIQKMLQTDPTARP---TINELLNDEFFT 270
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 260 bits (666), Expect = 2e-79
Identities = 79/310 (25%), Positives = 149/310 (48%), Gaps = 37/310 (11%)
Query: 476 QSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR 535
SSGV + + + S++ + ++ I G+FG+ L + G + IK + M
Sbjct: 7 HSSGVDLGTENLYFQ--SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS 64
Query: 536 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVGCLE 593
K + E E +L +++P +V++ SF +LY+VM+Y GGDL+ + +K +
Sbjct: 65 K-EREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQ 123
Query: 594 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653
ED + ++ LAL+++H I+HRD+K N+ + DG ++L DFG++++ +N+T++L
Sbjct: 124 EDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVEL 181
Query: 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 713
+ + +GTP YL+PEI + +D W++G +L+
Sbjct: 182 A-------------------------RACIGTPYYLSPEICENKPYNNKSDIWALGCVLY 216
Query: 714 EFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGA 773
E T F A S + + I++ P V S++ + L+++ +P R N
Sbjct: 217 ELCTLKHAFEAGSMKNLVLKIISGSF--PPVSLHYSYDLRSLVSQLFKRNPRDRPSVN-- 272
Query: 774 AEVKAHPFFK 783
+ F
Sbjct: 273 -SILEKGFIA 281
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 253 bits (648), Expect = 2e-77
Identities = 80/325 (24%), Positives = 131/325 (40%), Gaps = 49/325 (15%)
Query: 475 SQSSGVSTPLHSSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD 532
SSGV + + + S+ + I+K I G +VF ++AIK + +
Sbjct: 6 HHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNL-E 63
Query: 533 MIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 590
++ E L ++ + ++R + +Y+VME DL S L+K
Sbjct: 64 EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK 122
Query: 591 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650
++ + Y ++ A+ +H GIVH DLKP N LI DG +KL DFG++
Sbjct: 123 SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIAN------- 174
Query: 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-----------EH 699
M D T + + S VGT +Y+ PE + +
Sbjct: 175 ----------QMQPD--------TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 216
Query: 700 GYAADWWSVGIILFEFITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINR 758
+D WS+G IL+ G PF +I I++ P + QD++
Sbjct: 217 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKC 275
Query: 759 FLIHDPNQRLGANGAAEVKAHPFFK 783
L DP QR+ E+ AHP+ +
Sbjct: 276 CLKRDPKQRISIP---ELLAHPYVQ 297
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 1e-74
Identities = 83/303 (27%), Positives = 142/303 (46%), Gaps = 44/303 (14%)
Query: 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 551
+ +D+E++ I G++GR R+++ G + K L M + + +++E N+L
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRE 61
Query: 552 VRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELV 605
+++P +VR++ R N LY+VMEY GGDL S++ K L+E+ + +L
Sbjct: 62 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 121
Query: 606 LALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 660
LAL+ H ++HRDLKP N+ + ++KL DFGL++I +N+ +
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFA------ 173
Query: 661 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 720
+ VGTP Y++PE + + +D WS+G +L+E +P
Sbjct: 174 -------------------KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
Query: 721 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 780
PFTA S + + I K +P S E ++I R L R E+ +P
Sbjct: 215 PFTAFSQKELAGKIREGKF--RRIPYRYSDELNEIITRMLNLKDYHRP---SVEEILENP 269
Query: 781 FFK 783
Sbjct: 270 LIL 272
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 247 bits (632), Expect = 5e-74
Identities = 82/344 (23%), Positives = 134/344 (38%), Gaps = 49/344 (14%)
Query: 456 SPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSID--DFEIIKPISRGAFGRVFL 513
S + + R +DS + SS E S+ + I+K I G +VF
Sbjct: 15 SGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQ 74
Query: 514 ARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNLY 571
++AIK + + ++ E L ++ + ++R + +Y
Sbjct: 75 VLNEK-KQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132
Query: 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD 631
+VME DL S L+K ++ + Y ++ A+ +H GIVH DLKP N LI D
Sbjct: 133 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VD 190
Query: 632 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAP 691
G +KL DFG++ M D T + + S VG +Y+ P
Sbjct: 191 GMLKLIDFGIAN-----------------QMQPD--------TTSVVKDSQVGAVNYMPP 225
Query: 692 EILLGT-----------EHGYAADWWSVGIILFEFITGIPPFTAESPEI-IFDNILNRKI 739
E + + +D WS+G IL+ G PF +I I++
Sbjct: 226 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 285
Query: 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
P + QD++ L DP QR+ E+ AHP+ +
Sbjct: 286 EIE-FPDIPEKDLQDVLKCCLKRDPKQRI---SIPELLAHPYVQ 325
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 5e-74
Identities = 95/298 (31%), Positives = 146/298 (48%), Gaps = 47/298 (15%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
F ++ + GAF VFL ++R TG LFA+K +KK R + +E E +L +++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKH 65
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
+V + + YLVM+ ++GG+L+ + + G E A + I +++ A++YLH
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 615 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
GIVHRDLKP+NLL + I +TDFGLSK+ E +GIM
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM------------EQNGIM--------- 164
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731
+A GTP Y+APE+L + A D WS+G+I + + G PPF E+ +F
Sbjct: 165 --------STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLF 216
Query: 732 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
+ I W + S A+D I L DPN+R + +HP+ G
Sbjct: 217 EKIKEGYYEFESPFWDDI----SESAKDFICHLLEKDPNERY---TCEKALSHPWIDG 267
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 6e-74
Identities = 75/302 (24%), Positives = 122/302 (40%), Gaps = 47/302 (15%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-- 553
+ I+K I G +VF ++AIK + + ++ E L ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNL-EEADNQTLDSYRNEIAYLNKLQQH 67
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 613
+ ++R + +Y+VME DL S L+K ++ + Y ++ A+ +H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
GIVH DLKP N LI DG +KL DFG++ M D
Sbjct: 127 HGIVHSDLKPANFLI-VDGMLKLIDFGIAN-----------------QMQPD-------- 160
Query: 674 TDNRNRHSAVGTPDYLAPEILLGT-----------EHGYAADWWSVGIILFEFITGIPPF 722
T + + S VGT +Y+ PE + + +D WS+G IL+ G PF
Sbjct: 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF 220
Query: 723 TAESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
+I I++ P + QD++ L DP QR+ E+ AHP+
Sbjct: 221 QQIINQISKLHAIIDPNHEIE-FPDIPEKDLQDVLKCCLKRDPKQRISIP---ELLAHPY 276
Query: 782 FK 783
+
Sbjct: 277 VQ 278
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 3e-73
Identities = 69/308 (22%), Positives = 130/308 (42%), Gaps = 39/308 (12%)
Query: 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 553
+ DFE I+ + RG FG VF A+ + +AIK ++ + + E+++ E L +
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLE 61
Query: 554 NPFVVRFFYSFTCRDN------------LYLVMEYLNGGDLYSLLRK---VGCLEEDVAR 598
+P +VR+F ++ ++ LY+ M+ +L + + E V
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 599 IYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 658
++ A+E+LHS G++HRDLKP N+ D +K+ DFGL ++
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA--MDQD-------- 171
Query: 659 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 718
+ VGT Y++PE + G + + D +S+G+ILFE +
Sbjct: 172 -----EEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY- 225
Query: 719 IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778
P T ++ R + +P + + ++ L P +R A +
Sbjct: 226 -PFSTQMERVRTLTDV--RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAI---NIIE 279
Query: 779 HPFFKGVN 786
+ F+ ++
Sbjct: 280 NAVFEDLD 287
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 248 bits (634), Expect = 3e-73
Identities = 82/310 (26%), Positives = 140/310 (45%), Gaps = 44/310 (14%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
D ++ + + +G+FG V L + + TG A+KV+ K + +K D E +L E +L + +
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
P +++ + F + YLV E GG+L+ + E A I +++ + Y+H
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 615 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
IVHRDLKP+NLL+ D +I++ DFGLS
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTH--------------------------- 178
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731
++ +GT Y+APE+L G + D WS G+IL+ ++G PPF + I
Sbjct: 179 -FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 236
Query: 732 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786
+ K W V S A+DLI + L + P+ R+ A + H + +
Sbjct: 237 KKVEKGKYTFELPQWKKV----SESAKDLIRKMLTYVPSMRI---SARDALDHEWIQTYT 289
Query: 787 WDSLALQKAV 796
+ +++
Sbjct: 290 KEQISVDVPS 299
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 241 bits (616), Expect = 2e-72
Identities = 81/356 (22%), Positives = 137/356 (38%), Gaps = 74/356 (20%)
Query: 476 QSSGVSTPLHSSHKERTSI-DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVL--KKLD 532
S L+ + + + I +G++G V +A + T + AIK++ K+
Sbjct: 6 HHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIR 65
Query: 533 MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL 592
I D+ERI E ++ + +P + R + + + LVME +GG L L
Sbjct: 66 QINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDD 125
Query: 593 E----------------------------------------EDVARIYIAELVLALEYLH 612
E + + ++ AL YLH
Sbjct: 126 STGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185
Query: 613 SLGIVHRDLKPDNLLIAHDG--HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
+ GI HRD+KP+N L + + IKL DFGLSK + +
Sbjct: 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE-----------------------FYK 222
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESPE 728
+ + GTP ++APE+L T Y D WS G++L + G PF +
Sbjct: 223 LNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDA 282
Query: 729 IIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+LN+K+ + + +S A+DL++ L + ++R A HP+
Sbjct: 283 DTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF---DAMRALQHPWIS 335
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 3e-72
Identities = 83/319 (26%), Positives = 141/319 (44%), Gaps = 50/319 (15%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
D++++ + + +GAF V +TTG FA K++ + D +++ E I +++
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT-KKLSARDFQKLEREARICRKLQH 64
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
P +VR S YLV + + GG+L+ + E A I +++ ++ Y HS
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 615 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
GIVHR+LKP+NLL+A +KL DFGL+ ++
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIE------VN------------------- 159
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731
D+ H GTP YL+PE+L + D W+ G+IL+ + G PPF E ++
Sbjct: 160 ---DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY 216
Query: 732 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786
I W V + EA+ LI+ L +P +R+ A + P+
Sbjct: 217 AQIKAGAYDYPSPEWDTV----TPEAKSLIDSMLTVNPKKRI---TADQALKVPWICN-- 267
Query: 787 WDSLALQKAVFVPQPESVD 805
+ A + + ++VD
Sbjct: 268 ----RERVASAIHRQDTVD 282
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 4e-72
Identities = 82/298 (27%), Positives = 132/298 (44%), Gaps = 45/298 (15%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ + I+ + +G+FG V + R T +A+KV+ K + D IL E +L + +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINK-ASAKNKDTSTILREVELLKKLDH 80
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
P +++ F + Y+V E GG+L+ + K E A I ++ + Y+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 615 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
IVHRDLKP+N+L+ D IK+ DFGLS
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--------------------------- 173
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731
N +GT Y+APE+L GT + D WS G+IL+ ++G PPF ++ I
Sbjct: 174 -FQQNTKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
Query: 732 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
+ K W + S +A+DLI + L P+ R+ A + HP+ +
Sbjct: 232 KRVETGKYAFDLPQWRTI----SDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQK 282
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 1e-71
Identities = 82/321 (25%), Positives = 137/321 (42%), Gaps = 45/321 (14%)
Query: 473 SVSQSSGVSTPLHSSHKERTSIDD-FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKL 531
S++ + T D +++ + + +GAF V +TTG FA K++
Sbjct: 6 SMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINT- 64
Query: 532 DMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 591
+ D +++ E I +++P +VR S YLV + + GG+L+ +
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 592 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLIN 648
E A I +++ ++ Y HS GIVHR+LKP+NLL+A +KL DFGL+
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE---- 180
Query: 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSV 708
++ D+ H GTP YL+PE+L + D W+
Sbjct: 181 --VN----------------------DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWAC 216
Query: 709 GIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHD 763
G+IL+ + G PPF E ++ I W V + EA+ LI+ L +
Sbjct: 217 GVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV----TPEAKSLIDSMLTVN 272
Query: 764 PNQRLGANGAAEVKAHPFFKG 784
P +R+ A + P+
Sbjct: 273 PKKRI---TADQALKVPWICN 290
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 235 bits (603), Expect = 3e-71
Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 41/296 (13%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
D F + + GAFG V L +R++G IK + K + +E+I AE +L ++ +
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDH 79
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLY----SLLRKVGCLEEDVARIYIAELVLALEY 610
P +++ F F N+Y+VME GG+L S + L E + +++ AL Y
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 611 LHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
HS +VH+DLKP+N+L IK+ DFGL+++
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL----------------------- 176
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 727
+ + +A GT Y+APE+ + + D WS G++++ +TG PFT S
Sbjct: 177 -----FKSDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230
Query: 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
E + ++ + ++ +A DL+ + L DP +R AA+V H +FK
Sbjct: 231 EEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP---SAAQVLHHEWFK 283
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 3e-71
Identities = 82/300 (27%), Positives = 132/300 (44%), Gaps = 45/300 (15%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ + I+ + +G+FG V + R T +A+KV+ K K D IL E +L + +
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
P +++ F + Y+V E GG+L+ + K E A I ++ + Y+H
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 615 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
IVHRDLKP+N+L+ D IK+ DFGLS
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTC--------------------------- 173
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731
N +GT Y+APE+L G + D WS G+IL+ ++G PPF ++ I
Sbjct: 174 -FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL 231
Query: 732 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786
+ K W + S +A+DLI + L P+ R+ A + HP+ + +
Sbjct: 232 KRVETGKYAFDLPQWRTI----SDDAKDLIRKMLTFHPSLRI---TATQCLEHPWIQKYS 284
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 4e-71
Identities = 75/300 (25%), Positives = 129/300 (43%), Gaps = 36/300 (12%)
Query: 475 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 534
++ +F I K I RG F V+ A G A+K ++ D++
Sbjct: 12 PVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLM 71
Query: 535 RKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG---- 590
+ E ++L + +P V++++ SF + L +V+E + GDL +++
Sbjct: 72 DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKR 131
Query: 591 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650
+ E Y +L ALE++HS ++HRD+KP N+ I G +KL D GL + ++
Sbjct: 132 LIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSK 189
Query: 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 710
HS VGTP Y++PE + + + +D WS+G
Sbjct: 190 TTA-------------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGC 224
Query: 711 ILFEFITGIPPFTAESPEI--IFDNILNRKIPWPCVPSD-MSFEAQDLINRFLIHDPNQR 767
+L+E PF + + + I P +PSD S E + L+N + DP +R
Sbjct: 225 LLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSEELRQLVNMCINPDPEKR 282
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 1e-70
Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 47/298 (15%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ + I RG++G V +A ++ T A K + K + D++R E I+ ++ +
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDH 65
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
P ++R + +F ++YLVME GG+L+ + E A + +++ A+ Y H L
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 615 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
+ HRDLKP+N L D +KL DFGL+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--------------------------- 158
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731
+ + VGTP Y++P++L G +G D WS G++++ + G PPF+A + +
Sbjct: 159 -FKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM 216
Query: 732 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
I W V S +A+ LI R L P QR+ + + H +F+
Sbjct: 217 LKIREGTFTFPEKDWLNV----SPQAESLIRRLLTKSPKQRI---TSLQALEHEWFEK 267
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 239 bits (612), Expect = 5e-70
Identities = 89/342 (26%), Positives = 152/342 (44%), Gaps = 49/342 (14%)
Query: 472 DSVSQSSGVSTPLHSSHKERTSI-DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK 530
+ Q +TP ++ + + ++ +K + GA+G V L R + T AIK+++K
Sbjct: 13 NLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRK 72
Query: 531 LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 590
+ + ++L E +L + +P +++ + F + N YLVME GG+L+ +
Sbjct: 73 -TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM 131
Query: 591 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLI 647
E A + I +++ + YLH IVHRDLKP+NLL+ D IK+ DFGLS +
Sbjct: 132 KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV--- 188
Query: 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 707
+ + +GT Y+APE+L ++ D WS
Sbjct: 189 -------------------------FENQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWS 222
Query: 708 VGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIH 762
+G+ILF + G PPF ++ + I + K W V S A+DLI + L
Sbjct: 223 IGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNV----SEGAKDLIKQMLQF 278
Query: 763 DPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESV 804
D +R+ A + HP+ K + + +P +
Sbjct: 279 DSQRRI---SAQQALEHPWIKE---MCSKKESGIELPSLANA 314
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 1e-69
Identities = 85/326 (26%), Positives = 137/326 (42%), Gaps = 49/326 (15%)
Query: 473 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD 532
S S G L + + D +E+ + I +G F V R TG FA+K++
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAK 61
Query: 533 MIRKN--DIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLY----SLL 586
E + E +I +++P +V +++ LY+V E+++G DL
Sbjct: 62 FTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRA 121
Query: 587 RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSK 643
E VA Y+ +++ AL Y H I+HRD+KP +L+A +KL FG++
Sbjct: 122 DAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI 181
Query: 644 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 703
+ SG G VGTP ++APE++ +G
Sbjct: 182 Q------LGESGLVAGGR---------------------VGTPHFMAPEVVKREPYGKPV 214
Query: 704 DWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINR 758
D W G+ILF ++G PF +F+ I+ K W + S A+DL+ R
Sbjct: 215 DVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHI----SESAKDLVRR 269
Query: 759 FLIHDPNQRLGANGAAEVKAHPFFKG 784
L+ DP +R+ E HP+ K
Sbjct: 270 MLMLDPAERI---TVYEALNHPWLKE 292
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 238 bits (610), Expect = 1e-69
Identities = 77/320 (24%), Positives = 138/320 (43%), Gaps = 54/320 (16%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR----------KNDIERILA 544
+ + ++ + GA+G V L +++ AIKV+KK + + E I
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 545 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 604
E ++L ++ +P +++ F F + YLV E+ GG+L+ + +E A + ++
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 605 VLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGI 661
+ + YLH IVHRD+KP+N+L+ + +IK+ DFGLS
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF----------------- 198
Query: 662 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 721
+ + +GT Y+APE+L ++ D WS G+I++ + G PP
Sbjct: 199 -----------FSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPP 246
Query: 722 FTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 776
F ++ + I + K W + S EA++LI L +D N+R A E
Sbjct: 247 FGGQNDQDIIKKVEKGKYYFDFNDWKNI----SDEAKELIKLMLTYDYNKRC---TAEEA 299
Query: 777 KAHPFFKGVNWDSLALQKAV 796
+ K + +
Sbjct: 300 LNSRWIKKYANNINKSDQKT 319
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 1e-69
Identities = 63/312 (20%), Positives = 122/312 (39%), Gaps = 63/312 (20%)
Query: 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
++ DF+ I+ I G FG+VF A+ R G + IK ++ N+ E+ E L
Sbjct: 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIK------RVKYNN-EKAEREVKAL 58
Query: 550 ITVRNPFVVRFFYSF----------------TCRDNLYLVMEYLNGGDLYSLL--RKVGC 591
+ + +V + + + L++ ME+ + G L + R+
Sbjct: 59 AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118
Query: 592 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651
L++ +A ++ ++Y+HS +++RDLKP N+ + +K+ DFGL + N
Sbjct: 119 LDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS--LKNDG 176
Query: 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 711
R + GT Y++PE + ++G D +++G+I
Sbjct: 177 K--------------------------RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLI 210
Query: 712 LFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGAN 771
L E + TA F ++ + I + + L+ + L P R +
Sbjct: 211 LAELLH--VCDTAFETSKFFTDLRDGII-----SDIFDKKEKTLLQKLLSKKPEDRPNTS 263
Query: 772 GAAEVKAHPFFK 783
E+
Sbjct: 264 ---EILRTLTVW 272
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 2e-69
Identities = 81/306 (26%), Positives = 138/306 (45%), Gaps = 48/306 (15%)
Query: 492 TSIDDF-EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERN 547
+ ++D E+ + + G F V R++ TG +A K +KK + E I E N
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 548 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 607
IL +R+P ++ F + ++ L++E ++GG+L+ L + L ED A ++ +++
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 608 LEYLHSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
+ YLHS I H DLKP+N+++ + IKL DFG++ I +
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK--IEAGNEFKN-------- 170
Query: 664 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 723
GTP+++APEI+ G AD WS+G+I + ++G PF
Sbjct: 171 ------------------IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 212
Query: 724 AESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778
E+ + NI + S A+D I R L+ DP +R+ A+
Sbjct: 213 GETKQETLTNISAVNYDFDEEYFSNT----SELAKDFIRRLLVKDPKRRM---TIAQSLE 265
Query: 779 HPFFKG 784
H + K
Sbjct: 266 HSWIKA 271
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 2e-69
Identities = 85/299 (28%), Positives = 145/299 (48%), Gaps = 36/299 (12%)
Query: 486 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 545
S E+ I ++ ++K I +G F +V LAR TG AIK++ K + ++++ E
Sbjct: 6 SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDK-TQLNPTSLQKLFRE 64
Query: 546 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 605
I+ + +P +V+ F LYL+MEY +GG+++ L G ++E AR ++V
Sbjct: 65 VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV 124
Query: 606 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 665
A++Y H IVHRDLK +NLL+ D +IK+ DFG S
Sbjct: 125 SAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN---------------------- 162
Query: 666 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 724
+ T + G P Y APE+ G + G D WS+G+IL+ ++G PF
Sbjct: 163 ------EFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216
Query: 725 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
++ + + + +L K +P MS + ++L+ RFL+ +P +R ++ +
Sbjct: 217 QNLKELRERVLRGKYR---IPFYMSTDCENLLKRFLVLNPIKRG---TLEQIMKDRWIN 269
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 2e-69
Identities = 77/298 (25%), Positives = 136/298 (45%), Gaps = 43/298 (14%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+++++ + + +GAF V K G +A ++ + D +++ E I +++
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINT-KKLSARDHQKLEREARICRLLKH 69
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
P +VR S + + YL+ + + GG+L+ + E A I +++ A+ + H +
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 615 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
G+VHR+LKP+NLL+A +KL DFGL+
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAI---------------------------E 162
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731
+ + + GTP YL+PE+L +G D W+ G+IL+ + G PPF E ++
Sbjct: 163 VEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY 222
Query: 732 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
I W V + EA+DLIN+ L +P++R+ AAE HP+
Sbjct: 223 QQIKAGAYDFPSPEWDTV----TPEAKDLINKMLTINPSKRI---TAAEALKHPWISH 273
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 2e-69
Identities = 80/316 (25%), Positives = 139/316 (43%), Gaps = 47/316 (14%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERNILIT 551
D ++I + + G F V R+++TG +A K +KK E I E +IL
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 552 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 611
V + V+ + R ++ L++E ++GG+L+ L + L E+ A +I +++ + YL
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 612 HSLGIVHRDLKPDNLLIA----HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
H+ I H DLKP+N+++ HIKL DFGL+ I
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE----------------IEDGVEF 175
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 727
+ GTP+++APEI+ G AD WS+G+I + ++G PF ++
Sbjct: 176 K------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223
Query: 728 EIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
+ NI + + S A+D I + L+ + +RL E HP+
Sbjct: 224 QETLANITSVSYDFDEEFFSHT----SELAKDFIRKLLVKETRKRL---TIQEALRHPWI 276
Query: 783 KGVNWDSLALQKAVFV 798
V+ +++ V
Sbjct: 277 TPVDNQQAMVRRESVV 292
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 4e-69
Identities = 69/337 (20%), Positives = 121/337 (35%), Gaps = 76/337 (22%)
Query: 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 548
+ TS + + + +GA VF R + TGDLFAIKV + +R ++ + E +
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEV 60
Query: 549 LITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAE 603
L + + +V+ F T + L+ME+ G LY++L + L E I + +
Sbjct: 61 LKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120
Query: 604 LVLALEYLHSLGIVHRDLKPDNLLIA----HDGHIKLTDFGLSKIGLINNTIDLSGPETD 659
+V + +L GIVHR++KP N++ KLTDFG ++
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--------------- 165
Query: 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--------LGTEHGYAADWWSVGII 711
D+ S GT +YL P++ ++G D WS+G+
Sbjct: 166 -------------LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212
Query: 712 LFEFITGIPPFTAESPEIIFDNILNRKI--------------------------PWPCVP 745
+ TG PF ++ + I +
Sbjct: 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLS 272
Query: 746 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
+ ++ L D + G + + A
Sbjct: 273 RGLQVLLTPVLANILEADQEKCWGFD---QFFAETSD 306
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 5e-69
Identities = 81/314 (25%), Positives = 131/314 (41%), Gaps = 53/314 (16%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK--LDMIRKNDI----ERILAERNI 548
+++E + + RG V + T +A+K++ ++ E L E +I
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 549 LITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 607
L V P +++ ++ +LV + + G+L+ L + L E R + L+
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
+ LH L IVHRDLKP+N+L+ D +IKLTDFG S
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ----------------------- 173
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEFITGIPP 721
GTP YLAPEI+ + +G D WS G+I++ + G PP
Sbjct: 174 -----LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
Query: 722 FTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV 776
F ++ I++ W S +DL++RFL+ P +R A E
Sbjct: 229 FWHRKQMLMLRMIMSGNYQFGSPEWDDY----SDTVKDLVSRFLVVQPQKRY---TAEEA 281
Query: 777 KAHPFFKGVNWDSL 790
AHPFF+ + +
Sbjct: 282 LAHPFFQQYVVEEV 295
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 230 bits (590), Expect = 6e-69
Identities = 79/316 (25%), Positives = 140/316 (44%), Gaps = 47/316 (14%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERNILIT 551
D ++ + + G F V R+++TG +A K +KK E I E +IL
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 552 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 611
+++P V+ + + ++ L++E + GG+L+ L + L E+ A ++ +++ + YL
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 612 HSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
HSL I H DLKP+N+++ IK+ DFGL+ I +
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK----------------IDFGNEF 174
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 727
+ GTP+++APEI+ G AD WS+G+I + ++G PF ++
Sbjct: 175 ------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 222
Query: 728 EIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
+ N+ + S A+D I R L+ DP +R+ + HP+
Sbjct: 223 QETLANVSAVNYEFEDEYFSNT----SALAKDFIRRLLVKDPKKRM---TIQDSLQHPWI 275
Query: 783 KGVNWDSLALQKAVFV 798
K + +KA V
Sbjct: 276 KPKDTQQALSRKASAV 291
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 7e-69
Identities = 87/303 (28%), Positives = 145/303 (47%), Gaps = 45/303 (14%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-----LDMIRKNDIERILAERNIL 549
D++ + K + GA G V LA +R T AI+++ K + + E IL
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 609
+ +P +++ F ++ Y+V+E + GG+L+ + L+E ++Y +++LA++
Sbjct: 195 KKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 610 YLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
YLH GI+HRDLKP+N+L++ D IK+TDFG SKI
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---------------------- 291
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPPFT 723
+ + GTP YLAPE+L+ A D WS+G+ILF ++G PPF+
Sbjct: 292 ------LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 345
Query: 724 AES-PEIIFDNILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
+ D I + K + +++S +A DL+ + L+ DP R E HP+
Sbjct: 346 EHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF---TTEEALRHPW 402
Query: 782 FKG 784
+
Sbjct: 403 LQD 405
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 8e-69
Identities = 92/326 (28%), Positives = 146/326 (44%), Gaps = 60/326 (18%)
Query: 486 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK--------- 536
S + ++ + + I +G++G V LA +A+KVL K +IR+
Sbjct: 4 GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63
Query: 537 --------------NDIERILAERNILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGG 580
IE++ E IL + +P VV+ D+LY+V E +N G
Sbjct: 64 RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123
Query: 581 DLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 640
+ + L ED AR Y +L+ +EYLH I+HRD+KP NLL+ DGHIK+ DFG
Sbjct: 124 PVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 641 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 700
+S + + + VGTP ++APE L T
Sbjct: 183 VSNE---------------------------FKGSDALLSNTVGTPAFMAPESLSETRKI 215
Query: 701 Y---AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLIN 757
+ A D W++G+ L+ F+ G PF E + I ++ + +P P D++ + +DLI
Sbjct: 216 FSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQP-DIAEDLKDLIT 274
Query: 758 RFLIHDPNQRLGANGAAEVKAHPFFK 783
R L +P R+ E+K HP+
Sbjct: 275 RMLDKNPESRI---VVPEIKLHPWVT 297
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 1e-68
Identities = 95/301 (31%), Positives = 143/301 (47%), Gaps = 49/301 (16%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
D FE+ + RGA V+ +++ T +A+KVLKK D + + E +L+ + +
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKK-----TVDKKIVRTEIGVLLRLSH 107
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
P +++ F + LV+E + GG+L+ + + G E A + +++ A+ YLH
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 615 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
GIVHRDLKP+NLL A D +K+ DFGLSKI E +M
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-----------EHQVLM--------- 207
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE-II 730
+ GTP Y APEIL G +G D WSVGII + + G PF E + +
Sbjct: 208 --------KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM 259
Query: 731 FDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785
F ILN + W V S A+DL+ + ++ DP +RL + HP+ G
Sbjct: 260 FRRILNCEYYFISPWWDEV----SLNAKDLVRKLIVLDPKKRL---TTFQALQHPWVTGK 312
Query: 786 N 786
Sbjct: 313 A 313
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 1e-68
Identities = 91/316 (28%), Positives = 144/316 (45%), Gaps = 53/316 (16%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-----LDMIRKNDIERILAERNIL 549
D++ + K + GA G V LA +R T AIK++ K + + E IL
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 609
+ +P +++ F D Y+V+E + GG+L+ + L+E ++Y +++LA++
Sbjct: 70 KKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 610 YLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
YLH GI+HRDLKP+N+L++ D IK+TDFG SKI
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---------------------- 166
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE---HGYAADWWSVGIILFEFITGIPPFT 723
+ + GTP YLAPE+L+ + A D WS+G+ILF ++G PPF+
Sbjct: 167 ------LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS 220
Query: 724 AES-PEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777
+ D I + K W V S +A DL+ + L+ DP R E
Sbjct: 221 EHRTQVSLKDQITSGKYNFIPEVWAEV----SEKALDLVKKLLVVDPKARF---TTEEAL 273
Query: 778 AHPFFKGVNWDSLALQ 793
HP+ + +
Sbjct: 274 RHPWLQDEDMKRKFQD 289
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 227 bits (582), Expect = 2e-68
Identities = 79/299 (26%), Positives = 139/299 (46%), Gaps = 35/299 (11%)
Query: 486 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 545
S H R I + + + G FG+V + + TG A+K+L + + + + +I E
Sbjct: 2 SKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKRE 61
Query: 546 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 605
L R+P +++ + + + ++VMEY++GG+L+ + K G +EE AR +++
Sbjct: 62 IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL 121
Query: 606 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 665
A++Y H +VHRDLKP+N+L+ + K+ DFGLS +
Sbjct: 122 SAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--------------------- 160
Query: 666 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 724
+D ++ G+P+Y APE++ G G D WS G+IL+ + G PF
Sbjct: 161 -------MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD 213
Query: 725 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
E +F I +P ++ L+ L DP +R +++ H +FK
Sbjct: 214 EHVPTLFKKIRGGVFY---IPEYLNRSVATLLMHMLQVDPLKRA---TIKDIREHEWFK 266
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-68
Identities = 70/298 (23%), Positives = 131/298 (43%), Gaps = 47/298 (15%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ + I + + RG FG V + ++ + K +K + D + E +IL R+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLY-SLLRKVGCLEEDVARIYIAELVLALEYLHS 613
++ SF + L ++ E+++G D++ + L E Y+ ++ AL++LHS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 614 LGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
I H D++P+N++ IK+ +FG ++ + P D
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ----------------LKPGDNF---- 160
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731
P+Y APE+ A D WS+G +++ ++GI PF AE+ + I
Sbjct: 161 --------RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
Query: 732 DNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
+NI+N + + + S EA D ++R L+ + R+ A+E HP+ K
Sbjct: 213 ENIMNAEYTFDEEAFKEI----SIEAMDFVDRLLVKERKSRM---TASEALQHPWLKQ 263
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 3e-68
Identities = 81/324 (25%), Positives = 143/324 (44%), Gaps = 47/324 (14%)
Query: 487 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERIL 543
+ K++ D ++I + + G F V R+++TG +A K +KK E I
Sbjct: 4 TFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIE 63
Query: 544 AERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE 603
E +IL V +P ++ + R ++ L++E ++GG+L+ L + L E+ A +I +
Sbjct: 64 REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQ 123
Query: 604 LVLALEYLHSLGIVHRDLKPDNLLIAH----DGHIKLTDFGLSKIGLINNTIDLSGPETD 659
++ + YLH+ I H DLKP+N+++ HIKL DFGL+
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--------------- 168
Query: 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 719
I + GTP+++APEI+ G AD WS+G+I + ++G
Sbjct: 169 -IEDGVEFK------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215
Query: 720 PPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 774
PF ++ + NI + S A+D I + L+ + +RL
Sbjct: 216 SPFLGDTKQETLANITAVSYDFDEEFFSQT----SELAKDFIRKLLVKETRKRL---TIQ 268
Query: 775 EVKAHPFFKGVNWDSLALQKAVFV 798
E HP+ V+ +++ V
Sbjct: 269 EALRHPWITPVDTQQAMVRRESVV 292
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 9e-68
Identities = 88/347 (25%), Positives = 136/347 (39%), Gaps = 52/347 (14%)
Query: 454 EKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFL 513
+ + + QS G L + ++ I RG V
Sbjct: 53 NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRR 112
Query: 514 ARKRTTGDLFAIKVLKKLDMIRKND-----IERILAERNILITVRN-PFVVRFFYSFTCR 567
R TG FA+K+++ + E E +IL V P ++ S+
Sbjct: 113 CVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS 172
Query: 568 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 627
++LV + + G+L+ L + L E R + L+ A+ +LH+ IVHRDLKP+N+L
Sbjct: 173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENIL 232
Query: 628 IAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPD 687
+ + I+L+DFG S + P + GTP
Sbjct: 233 LDDNMQIRLSDFGFSCH----------------LEPGEKLR------------ELCGTPG 264
Query: 688 YLAPEILLGTE------HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-- 739
YLAPEIL + +G D W+ G+ILF + G PPF ++ I+ +
Sbjct: 265 YLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQF 324
Query: 740 ---PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
W S +DLI+R L DP RL A + HPFF+
Sbjct: 325 SSPEWDDR----SSTVKDLISRLLQVDPEARL---TAEQALQHPFFE 364
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 229 bits (584), Expect = 2e-67
Identities = 45/352 (12%), Positives = 100/352 (28%), Gaps = 87/352 (24%)
Query: 478 SGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN 537
+G + S ER + + A + TG+ F + V + N
Sbjct: 58 TGQPFRVESELGERPR--TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN 115
Query: 538 DIE-------------------------RILAERNILITVRNPFVVRFFYSFTCRD--NL 570
I+ R + +++ + ++R +
Sbjct: 116 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 175
Query: 571 YLVMEYLN------GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 624
+ + + G L S L +++ L LH G+VH L+P
Sbjct: 176 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 235
Query: 625 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 684
++++ G + LT F + R +
Sbjct: 236 DIVLDQRGGVFLTGFEHLV-------------------------------RDGARVVSSV 264
Query: 685 TPDYLAPEILL-----------GTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733
+ + PE+ T ++ D W++G++++ P T ++ +
Sbjct: 265 SRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW 324
Query: 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785
I ++ + L+ FL + RL + P ++ +
Sbjct: 325 IFRS-------CKNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQL 366
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 4e-67
Identities = 84/323 (26%), Positives = 139/323 (43%), Gaps = 55/323 (17%)
Query: 476 QSSGVSTPLHSSHKERTSI-DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 534
Q+ GV + + H+ D +E+ + I G++ + T FA+K++ K
Sbjct: 2 QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK---- 57
Query: 535 RKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 593
K D E IL+ P ++ + +Y+V E + GG+L + +
Sbjct: 58 SKRDPTE---EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFS 114
Query: 594 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH----IKLTDFGLSKIGLINN 649
E A + + +EYLH+ G+VHRDLKP N+L + I++ DFG +K
Sbjct: 115 EREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL---- 170
Query: 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 709
+ +N + T +++APE+L + A D WS+G
Sbjct: 171 -----------------------RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLG 207
Query: 710 IILFEFITGIPPFTA---ESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLI 761
++L+ +TG PF ++PE I I + K W V S A+DL+++ L
Sbjct: 208 VLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV----SDTAKDLVSKMLH 263
Query: 762 HDPNQRLGANGAAEVKAHPFFKG 784
DP+QRL AA V HP+
Sbjct: 264 VDPHQRL---TAALVLRHPWIVH 283
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 225 bits (577), Expect = 5e-67
Identities = 82/328 (25%), Positives = 134/328 (40%), Gaps = 48/328 (14%)
Query: 475 SQSSGVSTPLHSSHKERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM 533
S + T + + + K + RG F V ++TG +A K LKK
Sbjct: 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKK-RR 66
Query: 534 IRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL--RKVG 590
++ IL E +L + P V+ + + L++EY GG+++SL
Sbjct: 67 RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE 126
Query: 591 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLI 647
+ E+ I +++ + YLH IVH DLKP N+L++ G IK+ DFG+S+
Sbjct: 127 MVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--- 183
Query: 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWS 707
I +GTP+YLAPEIL A D W+
Sbjct: 184 ---IG----------------------HACELREIMGTPEYLAPEILNYDPITTATDMWN 218
Query: 708 VGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIH 762
+GII + +T PF E + + NI + + V S A D I L+
Sbjct: 219 IGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSV----SQLATDFIQSLLVK 274
Query: 763 DPNQRLGANGAAEVKAHPFFKGVNWDSL 790
+P +R A +H + + ++++L
Sbjct: 275 NPEKRP---TAEICLSHSWLQQWDFENL 299
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 2e-66
Identities = 68/325 (20%), Positives = 119/325 (36%), Gaps = 73/325 (22%)
Query: 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
+ TS + + + +GA VF R + TGDLFAIKV + +R ++ + E +L
Sbjct: 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVL 61
Query: 550 ITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEEDVARIYIAEL 604
+ + +V+ F T + L+ME+ G LY++L + L E I + ++
Sbjct: 62 KKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDV 121
Query: 605 VLALEYLHSLGIVHRDLKPDNLLIA----HDGHIKLTDFGLSKIGLINNTIDLSGPETDG 660
V + +L GIVHR++KP N++ KLTDFG ++
Sbjct: 122 VGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE---------------- 165
Query: 661 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--------LGTEHGYAADWWSVGIIL 712
D+ S GT +YL P++ ++G D WS+G+
Sbjct: 166 ------------LEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTF 213
Query: 713 FEFITGIPPFTAESPEIIFDNILNRKI--------------------------PWPCVPS 746
+ TG PF ++ + I +
Sbjct: 214 YHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSR 273
Query: 747 DMSFEAQDLINRFLIHDPNQRLGAN 771
+ ++ L D + G +
Sbjct: 274 GLQVLLTPVLANILEADQEKCWGFD 298
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 5e-66
Identities = 82/334 (24%), Positives = 135/334 (40%), Gaps = 56/334 (16%)
Query: 501 KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVR 559
KP+ G+F + + FA+K+ I K E L P +V+
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKI------ISKRMEANTQKEITALKLCEGHPNIVK 70
Query: 560 FFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHR 619
F + + +LVME LNGG+L+ ++K E A + +LV A+ ++H +G+VHR
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 620 DLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 676
DLKP+NLL + IK+ DFG +++ + DN
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARL---------------------------KPPDN 163
Query: 677 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE-------SPEI 729
+ + T Y APE+L + + D WS+G+IL+ ++G PF + S
Sbjct: 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVE 223
Query: 730 IFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
I I W V S EA+DLI L DPN+RL + ++ + + +
Sbjct: 224 IMKKIKKGDFSFEGEAWKNV----SQEAKDLIQGLLTVDPNKRL---KMSGLRYNEWLQD 276
Query: 785 VNWDSLALQKAVFVPQPESVDDTSYFLSRFSQIS 818
+ S + + + F +
Sbjct: 277 GSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFN 310
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 5e-66
Identities = 71/340 (20%), Positives = 138/340 (40%), Gaps = 47/340 (13%)
Query: 454 EKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDD-FEIIKPISRGAFGRVF 512
KY D + ++ S+ D ++I++ + GAFG V
Sbjct: 9 HHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVH 68
Query: 513 LARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572
++ TG +F K + + K ++ E +I+ + +P ++ +F + + L
Sbjct: 69 RCVEKATGRVFVAKFINTPYPLDKYTVKN---EISIMNQLHHPKLINLHDAFEDKYEMVL 125
Query: 573 VMEYLNGGDLY-SLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH- 630
++E+L+GG+L+ + + + E Y+ + L+++H IVH D+KP+N++
Sbjct: 126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK 185
Query: 631 -DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYL 689
+K+ DFGL+ + P + T ++
Sbjct: 186 KASSVKIIDFGLATK----------------LNPDEIV------------KVTTATAEFA 217
Query: 690 APEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPCV 744
APEI+ G+ D W++G++ + ++G+ PF E N+ + V
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 277
Query: 745 PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
S EA+D I L +P +RL + HP+ KG
Sbjct: 278 ----SPEAKDFIKNLLQKEPRKRL---TVHDALEHPWLKG 310
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 1e-65
Identities = 74/295 (25%), Positives = 136/295 (46%), Gaps = 39/295 (13%)
Query: 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 553
++D+++++ + GA+G V LA R T + A+K++ + + E I E I +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 613
+ VV+F+ + YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
+GI HRD+KP+NLL+ ++K++DFGL+ + NN L
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-------------------- 163
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF-TAESPEIIF 731
+ GT Y+APE+L E H D WS GI+L + G P+ +
Sbjct: 164 -----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
Query: 732 DNILNRK---IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+ +K PW + L+++ L+ +P+ R+ ++K ++
Sbjct: 219 SDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYN 266
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 4e-65
Identities = 75/343 (21%), Positives = 140/343 (40%), Gaps = 47/343 (13%)
Query: 453 DEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDD-FEIIKPISRGAFGRV 511
D + K D+ + + D ++I + + GAFG V
Sbjct: 114 DVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVV 173
Query: 512 FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571
+R TG+ FA K + ++D E + E + +R+P +V +F + +
Sbjct: 174 HRVTERATGNNFAAKFVMT---PHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230
Query: 572 LVMEYLNGGDLYS-LLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH 630
++ E+++GG+L+ + + + ED A Y+ ++ L ++H VH DLKP+N++
Sbjct: 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290
Query: 631 --DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDY 688
+KL DFGL+ ++ GT ++
Sbjct: 291 KRSNELKLIDFGLTA----------------------------HLDPKQSVKVTTGTAEF 322
Query: 689 LAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI-----PWPC 743
APE+ G GY D WSVG++ + ++G+ PF E+ + N+ + +
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 382
Query: 744 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786
+ S + +D I + L+ DPN R+ + HP+ N
Sbjct: 383 I----SEDGKDFIRKLLLADPNTRM---TIHQALEHPWLTPGN 418
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 4e-65
Identities = 83/339 (24%), Positives = 133/339 (39%), Gaps = 52/339 (15%)
Query: 477 SSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK---LDM 533
G TP ++ + + +G FG VF + T AIKV+ + L
Sbjct: 13 PPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGW 72
Query: 534 IRKNDIERILAERNILITVRN----PFVVRFFYSFTCRDNLYLVMEY-LNGGDLYSLLRK 588
+D E +L V P V+R F ++ LV+E L DL+ + +
Sbjct: 73 SPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE 132
Query: 589 VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLI 647
G L E +R + ++V A+++ HS G+VHRD+K +N+LI G KL DFG +
Sbjct: 133 KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL--- 189
Query: 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWW 706
D Y GT Y PE + + H A W
Sbjct: 190 ---------------LHDEPY-----------TDFDGTRVYSPPEWISRHQYHALPATVW 223
Query: 707 SVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 766
S+GI+L++ + G PF + IL ++ P+ +S + LI R L P+
Sbjct: 224 SLGILLYDMVCGDIPFERD------QEILEAELH---FPAHVSPDCCALIRRCLAPKPSS 274
Query: 767 RLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVD 805
R E+ P+ + + + L + P P +
Sbjct: 275 RP---SLEEILLDPWMQ-TPAEDVPLNPSKGGPAPLAWS 309
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 6e-65
Identities = 77/339 (22%), Positives = 136/339 (40%), Gaps = 48/339 (14%)
Query: 473 SVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-- 530
++ + + E + + P+ GAFG V+ A + +K +KK
Sbjct: 2 ALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEK 61
Query: 531 ---LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME-YLNGGDLYSLL 586
I + ++ E IL V + +++ F + LVME + +G DL++ +
Sbjct: 62 VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI 121
Query: 587 RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646
+ L+E +A +LV A+ YL I+HRD+K +N++IA D IKL DFG +
Sbjct: 122 DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY-- 179
Query: 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADW 705
+ ++ GT +Y APE+L+G G +
Sbjct: 180 --------------------------LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEM 213
Query: 706 WSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPN 765
WS+G+ L+ + PF + + I P +S E L++ L P
Sbjct: 214 WSLGVTLYTLVFEENPFCE------LEETVEAAIH---PPYLVSKELMSLVSGLLQPVPE 264
Query: 766 QRLGANGAAEVKAHPFF-KGVNWDSLALQKAVFVPQPES 803
+R ++ P+ + VN ++ V +PES
Sbjct: 265 RRT---TLEKLVTDPWVTQPVNLADYTWEEVFRVNKPES 300
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 8e-65
Identities = 68/300 (22%), Positives = 120/300 (40%), Gaps = 36/300 (12%)
Query: 486 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 545
++ R + + RG+FG V + + TG A+K ++ L++ R ++
Sbjct: 49 VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR-LEVFRVEELV----- 102
Query: 546 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 605
+ +P +V + + + + ME L GG L L++++GCL ED A Y+ + +
Sbjct: 103 --ACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160
Query: 606 LALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 664
LEYLH+ I+H D+K DN+L++ DG L DFG + L +
Sbjct: 161 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC--------LQPDGLGKSLL- 211
Query: 665 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 724
GT ++APE+++G D WS ++ + G P+T
Sbjct: 212 -------------TGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQ 258
Query: 725 ESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+ I + P +P + I L +P R A E++
Sbjct: 259 YFRGPLCL-KIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA---SAMELRRKVGKA 314
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 1e-64
Identities = 69/302 (22%), Positives = 138/302 (45%), Gaps = 46/302 (15%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
+ + G FG+V + TG A K++K D E + E +++ + +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT---RGMKDKEEVKNEISVMNQLDHA 146
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLY-SLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
+++ + +F ++++ LVMEY++GG+L+ ++ + L E +++ ++ + ++H +
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 615 GIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
I+H DLKP+N+L + IK+ DFGL++
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARR---------------------------- 238
Query: 673 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732
GTP++LAPE++ + D WSVG+I + ++G+ PF ++ +
Sbjct: 239 YKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN 298
Query: 733 NILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 787
NIL + + + S EA++ I++ LI + + R+ A+E HP+
Sbjct: 299 NILACRWDLEDEEFQDI----SEEAKEFISKLLIKEKSWRI---SASEALKHPWLSDHKL 351
Query: 788 DS 789
S
Sbjct: 352 HS 353
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 2e-64
Identities = 81/348 (23%), Positives = 150/348 (43%), Gaps = 42/348 (12%)
Query: 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 553
++D+++++ + GA+G V LA R T + A+K++ + + E I E I +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 613
+ VV+F+ + YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 64 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
+GI HRD+KP+NLL+ ++K++DFGL+ + NN L
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL-------------------- 163
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF--TAESPEII 730
+ GT Y+APE+L E H D WS GI+L + G P+ ++S +
Sbjct: 164 -----LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 218
Query: 731 FDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF-KGVNW 787
D PW + L+++ L+ +P+ R+ ++K ++ K +
Sbjct: 219 SDWKEKKTYLNPW----KKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYNKPLKK 271
Query: 788 DSL--ALQKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDAD 833
+ + P FS ++S +G +
Sbjct: 272 GAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRTPGSGWSKEHH 319
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 3e-64
Identities = 77/320 (24%), Positives = 133/320 (41%), Gaps = 49/320 (15%)
Query: 475 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK---L 531
+ +T L ++ +++ + G FG V+ + + AIK ++K
Sbjct: 23 PCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRIS 82
Query: 532 DMIRKNDIERILAERNILITVRN--PFVVRFFYSFTCRDNLYLVMEYLNG-GDLYSLLRK 588
D + R+ E +L V + V+R F D+ L++E DL+ + +
Sbjct: 83 DWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITE 142
Query: 589 VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLI 647
G L+E++AR + +++ A+ + H+ G++HRD+K +N+LI + G +KL DFG +
Sbjct: 143 RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL--- 199
Query: 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWW 706
D Y GT Y PE + HG +A W
Sbjct: 200 ---------------LKDTVY-----------TDFDGTRVYSPPEWIRYHRYHGRSAAVW 233
Query: 707 SVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 766
S+GI+L++ + G PF E E I + +S E Q LI L P+
Sbjct: 234 SLGILLYDMVCGDIPF--EHDEEIIRGQVF-------FRQRVSSECQHLIRWCLALRPSD 284
Query: 767 RLGANGAAEVKAHPFFKGVN 786
R E++ HP+ + V
Sbjct: 285 RP---TFEEIQNHPWMQDVL 301
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 5e-64
Identities = 83/296 (28%), Positives = 143/296 (48%), Gaps = 36/296 (12%)
Query: 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 548
+ I + I + + G+FG+V LA T A+K + + + + + R+ E +
Sbjct: 3 ISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISY 62
Query: 549 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 608
L +R+P +++ + T ++ +V+EY GG+L+ + + + ED R + +++ A+
Sbjct: 63 LKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
EY H IVHRDLKP+NLL+ + ++K+ DFGLS I
Sbjct: 122 EYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI------------------------ 157
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESP 727
TD ++ G+P+Y APE++ G G D WS GI+L+ + G PF E
Sbjct: 158 ----MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213
Query: 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+F + + +P +S AQ LI R ++ DP QR+ E++ P+F
Sbjct: 214 PNLFKKVNSCVYV---MPDFLSPGAQSLIRRMIVADPMQRI---TIQEIRRDPWFN 263
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 8e-64
Identities = 103/394 (26%), Positives = 165/394 (41%), Gaps = 52/394 (13%)
Query: 474 VSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM 533
+ ++ + PL D ++ +K I G FG L R + T +L A+K +++
Sbjct: 1 MDRAPVTTGPLDMPIMHD--SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA 58
Query: 534 IRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLE 593
I +N ++R E ++R+P +VRF +L ++MEY +GG+LY + G
Sbjct: 59 IDEN-VQR---EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFS 114
Query: 594 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIGLINNTI 651
ED AR + +L+ + Y HS+ I HRDLK +N L+ + +K+ DFG SK
Sbjct: 115 EDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS------- 167
Query: 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGI 710
P S VGTP Y+APE+LL E G AD WS G+
Sbjct: 168 -----SVLHSQP----------------KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGV 206
Query: 711 ILFEFITGIPPFTAESPEIIFDNILNR------KIPWPCVPSDMSFEAQDLINRFLIHDP 764
L+ + G PF + + R IP +S E LI+R + DP
Sbjct: 207 TLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP---DDIRISPECCHLISRIFVADP 263
Query: 765 NQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISS--GLP 822
R+ E+K H +F N + + ++ Q + + L QI S +P
Sbjct: 264 ATRI---SIPEIKTHSWFL-KNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIP 319
Query: 823 DDQNGSYSDADTCDSSSNSRTEMDECGDLAEFGS 856
+N D T + + + + + S
Sbjct: 320 AVRNRCLDDFMTDNLDLDDDMDDFDSESEIDIDS 353
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 8e-64
Identities = 68/300 (22%), Positives = 117/300 (39%), Gaps = 37/300 (12%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 553
+F ++ I G FG VF KR G ++AIK KK D + L E + +
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQ 69
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL----RKVGCLEEDVARIYIAELVLALE 609
+ VVR+F ++ D++ + EY NGG L + R + +E + + ++ L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI-----DLSGPETDGIMPS 664
Y+HS+ +VH D+KP N+ I+ + +N + DL G +
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL------GHV-- 181
Query: 665 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFT 723
T + G +LA E+L H AD +++ + + P
Sbjct: 182 ---------TRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR 232
Query: 724 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+ I R+ P +P +S E +L+ + DP +R A + H
Sbjct: 233 NGDQ---WHEI--RQGRLPRIPQVLSQEFTELLKVMIHPDPERRP---SAMALVKHSVLL 284
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 1e-63
Identities = 63/378 (16%), Positives = 105/378 (27%), Gaps = 77/378 (20%)
Query: 450 ELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSID----DFEIIKPISR 505
+LL + +E + V + P ++ + + ++++P+
Sbjct: 13 DLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRV 72
Query: 506 GAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF---- 561
G VFL R + FA+KV ++++ER+ +
Sbjct: 73 GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132
Query: 562 ----------------------YSFTCRDNLYLVMEYLNG--GDLYSLLRKV----GCLE 593
N L+M + L+S L V G
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192
Query: 594 EDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653
I A+L+ L S G+VH PDNL I DG + L D
Sbjct: 193 ILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW---------- 242
Query: 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGII 711
++ Y E L +A + W +G+
Sbjct: 243 --------------------KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLS 282
Query: 712 LFEFITGIPPFTAESPEIIFDNILN-----RKIPWP-CVPSDMSFEAQDLINRFLIHDPN 765
++ PF +P I + + + LI RFL D
Sbjct: 283 IYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRR 342
Query: 766 QRLGANGAAEVKAHPFFK 783
+RL E P F
Sbjct: 343 RRL---LPLEAMETPEFL 357
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 2e-63
Identities = 75/299 (25%), Positives = 138/299 (46%), Gaps = 35/299 (11%)
Query: 486 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 545
H R I + + + G FG+V + + TG A+K+L + + + + +I E
Sbjct: 7 QKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRRE 66
Query: 546 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 605
L R+P +++ + + ++++VMEY++GG+L+ + K G L+E +R +++
Sbjct: 67 IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL 126
Query: 606 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 665
++Y H +VHRDLKP+N+L+ + K+ DFGLS +
Sbjct: 127 SGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--------------------- 165
Query: 666 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 724
+D ++ G+P+Y APE++ G G D WS G+IL+ + G PF
Sbjct: 166 -------MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDD 218
Query: 725 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+ +F I + P ++ L+ L DP +R +++ H +FK
Sbjct: 219 DHVPTLFKKICDGIFY---TPQYLNPSVISLLKHMLQVDPMKRA---TIKDIREHEWFK 271
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 6e-63
Identities = 77/335 (22%), Positives = 124/335 (37%), Gaps = 66/335 (19%)
Query: 485 HSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA 544
S + +E+ + + G FG V + TG+ AIK ++ ++ KN ER
Sbjct: 4 RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQ-ELSPKN-RERWCL 61
Query: 545 ERNILITVRNPFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVG---CLEED 595
E I+ + +P VV D L MEY GGDL L + L+E
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG 121
Query: 596 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTID 652
R ++++ AL YLH I+HRDLKP+N+++ K+ D G +K
Sbjct: 122 PIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE-------- 173
Query: 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 712
VGT YLAPE+L ++ D+WS G +
Sbjct: 174 --------------------LDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLA 213
Query: 713 FEFITGIPPFTAESPEIIFDNILNRK--------------------IPWPC-VPSDMSFE 751
FE ITG PF + + + K +P P + ++ +
Sbjct: 214 FECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGK 273
Query: 752 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786
+ + L+ QR + F+ ++
Sbjct: 274 LERWLQCMLMWHQRQR---GTDPQNPNVGCFQALD 305
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 217 bits (553), Expect = 8e-63
Identities = 50/368 (13%), Positives = 102/368 (27%), Gaps = 76/368 (20%)
Query: 478 SGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN 537
+G + S ER + + A + TG+ F + V + N
Sbjct: 63 TGQPFRVESELGERPR--TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSN 120
Query: 538 DIERILAERNI---LITVRNP------------------------FVVRFFYSFTCRDNL 570
I+++ E L ++N VR +
Sbjct: 121 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR 180
Query: 571 YLVMEYLNG------GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 624
+ + + L S L +++ L LH G+VH L+P
Sbjct: 181 FFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPV 240
Query: 625 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 684
++++ G + LT F + P
Sbjct: 241 DIVLDQRGGVFLTGFEHLVR-----------DGASAVSPI---------------GRGFA 274
Query: 685 TPDYLAPEILLGTEHG-----YAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI 739
P+ A +L +H +A D W++G+ ++ P T ++ + I
Sbjct: 275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRS-- 332
Query: 740 PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVP 799
++ + L+ FL + RL + P ++ + + A
Sbjct: 333 -----CKNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQLRTELSAALPLYQTD 384
Query: 800 QPESVDDT 807
+ +
Sbjct: 385 GEPTREGG 392
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 1e-62
Identities = 82/320 (25%), Positives = 139/320 (43%), Gaps = 60/320 (18%)
Query: 495 DDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 553
D +++ + + GA RV T +A+K+++K ++ + R E +L +
Sbjct: 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQ 68
Query: 554 N-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 612
V+ F D YLV E + GG + S + K E A + + ++ AL++LH
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 613 SLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 669
+ GI HRDLKP+N+L H +K+ DF L I L+G +
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG------IKLNGDCSP---------- 172
Query: 670 EYQQTDNRNRHSAVGTPDYLAPEILLG-----TEHGYAADWWSVGIILFEFITGIPPFTA 724
+ G+ +Y+APE++ + + D WS+G+IL+ ++G PPF
Sbjct: 173 ----ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG 228
Query: 725 E---------------SPEIIFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDP 764
++F++I K W + S A+DLI++ L+ D
Sbjct: 229 RCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHI----SCAAKDLISKLLVRDA 284
Query: 765 NQRLGANGAAEVKAHPFFKG 784
QRL AA+V HP+ +G
Sbjct: 285 KQRL---SAAQVLQHPWVQG 301
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-62
Identities = 74/297 (24%), Positives = 130/297 (43%), Gaps = 39/297 (13%)
Query: 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE-RILAERNILITV 552
I + + + G++G+V T A+K+LKK + R + E + E +L +
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 553 RNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLAL 608
R+ V++ + +Y+VMEY G + +L V A Y +L+ L
Sbjct: 64 RHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
EYLHS GIVH+D+KP NLL+ G +K++ G++ +
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA------EALH---------------- 160
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTE--HGYAADWWSVGIILFEFITGIPPFTAES 726
+ ++ G+P + PEI G + G+ D WS G+ L+ TG+ PF ++
Sbjct: 161 ---PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217
Query: 727 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+F+NI +P D DL+ L ++P +R +++ H +F+
Sbjct: 218 IYKLFENIGKGSYA---IPGDCGPPLSDLLKGMLEYEPAKRF---SIRQIRQHSWFR 268
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 1e-61
Identities = 57/299 (19%), Positives = 103/299 (34%), Gaps = 37/299 (12%)
Query: 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
+ I+ + G F V L G +A+K + + D E E ++ +P
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLFNHP 86
Query: 556 FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLA 607
++R +L++ + G L++ + ++ L ED + +
Sbjct: 87 NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
LE +H+ G HRDLKP N+L+ +G L D G + +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ---------------ACIHVEGS 191
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEFITGIPPFTA 724
D + T Y APE+ H D WS+G +L+ + G P+
Sbjct: 192 RQALTLQDWAAQR---CTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248
Query: 725 ESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
+ + ++ P S L+N + DP+QR + +
Sbjct: 249 VFQKGDSVALAVQNQLSIP-QSPRHSSALWQLLNSMMTVDPHQRPHIP---LLLSQLEA 303
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-61
Identities = 83/330 (25%), Positives = 136/330 (41%), Gaps = 67/330 (20%)
Query: 477 SSGVSTPLHSSHKERTSI-DDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 534
SSG+ ++ ++ DD+++ K + G G+V R TG A+K+L
Sbjct: 9 SSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA 68
Query: 535 RKNDIERILAERNILITVRN-PFVVRFFYSF----TCRDNLYLVMEYLNGGDLYS--LLR 587
R+ E + P +V + + L ++ME + GG+L+S R
Sbjct: 69 RQ--------EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER 120
Query: 588 KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKI 644
E A + ++ A+++LHS I HRD+KP+NLL D +KLTDFG +K
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180
Query: 645 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 704
T + TP Y+APE+L ++ + D
Sbjct: 181 -----------------------------TTQNALQTPCYTPYYVAPEVLGPEKYDKSCD 211
Query: 705 WWSVGIILFEFITGIPPFTAESPEIIFDNILNRKI----------PWPCVPSDMSFEAQD 754
WS+G+I++ + G PPF + + + I + R+I W V S +A+
Sbjct: 212 MWSLGVIMYILLCGFPPFYSNTGQAISPGMK-RRIRLGQYGFPNPEWSEV----SEDAKQ 266
Query: 755 LINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
LI L DP +RL + HP+
Sbjct: 267 LIRLLLKTDPTERL---TITQFMNHPWINQ 293
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 3e-60
Identities = 86/289 (29%), Positives = 134/289 (46%), Gaps = 43/289 (14%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
+ +G +G V+ R + AIK + + D + + E + +++ +V++
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 563 SFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLE--EDVARIYIAELVLALEYLHSLGIVHR 619
SF+ + + ME + GG L +LLR K G L+ E Y +++ L+YLH IVHR
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 620 DLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN 678
D+K DN+LI + G +K++DFG SK L+G N
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKR--------LAG-------------------INPC 179
Query: 679 RHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPFT--AESPEIIFDNI 734
+ GT Y+APEI+ GY AAD WS+G + E TG PPF E +F +
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KV 238
Query: 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
K+ P +P MS EA+ I + DP++R A ++ F K
Sbjct: 239 GMFKVH-PEIPESMSAEAKAFILKCFEPDPDKRA---CANDLLVDEFLK 283
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 7e-60
Identities = 47/336 (13%), Positives = 94/336 (27%), Gaps = 76/336 (22%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
+ + GAF +V+ A + F +KV K + L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP---ANPWEFYIGTQLMERL 121
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG-----CLEEDVARIYIAEL 604
++F+ + ++ LV E + G L + + + + + + +
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 605 VLALEYLHSLGIVHRDLKPDNLLIAH-----------DGHIKLTDFGLSKIGLINNTIDL 653
+ +E +H I+H D+KPDN ++ + + L D G S ID+
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS--------IDM 233
Query: 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILF 713
I + T + E+L Y D++ V ++
Sbjct: 234 KLFPKGTIF-----------------TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVY 276
Query: 714 EFITGIPPFTAESPEI------------------IFDNILNRKIPWPCVPSDMSFEAQDL 755
+ G F +LN +P + DL
Sbjct: 277 CMLFGTYMKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLN-------IPDCHHLPSLDL 329
Query: 756 INRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 791
+ + L Q + + +
Sbjct: 330 LRQKLKKVFQQHYTNKI--RALRNRLIVLLLECKRS 363
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-59
Identities = 84/349 (24%), Positives = 138/349 (39%), Gaps = 63/349 (18%)
Query: 456 SPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEII-KPISRGAFGRVFLA 514
P + + ++ Q K+ IDD+++ + + G G+V
Sbjct: 22 QPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQI 81
Query: 515 RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRF--FY--SFTCRDN 569
+ T + FA+K+L+ R+ E + P +VR Y + R
Sbjct: 82 FNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCPHIVRIVDVYENLYAGRKC 133
Query: 570 LYLVMEYLNGGDLYS--LLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 627
L +VME L+GG+L+S R E A + + A++YLHS+ I HRD+KP+NLL
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLL 193
Query: 628 IAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVG 684
+ +KLTDFG +K + + +
Sbjct: 194 YTSKRPNAILKLTDFGFAKE-----------TTSHNSL-----------------TTPCY 225
Query: 685 TPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI----IFDNILNRKI- 739
TP Y+APE+L ++ + D WS+G+I++ + G PPF + + I +
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 285
Query: 740 ----PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
W V S E + LI L +P QR+ E HP+
Sbjct: 286 FPNPEWSEV----SEEVKMLIRNLLKTEPTQRM---TITEFMNHPWIMQ 327
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 8e-58
Identities = 59/288 (20%), Positives = 120/288 (41%), Gaps = 41/288 (14%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562
I RG+F V+ T A L+ + K++ +R E +L +++P +VRF+
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQ-DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 563 SFTC----RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--I 616
S+ + + LV E + G L + L++ ++ V R + +++ L++LH+ I
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 617 VHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
+HRDLK DN+ I G +K+ D GL+
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLAT-----------------------------LKR 183
Query: 676 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 735
+ +GTP+++APE + ++ + D ++ G+ + E T P++ +
Sbjct: 184 ASFAKAVIGTPEFMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV 242
Query: 736 NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+ E +++I + + ++R ++ H FF+
Sbjct: 243 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFFQ 287
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 2e-57
Identities = 66/349 (18%), Positives = 123/349 (35%), Gaps = 80/349 (22%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFA-------------------IKVLKKLD--- 532
DFE I+ + RG FG VF A+ + +A +K L KL+
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 533 ---------------------------------MIRKNDIERILAERNILITVRNPFVVR 559
+ + ++ + + V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 560 FFYSFTCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVLALEYLHSLGI 616
+ + LY+ M+ +L + + + E V ++ A+E+LHS G+
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 617 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 676
+HRDLKP N+ D +K+ DFGL ++ + T
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTA--MDQDEEEQTVLTP-------------MPAY 230
Query: 677 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 736
VGT Y++PE + G + + D +S+G+ILFE + T I ++
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY--SFSTQMERVRIITDV-- 286
Query: 737 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785
R + +P + + + ++ L P +R A ++ + F+ +
Sbjct: 287 RNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEAT---DIIENAIFENL 332
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 7e-57
Identities = 85/314 (27%), Positives = 139/314 (44%), Gaps = 43/314 (13%)
Query: 486 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 545
S+ + DD+E+ + I GA V A + AIK + L+ + ++ +L E
Sbjct: 6 SALPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN-LEKCQ-TSMDELLKE 63
Query: 546 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--------KVGCLEEDVA 597
+ +P +V ++ SF +D L+LVM+ L+GG + +++ K G L+E
Sbjct: 64 IQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTI 123
Query: 598 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 657
+ E++ LEYLH G +HRD+K N+L+ DG +++ DFG+S + D
Sbjct: 124 ATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS--AFLATGGD----- 176
Query: 658 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPE-ILLGTEHGYAADWWSVGIILFEFI 716
T N+ R + VGTP ++APE + + + AD WS GI E
Sbjct: 177 ---------------ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221
Query: 717 TGIPPFTAESPEIIFDNILNRKIP-------WPCVPSDMSFEAQDLINRFLIHDPNQRLG 769
TG P+ P + L P + + +I+ L DP +R
Sbjct: 222 TGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP- 280
Query: 770 ANGAAEVKAHPFFK 783
AAE+ H FF+
Sbjct: 281 --TAAELLRHKFFQ 292
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 3e-56
Identities = 67/310 (21%), Positives = 103/310 (33%), Gaps = 46/310 (14%)
Query: 486 SSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE 545
+ F + GA G + A+K I E
Sbjct: 15 ETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKR------ILPECFSFADRE 67
Query: 546 RNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAE 603
+L P V+R+F + R Y+ +E L + +K + +
Sbjct: 68 VQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQ 126
Query: 604 LVLALEYLHSLGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIGLINNTIDLSGPET 658
L +LHSL IVHRDLKP N+LI+ ++DFGL K
Sbjct: 127 TTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK--------------- 171
Query: 659 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH---GYAADWWSVGIILFEF 715
+ + +R R GT ++APE+L Y D +S G + +
Sbjct: 172 --------KLAVGRHSFSR-RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
Query: 716 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAA 774
I+ G PF + + A++LI + + DP +R A
Sbjct: 223 ISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP---SAK 279
Query: 775 EVKAHPFFKG 784
V HPFF
Sbjct: 280 HVLKHPFFWS 289
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 4e-56
Identities = 81/290 (27%), Positives = 142/290 (48%), Gaps = 36/290 (12%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ I G+ G V LAR++ +G A+K++ D+ ++ E + E I+ ++
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMM---DLRKQQRRELLFNEVVIMRDYQH 101
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
VV + S+ + L+++ME+L GG L ++ +V EE +A + ++ AL YLH+
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATV-CEAVLQALAYLHAQ 160
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
G++HRD+K D++L+ DG +KL+DFG Q +
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCA----------------------------QIS 192
Query: 675 DNRN-RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733
+ R S VGTP ++APE++ + + D WS+GI++ E + G PP+ ++SP
Sbjct: 193 KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252
Query: 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+ + P +S +D + R L+ DP +R A E+ HPF
Sbjct: 253 LRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERA---TAQELLDHPFLL 299
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 8e-56
Identities = 89/290 (30%), Positives = 139/290 (47%), Gaps = 36/290 (12%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ + I +GA G V+ A TG AI+ ++++ ++ E I+ E ++ +N
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIR---QMNLQQQPKKELIINEILVMRENKN 76
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
P +V + S+ D L++VMEYL GG L ++ + E +A + E + ALE+LHS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAV-CRECLQALEFLHSN 135
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
++HRD+K DN+L+ DG +KLTDFG Q T
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCA----------------------------QIT 167
Query: 675 DNRN-RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733
++ R + VGTP ++APE++ +G D WS+GI+ E I G PP+ E+P
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
Query: 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
I P P +S +D +NR L D +R A E+ H F K
Sbjct: 228 IATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAK---ELLQHQFLK 274
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 1e-55
Identities = 70/323 (21%), Positives = 124/323 (38%), Gaps = 65/323 (20%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ K + G+ G V G A+K + + + L E +L +
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKR------MLIDFCDIALMEIKLLTESDD 67
Query: 555 -PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-------ARIYIAELVL 606
P V+R++ S T LY+ +E +L L+ +E++ + ++
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAH-------------DGHIKLTDFGLSKIGLINNTIDL 653
+ +LHSL I+HRDLKP N+L++ + I ++DFGL K
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK--------- 177
Query: 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-------GYAADWW 706
Q + N ++ GT + APE+L + + + D +
Sbjct: 178 --------------LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223
Query: 707 SVGIILFEFIT-GIPPFTAESPEI--IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHD 763
S+G + + ++ G PF + I I + + EA DLI++ + HD
Sbjct: 224 SMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD 283
Query: 764 PNQRLGANGAAEVKAHPFFKGVN 786
P +R A +V HP F +
Sbjct: 284 PLKRP---TAMKVLRHPLFWPKS 303
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 3e-55
Identities = 83/290 (28%), Positives = 141/290 (48%), Gaps = 37/290 (12%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ F ++ I +G+FG VF T + AIK++ L+ +++IE I E +L +
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEA-EDEIEDIQQEITVLSQCDS 79
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
P+V +++ S+ L+++MEYL GG LL G L+E + E++ L+YLHS
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSE 138
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
+HRD+K N+L++ G +KL DFG++ G + +T
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQI---------------------- 174
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIFDN 733
R++ VGTP ++APE++ + + AD WS+GI E G PP + P +++F
Sbjct: 175 ---KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-- 229
Query: 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
L K P + + S ++ + L +P+ R A E+ H F
Sbjct: 230 -LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRP---TAKELLKHKFIL 275
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 9e-55
Identities = 76/321 (23%), Positives = 135/321 (42%), Gaps = 43/321 (13%)
Query: 471 LDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK 530
S + +G T + + I+D E + + G G+V+ R R TG + A+K ++
Sbjct: 3 SGSSGKQTGYLTI--GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR- 59
Query: 531 LDMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV 589
K + +RIL + ++++ + P++V+ F +F ++++ ME + R
Sbjct: 60 RS-GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ 118
Query: 590 GCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648
G + E + +V AL YL G++HRD+KP N+L+ G IKL DFG+S
Sbjct: 119 GPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISG----- 173
Query: 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL-----LGTEHGYAA 703
+ D++ + + G Y+APE + ++ A
Sbjct: 174 -----------------------RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRA 210
Query: 704 DWWSVGIILFEFITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIH 762
D WS+GI L E TG P+ + + +L + P S + Q + L
Sbjct: 211 DVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTK 270
Query: 763 DPNQRLGANGAAEVKAHPFFK 783
D +R ++ H F K
Sbjct: 271 DHRKRP---KYNKLLEHSFIK 288
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 4e-54
Identities = 84/298 (28%), Positives = 145/298 (48%), Gaps = 41/298 (13%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ +EI+ + GAFG+V+ A+ + TG L A KV+ + + ++E + E IL T +
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATCDH 75
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 613
P++V+ ++ L++++E+ GG + +++ ++ L E ++ +++ AL +LHS
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
I+HRDLK N+L+ +G I+L DFG+S T+
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVS--AKNLKTLQ--------------------- 172
Query: 674 TDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESP- 727
R S +GTP ++APE+++ T + Y AD WS+GI L E PP +P
Sbjct: 173 ----KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM 228
Query: 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785
++ I P PS S E +D + L +P R AA++ HPF +
Sbjct: 229 RVLL-KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRP---SAAQLLEHPFVSSI 282
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 7e-53
Identities = 76/316 (24%), Positives = 120/316 (37%), Gaps = 84/316 (26%)
Query: 489 KERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN 547
K+ IDD+++ + + G G+V + T + FA+K+L+ R+ E
Sbjct: 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVE 62
Query: 548 ILITVRN-PFVVRFFYSF----TCRDNLYLVMEYLNGGDLYS--LLRKVGCLEEDVARIY 600
+ P +VR + R L +VME L+GG+L+S R E A
Sbjct: 63 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122
Query: 601 IAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPE 657
+ + A++YLHS+ I HRD+KP+NLL + +KLTDFG
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG----------------- 165
Query: 658 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 717
A E G ++ + D WS+G+I++ +
Sbjct: 166 -------------------------------FAKET-TGEKYDKSCDMWSLGVIMYILLC 193
Query: 718 GIPPFTAESPEI----IFDNILNRKI-----PWPCVPSDMSFEAQDLINRFLIHDPNQRL 768
G PPF + + I + W V S E + LI L +P QR+
Sbjct: 194 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV----SEEVKMLIRNLLKTEPTQRM 249
Query: 769 GANGAAEVKAHPFFKG 784
E HP+
Sbjct: 250 ---TITEFMNHPWIMQ 262
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-52
Identities = 82/292 (28%), Positives = 138/292 (47%), Gaps = 40/292 (13%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ F++++ + G++G V+ A + TG + AIK + ++D++ I+ E +I+ +
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ-----VPVESDLQEIIKEISIMQQCDS 83
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 613
P VV+++ S+ +L++VMEY G + ++R L ED + + LEYLH
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
+ +HRD+K N+L+ +GH KL DFG++ Q
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAG----------------------------QL 175
Query: 674 TDNRN-RHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EIIF 731
TD R++ +GTP ++APE++ + AD WS+GI E G PP+ P IF
Sbjct: 176 TDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF 235
Query: 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
I P P S D + + L+ P QR A ++ HPF +
Sbjct: 236 -MIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRA---TATQLLQHPFVR 283
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 7e-52
Identities = 87/335 (25%), Positives = 138/335 (41%), Gaps = 80/335 (23%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 552
DDFE I + G G VF + +G + A K++ L+ I+ +I+ E +L
Sbjct: 31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LE-IKPAIRNQIIRELQVLHEC 88
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 612
+P++V F+ +F + + ME+++GG L +L+K G + E + ++ L YL
Sbjct: 89 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 613 S-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
I+HRD+KP N+L+ G IKL DFG+S G + +++
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDSM-------------------- 186
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES----- 726
+S VGT Y++PE L GT + +D WS+G+ L E G P
Sbjct: 187 -------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELE 239
Query: 727 ----------------------------------PEIIFD---NILNRKIP-WPCVPSDM 748
P IF+ I+N P P
Sbjct: 240 LMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP--SGVF 297
Query: 749 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
S E QD +N+ LI +P +R ++ H F K
Sbjct: 298 SLEFQDFVNKCLIKNPAERA---DLKQLMVHAFIK 329
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 2e-51
Identities = 78/302 (25%), Positives = 133/302 (44%), Gaps = 46/302 (15%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-T 551
DD E I + RGA+G V R +G + A+K ++ + + +R+L + +I + T
Sbjct: 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIR-AT-VNSQEQKRLLMDLDISMRT 62
Query: 552 VRNPFVVRFFYSFTCRDNLYLVMEYLNGG--DLY-SLLRKVGCLEEDVARIYIAELVLAL 608
V PF V F+ + ++++ ME ++ Y ++ K + ED+ +V AL
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 609 EYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
E+LHS L ++HRD+KP N+LI G +K+ DFG+S
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG------------------------ 158
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG----YAADWWSVGIILFEFITGIPPFT 723
D+ + G Y+APE + + +D WS+GI + E P+
Sbjct: 159 ----YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYD 214
Query: 724 A-ESPEIIFDNILNRKIPWPCVPSDM-SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
+ +P ++ P P +P+D S E D ++ L + +R E+ HPF
Sbjct: 215 SWGTPFQQLKQVVEE--PSPQLPADKFSAEFVDFTSQCLKKNSKERP---TYPELMQHPF 269
Query: 782 FK 783
F
Sbjct: 270 FT 271
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 6e-51
Identities = 67/313 (21%), Positives = 130/313 (41%), Gaps = 46/313 (14%)
Query: 484 LHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL 543
+ + +D + + I RGA+G V + +G + A+K ++ + + + +++L
Sbjct: 11 ISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR-ST-VDEKEQKQLL 68
Query: 544 AERNILI-TVRNPFVVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKV--GCLEEDVAR 598
+ ++++ + P++V+F+ + + ++ ME ++ Y + V + E++
Sbjct: 69 MDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 599 IYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 657
V AL +L L I+HRD+KP N+L+ G+IKL DFG+S
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG-------------- 174
Query: 658 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG----YAADWWSVGIILF 713
Q D+ + G Y+APE + + +D WS+GI L+
Sbjct: 175 --------------QLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLY 220
Query: 714 EFITGIPPFTAESPEI-IFDNILNRKIPWPCVPSDMSF--EAQDLINRFLIHDPNQRLGA 770
E TG P+ + ++ P + F + +N L D ++R
Sbjct: 221 ELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP-- 278
Query: 771 NGAAEVKAHPFFK 783
E+ HPF
Sbjct: 279 -KYKELLKHPFIL 290
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 8e-51
Identities = 72/295 (24%), Positives = 114/295 (38%), Gaps = 44/295 (14%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
F ++ I G+FG V+ AR ++ AIK + + I+ E L +R+
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGG--DLYSLLRKVGCLEEDVARIYIAELVLALEYLH 612
P +++ + +LVMEY G DL + + L+E + L YLH
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH 171
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
S ++HRD+K N+L++ G +KL DFG +
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-----------------------------S 202
Query: 673 QTDNRNRHSAVGTPDYLAPE-ILLGTEHGY--AADWWSVGIILFEFITGIPPFTAESP-E 728
N S VGTP ++APE IL E Y D WS+GI E PP +
Sbjct: 203 IMAPAN--SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 260
Query: 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
++ +I + P S ++ ++ L P R + + H F
Sbjct: 261 ALY-HIAQNESP-ALQSGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVL 310
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 1e-50
Identities = 66/301 (21%), Positives = 111/301 (36%), Gaps = 42/301 (13%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 555
+ + ++ G F V+ A+ +G +A+K L + + I + E + + P
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---EVCFMKKLSGHP 86
Query: 556 FVVRFFYSFTCRDN--------LYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELV 605
+V+F + + L+ E G + L + G L D +
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 606 LALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
A++++H I+HRDLK +NLL+++ G IKL DFG + +
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT------------TISHYPDY 194
Query: 664 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL---LGTEHGYAADWWSVGIILFEFITGIP 720
S + + R+ TP Y PEI+ G D W++G IL+
Sbjct: 195 SWSAQRRALVEEEITRN---TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH 251
Query: 721 PFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 780
PF + I+N K P + LI L +P +RL EV
Sbjct: 252 PFEDGAKL----RIVNGKYSIPPHDT-QYTVFHSLIRAMLQVNPEERLSIA---EVVHQL 303
Query: 781 F 781
Sbjct: 304 Q 304
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 1e-50
Identities = 62/338 (18%), Positives = 119/338 (35%), Gaps = 73/338 (21%)
Query: 495 DDFEIIKPISRGA--FGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 552
+E++ I +G V LAR + TG+ ++ + L+ + + E ++
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKLF 83
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELVLALEY 610
+P +V + +F + L++V ++ G L+ + + E + ++ AL+Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
+H +G VHR +K ++LI+ DG + L+ + + +
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSN--LSMISHGQ------------------ 183
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIPPF------ 722
Q+ + +V +L+PE+L GY +D +SVGI E G PF
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243
Query: 723 -------------------------------------TAESPEIIFDNILNRKIPWPCVP 745
++S N P
Sbjct: 244 QMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYH 303
Query: 746 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
S + + L +P+ R A+ + H FFK
Sbjct: 304 RTFSPHFHHFVEQCLQRNPDARP---SASTLLNHSFFK 338
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 3e-49
Identities = 77/304 (25%), Positives = 134/304 (44%), Gaps = 51/304 (16%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-R 553
FE+++ + G +G+V+ R TG L AIKV+ + ++ E I E N+L
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 554 NPFVVRFFYSF------TCRDNLYLVMEYLNGGDLYSLLR--KVGCLEEDVARIYIAELV 605
+ + ++ +F D L+LVME+ G + L++ K L+E+ E++
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 606 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 665
L +LH ++HRD+K N+L+ + +KL DFG+S ++ T+
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS--AQLDRTVG------------- 184
Query: 666 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-----GYAADWWSVGIILFEFITGIP 720
R++ +GTP ++APE++ E+ + +D WS+GI E G P
Sbjct: 185 ------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232
Query: 721 PFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779
P P +F I P S + Q I L+ + +QR ++ H
Sbjct: 233 PLCDMHPMRALF-LIPRNPAP-RLKSKKWSKKFQSFIESCLVKNHSQRP---ATEQLMKH 287
Query: 780 PFFK 783
PF +
Sbjct: 288 PFIR 291
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 6e-45
Identities = 62/274 (22%), Positives = 115/274 (41%), Gaps = 17/274 (6%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
D + + +G FG+ R TG++ +K L + D + L E ++ + +
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEH 66
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV-LALEYLHS 613
P V++F L + EY+ GG L +++ + R+ A+ + + YLHS
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
+ I+HRDL N L+ + ++ + DFGL+++ + + P
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARL--MVDEKTQPEGLRSLKKP---------- 174
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733
D + R++ VG P ++APE++ G + D +S GI+L E I + P +
Sbjct: 175 -DRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233
Query: 734 ILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
+ R P + + R DP +R
Sbjct: 234 LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 1e-44
Identities = 81/352 (23%), Positives = 142/352 (40%), Gaps = 75/352 (21%)
Query: 475 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI 534
+Q+ G + S+ TSID + I + G +G V+ A T + AIK ++ L+
Sbjct: 14 AQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR-LE-- 70
Query: 535 RKNDIERI----LAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG 590
++ E + + E ++L +++ ++ L+L+ EY DL + K
Sbjct: 71 --HEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP 127
Query: 591 CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-----AHDGHIKLTDFGLSKIG 645
+ V + ++ +L+ + + HS +HRDLKP NLL+ + +K+ DFGL++
Sbjct: 128 DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-- 185
Query: 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAAD 704
+ + H + T Y PEILLG+ H + D
Sbjct: 186 ------------------------AFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTSVD 220
Query: 705 WWSVGIILFEFITGIPPFTAESPEI-----IFD-----------------NILNRKIPWP 742
WS+ I E + P F +S EI IF+ + +
Sbjct: 221 IWSIACIWAEMLMKTPLFPGDS-EIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFR 279
Query: 743 ------CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 788
+ + + E DL+ L DP +R+ A A E HP+F ++D
Sbjct: 280 GKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE---HPYFSHNDFD 328
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-44
Identities = 79/308 (25%), Positives = 135/308 (43%), Gaps = 43/308 (13%)
Query: 472 DSVSQSSGVSTPLHSSHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLFA 524
+ T + + DD +I + I G+FG V A G A
Sbjct: 7 HHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVA 64
Query: 525 IKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYS 584
+K+L + D + L E I+ +R+P +V F + T NL +V EYL+ G LY
Sbjct: 65 VKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123
Query: 585 LLRKVGCLEE--DVARIYIA-ELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDF 639
LL K G E+ + R+ +A ++ + YLH+ IVHR+LK NLL+ +K+ DF
Sbjct: 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDF 183
Query: 640 GLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH 699
GLS++ + + + SA GTP+++APE+L
Sbjct: 184 GLSRL---------------------------KASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 700 GYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRF 759
+D +S G+IL+E T P+ +P + + + +P +++ + +I
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKR-LEIPRNLNPQVAAIIEGC 275
Query: 760 LIHDPNQR 767
++P +R
Sbjct: 276 WTNEPWKR 283
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 1e-44
Identities = 80/326 (24%), Positives = 136/326 (41%), Gaps = 70/326 (21%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NILITV 552
+ +E I I G++G VF R R TG + AIK K + + + +A R +L +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQL 59
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYL 611
++P +V F + L+LV EY + + L + + E + + + + A+ +
Sbjct: 60 KHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFC 118
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
H +HRD+KP+N+LI IKL DFG +++ L+GP +Y +
Sbjct: 119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARL--------LTGP--------SDYYDDE 162
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEI- 729
V T Y +PE+L+G G D W++G + E ++G+P + +S ++
Sbjct: 163 -----------VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKS-DVD 210
Query: 730 ----IFDNIL------------------NRKIPWPCVPSD-------MSFEAQDLINRFL 760
I L KIP P +S+ A L+ L
Sbjct: 211 QLYLIR-KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCL 269
Query: 761 IHDPNQRLGANGAAEVKAHPFFKGVN 786
DP +RL HP+F+ +
Sbjct: 270 HMDPTERLTCEQLLH---HPYFENIR 292
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 6e-44
Identities = 77/314 (24%), Positives = 118/314 (37%), Gaps = 56/314 (17%)
Query: 497 FEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP 555
+E+ I+ G G ++LA + G +K L + +AER L V +P
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGL--VHSGDAEAQAMAMAERQFLAEVVHP 139
Query: 556 FVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 610
+V+ F Y+VMEY+ G L L A Y+ E++ AL Y
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSY 197
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
LHS+G+V+ DLKP+N+++ + +KL D G I+ G
Sbjct: 198 LHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS------RINSFG--------------- 235
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730
GTP + APEI+ A D ++VG L +P +
Sbjct: 236 ----------YLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRYVD-- 282
Query: 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 790
L P S+ L+ R + DP QR A E+ A GV + +
Sbjct: 283 ---GLPEDDPVLKTYD--SYGR--LLRRAIDPDPRQRFTT--AEEMSAQ--LTGVLREVV 331
Query: 791 ALQKAVFVPQPESV 804
A V P ++
Sbjct: 332 AQDTGVPRPGLSTI 345
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 1e-43
Identities = 79/335 (23%), Positives = 131/335 (39%), Gaps = 86/335 (25%)
Query: 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NI 548
++ +E + + G F V+ AR + T + AIK +K D A R +
Sbjct: 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 65
Query: 549 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLA 607
L + +P ++ +F + N+ LV +++ DL +++ L + Y+ +
Sbjct: 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
LEYLH I+HRDLKP+NLL+ +G +KL DFGL+K
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK------------------------ 160
Query: 668 YPEYQQTDNRNRHSAVGTPD-----------YLAPEILLGTEH-GYAADWWSVGIILFEF 715
+ G+P+ Y APE+L G G D W+VG IL E
Sbjct: 161 --------------SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAEL 206
Query: 716 ITGIPPFTAESPEI-----IFDNIL---NRKI--------------PWPCVP-----SDM 748
+ +P +S ++ IF+ L + +P +P S
Sbjct: 207 LLRVPFLPGDS-DLDQLTRIFE-TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAA 264
Query: 749 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+ DLI + +P R+ A A + +F
Sbjct: 265 GDDLLDLIQGLFLFNPCARITATQALK---MKYFS 296
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 1e-43
Identities = 85/326 (26%), Positives = 139/326 (42%), Gaps = 71/326 (21%)
Query: 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNIL 549
++ + ++ I G +G V+ A+ G+ FA+K ++ L+ + E I + E +IL
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIR-LE----KEDEGIPSTTIREISIL 54
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLAL 608
+++ +V+ + + L LV E+L+ DL LL LE A+ ++ +L+ +
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
Y H ++HRDLKP NLLI +G +K+ DFGL++
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR------------------------- 148
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 727
+ + H V T Y AP++L+G++ D WSVG I E + G P F S
Sbjct: 149 -AFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVS- 205
Query: 728 EI-----IFD-----------------NILNRKIPWPCVP-----SDMSFEAQDLINRFL 760
E IF + +P + DL+++ L
Sbjct: 206 EADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKML 265
Query: 761 IHDPNQRLGANGAAEVKAHPFFKGVN 786
DPNQR+ A A E H +FK N
Sbjct: 266 KLDPNQRITAKQALE---HAYFKENN 288
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 67/288 (23%), Positives = 116/288 (40%), Gaps = 47/288 (16%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA----ERNILI 550
++ E K I +G FG V R + AIK L D + ++ E I+
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALE 609
+ +P +V+ + + +VME++ GDLY L + ++ + ++ L +E
Sbjct: 79 NLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIE 136
Query: 610 YLHSLG--IVHRDLKPDNLLIAHDG-----HIKLTDFGLSKIGLINNTIDLSGPETDGIM 662
Y+ + IVHRDL+ N+ + K+ DFGLS+ +
Sbjct: 137 YMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ------------SVHSVS 184
Query: 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITGIP 720
+G ++APE + E Y AD +S +IL+ +TG
Sbjct: 185 ------------------GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
Query: 721 PFTAESP-EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
PF S +I F N++ + P +P D +++I DP +R
Sbjct: 227 PFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 66/311 (21%), Positives = 118/311 (37%), Gaps = 46/311 (14%)
Query: 474 VSQSSGVSTPLHSSHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLFAIK 526
+S S S P +S + + +++I + I +G FG+V+ R G++ AI+
Sbjct: 6 LSLLSARSFPRKAS-QTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH--GEV-AIR 61
Query: 527 VLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL 586
++ ++ ++ E R+ VV F + +L ++ G LYS++
Sbjct: 62 LIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVV 120
Query: 587 RKVGCLEEDVARIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645
R + + IA E+V + YLH+ GI+H+DLK N+ +G + +TDFGL I
Sbjct: 121 RDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSIS 179
Query: 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---- 701
+ G +LAPEI+
Sbjct: 180 GVLQAGRREDKLR----------------------IQNGWLCHLAPEIIRQLSPDTEEDK 217
Query: 702 -----AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLI 756
+D +++G I +E PF + E I + P M E D++
Sbjct: 218 LPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKP-NLSQIGMGKEISDIL 276
Query: 757 NRFLIHDPNQR 767
+ +R
Sbjct: 277 LFCWAFEQEER 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-43
Identities = 75/292 (25%), Positives = 123/292 (42%), Gaps = 70/292 (23%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ E+ + + RGAFG V A+ R AIK ++ +++ + + E L V +
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIES-----ESERKAFIVELRQLSRVNH 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEE-----------DVARIYIAE 603
P +V+ + + C + + LVMEY GG LY++L L ++
Sbjct: 61 PNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ----- 113
Query: 604 LVLALEYLHSL---GIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTIDLSGPETD 659
+ YLHS+ ++HRDLKP NLL+ G +K+ DFG + +
Sbjct: 114 ---GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-------------DIQ 157
Query: 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 719
M T + G+ ++APE+ G+ + D +S GIIL+E IT
Sbjct: 158 THM-----------T------NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRR 200
Query: 720 PPF--TAESPEIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
PF I + N R P + ++ + L+ R DP+QR
Sbjct: 201 KPFDEIGGPAFRIMWAVHNGTR----PPLIKNLPKPIESLMTRCWSKDPSQR 248
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-43
Identities = 77/345 (22%), Positives = 135/345 (39%), Gaps = 70/345 (20%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAER--NILI 550
S++ +E + + G++G V R + TG + A +KK + + + +A R +L
Sbjct: 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVA---IKKFLESDDDKMVKKIAMREIKLLK 79
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALE 609
+R+ +V + YLV E+++ + L L+ V + Y+ +++ +
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 669
+ HS I+HRD+KP+N+L++ G +KL DFG ++ L+ P
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFART--------LAAP-----GEVYDDE- 184
Query: 670 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE 728
V T Y APE+L+G G A D W++G ++ E G P F +S +
Sbjct: 185 -------------VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS-D 230
Query: 729 I-----IFDNILNRKIP--WPCVPS-----------------------DMSFEAQDLINR 758
I I L IP +S DL +
Sbjct: 231 IDQLYHIM-MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKK 289
Query: 759 FLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPES 803
L DP++R H FF+ + Q+ Q ++
Sbjct: 290 CLHIDPDKRPFCAELLH---HDFFQMDGFAERFSQELQLKVQKDA 331
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 3e-43
Identities = 83/340 (24%), Positives = 133/340 (39%), Gaps = 91/340 (26%)
Query: 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--------IRKNDIERIL 543
+S F+ ++ + G + V+ +TTG A+K +K LD IR
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-LDSEEGTPSTAIR-------- 52
Query: 544 AERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC------LEEDVA 597
E +++ +++ +VR + + L LV E+++ DL + LE ++
Sbjct: 53 -EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLV 110
Query: 598 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 657
+ + +L+ L + H I+HRDLKP NLLI G +KL DFGL++
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR-------------- 156
Query: 658 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFI 716
GI P + E V T Y AP++L+G+ + D WS G IL E I
Sbjct: 157 AFGI-PVNTFSSE------------VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203
Query: 717 TGIPPFTAESPEI-----IFD----------------------------NILNRKIPWPC 743
TG P F + + IFD L + +
Sbjct: 204 TGKPLFPGTN-DEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHT 262
Query: 744 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+ D ++ L +P+ RL A A HP+F
Sbjct: 263 KEP-LDGNLMDFLHGLLQLNPDMRLSAKQALH---HPWFA 298
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 5e-43
Identities = 83/330 (25%), Positives = 139/330 (42%), Gaps = 72/330 (21%)
Query: 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAER 546
+ ++ ++ ++ + G +G V+ A+ G + A+K ++ LD + E I + E
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIR-LD----AEDEGIPSTAIREI 70
Query: 547 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELV 605
++L + +P +V L LV E++ DL +L + L++ +IY+ +L+
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 606 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 665
+ + H I+HRDLKP NLLI DG +KL DFGL++
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR---------------------- 167
Query: 666 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTA 724
+ H V T Y AP++L+G++ + D WS+G I E ITG P F
Sbjct: 168 ----AFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPG 222
Query: 725 ESPEI-----IFD-----------------NILNRKIP-WPCVP-----SDMSFEAQDLI 756
+ + IF R + P E DL+
Sbjct: 223 VT-DDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLL 281
Query: 757 NRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786
+ L DPN+R+ A A HP+FK ++
Sbjct: 282 SNMLCFDPNKRISARDAMN---HPYFKDLD 308
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-43
Identities = 80/332 (24%), Positives = 124/332 (37%), Gaps = 78/332 (23%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL---AERNI- 548
+ +E + I GA+G V+ AR +G A LK + + L R +
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVA---LKSVRVPNGGGGGGGLPISTVREVA 63
Query: 549 ----LITVRNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVA 597
L +P VVR + LV E+++ DL + L K L +
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI 122
Query: 598 RIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 657
+ + + + L++LH+ IVHRDLKP+N+L+ G +KL DFGL++
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR------IYSYQMAL 176
Query: 658 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 717
T V T Y APE+LL + + D WSVG I E
Sbjct: 177 T----------------------PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR 214
Query: 718 GIPPFTAESPEI-----IFDNIL----------NRKIPWPCVP-----------SDMSFE 751
P F S E IFD ++ + +P P +M
Sbjct: 215 RKPLFCGNS-EADQLGKIFD-LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEES 272
Query: 752 AQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
L+ L +P++R+ A A + H +
Sbjct: 273 GAQLLLEMLTFNPHKRISAFRALQ---HSYLH 301
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 8e-43
Identities = 82/326 (25%), Positives = 134/326 (41%), Gaps = 75/326 (23%)
Query: 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERI----LAERNIL 549
+ +E ++ I G +G VF A+ R T ++ A+K ++ LD +D E + L E +L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR-LD----DDDEGVPSSALREICLL 55
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLAL 608
+++ +VR L LV E+ + DL L+ ++ + ++ +L+ L
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGL 114
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
+ HS ++HRDLKP NLLI +G +KL +FGL++ GI P +
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR--------------AFGI-PVRCYS 159
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFIT-GIPPFTAES 726
E V T Y P++L G + + D WS G I E G P F
Sbjct: 160 AE------------VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
Query: 727 PEI-----IFDNIL---NRKIPWPCVPS---------------------DMSFEAQDLIN 757
IF +L + WP + ++ +DL+
Sbjct: 208 -VDDQLKRIFR-LLGTPTEEQ-WPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQ 264
Query: 758 RFLIHDPNQRLGANGAAEVKAHPFFK 783
L +P QR+ A A + HP+F
Sbjct: 265 NLLKCNPVQRISAEEALQ---HPYFS 287
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 1e-42
Identities = 86/335 (25%), Positives = 142/335 (42%), Gaps = 88/335 (26%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
DD+++++ + RG + VF A T + +K+LK + ++I E IL +R
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRG 89
Query: 555 -PFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 607
P ++ S LV E++N D L + L + R Y+ E++ A
Sbjct: 90 GPNIITLADIVKDPVSR----TPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKA 142
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
L+Y HS+GI+HRD+KP N++I H+ ++L D+GL++ P +
Sbjct: 143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY---------HPGQE------- 186
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPF--- 722
Y V + + PE+L+ + Y+ D WS+G +L I PF
Sbjct: 187 -YNVR-----------VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 234
Query: 723 ---------------TAESPEII----------FDNILNR--KIPW-PCVPSD----MSF 750
T + + I F++IL R + W V S+ +S
Sbjct: 235 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 294
Query: 751 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785
EA D +++ L +D RL A A E HP+F V
Sbjct: 295 EALDFLDKLLRYDHQSRLTAREAME---HPYFYTV 326
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 2e-42
Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 30/278 (10%)
Query: 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-IERILAERNILI 550
T + + + + RG G V+ A + A+K++ + R+ E
Sbjct: 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAG 89
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 610
++ P VV LY+ M +NG DL ++LR+ G L A + ++ AL+
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
H+ G HRD+KP+N+L++ D L DFG++ + + T
Sbjct: 150 AHAAGATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKL------T------------ 190
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730
Q + VGT Y+APE + Y AD +++ +L+E +TG PP+ + ++
Sbjct: 191 --QLG-----NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM 243
Query: 731 FDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQR 767
+ +N+ IP P V + +I R + +P R
Sbjct: 244 GAH-INQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-42
Identities = 65/297 (21%), Positives = 125/297 (42%), Gaps = 44/297 (14%)
Query: 485 HSSHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN 537
H H R + DD+EI + I G+FG V+ + GD+ A+K+L
Sbjct: 7 HHHHGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH--GDV-AVKMLNVTAP-TPQ 62
Query: 538 DIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA 597
++ E +L R+ ++ F ++ L +V ++ G LY L E
Sbjct: 63 QLQAFKNEVGVLRKTRHVNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKK 121
Query: 598 RIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 656
I IA + ++YLH+ I+HRDLK +N+ + D +K+ DFGL+
Sbjct: 122 LIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE------------ 169
Query: 657 ETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILF 713
+ + + + G+ ++APE++ + + +D ++ GI+L+
Sbjct: 170 -------------KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLY 216
Query: 714 EFITGIPPFTAESP-EIIFDNIL--NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
E +TG P++ + + I + + + V S+ + L+ L ++R
Sbjct: 217 ELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-42
Identities = 80/330 (24%), Positives = 129/330 (39%), Gaps = 84/330 (25%)
Query: 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM--------IRKNDIERILAE 545
++ + + + G + V+ + + T +L A+K ++ L+ IR E
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-LEHEEGAPCTAIR---------E 50
Query: 546 RNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAEL 604
++L +++ +V +L LV EYL+ DL L G + ++++ +L
Sbjct: 51 VSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 605 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 664
+ L Y H ++HRDLKP NLLI G +KL DFGL++ S P
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA--------KSIP-------- 153
Query: 665 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFT 723
+ + V T Y P+ILLG+ D W VG I +E TG P F
Sbjct: 154 -----------TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202
Query: 724 AESPEI-----IFDNIL---NRKIPWPCVPS----------------------DMSFEAQ 753
+ IF IL + WP + S + +
Sbjct: 203 GST-VEEQLHFIFR-ILGTPTEET-WPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGA 259
Query: 754 DLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
DL+ + L + R+ A A + HPFF
Sbjct: 260 DLLTKLLQFEGRNRISAEDAMK---HPFFL 286
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 7e-42
Identities = 86/335 (25%), Positives = 134/335 (40%), Gaps = 86/335 (25%)
Query: 493 SIDDFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIRKNDIER----ILAERN 547
+ +E + I GA+G+VF AR + G A LK++ + + R
Sbjct: 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVA---LKRVRV----QTGEEGMPLSTIRE 61
Query: 548 I-----LITVRNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEED 595
+ L T +P VVR F L LV E+++ DL + L KV + +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 596 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655
+ + +L+ L++LHS +VHRDLKP N+L+ G IKL DFGL++I S
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI--------YSF 172
Query: 656 PETDGIMPSDAHY-PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 714
V T Y APE+LL + + D WSVG I E
Sbjct: 173 QMA---------LTSV------------VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAE 211
Query: 715 FITGIPPFTAESPEI-----IFDNIL----------NRKIPWPCVP-----------SDM 748
P F S ++ I D ++ + +P +D+
Sbjct: 212 MFRRKPLFRGSS-DVDQLGKILD-VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI 269
Query: 749 SFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+DL+ + L +P +R+ A A HP+F+
Sbjct: 270 DELGKDLLLKCLTFNPAKRISAYSALS---HPYFQ 301
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 8e-42
Identities = 89/337 (26%), Positives = 131/337 (38%), Gaps = 81/337 (24%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-----------IRKNDIER 541
+ +E + I +G FG VF AR R TG A LKK+ M +R+ I +
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVA---LKKVLMENEKEGFPITALREIKILQ 71
Query: 542 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 600
+L N+ + + + C+ ++YLV ++ DL LL V +
Sbjct: 72 LLKHENV-VNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV 129
Query: 601 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS-KIGLINNTIDLSGPETD 659
+ L+ L Y+H I+HRD+K N+LI DG +KL DFGL+ L
Sbjct: 130 MQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL------------- 176
Query: 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITG 718
++ Y T NR V T Y PE+LLG G D W G I+ E T
Sbjct: 177 ---AKNSQPNRY--T-NR-----VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR 225
Query: 719 IPPFTAESPEI-----IFDNIL---NRKIPWPCVPS------------------------ 746
P + E I + ++ WP V +
Sbjct: 226 SPIMQGNT-EQHQLALIS-QLCGSITPEV-WPNVDNYELYEKLELVKGQKRKVKDRLKAY 282
Query: 747 DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
A DLI++ L+ DP QR+ ++ A H FF
Sbjct: 283 VRDPYALDLIDKLLVLDPAQRIDSDDALN---HDFFW 316
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 30/274 (10%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-IERILAERNILITVRNP 555
++I+ + G V+LA AIK + + K + ++R E + + +
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIF-IPPREKEETLKRFEREVHNSSQLSHQ 71
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 615
+V D YLVMEY+ G L + G L D A + +++ +++ H +
Sbjct: 72 NIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR 131
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
IVHRD+KP N+LI + +K+ DFG++K L ++ +
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKA-LSETSLTQTN-------------------- 170
Query: 676 NRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNIL 735
+GT Y +PE G D +S+GI+L+E + G PPF E+ I +
Sbjct: 171 -----HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI 225
Query: 736 NRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQR 767
+P V D+ ++I R D R
Sbjct: 226 QDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 5e-41
Identities = 84/340 (24%), Positives = 140/340 (41%), Gaps = 82/340 (24%)
Query: 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIK-VLKKLDMIRKNDIERILAERN 547
+ R +D F++ + +G FG V L ++++TG AIK V+ D +N R L
Sbjct: 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI--QDPRFRN---RELQIMQ 71
Query: 548 ILITVRNPFVVR---FFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGC----LEEDV 596
L + +P +V+ +FY+ RD L +VMEY+ L+ R +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPIL 130
Query: 597 ARIYIAELVLALEYLH--SLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDL 653
++++ +L+ ++ LH S+ + HRD+KP N+L+ DG +KL DFG +K
Sbjct: 131 IKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK---------- 180
Query: 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIIL 712
+ Y + + Y APE++ G + A D WSVG I
Sbjct: 181 -------KLSPSEPNVAY-----------ICSRYYRAPELIFGNQHYTTAVDIWSVGCIF 222
Query: 713 FEFITGIPPFTAESP-----EII----------FDNILN----------RKIPW----PC 743
E + G P F ++ EI+ + + IPW
Sbjct: 223 AEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSD 282
Query: 744 VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+ EA DL++ L + P +R+ E HP+F
Sbjct: 283 HSLKDAKEAYDLLSALLQYLPEERM---KPYEALCHPYFD 319
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 9e-41
Identities = 89/334 (26%), Positives = 132/334 (39%), Gaps = 81/334 (24%)
Query: 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
+R + K I G+FG V+ A+ +G+L AIK K+ D E I+
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIK---KV----LQDKRFKNRELQIM 101
Query: 550 ITVRNPFVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVGC----LEEDVARI 599
+ + +VR FFYS + + L LV++Y+ +Y + R L ++
Sbjct: 102 RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKL 160
Query: 600 YIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPET 658
Y+ +L +L Y+HS GI HRD+KP NLL+ +KL DFG +K
Sbjct: 161 YMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--------------- 205
Query: 659 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFIT 717
+ Y + + Y APE++ G T++ + D WS G +L E +
Sbjct: 206 --QLVRGEPNVSY-----------ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLL 252
Query: 718 GIPPFTAESP-----EII----------------------FDNILNRKIPWP-CVPSDMS 749
G P F +S EII F I + PW
Sbjct: 253 GQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI--KAHPWTKVFRPRTP 310
Query: 750 FEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
EA L +R L + P RL E AH FF
Sbjct: 311 PEAIALCSRLLEYTPTARL---TPLEACAHSFFD 341
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 71/277 (25%), Positives = 125/277 (45%), Gaps = 31/277 (11%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND-IERILAERNILITVRNP 555
+E+ + + G V LAR A+KVL+ D+ R R E + +P
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHP 72
Query: 556 FVVRFF----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 611
+V + Y+VMEY++G L ++ G + A IA+ AL +
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
H GI+HRD+KP N++I+ +K+ DFG+++ + ++ ++
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIAR-AIADSGNSVT----------------- 174
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP-EII 730
QT + +GT YL+PE G +D +S+G +L+E +TG PPFT +SP +
Sbjct: 175 -QTA-----AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228
Query: 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
+ ++ IP +S + ++ + L +P R
Sbjct: 229 YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENR 265
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-40
Identities = 67/285 (23%), Positives = 112/285 (39%), Gaps = 45/285 (15%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK-LDMIRKNDIERILAERNILITVR 553
+ + + I G FG+V+ A GD A+K + D IE + E + ++
Sbjct: 7 AELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 613
+P ++ NL LVME+ GG L +L + D+ + ++ + YLH
Sbjct: 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQIARGMNYLHD 123
Query: 614 LG---IVHRDLKPDNLLIAHDGH--------IKLTDFGLSKIGLINNTIDLSGPETDGIM 662
I+HRDLK N+LI +K+TDFGL++
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE------------------ 165
Query: 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 722
+ SA G ++APE++ + +D WS G++L+E +TG PF
Sbjct: 166 -----------WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
Query: 723 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
+ + K+ +PS L+ DP+ R
Sbjct: 215 RGIDGLAVAYGVAMNKLA-LPIPSTCPEPFAKLMEDCWNPDPHSR 258
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-39
Identities = 79/326 (24%), Positives = 133/326 (40%), Gaps = 61/326 (18%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-DIERILAERNILITVR 553
DF++ + GA+G V A + TG++ AIK K++ K R L E IL +
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFDKPLFALRTLREIKILKHFK 67
Query: 554 NPFVVRFFYSFT--CRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 608
+ ++ F +N +Y++ E + DL+ ++ L +D + +I + + A+
Sbjct: 68 HENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVIST-QMLSDDHIQYFIYQTLRAV 125
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
+ LH ++HRDLKP NLLI + +K+ DFGL++I + + M
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM------ 179
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAES- 726
E+ V T Y APE++L ++ A D WS G IL E P F
Sbjct: 180 VEF-----------VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228
Query: 727 ---------------PEIIFDNILN-------------RKIPWPCVPSDMSFEAQDLINR 758
+ I + P + ++ + DL+ R
Sbjct: 229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288
Query: 759 FLIHDPNQRLGANGAAEVKAHPFFKG 784
L+ DP +R+ A E HP+ +
Sbjct: 289 MLVFDPAKRI---TAKEALEHPYLQT 311
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-39
Identities = 56/296 (18%), Positives = 103/296 (34%), Gaps = 56/296 (18%)
Query: 486 SSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERIL 543
+ H ID + ++ G ++ R + G+ +KVLK D
Sbjct: 2 NKHSG---IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRD-WSTRKSRDFN 55
Query: 544 AERNILITVRNPFVVRFFYSFTC--RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA-RIY 600
E L +P V+ + + L+ ++ G LY++L + D + +
Sbjct: 56 EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK 115
Query: 601 IA-ELVLALEYLHSLG--IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 657
A ++ + +LH+L I L +++I D +++ +
Sbjct: 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------------- 161
Query: 658 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY---AADWWSVGIILFE 714
+Q + P ++APE L +AD WS ++L+E
Sbjct: 162 ------------SFQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWE 203
Query: 715 FITGIPPFTAESP-EIIFDNILN--RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
+T PF S EI L R P +P +S L+ + DP +R
Sbjct: 204 LVTREVPFADLSNMEIGMKVALEGLR----PTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-39
Identities = 93/327 (28%), Positives = 137/327 (41%), Gaps = 82/327 (25%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
+ K I G+FG VF A+ + + AIK K+ D E I+ V++P
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDE-VAIK---KV----LQDKRFKNRELQIMRIVKHPN 93
Query: 557 VVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVG----CLEEDVARIYIAELVL 606
VV FFYS + + L LV+EY+ +Y R + + ++Y+ +L+
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 607 ALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 665
+L Y+HS+GI HRD+KP NLL+ G +KL DFG +KI ++ +
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI----------------LIAGE 196
Query: 666 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTA 724
Y + + Y APE++ G T + D WS G ++ E + G P F
Sbjct: 197 P-NVSY-----------ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPG 244
Query: 725 ESP-----EII----------------------FDNILNRKIPWP-CVPSDMSFEAQDLI 756
ES EII F I R P+ +A DLI
Sbjct: 245 ESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQI--RPHPFSKVFRPRTPPDAIDLI 302
Query: 757 NRFLIHDPNQRLGANGAAEVKAHPFFK 783
+R L + P+ RL A E HPFF
Sbjct: 303 SRLLEYTPSARL---TAIEALCHPFFD 326
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 9e-38
Identities = 81/358 (22%), Positives = 134/358 (37%), Gaps = 113/358 (31%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
+ + K + G+FG V +G FA+K K+ D E +I+ + +
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALK---KV----LQDPRYKNRELDIMKVLDHVN 61
Query: 557 VVRFFYSFTCRDN--------------------------------------LYLVMEYLN 578
+++ F + L ++MEY+
Sbjct: 62 IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV- 120
Query: 579 GGDLYSLLRKVGC----LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI-AHDGH 633
L+ +L+ + ++ IYI +L A+ ++HSLGI HRD+KP NLL+ + D
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNT 180
Query: 634 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEI 693
+KL DFG +K + Y + + Y APE+
Sbjct: 181 LKLCDFGSAK-----------------KLIPSEPSVAY-----------ICSRFYRAPEL 212
Query: 694 LLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP-----EII----------------- 730
+LG TE+ + D WS+G + E I G P F+ E+ II
Sbjct: 213 MLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPH 272
Query: 731 -----FDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
F + + W + P A DL+ + L ++P+ R+ E AHPFF
Sbjct: 273 YTEVRFPTL--KAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEAMAHPFF 325
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 83/331 (25%), Positives = 130/331 (39%), Gaps = 75/331 (22%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE---------RN 547
+ +KP+ G G VF A AIK K+ + ++ L E N
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 548 I-----LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 602
I ++ + S T +++Y+V EY+ DL ++L + G L E+ AR+++
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQ-GPLLEEHARLFMY 127
Query: 603 ELVLALEYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 661
+L+ L+Y+HS ++HRDLKP NL I D +K+ DFGL++I D
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARI-------------MDPH 174
Query: 662 MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIP 720
H E + T Y +P +LL + A D W+ G I E +TG
Sbjct: 175 YSHKGHLSEG-----------LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223
Query: 721 PFTAESP----EIIFD-------------------NILN----RKIPWPCVPSDMSFEAQ 753
F ++I + I N P + +S EA
Sbjct: 224 LFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAV 283
Query: 754 DLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
D + + L P RL A E +HP+
Sbjct: 284 DFLEQILTFSPMDRL---TAEEALSHPYMSI 311
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-37
Identities = 81/327 (24%), Positives = 132/327 (40%), Gaps = 76/327 (23%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 552
+ + GA+G V A + +G+ AIK KL +++I R E +L +
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIK---KLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 553 RNPFVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 606
++ V+ F + N YLVM ++ DL ++ E+ + + +++
Sbjct: 81 QHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLK--FSEEKIQYLVYQMLK 137
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
L+Y+HS G+VHRDLKP NL + D +K+ DFGL++ +DA
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-------------------HADA 178
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 725
Y V T Y APE++L H D WSVG I+ E +TG F +
Sbjct: 179 EMTGY-----------VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGK 227
Query: 726 SP----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLIN 757
I + + + + + S +A DL+
Sbjct: 228 DYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLE 287
Query: 758 RFLIHDPNQRLGANGAAEVKAHPFFKG 784
+ L D ++RL AA+ HPFF+
Sbjct: 288 KMLELDVDKRL---TAAQALTHPFFEP 311
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 8e-37
Identities = 79/354 (22%), Positives = 127/354 (35%), Gaps = 74/354 (20%)
Query: 456 SPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLAR 515
S T + LI S S SG PL +RT +++K I +G +G V++ +
Sbjct: 1 SMTYIPPGESLRDLIEQSQSSGSGSGLPLLV---QRTIAKQIQMVKQIGKGRYGEVWMGK 57
Query: 516 KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV--RNPFVVRFF----YSFTCRDN 569
R G+ A+KV + E I TV R+ ++ F
Sbjct: 58 WR--GEKVAVKVFFT------TEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109
Query: 570 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL--------GIVHRDL 621
LYL+ +Y G LY L+ + + ++ V L +LH+ I HRDL
Sbjct: 110 LYLITDYHENGSLYDYLKSTTLDAKSMLKL-AYSSVSGLCHLHTEIFSTQGKPAIAHRDL 168
Query: 622 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHS 681
K N+L+ +G + D GL+ E D ++
Sbjct: 169 KSKNILVKKNGTCCIADLGLAVK------FISDTNEVDIPP-----------------NT 205
Query: 682 AVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFITGI----------PPFTAE 725
VGT Y+ PE+L + + AD +S G+IL+E P+
Sbjct: 206 RVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265
Query: 726 SP-----EIIFDNILNRK----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 770
P E + + + +K P + + L+ H+P RL A
Sbjct: 266 VPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTA 319
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 9e-37
Identities = 79/325 (24%), Positives = 131/325 (40%), Gaps = 67/325 (20%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN-DIERILAERNILITVR 553
+ + I GA+G V A AIK K+ +R L E IL+ R
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK---KISPFEHQTYCQRTLREIKILLRFR 83
Query: 554 NPFVVRFFYSFT--CRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 608
+ ++ + +Y+V + + DLY LL+ L D ++ +++ L
Sbjct: 84 HENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKT-QHLSNDHICYFLYQILRGL 141
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
+Y+HS ++HRDLKP NLL+ +K+ DFGL+++ D
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-------------ADPDHDHTGFL 188
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESP 727
EY V T Y APEI+L ++ + D WSVG IL E ++ P F +
Sbjct: 189 TEY-----------VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 237
Query: 728 ----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLINRF 759
I I+N K+PW + + +A DL+++
Sbjct: 238 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKM 297
Query: 760 LIHDPNQRLGANGAAEVKAHPFFKG 784
L +P++R+ + AHP+ +
Sbjct: 298 LTFNPHKRI---EVEQALAHPYLEQ 319
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 4e-36
Identities = 75/354 (21%), Positives = 123/354 (34%), Gaps = 104/354 (29%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--- 553
+E++K I +G+FG+V A A+K+++ + E IL +R
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ----AAEEIRILEHLRKQD 154
Query: 554 ---NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLAL 608
V+ +FT R+++ + E L +LY L++K + R + ++ L
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
+ LH I+H DLKP+N+L+ G IK+ DFG S
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS------------------CYEHQR 255
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF---- 722
Y Y Q+ R Y APE++LG +G D WS+G IL E +TG P
Sbjct: 256 VYT-YIQS----RF-------YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303
Query: 723 ------------------------------------------TAESPEIIFDNILNRKIP 740
T ++ + +R+
Sbjct: 304 EGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGK 363
Query: 741 WPCVPSDMSFEAQ----------DLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
P + D + + L DP R+ A HP+ +
Sbjct: 364 LRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQA---LRHPWLRR 414
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-36
Identities = 66/334 (19%), Positives = 114/334 (34%), Gaps = 77/334 (23%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN--------DIERILAER 546
+ + + IS G++G V + G AIK + + +R+L E
Sbjct: 22 SPYTVQRFISSGSYGAVCAG-VDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 547 NILITVRNPFVVRFFYSFTCRDN-----LYLVMEYLNGGDLYSLLR-KVGCLEEDVARIY 600
+L +P ++ F + LYLV E + DL ++ + + + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 601 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 660
+ ++L L LH G+VHRDL P N+L+A + I + DF L++ D
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR-----------EDTADA 188
Query: 661 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGI 719
Y V Y APE+++ + D WS G ++ E
Sbjct: 189 NK------THY-----------VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
Query: 720 PPFTAESP----EIIFD-----------NILN--------------RKIPWPCVPSDMSF 750
F + I + + W V
Sbjct: 232 ALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADP 291
Query: 751 EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
A DLI + L +P +R+ + HP+F+
Sbjct: 292 VALDLIAKMLEFNPQRRI---STEQALRHPYFES 322
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-36
Identities = 83/326 (25%), Positives = 134/326 (41%), Gaps = 75/326 (23%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 552
+ ++ + P+ GA+G V A TG A+K KL ++ I R E +L +
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---KLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 553 RNPFVVR---FFYSFTCRDN---LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 606
++ V+ F + +YLV + G DL ++++ L +D + I +++
Sbjct: 86 KHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILR 143
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
L+Y+HS I+HRDLKP NL + D +K+ DFGL++ T M
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-------------HTADEM---- 186
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 725
Y V T Y APEI+L H D WSVG I+ E +TG F
Sbjct: 187 --TGY-----------VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 233
Query: 726 SP----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLIN 757
++I I + K+ + V + A DL+
Sbjct: 234 DHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLE 293
Query: 758 RFLIHDPNQRLGANGAAEVKAHPFFK 783
+ L+ D ++R+ AA+ AH +F
Sbjct: 294 KMLVLDSDKRI---TAAQALAHAYFA 316
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-36
Identities = 83/327 (25%), Positives = 135/327 (41%), Gaps = 75/327 (22%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 552
+ ++P+ GA+G V A TG AIK KL ++++ R E +L +
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIK---KLYRPFQSELFAKRAYRELRLLKHM 81
Query: 553 RNPFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 606
R+ V+ + + YLVM ++ G DL L++ L ED + + +++
Sbjct: 82 RHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLK 139
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
L Y+H+ GI+HRDLKP NL + D +K+ DFGL++ +D+
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------------------QADS 180
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAE 725
Y V T Y APE++L + D WSVG I+ E ITG F
Sbjct: 181 EMTGY-----------VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 229
Query: 726 SP----EIIFD-----------NILN-------------RKIPWPCVPSDMSFEAQDLIN 757
+ I + + K + + ++ S A +L+
Sbjct: 230 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLE 289
Query: 758 RFLIHDPNQRLGANGAAEVKAHPFFKG 784
+ L+ D QR+ A E AHP+F+
Sbjct: 290 KMLVLDAEQRV---TAGEALAHPYFES 313
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 70/322 (21%), Positives = 118/322 (36%), Gaps = 68/322 (21%)
Query: 452 LDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRV 511
LD + + K+ LI D + SG PL +RT + + I +G FG V
Sbjct: 5 LDRPFISEGTTLKD---LIYDMTTSGSGSGLPLLV---QRTIARTIVLQESIGKGRFGEV 58
Query: 512 FLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT--VRNPFVVRFFYSFTCRDN 569
+ + R G+ A+K+ + E I T +R+ ++ F + +
Sbjct: 59 WRGKWR--GEEVAVKIF------SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG 110
Query: 570 ----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS--------LGIV 617
L+LV +Y G L+ L + E + ++ L +LH I
Sbjct: 111 TWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHMEIVGTQGKPAIA 169
Query: 618 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 677
HRDLK N+L+ +G + D GL+ + T +
Sbjct: 170 HRDLKSKNILVKKNGTCCIADLGLAVR-----------------------HDSATDTIDI 206
Query: 678 NRHSAVGTPDYLAPEILLGT------EHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731
+ VGT Y+APE+L + E AD +++G++ +E
Sbjct: 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY--- 263
Query: 732 DNILNRKIPWP-CVPSDMSFEA 752
++P+ VPSD S E
Sbjct: 264 ------QLPYYDLVPSDPSVEE 279
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 62/283 (21%), Positives = 107/283 (37%), Gaps = 62/283 (21%)
Query: 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
+RT D +++ + +G +G V+ + G+ A+K+ D + E +
Sbjct: 3 QRTVARDITLLECVGKGRYGEVWRGSWQ--GENVAVKIF------SSRDEKSWFRETELY 54
Query: 550 ITV--RNPFVVRFF----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAE 603
TV R+ ++ F S L+L+ Y G LY L+ RI +
Sbjct: 55 NTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI-VLS 113
Query: 604 LVLALEYLHSL--------GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655
+ L +LH I HRDLK N+L+ +G + D GL+ +
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM----------- 162
Query: 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT------EHGYAADWWSVG 709
+ + + + VGT Y+APE+L T + D W+ G
Sbjct: 163 ------------HSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFG 210
Query: 710 IILFEFITGIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFE 751
++L+E + + + K P+ VP+D SFE
Sbjct: 211 LVLWEVARRMVS---------NGIVEDYKPPFYDVVPNDPSFE 244
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-35
Identities = 87/358 (24%), Positives = 134/358 (37%), Gaps = 74/358 (20%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 552
D +EI I G++G V A + + AIK K+ + ++ I+ RIL E IL +
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK---KILRVFEDLIDCKRILREIAILNRL 109
Query: 553 RNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 607
+ VV+ D LY+V+E D L R L E + + L++
Sbjct: 110 NHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
++Y+HS GI+HRDLKP N L+ D +K+ DFGL++ + P + +
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAES 726
+ + R V T Y APE++L E+ A D WS+G I E + I A
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 727 P-----------------------------------EIIFD------------------- 732
+IF+
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK 348
Query: 733 NILNRKIPWPCVP-----SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785
+ S +A L+ R L+ +PN+R+ N HPFFK V
Sbjct: 349 RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA---HPFFKEV 403
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 3e-35
Identities = 75/363 (20%), Positives = 137/363 (37%), Gaps = 101/363 (27%)
Query: 486 SSHKERTSIDDFEIIKP-ISRGAFGRVFLARKR--TTGDLFAIKVLKKLDM----IRKND 538
SS +ER D FE + RG +G V+ A+++ +A+K ++ + R+
Sbjct: 12 SSERER-VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIA 70
Query: 539 IERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC------- 591
+ R L N+ I+++ F+ ++L+ +Y DL+ +++
Sbjct: 71 LLRELKHPNV-ISLQKVFLSH------ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKP 122
Query: 592 --LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIG 645
L + + + +++ + YLH+ ++HRDLKP N+L+ + G +K+ D G +++
Sbjct: 123 VQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL- 181
Query: 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAAD 704
+ P D V T Y APE+LLG H A D
Sbjct: 182 --------------------FNSPLKPLADLDPV---VVTFWYRAPELLLGARHYTKAID 218
Query: 705 WWSVGIILFEFITGIPPFTAESPEIIFDNILNR----KI------P----WPCVPS---- 746
W++G I E +T P F +I N + +I P W +
Sbjct: 219 IWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEH 278
Query: 747 --------------------------DMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 780
+A L+ + L DP +R+ + A + P
Sbjct: 279 STLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ---DP 335
Query: 781 FFK 783
+F
Sbjct: 336 YFL 338
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 8e-35
Identities = 72/346 (20%), Positives = 120/346 (34%), Gaps = 81/346 (23%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--- 553
F +I+ + G FGRV L + +A+KV++ + E +IL ++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYT----RSAKIEADILKKIQNDD 92
Query: 554 --NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALE 609
N +V++ F D++ L+ E L G LY ++ + + ++Y E++ AL
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI-------- 661
YL + + H DLKP+N+L+ K I + ++ GI
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTD--GKKIQIYRTKSTGIKLIDFGCA 209
Query: 662 -MPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 720
SD H T R Y APE++L ++D WS G +L E TG
Sbjct: 210 TFKSDYHGS-IINT----RQ-------YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
Query: 721 PFTAES----------------PEII----------FDNILNRKIPWPCVPSDMSF---- 750
F ++ + N K+ WP S ++
Sbjct: 258 LFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHV 317
Query: 751 -------------EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
D + L DP R + H F +
Sbjct: 318 KKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK---HKFLE 360
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 74/337 (21%), Positives = 129/337 (38%), Gaps = 84/337 (24%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 552
++ +KPI GA G V A AIK KL +N R E ++ V
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIK---KLSRPFQNQTHAKRAYRELVLMKCV 81
Query: 553 RNPFVVRFFYSFTCRDN------LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 606
+ ++ FT + + +Y+VME + +L +++ L+ + + +++
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 138
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
+++LHS GI+HRDLKP N+++ D +K+ DFGL++ T +M
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMM---- 183
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF---- 722
Y V T Y APE++LG + D WSVG I+ E I G F
Sbjct: 184 --TPY-----------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230
Query: 723 ---------------TAESPEIIFDNILN--------RKIPW------------PCVPSD 747
E + + + +
Sbjct: 231 HIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKL 290
Query: 748 MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
+ +A+DL+++ L+ D ++R+ E HP+
Sbjct: 291 KASQARDLLSKMLVIDASKRI---SVDEALQHPYINV 324
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 74/357 (20%), Positives = 123/357 (34%), Gaps = 107/357 (29%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNP- 555
+ +++ + G F V+LA+ A+K+++ K E E +L V +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDAD 76
Query: 556 ----------FVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGC--LEEDVARI 599
+++ F + + +V E L G +L +L++K + +
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135
Query: 600 YIAELVLALEYLHS-LGIVHRDLKPDNLLIAH------DGHIKLTDFGLSKIGLINNTID 652
+L+L L+Y+H GI+H D+KP+N+L+ IK+ D G +
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA---------- 185
Query: 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 712
D HY QT R Y +PE+LLG G AD WS ++
Sbjct: 186 ---------CWYDEHYTNSIQT----RE-------YRSPEVLLGAPWGCGADIWSTACLI 225
Query: 713 FEFITGIPPFTAESPEI-------------------------------IFDNILNRKI-- 739
FE ITG F + F++ +
Sbjct: 226 FELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNIS 285
Query: 740 ---PWP---CVPSDMSFEAQ------DLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
WP + F D ++ L DP +R A G HP+ K
Sbjct: 286 KLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN---HPWLKD 339
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-34
Identities = 33/286 (11%), Positives = 70/286 (24%), Gaps = 60/286 (20%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF 556
+ ++ + + A A+ + ++ + ++ L+ L + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92
Query: 557 VVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGI 616
V R R +V E++ GG L + R + L A + H G+
Sbjct: 93 VARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-SPSPVGAIRA-MQSLAAAADAAHRAGV 150
Query: 617 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 676
P + ++ DG + L
Sbjct: 151 ALSIDHPSRVRVSIDGDVVLAYPA------------------------------------ 174
Query: 677 RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNILN 736
+ D +G L+ + P
Sbjct: 175 -----------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAER 216
Query: 737 RKIPWPCVPS----DMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778
P P+ D+ F+ + R + D R + ++
Sbjct: 217 DTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQ 262
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-34
Identities = 84/356 (23%), Positives = 142/356 (39%), Gaps = 78/356 (21%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 552
D++ I I RG++G V+LA + T AIK K++ + ++ I+ RIL E IL +
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK---KVNRMFEDLIDCKRILREITILNRL 82
Query: 553 RNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 607
++ +++R + D LY+V+E DL L + L E+ + + L+L
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
++H GI+HRDLKP N L+ D +K+ DFGL++ ++ + P +
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 668 YPEYQQ-TDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 725
+Q T + V T Y APE++L E+ + D WS G I E + + +
Sbjct: 202 KNLKKQLTSH------VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255
Query: 726 SP--------------------------------EIIFD-----------NILN------ 736
IIF+ NI
Sbjct: 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKY 315
Query: 737 -------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785
+ I +S + +L+ L +PN+R+ + HP+ K V
Sbjct: 316 IKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRI---TIDQALDHPYLKDV 368
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-34
Identities = 87/340 (25%), Positives = 149/340 (43%), Gaps = 64/340 (18%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 552
+E++K + +GA+G V+ + R TG++ A+K K+ +N + R E IL +
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK---KIFDAFQNSTDAQRTFREIMILTEL 65
Query: 553 RN-PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 609
+V ++ +YLV +Y+ DL++++R LE + + +L+ ++
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRA-NILEPVHKQYVVYQLIKVIK 123
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 669
YLHS G++HRD+KP N+L+ + H+K+ DFGLS+ + + + P + +
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 670 EYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP- 727
+ TD V T Y APEILLG T++ D WS+G IL E + G P F S
Sbjct: 184 QPILTD------YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237
Query: 728 ---EIIFD-------------------NILNRKIPWPCVP-------------------- 745
E I ++ +
Sbjct: 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINP 297
Query: 746 -SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
+D + EA DL+++ L +PN+R+ A + HPF
Sbjct: 298 KADCNEEALDLLDKLLQFNPNKRI---SANDALKHPFVSI 334
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-34
Identities = 75/337 (22%), Positives = 131/337 (38%), Gaps = 84/337 (24%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE--RILAERNILITV 552
++ +KPI GA G V A AIK KL +N R E ++ V
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIK---KLSRPFQNQTHAKRAYRELVLMKCV 118
Query: 553 RNPFVVRFFYSFTCRDN------LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 606
+ ++ FT + +YLVME + +L +++ L+ + + +++
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQME--LDHERMSYLLYQMLC 175
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
+++LHS GI+HRDLKP N+++ D +K+ DFGL++ T +M
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----------TAGTSFMM---- 220
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF---- 722
Y V T Y APE++LG + D WSVG I+ E + F
Sbjct: 221 --TPY-----------VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267
Query: 723 ---------------TAESPEIIFDNILN--------RKIPWPCV------------PSD 747
E + + + N + +P +
Sbjct: 268 YIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL 327
Query: 748 MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
+ +A+DL+++ L+ DP +R+ + HP+
Sbjct: 328 KASQARDLLSKMLVIDPAKRI---SVDDALQHPYINV 361
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 74/238 (31%), Positives = 110/238 (46%), Gaps = 39/238 (16%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLK-KLDMIRKNDIE-RILAERNILITVRN 554
+EI I +G+FG+V A R + AIK++K K + + IE R+L N T
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALEYLH 612
++V F R++L LV E L +LY LLR + ++ R + ++ AL +L
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174
Query: 613 S--LGIVHRDLKPDNLLIAHDGH--IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
+ L I+H DLKP+N+L+ + IK+ DFG S Y
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS------------------CQLGQRIY 216
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 726
Y Q+ R Y +PE+LLG + A D WS+G IL E TG P F+ +
Sbjct: 217 Q-YIQS----RF-------YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 4e-33
Identities = 71/352 (20%), Positives = 108/352 (30%), Gaps = 95/352 (26%)
Query: 497 FEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKK--------------LDMIRKNDIER 541
+EI+ + G FG+V A+K+++ L I++ D E
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 542 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARI 599
+ V F ++ + E L G + + L++ R
Sbjct: 81 ---KFLC---------VLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRH 127
Query: 600 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT-----IDLS 654
+L AL +LH + H DLKP+N+L + L + S D
Sbjct: 128 MAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
Query: 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFE 714
+ H T RH Y PE++L D WS+G ILFE
Sbjct: 188 S----ATFDHEHHTT-IVAT----RH-------YRPPEVILELGWAQPCDVWSIGCILFE 231
Query: 715 FITGIPPFTAES---------------PEIIFDNILNRK------IPWPCVPSD------ 747
+ G F P + +K + W SD
Sbjct: 232 YYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE 291
Query: 748 --------------MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785
+ DL+ R L DP QR+ A HPFF G+
Sbjct: 292 NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALL---HPFFAGL 340
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-33
Identities = 70/354 (19%), Positives = 116/354 (32%), Gaps = 99/354 (27%)
Query: 497 FEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKK--------------LDMIRKNDIER 541
+EI+ + GAFG+V + G A+K++K L+ + D
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 542 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARI 599
V+ F ++ +V E L G Y +++ G D R
Sbjct: 76 ---TFRC---------VQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRK 122
Query: 600 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT-----IDLS 654
++ ++ +LHS + H DLKP+N+L + + + + + +D
Sbjct: 123 MAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF- 181
Query: 655 GPETDG--IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 712
G + H T RH Y APE++L D WS+G IL
Sbjct: 182 -----GSATYDDEHHST-LVST----RH-------YRAPEVILALGWSQPCDVWSIGCIL 224
Query: 713 FEFITGIPPFTAES---------------PEIIFDNILNRK------IPWPCVPSDMSF- 750
E+ G F P+ + RK + W S +
Sbjct: 225 IEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYV 284
Query: 751 -------------------EAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785
DLI + L +DP +R+ A + HPFF +
Sbjct: 285 SRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALK---HPFFDLL 335
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-32
Identities = 59/282 (20%), Positives = 103/282 (36%), Gaps = 58/282 (20%)
Query: 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-- 551
+D+ ++++ I RG +G V+ A+KV + + + E+NI
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSLD--ERPVAVKVFSFANR------QNFINEKNIYRVPL 63
Query: 552 VRNPFVVRFF-----YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 606
+ + + RF + R LVMEY G L L R+ +
Sbjct: 64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-AHSVTR 122
Query: 607 ALEYLHS---------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPE 657
L YLH+ I HRDL N+L+ +DG ++DFGLS
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR------------- 169
Query: 658 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-------EHGYAADWWSVGI 710
+ ++ S VGT Y+APE+L G D +++G+
Sbjct: 170 ------LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223
Query: 711 ILFEFITGIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFE 751
I +E + +++ ++ + V + +FE
Sbjct: 224 IYWEIFMR------CTDLFPGESVPEYQMAFQTEVGNHPTFE 259
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 53/300 (17%), Positives = 107/300 (35%), Gaps = 69/300 (23%)
Query: 475 SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLD-- 532
SSGV + ++ ++++ +RG FG V+ A+ + A+K+ D
Sbjct: 7 HHSSGVDLGT-ENLYFQS--MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQ 61
Query: 533 -MIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLR 587
+ ++ L +++ +++F + + L+L+ + G L L+
Sbjct: 62 SWQNEYEVY-------SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK 114
Query: 588 KVGCLEEDVARIYIAELVLALEYLHS----------LGIVHRDLKPDNLLIAHDGHIKLT 637
++ I + L YLH I HRD+K N+L+ ++ +
Sbjct: 115 ANVVSWNELCHIAE-TMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 638 DFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEIL--- 694
DFGL+ + + H VGT Y+APE+L
Sbjct: 174 DFGLALKFEAGKSAG-------------------------DTHGQVGTRRYMAPEVLEGA 208
Query: 695 LGTEHGY--AADWWSVGIILFEFITGIPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFE 751
+ + D +++G++L+E + E +P+ + S E
Sbjct: 209 INFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE--------YMLPFEEEIGQHPSLE 260
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-26
Identities = 60/276 (21%), Positives = 104/276 (37%), Gaps = 49/276 (17%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-- 554
+ +I+ + G F V+L+ A+KV+K ++ E L E +L +VRN
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIRLLKSVRNSD 94
Query: 555 ------PFVVRFFYSFT---------CRDNLYLVMEYLNGGDLYSLLRK--VGCLEEDVA 597
VV+ F C +V E L G L + K L
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHIC-----MVFEVL-GHHLLKWIIKSNYQGLPLPCV 148
Query: 598 RIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGP 656
+ I +++ L+YLH+ I+H D+KP+N+L++ + + + SG
Sbjct: 149 KKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS 208
Query: 657 ETDGIM------------PSDAHYPEYQQTD-------NRNRHSAVGTPDYLAPEILLGT 697
P +A + + D +++ + T Y + E+L+G+
Sbjct: 209 AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGS 268
Query: 698 EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733
+ AD WS + FE TG F S E +
Sbjct: 269 GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRD 304
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 62/254 (24%), Positives = 102/254 (40%), Gaps = 38/254 (14%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 555
F + K I G FG + L + T + AIK+ K+ ++ E + +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEP-----MKSRAPQLHLEYRFYKQLGSGD 65
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 613
+ + +Y C +V+E L G L L + V I I +L+ +EY+HS
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAI-QLISRMEYVHS 123
Query: 614 LGIVHRDLKPDNLLIAHDGH-----IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
+++RD+KP+N LI G+ I + DF L+K ID + H
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE-----YIDPETKK---------HI 169
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP---FTAE 725
P R S GT Y++ LG E D ++G + F+ G P A+
Sbjct: 170 PY------REHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD 223
Query: 726 SPEIIFDNILNRKI 739
+ + + I + K
Sbjct: 224 TLKERYQKIGDTKR 237
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 56/257 (21%), Positives = 98/257 (38%), Gaps = 38/257 (14%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 555
+++ + I G+FG +F AIK R++D ++ E +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP-----RRSDAPQLRDEYRTYKLLAGCT 66
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 613
+ +Y + LV++ L G L LL G + VA +++ ++ +H
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAK-QMLARVQSIHE 124
Query: 614 LGIVHRDLKPDNLLI-----AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
+V+RD+KPDN LI + I + DFG+ K T H
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT--------------KQHI 170
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP---FTAE 725
P R + + GT Y++ LG E D ++G + F+ G P A
Sbjct: 171 PY------REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 224
Query: 726 SPEIIFDNILNRKIPWP 742
+ + ++ I +K P
Sbjct: 225 TNKQKYERIGEKKQSTP 241
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 58/252 (23%), Positives = 96/252 (38%), Gaps = 36/252 (14%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 555
+ + + I G+FG ++L G+ AIK+ K ++ E I ++
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLEC-----VKTKHPQLHIESKIYKMMQGGV 65
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 613
+ + D +VME L G L L + V + +++ +EY+HS
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLAD-QMISRIEYIHS 123
Query: 614 LGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
+HRD+KPDN L+ + + DFGL+K D + H P
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK-----KYRDARTHQ---------HIP- 168
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP---FTAESP 727
R + GT Y + LG E D S+G +L F G P A +
Sbjct: 169 -----YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 223
Query: 728 EIIFDNILNRKI 739
++ I +K+
Sbjct: 224 RQKYERISEKKM 235
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 60/231 (25%), Positives = 94/231 (40%), Gaps = 31/231 (13%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+D + + I RG FG VF R R L A+K ++ + + L E IL +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSH 171
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHS 613
P +VR T + +Y+VME + GGD + LR G + + + +EYL S
Sbjct: 172 PNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
+HRDL N L+ +K++DFG+S+ +
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSR-----------------EEADGVYAA---- 270
Query: 674 TDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 722
P + APE L + +D WS GI+L+E + G P+
Sbjct: 271 -----SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 64/257 (24%), Positives = 101/257 (39%), Gaps = 49/257 (19%)
Query: 476 QSSGVSTPLHSSHKERTSI--DDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLK 529
G L + T + I+ + G FG+V L T D + A+K LK
Sbjct: 10 HHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK 69
Query: 530 KLDMIRKNDIERILAERNILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLR 587
E +IL T+ + ++++ +L LVMEY+ G L L
Sbjct: 70 --ADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLP 127
Query: 588 KVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 640
+ I +A+L+L + YLH+ +HRDL N+L+ +D +K+ DFG
Sbjct: 128 R--------HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFG 179
Query: 641 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHG 700
L+K + + DG P + APE L +
Sbjct: 180 LAK--AVPEGHEYYRVREDGDSPV----------------------FWYAPECLKEYKFY 215
Query: 701 YAADWWSVGIILFEFIT 717
YA+D WS G+ L+E +T
Sbjct: 216 YASDVWSFGVTLYELLT 232
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 60/237 (25%), Positives = 106/237 (44%), Gaps = 48/237 (20%)
Query: 495 DDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 550
+ ++ + +G FG V + R + TG++ A+K L+ D E IL
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILK 66
Query: 551 TVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-- 606
++++ +V++ R NL L+MEYL G L L+K RI +L+
Sbjct: 67 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHK------ERIDHIKLLQYT 120
Query: 607 -----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 661
+EYL + +HRDL N+L+ ++ +K+ DFGL+K +
Sbjct: 121 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK-----------------V 163
Query: 662 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT 717
+P D + ++ + +P + APE L ++ A+D WS G++L+E T
Sbjct: 164 LPQDKEF--FKVKEPGE------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 57/253 (22%), Positives = 91/253 (35%), Gaps = 45/253 (17%)
Query: 489 KERTSIDD-----FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKK------------- 530
E +DD + + K I G FG ++LA + A V+K
Sbjct: 26 PEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELK 85
Query: 531 -LDMIRKNDIERILAERNILITVRNPFVVRF-FYSFTCRDNLYLVMEYLNGGDLYSLLRK 588
+ K D + ER L + P F R ++VME L G DL + +
Sbjct: 86 FYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ 144
Query: 589 VGCL-EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIG 645
G + V ++ I ++ LEY+H VH D+K NLL+ + + L D+GLS
Sbjct: 145 NGTFKKSTVLQLGI-RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
Query: 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 705
N Y E R GT ++ + + G +D
Sbjct: 204 CPNGN--------------HKQYQE------NPRKGHNGTIEFTSLDAHKGVALSRRSDV 243
Query: 706 WSVGIILFEFITG 718
+G + ++ G
Sbjct: 244 EILGYCMLRWLCG 256
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 5e-23
Identities = 65/254 (25%), Positives = 110/254 (43%), Gaps = 49/254 (19%)
Query: 480 VSTPLHSSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDM 533
VS ++ + T + + I+ + G FG+V L R GD A+K LK
Sbjct: 4 VSEKKPATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PE 61
Query: 534 IRKNDIERILAERNILITVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 591
N I + E IL + + +V++ + + + L+ME+L G L L K
Sbjct: 62 SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK--- 118
Query: 592 LEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644
+ +I + + + ++YL S VHRDL N+L+ + +K+ DFGL+K
Sbjct: 119 ---NKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK- 174
Query: 645 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAA 703
+ +D Y Y D+R+ +P + APE L+ ++ A+
Sbjct: 175 ----------------AIETDKEY--YTVKDDRD------SPVFWYAPECLMQSKFYIAS 210
Query: 704 DWWSVGIILFEFIT 717
D WS G+ L E +T
Sbjct: 211 DVWSFGVTLHELLT 224
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 66/262 (25%), Positives = 114/262 (43%), Gaps = 51/262 (19%)
Query: 495 DDFEIIKPISRGAFGRVFLAR----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 550
+ ++ + +G FG V + R + TG++ A+K L+ D E IL
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF---EREIEILK 97
Query: 551 TVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-- 606
++++ +V++ R NL L+MEYL G L L+K RI +L+
Sbjct: 98 SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK------HKERIDHIKLLQYT 151
Query: 607 -----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 661
+EYL + +HRDL N+L+ ++ +K+ DFGL+K +
Sbjct: 152 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK-----------------V 194
Query: 662 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 720
+P D Y Y+ + +P + APE L ++ A+D WS G++L+E T I
Sbjct: 195 LPQDKEY--YKVKEPGE------SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIE 246
Query: 721 PFTAESPEIIFDNILNRKIPWP 742
++SP F ++
Sbjct: 247 K--SKSPPAEFMRMIGN-DKQG 265
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 68/265 (25%), Positives = 106/265 (40%), Gaps = 49/265 (18%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILI 550
+ I + +G FG V L R GD L A+K L+ ++ D E IL
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDF---QREIQILK 79
Query: 551 TVRNPFVVRFF--YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-- 606
+ + F+V++ R +L LVMEYL G L L++ AR+ + L+L
Sbjct: 80 ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR------HRARLDASRLLLYS 133
Query: 607 -----ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGI 661
+EYL S VHRDL N+L+ + H+K+ DFGL+K +
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK-----------------L 176
Query: 662 MPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GI 719
+P D Y Y + +P + APE L +D WS G++L+E T
Sbjct: 177 LPLDKDY--YVVREPG------QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCD 228
Query: 720 PPFTAESPEIIFDNILNRKIPWPCV 744
+ + + +
Sbjct: 229 KSCSPSAEFLRMMGCERDVPALSRL 253
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 7e-22
Identities = 60/255 (23%), Positives = 101/255 (39%), Gaps = 36/255 (14%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 555
F + + I G+FG ++L T + AIK+ K ++L E I ++
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLEN-----VKTKHPQLLYESKIYRILQGGT 63
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHS 613
+ + D LVM+ L G L L + V + +++ +E++HS
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD-QMINRVEFVHS 121
Query: 614 LGIVHRDLKPDNLLIAHDGH---IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
+HRD+KPDN L+ + + DFGL+K D S + H P
Sbjct: 122 KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK-----KYRDTSTHQ---------HIPY 167
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT---AESP 727
R + GT Y + LG E D S+G +L F+ G P+ A +
Sbjct: 168 ------RENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTK 221
Query: 728 EIIFDNILNRKIPWP 742
+ ++ I +K+
Sbjct: 222 KQKYEKISEKKVATS 236
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 9e-22
Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 47/237 (19%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ + + +G FG V++ T + AIK LK M E L E ++ +R+
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 238
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 607
+V+ + + + +Y+V EY++ G L L+ E + + +LV
Sbjct: 239 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASG 292
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
+ Y+ + VHRDL+ N+L+ + K+ DFGL++
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR---------------------LIE 331
Query: 668 YPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 722
EY P + APE L +D WS GI+L E T G P+
Sbjct: 332 DNEYTARQGAK------FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 382
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 54/232 (23%), Positives = 98/232 (42%), Gaps = 35/232 (15%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
D + + G +G V+ + A+K LK+ M ++E L E ++ +++
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 275
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIA-ELVLALEYLH 612
P +V+ T Y++ E++ G+L LR+ E +Y+A ++ A+EYL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
+HR+L N L+ + +K+ DFGLS++ D Y
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRL-----------MTGD----------TYT 374
Query: 673 QTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 722
P + APE L + +D W+ G++L+E T G+ P+
Sbjct: 375 AHAGAK------FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 420
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 98.0 bits (244), Expect = 2e-21
Identities = 56/237 (23%), Positives = 94/237 (39%), Gaps = 47/237 (19%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ + + +G FG V++ T + AIK LK M E L E ++ +R+
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 321
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 607
+V+ + + + +Y+V EY++ G L L+ E + + +LV
Sbjct: 322 EKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKG-----ETGKYLRLPQLVDMAAQIASG 375
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
+ Y+ + VHRDL+ N+L+ + K+ DFGL++
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR---------------------LIE 414
Query: 668 YPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 722
EY P + APE L +D WS GI+L E T G P+
Sbjct: 415 DNEYTARQGAK------FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 57/241 (23%), Positives = 98/241 (40%), Gaps = 48/241 (19%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILI 550
+F+ IK + GAFG V+ G+ AIK L++ + IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMA 72
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---- 606
+V NP V R + L+ + + G L +R+ I L+
Sbjct: 73 SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQ 125
Query: 607 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
+ YL +VHRDL N+L+ H+K+TDFGL+K ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-----------------LLG 168
Query: 664 SDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 721
++ Y + P ++A E +L + + +D WS G+ ++E +T G P
Sbjct: 169 AEEKE--YHAEGGK-------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 722 F 722
+
Sbjct: 220 Y 220
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 5e-21
Identities = 46/276 (16%), Positives = 87/276 (31%), Gaps = 50/276 (18%)
Query: 473 SVSQSSGVSTPLHSSHKERTSIDD-----FEIIKPISRGAFGRVFLARKRTTGDL----- 522
+ S L I D +++ PI +G FG ++LA ++ +
Sbjct: 8 QAGRQSSAKRHLAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAP 67
Query: 523 FAIKVLKK-----------LDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571
+KV K + + L + P Y
Sbjct: 68 CVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY-WGSGLHDKNGKSY 126
Query: 572 --LVMEYLNGGDLYSLLRKVGCL--EEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLL 627
++M+ G DL + + V ++ + ++ LEY+H VH D+K NLL
Sbjct: 127 RFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSL-RILDILEYIHEHEYVHGDIKASNLL 184
Query: 628 I--AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGT 685
+ + + L D+GL+ Y + GT
Sbjct: 185 LNYKNPDQVYLVDYGLAYRYCPEGV--------------HKAYAA------DPKRCHDGT 224
Query: 686 PDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPP 721
++ + + G D +G + +++TG P
Sbjct: 225 IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 61/277 (22%), Positives = 109/277 (39%), Gaps = 57/277 (20%)
Query: 487 SHKERTSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRK 536
S + + ++D I + + +G FG V A+ + F A+K+LK D+I
Sbjct: 8 SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA-DIIAS 66
Query: 537 NDIERILAERNILITVRNPFVVRFF------YSFTCRDNLYLVMEYLNGGDLYSLLRKVG 590
+DIE L E + +P V + + +++ ++ GDL++ L
Sbjct: 67 SDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASR 126
Query: 591 CLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
E + + LV +EYL S +HRDL N ++A D + + DFGLS+
Sbjct: 127 IGENP-FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185
Query: 644 IGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRN---RHSAVGTPDYLAPEILLGTEHG 700
I D Y+Q + +LA E L +
Sbjct: 186 ----------------KIYSGD----YYRQGCASKLPVK--------WLALESLADNLYT 217
Query: 701 YAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 736
+D W+ G+ ++E +T G P+ I++ ++
Sbjct: 218 VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 55/242 (22%), Positives = 90/242 (37%), Gaps = 48/242 (19%)
Query: 495 DDFEIIKPISRGAFGRVFLAR-KRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILIT 551
D +++ + G+FG V +G A+K LK + + ++ + E N + +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 552 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 606
+ + ++R Y + +V E G L LRK + L
Sbjct: 78 LDHRNLIRL-YGVVLTPPMKMVTELAPLGSLLDRLRKHQ------GHFLLGTLSRYAVQV 130
Query: 607 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 664
+ YL S +HRDL NLL+A +K+ DFGL + + +
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA----------------LPQN 174
Query: 665 DAHYPEYQQTDNRNRHSAVGT--P-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 720
D HY P + APE L +A+D W G+ L+E T G
Sbjct: 175 DDHY-----------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223
Query: 721 PF 722
P+
Sbjct: 224 PW 225
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 2e-20
Identities = 38/152 (25%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
D + + G +G V+ + A+K LK+ M ++E L E ++ +++
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 68
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARI--YIAELVLALEYLH 612
P +V+ T Y++ E++ G+L LR+ E + ++ A+EYL
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644
+HRDL N L+ + +K+ DFGLS++
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL 160
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 2e-20
Identities = 35/157 (22%), Positives = 66/157 (42%), Gaps = 18/157 (11%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ ++ I G FG V L + AIK +++ M E + E +++ + +
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMKLSH 62
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 607
P +V+ + + + LV E++ G L LR L+
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR------GLFAAETLLGMCLDVCEG 116
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644
+ YL ++HRDL N L+ + IK++DFG+++
Sbjct: 117 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 40/160 (25%), Positives = 73/160 (45%), Gaps = 12/160 (7%)
Query: 495 DDFEI--------IKPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILA 544
+ + K + G FG V + + A+K+LK + + +LA
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLA 67
Query: 545 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 604
E N++ + NP++VR ++ LVME G L L++ +++ + ++
Sbjct: 68 EANVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126
Query: 605 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644
+ ++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 7e-20
Identities = 38/151 (25%), Positives = 78/151 (51%), Gaps = 6/151 (3%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
++ ++K + G FG V L + + D+ A+K++K+ M + E ++ + +
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM----SEDEFFQEAQTMMKLSH 62
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHS 613
P +V+F+ + +Y+V EY++ G L + LR G E + + ++ + +L S
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644
+HRDL N L+ D +K++DFG+++
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 34/152 (22%), Positives = 80/152 (52%), Gaps = 8/152 (5%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ ++++ + G FG V++ + A+K LK+ M + LAE N++ +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIA-ELVLALEYLH 612
+VR + T ++ +Y++ EY+ G L L+ ++ + + + +A ++ + ++
Sbjct: 68 QRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644
+HRDL+ N+L++ K+ DFGL+++
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARL 158
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 58/253 (22%), Positives = 100/253 (39%), Gaps = 48/253 (18%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRKNDIERILAERNILI 550
+F+ IK + GAFG V+ G+ AIK L++ + IL E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMA 72
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL---- 606
+V NP V R + L+ + + G L +R+ I L+
Sbjct: 73 SVDNPHVCRL-LGICLTSTVQLITQLMPFGCLLDYVREHK------DNIGSQYLLNWCVQ 125
Query: 607 ---ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
+ YL +VHRDL N+L+ H+K+TDFGL+K ++
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK-----------------LLG 168
Query: 664 SDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 721
++ Y + P ++A E +L + + +D WS G+ ++E +T G P
Sbjct: 169 AEEKE--YHAEGGK-------VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
Query: 722 FTAESPEIIFDNI 734
+ I +
Sbjct: 220 YDGIPASEISSIL 232
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 18/157 (11%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
D +K + G FG V + R D+ AIK++K+ M + + E +++ + +
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEEAKVMMNLSH 78
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 607
+V+ + T + ++++ EY+ G L + LR++ R +L+ A
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR------HRFQTQQLLEMCKDVCEA 132
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644
+EYL S +HRDL N L+ G +K++DFGLS+
Sbjct: 133 MEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 65/253 (25%), Positives = 100/253 (39%), Gaps = 45/253 (17%)
Query: 483 PLHSSHKERTSID--DFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKN 537
P + I+ I K I G G V R R G AIK LK +
Sbjct: 35 PGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ER 92
Query: 538 DIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVA 597
L+E +I+ +P ++R T +V EY+ G L + LR
Sbjct: 93 QRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD------G 146
Query: 598 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650
+ I +LV + YL LG VHRDL N+L+ + K++DFGLS+ ++ +
Sbjct: 147 QFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSR--VLEDD 204
Query: 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 710
D + T G +P + T APE + A+D WS G+
Sbjct: 205 PDAAYTTTGGKIP-------IRWT---------------APEAIAFRTFSSASDVWSFGV 242
Query: 711 ILFEFIT-GIPPF 722
+++E + G P+
Sbjct: 243 VMWEVLAYGERPY 255
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-19
Identities = 35/157 (22%), Positives = 79/157 (50%), Gaps = 18/157 (11%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ ++ K + G FG V++A + A+K +K M +E LAE N++ T+++
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 242
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------A 607
+V+ T ++ +Y++ E++ G L L+ ++ ++ + +L+
Sbjct: 243 DKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKS-----DEGSKQPLPKLIDFSAQIAEG 296
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644
+ ++ +HRDL+ N+L++ K+ DFGL+++
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV 333
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 34/165 (20%), Positives = 69/165 (41%), Gaps = 19/165 (11%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLF-------AIKVLKKLDMIRKNDIERILAERN 547
+D + + +G F ++F +R GD +KVL K +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF---FEAAS 64
Query: 548 ILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVL 606
++ + + +V + C D LV E++ G L + L+K + ++ +A +L
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAHDGH--------IKLTDFGLSK 643
A+ +L ++H ++ N+L+ + IKL+D G+S
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 6e-19
Identities = 58/273 (21%), Positives = 102/273 (37%), Gaps = 55/273 (20%)
Query: 467 SRLILDSVSQSSGVSTPLHSSHKE--RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF- 523
+ + + S + + E + + K I G FG V+ +T+
Sbjct: 17 TENLYFQGAMGSDPNQAVLKFTTEIHPSCV---TRQKVIGAGEFGEVYKGMLKTSSGKKE 73
Query: 524 ---AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGG 580
AIK LK + L E I+ + ++R + + ++ EY+ G
Sbjct: 74 VPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENG 131
Query: 581 DLYSLLRKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGH 633
L LR+ + +LV ++YL ++ VHRDL N+L+ +
Sbjct: 132 ALDKFLREKD------GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV 185
Query: 634 IKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGT--P-DYLA 690
K++DFGLS++ D Y + G P + A
Sbjct: 186 CKVSDFGLSRV------------------LEDDPEATY---------TTSGGKIPIRWTA 218
Query: 691 PEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 722
PE + + A+D WS GI+++E +T G P+
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 251
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 6e-19
Identities = 46/273 (16%), Positives = 92/273 (33%), Gaps = 52/273 (19%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDL--------FAIKVLKK--------LDMIRKNDIE 540
+++ +R G ++ A +T F++K+ K R
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 541 RILAERNILITVRNPFVVRFFYSFTCRDNL-YLVMEYLNGGDLYSLLRKVGCL---EEDV 596
++ + L + + +D +LV+ L G L S L E V
Sbjct: 104 QVNKWKK-LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSV 161
Query: 597 ARIYIAELVLALEYLHSLGIVHRDLKPDNLLI--AHDGHIKLTDFGLSKIGLINNTIDLS 654
++ L+ ALE+LH VH ++ +N+ + + L +G +
Sbjct: 162 LQVAC-RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR---------- 210
Query: 655 GPETDGIMPSDAH--YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 712
PS H Y E +R G ++++ ++ G +D S+G +
Sbjct: 211 ------YCPSGKHVAYVE------GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCM 258
Query: 713 FEFITGIPP---FTAESPEIIFDNILNRKIPWP 742
+++ G P + +I+ P P
Sbjct: 259 LKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGP 291
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 8e-19
Identities = 48/255 (18%), Positives = 97/255 (38%), Gaps = 53/255 (20%)
Query: 483 PLHSSHKE--RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF----AIKVLKKLDMIRK 536
+ + T + +K + G FG V G+ IKV++ D +
Sbjct: 2 AMKVLARIFKETEL---RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGR 56
Query: 537 NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDV 596
+ + + ++ + +VR +L LV +YL G L +R+
Sbjct: 57 QSFQAVTDHMLAIGSLDHAHIVRL-LGLCPGSSLQLVTQYLPLGSLLDHVRQ------HR 109
Query: 597 ARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649
+ L+ + YL G+VHR+L N+L+ +++ DFG++
Sbjct: 110 GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVAD------ 163
Query: 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSV 708
++P D ++ + TP ++A E + ++ + +D WS
Sbjct: 164 -----------LLPPDDKQ--LLYSEAK-------TPIKWMALESIHFGKYTHQSDVWSY 203
Query: 709 GIILFEFIT-GIPPF 722
G+ ++E +T G P+
Sbjct: 204 GVTVWELMTFGAEPY 218
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 1e-18
Identities = 46/197 (23%), Positives = 77/197 (39%), Gaps = 26/197 (13%)
Query: 471 LDSVSQSSGVSTPLHSSHKE--RTSIDDFEI-------IKPISRGAFGRVFLARKRTTGD 521
+ S S+ L E + ++D I K + G FG V +
Sbjct: 1 MGSSHHHHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDG 60
Query: 522 LF---AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-----YSFTCRDNLYLV 573
A+K +K D + +IE L+E + +P V+R S ++
Sbjct: 61 TSLKVAVKTMKL-DNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVI 119
Query: 574 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNL 626
+ ++ GDL++ L LE I + L+ +EYL + +HRDL N
Sbjct: 120 LPFMKYGDLHTYLLYSR-LETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNC 178
Query: 627 LIAHDGHIKLTDFGLSK 643
++ D + + DFGLSK
Sbjct: 179 MLRDDMTVCVADFGLSK 195
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 61/242 (25%), Positives = 97/242 (40%), Gaps = 50/242 (20%)
Query: 495 DDFEIIK-PISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILIT 551
D+ I + G FG V R AIKVLK+ K D E ++ E I+
Sbjct: 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQ 66
Query: 552 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 606
+ NP++VR + L LVME GG L+ L I ++ +
Sbjct: 67 LDNPYIVRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQV 119
Query: 607 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 664
++YL VHRDL N+L+ + + K++DFGLSK +
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA----------------LGAD 163
Query: 665 DAHYPEYQQTDNRNRHSAVGT--P-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIP 720
D++Y + P + APE + + +D WS G+ ++E ++ G
Sbjct: 164 DSYY-----------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
Query: 721 PF 722
P+
Sbjct: 213 PY 214
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 66/256 (25%), Positives = 103/256 (40%), Gaps = 50/256 (19%)
Query: 481 STPLHSSHKE--RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIR 535
+ +H KE T+I I K + G FG V R + AIK LK
Sbjct: 32 TQTVHEFAKELDATNI---SIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-- 86
Query: 536 KNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEED 595
+ L E +I+ +P ++R T + +V EY+ G L S LRK
Sbjct: 87 EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD----- 141
Query: 596 VARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648
A+ + +LV ++YL +G VHRDL N+LI + K++DFGL ++
Sbjct: 142 -AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRV---- 196
Query: 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWS 707
D Y + P + +PE + + A+D WS
Sbjct: 197 --------------LEDDPEAAYTTRGGK-------IPIRWTSPEAIAYRKFTSASDVWS 235
Query: 708 VGIILFEFIT-GIPPF 722
GI+L+E ++ G P+
Sbjct: 236 YGIVLWEVMSYGERPY 251
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-18
Identities = 54/266 (20%), Positives = 103/266 (38%), Gaps = 57/266 (21%)
Query: 495 DDFEIIKPISRGAFGRVFLAR-KRTTGD----LFAIKVLKKLDMIRKNDIERILAERNIL 549
+ + + + +G+FG V+ K D AIK + + +R + L E +++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 82
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---VGCLEEDVARIYIAELVL 606
VVR + ++ME + GDL S LR +A +++++
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 607 -------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659
+ YL++ VHRDL N ++A D +K+ DFG+++
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR---------------- 186
Query: 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYL-----APEILLGTEHGY--AADWWSVGIIL 712
D + +Y + + L +PE L + + +D WS G++L
Sbjct: 187 -----DIYETDYYRKGGKGL---------LPVRWMSPESLK--DGVFTTYSDVWSFGVVL 230
Query: 713 FEFIT-GIPPFTAESPEIIFDNILNR 737
+E T P+ S E + ++
Sbjct: 231 WEIATLAEQPYQGLSNEQVLRFVMEG 256
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 2e-18
Identities = 40/160 (25%), Positives = 70/160 (43%), Gaps = 19/160 (11%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILIT 551
+D + + + G FG V+ A+K KK + E+ ++E I+
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKN 69
Query: 552 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL----- 606
+ +P +V+ + +++ME G+L L + + + LVL
Sbjct: 70 LDHPHIVKL-IGIIEEEPTWIIMELYPYGELGHYLERNK------NSLKVLTLVLYSLQI 122
Query: 607 --ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644
A+ YL S+ VHRD+ N+L+A +KL DFGLS+
Sbjct: 123 CKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 26/170 (15%)
Query: 492 TSIDDFEI-------IKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIER 541
+S D+EI + I G FG V + + AIK K E+
Sbjct: 5 SSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREK 62
Query: 542 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYI 601
L E + +P +V+ + ++++ME G+L S L+ + +
Sbjct: 63 FLQEALTMRQFDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRK------YSLDL 115
Query: 602 AELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644
A L+L AL YL S VHRD+ N+L++ + +KL DFGLS+
Sbjct: 116 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 44/152 (28%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ ++++ I +G FG V L R A+K +K + LAE +++ +R+
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA-----FLAEASVMTQLRH 73
Query: 555 PFVVRFFYSFT-CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIAELV-LALEYL 611
+V+ + LY+V EY+ G L LR G + + V A+EYL
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
VHRDL N+L++ D K++DFGL+K
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 5e-18
Identities = 55/302 (18%), Positives = 109/302 (36%), Gaps = 60/302 (19%)
Query: 455 KSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLA 514
K+ + ++ + + +D + + + + S + I RG FG V+
Sbjct: 50 KAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGP-SSLIVHFNEVIGRGHFGCVYHG 108
Query: 515 RKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-YSFTCRDNL 570
A+K L ++ I ++ + L E I+ +P V+ +
Sbjct: 109 TLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166
Query: 571 YLVMEYLNGGDLYSLLRK----------VGCLEEDVARIYIAELVLALEYLHSLGIVHRD 620
+V+ Y+ GDL + +R +G VA+ +++L S VHRD
Sbjct: 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAK--------GMKFLASKKFVHRD 217
Query: 621 LKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN---- 676
L N ++ +K+ DFGL++ + + +
Sbjct: 218 LAARNCMLDEKFTVKVADFGLARD----------------MYDKE--FDSVHNKTGAKLP 259
Query: 677 -RNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNI 734
+ ++A E L + +D WS G++L+E +T G PP+ + I +
Sbjct: 260 VK----------WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309
Query: 735 LN 736
L
Sbjct: 310 LQ 311
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 5e-18
Identities = 56/246 (22%), Positives = 100/246 (40%), Gaps = 36/246 (14%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILIT 551
+ E+ + I G FG V + + AIK K + E+ L E +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--DSVREKFLQEALTMRQ 447
Query: 552 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEY 610
+P +V+ + ++++ME G+L S L+ L+ +Y +L AL Y
Sbjct: 448 FDHPHIVKL-IGVITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
L S VHRD+ N+L++ + +KL DFGLS+ + ++
Sbjct: 507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR--YMEDST------------------Y 546
Query: 671 YQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 728
Y+ + + P ++APE + A+D W G+ ++E + G+ PF
Sbjct: 547 YKASKGK-------LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 599
Query: 729 IIFDNI 734
+ I
Sbjct: 600 DVIGRI 605
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-18
Identities = 55/254 (21%), Positives = 97/254 (38%), Gaps = 49/254 (19%)
Query: 498 EIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ I RG FG V+ A+K L ++ I ++ + L E I+ +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIG--EVSQFLTEGIIMKDFSH 85
Query: 555 PFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRK----------VGCLEEDVARIYIAE 603
P V+ + +V+ Y+ GDL + +R +G VA+
Sbjct: 86 PNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL-QVAK----- 139
Query: 604 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
++YL S VHRDL N ++ +K+ DFGL++ + + +T +P
Sbjct: 140 ---GMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR-DMYDKEYYSVHNKTGAKLP 195
Query: 664 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 722
++A E L + +D WS G++L+E +T G PP+
Sbjct: 196 V----------------------KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233
Query: 723 TAESPEIIFDNILN 736
+ I +L
Sbjct: 234 PDVNTFDITVYLLQ 247
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 45/169 (26%), Positives = 75/169 (44%), Gaps = 24/169 (14%)
Query: 495 DDFEIIKPISRGAFGRVFLAR-KRTTGD----LFAIKVLKKLDMIRKNDIERILAERNIL 549
D + + + GAFG+VFLA + L A+K LK + + D E +L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF---QREAELL 71
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDVARIY 600
+++ +V+F+ D L +V EY+ GDL LR G + +
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 601 IAELV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 642
+++++ + YL S VHRDL N L+ + +K+ DFG+S
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 1e-17
Identities = 66/296 (22%), Positives = 111/296 (37%), Gaps = 51/296 (17%)
Query: 442 REKYILACELLDEKSPTSFSKYKENSRLILDSVSQSSGVSTPLHSSHKERTSIDDFEII- 500
+ + P + + + +D+ S S P K+ D +I
Sbjct: 281 QRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIA 340
Query: 501 -KPISRGAFGRVFLARKRTTGDLF--AIKVLKKLDMIRKNDIERILAERNILITVRNPFV 557
+ G FG V R AIKVLK+ K D E ++ E I+ + NP++
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYI 398
Query: 558 VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL-------ALEY 610
VR + L LVME GG L+ L I ++ + ++Y
Sbjct: 399 VRL-IGVCQAEALMLVMEMAGGGPLHKFLVGKR------EEIPVSNVAELLHQVSMGMKY 451
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
L VHR+L N+L+ + + K++DFGLSK + D++Y
Sbjct: 452 LEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA----------------LGADDSYY-- 493
Query: 671 YQQTDNRNRHSAVGT--P-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPF 722
+ P + APE + + +D WS G+ ++E ++ G P+
Sbjct: 494 ---------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 540
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-17
Identities = 48/168 (28%), Positives = 72/168 (42%), Gaps = 23/168 (13%)
Query: 495 DDFEIIKPISRGAFGRVFLAR-KRTTGD----LFAIKVLKKLDMIRKNDIERILAERNIL 549
D + + GAFG+VFLA + L A+K LK+ + D E +L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF---QREAELL 97
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK--------VGCLEEDVARIYI 601
+++ +VRFF T L +V EY+ GDL LR G + + +
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 602 AELV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 642
+L+ + YL L VHRDL N L+ +K+ DFG+S
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 5e-17
Identities = 70/281 (24%), Positives = 108/281 (38%), Gaps = 63/281 (22%)
Query: 461 SKYKENSRLILDSVSQSSGVSTPLHS-SHKE-RTSIDDFEIIKPISRGAFGRVFLARKRT 518
SKY + + I D++S S V + + + ++F+ I G FG+V+ R
Sbjct: 3 SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD 62
Query: 519 TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFF-YSFTC--RDNLYLVME 575
G A+K IE E L R+P +V + C R+ + L+ +
Sbjct: 63 -GAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGF---CDERNEMILIYK 115
Query: 576 YLNGGDLYSLLRKVGCLEED---VARIYIA-ELVLALEYLHSLGIVHRDLKPDNLLIAHD 631
Y+ G+L L R+ I L YLH+ I+HRD+K N+L+ +
Sbjct: 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDEN 175
Query: 632 GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRH--SAV-GTPDY 688
K+TDFG+SK G E QT H + V GT Y
Sbjct: 176 FVPKITDFGISKKG-----------------------TELDQT-----HLSTVVKGTLGY 207
Query: 689 LAPEILLGTEHGYA--------ADWWSVGIILFEFITGIPP 721
+ PE Y +D +S G++LFE +
Sbjct: 208 IDPE--------YFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 5e-17
Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 31/178 (17%)
Query: 495 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
+ + K + G FG+V A R A+K+LK+ ++ +L+E N+L
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS--ELRDLLSEFNVL 80
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----------------VGCL 592
V +P V++ + + + L L++EY G L LR+
Sbjct: 81 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140
Query: 593 EEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
D + + +L+ ++YL + +VHRDL N+L+A +K++DFGLS+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 7e-17
Identities = 48/168 (28%), Positives = 70/168 (41%), Gaps = 21/168 (12%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAERNILITV 552
+D + I G FG+V AR + G AIK +K+ K+D E +L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKL 82
Query: 553 -RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL--- 608
+P ++ + R LYL +EY G+L LRK LE D A L
Sbjct: 83 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 609 -------------EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
+YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 8e-17
Identities = 59/234 (25%), Positives = 95/234 (40%), Gaps = 40/234 (17%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER-ILAERNILITVRNPFVVRFF 561
+ G FG V+ + A+K L + I ++++ E ++ ++ +V
Sbjct: 39 MGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 562 -YSFTCRDNLYLVMEYLNGGDLYS-LLRKVGCLEED-VARIYIAELVLA--LEYLHSLGI 616
+S D+L LV Y+ G L L G R IA A + +LH
Sbjct: 97 GFSSD-GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIA-QGAANGINFLHENHH 154
Query: 617 VHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDN 676
+HRD+K N+L+ K++DFGL++ ++ QT
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARAS-----------------------EKFAQTVM 191
Query: 677 RNRHSAVGTPDYLAPEILLG--TEHGYAADWWSVGIILFEFITGIPPFTAESPE 728
+R VGT Y+APE L G T +D +S G++L E ITG+P
Sbjct: 192 TSR--IVGTTAYMAPEALRGEITPK---SDIYSFGVVLLEIITGLPAVDEHREP 240
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 9e-17
Identities = 45/152 (29%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ ++++ I +G FG V L R G+ A+K +K + LAE +++ +R+
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA-----FLAEASVMTQLRH 245
Query: 555 PFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVAR-IYIAELV-LALEYL 611
+V+ + LY+V EY+ G L LR G + + V A+EYL
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 305
Query: 612 HSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
VHRDL N+L++ D K++DFGL+K
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 41/173 (23%), Positives = 77/173 (44%), Gaps = 26/173 (15%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLF-------AIKVLKKLDMIRKNDIERILAERN 547
D + KP+ GAFG+V +A A+K+LK + D+ +++E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 92
Query: 548 ILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDVA 597
++ + ++ ++ + T LY+++EY + G+L LR
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 152
Query: 598 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
++ +LV +EYL S +HRDL N+L+ + +K+ DFGL++
Sbjct: 153 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 51/259 (19%), Positives = 94/259 (36%), Gaps = 46/259 (17%)
Query: 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLF---AIKVLKKLDMIRKNDIERILAER 546
ER + I +G FG V+ AIK L ++ ++ +E L E
Sbjct: 19 ERVVT---HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ--QVEAFLREG 73
Query: 547 NILITVRNPFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 605
++ + +P V+ + ++++ Y+ GDL +R + +L+
Sbjct: 74 LLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ------RNPTVKDLI 127
Query: 606 L-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 658
+EYL VHRDL N ++ +K+ DFGL++ +++
Sbjct: 128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARD-ILDREYYSVQQHR 186
Query: 659 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT- 717
+P + A E L +D WS G++L+E +T
Sbjct: 187 HARLPV----------------------KWTALESLQTYRFTTKSDVWSFGVLLWELLTR 224
Query: 718 GIPPFTAESPEIIFDNILN 736
G PP+ P + +
Sbjct: 225 GAPPYRHIDPFDLTHFLAQ 243
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 24/203 (11%)
Query: 462 KYKENSRLILDSVSQSSGVSTPLHSSHKERTSI--DDFEIIKPISRGAFGRVFLA----- 514
KY+ ++I S P + E+ ++ + K + GAFG+V A
Sbjct: 11 KYQVRWKIIESYEGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGL 70
Query: 515 RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYLV 573
K A+K+LK + E +++E I+ + +V + T + ++
Sbjct: 71 GKEDAVLKVAVKMLKSTAHAD--EKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVI 128
Query: 574 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL--------------EYLHSLGIVHR 619
EY GDL + LR+ + E IA + +L S +HR
Sbjct: 129 TEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHR 188
Query: 620 DLKPDNLLIAHDGHIKLTDFGLS 642
D+ N+L+ + K+ DFGL+
Sbjct: 189 DVAARNVLLTNGHVAKIGDFGLA 211
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 36/169 (21%), Positives = 60/169 (35%), Gaps = 23/169 (13%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNIL 549
++ + FG+V+ AIK LK E E +
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE--GPLREEFRHEAMLR 66
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL- 608
+++P VV T L ++ Y + GDL+ L + + + AL
Sbjct: 67 ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126
Query: 609 ---------------EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 642
EYL S +VH+DL N+L+ ++K++D GL
Sbjct: 127 PPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 42/172 (24%), Positives = 73/172 (42%), Gaps = 26/172 (15%)
Query: 495 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
+ K + GAFG+V A K A+K+LK + + E +++E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT--EREALMSELKVL 80
Query: 550 ITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----------VGCLEEDVA 597
+ N +V + T ++ EY GDL + LR+ +E+D
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 598 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 642
+ + +L+ + +L S +HRDL N+L+ H K+ DFGL+
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-16
Identities = 41/173 (23%), Positives = 77/173 (44%), Gaps = 26/173 (15%)
Query: 495 DDFEIIKPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAERN 547
D + KP+ G FG+V +A K A+K+LK + D+ +++E
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEK--DLSDLVSEME 138
Query: 548 ILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK---------VGCLEEDVA 597
++ + ++ ++ + T LY+++EY + G+L LR
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEE 198
Query: 598 RIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
++ +LV +EYL S +HRDL N+L+ + +K+ DFGL++
Sbjct: 199 QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 3e-16
Identities = 44/178 (24%), Positives = 68/178 (38%), Gaps = 31/178 (17%)
Query: 495 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
++ E ++ I GAFGRVF AR + A+K+LK+ + E ++
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALM 104
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-----------------VGCL 592
NP +V+ + L+ EY+ GDL LR
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164
Query: 593 EEDVARIYIAELV-------LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
+ AE + + YL VHRDL N L+ + +K+ DFGLS+
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 17/164 (10%)
Query: 495 DDFEIIKPISRGAFGRVFLAR-KRTTGDLF----AIKVLKKLDMIRKNDIERILAERNIL 549
+ +I+ + GAFG V+ + D A+K L ++ + D L E I+
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 87
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL--- 606
+ +VR +++ME + GGDL S LR+ + + + +L+
Sbjct: 88 SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 607 ----ALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSK 643
+YL +HRD+ N L+ G K+ DFG+++
Sbjct: 148 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 37/164 (22%), Positives = 69/164 (42%), Gaps = 17/164 (10%)
Query: 495 DDFEIIKPISRGAFGRVFLAR-KRTTGDLF----AIKVLKKLDMIRKNDIERILAERNIL 549
+ +I+ + GAFG V+ + D A+K L ++ + D L E I+
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQ--DELDFLMEALII 128
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV---- 605
+ +VR ++++E + GGDL S LR+ + + + +L+
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 606 ---LALEYLHSLGIVHRDLKPDNLLIAHDGH---IKLTDFGLSK 643
+YL +HRD+ N L+ G K+ DFG+++
Sbjct: 189 DIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 5e-16
Identities = 45/172 (26%), Positives = 79/172 (45%), Gaps = 25/172 (14%)
Query: 495 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
D ++ KP+ RGAFG+V A K T A+K+LK+ + +++E IL
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 84
Query: 550 ITV-RNPFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRK---------VGCLEEDVAR 598
I + + VV + T L +++E+ G+L + LR V +
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 599 IYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
+ + L+ +E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-15
Identities = 42/173 (24%), Positives = 73/173 (42%), Gaps = 26/173 (15%)
Query: 495 DDFEIIKPISRGAFGRVFLAR-------KRTTGDLFAIKVLKKLDMIRKNDIERILAERN 547
D + KP+ GAFG+V LA K A+K+LK + D+ +++E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEK--DLSDLISEME 126
Query: 548 ILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 606
++ + ++ + T LY+++EY + G+L L+ + +
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 607 AL----------------EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
L EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-15
Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 31/177 (17%)
Query: 495 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
++ E K + GAFG+V A K A+K+LK+ + E +++E ++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS--EREALMSELKMM 102
Query: 550 ITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK----------------VGCL 592
+ + +V + T +YL+ EY GDL + LR
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 593 EEDVARIYIAELVL-------ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 642
EED+ + +L+ +E+L VHRDL N+L+ H +K+ DFGL+
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 78.4 bits (192), Expect = 7e-15
Identities = 101/726 (13%), Positives = 194/726 (26%), Gaps = 240/726 (33%)
Query: 204 HEQGQSLDGSDSVICRICEEVVPISHLESHSYICAYADKCELNCLDVDERLLKL--SEIL 261
H +D ++++ E A +C DV + + E +
Sbjct: 1 HHHHHHMDFETGEHQYQYKDILS--VFED-------AFVDNFDCKDVQDMPKSILSKEEI 51
Query: 262 EQISESCNSSSHP------ILGSPENSRTQSMNSAITYDGYSPKISEWRNK-----GVEG 310
+ I S ++ S +L E + + + + Y +S + + +
Sbjct: 52 DHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRIN-YKFLMSPIKTEQRQPSMMTR 110
Query: 311 MFEDIHEM---DTACIDDSHLGS----LNLRGHLGLKLS-----------GYGASSSTGS 352
M+ + + D ++ L LR L L+L G G +
Sbjct: 111 MYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQAL-LELRPAKNVLIDGVLGSGKTWVALD 169
Query: 353 MTSVSSTNTPKAGHFDPFWLERNHPAELEDVQQMIELADIARCVADTDFSKEGSEFLLAC 412
S F FWL ++ C + + + L
Sbjct: 170 --VCLSYKVQCKMDFKIFWL------------------NLKNCNSPETVLEMLQKLLYQI 209
Query: 413 MHDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDEKSPTSFSKYKENSRLILD 472
+ HS L I + + + +LL+ K Y+ N L+L
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK-----------------PYE-NCLLVLL 251
Query: 473 SV------------------SQSSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLA 514
+V ++ V+ L ++ S+D
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHS-------MTLT----- 299
Query: 515 RKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVV----RFFYSFTCR--- 567
L K LD R D L + NP +
Sbjct: 300 -PDEVKSLLL----KYLDC-RPQD----LPREVLTT---NPRRLSIIAESIRDGLATWDN 346
Query: 568 ------DNLYLVME----YLNGGDLYSLLRKVGCLEEDVARIYIAELVLA---------- 607
D L ++E L + + ++ +I ++L+
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA---HIPTILLSLIWFDVIKSD 403
Query: 608 ----LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
+ LH +V + K + I +++L ++ L + +D
Sbjct: 404 VMVVVNKLHKYSLVEKQPKESTISI-PSIYLELKVKLENEYALHRSIVD----------- 451
Query: 664 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFI------T 717
HY + D+ D L P Y + I
Sbjct: 452 ---HYNIPKTFDS----------DDLIPP----YLDQY----------FYSHIGHHLKNI 484
Query: 718 GIPPFTAESPEIIFD-NILNRKI-----PWPCVPSDMSFEAQDLIN--RFLI-HDP-NQR 767
P + D L +KI W S ++ Q L ++ +DP +R
Sbjct: 485 EHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN-TLQQLKFYKPYICDNDPKYER 543
Query: 768 LGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQI-SSGLPDDQN 826
L VN A+ F+P+ E + S+++ + L +
Sbjct: 544 L----------------VN----AILD--FLPKIE----ENLICSKYTDLLRIALMAEDE 577
Query: 827 GSYSDA 832
+ +A
Sbjct: 578 AIFEEA 583
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 70.7 bits (172), Expect = 2e-12
Identities = 77/597 (12%), Positives = 166/597 (27%), Gaps = 169/597 (28%)
Query: 414 HDLQDVLQHSKLKALVIDTFGSRIEKLLREKYILACELLDE--KSPTSFSKYKENSRLIL 471
+ +D+L A V + ++ + + IL+ E +D S + + +
Sbjct: 16 YQYKDILSVF-EDAFVDNFDCKDVQDMPKS--ILSKEEIDHIIMSKDA----VSGTLRLF 68
Query: 472 DSV--SQSSGVSTPLHSSHKERTSIDDFEII------KPISRGAFGRVFL-ARKRTTGDL 522
++ Q V + + +++ + + R+++ R R D
Sbjct: 69 WTLLSKQEEMVQKFVEEVLR-----INYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYND- 122
Query: 523 FAIKVLKKLDMIRKNDIERI-------------------------LAE---RNILITVRN 554
+V K ++ R ++ +A + + +
Sbjct: 123 --NQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKM 180
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
F + F+ + ++ V+E L L + D + + L L
Sbjct: 181 DFKI-FWLNLKNCNSPETVLEMLQ--KLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRL 237
Query: 615 GIVHRDLKPDNLLIAHD----GHIKLTDFGLSKIGLI----NNTIDLSGPETDGIMPSDA 666
+ + + LL+ + + KI L+ D T + D
Sbjct: 238 -LKSKPY-ENCLLVLLNVQNAKAWNAFNLS-CKI-LLTTRFKQVTDFLSAATTTHISLDH 293
Query: 667 HYPEYQQTDNRN-------------RHSAVGT-PDYLAPEILLGTE-HGYAADW------ 705
H + ++ + T P L+ ++ A W
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLS---IIAESIRDGLATWDNWKHV 350
Query: 706 --WSVGIILFEFITGIPPFTAESPEI-----IFDNILNRKIP-------WP-CVPSDMSF 750
+ I+ + + P AE ++ +F + IP W + SD+
Sbjct: 351 NCDKLTTIIESSLNVLEP--AEYRKMFDRLSVFPP--SAHIPTILLSLIWFDVIKSDVMV 406
Query: 751 EAQDLINRFL-----------IHDPNQRLGANGAAEVKAH-------PFFKGVNWDSLAL 792
L L I L E H K + D L
Sbjct: 407 VVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLI- 465
Query: 793 QKAVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGS--------YSDAD--------TCD 836
P +D YF +S I L + ++ + D
Sbjct: 466 --------PPYLDQ--YF---YSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDST 512
Query: 837 SSSNSRTEMDECGDLAEFG-----SCP----LDLSLINFSFKNLSQLASINHEVLVQ 884
+ + S + ++ L + + P L ++++F K L + L++
Sbjct: 513 AWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLR 569
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.1 bits (173), Expect = 3e-13
Identities = 45/219 (20%), Positives = 71/219 (32%), Gaps = 56/219 (25%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVL-----KKLDMIRKNDIERILAERN 547
+ + + I G FG VF AIK++ ++ + E IL E
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 548 IL-----------------ITVRNPFVVRFFY----------------------SFTCRD 568
I I + + V+ Y F D
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 569 NLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLALEYLH-SLGIVHRDLKPDNL 626
L++V+E+ GG DL + K+ A+ + +L +L SL HRDL N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 627 LIAHDGHIKLTDFGLSKI------GLINNTIDLSGPETD 659
L+ KL K GL + ID + +
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE 232
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 5e-13
Identities = 66/246 (26%), Positives = 100/246 (40%), Gaps = 58/246 (23%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
D+F + RG FG+V+ R G L A+K LK+ + + +++ E ++ +
Sbjct: 30 DNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKE-ERTQGGELQ-FQTEVEMISMAVH 86
Query: 555 PFVVRFFYSFTC--RDNLYLVMEYLNGGDLYSLLRKVGCLEEDV-----ARIYIAELVLA 607
++R F C LV Y+ G + S LR E R IA L A
Sbjct: 87 RNLLRL-RGF-CMTPTERLLVYPYMANGSVASCLR--ERPESQPPLDWPKRQRIA-LGSA 141
Query: 608 --LEYLH---SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 662
L YLH I+HRD+K N+L+ + + DFGL+K+ +T
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT------------ 189
Query: 663 PSDAHYPEYQQTDNRNRH--SAV-GTPDYLAPEILLGTEHGYA---ADWWSVGIILFEFI 716
H +AV GT ++APE L G + D + G++L E I
Sbjct: 190 -----------------HVTTAVRGTIGHIAPEYLS---TGKSSEKTDVFGYGVMLLELI 229
Query: 717 TGIPPF 722
TG F
Sbjct: 230 TGQRAF 235
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 39/186 (20%), Positives = 71/186 (38%), Gaps = 14/186 (7%)
Query: 495 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
D ++ KP+ RGAFG+V A K T A+K+LK + ++ +++E IL
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EGATHSEHRALMSELKIL 79
Query: 550 ITVRN-PFVVRFFYSFTCRDN-LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 607
I + + VV + T L +++E+ G+L + LR + + Y +
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS----KRNEFVPYKTKGARF 135
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK-IGLINNTIDLSGPETDGIMPSDA 666
+ +G + DLK I + F K + + D +
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195
Query: 667 HYPEYQ 672
+Q
Sbjct: 196 ICYSFQ 201
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 1e-05
Identities = 27/115 (23%), Positives = 48/115 (41%), Gaps = 28/115 (24%)
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 207 EFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR------------------------- 241
Query: 669 PEYQQTDNRNRHSAVGTP-DYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPP 721
+ + + R P ++APE + + +D WS G++L+E + G P
Sbjct: 242 -DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 2e-07
Identities = 34/149 (22%), Positives = 57/149 (38%), Gaps = 21/149 (14%)
Query: 503 ISRGAFGRVFLARKRTTGDLFAIKVLK-----KLD-MIRKNDIERILAERNILITVRNPF 556
I +GA + + +V K +LD IRK R E L V++
Sbjct: 344 IGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRK---SRTAREARYLALVKDFG 400
Query: 557 V-VRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 615
+ + + DN ++M Y+NG ++ + + I + LH
Sbjct: 401 IPAPYIFDVD-LDNKRIMMSYINGKLAKDVIEDNLDIAYKIGEI--------VGKLHKND 451
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644
++H DL N + D + + DFGL KI
Sbjct: 452 VIHNDLTTSNFIF--DKDLYIIDFGLGKI 478
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 28/169 (16%), Positives = 54/169 (31%), Gaps = 30/169 (17%)
Query: 487 SHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM------------- 533
+D I K + G VF +K K
Sbjct: 84 RLVRSGKVDA--IGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGD 140
Query: 534 IRKNDIERILAER--NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC 591
+ + + A L ++ V + + N ++ME ++ +LY +
Sbjct: 141 LHFSVLAIRSARNEFRALQKLQGLAVPKVYA---WEGNA-VLMELIDAKELYRVR----- 191
Query: 592 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFG 640
E+ + ++ + + GIVH DL N+L+ + I + DF
Sbjct: 192 -VENPDEVL-DMILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFP 237
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 9e-04
Identities = 32/168 (19%), Positives = 57/168 (33%), Gaps = 28/168 (16%)
Query: 498 EIIKPISRGAFGRVFLARKRTTGD--LFAIKVLK-------------------KLDMIRK 536
+ IS G VF A G A+K+ + + I
Sbjct: 50 AMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISP 109
Query: 537 NDIERILAERNILITVR-NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYS--LLRKVGCLE 593
+ I E+ R V +T N+ L+ME++ +L + L+ L+
Sbjct: 110 KEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNV-LLMEFIGEDELPAPTLVELGRELK 168
Query: 594 EDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFG 640
E ++V ++ L+ +VH DL N++ + D G
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMY--IDKVYFIDMG 214
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 900 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-91 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-89 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-88 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-86 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-85 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 4e-84 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-80 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-79 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-79 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-79 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-78 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-77 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-77 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-77 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-76 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-76 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-75 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-73 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-71 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-70 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-70 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-67 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-65 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 9e-65 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-64 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-63 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-63 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-62 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-61 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-60 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-60 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-59 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-59 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-58 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-58 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-58 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-58 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-57 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-56 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-56 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-56 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-55 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-55 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-55 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-55 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-52 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-52 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-50 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-50 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-49 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 7e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-46 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-46 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-45 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-38 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-20 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 288 bits (738), Expect = 3e-91
Identities = 101/312 (32%), Positives = 170/312 (54%), Gaps = 31/312 (9%)
Query: 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 550
+ +DF+ K + G+F V LAR+ T +AIK+L+K +I++N + + ER+++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 610
+ +PF V+ +++F + LY + Y G+L +RK+G +E R Y AE+V ALEY
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEY 123
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
LH GI+HRDLKP+N+L+ D HI++TDFG +K+
Sbjct: 124 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKV-------------------------L 158
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730
++ +S VGT Y++PE+L ++D W++G I+++ + G+PPF A + +I
Sbjct: 159 SPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI 218
Query: 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA---NGAAEVKAHPFFKGVNW 787
F I+ + + P +A+DL+ + L+ D +RLG G +KAHPFF+ V W
Sbjct: 219 FQKIIKLEYDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275
Query: 788 DSLALQKAVFVP 799
++L Q +
Sbjct: 276 ENLHQQTPPKLT 287
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 283 bits (726), Expect = 5e-89
Identities = 116/343 (33%), Positives = 183/343 (53%), Gaps = 35/343 (10%)
Query: 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL-ITV 552
I+DF + K + +G+FG+VFLA + T FAIK LKK ++ +D+E + E+ +L +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 612
+PF+ F +F ++NL+ VMEYLNGGDL ++ + A Y AE++L L++LH
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
S GIV+RDLK DN+L+ DGHIK+ DFG+ K
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN--------------------------- 153
Query: 673 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732
+ ++ GTPDY+APEILLG ++ ++ DWWS G++L+E + G PF + E +F
Sbjct: 154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
Query: 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLAL 792
+I + P + EA+DL+ + + +P +RLG +++ HP F+ +NW+ L
Sbjct: 214 SIRMDNPFY---PRWLEKEAKDLLVKLFVREPEKRLGV--RGDIRQHPLFREINWEELER 268
Query: 793 QK--AVFVPQPESVDDTSYFLSRFSQISSGLPDDQNGSYSDAD 833
++ F P+ +S D S F F L + D
Sbjct: 269 KEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALINSMD 311
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 282 bits (723), Expect = 2e-88
Identities = 126/356 (35%), Positives = 191/356 (53%), Gaps = 35/356 (9%)
Query: 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI 550
+ +++DF+ +K + +G FG+V L R++ TG +A+K+L+K +I K+++ + E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 610
R+PF+ Y+F D L VMEY NGG+L+ L + E+ AR Y AE+V ALEY
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
LHS +V+RD+K +NL++ DGHIK+TDFGL K G
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG------------------------- 155
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730
+D + GTP+YLAPE+L ++G A DWW +G++++E + G PF + E +
Sbjct: 156 --ISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
Query: 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWD 788
F+ IL +I + P +S EA+ L+ L DP QRLG + A EV H FF +NW
Sbjct: 214 FELILMEEIRF---PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270
Query: 789 SLALQKAV--FVPQPESVDDTSYFLSRFSQISSGL-PDDQNGSYSDADTCDSSSNS 841
+ +K + F PQ S DT YF F+ S + P D+ S +
Sbjct: 271 DVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQE 326
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 273 bits (700), Expect = 5e-86
Identities = 92/292 (31%), Positives = 148/292 (50%), Gaps = 35/292 (11%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 552
+++DFEI +P+ +G FG V+LAR++ + + A+KVL K + + ++ E I +
Sbjct: 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 63
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 612
R+P ++R + F +YL++EY G +Y L+K+ +E YI EL AL Y H
Sbjct: 64 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 123
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
S ++HRD+KP+NLL+ G +K+ DFG S
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSV----------------------------- 154
Query: 673 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732
+ R + GT DYL PE++ G H D WS+G++ +EF+ G PPF A + + +
Sbjct: 155 HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK 214
Query: 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
I + + P ++ A+DLI+R L H+P+QR EV HP+
Sbjct: 215 RISRVEFTF---PDFVTEGARDLISRLLKHNPSQRP---MLREVLEHPWITA 260
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 274 bits (702), Expect = 5e-85
Identities = 104/333 (31%), Positives = 163/333 (48%), Gaps = 38/333 (11%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 552
+++DF + + I RG FG V+ RK TG ++A+K L K + K L ER +L V
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 553 RN---PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 609
PF+V Y+F D L +++ +NGGDL+ L + G E R Y AE++L LE
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 669
++H+ +V+RDLKP N+L+ GH++++D GL+
Sbjct: 122 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC-------------------------- 155
Query: 670 EYQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 728
+ H++VGT Y+APE+L G + +ADW+S+G +LF+ + G PF +
Sbjct: 156 ---DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212
Query: 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG--ANGAAEVKAHPFFKGVN 786
+ +P S E + L+ L D N+RLG GA EVK PFF+ ++
Sbjct: 213 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272
Query: 787 WDSLALQK--AVFVPQPESVDDTSYF-LSRFSQ 816
W + LQK +P V+ F + F +
Sbjct: 273 WQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDE 305
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 270 bits (691), Expect = 4e-84
Identities = 115/323 (35%), Positives = 180/323 (55%), Gaps = 38/323 (11%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 552
S+ DF+I++ + G+FGRV L R R G +A+KVLKK ++R +E ER +L V
Sbjct: 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV 61
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 612
+PF++R + +F ++++M+Y+ GG+L+SLLRK VA+ Y AE+ LALEYLH
Sbjct: 62 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 121
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
S I++RDLKP+N+L+ +GHIK+TDFG +K
Sbjct: 122 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--------------------------- 154
Query: 673 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732
++ GTPDY+APE++ + + DWWS GI+++E + G PF + ++
Sbjct: 155 ---PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211
Query: 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSL 790
ILN ++ + P + + +DL++R + D +QRLG NG +VK HP+FK V W+ L
Sbjct: 212 KILNAELRF---PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268
Query: 791 ALQK--AVFVPQPE-SVDDTSYF 810
+ + P + DTS F
Sbjct: 269 LSRNIETPYEPPIQQGQGDTSQF 291
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 257 bits (658), Expect = 7e-80
Identities = 73/291 (25%), Positives = 134/291 (46%), Gaps = 31/291 (10%)
Query: 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 553
++D+++++ + GA+G V LA R T + A+K++ + + E I E I +
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 613
+ VV+F+ + YL +EY +GG+L+ + + E A+ + +L+ + YLH
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
+GI HRD+KP+NLL+ ++K++DFGL+ + NN
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN------------------------ 157
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732
R + GT Y+APE+L E H D WS GI+L + G P+ S
Sbjct: 158 -RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 216
Query: 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+ K + + L+++ L+ +P+ R+ ++K ++
Sbjct: 217 SDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKKDRWYN 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 257 bits (657), Expect = 1e-79
Identities = 82/296 (27%), Positives = 138/296 (46%), Gaps = 39/296 (13%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
D +EII + GAFG+V+ A+ + T L A KV+ + ++E + E +IL + +
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDH 68
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 613
P +V+ +F +NL++++E+ GG + +++ ++ L E ++ + + AL YLH
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
I+HRDLK N+L DG IKL DFG+S
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKN---------------------------T 161
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTE-----HGYAADWWSVGIILFEFITGIPPFTAESPE 728
+ R S +GTP ++APE+++ + Y AD WS+GI L E PP +P
Sbjct: 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221
Query: 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784
+ I + P PS S +D + + L + + R +++ HPF
Sbjct: 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW---TTSQLLQHPFVTV 274
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 258 bits (660), Expect = 3e-79
Identities = 116/326 (35%), Positives = 183/326 (56%), Gaps = 37/326 (11%)
Query: 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI 548
+ +D F+ IK + G+FGRV L + + +G+ +A+K+L K +++ IE L E+ I
Sbjct: 35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 549 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 608
L V PF+V+ +SF NLY+VMEY+ GG+++S LR++G E AR Y A++VL
Sbjct: 95 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
EYLHSL +++RDLKP+NLLI G+I++TDFG +K
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR------------------------ 190
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 728
+ GTP+ LAPEI+L + A DWW++G++++E G PPF A+ P
Sbjct: 191 ------VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVN 786
I++ I++ K+ + PS S + +DL+ L D +R G NG ++K H +F +
Sbjct: 245 QIYEKIVSGKVRF---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301
Query: 787 WDSLALQK--AVFVPQPESVDDTSYF 810
W ++ +K A F+P+ + DTS F
Sbjct: 302 WIAIYQRKVEAPFIPKFKGPGDTSNF 327
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 257 bits (658), Expect = 7e-79
Identities = 76/342 (22%), Positives = 140/342 (40%), Gaps = 38/342 (11%)
Query: 482 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER 541
P K +D ++I + + GAFG V +R TG+ FA K + +D E
Sbjct: 13 YPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKET 69
Query: 542 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIY 600
+ E + +R+P +V +F + + ++ E+++GG+L+ + + + ED A Y
Sbjct: 70 VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY 129
Query: 601 IAELVLALEYLHSLGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINNTIDLSGPET 658
+ ++ L ++H VH DLKP+N++ +KL DFGL+
Sbjct: 130 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA--------------- 174
Query: 659 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 718
++ GT ++ APE+ G GY D WSVG++ + ++G
Sbjct: 175 -------------HLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221
Query: 719 IPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777
+ PF E+ + N+ + S +S + +D I + L+ DPN R+ +
Sbjct: 222 LSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM---TIHQAL 278
Query: 778 AHPFFKGVNWDSLALQKAVFVPQPESVDDTSYFLSRFSQISS 819
HP+ N Q + + + +
Sbjct: 279 EHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPP 320
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 254 bits (650), Expect = 4e-78
Identities = 124/333 (37%), Positives = 189/333 (56%), Gaps = 38/333 (11%)
Query: 486 SSHKERTSIDDFEIIKPISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMIRK-NDIER 541
+ H E+ I++FE++K + GA+G+VFL RK TG L+A+KVLKK +++K E
Sbjct: 15 TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 74
Query: 542 ILAERNILITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIY 600
ER +L +R PF+V Y+F L+L+++Y+NGG+L++ L + E +IY
Sbjct: 75 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 134
Query: 601 IAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDG 660
+ E+VLALE+LH LGI++RD+K +N+L+ +GH+ LTDFGLS
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS------------------ 176
Query: 661 IMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY--AADWWSVGIILFEFITG 718
E+ + + GT +Y+AP+I+ G + G+ A DWWS+G++++E +TG
Sbjct: 177 --------KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 228
Query: 719 IPPFTAESPEIIFDNILNRKIPW-PCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAE 775
PFT + + I R + P P +MS A+DLI R L+ DP +RLG A E
Sbjct: 229 ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADE 288
Query: 776 VKAHPFFKGVNWDSLALQK--AVFVPQPESVDD 806
+K H FF+ +NWD LA +K A F P D
Sbjct: 289 IKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD 321
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 250 bits (640), Expect = 6e-77
Identities = 90/299 (30%), Positives = 137/299 (45%), Gaps = 38/299 (12%)
Query: 489 KERTSIDD----FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILA 544
+ S+ D + + I +GA G V+ A TG AI+ + +K E I+
Sbjct: 10 RSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIIN 66
Query: 545 ERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 604
E ++ +NP +V + S+ D L++VMEYL GG L ++ + C++E E
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCREC 125
Query: 605 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 664
+ ALE+LHS ++HRD+K DN+L+ DG +KLTDFG
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--------------------- 164
Query: 665 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTA 724
+ R + VGTP ++APE++ +G D WS+GI+ E I G PP+
Sbjct: 165 ------QITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218
Query: 725 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
E+P I P P +S +D +NR L D +R A E+ H F K
Sbjct: 219 ENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG---SAKELLQHQFLK 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 252 bits (645), Expect = 6e-77
Identities = 74/367 (20%), Positives = 148/367 (40%), Gaps = 49/367 (13%)
Query: 482 TPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIER 541
P K+ + D ++I++ + GAFG V ++ TG +F K + + K ++
Sbjct: 16 VPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN 75
Query: 542 ILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIY 600
E +I+ + +P ++ +F + + L++E+L+GG+L+ + + E Y
Sbjct: 76 ---EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY 132
Query: 601 IAELVLALEYLHSLGIVHRDLKPDNLLIA--HDGHIKLTDFGLSKIGLINNTIDLSGPET 658
+ + L+++H IVH D+KP+N++ +K+ DFGL+
Sbjct: 133 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT--------------- 177
Query: 659 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG 718
+ + T ++ APEI+ G+ D W++G++ + ++G
Sbjct: 178 -------------KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 224
Query: 719 IPPFTAESPEIIFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777
+ PF E N+ + S +S EA+D I L +P +RL +
Sbjct: 225 LSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDAL 281
Query: 778 AHPFFKGVNWDSLALQKAVFVPQPESVDDTSYF-----------LSRFSQISSGLPDDQN 826
HP+ KG + + + + + Y ++ FS + P +
Sbjct: 282 EHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQ 341
Query: 827 GSYSDAD 833
S D
Sbjct: 342 IYDSYFD 348
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 249 bits (637), Expect = 7e-77
Identities = 82/303 (27%), Positives = 130/303 (42%), Gaps = 45/303 (14%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR------KNDIERILAERNI 548
+++E + + RG V + T +A+K++ + E L E +I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 549 LITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLA 607
L V P +++ ++ +LV + + G+L+ L + L E R + L+
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
+ LH L IVHRDLKP+N+L+ D +IKLTDFG S
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC------------------------ 158
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFEFITGIPP 721
Q GTP YLAPEI+ + +G D WS G+I++ + G PP
Sbjct: 159 ----QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214
Query: 722 FTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHP 780
F ++ I++ + D S +DL++RFL+ P +R A E AHP
Sbjct: 215 FWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY---TAEEALAHP 271
Query: 781 FFK 783
FF+
Sbjct: 272 FFQ 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 249 bits (637), Expect = 3e-76
Identities = 83/344 (24%), Positives = 136/344 (39%), Gaps = 76/344 (22%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
DDFE I + G G VF + +G + A K++ I+ +I+ E +L +
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHL--EIKPAIRNQIIRELQVLHECNS 63
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS- 613
P++V F+ +F + + ME+++GG L +L+K G + E + ++ L YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
I+HRD+KP N+L+ G IKL DFG+S Q
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSG-----------------------------Q 154
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733
+ +S VGT Y++PE L GT + +D WS+G+ L E G P + +
Sbjct: 155 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
Query: 734 ILNR----------------------------------------KIPWPCVPSD-MSFEA 752
+ P P +PS S E
Sbjct: 215 FGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 274
Query: 753 QDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAV 796
QD +N+ LI +P +R ++ H F K + + + +
Sbjct: 275 QDFVNKCLIKNPAERA---DLKQLMVHAFIKRSDAEEVDFAGWL 315
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 246 bits (630), Expect = 7e-76
Identities = 82/298 (27%), Positives = 138/298 (46%), Gaps = 44/298 (14%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+D+E++ I G++GR R+++ G + K L + + + + +++E N+L +++
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY-GSMTEAEKQMLVSEVNLLRELKH 62
Query: 555 PFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKV----GCLEEDVARIYIAELVLAL 608
P +VR++ R N LY+VMEY GGDL S++ K L+E+ + +L LAL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 609 EYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
+ H ++HRDLKP N+ + ++KL DFGL++I
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI------------------- 163
Query: 664 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 723
D + VGTP Y++PE + + +D WS+G +L+E +PPFT
Sbjct: 164 --------LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215
Query: 724 AESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781
A S + + I K P S E ++I R L R E+ +P
Sbjct: 216 AFSQKELAGKIREGKFRRI--PYRYSDELNEIITRMLNLKDYHRP---SVEEILENPL 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 247 bits (631), Expect = 2e-75
Identities = 91/328 (27%), Positives = 150/328 (45%), Gaps = 38/328 (11%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
D ++ + GAF V LA + T L AIK + K + + + E +L +++
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
P +V + +LYL+M+ ++GG+L+ + + G E A I +++ A++YLH L
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 615 GIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
GIVHRDLKP+NLL D I ++DFGLSK+
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--------------------------- 159
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731
+ +A GTP Y+APE+L + A D WS+G+I + + G PPF E+ +F
Sbjct: 160 -EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 218
Query: 732 DNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 790
+ IL + + D+S A+D I + DP +R + HP+ G
Sbjct: 219 EQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQALQHPWIAGDTALDK 275
Query: 791 ALQKAVFVPQPESVDDTSYFLSRFSQIS 818
+ ++V Q + S + F+ +
Sbjct: 276 NIHQSV-SEQIKKNFAKSKWKQAFNATA 302
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 241 bits (617), Expect = 2e-73
Identities = 69/292 (23%), Positives = 111/292 (38%), Gaps = 38/292 (13%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
F ++ I G+FG V+ AR ++ AIK + + I+ E L +R+
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
P +++ + +LVMEY G L L+E + L YLHS
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
++HRD+K N+L++ G +KL DFG + I
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASI------------------------------ 164
Query: 675 DNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPPFTAESPEIIF 731
+S VGTP ++APE++L + G D WS+GI E PP +
Sbjct: 165 -MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL 223
Query: 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+I + P S ++ ++ L P R + + H F
Sbjct: 224 YHIAQNESPALQ-SGHWSEYFRNFVDSCLQKIPQDRP---TSEVLLKHRFVL 271
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 1e-71
Identities = 70/293 (23%), Positives = 131/293 (44%), Gaps = 39/293 (13%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ + I + + RG FG V + ++ + K +K + D + E +IL R+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC-LEEDVARIYIAELVLALEYLHS 613
++ SF + L ++ E+++G D++ + L E Y+ ++ AL++LHS
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 614 LGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEY 671
I H D++P+N++ IK+ +FG ++
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---------------------------- 152
Query: 672 QQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731
Q N P+Y APE+ A D WS+G +++ ++GI PF AE+ + I
Sbjct: 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
Query: 732 DNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+NI+N + + ++S EA D ++R L+ + R+ A+E HP+ K
Sbjct: 213 ENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEALQHPWLK 262
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (594), Expect = 1e-70
Identities = 81/314 (25%), Positives = 142/314 (45%), Gaps = 40/314 (12%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND---IERILAERNILIT 551
D ++ + + G F V R+++TG +A K +KK E I E +IL
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 552 VRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYL 611
+++P V+ + + ++ L++E + GG+L+ L + L E+ A ++ +++ + YL
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 612 HSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
HSL I H DLKP+N+++ IK+ DFGL+
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH------------------------ 165
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 727
+ + GTP+++APEI+ G AD WS+G+I + ++G PF ++
Sbjct: 166 ----KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221
Query: 728 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786
+ N+ + S+ S A+D I R L+ DP +R+ + HP+ K +
Sbjct: 222 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM---TIQDSLQHPWIKPKD 278
Query: 787 WDSLALQKAVFVPQ 800
AL A PQ
Sbjct: 279 TQQ-ALSSAWSHPQ 291
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 2e-70
Identities = 61/301 (20%), Positives = 124/301 (41%), Gaps = 43/301 (14%)
Query: 492 TSIDD--FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
S D + I RG+F V+ T A L+ + K++ +R E +L
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD-RKLTKSERQRFKEEAEML 62
Query: 550 ITVRNPFVVRFFYSFTC----RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 605
+++P +VRF+ S+ + + LV E + G L + L++ ++ V R + +++
Sbjct: 63 KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQIL 122
Query: 606 LALEYLHSLG--IVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 662
L++LH+ I+HRDLK DN+ I G +K+ D GL+ +
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL------------------ 164
Query: 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 722
+ +GTP+++APE+ ++ + D ++ G+ + E T P+
Sbjct: 165 -----------KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY 212
Query: 723 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782
+ + + E +++I + + ++R ++ H FF
Sbjct: 213 SECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY---SIKDLLNHAFF 269
Query: 783 K 783
+
Sbjct: 270 Q 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 223 bits (570), Expect = 2e-67
Identities = 72/289 (24%), Positives = 122/289 (42%), Gaps = 31/289 (10%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
D +E+ + + G V LAR A+KVL+ + R E + +
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 555 PFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 610
P +V + + Y+VMEY++G L ++ G + A IA+ AL +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
H GI+HRD+KP N++I+ +K+ DFG+++
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIAR------------------------AIA 162
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730
+ +GT YL+PE G +D +S+G +L+E +TG PPFT +SP +
Sbjct: 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV 222
Query: 731 FDNILNRK-IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778
+ IP +S + ++ + L +P R AAE++A
Sbjct: 223 AYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT--AAEMRA 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (560), Expect = 4e-65
Identities = 82/311 (26%), Positives = 139/311 (44%), Gaps = 55/311 (17%)
Query: 489 KERTSIDDFEII-KPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN 547
K+ IDD+++ + + G G+V + T + FA+K+L+ R+ E
Sbjct: 5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVE 56
Query: 548 ILITV-RNPFVVRFFYSF----TCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIY 600
+ + P +VR + R L +VME L+GG+L+S ++ G E A
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116
Query: 601 IAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINNTIDLSGPE 657
+ + A++YLHS+ I HRD+KP+NLL + +KLTDFG +K
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------------- 162
Query: 658 TDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT 717
+ T + + + TP Y+APE+L ++ + D WS+G+I++ +
Sbjct: 163 --------------ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 208
Query: 718 GIPPFTAESP----EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANG 772
G PPF + + I + +P S++S E + LI L +P QR+
Sbjct: 209 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM---T 265
Query: 773 AAEVKAHPFFK 783
E HP+
Sbjct: 266 ITEFMNHPWIM 276
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 9e-65
Identities = 70/299 (23%), Positives = 130/299 (43%), Gaps = 49/299 (16%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIE---RILAERNILIT 551
+++ + G FG V+ + + AIK ++K + ++ R+ E +L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 552 VRN--PFVVRFFYSFTCRDNLYLVMEYLNGG-DLYSLLRKVGCLEEDVARIYIAELVLAL 608
V + V+R F D+ L++E DL+ + + G L+E++AR + +++ A+
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 609 EYLHSLGIVHRDLKPDNLLI-AHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
+ H+ G++HRD+K +N+LI + G +KL DFG +
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----------------------- 160
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAES 726
+ GT Y PE + HG +A WS+GI+L++ + G PF +
Sbjct: 161 ------LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD- 213
Query: 727 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785
+ I+ ++ + +S E Q LI L P+ R E++ HP+ + V
Sbjct: 214 -----EEIIRGQVFF---RQRVSSECQHLIRWCLALRPSDRP---TFEEIQNHPWMQDV 261
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (549), Expect = 2e-64
Identities = 54/280 (19%), Positives = 112/280 (40%), Gaps = 37/280 (13%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ + I G+FG V+ + A+K+L ++ E +L R+
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNV-TAPTPQQLQAFKNEVGVLRKTRH 63
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHS 613
++ F ++ L +V ++ G LY L + E + ++YLH+
Sbjct: 64 VNILLF-MGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
I+HRDLK +N+ + D +K+ DFGL+ + + +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATV-------------------------KSRW 157
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTEHG---YAADWWSVGIILFEFITGIPPFTAESPEII 730
+ + G+ ++APE++ + + +D ++ GI+L+E +TG P++ +
Sbjct: 158 SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217
Query: 731 FDNILNRKIPWPC---VPSDMSFEAQDLINRFLIHDPNQR 767
++ R P V S+ + L+ L ++R
Sbjct: 218 IIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 3e-63
Identities = 76/314 (24%), Positives = 117/314 (37%), Gaps = 58/314 (18%)
Query: 498 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKND--IERILAERNILITVRNP 555
E + + G F V+ AR + T + AIK +K D L E +L + +P
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 615
++ +F + N+ LV +++ + L + Y+ + LEYLH
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 616 IVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTD 675
I+HRDLKP+NLL+ +G +KL DFGL+K +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK---------------------------SFGSP 153
Query: 676 NRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734
NR V T Y APE+L G +G D W+VG IL E + +P +S I
Sbjct: 154 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213
Query: 735 LN-------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLG 769
IP + S + DLI + +P R+
Sbjct: 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI- 272
Query: 770 ANGAAEVKAHPFFK 783
A + +F
Sbjct: 273 --TATQALKMKYFS 284
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 4e-63
Identities = 61/303 (20%), Positives = 119/303 (39%), Gaps = 35/303 (11%)
Query: 489 KERTSIDDFEIIKPISRGAFGRVFLA--RKRTTGDLFAIKVLKKLDMIRKNDIERILAER 546
++ +++D K + G FG V + + A+K+LK + + +LAE
Sbjct: 5 RKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEA 59
Query: 547 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 606
N++ + NP++VR ++ LVME G L L++ +++ + ++ +
Sbjct: 60 NVMQQLDNPYIVRM-IGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 118
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDA 666
++YL VHRDL N+L+ + K++DFGLSK
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL--------------------- 157
Query: 667 HYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 725
+ + + + APE + + +D WS G++++E + G P+
Sbjct: 158 ---RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 214
Query: 726 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785
+ + + P+ E DL+N +D R G + ++ V
Sbjct: 215 KGSEVTAMLEKGERMGC--PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272
Query: 786 NWD 788
N
Sbjct: 273 NEG 275
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 210 bits (534), Expect = 3e-62
Identities = 75/316 (23%), Positives = 128/316 (40%), Gaps = 59/316 (18%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ + ++ I G +G V+ A+ G+ FA+K ++ + + + E +IL +++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRL-EKEDEGIPSTTIREISILKELKH 59
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
+V+ + + L LV E+L+ L G LE A+ ++ +L+ + Y H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
++HRDLKP NLLI +G +K+ DFGL++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARA---------------------------FGI 152
Query: 675 DNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESPEIIFDN 733
R + T Y AP++L+G++ + D WSVG I E + G P F S
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212
Query: 734 ILN--------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
I +PW + DL+++ L DPNQR
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 768 LGANGAAEVKAHPFFK 783
+ A + H +FK
Sbjct: 273 I---TAKQALEHAYFK 285
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 1e-61
Identities = 76/329 (23%), Positives = 121/329 (36%), Gaps = 65/329 (19%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 552
+ +E + I +G FG VF AR R TG A+K + + ++ L E IL +
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM-ENEKEGFPITALREIKILQLL 66
Query: 553 RNPFVVRFFYSFT--------CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAEL 604
++ VV C+ ++YLV ++ L + + + L
Sbjct: 67 KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126
Query: 605 VLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPS 664
+ L Y+H I+HRD+K N+LI DG +KL DFGL++
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA-------------------- 166
Query: 665 DAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT 723
+ + + + V T Y PE+LLG ++G D W G I+ E T P
Sbjct: 167 ---FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223
Query: 724 AESPEIIFDNILN-----------------------------RKIPWPCVPSDMSFEAQD 754
+ + I RK+ A D
Sbjct: 224 GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 283
Query: 755 LINRFLIHDPNQRLGANGAAEVKAHPFFK 783
LI++ L+ DP QR+ + + H FF
Sbjct: 284 LIDKLLVLDPAQRI---DSDDALNHDFFW 309
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 2e-60
Identities = 81/321 (25%), Positives = 136/321 (42%), Gaps = 59/321 (18%)
Query: 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR 553
+++F+ ++ I G +G V+ AR + TG++ A+K ++ D + + E ++L +
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELN 59
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLH 612
+P +V+ + LYLV E+L+ + + + + Y+ +L+ L + H
Sbjct: 60 HPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
S ++HRDLKP NLLI +G IKL DFGL++
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARA---------------------------F 152
Query: 673 QTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 731
R V T Y APEILLG ++ A D WS+G I E +T F +S
Sbjct: 153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 732 DNILN--------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPN 765
I + + V + + + L+++ L +DPN
Sbjct: 213 FRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPN 272
Query: 766 QRLGANGAAEVKAHPFFKGVN 786
+R+ A AHPFF+ V
Sbjct: 273 KRI---SAKAALAHPFFQDVT 290
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 3e-60
Identities = 62/291 (21%), Positives = 113/291 (38%), Gaps = 46/291 (15%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 552
++ + ++++ I +G FG V L R G+ A+K +K + LAE +++ +
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKN-----DATAQAFLAEASVMTQL 57
Query: 553 RNPFVVRFF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--LEEDVARIYIAELVLALE 609
R+ +V+ + LY+V EY+ G L LR G L D + ++ A+E
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 669
YL VHRDL N+L++ D K++DFGL+K
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------------------------ 153
Query: 670 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPE 728
+ + + + APE L + +D WS GI+L+E + G P+ +
Sbjct: 154 ------SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 207
Query: 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779
+ + P +++ D R +++
Sbjct: 208 DVVPRVEKGYKMDA--PDGCPPAVYEVMKNCWHLDAAMRP---SFLQLREQ 253
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (521), Expect = 1e-59
Identities = 74/322 (22%), Positives = 127/322 (39%), Gaps = 63/322 (19%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ + I GA+G V A AIK + + + +R L E IL+ R+
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRH 65
Query: 555 PFVVRFFYSFTCRD----NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 610
++ ++ +L G DLY LL+ L D ++ +++ L+Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKY 124
Query: 611 LHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
+HS ++HRDLKP NLL+ +K+ DFGL+++ +
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA------------------------D 160
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILL-GTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 729
V T Y APEI+L + + D WSVG IL E ++ P F +
Sbjct: 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
Query: 730 IFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFLI 761
++IL K+PW + + +A DL+++ L
Sbjct: 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLT 280
Query: 762 HDPNQRLGANGAAEVKAHPFFK 783
+P++R+ + AHP+ +
Sbjct: 281 FNPHKRI---EVEQALAHPYLE 299
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-59
Identities = 67/299 (22%), Positives = 111/299 (37%), Gaps = 37/299 (12%)
Query: 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGD--LFAIKVLKKLDMIRKNDIERILAER 546
++ I D E+ G FG V R AIKVLK+ K D E ++ E
Sbjct: 7 RDNLLIADIEL----GCGNFGSVRQGVYRMRKKQIDVAIKVLKQ--GTEKADTEEMMREA 60
Query: 547 NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELV 605
I+ + NP++VR L LVME GG L+ L K + + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119
Query: 606 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 665
+ ++YL VHRDL N+L+ + + K++DFGLSK
Sbjct: 120 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA--------------------- 158
Query: 666 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 724
+ R + + APE + + +D WS G+ ++E ++ G P+
Sbjct: 159 ---LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 215
Query: 725 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+ I K P + E L++ I+ R + ++
Sbjct: 216 MKGPEVMAFIEQGKRMEC--PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 2e-58
Identities = 82/328 (25%), Positives = 126/328 (38%), Gaps = 64/328 (19%)
Query: 493 SIDDFEIIKPISRGAFGRVFLAR-KRTTGDLFAIKVLKKLDMIRKN--DIERILAERNIL 549
+ +E + I GA+G+VF AR + G A+K ++ R +A L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 550 ITVRNPFVVRFFYSFTC-----RDNLYLVMEYLNGGDL-YSLLRKVGCLEEDVARIYIAE 603
T +P VVR F T L LV E+++ Y + + + + +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 604 LVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMP 663
L+ L++LHS +VHRDLKP N+L+ G IKL DFGL++I
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI------------------- 165
Query: 664 SDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT 723
+ S V T Y APE+LL + + D WSVG I E P F
Sbjct: 166 ---------YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFR 216
Query: 724 AESPEIIFDNILN------------------------RKIPWPCVPSDMSFEAQDLINRF 759
S IL+ P +D+ +DL+ +
Sbjct: 217 GSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKC 276
Query: 760 LIHDPNQRLGANGAAEVKAHPFFKGVNW 787
L +P +R+ A +HP+F+ +
Sbjct: 277 LTFNPAKRI---SAYSALSHPYFQDLER 301
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (512), Expect = 2e-58
Identities = 85/348 (24%), Positives = 135/348 (38%), Gaps = 71/348 (20%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ ++P+ GA+G V A TG AIK L + + +R E +L +R+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76
Query: 555 PFVVRFFYSFTCRD------NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLAL 608
V+ FT + + YLVM ++ G L K L ED + + +++ L
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
Y+H+ GI+HRDLKP NL + D +K+ DFGL++
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA----------------------- 171
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESP 727
+ V T Y APE++L + D WSVG I+ E ITG F
Sbjct: 172 -------DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224
Query: 728 EIIFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRF 759
I+ K + + ++ S A +L+ +
Sbjct: 225 LDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKM 284
Query: 760 LIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDT 807
L+ D QR+ A E AHP+F+ ++ Q + + VD T
Sbjct: 285 LVLDAEQRV---TAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRT 329
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 2e-58
Identities = 56/280 (20%), Positives = 98/280 (35%), Gaps = 31/280 (11%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNIL 549
D +++ + G+FG V A+K LK + + ++ + E N +
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLAL 608
++ + ++R + + +V E G L L + G Y ++ +
Sbjct: 66 HSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 609 EYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHY 668
YL S +HRDL NLL+A +K+ DFGL +
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL----------------------- 161
Query: 669 PEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESP 727
+ + APE L +A+D W G+ L+E T G P+ +
Sbjct: 162 -PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220
Query: 728 EIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
I I P P D + +++ + H P R
Sbjct: 221 SQILHKIDKEGERLPR-PEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (506), Expect = 3e-58
Identities = 56/304 (18%), Positives = 101/304 (33%), Gaps = 35/304 (11%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ + + + I G+FG ++L G+ AIK+ K ++ E I ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIESKIYKMMQG 61
Query: 555 P-FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS 613
+ + D +VME L + +++ +EY+HS
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 121
Query: 614 LGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
+HRD+KPDN L+ + + DFGL+K T
Sbjct: 122 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART-------------------- 161
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730
+Q R + GT Y + LG E D S+G +L F G P+
Sbjct: 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221
Query: 731 FDNILNRK-----IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK-G 784
P + E +N + + + ++ + F + G
Sbjct: 222 RQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
Query: 785 VNWD 788
++D
Sbjct: 282 FSYD 285
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 5e-58
Identities = 88/367 (23%), Positives = 135/367 (36%), Gaps = 77/367 (20%)
Query: 477 SSGVSTPLHSSHKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK 536
++ V+TP +R + K I G+FG V+ A+ +G+L AIK + +
Sbjct: 4 TTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ------ 55
Query: 537 NDIERILAERNILITVRNPFVVRFFYSFTCRDN------LYLVMEYLNGGDLYSLL---R 587
D E I+ + + +VR Y F L LV++Y+ R
Sbjct: 56 -DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 114
Query: 588 KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGL 646
L ++Y+ +L +L Y+HS GI HRD+KP NLL+ D +KL DFG +K
Sbjct: 115 AKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--- 171
Query: 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADW 705
Q S + + Y APE++ G ++ + D
Sbjct: 172 -------------------------QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV 206
Query: 706 WSVGIILFEFITGIPPFTAESPEIIFDNILN-------------------------RKIP 740
WS G +L E + G P F +S I+ + P
Sbjct: 207 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 266
Query: 741 WPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVP 799
W V EA L +R L + P RL E AH FF + ++ L P
Sbjct: 267 WTKVFRPRTPPEAIALCSRLLEYTPTARL---TPLEACAHSFFDELRDPNVKLPNGRDTP 323
Query: 800 QPESVDD 806
+
Sbjct: 324 ALFNFTT 330
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 197 bits (502), Expect = 4e-57
Identities = 79/339 (23%), Positives = 135/339 (39%), Gaps = 80/339 (23%)
Query: 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
E + DD+++++ + RG + VF A T + +K+LK ++I E IL
Sbjct: 30 EWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKIL 83
Query: 550 ITVR-NPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVL 606
+R P ++ + LV E++N D L + L + R Y+ E++
Sbjct: 84 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILK 140
Query: 607 ALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 665
AL+Y HS+GI+HRD+KP N++I H+ ++L D+GL++
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY-------------------- 180
Query: 666 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTA 724
+ + V + + PE+L+ + + Y+ D WS+G +L I PF
Sbjct: 181 --------HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 232
Query: 725 ESPEI----------------------------IFDNILNR-------KIPWPCVPSDMS 749
F++IL R + +S
Sbjct: 233 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS 292
Query: 750 FEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 788
EA D +++ L +D RL A E HP+F V D
Sbjct: 293 PEALDFLDKLLRYDHQSRL---TAREAMEHPYFYTVVKD 328
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 4e-56
Identities = 58/293 (19%), Positives = 115/293 (39%), Gaps = 42/293 (14%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ ++++ + G FG V++ A+K LK+ M + LAE N++ +++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLH 612
+VR Y+ ++ +Y++ EY+ G L L+ L + A++ + ++
Sbjct: 68 QRLVRL-YAVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
+HRDL+ N+L++ K+ DFGL+++ +
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARL--------------------------IE 160
Query: 673 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 731
+ R A + APE + +D WS GI+L E +T G P+ + +
Sbjct: 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI 220
Query: 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA--HPFF 782
N+ + P + E L+ P R +++ FF
Sbjct: 221 QNL--ERGYRMVRPDNCPEELYQLMRLCWKERPEDRP---TFDYLRSVLEDFF 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 4e-56
Identities = 52/275 (18%), Positives = 110/275 (40%), Gaps = 35/275 (12%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
D +K + G FG V + R AIK++K+ M + + E +++ + +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSH 58
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHS 613
+V+ + T + ++++ EY+ G L + LR + ++ A+EYL S
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
+HRDL N L+ G +K++DFGLS+
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSR--------------------------YVLD 152
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD 732
+ + + + PE+L+ ++ +D W+ G++++E + G P+ + +
Sbjct: 153 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 212
Query: 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
+I + P S + ++ ++R
Sbjct: 213 HIAQGLRLYR--PHLASEKVYTIMYSCWHEKADER 245
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 5e-56
Identities = 61/303 (20%), Positives = 114/303 (37%), Gaps = 58/303 (19%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDL-----FAIKVLKKLDMIRKNDIERILAERNIL 549
++ E K + GAFG+V A A+K+LK+ ++ E +++E ++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE--KADSSEREALMSELKMM 94
Query: 550 ITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK-------------------- 588
+ + +V + T +YL+ EY GDL + LR
Sbjct: 95 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154
Query: 589 ---VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645
+ L + + ++ +E+L VHRDL N+L+ H +K+ DFGL++
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD- 213
Query: 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 705
++ R +A ++APE L + +D
Sbjct: 214 ------------------------IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDV 249
Query: 706 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDP 764
WS GI+L+E + G+ P+ + F ++ P + E ++ D
Sbjct: 250 WSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ-PFYATEEIYIIMQSCWAFDS 308
Query: 765 NQR 767
+R
Sbjct: 309 RKR 311
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 5e-56
Identities = 71/317 (22%), Positives = 119/317 (37%), Gaps = 59/317 (18%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+E ++ I G +G VF A+ R T ++ A+K ++ D + L E +L +++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-DDDDEGVPSSALREICLLKELKH 60
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSL 614
+VR L LV E+ + G L+ ++ + ++ +L+ L + HS
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 615 GIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQT 674
++HRDLKP NLLI +G +KL +FGL++
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARA---------------------------FGI 153
Query: 675 DNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITG-IPPFTAESPEIIFD 732
R + V T Y P++L G + + + D WS G I E P F +
Sbjct: 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213
Query: 733 NILN--------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQ 766
I V ++ +DL+ L +P Q
Sbjct: 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273
Query: 767 RLGANGAAEVKAHPFFK 783
R+ A E HP+F
Sbjct: 274 RI---SAEEALQHPYFS 287
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-55
Identities = 61/294 (20%), Positives = 108/294 (36%), Gaps = 42/294 (14%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ + + +G FG V++ T AIK LK E L E ++ +R+
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKP----GTMSPEAFLQEAQVMKKLRH 71
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL--LRKVGCLEEDVARIYIAELVLALEYLH 612
+V+ Y+ + +Y+V EY++ G L L A++ + Y+
Sbjct: 72 EKLVQL-YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
+ VHRDL+ N+L+ + K+ DFGL+++ +
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARL--------------------------IE 164
Query: 673 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 731
+ R A + APE L +D WS GI+L E T G P+ +
Sbjct: 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224
Query: 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA--HPFFK 783
D + P + DL+ + +P +R ++A +F
Sbjct: 225 DQVERGYRMP--CPPECPESLHDLMCQCWRKEPEERP---TFEYLQAFLEDYFT 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 2e-55
Identities = 51/275 (18%), Positives = 102/275 (37%), Gaps = 35/275 (12%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ ++ I G FG V L D AIK +++ E + E +++ + +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIRE----GAMSEEDFIEEAEVMMKLSH 59
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCL-EEDVARIYIAELVLALEYLHS 613
P +V+ + + + LV E++ G L LR L + ++ + YL
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 614 LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQ 673
++HRDL N L+ + IK++DFG+++
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRF--------------------------VLD 153
Query: 674 TDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFD 732
+ + +PE+ + + +D WS G++++E + G P+ S + +
Sbjct: 154 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 213
Query: 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
+I + P S ++N P R
Sbjct: 214 DISTGFRLYK--PRLASTHVYQIMNHCWKERPEDR 246
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-55
Identities = 59/293 (20%), Positives = 107/293 (36%), Gaps = 48/293 (16%)
Query: 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITV 552
+D + I G FG+V AR + G + + + K+D E +L +
Sbjct: 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67
Query: 553 RN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRK----------------VGCLEED 595
+ P ++ + R LYL +EY G+L LRK L
Sbjct: 68 GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 596 VARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655
+ A++ ++YL +HRDL N+L+ + K+ DFGLS+
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG----------- 176
Query: 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEF 715
Q + ++A E L + + +D WS G++L+E
Sbjct: 177 -----------------QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 219
Query: 716 IT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
++ G P+ + +++ + P + E DL+ + P +R
Sbjct: 220 VSLGGTPYCGMTCAELYEKLPQGYRLEK--PLNCDDEVYDLMRQCWREKPYER 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 191 bits (485), Expect = 3e-55
Identities = 61/281 (21%), Positives = 104/281 (37%), Gaps = 27/281 (9%)
Query: 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDM-IRKNDIERILAERNI 548
+ I +I + I G FG V + G +K L + L+E +I
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASI 80
Query: 549 LITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLA 607
+ +P V+ T + ++ E++ G L S LR G + +
Sbjct: 81 MGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140
Query: 608 LEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAH 667
++YL + VHRDL N+L+ + K++DFGLS+ + D
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSR-----------------FLEDDTS 183
Query: 668 YPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 726
P Y + APE + + A+D WS GI+++E ++ G P+ +
Sbjct: 184 DPTYTSALGG-----KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238
Query: 727 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
+ + + I P P D L+ D N R
Sbjct: 239 NQDVINAIEQDYRLPP--PMDCPSALHQLMLDCWQKDRNHR 277
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (485), Expect = 3e-55
Identities = 60/303 (19%), Positives = 106/303 (34%), Gaps = 59/303 (19%)
Query: 495 DDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
++ E ++ I GAFGRVF AR + A+K+LK+ + E ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE--EASADMQADFQREAALM 70
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------------- 590
NP +V+ + L+ EY+ GDL LR +
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 591 -----CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645
L ++ + YL VHRDL N L+ + +K+ DFGLS+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN- 189
Query: 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADW 705
Y + + ++ PE + + +D
Sbjct: 190 ------------------------IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDV 225
Query: 706 WSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDP 764
W+ G++L+E + G+ P+ + E + + + I P + E +L+ P
Sbjct: 226 WAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLP 283
Query: 765 NQR 767
R
Sbjct: 284 ADR 286
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-54
Identities = 61/288 (21%), Positives = 112/288 (38%), Gaps = 35/288 (12%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDI-ERILAERNILITVR 553
+ E+ + I G FG V + + +K + + E+ L E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 554 NPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLL-RKVGCLEEDVARIYIAELVLALEYLH 612
+P +V+ T + ++++ME G+L S L + L+ +Y +L AL YL
Sbjct: 67 HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
S VHRD+ N+L++ + +KL DFGLS+ +
Sbjct: 126 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--------------------------ME 159
Query: 673 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 731
+ ++APE + A+D W G+ ++E + G+ PF +
Sbjct: 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219
Query: 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779
I N + +P + L+ + +DP++R E+KA
Sbjct: 220 GRIENGERLP--MPPNCPPTLYSLMTKCWAYDPSRRP---RFTELKAQ 262
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 2e-53
Identities = 58/324 (17%), Positives = 114/324 (35%), Gaps = 33/324 (10%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKV-LKKL-DMIRKNDIERILAERNILITV 552
+F+ IK + GAFG V+ G+ I V +K+L + + IL E ++ +V
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 553 RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH 612
NP V R + G L + + + ++ + YL
Sbjct: 69 DNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE 128
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
+VHRDL N+L+ H+K+TDFGL+K+
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---------------------- 166
Query: 673 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 731
+ ++A E +L + + +D WS G+ ++E +T G P+ I
Sbjct: 167 ---EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223
Query: 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 791
+ + P + + ++ + + D + R E+ +
Sbjct: 224 SILEKGERLPQ--PPICTIDVYMIMVKCWMIDADSRP---KFRELIIEFSKMARDPQRYL 278
Query: 792 LQKAVFVPQPESVDDTSYFLSRFS 815
+ + S D++++ +
Sbjct: 279 VIQGDERMHLPSPTDSNFYRALMD 302
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 185 bits (470), Expect = 3e-53
Identities = 48/282 (17%), Positives = 96/282 (34%), Gaps = 36/282 (12%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-P 555
+++ + I G+FG +F AIK + ++D ++ E +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 556 FVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG 615
+ +Y + LV++ L L + +++ ++ +H
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 616 IVHRDLKPDNLLIA-----HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPE 670
+V+RD+KPDN LI + I + DFG+ K T
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT-------------------- 161
Query: 671 YQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITG---IPPFTAESP 727
Q R + + GT Y++ LG E D ++G + F+ G A +
Sbjct: 162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN 221
Query: 728 EIIFDNILNRKIPWP--CVPSDMSFEAQDLINRFLIHDPNQR 767
+ ++ I +K P + + E ++ +
Sbjct: 222 KQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (461), Expect = 4e-52
Identities = 54/276 (19%), Positives = 105/276 (38%), Gaps = 35/276 (12%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
D + + G +G V+ + A+K LK+ ++E L E ++ +++
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKH 72
Query: 555 PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLH 612
P +V+ T Y++ E++ G+L LR+ + V ++ A+EYL
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 613 SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQ 672
+HRDL N L+ + +K+ DFGLS++
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------------------------MT 166
Query: 673 QTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIF 731
A + APE L + +D W+ G++L+E T G+ P+ ++
Sbjct: 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226
Query: 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
+ + P + +L+ +P+ R
Sbjct: 227 ELLEKDYRMER--PEGCPEKVYELMRACWQWNPSDR 260
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 6e-52
Identities = 81/347 (23%), Positives = 132/347 (38%), Gaps = 69/347 (19%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ ++ + P+ GA+G V A TG A+K L + +R E +L +++
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 555 PFVVRFFYSFT-----CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALE 609
V+ FT N ++ +L G DL ++++ L +D + I +++ L+
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLK 135
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 669
Y+HS I+HRDLKP NL + D +K+ DFGL+
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLA--------------------------- 168
Query: 670 EYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPE 728
+ + V T Y APEI+L H D WSVG I+ E +TG F
Sbjct: 169 ---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225
Query: 729 IIFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFL 760
IL K+ + V + A DL+ + L
Sbjct: 226 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 285
Query: 761 IHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQKAVFVPQPESVDDT 807
+ D ++R+ AA+ AH +F + + ES D
Sbjct: 286 VLDSDKRI---TAAQALAHAYFAQYHDPDDEPVADPYDQSFESRDLL 329
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 4e-51
Identities = 68/337 (20%), Positives = 129/337 (38%), Gaps = 80/337 (23%)
Query: 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT 551
T + ++ +KPI GA G V A AIK L + + +R E ++
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 72
Query: 552 VRNPFVVRFFYSFTCRD------NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELV 605
V + ++ FT + ++YLVME ++ + ++ + + + +++
Sbjct: 73 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQML 129
Query: 606 LALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSD 665
+++LHS GI+HRDLKP N+++ D +K+ DFGL++
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART--------------------- 168
Query: 666 AHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAE 725
+ V T Y APE++LG + D WSVG I+ E + F
Sbjct: 169 -------AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221
Query: 726 SPEIIFDNILN---------------------------RKIPWPCVPSD----------- 747
++ ++ + +P + D
Sbjct: 222 DYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK 281
Query: 748 -MSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783
+ +A+DL+++ L+ DP +R+ + HP+
Sbjct: 282 LKASQARDLLSKMLVIDPAKRI---SVDDALQHPYIN 315
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 1e-50
Identities = 59/311 (18%), Positives = 109/311 (35%), Gaps = 48/311 (15%)
Query: 495 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
+ + + + +G+FG V+ K AIK + + +R + L E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77
Query: 550 ITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLR----------KVGCLEEDVARI 599
VVR + ++ME + GDL S LR +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 600 YIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETD 659
E+ + YL++ VHRDL N ++A D +K+ DFG+
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM------------------ 179
Query: 660 GIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI 719
Y+ R + +++PE L +D WS G++L+E T
Sbjct: 180 -------TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLA 232
Query: 720 -PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEV-- 776
P+ S E + ++ + P + +L+ ++P R
Sbjct: 233 EQPYQGLSNEQVLRFVMEGGLLDK--PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290
Query: 777 -KAHPFFKGVN 786
+ P F+ V+
Sbjct: 291 EEMEPGFREVS 301
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-50
Identities = 60/298 (20%), Positives = 109/298 (36%), Gaps = 53/298 (17%)
Query: 495 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
+ K + GAFG+V A K A+K+LK + E +++E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVL 80
Query: 550 ITVRN-PFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC----------------- 591
+ N +V + T ++ EY GDL + LR+
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 592 -LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650
L+ + + ++ + +L S +HRDL N+L+ H K+ DFGL++
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI----- 195
Query: 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 710
++ + +A ++APE + + + +D WS GI
Sbjct: 196 --------------------KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
Query: 711 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
L+E + G P+ + F ++ P E D++ DP +R
Sbjct: 236 FLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS-PEHAPAEMYDIMKTCWDADPLKR 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 3e-49
Identities = 62/298 (20%), Positives = 115/298 (38%), Gaps = 54/298 (18%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGD-------LFAIKVLKKLDMIRKNDIERILAERN 547
D + KP+ GAFG+V LA A+K+LK + D+ +++E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS--DATEKDLSDLISEME 70
Query: 548 ILITV-RNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGC--------------- 591
++ + ++ ++ + T LY+++EY + G+L L+
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 592 -LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650
L ++ +EYL S +HRDL N+L+ D +K+ DFGL++
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----- 185
Query: 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 710
+ + + ++APE L + + +D WS G+
Sbjct: 186 --------------------HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 225
Query: 711 ILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
+L+E T G P+ E +F + PS+ + E ++ P+QR
Sbjct: 226 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK--PSNCTNELYMMMRDCWHAVPSQR 281
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 7e-47
Identities = 56/278 (20%), Positives = 95/278 (34%), Gaps = 32/278 (11%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILI 550
K I G FG V+ +T+ AIK LK + L E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA--GYTEKQRVDFLGEAGIMG 64
Query: 551 TVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSL-LRKVGCLEEDVARIYIAELVLALE 609
+ ++R + + ++ EY+ G L K G + + ++
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 610 YLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYP 669
YL ++ VHRDL N+L+ + K++DFGLS++
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL------------------------ 160
Query: 670 EYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 729
E + APE + + A+D WS GI+++E +T E
Sbjct: 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH 220
Query: 730 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
+N P P D L+ + + +R
Sbjct: 221 EVMKAINDGFRLPT-PMDCPSAIYQLMMQCWQQERARR 257
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-46
Identities = 65/309 (21%), Positives = 118/309 (38%), Gaps = 55/309 (17%)
Query: 495 DDFEIIKPISRGAFGRVFLAR-----KRTTGDLFAIKVLKKLDMIRKNDIERILAERNIL 549
D ++ KP+ RGAFG+V A K T A+K+LK+ ++ +++E IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKIL 70
Query: 550 ITVRNPFVVRFFYSFTCRDN--LYLVMEYLNGGDLYSLLRKVG----------------C 591
I + + V + L +++E+ G+L + LR
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130
Query: 592 LEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651
L + Y ++ +E+L S +HRDL N+L++ +K+ DFGL++
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD------- 183
Query: 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGII 711
Y+ D + A ++APE + + +D WS G++
Sbjct: 184 ------------------IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVL 225
Query: 712 LFEFITGI-PPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA 770
L+E + P+ + F L P + E + +P+QR
Sbjct: 226 LWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-PDYTTPEMYQTMLDCWHGEPSQRP-- 282
Query: 771 NGAAEVKAH 779
+E+ H
Sbjct: 283 -TFSELVEH 290
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-46
Identities = 55/313 (17%), Positives = 106/313 (33%), Gaps = 67/313 (21%)
Query: 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN 554
+ + I +G FG V+ + G+ A+K+ R+ AE + +R+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRH 56
Query: 555 PFVVRFFYSFTCRDN----LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEY 610
++ F + + L+LV +Y G L+ L + E + ++ + L +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLAL-STASGLAH 115
Query: 611 LHS--------LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIM 662
LH I HRDLK N+L+ +G + D GL+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV------------------- 156
Query: 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH------GYAADWWSVGIILFEFI 716
+ T + + VGT Y+APE+L + + AD +++G++ +E
Sbjct: 157 ----RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212
Query: 717 TGIPPFTAESP-------------------EIIFDNILNRKIPWPCVPSDMSFEAQDLIN 757
+++ + L IP + ++
Sbjct: 213 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR 272
Query: 758 RFLIHDPNQRLGA 770
+ RL A
Sbjct: 273 ECWYANGAARLTA 285
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-45
Identities = 53/271 (19%), Positives = 99/271 (36%), Gaps = 33/271 (12%)
Query: 503 ISRGAFGRVFLAR---KRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVR 559
I RG FG V+ A+K L ++ ++ + L E I+ +P V+
Sbjct: 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 560 FF-YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA-ELVLALEYLHSLGIV 617
+ +V+ Y+ GDL + +R I ++ +++L S V
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152
Query: 618 HRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNR 677
HRDL N ++ +K+ DFGL++ + +
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARD-----------------------MYDKEFDSVH 189
Query: 678 NRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILN 736
N+ A ++A E L + +D WS G++L+E +T G PP+ + I +L
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 737 RKIPWPCVPSDMSFEAQDLINRFLIHDPNQR 767
+ P +++ + R
Sbjct: 250 GRRLLQ--PEYCPDPLYEVMLKCWHPKAEMR 278
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 144 bits (364), Expect = 3e-38
Identities = 57/348 (16%), Positives = 119/348 (34%), Gaps = 87/348 (25%)
Query: 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNI-------L 549
+ +++ + G F V+LA+ A+K+++ + + + I + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 550 ITVRNPFVVRFFYSFT--CRDNLYLVMEYLNGG---DLYSLLRKVGCLEEDVARIYIAEL 604
++ +++ F + +++VM + G + + + +L
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 605 VLALEYL-HSLGIVHRDLKPDNLLIAHDGHI-KLTDFGLSKIGLINNTIDLSGPETDGIM 662
+L L+Y+ GI+H D+KP+N+L+ L ++ +G +
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---------- 184
Query: 663 PSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 722
+ +++ T +Y +PE+LLG G AD WS ++FE ITG F
Sbjct: 185 ---------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229
Query: 723 TAESPEIIFDNI------------------------------------LNRKIPWPC--- 743
+ + +++ WP
Sbjct: 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289
Query: 744 ------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785
D + E D ++ L DP +R A + HP+ K
Sbjct: 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRA---DAGGLVNHPWLKDT 334
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 86.0 bits (212), Expect = 8e-20
Identities = 27/161 (16%), Positives = 50/161 (31%), Gaps = 28/161 (17%)
Query: 498 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLK-------KLDMIRKNDIERILAER---- 546
I K + G VF +K K K+ R
Sbjct: 3 AIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 547 ----NILITVRNPFVVRFFYSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIA 602
L ++ V + + ++ME ++ +LY + + +
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELY-------RVRVENPDEVLD 110
Query: 603 ELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSK 643
++ + + GIVH DL N+L+ + I + DF S
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 900 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.61 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.44 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.94 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.57 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.26 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.09 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=512.89 Aligned_cols=302 Identities=40% Similarity=0.755 Sum_probs=275.6
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEE
Q ss_conf 54589907997760279659999999789968999995323213535799999999999945999557892231147704
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNL 570 (900)
Q Consensus 491 ~i~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~L 570 (900)
++++++|++++.||+|+||.||+|+++.+|+.||+|++++.........+++.+|+.+|+.++|||||+++++|++.+.+
T Consensus 1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCC
T ss_conf 98447428988983176849999999899989999998156544979999999999999867999887787640356421
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 99996517988577888507899899999999999999864305717403799838855799199970577523333565
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s 650 (900)
|+||||++||+|..++.+.+.+++..+++|++||+.||+|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~---- 156 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI---- 156 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC----
T ss_pred CCCEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCC----
T ss_conf 1100035798605555325677599999999999652113431596224647778476589988882056520035----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHHHH
Q ss_conf 56999988898999999974223566776665579998873443179998421030025899999939999999985799
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 651 ~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~~~s~~ei 730 (900)
.........+||+.|||||++.+.+|+.++|||||||++|||++|++||.+.+..++
T Consensus 157 -----------------------~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~ 213 (337)
T d1o6la_ 157 -----------------------SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213 (337)
T ss_dssp -----------------------CTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred -----------------------CCCCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHH
T ss_conf -----------------------678620551008899666650489888333102230678899878999999699999
Q ss_pred HHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH--HCHHHHHCCCCCCCCCCCHHHHC--CCCCCCCCCCCCC
Q ss_conf 9864118988999999999889999987535995888992--02999981999889993011001--6975588999998
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDD 806 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D 806 (900)
+.++....+.+| ..+|+++++||.+||++||.+|++. .++.++++||||++++|+.+..+ .||++|.+.+..|
T Consensus 214 ~~~i~~~~~~~p---~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~~~~~ 290 (337)
T d1o6la_ 214 FELILMEEIRFP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVD 290 (337)
T ss_dssp HHHHHHCCCCCC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCSSTTC
T ss_pred HHHHHCCCCCCC---CCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCCCCCCCCHHHHHHCCCCCCCCCCCCCHHH
T ss_conf 999852899898---66899999999866638934422565234999972915036999999847899897888898014
Q ss_pred CCCCCCCCCCCCCCCC
Q ss_conf 6210000115899999
Q 002616 807 TSYFLSRFSQISSGLP 822 (900)
Q Consensus 807 ~s~fds~fs~~~~~l~ 822 (900)
+++|+..+.......+
T Consensus 291 ~~~f~~~~~~~~~~~~ 306 (337)
T d1o6la_ 291 TRYFDDEFTAQSITIT 306 (337)
T ss_dssp CTTSCHHHHTSCCC--
T ss_pred HHHCCCHHHHCCCCCC
T ss_conf 3323833342667789
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=481.64 Aligned_cols=288 Identities=40% Similarity=0.779 Sum_probs=264.0
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEE
Q ss_conf 58990799776027965999999978996899999532321353579999999999994599955789223114770499
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~LyL 572 (900)
.+++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.+|+.++|||||+++++|.+...+|+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCC
T ss_conf 72370898896117680899999989998999999826774588999999999999997487727403444432222232
Q ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 99651798857788850789989999999999999986430571740379983885579919997057752333356556
Q 002616 573 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 573 VmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s~d 652 (900)
||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+...
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~------ 192 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------ 192 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS------
T ss_pred CCCCCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCCCEEEEECEEEEECC------
T ss_conf 22233466226667515898999999999999998999985998617679999360778978861010333225------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHHHHHH
Q ss_conf 99998889899999997422356677666557999887344317999842103002589999993999999998579998
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 653 ls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~~~s~~ei~~ 732 (900)
....+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+...++.
T Consensus 193 ------------------------~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 248 (350)
T d1rdqe_ 193 ------------------------GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE 248 (350)
T ss_dssp ------------------------SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ------------------------CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf ------------------------66643367635678899717998853311450078999975889989959999999
Q ss_pred HHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH--HCHHHHHCCCCCCCCCCCHHHHC--CCCCCCCCCCCCCCC
Q ss_conf 64118988999999999889999987535995888992--02999981999889993011001--697558899999862
Q 002616 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTS 808 (900)
Q Consensus 733 kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s 808 (900)
+|......+| ..+|+++.+||++||.+||.+|+.. ..+.++++||||++++|+.+..+ .+||+|...++.|++
T Consensus 249 ~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~~~~d~s 325 (350)
T d1rdqe_ 249 KIVSGKVRFP---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTS 325 (350)
T ss_dssp HHHHCCCCCC---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCCSTTCCT
T ss_pred HHHCCCCCCC---CCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCHHH
T ss_conf 9861798897---6689999999999834099860655345499997190515899899983678969368889921133
Q ss_pred CCCCC
Q ss_conf 10000
Q 002616 809 YFLSR 813 (900)
Q Consensus 809 ~fds~ 813 (900)
||++.
T Consensus 326 ~~~~~ 330 (350)
T d1rdqe_ 326 NFDDY 330 (350)
T ss_dssp TSCCC
T ss_pred HCCCC
T ss_conf 25999
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=485.00 Aligned_cols=292 Identities=39% Similarity=0.753 Sum_probs=261.8
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHH-HCCCCCEEEEEEEECCCCEEEE
Q ss_conf 899079977602796599999997899689999953232135357999999999999-4599955789223114770499
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILI-TVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 494 ~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~-~l~HPnIVkL~~~f~~~~~LyL 572 (900)
+++|++++.||+|+||+||+|+++.+|+.||+|++++.........+.+..|..++. .++|||||++++++.+.+.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEE
T ss_conf 99718865894087828999999999989999998055533848999999999999984799968789889704983167
Q ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 99651798857788850789989999999999999986430571740379983885579919997057752333356556
Q 002616 573 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 573 VmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s~d 652 (900)
||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~------ 154 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENM------ 154 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC------
T ss_pred EEEECCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEECCCCCHHHHCC------
T ss_conf 77503798089986404789999999999999999999986893403476540444489963015553023235------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHHHHHH
Q ss_conf 99998889899999997422356677666557999887344317999842103002589999993999999998579998
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 653 ls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~~~s~~ei~~ 732 (900)
.........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+++.
T Consensus 155 ---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~ 213 (320)
T d1xjda_ 155 ---------------------LGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213 (320)
T ss_dssp ---------------------CTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ---------------------CCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf ---------------------66533454578777689999827998832320112278989873889999989999999
Q ss_pred HHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCCCCCCHHHHC--CCCCCCCCCCCCCCCCC
Q ss_conf 6411898899999999988999998753599588899202999981999889993011001--69755889999986210
Q 002616 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPESVDDTSYF 810 (900)
Q Consensus 733 kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s~~D~s~f 810 (900)
+|......+| ..+|+++++||.+||.+||.+||++. .++++||||++++|+.+..+ .||++|...++.|+++|
T Consensus 214 ~i~~~~~~~p---~~~s~~~~dli~~~L~~dP~~R~s~~--~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~~~~d~~~f 288 (320)
T d1xjda_ 214 SIRMDNPFYP---RWLEKEAKDLLVKLFVREPEKRLGVR--GDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNF 288 (320)
T ss_dssp HHHHCCCCCC---TTSCHHHHHHHHHHSCSSGGGSBTTB--SCGGGSGGGTTCCHHHHHTTCSCC---------------
T ss_pred HHHCCCCCCC---CCCCHHHHHHHHHHCCCCCCCCCCHH--HHHHHCCHHCCCCHHHHHHCCCCCCCCCCCCCCCCHHHC
T ss_conf 9971899897---56799999999996544898783889--999809013158999998368998977978996412442
Q ss_pred CCCCCCC
Q ss_conf 0001158
Q 002616 811 LSRFSQI 817 (900)
Q Consensus 811 ds~fs~~ 817 (900)
+..+...
T Consensus 289 ~~~~~~~ 295 (320)
T d1xjda_ 289 DKEFLNE 295 (320)
T ss_dssp -------
T ss_pred CHHHHHC
T ss_conf 9576628
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=478.28 Aligned_cols=288 Identities=40% Similarity=0.763 Sum_probs=261.4
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEE
Q ss_conf 58990799776027965999999978996899999532321353579999999999994599955789223114770499
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~LyL 572 (900)
++++|++++.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEE
T ss_conf 65470888897207680899999989997999999845775488999999999999986369675330356852880056
Q ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 99651798857788850789989999999999999986430571740379983885579919997057752333356556
Q 002616 573 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 573 VmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s~d 652 (900)
||||++||+|..++.....+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~------ 155 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP------ 155 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS------
T ss_pred EEEECCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCCCEEEECCCCCEEEC------
T ss_conf 76503786322343222211100799999999876554124767705568105038689988983175216712------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHHHHHH
Q ss_conf 99998889899999997422356677666557999887344317999842103002589999993999999998579998
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 653 ls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~~~s~~ei~~ 732 (900)
....+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++.
T Consensus 156 ------------------------~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~ 211 (316)
T d1fota_ 156 ------------------------DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE 211 (316)
T ss_dssp ------------------------SCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred ------------------------CCCCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf ------------------------45643457634359999838999804304653336899975989999969999999
Q ss_pred HHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH--HCHHHHHCCCCCCCCCCCHHHHC--CCCCCCCCCC-CCCC
Q ss_conf 64118988999999999889999987535995888992--02999981999889993011001--6975588999-9986
Q 002616 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQPES-VDDT 807 (900)
Q Consensus 733 kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~~~s-~~D~ 807 (900)
+|......+| ..+|+++++||.+||.+||.+|++. ..+.++++||||++++|+.+..+ .+|+.|.... ..|+
T Consensus 212 ~i~~~~~~~p---~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~~~~~d~ 288 (316)
T d1fota_ 212 KILNAELRFP---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDT 288 (316)
T ss_dssp HHHHCCCCCC---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-------
T ss_pred HHHCCCCCCC---CCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCHH
T ss_conf 9970898899---7789999999999954499766643102199998193514679899983789969889867886413
Q ss_pred CCCCCC
Q ss_conf 210000
Q 002616 808 SYFLSR 813 (900)
Q Consensus 808 s~fds~ 813 (900)
++|+..
T Consensus 289 ~~f~~~ 294 (316)
T d1fota_ 289 SQFDKY 294 (316)
T ss_dssp ------
T ss_pred HHCCCC
T ss_conf 325888
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=476.36 Aligned_cols=280 Identities=36% Similarity=0.718 Sum_probs=253.1
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEE
Q ss_conf 45899079977602796599999997899689999953232135357999999999999459995578922311477049
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 i~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~Ly 571 (900)
...++|++++.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+|+.++|||||+++++|.+.+.+|
T Consensus 5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEE
T ss_conf 89987789889850879099999998999799999986577557778999999999998768888617999999899889
Q ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99965179885778885078998999999999999998643057174037998388557991999705775233335655
Q 002616 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 572 LVmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
+||||++||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~--- 161 (288)
T d1uu3a_ 85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE--- 161 (288)
T ss_dssp EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCC---
T ss_conf 99970489877776531599999999999999999997621650884767741236688853886032102422567---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHHHHH
Q ss_conf 69999888989999999742235667766655799988734431799984210300258999999399999999857999
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 652 dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~~~s~~ei~ 731 (900)
.......+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++
T Consensus 162 ----------------------~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~ 219 (288)
T d1uu3a_ 162 ----------------------SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 219 (288)
T ss_dssp ------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred ----------------------CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHH
T ss_conf ----------------------7643335556775525844002689896662304569999980388998995999999
Q ss_pred HHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHC---HHHHHCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 86411898899999999988999998753599588899202---999981999889993011001697558
Q 002616 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG---AAEVKAHPFFKGVNWDSLALQKAVFVP 799 (900)
Q Consensus 732 ~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~---a~EIL~HPFFk~idw~~L~~~~ppf~P 799 (900)
.+|.+....+| ..+|+++++||.+||++||.+|||+.+ ...+++||||++++|+.+..+.||-.|
T Consensus 220 ~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 220 QKIIKLEYDFP---EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp HHHHTTCCCCC---TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred HHHHCCCCCCC---CCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHHHHCCCCCCCCCHHHHHCCCCCCCC
T ss_conf 99971899998---547999999999985579768919789737789876976478998896157999999
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=471.05 Aligned_cols=288 Identities=35% Similarity=0.623 Sum_probs=245.2
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHH---HHHHHHCCCCCEEEEEEEECCCC
Q ss_conf 458990799776027965999999978996899999532321353579999999---99999459995578922311477
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAE---RNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 492 i~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~E---i~IL~~l~HPnIVkL~~~f~~~~ 568 (900)
+++++|++.+.||+|+||.||+|+++.+|+.||+|++.+...........+.+| ..++..++|||||+++++|.+.+
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CCHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
T ss_conf 97776851018842889099999999999799999984587542667999999999999985089985889999999899
Q ss_pred EEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 04999965179885778885078998999999999999998643057174037998388557991999705775233335
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 569 ~LyLVmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~ 648 (900)
.+|+||||++||+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~-- 158 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-- 158 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS--
T ss_pred EEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCCCEEEEEECEEEECC--
T ss_conf 889999914898389998732553278999999999999999997796220444221678588967982201023337--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCCCEEECHHHHHHHHHHCCCCCCCCCH
Q ss_conf 655699998889899999997422356677666557999887344317-9998421030025899999939999999985
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESP 727 (900)
Q Consensus 649 ~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyELLtGk~PF~~~s~ 727 (900)
.......+||+.|||||++.+ ..|+.++|||||||++|||++|++||.+.+.
T Consensus 159 ---------------------------~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 211 (364)
T d1omwa3 159 ---------------------------KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211 (364)
T ss_dssp ---------------------------SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS
T ss_pred ---------------------------CCCCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf ---------------------------88643311345542168760389998441046778999999859998888998
Q ss_pred H---HHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH--HCHHHHHCCCCCCCCCCCHHHHC--CCCCCCC
Q ss_conf 7---999864118988999999999889999987535995888992--02999981999889993011001--6975588
Q 002616 728 E---IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KAVFVPQ 800 (900)
Q Consensus 728 ~---ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~--~~a~EIL~HPFFk~idw~~L~~~--~ppf~P~ 800 (900)
. .+...+......+ +..+|+++++||.+||.+||.+||+. ..|.++++||||++++|+.+..+ +||++|.
T Consensus 212 ~~~~~~~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~ 288 (364)
T d1omwa3 212 KDKHEIDRMTLTMAVEL---PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP 288 (364)
T ss_dssp SCHHHHHHHSSSCCCCC---CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHHHHHHHCCCCCCCC---CCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCCCCCCCHHHHHCCCCCCCCCCC
T ss_conf 99999998604688878---877899999999998566988808874357999974910237898799628899593799
Q ss_pred CCCCCCCCCCC
Q ss_conf 99999862100
Q 002616 801 PESVDDTSYFL 811 (900)
Q Consensus 801 ~~s~~D~s~fd 811 (900)
.......++|+
T Consensus 289 ~~~~~~~~~~d 299 (364)
T d1omwa3 289 RGEVNAADAFD 299 (364)
T ss_dssp CC---------
T ss_pred CCCCCCCCCCC
T ss_conf 88888687454
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=451.53 Aligned_cols=258 Identities=36% Similarity=0.648 Sum_probs=238.1
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEE
Q ss_conf 45899079977602796599999997899689999953232135357999999999999459995578922311477049
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 i~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~Ly 571 (900)
..+++|++.+.||+|+||+||+|+++.+++.||+|++.+...........+.+|+.+++.++|||||++++++.+.+.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CCHHHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEE
T ss_conf 61537699889851778589999998999499999981688567689999999999998568888885999999899989
Q ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 99965179885778885078998999999999999998643057174037998388557991999705775233335655
Q 002616 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 572 LVmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
+||||++||+|.+++.+.+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----- 157 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----- 157 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC-----
T ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCCCEEECCCCEEEECC-----
T ss_conf 998504798589887504899999999999999999999998894652202344146689987115556335448-----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHHHHH
Q ss_conf 69999888989999999742235667766655799988734431799984210300258999999399999999857999
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 652 dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~~~s~~ei~ 731 (900)
.......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++
T Consensus 158 ------------------------~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~ 213 (263)
T d2j4za1 158 ------------------------SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 213 (263)
T ss_dssp ------------------------CCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH
T ss_pred ------------------------CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf ------------------------88523557887634999975899893144046759999983299998889999999
Q ss_pred HHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf 86411898899999999988999998753599588899202999981999889
Q 002616 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 732 ~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~ 784 (900)
.++......+| ..+|+++++||.+||.+||.+||+ +.++++||||..
T Consensus 214 ~~i~~~~~~~p---~~~s~~~~~li~~~L~~dp~~R~t---~~eil~hp~~~~ 260 (263)
T d2j4za1 214 KRISRVEFTFP---DFVTEGARDLISRLLKHNPSQRPM---LREVLEHPWITA 260 (263)
T ss_dssp HHHHTTCCCCC---TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTCHHHHH
T ss_pred HHHHCCCCCCC---CCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCCCCCC
T ss_conf 99971899998---668999999999976479768909---999971907078
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=442.07 Aligned_cols=265 Identities=28% Similarity=0.508 Sum_probs=236.0
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEE
Q ss_conf 45899079977602796599999997899689999953232135357999999999999459995578922311477049
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 i~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~Ly 571 (900)
-.+++|++++.||+|+||+||+|+++.+|+.||+|++.+.. ....+.+.+|+.+|..++|||||+++++|.+.+.+|
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 78657589889840768199999988999899999984524---316999999999998679979992999999899999
Q ss_pred EEEEECCCCCHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECC--CCCEEEEECCCCCCCCCC
Q ss_conf 9996517988577888-5078998999999999999998643057174037998388557--991999705775233335
Q 002616 572 LVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH--DGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 572 LVmEyl~GGSL~dlL~-k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~--~G~VKLsDFGLAk~~~~~ 648 (900)
+||||++||+|.+++. ..+.+++..++.|+.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+...
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~-- 177 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-- 177 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC--
T ss_pred EEEECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECC--
T ss_conf 999857998899999762378999999999999999999997569760001546736416889869995452104425--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 65569999888989999999742235667766655799988734431799984210300258999999399999999857
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 728 (900)
Q Consensus 649 ~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~~~s~~ 728 (900)
......+.+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..
T Consensus 178 --------------------------~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 231 (350)
T d1koaa2 178 --------------------------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 231 (350)
T ss_dssp --------------------------TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred --------------------------CCCCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH
T ss_conf --------------------------654320006862421889975899872676554659999998598998997999
Q ss_pred HHHHHHHCCCCCCCC-CCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCCCCCCHH
Q ss_conf 999864118988999-99999988999998753599588899202999981999889993011
Q 002616 729 IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSL 790 (900)
Q Consensus 729 ei~~kIl~~~l~~P~-ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~idw~~L 790 (900)
+++..|......++. ....+|+++++||.+||++||.+||+ +.++|+||||+..+|...
T Consensus 232 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hp~~~~~~~~~~ 291 (350)
T d1koaa2 232 ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPGR 291 (350)
T ss_dssp HHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCC---HHHHHHSTTTSCTTCCSC
T ss_pred HHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCCCCCCCCCCCC
T ss_conf 999999847889894223589999999999975689667908---999862913288988875
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=438.11 Aligned_cols=266 Identities=29% Similarity=0.500 Sum_probs=239.1
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCH---HHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEE
Q ss_conf 990799776027965999999978996899999532321353---57999999999999459995578922311477049
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK---NDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 495 ~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~---~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~Ly 571 (900)
+.|++++.||+|+||+||+|+++.+|+.||+|++++...... ...+.+.+|+.+|+.++|||||+++++|.+...+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 67798279811789599999999999899999987566321340689999999999998679989993889999799899
Q ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCC----CEEEEECCCCCCCCC
Q ss_conf 9996517988577888507899899999999999999864305717403799838855799----199970577523333
Q 002616 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG----HIKLTDFGLSKIGLI 647 (900)
Q Consensus 572 LVmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G----~VKLsDFGLAk~~~~ 647 (900)
+|||||+||+|.+++.+.+.+++..++.++.|++.||+|||+++|+||||||+|||++.++ .+||+|||+|+...
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~- 168 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID- 168 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT-
T ss_pred EEEECCCCCCCCCHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHHHHHCC-
T ss_conf 9998677864310010356421557899999999998766625422113330127982589866646964334421057-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCH
Q ss_conf 56556999988898999999974223566776665579998873443179998421030025899999939999999985
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 727 (900)
Q Consensus 648 ~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~~~s~ 727 (900)
......+.+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+.
T Consensus 169 ---------------------------~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 221 (293)
T d1jksa_ 169 ---------------------------FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221 (293)
T ss_dssp ---------------------------TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------CCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCH
T ss_conf ---------------------------77631224777743099998189999766522140999999708899889999
Q ss_pred HHHHHHHHCCCCCCCC-CCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCCCCCCHHH
Q ss_conf 7999864118988999-999999889999987535995888992029999819998899930110
Q 002616 728 EIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWDSLA 791 (900)
Q Consensus 728 ~ei~~kIl~~~l~~P~-ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~idw~~L~ 791 (900)
.+++..|......++. .+..+|+++++||++||..||.+||+ +.++++||||++.+|....
T Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~~~~~~~l 283 (293)
T d1jksa_ 222 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT---IQDSLQHPWIKPKDTQQAL 283 (293)
T ss_dssp HHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTCC-------
T ss_pred HHHHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCCCCCCCCHHHHH
T ss_conf 9999999816888870104788999999999986389668919---9999619041888705764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=441.26 Aligned_cols=259 Identities=34% Similarity=0.583 Sum_probs=233.0
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 89907997760279659999999789968999995323213535799999999999945999557892231147704999
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~LyLV 573 (900)
.+.|++.+.||+|+||+||+|+++.+|+.||+|++.+.... .....+.+|+.+|..++|||||+++++|.+.+.+|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 66669988994065839999999999989999998157731--2899999999999867998999198999989988898
Q ss_pred EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEEC---CCCCEEEEECCCCCCCCCCCC
Q ss_conf 96517988577888507899899999999999999864305717403799838855---799199970577523333565
Q 002616 574 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA---HDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 574 mEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD---~~G~VKLsDFGLAk~~~~~~s 650 (900)
|||++||+|.+++.+.+.+++..++.|+.||+.||.|||++||+||||||+|||+. .++.+||+|||+|+...
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~---- 161 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED---- 161 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEECC----
T ss_conf 8526898488865303678878999999999999875241305568704630011046888249983154358725----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHHHH
Q ss_conf 56999988898999999974223566776665579998873443179998421030025899999939999999985799
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 651 ~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~~~s~~ei 730 (900)
......+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..++
T Consensus 162 ------------------------~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~ 217 (307)
T d1a06a_ 162 ------------------------PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217 (307)
T ss_dssp -----------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred ------------------------CCCEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
T ss_conf ------------------------89704400328422591887379998078734515999999859799999899999
Q ss_pred HHHHHCCCCCCCC-CCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCCC
Q ss_conf 9864118988999-999999889999987535995888992029999819998899
Q 002616 731 FDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 731 ~~kIl~~~l~~P~-ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~i 785 (900)
...+......++. .+..+|+++++||.+||.+||.+||+ +.++++||||++.
T Consensus 218 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~~ 270 (307)
T d1a06a_ 218 FEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT---CEQALQHPWIAGD 270 (307)
T ss_dssp HHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHSTTTTSS
T ss_pred HHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHCCC
T ss_conf 9998616877787666678999999999976089757918---9998629844799
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=436.49 Aligned_cols=260 Identities=25% Similarity=0.482 Sum_probs=233.4
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEE
Q ss_conf 45899079977602796599999997899689999953232135357999999999999459995578922311477049
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 i~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~Ly 571 (900)
...++|++++.||+|+||+||+|+++.+|+.||+|++++.. ......+.+|+.+|+.++|||||+++++|.+...+|
T Consensus 26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 102 (352)
T d1koba_ 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMV 102 (352)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 85403599899931778299999998999799999988726---467999999999998679979891999999899999
Q ss_pred EEEEECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCCCCC
Q ss_conf 9996517988577888507-899899999999999999864305717403799838855--7991999705775233335
Q 002616 572 LVMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA--HDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 572 LVmEyl~GGSL~dlL~k~g-~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD--~~G~VKLsDFGLAk~~~~~ 648 (900)
+||||++||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+...
T Consensus 103 ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~-- 180 (352)
T d1koba_ 103 LILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-- 180 (352)
T ss_dssp EEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC--
T ss_pred EEEECCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECC--
T ss_conf 999828998088889863899899999999999999999999779265131445531134678848995256303437--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 65569999888989999999742235667766655799988734431799984210300258999999399999999857
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPE 728 (900)
Q Consensus 649 ~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~~~s~~ 728 (900)
........+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..
T Consensus 181 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 234 (352)
T d1koba_ 181 --------------------------PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234 (352)
T ss_dssp --------------------------TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred --------------------------CCCCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH
T ss_conf --------------------------887201004764534899974799897633389899999999688998997999
Q ss_pred HHHHHHHCCCCCCCC-CCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCCC
Q ss_conf 999864118988999-999999889999987535995888992029999819998899
Q 002616 729 IIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 729 ei~~kIl~~~l~~P~-ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~i 785 (900)
+++..|......++. .+..+|+++++||.+||++||.+||+ +.++|+||||++.
T Consensus 235 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~Hp~~~~~ 289 (352)
T d1koba_ 235 ETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT---VHDALEHPWLKGD 289 (352)
T ss_dssp HHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHTSTTTSSC
T ss_pred HHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHCCC
T ss_conf 999999847889893002479999999999975699668918---9999609734888
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=443.01 Aligned_cols=262 Identities=27% Similarity=0.467 Sum_probs=225.1
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEE
Q ss_conf 58990799776027965999999978996899999532321353579999999999994599955789223114770499
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~LyL 572 (900)
.+++|++++.||+|+||+||+|+++.+|+.||+|++++... .+..+.+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC--CHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEE
T ss_conf 87460899897217480999999999997999999845664--1279999999999985799888469654046743679
Q ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 99651798857788850789989999999999999986430571740379983885579919997057752333356556
Q 002616 573 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 573 VmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s~d 652 (900)
||||++||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 81 vmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~---- 156 (271)
T d1nvra_ 81 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN---- 156 (271)
T ss_dssp EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET----
T ss_pred EEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC----
T ss_conf 8864589808999753799999999999999999999999759835754689978878998798323142240468----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC-CCCCEEECHHHHHHHHHHCCCCCCCCCHHHHH
Q ss_conf 99998889899999997422356677666557999887344317999-84210300258999999399999999857999
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 653 ls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGVILyELLtGk~PF~~~s~~ei~ 731 (900)
.........+||+.|||||++.+..| +.++|||||||++|||++|++||...+.....
T Consensus 157 ---------------------~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~ 215 (271)
T d1nvra_ 157 ---------------------NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215 (271)
T ss_dssp ---------------------TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH
T ss_pred ---------------------CCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHH
T ss_conf ---------------------86531113255747428728618999997101617379999998299788889859999
Q ss_pred HHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf 86411898899999999988999998753599588899202999981999889
Q 002616 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 732 ~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~ 784 (900)
..........+.....+|+++++||.+||+.||.+||+ +.++++||||+.
T Consensus 216 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hpwf~~ 265 (271)
T d1nvra_ 216 YSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTC
T ss_pred HHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHCC
T ss_conf 99986388878864469999999999976799668909---999961984585
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=439.96 Aligned_cols=256 Identities=34% Similarity=0.548 Sum_probs=228.4
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf 99079977602796599999997899689999953232135357999999999999459995578922311477049999
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~LyLVm 574 (900)
++|++++.||+|+||+||+|+++.+|+.||+|++++.... ..+.+.+|+.+|+.++|||||+++++|.+.+.+|+||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCH---HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 0538878981285829999999899989999998430172---7999999999998679998805857798899989999
Q ss_pred EECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCC
Q ss_conf 65179885778885078998999999999999998643057174037998388557991999705775233335655699
Q 002616 575 EYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLS 654 (900)
Q Consensus 575 Eyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s~dls 654 (900)
||++||+|.+++.+ +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+...
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~-------- 167 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT-------- 167 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC--------
T ss_pred EECCCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEEC--------
T ss_conf 70379808988641-599999999999999999999998797226776888688789968642515641321--------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHHHHHHHH
Q ss_conf 99888989999999742235667766655799988734431799984210300258999999399999999857999864
Q 002616 655 GPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734 (900)
Q Consensus 655 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~~~s~~ei~~kI 734 (900)
.........+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+..+....+
T Consensus 168 -------------------~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~ 228 (293)
T d1yhwa1 168 -------------------PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228 (293)
T ss_dssp -------------------STTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred -------------------CCCCCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHH
T ss_conf -------------------3666444444477736826644799880120313729999980488998997999999999
Q ss_pred HCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf 11898899999999988999998753599588899202999981999889
Q 002616 735 LNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 735 l~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~ 784 (900)
.....+....+..+|+++++||.+||.+||.+||+ +.++|+||||+.
T Consensus 229 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~Hp~~~~ 275 (293)
T d1yhwa1 229 ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS---AKELLQHQFLKI 275 (293)
T ss_dssp HHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCC---HHHHTTCGGGGG
T ss_pred HHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHCC
T ss_conf 85799988885537999999999986699668909---999964996577
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=442.45 Aligned_cols=263 Identities=31% Similarity=0.510 Sum_probs=225.8
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEE
Q ss_conf 45899079977602796599999997899689999953232135357999999999999459995578922311477049
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 i~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~Ly 571 (900)
+..++|++++.||+|+||+||+|+++.+|+.||+|++++.. .......+.+|+.+|+.++|||||+++++|.+...+|
T Consensus 3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 87568889789712778099999998999699999987540--9789999999999998679999994999999899999
Q ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 999651798857788850789989999999999999986430-5717403799838855799199970577523333565
Q 002616 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 572 LVmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs-~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s 650 (900)
+||||++||+|.+++.+.+.+++..++.++.|++.||.|||+ +||+||||||+|||++.+|++||+|||+|+...
T Consensus 81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~---- 156 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---- 156 (322)
T ss_dssp EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH----
T ss_pred EEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEEEECCCCCCCC----
T ss_conf 9997679986899874249999999999999999999999985999714457799468789989995487762567----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHHHH
Q ss_conf 56999988898999999974223566776665579998873443179998421030025899999939999999985799
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEII 730 (900)
Q Consensus 651 ~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~~~s~~ei 730 (900)
.....+.+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+.
T Consensus 157 -------------------------~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~ 211 (322)
T d1s9ja_ 157 -------------------------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211 (322)
T ss_dssp -------------------------HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHH
T ss_pred -------------------------CCCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
T ss_conf -------------------------8862111377141194687589989488899899999999988899899887899
Q ss_pred HHH------------------------------------------HHCCCCCCCCCC-CCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 986------------------------------------------411898899999-9999889999987535995888
Q 002616 731 FDN------------------------------------------ILNRKIPWPCVP-SDMSFEAQDLINRFLIHDPNQR 767 (900)
Q Consensus 731 ~~k------------------------------------------Il~~~l~~P~ip-~~iS~elkDLIkklL~~DP~kR 767 (900)
... +.... .|..+ ..+|.+++|||.+||+.||.+|
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R 289 (322)
T d1s9ja_ 212 ELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAER 289 (322)
T ss_dssp HHHC------------------------------CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCC--CCCCCCCCCCHHHHHHHHHHCCCCHHHC
T ss_conf 99998875177545774212333221111222354134778876650268--7667644489999999999868994679
Q ss_pred CCHHCHHHHHCCCCCCCCCCCHH
Q ss_conf 99202999981999889993011
Q 002616 768 LGANGAAEVKAHPFFKGVNWDSL 790 (900)
Q Consensus 768 ps~~~a~EIL~HPFFk~idw~~L 790 (900)
|+ +.++|+||||+..+|+..
T Consensus 290 ~t---a~e~L~Hpf~~~~~~~~~ 309 (322)
T d1s9ja_ 290 AD---LKQLMVHAFIKRSDAEEV 309 (322)
T ss_dssp CC---HHHHHTSHHHHHHHHSCC
T ss_pred CC---HHHHHHCHHHCCCCCCCC
T ss_conf 08---999960986476982313
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=436.31 Aligned_cols=258 Identities=32% Similarity=0.542 Sum_probs=229.9
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEE
Q ss_conf 99079977602796599999997899689999953232135357999999999999459995578922311477049999
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVM 574 (900)
Q Consensus 495 ~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~LyLVm 574 (900)
+.|++++.||+|+||+||+|+++.+|..||+|++++.. ....+.+.+|+.+|+.++|||||++++++.+.+.+|+||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37598479930778199999999999399999987289---999999999999998679999884988980099589999
Q ss_pred EECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 651798857788850-7899899999999999999864305717403799838855799199970577523333565569
Q 002616 575 EYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 575 Eyl~GGSL~dlL~k~-g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s~dl 653 (900)
||++||+|.+++.+. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~------ 162 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR------ 162 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH------
T ss_pred ECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCCCEEEEECHHHHCCCC------
T ss_conf 62799818899986289999999999999999999999988988714070031487899989971612303577------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHC-----CCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHH
Q ss_conf 999888989999999742235667766655799988734431-----799984210300258999999399999999857
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILL-----GTEHGYAADWWSVGIILFEFITGIPPFTAESPE 728 (900)
Q Consensus 654 s~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~-----g~~ys~ksDIWSLGVILyELLtGk~PF~~~s~~ 728 (900)
......+.+||+.|||||++. +..|+.++|||||||++|||++|++||.+.++.
T Consensus 163 ---------------------~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~ 221 (288)
T d2jfla1 163 ---------------------TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221 (288)
T ss_dssp ---------------------HHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred ---------------------CCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH
T ss_conf ---------------------86410010256264799998320257888880665787899999982088999998999
Q ss_pred HHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCCC
Q ss_conf 999864118988999999999889999987535995888992029999819998899
Q 002616 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 729 ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~i 785 (900)
+++.++.....+....+..+|+++++||.+||++||.+||+ +.++++||||+.-
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~ell~hp~~~~~ 275 (288)
T d2jfla1 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWT---TSQLLQHPFVTVD 275 (288)
T ss_dssp GHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTSGGGCCC
T ss_pred HHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCCCCCCC
T ss_conf 99999970799877765669999999999976699668919---9999629231889
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=433.94 Aligned_cols=254 Identities=27% Similarity=0.395 Sum_probs=230.0
Q ss_pred CEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
Q ss_conf 90799776027965999999978996899999532321353579999999999994599955789223114770499996
Q 002616 496 DFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 496 dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~LyLVmE 575 (900)
.|+.++.||+|+||+||+|+++.+|+.||+|++++.........+.+.+|+.+|..++|||||++++++.+.+.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998998899998
Q ss_pred ECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCC
Q ss_conf 51798857788850789989999999999999986430571740379983885579919997057752333356556999
Q 002616 576 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 576 yl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s~dls~ 655 (900)
||+||+|..++...+.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~--------- 166 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA--------- 166 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS---------
T ss_pred ECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCCCEEEEECCCCCCCC---------
T ss_conf 06999457899737999999999999999999999986897666788421798799978984436533467---------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC---CCCCCCCEEECHHHHHHHHHHCCCCCCCCCHHHHHH
Q ss_conf 98889899999997422356677666557999887344317---999842103002589999993999999998579998
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG---TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g---~~ys~ksDIWSLGVILyELLtGk~PF~~~s~~ei~~ 732 (900)
.....+||+.|||||++.+ ..|+.++|||||||++|||++|.+||.+.+..+...
T Consensus 167 ----------------------~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~ 224 (309)
T d1u5ra_ 167 ----------------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY 224 (309)
T ss_dssp ----------------------SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred ----------------------CCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf ----------------------7873134766368899834678886721454558999999987889999979999999
Q ss_pred HHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf 6411898899999999988999998753599588899202999981999889
Q 002616 733 NILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 733 kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~ 784 (900)
++.....+.+ .+..+|+++++||.+||.+||.+||+ +.++++||||..
T Consensus 225 ~i~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 225 HIAQNESPAL-QSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLR 272 (309)
T ss_dssp HHHHSCCCCC-SCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTCHHHHS
T ss_pred HHHHCCCCCC-CCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHHCHHHCC
T ss_conf 9982899988-87888999999999977379657918---999971997537
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=423.85 Aligned_cols=252 Identities=24% Similarity=0.439 Sum_probs=218.9
Q ss_pred EEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC----CCEEEE
Q ss_conf 0799776027965999999978996899999532321353579999999999994599955789223114----770499
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC----RDNLYL 572 (900)
Q Consensus 497 feilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~----~~~LyL 572 (900)
|++.+.||+|+||+||+|+++.++..||+|++..... .....+.+.+|+++|+.++|||||++++++.+ ...+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEE
T ss_conf 8851697008284999999999995999999851227-989999999999999857999850699998403345888999
Q ss_pred EEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCCCCCCEEEC-CCCCEEEEECCCCCCCCCCC
Q ss_conf 9965179885778885078998999999999999998643057--17403799838855-79919997057752333356
Q 002616 573 VMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLG--IVHRDLKPDNLLIA-HDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 573 VmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~G--IIHRDIKPeNILLD-~~G~VKLsDFGLAk~~~~~~ 649 (900)
||||++||+|.+++.+.+.+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+|+...
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~--- 166 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--- 166 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC---
T ss_pred EEECCCCCCHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEECCCCEECC---
T ss_conf 99578989489997513554699999999999999999997899799687674351166799988980057654236---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCC-HH
Q ss_conf 55699998889899999997422356677666557999887344317999842103002589999993999999998-57
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES-PE 728 (900)
Q Consensus 650 s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~~~s-~~ 728 (900)
.....+.+||+.|||||++.+ .|+.++|||||||++|||++|++||.+.. ..
T Consensus 167 --------------------------~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~ 219 (270)
T d1t4ha_ 167 --------------------------ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA 219 (270)
T ss_dssp --------------------------TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH
T ss_pred --------------------------CCCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHH
T ss_conf --------------------------876677553813008988478-99986711007999999987889998765599
Q ss_pred HHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCC
Q ss_conf 9998641189889999999998899999875359958889920299998199988
Q 002616 729 IIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 729 ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk 783 (900)
.+++.+..+.. .+..+...++++++||.+||.+||.+||+ +.++++||||+
T Consensus 220 ~~~~~i~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~ell~Hp~fk 270 (270)
T d1t4ha_ 220 QIYRRVTSGVK-PASFDKVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQ 270 (270)
T ss_dssp HHHHHHTTTCC-CGGGGGCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC
T ss_pred HHHHHHHCCCC-CCCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCCCCC
T ss_conf 99999973899-86567557899999999976379758929---99996775409
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=427.24 Aligned_cols=256 Identities=32% Similarity=0.548 Sum_probs=228.7
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC--CCEEE
Q ss_conf 8990799776027965999999978996899999532321353579999999999994599955789223114--77049
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC--RDNLY 571 (900)
Q Consensus 494 ~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~--~~~Ly 571 (900)
.++|++++.||+|+||+||+|+++.+|+.||+|++++... .+...+.+.+|+.+++.++|||||++++++.+ ...+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
T ss_conf 3337996798308891999999999997999999874657-979999999999999977899982489999917899899
Q ss_pred EEEEECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----EEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 99965179885778885----078998999999999999998643057-----174037998388557991999705775
Q 002616 572 LVMEYLNGGDLYSLLRK----VGCLEEDVARIYIAELVLALEYLHSLG-----IVHRDLKPDNLLIAHDGHIKLTDFGLS 642 (900)
Q Consensus 572 LVmEyl~GGSL~dlL~k----~g~Lse~~ar~ii~QIl~AL~yLHs~G-----IIHRDIKPeNILLD~~G~VKLsDFGLA 642 (900)
+||||++||+|.+++.+ ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCE
T ss_conf 99956899938999985154578999999999999999999999971677887885867654257478885798001000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCC
Q ss_conf 23333565569999888989999999742235667766655799988734431799984210300258999999399999
Q 002616 643 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 722 (900)
Q Consensus 643 k~~~~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF 722 (900)
+... .........+||+.|||||++.+..|+.++|||||||++|||++|++||
T Consensus 162 ~~~~---------------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf 214 (269)
T d2java1 162 RILN---------------------------HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF 214 (269)
T ss_dssp HHC--------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred EECC---------------------------CCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCC
T ss_conf 3224---------------------------5777556677882327999983999993898875278999980188998
Q ss_pred CCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCC
Q ss_conf 999857999864118988999999999889999987535995888992029999819998
Q 002616 723 TAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFF 782 (900)
Q Consensus 723 ~~~s~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFF 782 (900)
.+.+..++..+|...... .+|..+|+++++||.+||..||.+||+ +.++++|||.
T Consensus 215 ~~~~~~~~~~~i~~~~~~--~~~~~~s~~l~~li~~~L~~dp~~Rps---~~ell~hp~i 269 (269)
T d2java1 215 TAFSQKELAGKIREGKFR--RIPYRYSDELNEIITRMLNLKDYHRPS---VEEILENPLI 269 (269)
T ss_dssp CCSSHHHHHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSTTC
T ss_pred CCCCHHHHHHHHHCCCCC--CCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHHCCCC
T ss_conf 998999999999718998--897435999999999976799557918---9999729819
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=416.32 Aligned_cols=261 Identities=31% Similarity=0.509 Sum_probs=232.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCC------HHHHHHHHHHHHHHHHCC-CCCEEEEEEEECC
Q ss_conf 899079977602796599999997899689999953232135------357999999999999459-9955789223114
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIR------KNDIERILAERNILITVR-NPFVVRFFYSFTC 566 (900)
Q Consensus 494 ~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~------~~~~e~il~Ei~IL~~l~-HPnIVkL~~~f~~ 566 (900)
.++|++.+.||+|+||+||+|+++.+|+.||+|++++..... +...+.+.+|+.++..++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 77049999651798857788850789989999999999999986430571740379983885579919997057752333
Q 002616 567 RDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 567 ~~~LyLVmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~ 646 (900)
++.+|+||||++||+|.+++...+.+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCHHEEECC
T ss_conf 76059999768986689999865999999999999999999999987599432346254898689983871240316726
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC------CCCCCCCEEECHHHHHHHHHHCCC
Q ss_conf 35655699998889899999997422356677666557999887344317------999842103002589999993999
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG------TEHGYAADWWSVGIILFEFITGIP 720 (900)
Q Consensus 647 ~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g------~~ys~ksDIWSLGVILyELLtGk~ 720 (900)
........+||+.|+|||++.+ ..|+.++||||+||++|||++|++
T Consensus 162 ----------------------------~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~ 213 (277)
T d1phka_ 162 ----------------------------PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 213 (277)
T ss_dssp ----------------------------TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ----------------------------CCCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCC
T ss_conf ----------------------------8872134524678889888605344567889923318565602310322888
Q ss_pred CCCCCCHHHHHHHHHCCCCCCCC-CCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCCC
Q ss_conf 99999857999864118988999-999999889999987535995888992029999819998899
Q 002616 721 PFTAESPEIIFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 721 PF~~~s~~ei~~kIl~~~l~~P~-ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~i 785 (900)
||.+.+.......+..+...++. ....+|+++++||.+||++||.+||+ +.++|+||||+..
T Consensus 214 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s---~~eil~h~~~~~~ 276 (277)
T d1phka_ 214 PFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT---AEEALAHPFFQQY 276 (277)
T ss_dssp SSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGCTT
T ss_pred CCCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHHHH
T ss_conf 98899999999999818988898543468999999999976589668919---9999739787975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=422.64 Aligned_cols=257 Identities=27% Similarity=0.493 Sum_probs=230.6
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEE
Q ss_conf 58990799776027965999999978996899999532321353579999999999994599955789223114770499
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~LyL 572 (900)
..++|++++.||+|+||+||+|+++.+|+.||+|++++.. .....+.+|+.+|..++|||||+++++|.+.+.+|+
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEE
T ss_conf 7010588789831778399999998999699999975786----659999999999985799798909899988998899
Q ss_pred EEEECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCC--CCEEEEECCCCCCCCCCC
Q ss_conf 996517988577888507-89989999999999999986430571740379983885579--919997057752333356
Q 002616 573 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD--GHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 573 VmEyl~GGSL~dlL~k~g-~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~--G~VKLsDFGLAk~~~~~~ 649 (900)
|||||+||+|.+++.+.+ .+++..++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~--- 155 (321)
T d1tkia_ 79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--- 155 (321)
T ss_dssp EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred EEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCC---
T ss_conf 99538998088998753899999999999999999999998769975135544434437885189976441110034---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf 55699998889899999997422356677666557999887344317999842103002589999993999999998579
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 729 (900)
Q Consensus 650 s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~~~s~~e 729 (900)
........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+
T Consensus 156 -------------------------~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~ 210 (321)
T d1tkia_ 156 -------------------------PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ 210 (321)
T ss_dssp -------------------------TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred -------------------------CCCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHH
T ss_conf -------------------------6775321223322234021048777840113027999999982899999989999
Q ss_pred HHHHHHCCCCCCCC-CCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf 99864118988999-99999988999998753599588899202999981999889
Q 002616 730 IFDNILNRKIPWPC-VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 730 i~~kIl~~~l~~P~-ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~ 784 (900)
++.+|......++. .+..+|+++++||.+||.+||.+||+ +.++++||||+.
T Consensus 211 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~~~~ 263 (321)
T d1tkia_ 211 IIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQ 263 (321)
T ss_dssp HHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHS
T ss_pred HHHHHHHCCCCCCHHHCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHCC
T ss_conf 99999838999880223678999999999986699668909---999963996566
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=425.54 Aligned_cols=288 Identities=41% Similarity=0.782 Sum_probs=245.6
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEE---CCCCCEEEEEEEECCCCC-CHHHHHHHHHHHHHHHHCCC-CCEEEEEEEEC
Q ss_conf 54589907997760279659999999---789968999995323213-53579999999999994599-95578922311
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARK---RTTGDLFAIKVLKKLDMI-RKNDIERILAERNILITVRN-PFVVRFFYSFT 565 (900)
Q Consensus 491 ~i~~~dfeilk~IGkGsFG~Vyla~~---k~tg~~VAIKvLkK~~~~-~~~~~e~il~Ei~IL~~l~H-PnIVkL~~~f~ 565 (900)
++.+++|++++.||+|+||+||+|++ +.+|+.||+|++++.... .....+.+.+|+.++.+++| |||+++++.+.
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred CCCHHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 34510259998983287839999998765887948999998367721016899999999999986467983999620002
Q ss_pred CCCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 47704999965179885778885078998999999999999998643057174037998388557991999705775233
Q 002616 566 CRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645 (900)
Q Consensus 566 ~~~~LyLVmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~ 645 (900)
+...+|++|||+.||+|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++..
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred CCCCEEEEEECCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCCCEEEEECCCHHHH
T ss_conf 48730012312341179999873045437888888999999998851499896547732012469998887413202220
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC--CCCCCCEEECHHHHHHHHHHCCCCCC
Q ss_conf 3356556999988898999999974223566776665579998873443179--99842103002589999993999999
Q 002616 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT--EHGYAADWWSVGIILFEFITGIPPFT 723 (900)
Q Consensus 646 ~~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~--~ys~ksDIWSLGVILyELLtGk~PF~ 723 (900)
.. .......+..|++.|+|||.+.+. .++.++|||||||+||+|++|..||.
T Consensus 180 ~~--------------------------~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~ 233 (322)
T d1vzoa_ 180 VA--------------------------DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFT 233 (322)
T ss_dssp CG--------------------------GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTS
T ss_pred CC--------------------------CCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 34--------------------------4443221222333331068760577688713251777799999976899988
Q ss_pred CCCHHHHHHHHH----CCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH--HCHHHHHCCCCCCCCCCCHHHHC--CC
Q ss_conf 998579998641----18988999999999889999987535995888992--02999981999889993011001--69
Q 002616 724 AESPEIIFDNIL----NRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGA--NGAAEVKAHPFFKGVNWDSLALQ--KA 795 (900)
Q Consensus 724 ~~s~~ei~~kIl----~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~--~~a~EIL~HPFFk~idw~~L~~~--~p 795 (900)
+.+.......+. ....++ |..+|+++.+||++||.+||.+||+. ..+.++++||||++++|+.+..+ ++
T Consensus 234 ~~~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~~~~ 310 (322)
T d1vzoa_ 234 VDGEKNSQAEISRRILKSEPPY---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPA 310 (322)
T ss_dssp CTTSCCCHHHHHHHHHHCCCCC---CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTCSCC
T ss_pred CCCHHHHHHHHHHHCCCCCCCC---CCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHHHCCCCHHHHHHCCCCC
T ss_conf 8877779999998335689988---6547999999999974458988199974509999749723489988997378985
Q ss_pred CCCCCCCCCCCC
Q ss_conf 755889999986
Q 002616 796 VFVPQPESVDDT 807 (900)
Q Consensus 796 pf~P~~~s~~D~ 807 (900)
|++|..++..|.
T Consensus 311 p~~p~~~~~~~~ 322 (322)
T d1vzoa_ 311 PFKPVIRDELDV 322 (322)
T ss_dssp SCCCCCCC-CCC
T ss_pred CCCCCCCCCCCC
T ss_conf 989999997779
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=416.28 Aligned_cols=259 Identities=29% Similarity=0.432 Sum_probs=220.4
Q ss_pred EEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
Q ss_conf 799776027965999999978996899999532321353--579999999999994599955789223114770499996
Q 002616 498 EIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRK--NDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVME 575 (900)
Q Consensus 498 eilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~--~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~LyLVmE 575 (900)
+.+++||+|+||+||+|+++.+|+.||||++++...... .....+.+|+.+|+.++|||||+++++|.+.+.+|+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CCCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHH
T ss_conf 95638512728299999999999699999984202124567999999999999986799998689854225874022045
Q ss_pred ECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCC
Q ss_conf 51798857788850789989999999999999986430571740379983885579919997057752333356556999
Q 002616 576 YLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSG 655 (900)
Q Consensus 576 yl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s~dls~ 655 (900)
|+.||++..+......+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+...
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~--------- 151 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG--------- 151 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT---------
T ss_pred HHCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCC---------
T ss_conf 53450776554126677899999999999999988631635503577625885377841146576100057---------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCCCEEECHHHHHHHHHHCCCCCCCCCHHHHHHHH
Q ss_conf 98889899999997422356677666557999887344317-99984210300258999999399999999857999864
Q 002616 656 PETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEIIFDNI 734 (900)
Q Consensus 656 ~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyELLtGk~PF~~~s~~ei~~kI 734 (900)
.........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+...+|
T Consensus 152 ------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i 213 (299)
T d1ua2a_ 152 ------------------SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213 (299)
T ss_dssp ------------------SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ------------------CCCCCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHH
T ss_conf ------------------87554330204733363999726778880564363042899998596999999999999999
Q ss_pred HCCC-----C---------------CCCC-----CCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCCCC
Q ss_conf 1189-----8---------------8999-----9999998899999875359958889920299998199988999
Q 002616 735 LNRK-----I---------------PWPC-----VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786 (900)
Q Consensus 735 l~~~-----l---------------~~P~-----ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~id 786 (900)
.... . .++. +...+++++.+||.+||++||.+||| +.++|+||||++..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s---a~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT---ATQALKMKYFSNRP 287 (299)
T ss_dssp HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC---HHHHHTSGGGTSSS
T ss_pred HHHCCCCCHHHCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHCCCC
T ss_conf 985189972545210002134430347898867856568999999999976389456908---99996799657899
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=413.69 Aligned_cols=254 Identities=31% Similarity=0.531 Sum_probs=215.6
Q ss_pred CCCCCEEEEE-EECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHH-CCCCCEEEEEEEECC---
Q ss_conf 4589907997-76027965999999978996899999532321353579999999999994-599955789223114---
Q 002616 492 TSIDDFEIIK-PISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILIT-VRNPFVVRFFYSFTC--- 566 (900)
Q Consensus 492 i~~~dfeilk-~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~-l~HPnIVkL~~~f~~--- 566 (900)
..+++|+++. .||+|+||.||+|+++.+++.||+|++++. ..+.+|+.++.+ .+|||||+++++|.+
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~ 79 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYA 79 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred CCCCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC--------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCC
T ss_conf 70148798107965454869999998899989999998974--------7799999999986699997829899950346
Q ss_pred -CCEEEEEEEECCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECC---CCCEEEEECC
Q ss_conf -770499996517988577888507--8998999999999999998643057174037998388557---9919997057
Q 002616 567 -RDNLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFG 640 (900)
Q Consensus 567 -~~~LyLVmEyl~GGSL~dlL~k~g--~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~---~G~VKLsDFG 640 (900)
...+|+|||||+||+|.+++.+.+ .+++..++.|+.||+.||+|||++||+||||||+|||++. .+.+||+|||
T Consensus 80 ~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 80 GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred CCCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 89789999977899849999986278775799999999999999999997698644410022011355556631135455
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCC
Q ss_conf 75233335655699998889899999997422356677666557999887344317999842103002589999993999
Q 002616 641 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIP 720 (900)
Q Consensus 641 LAk~~~~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~ 720 (900)
+|+... ........+||+.|||||++.+..|+.++|||||||++|+|++|++
T Consensus 160 ~a~~~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~ 211 (335)
T d2ozaa1 160 FAKETT----------------------------SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 211 (335)
T ss_dssp TCEECC----------------------------CCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSC
T ss_pred EEEECC----------------------------CCCCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCC
T ss_conf 123336----------------------------8886432267756379277748988888888764516778865889
Q ss_pred CCCCCCHHHH----HHHHHCCCCCCCCC-CCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf 9999985799----98641189889999-9999988999998753599588899202999981999889
Q 002616 721 PFTAESPEII----FDNILNRKIPWPCV-PSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 721 PF~~~s~~ei----~~kIl~~~l~~P~i-p~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~ 784 (900)
||.+.+.... ...+......+|.. ...+|+++++||.+||++||.+||+ +.++++||||..
T Consensus 212 Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~ 277 (335)
T d2ozaa1 212 PFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIMQ 277 (335)
T ss_dssp SCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSHHHHT
T ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHHC
T ss_conf 988988778899999998538888898543469999999999975699657909---999970987617
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=403.97 Aligned_cols=264 Identities=30% Similarity=0.442 Sum_probs=217.3
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCC-CCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC---CCCCEEEEEEEECC--
Q ss_conf 589907997760279659999999789-968999995323213535799999999999945---99955789223114--
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTT-GDLFAIKVLKKLDMIRKNDIERILAERNILITV---RNPFVVRFFYSFTC-- 566 (900)
Q Consensus 493 ~~~dfeilk~IGkGsFG~Vyla~~k~t-g~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l---~HPnIVkL~~~f~~-- 566 (900)
..++|++++.||+|+||+||+|++..+ ++.||+|++++... .......+.+|+.+|+.+ +||||++++++|..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBC-TTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHC-CCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCC
T ss_conf 758979888992155869999999888998999999802324-5167999999999999874258988023663221466
Q ss_pred ---CCEEEEEEEECCCCCHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf ---770499996517988577888-5078998999999999999998643057174037998388557991999705775
Q 002616 567 ---RDNLYLVMEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLS 642 (900)
Q Consensus 567 ---~~~LyLVmEyl~GGSL~dlL~-k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLA 642 (900)
...+|++|||+.+|.+..... ....+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCCCEEECCHHHH
T ss_conf 66674699999740587144444303789998999999999999999997588983579862789858997542100010
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCC
Q ss_conf 23333565569999888989999999742235667766655799988734431799984210300258999999399999
Q 002616 643 KIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPF 722 (900)
Q Consensus 643 k~~~~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF 722 (900)
+... ........+||+.|||||++.+..|+.++||||+||++|||++|++||
T Consensus 164 ~~~~----------------------------~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf 215 (305)
T d1blxa_ 164 RIYS----------------------------FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF 215 (305)
T ss_dssp CCCC----------------------------GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred HHHC----------------------------CCCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCC
T ss_conf 1100----------------------------234577765485114831001798881110003289999998787998
Q ss_pred CCCCHHHHHHHHHCCC------------------------CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHC
Q ss_conf 9998579998641189------------------------8899999999988999998753599588899202999981
Q 002616 723 TAESPEIIFDNILNRK------------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 723 ~~~s~~ei~~kIl~~~------------------------l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~ 778 (900)
.+.+..+...+|.... .+.+..+..+++++++||.+||.+||.+||| +.++|+
T Consensus 216 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s---a~e~L~ 292 (305)
T d1blxa_ 216 RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS---AYSALS 292 (305)
T ss_dssp CCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC---HHHHHT
T ss_pred CCCCHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHC
T ss_conf 99898999999998407996110532111103330223456454404458999999999987489667918---999966
Q ss_pred CCCCCCCCCC
Q ss_conf 9998899930
Q 002616 779 HPFFKGVNWD 788 (900)
Q Consensus 779 HPFFk~idw~ 788 (900)
||||+++++.
T Consensus 293 Hpff~~i~~~ 302 (305)
T d1blxa_ 293 HPYFQDLERC 302 (305)
T ss_dssp SGGGTTCCCC
T ss_pred CHHHCCCHHH
T ss_conf 9634075210
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=405.66 Aligned_cols=262 Identities=31% Similarity=0.503 Sum_probs=220.3
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 89907997760279659999999789968999995323213535799999999999945999557892231147704999
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~LyLV 573 (900)
+++|++++.||+|+||+||+|+++.+|+.||+|+++... ..+...+.+.+|+++|+.++|||||+++++|.+...+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
T ss_conf 999776517723768099999999999799999980222-5758999999999999867998388744533224320378
Q ss_pred EEECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 965179885778885-0789989999999999999986430571740379983885579919997057752333356556
Q 002616 574 MEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 574 mEyl~GGSL~dlL~k-~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s~d 652 (900)
|||+.++.+...... ...+++..++.|+.|++.||.|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~------ 153 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG------ 153 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHC------
T ss_pred EEECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCCCCEECCCCCCEECC------
T ss_conf 86237744555442025688889999999999999998652889921357114011346762103578613436------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC-CCCCEEECHHHHHHHHHHCCCCCCCCCHHHHH
Q ss_conf 99998889899999997422356677666557999887344317999-84210300258999999399999999857999
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAESPEIIF 731 (900)
Q Consensus 653 ls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGVILyELLtGk~PF~~~s~~ei~ 731 (900)
.........+||+.|+|||++....+ +.++|+|||||++|+|++|++||.+.+..+..
T Consensus 154 ---------------------~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~ 212 (298)
T d1gz8a_ 154 ---------------------VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212 (298)
T ss_dssp ---------------------CCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred ---------------------CCCCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHH
T ss_conf ---------------------88641001036521541122136657774221033331342796687998988999999
Q ss_pred HHHHCCC-----C-------------CCCC--------CCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCCC
Q ss_conf 8641189-----8-------------8999--------999999889999987535995888992029999819998899
Q 002616 732 DNILNRK-----I-------------PWPC--------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 732 ~kIl~~~-----l-------------~~P~--------ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~i 785 (900)
.++.... . .++. ....+|.++++||.+||.+||.+||| +.++++||||+++
T Consensus 213 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t---~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 213 FRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS---AKAALAHPFFQDV 289 (298)
T ss_dssp HHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGGGTTC
T ss_pred HHHHHHCCCCCHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHCCC
T ss_conf 9999832898333144422242124345432222044416678999999999976399557918---9999678701469
Q ss_pred C
Q ss_conf 9
Q 002616 786 N 786 (900)
Q Consensus 786 d 786 (900)
.
T Consensus 290 ~ 290 (298)
T d1gz8a_ 290 T 290 (298)
T ss_dssp C
T ss_pred C
T ss_conf 9
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=403.29 Aligned_cols=261 Identities=24% Similarity=0.369 Sum_probs=220.9
Q ss_pred CCCCCCCCCEEEEEEECCCCCEEEEEEEECCCCC-----EEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEE
Q ss_conf 6555458990799776027965999999978996-----8999995323213535799999999999945-999557892
Q 002616 488 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGD-----LFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 561 (900)
Q Consensus 488 ~~~~i~~~dfeilk~IGkGsFG~Vyla~~k~tg~-----~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l-~HPnIVkL~ 561 (900)
..+.+..++|++.+.||+|+||+||+|+++.+++ .||+|++.+.. .......+.+|+.++..+ +|||||+++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~ 107 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLL 107 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCCEEEEE
T ss_conf 44657789939701983078819999998578855420499999966335--8789999999999999715899686877
Q ss_pred EEECCCCEEEEEEEECCCCCHHHHHHHC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEE
Q ss_conf 2311477049999651798857788850-----------------------78998999999999999998643057174
Q 002616 562 YSFTCRDNLYLVMEYLNGGDLYSLLRKV-----------------------GCLEEDVARIYIAELVLALEYLHSLGIVH 618 (900)
Q Consensus 562 ~~f~~~~~LyLVmEyl~GGSL~dlL~k~-----------------------g~Lse~~ar~ii~QIl~AL~yLHs~GIIH 618 (900)
+++.+.+.+|+||||++||+|.+++.+. +.+++..++.|+.|++.||+|||+++|||
T Consensus 108 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH 187 (325)
T d1rjba_ 108 GACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 187 (325)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEE
T ss_conf 88862995899997279995999998625777510221000012220012577899999999999999999997399050
Q ss_pred CCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCC
Q ss_conf 03799838855799199970577523333565569999888989999999742235667766655799988734431799
Q 002616 619 RDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE 698 (900)
Q Consensus 619 RDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ 698 (900)
|||||+|||++.++++||+|||+|+..... .......+.+||+.|||||++.+..
T Consensus 188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~l~~~~ 242 (325)
T d1rjba_ 188 RDLAARNVLVTHGKVVKICDFGLARDIMSD-------------------------SNYVVRGNARLPVKWMAPESLFEGI 242 (325)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGC-------------------------TTSEEETTEEECGGGCCHHHHHHCC
T ss_pred CCCCHHCCCCCCCCEEEEEECCCCCCCCCC-------------------------CCEEEECCCCCCCCCCCHHHHCCCC
T ss_conf 527032144345982898514222204577-------------------------8615623435787657838872799
Q ss_pred CCCCCEEECHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHH
Q ss_conf 9842103002589999993-999999998579998641189889999999998899999875359958889920299998
Q 002616 699 HGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 699 ys~ksDIWSLGVILyELLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL 777 (900)
|+.++|||||||++|||++ |.+||.+.+....+.+++....++ ..|..+|+++++||.+||..||.+||+ +.+|+
T Consensus 243 ~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~-~~p~~~~~~l~~li~~cl~~dP~~RPt---~~ei~ 318 (325)
T d1rjba_ 243 YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM-DQPFYATEEIYIIMQSCWAFDSRKRPS---FPNLT 318 (325)
T ss_dssp CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHH
T ss_pred CCCCEECCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC-CCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHH
T ss_conf 99633030003999999838999999989899999998569989-988767899999999975889668939---99999
Q ss_pred CC
Q ss_conf 19
Q 002616 778 AH 779 (900)
Q Consensus 778 ~H 779 (900)
+|
T Consensus 319 ~~ 320 (325)
T d1rjba_ 319 SF 320 (325)
T ss_dssp HH
T ss_pred HH
T ss_conf 99
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=398.81 Aligned_cols=260 Identities=32% Similarity=0.495 Sum_probs=221.5
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC----
Q ss_conf 5899079977602796599999997899689999953232135357999999999999459995578922311477----
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD---- 568 (900)
Q Consensus 493 ~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~---- 568 (900)
..+.|++++.||+|+||+||+|+++.+|+.||+|++++. .......+.+.+|+.+|+.++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~-~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST-TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH-HCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCC
T ss_conf 477189988980177819999999999989999998522-2596999999999999986689875479998635765555
Q ss_pred --EEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf --049999651798857788850789989999999999999986430571740379983885579919997057752333
Q 002616 569 --NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 569 --~LyLVmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~ 646 (900)
.+|+||||+ |++|..++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 95 ~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~- 171 (346)
T d1cm8a_ 95 FTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA- 171 (346)
T ss_dssp CCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred CCEEEEEEECC-CCCHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCCCCCCCCCCCEECC-
T ss_conf 41599998405-521899987-402269999999999999999987378764566851111210012211343102206-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCEEECHHHHHHHHHHCCCCCCCC
Q ss_conf 356556999988898999999974223566776665579998873443179-9984210300258999999399999999
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAE 725 (900)
Q Consensus 647 ~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyELLtGk~PF~~~ 725 (900)
.......+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.
T Consensus 172 -----------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~ 222 (346)
T d1cm8a_ 172 -----------------------------DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGS 222 (346)
T ss_dssp -----------------------------CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred -----------------------------CCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCC
T ss_conf -----------------------------876310245533358899817878996501030038999999786998889
Q ss_pred CHHHHHHHHHC----------------------------CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHH
Q ss_conf 85799986411----------------------------89889999999998899999875359958889920299998
Q 002616 726 SPEIIFDNILN----------------------------RKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 726 s~~ei~~kIl~----------------------------~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL 777 (900)
+.......+.. ....++.....+++++.+||.+||..||.+||| +.++|
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t---a~eiL 299 (346)
T d1cm8a_ 223 DHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT---AGEAL 299 (346)
T ss_dssp SHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC---HHHHH
T ss_pred CHHHHHHHHHHCCCCCCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHH
T ss_conf 768999999850378848888653000344331157866655667755689999999999977299557929---99996
Q ss_pred CCCCCCCCCCC
Q ss_conf 19998899930
Q 002616 778 AHPFFKGVNWD 788 (900)
Q Consensus 778 ~HPFFk~idw~ 788 (900)
+||||+++.+.
T Consensus 300 ~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 300 AHPYFESLHDT 310 (346)
T ss_dssp HSGGGTTTC--
T ss_pred CCHHHCCCCCC
T ss_conf 39623758776
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=405.27 Aligned_cols=253 Identities=27% Similarity=0.443 Sum_probs=218.4
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHH---HHHHHHHHHHHHHHCC--CCCEEEEEEEECCCC
Q ss_conf 89907997760279659999999789968999995323213535---7999999999999459--995578922311477
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKN---DIERILAERNILITVR--NPFVVRFFYSFTCRD 568 (900)
Q Consensus 494 ~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~---~~e~il~Ei~IL~~l~--HPnIVkL~~~f~~~~ 568 (900)
-++|++.+.||+|+||+||+|+++.+|+.||+|++++....... ....+.+|+.+|+.++ |||||+++++|.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred EEEEEEEECCC-CCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCC-CCEEEEECCCCCCCC
Q ss_conf 04999965179-8857788850789989999999999999986430571740379983885579-919997057752333
Q 002616 569 NLYLVMEYLNG-GDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHD-GHIKLTDFGLSKIGL 646 (900)
Q Consensus 569 ~LyLVmEyl~G-GSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~-G~VKLsDFGLAk~~~ 646 (900)
.+|+||||+.+ +++.+++.+...+++..++.++.|++.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEECCCCCCEECC
T ss_conf 68999983368622899986158999999999999999999999877975566761114774478848977546535324
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC-CCCCEEECHHHHHHHHHHCCCCCCCC
Q ss_conf 35655699998889899999997422356677666557999887344317999-84210300258999999399999999
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEH-GYAADWWSVGIILFEFITGIPPFTAE 725 (900)
Q Consensus 647 ~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~y-s~ksDIWSLGVILyELLtGk~PF~~~ 725 (900)
.....+.+||+.|+|||++.+..+ +.++|||||||++|||++|++||.+.
T Consensus 163 -----------------------------~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 163 -----------------------------DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp -----------------------------SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred -----------------------------CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCC
T ss_conf -----------------------------445566565877479999848997886533255403453675688998873
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCCCCC
Q ss_conf 85799986411898899999999988999998753599588899202999981999889993
Q 002616 726 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNW 787 (900)
Q Consensus 726 s~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~idw 787 (900)
+ .+......++ ..+|+++++||.+||..||.+||+ +.++++||||+++..
T Consensus 214 ~------~i~~~~~~~~---~~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~~~~~~~ 263 (273)
T d1xwsa_ 214 E------EIIRGQVFFR---QRVSSECQHLIRWCLALRPSDRPT---FEEIQNHPWMQDVLL 263 (273)
T ss_dssp H------HHHHCCCCCS---SCCCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGSSCCC
T ss_pred H------HHHHCCCCCC---CCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHCCCCC
T ss_conf 6------7761544778---779999999999976089758939---999853986678878
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=399.09 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=218.0
Q ss_pred CCCCCCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC
Q ss_conf 65554589907997760279659999999789968999995323213535799999999999945999557892231147
Q 002616 488 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 488 ~~~~i~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~ 567 (900)
..+++..++|++.+.||+|+||+||+|+++.++..||+|++++.. ...+.+.+|+.+|+.++|||||++++++.+.
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC----CHHHHHHHHHHHHHHCCCCCEECCCCCEEEC
T ss_conf 651745799398659820888089999999999699999977761----0399999999999867999882677527457
Q ss_pred CEEEEEEEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 7049999651798857788850--78998999999999999998643057174037998388557991999705775233
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645 (900)
Q Consensus 568 ~~LyLVmEyl~GGSL~dlL~k~--g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~ 645 (900)
+.+|+||||+++|+|.+++.+. ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+|+..
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred CEEEEEEECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 85478763146760677753035541579999999999999788898789305760457689989992898324454653
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCC-CCCCC
Q ss_conf 33565569999888989999999742235667766655799988734431799984210300258999999399-99999
Q 002616 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGI-PPFTA 724 (900)
Q Consensus 646 ~~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk-~PF~~ 724 (900)
.. ..........||+.|||||++.+..|+.++|||||||++|||++|. +||.+
T Consensus 166 ~~--------------------------~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~ 219 (287)
T d1opja_ 166 TG--------------------------DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219 (287)
T ss_dssp CS--------------------------SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CC--------------------------CCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 78--------------------------8722103556654666927872799981043021789999998679988774
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHH
Q ss_conf 98579998641189889999999998899999875359958889920299998
Q 002616 725 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 725 ~s~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL 777 (900)
.+...++..+..+ .. +..+..+|+++++||.+||..||.+||++.++.+.|
T Consensus 220 ~~~~~~~~~i~~~-~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L 270 (287)
T d1opja_ 220 IDLSQVYELLEKD-YR-MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270 (287)
T ss_dssp CCHHHHHHHHHTT-CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CHHHHHHHHHHCC-CC-CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 2599999998558-88-888743309999999997577976893999999999
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=398.90 Aligned_cols=261 Identities=27% Similarity=0.409 Sum_probs=226.8
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC----E
Q ss_conf 899079977602796599999997899689999953232135357999999999999459995578922311477----0
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----N 569 (900)
Q Consensus 494 ~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~----~ 569 (900)
.++|++.+.||+|+||+||+|+++.+|+.||+|++++...........+.+|+.+++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 49999651798857788850789989999999999999986430571740379983885579919997057752333356
Q 002616 570 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 570 LyLVmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~ 649 (900)
+|+||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||+++......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEEHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHCCCC
T ss_conf 99999778898710112035899999999999999999999985795276346755665754320100344432212354
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf 55699998889899999997422356677666557999887344317999842103002589999993999999998579
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 729 (900)
Q Consensus 650 s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~~~s~~e 729 (900)
.........+||+.|||||++.+..|+.++|||||||++|||++|++||.+.++.+
T Consensus 166 ------------------------~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~ 221 (277)
T d1o6ya_ 166 ------------------------NSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS 221 (277)
T ss_dssp -------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ------------------------CCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHH
T ss_conf ------------------------43333464257624369999839999966320265289999976979989969999
Q ss_pred HHHHHHCCCCCCC-CCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCC
Q ss_conf 9986411898899-999999988999998753599588899202999981999
Q 002616 730 IFDNILNRKIPWP-CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781 (900)
Q Consensus 730 i~~kIl~~~l~~P-~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPF 781 (900)
...++.......+ .....+|+++.+||.+||.+||.+||+. +.+++ |+|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~s--a~~l~-~~l 271 (277)
T d1o6ya_ 222 VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT--AAEMR-ADL 271 (277)
T ss_dssp HHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSS--HHHHH-HHH
T ss_pred HHHHHHHCCCCCCCHHCCCCCHHHHHHHHHHCCCCHHHCHHH--HHHHH-HHH
T ss_conf 999998469999710034789999999999866797677739--99999-999
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=391.73 Aligned_cols=253 Identities=31% Similarity=0.454 Sum_probs=210.1
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC------CC
Q ss_conf 990799776027965999999978996899999532321353579999999999994599955789223114------77
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------RD 568 (900)
Q Consensus 495 ~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~------~~ 568 (900)
-+|+.+++||+|+||+||+|+++.+|+.||+|++++.... ..+|+.+|+.++||||++++++|.. ..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH-------HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 7767516982176839999999999979999998816068-------999999998668989873878997447657731
Q ss_pred EEEEEEEECCCCCHHHHH---HHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCC-CEEEEECCCCCC
Q ss_conf 049999651798857788---8507899899999999999999864305717403799838855799-199970577523
Q 002616 569 NLYLVMEYLNGGDLYSLL---RKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKI 644 (900)
Q Consensus 569 ~LyLVmEyl~GGSL~dlL---~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G-~VKLsDFGLAk~ 644 (900)
++|+||||+++|.+..+. .....+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCCCEEEECCCCHHH
T ss_conf 89999841688607888863103689999999999999999999998668764578860378735897116733660544
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCCCEEECHHHHHHHHHHCCCCCC
Q ss_conf 3335655699998889899999997422356677666557999887344317-999842103002589999993999999
Q 002616 645 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFT 723 (900)
Q Consensus 645 ~~~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyELLtGk~PF~ 723 (900)
.. ......+.+||+.|+|||++.+ ..|+.++||||+||++|||++|++||.
T Consensus 173 ~~----------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~ 224 (350)
T d1q5ka_ 173 LV----------------------------RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 224 (350)
T ss_dssp CC----------------------------TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSC
T ss_pred CC----------------------------CCCCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCC
T ss_conf 04----------------------------77653200255555682776404688821000246527785502879989
Q ss_pred CCCHHHHHHHHHCC-----------------CCCCCC---------CCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHH
Q ss_conf 99857999864118-----------------988999---------9999998899999875359958889920299998
Q 002616 724 AESPEIIFDNILNR-----------------KIPWPC---------VPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 724 ~~s~~ei~~kIl~~-----------------~l~~P~---------ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL 777 (900)
..+..+.+..+... ...++. ....+++++.+||.+||.+||.+||| +.++|
T Consensus 225 ~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t---a~e~L 301 (350)
T d1q5ka_ 225 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT---PLEAC 301 (350)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC---HHHHH
T ss_pred CCCHHHHHHHHHHHHCCCHHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHH
T ss_conf 879999999999974898177654306210110355445674444315689999999999976589557929---99996
Q ss_pred CCCCCCCC
Q ss_conf 19998899
Q 002616 778 AHPFFKGV 785 (900)
Q Consensus 778 ~HPFFk~i 785 (900)
+||||+++
T Consensus 302 ~Hp~f~~~ 309 (350)
T d1q5ka_ 302 AHSFFDEL 309 (350)
T ss_dssp TSGGGGGG
T ss_pred CCHHHCCC
T ss_conf 69845246
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=395.86 Aligned_cols=259 Identities=29% Similarity=0.489 Sum_probs=222.7
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 89907997760279659999999789968999995323213535799999999999945999557892231147704999
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~LyLV 573 (900)
+++|+++++||+|+||+||+|+++ +|+.||+|+++... ........+.+|+.+|+.++|||||+++++|...+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSS-GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCCEECCEEECCCCCEEEEEEEC-CCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEE
T ss_conf 999634318722778189999968-99999999981232-6858999999999999867998687660120467731589
Q ss_pred EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 96517988577888507899899999999999999864305717403799838855799199970577523333565569
Q 002616 574 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 574 mEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s~dl 653 (900)
||++.++.+..+....+.+++..++.++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|....
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~------- 151 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFG------- 151 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC-------
T ss_pred EEEEHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCCCEEECCCCCCEECC-------
T ss_conf 9740045678998604775144568999999999998605748826787750568689978732366430114-------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCEEECHHHHHHHHHHCCCCCCCCCHHHHHH
Q ss_conf 99988898999999974223566776665579998873443179-99842103002589999993999999998579998
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESPEIIFD 732 (900)
Q Consensus 654 s~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyELLtGk~PF~~~s~~ei~~ 732 (900)
.........+|++.|+|||++.+. .++.++|+|||||++|||++|++||.+.+..+...
T Consensus 152 --------------------~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~ 211 (286)
T d1ob3a_ 152 --------------------IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM 211 (286)
T ss_dssp --------------------C---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred --------------------CCCCCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHH
T ss_conf --------------------676541010243110137887178888841002111758999977979989889899999
Q ss_pred HHHCC--------------------------CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCC
Q ss_conf 64118--------------------------98899999999988999998753599588899202999981999889
Q 002616 733 NILNR--------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKG 784 (900)
Q Consensus 733 kIl~~--------------------------~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~ 784 (900)
++... ..+++.....+++++.|||++||.+||.+||+ +.++|+||||+.
T Consensus 212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s---~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 212 RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT---AKQALEHAYFKE 286 (286)
T ss_dssp HHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSGGGGC
T ss_pred HHHHHHCCCCHHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCCCCCC
T ss_conf 999863899711042123332214333335676466651258999999999986689668909---999856922074
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=392.74 Aligned_cols=258 Identities=23% Similarity=0.313 Sum_probs=218.4
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCC---EEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC
Q ss_conf 458990799776027965999999978996---89999953232135357999999999999459995578922311477
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGD---LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 492 i~~~dfeilk~IGkGsFG~Vyla~~k~tg~---~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~ 568 (900)
+..++|++.+.||+|+||+||+|+++.+++ .||+|.+.... .....+.+.+|+.+|+.++|||||++++++...+
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECC
T ss_conf 08004278569802788299999995799788999999978445--9899999999999998579988861899996288
Q ss_pred EEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 049999651798857788850-7899899999999999999864305717403799838855799199970577523333
Q 002616 569 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 569 ~LyLVmEyl~GGSL~dlL~k~-g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~ 647 (900)
.+|+||||++||+|.+++... +.+++..+..++.||+.||.|||+++|+||||||+|||++.++++||+|||+|+....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf 77999972279853002104567999999999999999988988527983576150448988999199888443157567
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCCCCCC
Q ss_conf 5655699998889899999997422356677666557999887344317999842103002589999993-999999998
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 726 (900)
Q Consensus 648 ~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLt-Gk~PF~~~s 726 (900)
.... ..........||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+
T Consensus 181 ~~~~----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~ 238 (299)
T d1jpaa_ 181 DTSD----------------------PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238 (299)
T ss_dssp -------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCC----------------------CEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
T ss_conf 7776----------------------536502566688300387888369978612144535789999867999999999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHH
Q ss_conf 5799986411898899999999988999998753599588899202999
Q 002616 727 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 775 (900)
Q Consensus 727 ~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~E 775 (900)
..++...+..+.. +..+..++.++.+||.+||..||.+||++.++.+
T Consensus 239 ~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~ 285 (299)
T d1jpaa_ 239 NQDVINAIEQDYR--LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285 (299)
T ss_dssp HHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHCCCC--CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9999999973788--9997422699999999975879768929999999
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=394.88 Aligned_cols=263 Identities=25% Similarity=0.330 Sum_probs=224.4
Q ss_pred CCCCCEEEEEE-ECCCCCEEEEEEEECCC--CCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC
Q ss_conf 45899079977-60279659999999789--9689999953232135357999999999999459995578922311477
Q 002616 492 TSIDDFEIIKP-ISRGAFGRVFLARKRTT--GDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 492 i~~~dfeilk~-IGkGsFG~Vyla~~k~t--g~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~ 568 (900)
+..++|.+... ||+|+||+||+|.++.+ +..||+|++++.. .....+.+.+|+.+|..++|||||++++++.. +
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ECCCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-C
T ss_conf 54447188784873060809999999608976899999988203--97899999999999986799888068656036-8
Q ss_pred EEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 049999651798857788850-7899899999999999999864305717403799838855799199970577523333
Q 002616 569 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 569 ~LyLVmEyl~GGSL~dlL~k~-g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~ 647 (900)
.+|+||||++||+|.+++... +.+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEECCCHHHHCCCC
T ss_conf 07999980789968997521256999999999999999987899868810576764660454688542033134211554
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCCCCCC
Q ss_conf 5655699998889899999997422356677666557999887344317999842103002589999993-999999998
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 726 (900)
Q Consensus 648 ~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLt-Gk~PF~~~s 726 (900)
.. .........+||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+
T Consensus 162 ~~------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~ 217 (285)
T d1u59a_ 162 DD------------------------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 217 (285)
T ss_dssp CS------------------------CEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CC------------------------CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCC
T ss_conf 34------------------------321135621137433586887279999541232201789999938999999979
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCC
Q ss_conf 579998641189889999999998899999875359958889920299998199988
Q 002616 727 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 727 ~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk 783 (900)
..++...+..+.. +..|..+|+++.+||.+||..||.+||++.++.+.|+|+|+.
T Consensus 218 ~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 218 GPEVMAFIEQGKR--MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp THHHHHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 9999999981899--999976789999999997577976890999999999999998
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=395.67 Aligned_cols=258 Identities=23% Similarity=0.337 Sum_probs=220.8
Q ss_pred EEECCCCCEEEEEEEECC--CCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEEECC
Q ss_conf 776027965999999978--996899999532321353579999999999994599955789223114770499996517
Q 002616 501 KPISRGAFGRVFLARKRT--TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLVMEYLN 578 (900)
Q Consensus 501 k~IGkGsFG~Vyla~~k~--tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~LyLVmEyl~ 578 (900)
+.||+|+||+||+|.++. +++.||+|+++... ......+.+.+|+.+|..++|||||++++++.. +.+|+||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCC
T ss_conf 7834587829999998169738599999988010-898999999999999986799898527777505-97799997478
Q ss_pred CCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 98857788850789989999999999999986430571740379983885579919997057752333356556999988
Q 002616 579 GGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPET 658 (900)
Q Consensus 579 GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s~dls~~~~ 658 (900)
+|+|.+++.+...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~--------- 161 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--------- 161 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC---------
T ss_pred CCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCC---------
T ss_conf 89689997522578999999999999999766874795567776113102356751234134533134323---------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCC
Q ss_conf 89899999997422356677666557999887344317999842103002589999993-99999999857999864118
Q 002616 659 DGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNR 737 (900)
Q Consensus 659 ~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLt-Gk~PF~~~s~~ei~~kIl~~ 737 (900)
..........||+.|||||++.+..|+.++|||||||++|||++ |++||.+.+..++...+..+
T Consensus 162 ---------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~ 226 (277)
T d1xbba_ 162 ---------------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 226 (277)
T ss_dssp ---------------SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT
T ss_pred ---------------CCCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC
T ss_conf ---------------44322445677842039166537999843443034031328965899999998999999999828
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCCCC
Q ss_conf 9889999999998899999875359958889920299998199988999
Q 002616 738 KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVN 786 (900)
Q Consensus 738 ~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~id 786 (900)
.. +..|..+|+++.+||.+||..||.+||++.++.+.|+|+|+.-++
T Consensus 227 ~~--~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 227 ER--MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273 (277)
T ss_dssp CC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHHH
T ss_pred CC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHHCCC
T ss_conf 99--999865679999999997588976890989999985288750479
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=391.98 Aligned_cols=256 Identities=29% Similarity=0.467 Sum_probs=211.9
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEECCC--CE
Q ss_conf 5899079977602796599999997899689999953232135357999999999999459-99557892231147--70
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCR--DN 569 (900)
Q Consensus 493 ~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~-HPnIVkL~~~f~~~--~~ 569 (900)
..++|++++.||+|+||+||+|+++.+|+.||+|++++. ..+.+.+|+.+|..+. ||||++++++|... ..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCC
T ss_conf 986718978983174819999998899979999998889------99999999999985157998767999998168771
Q ss_pred EEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCC-CEEEEECCCCCCCCCC
Q ss_conf 499996517988577888507899899999999999999864305717403799838855799-1999705775233335
Q 002616 570 LYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG-HIKLTDFGLSKIGLIN 648 (900)
Q Consensus 570 LyLVmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G-~VKLsDFGLAk~~~~~ 648 (900)
+|+||||+.+|+|..+. ..+++..++.+++||+.||.|||++||+||||||+|||++.++ .+||+|||+|+...
T Consensus 107 ~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~-- 181 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-- 181 (328)
T ss_dssp EEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECC--
T ss_pred EEEEEEECCCCCHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCEECC--
T ss_conf 26888631798589974---6899999999999999999887643344345644123774899836641565426646--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCEEECHHHHHHHHHHCCCCCCCCCH
Q ss_conf 6556999988898999999974223566776665579998873443179-998421030025899999939999999985
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFTAESP 727 (900)
Q Consensus 649 ~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyELLtGk~PF~~~s~ 727 (900)
........+||+.|+|||++.+. .|+.++||||+||++|||++|..||.....
T Consensus 182 --------------------------~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 182 --------------------------PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp --------------------------TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred --------------------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCH
T ss_conf --------------------------887444322486424761026888888452323354555876048899988760
Q ss_pred H-HHHHHHHC-------------CC---------------------CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHC
Q ss_conf 7-99986411-------------89---------------------8899999999988999998753599588899202
Q 002616 728 E-IIFDNILN-------------RK---------------------IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANG 772 (900)
Q Consensus 728 ~-ei~~kIl~-------------~~---------------------l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~ 772 (900)
. .....+.. .. .........+++++.|||++||++||.+|||
T Consensus 236 ~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t--- 312 (328)
T d3bqca1 236 NYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT--- 312 (328)
T ss_dssp HHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC---
T ss_pred HHHHHHHHHHHHCCCHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCC---
T ss_conf 18999999998788415555542254447430000033343311211552112448999999999986699568908---
Q ss_pred HHHHHCCCCCCCCCCC
Q ss_conf 9999819998899930
Q 002616 773 AAEVKAHPFFKGVNWD 788 (900)
Q Consensus 773 a~EIL~HPFFk~idw~ 788 (900)
+.++|+||||+++.|+
T Consensus 313 a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 313 AREAMEHPYFYTVVKD 328 (328)
T ss_dssp HHHHHTSGGGTTSCCC
T ss_pred HHHHHCCCCCCCCCCC
T ss_conf 9999649355887979
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=391.37 Aligned_cols=265 Identities=28% Similarity=0.387 Sum_probs=220.0
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC-----
Q ss_conf 589907997760279659999999789968999995323213535799999999999945999557892231147-----
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR----- 567 (900)
Q Consensus 493 ~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~----- 567 (900)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||+++++.+...
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCC
T ss_conf 62798899997227482999999989997999999842224-63789999999999998359996606765402465444
Q ss_pred ---CEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf ---70499996517988577888507899899999999999999864305717403799838855799199970577523
Q 002616 568 ---DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 568 ---~~LyLVmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~ 644 (900)
..+|+||||+.++.+.........+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCCCEEEEEEECCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCCCEEEEECCEEEE
T ss_conf 45763899985357874101222034433089999999999999885229988567672220366899687631350022
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCEEECHHHHHHHHHHCCCCCC
Q ss_conf 33356556999988898999999974223566776665579998873443179-99842103002589999993999999
Q 002616 645 GLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT-EHGYAADWWSVGIILFEFITGIPPFT 723 (900)
Q Consensus 645 ~~~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~-~ys~ksDIWSLGVILyELLtGk~PF~ 723 (900)
...... .......+.+||+.|+|||++.+. .|+.++|||||||++|||++|++||.
T Consensus 167 ~~~~~~-----------------------~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~ 223 (318)
T d3blha1 167 FSLAKN-----------------------SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQ 223 (318)
T ss_dssp CCC----------------------------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred CCCCCC-----------------------CCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCC
T ss_conf 355444-----------------------321135660249787428997079998917870067864661744879989
Q ss_pred CCCHHHHHHHHHCCCCCCCC-C-------------------C---------CCCCHHHHHHHHHHCCCCCCCCCCHHCHH
Q ss_conf 99857999864118988999-9-------------------9---------99998899999875359958889920299
Q 002616 724 AESPEIIFDNILNRKIPWPC-V-------------------P---------SDMSFEAQDLINRFLIHDPNQRLGANGAA 774 (900)
Q Consensus 724 ~~s~~ei~~kIl~~~l~~P~-i-------------------p---------~~iS~elkDLIkklL~~DP~kRps~~~a~ 774 (900)
+.+.......+......++. . + ...++++.|||.+||.+||++|+| +.
T Consensus 224 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s---a~ 300 (318)
T d3blha1 224 GNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID---SD 300 (318)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC---HH
T ss_pred CCCHHHHHHHHHHHCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCC---HH
T ss_conf 989999999999841899825534432034443320133445550334044459989999999987389658909---99
Q ss_pred HHHCCCCCCC
Q ss_conf 9981999889
Q 002616 775 EVKAHPFFKG 784 (900)
Q Consensus 775 EIL~HPFFk~ 784 (900)
++|.||||+.
T Consensus 301 elL~Hpff~~ 310 (318)
T d3blha1 301 DALNHDFFWS 310 (318)
T ss_dssp HHHHSGGGSS
T ss_pred HHHCCHHHCC
T ss_conf 9974950156
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=388.98 Aligned_cols=261 Identities=28% Similarity=0.471 Sum_probs=216.4
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC----EE
Q ss_conf 99079977602796599999997899689999953232135357999999999999459995578922311477----04
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----NL 570 (900)
Q Consensus 495 ~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~----~L 570 (900)
+.|++++.||+|+||+||+|+++.+|+.||||++++.. .....+.+++|+.+|+.++||||+++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHC--CHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 98599789940648099999999999499999980310--9589999999999999768989885888995056455414
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 99996517988577888507899899999999999999864305717403799838855799199970577523333565
Q 002616 571 YLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 571 yLVmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s 650 (900)
+++++|+.||+|.+++.. ..+++..++.++.|++.||+|||++|||||||||+|||++.++.+||+|||+|+......
T Consensus 86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~- 163 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH- 163 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG-
T ss_pred EEEEEEECCCCHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCC-
T ss_conf 999996259865664405-899999999999999999999997898677787643788799977875457056504777-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCCCEEECHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf 5699998889899999997422356677666557999887344317-999842103002589999993999999998579
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLG-TEHGYAADWWSVGIILFEFITGIPPFTAESPEI 729 (900)
Q Consensus 651 ~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g-~~ys~ksDIWSLGVILyELLtGk~PF~~~s~~e 729 (900)
.........+||+.|+|||++.. ..|+.++||||+||++|+|++|++||.+.+..+
T Consensus 164 -----------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~ 220 (345)
T d1pmea_ 164 -----------------------DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220 (345)
T ss_dssp -----------------------CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred -----------------------CCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHH
T ss_conf -----------------------641010110265200038786047888741010046701337766979978888899
Q ss_pred HHHHHHCC----------------------------CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCC
Q ss_conf 99864118----------------------------98899999999988999998753599588899202999981999
Q 002616 730 IFDNILNR----------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPF 781 (900)
Q Consensus 730 i~~kIl~~----------------------------~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPF 781 (900)
....+... ..++....+.+++++++||.+||++||.+||+ +.++|+|||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---a~e~L~hpf 297 (345)
T d1pmea_ 221 QLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE---VEQALAHPY 297 (345)
T ss_dssp HHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGG
T ss_pred HHHHHHHHCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHH
T ss_conf 99987652069975664234332222024467755778777837899999999999976489567908---999861986
Q ss_pred CCCC
Q ss_conf 8899
Q 002616 782 FKGV 785 (900)
Q Consensus 782 Fk~i 785 (900)
|+..
T Consensus 298 ~~~~ 301 (345)
T d1pmea_ 298 LEQY 301 (345)
T ss_dssp GTTT
T ss_pred HCCC
T ss_conf 5558
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=393.71 Aligned_cols=257 Identities=22% Similarity=0.323 Sum_probs=213.1
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCE
Q ss_conf 55458990799776027965999999978996899999532321353579999999999994599955789223114770
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDN 569 (900)
Q Consensus 490 ~~i~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~ 569 (900)
+++..++|++.+.||+|+||+||+|+++ ..||+|+++... ......+.+.+|+.+|..++|||||++++++. .+.
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSS-CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred CCCCCCCEEEEEEEEECCCCEEEEEEEC---CEEEEEEEECCC-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCE
T ss_conf 1315451899889830788589999999---989999997346-99899999999999998479987864567971-558
Q ss_pred EEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 49999651798857788850-78998999999999999998643057174037998388557991999705775233335
Q 002616 570 LYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 570 LyLVmEyl~GGSL~dlL~k~-g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~ 648 (900)
+|+||||++||+|.+++... +.+++..+..++.||+.||+|||+++||||||||+|||++.++++||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCCCEEECCCCCEEECCCC
T ss_conf 99999658998889998523578999999999999999988875099951614789979818997887500221333556
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC---CCCCCCEEECHHHHHHHHHHCCCCCCCC
Q ss_conf 6556999988898999999974223566776665579998873443179---9984210300258999999399999999
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGT---EHGYAADWWSVGIILFEFITGIPPFTAE 725 (900)
Q Consensus 649 ~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~---~ys~ksDIWSLGVILyELLtGk~PF~~~ 725 (900)
.......+.+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.
T Consensus 158 -------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~ 212 (276)
T d1uwha_ 158 -------------------------SGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNI 212 (276)
T ss_dssp ---------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred -------------------------CCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf -------------------------7763125665574317999995056899995315163599999999788998998
Q ss_pred CHHHHHHHHHCCCCCCC---CCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCC
Q ss_conf 85799986411898899---9999999889999987535995888992029999819
Q 002616 726 SPEIIFDNILNRKIPWP---CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 726 s~~ei~~kIl~~~l~~P---~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~H 779 (900)
+.......+.......| .++..+|+++.+||.+||..||.+||+ +.+++.+
T Consensus 213 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~~il~~ 266 (276)
T d1uwha_ 213 NNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL---FPQILAS 266 (276)
T ss_dssp CCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred CHHHHHHHHHHCCCCCCCCHHCCCCCHHHHHHHHHHHCCCCHHHCCC---HHHHHHH
T ss_conf 96999999996588898600036555499999999975889768929---9999999
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=385.48 Aligned_cols=252 Identities=21% Similarity=0.365 Sum_probs=217.5
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEE
Q ss_conf 45899079977602796599999997899689999953232135357999999999999459995578922311477049
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 492 i~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~Ly 571 (900)
+..++|++.+.||+|+||+||+|+++ ++..||+|++++... ..+.+.+|+.++..++|||||++++++...+.+|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CCHHHCEEEEEEEECCCEEEEEEEEC-CCCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEE
T ss_conf 89699588889820888299999988-999999999878867----6899999999999668997565352431599337
Q ss_pred EEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 999651798857788850-7899899999999999999864305717403799838855799199970577523333565
Q 002616 572 LVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNT 650 (900)
Q Consensus 572 LVmEyl~GGSL~dlL~k~-g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s 650 (900)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~--- 153 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD--- 153 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCCCEEECCCCHHEECCC---
T ss_conf 99983699918997520134788999999999999987765316431044315326666887768655321002368---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCCCCCCHHH
Q ss_conf 5699998889899999997422356677666557999887344317999842103002589999993-999999998579
Q 002616 651 IDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEI 729 (900)
Q Consensus 651 ~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLt-Gk~PF~~~s~~e 729 (900)
..........||+.|+|||++.+..|+.++|||||||++|||++ |.+||...+..+
T Consensus 154 -----------------------~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~ 210 (263)
T d1sm2a_ 154 -----------------------DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210 (263)
T ss_dssp ----------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH
T ss_pred -----------------------CCCEEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHH
T ss_conf -----------------------873350430017666785786079998403321059999999878988877899999
Q ss_pred HHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCC
Q ss_conf 99864118988999999999889999987535995888992029999819
Q 002616 730 IFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 730 i~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~H 779 (900)
+...+..+... ..|...++++.+||.+||..||.+||+ +.++++|
T Consensus 211 ~~~~i~~~~~~--~~p~~~~~~l~~li~~cl~~~p~~Rps---~~~il~~ 255 (263)
T d1sm2a_ 211 VVEDISTGFRL--YKPRLASTHVYQIMNHCWKERPEDRPA---FSRLLRQ 255 (263)
T ss_dssp HHHHHHHTCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHCCCC--CCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHHH
T ss_conf 99999806888--995436799999999976579768919---9999999
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=387.94 Aligned_cols=260 Identities=26% Similarity=0.410 Sum_probs=217.1
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC------C
Q ss_conf 8990799776027965999999978996899999532321353579999999999994599955789223114------7
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC------R 567 (900)
Q Consensus 494 ~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~------~ 567 (900)
.++|+++++||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++|||||+++++|.. .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCC
T ss_conf 377599889621758599999999999899999988233-6979999999999999864898764899897025643457
Q ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 70499996517988577888507899899999999999999864305717403799838855799199970577523333
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 568 ~~LyLVmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~ 647 (900)
..+|+||||+.|| +...+. ..+++..++.+++|++.||.|||++||+||||||+|||++.++.+|++|||+++...
T Consensus 95 ~~~~iv~Ey~~~~-l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~- 170 (355)
T d2b1pa1 95 QDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG- 170 (355)
T ss_dssp CEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CEEEEEEECCCHH-HHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECHHHHHCCC-
T ss_conf 6269998414467-787650--389999999999999999988652211245677632113654431320102321146-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCH
Q ss_conf 56556999988898999999974223566776665579998873443179998421030025899999939999999985
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESP 727 (900)
Q Consensus 648 ~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~~~s~ 727 (900)
........+||+.|+|||++.+..++.++||||+||++|+|++|++||.+.+.
T Consensus 171 ---------------------------~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~ 223 (355)
T d2b1pa1 171 ---------------------------TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223 (355)
T ss_dssp -------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ---------------------------CCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCH
T ss_conf ---------------------------66553322146555581331477778774333566257898659899888977
Q ss_pred HHHHHHHHC----------------------CCCCCCCC-----------------CCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 799986411----------------------89889999-----------------999998899999875359958889
Q 002616 728 EIIFDNILN----------------------RKIPWPCV-----------------PSDMSFEAQDLINRFLIHDPNQRL 768 (900)
Q Consensus 728 ~ei~~kIl~----------------------~~l~~P~i-----------------p~~iS~elkDLIkklL~~DP~kRp 768 (900)
.....++.. ........ ....++++.+||++||..||.+||
T Consensus 224 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ 303 (355)
T d2b1pa1 224 IDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303 (355)
T ss_dssp HHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC
T ss_pred HHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC
T ss_conf 88999999720589879998765667777641754356664212643335432101333799999999998769945790
Q ss_pred CHHCHHHHHCCCCCCCCCCC
Q ss_conf 92029999819998899930
Q 002616 769 GANGAAEVKAHPFFKGVNWD 788 (900)
Q Consensus 769 s~~~a~EIL~HPFFk~idw~ 788 (900)
+ |.++|+||||+..-+.
T Consensus 304 t---a~elL~Hpw~~~~~~~ 320 (355)
T d2b1pa1 304 S---VDDALQHPYINVWYDP 320 (355)
T ss_dssp C---HHHHHTSTTTGGGCCH
T ss_pred C---HHHHHCCCCCCCCCCC
T ss_conf 8---9999669420878881
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=387.58 Aligned_cols=260 Identities=22% Similarity=0.356 Sum_probs=217.0
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC
Q ss_conf 55545899079977602796599999997899689999953232135357999999999999459995578922311477
Q 002616 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 489 ~~~i~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~ 568 (900)
.+.+..++|++.+.||+|+||+||+|+++ ++..||+|++++.. ...+.+.+|+.++..++|||||++++++.+ +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CEECCHHHEEEEEEEECCCCCEEEEEEEC-CCCEEEEEEECCCC----CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-C
T ss_conf 70038899388679810798289999999-99999999986476----888999999999986799988578731045-9
Q ss_pred EEEEEEEECCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 049999651798857788850--789989999999999999986430571740379983885579919997057752333
Q 002616 569 NLYLVMEYLNGGDLYSLLRKV--GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 569 ~LyLVmEyl~GGSL~dlL~k~--g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~ 646 (900)
.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCEEECCCCCEEECC
T ss_conf 76999995789828888751478988788999999999999999974895467564225156202440423410147735
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCCCCC
Q ss_conf 35655699998889899999997422356677666557999887344317999842103002589999993-99999999
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 725 (900)
Q Consensus 647 ~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLt-Gk~PF~~~ 725 (900)
. ..........||+.|||||++.+..|+.++|||||||++|||++ |.+||...
T Consensus 161 ~--------------------------~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~ 214 (272)
T d1qpca_ 161 D--------------------------NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM 214 (272)
T ss_dssp S--------------------------SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred C--------------------------CCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 8--------------------------86442035677444458289837999824564525799999996898888888
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCC
Q ss_conf 8579998641189889999999998899999875359958889920299998199988
Q 002616 726 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 726 s~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk 783 (900)
+..++...+..+.. +..|..+++++.+||.+||..||.+||++.++.+.| |+||.
T Consensus 215 ~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L-~~~ft 269 (272)
T d1qpca_ 215 TNPEVIQNLERGYR--MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL-EDFFT 269 (272)
T ss_dssp CHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH-HHHHH
T ss_pred CHHHHHHHHHHCCC--CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHH-HHHHH
T ss_conf 99999999970688--889655719999999997588976893999999986-11321
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=388.42 Aligned_cols=257 Identities=30% Similarity=0.426 Sum_probs=219.0
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC-----
Q ss_conf 899079977602796599999997899689999953232135357999999999999459995578922311477-----
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD----- 568 (900)
Q Consensus 494 ~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~----- 568 (900)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++|||||++++++....
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 987188889831788399999999999799999988200-2868999999999999866898742599999634645668
Q ss_pred EEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 04999965179885778885078998999999999999998643057174037998388557991999705775233335
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLIN 648 (900)
Q Consensus 569 ~LyLVmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~ 648 (900)
..+++|+|+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++...
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~--- 171 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT--- 171 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC---
T ss_pred CEEEEEEEECCCCHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCC---
T ss_conf 64999996258862320022-45309999999999999999997388765166776334554322001321000125---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCCCEEECHHHHHHHHHHCCCCCCCCCH
Q ss_conf 65569999888989999999742235667766655799988734431799-98421030025899999939999999985
Q 002616 649 NTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPFTAESP 727 (900)
Q Consensus 649 ~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-ys~ksDIWSLGVILyELLtGk~PF~~~s~ 727 (900)
.....+..||+.|+|||++.+.. ++.++|||||||++|+|++|++||.+.+.
T Consensus 172 ---------------------------~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~ 224 (348)
T d2gfsa1 172 ---------------------------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224 (348)
T ss_dssp ---------------------------TGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ---------------------------CCCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf ---------------------------75444434543555835533775678551243205899999768899788988
Q ss_pred HHHHHHHHCCCCC-----------------------CC-----CCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCC
Q ss_conf 7999864118988-----------------------99-----9999999889999987535995888992029999819
Q 002616 728 EIIFDNILNRKIP-----------------------WP-----CVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 728 ~ei~~kIl~~~l~-----------------------~P-----~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~H 779 (900)
......|...... .+ .....++++++|||.+||..||.+||| +.++|+|
T Consensus 225 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t---a~elL~H 301 (348)
T d2gfsa1 225 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT---AAQALAH 301 (348)
T ss_dssp HHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHTS
T ss_pred HHHHHHHHHHCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCC
T ss_conf 9999999973079975773200102445444303557875556626789999999999977588345938---9998559
Q ss_pred CCCCCC
Q ss_conf 998899
Q 002616 780 PFFKGV 785 (900)
Q Consensus 780 PFFk~i 785 (900)
|||+..
T Consensus 302 p~f~~~ 307 (348)
T d2gfsa1 302 AYFAQY 307 (348)
T ss_dssp GGGTTT
T ss_pred HHHCCC
T ss_conf 954879
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.87 Aligned_cols=261 Identities=27% Similarity=0.448 Sum_probs=223.6
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEE
Q ss_conf 89907997760279659999999789968999995323213535799999999999945999557892231147704999
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 494 ~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~LyLV 573 (900)
+++|++++.||+|+||+||+|+++.+++.||+|++++.. ........+.+|+.+|+.++||||+++++++.+....++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEE
T ss_conf 999786269712868199999999999699999980321-7868999999999999856757888213544444311588
Q ss_pred EEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 96517988577888507899899999999999999864305717403799838855799199970577523333565569
Q 002616 574 MEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTIDL 653 (900)
Q Consensus 574 mEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s~dl 653 (900)
++++.|++|..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|+....
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~------ 153 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI------ 153 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS------
T ss_pred EEECCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCC------
T ss_conf 63023322211212356540367899999999998774339986001467612113378266520460110468------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCCCEEECHHHHHHHHHHCCCCC-CCCCHHHHH
Q ss_conf 999888989999999742235667766655799988734431799-984210300258999999399999-999857999
Q 002616 654 SGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE-HGYAADWWSVGIILFEFITGIPPF-TAESPEIIF 731 (900)
Q Consensus 654 s~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~-ys~ksDIWSLGVILyELLtGk~PF-~~~s~~ei~ 731 (900)
.........+++.|+|||++.+.. ++.++|||||||++|||++|+.|| .+.+..+..
T Consensus 154 ---------------------~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~ 212 (292)
T d1unla_ 154 ---------------------PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212 (292)
T ss_dssp ---------------------CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH
T ss_pred ---------------------CCCCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf ---------------------87510010344310146675069888804440265418899851899998899999999
Q ss_pred HHHHCC--------------------------CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCCC
Q ss_conf 864118--------------------------988999999999889999987535995888992029999819998899
Q 002616 732 DNILNR--------------------------KIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 732 ~kIl~~--------------------------~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~i 785 (900)
.++... .......+..+++++.+||.+||++||.+||| +.++|+||||++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s---a~e~L~Hp~f~~~ 289 (292)
T d1unla_ 213 KRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS---AEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHTTSGGGSSC
T ss_pred HHHHHHCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCHHHCCC
T ss_conf 9998611899735513443222113344454431043306568999999999986499668909---9999649534079
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=382.17 Aligned_cols=256 Identities=24% Similarity=0.361 Sum_probs=221.0
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEECCCCCE--EEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEEEEEC
Q ss_conf 5554589907997760279659999999789968--999995323213535799999999999945-9995578922311
Q 002616 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTGDL--FAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYSFT 565 (900)
Q Consensus 489 ~~~i~~~dfeilk~IGkGsFG~Vyla~~k~tg~~--VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l-~HPnIVkL~~~f~ 565 (900)
.+.+..++|++.+.||+|+||+||+|+++.+|.. ||+|.+++. ......+.+.+|+.+|..+ +|||||++++++.
T Consensus 4 ~~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 81 (309)
T d1fvra_ 4 YPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACE 81 (309)
T ss_dssp SSBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEE
T ss_pred CCCCCHHHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE
T ss_conf 996687996887798207882899999989996999999997823--385799999999999986228998836788884
Q ss_pred CCCEEEEEEEECCCCCHHHHHHHC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEEC
Q ss_conf 477049999651798857788850----------------7899899999999999999864305717403799838855
Q 002616 566 CRDNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIA 629 (900)
Q Consensus 566 ~~~~LyLVmEyl~GGSL~dlL~k~----------------g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD 629 (900)
+.+.+|+||||++||+|.+++++. ..+++..+..++.||+.||.|||+++|+||||||+|||++
T Consensus 82 ~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~ 161 (309)
T d1fvra_ 82 HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161 (309)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred CCCEEEEEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEEC
T ss_conf 18736999980289869999864035555512310123457899999999999999998766308954555052048986
Q ss_pred CCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHH
Q ss_conf 79919997057752333356556999988898999999974223566776665579998873443179998421030025
Q 002616 630 HDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVG 709 (900)
Q Consensus 630 ~~G~VKLsDFGLAk~~~~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLG 709 (900)
.++.+||+|||+|+... .........||+.|+|||.+.+..|+.++||||||
T Consensus 162 ~~~~~kl~DfG~a~~~~----------------------------~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfG 213 (309)
T d1fvra_ 162 ENYVAKIADFGLSRGQE----------------------------VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 213 (309)
T ss_dssp GGGCEEECCTTCEESSC----------------------------EECCC----CCTTTCCHHHHHHCEECHHHHHHHHH
T ss_pred CCCCEEECCCCCCCCCC----------------------------CCCCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHH
T ss_conf 88763874344322444----------------------------22345530137755553875269999622153138
Q ss_pred HHHHHHHHC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCC
Q ss_conf 899999939-9999999857999864118988999999999889999987535995888992029999819
Q 002616 710 IILFEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 710 VILyELLtG-k~PF~~~s~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~H 779 (900)
|++|||++| .+||.+.+..+++..+..+.. +..+..+++++++||.+||..||++||+ +.++++|
T Consensus 214 vil~ell~~~~~p~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~eil~~ 279 (309)
T d1fvra_ 214 VLLWEIVSLGGTPYCGMTCAELYEKLPQGYR--LEKPLNCDDEVYDLMRQCWREKPYERPS---FAQILVS 279 (309)
T ss_dssp HHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHHH
T ss_conf 8999998368999999999999999982688--8887667899999999976789668949---9999999
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=383.57 Aligned_cols=254 Identities=23% Similarity=0.343 Sum_probs=215.7
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCC----EEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC
Q ss_conf 58990799776027965999999978996----89999953232135357999999999999459995578922311477
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGD----LFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 493 ~~~dfeilk~IGkGsFG~Vyla~~k~tg~----~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~ 568 (900)
..++|++++.||+|+||+||+|.++.+|+ .||+|.++... .....+.+.+|+.++..++|||||++++++.+.
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred CHHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-
T ss_conf 88999783198208992999999958998898999999965134--979999999999999867998881589999619-
Q ss_pred EEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 049999651798857788850-7899899999999999999864305717403799838855799199970577523333
Q 002616 569 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 569 ~LyLVmEyl~GGSL~dlL~k~-g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~ 647 (900)
..+++++|+.+|+|.+.+... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++++||+|||+|+....
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CEEEEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf 83699984268740101113345799999999999999999999876950476212031167998758602552223354
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCCCCCC
Q ss_conf 5655699998889899999997422356677666557999887344317999842103002589999993-999999998
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 726 (900)
Q Consensus 648 ~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLt-Gk~PF~~~s 726 (900)
. ..........||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+
T Consensus 164 ~-------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~ 218 (317)
T d1xkka_ 164 E-------------------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 218 (317)
T ss_dssp T-------------------------CC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred C-------------------------CCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 4-------------------------453223651058644670887469998356544079999999977999999999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCC
Q ss_conf 57999864118988999999999889999987535995888992029999819
Q 002616 727 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 727 ~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~H 779 (900)
..++...+..+.. +..|..+++++.+||.+||..||.+||+ +.+|+.|
T Consensus 219 ~~~~~~~i~~~~~--~~~p~~~~~~~~~li~~cl~~dP~~RPs---~~eil~~ 266 (317)
T d1xkka_ 219 ASEISSILEKGER--LPQPPICTIDVYMIMVKCWMIDADSRPK---FRELIIE 266 (317)
T ss_dssp GGGHHHHHHHTCC--CCCCTTBCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHHH
T ss_conf 8999999975998--9998556899999999847899346919---9999999
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.93 Aligned_cols=251 Identities=21% Similarity=0.347 Sum_probs=219.8
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEE
Q ss_conf 58990799776027965999999978996899999532321353579999999999994599955789223114770499
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 493 ~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~~LyL 572 (900)
..++|++.+.||+|+||+||+|+++ ++..||+|++++... ..+.+++|+.++..++|||||++++++.+.+.+|+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred CHHHCEEEEEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEE
T ss_conf 9699799689820788399999988-998999999874757----78999999999996689860158899850781699
Q ss_pred EEEECCCCCHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 9965179885778885-078998999999999999998643057174037998388557991999705775233335655
Q 002616 573 VMEYLNGGDLYSLLRK-VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTI 651 (900)
Q Consensus 573 VmEyl~GGSL~dlL~k-~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s~ 651 (900)
||||+++|+|..++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~---- 152 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD---- 152 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS----
T ss_pred EEECCCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCCCEEECCCHHHEECCC----
T ss_conf 9970489938886410246776899999999999999987546843466541358876998479886144202357----
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCCCCCCHHHH
Q ss_conf 699998889899999997422356677666557999887344317999842103002589999993-9999999985799
Q 002616 652 DLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAESPEII 730 (900)
Q Consensus 652 dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLt-Gk~PF~~~s~~ei 730 (900)
..........||+.|+|||++.+..|+.++|||||||++|||++ |+.||.+.+..++
T Consensus 153 ----------------------~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~ 210 (258)
T d1k2pa_ 153 ----------------------DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 210 (258)
T ss_dssp ----------------------SSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH
T ss_pred ----------------------CCCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHH
T ss_conf ----------------------8722524657887757807863799885210336432467397559999889999999
Q ss_pred HHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCC
Q ss_conf 9864118988999999999889999987535995888992029999819
Q 002616 731 FDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 731 ~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~H 779 (900)
..++..+.. +..|...++++.+||.+||..||.+||+ +.+|++|
T Consensus 211 ~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~RPt---~~eil~~ 254 (258)
T d1k2pa_ 211 AEHIAQGLR--LYRPHLASEKVYTIMYSCWHEKADERPT---FKILLSN 254 (258)
T ss_dssp HHHHHTTCC--CCCCTTCCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHHH
T ss_conf 999980797--8996546599999999976689768939---9999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.25 Aligned_cols=263 Identities=23% Similarity=0.363 Sum_probs=218.5
Q ss_pred CCCCCCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC
Q ss_conf 65554589907997760279659999999789968999995323213535799999999999945999557892231147
Q 002616 488 HKERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 488 ~~~~i~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~ 567 (900)
..+.+..++|++.+.||+|+||+||+|+++.+ ..||+|+++.... ..+.+.+|+.++..++|||||++++++.+
T Consensus 10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp TCSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCEECCHHHEEEEEEEEECCCEEEEEEEECCC-CEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCEEEEEEEEEC-
T ss_conf 56074779979846993079809999999999-9999999880448----88999999999986666788689999823-
Q ss_pred CEEEEEEEECCCCCHHHHHHH--CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 704999965179885778885--078998999999999999998643057174037998388557991999705775233
Q 002616 568 DNLYLVMEYLNGGDLYSLLRK--VGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645 (900)
Q Consensus 568 ~~LyLVmEyl~GGSL~dlL~k--~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~ 645 (900)
+.+|+||||+++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCCCEEECCCCHHHHC
T ss_conf 97599999447994354200003553059999999999999999875411433531230799989992998442555425
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCCCC
Q ss_conf 335655699998889899999997422356677666557999887344317999842103002589999993-9999999
Q 002616 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 724 (900)
Q Consensus 646 ~~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLt-Gk~PF~~ 724 (900)
.. ..........||+.|+|||++.+..++.++|||||||++|||++ |++||..
T Consensus 164 ~~--------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~ 217 (285)
T d1fmka3 164 ED--------------------------NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217 (285)
T ss_dssp --------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred CC--------------------------CCCEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCC
T ss_conf 68--------------------------8733524545566545808983799891774132358999998689999988
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCCC
Q ss_conf 9857999864118988999999999889999987535995888992029999819998899
Q 002616 725 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGV 785 (900)
Q Consensus 725 ~s~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~i 785 (900)
....++...+..+. . +..+..+++++++||.+||..||++||++.++.+.+ |+||...
T Consensus 218 ~~~~~~~~~i~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L-~~~~~~~ 275 (285)
T d1fmka3 218 MVNREVLDQVERGY-R-MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL-EDYFTST 275 (285)
T ss_dssp CCHHHHHHHHHTTC-C-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH-HTTTSCS
T ss_pred CCHHHHHHHHHHCC-C-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH-HHHHCCC
T ss_conf 88999999998268-9-999832379999999997566975891999999987-6662389
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.09 Aligned_cols=257 Identities=22% Similarity=0.281 Sum_probs=215.8
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEECCCC----CEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC
Q ss_conf 545899079977602796599999997899----6899999532321353579999999999994599955789223114
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTG----DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC 566 (900)
Q Consensus 491 ~i~~~dfeilk~IGkGsFG~Vyla~~k~tg----~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~ 566 (900)
++..+.|++.+.||+|+||+||+|.++.++ ..||+|+++... .......+++|+.++..++|||||++++++..
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCHHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC
T ss_conf 5788996861598117790999999968998787999999988445--96899999999999985689878323677833
Q ss_pred CCEEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 77049999651798857788850-78998999999999999998643057174037998388557991999705775233
Q 002616 567 RDNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645 (900)
Q Consensus 567 ~~~LyLVmEyl~GGSL~dlL~k~-g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~ 645 (900)
.+.+|+||||+.+|++.+++.+. ..+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCEEEEEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCEEEECCCCHHHCC
T ss_conf 88038999721357402221023454208999999999998541212123425765644278889984998455103003
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCCCC
Q ss_conf 335655699998889899999997422356677666557999887344317999842103002589999993-9999999
Q 002616 646 LINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTA 724 (900)
Q Consensus 646 ~~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLt-Gk~PF~~ 724 (900)
.... ..........||+.|||||++.+..|+.++|||||||++|||++ |.+||..
T Consensus 161 ~~~~------------------------~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~ 216 (283)
T d1mqba_ 161 EDDP------------------------EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 216 (283)
T ss_dssp -------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred CCCC------------------------CCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCC
T ss_conf 5787------------------------6526742677773434888870499997355634489899999679886556
Q ss_pred CCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHH
Q ss_conf 985799986411898899999999988999998753599588899202999
Q 002616 725 ESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 775 (900)
Q Consensus 725 ~s~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~E 775 (900)
.+..+++..+..+.. +..+..++.++.+||.+||..||.+||++.++.+
T Consensus 217 ~~~~~~~~~i~~~~~--~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 217 LSNHEVMKAINDGFR--LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CCHHHHHHHHHTTCC--CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHCCCC--CCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 899999999863578--9985045799999999977679768939999999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.42 Aligned_cols=255 Identities=25% Similarity=0.358 Sum_probs=218.0
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEECCCC---CEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCC
Q ss_conf 545899079977602796599999997899---68999995323213535799999999999945999557892231147
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCR 567 (900)
Q Consensus 491 ~i~~~dfeilk~IGkGsFG~Vyla~~k~tg---~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~ 567 (900)
++..++|++.+.||+|+||+||+|++..++ ..||+|.++.. ......+.+.+|+.+++.++|||||++++++. .
T Consensus 3 ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 3 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred CCCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-C
T ss_conf 76889969877993078829999999369964499999993656--68799999999999998689999856988995-3
Q ss_pred CEEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 7049999651798857788850-789989999999999999986430571740379983885579919997057752333
Q 002616 568 DNLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 568 ~~LyLVmEyl~GGSL~dlL~k~-g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~ 646 (900)
+.+|+||||+++|+|.+++... +.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus 80 ~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 80 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCCCEEECCCHHHEECC
T ss_conf 74799998406980776542247899999999999999877523022674414102655320678967876503421336
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCCCCC
Q ss_conf 35655699998889899999997422356677666557999887344317999842103002589999993-99999999
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 725 (900)
Q Consensus 647 ~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLt-Gk~PF~~~ 725 (900)
. ..........||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.
T Consensus 160 ~--------------------------~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~ 213 (273)
T d1mp8a_ 160 D--------------------------STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213 (273)
T ss_dssp -------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred C--------------------------CCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC
T ss_conf 7--------------------------76233054005831032667516998874524442478999982699998889
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCC
Q ss_conf 857999864118988999999999889999987535995888992029999819
Q 002616 726 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 726 s~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~H 779 (900)
+..+++.++..+.. +.++..+|+++.+||.+||..||.+||+ +.+|++|
T Consensus 214 ~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dp~~Rps---~~ei~~~ 262 (273)
T d1mp8a_ 214 KNNDVIGRIENGER--LPMPPNCPPTLYSLMTKCWAYDPSRRPR---FTELKAQ 262 (273)
T ss_dssp CGGGHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred CHHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHHH
T ss_conf 99999999981899--9898777999999999976879768929---9999999
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=377.19 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=222.4
Q ss_pred CCCCCCEEEEEEECCCCCEEEEEEEECC-----CCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEC
Q ss_conf 5458990799776027965999999978-----99689999953232135357999999999999459995578922311
Q 002616 491 RTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFT 565 (900)
Q Consensus 491 ~i~~~dfeilk~IGkGsFG~Vyla~~k~-----tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~ 565 (900)
+...++|++++.||+|+||+||+|+++. ++..||+|+++... .....+.+.+|+.+|+.++||||+++++++.
T Consensus 9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHC--CHHHHHHHHHHHHHHHHCCCCCCCCCEEEEC
T ss_conf 38988938867982078839999998887657788299999988210--8579999999999999668997655246660
Q ss_pred CCCEEEEEEEECCCCCHHHHHHHCC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCEEECCC
Q ss_conf 4770499996517988577888507------------------------8998999999999999998643057174037
Q 002616 566 CRDNLYLVMEYLNGGDLYSLLRKVG------------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDL 621 (900)
Q Consensus 566 ~~~~LyLVmEyl~GGSL~dlL~k~g------------------------~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDI 621 (900)
....+++||||+++|+|.+++.... .+++..+..++.|++.||+|||+++||||||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDl 166 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 166 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 59803899981589929999985275542100001110012103467889899999999999999855413578685488
Q ss_pred CCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 99838855799199970577523333565569999888989999999742235667766655799988734431799984
Q 002616 622 KPDNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGY 701 (900)
Q Consensus 622 KPeNILLD~~G~VKLsDFGLAk~~~~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ 701 (900)
||+|||++.++++||+|||+|+..... .......+.+||+.|+|||++.+..|+.
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~~~~~~~t~ 221 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSA-------------------------DYYKADGNDAIPIRWMPPESIFYNRYTT 221 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGG-------------------------GCBC----CCBCGGGCCHHHHHHCCCCH
T ss_pred CCCCEEECCCCCEEECCCHHHEECCCC-------------------------CCCCCCCCCCCCCCCCCHHHHCCCCCCH
T ss_conf 401168989992898331442113677-------------------------6411157777676767989972688980
Q ss_pred CCEEECHHHHHHHHHHC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHC
Q ss_conf 21030025899999939-999999985799986411898899999999988999998753599588899202999981
Q 002616 702 AADWWSVGIILFEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA 778 (900)
Q Consensus 702 ksDIWSLGVILyELLtG-k~PF~~~s~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~ 778 (900)
++|||||||++|||++| .+||.+.+..++...+..+.. +.+|..+++++.+||.+||..||.+||++.++.+.|+
T Consensus 222 ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~--~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~ 297 (301)
T d1lufa_ 222 ESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI--LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQ 297 (301)
T ss_dssp HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHCCCHHHHHHHHCCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 563025236299998068999999899999999973997--8887325299999999974889657939999999999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.11 Aligned_cols=259 Identities=25% Similarity=0.351 Sum_probs=212.3
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECCC-----CCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEEEE
Q ss_conf 554589907997760279659999999789-----968999995323213535799999999999945-99955789223
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTT-----GDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFFYS 563 (900)
Q Consensus 490 ~~i~~~dfeilk~IGkGsFG~Vyla~~k~t-----g~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l-~HPnIVkL~~~ 563 (900)
+.+..++|++.+.||+|+||+||+|.++.. ++.||+|+++... .....+.+.+|..++.++ +|||||.++++
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCC--CCHHHHHHHHHHHHHHHHCCCCEEEEEEEE
T ss_conf 261679979844984167839999998677755578399999986001--717899999999998861499849974115
Q ss_pred ECCC-CEEEEEEEECCCCCHHHHHHHC----------------CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCE
Q ss_conf 1147-7049999651798857788850----------------7899899999999999999864305717403799838
Q 002616 564 FTCR-DNLYLVMEYLNGGDLYSLLRKV----------------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNL 626 (900)
Q Consensus 564 f~~~-~~LyLVmEyl~GGSL~dlL~k~----------------g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNI 626 (900)
+... ..+|+||||++||+|.+++... ..+++..+..|+.||+.||.|||+++|+||||||+||
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred ECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCE
T ss_conf 40479757999984589929999985366666532220233214689999999999999999988737971786773106
Q ss_pred EECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEE
Q ss_conf 85579919997057752333356556999988898999999974223566776665579998873443179998421030
Q 002616 627 LIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWW 706 (900)
Q Consensus 627 LLD~~G~VKLsDFGLAk~~~~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIW 706 (900)
|++.++++||+|||+|+..... .........+||+.|||||++.+..|+.++|||
T Consensus 166 Ll~~~~~~Kl~DFGla~~~~~~-------------------------~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiw 220 (299)
T d1ywna1 166 LLSEKNVVKICDFGLARDIYKD-------------------------PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 220 (299)
T ss_dssp EECGGGCEEECC------CCSC-------------------------TTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHH
T ss_pred EECCCCCEEECCCCCHHHCCCC-------------------------CCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEE
T ss_conf 5779982898457520011356-------------------------652224751667210203686468899663221
Q ss_pred CHHHHHHHHHHC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCC
Q ss_conf 025899999939-9999999857999864118988999999999889999987535995888992029999819
Q 002616 707 SVGIILFEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 707 SLGVILyELLtG-k~PF~~~s~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~H 779 (900)
||||++|||++| .+||.+.+..+.+..++..... +..|..+++++++||.+||..||.+||+ +.++++|
T Consensus 221 S~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rpt---~~eil~~ 290 (299)
T d1ywna1 221 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR-MRAPDYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 290 (299)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred EHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHHH
T ss_conf 36789999986889999899989999999963898-8888657899999999976779667919---9999999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=377.77 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=223.0
Q ss_pred CCCCCEEEEEEECCCCCEEEEEEEECCC-C--CEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCC
Q ss_conf 4589907997760279659999999789-9--689999953232135357999999999999459995578922311477
Q 002616 492 TSIDDFEIIKPISRGAFGRVFLARKRTT-G--DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTCRD 568 (900)
Q Consensus 492 i~~~dfeilk~IGkGsFG~Vyla~~k~t-g--~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~~~ 568 (900)
+..++|++++.||+|+||+||+|++... + ..||+|++++.........+.+.+|+.+|..++|||||++++++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ECHHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-C
T ss_conf 864891997898038883999999988999079999999983555798999999999999986899998789877740-1
Q ss_pred EEEEEEEECCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 049999651798857788850-7899899999999999999864305717403799838855799199970577523333
Q 002616 569 NLYLVMEYLNGGDLYSLLRKV-GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLI 647 (900)
Q Consensus 569 ~LyLVmEyl~GGSL~dlL~k~-g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~ 647 (900)
.+|+||||+++|+|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred CHHEEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCCCEEECCCHHHHHCCC
T ss_conf 00114654238612544421268999999999999999999875217875205668881565565433256115553035
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCCCCCC
Q ss_conf 5655699998889899999997422356677666557999887344317999842103002589999993-999999998
Q 002616 648 NNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAES 726 (900)
Q Consensus 648 ~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLt-Gk~PF~~~s 726 (900)
.. ..........||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+
T Consensus 164 ~~------------------------~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 164 ND------------------------DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp -C------------------------CEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CC------------------------CCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 88------------------------752654763257310799998379999421566148999999968999999969
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHH
Q ss_conf 579998641189889999999998899999875359958889920299998
Q 002616 727 PEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 727 ~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL 777 (900)
..++..++......++ .+..+|+++.+||.+||..||.+||++.++.++|
T Consensus 220 ~~~~~~~i~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L 269 (273)
T d1u46a_ 220 GSQILHKIDKEGERLP-RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269 (273)
T ss_dssp HHHHHHHHHTSCCCCC-CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 9999999984799999-8544539999999997688966792999999999
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.32 Aligned_cols=262 Identities=23% Similarity=0.351 Sum_probs=221.2
Q ss_pred CCCCCCCCCEEEEEEECCCCCEEEEEEEEC-----CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEEE
Q ss_conf 655545899079977602796599999997-----89968999995323213535799999999999945-999557892
Q 002616 488 HKERTSIDDFEIIKPISRGAFGRVFLARKR-----TTGDLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRFF 561 (900)
Q Consensus 488 ~~~~i~~~dfeilk~IGkGsFG~Vyla~~k-----~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l-~HPnIVkL~ 561 (900)
..+.+..++|++.+.||+|+||+||+|+++ .++..||+|++++.. .......+.+|+.++..+ +|||||+++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCCEEEEE
T ss_conf 02637789969854982068829999998066447788699999987424--8779999999999987626999887899
Q ss_pred EEECCCCEEEEEEEECCCCCHHHHHHHCC------------------CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCC
Q ss_conf 23114770499996517988577888507------------------899899999999999999864305717403799
Q 002616 562 YSFTCRDNLYLVMEYLNGGDLYSLLRKVG------------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKP 623 (900)
Q Consensus 562 ~~f~~~~~LyLVmEyl~GGSL~dlL~k~g------------------~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKP 623 (900)
+++.+.+.+|+||||+++|+|.+++.+.. .+++..+..|+.||+.||+|||+++++||||||
T Consensus 94 g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 94 GACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp EEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred EEEEECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCC
T ss_conf 89831997899997379987999998535665444445332223345889999999999999999988757926662410
Q ss_pred CCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCC
Q ss_conf 83885579919997057752333356556999988898999999974223566776665579998873443179998421
Q 002616 624 DNLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAA 703 (900)
Q Consensus 624 eNILLD~~G~VKLsDFGLAk~~~~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ks 703 (900)
+|||++.++.+|++|||+++..... .........+||+.|+|||++.+..++.++
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~-------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 228 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKND-------------------------SNYVVKGNARLPVKWMAPESIFNCVYTFES 228 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSC-------------------------TTSEECSSSEECGGGCCHHHHHHCCCCHHH
T ss_pred CCCCCCCCCCCCCCCCCHHEECCCC-------------------------CCCEEEEECCCCHHHCCHHHHCCCCCCCCC
T ss_conf 2100002575210234010233678-------------------------861586201359687677886179999740
Q ss_pred EEECHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHH
Q ss_conf 03002589999993-999999998579998641189889999999998899999875359958889920299998
Q 002616 704 DWWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 704 DIWSLGVILyELLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL 777 (900)
|||||||++|||++ |.+||...+..+.+.+++....+ +..+..++.++.+||.+||..||.+||++.++.+.|
T Consensus 229 DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~-~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L 302 (311)
T d1t46a_ 229 DVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFR-MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302 (311)
T ss_dssp HHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCC-CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 01025899999985899887789989999999866898-898543659999999997577965792999999999
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.29 Aligned_cols=270 Identities=21% Similarity=0.294 Sum_probs=226.8
Q ss_pred CCCCCCCCCEEEEEEECCCCCEEEEEEEECC-----CCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEE
Q ss_conf 6555458990799776027965999999978-----99689999953232135357999999999999459995578922
Q 002616 488 HKERTSIDDFEIIKPISRGAFGRVFLARKRT-----TGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFY 562 (900)
Q Consensus 488 ~~~~i~~~dfeilk~IGkGsFG~Vyla~~k~-----tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~ 562 (900)
+.+.+..++|++.+.||+|+||+||+|.++. ++..||||++++.. .......+.+|+.++..++|||||++++
T Consensus 13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred CCEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCC--CHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 10042689918835982078818999998786447789689999987012--8689999999999999769998841254
Q ss_pred EECCCCEEEEEEEECCCCCHHHHHHHC----------CCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCC
Q ss_conf 311477049999651798857788850----------7899899999999999999864305717403799838855799
Q 002616 563 SFTCRDNLYLVMEYLNGGDLYSLLRKV----------GCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDG 632 (900)
Q Consensus 563 ~f~~~~~LyLVmEyl~GGSL~dlL~k~----------g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G 632 (900)
.+...+.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+++|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEECCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEECCCC
T ss_conf 78428810677760489988999875033211344468879999999999999999987647965432867754035996
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHH
Q ss_conf 19997057752333356556999988898999999974223566776665579998873443179998421030025899
Q 002616 633 HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIIL 712 (900)
Q Consensus 633 ~VKLsDFGLAk~~~~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVIL 712 (900)
++||+|||+|+...... ........+||+.|+|||.+.+..++.++||||||+++
T Consensus 171 ~~Kl~DFGla~~~~~~~-------------------------~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il 225 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETD-------------------------YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 225 (308)
T ss_dssp CEEECCTTCCCGGGGGG-------------------------CEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred EEEEEECCCCEECCCCC-------------------------CEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHH
T ss_conf 49994245420235776-------------------------30313402316323788887369988333444378999
Q ss_pred HHHHHC-CCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHC---CCCCCCCC
Q ss_conf 999939-999999985799986411898899999999988999998753599588899202999981---99988999
Q 002616 713 FEFITG-IPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKA---HPFFKGVN 786 (900)
Q Consensus 713 yELLtG-k~PF~~~s~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~---HPFFk~id 786 (900)
|||++| .+||.+.+..+++..+..+.. +..|..+++.+.+||.+||+.||.+||++.++.+.|+ +|+|+.++
T Consensus 226 ~El~t~~~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~ 301 (308)
T d1p4oa_ 226 WEIATLAEQPYQGLSNEQVLRFVMEGGL--LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVS 301 (308)
T ss_dssp HHHHHTSCCTTTTSCHHHHHHHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHC
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHHCCC--CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCCCCCCCC
T ss_conf 9999689999999899999999980888--888633539999999997577965893999999997876177875778
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=370.74 Aligned_cols=260 Identities=24% Similarity=0.354 Sum_probs=221.3
Q ss_pred CCCCCCCCEEEEEEECCCCCEEEEEEEECCCC-------CEEEEEEEECCCCCCHHHHHHHHHHHHHHHHC-CCCCEEEE
Q ss_conf 55545899079977602796599999997899-------68999995323213535799999999999945-99955789
Q 002616 489 KERTSIDDFEIIKPISRGAFGRVFLARKRTTG-------DLFAIKVLKKLDMIRKNDIERILAERNILITV-RNPFVVRF 560 (900)
Q Consensus 489 ~~~i~~~dfeilk~IGkGsFG~Vyla~~k~tg-------~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l-~HPnIVkL 560 (900)
.+.+..++|++++.||+|+||.||+|+...++ ..||+|++++.. .......+.+|...+.++ +|||||++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHHHHCCCCEEEEC
T ss_conf 672258996970098516782899999857875556675499999988112--868899999999999981399969734
Q ss_pred EEEECCCCEEEEEEEECCCCCHHHHHHHCC----------------CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCC
Q ss_conf 223114770499996517988577888507----------------8998999999999999998643057174037998
Q 002616 561 FYSFTCRDNLYLVMEYLNGGDLYSLLRKVG----------------CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPD 624 (900)
Q Consensus 561 ~~~f~~~~~LyLVmEyl~GGSL~dlL~k~g----------------~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPe 624 (900)
++++.+...+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred CCCCCCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCC
T ss_conf 65220188689999736999099999860677643222334574346799999999999999998766379786302210
Q ss_pred CEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCE
Q ss_conf 38855799199970577523333565569999888989999999742235667766655799988734431799984210
Q 002616 625 NLLIAHDGHIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAAD 704 (900)
Q Consensus 625 NILLD~~G~VKLsDFGLAk~~~~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksD 704 (900)
|||++.++.+||+|||+++..... .........+||+.|+|||++.++.|+.++|
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~-------------------------~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~D 219 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHI-------------------------DYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 219 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGC-------------------------CTTCCCTTSCCGGGGSCHHHHHHCCCCHHHH
T ss_pred CEEECCCCCEEECCCHHHCCCCCC-------------------------CCCCCCCCCCCCHHHHHHHHHCCCCCCCHHH
T ss_conf 224547897676221110113555-------------------------5543146678884663266751798882555
Q ss_pred EECHHHHHHHHHH-CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHH
Q ss_conf 3002589999993-999999998579998641189889999999998899999875359958889920299998
Q 002616 705 WWSVGIILFEFIT-GIPPFTAESPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 705 IWSLGVILyELLt-Gk~PF~~~s~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL 777 (900)
||||||++|||++ |.+||.+.+..+++..+..+.. +..|..+++++++||.+||.+||.+||++.++.+.|
T Consensus 220 iwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~--~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L 291 (299)
T d1fgka_ 220 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR--MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291 (299)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC--CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHCCCC--CCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHH
T ss_conf 477588888740179898999999999999972888--898743529999999997667976793999999999
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.44 Aligned_cols=247 Identities=26% Similarity=0.420 Sum_probs=215.4
Q ss_pred CCCCCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CC
Q ss_conf 55458990799776027965999999978996899999532321353579999999999994599955789223114-77
Q 002616 490 ERTSIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RD 568 (900)
Q Consensus 490 ~~i~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~-~~ 568 (900)
+.+..++|++++.||+|+||.||+|+++ |..||+|++++.. ..+.+.+|+.++++++|||||++++++.+ .+
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CCCCHHHEEEEEEEECCCCEEEEEEEEC--CEEEEEEEECCHH-----HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCC
T ss_conf 9557899488579820798089999999--9099999988577-----79999999999986789898549878872389
Q ss_pred EEEEEEEECCCCCHHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 0499996517988577888507--89989999999999999986430571740379983885579919997057752333
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVG--CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGL 646 (900)
Q Consensus 569 ~LyLVmEyl~GGSL~dlL~k~g--~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~ 646 (900)
.+|+||||+++|+|.+++.+.. .+++..++.++.||+.||.|||+.+|+||||||+|||++.+|++||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred CEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCCCEEECCCCCCEECC
T ss_conf 28999963699989999874578888999999999999852321133765536665676014689977632456003447
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHH-CCCCCCCC
Q ss_conf 35655699998889899999997422356677666557999887344317999842103002589999993-99999999
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFIT-GIPPFTAE 725 (900)
Q Consensus 647 ~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLt-Gk~PF~~~ 725 (900)
.......+|+.|+|||++.+..|+.++|||||||++|||++ |++||...
T Consensus 155 ------------------------------~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~ 204 (262)
T d1byga_ 155 ------------------------------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204 (262)
T ss_dssp -------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred ------------------------------CCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf ------------------------------87765566646778178727988858877757999999997899999999
Q ss_pred CHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHH
Q ss_conf 85799986411898899999999988999998753599588899202999
Q 002616 726 SPEIIFDNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAE 775 (900)
Q Consensus 726 s~~ei~~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~E 775 (900)
+..++...+.++.. |.++..+++++.+||.+||..||.+||++.++.+
T Consensus 205 ~~~~~~~~i~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 205 PLKDVVPRVEKGYK--MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp CGGGHHHHHTTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHHHHHHHHHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 99999999980899--9997657999999999975669768939999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.62 Aligned_cols=252 Identities=20% Similarity=0.259 Sum_probs=206.5
Q ss_pred EEEEEECCCCCEEEEEEEECCCC---CEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEE
Q ss_conf 79977602796599999997899---6899999532321353579999999999994599955789223114-7704999
Q 002616 498 EIIKPISRGAFGRVFLARKRTTG---DLFAIKVLKKLDMIRKNDIERILAERNILITVRNPFVVRFFYSFTC-RDNLYLV 573 (900)
Q Consensus 498 eilk~IGkGsFG~Vyla~~k~tg---~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPnIVkL~~~f~~-~~~LyLV 573 (900)
...++||+|+||+||+|++..++ ..||+|++++. ......+.+.+|+++|.+++|||||++++++.. +..+|+|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred CCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCC--CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 2666981368809999999779987999999998843--69789999999999998678999867867898069943899
Q ss_pred EEECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 96517988577888507-89989999999999999986430571740379983885579919997057752333356556
Q 002616 574 MEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIGLINNTID 652 (900)
Q Consensus 574 mEyl~GGSL~dlL~k~g-~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~~~~~s~d 652 (900)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~-- 185 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF-- 185 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC--
T ss_pred EEEEECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCC--
T ss_conf 987406741442101345404899999999988765200336762577668757677999889910652322556655--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCC-CCCHHHHH
Q ss_conf 99998889899999997422356677666557999887344317999842103002589999993999999-99857999
Q 002616 653 LSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFT-AESPEIIF 731 (900)
Q Consensus 653 ls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~-~~s~~ei~ 731 (900)
..........||+.|+|||++.+..++.++||||||+++|||++|..||. ..+..++.
T Consensus 186 ---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~ 244 (311)
T d1r0pa_ 186 ---------------------DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 244 (311)
T ss_dssp ---------------------CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CH
T ss_pred ---------------------CCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf ---------------------53100256555645567688743799974574661999999997899998889999999
Q ss_pred HHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCC
Q ss_conf 864118988999999999889999987535995888992029999819
Q 002616 732 DNILNRKIPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAH 779 (900)
Q Consensus 732 ~kIl~~~l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~H 779 (900)
..+..+.. +..|..+++++.+||.+||..||.+||+ +.++++|
T Consensus 245 ~~i~~g~~--~~~p~~~~~~l~~li~~cl~~dP~~RPs---~~ei~~~ 287 (311)
T d1r0pa_ 245 VYLLQGRR--LLQPEYCPDPLYEVMLKCWHPKAEMRPS---FSELVSR 287 (311)
T ss_dssp HHHHTTCC--CCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHCCCC--CCCCCCCCHHHHHHHHHHCCCCHHHCCC---HHHHHHH
T ss_conf 99980898--8996447599999999976889768939---9999999
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=360.48 Aligned_cols=263 Identities=21% Similarity=0.285 Sum_probs=209.3
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCC-EEEEEEEECCCCEEEEE
Q ss_conf 99079977602796599999997899689999953232135357999999999999459995-57892231147704999
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRNPF-VVRFFYSFTCRDNLYLV 573 (900)
Q Consensus 495 ~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~HPn-IVkL~~~f~~~~~LyLV 573 (900)
+.|++.+.||+|+||+||+|+++.+|+.||+|++..... ...+..|.++++.+.|++ |+.+.+++...+..|+|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC-----CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEE
T ss_conf 889996898507880999999988998999999721005-----888999999999703899601799999519877899
Q ss_pred EEECCCCCHHHHHH-HCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECC---CCCEEEEECCCCCCCCCCC
Q ss_conf 96517988577888-5078998999999999999998643057174037998388557---9919997057752333356
Q 002616 574 MEYLNGGDLYSLLR-KVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH---DGHIKLTDFGLSKIGLINN 649 (900)
Q Consensus 574 mEyl~GGSL~dlL~-k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~---~G~VKLsDFGLAk~~~~~~ 649 (900)
|||+.+ +|...+. ....+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|+......
T Consensus 82 me~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEECCC-CHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCCCC
T ss_conf 987387-1333244306887689999999999999999997994426678766064335777615650467513425544
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCCHHH
Q ss_conf 55699998889899999997422356677666557999887344317999842103002589999993999999998579
Q 002616 650 TIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAESPEI 729 (900)
Q Consensus 650 s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~~~s~~e 729 (900)
+. .........+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.......
T Consensus 161 ~~--------------------~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~ 220 (299)
T d1ckia_ 161 TH--------------------QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220 (299)
T ss_dssp TC--------------------CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred CC--------------------CCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHH
T ss_conf 55--------------------4100013577678735329999918998983218861778999984987665530577
Q ss_pred HHHHHH---CCC--CCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCC
Q ss_conf 998641---189--889999999998899999875359958889920299998199988
Q 002616 730 IFDNIL---NRK--IPWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFK 783 (900)
Q Consensus 730 i~~kIl---~~~--l~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk 783 (900)
....+. ... .+.+.....+|+++.+||.+||..||.+||++..+.++++|+|.+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 221 KRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp ----HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 99999985235678983575347889999999998439955791999999999999997
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=348.56 Aligned_cols=258 Identities=20% Similarity=0.249 Sum_probs=208.6
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCC-CCEEEEEEEECCCCEEEE
Q ss_conf 8990799776027965999999978996899999532321353579999999999994599-955789223114770499
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVRN-PFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 494 ~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~H-PnIVkL~~~f~~~~~LyL 572 (900)
-+.|++.+.||+|+||+||+|+++.+|+.||+|++.+... ...+.+|++++..+.| ++|+.+++++......|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEE
T ss_conf 9806997998417882999999988997999999750258-----29999999999996489998779999601881179
Q ss_pred EEEECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECC-----CCCEEEEECCCCCCCC
Q ss_conf 996517988577888507-8998999999999999998643057174037998388557-----9919997057752333
Q 002616 573 VMEYLNGGDLYSLLRKVG-CLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAH-----DGHIKLTDFGLSKIGL 646 (900)
Q Consensus 573 VmEyl~GGSL~dlL~k~g-~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~-----~G~VKLsDFGLAk~~~ 646 (900)
||||+ +|+|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++. .+.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEEC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEECC
T ss_conf 99964-88879999752031106899999999999999999779662667713152347543447956872366057714
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHHHHHHHHHCCCCCCCCC
Q ss_conf 35655699998889899999997422356677666557999887344317999842103002589999993999999998
Q 002616 647 INNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGIILFEFITGIPPFTAES 726 (900)
Q Consensus 647 ~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGVILyELLtGk~PF~~~s 726 (900)
..... .........+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+..
T Consensus 158 ~~~~~--------------------~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 158 DPVTK--------------------QHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp CTTTC--------------------CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CCCCC--------------------CCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 67665--------------------4111024676277510267989648888869998983199999986987678853
Q ss_pred ---HHHHHHHHHCCCC--CCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHH
Q ss_conf ---5799986411898--89999999998899999875359958889920299998
Q 002616 727 ---PEIIFDNILNRKI--PWPCVPSDMSFEAQDLINRFLIHDPNQRLGANGAAEVK 777 (900)
Q Consensus 727 ---~~ei~~kIl~~~l--~~P~ip~~iS~elkDLIkklL~~DP~kRps~~~a~EIL 777 (900)
....+.++..... +.+.+...+|+++.+++..|+..+|.+||.+..+.+++
T Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l 273 (293)
T d1csna_ 218 AATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273 (293)
T ss_dssp SCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHH
T ss_pred CHHHHHHHHHHHHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHH
T ss_conf 02199999999705679995896579989999999998439930085999999999
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.68 Aligned_cols=248 Identities=22% Similarity=0.328 Sum_probs=190.6
Q ss_pred CCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHH--HHHHCCCCCEEEEEEEECCCC----
Q ss_conf 99079977602796599999997899689999953232135357999999999--999459995578922311477----
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERN--ILITVRNPFVVRFFYSFTCRD---- 568 (900)
Q Consensus 495 ~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~--IL~~l~HPnIVkL~~~f~~~~---- 568 (900)
.+|.+.+.||+|+||+||+|++. |+.||+|+++.. ....+..|.+ .+..++|||||++++++.+..
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~--g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEEC--CEEEEEEEECCC------CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCE
T ss_conf 68999889820788199999999--989999998720------0467999999999962799868326889983798604
Q ss_pred EEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH--------CCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 049999651798857788850789989999999999999986430--------571740379983885579919997057
Q 002616 569 NLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHS--------LGIVHRDLKPDNLLIAHDGHIKLTDFG 640 (900)
Q Consensus 569 ~LyLVmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs--------~GIIHRDIKPeNILLD~~G~VKLsDFG 640 (900)
.+|+||||+++|+|.+++++. .+++.....++.+++.||.|+|. +||+||||||+|||++.++.+||+|||
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEEEECCCCCCHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECC
T ss_conf 899999646698989998658-9998999999999999999988766520468986615317313578688776887638
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCC------CCCCCEEECHHHHHHH
Q ss_conf 7523333565569999888989999999742235667766655799988734431799------9842103002589999
Q 002616 641 LSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTE------HGYAADWWSVGIILFE 714 (900)
Q Consensus 641 LAk~~~~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~------ys~ksDIWSLGVILyE 714 (900)
+++....... .........+||+.|||||++.+.. ++.++|||||||+|||
T Consensus 154 l~~~~~~~~~-----------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~e 210 (303)
T d1vjya_ 154 LAVRHDSATD-----------------------TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 210 (303)
T ss_dssp TCEEEETTTT-----------------------EECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCC-----------------------CEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHH
T ss_conf 6623467776-----------------------20013552503547678221056545467776750122015999999
Q ss_pred HHHCCCCCCCCC---------------HHHHHHHHHCCCCCCCCCCCC-----CCHHHHHHHHHHCCCCCCCCCCHHCHH
Q ss_conf 993999999998---------------579998641189889999999-----998899999875359958889920299
Q 002616 715 FITGIPPFTAES---------------PEIIFDNILNRKIPWPCVPSD-----MSFEAQDLINRFLIHDPNQRLGANGAA 774 (900)
Q Consensus 715 LLtGk~PF~~~s---------------~~ei~~kIl~~~l~~P~ip~~-----iS~elkDLIkklL~~DP~kRps~~~a~ 774 (900)
|++|.+||.... .......+.....+ |.++.. ....+.+|+.+||..||.+||++.++.
T Consensus 211 l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~ 289 (303)
T d1vjya_ 211 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289 (303)
T ss_dssp HHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-CCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHH
T ss_pred HHHCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCC-CCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 96289988766311241012255643099999987502468-88776557768999999999997606985895999999
Q ss_pred H
Q ss_conf 9
Q 002616 775 E 775 (900)
Q Consensus 775 E 775 (900)
+
T Consensus 290 ~ 290 (303)
T d1vjya_ 290 K 290 (303)
T ss_dssp H
T ss_pred H
T ss_conf 9
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=342.11 Aligned_cols=258 Identities=24% Similarity=0.395 Sum_probs=199.8
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-----------CCCEEEEEE
Q ss_conf 899079977602796599999997899689999953232135357999999999999459-----------995578922
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----------NPFVVRFFY 562 (900)
Q Consensus 494 ~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~-----------HPnIVkL~~ 562 (900)
-++|+++++||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+++.+. |+||+++++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC----CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEE
T ss_conf 785799899750778189999999999799999983431----3368999999999984014555554227676478998
Q ss_pred EECCC--CEEEEEEEECCCCCHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHH-CCEEECCCCCCCEEECCCC----
Q ss_conf 31147--70499996517988577888---50789989999999999999986430-5717403799838855799----
Q 002616 563 SFTCR--DNLYLVMEYLNGGDLYSLLR---KVGCLEEDVARIYIAELVLALEYLHS-LGIVHRDLKPDNLLIAHDG---- 632 (900)
Q Consensus 563 ~f~~~--~~LyLVmEyl~GGSL~dlL~---k~g~Lse~~ar~ii~QIl~AL~yLHs-~GIIHRDIKPeNILLD~~G---- 632 (900)
++... ...+++|+++..+....... ....+++..++.++.|++.||.|||+ .||+||||||+|||++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred EEEECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCCCC
T ss_conf 76312565202343200035420000012234678689999999999999888764058646567705705630576564
Q ss_pred --CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCEEECHHH
Q ss_conf --199970577523333565569999888989999999742235667766655799988734431799984210300258
Q 002616 633 --HIKLTDFGLSKIGLINNTIDLSGPETDGIMPSDAHYPEYQQTDNRNRHSAVGTPDYLAPEILLGTEHGYAADWWSVGI 710 (900)
Q Consensus 633 --~VKLsDFGLAk~~~~~~s~dls~~~~~~~~~~~~~~~~~~~~~~~~~~s~vGTp~YmAPEvL~g~~ys~ksDIWSLGV 710 (900)
.+|++|||.++.. .......+||+.|+|||++.+..|+.++|+||+||
T Consensus 168 ~~~~kl~dfg~s~~~------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 217 (362)
T d1q8ya_ 168 LIQIKIADLGNACWY------------------------------DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTAC 217 (362)
T ss_dssp EEEEEECCCTTCEET------------------------------TBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHH
T ss_pred CCEEEEEECCCCCCC------------------------------CCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHH
T ss_conf 430567531442123------------------------------44542236652105713214667776432012378
Q ss_pred HHHHHHHCCCCCCCCCHHH------HHHH---HHC-----------------CCC----CC---------------CCCC
Q ss_conf 9999993999999998579------9986---411-----------------898----89---------------9999
Q 002616 711 ILFEFITGIPPFTAESPEI------IFDN---ILN-----------------RKI----PW---------------PCVP 745 (900)
Q Consensus 711 ILyELLtGk~PF~~~s~~e------i~~k---Il~-----------------~~l----~~---------------P~ip 745 (900)
++++|++|++||....... .... ++. ... .. ...+
T Consensus 218 il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (362)
T d1q8ya_ 218 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFS 297 (362)
T ss_dssp HHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCC
T ss_pred HHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCC
T ss_conf 99999878899898755432102689999999837998788624532200013201220243235776444210001567
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCCCHHCHHHHHCCCCCCCCCCC
Q ss_conf 9999889999987535995888992029999819998899930
Q 002616 746 SDMSFEAQDLINRFLIHDPNQRLGANGAAEVKAHPFFKGVNWD 788 (900)
Q Consensus 746 ~~iS~elkDLIkklL~~DP~kRps~~~a~EIL~HPFFk~idw~ 788 (900)
...+++++|||.+||.+||.+||| +.++|+||||+++.+.
T Consensus 298 ~~~~~~~~dll~~mL~~dP~~Rpt---a~e~L~Hp~f~~~~~~ 337 (362)
T d1q8ya_ 298 KDEAKEISDFLSPMLQLDPRKRAD---AGGLVNHPWLKDTLGM 337 (362)
T ss_dssp HHHHHHHHHHHGGGGCSSTTTCBC---HHHHHTCGGGTTCTTC
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCC---HHHHHCCCCCCCCCCC
T ss_conf 435899999999987799457908---9999669340789874
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=3e-25 Score=177.85 Aligned_cols=135 Identities=20% Similarity=0.164 Sum_probs=106.7
Q ss_pred EEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCC---------------CHHHHHHHHHHHHHHHHCCCCCEEEEE
Q ss_conf 07997760279659999999789968999995323213---------------535799999999999945999557892
Q 002616 497 FEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMI---------------RKNDIERILAERNILITVRNPFVVRFF 561 (900)
Q Consensus 497 feilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~---------------~~~~~e~il~Ei~IL~~l~HPnIVkL~ 561 (900)
+.+.++||+|+||+||+|++. +|+.||+|+++..... .......+.+|...+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred CHHCCEEEECCCEEEEEEECC-CCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEE
T ss_conf 022778024856599999979-9999999998604434666556563000888999999778999999981699914499
Q ss_pred EEECCCCEEEEEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf 23114770499996517988577888507899899999999999999864305717403799838855799199970577
Q 002616 562 YSFTCRDNLYLVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLHSLGIVHRDLKPDNLLIAHDGHIKLTDFGL 641 (900)
Q Consensus 562 ~~f~~~~~LyLVmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLHs~GIIHRDIKPeNILLD~~G~VKLsDFGL 641 (900)
+... .+++|||++++.+.. ++...+..++.|++.||.|||+.||+||||||+|||++++ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EECC----CEEEEEEECCCCCCC-------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEECC-CEEEEECCC
T ss_conf 8628----889999504565420-------0157899999999999999826888983689036114289-899987788
Q ss_pred CCC
Q ss_conf 523
Q 002616 642 SKI 644 (900)
Q Consensus 642 Ak~ 644 (900)
|+.
T Consensus 149 a~~ 151 (191)
T d1zara2 149 SVE 151 (191)
T ss_dssp CEE
T ss_pred CCC
T ss_conf 430
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.61 E-value=2.4e-07 Score=62.48 Aligned_cols=142 Identities=13% Similarity=0.112 Sum_probs=88.6
Q ss_pred CCCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEECCCCEEE
Q ss_conf 5899079977602796599999997899689999953232135357999999999999459-995578922311477049
Q 002616 493 SIDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTCRDNLY 571 (900)
Q Consensus 493 ~~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~-HPnIVkL~~~f~~~~~Ly 571 (900)
-+..|+..+..+.++.+.||++.. .+..+.+|+...... .....+.+|...+..+. +--+.++++.....+..|
T Consensus 12 ~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 12 LIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHCEEEEECCCCCCCCCEEEEEE--CCCEEEEEECCCCCC---CCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEE
T ss_conf 513527997678998771899990--898699998488765---325569999999998760699872899975089649
Q ss_pred EEEEECCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHH---------------------------------------
Q ss_conf 99965179885778885078998999999999999998643---------------------------------------
Q 002616 572 LVMEYLNGGDLYSLLRKVGCLEEDVARIYIAELVLALEYLH--------------------------------------- 612 (900)
Q Consensus 572 LVmEyl~GGSL~dlL~k~g~Lse~~ar~ii~QIl~AL~yLH--------------------------------------- 612 (900)
+||++++|..+........ . ...++.++...+..||
T Consensus 87 lv~~~l~G~~~~~~~~~~~--~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ--S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS--C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEEEECCCCCCCCCCCCCC--C---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 9998604334354334402--6---9999998999999985568421435764465655577899877655554303323
Q ss_pred --------------------HCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf --------------------05717403799838855799199970577523
Q 002616 613 --------------------SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 613 --------------------s~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~ 644 (900)
...++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 2005799999999844986781789860047642364996599960231441
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.44 E-value=1.4e-06 Score=57.50 Aligned_cols=142 Identities=20% Similarity=0.208 Sum_probs=80.6
Q ss_pred EEEECCCCCEEEEEEEECCCCCEEEEEEEECC-CCC---CHHHHHHHHHHHHHHHHCC--C-CCEEEEEEEECCCCEEEE
Q ss_conf 97760279659999999789968999995323-213---5357999999999999459--9-955789223114770499
Q 002616 500 IKPISRGAFGRVFLARKRTTGDLFAIKVLKKL-DMI---RKNDIERILAERNILITVR--N-PFVVRFFYSFTCRDNLYL 572 (900)
Q Consensus 500 lk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~-~~~---~~~~~e~il~Ei~IL~~l~--H-PnIVkL~~~f~~~~~LyL 572 (900)
.+.||.|....||++.....++.+++|.-... +.. ......+...|...|..+. . ..+.++++. ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEEECCCCCHHH-HHHHCCCCCHHHHHHHHH-------------------------------------------------
Q ss_conf 996517988577-888507899899999999-------------------------------------------------
Q 002616 573 VMEYLNGGDLYS-LLRKVGCLEEDVARIYIA------------------------------------------------- 602 (900)
Q Consensus 573 VmEyl~GGSL~d-lL~k~g~Lse~~ar~ii~------------------------------------------------- 602 (900)
|||++++..+.. .+...... ...+..+..
T Consensus 109 vmE~L~~~~~~~~~l~~~~~~-~~~a~~lg~~La~~h~~~~~~~~~~~~~~~~~~~~~n~~l~~~~e~~~~~~py~~~~~ 187 (392)
T d2pula1 109 VMEDLSHLKIARKGLIEGENY-PHLSQHIGEFLGKTLFYSSDYALEPKVKKQLVKQFTNPELCDITERLVFTDPFFDHDT 187 (392)
T ss_dssp EECCCTTSEEHHHHHHHTCCC-TTHHHHHHHHHHHHHHHTSTTTSCHHHHHHHHHHTCCHHHHHHHHHHTTTGGGTTCTT
T ss_pred EEECCCCCCCCHHHHCCCCHH-HHHHHHHHHHHHHHHHHHCCCCCCCHHHCCCCCCCCCHHHHHHHHHHHCCHHHHHHHH
T ss_conf 871357765302220154212-8999999999999998735033442111012334465788877776401047889887
Q ss_pred ------------------HHHHHHHHHH------HCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf ------------------9999998643------057174037998388557991999705775233
Q 002616 603 ------------------ELVLALEYLH------SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKIG 645 (900)
Q Consensus 603 ------------------QIl~AL~yLH------s~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~~ 645 (900)
.+...+..+. ...++|+|+.|.|||++.++ ++|+||.+|..+
T Consensus 188 ~~~~~~~~~~~~~l~~d~~l~~~~~~l~~~~~~~~~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G 253 (392)
T d2pula1 188 NDFEEELRPFVEKLWNNDSVKIEAAKLKKSFLTSAETLIHGDLHTGSIFASEHE-TKVIDPEFAFYG 253 (392)
T ss_dssp CCCCGGGHHHHHHHHTCHHHHHHHHHHHHHHHHBCCEEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred HHCCHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCCCEECCCCCCCCEEECCCC-EEEECHHHCCCC
T ss_conf 410654557787655207899999998743236886003357767846675993-089522652228
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.94 E-value=3.3e-05 Score=48.76 Aligned_cols=136 Identities=15% Similarity=0.116 Sum_probs=78.3
Q ss_pred EECCCC-CEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC--CCCEEEEEEEECCCCEEEEEEEECC
Q ss_conf 760279-6599999997899689999953232135357999999999999459--9955789223114770499996517
Q 002616 502 PISRGA-FGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR--NPFVVRFFYSFTCRDNLYLVMEYLN 578 (900)
Q Consensus 502 ~IGkGs-FG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~--HPnIVkL~~~f~~~~~LyLVmEyl~ 578 (900)
.+..|. .+.||++... .+..+.+|...... ...+..|...++.+. .-.+.+++....+.+..|+||++++
T Consensus 17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECT-TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred ECCCCCCCCEEEEEEEC-CCCEEEEEECCCCC------HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEE
T ss_conf 76786547758999938-98789999589667------768999999999998659998861322245661599987441
Q ss_pred CCCHHH--------------HHHHCC-------CCC--HHHHH-----HHH---------------HHHHHHHHHHH---
Q ss_conf 988577--------------888507-------899--89999-----999---------------99999998643---
Q 002616 579 GGDLYS--------------LLRKVG-------CLE--EDVAR-----IYI---------------AELVLALEYLH--- 612 (900)
Q Consensus 579 GGSL~d--------------lL~k~g-------~Ls--e~~ar-----~ii---------------~QIl~AL~yLH--- 612 (900)
|-++.. .+.+.. .+. ..... .+. ......+..+.
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHC
T ss_conf 35543221268999999999999873688544887554124688999999875411011340112137999999998718
Q ss_pred ----HCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf ----05717403799838855799199970577523
Q 002616 613 ----SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 613 ----s~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~ 644 (900)
...++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 765795678678887635773796589998533265
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.57 E-value=0.00086 Score=39.60 Aligned_cols=78 Identities=18% Similarity=0.267 Sum_probs=50.4
Q ss_pred CCEEEEEEECCCCCEEEEEEEECC-------CCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-CCCEEEEEEEECC
Q ss_conf 990799776027965999999978-------99689999953232135357999999999999459-9955789223114
Q 002616 495 DDFEIIKPISRGAFGRVFLARKRT-------TGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-NPFVVRFFYSFTC 566 (900)
Q Consensus 495 ~dfeilk~IGkGsFG~Vyla~~k~-------tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~-HPnIVkL~~~f~~ 566 (900)
+++++ +.|+.|-.-.+|++.... .++.|.+++.-... . .....+|..+++.+. +....++++.+..
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----T-ESHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----C-HHHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred CCEEE-EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCCC----H-HHHHHHHHHHHHHHHHCCCCCEEEEECCC
T ss_conf 01699-991785334348999688775445789817999659961----1-65899999999999757999808998189
Q ss_pred CCEEEEEEEECCCCCH
Q ss_conf 7704999965179885
Q 002616 567 RDNLYLVMEYLNGGDL 582 (900)
Q Consensus 567 ~~~LyLVmEyl~GGSL 582 (900)
.+|+||++|..|
T Consensus 117 ----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPL 128 (395)
T ss_dssp ----EEEECCCCEEEC
T ss_pred ----CEEEEEECCCCC
T ss_conf ----569997345548
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.26 E-value=0.005 Score=34.70 Aligned_cols=144 Identities=19% Similarity=0.160 Sum_probs=76.2
Q ss_pred CCCEEEEEEECCCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC-----CCCEEEEE---EEEC
Q ss_conf 899079977602796599999997899689999953232135357999999999999459-----99557892---2311
Q 002616 494 IDDFEIIKPISRGAFGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR-----NPFVVRFF---YSFT 565 (900)
Q Consensus 494 ~~dfeilk~IGkGsFG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~-----HPnIVkL~---~~f~ 565 (900)
++.+.-.+.|..|---+.|++... +..|++|+..+.. ...... .|..++..+. .|..+... ....
T Consensus 17 lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~--~~~~l~---~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~ 89 (316)
T d2ppqa1 17 VGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--EKNDLP---FFLGLMQHLAAKGLSCPLPLPRKDGELLGE 89 (316)
T ss_dssp CCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC-----CCHHH---HHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred CCCCEEEECCCCCCCCCEEEEEEC--CCCEEEEECCCCC--CHHHHH---HHHHHHHHHHHCCCCCCCCCEECCCCCCEE
T ss_conf 998568523788852673899978--9728999807899--988999---999998754302555455641048976213
Q ss_pred CCCEEEEEEEECCCCCHHH--------------HHHHC---------------------------CCCCHHHHHHHHHHH
Q ss_conf 4770499996517988577--------------88850---------------------------789989999999999
Q 002616 566 CRDNLYLVMEYLNGGDLYS--------------LLRKV---------------------------GCLEEDVARIYIAEL 604 (900)
Q Consensus 566 ~~~~LyLVmEyl~GGSL~d--------------lL~k~---------------------------g~Lse~~ar~ii~QI 604 (900)
.......++.+..|..... .++.. ...........+..+
T Consensus 90 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 169 (316)
T d2ppqa1 90 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 169 (316)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred EECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHH
T ss_conf 41255024531146553332046788888998764544432024531011101200245677776531141279999999
Q ss_pred HHHHHHHH----HCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 99998643----05717403799838855799199970577523
Q 002616 605 VLALEYLH----SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 605 l~AL~yLH----s~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~ 644 (900)
...+...+ ..|+||+|+.++||+++.+...-+.||+.|..
T Consensus 170 ~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 170 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 87642048554545033378636564020454126742221236
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.09 E-value=0.0061 Score=34.14 Aligned_cols=130 Identities=16% Similarity=0.248 Sum_probs=70.1
Q ss_pred CEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCC---CCC--EEEEE--EEECCCCEEEEEEEECCCC
Q ss_conf 6599999997899689999953232135357999999999999459---995--57892--2311477049999651798
Q 002616 508 FGRVFLARKRTTGDLFAIKVLKKLDMIRKNDIERILAERNILITVR---NPF--VVRFF--YSFTCRDNLYLVMEYLNGG 580 (900)
Q Consensus 508 FG~Vyla~~k~tg~~VAIKvLkK~~~~~~~~~e~il~Ei~IL~~l~---HPn--IVkL~--~~f~~~~~LyLVmEyl~GG 580 (900)
--.||++... +|..|++|+.+.... ..+.+..|...+..+. -|- .+..- ..+......+.++++++|.
T Consensus 35 EN~vy~v~~~-dg~~~VlK~~rp~~~----s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDE-DRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCT-TCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred CCEEEEEECC-CCCEEEEEEECCCCC----CHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCC
T ss_conf 2026999838-999799998478778----89999999999999985599878752068980566534799998652776
Q ss_pred CHH--------------HHHHHC----------------------------CCCCHHHHHHH---HHHHHHHHHHHH---
Q ss_conf 857--------------788850----------------------------78998999999---999999998643---
Q 002616 581 DLY--------------SLLRKV----------------------------GCLEEDVARIY---IAELVLALEYLH--- 612 (900)
Q Consensus 581 SL~--------------dlL~k~----------------------------g~Lse~~ar~i---i~QIl~AL~yLH--- 612 (900)
.+. ..++.. ..++......+ +..+...+.-.-
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCC
T ss_conf 88999999999989999998863035786556778978876656899987476998898999999999999999845456
Q ss_pred -HCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -05717403799838855799199970577523
Q 002616 613 -SLGIVHRDLKPDNLLIAHDGHIKLTDFGLSKI 644 (900)
Q Consensus 613 -s~GIIHRDIKPeNILLD~~G~VKLsDFGLAk~ 644 (900)
..++||+|+.+.|||++. + ..++||+.|..
T Consensus 190 ~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp SCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred CCCEEECCCCCCCCEEEEC-C-CEEEECHHCCC
T ss_conf 8712024788804287838-9-35886520146
|